Mammalian Phenotype Ontology Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

9191 genotypes with 23522 annotations displayed of selected term and subterms
Searched Term: abnormal immune system physiology
Allelic Composition (Genetic Background)	Annotated Term	Reference
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (C.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan})	abnormal T cell activation	J:93488
	decreased cytotoxic T cell cytolysis	J:93488
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	abnormal NK cell physiology	J:96123
	abnormal NK T cell physiology	J:96123
	decreased circulating interferon-gamma level	J:96123
	decreased circulating interleukin-12 level	J:96123
	decreased interferon-gamma secretion	J:96123
	decreased interleukin-4 secretion	J:96123
	decreased interleukin-12b secretion	J:125611
	impaired natural killer cell mediated cytotoxicity	J:125611
	sepsis	J:113232
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (C.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	abnormal NK cell physiology	J:96123
	decreased circulating interferon-gamma level	J:96123
	decreased circulating interleukin-12 level	J:96123
	decreased interferon-gamma secretion	J:96123
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: C57BL/6 * FVB/N)	decreased interferon-gamma secretion	J:137452
	increased susceptibility to Orthomyxoviridae infection	J:137452
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (NOD.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/Jdk)	abnormal professional antigen presenting cell physiology	J:137009
	decreased susceptibility to autoimmune diabetes	J:137009
	increased interferon-gamma secretion	J:137009
	increased tumor necrosis factor secretion	J:137009
	insulitis	J:137009
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: FVB/N)	abnormal response to infection	J:189122
	decreased interleukin-17 secretion	J:193548
	decreased susceptibility to bacterial infection	J:210086
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan})	abnormal circulating cytokine level	J:194800
	abnormal susceptibility to infection	J:194800
	impaired neutrophil recruitment	J:194800
	increased susceptibility to bacterial infection	J:194800
1700067K01Rik^{tm2a(KOMP)Wtsi}/1700067K01Rik^{tm2a(KOMP)Wtsi} (C57BL/6N-1700067K01Rik^{tm2a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
4933434E20Rik^{tm1a(EUCOMM)Wtsi}/4933434E20Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-4933434E20Rik^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
9030622O22Rik^em1Eem/9030622O22Rik⁺ Foxa2^tm1.1Khk/Foxa2⁺ (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	respiratory system inflammation	J:284174
9030622O22Rik^em1Eem/9030622O22Rik^em1Eem (involves: C57BL/6 * CD-1)	lung inflammation	J:284174
A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ Tg(Myh6-2A)#Know/0 (involves: BALB/c C57BL/6 * FVB/N)	heart inflammation	J:128060
A4gnt^tm1Jnaka/A4gnt^tm1Jnaka (B6.129S6-A4gnt^tm1Jnaka)	stomach inflammation	J:184485
A930024E05Rik^em2Zfa/A930024E05Rik^em2Zfa Satb1^em1Zfa/Satb1^em1Zfa Tg(Rorc-cre)1Litt/0 (involves: C57BL/6 * FVB)	increased susceptibility to bacterial infection	J:259392
	increased susceptibility to bacterial infection induced morbidity/mortality	J:259392
A930024E05Rik^em2Zfa/A930024E05Rik^em2Zfa Tg(Rorc-cre)1Litt/0 (involves: C57BL/6 * FVB)	abnormal interleukin secretion	J:259392
	increased susceptibility to bacterial infection	J:259392
	increased susceptibility to bacterial infection induced morbidity/mortality	J:259392
A^y/a Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)	abnormal inflammatory response	J:177084
AA467197^em1Nyam/AA467197^em1Nyam (C57BL/6J-AA467197^em1Nyam)	increased IgG level	J:347271
	kidney inflammation	J:347271
	liver inflammation	J:347271
	lung inflammation	J:347271
AA467197^em1Nyam/AA467197^em1Nyam (C.B6-AA467197^em1Nyam)	increased susceptibility to autoimmune disorder	J:347271
Aabpr^NZB/Slc/? (involves: NZB/Slc * NZW/Slc)	increased B cell proliferation	J:87690
Abca1^tm1Jdm/Abca1^tm1Jdm (DBA/1LacJ-Abca1^tm1Jdm)	impaired macrophage phagocytosis	J:63265
Abca1^tm1Jdm/Abca1^tm1Jdm (involves: C57BL/6 * DBA/1LacJ)	impaired macrophage phagocytosis	J:132254
Abca1^tm1Jdm/Abca1^tm1Jdm Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6 * DBA/1LacJ)	abnormal chemokine secretion	J:130777
	abnormal cytokine secretion	J:130777
Abca1^tm1Jdm/Abca1^tm1Jdm Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	impaired macrophage phagocytosis	J:132254
Abca1^tm1Jp/Abca1^tm1Jp Abcg1^tm1Tall/Abcg1^tm1Tall Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	increased interleukin-17 secretion	J:190966
	increased interleukin-23 secretion	J:190966
Abca1^tm1Jp/Abca1^tm1Jp Abcg1^tm1Tall/Abcg1^tm1Tall Tg(Itgax-cre,-EGFP)4097Ach/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)	increased interleukin-17 secretion	J:190966
	increased interleukin-23 secretion	J:190966
Abca1^tm1Wpfl/Abca1^tm1Wpfl (involves: 129P2/OlaHsd * C57BL/6J)	glomerulonephritis	J:64390
	uterus inflammation	J:64390
Abcb1a^tm1Bor/Abcb1a^tm1Bor (FVB.129P2-Abcb1a^tm1Bor/TacImx)	abnormal lymphocyte physiology	J:51190
	colitis	J:51190
	increased IgA level	J:51190
	increased IgE level	J:51190
	increased IgG1 level	J:51190
	increased IgG2 level	J:51190
	increased IgG2a level	J:51190
	increased IgG2b level	J:51190
	increased IgG3 level	J:51190
	increased IgM level	J:51190
	increased immunoglobulin level	J:51190
	large intestinal inflammation	J:51190
Abcb1a^tm1Bor/Abcb1a^tm1Bor Abcb1b^tm1Bor/Abcb1b^tm1Bor (FVBTac.129P2-Abcb1b^tm1Bor Abcb1a^tm1Bor)	abnormal T cell physiology	J:102640
	increased interferon-gamma secretion	J:102640
	increased interleukin-2 secretion	J:102640
Abcb4^tm1Bor/Abcb4^tm1Bor (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB/N))	bile duct inflammation	J:15531, J:21232
	liver inflammation	J:15531
Abcb4^tm1Bor/Abcb4^tm1Bor (involves: 129P2/OlaHsd * FVB/N)	bile duct inflammation	J:175015
Abcb4^tm1Bor/Abcb4^tm1Bor (involves: 129P2/OlaHsd * FVB/N)	liver inflammation	J:175015
Abcb4^tm1Bor/Abcb4^tm1Bor (FVB.129P2-Abcb4^tm1Bor/J)	bile duct inflammation	J:105357
Abcb4^tm1Bor/Abcb4^tm1Bor (involves: 129P2/OlaHsd * BALB/c)	bile duct inflammation	J:168123
Abcc1^tm1Bor/Abcc1^tm1Bor (involves: 129P2/OlaHsd * FVB)	abnormal mast cell physiology	J:44110
Abcc1^tm1Bor/Abcc1^tm1Bor (involves: 129P2/OlaHsd * FVB)	decreased inflammatory response	J:44110
Abcc4^tm1Kruh/Abcc4^tm1Kruh (B6.129-Abcc4^tm1Kruh)	increased susceptibility to induced colitis	J:117326
	intestinal inflammation	J:117326
	small intestinal inflammation	J:117326
Abcd1^tm1Kds/Y Abcd2^tm1Apuj/Abcd2^tm1Apuj (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)	increased inflammatory response	J:94583
Abcg1^tm1Dgen/Abcg1^tm1Dgen (B6.129P2-Abcg1^tm1Dgen)	abnormal macrophage physiology	J:117028
Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine secretion	J:130777
	abnormal cytokine secretion	J:130777
	lung inflammation	J:132952
Abcg2^tm1.1Ssf/Abcg2^tm1.1Ssf (involves: 129 * C57BL/6 * FVB)	liver inflammation	J:201884
Abhd5^tm1.1Lqyu/Abhd5^tm1.1Lqyu Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * DBA)	liver inflammation	J:199570
Abhd16a^{tm1a(EUCOMM)Wtsi}/Abhd16a^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal macrophage physiology	J:232688
	decreased interleukin-1 beta secretion	J:232688
	decreased interleukin-6 secretion	J:232688
	decreased macrophage cytokine production	J:232688
	decreased tumor necrosis factor secretion	J:232688
Abi1^tm1Pen/Abi1⁺ Abi2^tm1Pen/Abi2^tm1Pen (Not Specified)	decreased interleukin-2 secretion	J:104623
Abi1^tm1Pen/Abi1⁺ Abi2^tm1Pen/Abi2^tm1Pen (Not Specified)	decreased T cell proliferation	J:104623
Abl1^m1/Abl1^m1 (either: 129S/SvEv-Abl1^m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))	increased susceptibility to infection	J:14644
Abl1^m1/Abl1^m1 (involves: 129S/SvEv)	abnormal splenocyte physiology	J:34903
Abl1^m1/Abl1^m1 (involves: 129S/SvEv * C57BL/6)	abnormal B cell physiology	J:148105
Abl1^tm1Mlg/Abl1^tm1Mlg (involves: 129S/SvEv * C57BL/6J)	lung inflammation	J:72875
Abl1^tm1Mlg/Abl1^tm1Mlg (involves: 129S/SvEv * C57BL/6J * CBA)	increased susceptibility to infection	J:34643
Abl1^tm1Mlg/Abl1^tm1Mlg Tg(ACTB-Abl1K290R)1Spg/0 (involves: 129S/SvEv C57BL/6J * CBA)	increased susceptibility to infection	J:34643
Abmm^DBA/2J/? (involves: BALB/cByJ * DBA/2J)	myocarditis	J:52296
Acaca^tm1Dejs/Acaca^tm1Dejs Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	abnormal T cell physiology	J:209886
Acaca^tm1Dejs/Acaca^tm1Dejs Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6 * DBA/2)	increased T cell proliferation	J:209886
Acan^tm2Afos/Acan^tm2Afos (involves: C57BL/6)	decreased susceptibility to induced arthritis	J:122102
Acbd5^{tm1a(EUCOMM)Wtsi}/Acbd5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Acbd5^{tm1a(EUCOMM)Wtsi}/WtsiCnbc)	brain inflammation	J:299448
Ace2^{em1(ACE2)Yowa}/Ace2^{em1(ACE2)Yowa} (C57BL/6-Ace2^{em1(ACE2)Yowa})	abnormal circulating cytokine level	J:288243
	increased circulating interferon-gamma level	J:288243
	increased circulating interleukin-9 level	J:288243
	increased susceptibility to Coronaviridae infection	J:288243
	interstitial pneumonia	J:288243
Ace2^em1Cya/Y (C57BL/6J-Ace2^em1Cya/Cya)	increased susceptibility to induced colitis	J:299383
Ace2^em1Cya/Y (C57BL/6J-Ace2^em1Cya/Cya)	intestinal inflammation	J:299383
Ace2^em2(ACE2)Gpt/Y (C57BL/6JGpt-Ace2^em2(ACE2)Gpt/Gpt)	increased susceptibility to Coronaviridae infection	J:302150
Ace2^em2(ACE2)Gpt/Y (C57BL/6JGpt-Ace2^em2(ACE2)Gpt/Gpt)	lung inflammation	J:302150
Ace2^em#Yngh/Y (involves: Kunming)	increased susceptibility to induced colitis	J:221616
Ace2^{tm1a(KOMP)Wtsi}/Y Tg(FOXJ1-cre)F26Htzm/0 (involves: C57BL/6N * C57BL/6NTac)	increased susceptibility to bacterial infection	J:282139
	increased susceptibility to bacterial infection induced morbidity/mortality	J:282139
	lung inflammation	J:282139
Ace2^{tm1a(KOMP)Wtsi}/Ace2^{tm1a(KOMP)Wtsi} Tg(FOXJ1-cre)F26Htzm/0 (involves: C57BL/6N * C57BL/6NTac)	increased susceptibility to bacterial infection	J:282139
	increased susceptibility to bacterial infection induced morbidity/mortality	J:282139
	lung inflammation	J:282139
Ace2^tm1Cof/Ace2^tm1Cof (involves: 129S6/SvEvTac * C57BL/6)	increased incidence of corneal inflammation	J:289503
Ace2^tm1Lex/Ace2^tm1Lex (B6;129S5-Ace2^tm1Lex/Mmucd)	lung inflammation	J:264991
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:124548
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd * C57BL/6)	heart inflammation	J:124548
Ace2^tm1Pngr/Y (B6.129P2-Ace2^tm1Pngr/J)	decreased susceptibility to Coronaviridae infection	J:286299
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd)	increased susceptibility to bacterial infection	J:282139
	increased susceptibility to bacterial infection induced morbidity/mortality	J:282139
	lung inflammation	J:282139, J:100334
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to Orthomyxoviridae infection	J:277074
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:277074
	lung inflammation	J:277074
Ace2^tm1Pngr/Ace2^tm1Pngr (involves: 129P2/OlaHsd)	increased susceptibility to bacterial infection	J:282139
	increased susceptibility to bacterial infection induced morbidity/mortality	J:282139
	lung inflammation	J:282139, J:100334
Ace2^tm1Pngr/Ace2^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to Orthomyxoviridae infection	J:277074
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:277074
	lung inflammation	J:277074
Ace2^tm1Pngr/Ace2^tm1Pngr (B6.129P2-Ace2^tm1Pngr/J)	decreased susceptibility to Coronaviridae infection	J:286299
Ace^tm1Keb/Ace^tm1Keb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	kidney inflammation	J:33018
Ace^tm1Mcf/Ace^tm1Mcf (Not Specified)	kidney inflammation	J:32114
Ace^tm1Mcf/Ace^tm1Mcf (Not Specified)	tubulointerstitial nephritis	J:32114
Ace^tm1Unc/Ace^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	kidney inflammation	J:25284
Ace^tm6Keb/Ace^tm6Keb (involves: 129 * C57BL/6)	abnormal interleukin level	J:122178
Ace^tm9Keb/Ace^tm9Keb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	kidney inflammation	J:185888
Acer1^{tm1a(EUCOMM)Wtsi}/Acer1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Acer1^{tm1a(EUCOMM)Wtsi})	skin inflammation	J:235775
Ackr1^tm1Scp/Ackr1^tm1Scp (involves: 129P2/OlaHsd * C57BL/6)	increased inflammatory response	J:64222
Ackr1^tm1Scp/Ackr1^tm1Scp (involves: 129P2/OlaHsd)	abnormal circulating chemokine level	J:162629
Ackr1^tm1Skmz/Ackr1^tm1Skmz (involves: 129P2/OlaHsd * C57BL/6J)	abnormal chemokine level	J:82938
Ackr2^tm1Gjg/Ackr2^tm1Gjg (involves: 129/Sv * C57BL/6)	dermatitis	J:97607
Ackr2^tm1Gjg/Ackr2^tm1Gjg (involves: 129/Sv * C57BL/6)	increased inflammatory response	J:97806
Ackr3^tm1Jgo/Ackr3⁺ (involves: 129S/SvEvBrd * C57BL/6)	lung inflammation	J:136246
Ackr3^tm1Jgo/Ackr3^tm1Jgo (involves: 129S/SvEvBrd * C57BL/6)	lung inflammation	J:136246
Ackr4^tm1.1Rjbn/Ackr4^tm1.1Rjbn (B6.129S6-Ackr4^tm1.1Rjbn)	abnormal CD4-positive, alpha-beta T cell physiology	J:166490
	abnormal chemokine level	J:166490
	abnormal circulating chemokine level	J:166490
	decreased T cell proliferation	J:166490
	increased interleukin-23 secretion	J:166490
	increased susceptibility to experimental autoimmune encephalomyelitis	J:166490
Acla1^BXSB/Slc/Acla1^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Acla1^NZW/Slc/Acla1^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Acla2^BXSB/Slc/Acla2^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Acla2^NZW/Slc/Acla2^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Acod1^{tm1a(KOMP)Wtsi}/Acod1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal macrophage physiology	J:235002
Acot11^tm1Deco/Acot11^tm1Deco (involves: 129S6/SvEvTac * C57BL/6)	decreased inflammatory response	J:182660
Acox1^lampe1/Acox1^lampe1 (involves: C57BL/6J)	liver inflammation	J:174942
Acox2^em1Jynz/Acox2^em1Jynz (involves: C57BL/6N)	liver inflammation	J:323193
Acp1^tm1Lex/Acp1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased interleukin-6 secretion	J:171883
Acp5^tm1Ahdm/Acp5^tm1Ahdm (involves: 129S/SvEv)	abnormal osteoclast physiology	J:36232
Acsl3^{Gt(OST148301)Lex}/Acsl3^{Gt(OST148301)Lex} (B6;129S5-Acsl3^{Gt(OST148301)Lex}/Orl)	abnormal humoral immune response	J:82809
Acsl6^tm1.1Jeme/Acsl6^tm1.1Jeme (involves: BALB/cJ * C57BL/6)	abnormal microglial cell activation	J:267563
Acsns1^A/J/Acsns1^A/J (involves: A/J * SM/J)	decreased susceptibility to parasitic infection	J:75549
Acsns2^SM/J/Acsns2^SM/J (involves: A/J * SM/J)	increased susceptibility to parasitic infection	J:75549
Acsns2^SM/J/Acsns2^SM/J Acsns3^SM/J/Acsns3^SM/J (involves: A/J * SM/J)	increased susceptibility to parasitic infection	J:75549
Acsns3^SM/J/Acsns3^SM/J (involves: A/J * SM/J)	increased susceptibility to parasitic infection	J:75549
Acss2^em22Gpt/Acss2^em22Gpt (C57BL/6JGpt-Acss2^em22Gpt/Gpt)	decreased interleukin-1 beta secretion	J:346990
Acss2^em22Gpt/Acss2^em22Gpt (C57BL/6JGpt-Acss2^em22Gpt/Gpt)	decreased susceptibility to endotoxin shock	J:346990
Actb^{tm4(cre/ERT2)Npa}/Actb⁺ Sgpl1^tm1.1Npa/Sgpl1^tm1.1Npa (involves: BALB/cJ * C57BL/6)	abnormal type IV hypersensitivity reaction	J:199525
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:199525
Actn4^{tm1a(EUCOMM)Wtsi}/Actn4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Actn4^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Actn4^tm1Mrpk/Actn4^tm1Mrpk (involves: 129 * C57BL/6)	abnormal lymphocyte chemotaxis	J:83911
Acvr1^tm1Emsh/Acvr1⁺ (chimera involves: BALB/c * C57BL/6 * CD-1)	increased inflammatory response	J:194134
Ada^tm1Mw/Ada^tm1Mw (involves: 129S7/SvEvBrd)	abnormal dendritic cell physiology	J:138722
Ada^tm1Mw/Ada^tm1Mw Tg(PLADA)4118Rkmb/0 (involves: 129S7/SvEvBrd * C57BL/6)	decreased immunoglobulin level	J:73418
	lung inflammation	J:73418
Adam7^tm1Tigm/Adam7^tm1Tigm (involves: C57BL/6)	spermatic granuloma	J:226260
Adam8^tm1.1Mdz/Adam8^tm1.1Mdz (DBA/1LacJ-Adam8^tm1.1Mdz)	decreased susceptibility to induced arthritis	J:155243
Adam17^m1Btlr/Adam17^m1Btlr (C57BL/6J-Adam17^m1Btlr)	decreased circulating tumor necrosis factor level	J:166602
Adam17^m1Btlr/Adam17^m1Btlr (C57BL/6J-Adam17^m1Btlr)	increased susceptibility to induced colitis	J:166602
Adam17^tm1.1Srj/Adam17^tm1.1Srj (involves: 129S/SvEv * C57BL/6 * SJL)	abnormal chemokine level	J:163380
	abnormal interleukin secretion	J:163380
	increased interleukin-10 secretion	J:163380
	increased susceptibility to induced colitis	J:163380
	skin inflammation	J:163380
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Il17a^tm1Yiw/Il17a^tm1Yiw Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL)	dermatitis	J:229771
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Il23a^tm1Dnax/Il23a^tm1Dnax Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL)	dermatitis	J:229771
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	increased circulating interleukin-17 level	J:144795
	increased interleukin-17 secretion	J:144795
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (B6.129(SJL)-Sox9^tm3(cre)Crm Adam17^tm1.2Bbl)	abnormal circulating chemokine level	J:229771
	dermatitis	J:229771
	increased IgE level	J:229771
Adam17^tm1Bbl/Adam17^tm1Bbl Lyz2^tm1(cre)Ifo/0 (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:139846
	decreased circulating tumor necrosis factor level	J:139846
	decreased susceptibility to endotoxin shock	J:139846
Adam17^tm1Bbl/Adam17^tm1Bbl Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased circulating tumor necrosis factor level	J:139846
	decreased susceptibility to endotoxin shock	J:139846
Adam17^tm1Ckww/Adam17^tm1Ckww (Not Specified)	abnormal dendritic cell physiology	J:138782
Adam17^tm1Imx/Adam17^tm1Imx (involves: 129 * C57BL/6)	increased incidence of corneal inflammation	J:51053
Adam17^tm1Imx/Adam17^tm1Imx (B6.129-Adam17^tm1Imx)	enhanced leukocyte tethering or rolling	J:174865
Adam17^tm1Rain/Adam17^tm1Rain (involves: C57BL/6)	enhanced leukocyte tethering or rolling	J:174865
Adam17^woe/Adam17^woe (C57BL/6-Adam17^woe)	dermatitis	J:160781
Adam17^woe/Adam17^woe (C57BL/6-Adam17^woe)	increased incidence of corneal inflammation	J:160781
Adamdec1^tm1Dgen/Adamdec1⁺ (B6.129P2-Adamdec1^tm1Dgen)	increased susceptibility to induced colitis	J:301741
Adamdec1^tm1Dgen/Adamdec1^tm1Dgen (B6.129P2-Adamdec1^tm1Dgen)	decreased circulating interleukin-10 level	J:301741
	increased circulating interleukin-1 beta level	J:301741
	increased circulating interleukin-6 level	J:301741
	increased susceptibility to bacterial infection	J:301741
	increased susceptibility to bacterial infection induced morbidity/mortality	J:301741
	increased susceptibility to colitis induced morbidity/mortality	J:301741
	increased susceptibility to induced colitis	J:301741
	intestinal inflammation	J:301741
Adamts2^tm1Prc/Adamts2^tm1Prc (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	increased interferon-gamma secretion	J:271185
Adamts5^tm1.1Eam/Adamts5⁺ (involves: 129S5/SvEvBrd)	decreased susceptibility to induced arthritis	J:97590
Adamts5^tm1.1Eam/Adamts5^tm1.1Eam (involves: 129S5/SvEvBrd)	decreased susceptibility to induced arthritis	J:97590
Adamts5^tm1Lex/Adamts5^tm1Lex Tg(CMV-cre)1Cgn/0 (involves: 129S5/SvEvBrd * BALB/cJ)	osteoarthritis	J:105138
Adamts5^tm2.2Lex/Adamts5^tm2.2Lex (B6.129S5-Adamts5^tm2.2Lex)	decreased susceptibility to induced arthritis	J:175366
Adamts13^tm1Dgi/Adamts13^tm1Dgi (involves: 129X1/SvJ * C57BL/6J * CASA/Rk)	increased susceptibility to bacterial infection	J:101752
Adamts14^{Gt(511E11)Cmhd}/Adamts14^{Gt(511E11)Cmhd} (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	increased interferon-gamma secretion	J:271185
	increased interleukin-2 secretion	J:271185
Adamts14^{Gt(511E11)Cmhd}/Adamts14^{Gt(511E11)Cmhd} Adamts2^tm1Prc/Adamts2^tm1Prc (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell activation	J:271185
	dermatitis	J:271185
	increased interferon-gamma secretion	J:271185
	increased interleukin-2 secretion	J:271185
	increased T cell proliferation	J:271185
Adamts18^tm1.1Wzha/Adamts18^tm1.1Wzha (involves: 129 * C57BL/6)	increased acute inflammation	J:258487
	increased susceptibility to induced colitis	J:258487
Adar^em3Qwan/Adar^em3Qwan (Not Specified)	abnormal chemokine level	J:325221
	increased circulating interleukin-1 level	J:325221
	increased circulating interleukin-6 level	J:325221
	increased circulating interleukin-17 level	J:325221
	increased CXCL10 level	J:325221
Adar^tm1Olds/Adar^tm1Olds (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to Orthomyxoviridae infection	J:169014
Adar^tm1Olds/Adar^tm1Olds (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to Paramyxoviridae infection	J:169014
Adar^tm2Phs/Adar^tm2Phs (B6.Cg-Adar^tm2Phs)	abnormal circulating interferon-beta level	J:142338
Adar^tm2Phs/Adar^tm2Phs (B6.Cg-Adar^tm2Phs)	increased circulating interferon-alpha level	J:142338
Adaz1^NZM2328/J/Adaz1^NZM2328/J (involves: C57L/J * NZM2328/J)	increased anti-double stranded DNA antibody level	J:71397
Adcy7^tm1.1Pcst/Adcy7^tm1.1Pcst Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased tumor necrosis factor secretion	J:191067
	peritoneal inflammation	J:191067
Adcy9^{Gt(OST193739)Lex}/Adcy9^{Gt(OST193739)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased IgG1 level	J:103485
Adcy9^{tm1b(EUCOMM)Wtsi}/Adcy9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adcy9^{tm1b(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Adcyap1^tm1Clw/Adcyap1^tm1Clw (B6.129S4-Adcyap1^tm1Clw)	abnormal regulatory T cell physiology	J:194151
	abnormal T cell activation	J:194151
	increased microglial cell activation	J:194151
Adcyap1r1^tm1Bbt/Adcyap1r1^tm1Bbt (involves: 129 * C57BL/6J)	increased susceptibility to bacterial infection	J:73990
Adgrd1^{tm1b(EUCOMM)Wtsi}/Adgrd1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adgrd1^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Adgre1^m2Btlr/Adgre1^m2Btlr (C57BL/6J-Adgre1^m2Btlr)	abnormal macrophage physiology	J:195410
Adgre1^m3Btlr/Adgre1^m3Btlr (C57BL/6J-Adgre1^m3Btlr)	abnormal macrophage physiology	J:234244
Adgre1^tm1Stst/Adgre1^tm1Stst (B6.129S1-Emr1^tm1Stst)	abnormal immune tolerance	J:99213
Adgre1^tm1Stst/Adgre1^tm1Stst (B6.129S1-Emr1^tm1Stst)	abnormal regulatory T cell physiology	J:99213
Adgre5^tm1Kake/Adgre5^tm1Kake (B6.129S6-Adgre5^tm1Kake)	decreased susceptibility to bacterial infection	J:118705
Adgre5^tm1Kake/Adgre5^tm1Kake (B6.129S6-Adgre5^tm1Kake)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:118705
Adgrg3^tm1Zgwg/Adgrg3^tm1Zgwg (involves: 129 * C57BL/6)	abnormal IgG1 level	J:222670
	abnormal IgG2 level	J:222670
	abnormal IgG level	J:222670
	abnormal immune system physiology	J:222670
	abnormal immunoglobulin level	J:222670
	decreased IgA level	J:222670
	decreased IgG1 level	J:222670
	decreased IgG2b level	J:222670
	decreased IgG3 level	J:222670
	decreased IgM level	J:222670
	increased B cell apoptosis	J:222670
	increased IgG1 level	J:222670
	increased IgG2a level	J:222670
Adh5^tm1.1Llli/Adh5^tm1.1Llli Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Adh5^tm1.1Llli Speer6-ps1^{Tg(Alb-cre)21Mgn})	increased susceptibility to bacterial infection induced morbidity/mortality	J:173666
Adh5^tm1Stam/Adh5^tm1Stam (B6.129-Adh5^tm1Stam)	increased susceptibility to bacterial infection	J:88337
Adh5^tm1Stam/Adh5^tm1Stam (B6.129-Adh5^tm1Stam)	increased susceptibility to bacterial infection induced morbidity/mortality	J:88337
Adipoq^tm1Chan/Adipoq⁺ (B6.129-Adipoq^tm1Chan)	abnormal leukocyte physiology	J:122020
Adipoq^tm1Chan/Adipoq^tm1Chan (B6.129-Adipoq^tm1Chan)	abnormal leukocyte physiology	J:122020
Adm2^em1Zhan/Adm2^em1Zhan (Not Specified)	increased inflammatory response	J:266495
	increased susceptibility to infection	J:266495
	liver inflammation	J:266495
Adm^tm1Tfjt/Adm⁺ (involves: C57BL/6 * CBA)	blood vessel inflammation	J:102946
Adora2a^tm1Map/Adora2a^tm1Map (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased interleukin-10 secretion	J:147023
Adora2b^tm1.1Msit/Adora2b^tm1.1Msit (either: (involves: C57BL/6) or (involves: C57BL/6 * CD-1 * ICR))	abnormal macrophage physiology	J:169155
	increased interleukin-6 secretion	J:169155
	increased tumor necrosis factor secretion	J:169155
Adora2b^tm1Dgen/Adora2b^tm1Dgen (B6.129P2-Adora2b^tm1Dgen)	abnormal dendritic cell physiology	J:138722
Adora2b^tm1Dgen/Adora2b^tm1Dgen (B6.129P2-Adora2b^tm1Dgen)	decreased interleukin-10 secretion	J:147023
Adora2b^tm1Kra/Adora2b^tm1Kra (involves: 129 * C57BL/6J)	abnormal cytokine level	J:111715
	abnormal inflammatory response	J:111715
	abnormal interleukin level	J:111715
	abnormal leukocyte adhesion	J:111715
	abnormal leukocyte migration	J:111715
	abnormal tumor necrosis factor level	J:111715
	decreased interleukin-10 secretion	J:111715
	enhanced leukocyte tethering or rolling	J:111715
	increased circulating interleukin-6 level	J:111715
Adora2b^tm1Till/Adora2b^tm1Till (B6.129P2-Adora2b^tm1Till)	abnormal cellular extravasation	J:125297
	increased interleukin-6 secretion	J:125297
	increased susceptibility to type I hypersensitivity reaction	J:125297
Adora3^{tm1(ADORA3)Msth}/Adora3^{tm1(ADORA3)Msth} (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal mast cell physiology	J:104494
	decreased mast cell degranulation	J:104494
Adora3^tm1Jbsn/Adora3^tm1Jbsn (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal mast cell physiology	J:60293
	decreased tumor necrosis factor secretion	J:60293
Adora3^tm1Jbsn/Adora3^tm1Jbsn (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased acute inflammation	J:120442
Adora3^tm1Jbsn/Adora3^tm1Jbsn (B6.129P2-Adora3^tm1Jbsn)	abnormal mast cell degranulation	J:123463
Adora3^tm1Jbsn/Adora3^tm1Jbsn (B6.129P2-Adora3^tm1Jbsn)	impaired neutrophil recruitment	J:123463
Adprh^tm1Jlms/Adprh^tm1Jlms (involves: 129X1/SvJ * C57BL/6J)	increased susceptibility to infection	J:123619
Adrb2^tm1Bkk/Adrb2^tm1Bkk (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast physiology	J:97566
Adrb2^tm1Bkk/Adrb2^tm1Bkk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)	increased tumor necrosis factor secretion	J:204379
Ads1^NZB/Ads1^NZB (involves: NZB * NZW)	increased anti-double stranded DNA antibody level	J:7239, J:7111
Ads1^NZB/Ads1^NZB (involves: NZB * NZW)	increased susceptibility to autoimmune disorder	J:7111
Ads1^NZB/Ads1^NZW (involves: NZB * NZW)	increased anti-double stranded DNA antibody level	J:7111
Ads1^NZB/Ads1^NZW (involves: NZB * NZW)	increased susceptibility to autoimmune disorder	J:7111
Ads2^NZB/Ads2^NZB (involves: NZB * NZW)	increased anti-double stranded DNA antibody level	J:7111
Ads2^NZB/Ads2^NZB (involves: NZB * NZW)	increased susceptibility to autoimmune disorder	J:7111
Ads2^NZB/Ads2^NZW (involves: NZB * NZW)	increased anti-double stranded DNA antibody level	J:7111
Ads2^NZB/Ads2^NZW (involves: NZB * NZW)	increased susceptibility to autoimmune disorder	J:7111
Ads3^NZB/Ads3^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
Ads3^NZB/Ads3^NZW (involves: NZB * NZW)	increased susceptibility to autoimmune disorder	J:7111
Ads3^NZW/Ads3^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
	increased anti-double stranded DNA antibody level	J:7239
	increased susceptibility to autoimmune disorder	J:7111
Ads4^NZB/Ads4^NZB (involves: NZB * NZW)	decreased anti-double stranded DNA antibody level	J:11074
Ads4^NZB/Ads4^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
Ads4^NZB/Ads4^NZW (involves: NZB * NZW)	increased susceptibility to autoimmune disorder	J:7111
Ads4^NZW/Ads4^NZW (involves: NZB * NZW)	abnormal immunoglobulin level	J:7111
Ads4^NZW/Ads4^NZW (involves: NZB * NZW)	increased susceptibility to autoimmune disorder	J:7111
Adtrp^tm1.1Clu/Adtrp^tm1.1Clu (involves: 129S4/SvJaeSor * C57BL/6)	increased inflammatory response	J:295059
Aec1^NOD/Uf/Aec1^NOD/Uf Aec2^NOD/Uf/Aec2^NOD/Uf (B6.NOD-Aec2^NOD/Uf Aec1^NOD/Uf)	increased anti-nuclear antigen antibody level	J:129282
	increased susceptibility to autoimmune disorder	J:128900
	lacrimal gland inflammation	J:129282
	salivary gland inflammation	J:129282
Aem1^C57BL/6/Aem1^NZB (involves: C57BL/6 * NZB)	decreased autoantibody level	J:7191
Aem2^C57BL/6/Aem2^C57BL/6 (involves: C57BL/6 * NZB)	decreased autoantibody level	J:59427
Aem2^C57BL/6/Aem2^NZB (involves: C57BL/6 * NZB)	decreased autoantibody level	J:59427
Aem2^C57BL/6/Aem2^NZB Aem3^C57BL/6/Aem3^NZB (involves: C57BL/6 * NZB)	decreased autoantibody level	J:59427
Aem3^C57BL/6/? (involves: C57BL/6 * NZB)	abnormal immune system physiology	J:59427
Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu}/Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu} (involves: FVB/N)	increased susceptibility to Herpesvirales infection	J:231311
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:231311
	increased susceptibility to Poxviridae infection	J:231311
	increased susceptibility to Poxviridae infection induced morbidity/mortality	J:231311
Agbl5^em1Zfa/Agbl5^em1Zfa (Not Specified)	increased susceptibility to Herpesvirales infection	J:231311
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:231311
	increased susceptibility to Poxviridae infection	J:231311
	increased susceptibility to Poxviridae infection induced morbidity/mortality	J:231311
Ager^tm1.1Arnd/Ager^tm1.1Arnd (B6.129P2-Ager^tm1.1Arnd)	decreased circulating interleukin-6 level	J:104998
Ager^tm1.1Arnd/Ager^tm1.1Arnd (involves: 129P2/OlaHsd)	abnormal immune system physiology	J:113376
Agk^em1Qiz/Agk^em1Qiz (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:282052
Agnm1^MRL/MpJ/Agnm1^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	glomerulonephritis	J:97786
	increased susceptibility to systemic lupus erythematosus	J:97786
Agnm2^C3H/HeJ/Agnm2^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	glomerulonephritis	J:97786
	increased susceptibility to systemic lupus erythematosus	J:97786
Agnm2^MRL/MpJ/Agnm2^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	glomerulonephritis	J:97786
	increased susceptibility to systemic lupus erythematosus	J:97786
Agnm3^C3H/HeJ/Agnm3^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	glomerulonephritis	J:97786
	increased susceptibility to systemic lupus erythematosus	J:97786
Agnm3^MRL/MpJ/Agnm3^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	glomerulonephritis	J:97786
	increased susceptibility to systemic lupus erythematosus	J:97786
Agp1^NZB/Agp1^NZB (involves: NZB * NZW)	increased susceptibility to type III hypersensitivity reaction	J:6920
Agp1^NZB/Agp1^NZW (involves: NZB * NZW)	increased susceptibility to type III hypersensitivity reaction	J:6920
Agp2^NZB/Agp2^NZW (involves: NZB * NZW)	increased susceptibility to type III hypersensitivity reaction	J:6920
Agp2^NZW/Agp2^NZW (involves: NZB * NZW)	increased susceptibility to type III hypersensitivity reaction	J:6920
Agpat2^{Gt(OST438470)Lex}/Agpat2^{Gt(OST438470)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	brown adipose tissue inflammation	J:186035
	granulomatous inflammation	J:186035
	liver inflammation	J:186035
Agr2^tm1.1Lpkn/Agr2^tm1.1Lpkn Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129 * 129S6/SvEvTac * C57BL/6)	colitis	J:156704
Agr2^tm1.2Erle/Agr2^tm1.2Erle (involves: 129S4/SvJae * FVB/N)	increased susceptibility to induced colitis	J:148339
Agr2^tm1.2Lpkn/Agr2^tm1.2Lpkn (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	colitis	J:156704
	ileum inflammation	J:156704
Agt^tm1Afu/Agt^tm1Afu (involves: C57BL/6 * CBA)	tubulointerstitial nephritis	J:46506
Agt^tm1Unc/Agt^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	tubulointerstitial nephritis	J:24156
Agtpbp1^atms/Agtpbp1^atms (MRL/Mp-Agtpbp1^atms)	abnormal T cell physiology	J:103944
Agtr1a^tm1Unc/Agtr1a^tm1Unc Agtr1b^tm1Cof/Agtr1b^tm1Cof (involves: 129P2/OlaHsd * C57BL/6)	kidney inflammation	J:137944
Ahi1^tm1Jgg/Ahi1^tm1Jgg Tg(TCF/Lef1-lacZ)34Efu/0 (involves: 129S1/Sv * 129X1/SvJ)	kidney inflammation	J:154321
Ahnak^tm1Vtm/Ahnak^tm1Vtm (involves: 129S1/Sv * C57BL/6)	abnormal T cell activation	J:131148
	abnormal T-helper 1 physiology	J:131148
	decreased interferon-gamma secretion	J:131148
	decreased interleukin-2 secretion	J:131148
	decreased T cell proliferation	J:131148
	increased interleukin-4 secretion	J:131148
	increased susceptibility to parasitic infection	J:131148
Ahr^b-1/Ahr^b-1 (C57BL/6J)	increased inflammatory response	J:5244, J:5387
Ahr^b-1/Ahr^b-1 (involves: C57BL/6J * DBA/2J)	abnormal immune system physiology	J:5387
Ahr^tm1Bra/Ahr^tm1Bra (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:148870
	abnormal Langerhans cell physiology	J:148870
	decreased susceptibility to type IV hypersensitivity reaction	J:148870
Ahr^tm1Bra/Ahr^tm1Bra (B6.129-Ahr^tm1Bra/J)	abnormal chemokine level	J:118646
	abnormal cytokine level	J:118646
	abnormal interleukin level	J:118646
	abnormal macrophage physiology	J:118646
	abnormal tumor necrosis factor level	J:118646
	increased susceptibility to bacterial infection	J:118646
	lung inflammation	J:118646, J:100359
Ahr^tm1Gonz/Ahr^tm1Gonz (involves: 129S4/SvJae * C57BL/6N)	bile duct inflammation	J:25048
	colitis	J:44690
	folliculitis	J:44690
	heart inflammation	J:44690
	increased inflammatory response	J:25048
Ahr^tm1Yfk/Ahr^tm1Yfk (involves: 129S/SvEv * C57BL/6J)	urinary bladder inflammation	J:179919
Aia1^NZB/Omr/Aia1^NZB/Omr (involves: NZB/Omr * NZC/Omr)	increased susceptibility to autoimmune hemolytic anemia	J:6517
Aia1^NZB/Omr/Aia1^NZC/Omr (involves: NZB/Omr * NZC/Omr)	increased susceptibility to autoimmune hemolytic anemia	J:6517
Aicda^em1Jaych/Aicda^em1Jaych (involves: C57BL/6J)	abnormal class switch recombination	J:305843
Aicda^em1Jaych/Aicda^em1Jaych (involves: C57BL/6J)	increased IgM level	J:305843
Aicda^m1Btlr/Aicda^m1Btlr (C57BL/6J-Aicda^m1Btlr)	abnormal humoral immune response	J:265155
	decreased IgE level	J:265155
	increased IgM level	J:265155
Aicda^m2Btlr/Aicda^m2Btlr (C57BL/6J-Aicda^m2Btlr)	abnormal humoral immune response	J:265156
	decreased IgE level	J:265156
	increased IgM level	J:265156
Aicda^tm1(cre)Mnz/Aicda⁺ Igh^tm3Mnz/Igh⁺ Myc^tm37Mnz/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:145691
Aicda^tm1(cre)Mnz/Aicda⁺ Igh^tm3Mnz/Igh⁺ Myc^tm39Mnz/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:145691
Aicda^tm1.1Fwa/Aicda^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:209271
Aicda^tm1.1Fwa/Aicda^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal somatic hypermutation frequency	J:209271
Aicda^tm1Hon/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:136224, J:141427
Aicda^tm1Hon/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm1Hon/Aicda^tm1.1Fwa (involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)	abnormal class switch recombination	J:209271
Aicda^tm1Hon/Aicda^tm1Hon (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427, J:73659, J:120658
	abnormal somatic hypermutation frequency	J:136224, J:141427
	decreased IgA level	J:169227
	decreased IgG1 level	J:169227, J:73659
	decreased IgG2a level	J:73659
	decreased IgG2b level	J:169227
	decreased IgG3 level	J:169227
	decreased IgG level	J:169227
	increased IgM level	J:169227, J:73659
	increased susceptibility to bacterial infection induced morbidity/mortality	J:169227
Aicda^tm1Hon/Aicda^tm1Hon Bcl6^tm1.1Jwan/Bcl6^tm1.1Jwan (involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)	abnormal somatic hypermutation frequency	J:190534
Aicda^tm1Hon/Aicda^tm1Hon Igh^tm3Mnz/Igh^tm4.1Mnz Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6 * CBA)	abnormal class switch recombination	J:159173
Aicda^tm1Hon/Aicda^tm1Hon Ighm^{tm1.1(IGH-2)Cog}/Ighm⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)	abnormal B cell physiology	J:157575
Aicda^tm1Hon/Aicda^tm3Mnz (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm1Hon/Aicda^tm3Mnz (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm1Hon/Aicda^tm4Mnz (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm1Hon/Aicda^tm4Mnz (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm2.1Hon/Aicda^tm2.1Hon (C57BL/6-Aicda^tm2.1Hon)	abnormal somatic hypermutation frequency	J:169227
	decreased IgG1 level	J:169227
	increased susceptibility to bacterial infection	J:169227
	increased susceptibility to bacterial infection induced morbidity/mortality	J:169227
Aicda^tm3.1Mnz/Aicda^tm3.1Mnz (involves: C57BL/6)	abnormal class switch recombination	J:147109
Aicda^tm3.1Mnz/Aicda^tm3.1Mnz (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:147109
Aicda^tm3Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm3Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm4.1Mnz/Aicda^tm4.1Mnz (involves: C57BL/6)	abnormal class switch recombination	J:147109
Aicda^tm4.1Mnz/Aicda^tm4.1Mnz (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:147109
Aicda^tm4Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm4Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aif1^tm1Nsib/Aif1^tm1Nsib (involves: 129S/SvEv * C57BL/6)	decreased susceptibility to induced arthritis	J:204462
Aim2^{Gt(CSG445)Byg}/Aim2^{Gt(CSG445)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:158969
	decreased circulating interleukin-18 level	J:158969
	decreased interleukin-1 beta secretion	J:158969
	decreased interleukin-18 secretion	J:158969
	increased interferon-beta secretion	J:158969
	increased susceptibility to bacterial infection	J:158969
	increased susceptibility to Herpesvirales infection	J:158969
	increased susceptibility to Poxviridae infection	J:158969
Aim2^{Gt(CSG445)Byg}/Aim2^{Gt(CSG445)Byg} (B6.129P2-Aim2^{Gt(CSG445)Byg}/J)	abnormal interferon secretion	J:234263
	decreased interleukin-1 beta secretion	J:234263
	decreased macrophage apoptosis	J:234263
Aim2^tm1.1Vmd/Aim2^tm1.1Vmd (C57BL/6-Aim2^tm1.1Vmd)	abnormal cytokine secretion	J:160545
	abnormal macrophage physiology	J:160545
	decreased interleukin-1 beta secretion	J:160545
	decreased interleukin-18 secretion	J:160545
	increased interferon-beta secretion	J:160545
	increased susceptibility to bacterial infection	J:160545
	increased tumor necrosis factor secretion	J:160545
Aim2^tm1.2Arte/Aim2^tm1.2Arte Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129 * BALB/c * C57BL/6 * C57BL/6J)	increased autoantibody level	J:238323
	increased circulating interleukin-10 level	J:238323
	increased circulating tumor necrosis factor level	J:238323
	rheumatoid arthritis	J:238323
Aim2^tm1Ktak/Aim2^tm1Ktak (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-18 level	J:188013
	decreased interferon-gamma secretion	J:188013
	decreased interleukin-1 beta secretion	J:188013
	decreased interleukin-18 secretion	J:188013
	increased susceptibility to bacterial infection	J:188013
	increased susceptibility to bacterial infection induced morbidity/mortality	J:188013
Aimp1^{Gt(OST58507)Lex}/Aimp1^{Gt(OST58507)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased inflammatory response	J:95974
Aire^tm1.1Doi/Aire^tm1.1Doi (involves: 129S2/SvPas * C57BL/6)	increased autoantibody level	J:119475
	increased susceptibility to autoimmune disorder	J:83422
	stomach inflammation	J:119475
Aire^tm1.1Doi/Aire^tm1.1Doi (B6.129S2-Aire^tm1.1Doi/Doi)	increased autoantibody level	J:107432
	increased incidence of corneal inflammation	J:107432
	lung inflammation	J:107432
	salivary gland inflammation	J:107432
	stomach inflammation	J:107432
Aire^tm1.1Doi/Aire^tm1.1Doi (NOD.129S2(B6)-Aire^tm1.1Doi/Doi)	increased autoantibody level	J:107432
	increased incidence of corneal inflammation	J:107432
	liver inflammation	J:107432
	lung inflammation	J:107432
	ovary inflammation	J:107432
	pancreas inflammation	J:107432
	prostate gland inflammation	J:107432
	salivary gland inflammation	J:107432
	stomach inflammation	J:107432
	thyroid gland inflammation	J:107432
Aire^tm1.1Doi/Aire^tm1.1Doi (C.129S2-Aire^tm1.1Doi/Doi)	increased autoantibody level	J:107432
	increased incidence of corneal inflammation	J:107432
	liver inflammation	J:107432
	lung inflammation	J:107432
	ovary inflammation	J:107432
	prostate gland inflammation	J:107432
	salivary gland inflammation	J:107432
	stomach inflammation	J:107432
Aire^tm1.1Doi/Aire^tm1.1Doi (SJL.129S2-Aire^tm1.1Doi/Doi)	increased autoantibody level	J:107432
	liver inflammation	J:107432
	lung inflammation	J:107432
	ovary inflammation	J:107432
	pancreas inflammation	J:107432
	prostate gland inflammation	J:107432
	salivary gland inflammation	J:107432
	stomach inflammation	J:107432
Aire^tm1.1Doi/Aire^tm1.1Doi (involves: 129S2/SvPas * C57BL/6 * NOD)	liver inflammation	J:107432
	lung inflammation	J:107432
	pancreas inflammation	J:107432
	salivary gland inflammation	J:107432
	stomach inflammation	J:107432
Aire^tm1.1Doi/Aire^tm1.1Doi (NOD.129S2-Aire^tm1.1Doi)	abnormal CD4-positive, alpha-beta T cell physiology	J:135154
	chronic pancreas inflammation	J:135154
	insulitis	J:135154
	lacrimal gland inflammation	J:135154
	lung inflammation	J:135154
	salivary gland inflammation	J:135154
	stomach inflammation	J:135154
	thyroid gland inflammation	J:135154
	uveitis	J:135154
Aire^tm1.1Doi/Aire^tm1.1Doi H2^b/H2^b (NOD.Cg-Aire^tm1.1Doi H2^b/Doi)	stomach inflammation	J:107432
Aire^tm1.1Doi/Aire^tm1.1Doi Idd3^C57BL/6/Idd3^C57BL/6 Idd5^C57BL/10SnJ/Idd5^C57BL/10SnJ (NOD.Cg-Idd3^C57BL/6 Idd5^C57BL/10SnJ Aire^tm1.1Doi/Doi)	stomach inflammation	J:107432
Aire^tm1.1Doi/Aire^tm1.1Doi Il1r1^tm1Imx/Il1r1⁺ (involves: 129S2/SvPas * 129S7/SvEvBrd * NOD)	keratoconjunctivitis	J:163691
	lacrimal gland inflammation	J:163691
Aire^tm1.1Doi/Aire^tm1.1Doi Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129S2/SvPas * 129S7/SvEvBrd * NOD)	keratoconjunctivitis	J:163691
	lacrimal gland inflammation	J:163691
Aire^tm1Mand/Aire⁺ (involves: 129P2/OlaHsd * C57BL/6)	lacrimal gland inflammation	J:135154
Aire^tm1Mand/Aire⁺ (involves: 129P2/OlaHsd * C57BL/6)	salivary gland inflammation	J:135154
Aire^tm1Mand/Aire⁺ (NOD.129P2-Aire^tm1Mand)	abnormal CD4-positive, alpha-beta T cell physiology	J:135154, J:188686
	abnormal chemokine level	J:188686
	chronic pancreas inflammation	J:135154
	CNS inflammation	J:135154
	increased autoantibody level	J:188686
	increased CXCL10 level	J:188686
	increased inflammatory response	J:188686
	increased susceptibility to autoimmune diabetes	J:135154, J:188686
	insulitis	J:135154
	lacrimal gland inflammation	J:135154
	salivary gland inflammation	J:135154
	thyroid gland inflammation	J:135154
Aire^tm1Mand/Aire^tm1.1Doi (NOD.129-Aire^tm1Mand/Aire^tm1.1Doi)	abnormal CD4-positive, alpha-beta T cell physiology	J:135154
	chronic pancreas inflammation	J:135154
	insulitis	J:135154
	lacrimal gland inflammation	J:135154
	lung inflammation	J:135154
	salivary gland inflammation	J:135154
	stomach inflammation	J:135154
	thyroid gland inflammation	J:135154
	uveitis	J:135154
Aire^tm1Mand/Aire^tm1Mand (involves: 129P2/OlaHsd * C57BL/6)	eye inflammation	J:135154
	lacrimal gland inflammation	J:135154
	salivary gland inflammation	J:135154
Aire^tm1Mmat/Aire^tm1Mmat (involves: C57BL/6 * CBA)	autoimmune response	J:96580
	lacrimal gland inflammation	J:96580
	pancreas inflammation	J:96580
	parotid gland inflammation	J:96580
	stomach inflammation	J:96580
	submandibular gland inflammation	J:96580
Aire^tm1Mmat/Aire^tm1Mmat (C.Cg-Aire^tm1Mmat)	increased autoantibody level	J:96580
Aire^tm1Mmat/Aire^tm1Mmat (C.Cg-Aire^tm1Mmat)	stomach inflammation	J:96580
Aire^tm1Mmat/Aire^tm1Mmat (B6.Cg-Aire^tm1Mmat)	autoimmune response	J:96580
Aire^tm1Mmat/Aire^tm1Mmat (B6.Cg-Aire^tm1Mmat)	salivary gland inflammation	J:96580
Aire^tm1Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	autoimmune response	J:141379
Aire^tm1Pltn/Aire^tm1Pltn (involves: 129S4/SvJae * C57BL/6)	increased autoantibody level	J:77873
	increased T cell proliferation	J:77873
	liver inflammation	J:77873
Aire^tm1Pltn/Aire^tm1Pltn (B6.129S4-Aire^tm1Pltn)	liver inflammation	J:115076
Aire^tm1Ptsn/Aire^tm1Ptsn (C57BL/6-Aire^tm1Ptsn)	abnormal T cell activation	J:145910
	increased autoantibody level	J:145910
	parotid gland inflammation	J:145910
	sublingual gland inflammation	J:145910
	uveitis	J:145910
	vitreous body inflammation	J:145910
Aire^tm1Ptsn/Aire^tm1Ptsn (C.B6-Aire^tm1Ptsn)	abnormal adaptive immunity	J:174653
	abnormal cytokine level	J:174653
	abnormal regulatory T cell physiology	J:174653
	abnormal T-helper 1 physiology	J:174653
	abnormal T-helper 17 cell physiology	J:174653
	decreased susceptibility to fungal infection	J:174653
	increased interleukin-6 secretion	J:174653
	increased interleukin-12 secretion	J:174653
	increased interleukin-23 secretion	J:174653
	increased susceptibility to autoimmune disorder	J:174653
	increased susceptibility to fungal infection	J:174653
	increased tumor necrosis factor secretion	J:174653
	stomach inflammation	J:174653
Aire^tm2Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	abnormal thymus physiology	J:141379
Aire^tm2Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	autoimmune response	J:141379
Ak7^{Gt(OST434404)Lex}/Ak7^{Gt(OST434404)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	rhinosinusitis	J:185566
Ak7^{Tg(tetO-Hmox1)67Sami}/Ak7^{Tg(tetO-Hmox1)67Sami} (FVB/N-Ak7^{Tg(tetO-Hmox1)67Sami})	respiratory system inflammation	J:186062
	rhinitis	J:186062
Akap12^tm1Ihg/Akap12^tm1Ihg (involves: 129S4/SvJae * C57BL/6)	liver inflammation	J:138882
Akap13^tm1Segj/Akap13⁺ (involves: 129)	abnormal lymphocyte physiology	J:111574
	abnormal splenocyte physiology	J:181088
	decreased IgG1 level	J:181088
Akip1^em1Cya/Akip1^em1Cya (C57BL/6N-Akip1^em1Cya)	decreased susceptibility to endotoxin shock	J:326919
Akip1^em1Cya/Akip1^em1Cya (C57BL/6N-Akip1^em1Cya)	decreased susceptibility to viral infection	J:326919
Akna^tm1Mak/Akna^tm1Mak (B6.129P2-Akna^tm1Mak)	alveolitis	J:233952
	increased acute inflammation	J:233952
	increased susceptibility to fungal infection	J:233952
	lung inflammation	J:233952
Akna^tm2Mak/Akna^tm2Mak (B6.129-Akna^tm2Mak)	increased susceptibility to fungal infection	J:233952
Akr1a1^{Gt(OST222400)Lex}/Akr1a1^{Gt(OST222400)Lex} (B6.129S5-Akr1a1^{Gt(OST222400)Lex})	abnormal osteoclast physiology	J:164548
Akr1b8^tm1Dgen/Akr1b8^tm1Dgen (Not Specified)	abnormal interferon level	J:301852
	abnormal interleukin level	J:301852
	increased susceptibility to induced colitis	J:301852
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Akt3^tm1Mbb/Akt3^tm1Mbb Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	increased T cell apoptosis	J:135903
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	increased T cell apoptosis	J:135903
Aktip^{tm1a(EUCOMM)Hmgu}/Aktip^{tm1a(EUCOMM)Hmgu} Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6N)	kidney inflammation	J:276210
	liver inflammation	J:276210
	lung inflammation	J:276210
	peritoneal inflammation	J:276210
Alan2^B10.O20/Dem/Alan2^B10.O20/Dem (involves: B10.O20/Dem * O20/A)	abnormal immune system physiology	J:67657
Alan2^B10.O20/Dem/Alan2^O20/A (involves: B10.O20/Dem * O20/A)	abnormal immune system physiology	J:67657
Aldh18a1^{tm1a(KOMP)Wtsi}/Aldh18a1⁺ (C57BL/6N-Aldh18a1^{tm1a(KOMP)Wtsi}/Wtsi)	skin inflammation	J:232539
Aldob^{tm1(KOMP)Vlcg}/Aldob^{tm1(KOMP)Vlcg} (C57BL/6NTac-Aldob^{tm1(KOMP)Vlcg})	liver inflammation	J:220330
Alms1^Gt(XH152)Byg/Alms1^Gt(XH152)Byg (involves: 129P2/OlaHsd * C57BL/6J)	tubulointerstitial nephritis	J:100403
Alox5^tm1Bhk/Alox5^tm1Bhk (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	abnormal inflammatory response	J:68714
	abnormal neutrophil physiology	J:68714
	decreased acute inflammation	J:68714
	decreased susceptibility to type I hypersensitivity reaction	J:68714
	impaired neutrophil chemotaxis	J:68714
	impaired neutrophil recruitment	J:68714
Alox5^tm1Fun/Alox5^tm1Fun (involves: 129S2/SvPas * C57BL/6)	abnormal immune system physiology	J:21372
Alox5^tm1Fun/Alox5^tm1Fun (involves: 129S2/SvPas * C57BL/6)	decreased inflammatory response	J:21372, J:75371
Alox5^tm1Fun/Alox5^tm1Fun (B6.129S2-Alox5^tm1Fun/J)	decreased susceptibility to experimental autoimmune uveoretinitis	J:108446
Alox5ap^tm1Bhk/Alox5ap^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased susceptibility to type I hypersensitivity reaction	J:39229
Alox5ap^tm1Bhk/Alox5ap^tm1Bhk (involves: 129P2/OlaHsd * 129S/SvEv)	decreased acute inflammation	J:39229
	impaired neutrophil recruitment	J:39229
Alox5ap^tm1Jdm/Alox5ap⁺ (DBA/1LacJ-Alox5ap^tm1Jdm)	decreased susceptibility to induced arthritis	J:100736
Alox5ap^tm1Jdm/Alox5ap^tm1Jdm (DBA/1LacJ-Alox5ap^tm1Jdm)	decreased inflammatory response	J:100736
Alox5ap^tm1Jdm/Alox5ap^tm1Jdm (DBA/1LacJ-Alox5ap^tm1Jdm)	decreased susceptibility to induced arthritis	J:100736
Alox8^{tm1a(KOMP)Wtsi}/Alox8^{tm1a(KOMP)Wtsi} (C57BL/6N-Alox8^{tm1a(KOMP)Wtsi}/MbpMmucd)	abnormal susceptibility to Orthomyxoviridae infection	J:277623
	increased interleukin-6 secretion	J:277623
	lung inflammation	J:277623
Alox15^tm1Fun/Alox15^tm1Fun (involves: 129/Sv * C57BL/6)	abnormal immune system physiology	J:44778
Alox15^tm1Fun/Alox15^tm1Fun (B6.129S2-Alox15^tm1Fun/J)	dermatitis	J:119405
Alpk1^em1Dlka/Alpk1^em1Dlka Crb1^rd8/Crb1^rd8 (involves: C57BL/6N)	abnormal circulating chemokine level	J:344848
	increased circulating CXCL10 level	J:344848
Als2^tm1Jei/Als2^tm1Jei (involves: 129P2/OlaHsd * C57BL/6J)	CNS inflammation	J:104446
Altre^tm1.1Hbgl/Altre^tm1.1Hbgl Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal regulatory T cell physiology	J:342907
	increased interleukin-17 secretion	J:342907
	increased regulatory T cell apoptosis	J:342907
amd^A/J/amd^A/J (involves: A/J * C57BL/6J)	myocarditis	J:2843, J:11025
amd^DBA/2J/amd^DBA/2J (B10.D2-H8^b/(57N)SnJ)	myocarditis	J:11025
Amfr^{Gt(IST12797A11)Tigm}/Amfr^{Gt(IST12797A11)Tigm} (C57BL/6-Amfr^{Gt(IST12797A11)Tigm})	liver inflammation	J:221247
Ampd3^tm1Tm/Ampd3^tm1Tm (Not Specified)	lung inflammation	J:201211
anan/anan (involves: C57BL/6 * C57BL/10Sg * C57BR/c)	increased anti-nuclear antigen antibody level	J:169366
anan/anan⁺ (involves: C57BL/6 * C57BL/10Sg * C57BR/c)	increased anti-nuclear antigen antibody level	J:169366
anaya/anaya (involves: C57BL/6 * C57BL/10Sg * C57BR/c)	increased anti-nuclear antigen antibody level	J:169366
andra/andra (involves: C57BL/6 * C57BL/10Sg * C57BR/c)	increased anti-nuclear antigen antibody level	J:169366
Angptl2^tm1Yo/Angptl2^tm1Yo (B6.Cg-Angptl2^tm1Yo)	impaired macrophage chemotaxis	J:152387
Ank1^ity16/Ank1⁺ (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	increased susceptibility to bacterial infection	J:199427
Ank1^ity16/Ank1⁺ (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	increased susceptibility to bacterial infection induced morbidity/mortality	J:199427
Ank1^ity16/Ank1^ity16 (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	glomerulonephritis	J:199427
	increased susceptibility to bacterial infection	J:199427
	increased susceptibility to bacterial infection induced morbidity/mortality	J:199427
Ank1^MRI23420/Ank1⁺ (SJL/J-Ank1^MRI23420)	decreased susceptibility to parasitic infection	J:187820
Ank1^MRI23420/Ank1⁺ (SJL/J-Ank1^MRI23420)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:187820
Ank1^nb/Ank1⁺ (involves: C57BL/6J * WB/Re)	decreased susceptibility to parasitic infection	J:111131
Ank1^nb/Ank1^nb (involves: C57BL/6J * WB/Re)	decreased susceptibility to parasitic infection	J:111131
Ank1^Rbc2/Ank1⁺ (involves: 129S1/Sv * BALB/c)	decreased susceptibility to parasitic infection	J:148127
Ank^ank/Ank^ank (involves: C3HeB/FeJ * C57BL/6J * JGBF/LeJ)	arthritis	J:63420
Ankrd2^tm1Krc/Ankrd2^tm1Krc (involves: 129 * Black Swiss)	abnormal inflammatory response	J:214867
Ano5^em1Huyi/Ano5^em1Huyi (C57BL/6N-Ano5^em1Huyi)	periodontium inflammation	J:294237
Ano5^em2Huyi/Ano5^em2Huyi (C57BL/6-Ano5^em2Huyi)	abnormal osteoclast physiology	J:336715
Ano5^em2Huyi/Ano5^em2Huyi (C57BL/6-Ano5^em2Huyi)	osteomyelitis	J:336715
Anpep^tm1.1Lsha/Anpep^tm1.1Lsha (B6.Cg-Anpep^tm1.1Lsha)	abnormal macrophage physiology	J:163945
Anta/Anta⁺ (involves: C57BL/6 * C57BL/10 * C57BR/cd)	glomerulonephritis	J:169366
Anta/Anta⁺ (involves: C57BL/6 * C57BL/10 * C57BR/cd)	increased anti-nuclear antigen antibody level	J:169366
Anth2^CBA/J/? (involves: A/J * CBA/J)	decreased susceptibility to bacterial infection	J:9501
Anth^C3H/HeNCrj/Anth^C3H/HeNCrj (involves: C3H/HeNCrj * C57BL/6NCrj)	decreased susceptibility to bacterial infection	J:11149
Anth^C3H/HeNCrj/Anth^C57BL/6NCrj (involves: C3H/HeNCrj * C57BL/6NCrj)	decreased susceptibility to bacterial infection	J:11149
Antxr2^tm1.2Lepp/Antxr2^tm1.2Lepp (involves: C57BL/6)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:150952
anx/anx (B6C3Fe a/a-anx/J)	abnormal inflammatory response	J:103396
Anxa1^tm1Rjf/Anxa1⁺ (Not Specified)	increased inflammatory response	J:81498
Anxa1^tm1Rjf/Anxa1^tm1Rjf (Not Specified)	abnormal leukocyte physiology	J:81498
	impaired macrophage phagocytosis	J:81498
	increased inflammatory response	J:81498
Anxa1^tm1Rjf/Anxa1^tm1Rjf (involves: BALB/c)	increased susceptibility to induced colitis	J:142735
Anxa5^tm1Epo/Anxa5^tm1Epo (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:117249
	abnormal inflammatory response	J:117249
	decreased susceptibility to type IV hypersensitivity reaction	J:117249
Anxa7^tm1Pll/Anxa7⁺ (Not Specified)	pancreas inflammation	J:58572
Anxa8^tm1Resc/Anxa8^tm1Resc Tg(Pgk1-cre)1Lni/0 (involves: 129 * C57BL/6J * BALB/c)	impaired leukocyte tethering or rolling	J:225224
Aoah^tm1Rsm/Aoah^tm1Rsm (involves: 129S6/SvEvTac)	abnormal humoral immune response	J:90493
Aoc3^tm1Salm/Aoc3^tm1Salm (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	abnormal cellular extravasation	J:95656
	abnormal leukocyte adhesion	J:95656
	abnormal leukocyte migration	J:95656
	decreased inflammatory response	J:95656
	impaired leukocyte tethering or rolling	J:95656
Aod1a^A/J/? (involves: A/J * C57BL/6J)	ovary inflammation	J:83714
Aod1b^C57BL/6J/? (involves: A/J * C57BL/6J)	ovary inflammation	J:83714
Aod3^A/J/? (A/J)	ovary inflammation	J:78005
aol/aol (involves: C3H * C57BL/6)	osteoarthritis	J:115238
Ap3b1^m1Btlr/Ap3b1^m1Btlr (C57BL/6J-Ap3b1^m1Btlr)	increased susceptibility to Herpesvirales infection	J:132673
Ap3b1^pe/Ap3b1^pe Hps1^ep/Hps1^ep (involves: C3H/He * C3HeB/FeJ * C57BL/6J)	lung inflammation	J:85431
Apba3^tm1.1Ski/Apba3^tm1.1Ski Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129-Apba3^tm1.1Ski Lyz2^tm1(cre)Ifo)	decreased susceptibility to endotoxin shock	J:176742
Apba3^tm1.2Ski/Apba3^tm1.2Ski (B6.129-Apba3^tm1.2Ski)	abnormal macrophage physiology	J:176742
	decreased circulating interleukin-12 level	J:176742
	decreased circulating tumor necrosis factor level	J:176742
	decreased interleukin-12 secretion	J:176742
	decreased susceptibility to endotoxin shock	J:176742
	decreased tumor necrosis factor secretion	J:176742
Apc^Min/Apc⁺ (C57BL/6J-Apc^Min/J)	abnormal interleukin secretion	J:305794
Apc^Min/Apc⁺ Esr2^tm1Mma/Esr2^tm1Mma (involves: 129S2/SvPas * C57BL/6J)	colitis	J:118600
Apc^Min/Apc⁺ Mapkapk2^tm1.2Gkl/Mapkapk2^tm1.2Gkl (involves: BALB/cJ * C57BL/6J)	abnormal chemokine secretion	J:262876
	decreased interleukin-6 secretion	J:262876
Apc^tm1Kk/Apc^tm1Kk Tg(Lck-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased circulating tumor necrosis factor level	J:128606
Apc^tm1Tno/Apc⁺ Pten^tm2Mak/Pten^tm2Mak Tg(Cyp1a1-cre/ERT)1Dwi/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)	peritoneal inflammation	J:143082
Apc^tm2.1Cip/Apc⁺ Atg7^tm1Tchi/Atg7^tm1Tchi Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)	abnormal immune system physiology	J:227287
	increased interleukin-1 beta secretion	J:227287
	increased interleukin-10 secretion	J:227287
Apc^tm2.1Cip/Apc^tm2.1Cip Lect2^tm1Ymg/Lect2^tm1Ymg Tg(Ttr-cre/Esr1)1Vco/0 (B6.Cg-Lect2^tm1Ymg Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco)	abnormal chemokine level	J:184496
	abnormal neutrophil physiology	J:184496
	abnormal NK T cell physiology	J:184496
	decreased interferon-gamma secretion	J:184496
	increased interleukin-4 secretion	J:184496
	liver inflammation	J:184496
Apc^tm2.1Cip/Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco/0 (B6.Cg-Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco)	abnormal NK T cell physiology	J:184496
	increased interferon-gamma secretion	J:184496
	increased interleukin-4 secretion	J:184496
	liver inflammation	J:184496
Apc^tm2Rak/Apc⁺ Trp53^tm1Brn/Trp53^tm1Brn Tg(Pdx1-cre)6Tuv/0 (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)	abnormal cytokine level	J:234310
Apcs^tm1Mpe/Apcs⁺ (B6.Cg-Apcs^tm1Mpe)	glomerulonephritis	J:90502
Apcs^tm1Mpe/Apcs⁺ (B6.Cg-Apcs^tm1Mpe)	increased autoantibody level	J:90502
Apcs^tm1Mpe/Apcs^tm1Mpe (B6.Cg-Apcs^tm1Mpe)	decreased susceptibility to bacterial infection	J:125473
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:125473
	glomerulonephritis	J:90502
	increased autoantibody level	J:90502
	increased susceptibility to bacterial infection induced morbidity/mortality	J:125473
Apcs^tm1Mpe/Apcs^tm1Mpe (129.Cg-Apcs^tm1Mpe)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:125473
	glomerulonephritis	J:90502
	increased susceptibility to bacterial infection induced morbidity/mortality	J:125473
Apcs^tm1Smae/Apcs^tm1Smae (involves: 129S/SvEv * C57BL/6)	decreased susceptibility to endotoxin shock	J:71194
Apcs^tm1Smae/Apcs^tm1Smae (involves: 129S/SvEv * C57BL/6)	increased autoantibody level	J:71194
Apex1^tm1Cur/Apex1⁺ (involves: 129S1/Sv)	increased circulating interleukin-1 alpha level	J:119957
Apex1^tm1Cur/Apex1⁺ (involves: 129S1/Sv)	increased circulating interleukin-10 level	J:119957
Apex1^tm1Ecf/Apex1⁺ (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	heart inflammation	J:70397
	myocarditis	J:70397
	pericarditis	J:70397
Apex2^tm1Yun/Y (B6.129S-Apex2^tm1Yun)	decreased splenocyte proliferation	J:95267
Aplf^{Gt(RRF189)Byg}/Aplf^{Gt(RRF189)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal class switch recombination	J:168260
Apoa4^tm1Bres/Apoa4^tm1Bres (B6.129S4-Apoa4^tm1Bres)	increased susceptibility to induced colitis	J:91357
Apob^tm2Sgy/Apob^tm2Sgy Ldlr^tm1Her/Ldlr^tm1Her Tg(Ins-Igf2)1Fbos/? (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)	aortitis	J:227165
Apobec3^Gt(XN450)Byg/Apobec3^Gt(XN450)Byg (B6.Cg-Apobec3^Gt(XN450)Byg)	increased susceptibility to Retroviridae infection	J:118597
Apobec3^Gt(XN450)Byg/Apobec3^Gt(XN450)Byg (B6.129P2-Apobec3^Gt(XN450)Byg)	abnormal immunoglobulin level	J:138778
	increased susceptibility to Retroviridae infection	J:138778
Apobec3^Gt(XN450)Byg/Apobec3^Gt(XN450)Byg (129P2/OlaHsd-Apobec3^Gt(XN450)Byg)	abnormal immunoglobulin level	J:138778
	increased susceptibility to Retroviridae infection	J:138778
Apobec3^Gt(XN450)Byg/Apobec3^Rfv3-s H2^b/H2^b (involves: A.BY * C57BL/6)	abnormal immunoglobulin level	J:138778
Apobec3^Gt(XN450)Byg/Apobec3^Rfv3-s H2^b/H2^d (involves: BALB/c * C57BL/6)	abnormal immunoglobulin level	J:138778
	increased susceptibility to Retroviridae infection	J:138778
	increased susceptibility to Retroviridae infection induced morbidity/mortality	J:138778
Apobec3^Rfv3-r/Apobec3⁺ ((B10.A x A)F1)	decreased susceptibility to Retroviridae infection	J:6147
Apoe^tm1Bres/Apoe^tm1Bres Bcl2^tm1Irt/Bcl2^tm1Irt Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage apoptosis	J:144243
Apoe^tm1Bres/Apoe^tm1Bres Cx3cr1^tm1Ifc/Cx3cr1^tm1Ifc (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:81822
Apoe^tm1Bres/Apoe^tm1Bres Mapk9^tm1Flv/Mapk9^tm1Flv (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:94044
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc/J)	abnormal B cell activation	J:133606
	abnormal immune serum protein physiology	J:61564
	abnormal immune system physiology	J:61564
	blood vessel inflammation	J:91058
	decreased interferon-gamma secretion	J:47027
	decreased susceptibility to type IV hypersensitivity reaction	J:61564
	increased anti-double stranded DNA antibody level	J:133606
	increased anti-nuclear antigen antibody level	J:133606
	increased autoantibody level	J:133606
	increased IgM level	J:61564
	increased immunoglobulin level	J:133606
	increased susceptibility to systemic lupus erythematosus	J:133606
Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	lung inflammation	J:83615
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc)	abnormal cell-mediated immunity	J:125366
	abnormal dendritic cell physiology	J:125366
	increased susceptibility to parasitic infection	J:125366
Apoe^tm1Unc/Apoe^tm1Unc (B6.Cg-Apoe^tm1Unc Fas^lpr)	increased anti-double stranded DNA antibody level	J:133606
	increased anti-nuclear antigen antibody level	J:133606
	increased immunoglobulin level	J:133606
	increased susceptibility to systemic lupus erythematosus	J:133606
Apoe^tm1Unc/Apoe^tm1Unc Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBS)25Waku/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	increased circulating tumor necrosis factor level	J:168131
Apoe^tm1Unc/Apoe^tm1Unc Ccr1^tm1Gao/Ccr1^tm1Gao (involves: 129P2/OlaHsd * 129S4/SvJae)	increased interferon-gamma secretion	J:128063
Apoe^tm1Unc/Apoe^tm1Unc Ccr2^tm1Ifc/Ccr2^tm1Ifc (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:111471
Apoe^tm1Unc/Apoe^tm1Unc Ccr5^tm1Blck/Ccr5^tm1Blck (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:128063
	abnormal lymphocyte physiology	J:128063
	decreased interferon-gamma secretion	J:128063
	increased interleukin-10 secretion	J:128063
Apoe^tm1Unc/Apoe^tm1Unc Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:128063
	abnormal lymphocyte physiology	J:128063
	decreased interferon-gamma secretion	J:128063
	increased interleukin-10 secretion	J:128063
Apoe^tm1Unc/Apoe^tm1Unc Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:61672
Apoe^tm1Unc/Apoe^tm1Unc Cx3cl1^tm1Sgs/Cx3cl1^tm1Sgs (B6.129-Apoe^tm1Unc Cx3cl1^tm1Sgs)	impaired macrophage chemotaxis	J:95279
Apoe^tm1Unc/Apoe^tm1Unc Cxcl10^tm1Adl/Cxcl10^tm1Adl (B6.129-Cxcl10^tm1Adl Apoe^tm1Unc)	impaired macrophage chemotaxis	J:166204
Apoe^tm1Unc/Apoe^tm1Unc Cyp4f13^{Gt(OST14770)Lex}/Cyp4f13^{Gt(OST14770)Lex} (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)	abnormal macrophage chemotaxis	J:289999
Apoe^tm1Unc/Apoe^tm1Unc Cyp19a1^tm1Esi/Cyp19a1^tm1Esi (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	increased circulating C-reactive protein level	J:184647
	increased circulating interleukin-6 level	J:184647
	increased circulating tumor necrosis factor level	J:184647
Apoe^tm1Unc/Apoe^tm1Unc Fas^lpr/Fas^lpr (MRL.Cg-Apoe^tm1Unc Fas^lpr)	increased anti-double stranded DNA antibody level	J:133606
	increased anti-nuclear antigen antibody level	J:133606
	increased autoantibody level	J:133606
	increased immunoglobulin level	J:133606
	increased susceptibility to systemic lupus erythematosus	J:133606
Apoe^tm1Unc/Apoe^tm1Unc Fas^lpr/Fas^lpr (B6.Cg-Apoe^tm1Unc Fas^lpr)	decreased autoantibody level	J:121671
	glomerulonephritis	J:121671
	increased anti-double stranded DNA antibody level	J:121671
	increased autoantibody level	J:121671
	increased IgG level	J:121671
Apoe^tm1Unc/Apoe^tm1Unc Fasl^gld/Fasl^gld (B6.Cg-Fasl^gld Apoe^tm1Unc)	blood vessel inflammation	J:91058
	impaired macrophage phagocytosis	J:91058
	increased anti-nuclear antigen antibody level	J:200141, J:91058
	increased autoantibody level	J:91058
	increased IgG level	J:91058
	kidney inflammation	J:200141
Apoe^tm1Unc/Apoe^tm1Unc Gja5^tm1Mchn/Gja5^tm1Mchn Tg(TIE2-lacZ)182Sato/0 (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal neutrophil physiology	J:162224
	alveolitis	J:162224
Apoe^tm1Unc/Apoe^tm1Unc Glg1^{Gt(RST092)Byg}/Glg1⁺ (B6J.129P2-Apoe^tm1Unc Glg1^{Gt(RST092)Byg})	impaired macrophage chemotaxis	J:226586
Apoe^tm1Unc/Apoe^tm1Unc Hp^tm1Alev/Hp^tm1Alev (involves: 129)	abnormal macrophage chemotaxis	J:134942
Apoe^tm1Unc/Apoe^tm1Unc Hsd11b1^tm1Lex/Hsd11b1^tm1Lex (B6.129-Hsd11b1^tm1Lex Apoe^tm1Unc)	abnormal cytokine secretion	J:199430
	decreased tumor necrosis factor secretion	J:199430
Apoe^tm1Unc/Apoe^tm1Unc Il1r1^tm1Imx/Il1r1^tm1Imx (B6.129-Il1r1^tm1Imx Apoe^tm1Unc)	decreased circulating interleukin-6 level	J:148173
Apoe^tm1Unc/Apoe^tm1Unc Il1rn^tm1Dih/Il1rn^tm1Dih (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	abnormal macrophage chemotaxis	J:132570
Apoe^tm1Unc/Apoe^tm1Unc Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating cytokine level	J:105858
	increased circulating interferon-gamma level	J:105858
	increased circulating interleukin-12 level	J:105858
Apoe^tm1Unc/Apoe^tm1Unc Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	lung inflammation	J:83615
Apoe^tm1Unc/Apoe^tm1Unc Klf15^tm2Jain/Klf15^tm2Jain Tg(Tagln-cre)1Jjl/0 (involves: 129P2/OlaHsd * FVB/N)	blood vessel inflammation	J:203920
Apoe^tm1Unc/Apoe^tm1Unc Ncf1^tm1Shl/Ncf1^tm1Shl (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased acute inflammation	J:123854
Apoe^tm1Unc/Apoe^tm1Unc Nck1^tm1Paw/Nck1^tm1Paw Nck2^tm3Paw/Nck2^tm3Paw Tg(Cdh5-cre/ERT2)1Rha/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased inflammatory response	J:326659
Apoe^tm1Unc/Apoe^tm1Unc Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:143903
Apoe^tm1Unc/Apoe^tm1Unc Soat1^tm1Far/Soat1^tm1Far (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)	skin inflammation	J:61147
Apoe^tm1Unc/Apoe^tm1Unc Spp1^tm1Blh/Spp1^tm1Blh (involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6J)	abnormal macrophage physiology	J:86531
Apoe^tm1Unc/Apoe^tm1Unc Tg(CAG-IL1RN)1Cga/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/1 * FVB)	decreased circulating serum amyloid protein level	J:132570
Apoe^tm1Unc/Apoe^tm1Unc Tg(CAG-IL1RN)2Cga/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/1 * FVB)	decreased circulating serum amyloid protein level	J:132570
Apoe^tm1Unc/Apoe^tm1Unc Tg(MSR1-Plau)1Ddi/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	heart inflammation	J:101486
Apoe^{tm2(APOE3)Mae}/Apoe^{tm2(APOE3)Mae} (involves: 129P2/OlaHsd * C57BL/6J)	decreased interleukin-6 secretion	J:86768
	decreased tumor necrosis factor secretion	J:86768
Apoe^{tm3(APOE4)Mae}/Apoe^{tm3(APOE4)Mae} (involves: 129P2/OlaHsd * C57BL/6)	abnormal response to infection	J:138241
	increased interleukin-6 secretion	J:86768
	increased tumor necrosis factor secretion	J:86768
Apol6^em1Hsul/Apol6^em1Hsul (Not Specified)	decreased inflammatory response	J:344362
App^tm2.1Ldad/App^tm2.1Ldad (involves: 129 * C57BL/6J)	myositis	J:166989
App^tm3.1Tcs/App^tm3.1Tcs Mapt^{tm1.1(MAPT)Tcs}/Mapt^{tm1.1(MAPT)Tcs} (involves: 129S/SvEv * C57BL/6)	CNS inflammation	J:278451
Appl1^Gt(XM073)Byg/Appl1^Gt(XM073)Byg (B6.129P2-Appl1^Gt(XM073)Byg)	increased T cell proliferation	J:164696
Appl1^tm1.2Test/Appl1^tm1.2Test (involves: 129X1/SvJ)	increased T cell proliferation	J:164696
Aprt^tm1Dwm/Aprt^tm1Dwm (129P2/OlaHsd-Aprt^tm1Dwm)	pyelonephritis	J:38450
Aprt^tm1Jat/Aprt^tm1Jat (involves: 129S2/SvPas * Black Swiss)	kidney inflammation	J:33255
Aprt^tm1Jat/Aprt^tm1Jat (involves: 129S2/SvPas * C57BL/6J)	kidney inflammation	J:33255
Aprt^tm1Vri/Aprt^tm1Vri (involves: 129P2/OlaHsd * C57BL/6)	kidney inflammation	J:50874
Aqp3^m1Btlr/Aqp3^m1Btlr (C57BL/6J-Aqp3^m1Btlr)	increased susceptibility to induced colitis	J:153279
Aqp4^tm1.1Lmno/Aqp4^tm1.1Lmno (B6.Cg-Aqp4^tm1.1Lmno)	increased susceptibility to parasitic infection	J:193622
Aqp4^tm1.1Lmno/Aqp4^tm1.1Lmno (B6.Cg-Aqp4^tm1.1Lmno)	increased susceptibility to parasitic infection induced morbidity/mortality	J:193622
Aqp4^tm1.1Mysi/Aqp4^tm1.1Mysi (involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)	abnormal microglial cell physiology	J:214906
Aqp9^tm1Nlsn/Aqp9^tm1Nlsn (involves: 129S1/Sv)	decreased susceptibility to parasitic infection	J:123305
Aqp12^tm1Rai/Aqp12^tm1Rai (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to induced pancreatitis	J:155920
Ar^tm1Verh/Y Rnase10^tm1(cre)Hht/Rnase10⁺ (involves: 129S7/SvEvBrd * C57BL/6)	testis inflammation	J:173897
Areg^tm1Dle/Areg^tm1Dle Egf^tm1Dle/Egf^tm1Dle Tgfa^tm1Unc/Tgfa^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	dermatitis	J:54980
Areg^{tm2c(EUCOMM)Hmgu}/Areg^{tm2c(EUCOMM)Hmgu} Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	increased susceptibility to Orthomyxoviridae infection	J:224904
Areg^{tm2c(EUCOMM)Hmgu}/Areg^{tm2c(EUCOMM)Hmgu} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	increased susceptibility to Orthomyxoviridae infection	J:224904
Arel1^em1Bbc/Arel1⁺ (C57BL/6J-Arel1^em1Bbc)	decreased acute inflammation	J:280563
Arel1^em1Bbc/Arel1⁺ (C57BL/6J-Arel1^em1Bbc)	decreased response to antigen	J:280563
Arel1^em1Bbc/Arel1^em1Bbc (C57BL/6J-Arel1^em1Bbc)	decreased acute inflammation	J:280563
Arel1^em1Bbc/Arel1^em1Bbc (C57BL/6J-Arel1^em1Bbc)	decreased response to antigen	J:280563
Arg1^tm1.1Pmu/Arg1^tm1.1Pmu (involves: C57BL/6 * NZB)	increased macrophage nitric oxide production	J:143229
Arg1^tm1Ekoe/Arg1^tm1Ekoe (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:183882
Arg1^tm1Pmu/Arg1^tm1Pmu Lyz2^tm1(cre)Ifo/? (B6.Cg-Arg1^tm1Pmu Lyz2^tm1(cre)Ifo)	decreased susceptibility to parasitic infection	J:143229
Arg1^tm1Pmu/Arg1^tm1Pmu Tg(Tek-cre)1Ywa/? (B6.Cg-Tg(Tek-cre)1Ywa Arg1^tm1Pmu)	abnormal macrophage physiology	J:143229
	decreased susceptibility to bacterial infection	J:143229
	increased macrophage nitric oxide production	J:143229
Arhgap15^tm1Ehi/Arhgap15^tm1Ehi (B6.129-Arhgap15^tm1Ehi)	abnormal neutrophil physiology	J:174896
Arhgap15^tm1Ehi/Arhgap15^tm1Ehi (B6.129-Arhgap15^tm1Ehi)	decreased susceptibility to bacterial infection	J:174896
Arhgap17^{Gt(RRN062)Byg}/Arhgap17^{Gt(RRN062)Byg} (B6.129P2-Arhgap17^{Gt(RRN062)Byg})	increased susceptibility to induced colitis	J:277297
	increased tumor necrosis factor secretion	J:277297
Arhgap25^{tm1a(KOMP)Wtsi}/Arhgap25^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	abnormal cellular extravasation	J:240521
	abnormal neutrophil physiology	J:240521
	enhanced leukocyte migration	J:240521
	enhanced leukocyte tethering or rolling	J:240521
	increased acute inflammation	J:240521
Arhgap45^em1Ciphe/Arhgap45^em1Ciphe (C57BL/6-Arhgap45^em1Ciphe)	decreased lymphocyte chemotaxis	J:309971
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk (involves: 129S/SvEv * C57BL/6 * DBA)	tubulointerstitial nephritis	J:57995
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	abnormal B cell physiology	J:140671
	abnormal T cell physiology	J:140671
	decreased T cell proliferation	J:140671
	increased B cell proliferation	J:140671
	increased circulating interleukin-5 level	J:140671
Arhgdib^tm1Len/Arhgdib^tm1Len (involves: 129S4/SvJae * C57BL/6)	increased B cell proliferation	J:42604
Arhgef1^tm1.1Rmt/Arhgef1^tm1.1Rmt (C57BL/6-Arhgef1^tm1.1Rmt)	abnormal marginal zone B cell physiology	J:113295
	decreased IgM level	J:113295
Arhgef1^tm1Djle/Arhgef1^tm1Djle (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil physiology	J:129331
Arhgef1^tm1Kdf/Arhgef1^tm1Kdf (involves: 129S1/Sv * 129X1/SvJ)	abnormal humoral immune response	J:99463
	abnormal lymphocyte physiology	J:99463
	decreased B cell proliferation	J:99463
	decreased IgG level	J:99463
	decreased IgM level	J:99463
	increased T cell proliferation	J:99463
Arhgef2^{Gt(IST13976A8)Tigm}/Arhgef2^{Gt(IST13976A8)Tigm} (involves: C57BL/6N)	abnormal macrophage physiology	J:209086
	decreased interferon-beta secretion	J:209086
	increased susceptibility to Orthomyxoviridae infection	J:209086
Arhgef4^{tm1a(KOMP)Wtsi}/Arhgef4^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgef4^{tm1a(KOMP)Wtsi}/Wtsi)	decreased IgE level	J:165965
	decreased IgG1 level	J:165965
Arhgef5^tm1.1Dwu/Arhgef5^tm1.1Dwu (involves: 129S1/Sv * 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:157812
	abnormal dendritic cell physiology	J:157812
	decreased interleukin-4 secretion	J:157812
Arhgef6^tm1Kdf/Arhgef6^tm1Kdf (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:137269
	abnormal humoral immune response	J:137269
	abnormal T cell physiology	J:137269
	decreased B cell proliferation	J:137269
	decreased interleukin-2 secretion	J:137269
	decreased T cell proliferation	J:137269
Arhgef12^tm1.1Wet/Arhgef12^tm1.1Wet Tg(Lck-cre)548Jxm/0 (involves: 129 * C57BL/6 * CBA)	abnormal T cell proliferation	J:149560
Arid1a^tm1.1Mag/Arid1a^tm1.1Mag Gt(ROSA)26Sor^{tm1(Pik3caH1047R)Egan}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac CD-1)	increased interleukin-6 secretion	J:219794
Arid3a^tm1Pwt/Arid3a^tm1Pwt (involves: 129S6/SvEvTac * C57BL/6)	abnormal class switch recombination	J:169178
	decreased IgG1 level	J:169178
	decreased IgM level	J:169178
Arid4a^tm1Alb/Arid4a^tm1Alb Arid4b^tm1Alb/Arid4b⁺ (involves: 129S7/SvEvBrd)	hemophagocytosis	J:141004
Arid5a^tm1Rnis/Arid5a^tm1Rnis (B6.Cg-Arid5a^tm1Rnis)	decreased circulating interleukin-6 level	J:197418
	decreased circulating tumor necrosis factor level	J:197418
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:197418
Arid5b^{Gt(ROSA)75Sor}/Arid5b^{Gt(ROSA)75Sor} (involves: 129S4/SvJaeSor)	kidney inflammation	J:117491
Arigg1^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg2^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg3^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg4^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg5^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg6^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg7^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg8^BALB/cByJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg9^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigg10^BALB/cByJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased anti-erythrocyte antigen antibody level	J:93737
Arigm1^BALB/cByJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm2^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm3^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm4^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm5^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm6^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arigm7^NZB/BlNJ/? (involves: BALB/cByJ * NZB/BlNJ)	increased IgM level	J:93737
Arih1^em3Gpt/Arih1^em3Gpt Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C57BL/6JGpt)	decreased interferon-beta secretion	J:330879
	decreased interleukin-6 secretion	J:330879
	increased susceptibility to Herpesvirales infection	J:330879
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:330879
Arih1^em3Gpt/Arih1^em3Gpt Lyz2^em1(icre)Gpt/Lyz2⁺ (C57BL/6JGpt-Arih1^em3Gpt Lyz2^em1(icre)Gpt)	decreased circulating interferon-beta level	J:330879
	decreased circulating interleukin-6 level	J:330879
	decreased interferon-beta secretion	J:330879
	decreased interleukin-6 secretion	J:330879
	increased susceptibility to Herpesvirales infection	J:330879
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:330879
Arih2^tm1Mak/Arih2^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	dermatitis	J:191066
	heart inflammation	J:191066
	increased inflammatory response	J:191066
	liver inflammation	J:191066
	lung inflammation	J:191066
Arih2^tm1Mak/Arih2^tm1Mak (B6.129P2-Arih2^tm1Mak)	abnormal dendritic cell physiology	J:191066
Arih2^tm1Mak/Arih2^tm1Mak (B6.129P2-Arih2^tm1Mak)	increased inflammatory response	J:191066
Arl3^{Gt(OST263303)Lex}/Arl3^{Gt(OST263303)Lex} (involves: 129S5/SvEvBrd)	bile duct inflammation	J:107331
Arnt^tm1.1Gonz/Arnt^tm1.2Gonz Tg(Lck-cre)I57Jxm/0 (involves: 129X1/SvJ * ICR)	abnormal immune system physiology	J:85934
Arpc4^{tm1c(EUCOMM)Wtsi}/Arpc4^{tm1c(EUCOMM)Wtsi} Krt14^tm1(cre)Wbm/Krt14⁺ (B6.Cg-Arpc4^{tm1c(EUCOMM)Wtsi} Krt14^tm1(cre)Wbm)	dermatitis	J:253986
Arrb2^tm1Rjl/Arrb2^tm1Rjl (involves: 129X1/SvJ * C57BL/6)	abnormal circulating tumor necrosis factor level	J:112607
	abnormal lymphocyte physiology	J:76872
	increased acute inflammation	J:112607
	increased circulating interleukin-6 level	J:112607
	increased interleukin-6 secretion	J:112607
	increased interleukin-12b secretion	J:112607
	increased susceptibility to endotoxin shock	J:112607
	increased tumor necrosis factor secretion	J:112607
Art2a^tm1Fkn/Art2a^tm1Fkn Art2b^tm1Fkn/Art2b^tm1Fkn (NOD.129S4(B6)-Art2a^tm1Fkn Art2b^tm1Fkn/Lt)	decreased T cell apoptosis	J:108097
Art2a^tm1Fkn/Art2a^tm1Fkn Art2b^tm1Fkn/Art2b^tm1Fkn Cd38^tm1Lnd/Cd38^tm1Lnd (NOD.129(B6)-Cd38^tm1Lnd Art2a^tm1Fkn Art2b^tm1Fkn/Lt)	decreased susceptibility to autoimmune diabetes	J:108097
Arti1^C57BL/6J/Arti1^C57BL/6J Arti2^C57BL/6J/Arti2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal thymus involution	J:85261
Arti1^DBA/2J/Arti1^DBA/2J Arti2^DBA/2J/Arti2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal thymus involution	J:85261
Arvm2^MRL/MpJ/Arvm2^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	abnormal immune system physiology	J:63511
asa/asa (either: A/J or BALB/c or DBA/2J)	increased autoantibody level	J:2843
asa/asa (either: A/J or BALB/c or DBA/2J)	myocarditis	J:2843
Asah1^tm1.2Geno/Asah1^tm1.2Geno (involves: C57BL/6)	abnormal circulating cytokine level	J:285931
	increased circulating CXCL10 level	J:285931
	lung inflammation	J:285931
Asah1^tm1Medin/Asah1^tm1Medin (involves: 129S6/SvEvTac * CD-1)	abnormal chemokine secretion	J:232306
	abnormal circulating chemokine level	J:232306
	increased circulating interleukin-12b level	J:232306
Asb2^tm1.1Lutz/Asb2^tm1.1Lutz Tg(Mx1-cre)1Cgn/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	abnormal dendritic cell physiology	J:200966
Asbb1^BALB/c/Asbb1^BALB/c (involves: BALB/c * C57BL/6J)	increased susceptibility to systemic lupus erythematosus	J:76486
Asbb2^BALB/c/Asbb2^C57BL/6J (involves: BALB/c * C57BL/6J)	increased susceptibility to systemic lupus erythematosus	J:76486
Asbb2^C57BL/6J/Asbb2^C57BL/6J (involves: BALB/c * C57BL/6J)	increased susceptibility to systemic lupus erythematosus	J:76486
Asbb3^C57BL/6J/Asbb3^C57BL/6J (involves: BALB/c * C57BL/6J)	increased susceptibility to systemic lupus erythematosus	J:76486
Asf1b^m1Btlr/Asf1b^m1Btlr (C57BL/6J-Asf1b^m1Btlr)	increased IgE level	J:267479
Asgr1^tm1Sau/Asgr1^tm1Sau (B6.129S4-Asgr1^tm1Sau)	increased susceptibility to bacterial infection	J:136946
Asgr2^tm1Her/Asgr2^tm1Her (B6.129S7-Asgr2^tm1Her)	increased susceptibility to bacterial infection	J:136946
Ash1l^{Gt(AL0395)Wtsi}/Ash1l^{Gt(AL0395)Wtsi} (involves: 129P2/OlaHsd * C57BL/6J)	blepharitis	J:227516
Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu}/Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu} (B6.FVB-Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu})	glomerulonephritis	J:208213
	increased autoantibody level	J:208213
	increased circulating interleukin-6 level	J:208213
	increased circulating tumor necrosis factor level	J:208213
	increased IgA level	J:208213
	increased IgG1 level	J:208213
	increased IgG2a level	J:208213
	increased IgG2b level	J:208213
	increased IgM level	J:208213
	increased interleukin-6 secretion	J:208213
	increased susceptibility to autoimmune disorder	J:208213
	increased susceptibility to bacterial infection	J:208213
	increased susceptibility to bacterial infection induced morbidity/mortality	J:208213
	increased susceptibility to endotoxin shock	J:208213
	increased susceptibility to induced arthritis	J:208213
	increased tumor necrosis factor secretion	J:208213
Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu}/Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu} Il6^tm1Kopf/Il6^tm1Kopf (B6.Cg-Ash1l^{Tn(pb-Act-RFP)1.AF0-180T25Zhu} Il6^tm1Kopf)	abnormal inflammatory response	J:208213
	increased susceptibility to induced arthritis	J:208213
Asm1^MRL/MpJ/? (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	abnormal immune system physiology	J:66459
Asm2^MRL/MpJ/? (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	salivary gland inflammation	J:66459
Asq1^IQI/Asq1^IQI (involves: IQI * C57BL/6CrSlc)	salivary gland inflammation	J:127310
Asxl1^tm1.1Mjxu/Asxl1⁺ (involves: 129 * C57BL/6)	abnormal neutrophil physiology	J:208085
Atf2^{Tg(Gzma-Klra1)7Wum}/Atf2⁺ (involves: C57BL/6)	abnormal NK cell physiology	J:61178
Atf2^{Tg(Gzma-Klra1)7Wum}/Atf2⁺ (involves: C57BL/6)	decreased circulating interferon-gamma level	J:61178
Atf2^tm1Glm/Atf2^tm1Glm (involves: 129S2/SvPas)	eye inflammation	J:30611
Atf2^tm1Glm/Atf2^tm1Glm (involves: 129S2/SvPas)	increased susceptibility to bacterial infection	J:30611
Atf2^tm1Glm/Atf2^tm1Glm (C.Cg-Atf2^tm1Glm)	abnormal cytokine secretion	J:67176
	increased susceptibility to endotoxin shock	J:67176
	increased susceptibility to Herpesvirales infection	J:67176
	increased susceptibility to Picornaviridae infection	J:67176
Atf3^tm1Dron/Atf3^tm1Dron (involves: 129X1/SvJ * C57BL/6)	abnormal T-helper 2 physiology	J:140112
	decreased IgG2a level	J:140112
	increased interleukin-4 secretion	J:140112
	increased interleukin-5 secretion	J:140112
	increased interleukin-13 secretion	J:140112
	lung inflammation	J:140112
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Gt(ROSA)26Sor^{tm1(cre/ERT)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJaeSor * C57BL/6)	increased T cell apoptosis	J:172749
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)	decreased T cell proliferation	J:172749
	increased T cell apoptosis	J:172749
Atg5^tm1Myok/Atg5^tm1Myok Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal circulating chemokine level	J:235399
	abnormal macrophage physiology	J:235399
	decreased circulating interleukin-10 level	J:235399
	glomerulonephritis	J:235399
	increased anti-double stranded DNA antibody level	J:235399
	increased anti-nuclear antigen antibody level	J:235399
	increased autoantibody level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased IgG level	J:235399
	increased susceptibility to systemic lupus erythematosus	J:235399
Atg5^tm1Nmz/Atg5^tm1Nmz Tg(CAG-EGFP/Map1lc3b)53Nmz/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal thymus physiology	J:140583
Atg5^tm1Nmz/Atg5^tm1Nmz Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell physiology	J:211733
	decreased T cell proliferation	J:211733
Atg7^tm1Tchi/Atg7^tm1Tchi Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)	abnormal circulating chemokine level	J:235399
	abnormal macrophage physiology	J:235399
	decreased circulating interleukin-10 level	J:235399
	glomerulonephritis	J:235399
	increased anti-double stranded DNA antibody level	J:235399
	increased anti-nuclear antigen antibody level	J:235399
	increased autoantibody level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased IgG level	J:235399
	increased susceptibility to systemic lupus erythematosus	J:235399
Atg7^tm1Tchi/Atg7^tm1Tchi Lyz2^tm1(cre)Ifo/Lyz2⁺ Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)	abnormal circulating chemokine level	J:235399
	abnormal macrophage physiology	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
Atg7^tm1Tchi/Atg7^tm1Tchi Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Defa6-icre)1Rsb/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	small intestinal inflammation	J:206084
Atg7^tm1Tchi/Atg7^tm1Tchi Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)	ileum inflammation	J:206084
	intestinal inflammation	J:206084
Atg9a^tm1Aki/Atg9a^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal innate immunity	J:155552
	increased interferon-beta secretion	J:155552
	increased interleukin-6 secretion	J:155552
Atg16l1^tm1.1Mvlc/Atg16l1^tm1.1Mvlc (C57BL/6-Atg16l1^tm1.1Mvlc)	abnormal macrophage physiology	J:206931
	increased circulating interleukin-1 beta level	J:206931
	increased macrophage cytokine production	J:206931
	increased susceptibility to bacterial infection	J:206931
Atg16l1^{tm1a(EUCOMM)Wtsi}/Atg16l1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atg16l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Atg16l1^tm1Aki/Atg16l1^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:141420
	increased interleukin-1 beta secretion	J:141420
	increased interleukin-18 secretion	J:141420
	increased susceptibility to induced colitis	J:141420
Atg16l1^{tm1c(EUCOMM)Wtsi}/Atg16l1^{tm1c(EUCOMM)Wtsi} Tcrd^tm1Mom/Tcrd^tm1Mom Tg(Vil1-cre)997Gum/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N * SJL)	abnormal cytokine level	J:340266
	increased susceptibility to colitis induced morbidity/mortality	J:340266
Atg16l1^{tm1c(EUCOMM)Wtsi}/Atg16l1^{tm1c(EUCOMM)Wtsi} Tg(Defa6-icre)1Rsb/0 (involves: C57BL/6)	increased susceptibility to colitis induced morbidity/mortality	J:340266
	increased susceptibility to induced colitis	J:340266
Atg16l1^{tm1c(EUCOMM)Wtsi}/Atg16l1^{tm1c(EUCOMM)Wtsi} Tg(Vil1-cre)997Gum/? (involves: C57BL/6J * C57BL/6N * SJL)	abnormal chemokine level	J:221019
	abnormal circulating interleukin level	J:221019
	abnormal cytokine level	J:221019
	cecum inflammation	J:221019
	increased circulating interleukin-1 beta level	J:221019
	increased circulating interleukin-6 level	J:221019
	increased susceptibility to bacterial infection	J:221019
Atg16l1^tm1Kuv/Atg16l1^tm1Kuv Tg(Vil1-cre)997Gum/0 (B6.Cg-Atg16l1^tm1Kuv Tg(Vil1-cre)997Gum)	increased susceptibility to induced colitis	J:269933
	small intestinal inflammation	J:269933
Atg16l1^tm1Kuv/Atg16l1^tm1Kuv Tg(Vil1-cre)997Gum/0 Xbp1^tm2Glm/Xbp1^tm2Glm (B6.Cg-Atg16l1^tm1Kuv Xbp1^tm2Glm Tg(Vil1-cre)997Gum)	small intestinal inflammation	J:269933
Atg16l1^tm1Kuv/Atg16l1^tm1Kuv Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	ileum inflammation	J:206084
	intestinal inflammation	J:206084
Atl1^tm1.2Cbla/Atl1^tm1.2Cbla Reep1^{Gt(OST398247)Tigm}/Reep1^{Gt(OST398247)Tigm} (B6.Cg-Reep1^{Gt(OST398247)Tigm} Atl1^tm1.2Cbla)	increased susceptibility to otitis media	J:334532
Atm^m1Btlr/Atm^m1Btlr (C57BL/6J-Atm^m1Btlr)	decreased response to antigen	J:265252
	impaired humoral immune response	J:265252
	increased IgM level	J:265252
Atm^m5Btlr/Atm^m5Btlr (C57BL/6J-Atm^m5Btlr)	decreased interleukin-1 beta secretion	J:272824
Atm^m5Btlr/Atm^m5Btlr (C57BL/6J-Atm^m5Btlr)	impaired macrophage phagocytosis	J:272824
Atm^tm1Awb/Atm^tm1Awb (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:150435
Atm^tm1Awb/Atm^tm1Awb Paxx^em1Spj/Paxx^em1Spj (involves: A/J * C57BL/6NTac)	abnormal class switch recombination	J:236776
Atm^tm1Bal/Atm^tm1Bal (involves: 129S4/SvJae)	abnormal microglial cell physiology	J:44190
	abnormal T cell physiology	J:35914
	decreased IgG2a level	J:35914
	decreased IgG2b level	J:35914
	decreased IgG3 level	J:35914
	decreased IgG level	J:35914
Atm^tm1Fwa/Atm^tm1Fwa (involves: 129S4/SvJae)	abnormal class switch recombination	J:191288
Atm^tm1Pmc/Atm^tm1Pmc Trp73^tm2Mak/Trp73^tm2Mak (involves: 129P2/OlaHsd * C57BL/6J)	decreased thymocyte apoptosis	J:157905
Atm^tm1Shzh/Atm^tm2.1Fwa Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ (involves: 129 * 129S6/SvEvTac)	abnormal class switch recombination	J:191288
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ (B6.Cg-Cd79a^tm1(Cre)Reth Atmin^tm1.1Jhh)	decreased IgG1 level	J:230105
	increased B cell apoptosis	J:230105
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghMyc)22Bri/0 (B6.Cg-Cd79a^tm1(Cre)Reth Atmin^tm1.1Jhh Tg(IghMyc)22Bri)	increased B cell apoptosis	J:230105
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:191832
Atp5if1^em1Jpy/Atp5if1^em1Jpy (C57BL/6J-Atp5if1^em1Jpy)	decreased susceptibility to colitis induced morbidity/mortality	J:312819
Atp6v1h^em1Xhd/Atp6v1h⁺ (involves: C57BL/6)	abnormal osteoclast physiology	J:239439
Atp7a^Mo-3Btlr/Y (C57BL/6J-Atp7a^Mo-3Btlr)	decreased susceptibility to prion infection	J:188598
Atp7a^Mo-blo/Y (B6.Cg-Atp7a^Mo-blo/J)	osteoarthritis	J:36378
Atp11c^ambr/Y (C57BL/6-Atp11c^ambr)	abnormal humoral immune response	J:171924
Atp11c^m1Btlr/Y (involves: C57BL/6J)	decreased IgA level	J:171925
	decreased IgG1 level	J:171925
	decreased IgM level	J:171925
Atr^tm1Bal/Atr^tm2Bal Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal thymus involution	J:123200
	kidney inflammation	J:123200
Atxn3^{tm1a(KOMP)Wtsi}/Atxn3^{tm1a(KOMP)Wtsi} (C57BL/6N-Atxn3^{tm1a(KOMP)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
AU040320^em1Janc/AU040320^em2Janc (FVB/N-AU040320^em1Janc AU040320^em2Janc)	decreased susceptibility to Parvoviridae infection	J:229089
Avil^tm2(cre)Fawa/Avil^tm2(cre)Fawa (B6J.129P2-Avil^tm2(cre)Fawa)	increased susceptibility to experimental autoimmune encephalomyelitis	J:265529
Avpr1a^tm1Sbhu/Avpr1a^tm1Sbhu (involves: C57BL/6)	abnormal immunoglobulin level	J:105892
	decreased IgG2b level	J:105892
	increased IgG2a level	J:105892
AW112010^em2Flv/AW112010^em2Flv (involves: C57BL/6N)	decreased circulating interleukin-6 level	J:267975
	decreased circulating interleukin-12b level	J:267975
	decreased interleukin-6 secretion	J:267975
	decreased interleukin-12b secretion	J:267975
	decreased susceptibility to induced colitis	J:267975
	increased susceptibility to bacterial infection	J:267975
	increased susceptibility to bacterial infection induced morbidity/mortality	J:267975
Awat2^tm1.2Golc/Y (involves: 129 * C57BL/6 * C57BL/6J)	blepharitis	J:308387
Awat2^tm1.2Golc/Y (involves: 129 * C57BL/6 * C57BL/6J)	eye inflammation	J:308387
Awat2^tm1.2Golc/Awat2^tm1.2Golc (involves: 129 * C57BL/6 * C57BL/6J)	blepharitis	J:308387
	eye inflammation	J:308387
Axl^tm1Grl/Axl^tm1Grl Mertk^tm1Grl/Mertk^tm1Grl (involves: C57BL/6J)	increased anti-double stranded DNA antibody level	J:70420
Axl^tm1Grl/Axl^tm1Grl Mertk^tm1Grl/Mertk^tm1Grl Tyro3^tm1Grl/Tyro3^tm1Grl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal B cell activation	J:70420
	abnormal macrophage physiology	J:70420
	abnormal professional antigen presenting cell physiology	J:70420
	abnormal susceptibility to autoimmune disorder	J:70420
	abnormal T cell activation	J:70420
	increased anti-double stranded DNA antibody level	J:70420
	increased autoantibody level	J:70420
	increased B cell proliferation	J:70420
	increased circulating tumor necrosis factor level	J:70420
	increased splenocyte apoptosis	J:54681
	increased T cell proliferation	J:70420
	joint inflammation	J:70420
Axl^tm1Grl/Axl^tm1Grl Tyro3^tm1Grl/Tyro3^tm1Grl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased anti-double stranded DNA antibody level	J:70420
Azi2^tm1Aki/Azi2^tm1Aki (Not Specified)	abnormal dendritic cell physiology	J:204786
	decreased interferon-alpha secretion	J:204786
	decreased interleukin-6 secretion	J:204786
	decreased tumor necrosis factor secretion	J:204786
Azi2^tm1Aki/Azi2^tm1Aki Tbkbp1^tm1Aki/Tbkbp1^tm1Aki (Not Specified)	abnormal dendritic cell physiology	J:204786
	decreased interferon-alpha secretion	J:204786
	decreased interleukin-6 secretion	J:204786
	decreased tumor necrosis factor secretion	J:204786
B2m^tm1Jae/B2m^tm1Jae (involves: 129S2/SvPas * C57BL/6J)	abnormal cytotoxic T cell physiology	J:80910
B2m^tm1Jae/B2m^tm1Jae (B6.129S2-B2m^tm1Jae)	decreased interleukin-4 secretion	J:64283
	decreased susceptibility to parasitic infection	J:64283
	increased interleukin-3 secretion	J:64283
	increased tumor necrosis factor secretion	J:64283
B2m^tm1Jae/B2m^tm1Jae Foxp3^sf Otc^spf/Y (involves: 129/Rl * 129S2/SvPas)	abnormal interleukin level	J:20865
	abnormal tumor necrosis factor level	J:20865
	dermatitis	J:20865
	increased IgG level	J:20865
	increased IgM level	J:20865
	increased immunoglobulin level	J:20865
B2m^tm1Jae/B2m^tm1Jae Rr94^tm3.2Litt/Rr94^tm3.2Litt (involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)	increased T cell proliferation	J:158962
B2m^tm1Jae/B2m^tm1Jae Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)	small intestinal inflammation	J:108572
B2m^tm1Unc/B2m⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased level of surface class I molecules	J:64451
B2m^tm1Unc/B2m^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased level of surface class I molecules	J:64451
B2m^tm1Unc/B2m^tm1Unc (NOD.129P2-B2m^tm1Unc)	decreased susceptibility to autoimmune diabetes	J:121685, J:17000
B2m^tm1Unc/B2m^tm1Unc (involves: 129P2/OlaHsd * NOD/Lt)	insulitis	J:93557
B2m^tm1Unc/B2m^tm1Unc (B6.129P2-B2m^tm1Unc/DcrJ)	abnormal interleukin level	J:123934
	abnormal tumor necrosis factor level	J:123934
	decreased IgG level	J:110885
	decreased susceptibility to autoimmune diabetes	J:135214
	decreased susceptibility to bacterial infection	J:123934
	increased IgM level	J:110885
	increased susceptibility to infection induced morbidity/mortality	J:123934
B2m^tm1Unc/B2m^tm1Unc Cd4^tm1Mak/Cd4^tm1Mak Cd8a^{tm2.1(Cd4)Asin}/Cd8a^{tm2.1(Cd4)Asin} (involves: 129 * C57BL/6)	abnormal T cell physiology	J:180236
B2m^tm1Unc/B2m^tm1Unc Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.Cg-B2m^tm1Unc Ciita^tm1Ccum)	decreased susceptibility to autoimmune diabetes	J:107051
B2m^tm1Unc/B2m^tm1Unc Emv30^b/Emv30^b Prkdc^scid/Prkdc^scid Tg(B2M)55Hpl/? Mcph1^{Tg(HLA-A2.1)1Enge}/? (NOD.Cg-B2m^tm1Unc Mcph1^{Tg(HLA-A2.1)1Enge} Emv30^b Prkdc^scid Tg(B2M)55Hpl/Dvs)	decreased susceptibility to autoimmune diabetes	J:109851
B2m^tm1Unc/B2m^tm1Unc Il2^tm1Hor/Il2^tm1Hor (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:51450
	colitis	J:39981, J:51450
B2m^tm1Unc/B2m^tm1Unc Prkdc^scid/Prkdc^scid (NOD.Cg-B2m^tm1Unc Prkdc^scid)	abnormal NK cell physiology	J:102141
	abnormal response to transplant	J:102141
	decreased level of surface class I molecules	J:102141
B2m^tm1Unc/B2m^tm1Unc Tg(B2M)55Hpl/0 (NOD.Cg-B2m^tm1Unc Tg(B2M)55Hpl/Dvs)	decreased susceptibility to autoimmune diabetes	J:71837
B2m^tm1Unc/B2m^tm1Unc Tg(B2M)55Hpl/Tg(B2M)55Hpl Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1^{Tg(HLA-A2.1)1Enge} (NOD.Cg-B2m^tm1Unc Mcph1^{Tg(HLA-A2.1)1Enge} Tg(B2M)55Hpl)	increased susceptibility to autoimmune diabetes	J:109851
B2m^tm1Unc/B2m^tm1Unc Tg(GFAP-B2m)9Mdos/? (involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)	decreased susceptibility to autoimmune diabetes	J:135214
B2m^tm1Unc/B2m^tm1Unc Tg(GFAP-B2m)#Mdos/? (involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)	decreased susceptibility to autoimmune diabetes	J:135214
B2m^tm1Unc/B2m^tm1Unc Tg(HLA-A/H2-D/B2M)1Dvs/0 (NOD.Cg-B2m^tm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)	abnormal CD8-positive, alpha-beta T cell physiology	J:121685
	abnormal cell-mediated immunity	J:121685
	abnormal cytotoxic T cell physiology	J:121685
	increased susceptibility to autoimmune diabetes	J:121685
B2m^tm1Unc/B2m^tm1Unc Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-B2m^tm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	decreased susceptibility to autoimmune diabetes	J:93553
B2m^tm1Unc/B2m^tm1Unc X/Yaa (BXSB.129P2(B6)-B2m^tm1Unc/Dcr)	increased anti-nuclear antigen antibody level	J:179430
B2m^tm1Unc/B2m^tm1Unc X/Yaa (BXSB.129P2(B6)-B2m^tm1Unc/Dcr)	increased susceptibility to systemic lupus erythematosus	J:179430
B3gnt2^{Gt(OST237555)Lex}/B3gnt2^{Gt(OST237555)Lex} (involves: 129S5/SvEvBrd * C57BL/6N)	abnormal macrophage physiology	J:125556
	increased interleukin-1 beta secretion	J:125556
	increased interleukin-6 secretion	J:125556
	increased T cell proliferation	J:125556
	increased tumor necrosis factor secretion	J:125556
B3gnt5^tm1Nari/B3gnt5^tm1Nari (involves: 129P2/OlaHsd * C57BL/6)	increased IgG2a level	J:161366
	increased IgG2b level	J:161366
	increased IgG level	J:161366
B3gnt6^tm1Lx/B3gnt6^tm1Lx (involves: 129S1/Sv * C57BL/6J)	increased interferon-gamma secretion	J:123826
	increased interleukin-2 secretion	J:123826
	increased susceptibility to induced colitis	J:123826
	increased tumor necrosis factor secretion	J:123826
B3gnt6^tm1Lx/B3gnt6^tm1Lx C1galt1^tm1.1Rpmc/C1galt1^tm1.1Rpmc Tg(Vil1-cre)997Gum/0 (involves: 129S1/Sv * C57BL/6J * SJL)	small intestinal inflammation	J:239765
B4galt1^tm1Yiw/B4galt1^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal leukocyte physiology	J:106669
	abnormal neutrophil physiology	J:106669
	decreased acute inflammation	J:106669
	decreased susceptibility to type IV hypersensitivity reaction	J:106669
	impaired macrophage chemotaxis	J:89125
	impaired neutrophil recruitment	J:89125
B4galt1^tm1Yiw/B4galt1^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal IgM level	J:117891
	glomerulonephritis	J:117891
	increased IgA level	J:117891
B4gat1^tm1Mifu/B4gat1^tm1Mifu (B6.Cg-B4gat1^tm1Mifu)	impaired leukocyte tethering or rolling	J:120722
B4gat1^tm1Mifu/B4gat1^tm1Mifu Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:120722
	decreased susceptibility to type IV hypersensitivity reaction	J:120722
	impaired leukocyte tethering or rolling	J:120722
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal regulatory T cell physiology	J:204761
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal inflammatory response	J:123547
	abnormal interferon level	J:123547
	abnormal interleukin level	J:123547
	abnormal T cell activation	J:123547
	colitis	J:123547
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:123547
	increased anti-double stranded DNA antibody level	J:123547
	increased anti-nuclear antigen antibody level	J:123547
	increased T cell proliferation	J:123547
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S6/SvEvTac * 129X1/SvJ)	colitis	J:169839
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:169839
	liver inflammation	J:169839
	lung inflammation	J:169839
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal inflammatory response	J:123547
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal regulatory T cell physiology	J:204761
B9d2/Tgfb1^tm1Flv/B9d2⁺ Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S6/SvEvTac * 129X1/SvJ)	colitis	J:169839
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:169839
	liver inflammation	J:169839
	lung inflammation	J:169839
B9d2^{tm1a(EUCOMM)Wtsi}/B9d2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-B9d2^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Baa1^BALB/cJ/Baa1^NZW/LacJ (involves: BALB/cJ * NZW/LacJ)	increased IgM level	J:35434
Baa2^BALB/cJ/Baa2^NZW/LacJ (involves: BALB/cJ * NZW/LacJ)	increased IgM level	J:35434
Bach2^m2Anu/Bach2^m2Anu (C57BL/6NCrlAnu-Bach2^m2Anu)	increased IgM level	J:104190
Bach2^tm1Igar/Bach2^tm1Igar (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell physiology	J:91110
	abnormal class switch recombination	J:91110
	abnormal somatic hypermutation frequency	J:91110
	decreased IgA level	J:91110
	decreased IgG1 level	J:91110
	decreased IgG2a level	J:91110
	decreased IgG2b level	J:91110
	decreased IgG3 level	J:91110
	decreased IgG level	J:91110
	increased IgM level	J:91110
Bad^tm1Sjk/Bad^tm1Sjk (either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6))	abnormal B cell physiology	J:84987
	abnormal T cell physiology	J:84987
Bag4^tm1Yeh/Bag4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:83559
	increased circulating interleukin-6 level	J:83559
	increased inflammatory response	J:83559
	increased interleukin-6 secretion	J:83559
Bahd1^tm1.1Ics/Bahd1⁺ (involves: C57BL/6)	decreased susceptibility to bacterial infection	J:169470
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm1Sjk (involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)	abnormal splenocyte physiology	J:66872
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm2Sjk Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal B cell physiology	J:100463
	increased IgA level	J:100463
	increased IgG level	J:100463
	increased IgM level	J:100463
	increased immunoglobulin level	J:100463
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm2Sjk Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	arthritis	J:100463
	glomerulonephritis	J:100463
	increased anti-double stranded DNA antibody level	J:100463
	increased susceptibility to autoimmune disorder	J:100463
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm2Sjk/Bax^tm2Sjk Tg(Lck-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte apoptosis	J:220951
Bank1^tm1Kuro/Bank1^tm1Kuro (Not Specified)	abnormal B cell physiology	J:113321
	abnormal lymphocyte physiology	J:113321
	increased B cell proliferation	J:113321
	increased IgG2a level	J:113321
	increased IgM level	J:113321
Bap1^tm1.1Geno/Bap1^tm1.1Geno Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	heart inflammation	J:187380
Batf2^tm1Kmm/Batf2^tm1Kmm (129S6/SvEvTac-Batf2^tm1Kmm)	increased susceptibility to parasitic infection induced morbidity/mortality	J:101977
Batf3^tm1Kmm/Batf3^tm1Kmm (involves: 129S6/SvEvTac * BALB/cJ)	abnormal cytotoxic T cell physiology	J:141064
	abnormal dendritic cell antigen presentation	J:141064
	abnormal dendritic cell physiology	J:141064
	abnormal immune system physiology	J:141064
	decreased cytotoxic T cell cytolysis	J:141064
Batf3^tm1Kmm/Batf3^tm1Kmm (involves: 129S6/SvEvTac)	abnormal cytotoxic T cell physiology	J:181366
Batf3^tm1Kmm/Batf3^tm1Kmm Id2^tm1Gtbz/Id2^tm1Gtbz (B6.Cg-Batf3^tm1Kmm Id2^tm1Gtbz)	abnormal dendritic cell physiology	J:194760
Batf^tm1.1Ejt/Batf^tm1.1Ejt (involves: 129S/Sv * C57BL/6 * FVB/N)	abnormal class switch recombination	J:160935
	decreased IgA level	J:160935
	decreased IgE level	J:160935
	decreased IgG1 level	J:160935
	decreased IgG2c level	J:160935
	decreased IgM level	J:160935
	decreased interleukin-4 secretion	J:160935
	decreased interleukin-17 secretion	J:160935
Batf^tm1.1Kmm/Batf^tm1.1Kmm (129S6/SvEvTac-Batf^tm1.1Kmm)	decreased interleukin-17 secretion	J:150643
	decreased interleukin-21 secretion	J:150643
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:150643
Bbaa1^C3H/HeNCr/Bbaa1^C3H/HeNCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal inflammatory response	J:52017
Bbaa1^C3H/HeNCr/Bbaa1^C57BL/6NCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal inflammatory response	J:52017
Bbaa2^C3H/HeNCr/Bbaa2^C3H/HeNCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal immune system physiology	J:52017
Bbaa3^C3H/HeNCr/Bbaa3^C3H/HeNCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal inflammatory response	J:73060
Bbaa3^C3H/HeNCr/Bbaa3^C57BL/6NCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal inflammatory response	J:52017
Bbaa5^C57BL/6NCr/Bbaa5^C57BL/6NCr (involves: C3H/HeNCr * C57BL/6NCr)	increased IgM level	J:52017
Bbaa9^C57BL/6NCr/Bbaa9^C3H/HeNCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal immunoglobulin level	J:52017
Bbaa9^C57BL/6NCr/Bbaa9^C57BL/6NCr (involves: C3H/HeNCr * C57BL/6NCr)	abnormal immunoglobulin level	J:52017
Bbaa10^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa11^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa12^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa13^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa14^C3H/HeJ/? (involves: C3H/HeN * C57BL/6N)	increased IgG level	J:73060
Bbaa14^C3H/HeJ/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa15^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased IgG level	J:73060
Bbaa16^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa17^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa18^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa19^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased IgG level	J:73060
Bbaa20^C3H/HeJ/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa21^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased susceptibility to bacterial infection	J:73060
Bbaa22^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbaa23^C3H/HeN/? (involves: C3H/HeN * C57BL/6N)	increased inflammatory response	J:73060
Bbc3^tm1Ast/Bbc3^tm1Ast (involves: C57BL/6 * NZB)	abnormal CD8-positive, alpha-beta T cell physiology	J:132819
Bbs4^Gt1Nk/Bbs4^Gt1Nk (involves: 129S7/SvEvBrd)	increased immunoglobulin level	J:134093
Bbs12^tm1.1Vmar/Bbs12^tm1.1Vmar (involves: 129S6/SvEvTac * C57BL/6)	decreased circulating interleukin-6 level	J:189019
	decreased circulating tumor necrosis factor level	J:189019
	decreased inflammatory response	J:189019
Bbx^{tm1a(EUCOMM)Wtsi}/Bbx^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased IgA level	J:213427
Bcap31^tm1.1Bwang/Bcap31^tm1.1Bwang Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased inflammatory response	J:292505
	increased interleukin-1 beta secretion	J:292505
	increased microglial cell activation	J:292505
	increased tumor necrosis factor secretion	J:292505
Bcap31^tm1.1Bwang/Bcap31^tm1.1Bwang Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal T cell activation	J:274469
	decreased interferon-gamma secretion	J:274469
	decreased interleukin-2 secretion	J:274469
	decreased T cell proliferation	J:274469
	increased thymocyte apoptosis	J:274469
Bcas1^tm1Himo/Bcas1^tm1Himo (C57BL/6-Bcas1^tm1Himo)	brain inflammation	J:242041
Bcat1^tm1.2Eaa/Bcat1^tm1.2Eaa (involves: C57BL/6)	abnormal T cell physiology	J:216027
Bcl2^tm1Dlo/Bcl2^tm1Dlo (B6.129P2-Bcl2^tm1Dlo)	abnormal lymphocyte physiology	J:104487, J:73316
	increased B cell apoptosis	J:73316
	increased splenocyte apoptosis	J:153846
	increased T cell apoptosis	J:73316
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.129-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	abnormal lymphocyte physiology	J:73316
	increased T cell apoptosis	J:73316
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	abnormal lymphocyte physiology	J:73316
	decreased B cell apoptosis	J:73316
	increased T cell apoptosis	J:73316
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm3.1Boui/Bcl2l11^tm3.1Boui (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm3.1Boui)	decreased splenocyte apoptosis	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bik^tm1Ast/Bik^tm1Ast (B6.Cg-Bcl2^tm1Dlo Bik^tm1Ast)	abnormal lymphocyte physiology	J:104487
Bcl2^tm1Irt/Bcl2^tm1Irt Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage apoptosis	J:144243
Bcl2^tm1Lbox/Bcl2^tm1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal B cell activation	J:114637
	decreased B cell proliferation	J:114637
	increased B cell apoptosis	J:114637
Bcl2^tm1Sjk/Bcl2^tm1Sjk (involves: 129S2/SvPas * C57BL/6)	abnormal thymus involution	J:15224
Bcl2^tm1Sjk/Bcl2^tm1Sjk (involves: 129S2/SvPas * C57BL/6)	increased T cell apoptosis	J:15224
Bcl2^tm1Tsu/Bcl2^tm1Tsu (involves: 129P2/OlaHsd * ICR)	abnormal T cell physiology	J:22391
Bcl2^tm2.1Lbox/Bcl2⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal B cell physiology	J:175730
Bcl2^tm2.1Lbox/Bcl2^tm2.1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal B cell physiology	J:175730
Bcl2a1a^tm1.1Tac/Bcl2a1a^tm1.1Tac Bcl2a1b^tm1.1Tac/Bcl2a1b^tm1.1Tac Bcl2a1d^tm1.1Tac/Bcl2a1d^tm1.1Tac (involves: BALB/cJ * C57BL/6NTac)	abnormal dendritic cell physiology	J:258915
Bcl2a1a^tm1Prys/Bcl2a1a^tm1Prys (involves: 129/Sv * C57BL/6J * SJL)	abnormal neutrophil physiology	J:74478
	decreased inflammatory response	J:74478
	decreased susceptibility to parasitic infection	J:74478
Bcl2a1a^tm1Sen/Bcl2a1a^tm1Sen (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:52127
Bcl2l1^tm1Cant/Bcl2l1^tm1Cant (involves: 129S6/SvEvTac)	abnormal memory T cell physiology	J:77507
	abnormal T cell physiology	J:77507
	decreased interleukin-2 secretion	J:77507
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:77507
	decreased T cell proliferation	J:77507
Bcl2l1^tm1Dlo/Bcl2l1^tm1.1Mam Tg(Aicda-cre)9Mbu/0 (B6.Cg-Bcl2l1^tm1Dlo/Bcl2l1^tm1.1Mam Tg(Aicda-cre)9Mbu)	decreased IgG1 level	J:166069
Bcl2l11^tm1.1Ast/Bcl2l11⁺ (involves: 129S1/Sv * C57BL/6)	abnormal lymphocyte physiology	J:58641
	glomerulonephritis	J:58641
	increased IgA level	J:58641
	increased IgG level	J:58641
	increased IgM level	J:58641
	increased susceptibility to autoimmune disorder	J:58641
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (involves: 129S1/Sv * C57BL/6)	abnormal B cell proliferation	J:90963
	abnormal lymphocyte physiology	J:58641
	decreased B cell apoptosis	J:90963
	glomerulonephritis	J:58641
	increased anti-double stranded DNA antibody level	J:132217
	increased anti-histone antibody level	J:132217
	increased anti-nuclear antigen antibody level	J:132217
	increased anti-single stranded DNA antibody level	J:132217
	increased autoantibody level	J:132217
	increased IgA level	J:58641
	increased IgG level	J:58641
	increased IgM level	J:58641
	increased inflammatory response	J:58641
	increased susceptibility to autoimmune disorder	J:58641
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129S1-Bcl2l11^tm1.1Ast)	abnormal lymphocyte physiology	J:73316
	abnormal response to infection	J:123409
	decreased B cell apoptosis	J:73316
	decreased T cell apoptosis	J:73316, J:133084
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (involves: 129S1/Sv)	abnormal CD8-positive, alpha-beta T cell physiology	J:132819
	decreased splenocyte apoptosis	J:266833
	decreased thymocyte apoptosis	J:266833
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129S1-Bcl2l11^tm1.1Ast/J)	decreased T cell apoptosis	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bik^tm1Ast/Bik^tm1Ast (B6.Cg-Bcl2l11^tm1.1Ast Bik^tm1Ast)	abnormal lymphocyte physiology	J:103605
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bmf^tm1Rjd/Bmf^tm1Rjd (B6.129S-Bcl2l11^tm1.1Ast Bmf^tm1Rjd)	decreased T cell apoptosis	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Fas^lpr/Fas^lpr (B6.Cg-Bcl2l11^tm1.1Ast Fas^lpr)	increased anti-double stranded DNA antibody level	J:132217
	increased anti-histone antibody level	J:132217
	increased anti-nuclear antigen antibody level	J:132217
	increased anti-single stranded DNA antibody level	J:132217
	increased autoantibody level	J:132217
	increased susceptibility to autoimmune disorder	J:132217
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Mlf1^tm1Swm/Mlf1^tm1Swm (involves: 129S1/Sv * C57BL/6)	decreased splenocyte apoptosis	J:266833
	decreased thymocyte apoptosis	J:266833
Bcl2l11^tm1Sjk/Bcl2l11^tm1Sjk (involves: 129X1/SvJ)	abnormal B cell physiology	J:100463
Bcl2l11^tm1Sjk/Bcl2l11^tm1Sjk (involves: 129X1/SvJ)	increased immunoglobulin level	J:100463
Bcl2l11^tm3Rjd/Bcl2l11^tm3Rjd (B6.129S6-Bcl2l11^tm3Rjd)	decreased thymocyte apoptosis	J:137061
Bcl2l14^tm1.1Boui/Bcl2l14^tm1.1Boui (involves: C57BL/6)	abnormal susceptibility to induced colitis	J:296081
Bcl3^m1Btlr/Bcl3^m1Btlr (C57BL/6J-Bcl3^m1Btlr)	abnormal humoral immune response	J:255184
	decreased IgE level	J:255184
	decreased IgG level	J:255184
Bcl3^m2Btlr/Bcl3^m2Btlr (C57BL/6J-Bcl3^m2Btlr)	decreased IgD level	J:264818
Bcl3^m2Btlr/Bcl3^m2Btlr (C57BL/6J-Bcl3^m2Btlr)	increased IgM level	J:264818
Bcl3^tm1Rsch/Bcl3^tm1Rsch (involves: 129P2/OlaHsd * CD-1)	abnormal cytokine secretion	J:116724
	abnormal innate immunity	J:116724
	increased susceptibility to bacterial infection	J:116724
Bcl3^tm1Rsch/Bcl3^tm1Rsch (B6.Cg-Bcl3^tm1Rsch)	abnormal cytokine secretion	J:116724
Bcl3^tm1Rsch/Bcl3^tm1Rsch (B6.Cg-Bcl3^tm1Rsch)	abnormal macrophage physiology	J:116724
Bcl3^tm1Sbn/Bcl3^tm1Sbn (involves: 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:39747
	abnormal cytotoxic T cell physiology	J:39747
	decreased IgG2a level	J:39747
	decreased interferon-gamma secretion	J:39747
	decreased interleukin-12 secretion	J:39747
	increased susceptibility to parasitic infection	J:39747
Bcl3^tm1Sbn/Bcl3^tm1Sbn (involves: 129S4/SvJae)	abnormal B cell physiology	J:207111
	decreased B cell proliferation	J:207111
	increased B cell proliferation	J:207111
Bcl3^tm1Ver/Bcl3^tm1Ver (involves: 129P2/OlaHsd * FVB/NJ)	abnormal humoral immune response	J:38092
Bcl3^tm1Ver/Bcl3^tm1Ver (involves: 129P2/OlaHsd * FVB/NJ)	increased susceptibility to bacterial infection	J:38092
Bcl6^tm1.1Dent/Bcl6^tm1.1Dent Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)	decreased IgG level	J:202372
	decreased interleukin-4 secretion	J:202372
	increased interleukin-10 secretion	J:202372
Bcl6^tm1.1Jwan/Bcl6^tm1.1Jwan (involves: 129S6/SvEvTac)	abnormal somatic hypermutation frequency	J:190534
Bcl6^tm1.1Meln/Bcl6^tm1.1Meln (involves: 129 * C57BL/6 * FVB/N)	abnormal adaptive immunity	J:194821
	abnormal germinal center B cell physiology	J:194821
	abnormal professional antigen presenting cell physiology	J:194821
	decreased IgG1 level	J:194821
	decreased IgG2a level	J:194821
	decreased IgG level	J:194821
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * C57BL/6JJcl)	abnormal humoral immune response	J:190943
	abnormal memory B cell physiology	J:190943
	abnormal somatic hypermutation frequency	J:190943
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JJcl * DBA/2)	abnormal humoral immune response	J:190943
	abnormal somatic hypermutation frequency	J:190943
Bcl6^tm1.1Toka/Bcl6⁺ Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6 * NZB)	decreased T cell proliferation	J:174014
Bcl6^tm1.1Toka/Bcl6^tm1.1Toka Tg(IghelMD4)4Ccg/0 (involves: C57BL/6 * NZB)	abnormal germinal center B cell physiology	J:174014
	increased activation-induced B cell apoptosis	J:174014
Bcl6^tm1Gdba/Bcl6^tm1Gdba Tg(Adipoq-cre)1Evdr/0 (involves: C57BL/6 * FVB/NJ)	white adipose tissue inflammation	J:271078
Bcl6^tm1Htno/Bcl6^tm1Htno (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	lung inflammation	J:55952
	myocarditis	J:55952
Bcl6^tm1Rdf/Bcl6^tm1Rdf (involves: 129S1/Sv)	abnormal B cell physiology	J:40769
	abnormal humoral immune response	J:40769
	abnormal immune system physiology	J:40769
	abnormal T-helper 2 physiology	J:40769
	decreased IgG level	J:40769
	decreased IgM level	J:40769
	heart inflammation	J:40769
	increased inflammatory response	J:40769
	increased susceptibility to bacterial infection	J:40769
	liver inflammation	J:40769
	lung inflammation	J:40769
Bcl6^tm1Sdt/Bcl6^tm1Sdt (involves: 129/Sv * C57BL/6)	abnormal chemokine level	J:123621
Bcl6^tm1Sdt/Bcl6^tm1Sdt (involves: 129/Sv * C57BL/6)	abnormal immune system physiology	J:123621
Bcl6^tm1Sdt/Bcl6^tm1Sdt Bcl6b^tm2Dent/Bcl6b^tm2Dent (involves: 129/Sv * C57BL/6)	abnormal immune system physiology	J:123621
Bcl6^tm2Rdf/Bcl6^tm2Rdf (involves: 129S1/Sv)	abnormal B cell physiology	J:40769
	abnormal humoral immune response	J:40769
	abnormal immune system physiology	J:40769
	abnormal T-helper 2 physiology	J:40769
	decreased B cell proliferation	J:40769
	decreased IgG level	J:40769
	decreased IgM level	J:40769
	heart inflammation	J:40769
	increased inflammatory response	J:40769
	increased susceptibility to bacterial infection	J:40769
	liver inflammation	J:40769
	lung inflammation	J:40769
Bcl6b^tm1Dtf/Bcl6b^tm1Dtf (involves: 129P2/OlaHsd)	abnormal response to infection	J:99818
Bcl6b^tm1Dtf/Bcl6b^tm1Dtf (involves: 129P2/OlaHsd)	decreased T cell proliferation	J:99818
Bcl10^m1Btlr/Bcl10^m1Btlr (C57BL/6J-Bcl10^m1Btlr)	abnormal humoral immune response	J:265122
	decreased IgG level	J:265122
	increased IgE level	J:265122
	increased IgM level	J:265122
Bcl10^tm1Mak/Bcl10^tm1Mak (involves: 129P2/OlaHsd)	abnormal cytotoxic T cell physiology	J:67297
	abnormal dendritic cell physiology	J:111706
	abnormal immune cell physiology	J:67297
	abnormal response to infection	J:67297
	abnormal T cell activation	J:67297
	decreased B cell proliferation	J:109545, J:67297
	decreased IgG level	J:67297
	decreased IgM level	J:67297
	decreased immunoglobulin level	J:67297
	decreased T cell proliferation	J:109545, J:67297
	increased susceptibility to infection	J:67297
Bcl10^tm1Swm/Bcl10^tm1Swm (involves: 129P2/OlaHsd)	abnormal humoral immune response	J:85147
	abnormal marginal zone B cell physiology	J:85147
	decreased B cell proliferation	J:85147
	increased susceptibility to bacterial infection	J:85147
Bcl10^tm1Swm/Bcl10^tm1Swm (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:122394
	abnormal dendritic cell physiology	J:122394
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased circulating interferon-alpha level	J:207383
Bcl11a^tm2.1Peli/Bcl11a^tm2.1Peli Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	increased B cell apoptosis	J:194616
Bcl11b^tm1Avram/Bcl11b^tm1Avram Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal thymocyte activation	J:128515
Bcl11b^tm1Jpk/Bcl11b^tm1Jpk (involves: BALB/c * C57BL/6 * CBA)	increased thymocyte apoptosis	J:83651
Bclaf1^tm1Raz/Bclaf1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell proliferation	J:158087
Bclaf1^tm1Raz/Bclaf1^tm1Raz (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell proliferation	J:158087
Bcr^tm1Hkp/Bcr^tm1Hkp (involves: 129S2/SvPas)	abnormal neutrophil physiology	J:23804
	increased susceptibility to endotoxin shock	J:23804
	sepsis	J:23804
Bcs1l^tm1.1Levp/Bcs1l^tm1.1Levp (B6.129-Bcs1l^tm1.1Levp)	liver inflammation	J:273501
Bdkrb1^tm1Bdr/Bdkrb1^tm1Bdr (involves: 129P2/OlaHsd)	abnormal acute inflammation	J:63271
Bdkrb1^tm1Bdr/Bdkrb1^tm1Bdr (involves: 129P2/OlaHsd)	decreased susceptibility to endotoxin shock	J:135789
Bdkrb1^tm2Bdr/Bdkrb1^tm2Bdr Bdkrb2^tm1Jfh/Bdkrb2^tm1Jfh (involves: 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to endotoxin shock	J:135789
Becn1^tm1.1Bflu/Becn1^tm1.1Bflu Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:203090
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:203090
	decreased T cell proliferation	J:203090
	increased T cell apoptosis	J:203090
Becn1^tm1Ebr/Becn1^tm1Ebr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal circulating chemokine level	J:235399
	abnormal macrophage physiology	J:235399
	decreased circulating interleukin-10 level	J:235399
	glomerulonephritis	J:235399
	increased anti-double stranded DNA antibody level	J:235399
	increased anti-nuclear antigen antibody level	J:235399
	increased autoantibody level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased IgG level	J:235399
	increased susceptibility to systemic lupus erythematosus	J:235399
Belr1^BALB/cJ/Belr1^BALB/cJ (involves: BALB/cJ * C57BL/6J)	decreased susceptibility to parasitic infection	J:133125
Belr1^BALB/cJ/Belr1^BALB/cJ (B6.C-H2^d/bByJ)	decreased susceptibility to parasitic infection	J:133125
Berr1^WLA/Pas/? (involves: C57BL/6JRj * WLA/Pas)	decreased susceptibility to parasitic infection	J:78027
Berr2^WLA/Pas/? (involves: C57BL/6JRj * WLA/Pas)	decreased susceptibility to parasitic infection	J:78027
Best3^tm1.1Zhoj/Best3^tm1.1Zhoj Tg(Tagln-cre)1Her/0 (involves: C57BL/6 * SJL)	aortitis	J:338981
Bgn^tm1Mfy/Y (involves: 129S4/SvJae * C57BL/6)	osteoarthritis	J:76203
Bgn^tm1Mfy/Y Fmod^tm1Aol/Fmod^tm1Aol (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	osteoarthritis	J:76203
Bgn^tm1Mfy/Y Fmod^tm1Aol/Fmod^tm1Aol (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	accelerated temporomandibular joint osteoarthritis	J:112779, J:117908
Bgn^tm1Mfy/Bgn^tm1Mfy (involves: 129S4/SvJae)	osteoarthritis	J:222369
Bgn^tm1Mfy/Bgn^tm1Mfy Epyc^tm1Mhok/Epyc^tm1Mhok (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)	osteoarthritis	J:222369
Bgn^tm1Mfy/Bgn^tm1Mfy Fmod^tm1Aol/Fmod^tm1Aol (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	accelerated temporomandibular joint osteoarthritis	J:117908
bhe/bhe (Not Specified)	chronic inflammation	J:85113
Bhlhe40^tm1Tan/Bhlhe40^tm1Tan (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal CD4-positive, alpha-beta T cell physiology	J:72651
	abnormal immune system physiology	J:72651
	abnormal susceptibility to autoimmune disorder	J:72651
	abnormal T cell activation	J:72651
	decreased interleukin-2 secretion	J:72651
	decreased T cell proliferation	J:72651
	increased anti-nuclear antigen antibody level	J:72651
	increased IgE level	J:72651
	increased IgG1 level	J:72651
Bhlhe41^tm1.1Cdon/Bhlhe41^tm1.1Cdon (B6.129S6-Bhlhe41^tm1.1Cdon)	decreased interferon-gamma secretion	J:157740
	decreased interleukin-2 secretion	J:157740
	decreased interleukin-5 secretion	J:157740
	decreased interleukin-13 secretion	J:157740
	decreased T cell proliferation	J:157740
	increased interleukin-4 secretion	J:157740
	increased interleukin-17 secretion	J:157740
Bid^tm1Sjk/Bid^tm1Sjk (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to endotoxin shock	J:117693
Bin1^tm1Gcp/Bin1^tm2Gcp Tg(Wap-cre)11738Mam/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)	endometrium inflammation	J:117330
Bin3^tm1Gcp/Bin3^tm1Gcp (involves: 129 * C57BL/6)	liver inflammation	J:133313
Bin3^tm1Gcp/Bin3^tm1Gcp (involves: 129 * C57BL/6)	lung inflammation	J:133313
Birc2^tm1Rbr/Birc2^tm1Rbr Birc3^tm1.1Rbr/Birc3^tm1.1Rbr Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * NZB)	decreased B cell apoptosis	J:172843
Birc2^tm2.1Jda/Birc2^tm2.1Jda (B6.Cg-Birc2^tm2.1Jda)	increased interferon-gamma secretion	J:199221
Birc2^tm2.1Jda/Birc2^tm2.1Jda (B6.Cg-Birc2^tm2.1Jda)	increased T cell proliferation	J:199221
Birc3^tm1Jda/Birc3^tm1Jda (B6.Cg-Birc3^tm1Jda)	decreased B cell apoptosis	J:166899
	decreased IgG1 level	J:166899
	increased B cell proliferation	J:166899
	increased IgA level	J:166899
	increased IgG3 level	J:166899
	increased IgM level	J:166899
Birc3^tm1Jda/Birc3^tm1Jda (involves: 129 * C57BL/6)	increased interferon-gamma secretion	J:199221
Birc3^tm1Jda/Birc3^tm1Jda (involves: 129 * C57BL/6)	increased T cell proliferation	J:199221
Birc3^tm1Rgk/Birc3^tm1Rgk (B6.129X1-Birc3^tm1Rgk)	abnormal cytokine secretion	J:144012
	abnormal immune cell physiology	J:144012
	abnormal interleukin-1 beta secretion	J:144012
	abnormal interleukin-12 secretion	J:144012
	abnormal macrophage physiology	J:144012
	abnormal T cell physiology	J:144012
	abnormal tumor necrosis factor secretion	J:144012
	decreased susceptibility to endotoxin shock	J:144012
Birc5^tm1Mak/Birc5^tm1Mak Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd)	increased T cell apoptosis	J:90892
Birc6^tm1Nai/Birc6^tm1Nai (involves: 129S4/SvJae * C57BL/6J)	increased thymocyte apoptosis	J:96768
Bld/Bld⁺ (involves: BALB/cCi)	increased incidence of corneal inflammation	J:5076
Blk^m1Btlr/Blk^m1Btlr (C57BL/6J-Blk^m1Btlr)	increased IgE level	J:255004
Blk^m1Btlr/Blk^m1Btlr (C57BL/6J-Blk^m1Btlr)	increased interleukin-1 beta secretion	J:255004
Blm^tm3Brd/Blm^tm3Brd (involves: 129S7/SvEvBrd * C57BL/6)	decreased IgM level	J:66261
Blm^tm4Ches/Blm^tm4Ches Cd19^tm1(cre)Cgn/Cd19⁺ Nsmce2^tm2.1Ofc/Nsmce2^tm2.1Ofc (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal B cell physiology	J:227197
Blm^tm4Ches/Blm^tm4Ches Trp53bp1^tm1Jc/Trp53bp1^tm1Jc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal class switch recombination	J:194603
Blmh^tm1Geh/Blmh^tm1Geh (either: (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	dermatitis	J:54585
Blnk^m1Btlr/Blnk^m1Btlr (C57BL/6J-Blnk^m1Btlr)	decreased IgG level	J:159439
Blnk^m1Btlr/Blnk^m1Btlr (C57BL/6J-Blnk^m1Btlr)	decreased IgM level	J:159439
Blnk^m1Btlr/Blnk^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Blnk^tm1Achn/Blnk⁺ (involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)	decreased B cell proliferation	J:82430
Blnk^tm1Achn/Blnk⁺ Btk^tm1Wk/Btk^tm1Wk Tg(IGH-Btk)1Witt/0 (involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)	abnormal B cell physiology	J:82430
	decreased B cell proliferation	J:82430
Blnk^tm1Achn/Blnk^tm1Achn (involves: 129X1/SvJ)	decreased immunoglobulin level	J:58805
Blnk^tm1Dkit/Blnk^tm1Dkit (involves: C57BL/6)	abnormal B cell apoptosis	J:143854
	decreased IgG3 level	J:143854
	decreased IgM level	J:143854
	increased anti-double stranded DNA antibody level	J:94297
	increased B cell apoptosis	J:143854
Blnk^tm1Dkit/Blnk^tm1Dkit Prkcd^tm1Kin/Prkcd^tm1Kin (involves: 129P2/OlaHsd * C57BL/6 * NZB)	abnormal B cell proliferation	J:143854
	abnormal immunoglobulin level	J:143854
	increased B cell apoptosis	J:143854
	increased IgA level	J:143854
	increased IgG1 level	J:143854
	increased IgG2b level	J:143854
	increased IgG3 level	J:143854
	increased IgM level	J:143854
Blnk^tm1Kplm/Blnk^tm1Kplm (involves: 129P2/OlaHsd)	abnormal B cell activation	J:61130, J:131161
	decreased B cell proliferation	J:61130
	increased B cell apoptosis	J:131161
Blnk^tm1Kplm/Blnk^tm1Kplm Plcg2^tm1.1Kuro/Plcg2⁺ (involves: 129P2/OlaHsd)	abnormal B cell activation	J:131161
	increased B cell apoptosis	J:131161
Blnk^tm1Kplm/Blnk^tm1Kplm Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (involves: 129P2/OlaHsd)	increased B cell apoptosis	J:131161
Blnk^tm1Pjln/Blnk^tm1Pjln (involves: BALB/c)	decreased IgG3 level	J:58740
Blnk^tm1Pjln/Blnk^tm1Pjln (involves: BALB/c)	decreased IgM level	J:58740
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Gsv/Y (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	decreased IgG3 level	J:94768
	decreased IgM level	J:94768
	decreased immunoglobulin level	J:94768
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Gsv/Y Tg(CD19-BTKK430R)XK24Rwhe/? (involves: 129P2/OlaHsd BALB/c * C57BL/6 * FVB)	decreased IgG3 level	J:94768
	decreased IgM level	J:94768
	decreased immunoglobulin level	J:94768
Bloc1s3^rp/Bloc1s3^rp (involves: C57BL/10ScSn * C57BL/Tb)	abnormal NK cell physiology	J:6801
Bloc1s6^pa/Bloc1s6^pa (B6.Cg-Bloc1s6^pa/J)	abnormal NK cell physiology	J:6801
Bloc1s6^pa/Bloc1s6^pa (B6.Cg-Bloc1s6^pa/J)	lung inflammation	J:4098
Bmal1^em1Bwu/Bmal1^em1Bwu (C57BL/6-Bmal1^em1Bwu)	abnormal macrophage physiology	J:340220
Bmal1^tm1Bra/Bmal1^tm1Bra (B6.129-Bmal1^tm1Bra)	impaired leukocyte tethering or rolling	J:191844
	increased circulating fibrinogen level	J:191844
	increased incidence of corneal inflammation	J:110697
Bmal1^tm1Bra/Bmal1^tm1Bra (involves: 129/Sv * C57BL/6)	decreased IgG1 level	J:118522
Bmf^tm1.1Ast/Bmf^tm1.1Ast (B6.Cg-Bmf^tm1.1Anst)	decreased B cell apoptosis	J:133084
	decreased T cell apoptosis	J:133084
	increased immunoglobulin level	J:133084
Bmf^tm1Rjd/Bmf^tm1Rjd (B6.129S6-Bmf^tm1Rjd)	decreased T cell apoptosis	J:153652
Bmgr2^C57BL/6J/? Prf1^tm1Sdz/Prf1^tm1Sdz (involves: 129S6/SvEvTac * C57BL/6J)	abnormal response to transplant	J:116666
Bmgr3^{129S6/SvEvTac}/Bmgr3^{129S6/SvEvTac} Prf1^tm1Sdz/Prf1^tm1Sdz (involves: 129S6/SvEvTac * C57BL/6J)	abnormal response to transplant	J:116666
Bmgr4^C57BL/6J/? Ebmgr1^{129S6/SvEvTac}/Ebmgr1^{129S6/SvEvTac} Prf1^tm1Sdz/Prf1^tm1Sdz (involves: 129S6/SvEvTac * C57BL/6J)	abnormal response to transplant	J:116666
Bmgr4^C57BL/6J/? Prf1^tm1Sdz/Prf1^tm1Sdz (involves: 129S6/SvEvTac * C57BL/6J)	abnormal response to transplant	J:116666
Bmi1^tm1Brn/Bmi1^tm1Brn (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))	abnormal thymus involution	J:17712
	decreased IgM level	J:17712
	decreased splenocyte proliferation	J:17712
	lung inflammation	J:17712
Bmp5^se-Ca/Bmp5⁺ (SEACGn.CB-Bmp5^se-Ca)	granulomatous inflammation	J:5086
Bmp5^se-Ca/Bmp5^se-Ca (CBA/Ca-Bmp5^se-Ca)	granulomatous inflammation	J:5086
Bmp5^se-Ca/Bmp5^se-Ca (SEACGn.CB-Bmp5^se-Ca)	granulomatous inflammation	J:5086
Bmp5^se/Bmp5^se (SEC/1Gn)	granulomatous inflammation	J:5086
Bmp5^se/Bmp5^se (SEAC/Gn)	granulomatous inflammation	J:5086
Bmp7^tm1.1Dgra/Bmp7^tm1.1Dgra Tg(Prrx1-cre)1Cjt/0 (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * SJL/J)	joint inflammation	J:221175
	osteoarthritis	J:221175
Bmp7^tm1Rob/Bmp7⁺ Bmp8a^tm1Blh/Bmp8a^tm1Blh (involves: 129S/SvEv * 129S6/SvEvTac * Black Swiss * C57BL/6)	granulomatous inflammation	J:78867
Bmp8a^tm1Blh/Bmp8a⁺ Bmp8b^tm1Blh/Bmp8b⁺ (involves: 129/Sv * 129S6/SvEvTac * Black Swiss)	granulomatous inflammation	J:46927
Bmp8a^tm1Blh/Bmp8a^tm1Blh (involves: 129S6/SvEvTac * Black Swiss)	granulomatous inflammation	J:46927
Bmpr1a^tm2.1Bhr/Bmpr1a^tm2.1Bhr Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S7/SvEvBrd C57BL/6 * CBA)	stomach inflammation	J:163367
Bmpr1a^tm2.1Bhr/Bmpr1a^tm2.1Bhr Tg(Col1a1-cre/Esr1*)1Mis/0 (involves: 129S7/SvEvBrd)	abnormal osteoclast physiology	J:143588
Bmpr1a^tm2.1Bhr/Bmpr1a^tm2.2Bhr Tg(Gdf5-cre,-ALPP)1Kng/0 (involves: 129 * C57BL/6 * FVB/N-Tg(Gdf5-cre-ALPP)1Kng)	osteoarthritis	J:97780
Bmpr2^tm1Kmi/Bmpr2⁺ (involves: 129S4/SvJae * C57BL/6J)	abnormal leukocyte physiology	J:117167
Bmx^tm1Ali/Bmx^tm1Ali (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to induced arthritis	J:173099
Bod1l^em1Bltn/Bod1l^em1Bltn Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased IgG1 level	J:337726
	decreased IgG level	J:337726
Bod1l^em1Bltn/Bod1l^em1Bltn Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6J * C57BL/6NTac)	abnormal class switch recombination	J:337726
	decreased IgG1 level	J:337726
Bpgm^m1Pgrs/Bpgm^m1Pgrs (involves: C57BL/6 * C57BL/10J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:301620
Bpgm^m1Pgrs/Bpgm^m1Pgrs (involves: A/J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:301620
Bpi^tm1.1Buls/Bpi^tm1.1Buls (involves: BALB/cJ * C57BL/6J)	abnormal circulating interleukin level	J:346703
	abnormal immune cell physiology	J:346703
	abnormal interleukin secretion	J:346703
	decreased circulating interferon-gamma level	J:346703
	increased susceptibility to induced colitis	J:346703
Bpifa1^m1Ingm/Bpifa1^m1Ingm (involves: C3HeB/FeJ)	increased interleukin-1 alpha secretion	J:195535
	increased interleukin-1 beta secretion	J:195535
	increased susceptibility to bacterial infection	J:195535
	increased susceptibility to otitis media	J:221346
	increased tumor necrosis factor secretion	J:195535
	lung inflammation	J:195535
Bpifa1^{tm1(KOMP)Vlcg}/Bpifa1^{tm1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	increased susceptibility to bacterial infection	J:171589
Bpifa1^tm1.1Jpst/Bpifa1^tm1.1Jpst Scgb1a1^{tm1(cre/ERT)Blh}/Scgb1a1^{tm1(cre/ERT)Blh} (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to Orthomyxoviridae infection	J:265391
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:265391
Bpifa1^tm1.2Jpst/Bpifa1^tm1.2Jpst (involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL)	increased susceptibility to Orthomyxoviridae infection	J:265391
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:265391
Bptf^em1Zfa/Bptf^em1Zfa Tg(Rorc-cre)1Litt/0 (involves: C57BL/6 * FVB)	increased susceptibility to bacterial infection	J:259392
	increased susceptibility to bacterial infection induced morbidity/mortality	J:259392
Braf^tm1Bbd/Braf⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal immune system physiology	J:170095
	increased splenocyte apoptosis	J:170095
	increased thymocyte apoptosis	J:170095
Braf^tm1Bbd/Braf⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)	abnormal immune system physiology	J:170095
	increased splenocyte apoptosis	J:170095
	increased thymocyte apoptosis	J:170095
Braf^tm1Bbd/Braf⁺ (B6.129-Braf^tm1Bbd)	abnormal immune system physiology	J:170095
	increased splenocyte apoptosis	J:170095
	increased thymocyte apoptosis	J:170095
Braf^tm1Mmcm/Braf^tm1Mmcm Cd207^{tm2.1(cre)Bjec}/Cd207⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	liver inflammation	J:211690
	lung inflammation	J:211690
Braf^tm1Mmcm/Braf^tm1Mmcm Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	cytokine storm	J:211690
	granulomatous inflammation	J:211690
	increased inflammatory response	J:211690
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Shld1^em1Nus/Shld1^em1Nus (involves: 129S6/SvEvTac * C57BL/6NCrl)	abnormal class switch recombination	J:307190
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * 129S6/SvEvTac)	abnormal class switch recombination	J:307190
Brca1^tm2Mak/Brca1^tm2Mak Tg(Lck-cre)548Jxm/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased T cell proliferation	J:63282
Brca1^tm2Mak/Brca1^tm2Mak Tg(Lck-cre)548Jxm/? Tg(TcrLCMV)327Sdz/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased T cell proliferation	J:63282
Brca1^tm5.1Cxd/Brca1^tm5.1Cxd (involves: 129S6/SvEvTac * FVB/N)	dermatitis	J:155810
Brca2^tm1Hst/Brca2^tm1Hst (involves: 129S7/SvEvBrd * C57BL/6)	sepsis	J:82434
Brca2^tm1Mak/Brca2^tm2Mak Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased T cell apoptosis	J:79697
Brd2^{em1(IMPC)Wtsi}/Brd2^{em1(IMPC)Wtsi} (C57BL/6N-Brd2^{em1(IMPC)Wtsi}/WtsiIeg)	blood in lymph vessels	J:239583
Brd2^{Gt(RRT234)Byg}/Brd2⁺ (B6.129P2-Brd2^{Gt(RRT234)Byg})	increased circulating interleukin-1 beta level	J:159964
Brd2^{Gt(RRT234)Byg}/Brd2⁺ (B6.129P2-Brd2^{Gt(RRT234)Byg})	increased circulating tumor necrosis factor level	J:159964
Brf1^tm1Arte/Brf1^tm1Arte Tg(Cyp1a1-cre)1Dwi/0 (involves: C57BL/6 * CBA)	liver inflammation	J:285667
Bsg^tm1.1Znc/Bsg^tm1.1Znc Tg(Lck-cre)19Hhan/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	abnormal T cell activation	J:207886
	increased T cell proliferation	J:207886
Bsg^tm1Tmu/Bsg^tm1Tmu (involves: 129S2/SvPas * C57BL/6J)	interstitial pneumonia	J:46376
Bsg^tm1Tmu/Bsg^tm1Tmu (involves: 129/Sv * 129S2/SvPas)	interstitial pneumonia	J:46376
Bsg^tm1Tmu/Bsg^tm1Tmu (involves: 129S2/SvPas)	decreased circulating complement protein level	J:287636
	glomerulonephritis	J:287636
	increased susceptibility to systemic lupus erythematosus	J:287636
Bst1^tm1Thir/Bst1^tm1Thir (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:111424
	abnormal humoral immune response	J:111424
	decreased IgA level	J:111424
	decreased IgG3 level	J:111424
Bst2^tm1.1Bsz/Bst2^tm1.1Bsz (involves: C57BL/6)	increased susceptibility to Retroviridae infection	J:180252
Btk^m2Anu/Btk^m2Anu (C57BL/6NCrlAnu-Btk^m2Anu)	increased IgM level	J:104190
Btk^tm1Gsv/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:94768
	abnormal humoral immune response	J:120989
	abnormal immune system physiology	J:35769
	decreased IgG3 level	J:35769
	decreased IgM level	J:35769
	decreased immunoglobulin level	J:120989
Btk^tm1Gsv/Y Tg(CD19-BTKK430R)XK24Rwhe/? (involves: 129P2/OlaHsd C57BL/6 * FVB)	decreased B cell apoptosis	J:120989
	decreased immunoglobulin level	J:120989
Btk^tm1Wk/Btk^tm1Wk (involves: 129S4/SvJae * C57BL/6)	abnormal B cell activation	J:28968
	decreased B cell proliferation	J:82298
	decreased IgG3 level	J:28968, J:82298
	decreased IgM level	J:28968, J:82298
Btk^tm1Wk/Btk^tm1Wk Cd40^tm1Geha/Cd40^tm1Geha (involves: 129S4/SvJae * C57BL/6)	abnormal humoral immune response	J:82298
	decreased B cell proliferation	J:82298
	decreased IgA level	J:82298
	decreased IgG2a level	J:82298
	decreased IgG2b level	J:82298
	decreased IgG3 level	J:82298
	decreased IgM level	J:82298
Btk^tm1Wk/Btk^tm1Wk Tec^tm1Welm/Tec^tm1Welm (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:66080
	decreased B cell proliferation	J:66080
	decreased IgG2a level	J:66080
	decreased IgG3 level	J:66080
	decreased IgM level	J:66080
	decreased immunoglobulin level	J:66080
Btk^tm1Wk/Btk^tm1Wk Tg(IGH-Btk)1Witt/0 (involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)	decreased B cell proliferation	J:82430
Btk^vila/Btk^vila (C57BL/6JAnu-Btk^vila/AnuApb)	decreased IgD level	J:104190
	increased IgE level	J:104190
	increased IgG level	J:104190
Btk^xid/Y (CBA/HN-Btk^xid)	decreased B cell proliferation	J:81429
Btk^xid/Y (involves: CBA/HN * DBA/2N)	decreased B cell proliferation	J:81429
Btk^xid/? (involves: BALB/c * CBA/N)	decreased B cell proliferation	J:108696
	decreased IgG3 level	J:108696
	decreased IgM level	J:108696
Btk^xid/? Ptpn6^me/Ptpn6^me (involves: C57BL/6J * CBA/N * NFS)	increased autoantibody level	J:30994
	increased IgM level	J:30994
	increased splenocyte proliferation	J:30994
Btk^xid/? Tg(IGH-Btk)1Witt/0 (involves: BALB/c * C3H * C57BL/6 * CBA/N)	decreased B cell proliferation	J:108696
	decreased IgG3 level	J:108696
	decreased IgM level	J:108696
Btk^xid/? Tg(IGH-Btk)1Witt/Tg(IGH-Btk)1Witt (involves: BALB/c * C3H * C57BL/6 * CBA/N)	decreased B cell proliferation	J:108696
	decreased IgG3 level	J:108696
	decreased IgM level	J:108696
Btk^xid/Btk^xid (CBA/CaHN-Btk^xid/J)	abnormal macrophage physiology	J:92639
	abnormal neutrophil physiology	J:92639
	decreased acute inflammation	J:92639
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:92639
	impaired neutrophil phagocytosis	J:92639
	increased susceptibility to bacterial infection induced morbidity/mortality	J:128518
	increased susceptibility to induced colitis	J:92639
Btk^xid/Btk^xid (involves: CBA/HN * DBA/2N)	abnormal B cell physiology	J:81429
Btk^xid/Btk^xid (involves: CBA/HN * DBA/2N)	abnormal B cell proliferation	J:81429
Btk^xid/Btk^xid (CBA/HN-Btk^xid)	autoimmune response	J:125114
Btk^xid/Btk^xid (CBA/HN-Btk^xid)	decreased B cell proliferation	J:81429
Btla^tm1Dgra/Btla^tm1Dgra (involves: C57BL/6)	abnormal peripheral T cell anergy	J:147751
Btla^tm1Dgra/Btla^tm1Dgra (involves: C57BL/6)	abnormal T cell activation	J:147751
Btla^tm1Dgra/Btla^tm1Dgra Tg(TcraTcrb)425Cbn/? (involves: C57BL/6)	abnormal peripheral T cell anergy	J:147751
Btla^tm1Dgra/Btla^tm1Dgra Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal peripheral T cell anergy	J:147751
Btla^tm1Kay/Btla^tm1Kay (involves: 129S6/SvEvTac * C57BL/6J)	abnormal T cell activation	J:89864
Btla^tm1Kmm/Btla^tm1Kmm (involves: 129S/SvEv)	abnormal humoral immune response	J:84084
	increased B cell proliferation	J:84084
	increased IgG1 level	J:84084
	increased IgG2a level	J:84084
	increased IgG2b level	J:84084
	increased susceptibility to experimental autoimmune encephalomyelitis	J:84084
	increased T cell proliferation	J:84084
Btla^tm1Kmm/Btla^tm1Kmm (B6.129S-Btla^tm1Kmm)	abnormal T cell activation	J:119356
	decreased interferon-gamma secretion	J:119356
	decreased interleukin-2 secretion	J:119356
	decreased T cell proliferation	J:119356
	increased length of allograft survival	J:119356
	increased T cell proliferation	J:119356
Btla^tm1Kmm/Btla^tm1Kmm Pdcd1^tm1Hon/Pdcd1^tm1Hon (B6.129S-Pdcd1^tm1Hon Btla^tm1Kmm)	decreased length of allograft survival	J:119356
	increased T cell proliferation	J:119356
Btla^tm1Kmm/Btla^tm1Kmm Tg(DO11.10)10Dlo/? (involves: 129S/SvEv * BALB/c * C3H * C57BL/6)	increased T cell proliferation	J:84084
Btn2a2^tm1.2Wrth/Btn2a2^tm1.2Wrth (C57BL/6-Btn2a2^tm1.2Wrth)	abnormal T-helper 1 physiology	J:232636
	abnormal T-helper 2 physiology	J:232636
	increased anti-nuclear antigen antibody level	J:232636
	increased IgG1 level	J:232636
	increased IgG2c level	J:232636
	increased IgG level	J:232636
	increased response to antigen	J:232636
	increased susceptibility to experimental autoimmune encephalomyelitis	J:232636
Btnl2^em1Wche/Btnl2^em1Wche (C57BL/6-Btnl2^em1Wche)	abnormal cytokine level	J:321348
Btnl2^em1Wche/Btnl2^em1Wche (C57BL/6-Btnl2^em1Wche)	large intestinal inflammation	J:321348
Btrc^tm1Paga/Btrc^tm1Paga Fbxw11^tm1Ybn/Fbxw11^tm1Ybn Tg(Vil1-cre/ERT2)23Syr/? (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	increased circulating interleukin-1 beta level	J:206654
	intestinal inflammation	J:206654
Bub1b^tm1.1Hsl/Bub1b⁺ (involves: 129 * C57BL/6)	increased B cell proliferation	J:201641
Bxs6^BXSB/MpJ/Bxs6^BXSB/MpJ (involves: BXSB/MpJ * C57BL/10ScSnOlaHsd)	autoimmune response	J:145903
	glomerulonephritis	J:145903
	increased autoantibody level	J:145903
Bxs6^BXSB/MpJ/Bxs6^BXSB/MpJ (B10.BXSB-(D13Mit3-D13Mit78))	autoimmune response	J:145049
	increased anti-double stranded DNA antibody level	J:145049
	increased anti-single stranded DNA antibody level	J:145049
	increased autoantibody level	J:145049
Bxs6^BXSB/MpJ/Bxs6^BXSB/MpJ Gpab1^C57BL/6J/? (involves: BXSB/MpJ * C57BL/10ScSnOlaHsd)	autoimmune response	J:145903
	increased autoantibody level	J:145903
Bxs6^BXSB/MpJ/Bxs6^BXSB/MpJ X/Yaa (B10.BXSB-(D13Mit3-D13Mit78) Yaa)	autoimmune response	J:145049
	glomerulonephritis	J:145049
	increased anti-double stranded DNA antibody level	J:145049
	increased anti-single stranded DNA antibody level	J:145049
	increased autoantibody level	J:145049
C1galt1^ptl1/C1galt1^ptl1 (C57BL/6-C1galt1^ptl1)	glomerulonephritis	J:115272
C1galt1^ptl1/C1galt1^ptl1 (C57BL/6-C1galt1^ptl1)	kidney inflammation	J:115272
C1galt1^ptl1/C1galt1^ptl1 Rag1^tm1Bal/Rag1^tm1Bal (involves: 129S4/SvJae * C57BL/6)	kidney inflammation	J:115272
C1qa^tm1Mjw/C1qa^tm1Mjw (involves: 129P2/Ola * 129S/SvEv * C57BL/6)	glomerulonephritis	J:47315
	increased anti-histone antibody level	J:47315
	increased anti-nuclear antigen antibody level	J:47315
	increased susceptibility to bacterial infection	J:83712
C1qa^tm1Mjw/C1qa^tm1Mjw Sle16^{129S6/SvEvTac}/Sle16^{129S6/SvEvTac} (involves: 129S/SvEv * 129X1/Sv * C57BL/6)	increased anti-chromatin antibody level	J:118645
	increased anti-double stranded DNA antibody level	J:118645
	increased anti-nuclear antigen antibody level	J:118645
	increased anti-single stranded DNA antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle16^{129S6/SvEvTac}/Sle16^C57BL/6 (involves: 129S/SvEv * 129X1/Sv * C57BL/6)	increased anti-chromatin antibody level	J:118645
	increased anti-double stranded DNA antibody level	J:118645
	increased anti-nuclear antigen antibody level	J:118645
	increased anti-single stranded DNA antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle18^C57BL/6/Sle18^C57BL/6 (involves: 129S/SvEv * 129X1/Sv * C57BL/6)	increased anti-nuclear antigen antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle18^C57BL/6/Sle18^C57BL/6 (involves: 129P2/Ola * 129S/SvEv * C57BL/6)	increased anti-nuclear antigen antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle19^C57BL/6/? (involves: 129S/SvEv * 129X1/Sv * C57BL/6)	increased anti-nuclear antigen antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle19^C57BL/6/? (involves: 129P2/Ola * 129S/SvEv * C57BL/6)	increased anti-nuclear antigen antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle21^129P2/Ola/? Sle18^C57BL/6/Sle18^C57BL/6 (involves: 129P2/Ola * 129S/SvEv * C57BL/6)	increased anti-nuclear antigen antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle21^129P2/Ola/Sle21^129P2/Ola (involves: 129P2/Ola * 129S/SvEv * C57BL/6)	increased anti-chromatin antibody level	J:118645
	increased anti-double stranded DNA antibody level	J:118645
	increased anti-nuclear antigen antibody level	J:118645
	increased anti-single stranded DNA antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qa^tm1Mjw/C1qa^tm1Mjw Sle21^129P2/Ola/Sle21^C57BL/6 (involves: 129P2/Ola * 129S/SvEv * C57BL/6)	increased anti-chromatin antibody level	J:118645
	increased anti-double stranded DNA antibody level	J:118645
	increased anti-nuclear antigen antibody level	J:118645
	increased anti-single stranded DNA antibody level	J:118645
	increased susceptibility to systemic lupus erythematosus	J:118645
C1qtnf3^tm1Yiw/C1qtnf3^tm1Yiw (involves: C57BL/6NSlc)	increased IgG level	J:211893
	increased susceptibility to induced arthritis	J:211893
	joint inflammation	J:211893
C1qtnf4^em1Smoc/C1qtnf4^em1Smoc (C57BL/6J-C1qtnf4^em1Smoc/Smoc)	increased circulating interleukin-6 level	J:302282
	increased circulating interleukin-18 level	J:302282
	increased circulating tumor necrosis factor level	J:302282
	increased susceptibility to endotoxin shock	J:302282
	increased tumor necrosis factor secretion	J:302282
C1qtnf6^tm1Yiw/C1qtnf6^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6J)	increased anti-nuclear antigen antibody level	J:227217
	increased autoantibody level	J:227217
C1qtnf6^tm1Yiw/C1qtnf6^tm1Yiw (B6.129P2-C1qtnf6^tm1Yiw)	abnormal complement pathway	J:227217
	abnormal complement protein level	J:227217
	increased circulating complement protein level	J:227217
	increased IgG level	J:227217
	increased susceptibility to experimental autoimmune encephalomyelitis	J:227217
	increased susceptibility to induced arthritis	J:227217
	increased susceptibility to type III hypersensitivity reaction	J:227217
C3^tm1Crr/C3^tm1Crr (involves: 129S4/SvJae * C57BL/6)	abnormal cell-mediated immunity	J:30152
	abnormal humoral immune response	J:64282
	abnormal immune system physiology	J:44240
	abnormal mast cell physiology	J:44240
	abnormal tumor necrosis factor level	J:44240
	decreased circulating interleukin-6 level	J:166640, J:152533
	decreased circulating tumor necrosis factor level	J:152533
	increased susceptibility to bacterial infection	J:44240, J:30152
	increased susceptibility to bacterial infection induced morbidity/mortality	J:205353
	liver inflammation	J:30152
C3^tm1Crr/C3^tm1Crr (B6.129S4-C3^tm1Crr)	abnormal inflammatory response	J:113463
	brain inflammation	J:123658
	decreased susceptibility to autoimmune hemolytic anemia	J:145432
C3^tm1Crr/C3^tm1Crr (B6;129S4-C3^tm1Crr/J)	decreased susceptibility to Coronaviridae infection	J:286325
C3^tm1Crr/C3^tm1Crr (B6;129S4-C3^tm1Crr/J)	increased susceptibility to bacterial infection	J:136745
C3^tm1Crr/C3^tm1Crr (involves: 129S4/SvJae)	glomerulonephritis	J:44715
C3^tm1Crr/C3^tm1Crr C4b^tm1Crr/C4b^tm1Crr Fas^lpr/Fas^lpr (involves: 129S4/SvJae * C57BL/6 * MRL)	abnormal immune system physiology	J:127292
	increased anti-double stranded DNA antibody level	J:127292
	increased anti-nuclear antigen antibody level	J:127292
C3^tm1Crr/C3^tm1Crr Cd59a^tm1Bpm/Cd59a^tm1Bpm (B6.129-Cd59a^tm1Bpm C3^tm1Crr)	increased T cell proliferation	J:122201
C3^tm1Crr/C3^tm1Crr Fas^lpr/Fas^lpr (involves: 129S4/SvJae * C57BL/6 * MRL)	decreased susceptibility to autoimmune disorder	J:127292
C3^tm1Crr/C3^tm1Crr Fcer1g^tm1Rav/Fcer1g^tm1Rav Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased susceptibility to autoimmune diabetes	J:122114
C3^tm1Crr/C3^tm1Crr Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: 129S4/SvJae * C57BL/6)	decreased susceptibility to autoimmune diabetes	J:122114
	increased interferon-gamma secretion	J:122114
	increased T cell proliferation	J:122114
	insulitis	J:122114
C3^tm1Crr/C3^tm1Crr Zbtb20^{Tg(PDGFB-APPSwInd)20Lms}/? (involves: 129S4/SvJae * C57BL/6)	increased microglial cell activation	J:135902
C3^tm1Hrc/C3^tm1Hrc (either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))	increased susceptibility to bacterial infection	J:56193
C3^tm1Hrc/C3^tm1Hrc (B6.129-C3^tm1Hrc)	impaired complement alternative pathway	J:177350
C3^tm1Hrc/C3^tm1Hrc Cr1l^tm1Hmo/Cr1l^tm1Hmo (involves: 129/Sv * 129X1/SvJ * C57BL/6)	abnormal complement pathway	J:76578
C3^tm1Hrc/C3^tm1Hrc Lama2^dy/Lama2^dy (either: (involves: 129S2/SvPas * 129P1/ReJ) or (involves: 129X1/SvJ * 129P1/ReJ))	decreased IgM level	J:102959
	increased IgG level	J:102959
	increased IgM level	J:102959
C3^tm1Pkna/C3^tm1Pkna (D1.129P2-C3^tm1Pkna)	decreased susceptibility to induced arthritis	J:88872
C3ar1^tm1Cge/C3ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-6 level	J:166640
C3ar1^tm1Raw/C3ar1⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal immune system physiology	J:68807
C3ar1^tm1Raw/C3ar1^tm1Raw (involves: 129X1/SvJ * C57BL/6)	increased circulating interleukin-1 beta level	J:68807
C3ar1^tm1Raw/C3ar1^tm1Raw (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to endotoxin shock	J:68807
C3ar1^tm1Raw/C3ar1^tm1Raw (B6.129X1(B6)-C3ar1^tm1Raw)	abnormal adaptive immunity	J:80071
	abnormal eosinophil physiology	J:80071
	abnormal interleukin level	J:80071
	abnormal T-helper 2 physiology	J:80071
	decreased IgE level	J:80071
	decreased IgG1 level	J:80071
	decreased interleukin-4 secretion	J:80071
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:93791
	impaired neutrophil recruitment	J:80071
	increased circulating interleukin-1 beta level	J:93791
	increased susceptibility to type I hypersensitivity reaction	J:80071
C3ar1^tm1Raw/C3ar1^tm1Raw Cpn1^tm1Raw/Cpn1^tm1Raw (B6.129-C3ar1^tm1Raw Cpn1^tm1Raw)	increased acute inflammation	J:148315
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae * C57BL/6)	abnormal humoral immune response	J:64282
	decreased susceptibility to bacterial infection	J:30152
	increased susceptibility to bacterial infection induced morbidity/mortality	J:30152
	liver inflammation	J:30152
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae * C57BL/6J)	abnormal immune system physiology	J:111811
	glomerulonephritis	J:111811
	increased anti-double stranded DNA antibody level	J:111811
	increased anti-nuclear antigen antibody level	J:111811
	increased anti-single stranded DNA antibody level	J:111811
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae)	decreased susceptibility to Coronaviridae infection	J:286325
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae)	glomerulonephritis	J:44715
C4b^tm1Crr/C4b^tm1Crr Fas^lpr/Fas^lpr (involves: 129S4/SvJae * C57BL/6 * MRL)	abnormal immune system physiology	J:127292
	increased anti-double stranded DNA antibody level	J:127292
	increased anti-nuclear antigen antibody level	J:127292
C4bp^tm1Raw/C4bp^tm1Raw (B6.129-C4bp^tm1Raw)	increased circulating interleukin-6 level	J:244020
C5ar1^tm1Cge/C5ar1^tm1Cge (involves: 129S4/SvJae)	abnormal humoral immune response	J:35529
	impaired neutrophil recruitment	J:69177
	increased susceptibility to bacterial infection	J:69177
C5ar1^tm1Cge/C5ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-6 level	J:166640
C5ar1^tm1Song/C5ar1^tm1Song (involves: 129S6/SvEvTac * C57BL/6)	abnormal neutrophil physiology	J:184056
C5ar2^tm1Cge/C5ar2^tm1Cge (B6.129S1-C5ar2^tm1Cge)	abnormal immune cell physiology	J:104092
C5ar2^tm1Cge/C5ar2^tm1Cge (B6.129S1-C5ar2^tm1Cge)	increased inflammatory response	J:104092
C9^em1Sjlg/C9⁺ (C57BL/6-C9^em1Sjlg)	impaired complement classical pathway	J:301607
C9^em1Sjlg/C9^em1Sjlg (C57BL/6-C9^em1Sjlg)	decreased interleukin-1 beta secretion	J:301607
	decreased susceptibility to endotoxin shock	J:301607
	impaired complement classical pathway	J:301607
C9orf72^em1Eggn/C9orf72^em1Eggn (involves: C57BL/6)	increased anti-double stranded DNA antibody level	J:240357
C9orf72^em5Lutzy/C9orf72^em5Lutzy (C57BL/6-C9orf72^em5Lutzy)	abnormal macrophage physiology	J:101977
	abnormal microglial cell physiology	J:101977
C9orf72^tm1.1Eggn/C9orf72⁺ (involves: C57BL/6 * C57BL/6N)	abnormal circulating interleukin level	J:240357
	decreased circulating interleukin-2 level	J:240357
	dermatitis	J:240357
	increased autoantibody level	J:240357
	increased IgG level	J:240357
	increased IgM level	J:240357
C9orf72^tm1.1Eggn/C9orf72^tm1.1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal circulating cytokine level	J:240357
	brain inflammation	J:240357
	dermatitis	J:240357
	increased anti-double stranded DNA antibody level	J:240357
	increased autoantibody level	J:240357
	increased IgG level	J:240357
	increased IgM level	J:240357
	increased susceptibility to autoimmune disorder	J:240357
	liver inflammation	J:240357
C9orf72^tm1Eggn/C9orf72⁺ (involves: C57BL/6 * C57BL/6N)	dermatitis	J:240357
C9orf72^tm1Eggn/C9orf72^tm1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal circulating cytokine level	J:240357
	dermatitis	J:240357
	increased anti-double stranded DNA antibody level	J:240357
	increased susceptibility to autoimmune disorder	J:240357
Cabin1^tm1.1Che/Cabin1^tm1.1Che (involves: 129S4/SvJae * BALB/c)	abnormal cytokine secretion	J:72760
	abnormal humoral immune response	J:72760
	increased IgE level	J:72760
	increased IgG1 level	J:72760
	increased IgG2b level	J:72760
Cacna1c^tm2Itl/Cacna1c⁺ (involves: 129S6/SvEvTac * C57BL/6NTac)	dermatitis	J:201506
Cacna2d2^du-td/Cacna2d2^du-td (involves: DBA/2J)	abnormal thymus involution	J:12166
Cacna2d2^tm1Svi/Cacna2d2^tm1Svi (involves: 129S1/Sv * C57BL/6J)	rhinitis	J:92396
Cacnb3^tm1Acv/Cacnb3^tm1Acv (involves: 129S1/Sv * 129X1/SvJ)	abnormal CD4-positive, alpha-beta T cell physiology	J:115345
	abnormal interleukin secretion	J:115345
	decreased interferon-gamma secretion	J:115345
Cacnb4^lh/Cacnb4^lh (B6EiC3Sn a/A-Cacnb4^lh/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:115345
	abnormal interleukin secretion	J:115345
	abnormal thymus involution	J:5281
	decreased interferon-gamma secretion	J:115345
	decreased interleukin-2 secretion	J:115345
Cacnb4^lh/Cacnb4^lh (BALB/cGn-Cacnb4^lh)	abnormal thymus involution	J:12166
Cacnb4^lh/Cacnb4^lh (BALB/cGn-Cacnb4^lh)	increased length of allograft survival	J:5766
Cacnb4^lh/Cacnb4^lh (involves: BALB/cGn)	increased IgG1 level	J:5883
Cadm1^{Gt(Ayu21-W34)Imeg}/Cadm1^{Gt(Ayu21-W34)Imeg} (involves: C57BL/6 * CBA/JNCrlj)	decreased interferon-gamma secretion	J:178612
	decreased interleukin-2 secretion	J:178612
	decreased interleukin-4 secretion	J:178612
	decreased T cell proliferation	J:178612
Calcr^tm1Rda/Calcr^tm1Rda Tg(CMV-cre)1Cgn/0 (B6.Cg-Calcr^tm1Rda Tg(CMV-cre)1Cgn)	abnormal osteoclast physiology	J:150982
Camk2g^tm1.1Irt/Camk2g^tm1.1Irt (involves: C57BL/6 * C57BL/6J)	decreased macrophage apoptosis	J:154647
Camk2g^tm1.1Irt/Camk2g^tm1.1Irt (involves: C57BL/6J)	increased susceptibility to colitis induced morbidity/mortality	J:243363
Camk2g^tm1.1Irt/Camk2g^tm1.1Irt (involves: C57BL/6J)	increased susceptibility to induced colitis	J:243363
Caml^tm1Rjb/Caml^tm2Rjb Tg(Lck-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	increased T cell apoptosis	J:100536
Camp^tm1Rlg/Camp⁺ (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to bacterial infection	J:72924
Camp^tm1Rlg/Camp^tm1Rlg (involves: 129X1/SvJ * C57BL/6)	increased incidence of corneal inflammation	J:199719
	increased susceptibility to bacterial infection	J:72924
	increased susceptibility to fungal infection	J:199719
Camp^tm1Rlg/Camp^tm1Rlg (129X1(B6)-Camp^tm1Rlg/Kini)	increased susceptibility to bacterial infection	J:109553
Camp^tm1Rlg/Camp^tm1Rlg (129X1(B6)-Camp^tm1Rlg/Kini)	increased susceptibility to bacterial infection induced morbidity/mortality	J:109553
Cap2^{tm1a(EUCOMM)Wtsi}/Cap2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	eye inflammation	J:234044
	increased susceptibility to infection	J:234044
Capg^tm1Djk/Capg^tm1Djk (involves: 129S4/SvJae)	abnormal macrophage physiology	J:86517
Capg^tm1Djk/Capg^tm1Djk (involves: 129S4/SvJae)	impaired macrophage phagocytosis	J:86517
Capg^tm1Djk/Capg^tm1Djk (involves: 129S4/SvJae * BALB/c * C57BL/6)	abnormal dendritic cell physiology	J:86277
	impaired macrophage phagocytosis	J:86277
	impaired neutrophil chemotaxis	J:86277
	increased susceptibility to bacterial infection	J:86277
Capg^tm1Djk/Capg^tm1Djk Gsn^tm1Djk/Gsn^tm1Djk (involves: 129S4/SvJae)	abnormal macrophage physiology	J:86517
	impaired macrophage phagocytosis	J:86517
Capn1^tm1Dgen/Capn1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:183585
Capop^NOD/Capop^NOD (involves: C57BL/6 * NOD)	decreased T cell apoptosis	J:68151
Capza2^{tm1b(KOMP)Wtsi}/Capza2^{tm1b(KOMP)Wtsi} (C57BL/6N-Capza2^{tm1b(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Car2^{tm1(KOMP)Vlcg}/Car2^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	increased susceptibility to bacterial infection	J:216402
	pyelonephritis	J:216402
Card9^tm1Jrld/Card9^tm1Jrld (involves: 129P2/OlaHsd)	abnormal dendritic cell physiology	J:111706
Card9^tm1Jrld/Card9^tm1Jrld (involves: 129P2/OlaHsd)	increased susceptibility to fungal infection	J:111706
Card9^tm1Tks/Card9^tm1Tks (B6.129-Card9^tm1Tks)	abnormal chemokine secretion	J:141143
	abnormal cytokine secretion	J:122394
	abnormal dendritic cell physiology	J:122394
	abnormal macrophage physiology	J:141143, J:122394
	decreased interleukin-6 secretion	J:160680
	decreased interleukin-10 secretion	J:160680
	decreased interleukin-12b secretion	J:160680
	decreased interleukin-23 secretion	J:160680
	decreased tumor necrosis factor secretion	J:160680
	increased susceptibility to bacterial infection	J:122394
Card9^tm1Xlin/Card9^tm1Xlin (involves: 129/Sv * C57BL/6)	abnormal cytokine level	J:117799
	abnormal innate immunity	J:117799
	abnormal macrophage physiology	J:117799
	increased susceptibility to bacterial infection	J:117799
Card11^em1Welu/Card11⁺ (involves: C57BL/6)	impaired humoral immune response	J:292926
Card11^em1Welu/Card11^em1Welu (involves: C57BL/6)	decreased B cell proliferation	J:292926
	decreased IgG level	J:292926
	decreased IgM level	J:292926
	impaired humoral immune response	J:292926
Card11^em2Welu/Card11^em2Welu (involves: C57BL/6)	increased B cell proliferation	J:292926
Card11^m1Btlr/Card11^m1Btlr (C57BL/6J-Card11^m1Btlr)	abnormal cytokine secretion	J:149767
	abnormal cytotoxic T cell physiology	J:139069
	abnormal NK cell physiology	J:139069
	abnormal T cell activation	J:139069
	decreased B cell proliferation	J:149767, J:139069
	decreased IgG1 level	J:149767, J:139069
	decreased IgG2a level	J:149767, J:139069
	decreased IgG2b level	J:149767, J:139069
	decreased IgG2c level	J:149767
	decreased IgG3 level	J:149767, J:139069
	decreased IgM level	J:149767, J:139069
	decreased immunoglobulin level	J:139069
	decreased interferon-gamma secretion	J:139069
	decreased interleukin-2 secretion	J:139069
	decreased T cell proliferation	J:149767, J:139069
	dermatitis	J:149767, J:139069
Card11^M2Btlr/Card11^M2Btlr (involves: C57BL/6J)	decreased IgM level	J:198555
Card11^M4Btlr/Card11^M4Btlr (C57BL/6J-Card11^M4Btlr)	decreased IgM level	J:254856
Card11^M4Btlr/Card11^M4Btlr (C57BL/6J-Card11^M4Btlr)	impaired humoral immune response	J:254856
Card11^M5Btlr/Card11⁺ (C57BL/6J-Card11^M5Btlr)	decreased IgM level	J:254879
Card11^M5Btlr/Card11⁺ (C57BL/6J-Card11^M5Btlr)	impaired humoral immune response	J:254879
Card11^M5Btlr/Card11^M5Btlr (C57BL/6J-Card11^M5Btlr)	decreased IgM level	J:254879
Card11^M5Btlr/Card11^M5Btlr (C57BL/6J-Card11^M5Btlr)	impaired humoral immune response	J:254879
Card11^m8Btlr/Card11^m8Btlr (C57BL/6J-Card11^m8Btlr)	decreased IgG level	J:274940
	decreased IgM level	J:274940
	decreased response to antigen	J:274940
	impaired humoral immune response	J:274940
Card11^tm1.1Litt/Card11^tm1.1Litt Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ Tg(TcraTcrb)425Cbn/? (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal T cell activation	J:180410
Card11^tm1.1Litt/Card11^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal T cell activation	J:180410
	respiratory system inflammation	J:180410
Card11^tm1Litt/Card11^tm1Litt (involves: 129P2/OlaHsd)	abnormal B cell proliferation	J:89322
	abnormal T cell activation	J:89322
	abnormal T cell proliferation	J:89322
	decreased IgA level	J:89322
	decreased IgG1 level	J:89322
	decreased IgG2b level	J:89322
	decreased IgG3 level	J:89322
	decreased IgM level	J:89322
	decreased immunoglobulin level	J:89322
Card11^tm1Pngr/Card11^tm1Pngr (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:84036
	abnormal interleukin-2 secretion	J:84036
	abnormal T cell activation	J:84036
	decreased B cell proliferation	J:84036
	decreased IgA level	J:84036
	decreased IgE level	J:84036
	decreased IgG1 level	J:84036
	decreased IgG2a level	J:84036
	decreased IgG2b level	J:84036
	decreased IgG3 level	J:84036
	decreased IgG level	J:84036
	decreased IgM level	J:84036
	decreased immunoglobulin level	J:84036
Card11^tm1Vmd/Card11⁺ (involves: 129S6/SvEvTac * C57BL/6N)	decreased B cell proliferation	J:95800
Card11^tm1Vmd/Card11^tm1Vmd (involves: 129S6/SvEvTac * C57BL/6N)	abnormal B cell physiology	J:95800
	decreased B cell proliferation	J:95800
	decreased IgA level	J:95800
	decreased IgG1 level	J:95800
	decreased IgG2a level	J:95800
	decreased IgG2b level	J:95800
	decreased IgG3 level	J:95800
	decreased IgG level	J:95800
	decreased IgM level	J:95800
	decreased T cell proliferation	J:95800
Card11^tm1Xav/Card11^tm1Xav (involves: 129 * C57BL/6)	abnormal T cell activation	J:132226
	decreased circulating interleukin-4 level	J:132226
	decreased circulating interleukin-5 level	J:132226
	decreased IgE level	J:132226
	lung inflammation	J:132226
Card11^unm/Card11^unm (C57BL/6JSfdAnu-Card11^unm/Anu)	abnormal immune system physiology	J:84042
	abnormal T cell activation	J:84042
	decreased IgG3 level	J:84042
	decreased IgM level	J:84042
	decreased immunoglobulin level	J:84042
	dermatitis	J:84042
	erythroderma	J:84042
	increased IgE level	J:84042
	increased immunoglobulin level	J:84042
	increased inflammatory response	J:84042
Card14^em1Tshu/Card14^em1Tshu (C57BL/6-Card14^em1Tshu)	decreased susceptibility to chemically induced skin inflammation	J:289239
Card14^em2Tshu/Card14⁺ (involves: C57BL/6)	skin inflammation	J:289239
Card14^em3Tshu/Card14⁺ (involves: C57BL/6)	skin inflammation	J:289239
Card14^em3Tshu/Card14⁺ Il17a^tm1Cdon/Il17a^tm1Cdon (involves: C57BL/6)	decreased inflammatory response	J:289239
Card14^em9Lutzy/Card14⁺ (C57BL/6J-Card14^em9Lutzy/J)	skin inflammation	J:262723
Card14^tm1Lex/Card14^tm1Lex (B6.129S-Card14^tm1Lex)	decreased susceptibility to chemically induced skin inflammation	J:253409
Card19^tm1Rwen/Card19^tm1Rwen (involves: 129P2/OlaHsd * C57BL/6)	decreased autoantibody level	J:336763
Card19^tm1Rwen/Card19^tm1Rwen Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:336763
Card19^tm1Rwen/Card19^tm1Rwen Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd)	decreased B cell proliferation	J:336763
	increased B cell apoptosis	J:336763
carmelo/carmelo (involves: 129S1/SvImJ * C57BL/6J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:220661
Carmil2^bas/Carmil2^bas (involves: C3HeB/FeJ * C57BL/6)	decreased interferon-gamma secretion	J:205441
	decreased interleukin-2 secretion	J:205441
	decreased T cell proliferation	J:205441
Carmil2^bas/Carmil2^{tm1a(KOMP)Mbp} (involves: C3HeB/FeJ * C57BL/6 * C57BL/6N)	decreased interleukin-2 secretion	J:205441
	decreased T cell proliferation	J:205441
Casp1^tm1Flv/Casp1^tm1Flv Casp4^del/Casp4^del (involves: 129S2/SvPas * C57BL/6)	abnormal cytokine secretion	J:24258
	decreased circulating interferon-gamma level	J:115310
	decreased interferon-gamma secretion	J:115310
	decreased interleukin-1 alpha secretion	J:24258
	decreased interleukin-1 beta secretion	J:24258
	decreased interleukin-6 secretion	J:24258
	decreased interleukin-18 secretion	J:115310
	decreased susceptibility to endotoxin shock	J:43088
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:57101
	decreased thymocyte apoptosis	J:24258
	decreased tumor necrosis factor secretion	J:24258
	impaired neutrophil chemotaxis	J:124226
	increased susceptibility to bacterial infection	J:117251
Casp1^tm1Flv/Casp1^tm1Flv Casp4^del/Casp4^del (B6.129S2-Casp1^tm1Flv)	decreased interleukin-1 beta secretion	J:160545
	increased susceptibility to induced colitis	J:173245
Casp1^tm1Flv/Casp1^tm1Flv Casp4^del/Casp4^del Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to endotoxin shock	J:43088
Casp1^tm1Flv/Casp1^tm1Flv Casp4^del/Casp4^del Slc11a1^r/Slc11a1^r (involves: 129S2/SvPas)	increased susceptibility to bacterial infection	J:124378
Casp1^tm1Flv/Casp1^tm1Flv Casp4^del/Casp4^del Slc11a1^s/Slc11a1^s (B6.129S2-Casp1^tm1Flv)	cecum inflammation	J:124378
	increased susceptibility to bacterial infection	J:124378
Casp1^tm1Sesh/Casp1⁺ Casp4^del/Casp4⁺ (involves: 129S2/SvPas * C57BL/6)	decreased interleukin-1 beta secretion	J:22964
Casp1^tm1Sesh/Casp1⁺ Casp4^del/Casp4⁺ (involves: 129S1/SvImJ * 129S2/SvPas * NOD)	abnormal macrophage physiology	J:99748
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (involves: 129S2/SvPas * C57BL/6)	abnormal inflammatory response	J:80568
	abnormal macrophage physiology	J:22964
	abnormal neutrophil physiology	J:80568
	decreased circulating interleukin-1 alpha level	J:22964
	decreased circulating interleukin-1 beta level	J:22964
	decreased circulating interleukin-6 level	J:22964
	decreased circulating tumor necrosis factor level	J:22964
	decreased interleukin-1 alpha secretion	J:22964
	decreased interleukin-1 beta secretion	J:88212, J:22964
	decreased susceptibility to endotoxin shock	J:22964, J:40691
	decreased T cell apoptosis	J:40691
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (NOD.129S2(B6)-Casp1^tm1Sesh Casp4^del/LtJ)	decreased interleukin-1 alpha secretion	J:87250
	decreased interleukin-1 beta secretion	J:87250
	decreased interleukin-18 secretion	J:87250
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (C3N.129S2-Casp1^tm1Sesh Casp4^del)	abnormal response to infection	J:86761
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (B10.Cg-Casp1^tm1Sesh Casp4^del H2^r H2-T18^b)	decreased inflammatory response	J:63488
	decreased susceptibility to bacterial infection	J:63488
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:63488
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (involves: 129 * 129S2/SvPas * C57BL/6)	decreased interleukin-1 beta secretion	J:50775
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (C3.129S2-Casp1^tm1Sesh Casp4^del)	abnormal macrophage physiology	J:136368
	decreased interleukin-1 beta secretion	J:136368
	increased susceptibility to bacterial infection	J:136368
	increased susceptibility to bacterial infection induced morbidity/mortality	J:136368
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del (B6.129S2(NOD)-Casp1^tm1Sesh Casp4^del)	decreased circulating interleukin-1 alpha level	J:193522
	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
	decreased interleukin-1 alpha secretion	J:193522
	decreased interleukin-1 beta secretion	J:193522
	decreased interleukin-18 secretion	J:193522
	decreased macrophage apoptosis	J:193522
	decreased susceptibility to endotoxin shock	J:193522
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del Slc11a1^r/Slc11a1^s (involves: 129/Sv * 129S2/SvPas * C57BL/6)	increased susceptibility to bacterial infection	J:112400
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del Slc11a1^s/Slc11a1^s (B6.129S2-Casp1^tm1Sesh Casp4^del)	abnormal macrophage physiology	J:112400
	increased susceptibility to bacterial infection	J:112400
Casp1^tm1Sesh/Casp1^tm1Sesh Casp4^del/Casp4^del Tg(Casp4)#Gne/0 (involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ)	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
	decreased interleukin-1 alpha secretion	J:193522
	decreased interleukin-1 beta secretion	J:193522
	decreased interleukin-18 secretion	J:193522
	decreased macrophage apoptosis	J:193522
	decreased susceptibility to endotoxin shock	J:193522
Casp1^tm1Sesh/Casp1^tm1Sesh Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S2/SvPas * C57BL/6)	increased circulating interleukin-18 level	J:191055
Casp2^tm1Vaux/Casp2^tm1Vaux Casp9^tm1Flv/Casp9^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal T cell physiology	J:91156
Casp2^tm1Yuan/Casp2^tm1Yuan (involves: 129S4/SvJae * C57BL/6J * DBA/2)	abnormal B cell apoptosis	J:47601
Casp3^tm1Flv/Casp3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast physiology	J:94703
Casp3^tm1Flv/Casp3^tm1Flv Casp7^tm1Flv/Casp7⁺ (B6.129S-Casp3^tm1Flv Casp7^tm1Flv)	decreased thymocyte apoptosis	J:105496
Casp3^tm1Flv/Casp3^tm1Flv Casp7^tm1Flv/Casp7^tm1Flv (B6.129S-Casp3^tm1Flv Casp7^tm1Flv)	decreased thymocyte apoptosis	J:105496
Casp3^tm1Mak/Casp3^tm1Mak (B6.129P2-Casp3^tm1Mak)	decreased inflammatory response	J:97650, J:179279
Casp4^tm1.1Vmd/Casp4^tm1.1Vmd (involves: C57BL/6)	decreased circulating interleukin-1 alpha level	J:193522
	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
	decreased interleukin-1 alpha secretion	J:193522
	decreased interleukin-1 beta secretion	J:193522
	decreased macrophage apoptosis	J:193522
	decreased susceptibility to endotoxin shock	J:193522
Casp4^tm1Yuan/Casp4^tm1Yuan (involves: 129S4/SvJae * C57BL/6J * DBA/2)	decreased circulating interleukin-1 alpha level	J:46167
	decreased circulating interleukin-1 beta level	J:46167
	decreased susceptibility to endotoxin shock	J:46167
Casp4^tm1Yuan/Casp4^tm1Yuan (B6.129S4(D2)-Casp4^tm1Yuan/J)	decreased interleukin-1 beta secretion	J:270123
Casp4^tm1Yuan/Casp4^tm1Yuan (B6.129S4(D2)-Casp4^tm1Yuan/J)	decreased interleukin-18 secretion	J:270123
Casp8^tm1.1Raz/Casp8^tm1.1Raz Ripk3^tm1Vmd/Ripk3^tm1Vmd (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:170815
	decreased macrophage apoptosis	J:170815
	decreased thymocyte apoptosis	J:170814
	increased inflammatory response	J:170815
Casp8^tm1Clie/Casp8^tm1Clie Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	liver inflammation	J:218665
Casp8^tm1Hed/Casp8^tm1Hed Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal adaptive immunity	J:116713
	abnormal immunoglobulin level	J:116713
	decreased B cell proliferation	J:116713
Casp8^tm1Hed/Casp8^tm1Hed Tg(KRT14-cre)1Efu/0 (Not Specified)	abnormal T cell physiology	J:167299
	dermatitis	J:167299
	increased IgE level	J:167299
	increased IgG1 level	J:167299
Casp8^tm1Raz/Casp8^tm1Raz Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal CD8-positive, alpha-beta T cell physiology	J:82759
	abnormal T cell activation	J:107455
	abnormal T cell physiology	J:107455
	abnormal T cell proliferation	J:107455
	decreased T cell apoptosis	J:82759
	decreased T cell proliferation	J:82759
Casp9^tm1Flv/Casp9^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal thymocyte apoptosis	J:49088
Casp9^tm1Flv/Casp9^tm1Flv (involves: 129S1/Sv * C57BL/6)	decreased T cell apoptosis	J:91156
Casp9^tm1Mak/Casp9^tm1Mak (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))	abnormal splenocyte apoptosis	J:49087
	abnormal thymocyte apoptosis	J:49087
Casp12^tm1Dwni/Casp12^tm1Dwni (involves: 129S1/SvImJ * C57BL/6)	decreased susceptibility to bacterial infection	J:144912
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:144912
	increased circulating interleukin-18 level	J:144912
	increased interferon-gamma secretion	J:144912
	increased interleukin-1 beta secretion	J:144912
	increased susceptibility to endotoxin shock	J:144912
Casr^Nuf/Casr^Nuf (involves: 102/El * C3H/He)	tongue inflammation	J:92612
Cav1^tm1Mls/Cav1^tm1Mls (involves: 129/Sv * C57BL/6 * SJL)	abnormal chemokine secretion	J:115914
	abnormal cytokine level	J:115914
	abnormal macrophage physiology	J:115914
	abnormal neutrophil physiology	J:139304
	decreased susceptibility to endotoxin shock	J:139304
	impaired neutrophil recruitment	J:115914
	increased circulating CXCL10 level	J:115914
	increased circulating interferon-gamma level	J:115914
	increased circulating interleukin-6 level	J:115914
	increased circulating tumor necrosis factor level	J:115914
	increased susceptibility to bacterial infection	J:115914
	increased susceptibility to bacterial infection induced morbidity/mortality	J:115914
	lung inflammation	J:87282
Cav1^tm1Mls/Cav1^tm1Mls Cav3^tm1Mls/Cav3^tm1Mls (involves: 129/Sv * C57BL/6J * SJL)	heart inflammation	J:77372
Cbfa2t2^tm1Swh/Cbfa2t2^tm1Swh (either: B6.129S6-Cbfa2t2^tm1Swh or (involves: 129S6/SvEvTac * C57BL/6))	small intestinal inflammation	J:102172
Cbfb^tm1Itan/Cbfb^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased IgA level	J:125953
	increased IgE level	J:125953
	increased IgG1 level	J:125953
	increased immunoglobulin level	J:125953
	lung inflammation	J:125953
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lat^tm1Les/Lat^tm1Les (involves: 129P2/OlaHsd)	liver inflammation	J:91369
	lung inflammation	J:91369
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lcp2^tm1Gak/Lcp2^tm1Gak (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal cytokine secretion	J:91369
	liver inflammation	J:91369
	lung inflammation	J:91369
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv)	abnormal T cell physiology	J:81965
Cbl^tm1Ddlb/Cbl^tm2Wlan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell activation	J:103366
	abnormal T cell physiology	J:103366
Cbl^tm1Wlan/Cbl^tm1Wlan (involves: 129S1/Sv * C57BL/6)	abnormal T cell physiology	J:81965
Cbl^tm2Hua/Cbl^tm2Hua Cblb^tm1Hua/Cblb^tm1Hua Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * ICR)	abnormal immune system physiology	J:80427
	dermatitis	J:80427
	increased T cell proliferation	J:80427
Cblb^tm1Hua/Cblb^tm1Hua (Not Specified)	increased T cell proliferation	J:89761
Cblb^tm1Hua/Cblb^tm1Hua (B6.129P2-Cblb^tm1Hua)	increased interleukin-2 secretion	J:94685
	increased susceptibility to experimental autoimmune encephalomyelitis	J:94685
	increased T cell proliferation	J:94685
Cblb^tm1Hua/Cblb^tm1Hua Ubash3b^tm1Jni/Ubash3b^tm1Jni Ubash3a^tm1Jni/Ubash3a^tm1Jni (Not Specified)	increased susceptibility to experimental autoimmune encephalomyelitis	J:89761
	increased T cell proliferation	J:89761
Cblb^tm1Pngr/Cblb^tm1Pngr (involves: 129 * C57BL/6)	abnormal mast cell physiology	J:126361
	increased interleukin-6 secretion	J:126361
	increased tumor necrosis factor secretion	J:126361
Cblb^tm1Pngr/Cblb^tm1Pngr (B6.129P2-Cblb^tm1Pngr)	increased T cell proliferation	J:141390
Cblb^tm1Pngr/Cblb^tm1Pngr Itk^tm1Litt/Itk^tm1Litt (B6.129-Itk^tm1Litt Cblb^tm1Pngr)	decreased interleukin-2 secretion	J:141390
Cblb^tm1Pngr/Cblb^tm1Pngr Vav1^tm1Tyb/Vav1^tm1Tyb Was^tm1Sbs/Was^tm1Sbs (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal T cell physiology	J:79550
Cblb^tm1Pngr/Cblb^tm1Pngr Was^tm1Sbs/Was^tm1Sbs (Not Specified)	abnormal T cell physiology	J:79550
Cblb^tm1Wlan/Cblb^tm1Wlan (involves: 129X1/SvJ * C57BL/6)	abnormal mast cell physiology	J:126361
	increased interleukin-6 secretion	J:126361
	increased tumor necrosis factor secretion	J:126361
Cblif^{tm1a(KOMP)Wtsi}/Cblif^{tm1a(KOMP)Wtsi} (C57BL/6N-Cblif^{tm1a(KOMP)Wtsi})	increased susceptibility to bacterial infection	J:236022
	increased susceptibility to bacterial infection induced morbidity/mortality	J:236022
Cbs^tm1Unc/Cbs^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal interleukin level	J:101303
	abnormal tumor necrosis factor level	J:101303
	liver inflammation	J:101303
Cbx2^tm1Cim/Cbx2^tm1Cim (involves: 129P2/OlaHsd * BALB/c)	decreased splenocyte proliferation	J:38487
Cbx4^tm1.1Gxu/Cbx4^tm1.2Gxu Tg(Foxn1-cre)1Tbo/0 (involves: 129S2/SvPas * C57BL/6J)	abnormal thymus physiology	J:194053
Cbx4^tm1.2Gxu/Cbx4^tm1.2Gxu (involves: 129S2/SvPas * C57BL/6J)	abnormal thymus physiology	J:194053
Cbx5^tm1.1Ics/Cbx5^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:186702
Cbx6^{tm1a(EUCOMM)Wtsi}/Cbx6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cbx6^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Cby1^tm1Ktkm/Cby1^tm1Ktkm (B6.129-Cby1^tm1Ktkm)	increased susceptibility to bacterial infection	J:147413
	increased susceptibility to otitis media	J:147413
	sinus inflammation	J:147413
Cc2d1a^{tm1a(KOMP)Wtsi}/Cc2d1a^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased interferon-beta secretion	J:190401
	decreased interleukin-6 secretion	J:190401
Ccar2^Gt(XN876)Byg/Ccar2^Gt(XN876)Byg (involves: 129P2/OlaHsd * C57BL/6)	decreased tumor necrosis factor secretion	J:156677
Ccbe1^tm1Mlkn/Ccbe1^tm1Mlkn (either: B6.129-Ccbe1^tm1Mlkn or (involves: 129 * C57BL/6))	abnormal macrophage physiology	J:196696
Ccdc86^tm1Hfuj/Ccdc86⁺ (involves: C57BL/6NTac)	decreased T cell apoptosis	J:151722
Ccdc88b^m1Pgrs/Ccdc88b^m1Pgrs (involves: C57BL/6J * C57BL/10J)	decreased interferon-gamma secretion	J:230618
	decreased susceptibility to parasitic infection	J:230618
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:230618
	decreased T cell proliferation	J:230618
	decreased tumor necrosis factor secretion	J:230618
Ccdc88b^m1Pgrs/Ccdc88b^m1Pgrs (involves: 129S1/SvImJ * C57BL/6J * C57BL/10J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:230618
Ccdc92^{tm1a(KOMP)Mbp}/Ccdc92^{tm1a(KOMP)Mbp} (C57BL/6N-Ccdc92^{tm1a(KOMP)Mbp})	decreased circulating interleukin-1 beta level	J:332421
	decreased circulating interleukin-18 level	J:332421
	decreased inflammatory response	J:332421
Ccdc171^m1Anu/Ccdc171⁺ (C57BL/NCrlAnu-Ccdc171^m1Anu/Anu)	decreased IgD level	J:104190
Ccdc171^m1Anu/Ccdc171⁺ (C57BL/NCrlAnu-Ccdc171^m1Anu/Anu)	increased IgM level	J:104190
Ccdc171^m1Anu/Ccdc171^m1Anu (C57BL/NCrlAnu-Ccdc171^m1Anu/Anu)	decreased IgD level	J:104190
	increased IgM level	J:104190
Cckbr^tm1Tom/Cckbr^tm1Tom (involves: 129S4/SvJae * C57BL/6J)	decreased susceptibility to endotoxin shock	J:143853
Ccl1^tm1Sman/Ccl1^tm1Sman (B6.129-Ccl1^tm1Sman)	abnormal inflammatory response	J:138942
Ccl1^tm1Sman/Ccl1^tm1Sman (B6.129-Ccl1^tm1Sman)	abnormal regulatory T cell physiology	J:138942
Ccl2^tm1.1Pame/Ccl2^tm1.1Pame Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * SJL)	abnormal leukocyte migration	J:171379
	increased susceptibility to bacterial infection	J:171379
Ccl2^tm1.1Pame/Ccl2^tm1.1Pame Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6)	abnormal leukocyte migration	J:171379
	increased susceptibility to bacterial infection	J:171379
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv * C57BL/6)	abnormal chemokine level	J:151874
	abnormal chemokine secretion	J:151874
	abnormal neutrophil physiology	J:151874
	impaired macrophage chemotaxis	J:151874
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv)	abnormal dendritic cell chemotaxis	J:199611
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv)	abnormal dendritic cell physiology	J:199611
Ccl2^tm1Lex/Ccl2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	impaired macrophage chemotaxis	J:191510
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)	decreased interferon-gamma secretion	J:45920
	decreased interleukin-4 secretion	J:45920
	decreased interleukin-5 secretion	J:45920
	decreased susceptibility to type IV hypersensitivity reaction	J:45920
	impaired macrophage chemotaxis	J:45920
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage chemotaxis	J:116878
	abnormal T cell physiology	J:116878
	decreased interferon-gamma secretion	J:116878
	decreased interleukin-1 beta secretion	J:116878
	decreased interleukin-12b secretion	J:116878
	decreased susceptibility to induced colitis	J:116878
	impaired macrophage chemotaxis	J:108533
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae)	abnormal macrophage physiology	J:155025
	decreased inflammatory response	J:155025
	impaired macrophage chemotaxis	J:147697
	increased circulating interferon-gamma level	J:155025
	increased circulating interleukin-10 level	J:155025
	increased circulating tumor necrosis factor level	J:155025
	increased susceptibility to infection induced morbidity/mortality	J:155025
	increased susceptibility to parasitic infection	J:155025
Ccl2^tm1Rol/Ccl2^tm1Rol (B6.129S4-Ccl2^tm1Rol)	abnormal chemokine level	J:151874, J:118606
	abnormal chemokine secretion	J:151874
	abnormal cytokine secretion	J:68145
	abnormal macrophage chemotaxis	J:109290
	abnormal neutrophil physiology	J:151874
	decreased interferon-gamma secretion	J:68145
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:68145
	impaired macrophage chemotaxis	J:151874, J:68145, J:118606
	increased IgG1 level	J:68145
	increased IgG level	J:147328
	increased interleukin-10 secretion	J:68145
Ccl2^tm1Rol/Ccl2^tm1Rol (SJL.129S4-Ccl2^tm1Rol)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:68145
Ccl2^tm1Rol/Ccl2^tm1Rol (B6.129S4-Ccl2^tm1Rol/J)	abnormal microglial cell physiology	J:141739
Ccl2^tm1Rol/Ccl2^tm1Rol Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)	abnormal macrophage physiology	J:200877
	increased microglial cell activation	J:200877
Ccl2^tm1Rol/Ccl2^tm1Rol Mpz^tm1Msch/Mpz⁺ (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal cytokine level	J:133028
Ccl2^tm1Rol/Ccl2^tm1Rol Tg(Ccr2-GFP)8Pam/0 (involves: 129S4/SvJae * C57BL/6J)	abnormal leukocyte migration	J:171379
Ccl2^tm1Tyos/Ccl2^tm1Tyos (involves: 129S1/Sv * C57BL/6)	abnormal chemokine level	J:151874
Ccl2^tm1Tyos/Ccl2^tm1Tyos (involves: 129S1/Sv * C57BL/6)	abnormal chemokine secretion	J:151874
Ccl3^tm1Unc/Ccl3^tm1Unc (involves: 129P2/OlaHsd)	abnormal susceptibility to Orthomyxoviridae infection	J:107677
	cecum inflammation	J:107677
	decreased susceptibility to bacterial infection	J:107677
	decreased susceptibility to Orthomyxoviridae infection	J:107677
	decreased susceptibility to Picornaviridae infection	J:28704
Ccl3^tm1Unc/Ccl3^tm1Unc (B6.129P2-Ccl3^tm1Unc/J)	decreased susceptibility to type III hypersensitivity reaction	J:94599
Ccl3^tm1Unc/Ccl3^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased microglial cell activation	J:153059
Ccl3^tm1Unc/Ccl3^tm1Unc Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal tumor necrosis factor level	J:90687
	CNS inflammation	J:90687
Ccl4^em1Narl/Ccl4^em1Narl (C57BL/6JNarl-Ccl4^em1Narl)	decreased inflammatory response	J:346348
Ccl4^em1Narl/Ccl4^em1Narl (C57BL/6JNarl-Ccl4^em1Narl)	decreased susceptibility to autoimmune diabetes	J:346348
Ccl5^tm1Hso/Ccl5^tm1Hso (involves: 129P2/OlaHsd * C57BL/6)	decreased interferon-gamma secretion	J:75842
	decreased interleukin-2 secretion	J:75842
	decreased susceptibility to type IV hypersensitivity reaction	J:75842
	decreased T cell proliferation	J:75842
Ccl11^tm1Mer/Ccl11^tm1Mer (involves: 129S6/SvEvTac * NIH Black Swiss)	impaired eosinophil recruitment	J:38945
Ccl11^tm1Mer/Ccl11^tm1Mer Ccl24^tm1Mer/Ccl24^tm1Mer (129S.129S6(Cg)-Ccl24^tm1Mer Ccl11^tm1Mer)	abnormal immune system physiology	J:102034
	abnormal inflammatory response	J:102034
Ccl17^tm1.1Ifo/Ccl17^tm1.1Ifo (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to type IV hypersensitivity reaction	J:159098
	increased length of allograft survival	J:159098
Ccl17^{tm2.1(cre)Ifo}/Ccl17⁺ Hif1a^tm3Rsjo/Hif1a^tm3Rsjo (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal interleukin-1 beta secretion	J:187773
	abnormal leukocyte migration	J:187773
	abnormal tumor necrosis factor secretion	J:187773
Ccl21a^tm1Yout/Ccl21a^tm1Yout (involves: C57BL/6NCrlj * CBA/JNCrlj)	lacrimal gland inflammation	J:244640
Ccl22^{tm1(KOMP)Vlcg}/Ccl22^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal dendritic cell physiology	J:236051
Ccl24^tm1Mer/Ccl24^tm1Mer (129S.129S6-Ccl24^tm1Mer)	abnormal immune system physiology	J:98708, J:102034
Ccl24^tm1Mer/Ccl24^tm1Mer (involves: 129S6/SvEvTac * C57BL/6J)	abnormal immune system physiology	J:98708
Ccl25^tm1.1Mal/Ccl25^tm1.1Mal Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	intestinal inflammation	J:136667
Ccl28^tm1Takna/Ccl28^tm1Takna (C57BL/6J-Ccl28^tm1Takna)	decreased IgA level	J:256896
	increased IgG level	J:256896
	increased susceptibility to induced colitis	J:256896
Ccm2^tm1Kwhi/Ccm2^tm1.1Kwhi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/? (involves: C57BL/6 * CBA)	CNS inflammation	J:173947
Ccn3^tm1.1Ecan/Ccn3^tm1.1Ecan (B6.Cg-Ccn3^tm1.1Ecan)	abnormal osteoclast physiology	J:158478
Ccnd3^{tm1.1(Ccnd2)Iaai}/Ccnd3^{tm1.1(Ccnd2)Iaai} (involves: 129S6/SvEvTac)	decreased B cell proliferation	J:192031
	decreased T cell proliferation	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (Not Specified)	decreased B cell proliferation	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (Not Specified)	decreased T cell proliferation	J:88120, J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor)	decreased T cell proliferation	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv)	increased T cell proliferation	J:88120
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Rb1^tm2Brn/Rb1^tm2Brn Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	decreased T cell proliferation	J:192031
Ccne1^tm1Jro/Ccne1^tm1Jro (either: 129-Ccne1^tm1Jro or B6.129-Ccne1^tm1Jro)	increased splenocyte proliferation	J:99695
Ccnt1^{Gt(RRR115)Byg}/Ccnt1^{Gt(RRR115)Byg} (involves: 129P2/OlaHsd)	abnormal thymus physiology	J:130071
	autoimmune response	J:130071
	lacrimal gland inflammation	J:130071
	salivary gland inflammation	J:130071
Ccpg1^{tm1a(EUCOMM)Hmgu}/Ccpg1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Ccpg1^{tm1a(EUCOMM)Hmgu})	pancreas inflammation	J:256708
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae)	decreased tumor necrosis factor secretion	J:43569
	glomerulonephritis	J:115119
	impaired neutrophil recruitment	J:43569
	increased IgG2a level	J:115119
	increased interferon-gamma secretion	J:115119
	increased susceptibility to type IV hypersensitivity reaction	J:115119
	increased tumor necrosis factor secretion	J:115119
	lung inflammation	J:43569
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	cecum inflammation	J:107677
	decreased susceptibility to bacterial infection	J:107677
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:63952
	increased length of allograft survival	J:59235
Ccr1^tm1Cge/Ccr1^tm1Cge (involves: 129S4/SvJae * BALB/c)	abnormal chemokine secretion	J:169909
	abnormal circulating chemokine level	J:169909
	abnormal macrophage physiology	J:169909
	decreased circulating interferon-gamma level	J:169909
	decreased interleukin-10 secretion	J:169909
	decreased susceptibility to bacterial infection	J:169909
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:169909
	decreased tumor necrosis factor secretion	J:169909
	increased interleukin-12 secretion	J:169909
	increased macrophage nitric oxide production	J:169909
	increased tumor necrosis factor secretion	J:169909
Ccr1^tm1Cge/Ccr1^tm1Cge (C.129S4-Ccr1^tm1Cge)	decreased interleukin-13 secretion	J:95242
Ccr1^tm1Cge/Ccr1^tm1Cge (C.129S4-Ccr1^tm1Cge)	decreased susceptibility to Riboviria infection	J:95242
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil physiology	J:41324
	granulomatous inflammation	J:41324
	increased susceptibility to fungal infection	J:41324
	increased susceptibility to parasitic infection	J:41324
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: C57BL/6)	decreased susceptibility to type III hypersensitivity reaction	J:94599
Ccr1^tm1Gao/Ccr1^tm1Gao (B6.129S4-Ccr1^tm1Gao)	abnormal cellular extravasation	J:104744
	abnormal leukocyte adhesion	J:104744
	bronchiolitis	J:162707
	increased susceptibility to Coronaviridae infection	J:162707
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:162707
Ccr2^tm1.1Dnc/Ccr2^tm1.1Dnc (Not Specified)	abnormal dendritic cell chemotaxis	J:223508
Ccr2^tm1Blck/Ccr2^tm1Blck (B6.129P2-Ccr2^tm1Blck)	abnormal cellular extravasation	J:104744
Ccr2^tm1Blck/Ccr2^tm1Blck (B6.129P2-Ccr2^tm1Blck)	abnormal leukocyte adhesion	J:104744
Ccr2^tm1Blck/Ccr2^tm1Blck Fas^lpr/Fas^lpr (MRL.Cg-Ccr2^tm1Blck Fas^lpr)	abnormal interferon level	J:113343
	abnormal tumor necrosis factor level	J:113343
	glomerulonephritis	J:113343
	kidney inflammation	J:113343
Ccr2^tm1Brv/Ccr2^tm1Brv (involves: 129S1/Sv * ICR)	impaired macrophage chemotaxis	J:111517
	increased susceptibility to bacterial infection	J:111517
	liver inflammation	J:111517
Ccr2^tm1Ifc/Ccr2⁺ (involves: 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:121703
Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.129S4-Ccr2^tm1Ifc/J)	abnormal leukocyte migration	J:106738
	abnormal leukocyte physiology	J:122119
	abnormal microglial cell physiology	J:106738
	abnormal osteoclast physiology	J:149360
	decreased acute inflammation	J:106738
	decreased interferon-gamma secretion	J:106738
	increased susceptibility to Coronaviridae infection	J:106738
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:106738
Ccr2^tm1Ifc/Ccr2^tm1Ifc (involves: 129S4/SvJae * C57BL/6)	abnormal immune serum protein physiology	J:118971
	abnormal Langerhans cell physiology	J:112594
	abnormal macrophage chemotaxis	J:44345
	abnormal microglial cell physiology	J:121703
	decreased inflammatory response	J:44345
	decreased interferon-gamma secretion	J:75838, J:44345
	decreased interleukin-2 secretion	J:44345
	decreased interleukin-6 secretion	J:75838
	decreased splenocyte proliferation	J:75838
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:75838
	decreased susceptibility to type I hypersensitivity reaction	J:118971
	decreased T cell proliferation	J:75838
	impaired macrophage chemotaxis	J:81363, J:44345, J:121703
	increased interferon-gamma secretion	J:61542
	increased tumor necrosis factor secretion	J:61542
Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.129S4-Ccr2^tm1Ifc)	decreased susceptibility to induced colitis	J:161138
Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.129S4-Ccr2^tm1Ifc)	impaired leukocyte tethering or rolling	J:154558
Ccr2^tm1Ifc/Ccr2^tm1Ifc Tg(APPSWE)2576Kha/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal microglial cell physiology	J:121703
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * C57BL/6J)	abnormal cytokine secretion	J:110814
	decreased inflammatory response	J:110814
	increased susceptibility to induced colitis	J:110814
Ccr2^tm1Mae/Ccr2^tm1Mae (B6.129P2-Ccr2^tm1Mae)	bronchiolitis	J:162707
	increased IgG level	J:147328
	increased susceptibility to Coronaviridae infection	J:162707
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd)	abnormal chemokine secretion	J:151874
	abnormal leukocyte migration	J:171379
	impaired macrophage chemotaxis	J:191510, J:151874
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * BALB/c)	abnormal leukocyte physiology	J:162714
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * BALB/c)	impaired macrophage chemotaxis	J:162714
Ccr2^tm2.1Ifc/Ccr2^tm2.1Ifc Cx3cr1^tm1Litt/Cx3cr1⁺ (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal leukocyte physiology	J:166664
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:166664
Ccr2^tm2.1Ifc/Ccr2^tm2.1Ifc Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal leukocyte physiology	J:166664
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:166664
Ccr3^tm1Cge/Ccr3^tm1Cge (involves: 129S4/SvJae * BALB/c)	abnormal eosinophil physiology	J:74509, J:75347
	abnormal mast cell physiology	J:74509
	decreased circulating interleukin-4 level	J:115273
	impaired eosinophil chemotaxis	J:74509
	impaired eosinophil recruitment	J:74509, J:75347
	increased mast cell degranulation	J:74509
Ccr4^tm1Pwr/Ccr4^tm1Pwr (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine secretion	J:70088
	abnormal cytokine secretion	J:120221
	abnormal splenocyte physiology	J:70088
	decreased IgE level	J:120221
	decreased interleukin-1 beta secretion	J:70088
	decreased interleukin-4 secretion	J:120221
	decreased interleukin-5 secretion	J:120221
	decreased interleukin-10 secretion	J:120221
	decreased interleukin-13 secretion	J:120221
	decreased susceptibility to endotoxin shock	J:70088
	decreased susceptibility to fungal infection	J:120221
	decreased tumor necrosis factor secretion	J:70088
	increased IgE level	J:120221
	increased IgG1 level	J:120221
	increased interferon-gamma secretion	J:120221
	increased interleukin-4 secretion	J:120221
	increased interleukin-5 secretion	J:120221
	increased interleukin-10 secretion	J:120221
	increased tumor necrosis factor secretion	J:120221
Ccr4^tm1Pwr/Ccr4^tm1Pwr (B6.129P2-Ccr4^tm1Pwr)	increased length of allograft survival	J:95239
Ccr5^tm1Blck/Ccr5^tm1Blck (B6.129P2-Ccr5^tm1Blck)	abnormal cellular extravasation	J:104744
	abnormal leukocyte adhesion	J:104744
	increased length of allograft survival	J:105072
Ccr5^tm1Brv/Ccr5^tm1Brv (either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR))	abnormal cytokine secretion	J:46941
	decreased interleukin-1 beta secretion	J:46941
	decreased interleukin-6 secretion	J:46941
	decreased susceptibility to endotoxin shock	J:46941
	increased IgG1 level	J:46941
	increased interferon-gamma secretion	J:46941
	increased interleukin-4 secretion	J:46941
	increased susceptibility to bacterial infection	J:46941
	increased susceptibility to type IV hypersensitivity reaction	J:46941
Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:110814
	abnormal NK T cell physiology	J:100869
	decreased microglial cell activation	J:153059
	decreased susceptibility to induced colitis	J:110814
	decreased susceptibility to Retroviridae infection	J:132342
	impaired macrophage chemotaxis	J:153059, J:84243, J:64293
	increased susceptibility to fungal infection	J:64293
Ccr5^tm1Kuz/Ccr5^tm1Kuz (B6.129P2-Ccr5^tm1Kuz)	bronchiolitis	J:162707
Ccr5^tm1Kuz/Ccr5^tm1Kuz (B6.129P2-Ccr5^tm1Kuz)	increased susceptibility to Coronaviridae infection	J:162707
Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd)	decreased inflammatory response	J:227458
Ccr5^tm1Kuz/Ccr5^tm1Kuz Cxcr4^tm1Qma/Cxcr4^tm1Qma (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	decreased susceptibility to Retroviridae infection	J:132342
Ccr5^tm1Sush/Ccr5^tm1Sush (B6.129P2-Ccr5^tm1Sush)	abnormal leukocyte physiology	J:94937
Ccr5^tm1Sush/Ccr5^tm1Sush (B6.129P2-Ccr5^tm1Sush)	decreased T cell proliferation	J:94937
Ccr6^tm1(EGFP)Irw/Ccr6^tm1(EGFP)Irw (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:120122
	abnormal follicular dendritic cell physiology	J:113363
	abnormal T cell physiology	J:85086
	increased T cell proliferation	J:85086
Ccr6^tm1(EGFP)Irw/Ccr6^tm1(EGFP)Irw (B6.129S6-Ccr6^tm1(EGFP)Irw)	decreased interleukin-4 secretion	J:132012
	decreased interleukin-12 secretion	J:132012
	decreased susceptibility to bacterial infection	J:132012
	decreased tumor necrosis factor secretion	J:132012
	increased interferon-gamma secretion	J:132012
Ccr6^tm1.1Jmf/Ccr6^tm1.1Jmf (B6.129-Ccr6^tm1.1Jmf)	abnormal CD4-positive, alpha-beta T cell physiology	J:152716
	abnormal dendritic cell physiology	J:152716
	abnormal interleukin secretion	J:152716
	decreased inflammatory response	J:152716
Ccr6^tm1Gma/Ccr6^tm1Gma (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:68191
	decreased inflammatory response	J:68191
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129)	abnormal follicular dendritic cell antigen presentation	J:113363
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129)	abnormal T cell physiology	J:123150
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:148286
	abnormal macrophage physiology	J:124358
	decreased IgA level	J:76461
	decreased IgG3 level	J:76461
	decreased inflammatory response	J:124358
	decreased interleukin-10 secretion	J:124358
	decreased interleukin-12 secretion	J:124358
	decreased macrophage cytokine production	J:124358
	decreased macrophage nitric oxide production	J:124358
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:148286
	decreased tumor necrosis factor secretion	J:124358
	increased IgM level	J:76461
	increased susceptibility to Riboviria infection	J:76461
Ccr6^tm1Lira/Ccr6^tm1Lira (B6.129-Ccr6^tm1Lira)	decreased IgE level	J:71096
	decreased interleukin-5 secretion	J:71096
	decreased susceptibility to type I hypersensitivity reaction	J:71096
	impaired eosinophil recruitment	J:71096
Ccr7^tm1Dgen/Ccr7^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	chronic inflammation	J:101679
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129P2/OlaHsd * BALB/c)	abnormal B cell activation	J:57976
	abnormal B cell physiology	J:57976
	abnormal class switch recombination	J:57976
	abnormal dendritic cell physiology	J:57976
	abnormal humoral immune response	J:57976
	abnormal leukocyte migration	J:57976
	abnormal T cell physiology	J:57976
	decreased IgG3 level	J:57976
	decreased susceptibility to type IV hypersensitivity reaction	J:57976
	increased IgE level	J:57976
	increased IgG1 level	J:57976
	increased IgG2a level	J:57976
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal dendritic cell physiology	J:134784
Ccr7^tm1Rfor/Ccr7^tm1Rfor (B6.129P2-Ccr7^tm1Rfor)	abnormal dendritic cell physiology	J:183989
	abnormal leukocyte migration	J:93960, J:110910
	increased inflammatory response	J:110910
	increased susceptibility to autoimmune disorder	J:110910
	lacrimal gland inflammation	J:110910
	parotid gland inflammation	J:110910
	salivary gland inflammation	J:110910
	submandibular gland inflammation	J:110910
Ccr7^tm1Rfor/Ccr7^tm1Rfor (B6.129P2(C)-Ccr7^tm1Rfor/J)	decreased susceptibility to bacterial infection	J:210086
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129P2/OlaHsd)	abnormal dendritic cell chemotaxis	J:223508
Ccr7^tm1Rfor/Ccr7^tm1Rfor Tg(DO11.10)10Dlo/? (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	abnormal leukocyte migration	J:123482
	abnormal regulatory T cell physiology	J:123482
Ccr8^tm1Lira/Ccr8^tm1Lira (involves: 129S/SvEv * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:118417
Ccr9^tm1.1Mal/Ccr9^tm1.1Mal Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	intestinal inflammation	J:136667
Ccr10^tm1Cge/Ccr10^tm1Cge (C.129S4-Ccr10^tm1Cge)	abnormal leukocyte migration	J:140728
Ccr10^tm1Cge/Ccr10^tm1Cge (C.129S4-Ccr10^tm1Cge)	decreased IgA level	J:140728
Ccrl2^tm1Lex/Ccrl2^tm1Lex (involves: 129S/SvEvBrd * C57BL/6)	decreased susceptibility to type I hypersensitivity reaction	J:140110
Ccrl2^tm1Ssoz/Ccrl2^tm1Ssoz (B6.129-Ccrl2^tm1Ssoz)	abnormal dendritic cell chemotaxis	J:165873
	abnormal hypersensitivity reaction	J:165873
	abnormal T-helper 2 physiology	J:165873
	decreased interleukin-4 secretion	J:165873
	decreased interleukin-5 secretion	J:165873
	decreased interleukin-13 secretion	J:165873
Cd1^tm1Gru/Cd1^tm1Gru (involves: 129S2/SvPas * BALB/c)	decreased interleukin-4 secretion	J:47769
	decreased susceptibility to infection induced morbidity/mortality	J:126220
	myocarditis	J:126220
Cd1d1^tm1.1Aben/Cd1d1^tm1.1Aben Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.Cg-Cd1d1^tm1.1Aben Lyz2^tm1(cre)Ifo)	decreased interferon-gamma secretion	J:183087
	decreased interleukin-4 secretion	J:183087
Cd1d1^tm1.1Aben/Cd1d1^tm1.1Aben Tg(Itgax-cre,-EGFP)4097Ach/0 (C57BL/6-Cd1d1^tm1.1Aben Tg(Itgax-cre,-EGFP)4097Ach)	decreased interferon-gamma secretion	J:183087
	decreased interleukin-4 secretion	J:183087
Cd1d1^tm1.1Boes/Cd1d1^tm1.1Boes (involves: C57BL/6)	abnormal dendritic cell antigen presentation	J:151699
	abnormal interleukin-4 secretion	J:151699
	abnormal NK T cell physiology	J:151699
	decreased interleukin-2 secretion	J:151699
Cd1d1^tm1.1Boes/Cd1d1^tm1.1Boes Cd74^tm1Doi/Cd74^tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal dendritic cell antigen presentation	J:151699
Cd1d1^tm1.2Aben/Cd1d1^tm1.2Aben (B6(C)-Cd1d1^tm1.2Aben/J)	abnormal T cell activation	J:177038
	increased susceptibility to bacterial infection	J:177038
	increased susceptibility to bacterial infection induced morbidity/mortality	J:177038
	lung inflammation	J:177038
Cd1d1^tm1Crw/Cd1d1^tm1Crw (B6.129S4-Cd1d1^tm1Crw)	decreased IgG level	J:99107
Cd1d1^tm1Crw/Cd1d1^tm1Crw (B6.129S4-Cd1d1^tm1Crw)	decreased susceptibility to induced arthritis	J:99107
Cd1d1^tm1Luc/Cd1d1^tm1Luc (B6.129S6-Cd1d1^tm1Luc)	autoimmune response	J:122245
Cd1d1^tm1Luc/Cd1d1^tm1Luc (involves: 129S6/SvEvTac * C57BL/6)	decreased acute inflammation	J:93915
	decreased interferon-gamma secretion	J:93915, J:39748
	decreased interleukin-4 secretion	J:39748
	decreased tumor necrosis factor secretion	J:93915
Cd1d1^tm1Luc/Cd1d1^tm1Luc (C.129S6-Cd1d1^tm1Luc)	decreased interleukin-4 secretion	J:121187
	glomerulonephritis	J:121187
	increased anti-double stranded DNA antibody level	J:121187
	increased anti-nuclear antigen antibody level	J:121187
	increased IgG3 level	J:121187
	kidney inflammation	J:121187
Cd1d1^tm1Luc/Cd1d1^tm1Luc Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (B6.129-Cd1d1^tm1Luc Cx3cr1^tm1Litt)	increased susceptibility to experimental autoimmune encephalomyelitis	J:129712
Cd1d1^tm2Aben/Del(3Cd1d2-Cd1d1)1Crw (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal antigen presentation	J:174337
Cd1d1^tm2Aben/Cd1d1^tm2Aben (B6.129P2-Cd1d1^tm2Aben)	abnormal antigen presentation	J:174337
Cd1d1^tm2Aben/Cd1d1^tm2Aben (involves: 129P2/OlaHsd * C57BL/6)	abnormal antigen presentation	J:174337
Cd2ap^em1Irgu/Cd2ap^em1Irgu (C57BL/6-Cd2ap^em1Irgu)	kidney inflammation	J:294238
Cd2ap^tm1Shaw/Cd2ap^tm1Shaw (involves: 129X1/SvJ)	decreased T cell proliferation	J:57971
Cd2bp2^tm1.1Tbh/Cd2bp2^tm1.1Tbh Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * CBA/J)	impaired macrophage phagocytosis	J:283435
Cd3e^m1Btlr/Cd3e^m1Btlr (C57BL/6J-Cd3e^m1Btlr)	increased T cell apoptosis	J:132486
Cd3e^m1Btlr/Cd3e^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd3e^tm1Mal/Cd3e^tm1Mal (C57BL/6-Cd3e^tm1Mal)	abnormal regulatory T cell physiology	J:125748
Cd3e^tm1Mal/Cd3e^tm1Mal Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: C57BL/6)	increased susceptibility to infection induced morbidity/mortality	J:191055
	skin inflammation	J:191055
Cd3g^tm1.1Cage/Cd3g^tm1.1Cage (B6.129P2-Cd3g^tm1.1Cage)	abnormal response to infection	J:153813
Cd3g^tm1.1Cage/Cd3g^tm1.1Cage (B6.129P2-Cd3g^tm1.1Cage)	increased T cell apoptosis	J:153813
Cd3g^tm1.1Cage/Cd3g^tm1.1Cage Tg(TcrLCMV)318Sdz/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	abnormal response to infection	J:142387
	abnormal T cell physiology	J:142387
Cd3g^tm1Amk/Cd3g^tm1Amk (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell physiology	J:77504
	abnormal T cell activation	J:77504
	abnormal T cell physiology	J:77504
	abnormal T cell proliferation	J:77504
	decreased cytotoxic T cell cytolysis	J:77504
Cd4^del/Cd4^del (C57BR/cdJ-Cd4^del)	decreased IgG level	J:46692
	decreased IgM level	J:46692
	decreased immunoglobulin level	J:46692
Cd4^em1Litt/Cd4^em1Litt Rr386^em1Pdi/Rr386^em1Pdi (involves: C57BL/6J)	abnormal lymphocyte activation involved in immune response	J:333574
Cd4^m1Btlr/Cd4^m1Btlr (C57BL/6J-Cd4^m1Btlr)	impaired humoral immune response	J:212900
Cd4^{tm1(cre/ERT2)Thbu}/Cd4⁺ Gfm1^{tm1c(EUCOMM)Wtsi}/Gfm1^{tm1c(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N * SJL)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:302272
Cd4^tm1Doi/Cd4^tm1Doi Lag3^tm1Doi/Lag3^tm1Doi (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:33272
Cd4^tm1Doi/Cd4^tm1Litt Lag3^tm1Doi/Lag3⁺ (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:33272
Cd4^tm1Knw/Cd4^tm1Knw (B6.129S-Cd4^tm1Knw/J)	increased susceptibility to parasitic infection	J:87828
Cd4^tm1Knw/Cd4^tm1Knw (NOD.Cg-Cd4^tm1Knw)	decreased susceptibility to autoimmune diabetes	J:93553
Cd4^tm1Knw/Cd4^tm1Knw Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-Cd4^tm1Knw Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	increased susceptibility to autoimmune diabetes	J:93553
Cd4^tm1Litt/Cd4^tm1Litt (involves: 129S2/SvPas)	abnormal CD4-positive, alpha-beta T cell physiology	J:50435
Cd4^tm1Litt/Cd4^tm1Litt (involves: 129S2/SvPas)	decreased T cell proliferation	J:50435
Cd4^tm1Litt/Cd4^tm1Litt Foxp3^sf Otc^spf/Y (involves: 129/Rl * 129S2/SvPas)	abnormal cytokine secretion	J:20865
	increased IgG level	J:20865
	increased IgM level	J:20865
	increased interleukin-4 secretion	J:20865
	increased interleukin-6 secretion	J:20865
	increased tumor necrosis factor secretion	J:20865
Cd4^tm1Litt/Cd4^tm1Nik Tg(Lck-cre)3778Nik/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:73479
	abnormal interleukin-4 secretion	J:73479
	abnormal T-helper 2 physiology	J:73479
	decreased T cell proliferation	J:73479
Cd4^tm1Litt/Cd4^tm1Nik Tg(Lck-cre)3785Nik/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:73479
	increased T cell apoptosis	J:73479
	increased T cell proliferation	J:73479
Cd4^tm1Litt/Cd4^tm1Nik Tg(Lck-icre)3779Nik/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:73479
	decreased T cell proliferation	J:73479
Cd4^tm1Mak/Cd4^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:68957
	increased susceptibility to Picornaviridae infection	J:92227
Cd4^tm1Mak/Cd4^tm1Mak (PL.129S2(B6)-Cd4^tm1Mak/Rdgz)	brain inflammation	J:92227
Cd4^tm1Mak/Cd4^tm1Mak (PL.129S2(B6)-Cd4^tm1Mak/Rdgz)	increased susceptibility to Picornaviridae infection	J:92227
Cd4^tm1Mak/Cd4^tm1Mak (SJL.129S2(B6)-Cd4^tm1Mak/Rdgz)	brain inflammation	J:92227
Cd4^tm1Mak/Cd4^tm1Mak (SJL.129S2(B6)-Cd4^tm1Mak/Rdgz)	increased susceptibility to Picornaviridae infection	J:92227
Cd4^tm1Mak/Cd4^tm1Mak Cd8a^tm1Mak/Cd8a^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased cytotoxic T cell cytolysis	J:12572
	increased length of allograft survival	J:12572
Cd4^tm1Mak/Cd4^tm1Mak Cd8a^tm1Mak/Cd8a^tm1Mak (involves: 129S2/SvPas)	increased susceptibility to viral infection	J:110749
Cd4^tm1Mak/Cd4^tm1Mak Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (B6.Cg-Cd4^tm1Mak Igh-J^{tm2(3H9-VDJ)Mwg})	increased anti-double stranded DNA antibody level	J:142389
Cd4^tm1Mak/Cd4^tm1Mak Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)	small intestinal inflammation	J:108572
Cd4^tm1Nik/Cd4^tm1Nik Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ)	abnormal regulatory T cell physiology	J:152472
Cd5^tm1.1Chra/Cd5^tm1.1Chra (involves: C57BL/6 * FVB/N)	abnormal T cell anergy	J:189919
	abnormal T cell physiology	J:189919
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:189919
	decreased T cell proliferation	J:189919
	increased T cell proliferation	J:189919
Cd5^tm1.1Chra/Cd5^tm1.1Chra Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6 * FVB/N)	decreased interferon-gamma secretion	J:189919
	decreased interleukin-2 secretion	J:189919
	decreased T cell proliferation	J:189919
	increased interferon-gamma secretion	J:189919
	increased interleukin-6 secretion	J:189919
	increased interleukin-17 secretion	J:189919
Cd5^tm1Cgn/Cd5^tm1Cgn (B6.129P2-Cd5^tm1Cgn)	abnormal T cell anergy	J:189919
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:189919
	increased T cell proliferation	J:189919
Cd5l^tm1Nto/Cd5l^tm1Nto (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:82352
Cd6^tm1Linf/Cd6^tm1Linf (D1.Cg-Cd6^tm1Linf)	abnormal B cell physiology	J:238478
	decreased B cell proliferation	J:238478
	decreased IgM level	J:238478
	decreased interleukin-6 secretion	J:238478
Cd7^tm1Bfh/Cd7^tm1Bfh (B6.129-Cd7^tm1Bfh)	decreased cytotoxic T cell cytolysis	J:48758
Cd7^tm1Bfh/Cd7^tm1Bfh (B6.129-Cd7^tm1Bfh)	decreased interferon-gamma secretion	J:48758
Cd8a^m1Btlr/Cd8a^m1Btlr (C57BL/6J-Cd8a^m1Btlr)	increased susceptibility to Herpesvirales infection	J:221492
Cd8a^m2Btlr/Cd8a^m2Btlr (C57BL/6J-Cd8a^m2Btlr)	abnormal CD8-positive, alpha-beta T cell physiology	J:236677
Cd8a^m2Btlr/Cd8a^m2Btlr (C57BL/6J-Cd8a^m2Btlr)	increased CD8-positive, alpha-beta memory T cell proliferation	J:236677
Cd8a^tm1Mak/Cd8a^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:68956
	increased susceptibility to Picornaviridae infection	J:92227
Cd8a^tm1Mak/Cd8a^tm1Mak (PL.129S2(B6)-Cd8a^tm1Mak/Rdgz)	increased susceptibility to Picornaviridae infection	J:92227
Cd8a^tm1Mak/Cd8a^tm1Mak (SJL.129S2(B6)-Cd8a^tm1Mak/Rdgz)	increased susceptibility to Picornaviridae infection	J:92227
Cd8a^tm1Mak/Cd8a^tm1Mak (B6.129S2-Cd8a^tm1Mak)	abnormal response to transplant	J:91742
Cd8a^tm1Mak/Cd8a^tm1Mak Il15^tm1Imx/Il15^tm1Imx X/Yaa (BXSB.Cg-Cd8a^tm1Mak Il15^tm1Imx/Dcr)	increased anti-nuclear antigen antibody level	J:179430
	increased IgG1 level	J:179430
	increased IgG2a level	J:179430
	increased IgG2b level	J:179430
	increased susceptibility to systemic lupus erythematosus	J:179430
Cd8a^tm1Mak/Cd8a^tm1Mak X/Yaa (BXSB.129S2(B6)-Cd8a^tm1Mak/4Dcr)	increased susceptibility to systemic lupus erythematosus	J:179430
Cd8b1^M1Btlr/Cd8b1^M1Btlr (C57BL/6J-Cd8b1^M1Btlr)	enhanced humoral immune response	J:255009
Cd8b1^M1Btlr/Cd8b1^M1Btlr (C57BL/6J-Cd8b1^M1Btlr)	increased IgG level	J:255009
Cd8b1^tm1Litt/Cd8b1^tm1Litt (involves: 129S4/SvJae * C57BL/6J)	abnormal cytotoxic T cell physiology	J:112551
Cd14^hdl/Cd14^hdl (C57BL/6-Cd14^hdl)	abnormal interferon secretion	J:98908
	decreased susceptibility to endotoxin shock	J:98908
	decreased tumor necrosis factor secretion	J:98908
	increased susceptibility to Riboviria infection	J:98908
Cd14^tm1Frm/Cd14⁺ (involves: 129S4/SvJae * C57BL/6J)	abnormal cytokine secretion	J:65107
	decreased interleukin-6 secretion	J:65107
	decreased tumor necrosis factor secretion	J:65107
Cd14^tm1Frm/Cd14^tm1Frm (involves: 129S4/SvJae * C57BL/6J)	abnormal cytokine secretion	J:65107
	decreased interleukin-6 secretion	J:65107
	decreased tumor necrosis factor secretion	J:65107
Cd14^tm1Frm/Cd14^tm1Frm (involves: 129S4/SvJae)	abnormal interferon secretion	J:98908
	decreased susceptibility to endotoxin shock	J:98908
	increased susceptibility to Riboviria infection	J:98908
Cd14^tm1Frm/Cd14^tm1Frm (B6.129S4-Cd14^tm1Frm)	abnormal cytokine level	J:96680
	abnormal interleukin level	J:96680
	abnormal tumor necrosis factor level	J:96680
Cd14^tm1Smg/Cd14^tm1Smg (involves: 129S1/Sv * C57BL/6)	decreased circulating interleukin-6 level	J:32729
	decreased circulating tumor necrosis factor level	J:32729
	decreased interleukin-6 secretion	J:32729
	decreased susceptibility to bacterial infection	J:32729
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:32729
	decreased susceptibility to endotoxin shock	J:32729
	decreased tumor necrosis factor secretion	J:32729
Cd14^tm1Smg/Cd14^tm1Smg (C.129S1-CD14^tm1Smg)	abnormal macrophage physiology	J:116691
	abnormal neutrophil physiology	J:127072
	decreased susceptibility to bacterial infection	J:127072
	decreased tumor necrosis factor secretion	J:116691
Cd14^tm1Smg/Cd14^tm1Smg (B6.129S1-CD14^tm1Smg)	decreased susceptibility to bacterial infection	J:127072
Cd14^tm1Smg/Cd14^tm1Smg (involves: 129S1/Sv)	abnormal tumor necrosis factor level	J:103464
Cd14^tm1Smg/Cd14^tm1Smg Tlr4^Lps-d/Tlr4^Lps-d (C3.129S1-CD14^tm1Smg)	abnormal macrophage physiology	J:116691
	decreased tumor necrosis factor secretion	J:116691
Cd19^tm1(cre)Cgn/Cd19⁺ Ctnnbl1^tm1.1Crad/Ctnnbl1^tm1.1Crad (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased B cell proliferation	J:232010
Cd19^tm1(cre)Cgn/Cd19⁺ Ell2^tm1.1Cmil/Ell2^tm1.1Cmil (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased IgA level	J:234692
	decreased IgG1 level	J:234692
	decreased IgM level	J:234692
	decreased immunoglobulin level	J:234692
	impaired humoral immune response	J:234692
Cd19^tm1(cre)Cgn/Cd19⁺ Ell2^tm2.1Cmil/Ell2^tm2.1Cmil (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased IgA level	J:234692
	decreased IgG1 level	J:234692
	decreased IgM level	J:234692
	decreased immunoglobulin level	J:234692
Cd19^tm1(cre)Cgn/Cd19⁺ Ep300^tm2Reck/Ep300⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal adaptive immunity	J:147840
	abnormal humoral immune response	J:147840
	arteritis	J:147840
	decreased B cell proliferation	J:147840
	glomerulonephritis	J:147840
	increased anti-double stranded DNA antibody level	J:147840
	increased B cell apoptosis	J:147840
	increased IgG2b level	J:147840
	increased immunoglobulin level	J:147840
	increased susceptibility to systemic lupus erythematosus	J:147840
	kidney inflammation	J:147840
Cd19^tm1(cre)Cgn/Cd19⁺ Ep300^tm2Reck/Ep300⁺ (involves: 129/Sv * 129P2/OlaHsd * FVB/N)	increased susceptibility to systemic lupus erythematosus	J:147840
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^tm1Ach/Fas^tm1Ach (involves: 129P2/OlaHsd * BALB/c)	increased anti-nuclear antigen antibody level	J:123556
	increased immunoglobulin level	J:123556
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^tm1Cgn/Fas^tm1Cgn (B6.Cg-Cd19^tm1(cre)Cgn Fas^tm1Cgn)	increased anti-single stranded DNA antibody level	J:114948
Cd19^tm1(cre)Cgn/Cd19⁺ Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N)	abnormal B cell physiology	J:117663
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm1(ITK/SYK)Jrld}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	abnormal T cell activation	J:160931
	increased T cell proliferation	J:160931
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm2(CARD11*L225LI)Jrld}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	abnormal B cell activation	J:228288
	increased B cell proliferation	J:228288
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm2(Cd74/MOG)Awai}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:140751
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:140751
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm2(Cd74/MOG)Awai}/Gt(ROSA)26Sor⁺ Il10^tm1Roer/Il10^tm1Roer (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:140751
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:140751
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:113365
	decreased B cell apoptosis	J:113365
Cd19^tm1(cre)Cgn/Cd19⁺ Ifnar1^tm1Uka/Ifnar1^tm1Uka (B6.129P2-Cd19^tm1(cre)Cgn Ifnar1^tm1Uka)	decreased IgG1 level	J:129128
	decreased IgG2a level	J:129128
	decreased IgG3 level	J:129128
	decreased IgM level	J:129128
Cd19^tm1(cre)Cgn/Cd19⁺ Igbp1^tm1Imku/Y (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:74619
	abnormal somatic hypermutation frequency	J:74619
	decreased B cell proliferation	J:74619
	decreased immunoglobulin level	J:74619
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm1Cgn/Ikbkb^tm1.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	increased B cell proliferation	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm2Mka/Ikbkb^tm2Mka (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:82995
	decreased B cell proliferation	J:82995
	decreased IgG level	J:82995
	decreased IgM level	J:82995
	increased B cell apoptosis	J:82995
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkg^tm1.1Mpa/Y (involves: 129P2/OlaHsd * C57BL/6)	increased B cell proliferation	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Il10^tm1Roer/Il10^tm1Roer (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell physiology	J:151551
	decreased circulating interleukin-10 level	J:151551
Cd19^tm1(cre)Cgn/Cd19⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav Pten^tm1Hwu/Pten^tm1Hwu (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal B cell physiology	J:166155
	increased B cell proliferation	J:166155
Cd19^tm1(cre)Cgn/Cd19⁺ Ltb^tm1Avt/Ltb^tm1Avt (involves: 129P2/OlaHsd * C57BL/6)	abnormal adaptive immunity	J:79129
Cd19^tm1(cre)Cgn/Cd19⁺ Map3k7^tm1Aki/Map3k7^tm1.1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:112597
	decreased B cell proliferation	J:112597
	decreased IgG1 level	J:112597
	decreased IgG3 level	J:112597
	decreased IgG level	J:112597
	decreased immunoglobulin level	J:112597
Cd19^tm1(cre)Cgn/Cd19⁺ Mcl1^tm2Sjk/Mcl1^tm3Sjk (involves: 129P2/OlaHsd * 129X1/SvJ)	increased B cell apoptosis	J:86906
Cd19^tm1(cre)Cgn/Cd19⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: C57BL/6NTac)	increased IgM level	J:308792
Cd19^tm1(cre)Cgn/Cd19⁺ Myd88^em1.1Rsky/Myd88^em1.1Rsky (involves: C57BL/6NTac)	increased B cell proliferation	J:308792
Cd19^tm1(cre)Cgn/Cd19⁺ Pax5^tm1Mbu/Pax5^tm3Mbu (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal class switch recombination	J:75504
	decreased IgG1 level	J:75504
	decreased IgG3 level	J:75504
	decreased IgG level	J:75504
	decreased immunoglobulin level	J:75504
Cd19^tm1(cre)Cgn/Cd19⁺ Pdia3^tm1Gjh/Pdia3^tm1Gjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:112606
Cd19^tm1(cre)Cgn/Cd19⁺ Prdm1^tm1Clme/Prdm1^tm1Clme (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	decreased IgG level	J:101890
	decreased IgM level	J:101890
	decreased immunoglobulin level	J:101890
Cd19^tm1(cre)Cgn/Cd19⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal B cell physiology	J:83213
	abnormal class switch recombination	J:114881
	decreased IgG level	J:114881
	increased B cell apoptosis	J:83213
	increased B cell proliferation	J:155314, J:83213
	increased IgM level	J:114881
Cd19^tm1(cre)Cgn/Cd19⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal peripheral B cell anergy	J:155314
Cd19^tm1(cre)Cgn/Cd19⁺ Ptpn6^tm1Rsky/Ptpn6^tm1Rsky (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:123568
	abnormal immune system physiology	J:123568
	decreased B cell proliferation	J:123568
	increased susceptibility to systemic lupus erythematosus	J:123568
Cd19^tm1(cre)Cgn/Cd19⁺ Rbpj^tm1Hon/Rbpj^tm1Hon (involves: 129P2/OlaHsd * C57BL/6)	increased IgG3 level	J:76240
	increased susceptibility to bacterial infection	J:76240
	increased susceptibility to bacterial infection induced morbidity/mortality	J:76240
Cd19^tm1(cre)Cgn/Cd19⁺ Slc3a2^tm1.1Mgin/Slc3a2^tm1.1Mgin (involves: 129 * C57BL/6 * SJL)	abnormal B cell activation	J:148000
	abnormal B cell physiology	J:148000
	abnormal class switch recombination	J:148000
	decreased B cell proliferation	J:148000
	decreased IgG level	J:148000
	decreased IgM level	J:148000
Cd19^tm1(cre)Cgn/Cd19⁺ Slc3a2^tm1.1Mgin/Slc3a2^tm1Yai (involves: 129 * C57BL/6 * SJL)	decreased IgG3 level	J:148000
	decreased IgM level	J:148000
Cd19^tm1(cre)Cgn/Cd19⁺ Tgfbr2^tm1Roes/Tgfbr2^tm1Roes (involves: 129P2/OlaHsd * BALB/c)	abnormal B cell physiology	J:90558
	decreased IgA level	J:90558
	increased IgG level	J:90558
	increased IgM level	J:90558
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfaip3^tm1.1Awai/Tnfaip3^tm1.1Awai (involves: 129P2/OlaHsd)	increased anti-nuclear antigen antibody level	J:175422
	increased B cell proliferation	J:175422
	increased IgA level	J:175422
	increased IgG2a level	J:175422
	increased IgM level	J:175422
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfaip3^tm2Ama/Tnfaip3⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell apoptosis	J:163917
	increased autoantibody level	J:163917
	increased immunoglobulin level	J:163917
	increased susceptibility to autoimmune disorder	J:163917
Cd19^tm1(cre)Cgn/Cd19⁺ Traf2^tm1Rbr/Traf2^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf2^tm1Rbr/Traf2^tm1Rbr Traf3^tm1Rbr/Traf3^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal B cell physiology	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf3^tm1Rbr/Traf3^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal B cell physiology	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Ube2n^tm1Aki/Ube2n^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:112287
	abnormal humoral immune response	J:112287
	decreased B cell proliferation	J:112287
	decreased immunoglobulin level	J:112287
	increased B cell apoptosis	J:112287
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:27463
	abnormal immunoglobulin level	J:27463
	decreased IgE level	J:27463
	decreased IgG1 level	J:27463
	decreased IgM level	J:27463
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Igh^tm1Mnz/Igh^tm1Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:75653
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Igh^tm2Mnz/Igh^tm2Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:75653
Cd19^{tm1(cre/ERT2)Rsky}/Cd19⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: 129P2/OlaHsd * C57BL/6NTac)	increased IgM level	J:308792
Cd19^tm1Tft/Cd19^tm1Tft (Not Specified)	abnormal B cell physiology	J:27236
	decreased B cell proliferation	J:27236
	decreased IgA level	J:27236
	decreased IgG1 level	J:27236
	decreased IgG2a level	J:27236
	decreased IgG2b level	J:27236
	decreased IgG3 level	J:27236
	decreased IgM level	J:27236
Cd19^tm1Tft/Cd19^tm1Tft (involves: 129/Sv * C57BL/6)	decreased tumor necrosis factor secretion	J:66111
Cd19^tm1Tft/Cd19^tm1Tft (involves: 129 * C57BL/6)	abnormal humoral immune response	J:71174
	decreased B cell proliferation	J:71174
	decreased IgA level	J:71174
	decreased IgG1 level	J:71174
	decreased IgG2b level	J:71174
	decreased IgM level	J:71174
Cd19^tm1Tft/Cd19^tm1Tft (B6.Cg-Cd19^tm1Tft)	abnormal B cell physiology	J:136210
	decreased anti-double stranded DNA antibody level	J:136210
	decreased anti-nuclear antigen antibody level	J:136210
	decreased circulating interferon-gamma level	J:136210
	decreased circulating interleukin-4 level	J:136210
	decreased circulating interleukin-6 level	J:136210
	decreased circulating interleukin-10 level	J:136210
	decreased circulating tumor necrosis factor level	J:136210
	decreased IgA level	J:136210
	decreased IgG1 level	J:136210
	decreased IgG2a level	J:136210
	decreased IgG2b level	J:136210
	decreased IgG3 level	J:136210
	decreased IgM level	J:136210
	decreased interleukin-10 secretion	J:106487
	increased interferon-gamma secretion	J:106487
	increased susceptibility to experimental autoimmune encephalomyelitis	J:106487
Cd19^tm1Tft/Cd19^tm1Tft Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor * C57BL/6)	abnormal humoral immune response	J:71174
	decreased anti-double stranded DNA antibody level	J:71174
	decreased B cell proliferation	J:71174
	decreased susceptibility to systemic lupus erythematosus	J:71174
Cd22^m1Btlr/Cd22^m1Btlr (C57BL/6J-Cd22^m1Btlr)	abnormal humoral immune response	J:173079
Cd22^m1Btlr/Cd22^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Cd22^m2Btlr/Cd22^m2Btlr (C57BL/6J-Cd22^m2Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:215821
Cd22^{tm1.1(CD22)Lnit}/Cd22^{tm1.1(CD22)Lnit} (involves: 129S4/SvJae)	abnormal B cell physiology	J:189017
Cd22^tm1Eac/Cd22⁺ Lyn^tm1Ard/Lyn⁺ Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	increased IgM level	J:110531
Cd22^tm1Eac/Cd22^tm1Eac (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:37451
	abnormal B cell proliferation	J:37451, J:132991
	decreased IgG1 level	J:37451
	decreased IgG3 level	J:37451
	decreased IgM level	J:37451
	increased B cell apoptosis	J:132991
Cd22^tm1Lam/Cd22^tm1Lam (involves: 129 * C57BL/6)	abnormal B cell activation	J:125719
Cd22^tm1Lam/Cd22^tm1Lam Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd22^tm1Lam/Cd22^tm1Lam Igh^tm1.2Rsky/Igh^tm1.2Rsky (involves: 129 * BALB/c * C57BL/6)	abnormal B cell activation	J:125719
Cd22^tm1Msn/Cd22^tm1Msn (either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J))	abnormal B cell activation	J:76974
	abnormal B cell physiology	J:76974
	abnormal immune system physiology	J:76974
	abnormal immunoglobulin level	J:76974
	increased anti-double stranded DNA antibody level	J:76974, J:76975
	increased IgG2a level	J:76975
	increased IgG level	J:76975
	increased IgM level	J:76974
Cd22^tm1Tft/Cd22^tm1Tft (involves: 129P2/OlaHsd * C57BL/6)	increased B cell proliferation	J:92736
Cd22^tm2Lnit/Cd22^tm2Lnit (involves: 129P2/OlaHsd * C57BL/6)	autoimmune response	J:198790
Cd22^tm2Tft/Cd22^tm2Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased B cell proliferation	J:92736
	increased B cell proliferation	J:92736
Cd22^tm2Tft/Cd22^tm2Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal peripheral B cell anergy	J:208364
	decreased B cell proliferation	J:208364
	increased activation-induced B cell apoptosis	J:208364
Cd22^tm3Lnit/Cd22^tm3Lnit (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:198790
	abnormal immune system physiology	J:198790
	autoimmune response	J:198790
	increased B cell apoptosis	J:198790
	increased IgG1 level	J:198790
Cd22^tm3Tft/Cd22^tm3Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased B cell proliferation	J:92736
	increased B cell proliferation	J:92736
Cd24a^tm1Pjln/Cd24a^tm1Pjln (C57BL/6-Cd24a^tm1Pjln)	increased susceptibility to parasitic infection	J:76695
Cd27^tm1Jbo/Cd27^tm1Jbo (either: B6.129P2-CD27^tm1Jbo or 129P2/OlaHsd-Tnfrsf7^tm1Jbo)	abnormal CD4-positive, alpha-beta T cell physiology	J:65516
	abnormal cytotoxic T cell physiology	J:65516
	abnormal T cell physiology	J:65516
Cd27^tm1Jbo/Cd27^tm1Jbo (B6.129P2-Cd27^tm1Jbo)	increased T cell apoptosis	J:198200
Cd28^tm1.1Huen/Cd28^tm1.1Huen Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal regulatory T cell physiology	J:191101
Cd28^tm1Jmg/Cd28^tm1Jmg (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:124570
	abnormal germinal center B cell physiology	J:124570
	decreased immunoglobulin level	J:124570
	decreased interleukin-2 secretion	J:124570
Cd28^tm1Jmg/Cd28^tm1Jmg (B6.129X1-Cd28^tm1Jmg)	decreased interleukin-2 secretion	J:149888
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:149888
	increased susceptibility to type I hypersensitivity reaction	J:149888
Cd28^tm1Jmg/Cd28^tm1Mak (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:124570
	abnormal germinal center B cell physiology	J:124570
	decreased immunoglobulin level	J:124570
	decreased interleukin-2 secretion	J:124570
	decreased T cell proliferation	J:149888, J:124570
Cd28^tm1Ltu/Cd28^tm1Ltu Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased T cell proliferation	J:194503
	increased susceptibility to autoimmune disorder	J:194503
	increased susceptibility to experimental autoimmune encephalomyelitis	J:194503
	skin inflammation	J:194503
Cd28^tm1Mak/Cd28⁺ Cd5^tm1Cgn/Cd5^tm1Cgn (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:14194
	abnormal class switch recombination	J:14194
	decreased IgG1 level	J:14194
	decreased IgG2b level	J:14194
	decreased immunoglobulin level	J:14194
	decreased interleukin-2 secretion	J:14194
	decreased T cell proliferation	J:14194
	increased IgG2a level	J:14194
Cd28^tm1Mak/Cd28^tm1Mak (NOD.129S2-Cd28^tm1Mak)	abnormal CD4-positive, alpha-beta T cell physiology	J:61905
	abnormal response to transplant	J:61905
	increased susceptibility to autoimmune diabetes	J:93421
	increased T cell proliferation	J:93421
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas)	abnormal class switch recombination	J:123989
	abnormal regulatory T cell physiology	J:191101
	decreased interferon-gamma secretion	J:205441
	decreased interleukin-2 secretion	J:205441, J:130882
	decreased T cell proliferation	J:205441, J:130882, J:123989
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * NOD)	abnormal T-helper 1 physiology	J:35353
	abnormal T-helper 2 physiology	J:35353
	decreased IgG2a level	J:35353
	decreased interleukin-2 secretion	J:35353
	decreased interleukin-4 secretion	J:35353
	decreased T cell proliferation	J:35353
	increased interferon-gamma secretion	J:35353
	increased susceptibility to autoimmune diabetes	J:35353
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * C57BL/6)	abnormal NK cell physiology	J:95353
	decreased circulating interferon-gamma level	J:95353
	decreased circulating interleukin-4 level	J:95353
	decreased interleukin-2 secretion	J:149888
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:149888
	decreased T cell proliferation	J:149888
	increased susceptibility to type I hypersensitivity reaction	J:149888
	increased T cell apoptosis	J:149888
Cd28^tm1Mak/Cd28^tm1Mak (B6.129S2-Cd28^tm1Mak)	abnormal cytotoxic T cell physiology	J:76373
Cd28^tm1Mak/Cd28^tm1Mak (B6.129S2-Cd28^tm1Mak/J)	brain inflammation	J:57613
Cd28^tm1Mak/Cd28^tm1Mak (B6.129S2-Cd28^tm1Mak/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:57613
Cd28^tm1Mak/Cd28^tm1Mak Cd5^tm1Cgn/Cd5⁺ (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
Cd28^tm1Mak/Cd28^tm1Mak Cd5^tm1Cgn/Cd5^tm1Cgn (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
Cd28^tm1Mak/Cd28^tm1Mak Cd40lg^tm1Flv/Cd40lg^tm1Flv (NOD.Cg-Cd40lg^tm1Flv Cd28^tm1Mak)	increased susceptibility to autoimmune diabetes	J:93421
	insulitis	J:93421
Cd28^tm1Mak/Cd28^tm1Mak Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd * 129S2/SvPas)	esophageal inflammation	J:205692
	increased interleukin-2 secretion	J:205692
	increased interleukin-4 secretion	J:205692
Cd28^tm1Mak/Cd28^tm1Mak Stat6^tm1Gru/Stat6^tm1Gru (C.129S2(B6)-Cd28^tm1Mak Stat6^tm1Gru)	increased susceptibility to parasitic infection	J:90987
Cd28^tm1Mak/Cd28^tm1Mak Tg(Cd4-cre)1Cwi/? Traf6^tm2Ywc/Traf6^tm2Ywc (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased interleukin-2 secretion	J:130882
	decreased T cell proliferation	J:130882
Cd28^tm1Mak/Cd28^tm1Mak Tg(TcrLCMV)327Sdz/0 (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal T cell anergy	J:123989
	decreased cytotoxic T cell cytolysis	J:123989
	decreased splenocyte proliferation	J:123989
	decreased T cell proliferation	J:123989
Cd28^tm1Mak/Cd28^tm1Mak Tnfsf9^tm1Thw/Tnfsf9^tm1Thw (involves: 129 * 129S2/SvPas * C57BL/6)	abnormal cytotoxic T cell physiology	J:76373
	increased length of allograft survival	J:76373
Cd28^tm1Mak/Cd28^tm1Mak Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased length of allograft survival	J:77250
Cd28^tm1Pjl/Cd28^tm1Pjl (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:83722
	abnormal cytotoxic T cell physiology	J:83722
	abnormal immunoglobulin level	J:83722
	decreased IgG1 level	J:83722
	decreased IgG2a level	J:83722
	decreased IgM level	J:83722
	decreased interleukin-12 secretion	J:83722
	decreased susceptibility to type IV hypersensitivity reaction	J:83722
	increased splenocyte proliferation	J:83722
Cd28^tm1Pjl/Cd28^tm1Pjl Tg(DO11.10)10Dlo/0 (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	abnormal T cell activation	J:25536
	abnormal T cell proliferation	J:25536
	abnormal thymocyte activation	J:25536
	decreased interleukin-2 secretion	J:25536
Cd28^tm1Pjl/Cd28^tm1Pjl Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (either: B6.Cg-Cd28^tm1Pjl Tnfrsf9^tm1Byk or C.Cg-Cd28^tm1Pjl Tnfrsf9^tm1Byk)	abnormal class switch recombination	J:83722
	abnormal cytotoxic T cell physiology	J:83722
	decreased IgG1 level	J:83722
	decreased IgG2a level	J:83722
	decreased IgM level	J:83722
	decreased interleukin-12 secretion	J:83722
	decreased splenocyte proliferation	J:83722
	decreased susceptibility to type IV hypersensitivity reaction	J:83722
Cd28^tm1Shr/Cd28^tm1Shr (involves: 129S4/SvJae * BALB/c * C57BL/6)	decreased interleukin-2 secretion	J:68642
	decreased T cell proliferation	J:68642
Cd28^tm1Shr/Cd28^tm1Shr Ctla4^tm1Shr/Ctla4⁺ (C.129S4-Cd28^tm1Shr Ctla4^tm1Shr)	increased susceptibility to autoimmune disorder	J:125259
Cd28^tm1Shr/Cd28^tm1Shr Ctla4^tm1Shr/Ctla4^tm1Shr (C.129S4-Cd28^tm1Shr Ctla4^tm1Shr)	abnormal interferon level	J:68642
	abnormal interleukin secretion	J:68642
	decreased T cell proliferation	J:68642
	increased length of allograft survival	J:68642
Cd33^tm1Avrk/Cd33^tm1Avrk (involves: 129X1/SvJ * C57BL/6)	decreased inflammatory response	J:83728
Cd36^obl/Cd36^obl (C57BL/6-Cd36^obl)	abnormal cell-mediated immunity	J:96018
	abnormal macrophage physiology	J:96018
	endophthalmitis	J:96018
	increased susceptibility to bacterial infection	J:96018
Cd36^tm1Frm/Cd36^tm1Frm (involves: 129S4/SvJae)	abnormal microglial cell physiology	J:140907
Cd36^tm1Frm/Cd36^tm1Frm (involves: 129S4/SvJae * C57BL/6J)	abnormal chemokine level	J:80658
Cd36^tm1Frm/Cd36^tm1Frm (involves: 129S4/SvJae * C57BL/6J)	abnormal macrophage physiology	J:80658
Cd36^tm1Frm/Cd36^tm1Frm (B6.129S4-Cd36^tm1Frm)	abnormal response to infection	J:100140
	decreased interleukin-6 secretion	J:100140
	decreased interleukin-12 secretion	J:100140
	decreased tumor necrosis factor secretion	J:100140
	impaired macrophage phagocytosis	J:100140
	increased susceptibility to bacterial infection induced morbidity/mortality	J:100140
	sepsis	J:100140
Cd36^tm1Mfe/Cd36^tm1Mfe (B6.129S1-Cd36^tm1Mfe)	decreased IgG1 level	J:130897
	decreased IgG2a level	J:130897
	decreased IgG2c level	J:130897
	decreased IgG level	J:130897
	decreased IgM level	J:130897
	decreased immunoglobulin level	J:130897
Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129S1/Sv)	abnormal macrophage chemotaxis	J:89664
Cd37^tm1Hor/Cd37^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:63315
	abnormal humoral immune response	J:63315
	decreased IgG1 level	J:63315
Cd38^tm1Lnd/Cd38^tm1Lnd (involves: 129P2/OlaHsd * C57BL/6J)	abnormal humoral immune response	J:49170
Cd38^tm1Lnd/Cd38^tm1Lnd (NOD.129P2(B6)-Cd38^tm1Lnd/LtJ)	increased susceptibility to autoimmune diabetes	J:108097
	increased T cell apoptosis	J:108097
	insulitis	J:108097
Cd40^m1Btlr/Cd40^m1Btlr (C57BL/6J-Cd40^m1Btlr)	impaired humoral immune response	J:221482
Cd40^m2Btlr/Cd40^m2Btlr (C57BL/6J-Cd40^m2Btlr)	abnormal humoral immune response	J:254828
Cd40^m2Btlr/Cd40^m2Btlr (C57BL/6J-Cd40^m2Btlr)	decreased IgG level	J:254828
Cd40^tm1Arah/Cd40^tm1Arah (B6.129S1-Cd40^tm1Arah)	abnormal immunoglobulin level	J:120512
	abnormal response to transplant	J:120512
	decreased IgE level	J:120512
	decreased IgG1 level	J:120512
	decreased IgG2b level	J:120512
	decreased IgG level	J:120512
	decreased IgM level	J:120512
	increased IgG3 level	J:120512
	increased IgM level	J:120512
Cd40^tm1Geha/Cd40^tm1Geha (involves: 129S4/SvJae * C57BL/6)	decreased IgA level	J:82298
	decreased IgG1 level	J:82298
	decreased IgG2a level	J:82298
	decreased IgG2b level	J:82298
Cd40^tm1Kik/Cd40^tm1Kik (B6.129P2-Cd40^tm1Kik/J)	abnormal dendritic cell physiology	J:86998
Cd40^tm1Kik/Cd40^tm1Kik (B6.129P2-Cd40^tm1Kik/J)	increased susceptibility to bacterial infection	J:86998
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:25007
	decreased IgA level	J:25007
	decreased IgE level	J:25007
	decreased IgG1 level	J:25007
	decreased IgG2a level	J:25007
	decreased IgG2b level	J:25007
	decreased IgG3 level	J:25007
	decreased immunoglobulin level	J:25007
	decreased susceptibility to type II hypersensitivity reaction	J:61673
Cd40^tm1Kik/Cd40^tm1Kik Tg(Tnfsf13b)1Fma/? (B6.Cg-Cd40^tm1Kik Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	abnormal class switch recombination	J:113556
	glomerulonephritis	J:113556
	increased anti-double stranded DNA antibody level	J:113556
Cd40^tm1Kik/Cd40^tm1Kik Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (involves: 129 * 129P2/OlaHsd * BALB/c)	abnormal B cell physiology	J:138560
Cd40lg^m1Btlr/Y (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd40lg^m1Btlr/Y (involves: C57BL/6J)	decreased IgG level	J:185495
Cd40lg^m1Btlr/Cd40lg^m1Btlr (C57BL/6J-Cd40lg^m1Btlr)	decreased IgG level	J:162147
Cd40lg^m1Btlr/Cd40lg^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd40lg^m1Btlr/Cd40lg^m1Btlr (involves: C57BL/6J)	decreased IgG level	J:185495
Cd40lg^tm1Flv/Y Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased autoantibody level	J:38492
	decreased IgG level	J:38492
	decreased immunoglobulin level	J:38492
Cd40lg^tm1Flv/Y Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased autoantibody level	J:38492
	increased anti-double stranded DNA antibody level	J:38492
Cd40lg^tm1Flv/Cd40lg^tm1Flv (involves: 129S2/SvPas * C57BL/6)	abnormal adaptive immunity	J:25010
	abnormal class switch recombination	J:25010
	abnormal immune system physiology	J:25010
	abnormal T-helper 2 physiology	J:25010
	decreased IgA level	J:25010
	decreased IgD level	J:25010
	decreased IgE level	J:25010
	decreased IgG1 level	J:25010
	decreased IgG3 level	J:25010
	decreased immunoglobulin level	J:25010
Cd40lg^tm1Flv/Cd40lg^tm1Flv (NOD.129S2-Cd40lg^tm1Flv)	decreased susceptibility to autoimmune diabetes	J:93421
Cd40lg^tm1Flv/Cd40lg^tm1Flv Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased autoantibody level	J:38492
	decreased IgG level	J:38492
	decreased immunoglobulin level	J:38492
Cd40lg^tm1Flv/Cd40lg^tm1Flv Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased autoantibody level	J:38492
	increased anti-double stranded DNA antibody level	J:38492
Cd40lg^tm1Imx/Y (involves: 129S2/SvPas * C57BL/6)	abnormal antigen presentation	J:21137
	abnormal class switch recombination	J:21137
	abnormal immune system physiology	J:21137
	decreased IgA level	J:21137
	decreased IgE level	J:21137
	decreased IgG1 level	J:21137
	decreased IgG2b level	J:21137
	decreased immunoglobulin level	J:21137
Cd40lg^tm1Imx/Y (B6.129S2-Cd40lg^tm1Imx/J)	abnormal leukocyte adhesion	J:108988
Cd40lg^tm1Imx/Cd40lg^tm1Imx (involves: 129S2/SvPas * C57BL/6J * BALB/c)	abnormal T cell clonal deletion	J:110925
Cd40lg^tm1Imx/Cd40lg^tm1Imx (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to prion infection	J:115487
Cd40lg^tm1Parl/Y Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased IgM level	J:213459
	increased IgG1 level	J:213459
Cd40lg^tm1Parl/Y Tg(Tek-cre)1Ywa/0 (involves: 129 * C57BL/6 * CD-1 * SJL)	decreased IgA level	J:213459
	decreased IgG1 level	J:213459
	decreased IgG2a level	J:213459
	decreased IgG3 level	J:213459
	decreased IgM level	J:213459
Cd40lg^tm1Parl/Cd40lg^tm1Parl Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased IgM level	J:213459
	increased IgG1 level	J:213459
Cd40lg^tm1Parl/Cd40lg^tm1Parl Tg(Tek-cre)1Ywa/0 (involves: 129 * C57BL/6 * CD-1 * SJL)	decreased IgA level	J:213459
	decreased IgG1 level	J:213459
	decreased IgG2a level	J:213459
	decreased IgG3 level	J:213459
	decreased IgM level	J:213459
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 1 physiology	J:62867
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 2 physiology	J:62867
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (B6.129(Cg)-Cd44^tm1.1Ugu)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:199279
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (SJL.129(Cg)-Cd44^tm1.1Ugu)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:199279
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu (SJL.129(Cg)-Cd44^tm1.1Ugu)	decreased T cell proliferation	J:199279
Cd44^tm1.1Ugu/Cd44^tm1.1Ugu Il10^tm1Cgn/Il10^tm1Cgn (involves: 129/Sv * C57BL/6)	abnormal immune system physiology	J:62867
Cd44^tm1Hbg/Cd44⁺ Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6)	ileum inflammation	J:145626
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:68069
	abnormal neutrophil physiology	J:94850
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ)	abnormal response to infection	J:86947
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ)	increased acute inflammation	J:131974
Cd44^tm1Hbg/Cd44^tm1Hbg Tg(TNF)197Gkl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	arthritis	J:97992
	increased circulating interleukin-1 level	J:97992
	increased circulating interleukin-6 level	J:97992
	increased interleukin-1 secretion	J:97992
	increased interleukin-6 secretion	J:97992
Cd44^tm1Mak/Cd44⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal leukocyte migration	J:99032
Cd44^tm1Mak/Cd44^tm1Mak (involves: 129P2/OlaHsd * C57BL/6J)	abnormal leukocyte migration	J:99032
Cd44^tm1Mak/Cd44^tm1Mak (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to parasitic infection	J:72658
Cd44^tm1Mak/Cd44^tm1Mak (B6.129P2-Cd44^tm1Mak)	abnormal circulating cytokine level	J:69351
	abnormal leukocyte migration	J:108245
	decreased activation-induced cell death of T cells	J:69351
	impaired macrophage phagocytosis	J:111216
	impaired natural killer cell mediated cytotoxicity	J:110889
	increased circulating interferon-gamma level	J:69351
	increased circulating interleukin-2 level	J:69351
	increased circulating tumor necrosis factor level	J:69351
	liver inflammation	J:69351
	lung inflammation	J:111216, J:108245
Cd44^tm1Mak/Cd44^tm1Mak (D1.129P2-Cd44^tm1Mak)	increased susceptibility to induced arthritis	J:95275
Cd44^tm1Mak/Cd44^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine secretion	J:155691
	abnormal circulating chemokine level	J:155691
	abnormal interleukin secretion	J:155691
	decreased acute inflammation	J:114341
	decreased circulating tumor necrosis factor level	J:155691
	increased interleukin-1 beta secretion	J:155691
	increased interleukin-6 secretion	J:155691
	increased interleukin-10 secretion	J:155691
	increased tumor necrosis factor secretion	J:155691
	peritoneal inflammation	J:155691
Cd44^tm1Mak/Cd44^tm1Mak Itgal^tm1Mak/Itgal^tm1Mak (B6.129P2-Cd44^tm1Mak Itgal^tm1Mak)	impaired natural killer cell mediated cytotoxicity	J:110889
Cd44^tm1Ugu/Cd44^tm1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 1 physiology	J:62867
Cd44^tm1Ugu/Cd44^tm1Ugu (involves: 129/Sv * C57BL/6)	abnormal T-helper 2 physiology	J:62867
Cd44^tm2.1Ugu/Cd44^tm2.1Ugu (B6.129-Cd44^tm2.1Ugu)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:199279
Cd44^tm2.1Ugu/Cd44^tm2.1Ugu (B6.129-Cd44^tm2.1Ugu)	decreased T cell proliferation	J:199279
Cd44^tm2Kmz/Cd44^tm2Kmz (DBA/1LacJ-Cd44^tm2Kmz)	decreased susceptibility to induced arthritis	J:74268
Cd44^tm2Kmz/Cd44^tm2Kmz (involves: BALB/c * DBA/1)	abnormal CD4-positive, alpha-beta T cell physiology	J:114317
	abnormal leukocyte adhesion	J:114317
	decreased susceptibility to type IV hypersensitivity reaction	J:114317
	impaired leukocyte tethering or rolling	J:114317
	impaired neutrophil recruitment	J:114317
Cd44^tm2Kmz/Cd44^tm2Kmz Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * BALB/c * DBA/1)	abnormal CD4-positive, alpha-beta T cell physiology	J:114317
	abnormal leukocyte adhesion	J:114317
	decreased susceptibility to type IV hypersensitivity reaction	J:114317
	impaired leukocyte tethering or rolling	J:114317
	impaired neutrophil recruitment	J:114317
Cd47^tm1Fpl/Cd47⁺ (B6.129S7-Cd47^tm1Fpl)	increased susceptibility to bacterial infection induced morbidity/mortality	J:36489
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd)	impaired neutrophil recruitment	J:148196
Cd47^tm1Fpl/Cd47^tm1Fpl (B6.129S7-Cd47^tm1Fpl)	abnormal neutrophil physiology	J:36489
	impaired granulocyte bactericidal activity	J:36489
	impaired neutrophil chemotaxis	J:36489
	impaired neutrophil phagocytosis	J:36489
	increased susceptibility to bacterial infection	J:36489
	increased susceptibility to bacterial infection induced morbidity/mortality	J:36489
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytokine level	J:134866
	abnormal tumor necrosis factor level	J:134866
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:134866
	increased susceptibility to bacterial infection	J:134866
Cd48^tm1Rsr/Cd48^tm1Rsr (B6.129S4-Cd48^tm1Rsr)	abnormal T cell activation	J:53718
Cd48^tm1Rsr/Cd48^tm1Rsr (B6.129S4-Cd48^tm1Rsr)	decreased T cell proliferation	J:53718
Cd53^tm1.1Nmg/Cd53^tm1.1Nmg (involves: C57BL/6J)	abnormal B cell physiology	J:260065
Cd55^tm1Mme/Cd55^tm1Mme (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to experimental autoimmune myasthenia gravis	J:80116
Cd55^tm1Song/Cd55^tm1Song (involves: 129S6/SvEvTac * C57BL/6)	abnormal complement pathway	J:52968
	impaired complement alternative pathway	J:52968
	impaired complement classical pathway	J:52968
Cd55^tm1Song/Cd55^tm1Song (involves: 129S6/SvEvTac)	abnormal complement pathway	J:76578
Cd55^tm1Song/Cd55^tm1Song (B6.129S6-Cd55^tm1Song)	increased susceptibility to experimental autoimmune myasthenia gravis	J:113567
Cd55^tm1Song/Cd55^tm1Song Cd59a^tm1Bpm/Cd59a^tm1Bpm (B6.129-Cd55^tm1Song Cd59a^tm1Bpm)	abnormal complement pathway	J:113567
	increased susceptibility to experimental autoimmune myasthenia gravis	J:113567
	myositis	J:113567
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129 * C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:89014
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129)	abnormal complement pathway	J:148367
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129)	increased susceptibility to induced arthritis	J:146711
Cd59a^tm1Bpm/Cd59a^tm1Bpm (B6.129-Cd59a^tm1Bpm)	abnormal CD4-positive, alpha-beta T cell physiology	J:119703, J:123582
	abnormal complement pathway	J:92414
	abnormal humoral immune response	J:119703
	decreased B cell proliferation	J:119703
	decreased IgG level	J:119703
	decreased susceptibility to Poxviridae infection	J:122201
	increased susceptibility to experimental autoimmune myasthenia gravis	J:113567
	increased susceptibility to Orthomyxoviridae infection	J:123582
	increased T cell proliferation	J:122201
	lung inflammation	J:123582
	myositis	J:113567
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129 * BALB/c)	increased susceptibility to Orthomyxoviridae infection	J:123582
Cd59a^tm1Song/Cd59a^tm1Song (involves: 129S6/SvEvTac)	abnormal complement pathway	J:76578
Cd59a^tm1Song/Cd59a^tm1Song Cd55^tm1Song/Cd55^tm1Song (involves: 129S6/SvEvTac * C57BL/6)	abnormal complement pathway	J:76578
Cd68^tm1Shnd/Cd68^tm1Shnd (either: B6.129-Cd68^tm1Shnd or (involves: 129S1/Sv * 129X1/SvJ))	abnormal dendritic cell antigen presentation	J:175275
Cd68^tm1Xfen/Cd68^tm1Xfen (C57BL/6J-Cd68^tm1Xfen)	abnormal osteoclast physiology	J:178120
Cd69^tm1Fsm/Cd69^tm1Fsm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal humoral immune response	J:61329
	increased IgG2a level	J:61329
	increased IgM level	J:61329
Cd69^tm1Naka/Cd69^tm1Naka (C.129P2-Cd69^tm1Naka)	decreased susceptibility to induced arthritis	J:84940
	impaired neutrophil chemotaxis	J:84940
	impaired neutrophil recruitment	J:84940
Cd69^tm1Naka/Cd69^tm1Naka (B6.129P2-Cd69^tm1Naka)	abnormal CD4-positive, alpha-beta T cell physiology	J:184704
	abnormal humoral immune response	J:184704
	abnormal memory T cell physiology	J:184704
	abnormal T cell physiology	J:184704
	decreased interferon-gamma secretion	J:184704
	decreased tumor necrosis factor secretion	J:184704
Cd70^tm1.1Jda/Cd70^tm1.1Jda (B6.Cg-Cd70^tm1.1Jda)	abnormal CD8-positive, alpha-beta T cell physiology	J:193042
	abnormal immune system physiology	J:193042
	abnormal T cell physiology	J:193042
	increased susceptibility to Riboviria infection	J:193042
Cd72^b/Cd72^b Fas^lpr/Fas^lpr (involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)	autoimmune response	J:204782
	decreased anti-double stranded DNA antibody level	J:204782
	decreased anti-nuclear antigen antibody level	J:204782
	decreased IgG level	J:204782
	decreased susceptibility to autoimmune disorder	J:204782
Cd72^c/Cd72^c (involves: C57BL/6 * MRL)	increased B cell proliferation	J:204782
Cd72^c/Cd72^c Fas^lpr/Fas^lpr (involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)	autoimmune response	J:204782
	increased anti-chromatin antibody level	J:204782
	increased anti-double stranded DNA antibody level	J:204782
	increased anti-single stranded DNA antibody level	J:204782
	increased IgG level	J:204782
	increased susceptibility to systemic lupus erythematosus	J:204782
	liver inflammation	J:204782
	lung inflammation	J:204782
Cd72^tm1Jrp/Cd72^tm1Jrp (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal B cell activation	J:76990
	abnormal B cell physiology	J:76990
	increased B cell proliferation	J:76990
	increased IgM level	J:76990
Cd72^tm1Jrp/Cd72^tm1Jrp Tg(BCL2)22Wehi/0 (either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))	abnormal B cell physiology	J:76990
Cd72^tm1Tsub/Cd72^tm1Tsub (involves: C57BL/6J)	glomerulonephritis	J:204782
	increased anti-chromatin antibody level	J:204782
	increased anti-double stranded DNA antibody level	J:204782
	increased anti-single stranded DNA antibody level	J:204782
	increased B cell proliferation	J:204782
	lung inflammation	J:204782
Cd72^tm1Tsub/Cd72^tm1Tsub Fas^lpr/Fas^lpr (involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)	autoimmune response	J:204782
	glomerulonephritis	J:204782
	increased anti-chromatin antibody level	J:204782
	increased anti-double stranded DNA antibody level	J:204782
	increased anti-single stranded DNA antibody level	J:204782
	liver inflammation	J:204782
	lung inflammation	J:204782
Cd74^tm1Doi/Cd74^tm1Doi (either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6))	abnormal antigen presentation	J:4119
	abnormal level of surface class II molecules	J:45185
Cd74^tm1Doi/Cd74^tm1Doi (involves: 129S2/SvPas)	abnormal dendritic cell antigen presentation	J:151699
Cd74^tm1Doi/Cd74^tm1Doi H2-DMa^tm1Doi/H2-DMa^tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal professional antigen presenting cell physiology	J:42482
Cd74^tm1Eae/Cd74^tm1Eae (involves: 129S2/SvPas)	abnormal level of surface class II molecules	J:65917
	decreased B cell proliferation	J:113050, J:132865
	decreased IgM level	J:113050
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6J)	abnormal antigen presentation	J:72243
	abnormal antigen presentation via MHC class II	J:65918
	abnormal level of surface class II molecules	J:65918
	decreased interferon-gamma secretion	J:72243
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:72243
	decreased T cell proliferation	J:72243
	defective assembly of class II molecules	J:65918
Cd74^tm1Liz/Cd74^tm1Liz (B6.129S-Cd74^tm1Liz)	abnormal antigen presentation	J:125654
	abnormal antigen presentation via MHC class II	J:28966
	abnormal level of surface class II molecules	J:28966
	abnormal T-helper 1 physiology	J:125654
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:125654
	decreased susceptibility to type IV hypersensitivity reaction	J:125654
	decreased T cell proliferation	J:28966
	defective assembly of class II molecules	J:28966
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6)	abnormal antigen presentation via MHC class II	J:111565
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * BALB/cAn)	abnormal antigen presentation via MHC class II	J:110927, J:113714
	abnormal dendritic cell antigen presentation	J:110927
	abnormal professional antigen presenting cell physiology	J:113714
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * BALB/c * C57BL)	abnormal antigen presentation via MHC class II	J:110927
	abnormal dendritic cell antigen presentation	J:110927
	abnormal T cell proliferation	J:110927
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)	abnormal antigen presentation via MHC class II	J:110927
	abnormal dendritic cell antigen presentation	J:110927
	abnormal T cell proliferation	J:110927
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Luc/H2-DMa^tm1Luc Tg(CD74)AR194Ayr/? (involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J)	abnormal antigen presentation via MHC class II	J:88717
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Luc/H2-DMa^tm1Luc Tg(CD74)1Ayr/0 (involves: 129S/SvEv 129S4/SvJae * C57BL/6J * DBA/2J)	abnormal antigen presentation via MHC class II	J:88717
Cd74^tm2Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6)	abnormal antigen presentation via MHC class II	J:28966
Cd74^tm2Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6)	increased T cell proliferation	J:28966
Cd74^tm2Liz/Cd74^tm2Liz (involves: 129S/SvEv * C57BL/6)	decreased interleukin-2 secretion	J:72243
Cd74^tm2Liz/Cd74^tm2Liz (involves: 129S/SvEv * C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:72243
Cd74^tm3Liz/Cd74^tm3Liz (involves: 129S/SvEv * C57BL/6)	abnormal antigen presentation via MHC class II	J:82880
	abnormal level of surface class II molecules	J:82880
	decreased interleukin-2 secretion	J:72243
	defective assembly of class II molecules	J:82880
	increased susceptibility to experimental autoimmune encephalomyelitis	J:72243
Cd79a^m1Anu/Cd79a^m1Anu (involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd)	decreased IgG level	J:104190
Cd79a^m1Btlr/Cd79a^m1Btlr (involves: C57BL/6J * C57BL/10J)	abnormal humoral immune response	J:174338
	decreased IgG level	J:174338
	decreased IgM level	J:174338
Cd79a^m1Btlr/Cd79a^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Cd79a^m2Btlr/Cd79a^m2Btlr (C57BL/6J-Cd79a^m2Btlr)	decreased IgM level	J:254836
Cd79a^m2Btlr/Cd79a^m2Btlr (C57BL/6J-Cd79a^m2Btlr)	impaired humoral immune response	J:254836
Cd79a^tm1(cre)Reth/Cd79a⁺ Commd3^tm1.1Ksuz/Commd3^tm1.1Ksuz (involves: BALB/c * C57BL/6NSlc * SJL)	abnormal follicular B cell physiology	J:278399
	decreased IgG1 level	J:278399
	decreased IgG2b level	J:278399
	decreased IgG2c level	J:278399
	decreased IgM level	J:278399
Cd79a^tm1(cre)Reth/Cd79a⁺ Commd8^tm1.1Ksuz/Commd8^tm1.1Ksuz (involves: BALB/c * C57BL/6NSlc * SJL)	abnormal follicular B cell physiology	J:278399
	decreased IgG1 level	J:278399
	decreased IgG2b level	J:278399
	decreased IgG2c level	J:278399
	decreased IgG3 level	J:278399
	decreased IgM level	J:278399
Cd79a^tm1(cre)Reth/Cd79a⁺ Ctnnbl1^tm1.1Crad/Ctnnbl1^tm1.1Crad (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal B cell proliferation	J:232010
	abnormal class switch recombination	J:232010
	decreased B cell proliferation	J:232010
Cd79a^tm1(cre)Reth/Cd79a⁺ Huwe1^tm1.1Mak/Y (B6.Cg-Cd79a^tm1(cre)Reth Huwe1^tm1.1Mak)	abnormal class switch recombination	J:181705
	abnormal humoral immune response	J:181705
	decreased B cell proliferation	J:181705
	decreased IgA level	J:181705
	decreased IgG1 level	J:181705
	decreased IgG2a level	J:181705
	decreased IgG3 level	J:181705
	decreased IgM level	J:181705
	increased B cell apoptosis	J:181705
	increased susceptibility to Riboviria infection	J:181705
Cd79a^tm1(cre)Reth/Cd79a⁺ Huwe1^tm1.1Mak/Y Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal class switch recombination	J:181705
	decreased IgG1 level	J:181705
	decreased IgM level	J:181705
Cd79a^tm1(cre)Reth/Cd79a⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav (involves: 129 * BALB/c * C57BL/6)	increased anti-chromatin antibody level	J:178833
	increased anti-double stranded DNA antibody level	J:178833
	increased anti-nuclear antigen antibody level	J:178833
	increased anti-single stranded DNA antibody level	J:178833
	increased autoantibody level	J:178833
	increased IgG level	J:178833
	increased susceptibility to systemic lupus erythematosus	J:178833
Cd79a^tm1(cre)Reth/Cd79a⁺ Nr4a1^tm1Pcn/Nr4a1^tm1Pcn (involves: 129 * BALB/c)	increased B cell proliferation	J:306652
Cd79a^tm1(cre)Reth/Cd79a⁺ Nr4a1^tm1Pcn/Nr4a1^tm1Pcn Nr4a3^em1Juz/Nr4a3^em1Juz (involves: 129 * BALB/c * C57BL/6)	decreased B cell apoptosis	J:306652
	increased B cell proliferation	J:306652
Cd79a^tm1(cre)Reth/Cd79a⁺ Phf5a^tm1.1Oux/Phf5a^tm1.1Oux (involves: BALB/c * C57BL/6J)	abnormal B cell physiology	J:345807
Cd79a^tm1(cre)Reth/Cd79a⁺ Slc39a10^tm1.1Tfk/Slc39a10^tm1.1Tfk (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)	decreased IgA level	J:213935
	decreased IgE level	J:213935
	decreased IgG1 level	J:213935
	decreased IgG2b level	J:213935
	decreased IgG2c level	J:213935
	decreased IgG3 level	J:213935
	decreased IgM level	J:213935
	decreased immunoglobulin level	J:213935
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Y (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:182528
	increased anti-chromatin antibody level	J:182528
	increased anti-double stranded DNA antibody level	J:182528
	increased anti-single stranded DNA antibody level	J:182528
	increased autoantibody level	J:182528
	increased IgM level	J:182528
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Was⁺ (involves: BALB/c * C57BL/6)	abnormal B cell proliferation	J:182528
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Was^tm1.1Ldn (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:182528
	increased anti-chromatin antibody level	J:182528
	increased anti-double stranded DNA antibody level	J:182528
	increased anti-single stranded DNA antibody level	J:182528
	increased autoantibody level	J:182528
	increased IgM level	J:182528
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:71100
	decreased IgG1 level	J:71100
Cd79a^tm1.1Rsky/Cd79a^tm1.1Rsky (involves: C57BL/6)	abnormal humoral immune response	J:179254
	decreased IgG2b level	J:179254
	decreased IgG2c level	J:179254
	decreased IgG3 level	J:179254
	increased anti-single stranded DNA antibody level	J:179254
	increased IgG2b level	J:179254
	increased IgG2c level	J:179254
Cd79a^tm2Cgn/Cd79a^tm2Cgn (involves: C57BL/6 * C.B-20)	decreased immunoglobulin level	J:80885
Cd79a^tm4Cgn/Cd79a^tm4.1Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased IgD level	J:91091
	decreased IgM level	J:91091
Cd79a^tm5.1Cgn/Cd79a⁺ Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn Igh^tm1.2Rsky/Igh^tm1.2Rsky (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd79a^tm6Cgn/Cd79a^tm6Cgn (involves: C57BL/6)	abnormal B cell physiology	J:113407
	abnormal humoral immune response	J:113407
	abnormal immunoglobulin level	J:113407
	decreased B cell proliferation	J:113407
	decreased IgG2a level	J:113407
	decreased IgG3 level	J:113407
	decreased IgM level	J:113407
Cd79a^tm7Cgn/Cd79a^tm7Cgn (involves: C57BL/6)	abnormal immune system physiology	J:113407
Cd79b^m1Ghost/Cd79b^m1Ghost (B10.Cg-Ptprc^a Cd79b^m1Ghost H2^a)	decreased IgA level	J:157450
	decreased IgG level	J:157450
Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129/Sv * C57BL/6)	abnormal immune system physiology	J:124400
	decreased IgG1 level	J:124400
	increased IgD level	J:124400
	increased IgM level	J:124400
Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129/Sv * C57BL/6)	abnormal B cell activation	J:66840
Cd79b^tm3Mnz/Cd79b^tm3Mnz (involves: 129/Sv * C57BL/6)	abnormal B cell physiology	J:128768
	abnormal immune system physiology	J:128768
	decreased B cell proliferation	J:128768
Cd80^tm1Lbgn/Cd80^tm1Lbgn (C3.Cg-Cd80^tm1Lbgn)	abnormal T cell physiology	J:110947
Cd80^tm1Shr/Cd80^tm1Shr (involves: 129S4/SvJae)	abnormal immunoglobulin level	J:39089
Cd80^tm1Shr/Cd80^tm1Shr (involves: 129S4/SvJae)	decreased B cell proliferation	J:74662
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm1Shr/Cd86^tm1Shr (B6.129S4-Cd80^tm1Shr Cd86^tm1Shr)	brain inflammation	J:57613
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:57613
	decreased T cell proliferation	J:57613
	increased interferon-gamma secretion	J:57613
	increased tumor necrosis factor secretion	J:57613
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae)	abnormal T cell physiology	J:57090
	abnormal T cell proliferation	J:57090
	decreased IgG1 level	J:39089
	decreased IgG2a level	J:39089
	decreased IgG level	J:39089
	increased IgG3 level	J:39089
	increased IgM level	J:39089
	increased susceptibility to autoimmune diabetes	J:113109
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae * NOD)	abnormal CD4-positive, alpha-beta T cell physiology	J:61905
	abnormal cytokine secretion	J:61905
	increased susceptibility to autoimmune diabetes	J:61905
	insulitis	J:61905
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (129.SJL-Cd86^tm2Shr)	decreased interleukin-2 secretion	J:78992
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:78992
	increased susceptibility to experimental autoimmune encephalomyelitis	J:78992
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae * C57BL/6J * SJL)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:78992
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr Ctla4^tm1Shr/Ctla4^tm1Shr (involves: 129S4/SvJae * BALB/c)	abnormal cytokine secretion	J:57090
	abnormal T cell physiology	J:57090
	increased T cell proliferation	J:57090
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0 (involves: 129S4/SvJae * FVB/N * NOD)	decreased susceptibility to autoimmune diabetes	J:113109
	insulitis	J:113109
Cd81^tm1Geha/Cd81^tm1Geha (involves: 129S4/SvJae * C57BL/6)	increased B cell proliferation	J:43975
	increased IgA level	J:43975
	increased IgG3 level	J:43975
	increased IgM level	J:43975
Cd81^tm1Lvy/Cd81^tm1Lvy (involves: 129S1/Sv * 129X1/SvJ)	abnormal T-helper 2 physiology	J:40394
	decreased IgG1 level	J:40394
	decreased IgG level	J:40394
	decreased susceptibility to parasitic infection	J:126000
Cd81^tm1Lvy/Cd81^tm1Lvy (CByJ.129-Cd81^tm1Lvy)	abnormal T-helper 2 physiology	J:46171
Cd81^tm1Lvy/Cd81^tm1Lvy (CByJ.129-Cd81^tm1Lvy)	decreased susceptibility to type I hypersensitivity reaction	J:46171
Cd81^tm1Tmiy/Cd81^tm1Tmiy (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:83795
	abnormal T cell proliferation	J:41830
	decreased B cell proliferation	J:41830
	increased B cell proliferation	J:41830
Cd81^tm1Tmiy/Cd81^tm1Tmiy Cd9^tm1Mek/Cd9^tm1Mek (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:83795
Cd82^tm1Kjbr/Cd82^tm1Kjbr (Not Specified)	abnormal cellular extravasation	J:326451
	abnormal neutrophil physiology	J:326451
	impaired leukocyte tethering or rolling	J:326451
	increased susceptibility to bacterial infection	J:326451
Cd83^lcd4/Cd83^lcd4 (involves: C57BL/6J)	abnormal CD4-positive, alpha-beta T cell physiology	J:92721
	decreased susceptibility to type IV hypersensitivity reaction	J:92721
	decreased T cell proliferation	J:92721
Cd83^tm1Tft/Cd83^tm1Tft (involves: 129S4/SvJae * C57BL/6)	abnormal humoral immune response	J:75700
	decreased IgA level	J:75700
	decreased IgG1 level	J:75700
	decreased IgG2a level	J:75700
	decreased IgG2b level	J:75700
	decreased IgG3 level	J:75700
	decreased IgM level	J:75700
	decreased susceptibility to type IV hypersensitivity reaction	J:75700
Cd84^tm1Pls/Cd84^tm1Pls (C57BL/6J-Cd84^tm1Pls)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
	decreased IgG level	J:157915
	decreased interleukin-21 secretion	J:157915
Cd84^tm1Pls/Cd84^tm1Pls Tg(TcraTcrb)425Cbn/? (B6.Cg-Cd84^tm1Pls Tg(TcraTcrb)425Cbn)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
Cd86^tm1Shr/Cd86^tm1Shr (NOD.129S4-Cd86^tm1Shr)	abnormal T cell proliferation	J:142046
	decreased susceptibility to autoimmune diabetes	J:71352
	decreased T cell proliferation	J:93421
	increased autoantibody level	J:142046
	increased interferon-gamma secretion	J:142046
	increased susceptibility to autoimmune diabetes	J:93421
Cd86^tm1Shr/Cd86^tm1Shr (involves: 129S4/SvJae)	abnormal humoral immune response	J:39089
Cd86^tm1Shr/Cd86^tm1Shr (involves: 129S4/SvJae)	decreased IgG level	J:39089
Cd86^tm1Shr/Cd86^tm1Shr (B6.129S4-Cd86^tm1Shr)	decreased T cell proliferation	J:57613
Cd86^tm1Shr/Cd86^tm1Shr (B6.129S4-Cd86^tm1Shr)	increased interferon-gamma secretion	J:57613
Cd86^tm1Shr/Cd86^tm1Shr Marchf1^tm1.1Sish/Marchf1^tm1.1Sish (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	decreased interleukin-12 secretion	J:157516
	decreased tumor necrosis factor secretion	J:157516
Cd86^tm2Shr/Cd86^tm2Shr Icos^tm1Flv/Icos^tm1Flv (involves: 129S1/Sv * 129S4/SvJaeSor)	abnormal cytokine level	J:112600
Cd93^tm1Mbo/Cd93^tm1Mbo (either: 129/Sv or B6.129-Cd93^tm1Mbo or (involves: 129/Sv * C57BL/6))	impaired macrophage phagocytosis	J:88610
Cd96^tm1.1Mjs/Cd96^tm1.1Mjs (B6.129P2(Cg)-Cd96^tm1.1Mjs)	abnormal NK cell physiology	J:209990
	increased inflammatory response	J:209990
	increased susceptibility to endotoxin shock	J:209990
Cd99^{Gt(Ayu21-B6T44)Imeg}/Cd99^{Gt(Ayu21-B6T44)Imeg} (involves: C57BL/6 * C57BL/6NSlc)	abnormal splenocyte physiology	J:212222
Cd99l2^tm1.1Dvst/Cd99l2^tm1.1Dvst Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal cellular extravasation	J:193021
	decreased susceptibility to type IV hypersensitivity reaction	J:193021
Cd99l2^tm1.2Dvst/Cd99l2^tm1.2Dvst (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal cellular extravasation	J:193021
Cd109^tm1Mat/Cd109^tm1Mat (involves: 129S6/SvEvTac * C57BL/6J)	skin inflammation	J:188696
Cd151^tm1Lka/Cd151^tm1Lka (C57BL/6-Cd151^tm1Lka)	abnormal T cell proliferation	J:91605
Cd151^tm1Nki/Cd151^tm1Nki (involves: 129P2/OlaHsd * FVB/N)	tubulointerstitial nephritis	J:114988
Cd160^tm1Yxf/Cd160^tm1Yxf (C57BL/6-Cd160^tm1Yxf)	decreased interferon-gamma secretion	J:222131
Cd160^tm1Yxf/Cd160^tm1Yxf Rag1^tm1Mom/Rag1^tm1Mom (B6.Cg-Rag1^tm1Mom Cd160^tm1Yxf)	decreased interferon-gamma secretion	J:222131
Cd163^{tm1(KOMP)Vlcg}/Cd163^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal circulating cytokine level	J:224919
	abnormal macrophage chemotaxis	J:224919
Cd163^{tm1(KOMP)Vlcg}/Cd163^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	lung inflammation	J:233977
Cd177^{tm1(KOMP)Vlcg}/Cd177^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal neutrophil physiology	J:225335
Cd180^tm1Kmiy/Cd180^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:63145
	decreased IgG2b level	J:137066
	decreased IgG3 level	J:137066
Cd180^tm1Kmiy/Cd180^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6 * NZB * NZW)	decreased IgG2a level	J:137066
	decreased IgG3 level	J:137066
Cd180^tm1Kmiy/Cd180^tm1Kmiy Fas^lpr/Fas^lpr (MRL.Cg-Cd180^tm1Kmiy Fas^lpr)	blood vessel inflammation	J:137066
	decreased IgG2a level	J:137066
	decreased IgG3 level	J:137066
	glomerulonephritis	J:137066
	increased anti-nuclear antigen antibody level	J:137066
	increased autoantibody level	J:137066
Cd200^tm1Jods/Cd200^tm1Jods (C57BL/6-Cd200^tm1Jods)	abnormal cytokine level	J:95862
	abnormal immune system physiology	J:65982
	abnormal macrophage physiology	J:65982
	abnormal microglial cell physiology	J:65982
	increased susceptibility to experimental autoimmune encephalomyelitis	J:65982
	increased susceptibility to experimental autoimmune uveoretinitis	J:79906
	increased susceptibility to induced arthritis	J:65982
Cd200r1^tm1.1Rmgo/Cd200r1^tm1.1Rmgo (C57BL/6-Cd200r1^tm1.1Rmgo)	abnormal dendritic cell physiology	J:134313
	abnormal professional antigen presenting cell physiology	J:135069
	abnormal response to transplant	J:135069
	increased interleukin-12b secretion	J:135069
	increased tumor necrosis factor secretion	J:135069
Cd200r1^tm1.1Rmgo/Cd200r1^tm1.1Rmgo Tg(tetO/CMV-CD200)1Rmgo/Tg(tetO/CMV-CD200)1Rmgo (involves: C57BL/6)	abnormal dendritic cell physiology	J:134313
Cd200r1^tm1Eakj/Cd200r1^tm1Eakj (Not Specified)	abnormal macrophage physiology	J:326965
	decreased interferon-beta secretion	J:192198
	decreased interleukin-1 beta secretion	J:192198
	decreased interleukin-6 secretion	J:192198
	decreased susceptibility to Herpesvirales infection	J:192198
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:192198
Cd207^{tm1(Hbegf/EGFP)Bjec}/Cd207⁺ (involves: C57BL/6 * SJL)	decreased susceptibility to type IV hypersensitivity reaction	J:137517
	increased susceptibility to Orthomyxoviridae infection	J:137452
Cd207^{tm1(Hbegf/EGFP)Bjec}/Cd207⁺ (involves: C57BL/6)	abnormal type IV hypersensitivity reaction	J:179630
Cd207^tm1.1Cfg/Cd207^tm1.1Cfg (involves: C57BL/6)	decreased IgA level	J:217719
	decreased IgG1 level	J:217719
	decreased IgG2a level	J:217719
	decreased IgG3 level	J:217719
	decreased IgM level	J:217719
Cd207^{tm2.1(cre)Bjec}/Cd207⁺ Tgfbr1^tm1.1Karl/Tgfbr1^tm1.1Karl (involves: 129S4/SvJaeSor * C57BL/6)	abnormal type IV hypersensitivity reaction	J:179630
Cd209a^tm1.1Cfg/Cd209a^tm1.1Cfg (involves: C57BL/6)	decreased IgG2b level	J:217719
	increased inflammatory response	J:217719
	increased T cell proliferation	J:217719
Cd209b^tm1.1Cfg/Cd209b^tm1.1Cfg (involves: C57BL/6)	impaired macrophage phagocytosis	J:288225
	increased IgG2b level	J:217719
	increased IgG3 level	J:217719
	increased IgM level	J:217719
	increased susceptibility to bacterial infection	J:288225
	urinary bladder inflammation	J:288225
Cd209b^tm1Anjm/Cd209b^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:94698
	impaired macrophage phagocytosis	J:94698
	increased susceptibility to bacterial infection	J:94698
	increased susceptibility to bacterial infection induced morbidity/mortality	J:94698
Cd209b^tm1Anjm/Cd209b^tm1Anjm (B6.129P2-Cd209b^tm1Anjm)	decreased interleukin-1 beta secretion	J:159646
	decreased interleukin-18 secretion	J:159646
	decreased susceptibility to endotoxin shock	J:159646
	decreased susceptibility to induced colitis	J:159646
	increased susceptibility to bacterial infection induced morbidity/mortality	J:94698
Cd209d^tm1.1Cfg/Cd209d^tm1.1Cfg (involves: C57BL/6 * C57BL/6J)	increased circulating tumor necrosis factor level	J:153503
	increased susceptibility to bacterial infection	J:153503
Cd209d^tm1.1Cfg/Cd209d^tm1.1Cfg (involves: C57BL/6)	increased B cell proliferation	J:217719
Cd226^tm1.1Cln/Cd226^tm1.1Cln (B6.129P2-Cd226^tm1.1Cln)	decreased inflammatory response	J:209990
	decreased T cell proliferation	J:159749
	impaired natural killer cell mediated cytotoxicity	J:159749
Cd226^tm1.1Cln/Cd226^tm1.1Cln Tg(TcraTcrb)1100Mjb/0 (B6.Cg-Cd226^tm1.1Cln Tg(TcraTcrb)1100Mjb)	abnormal T cell activation	J:159749
	decreased cytotoxic T cell cytolysis	J:159749
	decreased interferon-gamma secretion	J:159749
	decreased T cell proliferation	J:159749
Cd226^tm1Shib/Cd226^tm1Shib (involves: BALB/c)	abnormal immune system physiology	J:165704
	decreased cytotoxic T cell cytolysis	J:165704
	impaired natural killer cell mediated cytotoxicity	J:165704
Cd244a^Chip/Cd244a⁺ (C57BL/6J-Cd244a^Chip)	abnormal NK cell physiology	J:196519
Cd244a^Chip/Cd244a⁺ (C57BL/6J-Cd244a^Chip)	impaired natural killer cell mediated cytotoxicity	J:196519
Cd244a^Chip/Cd244a^Chip (C57BL/6J-Cd244a^Chip)	abnormal NK cell physiology	J:196519
Cd244a^Chip/Cd244a^Chip (C57BL/6J-Cd244a^Chip)	impaired natural killer cell mediated cytotoxicity	J:196519
Cd244a^tm1Kmle/Cd244a^tm1Kmle (involves: C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:166054
Cd244a^tm1Kmle/Cd244a^tm1Kmle (involves: C57BL/6)	increased natural killer cell mediated cytotoxicity	J:92740
Cd247^m1Btlr/Cd247^m1Btlr (C57BL/6J-Cd247^m1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:158794
Cd247^tm1Lov/Cd247^tm1Lov (involves: 129S4/SvJae)	abnormal T-helper 1 physiology	J:46914
Cd247^tm1Lov/Cd247^tm1Lov Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal T cell activation	J:46914
	abnormal T-helper 1 physiology	J:46914
	impaired natural killer cell mediated cytotoxicity	J:64764
Cd247^tm1Mal/Cd247^tm1Mal (involves: C57BL/6)	abnormal thymocyte activation	J:110847
Cd247^tm1Mal/Cd247^tm1Mal Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas * C57BL/6)	abnormal thymocyte activation	J:110847
Cd247^tm1Mhu/Cd247^tm1Mhu (involves: 129S7/SvEvBrd * C57BL/6)	decreased splenocyte proliferation	J:15579
	decreased T cell proliferation	J:15579
Cd247^tm1Tks/Cd247^tm1Tks (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell proliferation	J:15271
Cd247^tm1Tks/Cd247^tm1Tks (B6.129P2-Cd247^tm1Tks)	abnormal NK cell physiology	J:66403
	increased interferon-gamma secretion	J:66403
	increased natural killer cell mediated cytotoxicity	J:66403
Cd247^tm2.1Lov/Cd247^tm2.1Lov (Not Specified)	abnormal regulatory T cell physiology	J:192915
	abnormal T cell physiology	J:192915
	decreased thymocyte apoptosis	J:192915
Cd247^tm2.1Lov/Cd247^tm2.1Lov (B6.Cg-Cd247^tm2.1Lov)	increased susceptibility to experimental autoimmune encephalomyelitis	J:192915
Cd274^tm1.1Lex/Cd274^tm1.1Lex (involves: 129S5/SvEvBrd)	abnormal cytokine secretion	J:126829
Cd274^tm1.1Lex/Cd274^tm1.1Lex (involves: 129S5/SvEvBrd)	increased susceptibility to experimental autoimmune encephalomyelitis	J:126829
Cd274^tm1Igu/Cd274^tm1Igu Vsir^tm1Lex/Vsir^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal T cell activation	J:222944
Cd274^tm1Lpc/Cd274^tm1Lpc (B6.129S-Cd274^tm1Lpc)	abnormal CD8-positive, alpha-beta T cell physiology	J:89781
	decreased T cell apoptosis	J:89781
	increased susceptibility to autoimmune disorder	J:89781
Cd274^tm1Lpc/Cd274^tm1Lpc (involves: 129S/SvEv)	abnormal chemokine secretion	J:158023
Cd274^tm1Lpc/Cd274^tm1Lpc (involves: 129S/SvEv)	increased tumor necrosis factor secretion	J:158023
Cd274^tm1Lpc/Cd274^tm1Lpc (involves: 129S/SvEv * C57BL/6)	abnormal dendritic cell physiology	J:152305
	decreased susceptibility to Riboviria infection	J:136330
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:136330
	decreased T cell apoptosis	J:136330
	increased IgG1 level	J:162539
	increased IgG2c level	J:162539
	increased susceptibility to bacterial infection	J:162539
	increased susceptibility to bacterial infection induced morbidity/mortality	J:162539
	increased susceptibility to experimental autoimmune encephalomyelitis	J:142815
Cd274^tm1Lpc/Cd274^tm1Lpc (C.129S-Cd274^tm1Lpc)	abnormal regulatory T cell physiology	J:165841
	abnormal T follicular helper cell physiology	J:165841
	decreased IgG1 level	J:165841
	decreased IgG2a level	J:165841
	decreased interleukin-17 secretion	J:165841
	increased interferon-gamma secretion	J:165841
	increased interleukin-4 secretion	J:165841
	increased susceptibility to induced arthritis	J:165841
	increased T cell proliferation	J:165841
Cd274^tm1Shr/Cd274^tm1Shr (C.B6-Cd274^tm1Shr)	abnormal interleukin secretion	J:123785
	increased interferon-gamma secretion	J:123785
	increased susceptibility to autoimmune diabetes	J:123785
Cd274^tm1Shr/Cd274^tm1Shr Pdcd1lg2^tm3Shr/Pdcd1lg2^tm3Shr (C.B6-Cd274^tm1Shr Pdcd1lg2^tm3Shr)	abnormal dendritic cell physiology	J:123785
	decreased interleukin-4 secretion	J:123785
	increased interferon-gamma secretion	J:123785
	increased interleukin-2 secretion	J:123785
Cd274^tm1Shr/Cd274^tm1Shr Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	increased susceptibility to autoimmune diabetes	J:153040
Cd274^tm2Shr/Cd274^tm2Shr (involves: 129/Sv * 129S4/SvJae)	abnormal cytokine secretion	J:113851
Cd274^tm2Shr/Cd274^tm2Shr (involves: 129/Sv * 129S4/SvJae)	decreased susceptibility to parasitic infection	J:113851
Cd274^tm2Shr/Cd274^tm2Shr Pdcd1lg2^tm4Shr/Pdcd1lg2^tm4Shr (involves: 129S4/SvJae)	abnormal immune system physiology	J:160970
Cd276^tm1Lpc/Cd276^tm1Lpc (B6.129-Cd276^tm1Lpc)	abnormal T-helper 1 physiology	J:237700
	abnormal T-helper 2 physiology	J:237700
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:237700
	increased susceptibility to type I hypersensitivity reaction	J:237700
Cd276^tm1Lpc/Cd276^tm1Lpc (D1J.129-Cd276^tm1Lpc)	abnormal T-helper 1 physiology	J:237700
	abnormal T-helper 17 cell physiology	J:237700
	decreased susceptibility to induced arthritis	J:237700
Cd276^tm1Mak/Cd276^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 physiology	J:84973
	increased anti-single stranded DNA antibody level	J:84973
	increased inflammatory response	J:84973
	increased susceptibility to experimental autoimmune encephalomyelitis	J:84973
	increased T cell proliferation	J:84973
Cd276^tm1Mak/Cd276^tm1Mak (C.129P2-Cd276^tm1Mak)	abnormal T-helper 1 physiology	J:84973
	increased inflammatory response	J:84973
	increased interferon-gamma secretion	J:84973
Cd276^tm1Wwh/Cd276^tm1Wwh (B6.Cg-B7h3^tm1Wwh)	abnormal cytokine secretion	J:95550
Cd276^tm1Wwh/Cd276^tm1Wwh (B6.Cg-B7h3^tm1Wwh)	abnormal response to transplant	J:95550
Cd300a^tm1Shib/Cd300a^tm1Shib (B6JJcl.C-Cd300a^tm1Shib)	abnormal chemokine secretion	J:189144
	abnormal mast cell physiology	J:189144
	increased interleukin-10 secretion	J:189144
	increased interleukin-13 secretion	J:189144
	increased tumor necrosis factor secretion	J:189144
Cd300c2^tm1Shib/Cd300c2^tm1Shib (B6.Cg-Cd300c2^tm1Shib)	increased B cell proliferation	J:177613
Cd300lf^tm1Gne/Cd300lf^tm1Gne (involves: C57BL/6N)	increased interleukin-1 alpha secretion	J:156819
	increased interleukin-1 beta secretion	J:156819
	increased interleukin-12 secretion	J:156819
	increased susceptibility to experimental autoimmune encephalomyelitis	J:156819
Cd300lf^tm1Toki/Cd300lf^tm1Toki (Not Specified)	abnormal interleukin secretion	J:190979
	abnormal mast cell physiology	J:190979
	increased interleukin-4 secretion	J:190979
	increased interleukin-5 secretion	J:190979
	increased interleukin-13 secretion	J:190979
	increased susceptibility to type I hypersensitivity reaction	J:190979
	respiratory system inflammation	J:190979
Cd302^tm1.1Dnjh/Cd302^tm1.1Dnjh (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:301848
Cd302^tm1.1Dnjh/Cd302^tm1.1Dnjh (involves: C57BL/6)	abnormal dendritic cell physiology	J:301848
Cdcs1^C3H/HeJBir/Cdcs1^C3H/HeJBir (involves: B6.129P2-Il10^tm1Cgn/Lt * C3Bir.129P2(B6)-Il10^tm1Cgn/Lt)	abnormal immune system physiology	J:72978
Cdcs1^C3H/HeJBir/Cdcs1^C57BL/6J (involves: C3H/HeJBir-Il10^tm1Cgn * C57BL/6J-Il10^tm1Cgn)	colitis	J:72978
Cdcs2^C3H/HeJBir/Cdcs2^C3H/HeJBir (involves: B6.129P2-Il10^tm1Cgn/Lt * C3Bir.129P2(B6)-Il10^tm1Cgn/Lt)	intestinal inflammation	J:72978
Cdcs2^C3H/HeJBir/Cdcs2^C57BL/6J (involves: B6.129P2-Il10^tm1Cgn/Lt * C3Bir.129P2(B6)-Il10^tm1Cgn/Lt)	intestinal inflammation	J:72978
Cdcs3^C3H/HeJBir/Cdcs3^C3H/HeJBir (involves: B6.129P2-Il10^tm1Cgn/Lt * C3Bir.129P2(B6)-Il10^tm1Cgn/Lt)	intestinal inflammation	J:72978
Cdcs4^C3H/HeJBir/Cdcs4^C57BL/6J (involves: C3H/HeJBir * C57BL/6J)	intestinal inflammation	J:72978
Cdcs4^C57BL/6J/Cdcs4^C57BL/6J (involves: C3H/HeJBir * C57BL/6J)	intestinal inflammation	J:72978
Cdcs5^C57BL/6J/Cdcs5^C57BL/6J (involves: C3H/HeJBir * C57BL/6J)	intestinal inflammation	J:72978
Cdcs6^C57BL/6J/? (involves: B6.129P2-Il10^tm1Cgn/Lt * C3Bir.129P2(B6)-Il10^tm1Cgn/Lt)	intestinal inflammation	J:72978
Cdcs7^C3H/HeJBir/Cdcs7^C3H/HeJBir (involves: C3H/HeJBir * C57BL/6J)	intestinal inflammation	J:78917
Cdcs8^C57BL/6J/Cdcs8^C57BL/6J (involves: C3H/HeJBir * C57BL/6J)	intestinal inflammation	J:78917
Cdcs9^C3H/HeJBir/Cdcs9^C3H/HeJBir (involves: C3H/HeJBir * C57BL/6J)	intestinal inflammation	J:78917
Cdcs9^C3H/HeJBir/Cdcs9^C57BL/6J (involves: C3H/HeJBir * C57BL/6J)	intestinal inflammation	J:78917
Cdcs10^C3H/HeJBir/Cdcs10^C3H/HeJBir (involves: C3H/HeJBir-Il10^tm1Cgn * C57BL/6J-Il10^tm1Cgn)	intestinal inflammation	J:78917
Cdcs10^C3H/HeJBir/Cdcs10^C57BL/6J (involves: C3H/HeJBir-Il10^tm1Cgn * C57BL/6J-Il10^tm1Cgn)	intestinal inflammation	J:72978
Cdh1^tm1Mlec/Cdh1^tm1Mlec (involves: 129S2/SvPas)	increased susceptibility to bacterial infection	J:142843
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (involves: 129 * C57BL/6)	abnormal cellular extravasation	J:177191
	abnormal leukocyte migration	J:177191
Cdh5^{tm4(Cdh5/Fkbp,Ptprb/Mtor)Dvst}/Cdh5^{tm4(Cdh5/Fkbp,Ptprb/Mtor)Dvst} (involves: C57BL/6)	abnormal cellular extravasation	J:178759
	impaired neutrophil recruitment	J:178759
Cdh5^tm5Dvst/Cdh5^tm5Dvst (B6.Cg-Cdh5^tm5Dvst)	abnormal cellular extravasation	J:209801
Cdh5^tm6Dvst/Cdh5^tm6Dvst (B6.Cg-Cdh5^tm6Dvst)	abnormal cellular extravasation	J:209801
Cdh17^M1Btlr/Cdh17^M1Btlr (C57BL/6J-Cdh17^M1Btlr)	increased susceptibility to induced colitis	J:272090
Cdh17^tm1Ohn/Cdh17^tm1Ohn (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG level	J:96738
Cdk2^tm2Sgo/Cdk2^tm2Sgo Cdk4^tm2.1Bbd/Cdk4^tm2.1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased susceptibility to autoimmune diabetes	J:125217
Cdk4^tm1Kiyo/Cdk4⁺ Lin9^tm1Orc/Lin9⁺ (involves: 129S1/Sv)	decreased susceptibility to autoimmune diabetes	J:111333
Cdk6^tm1Bbd/Cdk6^tm1Bbd (involves: 129S1/Sv * 129X1/SvJ * CD-1)	decreased T cell proliferation	J:92529
Cdk6^tm1Phin/Cdk6^tm1Phin (involves: 129S4/SvJae)	abnormal thymocyte activation	J:144975
Cdk6^tm1Phin/Cdk6^tm1Phin (involves: 129S4/SvJae)	decreased thymocyte apoptosis	J:144975
Cdk6^tm3.1Phin/Cdk6^tm3.1Phin (involves: 129 * C57BL/6 * FVB/N)	increased T cell apoptosis	J:174697
Cdkn1a^tm1Led/Cdkn1a^tm1Led (involves: 129S6/SvEvTac)	increased anti-double stranded DNA antibody level	J:76041
	increased anti-histone antibody level	J:76041
	increased anti-single stranded DNA antibody level	J:76041
	increased autoantibody level	J:76041
	increased T cell proliferation	J:76041
Cdkn1a^tm1Led/Cdkn1a^tm1Led Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))	abnormal T cell activation	J:76041
	glomerulonephritis	J:76041
	increased anti-double stranded DNA antibody level	J:76041
	increased anti-histone antibody level	J:76041
	increased anti-single stranded DNA antibody level	J:76041
	increased autoantibody level	J:76041
	increased IgG1 level	J:76041
	increased IgM level	J:76041
	increased inflammatory response	J:76041
	increased T cell proliferation	J:76041
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (B6;129S2-Cdkn1a^tm1Tyj/J)	decreased susceptibility to induced arthritis	J:108569
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (B6;129S2-Cdkn1a^tm1Tyj/J)	impaired macrophage chemotaxis	J:108569
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal self tolerance	J:60292
	abnormal thymus physiology	J:70894
	glomerulonephritis	J:60292, J:70894
	increased anti-double stranded DNA antibody level	J:60292
	increased anti-histone antibody level	J:60292
	increased anti-nuclear antigen antibody level	J:60292
	increased IgG1 level	J:60292
	increased T cell proliferation	J:60292
Cdkn1b^tm1Jro/Cdkn1b^tm1Jro (involves: 129S4/SvJaeSor * C57BL/6)	decreased T cell proliferation	J:71780
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor * C57BL/6J)	increased T cell proliferation	J:33400
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)	decreased T cell proliferation	J:73369
Cdkn2a^tm2.1Rdp/Cdkn2a^tm2.1Rdp (involves: 129S6/SvEvTac * FVB/N)	increased splenocyte proliferation	J:71394
Cdkn2c^tm1Yxi/Cdkn2c^tm1Yxi (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal T cell physiology	J:50053
Cdsn^tm1.1Ics/Cdsn^tm1.1Ics Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S2/SvPas)	skin inflammation	J:153292
Ceacam1^Hv2-r/Ceacam1^Hv2-r (SJL/J)	decreased susceptibility to Coronaviridae infection	J:92495
Ceacam1^Hv2-r/Ceacam1^Hv2-r (SJL/J)	decreased susceptibility to viral infection	J:25438
Ceacam1^tm1.1Fta/Ceacam1^tm1.1Fta (C57BL/6(FVB)-Ceacam1^tm1.1Fta)	decreased susceptibility to Coronaviridae infection	J:198335
	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	J:198335
Ceacam1^tm1Bcn/Ceacam1^tm1Bcn (either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	J:70815
Ceacam1^tm1Rsb/Ceacam1^tm1Rsb Tg(Lck-cre)1Cwi/0 (involves: 129)	abnormal cytokine secretion	J:116136
	increased interferon-gamma secretion	J:116136
	increased interleukin-2 secretion	J:116136
	increased T cell proliferation	J:116136
Ceacam1^tm2Bcn/Ceacam1^tm2Bcn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased susceptibility to Coronaviridae infection	J:92376
Ceat1^CBA/J/Ceat1^NOD (involves: CBA/J * NOD-H2^k)	increased susceptibility to experimental autoimmune thyroiditis	J:77545
Ceat1^NOD/Ceat1^NOD (involves: CBA/J * NOD-H2^k)	increased susceptibility to experimental autoimmune thyroiditis	J:77545
Cebpa^tm1Dgt/Cebpa^tm1Dgt Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	sepsis	J:94682
Cebpa^tm8.1Nerl/Cebpa^tm8.1Nerl (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	liver inflammation	J:136134
Cebpb^tm1.1Acle/Cebpb^tm1.1Acle (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal osteoclast physiology	J:150006
Cebpb^tm1.1Elgaz/Cebpb^tm1.1Elgaz Lyz2^{em1.1(cre)Elgaz}/Lyz2⁺ (BALB/cJ-Cebpb^tm1.1Elgaz Lyz2^em1.1Elgaz/Elgaz)	decreased circulating interleukin-10 level	J:247885
	decreased susceptibility to bacterial infection	J:247885
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:247885
	increased circulating interleukin-6 level	J:247885
	increased circulating tumor necrosis factor level	J:247885
Cebpb^tm1Aki/Cebpb^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:153025
	abnormal T-helper 1 physiology	J:153025
	decreased susceptibility to endotoxin shock	J:153025
	granulomatous inflammation	J:153025
	increased susceptibility to bacterial infection	J:153025
Cebpb^tm1Kish/Cebpb^tm1Kish (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:77003
	impaired macrophage phagocytosis	J:77003
	increased interleukin-12 secretion	J:126085
	increased susceptibility to bacterial infection	J:77003
Cebpb^tm1Pfj/Cebpb^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast physiology	J:150006
Cebpb^tm1Pfj/Cebpb^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal tumor necrosis factor level	J:192313
Cebpb^tm1Vpo/Cebpb^tm1Vpo (involves: 129S/SvEv * MF1)	abnormal cell-mediated immunity	J:25215
	abnormal humoral immune response	J:25215
	abnormal innate immunity	J:25215
	abnormal macrophage physiology	J:25215
	abnormal T-helper 1 physiology	J:25215
	abnormal T-helper 2 physiology	J:25215
	decreased circulating interleukin-12 level	J:25215
	decreased susceptibility to type IV hypersensitivity reaction	J:25215
	glomerulonephritis	J:25215
	increased circulating interleukin-6 level	J:25215
	increased IgG level	J:25215
	increased susceptibility to fungal infection	J:25215
Cebpb^tm2.1Acle/Cebpb^tm2.1Acle (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	increased circulating interleukin-6 level	J:155795
Cebpb^tm3Nerl/Cebpb^tm3Nerl (either: B6.129P2-Cebpb^tm3Nerl or (involves: 129P2/OlaHsd * C57BL/6))	myositis	J:153686
Cebpd^tm1Pfj/Cebpd^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal cytokine level	J:192313
Cebpd^tm1Pfj/Cebpd^tm1Pfj (involves: 129S1/Sv * C57BL/6)	decreased inflammatory response	J:192313
Cebpe^tm1Kgx/Cebpe^tm1Kgx (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal neutrophil physiology	J:76024
	colitis	J:76024
	conjunctivitis	J:76024
	increased inflammatory response	J:76024
	increased susceptibility to bacterial infection	J:76024
	lung inflammation	J:76024
	osteomyelitis	J:76024
	peritoneal inflammation	J:76024
	rhinitis	J:76024
Cebpe^tm1Kgx/Cebpe^tm1Kgx (involves: 129S6/SvEvTac)	abnormal neutrophil physiology	J:76024
	colitis	J:76024
	conjunctivitis	J:76024
	increased inflammatory response	J:76024
	increased susceptibility to bacterial infection	J:76024
	lung inflammation	J:76024
	osteomyelitis	J:76024
	peritoneal inflammation	J:76024
	pleuritis	J:76024
	rhinitis	J:76024
Cebpg^tm1Aki/Cebpg^tm1Aki (involves: 129P2/OlaHsd)	abnormal NK cell physiology	J:58801
Cebpg^tm1Aki/Cebpg^tm1Aki (involves: 129P2/OlaHsd)	impaired natural killer cell mediated cytotoxicity	J:58801
Celf4^{tm1a(EUCOMM)Wtsi}/Celf4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Celf4^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Celsr1^ctb-2J/Celsr1^ctb-2J (STOCK Celsr1^ctb-2J/GrsrJ)	increased susceptibility to otitis media	J:229303
Celsr1^ctb/Celsr1^ctb (CByJ.Cg-Celsr1^ctb/GrsrJ)	increased susceptibility to otitis media	J:229303
Cerk^tm1Fbor/Cerk^tm1Fbor (involves: BALB/c)	increased susceptibility to bacterial infection	J:131522
Cers3^tm1.1Rsnd/Cers3^tm1.1Rsnd (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to fungal infection	J:179754
Cers6^tm1.1Arte/Cers6^tm1.1Arte (involves: BALB/cJ * C57BL/6N)	decreased inflammatory response	J:215519
Cfap53^{em1(IMPC)Wtsi}/Cfap53^{em1(IMPC)Wtsi} (C57BL/6N-Cfap53^{em1(IMPC)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Cfb^tm1Hrc/Cfb⁺ Cfh^tm1Mbo/Cfh^tm1Mbo (involves: 129S/Sv * C57BL/6)	decreased circulating complement protein level	J:78193
Cfb^tm1Hrc/Cfb^tm1Hrc (involves: 129S/Sv * C57BL/6)	abnormal complement pathway	J:42679
Cfb^tm1Hrc/Cfb^tm1Hrc (involves: 129S/Sv * C57BL/6)	impaired complement alternative pathway	J:42679
Cfb^tm1Hrc/Cfb^tm1Hrc (involves: 129S/Sv)	decreased susceptibility to Coronaviridae infection	J:286325
Cfb^tm1Hrc/Cfb^tm1Hrc (involves: 129S/Sv)	impaired complement classical pathway	J:130108
Cfb^tm1Mbo/Cfb^tm1Mbo (involves: 129/Sv * C57BL/6)	increased susceptibility to bacterial infection	J:83712
Cfb^tm1Pkna/Cfb^tm1Pkna (D1.129P2-Cfb^tm1Pkna)	decreased susceptibility to induced arthritis	J:88872
Cfd^tm1Yxu/Cfd^tm1Yxu (involves: 129P2/OlaHsd * C57BL/6J)	impaired complement alternative pathway	J:73125
Cfd^tm1Yxu/Cfd^tm1Yxu (B6.129P2-Cfd^tm1Yxu)	impaired complement alternative pathway	J:94855
Cfd^tm1Yxu/Cfd^tm1Yxu (B6.129P2-Cfd^tm1Yxu)	increased susceptibility to bacterial infection	J:94855
Cfh^tm1.1Song/Cfh^tm1.1Song (involves: C57BL/6)	decreased circulating complement protein level	J:240426
	decreased complement C5 level	J:240426
	decreased serum complement activity	J:240426
Cfh^tm1Mbo/Cfh⁺ (involves: 129/Sv * C57BL/6)	decreased circulating complement protein level	J:78193
Cfh^tm1Mbo/Cfh^tm1Mbo (involves: 129/Sv * C57BL/6)	decreased circulating complement protein level	J:78193
	glomerulonephritis	J:78193
	increased susceptibility to type III hypersensitivity reaction	J:78193
Cfh^tm1Mbo/Cfh^tm1Mbo (involves: 129)	abnormal complement protein level	J:125860
	decreased circulating complement protein level	J:125860, J:131403
	glomerulonephritis	J:131403
Cfh^tm1Mbo/Cfh^tm1Mbo Tg(CAG-Cfh)#Mcp/0 (involves: 129/Sv C57BL/6 * CBA)	abnormal circulating complement protein level	J:125860
	abnormal complement protein level	J:125860
Cfi^em1Jiwe/Cfi^em1Jiwe (involves: C57BL/6J)	abnormal complement protein level	J:308307
Cfi^em1Jiwe/Cfi^em1Jiwe (involves: C57BL/6J)	impaired complement alternative pathway	J:308307
Cfi^tm1Mcp/Cfi^tm1Mcp (involves: 129/Sv * C57BL/6)	decreased circulating complement protein level	J:131403
Cflar^tm1Ywh/Cflar^tm1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)	increased thymocyte apoptosis	J:100558
Cfmq1^129X1/SvJ/Cfmq1^C57BL/6J Cftr^tm1Unc/Cftr^tm1Unc (involves: 129X1/SvJ * C57BL/6J)	intestinal inflammation	J:101842
Cfmq2^129X1/SvJ/Cfmq2^129X1/SvJ Cftr^tm1Unc/Cftr^tm1Unc (involves: 129X1/SvJ * C57BL/6J)	intestinal inflammation	J:101842
Cfmq3^129X1/SvJ/Cfmq3^C57BL/6J Cftr^tm1Unc/Cftr^tm1Unc (involves: 129X1/SvJ * C57BL/6J)	intestinal inflammation	J:101842
Cfp^tm1Cmst/Cfp^tm1Cmst (B6.129P2-Cfp^tm1Cmst)	sepsis	J:131526
Cfp^tm1Song/Y (involves: 129 * C57BL/6)	abnormal complement pathway	J:130108
	impaired complement alternative pathway	J:130108
	impaired complement classical pathway	J:130108
Cfp^tm1Song/Cfp^tm1Song (involves: 129 * C57BL/6)	decreased susceptibility to induced arthritis	J:165497
Cfp^tm1Song/Cfp^tm1Song (involves: 129 * C57BL/6)	impaired complement alternative pathway	J:165497
Cfp^tm2.1Song/Cfp^tm2.1Song Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL)	decreased susceptibility to induced arthritis	J:165497
	impaired complement alternative pathway	J:165497
Cfp^tm2.1Song/Cfp^tm2.1Song Tg(EIIa-cre)C5379Lmgd/0 (involves: 129 * C57BL/6 * FVB/N * SJL)	impaired complement alternative pathway	J:165497
Cftr^tm1Bay/Cftr^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	acute pancreas inflammation	J:15244
Cftr^tm1Cam/Cftr^tm1Cam (involves: 129S/SvEv)	increased susceptibility to infection	J:23850
Cftr^tm1Cam/Cftr^tm1Cam (involves: 129S/SvEv)	peritoneal inflammation	J:23850
Cftr^tm1Hgu/Cftr^tm1Hgu (involves: 129P2/OlaHsd)	increased susceptibility to bacterial infection	J:24119
Cftr^tm1Hgu/Cftr^tm1Hgu (involves: 129P2/OlaHsd)	lung inflammation	J:24119
Cftr^tm1Kth/Cftr^tm1Kth (involves: 129S7/SvEvBrd * C57BL/6J)	peritoneal inflammation	J:29074
Cftr^tm1Kth/Cftr^tm1Kth (B6.129S7-Cftr^tm1Kth)	increased susceptibility to bacterial infection induced morbidity/mortality	J:112450
Cftr^tm1Kth/Cftr^tm1Kth (B6.129S7-Cftr^tm1Kth)	lung inflammation	J:112450
Cftr^tm1Unc/Cftr^tm1Unc (B6.129P2-Cftr^tm1Unc/J)	increased susceptibility to bacterial infection induced morbidity/mortality	J:112450
Cftr^tm1Unc/Cftr^tm1Unc (B6.129P2-Cftr^tm1Unc/J)	lung inflammation	J:58571, J:112450
Cftr^tm1Unc/Cftr^tm1Unc (involves: 129P2/OlaHsd)	abnormal thymus involution	J:2079
Cftr^tm1Unc/Cftr^tm1Unc (involves: 129P2/OlaHsd)	peritoneal inflammation	J:2079
Cftr^tm1Unc/Cftr^tm1Unc (B6.129P2-Cftr^tm1Unc)	lung inflammation	J:44904
Cftr^tm1Unc/Cftr^tm1Unc Tg(FABPCFTR)1Jaw/0 Tg(Scgb1a1-Scnn1b)6608Bouc/0 (involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)	respiratory system inflammation	J:191673
Cftr^tm2Cam/Cftr^tm2Cam (involves: 129S/SvEv)	peritoneal inflammation	J:27734
Cftr^tm2Mrc/Cftr^tm2Mrc (B6.129S6-Cftr^tm2Mrc)	increased susceptibility to bacterial infection induced morbidity/mortality	J:112450
Cftr^tm2Mrc/Cftr^tm2Mrc (B6.129S6-Cftr^tm2Mrc)	lung inflammation	J:112450
Cftr^tm3Hgu/Cftr^tm3Hgu (involves: 129P2/OlaHsd)	gallbladder inflammation	J:32766
Cftr^tm3Hgu/Cftr^tm3Hgu (involves: 129P2/OlaHsd)	peritoneal inflammation	J:32766
Cftr^tm3Mrc/Cftr^tm3Mrc (B6.129S6-Cftr^tm3Mrc)	increased susceptibility to bacterial infection induced morbidity/mortality	J:112450
Cftr^tm3Mrc/Cftr^tm3Mrc (B6.129S6-Cftr^tm3Mrc)	lung inflammation	J:112450
Cgas^{tm1a(EUCOMM)Hmgu}/Cgas^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Cgas^{tm1a(EUCOMM)Hmgu})	abnormal dendritic cell physiology	J:201167
	abnormal immune cell physiology	J:201167
	abnormal macrophage physiology	J:201167
	abnormal plasmacytoid dendritic cell physiology	J:201167
	decreased circulating interferon-alpha level	J:201167
	decreased circulating interferon-beta level	J:201167
	increased susceptibility to Herpesvirales infection	J:201167
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:201167
Cgas^{tm1a(EUCOMM)Hmgu}/Cgas^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal interferon secretion	J:234263
Cgas^{tm1a(EUCOMM)Hmgu}/Cgas^{tm1a(EUCOMM)Hmgu} Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to Retroviridae infection	J:234263
Cgas^{tm1d(EUCOMM)Hmgu}/Cgas^{tm1d(EUCOMM)Hmgu} (involves: BALB/c * C57BL/6JJcl * C57BL/6N)	increased susceptibility to Flaviviridae infection	J:207826
	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:207826
	increased susceptibility to Herpesvirales infection	J:207826
	increased susceptibility to Poxviridae infection	J:207826
	increased susceptibility to Poxviridae infection induced morbidity/mortality	J:207826
Cgas^{tm1d(EUCOMM)Hmgu}/Cgas^{tm1d(EUCOMM)Hmgu} (involves: C57BL/6N)	increased susceptibility to Retroviridae infection	J:265023
Cgnz1^NZM2328/J/Cgnz1^NZM2328/J (involves: C57L/J * NZM2328/J)	increased susceptibility to systemic lupus erythematosus	J:71397
	kidney inflammation	J:71397
Ch25h^tm1Rus/Ch25h^tm1Rus (B6.129S6-Ch25h^tm1Rus)	increased IgA level	J:170807
	increased IgG2a level	J:170807
	increased IgG2b level	J:170807
	increased IgG3 level	J:170807
Char2a^C3H/HeJ/Char2a^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased susceptibility to parasitic infection	J:117548
Char2b^C3H/HeJ/Char2b^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased susceptibility to parasitic infection	J:117548
Char3^C3H/He/Char3^C57BL/6 (involves: C3H/He * C57BL/6)	decreased susceptibility to parasitic infection	J:72455
Char3^C57BL/6/Char3^C57BL/6 (involves: C3H/He * C57BL/6)	decreased susceptibility to parasitic infection	J:72455
Char4^C57BL/6J/Char4^C57BL/6J (involves: A/J * C57BL/6J)	decreased susceptibility to parasitic infection	J:71471
Char9^A/J/Char9^C57BL/6J (involves: A/J * C57BL/6J)	decreased susceptibility to parasitic infection	J:122131
Char9^C57BL/6J/Char9^C57BL/6J (involves: A/J * C57BL/6J)	decreased susceptibility to parasitic infection	J:122131
Char11^A/J/Char11^C57BL/6J (involves: A/J * C57BL/6J)	decreased susceptibility to parasitic infection	J:106220
Char11^C57BL/6J/Char11^C57BL/6J (involves: A/J * C57BL/6J)	decreased susceptibility to parasitic infection	J:106220
Chchd10^em8Lutzy/Chchd10⁺ (C57BL/6NJ-Chchd10^em8Lutzy/J)	increased susceptibility to otitis media	J:272524
Chd2^{Gt(RRBO46)Byg}/Chd2⁺ (involves: 129P2/OlaHsd * C57BL/6)	arteritis	J:146176
	heart inflammation	J:146176
	interstitial pneumonia	J:146743
	liver inflammation	J:146743
	myocarditis	J:146743
Chd4^tm1.1Kge/Chd4^tm1.1Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * SJL)	abnormal T cell physiology	J:109547
Chd4^tm1.1Kge/Chd4^tm1.2Kge Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased T cell proliferation	J:109547
Chd4^tm1.2Kge/Chd4^tm1.2Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased T cell proliferation	J:109547
Chd7^Flo/Chd7⁺ (involves: C3HeB/FeJ)	keratoconjunctivitis sicca	J:104123
Chd7^Looper/Chd7⁺ (BALB/c-Chd7^Looper)	blepharitis	J:252089
Chd7^Looper/Chd7⁺ (BALB/c-Chd7^Looper)	conjunctivitis	J:252089
Chd7^Ome/Chd7⁺ (involves: BALB/cByJ * C57BL/6J)	increased susceptibility to otitis media	J:187200
Chd7^Trooper/Chd7⁺ (BALB/c-Chd7^Trooper)	blepharitis	J:262283
Chd7^Trooper/Chd7⁺ (BALB/c-Chd7^Trooper)	conjunctivitis	J:262283
Chd7^Whi/Chd7⁺ (involves: C3HeB/FeJ)	keratoconjunctivitis sicca	J:104123
Chi3l1^tm1Eli/Chi3l1^tm1Eli (B6.Cg-Chi3l1^tm1Eli)	abnormal dendritic cell physiology	J:148490
	abnormal plasmacytoid dendritic cell physiology	J:148490
	abnormal T-helper 2 physiology	J:148490
	decreased IgE level	J:148490
	decreased interleukin-4 secretion	J:148490
	decreased interleukin-13 secretion	J:148490
	decreased splenocyte proliferation	J:148490
	impaired eosinophil recruitment	J:148490
	impaired neutrophil recruitment	J:148490
	increased T cell apoptosis	J:148490
Chi3l1^tm1Eli/Chi3l1^tm1Eli Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * CBA)	abnormal T-helper 2 physiology	J:148490
Chia1^tm1.1Lof/Chia1^tm1.1Lof (C57BL/6-Chia1^tm1.1Lof)	decreased interleukin-13 secretion	J:257728
Chit1^tm1Eli/Chit1^tm1Eli (involves: C57BL/6)	decreased susceptibility to bacterial infection	J:189872
Chit1^tm1Eli/Chit1^tm1Eli Tg(Scgb1a1-Il13)2Eli/0 (involves: C57BL/6 * CBA)	decreased susceptibility to bacterial infection	J:189872
Chit1^tm1Eli/Chit1^tm1Eli Tg(Scgb1a1-rtTA,tetO-CHIT1)#Eli/0 (involves: C57BL/6)	decreased susceptibility to bacterial infection	J:189872
Chrm1^tm1Jwe/Chrm1^tm1Jwe (involves: 129S6/SvEvTac * CF-1)	decreased cytotoxic T cell cytolysis	J:106393
Chrna3^tm1Bay/Chrna3^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	increased susceptibility to bacterial infection	J:54994
	urinary bladder inflammation	J:54994
Chrna4^tm1Jpc/Chrna4^tm1Jpc (involves: C57BL/6)	decreased IgG level	J:103908
	decreased immunoglobulin level	J:103908
	increased IgG level	J:103908
Chrna7^tm1Bay/Chrna7^tm1Bay (B6.Cg-Chrna7^tm1Bay)	abnormal interleukin level	J:89610
Chrna7^tm1Bay/Chrna7^tm1Bay (B6.Cg-Chrna7^tm1Bay)	abnormal tumor necrosis factor level	J:89610
Chrna7^tm1Bay/Chrna7^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	decreased IgG level	J:103908
	decreased immunoglobulin level	J:103908
Chrnb2^tm1Jpc/Chrnb2^tm1Jpc (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:103908
	abnormal immunoglobulin level	J:103908
	decreased immunoglobulin level	J:103908
	increased B cell proliferation	J:103908
	increased IgG level	J:103908
Chrnb2^tm1Mdb/Chrnb2^tm1Mdb Chrnb4^tm1Mdb/Chrnb4^tm1Mdb (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to bacterial infection	J:73590
	urinary bladder inflammation	J:73590
Chst1^{tm1(KOMP)Vlcg}/Chst1^{tm1(KOMP)Vlcg} Chst2^tm1Tmu/Chst2^tm1Tmu Chst4^tm1Sdr/Chst4^tm1Sdr (involves: 129S2/SvPas * C57BL/6NTac)	abnormal leukocyte migration	J:204813
Chst2^tm1Tmu/Chst2^tm1Tmu (involves: 129S2/SvPas * C57BL/6J)	abnormal leukocyte migration	J:92231
	abnormal leukocyte physiology	J:92231
Chst2^tm1Tmu/Chst2^tm1Tmu Chst4^tm1Sdr/Chst4^tm1Sdr (involves: 129S2/SvPas)	abnormal leukocyte migration	J:204813
Chst3^tm1Tmu/Chst3^tm1Tmu (involves: 129S2/SvPas)	increased T cell proliferation	J:217719
Chst4^tm1Mifu/Chst4^tm1Mifu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:113195
	impaired leukocyte tethering or rolling	J:113195
Chst4^tm1Mifu/Chst4^tm1Mifu Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:113195
	impaired leukocyte tethering or rolling	J:113195
Chst4^tm1Sdr/Chst4^tm1Sdr (involves: C57BL/6)	abnormal leukocyte adhesion	J:86759
Chst4^tm1Sdr/Chst4^tm1Sdr (involves: C57BL/6)	abnormal leukocyte migration	J:86759
Chst11^{tm1a(KOMP)Wtsi}/Chst11^{tm1a(KOMP)Wtsi} (C57BL/6N-Chst11^{tm1a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Chsy1^skt/Chsy1^skt Pde6b⁺/Pde6b⁺ (mixed)	kidney inflammation	J:286529
Chsy1^tm1Lex/Chsy1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	arthritis	J:171883
Chuk^tm1Lex/Chuk^tm1Lex Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEvBrd)	impaired macrophage chemotaxis	J:159873
	impaired neutrophil chemotaxis	J:159873
	impaired neutrophil recruitment	J:159873
Chuk^tm1Mka/Chuk^tm1Mka (B6.129-Chuk^tm1Mka)	abnormal B cell physiology	J:113556
Chuk^tm1Mpa/Chuk^tm1Mpa Ikbkb^tm2Cgn/Ikbkb^tm2Cgn Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	increased susceptibility to endotoxin shock	J:137861
Chuk^tm2Mka/Chuk^tm2Mka (B6.Cg-Chuk^tm2Mka)	abnormal B cell physiology	J:113556
Chuk^tm2Mka/Chuk^tm2Mka Tg(Tnfsf13b)1Fma/? (B6.Cg-Chuk^tm2Mka Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	increased anti-double stranded DNA antibody level	J:113556
Chuk^tm2Yhu/Chuk^tm2Yhu (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	skin inflammation	J:197037
Chuk^tm2Yhu/Chuk^tm2Yhu Tg(Lor-CHUK)8Yhu/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	lung inflammation	J:197037
Cia2^DBA/1J/Cia2^DBA/1J (involves: DBA/1J * SWR/J)	abnormal immune system physiology	J:53356
Cia2^DBA/1J/Cia2^DBA/1J (involves: DBA/1J * FVB/N)	increased susceptibility to induced arthritis	J:116665
Cia2^DBA/1J/Cia2^SWR/J (involves: DBA/1J * SWR/J)	abnormal immune system physiology	J:53356
Cia5^C57BL/10/Cia5^C57BL/10 (involves: B10.RIII * RIIIS/J)	abnormal inflammatory response	J:50472
Cia5b^RIIIS/J/? (involves: C57BL/10 * RIIIS/J)	decreased susceptibility to induced arthritis	J:101767
Cia5b^RIIIS/J/Cia5b^RIIIS/J Cia32^B10.RIII/Cia32^RIIIS/J (involves: C57BL/10 * RIIIS/J)	decreased susceptibility to induced arthritis	J:101767
Cia5c^RIIIS/J/? (involves: C57BL/10 * RIIIS/J)	decreased susceptibility to induced arthritis	J:101767
Cia6^C57BL/10SnSg/Cia6^C57BL/10SnSg (involves: B10.Q * DBA/1)	abnormal inflammatory response	J:57012
Cia6^C57BL/10SnSg/Cia6^DBA/1J (involves: B10.Q * DBA/1)	abnormal inflammatory response	J:57012
Cia6^DBA/1J/Cia6^DBA/1J (involves: B10.Q * DBA/1)	decreased inflammatory response	J:57012
Cia7^DBA/1J/Cia7^C57BL/10SnSg (involves: B10.Q * DBA/1)	increased inflammatory response	J:57012
Cia7^DBA/1J/Cia7^DBA/1J (involves: B10.Q * DBA/1)	increased inflammatory response	J:57012
Cia7^DBA/1J/Cia7^DBA/1J (involves: B10.Q * DBA/1)	increased susceptibility to induced arthritis	J:122130
Cia8^DBA/1J/Cia8^DBA/1J (involves: B10.Q * DBA/1)	increased inflammatory response	J:57012
Cia9^C57BL/10SnSg/Cia9^NOD/ShiLtJ (involves: B10.D1-H2^q/SgJ * NOD.C3-H2^q/Rhd)	increased inflammatory response	J:69981
Cia9^NOD/ShiLtJ/Cia9^NOD/ShiLtJ (involves: B10.D1-H2^q/SgJ * NOD.C3-H2^q/Rhd)	abnormal immune system physiology	J:69981
Cia10^C57BL/10/Cia10^C57BL/10 (involves: C57BL/10 * RIIIS/J)	abnormal inflammatory response	J:50472
Cia10^C57BL/10/Cia10^C57BL/10 Cia5^C57BL/10/Cia5^C57BL/10 (involves: C57BL/10 * RIIIS/J)	abnormal inflammatory response	J:50472
Cia23^C57BL/10SnSg/Cia23^C57BL/10SnSg (involves: B10.D1-H2^q/SgJ * NOD.C3-H2^q/Rhd)	abnormal inflammatory response	J:69981
Cia23^C57BL/10SnSg/Cia23^NOD/ShiLtJ (involves: B10.D1-H2^q/SgJ * NOD.C3-H2^q/Rhd)	abnormal inflammatory response	J:69981
Cia23^C57BL/10SnSg/Cia23^NOD/ShiLtJ Cia9^C57BL/10SnSg/Cia9^C57BL/10SnSg (involves: B10.D1-H2^q/SgJ * NOD.C3-H2^q/Rhd)	decreased inflammatory response	J:69981
Cia26^RIIIS/J/Cia26^RIIIS/J Cia30^B10.RIII/? (involves: B10.RIII * RIIIS/J)	arthritis	J:95848
Cia27^DBA/1J/? (involves: DBA/1J * FVB/N)	increased IgG level	J:116665, J:94347
Cia30^RIIIS/J/Cia30^RIIIS/J Cia5^B10.RIII/Cia5^B10.RIII (involves: B10.RIII * RIIIS/J)	decreased susceptibility to induced arthritis	J:95848
Cia31^B10.RIII/Cia31^RIIIS/J Cia5^B10.RIII/Cia5^B10.RIII (involves: B10.RIII * RIIIS/J)	arthritis	J:95848
Cia31^B10.RIII/Cia31^RIIIS/J Cia5^RIIIS/J/Cia5^RIIIS/J (involves: C57BL/10 * RIIIS/J)	decreased susceptibility to induced arthritis	J:101767
Cia32^B10.RIII/Cia32^RIIIS/J Cia5^B10.RIII/Cia5^B10.RIII (involves: B10.RIII * RIIIS/J)	arthritis	J:95848
Cia34^DBA/1J/Cia34^DBA/1J (involves: C57BL/10 * DBA/1J)	decreased autoantibody level	J:122130
Cia34^DBA/1J/Cia34^DBA/1J (involves: C57BL/10 * DBA/1J)	decreased susceptibility to induced arthritis	J:122130
Cia35^C57BL/10SnSg/Cia35^C57BL/10SnSg Cia42^DBA/1J/Cia42^DBA/1J (involves: B10.Q * DBA/1)	decreased susceptibility to induced arthritis	J:122130
Cia35^C57BL/10SnSg/Cia35^DBA/1J (involves: C57BL/10 * DBA/1J)	increased autoantibody level	J:122130
	increased susceptibility to induced arthritis	J:122130
Cia35^C57BL/10SnSg/Cia35^DBA/1J Cia42^DBA/1J/Cia42^DBA/1J (involves: B10.Q * DBA/1)	decreased susceptibility to induced arthritis	J:122130
Cia35^DBA/1J/Cia35^DBA/1J Cia42^DBA/1J/Cia42^DBA/1J (involves: B10.Q * DBA/1)	decreased susceptibility to induced arthritis	J:122130
Cia36^DBA/1J/Cia36^DBA/1J (involves: C57BL/10 * DBA/1J)	decreased autoantibody level	J:122130
Cia36^DBA/1J/Cia36^DBA/1J (involves: C57BL/10 * DBA/1J)	decreased susceptibility to induced arthritis	J:122130
Cia37^C57BL/10SnSg/Cia37^DBA/1J (involves: C57BL/10 * DBA/1J)	increased autoantibody level	J:122130
	increased susceptibility to induced arthritis	J:122130
Cia38^DBA/1J/Cia38^DBA/1J (involves: C57BL/10 * DBA/1J)	increased autoantibody level	J:122130
Cia38^DBA/1J/Cia38^DBA/1J (involves: C57BL/10 * DBA/1J)	increased susceptibility to induced arthritis	J:122130
Cia39^C57BL/10Sn/Cia39^C57BL/10Sn (involves: B10.Q/Lund-H2^q * B10.RIII/Lund-H2^r)	decreased susceptibility to induced arthritis	J:97801
Cia39^RIII/WySn/Cia39^RIII/WySn (involves: B10.Q/Lund-H2^q * B10.RIII/Lund-H2^r)	arthritis	J:97801
Cia40^C57BL/10SnSg/Cia40^C57BL/10SnSg (involves: C57BL/10SnSg * DBA/1J * NFS/N)	increased susceptibility to induced arthritis	J:106522
Cia43^DBA/1J/Cia43^FVB/N (involves: DBA/1J * FVB/N)	increased susceptibility to induced arthritis	J:146242
Cia43^FVB/N/Cia43^FVB/N (involves: DBA/1J * FVB/N)	increased susceptibility to induced arthritis	J:146242
Ciaaq1^DBA/1J/Ciaaq1^DBA/1J (involves: DBA/1J * FVB/NJ)	increased autoantibody level	J:122919
Ciaaq1^DBA/1J/Ciaaq1^FVB/NJ (involves: DBA/1J * FVB/NJ)	increased autoantibody level	J:122919
Cigs2^tm1.1Anse/Cigs2⁺ Il4^tm1(CD2)Mmrs/Il4⁺ (involves: 129 * BALB/cJ * C57BL/6)	decreased IgE level	J:181313
	decreased IgG1 level	J:181313
	decreased interleukin-4 secretion	J:181313
Cigs2^tm1.1Anse/Cigs2^tm1.1Anse (involves: BALB/cJ * C57BL/6)	abnormal class switch recombination	J:181313
	abnormal humoral immune response	J:181313
	abnormal susceptibility to infection	J:181313
	decreased IgE level	J:181313
	decreased IgG1 level	J:181313
	decreased interleukin-4 secretion	J:181313
	decreased interleukin-13 secretion	J:181313
	increased IgG2b level	J:181313
Cigs2^tm1.1Kubo/Cigs2^tm1.1Kubo (B6.Cg-Cigs2^tm1.1Kubo)	abnormal interleukin secretion	J:129048
	abnormal mast cell physiology	J:129048
	abnormal neutrophil physiology	J:129048
	decreased interleukin-4 secretion	J:167446, J:129048
	decreased interleukin-13 secretion	J:129048
Ciita^m1Btlr/Ciita^m1Btlr (C57BL/6J-Ciita^m1Btlr)	impaired humoral immune response	J:221483
Ciita^tm1.1Dim/Ciita^tm1.1Dim (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal level of surface class II molecules	J:51885
Ciita^tm1Adm/Ciita⁺ (involves: 129S1/Sv * C57BL/6)	abnormal immune system physiology	J:117111
Ciita^tm1Adm/Ciita^tm1Adm (involves: 129S1/Sv * C57BL/6)	abnormal immune system physiology	J:117111
Ciita^tm1Ccum/Ciita^tm1Ccum (involves: 129S2/SvPas * C57BL/6J)	abnormal B cell physiology	J:96421
	abnormal CD4-positive, alpha-beta T cell physiology	J:31601
	abnormal cytokine secretion	J:64283
	abnormal dendritic cell physiology	J:96421
	abnormal level of surface class II molecules	J:31601, J:96421
	abnormal lymphocyte physiology	J:96421
	abnormal MHC II cell surface expression on macrophages	J:31601
	abnormal susceptibility to infection	J:64283
	abnormal T cell physiology	J:31601
	decreased susceptibility to parasitic infection	J:64283
	decreased T cell proliferation	J:31601
	increased susceptibility to parasitic infection	J:64283
Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.129S2(B6)-Ciita^tm1Ccum)	abnormal inflammatory response	J:106081
	abnormal level of surface class II molecules	J:106081
	decreased susceptibility to autoimmune diabetes	J:107051
	insulitis	J:107051
	pancreas inflammation	J:106081
	periinsulitis	J:106081
Ciita^tm1Ccum/Ciita^tm1Ccum (involves: 129S2/SvPas * C57BL/6)	abnormal level of surface class II molecules	J:67941
Ciita^tm1Jpyt/Ciita^tm1Jpyt (involves: 129P2/OlaHsd * C57BL/6J)	decreased IgG level	J:57100
	increased IgM level	J:57100
Ciita^tm1Jpyt/Ciita^tm1Jpyt (B6.129P2-Ciita^tm1Jpyt)	abnormal T-helper 1 physiology	J:125654
Ciita^tm1Jpyt/Ciita^tm1Jpyt (B6.129P2-Ciita^tm1Jpyt)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:125654
Ciita^tm2Wrth/Ciita^tm2Wrth (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:92170
Cimap2^Retro/Cimap2⁺ (involves: C57BL/6J)	increased cytotoxic T cell cytolysis	J:223336
Cimap2^Retro/Cimap2^Retro (involves: C57BL/6J)	increased cytotoxic T cell cytolysis	J:223336
	increased interferon-gamma secretion	J:223336
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:223336
	increased T cell proliferation	J:223336
Cimap2^{tm1a(KOMP)Wtsi}/Cimap2⁺ (involves: C57BL/6)	decreased cytotoxic T cell cytolysis	J:223336
Cinda1^BALB/c/? (involves: BALB/c * CcS-4/Dem)	increased T cell proliferation	J:40728
Cinda2^STS/A/? (involves: BALB/c * CcS-4/Dem)	increased T cell proliferation	J:40728
Cinda3^O20/A/Cinda3^O20/A (involves: O20/A * OcB-9/Dem)	decreased T cell proliferation	J:95917
Cinda3^OcB9/Dem/Cinda3^O20/A (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda4^OcB9/Dem/Cinda4^O20/A (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda4^OcB9/Dem/Cinda4^OcB9/Dem (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda5^OcB9/Dem/Cinda5^O20/A (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cinda5^OcB9/Dem/Cinda5^OcB9/Dem (involves: O20/A * OcB-9/Dem)	increased T cell proliferation	J:95917
Cish^tm1.1Cdon/Cish^tm1.1Cdon Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)	increased interleukin-4 secretion	J:204829
	increased interleukin-5 secretion	J:204829
	increased interleukin-10 secretion	J:204829
	increased interleukin-13 secretion	J:204829
	increased susceptibility to type I hypersensitivity reaction	J:204829
Cish^tm1.2Cdon/Cish^tm1.2Cdon (B6.129S6(Cg)-Cish^tm1.2Cdon)	abnormal immune system physiology	J:204829
	increased interleukin-4 secretion	J:204829
	increased interleukin-5 secretion	J:204829
	increased interleukin-9 secretion	J:204829
	increased interleukin-13 secretion	J:204829
	increased susceptibility to type I hypersensitivity reaction	J:204829
	increased T cell proliferation	J:204829
	lung inflammation	J:204829
Cks1b^tm1Sir/Cks1b^tm1Sir Tg(IghMyc)22Bri/? (involves: C57BL * C57BL/6 * SJL)	decreased B cell proliferation	J:121564
Clca1^tm1.1Lex/Clca1^tm1.1Lex (involves: 129S/SvEvBrd)	abnormal chemokine level	J:125158
	increased inflammatory response	J:125158
	lung inflammation	J:125158
Clca1^tm1Dgen/Clca1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal inflammatory response	J:112942
Clcn2^tm1Tjj/Clcn2^tm1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal microglial cell physiology	J:122365
Clcn3^tm1Lamb/Clcn3^tm1Lamb (involves: 129S1/Sv * 129X1/SvJ)	abnormal neutrophil physiology	J:112692
	impaired neutrophil phagocytosis	J:112692
	sepsis	J:112692
Clcn3^tm1Tjj/Clcn3^tm1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal microglial cell physiology	J:77635
Clcn7^tm1.1Teti/Clcn7⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal osteoclast physiology	J:203761
Clcn7^tm1Tjj/Clcn7^tm1Tjj (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:67273
Clcn7^tm2Tjj/Clcn7^tm2Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:67273
Clcn7^tm4.1Tjj/Clcn7^tm4.1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:160702
Clcnka^m1Btlr/Clcnka^m1Btlr (C57BL/6J-Clcnka^m1Btlr)	increased susceptibility to induced colitis	J:271974
Clec1a^tm1Yiw/Clec1a^tm1Yiw (involves: C57BL/6J * C57BL/6NSlc)	abnormal dendritic cell antigen presentation	J:329240
	decreased CD8-positive, alpha-beta memory T cell proliferation	J:329240
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:329240
Clec1b^tm1.1Ksi/Clec1b^tm1.1Ksi (involves: C57BL/6)	abnormal lymphatic system physiology	J:165898
Clec1b^tm2Mlkn/Clec1b^tm2Mlkn Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6 * SJL)	lymph node hemorrhage	J:205423
Clec2h^tm1.1Apma/Clec2h^tm1.1Apma (B6(Cg)-Clec2h^tm1.1Apma)	kidney inflammation	J:322835
Clec2h^tm1.1Apma/Clec2h^tm1.1Apma Rag1^tm1Mom/Rag1^tm1Mom (B6.Cg-Rag1^tm1Mom Clec2h^tm1.1Apma)	kidney inflammation	J:322835
Clec4a2^tm1.1Cfg/Clec4a2^tm1.1Cfg (involves: C57BL/6)	increased B cell proliferation	J:217719
	increased IgG2a level	J:217719
	increased IgG2b level	J:217719
	increased IgG3 level	J:217719
	increased inflammatory response	J:217719
Clec4a2^tm1Yiw/Clec4a2^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating interleukin level	J:217720
	abnormal immune system physiology	J:217720
	enthesitis	J:217720
	increased anti-nuclear antigen antibody level	J:217720
	increased autoantibody level	J:217720
	increased circulating interleukin-4 level	J:217720
	increased circulating interleukin-10 level	J:217720
	increased circulating interleukin-17 level	J:217720
	increased circulating interleukin-23 level	J:217720
	increased IgG1 level	J:217720
	increased IgG3 level	J:217720
	increased IgG level	J:217720
	increased inflammatory response	J:217720
	increased susceptibility to induced arthritis	J:217720
	joint inflammation	J:217720
	salivary gland inflammation	J:217720
Clec4b1^em#Tsak/Clec4b1^em#Tsak (involves: C57BL/6N)	abnormal adaptive immunity	J:258645
	abnormal cytokine level	J:258645
	abnormal cytokine secretion	J:258645
	decreased interferon-gamma secretion	J:258645
	decreased interleukin-12 secretion	J:258645
	increased susceptibility to bacterial infection	J:258645
Clec4d^tm1.1Cfg/Clec4d^tm1.1Cfg (involves: C57BL/6)	decreased B cell proliferation	J:217719
	decreased T cell proliferation	J:217719
	increased interferon-gamma secretion	J:203221
	increased interleukin-6 secretion	J:203221
	increased interleukin-10 secretion	J:203221
	increased interleukin-17 secretion	J:203221
	increased susceptibility to bacterial infection	J:203221
	increased susceptibility to bacterial infection induced morbidity/mortality	J:203221
	increased tumor necrosis factor secretion	J:203221
	lung inflammation	J:203221
Clec4d^tm1.1Shoy/Clec4d^tm1.1Shoy (involves: 129P2/OlaHsd * C57BL/6)	abnormal antigen presentation	J:203159
	abnormal chemokine secretion	J:203159
	abnormal immune serum protein physiology	J:203159
	abnormal immune system physiology	J:203159
	abnormal interferon-gamma secretion	J:203159
	abnormal interleukin-17 secretion	J:203159
	abnormal response to infection	J:203159
	decreased circulating interleukin-17 level	J:203159
	decreased IgG level	J:203159
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:203159
	decreased susceptibility to type IV hypersensitivity reaction	J:203159
	decreased tumor necrosis factor secretion	J:203159
	granulomatous inflammation	J:203159
	lung inflammation	J:203159
Clec4e^tm1.1Cfg/Clec4e^tm1.1Cfg (B6.Cg-Clec4e^tm1.1Cfg)	abnormal macrophage physiology	J:136334
	decreased tumor necrosis factor secretion	J:136334
	increased susceptibility to fungal infection	J:136334
Clec4e^tm1Tks/Clec4e^tm1Tks (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal chemokine secretion	J:172959
	decreased interleukin-6 secretion	J:172959
	decreased interleukin-10 secretion	J:172959
	decreased susceptibility to fungal infection	J:172959
	decreased tumor necrosis factor secretion	J:172959
Clec4e^tm1Tks/Clec4e^tm1Tks (involves: 129S1/Sv * 129X1/SvJ)	abnormal chemokine secretion	J:203159
	abnormal immune serum protein physiology	J:203159
	abnormal interferon-gamma secretion	J:203159
	abnormal interleukin-17 secretion	J:203159
	abnormal response to infection	J:203159
	decreased circulating interleukin-17 level	J:203159
	decreased IgG level	J:203159
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:203159
	decreased susceptibility to type IV hypersensitivity reaction	J:203159
	decreased tumor necrosis factor secretion	J:203159
Clec4f^tm1Ymed/Clec4f^tm1Ymed (B6.129S7-Clec4f^tm1Ymed)	abnormal macrophage cytokine production	J:203199
Clec4f^tm1Ymed/Clec4f^tm1Ymed (B6.129S7-Clec4f^tm1Ymed)	decreased interferon-gamma secretion	J:203199
Clec4g^tm1.1Fhe/Clec4g^tm1.1Fhe (B6.129-Clec4g^tm1.1Fhe)	abnormal immune system physiology	J:200968
	decreased susceptibility to Adenoviridae infection	J:194891
	liver inflammation	J:200968
Clec4n^tm1.2Mgne/Clec4n^tm1.2Mgne (involves: C57BL/6 * C57BL/6J)	abnormal chemokine secretion	J:209284
	abnormal interferon secretion	J:209284
	abnormal interleukin secretion	J:209284
	abnormal macrophage physiology	J:209284
	abnormal neutrophil physiology	J:209284
	abnormal susceptibility to fungal infection	J:209284
	abnormal tumor necrosis factor secretion	J:209284
	decreased interferon-gamma secretion	J:209284
	decreased interleukin-17 secretion	J:209284
	decreased tumor necrosis factor secretion	J:209284
	impaired macrophage phagocytosis	J:209284
	impaired neutrophil phagocytosis	J:209284
	increased interferon-gamma secretion	J:209284
	increased interleukin-1 alpha secretion	J:209284
	increased interleukin-1 beta secretion	J:209284
	increased interleukin-6 secretion	J:209284
	increased interleukin-17 secretion	J:209284
	increased susceptibility to fungal infection	J:209284
	increased tumor necrosis factor secretion	J:209284
Clec4n^tm1Yiw/Clec4n^tm1Yiw (B6.129P2-Clec4n^tm1Yiw)	decreased interferon-gamma secretion	J:160680
	decreased interleukin-6 secretion	J:160680
	decreased interleukin-10 secretion	J:160680
	decreased interleukin-12b secretion	J:160680
	decreased interleukin-17 secretion	J:160680
	decreased interleukin-23 secretion	J:160680
	decreased tumor necrosis factor secretion	J:160680
	increased susceptibility to infection induced morbidity/mortality	J:160680
Clec4n^tm1Yiw/Clec4n^tm1Yiw (involves: 129P2/OlaHsd)	increased susceptibility to fungal infection	J:209284
Clec5a^tm1Cua/Clec5a^tm1Cua (involves: C57BL/6)	decreased susceptibility to induced arthritis	J:158811
Clec7a^tm1.1Bpip/Clec7a^tm1.1Bpip Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:203908
	decreased tumor necrosis factor secretion	J:203908
	impaired macrophage phagocytosis	J:203908
	increased susceptibility to fungal infection	J:203908
Clec7a^tm1Gdb/Clec7a^tm1Gdb (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytokine secretion	J:116669
	abnormal inflammatory response	J:116669
	abnormal macrophage physiology	J:116669
	abnormal neutrophil physiology	J:116669
	increased susceptibility to fungal infection	J:116669
Clec7a^tm1Gdb/Clec7a^tm1Gdb (B6.129S6-Clec7a^tm1Gdb)	abnormal circulating interleukin level	J:179011
	decreased circulating interleukin-17 level	J:179011
	increased susceptibility to fungal infection	J:179011
	lung inflammation	J:179011
Clec7a^tm1Yiw/Clec7a^tm1Yiw (C.129P2-Clec7a^tm1Yiw)	abnormal cytokine secretion	J:116670
	abnormal dendritic cell physiology	J:116670
	abnormal macrophage physiology	J:116670
	increased susceptibility to fungal infection	J:116670
Clec7a^tm1Yiw/Clec7a^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6)	abnormal dendritic cell physiology	J:122394
Clec7a^tm1Yiw/Clec7a^tm1Yiw Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)	abnormal cytokine secretion	J:116670
	abnormal dendritic cell physiology	J:116670
Clec9a^tm1.1Crs/Clec9a^tm1.1Crs (C57BL/6-Clec9a^tm1.1Crs)	abnormal dendritic cell antigen presentation	J:178441
Clec9a^tm1.1Kens/Clec9a^tm1.1Kens (involves: C57BL/6)	abnormal humoral immune response	J:181366
Clec9a^tm1Crs/Clec9a^tm1Crs (involves: 129S6/SvEvTac * C57BL/6)	abnormal dendritic cell antigen presentation	J:147472
Clec10a^m1/Clec10a^m1 (NC/Nga)	dermatitis	J:283174
Clec10a^tm1Hed/Clec10a^tm1Hed (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	dermatitis	J:283174
Clec12a^tm1Gdb/Clec12a^tm1Gdb (involves: C57BL/6)	increased susceptibility to bacterial infection	J:224869
Clec12a^tm1Gdb/Clec12a^tm1Gdb (involves: C57BL/6)	increased susceptibility to bacterial infection induced morbidity/mortality	J:224869
Clec12a^tm1Jrld/Clec12a^tm1Jrld (B6J.129-Clec12a^tm1Jrld)	abnormal chemokine secretion	J:210326
	abnormal neutrophil physiology	J:210326
	increased inflammatory response	J:210326
	increased tumor necrosis factor secretion	J:210326
Clic4^tm1.1Aidi/Clic4^tm1.1Aidi (involves: C57BL/6 * C57BL/6J)	abnormal chemokine secretion	J:175404
	decreased circulating interleukin-6 level	J:175404
	decreased circulating tumor necrosis factor level	J:175404
	decreased interleukin-6 secretion	J:175404
	decreased interleukin-12 secretion	J:175404
	decreased susceptibility to endotoxin shock	J:175404
	decreased tumor necrosis factor secretion	J:175404
	increased susceptibility to bacterial infection	J:175404
Clic4^tm1.1Yus/Clic4^tm1.1Yus (involves: 129S4/SvJae * C57BL/6J)	impaired macrophage phagocytosis	J:183611
Cln3^em1Dprc/Cln3^em1Dprc (C57BL/6-Cln3^em1Dprc)	increased microglial cell activation	J:294634
Cln3^tm1Nbm/Cln3^tm1Nbm (involves: 129S6/SvEvTac * C57BL/6J)	abnormal dendritic cell physiology	J:233445
	abnormal macrophage physiology	J:233445
	decreased macrophage cytokine production	J:233445
Clnk^tm1Rygo/Clnk^tm1Rygo (B6.129P2-Clnk^tm1Rygo)	abnormal interferon-gamma secretion	J:131738
	abnormal NK T cell physiology	J:131738
	decreased interleukin-4 secretion	J:131738
	increased natural killer cell mediated cytotoxicity	J:131738
Clnk^tm1Rygo/Clnk^tm1Rygo (involves: 129P2/OlaHsd * BALB/c)	increased interferon-gamma secretion	J:131621
Clnk^tm1Rygo/Clnk^tm1Rygo (involves: 129P2/OlaHsd * BALB/c)	increased natural killer cell mediated cytotoxicity	J:131621
Clnk^tm1Rygo/Clnk^tm1Rygo Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c)	decreased interferon-gamma secretion	J:131621
	impaired natural killer cell mediated cytotoxicity	J:131621
Clnk^tm1Vei/Clnk^tm1Vei (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mast cell physiology	J:91590
	increased natural killer cell mediated cytotoxicity	J:91590
Clpp^{Gt(IST11134F10)Tigm}/Clpp^{Gt(IST11134F10)Tigm} (involves: C57BL/6N)	abnormal T cell activation	J:203140
	dermatitis	J:203140
Clpp^{Gt(IST13563G11)Tigm}/Clpp^{Gt(IST13563G11)Tigm} (involves: C57BL/6N)	abnormal T cell activation	J:203140
	dermatitis	J:203140
Clptm1l^{tm1d(EUCOMM)Wtsi}/Clptm1l⁺ (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)	abnormal class switch recombination	J:265892
Clta^tm1.2Fmb/Clta^tm1.2Fmb (involves: C57BL/6)	abnormal class switch recombination	J:235591
Clu^tm1Jakh/Clu^tm1Jakh (involves: Black Swiss * FVB/N)	heart inflammation	J:65660
Clu^tm1Jakh/Clu^tm1Jakh (involves: Black Swiss * FVB/N)	myocarditis	J:65660
Cma1^tm1Mfg/Cma1^tm1Mfg (either: (involves: 129 * C57BL/6) or (involves: 129 * BALB/c))	abnormal mast cell physiology	J:98963
Cmah^tm1Avrk/Cmah^tm1Avrk Dock2^m1Hsd/Dock2^m1Hsd (B6NHsd.Cg-Dock2^m1Hsd Cmah^tm1Avrk)	abnormal B cell activation	J:144035
Cmah^tm1Avrk/Cmah^tm1Avrk Dock2^m1Hsd/Dock2^m1Hsd Siae^tm1.2Avrk/Siae^tm1.2Avrk (B6NHsd.Cg-Siae^tm1.2Avrk Dock2^m1Hsd Cmah^tm1Avrk)	abnormal B cell activation	J:144035
Cmah^tm1Ykoz/Cmah^tm1Ykoz (B6.129P2-Cmah^tm1Ykoz)	abnormal B cell physiology	J:121365
	abnormal humoral immune response	J:121365
	abnormal interleukin secretion	J:121365
	abnormal T cell physiology	J:121365
	decreased interferon-gamma secretion	J:121365
	increased B cell proliferation	J:121365
	increased IgG1 level	J:121365
Cmas^tm1.1Bwei/Cmas^tm1.1Bwei Tg(NPHS2-cre)295Lbh/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	tubular nephritis	J:286022
Cmcs^CBA/N/? (involves: CBA/N * DBA/2)	abnormal immune system physiology	J:94127
Cmcs^DBA/2/? (involves: CBA/N * DBA/2)	abnormal immune system physiology	J:94127
Cmklr1^tm1Dgen/Cmklr1^tm1Dgen (B6.Cg-Cmklr1^tm1Dgen)	abnormal dendritic cell physiology	J:157190
	abnormal macrophage chemotaxis	J:157190
	abnormal professional antigen presenting cell physiology	J:157190
	increased susceptibility to endotoxin shock	J:157190
	lung inflammation	J:157190
Cmklr1^tm1Drg/Cmklr1^tm1Drg (Not Specified)	impaired macrophage chemotaxis	J:133968
Cmklr1^tm1Drg/Cmklr1^tm1Drg (Not Specified)	impaired neutrophil recruitment	J:133968
Cms1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	decreased susceptibility to fungal infection	J:55132
Cms2^DBA/2J/? (involves: C57BL/6J * DBA/2J)	decreased susceptibility to infection	J:55132
Cmtm4^{tm1d(EUCOMM)Wtsi}/Cmtm4^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased inflammatory response	J:333836
	decreased susceptibility to chemically induced skin inflammation	J:333836
Cmtm7^{tm2a(EUCOMM)Hmgu}/Cmtm7⁺ Rag1^tm1Fwa/Rag1^tm1Fwa (chimera involves: C57BL/6 * C57BL/6N)	abnormal B cell physiology	J:207033
	decreased B cell proliferation	J:207033
	decreased IgG2b level	J:207033
	decreased IgM level	J:207033
Cmtr1^{tm1b(EUCOMM)Hmgu}/Cmtr1^{tm1b(EUCOMM)Hmgu} Emx1^tm1(cre)Krj/Emx1⁺ Tg(Thy1-YFP)HJrs/0 (involves: 129S2/SvPas * C57BL/6J * C57BL/6N * CBA)	abnormal susceptibility to Riboviria infection	J:300305
Cnmd^tm1Ska/Cnmd^tm1Ska (involves: C57BL/6 * CBA)	abnormal osteoclast physiology	J:81137
Cnn2^tm1.2Jin/Cnn2^tm1.2Jin (B6.129X1-Cnn2^tm1.2Jin)	abnormal macrophage chemotaxis	J:141867
Cnn2^tm1.2Jin/Cnn2^tm1.2Jin (B6.129X1-Cnn2^tm1.2Jin)	abnormal macrophage physiology	J:141867
Cnpy3^tm1Kmiy/Cnpy3^tm1Kmiy (involves: C57BL/6)	abnormal lymphocyte physiology	J:128513
	abnormal macrophage physiology	J:128513
	decreased interleukin-6 secretion	J:128513
	decreased tumor necrosis factor secretion	J:128513
Cnr2^tm1Zim/Cnr2^tm1Zim (involves: 129 * C57BL/6)	abnormal macrophage physiology	J:62417
Cntf^tm1Mpin/Cntf^tm1Mpin (B6.129S2-Cntf^tm1Mpin)	increased susceptibility to experimental autoimmune encephalomyelitis	J:126852
Cog6^{tm1a(EUCOMM)Wtsi}/Cog6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cog6^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Col1a1^Aga2/Col1a1⁺ (C3HeB/FeJ-Col1a1^Aga2)	lung inflammation	J:185988
Col1a1^M1Jrt/Col1a1⁺ (involves: C3H/HeJ * C57BL/6J * FVB/NJ)	osteoarthritis	J:216423
Col1a1^M1Jrt/Col1a1⁺ (involves: C57BL/6 * FVB/N)	arthritis	J:228439
Col1a1^{tm1(tetO-Fos)Wag}/Col1a1⁺ Tg(KRT5-rtTA)T2D6Sgkd/0 (involves: 129S4/SvJae * C57BL/6 * FVB/N)	skin inflammation	J:201145
Col1a1^{tm1(tetO-Irf4)Sing}/Col1a1^{tm1(tetO-Irf4)Sing} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ Irf4^tm1Mak/Irf4⁺ (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:203903
Col1a1^{tm1(tetO-Irf4)Sing}/Col1a1^{tm1(tetO-Irf4)Sing} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:203903
Col1a1^{tm1(tetO-Stat1)Biat}/Col1a1^{tm1(tetO-Stat1)Biat} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} Stat1^tm1Dlv/Stat1^tm1Dlv (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	abnormal susceptibility to infection induced morbidity/mortality	J:212694
Col1a1^{tm1(tetO-Yod1)Hpl}/Col1a1^{tm1(tetO-Yod1)Hpl} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:194608
	abnormal professional antigen presenting cell physiology	J:194608
Col1a1^{tm1(tetO-Yod1)Hpl}/Col1a1^{tm1(tetO-Yod1)Hpl} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal professional antigen presenting cell physiology	J:194608
Col1a1^tm1Jae/Col1a1^tm1Jae (involves: 129S4/SvJae * C57BL/6)	abnormal osteoclast physiology	J:53079
Col1a1^{tm3(tetO-Fosl1,-DsRed)Wag}/Col1a1⁺ Tg(Cebpb-tTA)5Bjd/0 (involves: 129S4/SvJae * C57BL/6 * NMRI)	decreased circulating interleukin-6 level	J:210545
	liver inflammation	J:210545
Col2a1^tm1Prc/Col2a1⁺ Col9a1^tm1Jae/Col9a1^tm1Jae (involves: 129/Sv * 129S2/SvPas)	osteoarthritis	J:117910
Col3a1^m1Btlr/Col3a1^m1Btlr (C57BL/6J-Col3a1^m1Btlr)	increased susceptibility to induced colitis	J:271973
Col3a1^Tsk2/Col3a1⁺ (C3H101H-Col3a1^Tsk2/H)	adipose tissue inflammation	J:31216
Col3a1^Tsk2/Col3a1⁺ (C3H101H-Col3a1^Tsk2/H)	skin inflammation	J:31216
Col4a1^tm1.1Ics/Col4a1⁺ (involves: 129S2/SvPas * C57BL/6)	kidney inflammation	J:240798
Col4a1^tm1.1Ics/Col4a1^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	kidney inflammation	J:240798
Col4a2^{em1(IMPC)Wtsi}/Col4a2^{em1(IMPC)Wtsi} (C57BL/6N-Col4a2^{em1(IMPC)Wtsi}/WtsiOulu)	blood in lymph vessels	J:239583
Col4a3^tm1.1Rkl/Col4a3⁺ (involves: C57BL/6)	glomerulonephritis	J:167404
Col4a3^tm1Dec/Col4a3^tm1Dec (involves: 129X1/SvJ * C57BL/6)	glomerulonephritis	J:37963
Col4a3^tm1Dec/Col4a3^tm1Dec (129-Col4a3^tm1Dec/J)	glomerulonephritis	J:158731
Col4a3^tm1Dec/Col4a3^tm1Dec (B6.129X1-Col4a3^tm1Dec)	glomerulonephritis	J:167404
Col4a3^tm1Dec/Col4a3^tm1Dec Itga1^tm1Gdnr/Itga1^tm1Gdnr (involves: 129S4/SvJae * 129X1/SvJ * BALB/c)	tubular nephritis	J:71378
Col4a3^tm1Dec/Col4a3^tm1Dec Sostdc1^tm1Myan/Sostdc1^tm1Myan (involves: 129X1/SvJ)	glomerulonephritis	J:158731
Col4a3^tm1Jhm/Col4a3^tm1Jhm (involves: 129S1/Sv * 129X1/SvJ)	glomerulonephritis	J:37017
Col4a3^tm1Jhm/Col4a3^tm1Jhm Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	glomerulonephritis	J:63137
Col4a4^bwk/Col4a4^bwk (NON;NZO-Col4a4^bwk/J)	kidney inflammation	J:223185
Col4a4^bwk/Col4a4^bwk (NON;NZO-Col4a4^bwk/J)	tubulointerstitial nephritis	J:223185
Col4a4^bwk/Col4a4^bwk (D2.NON(NZO)-Col4a4^bwk/GrsrJ)	kidney inflammation	J:223185
Col4a4^bwk/Col4a4^bwk (129S1.NON(NZO)-Col4a4^bwk/PgnJ)	kidney inflammation	J:223185
Col4a5^tm1Yseg/Y (B6.Cg-Col4a5^tm1Yseg)	tubulointerstitial nephritis	J:102306
Col9a1^tm1Jae/Col9a1^tm1Jae (either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL))	osteoarthritis	J:18628
Col9a1^tm1Jae/Col9a1^tm1Jae (involves: 129S2/SvPas)	osteoarthritis	J:117910
Col10a1^tm1Ksec/Col10a1^tm1Ksec (involves: 129S/SvEv * C57BL/6)	decreased interleukin-2 secretion	J:193886
	decreased interleukin-4 secretion	J:193886
	decreased interleukin-10 secretion	J:193886
	decreased interleukin-17 secretion	J:193886
	increased interleukin-4 secretion	J:193886
Col11a1^cho/Col11a1⁺ (involves: C57BL/6Fr)	osteoarthritis	J:106282
Col13a1^tm1Pih/Col13a1^tm1Pih (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	myositis	J:71939
Col17a1^{tm1.1(COL17A1)Zliu}/Col17a1^{tm1.1(COL17A1)Zliu} (involves: 129P2/OlaHsd * C57BL/6J)	increased mast cell degranulation	J:261781
Col17a1^tm1Shzu/Col17a1^tm1Shzu Tg(KRT14-COL17A1)1Shzu/0 (involves: 129S/SvEv * C57BL/6J * C57BL/6Ncr)	decreased autoantibody level	J:121695
Col17a1^tm1Tiin/Col17a1^tm1Tiin (involves: C57BL/6)	increased autoantibody level	J:220622
	increased IgE level	J:220622
	skin inflammation	J:220622
Colec11^tm1Lex/Colec11^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal complement protein level	J:234934
Colgalt2^tm1.1Hwei/Colgalt2^tm1.1Hwei (involves: C57BL/6J)	increased circulating interleukin-1 beta level	J:310468
	increased circulating interleukin-4 level	J:310468
	increased circulating interleukin-6 level	J:310468
	increased circulating interleukin-9 level	J:310468
	increased T cell apoptosis	J:310468
Commd10^{Tg(Vav1-icre)A2Kio}/0 Map3k7^tm1.1Arte/Map3k7^tm1.1Arte (involves: C57BL/10 * C57BL/6J * C57BL/6NTac * CBA/Ca)	decreased interleukin-6 secretion	J:332172
	decreased interleukin-10 secretion	J:332172
	decreased interleukin-12b secretion	J:332172
	decreased tumor necrosis factor secretion	J:332172
Commd10^{Tg(Vav1-icre)A2Kio}/? Tnfrsf14^tm1.1Kro/Tnfrsf14^tm1.1Kro (involves: C57BL/6NCrl * C57BL/10 * CBA * SJL)	decreased susceptibility to Herpesvirales infection	J:243038
Comp^tm1Mbri/Comp^tm1Mbri (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	osteoarthritis	J:125086
Comt^tm1Kara/Comt^tm1Kara (involves: 129S4/SvJaeSor)	increased interferon-gamma secretion	J:137276
Copa^tm1.1Shum/Copa⁺ (B6(CBA)-Copa^tm1.1Shum)	abnormal T cell activation	J:288425
	bronchiolitis	J:288425
	lung inflammation	J:288425
Copg1^em1Geha/Copg1^em1Geha (involves: C57BL/6)	abnormal B cell physiology	J:345528
	abnormal IgG level	J:345528
	decreased circulating interferon-gamma level	J:345528
	increased susceptibility to bacterial infection induced morbidity/mortality	J:345528
	increased T cell apoptosis	J:345528
Cops5^tm1Rpar/Cops5^tm1Rpar Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	increased T cell apoptosis	J:132114
Cops6^{Gt(RRI087)Byg}/Cops6⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased thymocyte apoptosis	J:172038
Cops8^tm1Nwe/Cops8^tm1.1Nwe Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:126339
	abnormal T cell activation	J:126339
	decreased interleukin-2 secretion	J:126339
	decreased T cell proliferation	J:126339
Cora1^BALB/c/Cora1^BALB/c (involves: BALB/c * STS/A)	abnormal cytokine secretion	J:52119
Cora1^STS/A/Cora1^STS/A (involves: BALB/c * STS/A)	abnormal cytokine secretion	J:52119
Coro1a^koy/Coro1a^koy (C57BL/6-Coro1a^koy)	abnormal T cell physiology	J:141431
Coro1a^{Lmb3-C57BL/6Scr}/Coro1a^{Lmb3-C57BL/6Scr} (MRL.Cg-Coro1a^C57BL/6Scr Fas^lpr)	decreased autoantibody level	J:125557
	decreased susceptibility to systemic lupus erythematosus	J:125557
	glomerulonephritis	J:125557
Coro1a^{Lmb3-MRL/MpScr}/Coro1a^{Lmb3-MRL/MpScr} (B6.MRL-Coro1a^MRL/MpScr Fas^lpr)	increased susceptibility to systemic lupus erythematosus	J:125557
Coro1a^ptcd/Coro1a^ptcd (B6.CTS-Coro1a^ptcd)	abnormal T cell activation	J:141431
	abnormal T cell physiology	J:141431
	increased T cell apoptosis	J:141431
Coro1a^ptcd/Coro1a^tm1Achn (B6.Cg-Coro1a^ptcd Coro1a^tm1Achn)	abnormal T cell activation	J:141431
	abnormal T cell physiology	J:141431
Coro1a^tm1Achn/Coro1a^tm1Achn (involves: 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:111593
Coro1a^tm1Achn/Coro1a^tm1Achn (B6.129X1-Coro1a^tm1Achn)	increased T cell apoptosis	J:141431
Coro1a^tm1Achn/Coro1a^tm1Achn (involves: 129X1/SvJ)	decreased interleukin-6 secretion	J:177785
	decreased tumor necrosis factor secretion	J:177785
	increased mast cell degranulation	J:177785
Coro1a^tm1Achn/Coro1a^tm1Achn Coro1b^tm1.1Nfoe/Coro1b^tm1.1Nfoe (involves: 129X1/SvJ * C57BL/6N)	decreased interleukin-6 secretion	J:177785
	decreased tumor necrosis factor secretion	J:177785
	increased mast cell degranulation	J:177785
	increased susceptibility to type I hypersensitivity reaction	J:177785
Coro1a^tm1Jpie/Coro1a^tm1Jpie (involves: 129 * C57BL/6)	abnormal T cell activation	J:133258
	abnormal thymocyte activation	J:133258
	decreased interleukin-2 secretion	J:133258
	decreased susceptibility to bacterial infection	J:133404
	decreased T cell proliferation	J:133258
	impaired macrophage phagocytosis	J:133404
Coro1c^{tm1a(KOMP)Wtsi}/Coro1c^{tm1a(KOMP)Wtsi} (C57BL/6N-Coro1c^{tm1a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Cox4i2^tm1Hutt/Cox4i2⁺ (B6.129-Cox4i2^tm1Hutt)	lung inflammation	J:187640
Cox4i2^tm1Hutt/Cox4i2^tm1Hutt (B6.129-Cox4i2^tm1Hutt)	lung inflammation	J:187640
Cox10^tm1Ctm/Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn}/? (B6.Cg-Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn})	abnormal chemokine secretion	J:231810
	increased interleukin-1 beta secretion	J:231810
	increased microglial cell activation	J:231810
Cp^tm1Hrs/Cp^tm1Hrs Heph^sla/Y (involves: 129X1/SvJ * C57BL/6)	eye inflammation	J:136925
Cpa1^tm1.1Satom/Cpa1^tm1.1Satom (involves: C57BL/6NCrl * FVB/N)	pancreas inflammation	J:300042
Cpa3^tm3(icre)Hrr/Cpa3⁺ (B6.129P2-Cpa3^tm3(icre)Hrr)	abnormal inflammatory response	J:178942
Cpa3^tm3(icre)Hrr/Cpa3⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	decreased susceptibility to type I hypersensitivity reaction	J:178942
Cpa3^tm3(icre)Hrr/Cpa3⁺ Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	skin inflammation	J:221184
Cpb2^tm1Efp/Cpb2⁺ Plg^tm1Dco/Plg⁺ (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:80114
Cpb2^tm1Efp/Cpb2^tm1Efp Plg^tm1Dco/Plg⁺ (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:80114
Cpb2^tm1Mng/Cpb2^tm1Mng (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal chemokine level	J:107340
	abnormal tumor necrosis factor level	J:107340
Cpb2^tm1Nok/Cpb2^tm1Nok (involves: 129P2/OlaHsd * BALB/c)	impaired complement alternative pathway	J:93733
Cpb2^tm1Nok/Cpb2^tm1Nok (involves: 129P2/OlaHsd * BALB/c)	increased inflammatory response	J:93733
Cpn1^tm1Raw/Cpn1^tm1Raw (B6.129S1-Cpn1^tm1Raw)	abnormal complement pathway	J:148315
Cpn1^tm1Raw/Cpn1^tm1Raw (B6.129S1-Cpn1^tm1Raw)	increased acute inflammation	J:148315
Cpsf6^em1Bcgen/Cpsf6⁺ (Not Specified)	decreased susceptibility to Riboviria infection	J:346988
Cpsf6^em1Bcgen/Cpsf6⁺ (Not Specified)	increased interferon-beta secretion	J:346988
Cpt2^{tm1b(KOMP)Wtsi}/Cpt2^{tm1b(KOMP)Wtsi} (C57BL/6N-Cpt2^{tm1b(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Cr1l^tm1Hmo/Cr1l^tm1Hmo (involves: 129X1/SvJ)	increased inflammatory response	J:59432
Cr2^M1Btlr/Cr2^M1Btlr (C57BL/6J-Cr2^M1Btlr)	decreased IgG level	J:267527
Cr2^M1Btlr/Cr2^M1Btlr (C57BL/6J-Cr2^M1Btlr)	impaired humoral immune response	J:267527
Cr2^tm1.1Jhws/Cr2^tm1.1Jhws (Not Specified)	abnormal germinal center B cell physiology	J:205353
	decreased IgG2b level	J:205353
	decreased IgG2c level	J:205353
	decreased IgG3 level	J:205353
	decreased IgM level	J:205353
	increased susceptibility to bacterial infection induced morbidity/mortality	J:205353
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd * C57BL/6)	abnormal humoral immune response	J:31942, J:69452
	decreased IgG2a level	J:31942
	decreased IgG2b level	J:31942
	decreased IgG3 level	J:31942
	decreased IgG level	J:31942, J:69452
	decreased IgM level	J:69452
	decreased immunoglobulin level	J:69452
	decreased tumor necrosis factor secretion	J:66111
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd * C57BL/6J)	increased anti-double stranded DNA antibody level	J:111811
Cr2^tm1Crr/Cr2^tm1Crr Ggta1^tm1Jbl/Ggta1^tm1Jbl (involves: 129S2/SvPas * 129S7/SvEvBrd)	abnormal humoral immune response	J:113488
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd)	decreased IgG level	J:35112
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd)	decreased IgM level	J:35112
Cr2^tm1Hmo/Cr2^tm1Hmo (B6.129S7-Cr2^tm1Hmo)	increased susceptibility to bacterial infection	J:94855
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell activation	J:151991
	abnormal B cell physiology	J:151991
	abnormal class switch recombination	J:151991
Cr2^tm1Tft/Cr2^tm1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal adaptive immunity	J:95979
	decreased IgG1 level	J:95979
	decreased IgG2b level	J:95979
	decreased IgG3 level	J:95979
	decreased IgG level	J:95979
	decreased IgM level	J:95979
	increased susceptibility to bacterial infection	J:95979
Cr2^{tm2.1(HLA-A)Crr}/Cr2^{tm2.1(HLA-A)Crr} (involves: C57BL/6)	abnormal B cell physiology	J:151991
	abnormal class switch recombination	J:151991
Cr2^{tm2.1(HLA-A)Crr}/Cr2^{tm2.1(HLA-A)Crr} Tg(IghelMD4)4Ccg/? (involves: C57BL/6)	abnormal B cell activation	J:151991
Cr2^tm2.1Jhws/Cr2^tm2.1Jhws (B6.129-Cr2^tm2.1Jhws)	abnormal germinal center B cell physiology	J:205353
	decreased IgG3 level	J:205353
	decreased IgM level	J:205353
	increased IgM level	J:205353
Cracr2a^tm1.1Ygwa/Cracr2a^tm1.1Ygwa Tg(Cd4-cre)1Cwi/0 (B6.Cg-Cracr2a^tm1.1Ygwa Tg(Cd4-cre)1Cwi)	abnormal CD4-positive, alpha-beta T cell physiology	J:259523
	decreased interleukin-2 secretion	J:259523
Creb3l3^tm1.1Sad/Creb3l3^tm1.1Sad (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased acute inflammation	J:140018
	decreased circulating serum amyloid protein level	J:140018
Crebbp^{Gt(U-San)112Imeg}/Crebbp⁺ (involves: C57BL/6 * CBA)	abnormal tumor necrosis factor level	J:75361
Crh^tm1Maj/Crh^tm1Maj (involves: 129S2/SvPas * C57BL/6)	abnormal cell-mediated immunity	J:98419
	abnormal cytokine secretion	J:98419
	abnormal inflammatory response	J:98419
	abnormal professional antigen presenting cell physiology	J:98419
	decreased inflammatory response	J:90690, J:72196
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:98419
	decreased T cell proliferation	J:98419
	increased circulating interleukin-6 level	J:72196
Crim1^{em1(IMPC)Wtsi}/Crim1^{em1(IMPC)Wtsi} (C57BL/6N-Crim1^{em1(IMPC)Wtsi}/WtsiOrl)	blood in lymph vessels	J:239583
Crim1^{Gt(KST264)Byg}/Crim1^{Gt(KST264)Byg} (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	kidney inflammation	J:172334
Crispld2^tm1Lex/Crispld2^tm1Lex (B6;129S5-Crispld2^tm1Lex/Mmucd)	abnormal immune system physiology	J:171883
Crl1^A/WySnJ/Crl1^A/WySnJ (B10.A-H2^a/SgSnJ)	abnormal B cell physiology	J:5442
Crl1^AKR/J/Crl1^AKR/J (involves: AKR/J * DBA/2J)	abnormal B cell physiology	J:5442
Crl1^DBA/2J/Crl1^DBA/2J (involves: AKR/J * DBA/2J)	abnormal B cell physiology	J:5442
Crlf2^tm1Jni/Crlf2^tm1Jni (involves: 129P2/OlaHsd)	respiratory system inflammation	J:187770
Crlf2^tm1Wjl/Crlf2^tm1Wjl (involves: BALB/c)	abnormal cytokine secretion	J:107431
	abnormal T cell proliferation	J:107431
	decreased immunoglobulin level	J:107431
	decreased splenocyte proliferation	J:107431
	lung inflammation	J:107431
Crlf2^tm1Wjl/Crlf2^tm1Wjl (Not Specified)	colitis	J:175844
Crocc^tm1Tili/Crocc^tm1Tili (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	lung inflammation	J:98885
Crot^em1Akw/Crot^em1Akw Ldlr^tm1Her/Ldlr^tm1Her (B6.Cg-Crot^em1Akw Ldlr^tm1Her)	blood vessel inflammation	J:331161
Crp^tm1Hjf/Crp⁺ (C57BL/6-Crp^tm1Hjf)	decreased circulating C-reactive protein level	J:170409
Crp^tm1Hjf/Crp^tm1Hjf (C57BL/6-Crp^tm1Hjf)	decreased circulating C-reactive protein level	J:170409
Crsl/Crsl⁺ (involves: C3HeB/FeJ)	keratoconjunctivitis sicca	J:104123
Crtam^tm1Achn/Crtam^tm1Achn (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:145314
	abnormal interleukin secretion	J:145314
	abnormal T cell activation	J:145314
	abnormal T-helper 1 physiology	J:145314
	decreased interferon-gamma secretion	J:145314
	decreased interleukin-17 secretion	J:145314
	increased susceptibility to bacterial infection	J:145314
	increased T cell proliferation	J:145314
Crtam^tm1Tks/Crtam^tm1Tks (B6.Cg-Crtam^tm1Tks)	abnormal response to infection	J:152770
Crtc1^{tm1a(EUCOMM)Wtsi}/Crtc1⁺ (C57BL/6N-Crtc1^{tm1a(EUCOMM)Wtsi}/Ics)	increased IgG2b level	J:165965
Cry1^tm1Jhjh/Cry1^tm1Jhjh Cry2^tm1Jhjh/Cry2^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell activation	J:159504
	increased circulating interleukin-1 beta level	J:159504
	increased circulating interleukin-6 level	J:159504
	increased circulating tumor necrosis factor level	J:159504
	increased susceptibility to induced arthritis	J:159504
	increased tumor necrosis factor secretion	J:159504
Cry2^tm1Jhjh/Cry2^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:163112
Csf1^op/Csf1^op (B6C3Fe a/a-Csf1^op/J)	abnormal Langerhans cell physiology	J:112594
Csf1^op/Csf1^op (B6C3Fe a/a-Csf1^op/J)	abnormal splenocyte physiology	J:19549
Csf1^op/Csf1^op (B6;C3Fe a/a-Csf1^op/J)	impaired macrophage chemotaxis	J:147697
Csf1^op/Csf1^op Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	interstitial pneumonia	J:19089
	lung inflammation	J:19089
Csf1^op/Csf1^op Galc^twi/Galc^twi (involves: C3HeB/Fe * C57BL/6J * CE/J)	impaired macrophage chemotaxis	J:170081
Csf1^op/Csf1^op Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	increased circulating tumor necrosis factor level	J:117880
	liver inflammation	J:117880
Csf1^{tm1.1(CSF1)Flv}/Csf1^{tm1.1(CSF1)Flv} Csf2/Il3^{tm1.1(CSF2,IL3)Flv}/Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv Tg(SIRPA)1Flv/0 Thpo^{tm1.1(TPO)Flv}/Thpo^{tm1.1(TPO)Flv} (involves: 129S4/SvJae * BALB/cAnNTac)	abnormal response to transplant	J:207289
Csf1^{tm1.1(CSF1)Flv}/Csf1^{tm1.1(CSF1)Flv} Csf2/Il3^{tm1.1(CSF2,IL3)Flv}/Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv Thpo^{tm1.1(TPO)Flv}/Thpo^{tm1.1(TPO)Flv} (involves: 129S4/SvJae * BALB/cAnNTac)	abnormal response to transplant	J:207289
Csf1^{tm1.1(CSF1)Flv}/Csf1^{tm1.1(CSF1)Flv} Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Csf2/Il3^{tm1.1(CSF2,IL3)Flv}/Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Rag2^tm1.1Flv/Rag2^tm1.1Flv Tg(SIRPA)1Flv/0 Thpo^{tm1.1(TPO)Flv}/Thpo^{tm1.1(TPO)Flv} (involves: 129S4/SvJae * BALB/cAnNTac)	abnormal response to transplant	J:207289
Csf1^{tm1.1(CSF1)Flv}/Csf1^{tm1.1(CSF1)Flv} Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Csf2/Il3^{tm1.1(CSF2,IL3)Flv}/Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Rag2^tm1.1Flv/Rag2^tm1.1Flv Thpo^{tm1.1(TPO)Flv}/Thpo^{tm1.1(TPO)Flv} (involves: 129S4/SvJae * BALB/cAnNTac)	abnormal response to transplant	J:207289
Csf1^{tm1.1(CSF1)Flv}/Csf1^{tm1.1(CSF1)Flv} Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv (involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * BALB/cAnNTac)	abnormal immune system physiology	J:177073
Csf1r^tm1Ers/Csf1r^tm1Ers (involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)	abnormal circulating cytokine level	J:73663
Csf1r^tm1Ers/Csf1r^tm1Ers (FVB.129X1-Csf1r^tm1Ers)	abnormal Langerhans cell physiology	J:112594
Csf2/Il3^{tm1.1(CSF2,IL3)Flv}/Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv (involves: 129S4/SvJae * BALB/cAnNCr * BALB/cAnNTac)	abnormal response to transplant	J:168302
Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte physiology	J:86386
	abnormal MHC II cell surface expression on macrophages	J:86386
	impaired macrophage chemotaxis	J:86386
	increased susceptibility to bacterial infection	J:18747, J:53659
	increased susceptibility to fungal infection	J:18747
	increased susceptibility to parasitic infection	J:67766
	lung inflammation	J:18747
Csf2^tm1Dran/Csf2^tm1Dran Ifng^tm1Ts/Ifng^tm1Ts Il3^tm1Glli/Il3^tm1Glli (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	increased IgE level	J:83086
	increased IgG1 level	J:83086
	increased immunoglobulin level	J:83086
	increased inflammatory response	J:83086
Csf2^tm1Dran/Csf2^tm1Dran Il3^tm1Glli/Il3^tm1Glli (B6.129S2-Csf2^tm1Dran Il3^tm1Glli)	abnormal leukocyte physiology	J:83086
	decreased susceptibility to type IV hypersensitivity reaction	J:67404
	glomerulonephritis	J:83086
	increased anti-double stranded DNA antibody level	J:83086
	lung inflammation	J:67404
Csf2^tm1Dran/Csf2^tm1Dran Il3^tm1Glli/Il3^tm1Glli (C.129S2-Csf2^tm1Dran Il3^tm1Glli)	decreased susceptibility to type IV hypersensitivity reaction	J:67404
	lung inflammation	J:67404
Csf2^tm1Mlg/Csf2^tm1Mlg (involves: 129S2/SvPas)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:148120
Csf2ra^em1Szut/Csf2ra^em1Szut (C57BL/6-Csf2ra^em1Szut)	impaired macrophage phagocytosis	J:322934
Csf2ra^em1Szut/Csf2ra^em1Szut (C57BL/6-Csf2ra^em1Szut)	lung inflammation	J:322934
Csf2rb^tm1Cgb/Csf2rb^tm1Cgb (involves: 129S1/Sv * C57BL/6)	lung inflammation	J:29737
Csf2rb^tm1Clsc/Csf2rb^tm1Clsc Csf2rb2^tm1Cgb/Csf2rb2^tm1Cgb (C.129S1-Csf2rb2^tm1Cgb Csf2rb^tm1Clsc)	abnormal dendritic cell physiology	J:130939
	abnormal interleukin secretion	J:130939
	abnormal plasmacytoid dendritic cell physiology	J:130939
	abnormal T cell activation	J:130939
	abnormal T cell physiology	J:130939
	decreased interleukin-4 secretion	J:130939
	decreased interleukin-5 secretion	J:130939
	decreased interleukin-13 secretion	J:130939
	decreased susceptibility to type I hypersensitivity reaction	J:130939
	decreased T cell proliferation	J:130939
	impaired eosinophil recruitment	J:130939
	increased IgG1 level	J:130939
Csf2rb^tm1Mur/Csf2rb^tm1Mur (involves: 129P2/OlaHsd * C57BL/6)	abnormal eosinophil physiology	J:35829
	lung inflammation	J:35829
Csf2rb^tm1Mur/Csf2rb^tm1Mur (involves: 129P2/OlaHsd)	abnormal eosinophil physiology	J:24122
	increased susceptibility to infection	J:24122
	lung inflammation	J:24122
Csf2rb^tm1Mur/Csf2rb^tm1Mur Il3^tm1Tyb/Il3^tm1Tyb (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal eosinophil physiology	J:35829
	lung inflammation	J:35829
Csf3^tm1Ard/Csf3^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:20400
Csf3^tm1Ard/Csf3^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:20400
Csf3^tm1Ard/Csf3^tm1Ard Junb^tm3Wag/Junb^tm3Wag Tg(KRT5-cre)1Tak/0 (involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)	increased susceptibility to systemic lupus erythematosus	J:155575
Csf3r^tm1Link/Csf3r^tm1Link (involves: 129X1/SvJ)	impaired neutrophil chemotaxis	J:79825
Csf3r^tm1Link/Csf3r^tm1Link (B6.129X1-Csf3r^tm1Link)	impaired neutrophil chemotaxis	J:79567
Csf3r^tm2Link/Csf3r^tm2Link (B6.129X1-Csf3r^tm2Link)	abnormal neutrophil physiology	J:79567
Csf3r^{tm4(Epor)Link}/Csf3r^{tm4(Epor)Link} (involves: 129X1/SvJ * C57BL/6)	impaired neutrophil chemotaxis	J:79825
Csf3r^{tm4(Epor)Link}/Csf3r^{tm4(Epor)Link} (B6.129X1-Csf3r^{tm4(Epor)Link})	impaired neutrophil chemotaxis	J:79567
Csgalnact1^tm1.1Migar/Csgalnact1^tm1.1Migar (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	periodontium inflammation	J:269621
Csk^tm1Tara/Csk^tm2Tara Elane^tm1(cre)Roes/Elane⁺ (involves: 129P2/OlaHsd * CB20 * C57BL/6)	abnormal granulocyte physiology	J:89716
	increased acute inflammation	J:89716
	increased susceptibility to bacterial infection	J:89716
Cspg4^tm1Wbst/Cspg4^tm1Wbst (involves: 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:184220
Cstb^tm1Rm/Cstb^tm1Rm (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	increased incidence of corneal inflammation	J:50587
	uveitis	J:50587
Ct55^em1Xdzg/Ct55^em1Xdzg (involves: C57BL/6)	decreased susceptibility to induced colitis	J:280149
Ctc1^tm1.1Schg/Ctc1^tm1.1Schg (involves: 129S7/SvEvBrd * C57BL/6)	decreased splenocyte proliferation	J:184809
ctl/ctl (A/WySnJ-ctl/GrsrJ)	arthritis	J:91389
Ctl1^NZB/BlN/Ctl1^C57BL/10 (involves: C57BL/10 * NZB/BlN)	abnormal T cell physiology	J:6736
Ctla4^tm1All/Ctla4^tm1All (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD)	increased acute inflammation	J:109887
Ctla4^tm1All/Ctla4^tm1All Rag1^tm1Mom/Rag1^tm1Mom Tg(TcrAND)53Hed/0 (involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal T cell activation	J:119845
	increased interleukin-4 secretion	J:119845
	increased T cell proliferation	J:119845
Ctla4^tm1All/Ctla4^tm1All Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD * SJL)	abnormal splenocyte physiology	J:109887
	increased acute inflammation	J:109887
	insulitis	J:109887
Ctla4^tm1All/Ctla4^tm1All Tg(TcrAND)53Hed/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal T cell activation	J:119845
Ctla4^tm1All/Ctla4^tm1All Tg(TcraTcrb)8Rest/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased interferon-gamma secretion	J:140448
Ctla4^tm1Mak/Ctla4^tm1Mak (involves: 129P2/OlaHsd * BALB/c)	increased interferon-gamma secretion	J:140085
	increased interleukin-2 secretion	J:140085
	increased interleukin-4 secretion	J:140085
	increased interleukin-17 secretion	J:140085
Ctla4^tm1Saka/Ctla4^tm1Saka Foxp3^tm1(cre)Saka/Y (involves: BALB/c)	abnormal immunoglobulin level	J:140085
	abnormal regulatory T cell physiology	J:140085
	increased autoantibody level	J:140085
	increased IgE level	J:140085
	increased IgG level	J:140085
	increased inflammatory response	J:140085
	increased interferon-gamma secretion	J:140085
	increased interleukin-2 secretion	J:140085
	increased interleukin-4 secretion	J:140085
	lung inflammation	J:140085
	myocarditis	J:140085
	salivary gland inflammation	J:140085
	stomach inflammation	J:140085
Ctla4^tm1Shr/Ctla4^tm1Shr (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal cytokine secretion	J:30393
	increased T cell proliferation	J:30393
	joint inflammation	J:30393
	lung inflammation	J:30393
	myocarditis	J:30393
	pancreas inflammation	J:30393
	salivary gland inflammation	J:30393
Ctla4^tm1Shr/Ctla4^tm1Shr (B6.129S4-Ctla4^tm1Shr)	abnormal regulatory T cell physiology	J:146644
	abnormal T cell physiology	J:146644
	autoimmune response	J:146644
Ctla4^tm1Shr/Ctla4^tm1Shr Rag2^tm1Fwa/Rag2^tm1Fwa Tg(DO11.10)10Dlo/0 (involves: 129S/Sv * BALB/c * C3H * C57BL/6)	abnormal cytokine secretion	J:110446
	abnormal T cell physiology	J:110446
Ctla4^tm1Shr/Ctla4^tm1Shr Tg(DO11.10)10Dlo/0 (involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)	abnormal T cell physiology	J:57090
	increased T cell proliferation	J:57090
Ctnnb1^{tm1(Nfkbia)Rsu}/Ctnnb1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:71744
	conjunctivitis	J:71744
	increased inflammatory response	J:71744
	increased susceptibility to otitis media	J:71744
	increased susceptibility to parasitic infection	J:71744
	keratoconjunctivitis sicca	J:71744
Ctnnb1^{tm2(Nfkbia)Rsu}/Ctnnb1⁺ Tg(CMV-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal macrophage physiology	J:71744
	increased inflammatory response	J:71744
	increased susceptibility to otitis media	J:71744
	keratoconjunctivitis sicca	J:71744
Ctnnb1^tm2Kem/Ctnnb1⁺ Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:178340
Ctnnb1^tm4Wbm/Ctnnb1^tm4Wbm Tg(Pdx1-cre)6Tuv/0 (involves: 129P2/OlaHsd * FVB/N)	pancreas inflammation	J:119908
Ctrb1^em1Toth/Ctrb1^em1Toth (C57BL/6N-Ctrb1^em1Toth)	increased susceptibility to induced pancreatitis	J:294171, J:294035
Ctrc^m1/Ctrc^m1 (C57BL/6-Ctrc^m1)	increased susceptibility to induced pancreatitis	J:291240
Ctrq1^C3H/HeJ/Ctrq1^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased susceptibility to bacterial infection	J:106111
Ctrq2^C3H/HeJ/Ctrq2^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	decreased susceptibility to bacterial infection	J:106111
Ctrq2^C3H/HeJ/Ctrq2^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	decreased susceptibility to bacterial infection	J:106111
Ctrq3^C3H/HeJ/Ctrq3^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	increased susceptibility to bacterial infection	J:106111
Ctrq3^C3H/HeJ/Ctrq3^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	increased susceptibility to bacterial infection	J:106111
Ctsb^tm1Jde/Ctsb⁺ (NOD.129P2-Ctsb^tm1Jde)	decreased susceptibility to autoimmune diabetes	J:153355
Ctsb^tm1Jde/Ctsb⁺ (NOD.129P2-Ctsb^tm1Jde)	insulitis	J:153355
Ctsb^tm1Jde/Ctsb^tm1Jde (NOD.129P2-Ctsb^tm1Jde)	decreased susceptibility to autoimmune diabetes	J:153355
	insulitis	J:153355
	salivary gland inflammation	J:153355
Ctsc^tm1Ley/Ctsc^tm1Ley (either: 129X1/SvJ-Ctsc^tm1Ley or (involves: 129X1/SvJ * C57BL/6))	abnormal cytotoxic T cell physiology	J:77312
	abnormal T cell physiology	J:77312
Ctsc^tm1Ley/Ctsc^tm1Ley (B6.129X1-Ctsc^tm1Ley)	abnormal chemokine level	J:131520
	abnormal leukocyte migration	J:131520
	abnormal response to infection	J:131520
	decreased circulating interleukin-6 level	J:131520
	impaired neutrophil recruitment	J:131520
	increased circulating interleukin-6 level	J:88160
	sepsis	J:88160
Ctsd^tm1Cptr/Ctsd^tm1Cptr (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))	abnormal antigen presentation	J:47432
Ctse^{C57BL/6JOlaHsd}/Ctse^{C57BL/6JOlaHsd} (involves: 129S2/SvPasHsd * C57BL/6JOlaHsd)	abnormal dendritic cell antigen presentation	J:128538
	abnormal dendritic cell physiology	J:128538
	abnormal immune system physiology	J:128538
Ctse^tm1Kjy/Ctse⁺ (involves: C57BL/6)	increased IgE level	J:108745
Ctse^tm1Kjy/Ctse^tm1Kjy (involves: C57BL/6)	dermatitis	J:108745
	increased circulating interleukin-1 beta level	J:108745
	increased circulating interleukin-18 level	J:108745
	increased IgE level	J:108745
	increased interleukin-4 secretion	J:108745
	increased interleukin-5 secretion	J:108745
Ctsg^tm1.1Roes/Ctsg^tm1.1Roes (involves: 129P2/OlaHsd)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:77597
Ctsg^tm1.1Roes/Ctsg^tm1.1Roes (involves: 129P2/OlaHsd)	increased susceptibility to infection induced morbidity/mortality	J:77597
Ctsg^tm1.1Roes/Ctsg^tm1.1Roes Elane^tm1(cre)Roes/Elane^tm1(cre)Roes (involves: 129P2/OlaHsd)	decreased susceptibility to endotoxin shock	J:77597
	increased susceptibility to fungal infection	J:77597
Ctsk^tm1(cre)Ska/Ctsk⁺ Esr1^tm1Mma/Esr1^tm1Mma (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal osteoclast physiology	J:127179
Ctsk^tm1(cre)Ska/Ctsk⁺ Plekhm1^tm1.1Hzhao/Plekhm1^tm1.1Hzhao (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast physiology	J:236517
Ctsk^tm1(cre)Ska/Ctsk⁺ Snx10^{tm1c(EUCOMM)Raba}/Snx10^{tm1c(EUCOMM)Raba} (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast physiology	J:224711
Ctsk^tm1.1Rbar/Ctsk^tm1.1Rbar Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast physiology	J:194492
Ctsk^tm1Mbs/Ctsk^tm1Mbs (B6.129-Ctsk^tm1Mbs)	abnormal osteoclast physiology	J:128098
Ctsk^tm1Psa/Ctsk^tm1Psa (involves: 129X1/SvJ * C57BL/6J)	abnormal osteoclast physiology	J:50934
Ctsl^nkt/Ctsl^nkt (either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))	dermatitis	J:54856
	increased inflammatory response	J:54856
	liver inflammation	J:54856
	lymph node inflammation	J:54856
Ctsl^nkt/Ctsl^nkt (B6.Cg-Ctsl^nkt)	dermatitis	J:78460
Ctsl^nkt/Ctsl^nkt (C.Cg-Ctsl^nkt)	dermatitis	J:78460
Ctsl^tm1Alpk/Ctsl^tm1Alpk (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:99755
	dermatitis	J:99755
	folliculitis	J:99755
	granulomatous inflammation	J:99755
Ctsl^tm1Alpk/Ctsl^tm1Alpk (B6.129P2-Ctsl^tm1Alpk)	granulomatous inflammation	J:99755
Ctsl^tm1Cptr/Ctsl⁺ (NOD.129P2-Ctsl^tm1Cptr)	decreased susceptibility to autoimmune diabetes	J:153355
Ctsl^tm1Cptr/Ctsl⁺ (NOD.129P2-Ctsl^tm1Cptr)	insulitis	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (NOD.129P2-Ctsl^tm1Cptr)	decreased susceptibility to autoimmune diabetes	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (NOD.129P2-Ctsl^tm1Cptr)	salivary gland inflammation	J:153355
Ctss^m1Btlr/Ctss^m1Btlr (C57BL/6J-Ctss^m1Btlr)	decreased IgG level	J:267491
Ctss^m1Btlr/Ctss^m1Btlr (C57BL/6J-Ctss^m1Btlr)	impaired humoral immune response	J:267491
Ctss^tm1Eae/Ctss⁺ (NOD.D1-Ctss^tm1Eae)	insulitis	J:153355
Ctss^tm1Eae/Ctss^tm1Eae (involves: C57BL/6 * DBA/1LacJ)	abnormal B lymphocyte antigen presentation	J:53399
Ctss^tm1Eae/Ctss^tm1Eae (involves: C57BL/6 * DBA/1LacJ)	decreased susceptibility to induced arthritis	J:53399
Ctss^tm1Eae/Ctss^tm1Eae (NOD.D1-Ctss^tm1Eae)	decreased susceptibility to autoimmune diabetes	J:153355
	insulitis	J:153355
	salivary gland inflammation	J:153355
Ctss^tm1Hap/Ctss^tm1Hap (B6.129S2-Ctss^tm1Hap)	abnormal B cell physiology	J:96401
	abnormal cytokine secretion	J:96401
	abnormal humoral immune response	J:96401
	abnormal interleukin secretion	J:96401
	abnormal professional antigen presenting cell physiology	J:96401
	abnormal T cell physiology	J:96401
	decreased IgG level	J:96401
	decreased IgM level	J:96401
	decreased susceptibility to experimental autoimmune myasthenia gravis	J:96401
Ctss^tm1Hap/Ctss^tm1Hap Ldlr^tm1Her/Ldlr^tm1Her (B6.129S-Ctss^tm1Hap Ldlr^tm1Her)	abnormal leukocyte migration	J:82520
Cttn^tm1.2Dvst/Cttn^tm1.2Dvst (either: B6.Cg-Cttn^tm1.2Dvst or (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2 * SJL))	abnormal cellular extravasation	J:177602
	abnormal leukocyte adhesion	J:177602
	abnormal leukocyte migration	J:177602
	abnormal neutrophil physiology	J:177602
Cuedc2^tm1Qxia/Cuedc2^tm1Qxia (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	abnormal macrophage physiology	J:211782
	increased macrophage cytokine production	J:211782
	increased susceptibility to induced colitis	J:211782
Cul5^{tm1.1(KOMP)Vlcg}/Cul5⁺ (involves: C57BL/6NTac)	decreased interleukin-1 alpha secretion	J:244502
	decreased interleukin-6 secretion	J:244502
	decreased tumor necrosis factor secretion	J:244502
Cux1^tm1Rhsc/Cux1^tm1Rhsc (involves: 129S1/Sv * C57BL/6J)	abnormal tumor necrosis factor level	J:100055
Cux1^tm2Ejn/Cux1^tm2Ejn (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to bacterial infection	J:74660
Cux1^tm2Ejn/Cux1^tm2Ejn (involves: 129S4/SvJae * C57BL/6)	rhinitis	J:74660
Cuzd1^tm1Ljm/Cuzd1^tm1Ljm (involves: 129S6/SvEvTac * Black Swiss)	increased susceptibility to induced pancreatitis	J:80980
Cwc27^tm1Lex/Cwc27^tm1Lex (B6;129S5-Cwc27^tm1Lex/Mmucd)	abnormal immune system physiology	J:171883
Cx3cl1^tm1.1Yono/Cx3cl1^tm1.1Yono (involves: C57BL/6J)	abnormal dendritic cell physiology	J:271242
Cx3cl1^tm1.1Yono/Cx3cl1^tm1.1Yono (involves: C57BL/6J)	decreased inflammatory response	J:271242
Cx3cl1^tm1Sgs/Cx3cl1^tm1Sgs Ldlr^tm1Her/Ldlr^tm1Her (involves: B6.129S4-Cx3cl1^tm1Sgs * B6.129S7-Ldlr^tm1Her/J)	impaired macrophage chemotaxis	J:95279
Cx3cr1^tm1Ifc/Cx3cr1^tm1Ifc (involves: 129S4/SvJae * C57BL/6)	abnormal NK cell physiology	J:82033
	abnormal response to transplant	J:82033
	impaired macrophage chemotaxis	J:82033
Cx3cr1^tm1Litt/Cx3cr1⁺ (B6.129P2-Cx3cr1^tm1Litt)	increased susceptibility to experimental autoimmune encephalomyelitis	J:129712
Cx3cr1^tm1Litt/Cx3cr1⁺ Psen1^tm1Mpm/Psen1^tm1Mpm Tg(APPSwe,tauP301L)1Lfa/0 Tg(Thy1-YFP)HJrs/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal microglial cell physiology	J:159680
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte physiology	J:162714
	impaired macrophage chemotaxis	J:162714
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd)	abnormal dendritic cell physiology	J:271242, J:95694
	decreased inflammatory response	J:271242
	increased susceptibility to bacterial infection induced morbidity/mortality	J:95694
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (B6.129P2-Cx3cr1^tm1Litt)	abnormal leukocyte physiology	J:124722
	abnormal microglial cell physiology	J:110266, J:265696
	abnormal NK cell physiology	J:129712
	brain inflammation	J:129712
	increased susceptibility to experimental autoimmune encephalomyelitis	J:129712
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt H2-Ab1^b-tm1Hpl/H2-Ab1⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal response to infection	J:95694
Cx3cr1^tm1Zm/Cx3cr1^tm1Zm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal splenocyte physiology	J:103047
Cx3cr1^{tm2.1(cre/ERT2)Litt}/Cx3cr1⁺ Vps35^{Gt(RRK261)Byg}/Vps35^{Gt(RRK261)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased interleukin-1 beta secretion	J:292365
	decreased interleukin-6 secretion	J:292365
	decreased tumor necrosis factor secretion	J:292365
	increased interleukin-4 secretion	J:292365
	increased interleukin-10 secretion	J:292365
Cx3cr1^{tm3(Hbegf)Litt}/Cx3cr1^{tm3(Hbegf)Litt} Tg(Itgax-cre)1-1Reiz/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased susceptibility to bacterial infection	J:210086
Cxcl5^tm1.1Mkch/Cxcl5^tm1.1Mkch (B6.129P2-Cxcl5^tm1.1Mkch)	decreased interferon-alpha secretion	J:208901
	decreased interleukin-1 alpha secretion	J:208901
	decreased interleukin-6 secretion	J:208901
	decreased susceptibility to bacterial infection	J:208901
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:208901
	decreased tumor necrosis factor secretion	J:208901
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw (involves: 129)	abnormal circulating chemokine level	J:162629
	abnormal neutrophil physiology	J:162629
	decreased circulating interleukin-6 level	J:162629
	decreased susceptibility to bacterial infection	J:162629
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:162629
	decreased susceptibility to endotoxin shock	J:162629
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw Ackr1^tm1Scp/Ackr1^tm1Scp (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal circulating chemokine level	J:162629
Cxcl9^tm1Jmf/Cxcl9^tm1Jmf (either: B6.129S4-Cxcl9^tm1Jmf or (involves: 129S4/SvJae * C57BL/6))	decreased IgG level	J:121818
	decreased immunoglobulin level	J:121818
Cxcl9^tm1Jmf/Cxcl9^tm1Jmf (B6.129S4-Cxcl9^tm1Jmf)	abnormal cytokine secretion	J:120743
Cxcl9^tm1Jmf/Cxcl9^tm1Jmf (B6.129S4-Cxcl9^tm1Jmf)	decreased inflammatory response	J:120743
Cxcl10^tm1Adl/Cxcl10^tm1Adl (involves: 129S4/SvJae * 129X1/SvJ)	decreased IgG2a level	J:75584
	decreased interferon-gamma secretion	J:75584
	decreased splenocyte proliferation	J:75584
	decreased susceptibility to type IV hypersensitivity reaction	J:75584
Cxcl10^tm1Adl/Cxcl10^tm1Adl (involves: 129S4/SvJae * C57BL/6)	abnormal interferon level	J:75584
	abnormal T cell physiology	J:75584
	increased susceptibility to Hepadnaviridae infection	J:75584
Cxcl10^tm1Adl/Cxcl10^tm1Adl (B6.129S4-Cxcl10^tm1Adl)	abnormal cytokine secretion	J:120743
	CNS inflammation	J:87076
	increased susceptibility to experimental autoimmune encephalomyelitis	J:87076
	increased susceptibility to Herpesvirales infection	J:120743
Cxcl12^{tm3.1(HBEGF/EGFP)Tng}/Cxcl12⁺ (B6.Cg-Cxcl12^{tm3.1(HBEGF/EGFP)Tng})	increased B cell apoptosis	J:164657
Cxcl13^tm1Cys/Cxcl13^tm1Cys (involves: 129X1/SvJ * C57BL/6)	abnormal B cell physiology	J:78282
Cxcl13^tm1Cys/Cxcl13^tm1Cys (B6.129X1-Cxcl13^tm1Cys)	abnormal B cell physiology	J:118931
Cxcl13^tm1Mmi/Cxcl13^tm1Mmi (involves: C57BL/6)	abnormal B cell physiology	J:84804
	abnormal leukocyte adhesion	J:84804
	abnormal leukocyte migration	J:84804
Cxcl15^tm1Lira/Cxcl15^tm1Lira (involves: 129 * C57BL/6J)	increased susceptibility to bacterial infection	J:67605
Cxcl16^tm1Syon/Cxcl16^tm1Syon (B6.129P2-Cxcl16^tm1Syon)	decreased circulating interferon-gamma level	J:155199
	decreased circulating interleukin-4 level	J:155199
	decreased interferon-gamma secretion	J:155199
	decreased interleukin-4 secretion	J:155199
	decreased susceptibility to bacterial infection	J:155199
Cxcr2^{tm1a(EUCOMM)Wtsi}/Cxcr2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cxcr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Cxcr2^tm1Mwm/Cxcr2⁺ (C.129S2(B6)-Cxcr2^tm1Mwm/J)	impaired neutrophil recruitment	J:63935
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas * C57BL/6J)	impaired neutrophil chemotaxis	J:19570
	increased circulating interleukin-6 level	J:19570
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (C.129S2(B6)-Cxcr2^tm1Mwm/J)	abnormal chemokine level	J:73947
	abnormal cytokine secretion	J:72824
	abnormal eosinophil physiology	J:73947
	abnormal interleukin level	J:73947, J:87365
	abnormal leukocyte physiology	J:94170
	abnormal neutrophil physiology	J:93946, J:73947
	abnormal NK T cell physiology	J:66399
	abnormal T cell physiology	J:73947
	abnormal T-helper 1 physiology	J:73947
	abnormal T-helper 2 physiology	J:73947
	decreased susceptibility to fungal infection	J:73947
	decreased susceptibility to induced arthritis	J:142880
	impaired neutrophil chemotaxis	J:65905, J:72824
	impaired neutrophil recruitment	J:65425, J:63935, J:93116
	increased IgE level	J:73947
	increased susceptibility to bacterial infection	J:65905
	increased susceptibility to Herpesvirales infection	J:87365
	increased susceptibility to parasitic infection	J:72824
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas * BALB/c)	abnormal neutrophil physiology	J:113489
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:208901
Cxcr2^tm1Rmra/Cxcr2^tm1Rmra Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * CBA)	abnormal neutrophil physiology	J:204482
Cxcr3^tm1Raks/Cxcr3^tm1Raks (B6.129P2-Cxcr3^tm1Raks)	kidney inflammation	J:152790
Cxcr3^tm1Wwh/Y (B6.Cg-Cxcr3^tm1Wwh)	abnormal cellular extravasation	J:107646
	abnormal interferon level	J:91359
	impaired macrophage chemotaxis	J:107646
	increased length of allograft survival	J:65916
	lung inflammation	J:91359
Cxcr3^tm1Wwh/Cxcr3^tm1Wwh (B6.Cg-Cxcr3^tm1Wwh)	abnormal cellular extravasation	J:96905, J:107646
	abnormal interferon level	J:91359
	decreased susceptibility to Riboviria infection	J:96905
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:96905
	impaired macrophage chemotaxis	J:107646
	increased length of allograft survival	J:65916
	lung inflammation	J:91359
Cxcr4^tm1.1Bala/Cxcr4⁺ (B6.129S2-Cxcr4^tm1.1Bala)	abnormal immune system physiology	J:186735
	abnormal NK cell physiology	J:178789
	decreased B cell apoptosis	J:186735
	increased IgG level	J:186735
	increased IgM level	J:186735
	increased immunoglobulin level	J:186735
Cxcr4^tm1Qma/Cxcr4^tm1Qma (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to Retroviridae infection	J:132342
Cxcr4^tm1Qma/Cxcr4^tm1Qma (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to Retroviridae infection induced morbidity/mortality	J:132342
Cxcr4^tm1Yiw/Cxcr4^tm1Yiw Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	abnormal leukocyte migration	J:164872
	decreased susceptibility to induced arthritis	J:164872
Cxcr4^tm1Yzo/Cxcr4^tm1Yzo (Not Specified)	abnormal B cell physiology	J:167314
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	decreased immunoglobulin level	J:94911
Cxcr4^tm3.1Yzo/Cxcr4^tm3.1Yzo (Not Specified)	abnormal B cell physiology	J:167314
Cxcr5^tm1.1Namt/Cxcr5^tm1.1Namt Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6J * CBA)	abnormal dendritic cell chemotaxis	J:241561
	decreased susceptibility to prion infection	J:241561
Cxcr5^tm1.1Namt/Cxcr5^tm1.1Namt Tg(Itgax-cre)1-1Reiz/0 Tg(Prnp)a20Cwe/0 (involves: C57BL/6 * C57BL/6J * CBA)	decreased susceptibility to prion infection	J:241561
Cxcr5^tm1Lipp/Cxcr5^tm1Lipp (involves: 129S2/SvPas * CD-1)	abnormal leukocyte migration	J:37126
Cxv1^F/St/Cxv1^F/St (involves: AKR/J * F/St)	abnormal immune cell physiology	J:7030
Cxv2^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal immune cell physiology	J:6143
Cyba^nmf333/Cyba^nmf333 (A.B6 Tyr⁺-Cyba^nmf333/J)	abnormal neutrophil physiology	J:132359
	increased inflammatory response	J:132359
	increased susceptibility to bacterial infection	J:132359
	lung inflammation	J:132359
	sepsis	J:132359
Cyba^tm1Dgh/Cyba^tm1Dgh (B6.Cg-Cyba^tm1Dgh)	abnormal T cell activation	J:231269
Cyba^tm1Dgh/Cyba^tm1Dgh (B6.Cg-Cyba^tm1Dgh)	decreased inflammatory response	J:231269
Cybb^tm1.1Abk/Cybb^tm1.1Abk Lyz2^tm1(cre)Ifo/? (B6.Cg-Lyz2^tm1(cre)Ifo Cybb^tm1.1Abk)	abnormal macrophage chemotaxis	J:245699
Cybb^tm1Din/Y (involves: 129S/SvEv * C57BL/6)	abnormal immune system physiology	J:22868
	abnormal macrophage physiology	J:22868
	abnormal neutrophil physiology	J:22868
	increased inflammatory response	J:22868
	increased susceptibility to bacterial infection	J:22868
	increased susceptibility to infection	J:22868
Cybb^tm1Din/Cybb^tm1Din (B6.129S-Cybb^tm1Din)	granulomatous inflammation	J:146231
Cybb^tm1Din/Cybb^tm1Din (B6.129S-Cybb^tm1Din)	increased acute inflammation	J:110181
Cybb^tm1Din/Cybb^tm1Din (B6.129S-Cybb^tm1Din/J)	abnormal circulating chemokine level	J:235399
	abnormal macrophage physiology	J:235399
	decreased circulating interleukin-10 level	J:235399
	glomerulonephritis	J:235399
	increased anti-double stranded DNA antibody level	J:235399
	increased anti-nuclear antigen antibody level	J:235399
	increased autoantibody level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased IgG level	J:235399
	increased susceptibility to systemic lupus erythematosus	J:235399
Cyld^tm1.1Awai/Cyld^tm1.1Awai (Not Specified)	abnormal B cell physiology	J:126113
	abnormal class switch recombination	J:126113
	abnormal humoral immune response	J:126113
	decreased IgG3 level	J:126113
	decreased IgM level	J:126113
	increased IgA level	J:126113
	increased IgG1 level	J:126113
	increased IgG2a level	J:126113
	increased IgG2b level	J:126113
Cyld^tm1.1Mpa/Cyld^tm1.1Mpa Fadd^tm1Mpa/Fadd^tm1Mpa Tg(Vil1-cre)997Gum/0 (B6.Cg-Fadd^tm1Mpa Cyld^tm1.1Mpa Tg(Vil1-cre)997Gum)	cecum inflammation	J:175865
Cyld^tm1.1Mpa/Cyld^tm1.1Mpa Ikbkg^tm1.1Mpa/Y Tg(Vil1-cre)997Gum/0 (B6.Cg-Cyld^tm1.1Mpa Ikbkg^tm1.1Mpa Tg(Vil1-cre)997Gum)	colitis	J:175865
Cyld^tm1.1Mpa/Cyld^tm1.1Mpa Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Tg(Vil1-cre)997Gum/0 (B6.Cg-Cyld^tm1.1Mpa Ikbkg^tm1.1Mpa Tg(Vil1-cre)997Gum)	colitis	J:175865
Cyld^tm1Jdgl/Cyld^tm1Jdgl (involves: 129 * C57BL/6J)	decreased susceptibility to bacterial infection	J:124327
Cyld^tm1Jdgl/Cyld^tm1Jdgl (involves: 129 * C57BL/6J)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:124327
Cyld^tm1Lex/Cyld^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal inflammatory response	J:114972
Cyld^tm1Lex/Cyld^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased susceptibility to induced colitis	J:114972
Cyp2c^tm1104Arte/Cyp2c^tm1104Arte (B6NTac(Cg)-Cyp2c^tm1104Arte/Arte)	liver inflammation	J:241121
Cyp2c^{tm1897.1(Alb-CYP2C9)Arte}/Cyp2c^{tm1897.1(Alb-CYP2C9)Arte} (B6(Cg)-Cyp2c^{tm1897.1(Alb-CYP2C9)Arte}/Arte)	liver inflammation	J:241121
Cyp2g1^{tm1(rtTA)Lane}/Cyp2g1⁺ Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0 (involves: 129 * C57BL/6 * SJL)	rhinitis	J:157842
Cyp4v3^em1Xsu/Cyp4v3^em1Xsu (C57BL/6J-Cyp4v3^em1Xsu)	increased microglial cell activation	J:321817
Cyp7b1^tm1Rus/Cyp7b1^tm1Rus (involves: 129S/SvEv * C57BL/6J)	decreased IgA level	J:170807
Cyp11a1^tm2Bcc/Cyp11a1^tm2Bcc (Not Specified)	decreased T cell apoptosis	J:133007
Cyp19a1^tm1Esi/Cyp19a1^tm1Esi (involves: 129S6/SvEvTac * C57BL/6)	increased autoantibody level	J:92438
	increased IgG level	J:92438
	kidney inflammation	J:92438
	salivary gland inflammation	J:92438
Cyp19a1^tm1Sih/Cyp19a1^tm1Sih (involves: 129S/SvEv)	increased anti-single stranded DNA antibody level	J:216958
	increased autoantibody level	J:216958
	increased susceptibility to autoimmune disorder	J:216958
	lacrimal gland inflammation	J:216958
	salivary gland inflammation	J:216958
Cypr1^STS/A/? (involves: BALB/c * STS/A)	abnormal cytokine secretion	J:52119
Cypr2^BALB/c/? (involves: BALB/c * STS/A)	abnormal cytokine secretion	J:52119
Cypr3^BALB/c/? (involves: BALB/c * STS/A)	abnormal cytokine secretion	J:52119
Cyren^em1Vokh/Cyren^em1Vokh (C57BL/6-Cyren^em1Vokh)	abnormal class switch recombination	J:306598
Cyren^{tm1.1(KOMP)Vlcg}/Cyren^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal class switch recombination	J:265834
Cyrib^m1Ivdi/Cyrib^m1Ivdi (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	increased circulating interleukin-6 level	J:282597
	increased circulating interleukin-10 level	J:282597
	increased circulating tumor necrosis factor level	J:282597
	increased susceptibility to bacterial infection induced morbidity/mortality	J:282597
Cyrib^{tm1c(KOMP)Wtsi}/Cyrib^{tm1d(KOMP)Wtsi} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BcA17/Skmn * C57BL/6N)	abnormal circulating chemokine level	J:282597
	abnormal neutrophil physiology	J:282597
	increased circulating CXCL10 level	J:282597
	increased circulating interleukin-6 level	J:282597
	increased circulating interleukin-10 level	J:282597
	increased circulating tumor necrosis factor level	J:282597
	increased susceptibility to bacterial infection induced morbidity/mortality	J:282597
Cys1^cpk/Cys1^cpk (129.B6-Cys1^cpk)	liver inflammation	J:116210
Cysltr1^tm1Ykn/Cysltr1^tm1Ykn (involves: C57BL/6)	decreased susceptibility to type I hypersensitivity reaction	J:77087
Cysltr1^tm1Ykn/Cysltr1^tm1Ykn (involves: C57BL/6)	respiratory system inflammation	J:88647
Cysltr1^tm1Ykn/Cysltr1^tm1Ykn Cysltr2^tm1Ykn/Cysltr2^tm1Ykn (involves: BALB/c * C57BL/6)	abnormal immune system physiology	J:198383
Cysltr1^tm1Ykn/Cysltr1^tm1Ykn Cysltr2^tm1Ykn/Cysltr2^tm1Ykn Oxgr1^{tm1(KOMP)Vlcg}/Oxgr1^{tm1(KOMP)Vlcg} (involves: BALB/c * C57BL/6 * C57BL/6NTac)	abnormal immune system physiology	J:198383
Cysltr2^tm1Ykn/Cysltr2^tm1Ykn (C57BL/6-Cysltr2^tm1Ykn)	decreased susceptibility to type I hypersensitivity reaction	J:94488
Cysltr2^tm1Ykn/Cysltr2^tm1Ykn (C.B6-Cysltr2^tm1Ykn)	autoimmune response	J:182213
Cyth2^{tm1d(EUCOMM)Wtsi}/Cyth2^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased susceptibility to type I hypersensitivity reaction	J:307633
Cytip^tm1Tes/Cytip^tm1Tes (involves: 129S1/Sv * FVB/N)	abnormal cellular extravasation	J:110320
Cytip^tm1Tes/Cytip^tm1Tes (involves: 129S1/Sv * FVB/N)	abnormal leukocyte migration	J:110320
Cytip^tm1Wtw/Cytip^tm1Wtw (involves: 129S6/SvEvTac * C57BL/6)	abnormal response to transplant	J:112168
Cytl1^tm1Chun/Cytl1^tm1Chun (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to induced arthritis	J:175377
Dapp1^{Gt(OST111213)Lex}/Dapp1^{Gt(OST111213)Lex} (B6.Cg-Dapp1^{Gt(OST111213)Lex})	abnormal humoral immune response	J:110009
	decreased B cell proliferation	J:110009
	decreased IgG3 level	J:110009
	increased susceptibility to bacterial infection	J:110009
Dapp1^tm1Mnz/Dapp1^tm1Mnz (B6.129P2-Dapp1^tm1Mnz)	abnormal B cell activation	J:86182
	decreased B cell proliferation	J:86182
	decreased IgG3 level	J:86182
	decreased IgM level	J:86182
Dbacl^C57BL/6Jcl/Dbacl^C57BL/6Jcl (NOD.B6-(D4Mit193-D4Mit17))	increased susceptibility to autoimmune diabetes	J:144964
	insulitis	J:144964
Dbnl^{Gt(betageo)11Byg}/Dbnl^{Gt(betageo)11Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell activation	J:119847
	abnormal T cell physiology	J:119847
	decreased IgG1 level	J:119847
	decreased IgM level	J:119847
	decreased immunoglobulin level	J:119847
	decreased interleukin-2 secretion	J:119847
	decreased T cell proliferation	J:119847
Dbr1^{Gt(YTA280)Byg}/Dbr1⁺ (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:223318
Dcbld2^{tm1a(KOMP)Wtsi}/Dcbld2^{tm1a(KOMP)Wtsi} (C57BL/6N-Dcbld2^{tm1a(KOMP)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Dck^m1Btlr/Dck^m1Btlr (C57BL/6J-Dck^m1Btlr)	decreased IgG level	J:236696
	decreased response to antigen	J:236696
	increased IgE level	J:236696
Dck^memi/Dck^memi (C57BL/6J-Dck^memi)	abnormal response to infection	J:184080
	increased T cell apoptosis	J:184080
	increased T cell proliferation	J:184080
Dclk1^{tm1a(EUCOMM)Wtsi}/Dclk1⁺ (C57BL/6N-Dclk1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Dclk1^{tm1a(EUCOMM)Wtsi}/Dclk1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dclk1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Dclre1a^tm1Rleg/Dclre1a^tm1Rleg (involves: 129S7/SvEvBrd)	increased susceptibility to bacterial infection	J:102381
Dclre1c^m1Btlr/Dclre1c^m1Btlr (C57BL/6J-Dclre1c^m1Btlr)	decreased IgM level	J:217790
	decreased response to antigen	J:217790
	impaired humoral immune response	J:217790
Dclre1c^tm2.1Jpdv/Dclre1c^tm2.2Jpdv Tg(Cr2-cre)3Cgn/0 (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:153841
Dclre1c^tm2Mcow/Dclre1c^tm2Mcow (involves: 129/Sv * C57BL/6)	abnormal leukocyte physiology	J:96535
	decreased B cell proliferation	J:96535
	decreased T cell proliferation	J:96535
Dcn^tm1Ioz/Dcn⁺ (either: C.Cg-Dcn^tm1Ioz or C3.Cg-Dcn^tm1Ioz)	decreased susceptibility to bacterial infection	J:68640
Dcn^tm1Ioz/Dcn^tm1Ioz (involves: 129S1/Sv * 129X1/SvJ * Black Swiss)	tubular nephritis	J:75298
Dcn^tm1Ioz/Dcn^tm1Ioz (either: C.Cg-Dcn^tm1Ioz or C3.Cg-Dcn^tm1Ioz)	decreased susceptibility to bacterial infection	J:68640
Dcn^tm1Ioz/Dcn^tm1Ioz (C.129(Cg)-Dcn^tm1Ioz)	abnormal humoral immune response	J:92428
Dcstamp^tm1Suda/Dcstamp^tm1Suda (Not Specified)	abnormal macrophage physiology	J:100555
Dcstamp^tm1Suda/Dcstamp^tm1Suda (Not Specified)	abnormal osteoclast physiology	J:100555
Ddc^tm1.1Rhrs/Ddc^tm1.1Rhrs Tg(Ggt1-cre)M3Egn/0 (involves: 129 * C57BL/6 * SJL)	tubulointerstitial nephritis	J:175630
Ddc^tm1.1Rhrs/Ddc^tm1.1Rhrs Tg(Ggt1-cre)M3Egn/0 (129.Cg-Ddc^tm1.1Rhrs Tg(Ggt1-cre)M3Egn)	tubulointerstitial nephritis	J:175630
Ddit3^tm1Dron/Ddit3^tm1Dron (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	decreased susceptibility to Retroviridae infection	J:112354
Ddit3^tm1Dron/Ddit3^tm1Dron (B6.129-Ddit3^tm1Dron)	abnormal macrophage activation involved in immune response	J:153833
Ddit3^tm1Dron/Ddit3^tm1Dron (B6.129-Ddit3^tm1Dron)	decreased macrophage apoptosis	J:153833
Ddit3^tm1Dron/Ddit3^tm1Dron Tg(Col2a1-rtTA,tetO-COMP)2Jath/0 (involves: 129X1/SvJ 129S1/Sv * C57BL/6)	decreased inflammatory response	J:233238
Ddit3^tm2.1Dron/Ddit3^tm2.1Dron (B6.129S(Cg)-Ddit3^tm2.1Dron/J)	white adipose tissue inflammation	J:214136
Ddx19b^em1Chaw/Ddx19b⁺ (C57BL/6-Ddx19b^em1Chaw)	increased interferon-alpha secretion	J:289833
Ddx19b^em1Chaw/Ddx19b⁺ (C57BL/6-Ddx19b^em1Chaw)	increased interferon-beta secretion	J:289833
Ddx41^tm1.1Arte/Ddx41^tm1.1Arte Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to Retroviridae infection	J:265023
Ddx41^tm1.1Arte/Ddx41^tm1.1Arte Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6N * CBA)	increased susceptibility to Retroviridae infection	J:265023
Ddx46^em1Caox/Ddx46⁺ (involves: C57BL/6J)	abnormal innate immunity	J:271836
	abnormal macrophage physiology	J:271836
	decreased susceptibility to Riboviria infection	J:271836
	increased circulating interferon-beta level	J:271836
	increased interferon-beta secretion	J:271836
	increased interleukin-1 beta secretion	J:271836
	increased interleukin-6 secretion	J:271836
	increased macrophage cytokine production	J:271836
	increased tumor necrosis factor secretion	J:271836
Ddx60^{tm1b(EUCOMM)Wtsi}/Ddx60^{tm1b(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased circulating interferon-beta level	J:228452
	increased circulating interferon-alpha level	J:228452
	increased susceptibility to Riboviria infection	J:228452
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:228452
Ddx60^{tm1b(EUCOMM)Wtsi}/Ddx60^{tm1b(EUCOMM)Wtsi} Mavs^tm1Tsse/Mavs^tm1Tsse (involves: 129 * C57BL/6N)	increased susceptibility to Riboviria infection induced morbidity/mortality	J:228452
Def6^{Gt(OST307148)Lex}/Def6^{Gt(OST307148)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:106469
	decreased T cell apoptosis	J:106469
	increased anti-nuclear antigen antibody level	J:106469
	increased IgG level	J:106469
	increased immunoglobulin level	J:106469
Defb1^tm1Jmw/Defb1⁺ (B6.129S5-Defb1^tm1Jmw)	increased susceptibility to bacterial infection	J:76529
Defb1^tm1Jmw/Defb1^tm1Jmw (B6.129S5-Defb1^tm1Jmw)	increased susceptibility to bacterial infection	J:76529
Defb3^tm1Lex/Defb3^tm1Lex (B6;129S5-Defb3^tm1Lex/Mmucd)	increased susceptibility to bacterial infection	J:168725
Defb3^tm1Xen/Defb3^tm1Xen (involves: C57BL/6)	increased incidence of corneal inflammation	J:199719
Defb3^tm1Xen/Defb3^tm1Xen (involves: C57BL/6)	increased susceptibility to fungal infection	J:199719
Del(1Aim2-Ifi205)1Stsn/+ Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)	heart inflammation	J:234263
	increased autoantibody level	J:234263
	increased inflammatory response	J:234263
	kidney inflammation	J:234263
	myositis	J:234263
	stomach inflammation	J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn (B6(129S4)-Del(1Aim2-Ifi205)1Stsn)	abnormal interferon secretion	J:234263
	decreased interleukin-1 beta secretion	J:234263
	decreased macrophage apoptosis	J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)	stomach inflammation	J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)	heart inflammation	J:234263
	increased autoantibody level	J:234263
	increased inflammatory response	J:234263
	kidney inflammation	J:234263
	myositis	J:234263
	stomach inflammation	J:234263
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw (involves: 129S4/SvJae * C57BL/6)	abnormal antigen presentation	J:174337
	abnormal NK T cell physiology	J:112657
	decreased interleukin-4 secretion	J:39749
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw Tg(TcraAV19AJ33)1Shima/0 (involves: 129S4/SvJae * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:112657
	increased interleukin-10 secretion	J:112657
Del(3Cd1d2-Cd1d1)1Sbp/Del(3Cd1d2-Cd1d1)1Sbp (either: B6NTac.129S6-Del(3Cd1d2-Cd1d1)1Sbp or (involves: 129S6/SvEvTac * C57BL/6NTac))	abnormal immune tolerance	J:58315
Del(3Cd1d2-Cd1d1)1Sbp/Del(3Cd1d2-Cd1d1)1Sbp (involves: 129S6/SvEvTac)	abnormal dendritic cell antigen presentation	J:151699
Del(3Gbp2-ps-Gbp5)1Ktak/Del(3Gbp2-ps-Gbp5)1Ktak (involves: C57BL/6)	increased susceptibility to parasitic infection	J:187397
	increased susceptibility to parasitic infection induced morbidity/mortality	J:187397
Del(6Ephb6-Trpv6)1Mhed/+ (involves: 129S/SvEv)	dermatitis	J:133151
Del(6Ephb6-Trpv6)1Mhed/Del(6Ephb6-Trpv6)1Mhed (involves: 129S/SvEv)	dermatitis	J:133151
Del(6Gimap5-Gimap3)1Yout/Del(6Gimap5-Gimap3)1Yout (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal T cell physiology	J:209926
Del(6Snca)1Slab/Del(6Snca)1Slab Tg(Th-SNCA)1Mgsp/0 (involves: C57BL/6J C57BL/6JOlaHsd * CBA/Ca)	brain inflammation	J:108310
Del(7Mrgpra2a-Mrgpra2b)1Xzd/Del(7Mrgpra2a-Mrgpra2b)1Xzd (C57BL/6J-Del(7Mrgpra2a-Mrgpra2b)1Xzd)	abnormal neutrophil physiology	J:332494
	decreased interleukin-1 beta secretion	J:332494
	increased susceptibility to bacterial infection	J:332494
Del(7Pira1-Lilra6)1Fgla/Del(7Pira1-Lilra6)1Fgla (involves: C57BL/6)	decreased susceptibility to graft versus host disease	J:290663
Del(7Pira1-Lilra6)1Fgla/Del(7Pira1-Lilra6)1Fgla Il2rg^tm1Wjl/Il2rg^tm1Wjl Rag2^tm1Fwa/Rag2^tm1Fwa (involves: C57BL/6J * C57BL/6NTac)	abnormal response to transplant	J:290663
Del(8Ddx19a-Ddx19b)1Chaw/+ (C57BL/6-Del(8Ddx19a-Ddx19b)1Chaw)	decreased susceptibility to Picornaviridae infection	J:289833
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:289833
	increased interferon-alpha secretion	J:289833
	increased interferon-beta secretion	J:289833
Del(8Ddx19a-Ddx19b)2Chaw/+ (C57BL/6-Del(8Ddx19a-Ddx19b)2Chaw)	increased interferon-alpha secretion	J:289833
	increased interferon-beta secretion	J:289833
Del(8Defa1-Def)2Xzd/Del(8Defa1-Def)2Xzd Tg(KRT14-cre)1Amc/0 (involves: C57BL/6J * CBA)	increased susceptibility to bacterial infection	J:332494
Del(9Casp1-Casp4)1Bhk/Del(9Casp1-Casp4)1Bhk (129-Del(9Casp1-Casp4)1Bhk)	abnormal macrophage physiology	J:189777
	decreased interleukin-1 alpha secretion	J:189777
	decreased interleukin-1 beta secretion	J:189777
Del(9Hspb2-Cryab)1Wawr/Del(9Hspb2-Cryab)1Wawr (involves: 129S4/SvJae)	osteoarthritis	J:72926
Del(10Prmt2-Col6a1)1Yah/+ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal cytokine level	J:167506
	abnormal macrophage physiology	J:167506
	lung inflammation	J:167506
	respiratory system inflammation	J:167506
Del(10Prtn3-Elane)1Deje/Del(10Prtn3-Elane)1Deje (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	abnormal neutrophil physiology	J:137674
	impaired neutrophil recruitment	J:137674
Del(11Cxcl16-Zmynd15)1Ifc/Del(11Cxcl16-Zmynd15)1Ifc (B6.129S-Ldlr^tm1Her Del(11Cxcl16-Zmynd15)1Ifc)	abnormal macrophage physiology	J:123851
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk (involves: C57BL/6)	impaired macrophage chemotaxis	J:90288
	impaired macrophage phagocytosis	J:90288
Del(11Nlrp1a-Nlrp1c-ps)1Smas/Del(11Nlrp1a-Nlrp1c-ps)1Smas (Not Specified)	increased susceptibility to Riboviria infection	J:191055
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce (involves: C57BL/6)	decreased inflammatory response	J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce Nlrc4^em2Vnce/Nlrc4^em2Vnce (involves: C57BL/6)	decreased inflammatory response	J:294930
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (involves: C57BL/6J * C57BL/6N)	decreased inflammatory response	J:294930
Del(14Ltb4r2-Ltb4r1)1Bodd/+ (involves: 129S4/SvJaeSor * C57BL/6)	decreased susceptibility to induced arthritis	J:131779
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd (involves: 129S4/SvJaeSor * C57BL/6)	decreased susceptibility to induced arthritis	J:131779
	impaired neutrophil chemotaxis	J:163271
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal B cell proliferation	J:156946
Del(17Trem1-Trem3)1Jkt/Del(17Trem1-Trem3)1Jkt (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal chemokine level	J:194295
	abnormal circulating chemokine level	J:194295
	abnormal cytokine level	J:194295
	abnormal cytokine secretion	J:194295
	impaired neutrophil chemotaxis	J:194295
	increased circulating interleukin-1 alpha level	J:194295
	increased circulating interleukin-6 level	J:194295
	increased circulating interleukin-10 level	J:194295
	increased circulating tumor necrosis factor level	J:194295
	increased interleukin-1 alpha secretion	J:194295
	increased interleukin-1 beta secretion	J:194295
	increased interleukin-6 secretion	J:194295
	increased interleukin-10 secretion	J:194295
	increased interleukin-17 secretion	J:194295
	increased susceptibility to bacterial infection	J:194295
	increased susceptibility to bacterial infection induced morbidity/mortality	J:194295
Del(19Poll-Dcpd)1Nmt/Del(19Poll-Dcpd)1Nmt (involves: 129P2/OlaHsd)	sinus inflammation	J:75779
Dennd1b^tm1.2Achn/Dennd1b^tm1.2Achn (involves: C57BL/6)	abnormal interleukin secretion	J:229307
Dennd1b^tm1.2Achn/Dennd1b^tm1.2Achn (involves: C57BL/6)	abnormal T-helper 2 physiology	J:229307
Derm1^NC/Nga/Derm1^NC/Nga (involves: MSM/Ms * NC/Nga)	dermatitis	J:68698
Derms^BALB/cByJ/? (involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J)	dermatitis	J:80574
Derms^DBA/2J/? (involves: BALB/cByJ * C3H/HeJ * C57BL/6J * DBA/2J)	dermatitis	J:80574
Dffb^{em1(IMPC)Wtsi}/Dffb^{em1(IMPC)Wtsi} (C57BL/6N-Dffb^{em1(IMPC)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Dgka^tm1Xpz/Dgka^tm1Xpz (involves: 129 * C57BL/6)	abnormal lymphocyte anergy	J:113564
Dgka^tm1Xpz/Dgka^tm1Xpz (involves: 129 * C57BL/6)	increased interleukin-2 secretion	J:113564
Dgka^tm1Xpz/Dgka^tm1Xpz Dgkz^tm1Gak/Dgkz^tm1Gak (involves: 129 * 129X1/SvJ * C57BL/6)	abnormal thymocyte activation	J:113564
Dgkz^tm1Gak/Dgkz^tm1Gak (involves: 129X1/SvJ * C57BL/6)	abnormal cytokine level	J:293120
	abnormal cytokine secretion	J:293120
	abnormal inflammatory response	J:293120
	abnormal interferon level	J:85149
	abnormal macrophage physiology	J:293120
	abnormal T cell activation	J:85149
	abnormal T cell physiology	J:85149
	decreased interleukin-6 secretion	J:293120
	decreased susceptibility to induced arthritis	J:293120
	decreased susceptibility to Riboviria infection	J:85149
	increased T cell proliferation	J:85149
Dgkz^tm1Gak/Dgkz^tm1Gak (B6.129X1-Dgkz^tm1Gak)	abnormal interleukin-2 secretion	J:113564
Dgkz^tm1Gak/Dgkz^tm1Gak (B6.129X1-Dgkz^tm1Gak)	abnormal lymphocyte anergy	J:113564
Dh/Dh⁺ (B6.CBA-Dh)	decreased immunoglobulin level	J:5834
Dh/Dh⁺ Foxn1^nu/Foxn1^nu (involves: N:NIH(S))	increased IgA level	J:6062
Dh/Dh⁺ H2^d/H2^d (NZB.Cg-Dh)	decreased B cell proliferation	J:12036
	decreased IgG1 level	J:12036
	decreased IgG level	J:12036
	decreased IgM level	J:12036
	decreased susceptibility to graft versus host disease	J:12036
	glomerulonephritis	J:12036
	increased anti-erythrocyte antigen antibody level	J:12036
	increased anti-nuclear antigen antibody level	J:12036
	increased anti-single stranded DNA antibody level	J:12036
	increased autoantibody level	J:12036
	increased T cell proliferation	J:12036
Dhrs4^tm1Lex/Dhrs4^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal humoral immune response	J:171883
	decreased IgG2a level	J:171883
Dhx15^{tm1c(EUCOMM)Wtsi}/Dhx15^{tm1c(EUCOMM)Wtsi} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C3H * C57BL/6N)	decreased B cell proliferation	J:284624
Dhx58^tm1Aki/Dhx58^tm1Aki (involves: 129/Sv * C57BL/6)	decreased circulating interferon-beta level	J:156867
	decreased interferon-beta secretion	J:156867
	decreased interleukin-6 secretion	J:156867
	increased susceptibility to Picornaviridae infection	J:156867
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:156867
Dhx58^tm1Gnb/Dhx58^tm1Gnb (involves: 129P2/OlaHsd * C57BL/6J)	abnormal interferon secretion	J:146113
	abnormal susceptibility to Riboviria infection	J:146113
	decreased interferon-alpha secretion	J:146113
	decreased interferon-beta secretion	J:146113
	decreased susceptibility to Riboviria infection	J:146113
	increased circulating interferon-gamma level	J:146113
	increased circulating interleukin-12 level	J:146113
	increased interferon-alpha secretion	J:146113
	increased interferon-beta secretion	J:146113
	increased susceptibility to Picornaviridae infection	J:146113
Dhx58^tm1Itl/Dhx58^tm1Itl (C57BL/6-Dhx58^tm1Itl)	decreased interferon-beta secretion	J:187386
	decreased interferon-gamma secretion	J:187386
	decreased tumor necrosis factor secretion	J:187386
	increased susceptibility to Flaviviridae infection	J:187386
	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:187386
	increased T cell apoptosis	J:187386
Dhx58^tm2.1Aki/Dhx58^tm2.1Aki (involves: 129/Sv * C57BL/6)	decreased interferon-beta secretion	J:156867
	decreased interleukin-6 secretion	J:156867
	increased susceptibility to Picornaviridae infection	J:156867
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:156867
Diaph1^M1Btlr/Diaph1⁺ (C57BL/6J-Diaph1^M1Btlr)	decreased IgE level	J:254820
Diaph1^M1Btlr/Diaph1^M1Btlr (C57BL/6J-Diaph1^M1Btlr)	decreased IgE level	J:254820
Diaph1^M1Btlr/Diaph1^M1Btlr (C57BL/6J-Diaph1^M1Btlr)	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:254820
Diaph1^tm1.1Sna/Diaph1^tm1.1Sna (B6.Cg-Diaph1^tm1.1Sna)	abnormal humoral immune response	J:126090
	abnormal leukocyte migration	J:126090
	decreased T cell proliferation	J:126090
Diaph1^tm1Asal/Diaph1^tm1Asal (involves: 129S1/Sv * C57BL/6)	dermatitis	J:124319
Dice1b^C57BL/10Sn/Dice1b^C57BL/10Sn (involves: B10.D2-H2^d/oSnJ * BALB/cAnN)	decreased susceptibility to parasitic infection	J:95337
Dicer1^{Gt(RRF266)Byg}/Dicer1^{Gt(RRF266)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to Riboviria infection	J:123635
	increased susceptibility to Herpesvirales infection	J:123635
	increased susceptibility to Riboviria infection	J:123635
Dicer1^tm1Bdh/Dicer1^tm1Bdh Aicda^tm1(cre)Njen/Aicda⁺ (involves: 129 * C57BL/6)	abnormal germinal center B cell physiology	J:181782
	abnormal humoral immune response	J:181782
	decreased immunoglobulin level	J:181782
Dicer1^tm1Bdh/Dicer1^tm1Bdh Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ)	blood vessel inflammation	J:138683
	liver inflammation	J:138683
	lung inflammation	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} (involves: 129S1/Sv * 129X1/SvJ)	blood vessel inflammation	J:138683
	liver inflammation	J:138683
	lung inflammation	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh Tg(Foxp3-EGFP/icre)1aJbs/0 (involves: 129 * NOD/ShiLt)	abnormal CD4-positive, alpha-beta T cell physiology	J:138808
	abnormal regulatory T cell physiology	J:138808
	liver inflammation	J:138808
	lung inflammation	J:138808
Dicer1^tm1Dli/Dicer1^tm1Dli Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:100546
	abnormal T-helper 1 physiology	J:100546
	abnormal T-helper 2 physiology	J:100546
	decreased T cell proliferation	J:100546
	increased T cell apoptosis	J:100546
Dicer1^tm1Tara/Dicer1^tm1Tara Foxn1^tm3(cre)Nrm/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6NHsd)	abnormal thymus involution	J:180783
	abnormal thymus physiology	J:180783
	increased susceptibility to induced arthritis	J:180783
Dido1^tm3Cmar/Dido1^tm3.1Cmar Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129S/SvEv * C57BL/6)	liver inflammation	J:328215
Dis3^tm1.1Uba/Dis3^tm1.1Uba Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	abnormal class switch recombination	J:302856
Dkc1^tm1Ppp/Y (involves: 129S1/Sv)	lung inflammation	J:81054
Dkk3^tm1Cni/Dkk3^tm1Cni (involves: 129X1/SvJ * C57BL/6)	increased IgM level	J:106922
Dlg1^tm1Rlh/Dlg1^tm1Rlh Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:191788
	abnormal cytokine secretion	J:191788
	abnormal T-helper 1 physiology	J:191788
	abnormal T-helper 2 physiology	J:191788
	decreased interferon-gamma secretion	J:191788
	decreased interleukin-2 secretion	J:191788
	decreased tumor necrosis factor secretion	J:191788
	increased interleukin-4 secretion	J:191788
	increased interleukin-5 secretion	J:191788
Dlk1^tm1.1Jvs/Dlk1⁺ Myf5^tm3(cre)Sor/Myf5⁺ (involves: 129P2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)	increased inflammatory response	J:167124
Dlk1^tm1Srba/Dlk1^tm1Srba (involves: 129X1/SvJ * C57BL/6)	increased IgG1 level	J:145076
	increased IgG2a level	J:145076
	increased IgG2b level	J:145076
	increased IgG2c level	J:145076
	increased IgG3 level	J:145076
	increased IgM level	J:145076
	increased immunoglobulin level	J:145076
Dll1^tm1Gos/Dll1⁺ (C3Fe.129-Dll1^tm1Gos)	decreased IgA level	J:150183
	decreased IgG1 level	J:150183
	decreased IgG2b level	J:150183
	decreased IgG3 level	J:150183
Dmbt1^tm1Janm/Dmbt1^tm1Janm (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to induced colitis	J:130258
Dmd^em1Eno/Y (involves: C57BL/6J)	myositis	J:253191
Dmd^em4Eno/Y (C57BL/6-Dmd^em4Eno)	myositis	J:285447
Dmd^em4Eno/Dmd^em4Eno (C57BL/6-Dmd^em4Eno)	myositis	J:285447
Dmd^mdx/Y (C57BL/10ScSn-Dmd^mdx/J)	increased interferon-gamma secretion	J:150572
	increased interleukin-2 secretion	J:150572
	increased interleukin-4 secretion	J:150572
	increased interleukin-6 secretion	J:150572
	increased interleukin-12 secretion	J:150572
	increased tumor necrosis factor secretion	J:150572
Dmd^mdx/Y (involves: C57BL/10ScSn)	diaphragmitis	J:140282
Dmd^mdx/Y (involves: C57BL/10ScSn)	myositis	J:140282
Dmd^mdx/Y Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * C57BL/6J * C57BL/10ScSn * SJL)	myositis	J:167294
Dmd^mdx/Y Tg(DMD)#Spc/0 (involves: 129P2/OlaHsd C57BL/10ScSn * DBA/2)	myositis	J:280218
Dmd^mdx/Y Utrn^tm1Jrs/Utrn⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn)	diaphragmitis	J:140282
	myositis	J:140282
Dmd^mdx/Dmd^mdx (C57BL/10ScSn-Dmd^mdx/J)	increased interferon-gamma secretion	J:150572
	increased interleukin-2 secretion	J:150572
	increased interleukin-4 secretion	J:150572
	increased interleukin-6 secretion	J:150572
	increased interleukin-12 secretion	J:150572
	increased tumor necrosis factor secretion	J:150572
	myositis	J:226314
Dmd^mdx/Dmd^mdx (D2.B10-Dmd^mdx/J)	heart inflammation	J:226314
Dmd^mdx/Dmd^mdx (D2.B10-Dmd^mdx/J)	myositis	J:226314
Dmd^mdx/Dmd^mdx Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas * C57BL/6 * C57BL/10ScSn)	myositis	J:162340
Dmd^tm1.1Know/Dmd^tm1.1Know (involves: C3H)	decreased susceptibility to Picornaviridae infection	J:207775
Dmd^tm1.1Know/Dmd^tm1.1Know (involves: C3H)	myocarditis	J:207775
Dmd^tm1Kmf/Y (involves: C57BL/6)	myositis	J:233298
Dmp1^tm1Mis/Dmp1^tm1Mis (involves: 129S7/SvEvBrd * C57BL/6)	increased susceptibility to bacterial infection	J:241769
Dmtf1^tm1Cjs/Dmtf1^tm1Cjs (involves: 129/Sv * C57BL/6)	abnormal T cell physiology	J:63444
Dmxl2^{tm1a(EUCOMM)Wtsi}/Dmxl2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Dmxl2^{tm1a(EUCOMM)Wtsi}/WtsiH)	blood in lymph vessels	J:239583
Dnaaf5^em1Slb/Dnaaf5^em1Slb (C57BL/6-Dnaaf5^em1Slb)	sinus inflammation	J:342770
Dnaaf5^em1Slb/Dnaaf5^em2Slb (C57BL/6-Dnaaf5^em1Slb Dnaaf5^em2Slb)	sinus inflammation	J:342770
Dnah5^Tg1Htz/Dnah5^Tg1Htz (involves: C57BL/6 * CBA/J)	increased susceptibility to otitis media	J:76189
Dnah5^Tg1Htz/Dnah5^Tg1Htz (involves: C57BL/6 * CBA/J)	sinus inflammation	J:76189
Dnai1^tm1.1Leo/Dnai1^tm1.1Leo Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6)	rhinosinusitis	J:155730
Dnajc3^m1Btlr/Dnajc3^m1Btlr (C57BL/6J-Dnajc3^m1Btlr)	increased susceptibility to induced colitis	J:265248
Dnase1^tm1Tmo/Dnase1⁺ (involves: 129P2/OlaHsd * C57BL/6)	glomerulonephritis	J:62549
	increased anti-nuclear antigen antibody level	J:62549
	kidney inflammation	J:62549
Dnase1^tm1Tmo/Dnase1^tm1Tmo (involves: 129P2/OlaHsd * C57BL/6)	glomerulonephritis	J:62549
	increased anti-nuclear antigen antibody level	J:62549
	increased susceptibility to systemic lupus erythematosus	J:62549
	kidney inflammation	J:62549
Dnase1^tm1Tmo/Dnase1^tm1Tmo (involves: 129P2/OlaHsd * CD-1)	decreased susceptibility to systemic lupus erythematosus	J:110060
Dnase1^tm2092.1Arte/Dnase1^tm2092.1Arte (involves: C57BL/6)	glomerulonephritis	J:277126
	increased anti-double stranded DNA antibody level	J:277126
	increased anti-histone antibody level	J:277126
	increased anti-nuclear antigen antibody level	J:277126
	increased autoantibody level	J:277126
	increased susceptibility to systemic lupus erythematosus	J:277126
Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal cytokine level	J:114982
	increased anti-double stranded DNA antibody level	J:114982
	increased autoantibody level	J:238323
	increased circulating interleukin-10 level	J:238323
	increased circulating interleukin-18 level	J:114982
	increased circulating tumor necrosis factor level	J:238323, J:114982
	joint inflammation	J:238323, J:114982
	rheumatoid arthritis	J:238323, J:114982
Dnase2a^tm1Osa/Dnase2a^tm2Osa Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)	abnormal cytokine level	J:114982
	increased circulating interleukin-18 level	J:114982
	increased circulating tumor necrosis factor level	J:114982
	joint inflammation	J:114982
	rheumatoid arthritis	J:114982
Dnmt3b^tm1Enl/Dnmt3b^tm6Enl (involves: 129S4/SvJae * C57BL/6)	increased thymocyte apoptosis	J:106540
Dnmt3b^tm1Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	increased thymocyte apoptosis	J:106540
Dnmt3b^tm6Enl/Dnmt3b^tm6Enl (involves: 129S4/SvJae * C57BL/6)	increased thymocyte apoptosis	J:106540
Dnmt3b^tm6Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	increased thymocyte apoptosis	J:106540
Dnmt3b^tm7Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	increased thymocyte apoptosis	J:106540
Dntt^tm1Gfn/Dntt^tm1Gfn Fas^lpr/Fas^lpr (involves: 129S2/SvPas * C57BL/6 * MRL/MpJ)	decreased autoantibody level	J:110248
Dock2^m1Btlr/Dock2^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	abnormal humoral immune response	J:173592
	decreased IgG level	J:185495
Dock2^m1Hsd/Dock2^m1Hsd Irf5^tm1Ttg/Irf5^tm1Ttg (B6NHsd.Cg-Irf5^tm1Ttg Dock2^m1Hsd)	abnormal response to infection	J:182658
	decreased interferon-alpha secretion	J:182658
Dock2^m1Hsd/Dock2^m1Hsd Siae^tm1.2Avrk/Siae^tm1.2Avrk (B6NHsd.Cg-Siae^tm1.2Avrk Dock2^m1Hsd)	abnormal B cell activation	J:144035
	abnormal immunoglobulin level	J:144035
	glomerulonephritis	J:144035
	increased anti-double stranded DNA antibody level	J:144035
	increased anti-histone antibody level	J:144035
	increased anti-single stranded DNA antibody level	J:144035
	increased B cell proliferation	J:144035
	increased IgE level	J:144035
	increased IgG1 level	J:144035
	increased IgG2a level	J:144035
	increased IgG2b level	J:144035
	increased IgG3 level	J:144035
	increased IgM level	J:144035
Dock2^m2Btlr/Dock2^m2Btlr (C57BL/6J-Dock2^m2Btlr)	abnormal humoral immune response	J:173670
Dock2^m2Btlr/Dock2^m2Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	abnormal humoral immune response	J:185495
	decreased IgG level	J:185495
Dock2^m3Btlr/Dock2^m3Btlr (C57BL/6J-Dock2^m3Btlr)	abnormal humoral immune response	J:191187
Dock2^m3Btlr/Dock2^m3Btlr (C57BL/6J-Dock2^m3Btlr)	abnormal immune system physiology	J:191187
Dock2^m6Btlr/Dock2^m6Btlr (C57BL/6J-Dock2^m6Btlr)	decreased IgE level	J:236689
Dock2^m6Btlr/Dock2^m6Btlr (C57BL/6J-Dock2^m6Btlr)	decreased response to antigen	J:236689
Dock2^m7Btlr/Dock2^m7Btlr (C57BL/6J-Dock2^m7Btlr)	increased IgE level	J:255181
Dock2^tm1Tsas/Dock2^tm1Tsas (involves: C57BL/6)	abnormal leukocyte migration	J:71005
Dock2^tm1Tsas/Dock2^tm1Tsas (B6.Cg-Dock2^tm1Tsas)	impaired neutrophil chemotaxis	J:113266
Dock2^tm1Tsas/Dock2^tm1Tsas Tg(Tcra2B4)1Mmd/? Tg(Tcrb2B4)1Mmd/? (involves: C57BL/6)	abnormal T cell physiology	J:84581
Dock3^tm1Dasc/Dock3^tm1Dasc (B6.Cg-Dock3^tm1Dasc)	abnormal microglial cell physiology	J:144341
Dock8^cpm/Dock8^cpm (C57BL/6JSfdAnu-Dock8^cpm)	abnormal humoral immune response	J:155516
Dock8^m1Anu/Dock8^m1Anu (C57BL/6NCrlAnu-Dock8^m1Anu)	decreased IgM level	J:104190
Dock8^m1Btlr/Dock8^m1Btlr (C57BL/6J-Dock8^m1Btlr)	decreased IgG level	J:234247
Dock8^m1Btlr/Dock8^m1Btlr (C57BL/6J-Dock8^m1Btlr)	impaired humoral immune response	J:234247
Dock8^m2Anu/Dock8^m2Anu (C57BL/6NCrlAnu-Dock8^m2Anu)	decreased IgM level	J:104190
Dock8^M3Btlr/Dock8^M3Btlr (C57BL/6J-Dock8^M3Btlr)	decreased IgG level	J:272531
Dock8^M3Btlr/Dock8^M3Btlr (C57BL/6J-Dock8^M3Btlr)	impaired humoral immune response	J:272531
Dock8^pri/Dock8^pri (C57BL/6JAnu-Dock8^pri)	abnormal humoral immune response	J:155516
Dock8^pri/Dock8^pri (involves: C57BL/6JAnu)	abnormal cellular extravasation	J:238772
Dock8^pri/Dock8^pri (involves: C57BL/6JAnu)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:238772
Dock8^tm1Ysfk/Dock8^tm1Ysfk (B6.Cg-Dock8^tm1Ysfk)	abnormal dendritic cell physiology	J:185165
	decreased IgG level	J:185165
	decreased T cell proliferation	J:185165
Dock10^{tm1a(EUCOMM)Hmgu}/Dock10^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Dock10^{tm1a(EUCOMM)Hmgu}/Ieg)	abnormal B cell physiology	J:236911
	abnormal follicular B cell physiology	J:236911
Dock10^tm1Thar/Dock10^tm1Thar (involves: C57BL/6)	abnormal microglial cell chemotaxis	J:300632
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:300632
	impaired macrophage chemotaxis	J:300632
Dock11^tm1Thar/Dock11^tm1Thar (involves: C57BL/6)	impaired macrophage chemotaxis	J:300632
Dok1^tm1Ppp/Dok1^tm1Ppp (129S1/Sv-Dok1^tm1Ppp)	abnormal T cell proliferation	J:95640
Dok1^tm1Ppp/Dok1^tm1Ppp Dok2^tm1Ppp/Dok2^tm1Ppp (129S1/Sv-Dok1^tm1Ppp Dok2^tm1Ppp)	abnormal leukocyte physiology	J:95334
Dok1^tm1Yyam/Dok1^tm1Yyam (involves: 129S4/SvJae * C57BL/6)	decreased IgM level	J:95641
Dok1^tm1Yyam/Dok1^tm1Yyam (involves: 129S4/SvJae * C57BL/6)	increased B cell proliferation	J:95641
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam (B6.129-Dok1^tm1Yyam Dok2^tm1Yyam)	abnormal leukocyte physiology	J:95335
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:163407
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam Dok3^tm1Brs/Dok3^tm1Brs (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:163407
Dok2^tm1Ppp/Dok2^tm1Ppp (129S1/Sv-Dok2^tm1Ppp)	abnormal granulocyte physiology	J:95334
Dok3^tm1Kplm/Dok3^tm1Kplm (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:280795
	enhanced humoral immune response	J:280795
	increased B cell proliferation	J:280795
	increased IgG3 level	J:280795
	increased IgM level	J:280795
Dpcd/Poll^{Gt(OST280355)Lex}/Dpcd/Poll^{Gt(OST280355)Lex} (involves: 129S5/SvEvBrd * C57BL/6Brd)	increased susceptibility to otitis media	J:185566
Dpp3^{tm1d(EUCOMM)Hmgu}/Dpp3^{tm1d(EUCOMM)Hmgu} (involves: BALB/c * C57BL/6 * C57BL/6J * C57BL/6N * SJL)	abnormal interferon-gamma secretion	J:294242
	increased interleukin-1 beta secretion	J:294242
	increased interleukin-6 secretion	J:294242
	increased interleukin-10 secretion	J:294242
	increased tumor necrosis factor secretion	J:294242
Dpp4^em1Rba/Dpp4⁺ (C57BL/6J-Dpp4^em1Rba)	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	J:279834
	increased susceptibility to Coronaviridae infection	J:279834
	lung inflammation	J:279834
Dpp4^em1Rba/Dpp4^em1Rba (C57BL/6J-Dpp4^em1Rba)	increased susceptibility to Coronaviridae infection	J:279723, J:279834
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:279834
	lung inflammation	J:279834
Dpp4^{tm1(DPP4)Vlcg}/? (involves: 129S6/SvEvTac * C57BL/6NTac)	increased susceptibility to Coronaviridae infection	J:223728
	interstitial pneumonia	J:223728
	lung inflammation	J:223728
Dpp4^{tm1(DPP4)Vlcg}/? (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased susceptibility to Coronaviridae infection	J:238079
	lung inflammation	J:238079
	pleuritis	J:238079
Dpp4^{tm1.1(DPP4)Pbmj}/Dpp4^{tm1.1(DPP4)Pbmj} (involves: C57BL/6 * C57BL/6NTac)	increased susceptibility to Coronaviridae infection	J:242025
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:242025
	lung inflammation	J:242025
Drd1^tm1Jcd/Drd1^tm1Jcd Drd2^tm1Ebo/Drd2⁺ (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	small intestinal inflammation	J:91781
Drd1^tm2Jcd/Drd1⁺ Tg(Camk2a-cre)2Gsc/0 (involves: 129S4/SvJae * FVB/N)	abnormal microglial cell physiology	J:120070
Drd2^tm1Low/Drd2^tm1Low (B6.129S2-Drd2^tm1Low/J)	increased interleukin-1 beta secretion	J:194407
Drosha^tm1Litt/Drosha^tm1.1Litt Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal interferon-gamma secretion	J:138683
	abnormal interleukin-4 secretion	J:138683
	abnormal T cell activation	J:138683
	blood vessel inflammation	J:138683
	liver inflammation	J:138683
	lung inflammation	J:138683
Drosha^tm1Litt/Drosha^tm1.1Litt Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal interferon-gamma secretion	J:138683
	abnormal interleukin-4 secretion	J:138683
	abnormal T cell activation	J:138683
	blood vessel inflammation	J:138683
	liver inflammation	J:138683
	lung inflammation	J:138683
Drosha^tm1Litt/Drosha^tm1.1Litt Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal interferon-gamma secretion	J:138683
Drosha^tm1Litt/Drosha^tm1.1Litt Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	abnormal immune system physiology	J:138683
	intestinal inflammation	J:138683
	liver inflammation	J:138683
	lung inflammation	J:138683
Dsc1^tm1Dga/Dsc1^tm1Dga (involves: C57BL/6J)	dermatitis	J:73102
Dsg2^m1Btlr/Dsg2^m1Btlr (C57BL/6J-Dsg2^m1Btlr)	increased susceptibility to induced colitis	J:271975
Dsg2^m2Btlr/Dsg2^m2Btlr (C57BL/6J-Dsg2^m2Btlr)	increased susceptibility to induced colitis	J:271976
Dsg2^m3Btlr/Dsg2^m3Btlr (C57BL/6J-Dsg2^m3Btlr)	increased susceptibility to induced colitis	J:271977
Dsg2^{tm1d(EUCOMM)Wtsi}/Dsg2^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	heart inflammation	J:235770
Dsg2^tm3.1Leu/Dsg2^tm3.1Leu Tg(Vil1-cre)20Syr/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	increased susceptibility to colitis induced morbidity/mortality	J:302333
	increased susceptibility to induced colitis	J:302333
Dsg3^bal/Dsg3^bal (C57BL/6J-Dsg3^bal/J)	increased IgE level	J:18223
Dsg3^sqk/Dsg3^sqk (C57BL/6-Dsg3^sqk)	conjunctivitis	J:219200
Dsg3^sqk/Dsg3^sqk (C57BL/6-Dsg3^sqk)	increased susceptibility to infection	J:219200
Dsg3^tm1Stan/Dsg3^tm1Stan (involves: 129X1/SvJ * C57BL/6J)	conjunctivitis	J:40804
Dsg4^lah-J/Dsg4^lah-J (involves: DBA/1LacJ)	dermatitis	J:83117
Dsg4^lah-J/Dsg4^lah-J (involves: DBA/1LacJ)	increased IgE level	J:83117
Dsg4^lah/Dsg4^lah (LAH/Pas)	dermatitis	J:33849
Dspp^tm1Kul/Dspp^tm1Kul (B6;129-Dspp^tm1Kul/Mmnc)	periodontium inflammation	J:241990
Dssc1^C3H/HeJ/Dssc1^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	colitis	J:52852
Dssc1^C57BL/6J/Dssc1^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	colitis	J:52852
Dssc2^C3H/HeJ/Dssc2^C3H/HeJ (involves: C3H/HeJ * C57BL/6J)	colitis	J:52852
Dssc2^C3H/HeJ/Dssc2^C57BL/6J (involves: C3H/HeJ * C57BL/6J)	colitis	J:52852
Dst^Tg4/Dst^Tg4 (involves: C57BL/6 * CD-1)	conjunctivitis	J:209161
Dtnbp1^sdy-Btlr/Dtnbp1^sdy-Btlr (C57BL/6J-Dtnbp1^sdy-Btlr)	impaired natural killer cell mediated cytotoxicity	J:133620
Dtnbp1^sdy-Btlr/Dtnbp1^sdy-Btlr (C57BL/6J-Dtnbp1^sdy-Btlr)	increased susceptibility to Herpesvirales infection	J:133620
Dtx1^tm1.1Mzl/Dtx1^tm1.1Mzl Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal thymocyte activation	J:151605
	increased anti-double stranded DNA antibody level	J:151605
	increased anti-histone antibody level	J:151605
	increased autoantibody level	J:151605
	increased interleukin-2 secretion	J:151605
	increased T cell proliferation	J:151605
Dtx1^tm1.2Mzl/Dtx1^tm1.2Mzl (B6.129-Dtx1^tm1.2Mzl)	abnormal lymphocyte physiology	J:151605
	abnormal regulatory T cell physiology	J:151605
	abnormal T cell anergy	J:151605
	abnormal thymocyte activation	J:151605
	decreased thymocyte apoptosis	J:151605
	glomerulonephritis	J:151605
	increased anti-double stranded DNA antibody level	J:151605
	increased anti-histone antibody level	J:151605
	increased B cell proliferation	J:151605
	increased interferon-gamma secretion	J:151605
	increased interleukin-2 secretion	J:151605
	increased interleukin-4 secretion	J:151605
	increased T cell proliferation	J:151605
	liver inflammation	J:151605
	lung inflammation	J:151605
Ducm1^129X1/SvJ/Ducm1^129X1/SvJ (involves: 129X1/SvJ * C57BL/6J)	abnormal professional antigen presenting cell physiology	J:86617
Ducm1^129X1/SvJ/Ducm1^C57BL/6J (involves: 129X1/SvJ * C57BL/6J)	abnormal professional antigen presenting cell physiology	J:86617
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas)	abnormal cytokine secretion	J:118832
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas)	lung inflammation	J:118832
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas * C57BL/6)	increased circulating interleukin-6 level	J:118833
	increased circulating interleukin-10 level	J:118833
	increased circulating tumor necrosis factor level	J:118833
	increased interleukin-6 secretion	J:118833
	increased susceptibility to endotoxin shock	J:118833
	increased tumor necrosis factor secretion	J:118833
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas * various)	increased mast cell degranulation	J:125919
Dusp1^tm1Brv/Dusp1^tm1Brv (involves: 129S2/SvPas * various)	increased susceptibility to type I hypersensitivity reaction	J:125919
Dusp1^tm1Brv/Dusp1^tm1Brv (C3.129S2-Dusp1^tm1Brv)	abnormal chemokine secretion	J:164929
	increased interleukin-1 beta secretion	J:164929
	increased interleukin-6 secretion	J:164929
	increased susceptibility to bacterial infection	J:164929
	lung inflammation	J:164929
Dusp1^tm1Lex/Dusp1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal chemokine level	J:126383
	abnormal innate immunity	J:126383
	abnormal interleukin level	J:126383
	increased circulating interferon-gamma level	J:126383
	increased circulating interleukin-6 level	J:126383
	increased circulating interleukin-10 level	J:126383
	increased circulating tumor necrosis factor level	J:126383
	increased susceptibility to endotoxin shock	J:126383
	increased susceptibility to induced arthritis	J:126383
Dusp2^tm1Cmac/Dusp2^tm1Cmac (B6.Cg-Dusp2^tm1Cmac)	abnormal cytokine secretion	J:112609
	abnormal macrophage activation involved in immune response	J:112609
	abnormal mast cell physiology	J:112609
	decreased susceptibility to induced arthritis	J:112609
Dusp4^Gt(XG164)Byg/Dusp4^Gt(XG164)Byg (B6.129P2-Dusp4^Gt(XG164)Byg)	increased interleukin-10 secretion	J:180366
	increased T cell proliferation	J:180366
Dusp4^tm1Jmol/Dusp4^tm1Jmol (involves: 129)	decreased B cell apoptosis	J:140567
Dusp4^tm1Plev/Dusp4^tm1Plev (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:170774
	decreased IgG2a level	J:170774
	decreased interferon-gamma secretion	J:170774
	decreased interleukin-10 secretion	J:170774
	increased IgG1 level	J:170774
	increased interleukin-4 secretion	J:170774
	increased interleukin-6 secretion	J:170774
	increased interleukin-12 secretion	J:170774
	increased interleukin-13 secretion	J:170774
	increased susceptibility to parasitic infection	J:170774
	increased tumor necrosis factor secretion	J:170774
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn (involves: C57BL/6NCrl)	abnormal susceptibility to parasitic infection	J:218203
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn (involves: C57BL/6NCrl)	increased T cell proliferation	J:218203
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn Rag2^tm1.1Cgn/Rag2^tm1.1Cgn (involves: C57BL/6NCrl)	abnormal eosinophil physiology	J:218203
	abnormal susceptibility to parasitic infection	J:218203
Dusp5^{tm1a(KOMP)Wtsi}/Dusp5^{tm1a(KOMP)Wtsi} (C57BL/6-Dusp5^{tm1a(KOMP)Wtsi})	abnormal T cell physiology	J:240637
	increased T cell apoptosis	J:240637
	increased T cell proliferation	J:240637
Dusp5^{tm1d(KOMP)Wtsi}/Dusp5^{tm1d(KOMP)Wtsi} (B6(Cg)-Dusp5^{tm1d(KOMP)Wtsi})	increased T cell apoptosis	J:240637
Dusp10^tm1Flv/Dusp10^tm1Flv (involves: 129S6/SvEvTac)	abnormal adaptive immunity	J:92104
	abnormal cytokine secretion	J:92104
	abnormal interleukin secretion	J:92104
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:92104
	decreased T cell proliferation	J:92104
	increased interferon-gamma secretion	J:92104
	increased susceptibility to type I hypersensitivity reaction	J:92104
	increased tumor necrosis factor secretion	J:92104
Dusp11^{Gt(BB0198)Wtsi}/Dusp11^{Gt(BB0198)Wtsi} (B6.129P2-Dusp11^{Gt(BB0198)Wtsi})	abnormal macrophage activation involved in immune response	J:301503
	increased circulating interleukin-1 beta level	J:301503
	increased circulating interleukin-6 level	J:301503
	increased circulating tumor necrosis factor level	J:301503
	increased macrophage cytokine production	J:301503
	increased susceptibility to endotoxin shock	J:301503
Dusp14^{Gt(OST210117)Lex}/Dusp14^{Gt(OST210117)Lex} (B6.129S5-Dusp14^{Gt(OST210117)Lex})	abnormal cytokine secretion	J:209403
	abnormal humoral immune response	J:209403
	abnormal T cell activation	J:209403
	increased susceptibility to experimental autoimmune encephalomyelitis	J:209403
	increased T cell proliferation	J:209403
Dusp22^tm1Tht/Dusp22^tm1Tht (B6.129S7-Dusp22^tm1Tht)	abnormal B cell activation	J:213253
	abnormal cytokine level	J:213253
	abnormal T cell activation	J:213253
	decreased B cell proliferation	J:213253
	decreased IgG3 level	J:213253
	decreased IgM level	J:213253
	decreased immunoglobulin level	J:213253
	increased circulating interferon-gamma level	J:213253
	increased circulating interleukin-6 level	J:213253
	increased circulating interleukin-17 level	J:213253
	increased circulating tumor necrosis factor level	J:213253
	increased inflammatory response	J:213253
	increased interferon-gamma secretion	J:213253
	increased interleukin-2 secretion	J:213253
	increased interleukin-4 secretion	J:213253
	increased interleukin-17 secretion	J:213253
	increased susceptibility to autoimmune disorder	J:213253
	increased susceptibility to experimental autoimmune encephalomyelitis	J:213253
	increased T cell proliferation	J:213253
	kidney inflammation	J:213253
	liver inflammation	J:213253
	lung inflammation	J:213253
Dyrk1a^tm1Jdc/Dyrk1a^tm1Jdc Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)	increased T cell apoptosis	J:223138
Dysf^im/Dysf⁺ Large1^myd/Large1^myd (involves: C57BL/6 * SJL/J)	myositis	J:221523
Dysf^im/Dysf^im Fktn^tm1Ttd/Fktn^tm2(FCMD)Ttd (involves: 129S7/SvEvBrd * C57BL/6 * SJL/J)	myositis	J:221523
Dysf^im/Dysf^im Large1^myd/Large1^myd (involves: C57BL/6 * SJL/J)	myositis	J:221523
Dysf^tm1Kcam/Dysf^tm1Kcam (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	myositis	J:171870
E2f1^tm1Meg/E2f1^tm1Meg (NOD.Cg-E2f1^tm1Meg)	increased interferon-gamma secretion	J:93708
	increased interleukin-4 secretion	J:93708
	increased susceptibility to autoimmune diabetes	J:93708
	insulitis	J:93708
	salivary gland inflammation	J:93708
E2f1^tm1Meg/E2f1^tm1Meg (involves: 129S4/SvJae * C57BL/6)	decreased T cell proliferation	J:76318
E2f2^tm1Zubi/E2f2^tm1Zubi (involves: 129S1/Sv * C57BL/6)	abnormal immune system physiology	J:76318
	glomerulonephritis	J:76318
	increased anti-double stranded DNA antibody level	J:76318
	increased inflammatory response	J:76318
	increased susceptibility to autoimmune disorder	J:76318
	increased T cell proliferation	J:76318
	liver inflammation	J:76318
	lung inflammation	J:76318
E2f2^tm1Zubi/E2f2^tm1Zubi Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)	abnormal immune system physiology	J:76318
	increased inflammatory response	J:76318
	increased susceptibility to autoimmune disorder	J:76318
	increased T cell proliferation	J:76318
E2f3^tm1Lees/E2f3^tm1Lees (involves: 129S2/SvPas * C57BL/6)	lung inflammation	J:75765
E2f4^tm1Lees/E2f4^tm1Lees (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to bacterial infection	J:64193
	increased susceptibility to otitis media	J:64193
	rhinitis	J:64193
E2f4^tm1Lees/E2f4^tm1Lees Rb1^tm1Tyj/Rb1⁺ (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to infection	J:81082
Eae1^A/J/Eae1^A/J (involves: A/J * C57BL/10SnJ)	increased susceptibility to experimental autoimmune encephalomyelitis	J:30574
Eae1^PL/J/Eae1^PL/J (involves: C57BL/10SnJ * PL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:30574
Eae2^B10.RIII/Eae2^RIIIS/J (involves: B10.RIII * RIIIS/J)	arthritis	J:95848
Eae2^RIIIS/J/Eae2^RIIIS/J (involves: B10.RIII * RIIIS/J)	decreased susceptibility to induced arthritis	J:95848
Eae2b^C57BL/10SnSg/Eae2b^C57BL/10SnSg (involves: B10.RIII * RIIIS/J)	CNS inflammation	J:96204
Eae4^ABH/? (involves: ABH * NOD)	increased susceptibility to experimental autoimmune encephalomyelitis	J:29171
Eae5^B10.S/DvTe/Eae5^SJL/J (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae5^SJL/J/Eae5^SJL/J (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae7^B10.S/DvTe/Eae7^B10.S/DvTe (involves: B10.S/DvTe * SJL/J)	brain inflammation	J:49054
	increased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae7^B10.S/DvTe/Eae7^SJL/J (involves: B10.S/DvTe * SJL/J)	brain inflammation	J:49054
Eae7^B10.S/DvTe/Eae7^SJL/J (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae7^SJL/J/Eae7^SJL/J (involves: B10.S/DvTe * SJL/J)	brain inflammation	J:49054
Eae7^SJL/J/Eae7^SJL/J (involves: B10.S/DvTe * SJL/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae9^B10.S/DvTe/Eae9^SJL/J (involves: B10.S/DvTe * SJL/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae10^SJL/J/Eae10^SJL/J (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae11^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:53193
Eae12^SJL/J/Eae12^SJL/J (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:53193
Eae13^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:53193
Eae14^C57BL/10/? (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:69083
Eae16^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased inflammatory response	J:67840
Eae17^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:69083
Eae18^NOD/Eae18^NOD (involves: ABH * NOD)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:29171
Eae21^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased inflammatory response	J:67840
Eae22^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased inflammatory response	J:67840
Eae23^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased inflammatory response	J:67840
Eae25^SJL/J/? (involves: B10.S/DvTe * SJL/J)	increased inflammatory response	J:69083
Eae26^B10.RIII/Eae26^B10.RIII (involves: B10.RIII * RIIIS/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:73850
Eae26^B10.RIII/Eae26^RIIIS/J (involves: B10.RIII * RIIIS/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:73850
Eae27^C57BL/10SnSg/Eae27^RIIIS/J (involves: B10.RIII * RIIIS/J)	CNS inflammation	J:96204
Eae27^RIIIS/J/Eae27^RIIIS/J (involves: B10.RIII * RIIIS/J)	CNS inflammation	J:96204
Eae33^C57BL/10SnSg/? (involves: B10.S * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:99793
Eae34^C57BL/10SnSg/? (involves: B10.S * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:99793
Eae35^C57BL/10SnSg/? (involves: B10.S * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:99793
Eae36^SJL/J/? (involves: B10.S * SJL/J)	increased susceptibility to autoimmune disorder	J:99793
Eae37^C57BL/10SnSg/? (involves: B10.S * SJL/J)	increased susceptibility to autoimmune disorder	J:99793
Eae38^C57BL/10SnSg/? (involves: B10.S * SJL/J)	increased susceptibility to autoimmune disorder	J:99793
Eae39^C57BL/10SnSg/Eae39^RIIIS/J (involves: B10.RIII * RIIIS/J)	CNS inflammation	J:96204
Eae39^RIIIS/J/Eae39^RIIIS/J (involves: B10.RIII * RIIIS/J)	CNS inflammation	J:96204
Eae41^C57BL/10SnSg/Eae41^C57BL/10SnSg (involves: B10.RIII * RIIIS/J)	CNS inflammation	J:96204
Eae42^C57BL/10SnSg/? (involves: B10.S * SJL/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:34892
Eae42^SJL/J/? (involves: B10.S * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:34892
Eae43^B10.S/DvTe/? (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:53193
Eae43^B10.S/DvTe/Eae43^B10.S/DvTe (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Eae44a^B10.S/DvTe/Eae44a^B10.S/DvTe (involves: B10.S/DvTe * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:56752
Eae44a^B10.S/DvTe/Eae44a^SJL/J (involves: B10.S/DvTe * SJL/J)	brain inflammation	J:49054
Eae44a^SJL/J/Eae44a^SJL/J (involves: B10.S/DvTe * SJL/J)	brain inflammation	J:49054
Eae44b^B10.S/DvTe/Eae44b^SJL/J (involves: B10.S/DvTe * SJL/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:56752
Eae44b^SJL/J/Eae44b^SJL/J (involves: B10.S/DvTe * SJL/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:56752
Eaf1^tm1.1Zhow/Eaf1^tm1.1Zhow Eaf2^tm1Zhow/Eaf2^tm1Zhow Tg(Pbsn-cre)4Prb/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * DBA/2)	prostate gland inflammation	J:288972
Eaf1^tm1.1Zhow/Eaf1^tm1.1Zhow Tg(Pbsn-cre)4Prb/0 (B6(Cg)-Eaf1^tm1.1Zhow Tg(Pbsn-cre)4Prb)	prostate gland inflammation	J:288972
Eaf2^tm1Zhow/Eaf2^tm1Zhow (involves: 129P2/OlaHsd)	prostate gland inflammation	J:288972
Eamcd1^A/WySn/Eamcd1^A/WySn (B10.A-(D1Mit65-D1Mit334))	myocarditis	J:145043
Eamcd2^A/WySn/Eamcd2^A/WySn (involves: A.SW-H2^s/J * B10.S-H2^s/J)	myocarditis	J:96562
Ebag9^tm1Rehm/Ebag9^tm1Rehm (either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal cytotoxic T cell physiology	J:152534
	abnormal memory T cell physiology	J:152534
	decreased susceptibility to bacterial infection	J:152534
Ebf1^m1Btlr/Ebf1^m1Btlr (C57BL/6J-Ebf1^m1Btlr)	decreased IgD level	J:265157
Ebf1^m2Btlr/Ebf1^m2Btlr (C57BL/6J-Ebf1^m2Btlr)	abnormal humoral immune response	J:265158
	decreased IgD level	J:265158
	decreased IgM level	J:265158
	increased IgM level	J:265158
	increased tumor necrosis factor secretion	J:265158
Ebf1^m6Btlr/Ebf1^m6Btlr (C57BL/6J-Ebf1^m6Btlr)	decreased IgD level	J:272842
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ (involves: C57BL/6 * SJL)	abnormal germinal center B cell physiology	J:182210
	decreased B cell proliferation	J:182210
	decreased IgG1 level	J:182210
	decreased IgG3 level	J:182210
	increased B cell apoptosis	J:182210
Ebf1^tm1Rug/Ebf1^tm1Rug (involves: 129S2/SvPas)	decreased IgM level	J:52607
Ebi3^Gt716Lex/Ebi3^Gt716Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal T cell activation	J:286951
	brain inflammation	J:286951
	decreased interleukin-10 secretion	J:286951
	increased interferon-gamma secretion	J:286951
	increased susceptibility to Coronaviridae infection	J:286951
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:286951
Ebi3^Gt716Lex/Ebi3^Gt716Lex Tg(DO11.10)10Dlo/0 (involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)	abnormal circulating interleukin level	J:134148
	decreased susceptibility to bacterial infection	J:134148
	increased circulating interleukin-17 level	J:134148
	increased interleukin-17 secretion	J:134148
Ebi3^tm1Nkma/Ebi3^tm1Nkma Fas^lpr/Fas^lpr (MRL.Cg-Ebi3^tm1Nkma Fas^lpr)	abnormal cytokine level	J:181669
	decreased circulating interferon-gamma level	J:181669
	increased circulating interleukin-4 level	J:181669
	increased IgE level	J:181669
	increased IgG1 level	J:181669
	increased IgG level	J:181669
	increased immunoglobulin level	J:181669
Ebi3^tm1Rsb/Ebi3^tm1Rsb (involves: 129X1/SvJ * C57BL/6)	abnormal immune system physiology	J:81014
	decreased interleukin-4 secretion	J:81014
	decreased susceptibility to induced colitis	J:81014
	increased interferon-gamma secretion	J:81014
	increased susceptibility to parasitic infection	J:97822
Ecm1^tm1Bsun/Ecm1^tm1Bsun (involves: 129 * C57BL/6)	abnormal T-helper 2 physiology	J:168252
	decreased IgE level	J:168252
	decreased susceptibility to type I hypersensitivity reaction	J:168252
	increased susceptibility to autoimmune disorder	J:168252
Eda^Ta-6J/Y (C57BL/6J A^w-J-Eda^Ta-6J/J)	blepharitis	J:99510
	conjunctivitis	J:99510
	corneal limbitis	J:99510
	eye inflammation	J:99510
	increased incidence of corneal inflammation	J:99510
Edil3^Tg(lacZ)1Tq/Edil3^Tg(lacZ)1Tq (Not Specified)	increased susceptibility to induced arthritis	J:254384
Edil3^tm1Tq/Edil3^tm1Tq (B6.129S6-Edil3^tm1Tq)	abnormal cellular extravasation	J:141063
	abnormal leukocyte adhesion	J:141063
	abnormal neutrophil physiology	J:141063
	enhanced leukocyte tethering or rolling	J:141063
Edil3^tm1Tq/Edil3^tm1Tq Itgal^tm1Bll/Itgal^tm1Bll (involves: 129 * C57BL/6)	abnormal cellular extravasation	J:141063
	abnormal neutrophil physiology	J:141063
Ednrb^tm1Nrd/Ednrb^tm1Nrd Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}/Gt(ROSA)26Sor⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)	decreased IgA level	J:233811
	large intestinal inflammation	J:233811
Ednrb^tm1Ywa/Ednrb⁺ (involves: 129S/SvEvBrd)	decreased acute inflammation	J:103977
Ednrb^tm1Ywa/Ednrb^tm1Ywa (involves: 129S5/SvEvBrd)	decreased acute inflammation	J:103977
Eef1a2^wst/Eef1a2^wst (B6C3Fe a/a-Eef1a2^wst/J)	decreased susceptibility to type IV hypersensitivity reaction	J:6766
Eef1e1^{Gt(OST377244)Lex}/Eef1e1⁺ (involves: 129S5/SvEvBrd * C57BL/6)	decreased splenocyte apoptosis	J:96923
	increased splenocyte proliferation	J:96923
Efhd2^{tm1(KOMP)Vlcg}/Efhd2^{tm1(KOMP)Vlcg} (C57BL/6-Efhd2^{tm1(KOMP)Vlcg})	abnormal response to infection	J:228565
	increased IgE level	J:228565
	increased IgG1 level	J:228565
	increased IgG2a level	J:228565
	increased IgM level	J:228565
Efnb1^tm1.1Jwu/Efnb1^tm1.1Jwu Efnb2^tm1.1Jwu/Efnb2^tm1.1Jwu Tg(Lck-cre)I540Jxm/0 (B6.Cg-Efnb2^tm1.1Jwu Efnb1^tm1.1Jwu Tg(Lck-cre)I540Jxm)	increased length of allograft survival	J:178148
	increased susceptibility to Riboviria infection	J:178148
	increased thymocyte apoptosis	J:178148
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: C57BL/6)	abnormal lymph circulation	J:95885
Efnb2^tm6Kln/Efnb2^tm6Kln (involves: C57BL/6)	abnormal lymph circulation	J:95885
Efs^tm1Kale/Efs⁺ (either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))	increased IgA level	J:103757
	increased IgG level	J:103757
	increased inflammatory response	J:103757
	small intestinal inflammation	J:103757
Efs^tm1Kale/Efs^tm1Kale (either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))	abnormal interleukin secretion	J:103757
	abnormal T cell physiology	J:103757
	increased IgA level	J:103757
	increased IgG level	J:103757
	increased immunoglobulin level	J:103757
	increased inflammatory response	J:103757
	increased interferon-gamma secretion	J:103757
	kidney inflammation	J:103757
	liver inflammation	J:103757
	lung inflammation	J:103757
	small intestinal inflammation	J:103757
Egfr^Mhdadsk5/Egfr⁺ (involves: 129S1/SvImJ * C3HeB/FeJ)	increased susceptibility to Coronaviridae infection	J:243599
Egfr^Mhdadsk5/Egfr⁺ (involves: 129S1/SvImJ * C3HeB/FeJ)	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:243599
Egfr^tm1Dwt/Egfr^tm1Dwt Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	dermatitis	J:229771
	increased IgE level	J:229771
Egfr^tm1Msi/Egfr^tm1Msi Tg(Alb1-cre)7Gsc/? (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	increased circulating tumor necrosis factor level	J:125912
Egfr^tm1Msi/Egfr^tm1Msi Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased circulating tumor necrosis factor level	J:125912
Egr1^tm1Jmi/Egr1^tm1Jmi (B6.129-Egr1^tm1Jmi)	abnormal circulating tumor necrosis factor level	J:128421
Egr1^tm1Jmi/Egr1^tm1Jmi (B6.129-Egr1^tm1Jmi)	liver inflammation	J:128421
Egr1^tm1Jmi/Egr1^tm1Jmi (involves: 129 * C57BL/6)	abnormal microglial cell physiology	J:135238
	abnormal tumor necrosis factor level	J:105638
	decreased inflammatory response	J:152898
Egr1^tm1Jmi/Egr1^tm1Jmi Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1)1Eli/? (involves: 129 C57BL/6)	lung inflammation	J:92469
Ehbp1l1^{tm1a(EUCOMM)Wtsi}/Ehbp1l1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ehbp1l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Ehmt2^tm1.1Cza/Ehmt2^tm1.1Cza Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased IgG1 level	J:160938
	decreased interleukin-4 secretion	J:160938
	increased IgG2a level	J:160938
	increased interferon-gamma secretion	J:160938
	increased susceptibility to parasitic infection	J:160938
Ehmt2^tm1.1Cza/Ehmt2^tm1.1Cza Tg(VAV1-cre)1Graf/0 (involves: C57BL/6 * SJL)	decreased interleukin-4 secretion	J:160938
	decreased interleukin-5 secretion	J:160938
	decreased interleukin-13 secretion	J:160938
	increased interferon-gamma secretion	J:160938
	increased interleukin-17 secretion	J:160938
	increased susceptibility to parasitic infection	J:160938
Eif2ak2^tm1Cwe/Eif2ak2^tm1Cwe (involves: 129S/SvEv * C57BL/6)	increased interleukin-4 secretion	J:66112
	increased susceptibility to Picornaviridae infection	J:30617
	increased susceptibility to type IV hypersensitivity reaction	J:66112
	increased T cell proliferation	J:66112
Eif2ak2^tm1Cwe/Eif2ak2^tm1Cwe Rnasel^tm1Slvm/Rnasel^tm1Slvm (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	increased susceptibility to Picornaviridae infection	J:55974
Eif2ak2^tm1Jcbe/Eif2ak2^tm1Jcbe (involves: 129S4/SvJae)	increased susceptibility to Orthomyxoviridae infection	J:63671
Eif2ak2^tm1Jcbe/Eif2ak2^tm1Jcbe (involves: 129S4/SvJae)	increased susceptibility to Riboviria infection	J:167126, J:63671
Eif2ak3^tm1.1Drc/Eif2ak3^tm1.1Drc Tg(Ela1-cre)16Eps/0 (involves: 129S6/SvEvTac)	acute pancreas inflammation	J:129974
Eif2ak4^m1Btlr/Eif2ak4^m1Btlr (C57BL/6J-Eif2ak4^m1Btlr)	abnormal macrophage physiology	J:173669
	increased susceptibility to Adenoviridae infection	J:173669
	increased susceptibility to Herpesvirales infection	J:173669
Eif2ak4^tm1.2Dron/Eif2ak4^tm1.2Dron (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal cytokine secretion	J:120813
	abnormal dendritic cell physiology	J:120813
Eif2b5^tm1Itl/Eif2b5^tm1Itl (involves: 129S/SvEv)	abnormal microglial cell physiology	J:192103
Eif4b^tm1.1Smoc/Eif4b⁺ Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * C57BL/6)	increased susceptibility to Riboviria infection	J:311140
Eif4b^tm1.1Smoc/Eif4b^tm1.1Smoc Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129 * C57BL/6)	increased susceptibility to induced colitis	J:311140
	increased susceptibility to Orthomyxoviridae infection	J:311140
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:311140
	lung inflammation	J:311140
Eif4b^tm1.1Smoc/Eif4b^tm1.1Smoc Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * C57BL/6)	increased susceptibility to Orthomyxoviridae infection	J:311140
Elac2^em1Afi/Elac2^em1Afi (C57BL/6N-Elac2^em1Afi)	prostate gland inflammation	J:336403
Elane^M1Btlr/Elane^M1Btlr (C57BL/6J-Elane^M1Btlr)	decreased tumor necrosis factor secretion	J:218967
Elane^tm1(cre)Roes/Elane^tm1(cre)Roes (involves: 129)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:77597
Elane^tm1(cre)Roes/Elane^tm1(cre)Roes (involves: 129)	increased susceptibility to infection induced morbidity/mortality	J:77597
Elane^tm1(cre)Roes/Elane^tm1(cre)Roes (involves: 129S6/SvEvTac)	impaired neutrophil recruitment	J:137674
Elane^tm1Sds/Elane^tm1Sds (129X1/SvJ-Elane^tm1Sds)	abnormal neutrophil physiology	J:47420
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:47420
	increased susceptibility to bacterial infection	J:47420
	increased susceptibility to bacterial infection induced morbidity/mortality	J:47420
Elane^tm1Sds/Elane^tm1Sds (involves: 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:113463
Elavl1^tm1.1Atas/Elavl1^tm1.1Atas Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:207013
	decreased T cell proliferation	J:207013
Elavl1^tm1.1Dkon/Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129P2-Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo)	abnormal macrophage chemotaxis	J:184388
	increased circulating interleukin-1 beta level	J:184388
	increased circulating interleukin-6 level	J:184388
	increased circulating interleukin-12 level	J:184388
	increased circulating tumor necrosis factor level	J:184388
	increased susceptibility to endotoxin shock	J:184388
	increased susceptibility to induced colitis	J:184388
Elavl1^tm1.1Dkon/Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating interleukin-1 beta level	J:184388
	increased circulating interleukin-6 level	J:184388
	increased circulating interleukin-12 level	J:184388
	increased circulating tumor necrosis factor level	J:184388
	increased susceptibility to endotoxin shock	J:184388
Elavl1^tm1Dkon/Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm/0 (B6.Cg-Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm)	abnormal T cell physiology	J:148866
	abnormal thymocyte activation	J:148866
Elavl1^tm1Lix/Elavl1^tm1Lix Tg(Scgb1a1-rtTA)2Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * C57BL/6)	decreased inflammatory response	J:204952
	lung inflammation	J:204952
Elavl1^tm1Thla/Elavl1^tm1Thla Gt(ROSA)26Sor^{tm1(cre/ERT2)Alj}/Gt(ROSA)26Sor⁺ (involves: 129)	abnormal B cell physiology	J:155109
	decreased B cell apoptosis	J:155109
	increased T cell apoptosis	J:155109
Elf1^tm1Jml/Elf1^tm1Jml (Not Specified)	abnormal B cell physiology	J:100734
Elf4^em1Hdu/Elf4^em1Hdu (C57BL/6-Elf4^em1Hdu)	abnormal interferon level	J:328935
	abnormal interleukin level	J:328935
	abnormal macrophage physiology	J:328935
	abnormal tumor necrosis factor level	J:328935
	increased susceptibility to viral infection	J:328935
Elf4^tm1Nim/Elf4^tm1Nim (B6.129S1-Elf4^tm1Nim)	abnormal inflammatory response	J:79568
	abnormal lymphocyte physiology	J:79568
	abnormal NK cell physiology	J:79568
	decreased cytotoxic T cell cytolysis	J:79568
	impaired natural killer cell mediated cytotoxicity	J:79568
	increased B cell proliferation	J:79568
	increased T cell proliferation	J:79568
Elmo1^M1Btlr/Elmo1^M1Btlr (C57BL/6J-Elmo1^M1Btlr)	decreased IgM level	J:265231
Elmo1^M1Btlr/Elmo1^M1Btlr (C57BL/6J-Elmo1^M1Btlr)	impaired humoral immune response	J:265231
Elovl3^tm1Jaco/Elovl3^tm1Jaco (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	dermatitis	J:88477
Elp1^tm1Id/Elp1^tm1.1Id Tg(Hsp70-1-cre)6Arge/0 (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)	conjunctivitis	J:188923
Elp1^tm1Id/Elp1^tm1Id Tg(Hsp70-1-cre)6Arge/0 (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)	conjunctivitis	J:188923
Elsgp1^C57BL/6J/Elsgp1^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	abnormal immune serum protein physiology	J:63674
Elsgp1^NZB/BlNJ/Elsgp1^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	abnormal immune serum protein physiology	J:63674
Elsgp1^NZB/BlNJ/Elsgp1^NZB/BlNJ Elsgp2^NZB/BlNJ/Elsgp2^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	abnormal immune serum protein physiology	J:63674
Elsgp2^C57BL/6J/Elsgp2^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	abnormal immune serum protein physiology	J:63674
Elsgp2^NZB/BlNJ/Elsgp2^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	abnormal immune serum protein physiology	J:63674
Elsgp3^C57BL/6J/Elsgp3^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	abnormal immune serum protein physiology	J:63674
Elsgp3^NZB/BlNJ/Elsgp3^NZB/BlNJ (involves: C57BL/6J * NZB/BlNJ)	abnormal immune serum protein physiology	J:63674
Elsgp4^NZB/BlNJ/Elsgp4^NZB/BlNJ (involves: BALB/cByJ * NZB/BlNJ)	abnormal immune serum protein physiology	J:89134
Elsgp4^NZW/LacJ/? (involves: BALB/cByJ * NZW/LacJ)	abnormal immune serum protein physiology	J:89134
Emv72^a/Emv72^a (involves: BALB/cAnNCr * C57BL/6NCr)	abnormal cytotoxic T cell physiology	J:194735
Emv72^b/Emv72^b (CAnNCr.B6NCr-Emv72^b)	abnormal cytotoxic T cell physiology	J:194735
Emv72^b/Emv72^b (involves: BALB/cAnNCr * C57BL/6NCr)	abnormal cytotoxic T cell physiology	J:194735
Endou^tm1Tft/Endou^tm1Tft Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6JSfd)	decreased activation-induced B cell apoptosis	J:208364
	increased autoantibody level	J:208364
Enpp1^asj/Enpp1^asj (C57BL/6J-Enpp1^asj/GrsrJ)	increased susceptibility to otitis media	J:251638
	joint inflammation	J:174912
	osteoarthritis	J:174912
	osteomyelitis	J:174912
Enpp1^ttw/Enpp1^ttw (involves: ICR)	osteoarthritis	J:19124, J:37369
Enpp2^tm1Lex/Enpp2⁺ (involves: 129S/SvEvBrd * C57BL/6J)	abnormal chemokine level	J:103485
	decreased circulating interleukin-6 level	J:103485
	decreased circulating tumor necrosis factor level	J:103485
	decreased susceptibility to endotoxin shock	J:103485
Enpp3^tm1Ktak/Enpp3^tm1Ktak (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6))	abnormal basophil physiology	J:223825
	abnormal mast cell physiology	J:223825
	increased IgE level	J:223825
	increased interleukin-4 secretion	J:223825
	increased susceptibility to type I hypersensitivity reaction	J:223825
	intestinal inflammation	J:223825
	lung inflammation	J:223825
Entpd1^tm1Rdr/Entpd1^tm1Rdr (involves: 129S2/SvPas)	abnormal neutrophil physiology	J:129091
Entpd5^tm1Rre/Entpd5^tm1Rre (involves: 129S5/SvEvBrd * C57BL/6J)	liver inflammation	J:163795
Entpd7^tm1Ktak/Entpd7^tm1Ktak (B6.Cg-Entpd7^tm1Ktak)	decreased susceptibility to bacterial infection	J:191188
Entpd7^tm1Ktak/Entpd7^tm1Ktak (B6.Cg-Entpd7^tm1Ktak)	increased susceptibility to experimental autoimmune encephalomyelitis	J:191188
Eomes^tm1.1Bflu/Eomes^tm1.1Bflu Tbx21^tm1Glm/Tbx21^tm1Glm Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)	abnormal leukocyte migration	J:163822
	decreased interferon-gamma secretion	J:163822
	increased interleukin-4 secretion	J:163822
	increased interleukin-17 secretion	J:163822
Eomes^tm1.1Bflu/Eomes^tm1.1Bflu Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal leukocyte migration	J:163822
Eomes^tm1Apr/Eomes⁺ Tbx21^tm1Srnr/Tbx21^tm1Srnr (involves: C57BL/6)	decreased interferon-gamma secretion	J:112679
Eomes^tm1Srnr/Eomes^tm1Srnr Tbx21^tm1Srnr/Tbx21^tm1Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal immune system physiology	J:137655
	abnormal interleukin level	J:137655
	abnormal leukocyte physiology	J:137655
	increased susceptibility to Riboviria infection	J:137655
Epcam^tm1.1Mcu/Epcam^tm1.1Mcu Tg(CD207-cre)1Dhka/0 (involves: 129 * C57BL/6 * C57BL/6J * SJL/J)	abnormal Langerhans cell physiology	J:182665
	increased susceptibility to type IV hypersensitivity reaction	J:182665
Epcam^tm1.2Msiv/Epcam^tm1.2Msiv (involves: C57BL/6 * FVB/N * SJL)	small intestinal inflammation	J:210901
Epha1^tm1Sld/Epha1^tm1Sld (involves: 129 * C57BL/6J)	endometrium inflammation	J:142722
Epha1^tm1Sld/Epha1^tm1Sld (involves: 129 * C57BL/6J)	vaginal inflammation	J:142722
Ephb6^tm1Jwu/Ephb6^tm1Jwu (involves: 129)	abnormal cytokine secretion	J:94701
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:94701
	decreased susceptibility to type IV hypersensitivity reaction	J:94701
	decreased T cell proliferation	J:94701
Epm2a^{Tg(TcraK,TcrbK)TG-BFlv}/Epm2a⁺ Tg(Ela1-TAg)18Bri/0 (involves: C57BL/6 * CBA/J * SJL)	pancreas inflammation	J:107545
Eps15^{tm1a(KOMP)Wtsi}/Eps15^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	dermatitis	J:213427
Epyc^tm1Mhok/Epyc^tm1Mhok (involves: 129S7/SvEvBrd * C57BL/6J)	osteoarthritis	J:222369
Erap1^tm1.1Gnie/Erap1^tm1.1Gnie (involves: 129S6/SvEvTac * C57BL/6)	abnormal antigen presentation	J:143988
	abnormal cytotoxic T cell physiology	J:143988
	abnormal response to infection	J:143988
	decreased interferon-gamma secretion	J:143988
	decreased level of surface class I molecules	J:143988
	decreased T cell proliferation	J:143988
Erap1^tm1Iay/Erap1^tm1Iay (involves: C57BL/6)	abnormal cytotoxic T cell physiology	J:111047
Erap1^tm1Iay/Erap1^tm1Iay (involves: C57BL/6)	decreased level of surface class I molecules	J:111047
Erap1^tm1Luc/Erap1⁺ (involves: 129S6/SvEvTac)	abnormal antigen presentation	J:122479
Erap1^tm1Luc/Erap1⁺ (involves: 129S6/SvEvTac)	decreased level of surface class I molecules	J:122479
Erap1^tm1Luc/Erap1^tm1Luc (involves: 129S6/SvEvTac)	abnormal antigen presentation	J:122479
	abnormal CD8-positive, alpha-beta T cell physiology	J:122479
	abnormal lymphocyte physiology	J:122479
	decreased level of surface class I molecules	J:122479
	increased level of surface class I molecules	J:122479
Erap1^tm1Nsha/Erap1^tm1Nsha (B6.129S6-Erap1^tm1Nsha)	abnormal antigen presentation via MHC class I	J:112389, J:116606
	abnormal CD8-positive, alpha-beta T cell physiology	J:112389, J:116606
	abnormal cytokine secretion	J:116606
	decreased level of surface class I molecules	J:112389
Erap1^tm1Nsha/Erap1^tm1Nsha Tap1^tm1Arp/Tap1^tm1Arp (B6.129-Erap1^tm1Nsha Tap1^tm1Arp)	abnormal antigen presentation via MHC class I	J:112389
Erap1^tm1Nsha/Erap1^tm1Nsha Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/10 * DBA/2)	abnormal antigen presentation via MHC class I	J:116606
Erars1^DBA/2J/? (involves: BXD2/TyJ * C57BL/6J * DBA/2J)	increased anti-nuclear antigen antibody level	J:96064
Erars1^DBA/2J/? (involves: BXD2/TyJ * C57BL/6J * DBA/2J)	increased immunoglobulin level	J:96064
Erars2^C57BL/6J/? (involves: BXD2/TyJ * C57BL/6J * DBA/2J)	abnormal humoral immune response	J:96064
Erars2^C57BL/6J/? (involves: BXD2/TyJ * C57BL/6J * DBA/2J)	increased immunoglobulin level	J:96064
Erbb3^tm1.1Dwt/Erbb3^tm2.1Dwt Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	increased susceptibility to induced colitis	J:152703
Erbb4^tm1Grl/Erbb4^tm1Grl Tg(Myh6-ERBB4)HT2Gass/0 (involves: 129S1/Sv * 129X1/SvJ)	lung inflammation	J:132190
Ercc1^tm1Jhjh/Ercc1^tm1Jhjh (involves: C57BL/6 * FVB/N)	abnormal class switch recombination	J:92471
Ercc1^tm1Jhjh/Ercc1^tm1Jhjh (involves: C57BL/6 * FVB/N)	decreased B cell proliferation	J:92471
Ercc6l2^em1Mengf/Ercc6l2^em1Mengf (Not Specified)	abnormal class switch recombination	J:311900
	decreased IgA level	J:311900
	decreased IgG1 level	J:311900
	decreased IgG2b level	J:311900
	decreased IgG3 level	J:311900
	decreased IgG level	J:311900
Ercc6l2^em2Mengf/Ercc6l2^em2Mengf (Not Specified)	abnormal class switch recombination	J:311900
Ereg^tm1Dwt/Ereg^tm1Dwt (129S6/SvEvTac-Ereg^tm1Dwt)	increased susceptibility to induced colitis	J:93327
Ereg^tm1Sawa/Ereg^tm1Sawa (involves: 129X1/SvJ * C57BL/6J)	dermatitis	J:92618
Erg^tm1.1Iwamo/Erg^tm1.1Iwamo Tg(Gdf5-cre,-ALPP)1Kng/? (involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)	increased susceptibility to induced arthritis	J:243715
	osteoarthritis	J:243715
Ern1^tm2.1Tiw/Ern1^tm2.1Tiw Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Vil1-cre)997Gum/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * SJL)	small intestinal inflammation	J:206084
Ern2^m1Btlr/Ern2^m1Btlr (C57BL/6J-Ern2^m1Btlr)	increased susceptibility to induced colitis	J:216045
Ern2^M2Btlr/Ern2^M2Btlr (C57BL/6J-Ern2^M2Btlr)	increased susceptibility to induced colitis	J:234237
Ern2^m3Btlr/Ern2^m3Btlr (C57BL/6J-Ern2^m3Btlr)	increased susceptibility to induced colitis	J:236686
Ern2^tm1Dron/Ern2^tm1Dron (either: 129S6/SvEvTac-Ern2^tm1Dron or B6.129S6-Ern2^tm1Dron)	increased susceptibility to induced colitis	J:67934
Ero1a^{Gt(XST171)Byg}/Ero1a^{Gt(XST171)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:153833
	decreased macrophage apoptosis	J:153833
Errfi1^tm1Gvw/Errfi1^tm1Gvw (Not Specified)	accelerated temporomandibular joint osteoarthritis	J:100927
Errfi1^tm1Gvw/Errfi1^tm1Gvw (Not Specified)	osteoarthritis	J:100927
Errfi1^tm1Gvw/Errfi1^tm1Gvw Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv)	osteoarthritis	J:100927
Errfi1^tm3.1Gvw/Errfi1^tm3.1Gvw Tg(CMV-cre)1Cgn/0 (involves: 129 * 129S4/SvJaeSor * BALB/cJ)	osteoarthritis	J:206807
Errfi1^tm3.1Gvw/Errfi1^tm3.1Gvw Tg(Col2a1-cre)1Asz/0 (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6 * CBA)	osteoarthritis	J:206807
Esam^tm1Dvst/Esam^tm1Dvst (B6.129-Esam1^tm1Dvst)	abnormal cellular extravasation	J:124397
Esam^tm1Dvst/Esam^tm1Dvst (B6.129-Esam1^tm1Dvst)	abnormal leukocyte migration	J:124397
Esm1^tm1.1Rha/Esm1^tm1.1Rha (involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6NTac)	abnormal cellular extravasation	J:246778
Esmr^DBA/2NCrj/Esmr^DBA/2NCrj (involves: C57BL/6NCrj * DBA/2NCrj)	decreased susceptibility to parasitic infection	J:74563
Espl1^Gt(XL058)Byg/Espl1⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (B6.129-Trp53^tm1Tyj Espl1^Gt(XL058)Byg)	increased splenocyte proliferation	J:174926
Espn^je/? f/f Hps6^ru/Hps6^ru (JE/LeJ)	abnormal mast cell degranulation	J:37255
Esr1^tm1.1Lja/Esr1^tm1.1Mma (involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:128135
Esr1^tm1.1Mma/Esr1^tm1.1Mma (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin level	J:171276
	abnormal thymus physiology	J:171276
Esr1^tm1.1Ohl/Esr1^tm1.1Ohl (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin level	J:171276
	abnormal thymus physiology	J:171276
Esr1^tm1.1Scma/Esr1^tm1.1Scma Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal osteoclast physiology	J:156947
Esr1^tm1Arnal/Esr1^tm1Arnal (involves: C57BL/6)	abnormal immunoglobulin level	J:171276
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * C57BL/6J)	abnormal class switch recombination	J:82423
	abnormal immunoglobulin level	J:82423
	abnormal spleen physiology	J:88156
	glomerulonephritis	J:88156
	increased anti-double stranded DNA antibody level	J:88156
	increased IgG3 level	J:88156
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd)	spermatic granuloma	J:60490
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * C57BL/6N)	abnormal thymus physiology	J:111590
Esr1^tm1Ksk/Esr1^tm1Ksk Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal class switch recombination	J:82423
	abnormal immunoglobulin level	J:82423
Esr1^tm1Ksk/Esr1^tm1Ksk Inha^tm1Bay/Inha^tm1Bay (involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)	liver inflammation	J:84989
Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd)	colitis	J:107308
Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd)	urinary bladder inflammation	J:122274
Ess2^tm1.1Nbioc/Ess2^tm1.1Nbioc Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6N * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:339504
Ets1^tm1.1Dds/Ets1⁺ (129S6/SvEvTac-Ets1^tm1.1Dds)	decreased thymocyte apoptosis	J:121460
Ets1^tm1.1Dds/Ets1⁺ (129S6/SvEvTac-Ets1^tm1.1Dds)	increased splenocyte apoptosis	J:121460
Ets1^tm1.1Dds/Ets1^tm1.1Dds (129S6/SvEvTac-Ets1^tm1.1Dds)	decreased thymocyte apoptosis	J:121460
Ets1^tm1.1Dds/Ets1^tm1.1Dds (129S6/SvEvTac-Ets1^tm1.1Dds)	increased splenocyte apoptosis	J:121460
Ets1^tm1Fwa/Ets1^tm1Fwa (B6.129S4-Ets1^tm1Fwa)	decreased B cell proliferation	J:93845
Ets1^tm1Fwa/Ets1^tm1Fwa (B6.129S4-Ets1^tm1Fwa)	increased B cell apoptosis	J:93845
Ets1^tm2Jml/Ets1^tm2Jml (involves: 129X1/SvJ * C57BL/6)	abnormal leukocyte physiology	J:50627
	abnormal NK cell physiology	J:50627
	abnormal T cell activation	J:50627
	decreased T cell proliferation	J:50627
	impaired natural killer cell mediated cytotoxicity	J:50627
Evl^tm1Lfr/Evl^tm1Lfr (involves: 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:94077
exf/exf (involves: C3H/HeN(MTV^-))	conjunctivitis	J:5649
exf/exf (involves: C3H/HeN(MTV^-))	increased susceptibility to bacterial infection	J:5649
Exo1^tm2Wed/Exo1^tm2Wed (involves: 129 * C57BL/6)	abnormal class switch recombination	J:198719
Exo1^tm2Wed/Exo1^tm2Wed (involves: 129 * C57BL/6)	abnormal somatic hypermutation frequency	J:198719
Exph5^tm1Tiz/Exph5^tm1Tiz (B6NJcl.Cg-Exph5^tm1Tiz/Tiz)	abnormal interleukin secretion	J:313415
	abnormal T-helper 2 physiology	J:313415
	increased interleukin-5 secretion	J:313415
	increased interleukin-13 secretion	J:313415
	increased susceptibility to type I hypersensitivity reaction	J:313415
Eya4^tm1Jse/Eya4^tm1Jse (involves: 129S6/SvEvTac * CBA/J)	increased susceptibility to otitis media	J:131873
Ezh2^tm1Tara/Ezh2^tm1Tara Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd)	decreased B cell proliferation	J:199122
	decreased IgG1 level	J:199122
	decreased IgG2b level	J:199122
	decreased IgG3 level	J:199122
Ezr^tm2Aim/Ezr^tm2Aim Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased interleukin-2 secretion	J:143487
F2^tm1Jld/F2^tm1Jld Tg(Mx1-cre)1Cgn/0 (B6.Cg-F2^tm1Jld Tg(Mx1-cre)1Cgn)	increased susceptibility to bacterial infection	J:144572
F2^tm2Jld/F2⁺ (B6.129P2-F2^tm2Jld)	decreased susceptibility to endotoxin shock	J:174629
F2^tm2Jld/F2⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)	decreased susceptibility to induced arthritis	J:174629
F2r^tm1Ajc/F2r^tm1Ajc F2rl1^tm1Cgh/F2rl1^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to endotoxin shock	J:132733
F2r^tm1Pago/F2r^tm1Pago (involves: 129P2/OlaHsd * C57BL/6)	decreased inflammatory response	J:124648
F2r^tm1Pago/F2r^tm1Pago (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to induced colitis	J:94420
F2r^tm1Pago/F2r^tm1Pago (involves: 129P2/OlaHsd)	abnormal cytokine level	J:133917
F2r^tm1Pago/F2r^tm1Pago (involves: 129P2/OlaHsd)	decreased susceptibility to endotoxin shock	J:133917
F2rl1^tm1Bpd/F2rl1^tm1Bpd (involves: 129P2/OlaHsd * C57BL/6)	decreased inflammatory response	J:124648
	increased inflammatory response	J:96196
	increased susceptibility to induced pancreatitis	J:96196
F2rl1^tm1Bpd/F2rl1^tm1Bpd (B6.129P2-F2rl1^tm1Bpd)	decreased susceptibility to endotoxin shock	J:88245
F2rl1^tm1Cgh/F2rl1^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	glomerulonephritis	J:124303
F2rl1^tm1Cgh/F2rl1^tm1Cgh (involves: 129S4/SvJae * C57BL/6)	impaired leukocyte tethering or rolling	J:76626
F2rl1^tm1Jkaw/F2rl1^tm1Jkaw (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to type IV hypersensitivity reaction	J:106127
F2rl1^tm1Mslb/F2rl1^tm1Mslb (involves: 129X1/SvJ * C57BL/6)	decreased IgE level	J:79757
F2rl1^tm1Mslb/F2rl1^tm1Mslb (involves: 129X1/SvJ * C57BL/6)	decreased inflammatory response	J:79757
F2rl1^tm1Wrf/F2rl1^tm1Wrf (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to induced arthritis	J:81119
F2rl1^tm1Wrf/F2rl1^tm1Wrf (involves: 129P2/OlaHsd)	decreased circulating interleukin-18 level	J:102762
F2rl1^tm1Wrf/F2rl1^tm1Wrf (involves: 129P2/OlaHsd)	liver inflammation	J:102762
F3^tm1.1Dwr/F3^tm1.1Dwr (involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)	abnormal cellular extravasation	J:91165
	abnormal leukocyte adhesion	J:91165
	decreased circulating interleukin-1 beta level	J:91165
	decreased circulating interleukin-6 level	J:91165
	decreased circulating tumor necrosis factor level	J:91165
	decreased susceptibility to endotoxin shock	J:91165
	impaired leukocyte tethering or rolling	J:91165
F3^tm1Dco/F3^tm1Dco Tg(F3)1Nmk/0 (B6.Cg-F3^tm1Dco Tg(F3)1Nmk)	abnormal interleukin level	J:88245
	decreased susceptibility to endotoxin shock	J:88245
F3^tm1Gjb/F3⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal chemokine secretion	J:128891
	abnormal macrophage physiology	J:128891
	decreased interleukin-6 secretion	J:128891
F8^tm1Kaz/Y (involves: 129S4/SvJae * C57BL/6)	abnormal immune tolerance	J:178969
F11^tm1Gjb/F11^tm1Gjb Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymph circulation	J:67398
	lung inflammation	J:67398
	lymph node hemorrhage	J:67398
F11r^tm1.1Dej/F11r^tm1.1Dej (Not Specified)	abnormal dendritic cell physiology	J:92592
F11r^tm1.1Dej/F11r^tm1.1Dej (Not Specified)	increased susceptibility to type IV hypersensitivity reaction	J:92592
Fadd^tm1Mpa/Fadd^tm1Mpa Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	liver inflammation	J:118336
Fadd^tm1Mpa/Fadd^tm1Mpa Mog^tm1(cre)Gkl/Mog⁺ (involves: C57BL/6 * SJL)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:167475
Fadd^tm1Mpa/Fadd^tm1Mpa Myd88^tm1Aki/Myd88^tm1Aki Tg(Vil1-cre)997Gum/0 (B6.Cg-Fadd^tm1Mpa Myd88^tm1Aki Tg(Vil1-cre)997Gum)	cecum inflammation	J:175865
Fadd^tm1Mpa/Fadd^tm1Mpa Tg(Vil1-cre)997Gum/0 (B6.Cg-Fadd^tm1Mpa Tg(Vil1-cre)997Gum)	cecum inflammation	J:175865
	colitis	J:175865
Fadd^tm1Mpa/Fadd^tm1Mpa Tnf^tm1Gkl/Tnf^tm1Gkl Tg(Vil1-cre)997Gum/0 (B6.Cg-Fadd^tm1Mpa Tnf^tm1Gkl Tg(Vil1-cre)997Gum)	cecum inflammation	J:175865
	colitis	J:175865
Fadd^tm2.1Wnt/Fadd^tm2.1Wnt Tg(Cd4-cre)1Cwi/? (B6.Cg-Tg(Cd4-cre)1Cwi Fadd^tm2.1Wnt)	abnormal T cell proliferation	J:162312
	abnormal thymocyte apoptosis	J:162312
	increased susceptibility to parasitic infection	J:162312
Fads1^{Gt(IST11525H2)Tigm}/Fads1⁺ (C57BL/6-Fads1^{Gt(IST11525H2)Tigm})	decreased interferon-gamma secretion	J:186265
	decreased tumor necrosis factor secretion	J:186265
Fads1^{Gt(IST11525H2)Tigm}/Fads1^{Gt(IST11525H2)Tigm} (C57BL/6-Fads1^{Gt(IST11525H2)Tigm})	decreased interferon-gamma secretion	J:186265
	decreased tumor necrosis factor secretion	J:186265
Fads2^tm1Mtna/Fads2^tm1Mtna (involves: 129S6/SvEvTac * C57BL/6J)	dermatitis	J:153293
Fads2^tm1Wst/Fads2^tm1Wst (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:140341
Fah^tm1Mgo/Fah^tm1Mgo (involves: 129S7/SvEvBrd * PT)	kidney inflammation	J:77295
Fah^tm1Mgo/Fah^tm1Mgo (involves: 129S7/SvEvBrd * C57BL)	liver inflammation	J:27735
Fah^tm1Mgo/Fah^tm1Mgo Hgd^aku/Hgd⁺ (involves: 129S7/SvEvBrd * NB)	kidney inflammation	J:77295
Faim^tm1Kplm/Faim^tm1Kplm (involves: 129P2/OlaHsd * C57BL/6)	increased B cell apoptosis	J:164184
	increased thymocyte apoptosis	J:164184
	liver inflammation	J:164184
Fam3d^em1Wko/Fam3d^em1Wko (C57BL/6-Fam3d^em1Wko)	abnormal cytokine level	J:300819
	abnormal neutrophil physiology	J:304594
	colitis	J:300819
	increased susceptibility to colitis induced morbidity/mortality	J:300819
	increased susceptibility to induced colitis	J:300819
Fam13a^{tm1e(KOMP)Wtsi}/Fam13a^{tm1e(KOMP)Wtsi} (C57BL/6N-Fam13a^{tm1e(KOMP)Wtsi})	white adipose tissue inflammation	J:258290
Fam20c^tm1.1Cqi/Fam20c^tm1.1Cqi Tg(Col1a1-cre)2Bek/0 (involves: 129S6/SvEvTac * CD-1)	dental pulp inflammation	J:225679
	periodontium inflammation	J:225679
Fam72a^{tm1.1(KOMP)Vlcg}/Fam72a^{tm1.1(KOMP)Vlcg} (C57BL/6NTac-Fam72a^{tm1.1(KOMP)Vlcg})	abnormal class switch recombination	J:326431
	abnormal somatic hypermutation frequency	J:326431
	increased B cell apoptosis	J:326431
Fam72a^{tm1.1(KOMP)Vlcg}/Fam72a^{tm1.1(KOMP)Vlcg} Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Fam72a^{tm1.1(KOMP)Vlcg} Msh2^tm1Mak)	abnormal class switch recombination	J:326431
	abnormal somatic hypermutation frequency	J:326431
Fan1^{tm1a(KOMP)Wtsi}/Fan1^{tm1a(KOMP)Wtsi} (129S1.B6-Fan1^{tm1a(KOMP)Wtsi})	tubulointerstitial nephritis	J:242198
Farp2^tm1Akum/Farp2^tm1Akum (B6.Cg-Farp2^tm1Akum)	abnormal osteoclast physiology	J:166376
Fas^lpr-cg/Fas^lpr-cg (CBA/KlJms-Fas^lpr-cg/J)	abnormal hypersensitivity reaction	J:24805, J:81770
	autoimmune response	J:24805, J:81770
	increased anti-nuclear antigen antibody level	J:24805
	increased autoantibody level	J:81770
	increased IgG level	J:24805, J:81770
	increased IgM level	J:24805, J:81770
	increased immunoglobulin level	J:24805
Fas^lpr/Fas⁺ Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6 * MRL/Mp)	liver inflammation	J:72817
Fas^lpr/Fas^lpr (MRL/Mp-Fas^lpr)	abnormal cytotoxic T cell physiology	J:7488
	abnormal immune system physiology	J:28885
	abnormal interleukin level	J:8267
	abnormal T cell physiology	J:8267
	abnormal T cell proliferation	J:8267
	abnormal T-helper 2 physiology	J:6257
	abnormal type III hypersensitivity reaction	J:28885
	blood vessel inflammation	J:28885
	decreased interleukin-2 secretion	J:6638, J:7488
	glomerulonephritis	J:27634, J:13757, J:28885
	increased anti-double stranded DNA antibody level	J:27634, J:131138, J:6257
	increased anti-erythrocyte antigen antibody level	J:27634
	increased anti-nuclear antigen antibody level	J:27634, J:28885
	increased anti-single stranded DNA antibody level	J:27634
	increased autoantibody level	J:28885
	increased IgA level	J:28885
	increased IgG1 level	J:13757, J:28885
	increased IgG2a level	J:13757, J:28885
	increased IgG2b level	J:28885
	increased IgG level	J:27634
	increased IgM level	J:28885
	increased immunoglobulin level	J:13757, J:28885, J:6257
	increased susceptibility to autoimmune disorder	J:108760
	lacrimal gland inflammation	J:18512
	lymph node hemorrhage	J:27634
	salivary gland inflammation	J:18512
	submandibular gland inflammation	J:21965
	thyroid gland inflammation	J:28171
Fas^lpr/Fas^lpr (NOD.MRL(B6)-Fas^lpr)	decreased susceptibility to autoimmune diabetes	J:64051
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr/J)	abnormal immunoglobulin level	J:122315
	CNS inflammation	J:14151
	conjunctivitis	J:123192
	decreased IgG level	J:122315
	glomerulonephritis	J:92084, J:122315, J:127199, J:7454
	increased anti-double stranded DNA antibody level	J:92084, J:122315, J:7454
	increased anti-nuclear antigen antibody level	J:111811, J:92084, J:14151, J:7454
	increased autoantibody level	J:92084, J:14151
	increased IgG level	J:92084
	increased immunoglobulin level	J:122315, J:7454
	increased susceptibility to systemic lupus erythematosus	J:92084
	lymph node hemorrhage	J:7454
	salivary gland inflammation	J:92084
Fas^lpr/Fas^lpr (NOD.MRL-Fas^lpr)	decreased susceptibility to autoimmune diabetes	J:78679
Fas^lpr/Fas^lpr (involves: C3H * MRL/Mp)	autoimmune response	J:1060
	increased anti-nuclear antigen antibody level	J:34296
	increased susceptibility to systemic lupus erythematosus	J:34296
	increased susceptibility to type III hypersensitivity reaction	J:34296
Fas^lpr/Fas^lpr (B6.MRL-Fas^lpr/J)	abnormal NK cell physiology	J:115033
	brain inflammation	J:120427
	CNS inflammation	J:120427
	decreased B cell apoptosis	J:135830
	increased anti-double stranded DNA antibody level	J:132217
	increased anti-histone antibody level	J:132217
	increased anti-nuclear antigen antibody level	J:132217
	increased anti-single stranded DNA antibody level	J:132217
	increased autoantibody level	J:132217
	increased susceptibility to bacterial infection	J:136745
	increased susceptibility to Picornaviridae infection	J:120427
Fas^lpr/Fas^lpr (MRL-Fas^lpr)	abnormal T-helper 2 physiology	J:6257
	glomerulonephritis	J:126261
	increased anti-double stranded DNA antibody level	J:126261
	increased anti-nuclear antigen antibody level	J:126261
	increased IgG level	J:126261
	increased IgM level	J:126261
	increased immunoglobulin level	J:6257
Fas^lpr/Fas^lpr (MRL.Cg-Irf1^tm1Mak Fas^lpr)	glomerulonephritis	J:114771
Fas^lpr/Fas^lpr (MRL.Cg-Irf1^tm1Mak Fas^lpr)	increased anti-double stranded DNA antibody level	J:114771
Fas^lpr/Fas^lpr (C3.MRL-Fas^lpr/J)	abnormal B cell activation	J:7454
	decreased interleukin-2 secretion	J:7454
	glomerulonephritis	J:7454
	increased anti-double stranded DNA antibody level	J:7454
	increased anti-nuclear antigen antibody level	J:7454
	increased autoantibody level	J:7454
	increased immunoglobulin level	J:7454
	lymph node hemorrhage	J:7454
Fas^lpr/Fas^lpr (B6.MRL-Fas^lpr)	decreased interleukin-2 secretion	J:6638
	glomerulonephritis	J:135036, J:7454
	increased anti-double stranded DNA antibody level	J:7454
	increased anti-nuclear antigen antibody level	J:6638, J:135036
	increased autoantibody level	J:135036, J:7454
	increased immunoglobulin level	J:7454
	lymph node hemorrhage	J:7454
Fas^lpr/Fas^lpr (AK.MRL-Fas^lpr)	glomerulonephritis	J:7454
	increased anti-double stranded DNA antibody level	J:7454
	increased anti-nuclear antigen antibody level	J:7454
	increased autoantibody level	J:7454
	increased immunoglobulin level	J:7454
	lymph node hemorrhage	J:7454
Fas^lpr/Fas^lpr (C3.MRL-Fas^lpr)	abnormal interleukin level	J:8267
	abnormal T cell physiology	J:8267
	abnormal T cell proliferation	J:8267
	lacrimal gland inflammation	J:1028
	salivary gland inflammation	J:1028
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr)	abnormal leukocyte adhesion	J:126009
	autoimmune response	J:125114
	blood vessel inflammation	J:137066
	glomerulonephritis	J:125114, J:132514, J:137066
	impaired leukocyte tethering or rolling	J:126009
	increased anti-nuclear antigen antibody level	J:137066
	increased autoantibody level	J:137066
	increased immunoglobulin level	J:125114
Fas^lpr/Fas^lpr (involves: MRL/Mp)	decreased macrophage apoptosis	J:154647
Fas^lpr/Fas^lpr (involves: MRL/Mp)	increased susceptibility to bacterial infection	J:50903
Fas^lpr/Fas^lpr (involves: C57BL/6 * MRL/Mp)	increased anti-double stranded DNA antibody level	J:73396
	increased anti-single stranded DNA antibody level	J:73396
	increased IgA level	J:73396
	increased IgG1 level	J:73396
	increased IgG2a level	J:73396
	increased IgG2b level	J:73396
	increased IgG3 level	J:73396
	increased IgM level	J:73396
Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * MRL)	glomerulonephritis	J:45448
Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * MRL)	kidney inflammation	J:45448
Fas^lpr/Fas^lpr Fcer1g^tm1Tks/Fcer1g^tm1Tks (MRL.Cg-Fcer1g^tm1Tks Fas^lpr)	arteritis	J:106188
	decreased susceptibility to type III hypersensitivity reaction	J:106188
	glomerulonephritis	J:106188
	increased anti-double stranded DNA antibody level	J:106188
	increased IgG level	J:106188
Fas^lpr/Fas^lpr Havcr1^tm1Kuch/Havcr1^tm1Kuch (B6.Cg-Havcr1^tm1Kuch Fas^lpr)	abnormal immunoglobulin level	J:186484
	increased anti-double stranded DNA antibody level	J:186484
	increased autoantibody level	J:186484
	increased IgG1 level	J:186484
	increased IgG2a level	J:186484
	increased IgG2b level	J:186484
	increased IgG3 level	J:186484
	increased susceptibility to systemic lupus erythematosus	J:186484
Fas^lpr/Fas^lpr Hspa13^tm1.1Smoc/Hspa13^tm1.1Smoc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S * C57BL/6 * MRL/Mp)	decreased autoantibody level	J:303927
	decreased susceptibility to systemic lupus erythematosus	J:303927
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt (MRL.Cg-Ifnar1^tm1Agt Fas^lpr)	glomerulonephritis	J:92084
	increased anti-nuclear antigen antibody level	J:92084
	increased autoantibody level	J:92084
	increased IgA level	J:92084
	increased IgG2b level	J:92084
	increased IgG3 level	J:92084
	increased IgG level	J:92084
	increased IgM level	J:92084
	increased susceptibility to systemic lupus erythematosus	J:92084
	salivary gland inflammation	J:92084
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Ifnar1^tm1Agt Fas^lpr)	decreased anti-nuclear antigen antibody level	J:92084
	decreased autoantibody level	J:92084
	decreased IgG level	J:92084
	decreased susceptibility to systemic lupus erythematosus	J:92084
	glomerulonephritis	J:92084
	increased IgG level	J:92084
	increased susceptibility to systemic lupus erythematosus	J:92084
	salivary gland inflammation	J:92084
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng⁺ (MRL.Cg-Ifng^tm1Ts Fas^lpr)	abnormal macrophage chemotaxis	J:123834
	glomerulonephritis	J:123834
	increased autoantibody level	J:123834
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng^tm1Ts (MRL.Cg-Ifng^tm1Ts Fas^lpr)	abnormal macrophage chemotaxis	J:123834
	kidney inflammation	J:123834
	lung inflammation	J:123834
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)	decreased anti-double stranded DNA antibody level	J:39600
	decreased anti-nuclear antigen antibody level	J:39600
	decreased autoantibody level	J:39600
	decreased IgA level	J:39600
	decreased IgG2a level	J:39600
	decreased IgG2b level	J:39600
	decreased IgM level	J:39600
	decreased immunoglobulin level	J:39600
	decreased susceptibility to systemic lupus erythematosus	J:39600
Fas^lpr/Fas^lpr Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Fas^lpr)	decreased anti-nuclear antigen antibody level	J:92084
	decreased autoantibody level	J:92084
	decreased IgA level	J:92084
	decreased IgG2a level	J:92084
	decreased IgG2b level	J:92084
	decreased IgG3 level	J:92084
	decreased IgM level	J:92084
	decreased susceptibility to systemic lupus erythematosus	J:92084
	glomerulonephritis	J:92084
	increased IgG1 level	J:92084
	increased IgG level	J:92084
Fas^lpr/Fas^lpr Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (MRL.Cg-Fas^lpr Igh-J^{tm2(3H9-VDJ)Mwg})	increased anti-double stranded DNA antibody level	J:131138
Fas^lpr/Fas^lpr Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6 * MRL/Mp)	abnormal humoral immune response	J:119584
	abnormal immunoglobulin level	J:119584
	decreased IgM level	J:119584
	increased autoantibody level	J:119584
Fas^lpr/Fas^lpr Il4^tm1Cgn/Il4^tm1Cgn (MRL.Cg-Il4^tm1Cgn Fas^lpr)	glomerulonephritis	J:132514
	lacrimal gland inflammation	J:132514
Fas^lpr/Fas^lpr Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)	decreased anti-nuclear antigen antibody level	J:39600
	decreased IgA level	J:39600
	decreased IgE level	J:39600
	decreased IgG1 level	J:39600
	decreased IgG3 level	J:39600
	decreased immunoglobulin level	J:39600
	decreased susceptibility to systemic lupus erythematosus	J:39600
Fas^lpr/Fas^lpr Il27ra^tm1Mak/Il27ra^tm1Mak (MRL.Cg-Il27ra^tm1Mak Fas^lpr)	abnormal T-helper 2 physiology	J:122148
	decreased anti-double stranded DNA antibody level	J:122148
	decreased IgG2a level	J:122148
	decreased interferon-gamma secretion	J:122148
	decreased susceptibility to systemic lupus erythematosus	J:122148
	glomerulonephritis	J:122148
	increased circulating interleukin-4 level	J:122148
	increased circulating interleukin-5 level	J:122148
	increased IgE level	J:122148
	increased IgG1 level	J:122148
Fas^lpr/Fas^lpr Irf1^tm1Mak/Irf1⁺ (MRL.Cg-Irf1^tm1Mak Fas^lpr)	glomerulonephritis	J:114771
	increased anti-double stranded DNA antibody level	J:114771
Fas^lpr/Fas^lpr Irf1^tm1Mak/Irf1^tm1Mak (MRL.Cg-Irf1^tm1Mak Fas^lpr)	abnormal cytokine secretion	J:114771
	decreased anti-double stranded DNA antibody level	J:114771
	glomerulonephritis	J:114771
Fas^lpr/Fas^lpr Itfg2^{Gt(OST215121)Lex}/Itfg2^{Gt(OST215121)Lex} (involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)	increased anti-double stranded DNA antibody level	J:205951
	increased anti-nuclear antigen antibody level	J:205951
	increased IgG2a level	J:205951
	increased IgM level	J:205951
	increased susceptibility to systemic lupus erythematosus	J:205951
Fas^lpr/Fas^lpr Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd * MRL)	abnormal immunoglobulin level	J:42666
	decreased IgG level	J:42666
	decreased IgM level	J:42666
Fas^lpr/Fas^lpr Pou2af1^tm1Pmt/Pou2af1^tm1Pmt (involves: 129P2/OlaHsd * C57BL/6 * MRL)	autoimmune response	J:125114
	decreased immunoglobulin level	J:125114
Fas^lpr/Fas^lpr Selp^tm1Bay/Selp^tm1Bay (MRL.Cg-Selp^tm1Bay Fas^lpr)	abnormal chemokine secretion	J:127199
	abnormal leukocyte adhesion	J:126009
	dermatitis	J:127199
	glomerulonephritis	J:127199
	impaired leukocyte tethering or rolling	J:126009
Fas^lpr/Fas^lpr Selplg^tm1Fur/Selplg^tm1Fur (MRL.Cg-Selplg^tm1Fur Fas^lpr)	abnormal chemokine level	J:127199
	dermatitis	J:127199
	glomerulonephritis	J:127199
Fas^lpr/Fas^lpr Sh2d1a^rpl/Sh2d1a^rpl (MRL/Mp-Fas^lpr Sh2d1a^rpl)	abnormal immune system physiology	J:126261
	increased anti-nuclear antigen antibody level	J:126261
Fas^lpr/Fas^lpr Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp)	increased anti-double stranded DNA antibody level	J:73396
	increased anti-single stranded DNA antibody level	J:73396
	increased IgA level	J:73396
	increased IgG1 level	J:73396
	increased IgG2a level	J:73396
	increased IgG2b level	J:73396
	increased IgG3 level	J:73396
	increased IgM level	J:73396
	kidney inflammation	J:73396
Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * MRL)	kidney inflammation	J:45448
Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * 129S2/SvPas * MRL)	decreased autoantibody level	J:38492
	decreased immunoglobulin level	J:38492
Fas^lpr/Fas^lpr Tg(CD2-Foxj1)#Stlp/0 (MRL.Cg-Fas^lpr Tg(CD2-Foxj1)#Stlp)	abnormal T cell physiology	J:122222
	decreased susceptibility to systemic lupus erythematosus	J:122222
	increased anti-nuclear antigen antibody level	J:122222
	kidney inflammation	J:122222
	liver inflammation	J:122222
	lung inflammation	J:122222
	salivary gland inflammation	J:122222
Fas^lpr/Fas^lpr Tg(Ins2-Fasl)24Ach/0 (NOD.Cg-Fas^lpr Tg(Ins2-Fasl)24Ach)	decreased susceptibility to autoimmune diabetes	J:81416
Fas^lpr/Fas^lpr Tg(INS-Il10)#Sar/0 (NOD.Cg-Fas^lpr Tg(INS-Il10)#Sar)	increased susceptibility to autoimmune diabetes	J:64051
	insulitis	J:64051
Fas^lpr/Fas^lpr Tlr7^tm1Flv/Y (involves: 129S1/Sv * C57BL/6 * MRL/Mp)	abnormal B cell activation	J:113557
	abnormal plasmacytoid dendritic cell physiology	J:113557
	decreased autoantibody level	J:113557
	decreased IgG2a level	J:113557
	decreased IgG3 level	J:113557
	decreased susceptibility to systemic lupus erythematosus	J:113557
	increased anti-chromatin antibody level	J:113557
	increased autoantibody level	J:113557
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (B6.Cg-Tlr9^tm1Aki Fas^lpr)	autoimmune response	J:135036
	decreased IgM level	J:135036
	glomerulonephritis	J:135036
	increased IgG level	J:135036
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (MRL.Cg-Tlr9^tm1Aki Fas^lpr)	abnormal B cell activation	J:113557
	abnormal plasmacytoid dendritic cell physiology	J:113557
	decreased autoantibody level	J:113557
	glomerulonephritis	J:113557
	increased autoantibody level	J:113557
	increased circulating interferon-alpha level	J:113557
	increased IgG2a level	J:113557
	increased IgG3 level	J:113557
	increased IgG level	J:113557
	increased susceptibility to systemic lupus erythematosus	J:113557
	kidney inflammation	J:113557
Fas^lpr/Fas^lpr Tnfrsf1a^tm1.1Gkl/Tnfrsf1a^tm1.1Gkl (involves: 129/Sv * C57BL/6)	liver inflammation	J:92470
Fas^lpr/Fas^lpr Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (MRL.Cg-Tnfrsf9^tm1Byk Fas^lpr)	increased anti-nuclear antigen antibody level	J:127197
	increased immunoglobulin level	J:127197
	increased interleukin-4 secretion	J:126929
	increased susceptibility to systemic lupus erythematosus	J:127197
	lacrimal gland inflammation	J:126929
Fas^theo/Fas^theo (either: (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd) or (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd * CBA/CaJAnu))	increased anti-nuclear antigen antibody level	J:104190
Fas^tm1Ach/Fas^tm1Ach Tg(GZMB-cre)1Jcb/? (involves: C57BL/6 * FVB/N)	increased anti-nuclear antigen antibody level	J:123556
Fas^tm1Ach/Fas^tm1Ach Tg(Itgax-cre,-EGFP)4097Ach/? (Not Specified)	increased anti-nuclear antigen antibody level	J:123556
	increased IgG level	J:123556
	increased IgM level	J:123556
	increased immunoglobulin level	J:123556
Fas^tm1Ach/Fas^tm1Ach Tg(Lck-cre)548Jxm/? (involves: C57BL/6 * CBA)	increased anti-nuclear antigen antibody level	J:123556
Fas^tm1Cgn/Fas^tm1Cgn Cd19^tm1(cre)Cgn/Cd19⁺ Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Cd19^tm1(cre)Cgn Fas^tm1Cgn)	increased anti-single stranded DNA antibody level	J:114948
Fas^tm1Cgn/Fas^tm1Cgn Mog^tm1(cre)Gkl/Mog⁺ (involves: C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:114741
Fas^tm1Cgn/Fas^tm1Cgn Mog^tm1(cre)Gkl/Mog⁺ Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:114741
Fas^tm1Cgn/Fas^tm1Cgn Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Fas^tm1Cgn)	abnormal thymus involution	J:114948
	alveolitis	J:114948
	increased anti-single stranded DNA antibody level	J:114948
	increased inflammatory response	J:114948
	increased T cell apoptosis	J:114948
	kidney inflammation	J:114948
	liver inflammation	J:114948
	lung inflammation	J:114948
Fas^tm1Cgn/Fas^tm1Cgn Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:114741
Fas^tm1Dlo/Fas^tm1Dlo (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus involution	J:90750
Fas^tm1Dlo/Fas^tm1Dlo (involves: 129P2/OlaHsd * C57BL/6)	increased immunoglobulin level	J:31847
Fas^tm1Osa/Fas^tm1Osa (involves: 129P2/OlaHsd * C57BL/6)	abnormal hypersensitivity reaction	J:64296, J:32125
	abnormal T cell clonal deletion	J:32125
	increased anti-double stranded DNA antibody level	J:32125
	increased anti-single stranded DNA antibody level	J:32125
	increased autoantibody level	J:32125
	increased IgG1 level	J:32125
	increased IgG2a level	J:32125
	increased IgG2b level	J:32125
	increased IgG3 level	J:32125
	increased IgG level	J:32125
	increased susceptibility to parasitic infection	J:81397
Fas^tm1Osa/Fas^tm1Osa Gzma^tm1Simn/Gzma^tm1Simn Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased susceptibility to parasitic infection	J:81397
Fas^tm1Vbo/Fas^tm1Vbo Tg(Ins2-cre)25Mgn/0 Tg(Ins2-HA)165Bri/0 Tg(Tcra/Tcrb)1Vbo/0 (Not Specified)	increased susceptibility to autoimmune diabetes	J:85985
Fasl^del1Hong/Fasl^del1Hong (either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6))	increased IgG level	J:112563
	increased IgM level	J:112563
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld/J)	decreased cytotoxic T cell cytolysis	J:17698
	increased anti-double stranded DNA antibody level	J:7306
	increased anti-nuclear antigen antibody level	J:7306, J:29572
	increased autoantibody level	J:7306
	increased IgA level	J:7306, J:29572
	increased IgG1 level	J:7306
	increased IgG2a level	J:7306
	increased IgG2b level	J:7306
	increased IgG level	J:29572
	increased IgM level	J:7306, J:29572
	increased immunoglobulin level	J:7306, J:29572
	interstitial pneumonia	J:7306
Fasl^gld/Fasl^gld (B6Smn.C3-Fasl^gld/J)	abnormal NK cell physiology	J:115033
	abnormal osteoclast physiology	J:127179
	brain inflammation	J:120427
	CNS inflammation	J:120427
	eye inflammation	J:136745
	increased susceptibility to bacterial infection	J:136745
	increased susceptibility to Picornaviridae infection	J:120427
	liver inflammation	J:135830
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld)	abnormal interleukin level	J:8267
	abnormal T cell physiology	J:8267
	abnormal T cell proliferation	J:8267
Fasl^gld/Fasl^gld (involves: C3H/HeJ * C57BL/6)	dermatitis	J:153501
	increased anti-nuclear antigen antibody level	J:153501
	increased circulating tumor necrosis factor level	J:153501
	increased IgE level	J:153501
	increased IgG1 level	J:153501
	increased IgG2a level	J:153501
	increased IgG2b level	J:153501
	increased IgG level	J:153501
	increased susceptibility to systemic lupus erythematosus	J:153501
Fasl^gld/Fasl^gld (involves: C3H/HeJ)	abnormal osteoclast physiology	J:156947
Fasl^gld/Fasl^gld (B6.C3-Fasl^gld)	impaired macrophage phagocytosis	J:91058
	increased anti-nuclear antigen antibody level	J:91058
	increased autoantibody level	J:91058
Fasl^m1Btlr/Fasl^m1Btlr (C57BL/6J-Fasl^m1Btlr)	abnormal humoral immune response	J:212067
Fasl^m2Btlr/Fasl^m2Btlr (C57BL/6J-Fasl^m2Btlr)	decreased IgG level	J:224659
Fasl^m2Btlr/Fasl^m2Btlr (C57BL/6J-Fasl^m2Btlr)	impaired humoral immune response	J:224659
Fasl^tm1.1Ast/Fasl^tm1.1Ast (involves: BALB/cJ * C57BL/6)	decreased cytotoxic T cell cytolysis	J:153501
	dermatitis	J:153501
	glomerulonephritis	J:153501
	increased anti-double stranded DNA antibody level	J:153501
	increased anti-nuclear antigen antibody level	J:153501
	increased circulating tumor necrosis factor level	J:153501
	increased IgA level	J:153501
	increased IgE level	J:153501
	increased IgG1 level	J:153501
	increased IgG2a level	J:153501
	increased IgG2b level	J:153501
	increased IgG level	J:153501
	increased IgM level	J:153501
	increased immunoglobulin level	J:153501
	increased susceptibility to systemic lupus erythematosus	J:153501
Fasl^tm1.1Cgm/Fasl^tm1.1Cgm (involves: 129S2/SvPas * C57BL/6 * C57BL/6N)	increased B cell proliferation	J:168406
	increased IgM level	J:168406
	increased T cell proliferation	J:168406
Fasl^tm1.1Lest/Fasl^tm1.1Lest (involves: 129 * C57BL/6)	autoimmune response	J:87990
	glomerulonephritis	J:87990
	increased IgG level	J:87990
Fasl^tm1.1Lest/Fasl^tm1.1Lest (B6.129-Fasl^tm1.1Lest)	glomerulonephritis	J:87990
Fasl^tm2.1Ast/Fasl^tm2.1Ast (involves: BALB/cJ * C57BL/6)	abnormal cytotoxic T cell physiology	J:153501
Fastk^tm1.1Andp/Fastk^tm1.1Andp (B6.129S6-Fastk^tm1.1Andp)	abnormal chemokine secretion	J:160443
	abnormal neutrophil physiology	J:160443
	decreased interleukin-6 secretion	J:160443
	decreased interleukin-23 secretion	J:160443
	decreased tumor necrosis factor secretion	J:160443
Fat1^{Gt(KST249)Byg}/Fat1^{Gt(KST249)Byg} Tg(Myl1-lacZ)1Ibdml/0 (involves: 129P2/OlaHsd)	myositis	J:199157
Fat1^tm1.2Fhel/Fat1^tm1.2Fhel Tg(Myl1-lacZ)1Ibdml/0 (involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J * SJL)	myositis	J:199157
Fblim1^tm1.1Chen/Fblim1^tm1.1Chen (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	abnormal osteoclast physiology	J:186501
Fbn1^tm1Lper/Fbn1⁺ (involves: 129/Sv * CD-1)	lung inflammation	J:167276
Fbn1^tm2.1Hcd/Fbn1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal interleukin secretion	J:206074
	increased anti-nuclear antigen antibody level	J:206074
	increased autoantibody level	J:206074
	increased interleukin-9 secretion	J:206074
	increased interleukin-13 secretion	J:206074
Fbn1^tm2Rmz/Fbn1^tm2Rmz (involves: 129S1/Sv * 129X1/SvJ)	aortitis	J:54081
Fbn1^tm2Rmz/Fbn1^tm2Rmz (involves: 129S1/Sv * 129X1/SvJ)	lung inflammation	J:91815
Fbn1^tm3.1Hcd/Fbn1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal interleukin secretion	J:206074
	increased anti-nuclear antigen antibody level	J:206074
	increased autoantibody level	J:206074
	increased interleukin-9 secretion	J:206074
	increased interleukin-13 secretion	J:206074
Fbn1^Tsk/Fbn1⁺ (B6.Cg-Fbn1^Tsk)	alveolitis	J:15018, J:30961, J:6566
	increased autoantibody level	J:21987, J:14166
	increased susceptibility to type IV hypersensitivity reaction	J:7185
	lung inflammation	J:30961, J:6566
Fbn1^Tsk/Fbn1⁺ Il4^tm1Nnt/Il4^tm1Nnt (involves: C57BL/6 * C57BL/10 * DBA/2)	decreased interleukin-4 secretion	J:57957
Fbn1^Tsk/Fbn1⁺ Il4ra^tm1Sz/Il4ra⁺ (involves: BALB/cJ * C57BL/6J * C57BL/10 * DBA/2)	increased autoantibody level	J:68448
Fbn1^Tsk/Fbn1⁺ Stat6^tm1Gru/Stat6^tm1Gru (involves: 129S2/SvPas * C57BL/10 * DBA/2)	decreased interleukin-4 secretion	J:57957
Fbxl4^tm1.2Lrsn/Fbxl4^tm1.2Lrsn (involves: C57BL/6N)	liver inflammation	J:303084
Fbxl5^tm2.1Kei/Fbxl5^tm2.1Kei Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	liver inflammation	J:176655
Fbxo7^{tm1a(EUCOMM)Wtsi}/Fbxo7^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	increased susceptibility to bacterial infection	J:272313
	increased susceptibility to bacterial infection induced morbidity/mortality	J:272313
Fbxo11^Jf/Fbxo11⁺ (involves: BALB/cAnNCrl * C3H/HeN)	abnormal cytokine secretion	J:85263
Fbxo11^Jf/Fbxo11⁺ (involves: BALB/cAnNCrl * C3H/HeN)	increased susceptibility to otitis media	J:85263
Fbxo11^Jf/Fbxo11⁺ (involves: BALB/cAnNCrl * C3H/HeN * C57BL/6J)	increased susceptibility to otitis media	J:114851
Fbxo11^Jf/Fbxo11⁺ (involves: BALB/cAnNCrl)	increased susceptibility to otitis media	J:250208
Fbxo11^Jf/Fbxo11^Mutt (involves: BALB/c * C3H/HeN)	increased susceptibility to otitis media	J:114851
Fbxw7^tm1Kei/Fbxw7^tm1Kei Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell activation	J:128523
	increased T cell apoptosis	J:128523
Fcamr^tm1Shib/Fcamr^tm1Shib (involves: 129P2/OlaHsd * C57BL/6)	abnormal follicular dendritic cell antigen presentation	J:150824
	abnormal marginal zone B cell physiology	J:150824
	abnormal somatic hypermutation frequency	J:150824
Fcamr^tm2Shib/Fcamr^tm2Shib (BALB/c-Fcamr^tm2Shib)	abnormal follicular dendritic cell antigen presentation	J:150824
Fcamr^tm2Shib/Fcamr^tm2Shib (BALB/c-Fcamr^tm2Shib)	abnormal marginal zone B cell physiology	J:150824
Fcer1a^tm1Ftl/Fcer1a^tm1Ftl (CBy.129S2-Fcer1a^tm1Ftl)	abnormal humoral immune response	J:120702
	abnormal mast cell physiology	J:120702
	decreased circulating interleukin-4 level	J:120702
Fcer1a^tm1Knt/Fcer1a^tm1Knt (either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))	abnormal mast cell physiology	J:39250
	decreased susceptibility to type I hypersensitivity reaction	J:113572, J:39250
Fcer1a^tm1Knt/Fcer1a^tm1Knt (involves: 129 * BALB/c)	abnormal mast cell physiology	J:78659
Fcer1a^tm1Knt/Fcer1a^tm1Knt (involves: 129 * BALB/c)	increased susceptibility to type I hypersensitivity reaction	J:78659
Fcer1a^tm1Knt/Fcer1a^tm1Knt Fcer2a^tm1Max/Fcer2a^tm1Max (B6.Cg-Fcer1a^tm1Knt Fcer2a^tm1Max)	abnormal mast cell physiology	J:144620
Fcer1a^tm1Knt/Fcer1a^tm1Knt Fcer2a^tm1Max/Fcer2a^tm1Max Fcgr1^tm1Jsv/Fcgr1^tm1Jsv Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (B6.Cg-Fcgr2b^tm1Ttk Fcgr3^tm1Jsv Fcer1a^tm1Knt Fcgr1^tm1Jsv Fcer2a^tm1Max)	abnormal macrophage physiology	J:144620
	abnormal mast cell physiology	J:144620
	increased susceptibility to type I hypersensitivity reaction	J:144620
Fcer1a^tm1Knt/Fcer1a^tm1Knt Tg(FCER1A)1Bhk/? (B6.129-Fcer1a^tm1Knt Tg(FCER1A)1Bhk)	abnormal macrophage physiology	J:144620
	increased tumor necrosis factor secretion	J:144620
Fcer1a^tm1Knt/Fcer1a^tm1Knt Tg(SV40/HTLV-FCER1A)1Bhk/0 (either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))	abnormal type I hypersensitivity reaction	J:113572
Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * C57BL/6)	abnormal dendritic cell antigen presentation	J:83995
	abnormal immune cell physiology	J:39248
	abnormal immunoglobulin level	J:78659
	abnormal mast cell physiology	J:39248
	abnormal NK cell physiology	J:39248
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:126520
	decreased susceptibility to type I hypersensitivity reaction	J:78659, J:39248
	impaired macrophage phagocytosis	J:39248
	increased IgE level	J:78659
Fcer1g^tm1Rav/Fcer1g^tm1Rav (B6.129P2-Fcer1g^tm1Rav)	decreased interleukin-1 beta secretion	J:160680
	decreased interleukin-6 secretion	J:160680
	decreased interleukin-10 secretion	J:160680
	decreased interleukin-12b secretion	J:160680
	decreased interleukin-23 secretion	J:160680
	decreased tumor necrosis factor secretion	J:160680
Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd)	increased susceptibility to parasitic infection	J:163761
Fcer1g^tm1Rav/Fcer1g^tm1Rav Del(7Tyrobp-Hcst)1Ttk/Del(7Tyrobp-Hcst)1Ttk (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:147155
Fcer1g^tm1Rav/Fcer1g^tm1Rav Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased immunoglobulin level	J:87617
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to autoimmune diabetes	J:122114
	decreased T cell proliferation	J:122114
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * C57BL/6)	decreased interferon-gamma secretion	J:100668
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd)	abnormal osteoclast physiology	J:147155
Fcer1g^tm1Tks/Fcer1g^tm1Tks (involves: C57BL/6)	abnormal antigen presentation	J:112160
	abnormal CD4-positive, alpha-beta T cell physiology	J:112160
	abnormal chemokine secretion	J:141143
	abnormal cytokine level	J:258645
	abnormal macrophage physiology	J:141143
	abnormal NK cell physiology	J:111365
	abnormal NK T cell physiology	J:111365
	decreased IgG1 level	J:112160
	decreased IgG2a level	J:112160
	decreased IgG2b level	J:112160
	decreased IgG3 level	J:112160
	decreased IgG level	J:112160
	decreased inflammatory response	J:50023
	decreased interferon-gamma secretion	J:111365, J:112160
	decreased interleukin-2 secretion	J:112160
	decreased susceptibility to type IV hypersensitivity reaction	J:112160
	decreased T cell proliferation	J:112160
	impaired macrophage phagocytosis	J:50023
	impaired natural killer cell mediated cytotoxicity	J:111365
Fcer1g^tm1Tks/Fcer1g^tm1Tks (C57BL/6-Fcer1g^tm1Tks)	decreased susceptibility to autoimmune hemolytic anemia	J:145432
Fcer1g^tm1Tks/Fcer1g^tm1Tks (involves: C57BL/6J)	abnormal chemokine secretion	J:203159
	abnormal interferon-gamma secretion	J:203159
	abnormal interleukin-17 secretion	J:203159
	decreased tumor necrosis factor secretion	J:203159
Fcer2a^Hie/Fcer2a^Hie (NZB)	increased IgE level	J:93999
Fcer2a^tm1Kik/Fcer2a^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:129296
	abnormal humoral immune response	J:19437
	abnormal immune system physiology	J:129296
	increased immunoglobulin level	J:129296
Fcer2a^tm1Max/Fcer2a^tm1Max (involves: C57BL/6)	abnormal macrophage chemotaxis	J:57738
	decreased IgG1 level	J:18952
	decreased IgG2b level	J:18952
	impaired eosinophil recruitment	J:57738
	increased IgE level	J:57738, J:18952, J:107857
	increased IgM level	J:18952
	increased susceptibility to type I hypersensitivity reaction	J:57738
Fcer2a^tm1Max/Fcer2a^tm1Max Ighg1^tm1.1Pyu/Ighg1⁺ (involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)	decreased IgG1 level	J:198154
	decreased IgG2c level	J:198154
	decreased IgG level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
	increased susceptibility to type I hypersensitivity reaction	J:198154
Fcer2a^tm1Max/Fcer2a^tm1Max Ighg1^tm1.1Pyu/Ighg1^tm1.1Pyu (involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)	abnormal immunoglobulin level	J:198154
	decreased IgG2c level	J:198154
	decreased IgG level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
	increased susceptibility to type I hypersensitivity reaction	J:198154
Fcer2a^tm1Putt/Fcer2a⁺ (involves: 129S/SvEv * C57BL/6)	increased IgE level	J:69547
Fcer2a^tm1Putt/Fcer2a^tm1Putt (involves: 129S/SvEv * C57BL/6)	abnormal B cell proliferation	J:69547
Fcgr1^tm1Hoga/Fcgr1^tm1Hoga (involves: 129S1/Sv * 129X1/SvJ)	abnormal cell-mediated immunity	J:86281
	abnormal macrophage antigen presentation	J:86281
	decreased inflammatory response	J:86281
	impaired macrophage phagocytosis	J:86281
	increased IgG level	J:86281
Fcgr1^tm1Jgjw/Fcgr1^tm1Jgjw (involves: 129 * C57BL/6)	abnormal dendritic cell antigen presentation	J:112436
Fcgr1^tm1Jsv/Fcgr1^tm1Jsv (involves: 129P2/OlaHsd * BALB/c)	abnormal dendritic cell antigen presentation	J:83995
	abnormal macrophage physiology	J:83995
	abnormal type I hypersensitivity reaction	J:83995
	decreased susceptibility to autoimmune hemolytic anemia	J:83995
	decreased susceptibility to induced arthritis	J:83995
	increased susceptibility to bacterial infection	J:83995
Fcgr1^tm1Jsv/Fcgr1^tm1Jsv Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)	impaired macrophage phagocytosis	J:83995
Fcgr2b^tm1.2Jsv/Fcgr2b⁺ X/Yaa (involves: C57BL/6 * FVB/N * SB/Le)	increased anti-chromatin antibody level	J:179175
	increased anti-double stranded DNA antibody level	J:179175
	increased susceptibility to systemic lupus erythematosus	J:179175
Fcgr2b^tm1.2Jsv/Fcgr2b^tm1.2Jsv Sle16^C57BL/6/Sle16^C57BL/6 (involves: C57BL/6 * FVB/N)	abnormal adaptive immunity	J:179175
	increased immunoglobulin level	J:179175
	increased susceptibility to induced arthritis	J:179175
	kidney inflammation	J:179175
Fcgr2b^tm1Kgcs/Fcgr2b⁺ (involves: C57BL/6)	decreased B cell apoptosis	J:190890
	increased anti-chromatin antibody level	J:190890
	increased anti-double stranded DNA antibody level	J:190890
	increased IgG1 level	J:190890
	increased IgG3 level	J:190890
	increased IgM level	J:190890
	increased susceptibility to induced arthritis	J:190890
Fcgr2b^tm1Ttk/Fcgr2b^tm1.2Jsv Sle21^129P2/Ola/Sle21^C57BL/6 (involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N)	increased anti-chromatin antibody level	J:179175
	increased anti-double stranded DNA antibody level	J:179175
	increased anti-histone antibody level	J:179175
	increased anti-single stranded DNA antibody level	J:179175
	increased susceptibility to systemic lupus erythematosus	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (involves: 129S4/SvJae)	abnormal mast cell physiology	J:31133
	increased IgA level	J:31133
	increased IgG1 level	J:31133
	increased IgG2a level	J:31133
	increased IgG2b level	J:31133
	increased IgG3 level	J:31133
	increased IgG level	J:31133
	increased IgM level	J:31133
	increased susceptibility to type I hypersensitivity reaction	J:31133
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (C.129S4-Fcgr2b^tm1Ttk)	decreased susceptibility to parasitic infection	J:120905
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	abnormal hypersensitivity reaction	J:64152
	glomerulonephritis	J:64152
	increased immunoglobulin level	J:64152
	increased inflammatory response	J:64152
	kidney inflammation	J:64152
	liver inflammation	J:64152
	lung inflammation	J:64152
	pancreas inflammation	J:64152
	salivary gland inflammation	J:64152
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (Not Specified)	increased susceptibility to induced arthritis	J:106191
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Il17a^tm1Yiw/Il17a⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	glomerulonephritis	J:191090
	kidney inflammation	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased susceptibility to systemic lupus erythematosus	J:191090
	increased anti-double stranded DNA antibody level	J:191090
	increased anti-nuclear antigen antibody level	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129S2/SvPas * 129S4/SvJae * BALB/c)	abnormal cytokine level	J:207275
	abnormal urine cytokine level	J:207275
	increased autoantibody level	J:207275
	urinary bladder inflammation	J:207275
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Sle21^129P2/Ola/Sle21^129P2/Ola (B6.129S4-Fcgr2b^tm1Ttk)	abnormal adaptive immunity	J:179175
	increased anti-chromatin antibody level	J:179175
	increased anti-double stranded DNA antibody level	J:179175
	increased anti-histone antibody level	J:179175
	increased anti-single stranded DNA antibody level	J:179175
	increased autoantibody level	J:179175
	increased IgG2a level	J:179175
	increased immunoglobulin level	J:179175
	increased susceptibility to induced arthritis	J:179175
	increased susceptibility to systemic lupus erythematosus	J:179175
	kidney inflammation	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to autoimmune diabetes	J:122114
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Tlr7^tm1Flv/Y X/Yaa (B6.Cg-Fcgr2b^tm1Ttk Tlr7^tm1Flv Yaa)	abnormal splenocyte physiology	J:127600
	autoimmune response	J:127600
	increased anti-nuclear antigen antibody level	J:127600
	increased susceptibility to systemic lupus erythematosus	J:127600
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm1Sbn/Traf3ip2⁺ (involves: 129 * 129S4/SvJae * C57BL/6)	increased anti-double stranded DNA antibody level	J:191090
	increased anti-nuclear antigen antibody level	J:191090
	increased autoantibody level	J:191090
	increased IgG level	J:191090
	increased susceptibility to systemic lupus erythematosus	J:191090
	kidney inflammation	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm1Sbn/Traf3ip2^tm1Sbn (involves: 129 * 129S4/SvJae * C57BL/6)	decreased susceptibility to systemic lupus erythematosus	J:191090
	increased anti-double stranded DNA antibody level	J:191090
	increased anti-nuclear antigen antibody level	J:191090
	increased autoantibody level	J:191090
	increased IgG level	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm2Sbn/Traf3ip2^tm2Sbn Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6)	glomerulonephritis	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk X/Yaa (B6.Cg-Fcgr2b^tm1Ttk Yaa)	autoimmune response	J:127600
	increased anti-nuclear antigen antibody level	J:127600
	increased susceptibility to systemic lupus erythematosus	J:127600
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (involves: 129P2/OlaHsd * C57BL/6)	abnormal dendritic cell antigen presentation	J:83995
	abnormal type I hypersensitivity reaction	J:83995
	decreased mast cell degranulation	J:35057
	decreased susceptibility to autoimmune hemolytic anemia	J:83995
	decreased susceptibility to type II hypersensitivity reaction	J:35057
	impaired macrophage phagocytosis	J:35057
	impaired natural killer cell mediated cytotoxicity	J:35057
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (B6.129P2-Fcgr3^tm1Jsv/J)	abnormal neutrophil physiology	J:78297
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:126520
	decreased susceptibility to induced arthritis	J:106191
	impaired neutrophil recruitment	J:78297
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv Sle21^129P2/Ola/Sle21^129P2/Ola (B6.129P2-Fcgr3^tm1Jsv)	increased anti-chromatin antibody level	J:179175
	increased anti-double stranded DNA antibody level	J:179175
	increased anti-histone antibody level	J:179175
	increased anti-single stranded DNA antibody level	J:179175
Fcgr3^tm1Ttk/Fcgr3^tm1Ttk (involves: 129X1/SvJ)	decreased susceptibility to type I hypersensitivity reaction	J:107371
Fcgr4^tm1.1Rav/Fcgr4^tm1.1Rav (involves: C57BL/6)	decreased susceptibility to induced arthritis	J:167375
Fcgr4^tm1Rav/Fcgr4^tm1Rav Tg(Ctsk-cre)1Rda/0 (involves: C57BL/6)	arthritis	J:197378
Fcgrt^tm1Dcr/Fcgrt^tm1Dcr (either: 129 or (involves: 129 * C57BL/6))	decreased IgG level	J:94189
Fcgrt^tm1Dcr/Fcgrt^tm1Dcr (B6.129X1-Fcgrt^tm1Dcr/DcrJ)	decreased IgG level	J:110885
Fcgrt^tm1Esw/Fcgrt^tm1Esw Tg(Tek-cre)1Ywa/0 (B6.Cg-Tg(Tek-cre)1Ywa Fcgrt^tm1Esw)	abnormal humoral immune response	J:146640
	decreased IgG1 level	J:146640
Fcmr^tm1.2Khl/Fcmr^tm1.2Khl (involves: C57BL/6)	abnormal granulocyte physiology	J:194323
Fcmr^tm1.2Khl/Fcmr^tm1.2Khl (involves: C57BL/6)	increased T cell apoptosis	J:174871
Fcmr^tm1Mak/Fcmr^tm1Mak (B6.129S2-Fcmr^tm1Mak)	abnormal cytokine secretion	J:194323
	abnormal granulocyte physiology	J:194323
	decreased interleukin-6 secretion	J:194323
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:194323
	decreased tumor necrosis factor secretion	J:194323
	impaired granulocyte bactericidal activity	J:194323
	increased susceptibility to bacterial infection	J:194323
	increased susceptibility to bacterial infection induced morbidity/mortality	J:194323
Fcmr^tm1Ohno/Fcmr^tm1Ohno (B6.129-Fcmr^tm1Ohno)	abnormal immunoglobulin level	J:190117
	abnormal response to infection	J:190117
	decreased IgG1 level	J:190117
	decreased IgM level	J:190117
	increased anti-chromatin antibody level	J:190117
	increased anti-double stranded DNA antibody level	J:190117
	increased IgG3 level	J:190117
	increased IgM level	J:190117
Fcna^tm1Tefu/Fcna^tm1Tefu (B6.129-Fcna^tm1Tefu)	impaired lectin complement pathway	J:190858
	increased susceptibility to bacterial infection	J:190858
	increased susceptibility to bacterial infection induced morbidity/mortality	J:190858
Fcna^tm1Tefu/Fcna^tm1Tefu Fcnb^tm1Tefu/Fcnb^tm1Tefu (B6.129-Fcna^tm1Tefu Fcnb^tm1Yend)	impaired lectin complement pathway	J:190858
	increased susceptibility to bacterial infection	J:190858
	increased susceptibility to bacterial infection induced morbidity/mortality	J:190858
Fcnb^tm1Tefu/Fcnb^tm1Tefu (B6.129-Fcnb^tm1Yend)	increased susceptibility to bacterial infection	J:190858
Fcnb^tm1Tefu/Fcnb^tm1Tefu (B6.129-Fcnb^tm1Yend)	increased susceptibility to bacterial infection induced morbidity/mortality	J:190858
Fcrla^tm1.1Cln/Fcrla^tm1.1Cln (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:163261
	increased IgG1 level	J:163261
Fcrlb^tm1Pdb/Fcrlb^tm1Pdb (B6.129-Fcrlb^tm1Pdb)	increased anti-nuclear antigen antibody level	J:165408
Fcrlb^tm1Pdb/Fcrlb^tm1Pdb (B6.129-Fcrlb^tm1Pdb)	increased IgG1 level	J:165408
Fdxr^tm1Xch/Fdxr⁺ (B6.Cg-Fdxr^tm1Xch)	chronic liver inflammation	J:244082
Fem1a^tm1Seno/Fem1a^tm1Seno (C57BL/6-Fem1a^tm1Seno)	increased susceptibility to colitis induced morbidity/mortality	J:228893
Fem1a^tm1Seno/Fem1a^tm1Seno (C57BL/6-Fem1a^tm1Seno)	increased susceptibility to induced colitis	J:228893
Fen1^tm3.1Bhsh/Fen1⁺ (Not Specified)	chronic inflammation	J:231218
	glomerulonephritis	J:231218
	increased anti-double stranded DNA antibody level	J:231218
	increased anti-nuclear antigen antibody level	J:231218
	increased susceptibility to autoimmune disorder	J:231218
	interstitial pneumonia	J:231218
	lung inflammation	J:231218
Fen1^tm3.1Bhsh/Fen1^tm3.1Bhsh (Not Specified)	chronic inflammation	J:231218
	glomerulonephritis	J:231218
	increased anti-double stranded DNA antibody level	J:231218
	increased anti-nuclear antigen antibody level	J:231218
	increased susceptibility to autoimmune disorder	J:231218
	interstitial pneumonia	J:231218
	lung inflammation	J:231218
Fermt1^tm1Ref/Fermt1^tm1Ref (involves: 129S1/Sv * 129X1/SvJ)	ileum inflammation	J:142913
	large intestinal inflammation	J:142913
Fermt3^tm2.1Ref/Fermt3^tm2.1Ref Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell physiology	J:203436
Fes^tm1Mcs/Fes^tm1Mcs (involves: 129X1/SvJ)	abnormal macrophage physiology	J:64748
	conjunctivitis	J:64748
	increased susceptibility to bacterial infection	J:64748
Fes^tm2Pag/Fes^tm2Pag (involves: 129S1/Sv * 129X1/SvJ * CD-1)	increased susceptibility to endotoxin shock	J:98590
Ffar2^tm1Dgen/Ffar2^tm1Dgen (involves: C57BL/6)	abnormal granulocyte physiology	J:153951
	abnormal neutrophil physiology	J:153951
	impaired neutrophil chemotaxis	J:153951
	impaired neutrophil phagocytosis	J:153951
	increased susceptibility to induced arthritis	J:153951
	increased susceptibility to induced colitis	J:153951
	lung inflammation	J:153951
Ffar2^tm2Lex/Ffar2^tm2Lex (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytokine level	J:157383
	abnormal inflammatory response	J:157383
	decreased circulating tumor necrosis factor level	J:157383
	decreased susceptibility to induced colitis	J:157383
	decreased tumor necrosis factor secretion	J:157383
	impaired neutrophil chemotaxis	J:157383
	increased circulating tumor necrosis factor level	J:157383
	large intestinal inflammation	J:157383
	sepsis	J:157383
Fga^tm1Jld/Fga^tm1Jld (involves: 129P2/OlaHsd * CF-1)	decreased circulating fibrinogen level	J:28436
Fga^tm1Jld/Fga^tm1Jld (B6.129P2-Fga^tm1Jld)	decreased circulating fibrinogen level	J:28436
Fgf7^tm1Efu/Fgf7^tm1Efu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immune system physiology	J:129368
	abnormal response to transplant	J:129368
Fgfr1^Hspy/Fgfr1⁺ (C3HeB/FeJ-Hspy)	increased susceptibility to otitis media	J:95895
Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	abnormal chemokine level	J:221184
	dermatitis	J:221184
	increased IgE level	J:158802
	increased IgG1 level	J:158802
	increased IgG2a level	J:158802
	skin inflammation	J:158802, J:221184
Fgfr2^tm1Dsn/Fgfr2^tm1Dsn Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	adipose tissue inflammation	J:119723
	skin inflammation	J:119723
Fgfr2^tm1Ewj/Fgfr2⁺ Tg(EIIa-cre)C5379Lmgd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	bronchiolectasis	J:101174
Fgfr3^tm3.1Cxd/Fgfr3^tm3.1Cxd (involves: 129S6/SvEvTac)	abnormal osteoclast physiology	J:69849
Fgg^tm1Lord/Fgg⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating fibrinogen level	J:129828
Fgg^tm1Lord/Fgg^tm1Lord (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating fibrinogen level	J:129828
Fgg^tm2Jld/Fgg^tm2Jld (involves: 129P2/OlaHsd * Black Swiss * C57BL/6)	abnormal neutrophil physiology	J:90908
	increased susceptibility to bacterial infection	J:90908
Fgl1^{tm1b(EUCOMM)Hmgu}/Fgl1^{tm1b(EUCOMM)Hmgu} (involves: BALB/cJ * C57BL/6N)	dermatitis	J:269578
	increased anti-double stranded DNA antibody level	J:269578
Fgl2^tm1Pam/Fgl2⁺ (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to Coronaviridae infection	J:99453
Fgl2^tm1Pam/Fgl2^tm1Pam (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to Coronaviridae infection	J:99453
Fgl2^tm1Pam/Fgl2^tm1Pam (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	J:99453
Fgl2^tm1Pam/Fgl2^tm1Pam (B6.129X1-Fgl2^tm1Pam)	abnormal B cell physiology	J:130895
	abnormal dendritic cell physiology	J:130895
	abnormal regulatory T cell physiology	J:130895
	abnormal T cell physiology	J:130895
	decreased dendritic cell apoptosis	J:130895
	decreased susceptibility to Coronaviridae infection	J:99453
	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	J:99453
	glomerulonephritis	J:130895
	increased IgA level	J:130895
	increased IgG level	J:130895
	increased IgM level	J:130895
	increased T cell proliferation	J:130895
Fgl2^tm1Pam/Fgl2^tm1Pam (involves: 129X1/SvJ * C57BL/6J)	increased length of allograft survival	J:98997
Fgr^Mhdaali18/Fgr⁺ (C3HeB/FeJ-Fgr^Mhdaali18)	dermatitis	J:112868
Fgr^Mhdaali18/Fgr⁺ (C3HeB/FeJ-Fgr^Mhdaali18)	increased inflammatory response	J:112868
Fgr^Mhdaali18/Fgr^Mhdaali18 (C3HeB/FeJ-Fgr^Mhdaali18)	arthritis	J:112868
Fgr^Mhdaali18/Fgr^Mhdaali18 (C3HeB/FeJ-Fgr^Mhdaali18)	dermatitis	J:112868
Fgr^tm1Hev/Fgr^tm1Hev (involves: 129S7/SvEvBrd * C57BL/6)	abnormal interferon-gamma secretion	J:131738
Fgr^tm1Hev/Fgr^tm1Hev (B6.129S7-Fgr^tm1Hev)	abnormal inflammatory response	J:113463
Fgr^tm1Hev/Fgr^tm1Hev Hck^tm1Hev/Hck^tm1Hev (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal macrophage physiology	J:59037
	impaired macrophage phagocytosis	J:16994
	increased susceptibility to bacterial infection	J:16994
Fgr^tm1Hev/Fgr^tm1Hev Hck^tm1Hev/Hck^tm1Hev Lyn^tm1Sor/Lyn^tm1Sor (B6.Cg-Hck^tm1Hev Fgr^tm1Hev Lyn^tm1Sor)	abnormal inflammatory response	J:113463
	abnormal neutrophil physiology	J:113463
Fhip2b^em1Wwan/Fhip2b^em1Wwan (involves: C57BL/6)	abnormal cytokine level	J:302658, J:285283
	increased susceptibility to induced colitis	J:285283
	liver inflammation	J:302658
Fhit^tm1Hbn/Fhit⁺ (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to infection	J:71303
Fhit^tm1Hbn/Fhit^tm1Hbn (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to infection	J:71303
Fign^fi/Fign^fi (mixed)	conjunctivitis	J:13035
Fign^fi/Fign^fi (mixed)	eye inflammation	J:13035
Fis1^tm1.1Itl/Fis1^tm1.1Itl Tg(Ckmm-cre)5Khn/0 (involves: C57BL/6NTac * FVB)	increased circulating interferon-beta level	J:290485
	increased circulating interleukin-6 level	J:290485
	increased circulating interleukin-12b level	J:290485
	increased circulating interleukin-13 level	J:290485
Fitm2^tm1.1Dls/Fitm2^tm1.1Dls Tg(Fabp4-cre)1Rev/? (involves: 129S6/SvEvTac * C57BL/6J)	increased circulating tumor necrosis factor level	J:212437
Fkbp11^{Gt(OST298786)Lex}/Fkbp11^{Gt(OST298786)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased immunoglobulin level	J:103485
	increased inflammatory response	J:103485
Fkrp^tm1Scbr/Fkrp^tm1Scbr Sox1^tm1(cre)Take/Sox1⁺ (involves: C57BL/6NCrlj * CBA/JNCrlj)	myositis	J:207119
Fkrp^tm1Scbr/Fkrp^tm1Scbr Sox1^tm1(cre)Take/Sox1⁺ Tg(CAG-LARGE)126Fmu/0 (involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)	myositis	J:207119
Flg^ft/Flg^ft (involves: C57BL/6)	skin inflammation	J:151110
Flg^ft/Flg^ft (B6.Cg-Flg^ft)	increased IgE level	J:202453, J:151110
	increased IgG1 level	J:151110
	increased IgG2a level	J:151110
	increased IgG level	J:151110
	increased interferon-gamma secretion	J:151110
	increased interleukin-4 secretion	J:151110
	increased interleukin-5 secretion	J:151110
	increased interleukin-10 secretion	J:151110
	increased interleukin-13 secretion	J:151110
	increased interleukin-17 secretion	J:151110
	increased splenocyte proliferation	J:151110
Flg^ft/Flg^ft (Not Specified)	dermatitis	J:198332
Flg^ft/Flg^ft (STOCK a/a Tmem79^ma Flg^ft/J)	abnormal cytokine level	J:204304
Flg^ft/Flg^ft (STOCK a/a Tmem79^ma Flg^ft/J)	dermatitis	J:204304
Flg^ft/Flg^ft Tmem79^ma/Tmem79^ma (involves: CBA/CaGr)	blepharitis	J:202453
	increased IgE level	J:202453
	skin inflammation	J:202453
Flg^tm1Amag/Flg^tm1Amag (involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac)	abnormal humoral immune response	J:198332
	dermatitis	J:198332
	increased IgE level	J:198332
	increased IgG1 level	J:198332
	increased inflammatory response	J:229771
	increased susceptibility to type IV hypersensitivity reaction	J:198332
Flg^tm1Amag/Flg^tm1Amag Tg(CD207-Dta)312Dhka/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac * FVB)	decreased inflammatory response	J:229771
Fli1^tm1.1Dkw/Fli1^tm1.1Dkw (B6.129S6-Fli1^tm1.1Dkw)	abnormal class switch recombination	J:137876
	abnormal humoral immune response	J:137876
	decreased B cell proliferation	J:137876
	decreased IgG1 level	J:137876
	decreased IgG3 level	J:137876
Flicr^em1Doi/Flicr^em1Doi (NOD/ShiLtDoi-Flicr^em1Doi)	decreased susceptibility to autoimmune diabetes	J:241346
Flicr^em1Doi/Flicr^em1Doi (NOD/ShiLtDoi-Flicr^em1Doi)	insulitis	J:241346
Flot1^tm1.1Arte/Flot1^tm1.1Arte (involves: C57BL/6J)	abnormal leukocyte physiology	J:166672
	impaired neutrophil chemotaxis	J:166672
	impaired neutrophil recruitment	J:166672
Flt1^tm1Msh/Flt1^tm1Msh (involves: 129S4/SvJae * C57BL/6J)	impaired macrophage chemotaxis	J:49507
Flt3^m1Btlr/Flt3^m1Btlr (C57BL/6J-Flt3^m1Btlr)	abnormal dendritic cell antigen presentation	J:159599
	abnormal dendritic cell physiology	J:159599
	abnormal macrophage physiology	J:105543
	abnormal NK cell physiology	J:159599
	decreased circulating interferon-alpha level	J:159599
	decreased circulating interferon-gamma level	J:159599
	decreased circulating interleukin-12 level	J:159599
	decreased interferon-alpha secretion	J:159599
	decreased interferon-gamma secretion	J:159599
	decreased interleukin-12 secretion	J:159599
	increased circulating interleukin-6 level	J:159599
	increased circulating tumor necrosis factor level	J:159599
	increased susceptibility to Herpesvirales infection	J:105543
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:159599
	increased susceptibility to Riboviria infection	J:105543
Flt3l^tm1Imx/Flt3l^tm1Imx (C57BL/6-Flt3l^tm1Imx)	increased IgM level	J:62536
Flt3l^tm1Imx/Flt3l^tm1Imx (C57BL/6-Flt3l^tm1Imx)	increased length of allograft survival	J:89868
Flt3l^tm1Imx/Flt3l^tm1Imx (involves: C57BL/6)	abnormal dendritic cell antigen presentation	J:223508
	abnormal dendritic cell chemotaxis	J:223508
	abnormal memory T cell physiology	J:189122
	abnormal T-helper 1 physiology	J:189122
	increased susceptibility to parasitic infection	J:189122
Flt4^Chy/Flt4⁺ (involves: C3H)	abnormal lymph circulation	J:72387
Flt4^tm2Ali/Flt4⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymph circulation	J:137909
Flvcr2^tm1.2Tda/Flvcr2^tm1.2Tda (involves: C57BL/6J)	brain inflammation	J:287134
Flvcr2^{tm1a(EUCOMM)Hmgu}/Flvcr2^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Flvcr2^{tm1a(EUCOMM)Hmgu}/Wtsi)	blood in lymph vessels	J:239583
Fmnl1^tm1.2Sdb/Fmnl1^tm1.2Sdb Lyz2^tm1(cre)Ifo/Lyz2^tm1(cre)Ifo (involves: C3H * C57BL/6 * FVB/N)	abnormal macrophage physiology	J:250144
	impaired macrophage chemotaxis	J:250144
Fmod^tm1Aol/Fmod^tm1Aol (involves: 129S1/Sv * 129X1/SvJ * CD-1)	osteoarthritis	J:79115
Fmod^tm1Aol/Fmod^tm1Aol Lum^tm1Chak/Lum^tm1Chak (involves: 129S1/Sv * 129X1/SvJ * CD-1)	osteoarthritis	J:79115
Fndc4^tm1.1Mabo/Fndc4^tm1.1Mabo (involves: C57BL/6 * BALB/c)	increased susceptibility to induced colitis	J:236896
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	increased B cell apoptosis	J:189078
Fnip1^LPAB.1/Fnip1^LPAB.1 (C57BL/6J-Fnip1^LPAB.1)	abnormal B cell physiology	J:187318
	decreased IgE level	J:187318
	decreased IgG1 level	J:187318
	decreased IgG2a level	J:187318
	decreased IgG level	J:187318
	decreased IgM level	J:187318
	increased B cell apoptosis	J:187318
Fnip1^LPAB.1/Fnip1^LPAB.1 Tg(IghMyc)22Bri/0 (involves: C57BL * C57BL/6J * SJL)	increased B cell apoptosis	J:187318
Fnip1^m1Btlr/Fnip1^m1Btlr (C57BL/6J-Fnip1^m1Btlr)	decreased IgM level	J:234285
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba (involves: C57BL/6 * C57BL/6J * FVB/N * SJL)	increased B cell apoptosis	J:189078
Fos^tm1Wag/Fos^tm1Wag (involves: 129S2/SvPas * C57BL/6)	abnormal cytokine secretion	J:118693
	abnormal macrophage physiology	J:118693
	increased macrophage apoptosis	J:118693
	increased macrophage cytokine production	J:118693
	increased susceptibility to bacterial infection	J:118693
Fos^tm3.1Wag/Fos^tm3.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased interleukin-10 secretion	J:175064
	increased susceptibility to endotoxin shock	J:175064
	increased tumor necrosis factor secretion	J:175064
Fos^tm4.1Wag/Fos^tm4.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased interleukin-10 secretion	J:175064
	increased interleukin-6 secretion	J:175064
	increased susceptibility to endotoxin shock	J:175064
	increased tumor necrosis factor secretion	J:175064
Fos^tm5.1Wag/Fos^tm5.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased interleukin-10 secretion	J:175064
	increased circulating tumor necrosis factor level	J:175064
	increased interleukin-6 secretion	J:175064
	increased susceptibility to endotoxin shock	J:175064
	increased tumor necrosis factor secretion	J:175064
Fos^tm6.1Wag/Fos^tm6.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased circulating interleukin-6 level	J:175064
	increased circulating interleukin-10 level	J:175064
	increased circulating tumor necrosis factor level	J:175064
	increased susceptibility to endotoxin shock	J:175064
Fos^tm7Wag/Fos^tm7Wag Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased interleukin-10 secretion	J:175064
	increased circulating interleukin-6 level	J:175064
	increased circulating interleukin-10 level	J:175064
	increased circulating tumor necrosis factor level	J:175064
	increased interleukin-6 secretion	J:175064
	increased susceptibility to endotoxin shock	J:175064
	increased tumor necrosis factor secretion	J:175064
Fosl2^tm2.1Wag/Fosl2^tm2.1Wag (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:137646
Foxa1^tm1(cre)Sew/Foxa1⁺ Mst1r^tm1Sew/Mst1r^tm1Sew (involves: 129P2/OlaHsd * CD-1 * NIH Black Swiss)	decreased susceptibility to bacterial infection	J:105979
Foxa2^tm1.1Khk/Foxa2⁺ (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	respiratory system inflammation	J:284174
Foxc2^tm1Miu/Foxc2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	abnormal lymph circulation	J:83436
Foxf1^em1Vvk/Foxf1⁺ (involves: C57BL/6 * DBA/2)	lung inflammation	J:296328
Foxm1^tm1Rhc/Foxm1^tm1Rhc Tg(Tek-cre)1Ywa/0 (involves: 129X1/SvJ * C57BL/6 * SJL)	lung inflammation	J:167773
Foxn1^nu-str/Foxn1^nu-str (AKR/J-Foxn1^nu-str/J)	abnormal humoral immune response	J:30715
	abnormal immune system physiology	J:30715
	decreased immunoglobulin level	J:30715
	increased length of allograft survival	J:30715
Foxn1^nu/Foxn1⁺ (involves: BALB/c)	blepharitis	J:12543
	increased incidence of corneal inflammation	J:12543
	increased susceptibility to Herpesvirales infection	J:12543
Foxn1^nu/Foxn1^nu (B6NTac.Cg-Foxn1^nu/Tac)	decreased susceptibility to parasitic infection	J:64283
Foxn1^nu/Foxn1^nu (involves: BALB/c)	abnormal circulating cytokine level	J:50903
	blepharitis	J:12543
	decreased circulating interleukin-2 level	J:50903
	decreased circulating interleukin-6 level	J:50903
	decreased circulating tumor necrosis factor level	J:50903
	decreased interferon-gamma secretion	J:50903
	decreased susceptibility to bacterial infection	J:50903
	increased susceptibility to Herpesvirales infection	J:12543
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:12543
Foxn1^nu/Foxn1^nu (involves: CBA)	abnormal spleen physiology	J:202299
	abnormal T cell activation	J:202299
	increased length of allograft survival	J:202299
Foxn1^nu/Foxn1^nu Fv4^r/Fv4^r (involves: BALB/c)	decreased susceptibility to Retroviridae infection	J:5714, J:5684
Foxn1^nu/Foxn1^nu Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * BALB/c * CF-1)	abnormal T cell physiology	J:99033
	decreased inflammatory response	J:99033
Foxn1^nu/Foxn1^tm1.1Dmsu Tg(CAG-cre/Esr1)5Amc/0 (involves: 129/Sv C57BL/6 * CBA * SJL)	increased thymocyte apoptosis	J:159773
Foxo1^tm1.1Stlp/Foxo1^tm1.1Stlp Tg(Lck-cre)1Cwi/0 (involves: 129S4/SvJae)	decreased T cell proliferation	J:154205
	decreased thymocyte apoptosis	J:154205
Foxo1^tm1Flv/Foxo1^tm1Flv Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	abnormal inflammatory response	J:189962
	abnormal regulatory T cell physiology	J:189962
	increased interferon-gamma secretion	J:189962
	increased T cell proliferation	J:189962
Foxo1^tm1Flv/Foxo1^tm1Flv Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)	increased interferon-gamma secretion	J:189962
Foxo1^tm1Flv/Foxo1^tm1Flv Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:147057
	abnormal CD8-positive, alpha-beta T cell physiology	J:147057
	abnormal T cell activation	J:147057
	abnormal T cell physiology	J:147057
	increased anti-double stranded DNA antibody level	J:147057
	increased anti-nuclear antigen antibody level	J:147057
	increased susceptibility to induced colitis	J:147057
	increased T cell proliferation	J:147057
Foxo1^tm2.1Dac/Foxo1^tm2.1Dac (B6.Cg-Foxo1^tm2.1Dac)	decreased circulating tumor necrosis factor level	J:179687
Foxo3^Gt(XAO26)Byg/Foxo3^Gt(XAO26)Byg (involves: 129P2/OlaHsd)	abnormal T cell activation	J:93593
	abnormal T cell physiology	J:93593
	increased inflammatory response	J:93593
	increased T cell proliferation	J:93593
	kidney inflammation	J:93593
	lung inflammation	J:93593
	salivary gland inflammation	J:93593
Foxo3^tm1.1Rdp/Foxo3^tm1.1Rdp (involves: 129S6/SvEvTac * FVB/N)	dermatitis	J:118179
Foxo6^{tm1(KOMP)Vlcg}/Foxo6^{tm1(KOMP)Vlcg} (B6J.B6NTac-Foxo6^{tm1(KOMP)Vlcg})	impaired macrophage chemotaxis	J:236585
Foxp1^tm1.1Pwt/Foxp1^tm1.1Pwt Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal T cell activation	J:156832
	increased T cell apoptosis	J:156832
Foxp1^tm1Rao/Foxp1^tm1Rao (B6.129-Foxp1^tm1Rao)	abnormal B cell physiology	J:112644
Foxp3^sf/Y (either: 129Rl.Cg-Foxp3^sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))	abnormal B cell physiology	J:11262
	blepharitis	J:11262
	dermatitis	J:11262
	increased IgG level	J:11262
	increased IgM level	J:11262
	increased inflammatory response	J:11262
	liver inflammation	J:11262
Foxp3^sf/Y (involves: 101/H * C3H/HeH * STOCK MR)	conjunctivitis	J:10398
Foxp3^sf/? (Not Specified)	liver inflammation	J:138808
Foxp3^sf/? (Not Specified)	lung inflammation	J:138808
Foxp3^sf/Y (B6.Cg-Foxp3^sf)	abnormal CD4-positive, alpha-beta T cell physiology	J:82560
Foxp3^sf/Y (B6.Cg-Foxp3^sf/J)	lung inflammation	J:125129
	salivary gland inflammation	J:125129
	skin inflammation	J:125129
Foxp3^{tm1(CD2/CD52)Shori}/Foxp3^{tm1(CD2/CD52)Shori} (involves: C57BL/6)	increased susceptibility to type IV hypersensitivity reaction	J:171378
Foxp3^tm1(cre)Saka/Y (involves: BALB/c)	increased autoantibody level	J:140085
Foxp3^tm1(cre)Saka/Y (involves: BALB/c)	stomach inflammation	J:140085
Foxp3^tm1.1Ayr/Y (involves: 129S1/Sv * 129X1/SvJ)	increased susceptibility to autoimmune disorder	J:82560
Foxp3^tm1.1Ayr/Y (involves: 129S1/Sv * 129X1/SvJ)	skin inflammation	J:82560
Foxp3^tm1.1Ayr/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	dermatitis	J:117743
	increased susceptibility to autoimmune disorder	J:117743
	liver inflammation	J:117743
	lung inflammation	J:117743
	lymph node inflammation	J:117743
Foxp3^tm1.1Ayr/Foxp3^tm1.1Ayr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	dermatitis	J:117743
	increased susceptibility to autoimmune disorder	J:117743
	liver inflammation	J:117743
	lung inflammation	J:117743
	lymph node inflammation	J:117743
Foxp3^tm1.1Ayr/Foxp3^tm1.1Ayr Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphocyte physiology	J:167922
	blepharitis	J:167922
	conjunctivitis	J:167922
	decreased interferon-gamma secretion	J:167922
	dermatitis	J:167922
Foxp3^tm1.1Mal/Foxp3^tm1.1Mal Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal regulatory T cell physiology	J:131351
Foxp3^tm1Ayr/Y Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	dermatitis	J:97029
	increased susceptibility to autoimmune disorder	J:97029
Foxp3^tm1Kuch/? Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	decreased circulating interleukin-6 level	J:123352
	decreased interleukin-17 secretion	J:123352
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:123352
Foxp3^tm1Tch/Y (C.129X1-Foxp3^tm1Tch)	abnormal chemokine level	J:117165
	abnormal cytokine secretion	J:117165
	abnormal inflammatory response	J:117165
	abnormal lymphocyte physiology	J:117165
	dermatitis	J:117165
	increased circulating interferon-gamma level	J:117165
	increased circulating interleukin-4 level	J:117165
	increased circulating interleukin-5 level	J:117165
	increased circulating interleukin-6 level	J:117165
	increased circulating interleukin-10 level	J:117165
	increased circulating tumor necrosis factor level	J:117165
	increased IgE level	J:117165
	increased IgG1 level	J:117165
	respiratory system inflammation	J:117165
Foxp3^tm1Tch/Y (B6.129X1-Foxp3^tm1Tch)	abnormal inflammatory response	J:117165
	dermatitis	J:117165
	increased IgE level	J:117165
	respiratory system inflammation	J:117165
Foxp3^tm1Tch/Y Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Foxp3^tm1Tch)	abnormal cytokine secretion	J:117165
	increased circulating interferon-gamma level	J:117165
Foxp3^{tm2.1(EGFP/cre)Shori}/Y Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129 * 129S2/SvPas * C57BL/6)	increased susceptibility to autoimmune disorder	J:234397
	pancreas inflammation	J:234397
Foxp3^tm2Ayr/Foxp3⁺ Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal regulatory T cell physiology	J:160681
Foxp3^tm2Flv/Y (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:118631
	abnormal CD8-positive, alpha-beta T cell physiology	J:118631
	abnormal immune system physiology	J:118631
	blepharitis	J:118631
	increased autoantibody level	J:118631
Foxp3^{tm3(HBEGF/GFP)Ayr}/Foxp3⁺ Gpr174^tm1Cys/Gpr174⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:222307
Foxp3^{tm3(HBEGF/GFP)Ayr}/Foxp3^{tm3(HBEGF/GFP)Ayr} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:117743
	abnormal dendritic cell physiology	J:117743
	conjunctivitis	J:117743
	dermatitis	J:117743
	increased susceptibility to autoimmune disorder	J:117743
	liver inflammation	J:117743
	lung inflammation	J:117743
	lymph node inflammation	J:117743
Foxp3^tm3Tch/Y (C.129X1-Foxp3^tm3Tch)	abnormal CD4-positive, alpha-beta T cell physiology	J:120636
	abnormal cytokine secretion	J:120636
	abnormal lymphocyte physiology	J:120636
	abnormal regulatory T cell physiology	J:120636
	colitis	J:120636
	increased T cell proliferation	J:120636
Foxp3^tm3Tch/Foxp3⁺ (C.129X1-Foxp3^tm3Tch)	abnormal CD4-positive, alpha-beta T cell physiology	J:120636
Foxp3^tm3Tch/Foxp3⁺ (C.129X1-Foxp3^tm3Tch)	increased T cell apoptosis	J:120636
Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn (involves: 129S1/Sv * 129X1/SvJ)	abnormal regulatory T cell physiology	J:205658
Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} Ikzf4^tm1Djr/Ikzf4^tm1Djr (involves: 129S1/Sv * 129X1/SvJ)	chronic inflammation	J:294549
	glomerulonephritis	J:294549
	granulomatous inflammation	J:294549
	increased immunoglobulin level	J:294549
	increased susceptibility to experimental autoimmune encephalomyelitis	J:294549
	small intestinal inflammation	J:294549
Foxp3^tm8Ayr/Y (B6.129-Foxp3^tm8Ayr)	autoimmune response	J:157377
Foxq1^sa/Foxq1^sa (involves: 101/Rl * C3H/Rl)	impaired natural killer cell mediated cytotoxicity	J:7649
Foxq1^sa/Foxq1^sa Lyst^bg/Lyst^bg (involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl)	increased susceptibility to infection	J:5311
	interstitial pneumonia	J:15166, J:5311
Foxq1^sa/Foxq1^sa Lyst^bg/Lyst^bg (involves: 101/Rl * C3H/Rl * C57BL10/Rl)	interstitial pneumonia	J:5311
	lung inflammation	J:5311
Fpr1^tm1Gao/Fpr1^tm1Gao (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal innate immunity	J:53354
	impaired neutrophil chemotaxis	J:53354
	increased susceptibility to bacterial infection	J:53354
	increased susceptibility to bacterial infection induced morbidity/mortality	J:53354
Fpr2^tm1.1Jimw/Fpr2^tm1.1Jimw Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ)	decreased susceptibility to induced colitis	J:197568
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (B6.129X1-Fpr2^tm1.2Jimw)	abnormal cytokine secretion	J:160074
	abnormal dendritic cell physiology	J:160074
	abnormal innate immunity	J:160074
	decreased IgE level	J:160074
	decreased IgG1 level	J:160074
	decreased IgG2b level	J:160074
	decreased immunoglobulin level	J:160074
	decreased inflammatory response	J:160074
	decreased interferon-gamma secretion	J:160074
	decreased interleukin-2 secretion	J:160074
	decreased interleukin-4 secretion	J:160074
	decreased interleukin-5 secretion	J:160074
	decreased interleukin-13 secretion	J:160074
	impaired macrophage chemotaxis	J:160074
	impaired neutrophil chemotaxis	J:160074
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (involves: 129X1/SvJ)	abnormal dendritic cell chemotaxis	J:199611
	abnormal dendritic cell physiology	J:199611
	colitis	J:197568
	decreased acute inflammation	J:197568
Fpr2^tm1Rjf/Fpr2^tm1Rjf (involves: 129S/SvEv * C57BL/6)	abnormal neutrophil physiology	J:159658
	impaired macrophage chemotaxis	J:159658
	increased acute inflammation	J:159658
	increased susceptibility to induced arthritis	J:159658
fpw/fpw (involves: C3H/HeJ * C57BL/6J)	decreased circulating interferon-gamma level	J:151726
	decreased circulating interleukin-1 alpha level	J:151726
	decreased circulating interleukin-6 level	J:151726
	increased circulating interleukin-10 level	J:151726
	increased circulating tumor necrosis factor level	J:151726
Frmd8^em2Smoc/Frmd8^em2Smoc Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	increased susceptibility to colitis induced morbidity/mortality	J:338904
	increased susceptibility to induced colitis	J:338904
Fryl^{Gt(Ayu21-T312)Imeg}/Fryl^{Gt(Ayu21-T312)Imeg} (B6J.Cg-Fryl^{Gt(Ayu21-T312)Imeg})	kidney inflammation	J:260667
Fscn1^{Gt(OST124903)Lex}/Fscn1^{Gt(OST124903)Lex} (B6.129S5-Fscn1^{Gt(OST124903)Lex})	abnormal dendritic cell chemotaxis	J:169408
	abnormal dendritic cell physiology	J:169408
	abnormal Langerhans cell physiology	J:169408
Fth1^tm1.1Lck/Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn/0 (B6.Cg-Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn)	liver inflammation	J:166515
Fto^tm1.2Pzg/Fto^tm1.2Pzg (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	dermatitis	J:166984
Fto^tm1.3Pzg/Fto^tm1.3Pzg (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	dermatitis	J:166984
Fts/Fts⁺ (B6.Cg-Fts)	abnormal T cell physiology	J:108193
Furin^tm1Jwmc/Furin^tm1Jwmc Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal regulatory T cell physiology	J:204761
Fus^{Gt(U3NeoSV1)HO14Ggh}/Fus^{Gt(U3NeoSV1)HO14Ggh} (B6.129S2-Fus^{Gt(U3NeoSV1)HO14Ggh})	abnormal immunoglobulin level	J:60213
Fut2^tm1Sdo/Fut2^tm1Sdo (B6.129X1-Fut2^tm1Sdo)	increased susceptibility to fungal infection	J:90993
Fut4^tm1Jbl/Fut4^tm1Jbl (B6.129S2-Fut4^tm1Jbl)	impaired leukocyte tethering or rolling	J:79397
Fut4^tm1Jbl/Fut4^tm1Jbl Fut7^tm1Jbl/Fut7^tm1Jbl (B6.129S2-Fut7^tm1Jbl Fut4^tm1Jbl)	abnormal leukocyte migration	J:79397
	abnormal leukocyte physiology	J:79397
	abnormal neutrophil physiology	J:79397
	decreased susceptibility to bacterial infection	J:115682
	decreased susceptibility to type IV hypersensitivity reaction	J:79388
	impaired leukocyte tethering or rolling	J:79397
Fut7^tm1Jbl/Fut7^tm1Jbl (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal granulocyte physiology	J:35023
	abnormal immune system physiology	J:35023
	abnormal leukocyte adhesion	J:35023
	abnormal leukocyte migration	J:35023
	abnormal leukocyte physiology	J:35023
	abnormal leukocyte tethering or rolling	J:35023
	impaired neutrophil recruitment	J:35023
Fut7^tm1Jbl/Fut7^tm1Jbl (B6.129S2-Fut7^tm1Jbl)	decreased susceptibility to type IV hypersensitivity reaction	J:79388, J:74776
Fut7^tm1Jbl/Fut7^tm1Jbl (B6.129S2-Fut7^tm1Jbl)	impaired neutrophil recruitment	J:79397
Fut8^{em1(IMPC)Wtsi}/Fut8^{em1(IMPC)Wtsi} (C57BL/6N-Fut8^{em1(IMPC)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Fv4^r/Fv4⁺ (involves: AKR/J * BALB/c * FRG)	decreased susceptibility to Retroviridae infection	J:5714, J:5684
Fxn^tm1Mkn/Fxn^tm1Mkn Tg(FXN)YG8Pook/0 (involves: 129/Sv * C57BL/6 * CBA)	brain inflammation	J:216422
Fxn^tm1Mkn/Fxn^tm1Pand (involves: 129/Sv * C57BL/6)	brain inflammation	J:216422
Fyb1^tm1Gak/Fyb1^tm1Gak (involves: 129S1/Sv * 129X1/SvJ)	abnormal leukocyte adhesion	J:111368
	abnormal T cell physiology	J:126545
	decreased interleukin-2 secretion	J:111368, J:126545
	decreased T cell proliferation	J:111368, J:126545
Fyn^tm1Rmp/Fyn^tm1Rmp (involves: 129S2/SvPas * C57BL/6)	abnormal T cell activation	J:70886
	abnormal thymocyte activation	J:70886
	decreased T cell proliferation	J:70886
Fyn^tm1Rmp/Fyn^tm1Rmp (B6.129S2-Fyn^tm1Rmp)	abnormal eosinophil physiology	J:114287
	abnormal interleukin-4 secretion	J:114287
	decreased IgE level	J:114287
	decreased interleukin-2 secretion	J:114287
	increased interleukin-5 secretion	J:114287
	increased susceptibility to type I hypersensitivity reaction	J:114287
Fyn^tm1Sor/Fyn^tm1Sor (either: 129S7/SvEvBrd-Fyn^tm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	abnormal immune cell physiology	J:2242
	abnormal T cell clonal deletion	J:2242
	abnormal T cell physiology	J:2242
	abnormal thymocyte activation	J:2242
	decreased interleukin-2 secretion	J:2242
	decreased T cell proliferation	J:2242
	increased IgG2a level	J:2242
	increased IgM level	J:2242
Fyn^tm1Sor/Fyn^tm1Sor (B6.129S7-Fyn^tm1Sor)	abnormal CD4-positive, alpha-beta T cell physiology	J:93886
	abnormal NK cell physiology	J:187430
	abnormal T cell proliferation	J:93886
	decreased IgE level	J:93886
	decreased interferon-gamma secretion	J:187430
Fyn^tm1Sor/Fyn^tm1Sor (involves: 129S7/SvEvBrd)	abnormal chemokine level	J:80658
Fyn^tm1Sor/Fyn^tm1Sor (involves: 129S7/SvEvBrd)	abnormal macrophage physiology	J:80658
Fyn^tm1Sor/Fyn^tm1Sor Lck^tm1Litt/Lck^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S7/SvEvBrd * 129X1/SvJ)	abnormal regulatory T cell physiology	J:152472
	decreased T cell proliferation	J:152472
Fyn^tm1Yik/Fyn^tm1Yik (involves: C57BL/6 * CBA)	abnormal cytokine secretion	J:99347
	abnormal interleukin secretion	J:99347
	increased susceptibility to experimental autoimmune uveoretinitis	J:99347
	increased tumor necrosis factor secretion	J:99347
G6pc2^tm1.1Pesa/G6pc2^tm1.1Pesa (NOD.129S2-G6pc2^tm1.1Pesa)	abnormal CD8-positive, alpha-beta T cell physiology	J:160286
	decreased interferon-gamma secretion	J:160286
	decreased T cell proliferation	J:160286
G6pc3^tm1Jyc/G6pc3^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil physiology	J:120741
	impaired granulocyte bactericidal activity	J:120741
	increased susceptibility to bacterial infection	J:120741
Gab2^tm1Gsf/Gab2^tm1Gsf (involves: BALB/c)	abnormal response to infection	J:122213
Gab2^tm1Gsf/Gab2^tm1Gsf (involves: BALB/c)	decreased susceptibility to Retroviridae infection	J:122429
Gab2^tm1Hhg/Gab2^tm1Hhg (involves: 129S4/SvJae)	decreased mast cell degranulation	J:70424
Gab2^tm1Hhg/Gab2^tm1Hhg (involves: 129S4/SvJae)	decreased susceptibility to type I hypersensitivity reaction	J:70424
Gab2^tm1Thir/Gab2^tm1Thir (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mast cell physiology	J:75092
Gab2^tm3.1Thir/Gab2^tm3.1Thir (involves: 129T/SvJcl * C57BL/6Jcl)	decreased mast cell degranulation	J:178045
	decreased susceptibility to type I hypersensitivity reaction	J:178045
Gab2^tm4.1Thir/Gab2^tm4.1Thir (involves: 129T/SvJcl * C57BL/6Jcl)	decreased mast cell degranulation	J:178045
	decreased susceptibility to type I hypersensitivity reaction	J:178045
Gab3^em1Khoe/Gab3^em1Khoe (C57BL/6-Gab3^em1Khoe)	abnormal NK cell physiology	J:291290
Gab3^m1Khoe/Gab3^m1Khoe (C57BL/6-Gab3^m1Khoe)	abnormal NK cell physiology	J:291290
Gabpb2^{Gt(RRJ488)Byg}/Gabpb2^{Gt(RRJ488)Byg} (involves: 129P2/OlaHsd)	increased B cell proliferation	J:141846
	increased IgG1 level	J:141846
	increased IgM level	J:141846
Gad2^tm1Miya/Gad2^tm1Miya (NOD.129P2-Gad2^tm1Miya)	pancreas inflammation	J:88785
Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))	glomerulonephritis	J:76041
	increased anti-double stranded DNA antibody level	J:76041
	increased anti-histone antibody level	J:76041
	increased anti-single stranded DNA antibody level	J:76041
	increased autoantibody level	J:76041
	increased IgG1 level	J:76041
	increased IgM level	J:76041
	increased inflammatory response	J:76041
	increased T cell proliferation	J:76041
Gadd45b^tm1Flv/Gadd45b^tm1Flv (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:87396
	abnormal dendritic cell physiology	J:87396
	abnormal T-helper 1 physiology	J:87396
	abnormal T-helper 2 physiology	J:87396
	decreased interferon-gamma secretion	J:87396
	decreased interleukin-2 secretion	J:87396
	decreased interleukin-4 secretion	J:87396
	decreased interleukin-6 secretion	J:87396
	decreased interleukin-12 secretion	J:87396
Gadd45b^tm1Flv/Gadd45b^tm1Flv (B6.129S6-Gadd45b^tm1Flv)	abnormal T-helper 1 physiology	J:118837
	glomerulonephritis	J:118837
	increased interferon-gamma secretion	J:118837
	increased susceptibility to experimental autoimmune encephalomyelitis	J:118837
	increased T cell proliferation	J:118837
Gadd45b^tm1Flv/Gadd45b^tm1Flv Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)	glomerulonephritis	J:118837
	increased anti-double stranded DNA antibody level	J:118837
	increased anti-histone antibody level	J:118837
	increased IgG1 level	J:118837
	increased IgM level	J:118837
Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv)	abnormal NK cell physiology	J:87396
	abnormal T-helper 1 physiology	J:69475
	abnormal type IV hypersensitivity reaction	J:69475
	decreased interferon-gamma secretion	J:87396, J:69475
Galc^tm1Wngr/Galc^tm1Wngr (involves: 129S2/SvPas)	abnormal immune system physiology	J:78691
Galc^twi/Galc^twi (B6.CE-Galc^twi/J)	abnormal osteoclast physiology	J:165361
Galc^twi/Galc^twi (involves: CE/J)	CNS inflammation	J:78223
Galc^twi/Galc^twi Glb1^tm1Adz/Glb1^tm1Adz (involves: 129P2/OlaHsd * C57BL/6J * CE/J)	abnormal macrophage physiology	J:63197
Galc^twi/Galc^twi Il6⁺/? (involves: 129S2/SvPas * C57BL/6J * CE/J)	abnormal tumor necrosis factor level	J:56656
Galc^twi/Galc^twi Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6J * CE/J)	abnormal tumor necrosis factor level	J:56656
Galnt1^tm1.1Jxm/Galnt1^tm1.1Jxm (B6NHsd.Cg-Galnt1^tm1.1Jxm)	abnormal immune system physiology	J:128982
	decreased IgG level	J:128982
	impaired leukocyte tethering or rolling	J:128982
Galt^{Gt(E285B04)Wrst}/Galt^{Gt(E285B04)Wrst} (involves: 129P2/OlaHsd * C57BL/6J)	brain inflammation	J:234753
	liver inflammation	J:234753
Gapt^tm1.1Wz/Gapt^tm1.1Wz (Not Specified)	increased B cell proliferation	J:138146
	increased IgG2b level	J:138146
	increased IgG3 level	J:138146
	increased IgM level	J:138146
Gasa1^BALB/cCrSlc/Gasa1^BALB/cCrSlc (involves: BALB/cCrSlc * C57BL/6)	stomach inflammation	J:54699
Gasa1^BALB/cCrSlc/Gasa1^C57BL/6 (involves: BALB/cCrSlc * C57BL/6)	stomach inflammation	J:54699
Gasa2^BALB/cCrSlc/Gasa2^BALB/cCrSlc (involves: BALB/cCrSlc * C57BL/6)	stomach inflammation	J:54699
Gasa2^BALB/cCrSlc/Gasa2^BALB/cCrSlc Gasa4^BALB/cCrSlc/Gasa4^C57BL/6 (involves: BALB/cCrSlc * C57BL/6)	stomach inflammation	J:75277
Gasa2^BALB/cCrSlc/Gasa2^C57BL/6 (involves: BALB/cCrSlc * C57BL/6)	stomach inflammation	J:54699
Gasa3^BALB/cCrSlc/Gasa3^C57BL/6 (involves: BALB/cCrSlc * C57BL/6)	stomach inflammation	J:75277
Gasa4^BALB/cCrSlc/Gasa4^C57BL/6 (involves: BALB/cCrSlc * C57BL/6)	stomach inflammation	J:75277
Gast^tm1Lcs/Gast^tm1Lcs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	stomach inflammation	J:97527
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv * BALB/c)	decreased circulating interleukin-4 level	J:115273
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv * BALB/c)	decreased circulating interleukin-13 level	J:115273
Gata1^tm6Sho/Gata1^tm6Sho (C.129S1-Gata1^tm6Sho)	autoimmune response	J:182213
Gata3^tm1.1Mbu/Gata3^tm1.1Mbu (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal humoral immune response	J:123631
	decreased interleukin-4 secretion	J:123631
	increased interferon-gamma secretion	J:123631
Gata3^tm1Iho/Gata3^tm1Iho Il13^{tm1(YFP/cre)Lky}/Il13⁺ (involves: 129S4/SvJae)	increased susceptibility to parasitic infection	J:178986
Gata3^tm1Iho/Gata3^tm1Iho Tg(Lck-cre)1Cwi/0 (involves: BALB/c)	increased T cell apoptosis	J:86996
Gata3^tm1Jfz/Gata3^tm1Jfz Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased interleukin-13 secretion	J:172134
Gata3^tm1Jfz/Gata3^tm1Jfz Tg(Tnfrsf4-cre)1Nik/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased IgE level	J:93538
	increased susceptibility to parasitic infection	J:93538
Gata5^tm1.2Nemr/Gata5^tm1.2Nemr (Not Specified)	kidney inflammation	J:227997
Gata5^tm1Eno/Gata5^tm1Eno (involves: 129S6/SvEvTac * C57BL/6)	urethritis	J:63036
	vaginal inflammation	J:63036
Gatm^em1Btlr/Gatm^em1Btlr (C57BL/6J-Gatm^em1Btlr)	increased susceptibility to induced colitis	J:252049
Gatm^em1Btlr/Gatm^m1Btlr (C57BL/6J-Gatm^em1Btlr/Gatm^m1Btlr)	increased susceptibility to induced colitis	J:252049
Gatm^m1Btlr/Gatm⁺ (C57BL/6J-Gatm^m1Btlr)	increased susceptibility to induced colitis	J:252049
Gatm^m1Btlr/Gatm^m1Btlr (C57BL/6J-Gatm^m1Btlr)	increased susceptibility to induced colitis	J:252049
Gba1^tm1.1Pmis/Gba1^tm1.1Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal circulating chemokine level	J:167081
	abnormal circulating cytokine level	J:167081
	decreased circulating interleukin-1 alpha level	J:167081
	decreased circulating interleukin-1 beta level	J:167081
	decreased circulating interleukin-6 level	J:167081
	decreased circulating tumor necrosis factor level	J:167081
	increased circulating interferon-gamma level	J:167081
	increased circulating interleukin-2 level	J:167081
	increased circulating interleukin-3 level	J:167081
	increased circulating interleukin-9 level	J:167081
	increased circulating interleukin-10 level	J:167081
	increased circulating interleukin-13 level	J:167081
Gba1^tm1.1Pmis/Gba1^tm1.2Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal circulating chemokine level	J:167081
	abnormal circulating cytokine level	J:167081
	decreased circulating interleukin-1 alpha level	J:167081
	decreased circulating interleukin-1 beta level	J:167081
	decreased circulating interleukin-6 level	J:167081
	decreased circulating tumor necrosis factor level	J:167081
	increased circulating interferon-gamma level	J:167081
	increased circulating interleukin-2 level	J:167081
	increased circulating interleukin-3 level	J:167081
	increased circulating interleukin-9 level	J:167081
	increased circulating interleukin-10 level	J:167081
	increased circulating interleukin-13 level	J:167081
Gba1^tm1Karl/Gba1^tm1.1Karl Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal response to transplant	J:113751
Gba1^tm1Rlp/Gba1^tm1Rlp (involves: 129S4/SvJae * C57BL/6)	abnormal inflammatory response	J:76409
	abnormal spleen physiology	J:76409
	increased IgG level	J:76409
	liver inflammation	J:76409
	lung inflammation	J:76409
	lymph node inflammation	J:76409
	skin inflammation	J:76409
Gbp2^tm1.1Kpf/Gbp2^tm1.1Kpf (involves: 129P2/OlaHsd)	increased susceptibility to parasitic infection	J:192526
Gbp2^tm1.1Kpf/Gbp2^tm1.1Kpf (involves: 129P2/OlaHsd)	increased susceptibility to parasitic infection induced morbidity/mortality	J:192526
Gbp2b^tm1Tigm/Gbp2b^tm1Tigm (B6.129S5-Gbp2b^tm1Tigm/Jdmm)	abnormal macrophage physiology	J:172364
	increased susceptibility to bacterial infection	J:172364
	increased susceptibility to bacterial infection induced morbidity/mortality	J:172364
Gbp5^tm1Tigm/Gbp5^tm1Tigm (B6.Cg-Gbp5^tm1Tigm)	decreased circulating interleukin-1 beta level	J:183942
	decreased circulating interleukin-18 level	J:183942
	decreased interleukin-1 beta secretion	J:183942
	decreased interleukin-18 secretion	J:183942
	impaired neutrophil recruitment	J:183942
	increased susceptibility to bacterial infection	J:183942
Gbp7^tm1Ddgd/Gbp7^tm1Ddgd (B6.129P2-Gbp7^tm1Ddgd)	increased susceptibility to bacterial infection	J:314959
Gbp7^tm1Ddgd/Gbp7^tm1Ddgd (B6.129P2-Gbp7^tm1Ddgd)	increased susceptibility to bacterial infection induced morbidity/mortality	J:314959
Gca^tm1Roes/Gca^tm1Roes (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased susceptibility to endotoxin shock	J:81436
Gcc2^em1Cya/Gcc2^em1Cya (C57BL/6J-Gcc2^em1Cya)	increased autoantibody level	J:346915
Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129/Sv * C57BL/6)	abnormal acute inflammation	J:86387
	abnormal immune system physiology	J:86387
	abnormal inflammatory response	J:86387
Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:113195
	impaired leukocyte tethering or rolling	J:113195
Gcnt3^tm1.1Jxm/Gcnt3^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased IgA level	J:149909
	decreased IgG1 level	J:149909
	decreased IgG2a level	J:149909
	decreased IgG2b level	J:149909
	increased susceptibility to induced colitis	J:149909
Gdnf^tm1Lmgd/Gdnf⁺ (B6.129-Gdnf^tm1Lmgd)	tubulointerstitial nephritis	J:103081
Gfap^tm1Pkny/Gfap^tm1Pkny Ppt1^tm1Hof/Ppt1^tm1Hof Vim^tm1Cba/Vim^tm1Cba (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:177265
	brain inflammation	J:177265
Gfap^tm1Pkny/Gfap^tm1Pkny Vim^tm1Cba/Vim^tm1Cba (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased inflammatory response	J:123278
Gfer^tm1.1Crg/Gfer^tm1.1Crg Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129 * C57BL/6 * DBA)	liver inflammation	J:227242
Gfi1^Gen/Gfi1⁺ (C57BL/6J-Gfi1^Gen)	abnormal NK cell physiology	J:182679
Gfi1^Gen/Gfi1⁺ (C57BL/6J-Gfi1^Gen)	decreased NK cell degranulation	J:182679
Gfi1^tm1Tmo/Gfi1^tm1Tmo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:75143
	increased interleukin-1 beta secretion	J:75143
	increased interleukin-10 secretion	J:75143
	increased susceptibility to endotoxin shock	J:75143
	increased tumor necrosis factor secretion	J:75143
Gfi1^tm1Wep/Gfi1^tm1Wep (B6.129-Gfi1^tm1Wep)	abnormal T cell proliferation	J:117105
Gfi1^tm1Wep/Gfi1^tm1Wep Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell proliferation	J:117105
	abnormal T-helper 2 physiology	J:117105
Gfus^tm1Jbl/Gfus^tm1Jbl (involves: 129S2/SvPas * C57BL/6J)	large intestinal inflammation	J:82239
ggld/ggld (MRL/MpJ-Fas^lpr/J-ggld)	decreased IgG1 level	J:14258
Ggt5^tm1Mwl/Ggt5^tm1Mwl (involves: 129S7/SvEvBrd * C57BL/6J)	decreased acute inflammation	J:77691
Ggta1^tm1Jbl/Ggta1⁺ Igh^tm1Jiac/Igh^tm1Jiac Igk^tm1Jiac/Igk^tm1Jiac (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:133032
Ggta1^tm1Jbl/Ggta1^tm1Jbl (involves: 129S2/SvPas)	abnormal humoral immune response	J:113488, J:90851
	abnormal immunoglobulin level	J:113488
	abnormal response to transplant	J:90851
	decreased IgG level	J:90851
	increased IgM level	J:90851
Ghr^{tm1c(KOMP)Wtsi}/Ghr^{tm1c(KOMP)Wtsi} Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6N)	increased circulating interleukin-6 level	J:206358
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd * BALB/c)	decreased susceptibility to autoimmune diabetes	J:59132
Ghrh^tm1Salv/Ghrh^tm1Salv (involves: 129 * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:177054
Ghrhr^lit/Ghrhr^lit (C57BL/6J-Ghrhr^lit)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:85381
Gimap1^m1Btlr/Gimap1^m1Btlr (C57BL/6J-Gimap1^m1Btlr)	decreased IgD level	J:267546
Gimap1^m1Btlr/Gimap1^m1Btlr (C57BL/6J-Gimap1^m1Btlr)	increased IgM level	J:267546
Gimap1^tm1.1Gwb/Gimap1^tm1.1Gwb Tg(CD2-icre)4Kio/0 (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal CD4-positive, alpha-beta T cell physiology	J:160782
	abnormal CD8-positive, alpha-beta T cell physiology	J:160782
Gimap4^tm1Jcbs/Gimap4^tm1Jcbs (B6.129P2-Gimap4^tm1Jcbs)	abnormal T cell physiology	J:135744
Gimap5^m1Btlr/Gimap5^m1Btlr (involves: C57BL/6J)	abnormal B cell physiology	J:160090
	abnormal B cell proliferation	J:160090
	abnormal NK T cell physiology	J:160090
	abnormal response to transplant	J:160090
	colitis	J:160090
	decreased B cell proliferation	J:160090
	decreased circulating interferon-gamma level	J:160090
	decreased circulating interleukin-4 level	J:160090
	decreased IgG1 level	J:160090
	decreased IgG2a level	J:160090
	decreased IgG2b level	J:160090
	decreased IgG3 level	J:160090
	decreased IgG level	J:160090
	decreased IgM level	J:160090
	decreased interferon-gamma secretion	J:160090
	decreased interleukin-4 secretion	J:160090
	decreased tumor necrosis factor secretion	J:160090
	intestinal inflammation	J:160090
Gimap5^tm1Wlr/Gimap5^tm1Wlr (either: B6.129-Gimap5^tm1Wlr or C.129-Gimap5^tm1Wlr)	abnormal response to transplant	J:143620
Gimap6^tm1.1Gwb/Gimap6^tm1.1Gwb Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal T cell physiology	J:262059
	increased T cell apoptosis	J:262059
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha-beta T cell physiology	J:160613
	abnormal CD8-positive, alpha-beta T cell physiology	J:160613
Git2^tm1Hsb/Git2^tm1Hsb (involves: C57BL/6 * CBA)	abnormal neutrophil physiology	J:112663
	impaired neutrophil chemotaxis	J:112663
	increased susceptibility to fungal infection	J:112663
	lung inflammation	J:112663
Gja1^M1Jrt/Gja1⁺ (involves: C3H/HeJ * C57BL/6J)	heart inflammation	J:101733
Gja1^tm1.1Kwi/Gja1⁺ (involves: 129P2/OlaHsd)	abnormal neutrophil physiology	J:129091
Gja1^tm1Kwi/Gja1^{tm5(cre/ERT)Kwi} (involves: 129P2/OlaHsd)	abnormal neutrophil physiology	J:129091
Gjb1^tm1Kwi/Y Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	optic nerve inflammation	J:219594
	spinal cord inflammation	J:219594
Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi Gjb1^tm1Kwi/Gjb1^tm1Kwi (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	optic nerve inflammation	J:219594
	spinal cord inflammation	J:219594
Gkn2^{tm1.1(KOMP)Vlcg}/Gkn2^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal chemokine level	J:234656
	abnormal cytokine level	J:234656
	abnormal innate immunity	J:234656
	abnormal interleukin level	J:234656
	abnormal susceptibility to bacterial infection	J:234656
	abnormal T-helper 1 physiology	J:234656
	abnormal tumor necrosis factor level	J:234656
	increased susceptibility to bacterial infection	J:234656
	stomach inflammation	J:234656
Glb1^tm1Jmat/Glb1^tm1Jmat (involves: C57BL/6 * CBA * ICR)	abnormal macrophage chemotaxis	J:102576
Glg1^{Gt(RST092)Byg}/Glg1⁺ (B6J.129P2-Glg1^{Gt(RST092)Byg})	abnormal cellular extravasation	J:226586
	abnormal leukocyte adhesion	J:226586
	enhanced leukocyte tethering or rolling	J:226586
Glis2^tm1Amj/Glis2^tm1Amj (involves: 129P2/OlaHsd * C57BL/6)	glomerulonephritis	J:134208
Glmp^{Gt(P084H04)Wrst}/Glmp^{Gt(P084H04)Wrst} (involves: 129S2/SvPas * C57BL/6)	liver inflammation	J:208774
Glmp^tm1Lex/Glmp^tm1Lex (B6;129S5-Glmp^tm1Lex/Mmucd)	abnormal immune system physiology	J:171883
Glmp^tm1Lex/Glmp^tm1Lex (B6;129S5-Glmp^tm1Lex/Mmucd)	liver inflammation	J:171883
Glt8d2^tm1Lex/Glt8d2^tm1Lex (B6;129S5-Glt8d2^tm1Lex/Mmucd)	abnormal adaptive immunity	J:171883
	decreased IgG1 level	J:171883
	decreased IgG2a level	J:171883
Gm614^tm1.1Cya/Gm614^tm1.1Cya Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	decreased susceptibility to systemic lupus erythematosus	J:307345
	increased B cell apoptosis	J:307345
Gm5544^{tm1a(KOMP)Wtsi}/Gm5544^{tm1a(KOMP)Wtsi} (C57BL/6N-Gm5544^{tm1a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Gm16685^em1Osb/Gm16685^em1Osb (C57BL/6N-Gm16685^em1Osb)	decreased susceptibility to colitis induced morbidity/mortality	J:303079
Gm36723^em1Flv/Gm36723^em1Flv (C57BL/6-Gm36723^em1Flv)	abnormal NK cell physiology	J:258967
	decreased interferon-gamma secretion	J:258967
	decreased susceptibility to bacterial infection	J:258967
	impaired natural killer cell mediated cytotoxicity	J:258967
Gm40600^em1Cya/Gm40600^em1Cya (C57BL/6-Gm40600^em1Cya)	decreased IgA level	J:311878
	decreased IgE level	J:311878
	decreased IgG1 level	J:311878
	decreased IgG2b level	J:311878
	decreased IgG2c level	J:311878
	decreased IgG3 level	J:311878
	decreased IgG level	J:311878
	decreased IgM level	J:311878
	increased IgA level	J:311878
	increased IgE level	J:311878
	increased IgG1 level	J:311878
	increased IgG2b level	J:311878
	increased IgG2c level	J:311878
	increased IgG3 level	J:311878
	increased IgG level	J:311878
	increased IgM level	J:311878
Gm41610^em1Scrp/Gm41610^em1Scrp (C57BL/6-Gm41610^em1Scrp)	decreased susceptibility to endotoxin shock	J:302605
	increased circulating interleukin-5 level	J:302605
	increased circulating interleukin-13 level	J:302605
Gmnn^tm1.1Kio/Gmnn^tm1.2Kio Tg(CD2-icre)4Kio/0 (involves: 129S4/SvJae * C57BL/10 * CBA/Ca)	decreased T cell proliferation	J:159657
Gna11^tm1Soff/Gna11^tm1Soff (involves: 129S7/SvEvBrd)	decreased susceptibility to type I hypersensitivity reaction	J:146132
Gna11^tm1Soff/Gna11^tm1Soff Gnaq^tm2Soff/Gnaq^tm2Soff Tg(Tek-icre/ERT2)1Soff/? (involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)	decreased susceptibility to type I hypersensitivity reaction	J:146132
Gna12^tm1.1Cgh/Gna12^tm1.1Cgh Gna13^tm2Cgh/Gna13^tm2Cgh Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	decreased B cell apoptosis	J:174313
Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal CD4-positive, alpha-beta T cell physiology	J:149560
	increased interleukin-2 secretion	J:149560
	increased susceptibility to autoimmune diabetes	J:149560
	increased susceptibility to type IV hypersensitivity reaction	J:149560
	increased T cell proliferation	J:149560
Gnai1^tm1Drs/Gnai1^tm1Drs Gnai3^tm1Lbi/Gnai3^tm1Lbi (involves: 129S/SvEv)	decreased interleukin-10 secretion	J:104683
	increased tumor necrosis factor secretion	J:104683
Gnai2^tm1Lbi/Gnai2^tm1Lbi (involves: 129S7/SvEvBrd * C57BL/6J)	colitis	J:24434
Gnai2^tm1Lbi/Gnai2^tm1Lbi (involves: 129S7/SvEvBrd)	abnormal cytokine level	J:121471
	abnormal cytokine secretion	J:30507
	abnormal immune system physiology	J:30507
	abnormal neutrophil physiology	J:121471
	colitis	J:24434
	increased circulating interferon-gamma level	J:121471
	increased circulating interleukin-4 level	J:121471
	increased circulating interleukin-5 level	J:121471
	increased IgA level	J:30507
	increased IgG level	J:30507
	increased immunoglobulin level	J:30507
	increased inflammatory response	J:30507
	increased interferon-gamma secretion	J:30507
	increased interleukin-2 secretion	J:30507
	increased susceptibility to parasitic infection	J:121471
	increased T cell proliferation	J:30507
	increased tumor necrosis factor secretion	J:30507
	large intestinal inflammation	J:30507
	peritoneal inflammation	J:30507
Gnai2^tm1Lbi/Gnai2^tm1Lbi (either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))	abnormal cytokine secretion	J:24434
	increased IgG level	J:24434
	increased IgM level	J:24434
Gnai2^tm1Lbi/Gnai2^tm1Lbi (129-Gnai2^tm1Lbi)	abnormal cytokine secretion	J:91100
	increased interleukin-1 beta secretion	J:91100
	increased tumor necrosis factor secretion	J:91100
Gnai2^tm1Lbi/Gnai2^tm1Lbi (B6.129S7-Gnai2^tm1Lbi)	abnormal cellular extravasation	J:120069
	abnormal eosinophil physiology	J:120069
	abnormal leukocyte adhesion	J:120069
	abnormal T cell physiology	J:121161
Gnai2^tm1Lbi/Gnai2^tm1Lbi (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:91100
	colitis	J:91100
	increased interleukin-1 beta secretion	J:91100
	increased tumor necrosis factor secretion	J:91100
Gnai2^tm2.1Lbi/Gnai2^tm2.1Lbi Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA)	increased susceptibility to induced colitis	J:194587
Gnai3^tm1Lbi/Gnai3^tm1Lbi (B6.129S-Gnai3^tm1Lbi)	abnormal T cell physiology	J:121161
Gnas^Oedsml/Gnas⁺ (involves: 101/H * C3H/HeH)	abnormal inflammatory response	J:65007
Gnb1l^{Gt(OST35527)Lex}/Gnb1l⁺ (B6;129S5-Gnb1l^{Gt(OST35527)Lex}/Orl)	glomerulonephritis	J:82809
Gne^tm1.1Masn/Gne^tm1.1Masn (involves: 129P2/OlaHsd * C57BL/6)	kidney inflammation	J:184315
Gnptab^nym/Gnptab^nym (involves: BALB/cAnNHsd * C3H/HeNHsd)	brain inflammation	J:218156
Gnptab^tm1Dkji/Gnptab^tm1Dkji (involves: 129 * C57BL/6)	increased interleukin-6 secretion	J:231531
Gnptab^tm1Kkol/Gnptab^tm1Kkol (involves: 129 * C57BL/6)	abnormal osteoclast physiology	J:202751
Golm1^{Gt(KST273)Byg}/Golm1^{Gt(KST273)Byg} (involves: 129P2/OlaHsd * C57BL/6)	kidney inflammation	J:151282
	liver inflammation	J:151282
Gon4l^justy/Gon4l^justy (C3HeB/FeJ-Gon4l^justy)	abnormal humoral immune response	J:163412
Gon4l^justy/Gon4l^justy (C3HeB/FeJ-Gon4l^justy)	decreased immunoglobulin level	J:163412
Gpa33^tm1Jkhh/Gpa33^tm1Jkhh (B6.129-Gpa33^tm1Jkhh)	abnormal immune tolerance	J:224768
	increased susceptibility to induced colitis	J:224768
	increased susceptibility to type IV hypersensitivity reaction	J:224768
Gpa33^tm1Jkhh/Gpa33^tm1Jkhh (involves: 129 * C57BL/6)	increased susceptibility to colitis induced morbidity/mortality	J:231808
Gpa33^tm1Jkhh/Gpa33^tm1Jkhh (involves: 129 * C57BL/6)	increased susceptibility to induced colitis	J:231808
Gpc3^tm1Fil/Y (B6.Cg-Gpc3^tm1Fil)	increased susceptibility to bacterial infection	J:73877
	lung inflammation	J:73877
	rhinitis	J:73877
Gpc3^tm1Fil/Gpc3^tm1Fil (B6.Cg-Gpc3^tm1Fil)	increased susceptibility to bacterial infection	J:73877
Gpc3^tm1Fil/Gpc3^tm1Fil (B6.Cg-Gpc3^tm1Fil)	lung inflammation	J:73877
Gpdc1^C3H/HeN/Gpdc1^C3H/HeN (involves: C3H/HeN-Gnai2^tm1Uru * C57BL/6J-Gna2^tm1Uru)	colitis	J:95140
Gpdc2^C3H/HeN/Gpdc2^C3H/HeN (involves: C3H/HeN-Gnai2^tm1Uru * C57BL/6J-Gna2^tm1Uru)	colitis	J:95140
Gpdc3^C3H/HeN/? (involves: C3H/HeN-Gnai2^tm1Uru * C57BL/6J-Gna2^tm1Uru)	colitis	J:95140
Gpnmb^tm1Ari/Gpnmb^tm1Ari (C57BL/6-Gpnmb^tm1Ari)	abnormal dendritic cell physiology	J:215931
Gpr15^tm1.1Litt/Gpr15^tm1.1Litt (B6.129P2-Gpr15^tm1.1Litt)	abnormal regulatory T cell physiology	J:199126
	increased susceptibility to bacterial infection	J:199126
	increased susceptibility to bacterial infection induced morbidity/mortality	J:199126
	increased susceptibility to induced colitis	J:199126
Gpr15^tm1.1Litt/Gpr15^tm1.1Litt (involves: 129P2/OlaHsd * C57BL/6)	increased interferon-gamma secretion	J:199126
	increased interleukin-17 secretion	J:199126
Gpr15^tm1.1Litt/Gpr15^tm1.1Litt Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * 129S/SvEv * BALB/c * C57BL/6)	abnormal immune system physiology	J:199126
Gpr15lg^tm1Lex/Gpr15lg^tm1Lex (B6;129S5-Gpr15lg^tm1Lex/Mmucd)	increased IgG2a level	J:171883
Gpr18^tm1Lex/Gpr18^tm1Lex (involves: 129S/SvEv * C57BL/6)	increased susceptibility to bacterial infection	J:226433
Gpr21^tm1Dgen/Gpr21^tm1Dgen (B6.129P2-Gpr21^tm1Dgen)	abnormal circulating chemokine level	J:181127
Gpr21^tm1Dgen/Gpr21^tm1Dgen (B6.129P2-Gpr21^tm1Dgen)	decreased circulating serum amyloid protein level	J:181127
Gpr31b^tm1Ktak/Gpr31b^tm1Ktak (B6.Cg-Gpr31b^tm1Ktak)	abnormal dendritic cell physiology	J:271242
	decreased inflammatory response	J:271242
	increased susceptibility to bacterial infection	J:271242
Gpr34^tm1.1Shbg/Gpr34^tm1.1Shbg (B6.Cg-Gpr34^tm1.1Shbg)	abnormal chemokine secretion	J:168120
	abnormal cytokine secretion	J:168120
	abnormal leukocyte migration	J:168120
	increased interferon-gamma secretion	J:168120
	increased interleukin-2 secretion	J:168120
	increased interleukin-4 secretion	J:168120
	increased interleukin-5 secretion	J:168120
	increased interleukin-10 secretion	J:168120
	increased interleukin-12 secretion	J:168120
	increased susceptibility to fungal infection	J:168120
	increased susceptibility to type IV hypersensitivity reaction	J:168120
	increased tumor necrosis factor secretion	J:168120
Gpr35^em1Niess/Gpr35^em1Niess (C57BL/6N-Gpr35^em1Niess)	increased susceptibility to induced colitis	J:300275
Gpr35^em2Niess/Gpr35^em2Niess Cx3cr1^{tm2.1(cre/ERT2)Litt}/Cx3cr1⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to induced colitis	J:300275
Gpr35^{tm1(KOMP)Vlcg}/Gpr35^{tm1(KOMP)Vlcg} (C57BL/6N-Gpr35^{tm1(KOMP)Vlcg}/MbpMmucd)	abnormal chemokine level	J:306520
	abnormal interleukin level	J:306520
	decreased susceptibility to colitis induced morbidity/mortality	J:306520
	decreased susceptibility to induced colitis	J:306520
Gpr55^tm1.1Mijr/Gpr55^tm1.1Mijr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:153225
Gpr65^tm1Witt/Gpr65^tm1Witt (B6.Cg-Gpr65^tm1Witt)	abnormal immune cell physiology	J:96112
Gpr65^tm1Witt/Gpr65^tm1Witt (B6.Cg-Gpr65^tm1Witt)	abnormal leukocyte physiology	J:96112
Gpr65^tm1Witt/Gpr65^tm1Witt (C.Cg-Gpr65^tm1Witt)	abnormal leukocyte physiology	J:96112
Gpr65^{Tn(sb-lacZ,GFP)T1.88Jtak}/Gpr65^{Tn(sb-lacZ,GFP)T1.88Jtak} (B6.Cg-Gpr65^{Tn(sb-lacZ,GFP)T1.88Jtak})	abnormal interleukin-1 beta secretion	J:208788
	abnormal macrophage physiology	J:146233
	decreased tumor necrosis factor secretion	J:146233
Gpr68^tm1.1Yaxu/Gpr68^tm1.1Yaxu (B6.Cg-Gpr68^tm1.1Yaxu)	abnormal osteoclast physiology	J:149315
Gpr68^tm1.1Yaxu/Gpr68^tm1.1Yaxu (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal macrophage physiology	J:149315
	abnormal osteoclast physiology	J:149315
Gpr68^tm1Yaxu/Gpr68^tm1Yaxu (involves: C57BL/6)	abnormal macrophage physiology	J:149315
Gpr68^tm1Yaxu/Gpr68^tm1Yaxu (involves: C57BL/6)	abnormal osteoclast physiology	J:149315
Gpr84^tm1Lex/Gpr84^tm1Lex (involves: 129S/SvEvBrd * C57BL/6)	abnormal T-helper 2 physiology	J:186985
	increased interleukin-4 secretion	J:186985
	increased interleukin-5 secretion	J:186985
	increased interleukin-13 secretion	J:186985
Gpr89^tm1.1Ymae/Gpr89^tm1.1Ymae Tg(KRT5-cre)1Tak/0 (involves: C3H * C57BL/6)	dermatitis	J:189574
Gpr108^tm1.1Brs/Gpr108^tm1.1Brs (involves: 129S6/SvEvTac)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:266821
	decreased tumor necrosis factor secretion	J:266821
	increased interleukin-6 secretion	J:266821
	increased susceptibility to endotoxin shock	J:266821
	increased tumor necrosis factor secretion	J:266821
Gpr132^tm1Witt/Gpr132^tm1Witt (B6.129X1-Gpr132^tm1Witt)	impaired macrophage chemotaxis	J:96613
Gpr132^tm1Witt/Gpr132^tm1Witt (involves: 129X1/SvJ * BALB/c)	abnormal lymphocyte physiology	J:69473
	increased anti-nuclear antigen antibody level	J:69473
	increased B cell proliferation	J:69473
	increased IgA level	J:69473
	increased IgG1 level	J:69473
	increased immunoglobulin level	J:69473
	increased inflammatory response	J:69473
	increased T cell proliferation	J:69473
	kidney inflammation	J:69473
	liver inflammation	J:69473
	lung inflammation	J:69473
Gpr132^tm1Witt/Gpr132^tm1Witt Ldlr^tm1Her/Ldlr^tm1Her (B6.129-Ldlr^tm1Her Gpr132^tm1Witt)	decreased macrophage apoptosis	J:100498
Gpr174^tm1Cys/Y (B6.129-Gpr174^tm1Cys)	abnormal regulatory T cell physiology	J:222307
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:222307
	increased T cell proliferation	J:222307
Gpr174^tm1Cys/Gpr174⁺ (B6.129-Gpr174^tm1Cys)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:222307
Gpr182^{tm2c(KOMP)Wtsi}/Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha/0 (B6.Cg-Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha)	abnormal circulating chemokine level	J:305796
	increased circulating CXCL10 level	J:305796
Gpr183^tm1.1Cys/Gpr183^tm1.1Cys (B6.129P2-Gpr183^tm1.1Cys)	abnormal follicular B cell physiology	J:151077
Gpr183^tm1.2Rbr/Gpr183^tm1.2Rbr (involves: C57BL/6 * FVB/N * SJL)	abnormal B cell physiology	J:151883
Gpr183^tm1.2Rbr/Gpr183^tm1.2Rbr Igh^tm1Rbr/Igh^tm1Rbr Tg(IgkHyHEL10)1Rbr/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal B cell physiology	J:151883
	abnormal B cell proliferation	J:151883
	decreased IgG1 level	J:151883
	decreased IgM level	J:151883
Gpr183^tm1Lex/Gpr183^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal circulating interferon-beta level	J:211122
	increased circulating interferon-alpha level	J:211122
	increased circulating interferon-gamma level	J:211122
Gprc5a^tm1Rlo/Gprc5a^tm1Rlo (involves: 129 * C57BL/6)	lung inflammation	J:127821
Gpsm3^{Gt(IST12408A1)Tigm}/Gpsm3^{Gt(IST12408A1)Tigm} (involves: C57BL/6N)	abnormal leukocyte migration	J:193270
	abnormal leukocyte physiology	J:193270
	decreased susceptibility to induced arthritis	J:193270
Gpx1^tm1Kola/Gpx1^tm1Kola (involves: 129S2/SvPas * BALB/c * CF-1)	increased inflammatory response	J:79183
Gpx1^tm1Ysh/Gpx1⁺ Gpx2^tm2Coh/Gpx2^tm2Coh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	intestinal inflammation	J:71506
Gpx1^tm1Ysh/Gpx1^tm1Ysh Gpx2^tm2Coh/Gpx2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	intestinal inflammation	J:71506
Gpx1^tm1Ysh/Gpx1^tm1Ysh Gpx2^tm2Coh/Gpx2^tm2Coh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	colitis	J:71506
	intestinal inflammation	J:71506
	small intestinal inflammation	J:71506
Gpx7^tm1Whle/Gpx7^tm1Whle (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:193993
	glomerulonephritis	J:193993
	increased anti-nuclear antigen antibody level	J:193993
Gpx8^tm1Lex/Gpx8^tm1Lex (B6;129S5-Gpx8^tm1Lex/Mmucd)	dermatitis	J:171883
Grap^tm1Gsf/Grap^tm1Gsf (B6.129-Grap^tm1Gsf)	increased T cell proliferation	J:76243
Grass1^C57BL/6J/Grass1^C57BL/6J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:134374
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:134374
	sepsis	J:134374
Grass1^C57BL/6J/Grass1^DBA/2J (involves: C57BL/6J * DBA/2J)	increased susceptibility to bacterial infection	J:134374
Grass1^C57BL/6J/Grass1^DBA/2J (involves: C57BL/6J * DBA/2J)	sepsis	J:134374
Grass1^DBA/2J/Grass1^DBA/2J (involves: C57BL/6J * DBA/2J)	increased susceptibility to bacterial infection	J:134374
Grass1^DBA/2J/Grass1^DBA/2J (involves: C57BL/6J * DBA/2J)	sepsis	J:134374
Grb2^tm1Lnit/Grb2^tm1Lnit Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * BALB/cJ)	abnormal B cell physiology	J:171222
	abnormal memory B cell physiology	J:171222
	decreased IgG3 level	J:171222
	decreased IgG level	J:171222
	increased B cell apoptosis	J:171222
	increased B cell proliferation	J:171222
	increased IgM level	J:171222
Grb2^tm1Paw/Grb2⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	decreased susceptibility to Retroviridae infection	J:122429
Greb1^em1Rkom/Greb1^em1Rkom (C57BL/6NJ-Greb1^em1Rkom)	abnormal response to transplant	J:346713
Grem2^em1Stpg/Grem2^em1Stpg (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J)	ovary inflammation	J:318711
Grem2^tm1Akh/Grem2^tm1Akh (involves: 129/Sv * C57BL/6)	abnormal chemokine level	J:250034
	increased inflammatory response	J:250034
	increased interleukin-10 secretion	J:250034
Grhl3^{tm1a(EUCOMM)Wtsi}/Grhl3⁺ (C57BL/6N-Grhl3^{tm1a(EUCOMM)Wtsi}/Ics)	decreased IgE level	J:165965
Grhpr^{Gt(OST383093)Lex}/Grhpr^{Gt(OST383093)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	urinary bladder inflammation	J:181969
Grk2^tm1Gwd/Grk2^tm1Gwd Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal B cell physiology	J:176118
Grk2^tm1Gwd/Grk2^tm1Mca Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal T cell physiology	J:176118
	impaired leukocyte tethering or rolling	J:176118
Grk6^tm1.1Mca/Grk6^tm1.1Mca (involves: 129S4/SvJae * C57BL/6J)	abnormal B cell physiology	J:76872
	abnormal T cell physiology	J:76872
Grk6^tm1.1Mca/Grk6^tm1.1Mca (B6.129S4-Grk6^tm1.1Mca)	glomerulonephritis	J:225063
	impaired macrophage phagocytosis	J:225063
	increased anti-double stranded DNA antibody level	J:225063
	increased IgG level	J:225063
Grn^tm1.1Aidi/Grn^tm1.1Aidi (involves: C57BL/6 * C57BL/6J)	abnormal chemokine secretion	J:156824
	abnormal macrophage physiology	J:156824
	abnormal microglial cell physiology	J:156824
	increased interleukin-6 secretion	J:156824
	increased interleukin-12 secretion	J:156824
	increased susceptibility to bacterial infection	J:156824
	increased tumor necrosis factor secretion	J:156824
Grn^tm1.1Aidi/Grn^tm1.1Aidi (involves: C57BL/6J)	kidney inflammation	J:268827
Grn^tm1.1Far/Grn^tm1.1Far (involves: 129S4/SvJae * FVB/N)	abnormal macrophage physiology	J:170823
Grn^tm1.1Far/Grn^tm1.1Far (involves: 129S4/SvJae * C57BL/6J * FVB/N)	increased interleukin-1 beta secretion	J:188324
	increased interleukin-6 secretion	J:188324
	increased interleukin-10 secretion	J:188324
	increased tumor necrosis factor secretion	J:188324
Grn^tm2.1Far/Grn^tm2.1Far (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:259651
Gsdma3^Ae/Gsdma3⁺ (involves: C57BL/6J * CAST/Ei)	skin inflammation	J:180149
Gsdma3^M2Btlr/Gsdma3^M2Btlr (involves: C57BL/6J)	dermatitis	J:209203
Gsdma^em1Cya/Gsdma^em1Cya (C57BL/6J-Gsdma^em1Cya)	increased susceptibility to bacterial infection	J:326434
Gsdma^em1Cya/Gsdma^em1Cya (C57BL/6J-Gsdma^em1Cya)	increased susceptibility to bacterial infection induced morbidity/mortality	J:326434
Gsdmd^em1Fcw/Gsdmd^em2Fcw (involves: C57BL/6)	abnormal macrophage apoptosis	J:226781
Gsdmd^em1Fcw/Gsdmd^em2Fcw (involves: C57BL/6)	decreased interleukin-1 beta secretion	J:226781
Gsdmd^em1Flv/Gsdmd^em1Flv (C57BL/6N-Gsdmd^em1Flv)	increased susceptibility to Riboviria infection induced morbidity/mortality	J:243487
Gsdmd^em3Fcw/Gsdmd^em3Fcw (involves: C57BL/6)	abnormal macrophage apoptosis	J:226781
Gsdmd^em3Fcw/Gsdmd^em3Fcw (involves: C57BL/6)	decreased interleukin-1 beta secretion	J:226781
Gsdmd^em4Fcw/Gsdmd^em4Fcw (C57BL/6N-Gsdmd^em4Fcw/J)	abnormal macrophage apoptosis	J:101977
Gsdmd^em4Fcw/Gsdmd^em4Fcw (C57BL/6N-Gsdmd^em4Fcw/J)	abnormal susceptibility to bacterial infection	J:101977
Gsdmd^m1Btlr/Gsdmd^m1Btlr (C57BL/6J-Gsdmd^m1Btlr)	decreased interleukin-1 beta secretion	J:267555
Gsk3a^tm1Dral/Gsk3a^tm1Dral Gsk3b^tm1Dral/Gsk3b^tm1Dral (involves: 129P2/OlaHsd)	increased circulating interleukin-6 level	J:200517
Gsn^tm1Djk/Gsn^tm1Djk (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal immune system physiology	J:24346
	abnormal osteoclast physiology	J:60625
	decreased inflammatory response	J:24346
	impaired neutrophil chemotaxis	J:24346
	impaired neutrophil recruitment	J:24346
Gsta4^tm1Pzim/Gsta4⁺ (involves: 129S1/Sv * 129S6/SvEvTac)	increased susceptibility to bacterial infection	J:87983
Gsta4^tm1Pzim/Gsta4^tm1Pzim (involves: 129S1/Sv * 129S6/SvEvTac)	increased susceptibility to bacterial infection	J:87983
Gstcd^{tm1b(EUCOMM)Wtsi}/Gstcd^{tm1b(EUCOMM)Wtsi} (C57BL/6-Gstcd^{tm1b(EUCOMM)Wtsi})	increased tumor necrosis factor secretion	J:279480
Gstk1^tm1Pgb/Gstk1^tm1Pgb (BALB/c-Gstk1^tm1Pgb)	glomerulonephritis	J:177201
	urethritis	J:177201
	urinary bladder inflammation	J:177201
Gstz1^tm1Pgb/Gstz1^tm1Pgb (BALB/c-Gstz1^tm1Pgb/AnuApb)	chronic inflammation	J:91519
Gstz1^tm1Pgb/Gstz1^tm1Pgb (BALB/c-Gstz1^tm1Pgb/AnuApb)	liver inflammation	J:91519
Gt(ROSA)26Sor^{em1(DPP4)Yowa}/Gt(ROSA)26Sor^{em1(DPP4)Yowa} (C57BL/6-Gt(ROSA)26Sor^{em1(DPP4)Yowa})	increased susceptibility to Coronaviridae infection	J:279060
Gt(ROSA)26Sor^{em1(Ube2s)Chaw}/? (involves: C57BL/6)	decreased interferon level	J:306461
Gt(ROSA)26Sor^{em1(Ube2s)Chaw}/? (involves: C57BL/6)	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:306461
Gt(ROSA)26Sor^{tm1(B4galt1)Clib}/Gt(ROSA)26Sor^{tm1(B4galt1)Clib} Tg(Nes-cre)Wme/? (involves: 129S6/SvEvTac * C57BL/6 * CBA)	decreased acute inflammation	J:209737
	decreased circulating interleukin-6 level	J:209737
	decreased susceptibility to induced colitis	J:209737
Gt(ROSA)26Sor^{tm1(CAG-Bcl3,-EGFP)Hoev}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:208980
	decreased B cell apoptosis	J:208980
	decreased B cell proliferation	J:208980
	decreased IgG1 level	J:208980
	decreased IgG2b level	J:208980
	decreased IgG3 level	J:208980
	decreased IgM level	J:208980
Gt(ROSA)26Sor^{tm1(CAG-CAMK2GT287D,-EGFP)Whua}/Gt(ROSA)26Sor⁺ Tg(Vil1-cre)997Gum/0 (involves: 129 C57BL/6)	decreased susceptibility to induced colitis	J:243363
Gt(ROSA)26Sor^{tm1(CAG-Foxn1/ERT2,-GFP)Cbln}/Gt(ROSA)26Sor⁺ Foxn1^tm3(cre)Nrm/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus involution	J:208852
Gt(ROSA)26Sor^{tm1(CARD14)Ribt}/Gt(ROSA)26Sor⁺ Malt1^{tm1c(EUCOMM)Hmgu}/Malt1^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S6/SvEvTac C57BL/6NCrl * CD-1)	skin inflammation	J:292094
Gt(ROSA)26Sor^{tm1(CARD14)Ribt}/Gt(ROSA)26Sor⁺ Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S6/SvEvTac C57BL/6NCrl * CD-1)	skin inflammation	J:292094
Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ Mcl1^tm1Ywh/Mcl1^tm1Ywh (involves: 129/Sv * 129S6/SvEvTac * C57BL/6)	increased T cell apoptosis	J:137400
Gt(ROSA)26Sor^tm1(DTA)Jpmb/Gt(ROSA)26Sor⁺ Tg(Plp1-cre/ERT)3Pop/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	autoimmune response	J:234435
	CNS inflammation	J:234435
	lymph node inflammation	J:234435
Gt(ROSA)26Sor^tm1(DTA)Jpmb/Gt(ROSA)26Sor⁺ Tg(Trpv1-cre)1Hoon/0 (involves: 129S1/Sv)	decreased inflammatory response	J:169256
Gt(ROSA)26Sor^tm1(DTA)Lky/? Il5^{tm1.1(icre)Lky}/Il5⁺ Rag1^tm1Mom/Rag1^tm1Mom (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal immune system physiology	J:206097
Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ Il13^{tm1(YFP/cre)Lky}/Il13^{tm1(YFP/cre)Lky} (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased IgG1 level	J:178986
	decreased interleukin-5 secretion	J:178986
	decreased interleukin-13 secretion	J:178986
	increased susceptibility to parasitic infection	J:178986
Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor^tm1(DTA)Lky Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:133382
	increased susceptibility to parasitic infection	J:133382
Gt(ROSA)26Sor^tm1(DUX4)Sqh/Gt(ROSA)26Sor⁺ Tg(ACTA1-cre/Esr1)2Kesr/0 (involves: 129S6/SvEvTac C3H * C57BL/6)	abnormal acute inflammation	J:268959
Gt(ROSA)26Sor^{tm1(ETV6/SYK)Hjum}/Gt(ROSA)26Sor⁺ Cd79a^{tm3(cre/ERT2)Reth}/Cd79a⁺ (involves: 129S6/SvEvTac * BALB/c)	abnormal circulating chemokine level	J:208904
	abnormal cytokine level	J:208904
	increased B cell apoptosis	J:208904
	increased B cell proliferation	J:208904
	increased circulating interferon-gamma level	J:208904
	increased circulating interleukin-6 level	J:208904
	increased circulating interleukin-10 level	J:208904
	increased circulating tumor necrosis factor level	J:208904
	increased IgM level	J:208904
	increased interferon-gamma secretion	J:208904
	increased interleukin-10 secretion	J:208904
	increased tumor necrosis factor secretion	J:208904
Gt(ROSA)26Sor^{tm1(ETV6/SYK)Hjum}/Gt(ROSA)26Sor⁺ Cd79a^{tm3(cre/ERT2)Reth}/Cd79a⁺ Tg(BCL2)22Wehi/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)	abnormal B cell physiology	J:208904
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Rev3l^tm1.1Diaz/Rev3l^tm1.1Diaz Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)	abnormal class switch recombination	J:188723
	abnormal somatic hypermutation frequency	J:188723
	decreased B cell proliferation	J:188723
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ Prdm1^tm2Masu/Prdm1^tm2Masu (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal germinal center B cell physiology	J:167612
	decreased IgG1 level	J:167612
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Il22^{tm1.1(icre)Stck}/Il22⁺ (involves: 129X1/SvJ * C57BL/6N)	abnormal susceptibility to bacterial infection	J:220074
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	abnormal regulatory T cell physiology	J:157757
	abnormal T cell activation	J:157757
	decreased interferon-gamma secretion	J:157757
	decreased interleukin-2 secretion	J:157757
	decreased T cell proliferation	J:157757
	dermatitis	J:157757
	increased T cell apoptosis	J:157757
Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))	abnormal class switch recombination	J:172031
	decreased B cell apoptosis	J:172031
	decreased IgA level	J:172031
	decreased IgG1 level	J:172031
	decreased IgG2a level	J:172031
	decreased IgG3 level	J:172031
	increased IgE level	J:172031
Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))	abnormal class switch recombination	J:172031
	decreased IgA level	J:172031
	decreased IgG1 level	J:172031
	decreased IgG2a level	J:172031
	decreased IgG2b level	J:172031
	decreased IgG3 level	J:172031
	increased IgE level	J:172031
Gt(ROSA)26Sor^tm1(HA)Libl/Gt(ROSA)26Sor^tm1(HA)Libl Mog^tm1(cre)Gkl/? Tg(TcraCl4,TcrbCl4)1Shrm/0 (involves: 129/Sv * BALB/c * C57BL/6)	brain inflammation	J:137838
	optic nerve inflammation	J:137838
	spinal cord inflammation	J:137838
Gt(ROSA)26Sor^{tm1(HBEGF)Awai}/Gt(ROSA)26Sor^{tm1(HBEGF)Awai} Mog^tm1(cre)Gkl/? (involves: C57BL/6)	abnormal immune system physiology	J:131076
Gt(ROSA)26Sor^{tm1(ITK/SYK)Jrld}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal T cell activation	J:160931
	increased T cell proliferation	J:160931
Gt(ROSA)26Sor^{tm1(MAML1)Wsp}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Gt(ROSA)26Sor^{tm1(MAML1)Wsp})	abnormal immunoglobulin level	J:113262
	abnormal T-helper 1 physiology	J:113262
	abnormal T-helper 2 physiology	J:113262
	decreased susceptibility to parasitic infection	J:113262
	increased susceptibility to parasitic infection	J:113262
Gt(ROSA)26Sor^{tm1(MAML1)Wsp}/Gt(ROSA)26Sor⁺ Tg(KRT14-rtTA)F42Efu/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * C57BL/6 * FVB)	conjunctivitis	J:194073
Gt(ROSA)26Sor^{tm1(Mirn155)Rsky}/Gt(ROSA)26Sor^{tm1(Mirn155)Rsky} (involves: BALB/c * C57BL/6)	abnormal humoral immune response	J:121084
Gt(ROSA)26Sor^{tm1(Nfatc2)Rao}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 DBA/2)	abnormal interferon level	J:148341
	abnormal T cell activation	J:148341
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal circulating cytokine level	J:260047
	glomerulonephritis	J:260047
	increased inflammatory response	J:260047
	joint inflammation	J:260047
	small intestinal inflammation	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ Pycard^tm1Vmd/Pycard^tm1Vmd (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased circulating interferon-gamma level	J:260047
	increased circulating interleukin-6 level	J:260047
	increased circulating tumor necrosis factor level	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Tg(S100A8-cre,-EGFP)1Ilw/0 (involves: C3H * C57BL/6 * C57BL/6J)	abnormal circulating cytokine level	J:260047
	increased circulating interleukin-18 level	J:260047
Gt(ROSA)26Sor^{tm1(Ptpn22)Draw}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd C57BL/6)	glomerulonephritis	J:201448
	increased anti-double stranded DNA antibody level	J:201448
	increased autoantibody level	J:201448
Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv}/Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased circulating interleukin-17 level	J:205858
	increased interleukin-17 secretion	J:205858
	lung inflammation	J:205858
Gt(ROSA)26Sor^{tm1.1(CAG-Trp53,-EGFP)Medz}/Gt(ROSA)26Sor^{tm1.1(CAG-Trp53,-EGFP)Medz} (involves: C57BL/6)	decreased thymocyte apoptosis	J:158953
Gt(ROSA)26Sor^{tm1.1(DUX4)Plj}/Gt(ROSA)26Sor⁺ Tg(ACTA1-cre/Esr1)2Kesr/0 (involves: C3H * C57BL/6)	increased acute inflammation	J:256652
Gt(ROSA)26Sor^{tm1.1(DUX4)Plj}/Gt(ROSA)26Sor^{tm1.1(DUX4)Plj} (B6(Cg)-Gt(ROSA)26Sor^{tm1.1(DUX4*)Plj})	preputial gland inflammation	J:256652
Gt(ROSA)26Sor^{tm1.1(Loxl2)Acan}/Gt(ROSA)26Sor^{tm1.1(Loxl2)Acan} (Not Specified)	epididymis inflammation	J:220689
	increased inflammatory response	J:220689
Gt(ROSA)26Sor^{tm1.1(Ubc-BCL3)Sbn}/Gt(ROSA)26Sor⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	decreased B cell proliferation	J:207111
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor⁺ Tg(MMTV-cre)4Mam/0 (involves: C57BL/6J * C57BL/6N * FVB/N)	abnormal thymus physiology	J:202090
	increased inflammatory response	J:202090
	intestinal inflammation	J:202090
	kidney inflammation	J:202090
	liver inflammation	J:202090
	meningitis	J:202090
	stomach inflammation	J:202090
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)	abnormal thymus physiology	J:202090
	increased inflammatory response	J:202090
	intestinal inflammation	J:202090
	kidney inflammation	J:202090
	liver inflammation	J:202090
	meningitis	J:202090
	stomach inflammation	J:202090
Gt(ROSA)26Sor^{tm2(CAG-Notch2)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd 129S6/SvEvTac * C57BL/6J)	abnormal marginal zone B cell physiology	J:179036
	decreased IgG1 level	J:179036
	decreased IgG3 level	J:179036
	decreased IgM level	J:179036
	increased B cell proliferation	J:179036
Gt(ROSA)26Sor^{tm2(CAG-Nr5a1)Fjd}/Gt(ROSA)26Sor⁺ Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129S1/Sv * 129X1/SvJ)	uterus inflammation	J:269597
Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/0 Tg(Sftpc-Grem1)105Mmyl/0 (involves: 129P2/OlaHsd * C57BL/6N)	lung inflammation	J:82809
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal circulating cytokine level	J:207306
	abnormal cytokine secretion	J:207306
	abnormal immunoglobulin level	J:207306
	increased circulating interferon-gamma level	J:207306
	increased circulating interleukin-2 level	J:207306
	increased circulating interleukin-4 level	J:207306
	increased circulating interleukin-6 level	J:207306
	increased circulating interleukin-10 level	J:207306
	increased circulating tumor necrosis factor level	J:207306
	increased IgA level	J:207306
	increased IgG level	J:207306
	increased IgM level	J:207306
	increased inflammatory response	J:207306
	increased interferon-gamma secretion	J:207306
	increased interleukin-2 secretion	J:207306
	increased interleukin-4 secretion	J:207306
	increased interleukin-6 secretion	J:207306
	increased interleukin-10 secretion	J:207306
	increased tumor necrosis factor secretion	J:207306
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Lck-cre)I57Jxm/0 (involves: 129S6/SvEvTac * ICR)	abnormal circulating cytokine level	J:207306
	abnormal cytokine secretion	J:207306
	abnormal immunoglobulin level	J:207306
	increased circulating interferon-gamma level	J:207306
	increased circulating interleukin-2 level	J:207306
	increased circulating interleukin-4 level	J:207306
	increased circulating interleukin-6 level	J:207306
	increased circulating interleukin-10 level	J:207306
	increased circulating tumor necrosis factor level	J:207306
	increased IgA level	J:207306
	increased IgG level	J:207306
	increased IgM level	J:207306
	increased inflammatory response	J:207306
	increased interferon-gamma secretion	J:207306
	increased interleukin-2 secretion	J:207306
	increased interleukin-4 secretion	J:207306
	increased interleukin-6 secretion	J:207306
	increased interleukin-10 secretion	J:207306
	increased tumor necrosis factor secretion	J:207306
Gt(ROSA)26Sor^{tm2(Lmp1/CD40)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell activation	J:137122
	abnormal B cell physiology	J:137122
	abnormal class switch recombination	J:137122
	abnormal humoral immune response	J:137122
	abnormal T cell activation	J:137122
	increased B cell proliferation	J:137122
Gt(ROSA)26Sor^{tm2(Lmp1/CD40)Uzs}/Gt(ROSA)26Sor⁺ Tg(Cr2-cre)3Cgn/0 (involves: BALB/c * C57BL/6)	abnormal immune system physiology	J:137122
Gt(ROSA)26Sor^{tm2(Mirn150)Rsky}/Gt(ROSA)26Sor^{tm2(Mirn150)Rsky} (involves: C57BL/6 * SJL/J)	increased B cell apoptosis	J:127234
Gt(ROSA)26Sor^{tm2(Nfatc2)Rao}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 DBA/2)	abnormal interferon level	J:148341
	abnormal T cell activation	J:148341
Gt(ROSA)26Sor^{tm2(sb11)Njen}/Gt(ROSA)26Sor⁺ TgTn(sb-T2/Onc2)6070Njen/0 (involves: 129 * C57BL/6 * C57BL/6J)	increased susceptibility to infection	J:153656
Gt(ROSA)26Sor^{tm2.1(CAG-PSTPIP1)Dtg}/Gt(ROSA)26Sor⁺ (involves: BALB/cJ C57BL/6)	increased circulating interleukin-1 alpha level	J:196002
	increased circulating interleukin-1 beta level	J:196002
	increased circulating tumor necrosis factor level	J:196002
Gt(ROSA)26Sor^{tm2.1(Cd74/MOG)Awai}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * BALB/cJ)	abnormal humoral immune response	J:140751
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:140751
Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky}/Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky} (involves: C57BL/6 * SJL/J)	increased B cell apoptosis	J:127234
Gt(ROSA)26Sor^tm2Sho/Gt(ROSA)26Sor⁺ Lef1^tm1Hhx/Lef1^tm1Hhx Tg(GZMB-cre)1Jcb/0 (involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal memory T cell physiology	J:189838
Gt(ROSA)26Sor^{tm3(CAG-Il17a)Awai}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal immune system physiology	J:144710
	abnormal neutrophil physiology	J:144710
	increased circulating interleukin-17 level	J:144710
	increased interleukin-17 secretion	J:144710
Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky}/Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky} Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal B cell activation	J:133215
	abnormal CD4-positive, alpha-beta T cell physiology	J:133215
	abnormal immune system physiology	J:133215
	abnormal immunoglobulin level	J:133215
	abnormal T cell activation	J:133215
	increased anti-double stranded DNA antibody level	J:133215
	increased anti-single stranded DNA antibody level	J:133215
	increased B cell proliferation	J:133215
	increased IgG2a level	J:133215
	increased IgG2b level	J:133215
	increased IgG3 level	J:133215
	increased IgM level	J:133215
Gt(ROSA)26Sor^{tm3.1(CAG-Il17a)Awai}/Gt(ROSA)26Sor⁺ (involves: BALB/c * C57BL/6)	increased interleukin-17 secretion	J:144710
	skin inflammation	J:144710
Gt(ROSA)26Sor^{tm4(HIF2A)Kael}/Gt(ROSA)26Sor^{tm4(HIF2A)Kael} Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased susceptibility to colitis induced morbidity/mortality	J:307422
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased IgG1 level	J:167612
	increased IgM level	J:167612
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ Prdm1^tm2Masu/Prdm1^tm2Masu (involves: 129P2/OlaHsd * C57BL/6)	abnormal germinal center B cell physiology	J:167612
	decreased IgG1 level	J:167612
Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky}/Gt(ROSA)26Sor^{tm13(CAG-MYC,-CD2)Rsky} Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:191824
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/? Tnfaip3^tm1Homy/Tnfaip3^tm1Homy (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	abnormal circulating cytokine level	J:212681
	abnormal circulating interleukin level	J:212681
	increased circulating interferon-gamma level	J:212681
	increased circulating interleukin-1 beta level	J:212681
	increased circulating interleukin-6 level	J:212681
	increased circulating tumor necrosis factor level	J:212681
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Map3k14^tm1.1Gne/Map3k14^tm1.1Gne (B6(Cg)-Map3k14^tm1.1Gne Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte})	abnormal immunoglobulin level	J:240453
	decreased B cell proliferation	J:240453
	decreased IgA level	J:240453
	decreased IgG1 level	J:240453
	decreased IgM level	J:240453
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Ripk3^tm1Arte/Ripk3^tm1Arte (involves: C57BL/6NTac)	intestinal inflammation	J:209137
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ (involves: BALB/cJ)	increased B cell proliferation	J:181546
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * BALB/cJ)	abnormal CD8-positive, alpha-beta T cell physiology	J:181546
	abnormal immune system physiology	J:181546
	increased B cell proliferation	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	increased B cell proliferation	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:181546
	abnormal CD8-positive, alpha-beta T cell physiology	J:181546
	abnormal immune system physiology	J:181546
	increased B cell proliferation	J:181546
	increased interferon-gamma secretion	J:181546
	increased tumor necrosis factor secretion	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^{tm1(cre/ERT2)Rsky}/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell physiology	J:217520
Gucy1b1^tm1.1Frb/Gucy1b1^tm1.1Frb (involves: 129 * C57BL/6 * FVB/N)	peritoneal inflammation	J:121321
Gucy2c^tm1Gar/Gucy2c^tm1Gar (either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J))	decreased susceptibility to bacterial infection	J:43046
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:43046
Gucy2c^tm1Gian/Gucy2c^tm1Gian (involves: 129P2/OlaHsd * Black Swiss)	decreased susceptibility to infection	J:43682
Gvhd1^C57BL/10J/Gvhd1^C57BL/10J (involves: B10.D2-H2^d * C57BL/10J)	increased susceptibility to graft versus host disease	J:52834
Gvhd1^C57BL/10J/Gvhd1^C57BL/10J Gvhd2^C57BL/10J/Gvhd2^C57BL/10J (involves: B10.D2-H2^d * C57BL/10J)	increased susceptibility to graft versus host disease	J:52834
Gvhd2^C57BL/10J/Gvhd2^C57BL/10J (involves: B10.D2-H2^d * DBA/2J)	increased susceptibility to graft versus host disease	J:52834
Gvhd4^DBA/2J/Gvhd4^DBA/2J (involves: C57BL/10 * DBA/2J)	increased anti-single stranded DNA antibody level	J:66655
Gvhd4^DBA/2J/Gvhd4^DBA/2J Gvhd5^DBA/2J/Gvhd5^DBA/2J (involves: C57BL/10 * DBA/2J)	increased anti-single stranded DNA antibody level	J:66655
Gvhd5^DBA/2J/Gvhd5^DBA/2J (involves: C57BL/10 * DBA/2J)	increased anti-single stranded DNA antibody level	J:66655
Gy/Y (involves: 101/H * C3H/HeH)	blepharitis	J:8335
Gzma^tm1Ley/Gzma^tm1Ley (involves: 129X1/SvJ * C57BL/6)	decreased cytotoxic T cell cytolysis	J:49361
Gzma^tm1Simn/Gzma^tm1Simn Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte physiology	J:44204
Gzma^tm1Simn/Gzma^tm1Simn Gzmb^tm1Ley/Gzmb^tm1Ley (B6.Cg-Gzma^tm1Simn Gzmb^tm1Ley)	increased susceptibility to Flaviviridae infection	J:90852
	increased susceptibility to parasitic infection	J:81397
Gzma^tm1Simn/Gzma^tm1Simn Gzmb^tm1Ley/Gzmb^tm1Ley Prf1^tm1Sdz/Prf1^tm1Sdz (B6.Cg-Gzma^tm1Simn Gzmb^tm1Ley Prf1^tm1Sdz)	increased susceptibility to Flaviviridae infection	J:90852
	increased susceptibility to parasitic infection	J:81397
Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129S2/SvPas * C57BL/6J)	decreased cytotoxic T cell cytolysis	J:23560
Gzmb^tm1Ley/Gzmb^tm1Ley (B6.129S2-Gzmb^tm1Ley)	impaired natural killer cell mediated cytotoxicity	J:113213
Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129X1/SvJ)	abnormal NK cell physiology	J:126114
Gzmb^tm1Ley/Gzmb^tm1Ley (involves: 129X1/SvJ)	decreased T cell apoptosis	J:126114
Gzmb^tm1Ley/Gzmb^tm1Ley Serpinb9^tm1.1Pib/Serpinb9^tm1.1Pib (involves: 129S2/SvPas * BALB/cJ * C57BL/6J)	decreased cytotoxic T cell apoptosis	J:252016
Gzmb^tm1Ley/Gzmb^tm1Ley Serpinb9^tm1Arp/Serpinb9^tm1Arp (involves: 129S2/SvPas * C57BL/6)	abnormal cytotoxic T cell physiology	J:113349
Gzmb^tm2.1Ley/Gzmb^tm2.1Ley (129X1/SvJ-Gzmb^tm2.1Ley)	decreased cytotoxic T cell cytolysis	J:96538
Gzmb^tm2Ley/Gzmb^tm2Ley (129X1/SvJ-Gzmb^tm2Ley)	abnormal immune system physiology	J:96538
Gzmb^tm2Ley/Gzmb^tm2Ley (129X1/SvJ-Gzmb^tm2Ley)	decreased cytotoxic T cell cytolysis	J:96538
Gzmm^tm1(cre)Mjs/Gzmm^tm1(cre)Mjs (C57BL/6-Gzmm^tm1(cre)Mjs)	increased susceptibility to Herpesvirales infection	J:113213
H2-Aa^b-tm1Blt/H2-Aa^b-tm1Blt (C57BL/6-H2-Aa^b-tm1Blt)	abnormal MHC II cell surface expression on macrophages	J:67924
H2-Aa^b-tm1Blt/H2-Aa^b-tm1Blt (C57BL/6-H2-Aa^b-tm1Blt)	abnormal splenocyte physiology	J:16372
H2-Ab1^b-tm1.1Jssh/H2-Ab1^b-tm1.1Jssh (C57BL/6-H2-Ab1^b-tm1.1Jssh)	abnormal dendritic cell antigen presentation	J:201198
H2-Ab1^b-tm1.1Sish/H2-Ab1^b-tm1.1Sish (involves: 129S1/Sv * 129X1/SvJ)	abnormal dendritic cell physiology	J:157516
	decreased interleukin-12 secretion	J:157516
	decreased tumor necrosis factor secretion	J:157516
H2-Ab1^b-tm1Doi/H2-Ab1⁺ (involves: 129S2/SvPas * C57BL/6 * NOD/Lt)	insulitis	J:93557
H2-Ab1^b-tm1Doi/H2-Ab1^b-tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal B cell physiology	J:65736
	abnormal CD4-positive, alpha-beta T cell physiology	J:65736
	abnormal cytokine secretion	J:64283
	abnormal immune system physiology	J:65736
	abnormal T cell physiology	J:65736
	decreased IgG1 level	J:65736
	decreased susceptibility to parasitic infection	J:64283
	increased susceptibility to parasitic infection	J:64283
H2-Ab1^b-tm1Doi/H2-Ab1^b-tm1Doi (involves: 129S2/SvPas * C57BL/6 * NOD/Lt)	insulitis	J:93557
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129S2/SvPas * C57BL/6J)	abnormal humoral immune response	J:74418
	abnormal response to transplant	J:91742
	decreased IgG level	J:74418
	increased IgM level	J:74418
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (B6.129S2-H2-Ab1^b-tm1Gru)	abnormal B cell physiology	J:91341
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (B6.129S2-H2-Ab1^b-tm1Gru)	abnormal lymphocyte physiology	J:91341
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129S2/SvPas * C57BL/6)	abnormal level of surface class II molecules	J:67941
	decreased IgG1 level	J:67941
	decreased IgM level	J:67941
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Ighm^tm1Cgn/Ighm^tm1Cgn Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell (NOD.Cg-Ighm^tm1Cgn H2-Ab1^b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)	heart inflammation	J:113267
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Rag1^tm1Mom/Rag1^tm1Mom Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell (NOD.Cg-Rag1^tm1Mom H2-Ab1^b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)	abnormal response to transplant	J:113267
	heart inflammation	J:113267
	increased autoantibody level	J:113267
	myocarditis	J:113267
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Rag1^tm1Mom/Rag1^tm1Mom Tg(HLA-DQA1,HLA-DQB1)73Myl/0 (NOD.Cg-Rag1^tm1Mom H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)	abnormal response to transplant	J:88055
	myocarditis	J:88055
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Runx1^tm1Toku/Runx1^tm1Toku Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/2)	abnormal interferon secretion	J:131081
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(Ab1TL)1Gru/0 (B6.Cg-H2-Ab1^b-tm1Gru Tg(Ab1TL)1Gru)	abnormal macrophage antigen presentation	J:91341
	abnormal professional antigen presenting cell physiology	J:91341
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell (NOD.Cg-H2-Ab1^b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)	autoimmune response	J:87013, J:86540
	decreased susceptibility to autoimmune disorder	J:87013
	heart inflammation	J:87013, J:86540
	increased autoantibody level	J:113267
	lung inflammation	J:86540
	myositis	J:86540
	salivary gland inflammation	J:86540
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell (NOD.Cg-H2-Ab1^b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell)	increased autoantibody level	J:113509
	thyroid gland inflammation	J:113509
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL)	decreased susceptibility to autoimmune diabetes	J:68641
	salivary gland inflammation	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0 (B6.Cg-H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv)	increased susceptibility to autoimmune diabetes	J:59245
	salivary gland inflammation	J:59245
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA)	decreased interleukin-6 secretion	J:68641
	increased interferon-gamma secretion	J:68641
	increased susceptibility to autoimmune diabetes	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl/0 (NOD.Cg-H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl)	heart inflammation	J:88055
	increased autoantibody level	J:88055
	insulitis	J:88055
	myocarditis	J:88055
	salivary gland inflammation	J:88055
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl/0 (NOD.Cg-H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)	heart inflammation	J:88055
	increased autoantibody level	J:88055
	insulitis	J:88055
	myocarditis	J:88055
	salivary gland inflammation	J:88055
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * CBA * SJL)	decreased susceptibility to autoimmune diabetes	J:68641
	salivary gland inflammation	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	decreased susceptibility to autoimmune diabetes	J:68641
H2-Ab1^b-tm1Koni/H2-Ab1^b-tm1.1Koni Tg(Tek-cre)12Flv/0 (involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J)	abnormal T cell activation	J:131774
	decreased level of surface class II molecules	J:131774
H2-Ab1^b-tm1Wug/H2-Ab1^b-tm1Wug (involves: C57BL/6)	abnormal B cell physiology	J:204951
	abnormal dendritic cell physiology	J:204951
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:204951
H2-Ab1^b-tm1Wug/H2-Ab1^b-tm1Wug Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal B cell physiology	J:204951
	abnormal dendritic cell physiology	J:204951
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:204951
H2-Ab1^bm12/H2-Ab1^bm12 (B6(C)-H2-Ab1^bm12/KhEgJ)	abnormal level of surface class II molecules	J:100194
	abnormal T cell physiology	J:100123
	decreased susceptibility to autoimmune disorder	J:100123
	decreased susceptibility to experimental autoimmune myasthenia gravis	J:100213
	decreased susceptibility to parasitic infection	J:48242
H2-Ab1^bm12/H2-Ab1^bm12 (NZB.B6(C)-H2-Ab1^bm12)	abnormal immunoglobulin level	J:104189
	abnormal level of surface class II molecules	J:104189
	autoimmune response	J:4554
	increased anti-double stranded DNA antibody level	J:104189
	increased anti-erythrocyte antigen antibody level	J:4554
	increased anti-single stranded DNA antibody level	J:104189
H2-Ab1^g7-em1Dvs/H2-Ab1^g7-em1Dvs H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-Ab1^g7-em1Dvs H2-D1^em5Dvs/Dvs)	decreased susceptibility to autoimmune diabetes	J:257229
H2-D1^b-em1Dvs/H2-D1^b-em1Dvs (NOD/ShiLtDvs-H2-D1^b-em1Dvs/Dvs)	abnormal immune system physiology	J:257229
	decreased susceptibility to autoimmune diabetes	J:257229
H2-D1^b-em2Dvs/H2-D1^b-em2Dvs (NOD/ShiLtDvs-H2-D1^b-em2Dvs/Dvs)	abnormal immune system physiology	J:257229
	decreased susceptibility to autoimmune diabetes	J:257229
H2-D1^b-em3Dvs/H2-D1^b-em3Dvs (NOD/ShiLtDvs-H2-D1^b-em3Dvs/Dvs)	abnormal immune system physiology	J:257229
	decreased susceptibility to autoimmune diabetes	J:257229
H2-D1^b-em4Dvs/H2-D1^b-em4Dvs (NOD/ShiLtDvs-H2-D1^b-em4Dvs/Dvs)	abnormal immune system physiology	J:257229
	decreased susceptibility to autoimmune diabetes	J:257229
H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-D1^b-em5Dvs/Dvs)	decreased susceptibility to autoimmune diabetes	J:257229
H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs Tg(HLA-A/H2-D/B2M)1Dvs/? (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-D1^b-em5Dvs Tg(HLA-A/H2-D/B2M)1Dvs/Dvs)	autoimmune response	J:257229
	increased susceptibility to autoimmune diabetes	J:257229
	insulitis	J:257229
H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs Tg(HLA-B39/H2-D/B2m)2Dvs/? (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-D1^b-em5Dvs Tg(HLA-B39/H2-D/B2M)2Dvs/Dvs)	autoimmune response	J:257229
	increased susceptibility to autoimmune diabetes	J:257229
	insulitis	J:257229
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:54709
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe (B6.129P-H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe)	abnormal cytotoxic T cell physiology	J:118960
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe Klra1^tm1.1Wyok/Klra1^tm1.1Wyok Tg(H2-D^d)28Bee/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6NTac * DBA/2)	abnormal NK cell physiology	J:252851
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe X/Yaa (BXSB.129P2(B6)-H2-K1^b-tm1Bpe H2-D1^b-tm1Bpe/Dcr)	increased susceptibility to systemic lupus erythematosus	J:179430
H2-D1^bm14/H2-D1^bm14 (C57BL/6)	abnormal T cell activation	J:97717
H2-D1^bm14/H2-D1^bm14 (C57BL/6)	spinal cord inflammation	J:97717
H2-DMa^tm1Doi/H2-DMa^tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal professional antigen presenting cell physiology	J:31624
H2-DMa^tm1Liz/H2-DMa^tm1Liz (involves: BALB/cJ)	abnormal antigen presentation via MHC class II	J:113714
	abnormal professional antigen presenting cell physiology	J:111565, J:113714
	defective assembly of class II molecules	J:113714
H2-DMa^tm1Lkrl/H2-DMa^tm1Lkrl (involves: 129P2/OlaHsd)	abnormal antigen presentation	J:31786
	abnormal CD4-positive, alpha-beta T cell physiology	J:31786
	abnormal professional antigen presenting cell physiology	J:31786
H2-DMa^tm1Luc/H2-DMa^tm1Luc (involves: 129S4/SvJae)	abnormal antigen presentation via MHC class II	J:31625
	abnormal CD4-positive, alpha-beta T cell physiology	J:31625
	abnormal level of surface class II molecules	J:45185
	decreased interferon-gamma secretion	J:45185
	increased susceptibility to bacterial infection	J:45185
H2-DMa^tm1Luc/H2-DMa^tm1Luc (involves: 129S4/SvJae * C57BL/6)	abnormal antigen presentation	J:72243
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:72243
H2-DMa^tm1Luc/H2-DMa^tm1Luc (B6.129S4-H2-Dma^tm1Luc)	abnormal antigen presentation	J:125654
	abnormal T-helper 1 physiology	J:125654
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:125654
	decreased susceptibility to type IV hypersensitivity reaction	J:125654
H2-DMa^tm1Luc/H2-DMa^tm1Luc Cd74^tm1Doi/Cd74^tm1Doi (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal level of surface class II molecules	J:45185
	increased susceptibility to parasitic infection	J:45185
H2-DMa^tm2Liz/H2-DMa^tm2Liz (involves: C57BL/6 * C57BL/10 * C57BR * CBA)	abnormal antigen presentation via MHC class II	J:111565
	abnormal professional antigen presenting cell physiology	J:111565
	decreased T cell proliferation	J:111565
H2-K1^d-em4Dvs/H2-K1^d-em4Dvs (NOD/ShiLtDvs-H2-K1^d-em4Dvs/Dvs)	abnormal immune system physiology	J:257229
	decreased susceptibility to autoimmune diabetes	J:257229
H2-K1^d-em5Dvs/H2-K1^d-em5Dvs (NOD/ShiLtDvs-H2-K1^d-em5Dvs/Dvs)	abnormal immune system physiology	J:257229
	decreased susceptibility to autoimmune diabetes	J:257229
H2-K1^d-em7Dvs/H2-K1^d-em7Dvs (NOD/ShiLtDvs-H2-K1^d-em7Dvs/Dvs)	abnormal immune system physiology	J:257229
	decreased susceptibility to autoimmune diabetes	J:257229
H2-M3^tm1Crw/H2-M3^tm1Crw (B6.129-H2-M3^tm1Crw)	abnormal cytotoxic T cell physiology	J:118960
	abnormal innate immunity	J:118960
	decreased interferon-gamma secretion	J:118960
	decreased macrophage nitric oxide production	J:118960
	impaired natural killer cell mediated cytotoxicity	J:118960
	increased susceptibility to bacterial infection	J:118960
H2-Oa^tm1Dma/H2-Oa^tm1Dma (involves: 129/Sv * C57BL/6)	abnormal antigen presentation via MHC class II	J:65235
H2-Oa^tm1Lkar/H2-Oa^tm1Lkar (involves: 129P2/OlaHsd)	abnormal antigen presentation via MHC class II	J:85084
H2-Oa^tm1Lkar/H2-Oa^tm1Lkar (involves: 129P2/OlaHsd)	increased IgG1 level	J:85084
H2-Ob^em1Tvg/H2-Ob^em1Tvg (C57BL/6J-H2-Ob^em1Tvg/Tvg)	decreased susceptibility to Retroviridae infection	J:254532
H2-Ob^em1Tvg/H2-Ob^em1Tvg (C57BL/6J-H2-Ob^em1Tvg/Tvg)	defective assembly of class II molecules	J:254532
H2-Ob^vic1/H2-Ob^vic1 (I/LnJ)	decreased susceptibility to Retroviridae infection	J:163153
H2-Ob^vic1/H2-Ob^vic1 (I/LnJ)	decreased susceptibility to viral infection	J:81554, J:60602
H2-Ob^vic1/H2-Ob^vic1 (C3N.I-H2-Ob^vic1)	decreased susceptibility to Retroviridae infection	J:254532
H2-Ob^vic1/H2-Ob^vic1 (B6.I-H2-Ob^vic1)	decreased susceptibility to Retroviridae infection	J:254532
H2-Ob^vic1/H2-Ob^vic1 (C.I-H2-Ob^vic1)	decreased susceptibility to Retroviridae infection	J:254532
H2-T18^b/H2-T18^b H2-T3^tm1Luc/H2-T3^tm1Luc (C57BL/6-H2-T3^tm1Luc)	increased interferon-gamma secretion	J:142515
H2-T18^b/H2-T18^b H2-T3^tm1Luc/H2-T3^tm1Luc Tcra^tm1Mom/Tcra^tm1Mom (B6.Cg-Tcra^tm1Mom H2-T3^tm1Luc)	colitis	J:142515
	increased interleukin-4 secretion	J:142515
H2-T23^tm1Cant/H2-T23^tm1Cant (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087, J:123555
	abnormal memory T cell physiology	J:123555
	increased susceptibility to bacterial infection	J:89808
	increased susceptibility to experimental autoimmune encephalomyelitis	J:89808
	increased susceptibility to Herpesvirales infection	J:89808
H2-T23^tm2Cant/H2-T23^tm2Cant (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:123555
H2-T23^tm2Cant/H2-T23^tm2Cant (B6.129S6-H2-T23^tm2Cant)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
H2-T23^tm2Cant/H2-T23^tm2Cant (B6.129S6-H2-T23^tm2Cant)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:142087
H2-T23^tm2Cant/H2-T23^tm2Cant Tg(Tcra2D2,Tcrb2D2)1Kuch/? (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
	increased susceptibility to experimental autoimmune encephalomyelitis	J:142087
H2-T23^tm3Cant/H2-T23^tm3Cant (B6.129S6-H2-T23^tm3Cant)	increased susceptibility to experimental autoimmune encephalomyelitis	J:142087
H2-T23^tm3Cant/H2-T23^tm3Cant Tg(Tcra2D2,Tcrb2D2)1Kuch/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
H2-T23^tm3Cant/H2-T23^tm3Cant Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:142087
H2^b/H2^b (NOD.B10SnJ-H2^b)	decreased susceptibility to autoimmune diabetes	J:14178
H2^b/H2^b (NOD.B10SnJ-H2^b)	periinsulitis	J:14178
H2^b/H2^b Nfkbid^tm1Clay/Nfkbid^tm1Clay Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)	abnormal thymocyte activation	J:132071
	decreased interleukin-2 secretion	J:132071
	decreased T cell proliferation	J:132071
H2^b/H2^b Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? (involves: 129S/SvEv * C57BL/6)	abnormal cytotoxic T cell physiology	J:133112
	increased T cell proliferation	J:133112
H2^b/H2^d ((C57BL/6 x DBA/2)F1)	abnormal cytokine secretion	J:106141
	decreased susceptibility to parasitic infection	J:106141
	increased autoantibody level	J:106141
H2^b/H2^d Tg(Ins2-E3)1Dvs/0 (involves: BALB/c * C57BL/6 * DBA/2J)	increased length of allograft survival	J:109763
H2^b/H2^g7 (NOD.B10SnJ-H2^b)	decreased susceptibility to autoimmune diabetes	J:14178
H2^b/H2^g7 Tg(TcraR28,TcrbR28)KRNDim/0 (involves: C57BL/6 * NOD * SJL)	mitral valve inflammation	J:275827
	rheumatoid arthritis	J:36815, J:275827
H2^d/H2^d (DBA/2)	abnormal cytokine secretion	J:106141
	decreased susceptibility to parasitic infection	J:106141
	increased autoantibody level	J:106141
H2^d/H2^d Tg(TcraP1.5,TcrbP1.5)29Amsv/0 Trap1a^tm1.1Jvde/Y (involves: 129 * BALB/cJ * C57BL/10 * DBA/2)	abnormal T cell clonal deletion	J:180807
H2^d/H2^d Trap1a^tm1.1Jvde/Y (involves: 129 * BALB/cJ * C57BL/10 * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:180807
	abnormal immune tolerance	J:180807
H2^dlAb1-Ea/H2^dlAb1-Ea (B6.129S2-H2^dlAb1-Ea/J)	increased susceptibility to bacterial infection	J:123934
H2^dlAb1-Ea/H2^dlAb1-Ea (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin level	J:57484
	decreased IgG1 level	J:57484
	decreased IgG2a level	J:57484
	increased IgM level	J:57484
H2^dlAb1-Ea/H2^dlAb1-Ea Rag1^tm1Mom/Rag1^tm1Mom Tg(HLA-DRA,HLA-DRB50101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 (involves: 129S2/SvPas 129S7/SvEvBrd * C57BL/6)	brain inflammation	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Rag1^tm1Mom/Rag1^tm1Mom Tg(HLA-DRA,HLA-DRB50101)loKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 (involves: 129S2/SvPas 129S7/SvEvBrd * C57BL/6)	brain inflammation	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(HLA-DRA,HLA-DRB50101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 (involves: 129S2/SvPas C57BL/6)	abnormal cytokine secretion	J:189816
	brain inflammation	J:189816
	CNS inflammation	J:189816
	increased inflammatory response	J:189816
	increased interferon-gamma secretion	J:189816
	increased interleukin-17 secretion	J:189816
	increased susceptibility to experimental autoimmune encephalomyelitis	J:189816
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(HLA-DRA,HLA-DRB50101)loKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 (involves: 129S2/SvPas C57BL/6)	brain inflammation	J:189816
	increased susceptibility to experimental autoimmune encephalomyelitis	J:189816
H2^g7/H2^g7 Ins2^tm1Jja/Ins2^tm1Jja Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	increased susceptibility to autoimmune diabetes	J:111874
H2^g7/H2^g7 Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	increased susceptibility to autoimmune diabetes	J:111874
	insulitis	J:111874
H2^g7/H2^g7 Tg(Ins2-Vtcn1)#Xxz/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: C57BL/6 * NOD * SJL)	decreased interferon-gamma secretion	J:177612
	decreased interleukin-17 secretion	J:177612
	decreased susceptibility to autoimmune diabetes	J:177612
H2^g7/H2^g7 Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (B6.NOD-(D17Mit21-D17Mit10) Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	increased susceptibility to autoimmune diabetes	J:167508
H2^g7/H2^g7 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (B6.Cg-H2^g7 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	decreased susceptibility to autoimmune diabetes	J:86926
H2^g7/H2^g7 Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	decreased susceptibility to autoimmune diabetes	J:111874
	insulitis	J:111874
H2^g7/H2^q Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	increased susceptibility to autoimmune diabetes	J:111874
H2^h2/H2^g7 (NOD.Cg-H2^h2)	decreased susceptibility to autoimmune diabetes	J:14178
H2^h2/H2^h2 (NOD.Cg-H2^h2)	decreased susceptibility to autoimmune diabetes	J:14178
	insulitis	J:14178
	periinsulitis	J:14178
H2^h4/H2^g7 (NOD.Cg-H2^h4)	decreased susceptibility to autoimmune diabetes	J:14178
H2^h4/H2^h4 (NOD.Cg-H2^h4)	abnormal cytokine secretion	J:54563
	decreased susceptibility to autoimmune diabetes	J:14178
	insulitis	J:14178
	periinsulitis	J:14178
	thyroid gland inflammation	J:54563
H2ⁱ⁵/H2^g7 (NOD.Cg-H2ⁱ⁵)	decreased susceptibility to autoimmune diabetes	J:14178
H2ⁱ⁵/H2ⁱ⁵ (NOD.Cg-H2ⁱ⁵)	decreased susceptibility to autoimmune diabetes	J:14178
H2ⁱ⁵/H2ⁱ⁵ (NOD.Cg-H2ⁱ⁵)	periinsulitis	J:14178
H2ⁱ⁷/H2^g7 (NOD.Cg-H2ⁱ⁷)	decreased susceptibility to autoimmune diabetes	J:14178
H2ⁱ⁷/H2^g7 ((NOD x NOD.Cg-H2ⁱ⁷)F1)	insulitis	J:14178
H2ⁱ⁷/H2ⁱ⁷ (NOD.Cg-H2ⁱ⁷)	decreased susceptibility to autoimmune diabetes	J:14178
H2ⁱ⁷/H2ⁱ⁷ (NOD.Cg-H2ⁱ⁷)	periinsulitis	J:14178
H2^k/H2^g7 (NOD.Cg-H2^k)	decreased susceptibility to autoimmune diabetes	J:14178
H2^k/H2^k (NOD.Cg-H2^k)	increased susceptibility to autoimmune diabetes	J:14178
H2^k/H2^k (NOD.Cg-H2^k)	periinsulitis	J:14178
H2^q/? Ncf1^m1J/Ncf1^m1J (B6.Cg-Ncf1^m1J H2^q)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:92437
	increased susceptibility to experimental autoimmune encephalomyelitis	J:92437
	increased susceptibility to induced arthritis	J:92437
	increased susceptibility to type IV hypersensitivity reaction	J:92437
	rheumatoid arthritis	J:92437
H2^q/H2^q Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	decreased susceptibility to autoimmune diabetes	J:111874
H2^u/H2^u Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra19,Tcrb19)#Stl/0 (either: (involves: 129S7/SvEvBrd * C57BL/6 * PL/J) or (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * PL/J))	increased susceptibility to autoimmune disorder	J:19795
H2^u/H2^u Tg(Tcra19,Tcrb19)#Stl/0 (either: (involves: C57BL/6 * PL/J) or (involves: C57BL/6 * C57BL/10 * PL/J))	increased susceptibility to autoimmune disorder	J:19795
	increased susceptibility to experimental autoimmune encephalomyelitis	J:19795
H2^u/H2^u Tg(TCRA)B1Jg/? Tg(TCRB)C14Jg/? (involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:92991
	increased autoantibody level	J:92991
	increased susceptibility to experimental autoimmune encephalomyelitis	J:92991
H2ax^tm1Fwa/H2ax^tm1Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:84879
H2ax^tm1Nus/H2ax^tm1Nus (Not Specified)	abnormal class switch recombination	J:194603, J:120658
H2ax^tm1Nus/H2ax^tm1Nus (Not Specified)	decreased IgG level	J:73342
H13^{tm1b(KOMP)Wtsi}/H13^{tm1b(KOMP)Wtsi} (C57BL/6N-H13^{tm1b(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Habp2^tm1Lex/Habp2^tm1Lex (involves: 129S7/SvEvBrd * BALB/c * C57BL/6)	liver inflammation	J:207454
Hamp^tm1Svl/Hamp^tm1Svl (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	increased susceptibility to bacterial infection induced morbidity/mortality	J:199427
Havcr1^tm1Kuch/Havcr1^tm1Kuch (B6.Cg-Havcr1^tm1Kuch)	abnormal B cell physiology	J:186484
	abnormal CD4-positive, alpha-beta T cell physiology	J:186484
	abnormal dendritic cell physiology	J:186484
	autoimmune response	J:186484
	increased anti-double stranded DNA antibody level	J:186484
Havcr1^tm1Vlcg/Havcr1^tm1Vlcg (B6.129-Havcr1^tm1Vlcg)	increased interleukin-5 secretion	J:187793
Havcr1^tm1Vlcg/Havcr1^tm1Vlcg (B6.129-Havcr1^tm1Vlcg)	increased interleukin-13 secretion	J:187793
Havcr1^tm1Vlcg/Havcr1^tm1Vlcg (C.129-Havcr1^tm1Vlcg)	abnormal cytokine secretion	J:187793
	increased interleukin-4 secretion	J:187793
	increased interleukin-5 secretion	J:187793
	increased interleukin-10 secretion	J:187793
	increased interleukin-13 secretion	J:187793
	increased interleukin-17 secretion	J:187793
	respiratory system inflammation	J:187793
Havcr2^tm1Bmed/Havcr2^tm1Bmed (B6.Cg-Havcr2^tm1Bmed)	abnormal CD8-positive, alpha-beta T cell physiology	J:189839
	decreased activation-induced cell death of T cells	J:189839
	decreased interferon-gamma secretion	J:189839
	decreased susceptibility to Orthomyxoviridae infection	J:189839
	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:189839
	decreased T cell proliferation	J:189839
Havcr2^tm1Vlcg/Havcr2^tm1Vlcg (B6.129-Havcr2^tm1Vlcg)	decreased interferon-gamma secretion	J:209885
Havcr2^tm1Vlcg/Havcr2^tm1Vlcg Tg(TcraTcrb)1100Mjb/? (B6.Cg-Havcr2^tm1Vlcg Tg(TcraTcrb)1100Mjb)	decreased interferon-gamma secretion	J:209885
Hax1^tm1.1Gach/Hax1^tm1.1Gach (involves: BALB/c)	decreased IgG2a level	J:174159
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB)Tow}/Hbb^{tm2(HBG1,HBB)Tow} Slc12a4^Rbc10/Slc12a4⁺ (involves: 129 * BALB/c * C57BL/6J)	liver inflammation	J:227339
Hbnr1^CBA/Hbnr1^SWR (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:82261, J:85787
Hbnr1^SWR/Hbnr1^SWR (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:82261, J:110034, J:85787
Hbnr2^CBA/Hbnr2^SWR (involves: CBA * SWR)	granulomatous inflammation	J:85787
Hbnr2^SWR/? (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:82261
Hbnr2^SWR/Hbnr2^SWR (involves: CBA * SWR)	decreased IgE level	J:85787
	decreased susceptibility to parasitic infection	J:110034
	granulomatous inflammation	J:85787
Hbnr3^CBA/Hbnr3^SWR (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:85787
Hbnr3^CBA/Hbnr3^SWR (involves: CBA * SWR)	increased susceptibility to parasitic infection	J:82261
Hbnr3^SWR/Hbnr3^SWR (involves: CBA * SWR)	increased susceptibility to parasitic infection	J:82261, J:85787
Hbnr4^SWR/Hbnr4^SWR (involves: CBA * SWR)	abnormal immune serum protein physiology	J:85787
Hbnr5^CBA/Hbnr5^SWR (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:85787
Hbnr5^SWR/Hbnr5^SWR (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:85787
Hbnr6^SWR/Hbnr6^SWR (involves: CBA * SWR)	increased IgE level	J:85787
Hbnr7^CBA/Hbnr7^SWR (involves: CBA * SWR)	decreased IgG1 level	J:85787
Hbnr7^SWR/Hbnr7^SWR (involves: CBA * SWR)	decreased IgG2b level	J:85787
Hbnr8^CBA/Hbnr8^SWR (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:85787
Hbnr8^SWR/Hbnr8^SWR (involves: CBA * SWR)	decreased susceptibility to parasitic infection	J:85787
Hc⁰/Hc⁰ (involves: C57BL/10SnJ)	increased susceptibility to bacterial infection	J:44240
Hc⁰/Hc⁰ Tg(TcrbBL17)1Lmor/0 (involves: DBA/1J * SWR/J)	decreased susceptibility to induced arthritis	J:134111
Hc¹/? Tg(TcrbBL17)1Lmor/0 (involves: DBA/1J * SWR/J)	increased susceptibility to induced arthritis	J:134111
Hcfc2^em1Btlr/Hcfc2^em1Btlr (C57BL/6J-Hcfc2^em1Btlr)	decreased tumor necrosis factor secretion	J:251008
Hcfc2^fkls/Hcfc2⁺ (involves: C57BL/6J)	decreased interferon-beta secretion	J:251008
Hcfc2^fkls/Hcfc2⁺ (involves: C57BL/6J)	decreased tumor necrosis factor secretion	J:251008
Hcfc2^fkls/Hcfc2^fkls (C57BL/6J-Hcfc2^fkls)	abnormal innate immunity	J:94077
Hcfc2^fkls/Hcfc2^fkls (involves: C57BL/6J)	decreased circulating interferon-alpha level	J:251008
	decreased circulating interferon-beta level	J:251008
	decreased interferon-beta secretion	J:251008
	decreased tumor necrosis factor secretion	J:251008
	increased susceptibility to Herpesvirales infection	J:251008
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:251008
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:251008
Hcfc2^fkls/Hcfc2^min (involves: C57BL/6J)	decreased tumor necrosis factor secretion	J:251008
Hcfc2^fkls/Hcfc2^sca (involves: C57BL/6J)	decreased tumor necrosis factor secretion	J:251008
Hck^tm1Ern/Hck^tm1Ern (involves: 129S1/Sv * C57BL/6)	abnormal immune system physiology	J:111432
	abnormal macrophage physiology	J:111432
	increased circulating tumor necrosis factor level	J:111432
	increased interleukin-5 secretion	J:111432
	lung inflammation	J:111432
Hck^tm1Hev/Hck^tm1Hev (involves: 129S7/SvEvBrd * C57BL/6J)	impaired macrophage phagocytosis	J:16994
Hck^tm1Hev/Hck^tm1Hev (B6.129S7-Hck^tm1Hev)	abnormal inflammatory response	J:113463
Hck^tm1Hev/Hck^tm1Hev (B6.129S7-Hck^tm1Hev)	abnormal neutrophil physiology	J:113463
Hcls1^tm1Wtn/Hcls1^tm1Wtn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:28146
	abnormal humoral immune response	J:28146
	decreased T cell proliferation	J:28146
Hcls1^tm2Wtn/Hcls1^tm2Wtn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:28146
	abnormal humoral immune response	J:28146
	decreased T cell proliferation	J:28146
Hcst^tm1.1Cln/Hcst^tm1.1Cln (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:80426
Hcst^tm1.1Cln/Hcst^tm1.1Cln (involves: 129P2/OlaHsd * C57BL/6)	decreased interferon-gamma secretion	J:100668
Hcst^tm1.1Cln/Hcst^tm1.1Cln (B6.129P2-Hcst^tm1.1Cln)	abnormal osteoclast physiology	J:147155
Hcst^tm1.1Cln/Hcst^tm1.1Cln Tyrobp^tm1Lll/Tyrobp^tm1Lll (B6.Cg-Hcst^tm1.1Cln Tyrobp^tm1Lll)	abnormal NK T cell physiology	J:147867
	abnormal response to infection	J:147867
Hcst^tm1.1Dnax/Hcst^tm1.1Dnax (involves: C57BL/6)	abnormal NK T cell physiology	J:147867, J:148086
	abnormal response to infection	J:147867
	decreased interferon-gamma secretion	J:147867
	impaired natural killer cell mediated cytotoxicity	J:148086
	increased interferon-gamma secretion	J:148086
	increased interleukin-4 secretion	J:148086
	increased susceptibility to experimental autoimmune encephalomyelitis	J:148086
Hdac1^tm1.1Pmt/Hdac1^tm1.1Pmt Hdac2^tm1.1Pmt/Hdac2^tm1.1Pmt Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)	increased B cell apoptosis	J:157903
Hdac1^tm1.1Pmt/Hdac1^tm1.1Pmt Hdac2^tm1.1Pmt/Hdac2^tm1.1Pmt Tg(Fcer2a-cre)5Mbu/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)	decreased B cell proliferation	J:157903
	increased B cell apoptosis	J:157903
Hdac1^tm1.1Shmc/Hdac1^tm1.1Shmc Hdac2^tm1.1Shmc/Hdac2^tm1.1Shmc Tg(Lck-cre)1Cwi/0 (involves: 129S7/SvEvBrd)	increased T cell proliferation	J:194769
	increased thymocyte apoptosis	J:194769
Hdac6^tm1.1Pmt/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG level	J:132629
Hdac6^tm1.1Pmt/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased IgM level	J:132629
Hdac6^tm1.1Pmt/Hdac6^tm1.1Pmt (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG level	J:132629
	decreased IgM level	J:132629
Hdac6^tm1.1Pmt/Hdac6^tm1.1Pmt (involves: 129P2/OlaHsd)	decreased circulating interleukin-10 level	J:228570
Hdac6^tm1.1Pmt/Hdac6^tm1.1Pmt (involves: 129P2/OlaHsd)	decreased interleukin-10 secretion	J:228570
Hdac11^tm1.2Mrl/Hdac11^tm1.2Mrl (involves: C57BL/6NTac)	decreased interferon-gamma secretion	J:222335
Hdac11^tm1.2Mrl/Hdac11^tm1.2Mrl (involves: C57BL/6NTac)	increased interleukin-10 secretion	J:228570
Hectd3^tm1Lex/Hectd3^tm1Lex (FVB.129S5(B6)-Hectd3^tm1Lex)	decreased circulating interferon-beta level	J:266602
	decreased circulating interleukin-1 beta level	J:266602
	decreased circulating interleukin-6 level	J:266602
	decreased circulating tumor necrosis factor level	J:266602
	decreased susceptibility to bacterial infection	J:266602
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:266602
Heg1^tm1Mlkn/Heg1^tm1Mlkn (either: B6.129-Heg1^tm1Mlkn or (involves: 129 * C57BL/6))	abnormal lymph circulation	J:146528
Hells^{tm1a(EUCOMM)Wtsi}/Hells^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Hells^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased IgG1 level	J:165965
Hephl1^cw-thd/Hephl1^cw-thd (SJL/J)	abnormal humoral immune response	J:15004
Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	CNS inflammation	J:90687
	increased circulating interleukin-4 level	J:87617
	increased immunoglobulin level	J:87617
Hfgi1^C57BL/6Ola/? (involves: C57BL/6Ola * BALB/cOla)	stomach inflammation	J:123483
Hfgi2^C57BL/6Ola/? (involves: C57BL/6Ola * BALB/cOla)	stomach inflammation	J:123483
Hic1^tm1Sbb/Hic1⁺ (involves: 129S4/SvJae * C57BL/6)	dermatitis	J:81448
Hif1a^tm1Kats/Hif1a^tm1Kats (involves: 129 * C57BL/6)	abnormal cytokine level	J:117857
	abnormal interleukin secretion	J:117857
	increased interferon-gamma secretion	J:117857
	increased tumor necrosis factor secretion	J:117857
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Hprt1^{tm1(Pck1-cre)Vhh}/Y (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	kidney inflammation	J:130751
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Hprt1^{tm1(Pck1-cre)Vhh}/Y Vhl^tm1Jae/Vhl^tm1Jae (involves: 129 * BALB/c * C57BL/6)	kidney inflammation	J:106705
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal leukocyte physiology	J:117348
	abnormal macrophage physiology	J:107682
	decreased inflammatory response	J:107682
	decreased susceptibility to induced arthritis	J:107682
	decreased tumor necrosis factor secretion	J:107682
	impaired macrophage chemotaxis	J:107682
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased interleukin-1 alpha secretion	J:148597
	decreased interleukin-1 beta secretion	J:148597
	decreased interleukin-6 secretion	J:148597
	decreased interleukin-12 secretion	J:148597
	decreased susceptibility to endotoxin shock	J:148597
	decreased tumor necrosis factor secretion	J:148597
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Fabp1-cre)1Jig/0 (involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB/N)	increased susceptibility to induced colitis	J:93476
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Itgax-cre)1-1Reiz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal leukocyte migration	J:187773
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Lck-cre)1Jtak/0 (involves: 129S1/Sv * 129X1/SvJ)	increased interferon-gamma secretion	J:117857
Hivep2^tm1Sis/Hivep2^tm1Sis (either: (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj) or (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj))	CNS inflammation	J:263351
Hivep3^tm1Glm/Hivep3^tm1Glm (involves: 129 * C57BL/6)	decreased interleukin-2 secretion	J:100058
Hivep3^tm1Glm/Hivep3^tm1Glm (Not Specified)	abnormal osteoclast physiology	J:184764
hlb258/? (involves: 129S4/SvJae * C57BL/6J)	decreased circulating fibrinogen level	J:82961
Hmgb1^tm1.1Dltg/Hmgb1^tm1.1Dltg Tg(Pdx1-cre)6Tuv/0 (involves: C57BL/6 * FVB/N)	increased circulating interleukin-6 level	J:225260
	increased circulating tumor necrosis factor level	J:225260
	increased susceptibility to induced pancreatitis	J:225260
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:205499
	impaired macrophage phagocytosis	J:205499
	increased circulating interleukin-1 beta level	J:205499
	increased circulating interleukin-18 level	J:205499
	increased interleukin-1 beta secretion	J:205499
	increased interleukin-18 secretion	J:205499
	increased macrophage apoptosis	J:205499
	increased susceptibility to bacterial infection	J:205499
	increased susceptibility to endotoxin shock	J:205499
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	increased circulating interleukin-1 beta level	J:205499
	increased circulating interleukin-18 level	J:205499
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased circulating interleukin-1 beta level	J:205499
	increased circulating interleukin-18 level	J:205499
Hmgn5^tm1.2Mbus/Y (involves: 129S4/SvJae * C57BL/6J)	decreased IgE level	J:199604
Hmgn5^tm1.2Mbus/Y (involves: 129S4/SvJae * C57BL/6J)	increased IgA level	J:199604
Hmgn5^tm1.2Mbus/Hmgn5^tm1.2Mbus (involves: 129S4/SvJae * C57BL/6J)	decreased IgE level	J:199604
	increased IgA level	J:199604
Hmgxb3^{tm1a(EUCOMM)Wtsi}/Hmgxb3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Hmgxb3^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Hmox1^tm1.1Gkl/Hmox1^tm1.1Gkl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)	decreased interferon-beta secretion	J:148498
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:148498
	decreased susceptibility to Paramyxoviridae infection	J:148498
	increased circulating tumor necrosis factor level	J:148498
	increased interferon-gamma secretion	J:148498
	increased splenocyte proliferation	J:148498
	increased susceptibility to experimental autoimmune encephalomyelitis	J:148498
Hmox1^tm1.1Hes/Hmox1^tm1.1Hes Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)	decreased inflammatory response	J:214639
	decreased interleukin-1 beta secretion	J:214639
	decreased interleukin-6 secretion	J:214639
	decreased tumor necrosis factor secretion	J:214639
Hmox1^tm1.2Gkl/Hmox1^tm1.2Gkl (involves: 129 * BALB/cJ * C57BL/6)	increased inflammatory response	J:148498
	liver inflammation	J:148498
Hmox1^tm1Mlee/Hmox1^tm1Mlee (involves: 129S2/SvPas * BALB/c)	increased susceptibility to parasitic infection	J:153083
	increased susceptibility to parasitic infection induced morbidity/mortality	J:153083
Hmox1^tm1Poss/Hmox1^tm1Poss (involves: 129S2/SvPas * C57BL/6)	chronic inflammation	J:79254
	glomerulonephritis	J:79254
	liver inflammation	J:79254
	lung inflammation	J:79254
Hnf1b^tm1Mya/Hnf1b^tm3Mya Tg(Alb1-cre)7Gsc/0 (involves: 129S2/SvPas * C57BL/6 * FVB/N)	liver inflammation	J:75935
Hnf1b^tm2Ics/Hnf1b⁺ (involves: 129 * C57BL/6N)	chronic pancreas inflammation	J:306082
Hnrnpa2b1^tm1.1Caox/Hnrnpa2b1^tm1.1Caox Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal interferon level	J:283622
	decreased circulating interferon-beta level	J:283622
	decreased interferon-beta secretion	J:283622
	increased susceptibility to Herpesvirales infection	J:283622
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:283622
Hnrnpd^tm1Rjsc/Hnrnpd^tm1Rjsc (involves: 129S6/SvEvTac * C57BL/6J)	abnormal macrophage physiology	J:116112
	increased circulating tumor necrosis factor level	J:116112
	increased susceptibility to bacterial infection	J:116112
	increased susceptibility to endotoxin shock	J:116112
Hnrnpl^tm1.1Tmo/Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm/0 (B6.Cg-Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm)	increased T cell proliferation	J:188749
Hnrnpll^thdr/Hnrnpll^thdr (C57BL/6JSfdAnu-Hnrnpll^thdr/Anu)	abnormal memory T cell physiology	J:142641
Hoxa5^tm1Rob/Hoxa5^tm1Rob (involves: 129S/SvEv * C57BL/6 * MF1)	lung inflammation	J:113378
Hoxc4^tm2.1Mrc/Hoxc4^tm2.1Mrc (involves: 129S/SvEv * C57BL/6)	abnormal class switch recombination	J:148278
	abnormal somatic hypermutation frequency	J:148278
	decreased IgA level	J:148278
	decreased IgE level	J:148278
	decreased IgG1 level	J:148278
	decreased IgG2a level	J:148278
	decreased IgG2b level	J:148278
	decreased IgG3 level	J:148278
	decreased IgM level	J:148278
Hp^tm1Skl/Hp^tm1Skl Hpx^tm1Altr/Hpx^tm1Altr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)	liver inflammation	J:80539
Hpgds^tm1Urad/Hpgds^tm1Urad (B6.129-Hpgds^tm1Urad)	abnormal cytokine secretion	J:107651
	increased acute inflammation	J:107651
	increased inflammatory response	J:107651
	increased susceptibility to type I hypersensitivity reaction	J:197334
Hpi1^C57BL/6J/? (involves: A/J * C57BL/6J)	abnormal inflammatory response	J:69153
Hpi1^C57BL/6J/Hpi1^C57BL/6J Hpi2^C57BL/6J/Hpi2^C57BL/6J (involves: A/J * C57BL/6J)	abnormal inflammatory response	J:69153
Hpi2^C57BL/6J/? (involves: A/J * C57BL/6J)	abnormal inflammatory response	J:69153
Hprt1^b-m3/Y Impdh1^tm1Bmi/Impdh1^tm1Bmi (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased cytotoxic T cell cytolysis	J:85443
	decreased interleukin-4 secretion	J:85443
	decreased splenocyte proliferation	J:85443
	decreased T cell proliferation	J:85443
Hprt1^b-m3/Y Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd)	abnormal cytotoxic T cell physiology	J:86045
Hprt1^{tm1(CAG-Tgfbr1)Lba}/Y Tg(Cd4-cre)1Cwi/0 (involves: 129 C57BL/6 * DBA/2)	abnormal T cell activation	J:148747
Hprt1^{tm1(CAG-Tgfbr1)Lba}/Hprt1^{tm1(CAG-Tgfbr1)Lba} Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal T cell activation	J:148747
Hprt1^{tm1(Pck1-cre)Vhh}/Y Vhl^tm1Jae/Vhl^tm1Jae (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)	kidney inflammation	J:106705
Hps1^ep/Hps1^ep (involves: C3HeB/FeJ * C57BL/6J)	abnormal macrophage physiology	J:7869
Hps1^ep/Hps1^ep (B6.C3Fe-Hps1^ep/J)	abnormal NK cell physiology	J:6801
Hps1^ep/Hps1^ep (B6.C3Fe-Hps1^ep/J)	alveolitis	J:110157
Hps5^ru2-Btlr/Hps5^ru2-Btlr (C57BL/6J-Hps5^ru2-Btlr)	increased susceptibility to bacterial infection	J:133272
Hps5^ru2-Btlr/Hps5^ru2-Btlr (C57BL/6J-Hps5^ru2-Btlr)	increased susceptibility to Herpesvirales infection	J:133272
Hpse^tm1.2Mdh/Hpse^tm1.2Mdh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dendritic cell chemotaxis	J:209913
	decreased acute inflammation	J:209913
	impaired eosinophil recruitment	J:209913
Hr^hr/Hr^hr (HRS/J)	decreased T cell proliferation	J:6375
Hr^hr/Hr^hr Tg(CD2-Stat6V625AT626A)78Mhk/0 (involves: C3H * SKH1)	blepharitis	J:230018
	eye inflammation	J:230018
	Meibomian gland inflammation	J:230018
	uveitis	J:230018
Hr^m1Enu/Hr^m1Enu (BALB/cJ-Hr^m1Enu)	granulomatous inflammation	J:108173
Hr^rh/Hr^rh (Not Specified)	eye inflammation	J:16021
Hr^USP/Hr^USP (either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))	abnormal immunoglobulin level	J:21316
	abnormal thymus involution	J:21316
	decreased IgM level	J:21316
	glomerulonephritis	J:21316
	increased IgG level	J:21316
	increased susceptibility to autoimmune disorder	J:21316
	lymph node inflammation	J:21316
Hrg^tm1Wja/Hrg^tm1Wja (involves: 129P2/OlaHsd * C57BL/6)	increased circulating fibrinogen level	J:134621
Hrh1^Bphs-r/Hrh1^Bphs-s ((C3H/HeJ x SJL/J)F1)	abnormal immune system physiology	J:77938
	abnormal response to infection	J:77938
	increased susceptibility to bacterial infection	J:77938
	increased susceptibility to bacterial infection induced morbidity/mortality	J:77938
Hrh1^Bphs-s/Hrh1^Bphs-s (C3.SJL-Hrh1^Bphs-s)	abnormal response to infection	J:77938
	increased susceptibility to bacterial infection	J:77938
	increased susceptibility to bacterial infection induced morbidity/mortality	J:77938
Hrh1^tm1Wtn/Hrh1^tm1Wtn (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell proliferation	J:111704
	decreased IgG3 level	J:111704
	decreased IgM level	J:111704
	decreased interferon-gamma secretion	J:111704
	decreased interleukin-2 secretion	J:111704
	decreased T cell proliferation	J:111704
	increased interleukin-4 secretion	J:111704
Hrh1^tm1Wtn/Hrh1^tm1Wtn (B6.129P2-Hrh1^tm1Wtn)	decreased inflammatory response	J:110367
	decreased interferon-gamma secretion	J:110367
	decreased interleukin-5 secretion	J:110367
	decreased interleukin-13 secretion	J:110367
	increased IgG level	J:110367
	increased IgM level	J:110367
Hrh3^Eae8-r/? (B10.S-H2^s/SgMcdJ)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:34892
Hrh3^Eae8-r/Hrh3^Eae8-r (involves: B10.S/DvTe * SJL/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Hrh3^Eae8-s/? (involves: B10.S * SJL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:49054
Hrh3^tm1Twl/Hrh3^tm1Twl (B6.129X1-Hrh3^tm1Twl)	increased susceptibility to experimental autoimmune encephalomyelitis	J:122269
Hrh4^tm1Lex/Hrh4⁺ (involves: 129S/SvEv * C57BL/6)	abnormal mast cell physiology	J:132140
Hrh4^tm1Lex/Hrh4^tm1Lex (involves: 129S/SvEv * C57BL/6)	abnormal mast cell physiology	J:131785
Hrh4^tm1Lex/Hrh4^tm1Lex (involves: 129S/SvEv * BALB/c)	abnormal chemokine level	J:131785
	abnormal dendritic cell physiology	J:131785
	abnormal interleukin level	J:131785
	decreased IgE level	J:131785
	decreased IgG1 level	J:131785
	decreased inflammatory response	J:131785
Hrl^{129S6/SvEvTac}/Hrl^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to Herpesvirales infection	J:86189
Hrl^C57BL/6J/Hrl^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to Herpesvirales infection	J:86189
Hsd17b11^{Gt(OST237628)Lex}/Hsd17b11^{Gt(OST237628)Lex} (B6;129S5-Hsd17b11^{Gt(OST237628)Lex}/Mmucd)	increased IgG2a level	J:171883
Hsd17b13^tm1Lex/Hsd17b13^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6N)	liver inflammation	J:273927
Hsd17b14^tm1Lex/Hsd17b14^tm1Lex (B6;129S5-Hsd17b14^tm1Lex/Mmucd)	increased IgG2a level	J:171883
Hsf1^tm1Ijb/Hsf1^tm1Ijb (either: (involves: 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S6/SvEvTac * BALB/c) or (involves: 129S6/SvEvTac * C57BL/6J) or (involves: 129S6/SvEvTac * ICR))	increased susceptibility to bacterial infection	J:58383
	increased tumor necrosis factor secretion	J:58383
Hsf1^tm1Ijb/Hsf1^tm1Ijb Tg(TTR-V30M)15Imeg/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	increased interleukin-1 beta secretion	J:156658
	increased tumor necrosis factor secretion	J:156658
Hsh2d^tm1Viss/Hsh2d^tm1Viss (B6.129-Hsh2d^tm1Viss)	increased interleukin-2 secretion	J:111408
Hsh2d^tm1Viss/Hsh2d^tm1Viss (B6.129-Hsh2d^tm1Viss)	increased T cell proliferation	J:111408
Hsh2d^tm1Viss/Hsh2d^tm1Viss (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:111408
	abnormal CD8-positive, alpha-beta T cell physiology	J:111408
Hsp90aa1^tm1.1Udon/Hsp90aa1^tm1.1Udon (involves: C57BL/6)	abnormal dendritic cell antigen presentation	J:177143
	abnormal dendritic cell physiology	J:177143
	decreased interferon-gamma secretion	J:177143
Hsp90b1^tm1Zhli/Hsp90b1^tm1.1Zhli Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal cytokine secretion	J:118427
	abnormal inflammatory response	J:118427
	abnormal macrophage physiology	J:118427
	increased susceptibility to bacterial infection	J:118427
Hspa1b^tm1Clib/Hspa1b^tm1Clib (involves: 129P2/OlaHsd * C57BL/6J)	increased interleukin-6 secretion	J:76801
Hspa12a^tm1.1Zdi/Hspa12a^tm1.1Zdi (involves: 129 * C57BL/6)	increased susceptibility to endotoxin shock	J:302787
Hspa13^tm1.1Smoc/Hspa13^tm1.1Smoc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S * C57BL/6)	abnormal class switch recombination	J:303927
	abnormal humoral immune response	J:303927
	abnormal somatic hypermutation frequency	J:303927
	decreased autoantibody level	J:303927
	decreased IgA level	J:303927
	decreased IgE level	J:303927
	decreased IgG1 level	J:303927
	decreased IgG2b level	J:303927
	decreased IgG2c level	J:303927
	decreased IgG3 level	J:303927
	decreased IgG level	J:303927
	decreased IgM level	J:303927
Hspb1^tm1.1Jdn/Hspb1^tm1.1Jdn (B6.129S2(Cg)-Hspb1^tm1.1Jdn)	abnormal chemokine secretion	J:209117
	abnormal macrophage physiology	J:209117
	abnormal neutrophil physiology	J:209117
	increased inflammatory response	J:209117
	increased interleukin-6 secretion	J:209117
Hspb8^tm1.1Depr/Hspb8^tm1.1Depr (B.129-Hspb8^tm1.1Depr)	decreased circulating interleukin-6 level	J:186292
Hspg2^tm1Rdgr/Hspg2^tm1Rdgr (involves: 129S1/Sv * 129X1/SvJ)	osteoarthritis	J:121855
Htr2c^tm1Jul/Y (B6.129S-Htr2c^tm1Jul)	abnormal tumor necrosis factor level	J:50262
Htr3a^tm1Ckn/Htr3a^tm1Ckn (involves: 129S1/Sv * C57BL/6J * DBA/2)	kidney inflammation	J:90942
	prostate gland inflammation	J:90942
	pyelonephritis	J:90942
	seminal vesiculitis	J:90942
	tubulointerstitial nephritis	J:90942
Htra2^mnd2/Htra2^mnd2 (B6.Cg-Htra2^mnd2)	abnormal interleukin level	J:76481
Htra2^mnd2/Htra2^mnd2 (B6.Cg-Htra2^mnd2)	abnormal tumor necrosis factor level	J:76481
Hvcn1^{Gt(RRN293)Byg}/Hvcn1^{Gt(RRN293)Byg} (B6.129P2-Hvcn1^{Gt(RRN293)Byg})	abnormal macrophage physiology	J:148032
	abnormal neutrophil physiology	J:148032
hvlk/hvlk (C57BL/6J-hvlk)	increased susceptibility to Herpesvirales infection	J:105543
Hyal1^tm1Stn/Hyal1^tm1Stn (involves: 129X1/SvJ * C57BL/6J)	osteoarthritis	J:136860
Hydin^hyrh/Hydin^hyrh (involves: C57BL/6J * C57BL/10J * RIII)	rhinitis	J:137815
Ibdq1^C57BL/6J/Ibdq1^SAMP1/YitFcs (involves: C57BL/6J * SAMP1/YitFc)	ileum inflammation	J:84661
Ibdq1^SAMP1/YitFcs/Ibdq1^SAMP1/YitFcs (involves: C57BL/6J * SAMP1/YitFc)	ileum inflammation	J:84661
Ibdq2^SAMP1/YitFcs/Ibdq2^SAMP1/YitFcs (involves: AKR/J * SAMP1/YitFcs)	small intestinal inflammation	J:105411
Ibtk^Gt(XF224)Byg/Ibtk^Gt(XF224)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenocyte physiology	J:174707
Ica1^tm1Mdos/Ica1^tm1Mdos (NOD.129-Ica1^tm1Mdos)	abnormal T cell physiology	J:83526
Ica1^tm1Mdos/Ica1^tm1Mdos (NOD.129-Ica1^tm1Mdos)	decreased susceptibility to autoimmune diabetes	J:83526
Icam1^tm1Alb/Icam1^tm1Alb (B6.Cg-Icam1^tm1Alb)	abnormal leukocyte adhesion	J:100242
Icam1^tm1Alb/Icam1^tm1Alb (B6.Cg-Icam1^tm1Alb)	abnormal leukocyte tethering or rolling	J:100242
Icam1^tm1Bay/Icam1^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal cellular extravasation	J:14565
	abnormal immune system physiology	J:14565
	decreased susceptibility to type IV hypersensitivity reaction	J:14565
Icam1^tm1Bay/Icam1^tm1Bay (B6.129S7-Icam1^tm1Bay)	abnormal cellular extravasation	J:48271
	abnormal leukocyte migration	J:24239
	abnormal leukocyte tethering or rolling	J:48271
	decreased susceptibility to endotoxin shock	J:123460
Icam1^tm1Bay/Icam1^tm1Bay (either: B6.129S7-Icam1^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal leukocyte tethering or rolling	J:31374
Icam1^tm1Bay/Icam1^tm1Bay (B6.129S7-Icam1^tm1Bay/J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:193592
Icam1^tm1Bay/Icam1^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to induced colitis	J:111227
	impaired neutrophil recruitment	J:112286
	large intestinal inflammation	J:111227
Icam1^tm1Bay/Icam1^tm1Bay Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	decreased acute inflammation	J:112286
	impaired neutrophil chemotaxis	J:112286
Icam1^tm1Bay/Icam1^tm1Bay Sell^tm1Tft/Sell^tm1Tft (B6.129-Sell^tm1Tft Icam1^tm1Bay)	abnormal cellular extravasation	J:48271
	abnormal inflammatory response	J:124291
	abnormal leukocyte tethering or rolling	J:48271
	abnormal macrophage physiology	J:124291
	abnormal mast cell physiology	J:124291
	impaired macrophage chemotaxis	J:124291
Icam1^tm1Bay/Icam1^tm1Bay Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte migration	J:24239
Icam1^tm1Bay/Icam1^tm1Bay Selp^tm1Bay/Selp^tm1Bay (either: B6.129S7-Selp^tm1Bay Icam1^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	impaired leukocyte tethering or rolling	J:31374
Icam1^tm1Jcgr/Icam1^tm1Jcgr (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal interleukin level	J:18743
	abnormal T cell physiology	J:18743
	abnormal tumor necrosis factor level	J:18743
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:18743
	decreased susceptibility to type IV hypersensitivity reaction	J:18743
Icam1^tm1Jcgr/Icam1^tm1Jcgr Tg(INS-Il10)#Sar/0 (NOD.Cg-Icam1^tm1Jcgr Tg(INS-Il10)#Sar)	decreased susceptibility to autoimmune diabetes	J:66103
	periinsulitis	J:66103
Icam1^tm1Jcgr/Icam1^tm1Jcgr Vcam1^tm1Dmil/Vcam1^tm1Dmil (involves: 129S4/SvJae * C57BL/6)	impaired macrophage chemotaxis	J:227109
Icam2^tm1Jcgr/Icam2^tm1Jcgr (involves: 129S4/SvJae * C57BL/6)	abnormal eosinophil physiology	J:54748
Ichs^C57BL/6J/Ichs^C57BL/6J (involves: A/J * C57BL/6J * C57BL/6JOlaHsd)	abnormal type I hypersensitivity reaction	J:63737
Ichs^{C57BL/6JOlaHsd}/Ichs^{C57BL/6JOlaHsd} (involves: A/J * C57BL/6J * C57BL/6JOlaHsd)	abnormal type I hypersensitivity reaction	J:63737
Icos^tm1.1Wks/Icos^tm1.1Wks (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell physiology	J:155586
	abnormal class switch recombination	J:155586
	abnormal immune system physiology	J:155586
	decreased IgA level	J:155586
	decreased IgG1 level	J:155586
	decreased IgG2b level	J:155586
	decreased IgG2c level	J:155586
	decreased interleukin-4 secretion	J:155586
	decreased interleukin-21 secretion	J:155586
Icos^tm1Dgry/Icos^tm1Dgry (B6.129P2-Icos^tm1Dgry)	abnormal CD4-positive, alpha-beta T cell physiology	J:123477
	abnormal immune system physiology	J:123477
	abnormal interleukin secretion	J:123477
	abnormal response to infection	J:123477
	abnormal T cell physiology	J:123477
	decreased IgG level	J:123477
	decreased interleukin-4 secretion	J:123477
	decreased interleukin-5 secretion	J:123477
Icos^tm1Flv/Icos⁺ (NOD.129S1-Icos^tm1Flv)	insulitis	J:131529
Icos^tm1Flv/Icos^tm1Flv (involves: 129/Sv * C57BL/6)	abnormal immunoglobulin level	J:87123
	abnormal interferon level	J:87123
	abnormal interleukin level	J:87123
	abnormal T-helper 2 physiology	J:87123
	decreased IgE level	J:87123
	decreased IgG1 level	J:87123
	increased susceptibility to experimental autoimmune encephalomyelitis	J:87123
Icos^tm1Flv/Icos^tm1Flv (NOD.129S1-Icos^tm1Flv)	decreased anti-insulin autoantibody level	J:131529
	decreased autoantibody level	J:131529
	decreased IgG level	J:131529
	decreased interferon-gamma secretion	J:131529
	decreased susceptibility to autoimmune diabetes	J:131529
	insulitis	J:131529
Icos^tm1Flv/Icos^tm1Flv (involves: 129S1/Sv)	abnormal cytokine secretion	J:112600
Icos^tm1Flv/Icos^tm1Flv Tg(Cd4-Maf)6666Glm/0 (involves: 129S1/Sv * C57BL/6)	abnormal cytokine secretion	J:112600
Icos^tm1Flv/Icos^tm1Flv Tg(TcraTcrb)425Cbn/0 (involves: 129S1/Sv * C57BL/6)	abnormal cytokine secretion	J:112600
Icos^tm1Mak/Icos^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:66702
	abnormal class switch recombination	J:66702
	abnormal immune system physiology	J:66702
	abnormal T cell physiology	J:66702
	decreased IgA level	J:155586
	decreased IgE level	J:66702
	decreased IgG1 level	J:66702, J:155586
	decreased IgG2b level	J:155586
	decreased IgG2c level	J:155586
	decreased interleukin-21 secretion	J:155586
	decreased T cell proliferation	J:66702
Icos^tm1Shr/Icos^tm1Shr (Not Specified)	abnormal CD4-positive, alpha-beta T cell physiology	J:87124
	abnormal immunoglobulin level	J:87124
	abnormal interleukin level	J:87124
	decreased IgE level	J:87124
	decreased IgG1 level	J:87124
	decreased IgG2a level	J:87124
	decreased IgG level	J:87124
	increased IgG3 level	J:87124
Icos^tm1Tkan/Icos^tm1Tkan (involves: 129S7/SvEvBrd * C57BL/6)	abnormal NK cell physiology	J:95353
	decreased circulating interferon-gamma level	J:95353
	decreased circulating interleukin-4 level	J:95353
Icosl^tm1Cdon/Icosl^tm1Cdon (involves: 129S6/SvEvTac)	abnormal immunoglobulin level	J:86697
	abnormal interferon level	J:86697
	abnormal interleukin secretion	J:86697
	abnormal T-helper 2 physiology	J:86697
	decreased IgE level	J:86697
	decreased IgG1 level	J:86697
	decreased IgG2a level	J:86697
	decreased IgG level	J:86697
	decreased IgM level	J:86697
Icosl^tm1Kplm/Icosl^tm1Kplm (involves: 129P2/OlaHsd)	abnormal humoral immune response	J:84893
	abnormal immune serum protein physiology	J:84893
	decreased IgA level	J:84893
	decreased IgG2a level	J:84893
	decreased IgG2b level	J:84893
	decreased interleukin-4 secretion	J:84893
	decreased interleukin-10 secretion	J:84893
	increased interferon-gamma secretion	J:84893
Icosl^tm1Mak/Icosl^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:84668
	abnormal immune system physiology	J:84668
	decreased IgG1 level	J:84668
	decreased inflammatory response	J:84668
Id1^tm1Zhu/Id1⁺ Id3^tm1Zhu/Id3^tm1Zhu (involves: 129S1/Sv * 129S4/SvJaeSor)	increased susceptibility to otitis media	J:311050
Id1^tm1Zhu/Id1^tm1Zhu Id3^tm1Zhu/Id3⁺ (involves: 129S1/Sv * 129S4/SvJaeSor)	increased susceptibility to otitis media	J:311050
Id2^tm1Ago/Id2^tm1Ago Tg(TcraTcrb)1100Mjb/0 (B6.Cg-Id2^tm1Ago Tg(TcraTcrb)1100Mjb)	abnormal T cell activation	J:116119
Id2^tm1Mais/Id2^tm1Mais (involves: 129X1/SvJ * C57BL/6)	abnormal immune system physiology	J:146624
Id3^tm1Zhu/Id3^tm1Zhu (involves: 129/Sv * C57BL/6)	abnormal T cell physiology	J:56950
	decreased B cell proliferation	J:56950
	decreased immunoglobulin level	J:56950
Id3^tm1Zhu/Id3^tm1Zhu (involves: 129S4/SvJaeSor)	increased autoantibody level	J:93916
	lacrimal gland inflammation	J:93916
	salivary gland inflammation	J:93916
Id3^tm2.1Zhu/Id3^tm2.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)	parotid gland inflammation	J:172701
	submandibular gland inflammation	J:172701
Idc/Idc⁺ (involves: 101 * C3H)	blepharitis	J:6686
Idd1^NOD/Uf/Idd1^NOD/Uf (involves: C57BL/6 * NOD/Uf)	periinsulitis	J:33172
Idd3^A/J/Idd3^A/J (NOD.A-Idd3^A/J)	increased susceptibility to autoimmune diabetes	J:120349
Idd3^C57BL/6/Idd3^C57BL/6 (NOD.B6-Idd3^C57BL/6)	decreased susceptibility to autoimmune diabetes	J:120349
Idd3^C57BL/10SnJ/Idd3^C57BL/10SnJ Idd5.2^C57BL/10SnJ/Idd5.2^C57BL/10SnJ (involves: C57BL/10SnJ * NOD/MrkTac)	insulitis	J:143549
Idd3^C57BL/10SnJ/Idd3^C57BL/10SnJ Idd5^C57BL/10SnJ/Idd5^C57BL/10SnJ (involves: C57BL/10 * NOD/MrkTac)	pancreas inflammation	J:88667
Idd3^CAST/EiJ/Idd3^CAST/EiJ (NOD.CAST-Idd3^CAST/EiJ)	increased susceptibility to autoimmune diabetes	J:120349
Idd3^CZECHI/EiJ/Idd3^CZECHI/EiJ (NOD.CZECH-Idd3^CZECHI/EiJ)	decreased susceptibility to autoimmune diabetes	J:120349
Idd3^NOD/? (involves: C57BL/10 * NOD)	pancreas inflammation	J:17906
Idd3^SWR/J/Idd3^SWR/J (NOD.SWR-Idd3^SWR/J)	increased susceptibility to autoimmune diabetes	J:120349
Idd4.3^C57L/Idd4.3^C57L (involves: C57L/J * NOD)	abnormal cytokine secretion	J:118951
	abnormal macrophage physiology	J:118951
	increased susceptibility to autoimmune diabetes	J:118951
Idd4^C57BL/6/Idd4^C57BL/6 (involves: C57BL/6 * DBA/2)	increased T cell proliferation	J:25969
Idd4^C57BL/6/Idd4^C57BL/6 (involves: C57BL/6 * NOD)	increased T cell proliferation	J:25969
Idd4^C57BL/6J/? (involves: C57BL/6J * NOD)	pancreas inflammation	J:73763
Idd4^NOD/Jsd/? (involves: NOD/Jsd * NOR/LtJ)	pancreas inflammation	J:99002
Idd4^NOD/Jsd/Idd4^NOD/Jsd Idd9^NOD/Jsd/Idd9^NOD/Jsd (involves: NOD/Jsd * NOR/LtJ)	pancreas inflammation	J:99002
Idd4^NOD/Idd4^NOD (B6.NOD-Idd4)	abnormal cytokine secretion	J:85823
Idd4^NOR/LtJ/? (involves: NOD/Jsd * NOR/LtJ)	pancreas inflammation	J:99002
Idd5^NOD/Uf/Idd5^NOD/Uf (involves: C57BL/6 * NOD/Uf)	periinsulitis	J:33172
Idd6.1^C3H/HeJ/Idd6.1^C3H/HeJ (involves: C3H/HeJ * NOD)	decreased susceptibility to autoimmune diabetes	J:115021
Idd6.2^C3H/HeJ/Idd6.2^C3H/HeJ (involves: C3H/HeJ * NOD)	decreased susceptibility to autoimmune diabetes	J:115021
Idd6.3^C3H/HeJ/Idd6.3^C3H/HeJ (involves: C3H/HeJ * NOD)	decreased susceptibility to autoimmune diabetes	J:115021
Idd6^C3H/HeJ/Idd6^C3H/HeJ (NOD.C3-Idd6^C3H/HeJ)	decreased interferon-gamma secretion	J:137837
Idd6^C3H/HeJ/Idd6^C3H/HeJ (NOD.C3-Idd6^C3H/HeJ)	decreased interleukin-4 secretion	J:137837
Idd6^C57BL/6/Idd6^NOD (involves: C57BL/6 * NOD)	decreased T cell proliferation	J:72360
Idd6^NOD/Idd6^NOD (involves: C57BL/6 * NOD)	decreased T cell proliferation	J:72360
Idd6^NOD/Idd6^NOD (B6.NOD-Idd6)	abnormal NK cell physiology	J:85823
Idd7^NOD/ShiLt/Idd7^NOD/ShiLt (involves: C57BL/6 * NOD/ShiLt)	abnormal T cell clonal deletion	J:131557
Idd9^NOD/Jsd/? (involves: NOD/Jsd * NOR/LtJ)	pancreas inflammation	J:99002
Idd9^NOR/LtJ/? (involves: NOD/Jsd * NOR/LtJ)	pancreas inflammation	J:99002
Idd10^NOD/ShiLt/Idd10^NOD/ShiLt Idd3^NOD/Idd3^NOD (B6.NOD-Idd3^NOD Idd10^NOD/Lt)	abnormal cytokine secretion	J:85823
	abnormal NK T cell physiology	J:85823
Idd13^NOD/ShiLt/Idd13^NOD/ShiLt (B6.NOD-Idd13)	abnormal cytokine secretion	J:85823
Idd13^NOD/ShiLt/Idd13^NOD/ShiLt (B6.NOD-Idd13)	abnormal NK T cell physiology	J:85823
Idd16.1^ALR/LtJ/Idd16.1^ALR/LtJ (involves: ALR/LtJ * NOD/LtJ)	pancreas inflammation	J:98187
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal cytokine secretion	J:120813
	abnormal dendritic cell physiology	J:120813
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * BALB/c)	abnormal cytokine level	J:170565
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * BALB/c)	epididymis inflammation	J:170565
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * C57BL/6J * FVB/N)	decreased susceptibility to type IV hypersensitivity reaction	J:211949
	increased interferon-gamma secretion	J:211949
	increased interleukin-6 secretion	J:211949
	increased tumor necrosis factor secretion	J:211949
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * C57BL/6J)	abnormal macrophage physiology	J:282516
Ido2^em1Lamn/Ido2^em1Lamn (involves: BALB/c * C57BL/6J)	decreased susceptibility to type IV hypersensitivity reaction	J:342726
Ido2^em1Lamn/Ido2^em1Lamn Tg(TcraR28,TcrbR28)KRNDim/0 (involves: C57BL/6 * C57BL/6J * SJL)	arthritis	J:342726
Ido2^em2Lamn/Ido2^em2Lamn (involves: BALB/c * C57BL/6J)	decreased susceptibility to type IV hypersensitivity reaction	J:342726
Ido2^em2Lamn/Ido2^em2Lamn Tg(TcraR28,TcrbR28)KRNDim/0 (involves: C57BL/6 * C57BL/6J * SJL)	arthritis	J:342726
Ido2^tm1.2Gcp/Ido2^tm1.2Gcp (involves: C57BL/6J * FVB/N)	abnormal chemokine secretion	J:211949
	abnormal regulatory T cell physiology	J:211949
	decreased interferon-gamma secretion	J:211949
	decreased interleukin-6 secretion	J:211949
	decreased susceptibility to type IV hypersensitivity reaction	J:211949
	decreased tumor necrosis factor secretion	J:211949
Idua^tm1Efn/Idua^tm1Efn (involves: C57BL/6)	abnormal microglial cell physiology	J:81974
Idua^tm1Efn/Idua^tm1Efn (involves: C57BL/6)	increased susceptibility to otitis media	J:123676
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:157504
	abnormal interleukin level	J:157504
	abnormal macrophage physiology	J:157504
	abnormal response to infection	J:157504
	abnormal tumor necrosis factor level	J:157504
	abnormal tumor necrosis factor secretion	J:157504
	impaired macrophage phagocytosis	J:157504
	increased susceptibility to parasitic infection	J:157504
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: C57BL/6)	decreased susceptibility to induced colitis	J:194587
Ier3^tm1Mxw/Ier3^tm1Mxw Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to induced colitis	J:194587
If1^l/If1^l (involves: BALB/c)	abnormal circulating interferon level	J:5113
If1^l/If1^l (involves: BALB/c)	abnormal response to infection	J:38004
If1^l/If1^l (B6.C-Ifi44l^H28-c If1^l/(HW81)aByJ)	abnormal response to infection	J:38004
Ifi30^tm1Cres/Ifi30^tm1Cres (involves: 129S1/Sv * C57BL/6)	abnormal professional antigen presenting cell physiology	J:72708
Ifi35^em1Hhl/Ifi35^em1Hhl (C57BL/6-Ifi35^em1Hhl)	decreased circulating interleukin-6 level	J:298909
	decreased circulating tumor necrosis factor level	J:298909
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:298909
	decreased susceptibility to endotoxin shock	J:298909
Ifi44^{tm1b(KOMP)Wtsi}/Ifi44^{tm1b(KOMP)Wtsi} (involves: C57BL/6N)	decreased CXCL10 secretion	J:297991
	decreased interleukin-1 beta secretion	J:297991
	increased susceptibility to Riboviria infection	J:297991
Ifi47^tm1Gat/Ifi47^tm1Gat (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to parasitic infection	J:87535
Ifi204^tm1.1Cjul/Ifi204^tm1.1Cjul (B6.129(Cg)-Ifi204^tm1.1Cjul)	decreased circulating interferon-beta level	J:270123
	decreased circulating interleukin-1 beta level	J:270123
	decreased circulating interleukin-6 level	J:270123
	decreased circulating tumor necrosis factor level	J:270123
	decreased interferon-beta secretion	J:270123
	decreased interleukin-6 secretion	J:270123
	decreased susceptibility to endotoxin shock	J:270123
	decreased tumor necrosis factor secretion	J:270123
Ifih1^Rgsc422/Ifih1⁺ (D2JJcl.B6JJcl-Ifih1^Rgsc422)	abnormal chemokine level	J:209917
	abnormal cytokine level	J:209917
	abnormal dendritic cell antigen presentation	J:209917
	abnormal macrophage activation involved in immune response	J:209917
	abnormal T cell activation	J:209917
	autoimmune response	J:209917
	chronic liver inflammation	J:209917
	glomerulonephritis	J:209917
	increased anti-double stranded DNA antibody level	J:209917
	increased anti-nuclear antigen antibody level	J:209917
	increased IgA level	J:209917
	increased IgG level	J:209917
	increased IgM level	J:209917
	increased immunoglobulin level	J:209917
	increased inflammatory response	J:209917
	increased susceptibility to systemic lupus erythematosus	J:209917
	skin inflammation	J:209917
Ifih1^Rgsc422/Ifih1⁺ Ifnar1^tm1Agt/Ifnar1⁺ (involves: 129S2/SvPas * C57BL/6JJcl * DBA/2JJcl)	glomerulonephritis	J:209917
Ifih1^Rgsc422/Ifih1⁺ Mavs^tm1Aki/Mavs⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	glomerulonephritis	J:209917
Ifih1^Rgsc422/Ifih1^Rgsc422 (D2JJcl.B6JJcl-Ifih1^Rgsc422)	glomerulonephritis	J:209917
Ifih1^Rgsc422/Ifih1^Rgsc422 (D2JJcl.B6JJcl-Ifih1^Rgsc422)	increased susceptibility to systemic lupus erythematosus	J:209917
Ifih1^tm1.1Cln/Ifih1^tm1.1Cln (involves: 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:110201
	decreased interferon-alpha secretion	J:110201
	decreased interleukin-6 secretion	J:110201
	increased susceptibility to Picornaviridae infection	J:110201
Ifih1^tm1.1Cln/Ifih1^tm1.1Cln (involves: 129X1/SvJ)	decreased interferon-beta secretion	J:240099
Ifih1^tm1Aki/Ifih1^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal dendritic cell physiology	J:137522
	abnormal interferon level	J:137522
	abnormal interleukin level	J:137522
	increased susceptibility to Picornaviridae infection	J:137522
Ifih1^tm1Aki/Ifih1^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd)	abnormal interferon level	J:137522
	abnormal interleukin level	J:137522
Ifit1^{tm1(KOMP)Vlcg}/Ifit1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	increased susceptibility to Riboviria infection	J:187549
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:187549
Ifit1^{tm1(KOMP)Vlcg}/Ifit1^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal interferon level	J:205203
	abnormal T cell physiology	J:205203
	brain inflammation	J:205203
	increased susceptibility to Coronaviridae infection	J:205203
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:205203
Ifit2^tm1.1Ebsb/Ifit2^tm1.1Ebsb (B6NCrl.129P2(C)-Ifit2^tm1.1Ebsb)	decreased circulating interleukin-1 beta level	J:199862
	decreased circulating interleukin-6 level	J:199862
	decreased circulating interleukin-12b level	J:199862
	decreased circulating tumor necrosis factor level	J:199862
	decreased interleukin-6 secretion	J:199862
	decreased tumor necrosis factor secretion	J:199862
	increased susceptibility to bacterial infection induced morbidity/mortality	J:199862
Ifit2^tm1.1Ebsb/Ifit2^tm1.1Ebsb (B6.129P2(C)-Ifit2^tm1.1Ebsb)	enhanced humoral immune response	J:233986
	increased IgE level	J:233986
	increased IgG1 level	J:233986
	increased IgG3 level	J:233986
	increased IgM level	J:233986
Ifit2^tm1.1Tac/Ifit2⁺ (involves: C57BL/6)	increased susceptibility to Riboviria infection induced morbidity/mortality	J:195382
Ifit2^tm1.1Tac/Ifit2^tm1.1Tac (involves: C57BL/6)	increased susceptibility to Riboviria infection	J:195382
Ifit2^tm1.1Tac/Ifit2^tm1.1Tac (involves: C57BL/6)	increased susceptibility to Riboviria infection induced morbidity/mortality	J:195382
Ifitm1^tm1.1Ieg/Ifitm1^tm1.1Ieg (B6.129P2-Ifitm1^tm1.1Ieg)	increased IgE level	J:192287
Ifitm3^tm1Masu/Ifitm3^tm1Masu (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to Orthomyxoviridae infection	J:183865
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:183865
	increased susceptibility to Riboviria infection	J:209781
Ifna6^tm1Aki/Ifna6⁺ Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd)	decreased interferon-alpha secretion	J:124340
Ifnar1^m1Btlr/Ifnar1^m1Btlr (C57BL/6J-Ifnar1^m1Btlr)	abnormal macrophage physiology	J:142790
	decreased interferon-alpha secretion	J:142790
	decreased interferon-beta secretion	J:142790
	increased susceptibility to Adenoviridae infection	J:142790
	increased susceptibility to Herpesvirales infection	J:142790
	increased susceptibility to Orthomyxoviridae infection	J:142790
	increased susceptibility to Riboviria infection	J:142790
Ifnar1^m2Btlr/Ifnar1^m2Btlr (involves: C57BL/6J)	decreased interferon-beta secretion	J:198556
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas)	abnormal cytokine secretion	J:114555
	abnormal dendritic cell physiology	J:114555
	abnormal immunoglobulin level	J:101427
	abnormal inflammatory response	J:114555
	abnormal NK cell physiology	J:79552, J:139001
	impaired natural killer cell mediated cytotoxicity	J:79552
	increased susceptibility to Coronaviridae infection	J:144400
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:144400
	increased susceptibility to Herpesvirales infection	J:197569, J:81243
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:115139
	increased susceptibility to Paramyxoviridae infection	J:160878
	increased susceptibility to Paramyxoviridae infection induced morbidity/mortality	J:160878
	increased susceptibility to Picornaviridae infection	J:137522
	increased susceptibility to Poxviridae infection	J:101427
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * C57BL/6)	abnormal susceptibility to infection	J:120938
Ifnar1^tm1Agt/Ifnar1^tm1Agt (B6.129S2-Ifnar1^tm1Agt)	abnormal response to infection	J:116703
	decreased interferon-alpha secretion	J:125611
	decreased interferon-beta secretion	J:125611
	decreased interleukin-6 secretion	J:199862
	decreased tumor necrosis factor secretion	J:199862
	impaired natural killer cell mediated cytotoxicity	J:118750
	increased susceptibility to bacterial infection induced morbidity/mortality	J:199862
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	increased susceptibility to Orthomyxoviridae infection	J:119783
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * 129S6/SvEvTac)	abnormal CD8-positive, alpha-beta T cell physiology	J:54482
	abnormal interferon-gamma secretion	J:54482
	increased circulating interleukin-12 level	J:54482
	increased susceptibility to Riboviria infection	J:54482
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * BALB/c)	abnormal cytokine level	J:291874
	decreased susceptibility to Coronaviridae infection	J:291874
	decreased T cell apoptosis	J:291874
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:291874
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:291874
Ifnar1^tm1Agt/Ifnar1^tm1Agt Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S2/SvPas * 129S7/SvEvBrd)	abnormal immunoglobulin level	J:101427
	increased susceptibility to Herpesvirales infection	J:81243
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:115139
	increased susceptibility to Poxviridae infection	J:101427
	increased susceptibility to Togaviridae infection	J:81243
Ifnar1^tm1Agt/Ifnar1^tm1Agt Myd88^tm1Aki/Myd88⁺ (B6.129-Myd88^tm1Aki Ifnar1^tm1Agt)	increased susceptibility to parasitic infection	J:140485
Ifnar1^tm1Agt/Ifnar1^tm1Agt Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal leukocyte migration	J:171379
Ifnar1^tm1Agt/Ifnar1^tm1Agt Myd88^tm1Aki/Myd88^tm1Aki (B6.129-Myd88^tm1Aki Ifnar1^tm1Agt)	increased susceptibility to parasitic infection	J:140485
	increased susceptibility to parasitic infection induced morbidity/mortality	J:140485
Ifnar1^tm1Agt/Ifnar1^tm1Agt Otulin^{tm1c(EUCOMM)Hmgu}/Otulin^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre)1Cgn/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/6N * DBA/2)	dermatitis	J:312394
Ifnar1^tm1Agt/Ifnar1^tm1Agt Slamf1^tm1Oono/Slamf1^tm1Oono (B6.129-Slamf1^tm1Oono Ifnar1^tm1Agt)	increased susceptibility to Paramyxoviridae infection	J:117810
Ifnar1^tm1Agt/Ifnar1^tm1Agt Tg(CD46)373Zbz/Tg(CD46)373Zbz (involves: 129S2/SvPas * C3H/He * C57BL/6)	brain inflammation	J:160878
	increased susceptibility to Paramyxoviridae infection	J:160878
	increased susceptibility to Paramyxoviridae infection induced morbidity/mortality	J:160878
	lung inflammation	J:160878
	meningitis	J:160878
Ifnar1^tm1Agt/Ifnar1^tm1Agt Tg(Hmgcr-MX1)LStae/Tg(Hmgcr-MX1)LStae (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	decreased susceptibility to Orthomyxoviridae infection	J:119783
	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:119783
Ifnar1^tm1Agt/Ifnar1^tm1Agt Ythdf3^em1Caox/Ythdf3^em1Caox (involves: C57BL/6J)	abnormal macrophage physiology	J:276397
Ifnar1^tm1Pjh/Ifnar1^tm1Pjh (involves: 129S2/SvPas * BALB/c)	abnormal macrophage physiology	J:36004
	increased susceptibility to Picornaviridae infection	J:36004
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:36004
	increased susceptibility to Togaviridae infection	J:36004
	increased susceptibility to Togaviridae infection induced morbidity/mortality	J:36004
Ifnar1^tm1Pjh/Ifnar1^tm1Pjh (B6.129S2-Ifnar1^tm1Pjh)	impaired natural killer cell mediated cytotoxicity	J:125812
Ifnar2^m1Btlr/Ifnar2^m1Btlr (C57BL/6J-Ifnar2^m1Btlr)	abnormal macrophage physiology	J:147329
	decreased interferon-alpha secretion	J:147329
	decreased interferon-beta secretion	J:147329
	increased susceptibility to Adenoviridae infection	J:147329
	increased susceptibility to Herpesvirales infection	J:147329
	increased susceptibility to Orthomyxoviridae infection	J:147329
	increased susceptibility to Riboviria infection	J:147329
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh (B6.Cg-Ifnar2^tm1Pjh)	impaired natural killer cell mediated cytotoxicity	J:125812
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:132662
	abnormal cytotoxic T cell physiology	J:132662
	decreased IgG1 level	J:132662
	decreased IgG2a level	J:132662
	decreased IgG level	J:132662
	decreased interferon-gamma secretion	J:132662
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv)	increased circulating interleukin-6 level	J:168781
	increased susceptibility to endotoxin shock	J:168781
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-beta level	J:61048
	increased susceptibility to Poxviridae infection	J:61048
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (involves: 129P2/OlaHsd)	decreased tumor necrosis factor secretion	J:86527
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (involves: 129P2/OlaHsd)	increased T cell proliferation	J:86527
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (B6.129P2-Ifnb1^tm1Acgp)	abnormal macrophage physiology	J:136368
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (B6.129P2-Ifnb1^tm1Acgp)	decreased interleukin-1 beta secretion	J:136368
Ifnb1^tm1Tl/Ifnb1^tm1Tl (B10.129P2-Ifnb1^tm1Tl)	abnormal macrophage physiology	J:83021
	abnormal microglial cell physiology	J:83021
	CNS inflammation	J:83021
	increased interferon-gamma secretion	J:83021
	increased interleukin-4 secretion	J:83021
	increased susceptibility to experimental autoimmune encephalomyelitis	J:83021
	increased tumor necrosis factor secretion	J:83021
Ifnb1^tm1Tl/Ifnb1^tm1Tl (B6.129P2-Ifnb1^tm1Tl)	decreased circulating interferon-alpha level	J:172226
	decreased circulating interferon-beta level	J:172226
	decreased susceptibility to bacterial infection	J:172226
Ifnb1^tm1Ttg/Ifnb1^tm1Ttg (involves: C57BL/6)	abnormal response to infection	J:116703
Ifnb1^tm2.1Lien/Ifnb1^tm2.1Lien Tyr^c-2J/Tyr^c-2J Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-alpha level	J:172226
	decreased circulating interferon-beta level	J:172226
	decreased susceptibility to bacterial infection	J:172226
Ifne^tm1.2Pjh/Ifne^tm1.2Pjh (involves: C57BL/6)	increased susceptibility to bacterial infection	J:197569
Ifne^tm1.2Pjh/Ifne^tm1.2Pjh (involves: C57BL/6)	increased susceptibility to Herpesvirales infection	J:197569
Ifng^tm1.1Hayg/Ifng^tm1.1Hayg (Not Specified)	abnormal circulating cytokine level	J:220784
	abnormal cytokine level	J:220784
	abnormal T cell activation	J:220784
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:66802
	abnormal MHC II cell surface expression on macrophages	J:66802
	abnormal NK cell physiology	J:66802, J:115033
	abnormal type IV hypersensitivity reaction	J:55740
	decreased length of allograft survival	J:44346
	decreased susceptibility to parasitic infection	J:189794
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:189794
	increased splenocyte proliferation	J:66802
	increased susceptibility to bacterial infection	J:66802
Ifng^tm1Ts/Ifng^tm1Ts (NOD.129S7-Ifng^tm1Ts)	abnormal susceptibility to autoimmune disorder	J:33427
Ifng^tm1Ts/Ifng^tm1Ts (NOD.129S7-Ifng^tm1Ts)	decreased susceptibility to autoimmune diabetes	J:95105
Ifng^tm1Ts/Ifng^tm1Ts (NOD.Cg-Ifng^tm1Ts Prkdc^scid)	decreased susceptibility to autoimmune diabetes	J:72818
Ifng^tm1Ts/Ifng^tm1Ts (NOD.129S7(B6)-Ifng^tm1Ts/DvsJ)	abnormal cytotoxic T cell physiology	J:72818
	abnormal diapedesis	J:72818
	decreased susceptibility to autoimmune diabetes	J:72818
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd)	abnormal cytokine level	J:112600
	abnormal immunoglobulin level	J:29170
	abnormal response to infection	J:110721, J:29170
	decreased susceptibility to type IV hypersensitivity reaction	J:29170
	impaired natural killer cell mediated cytotoxicity	J:73948
	increased IgG1 level	J:110721
	increased interleukin-17 secretion	J:132905
	increased susceptibility to bacterial infection	J:110856
	increased susceptibility to bacterial infection induced morbidity/mortality	J:110856
	increased susceptibility to Herpesvirales infection	J:29170
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:29170
Ifng^tm1Ts/Ifng^tm1Ts (B6.129S7-Ifng^tm1Ts/J)	abnormal circulating cytokine level	J:47459
	abnormal cytokine secretion	J:120556
	abnormal dendritic cell antigen presentation	J:134949
	abnormal dendritic cell chemotaxis	J:134949
	abnormal dendritic cell physiology	J:134949
	abnormal humoral immune response	J:45665
	abnormal immune tolerance	J:45665
	abnormal immunoglobulin level	J:45665
	abnormal Langerhans cell physiology	J:134949
	abnormal macrophage chemotaxis	J:136628
	abnormal type IV hypersensitivity reaction	J:45665
	decreased interferon-gamma secretion	J:120556
	decreased interleukin-10 secretion	J:120556, J:134949
	decreased length of allograft survival	J:44346
	glomerulonephritis	J:118730
	increased circulating interleukin-6 level	J:47459
	increased interleukin-4 secretion	J:120556
	increased interleukin-12 secretion	J:134949
	increased susceptibility to bacterial infection	J:47459
	increased susceptibility to bacterial infection induced morbidity/mortality	J:47459
	increased susceptibility to parasitic infection	J:50832
	increased susceptibility to parasitic infection induced morbidity/mortality	J:50832
	increased susceptibility to type IV hypersensitivity reaction	J:118730
	stomach inflammation	J:120556
Ifng^tm1Ts/Ifng^tm1Ts (B6.129S7-Ifng^tm1Ts)	abnormal B cell physiology	J:112084
	abnormal cytokine secretion	J:18801, J:110826
	abnormal immunoglobulin level	J:18801
	abnormal response to infection	J:18801, J:110826
	abnormal response to transplant	J:42090
	decreased IgG2a level	J:18801
	decreased IgG3 level	J:18801
	increased IgE level	J:18801
	increased IgG1 level	J:18801, J:112048
	increased interleukin-2 secretion	J:112048
	increased interleukin-5 secretion	J:112048
	increased interleukin-10 secretion	J:112048
	increased susceptibility to Coronaviridae infection	J:112048
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:112048
	increased susceptibility to parasitic infection	J:18801
	increased susceptibility to parasitic infection induced morbidity/mortality	J:18801, J:110826
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to bacterial infection	J:15723
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to bacterial infection induced morbidity/mortality	J:15723
Ifng^tm1Ts/Ifng^tm1Ts (C.129S7-Ifng^tm1Ts)	abnormal cytokine secretion	J:110826
	abnormal humoral immune response	J:45665
	abnormal immune tolerance	J:45665
	abnormal immunoglobulin level	J:45665
	abnormal response to infection	J:110826
	increased interleukin-5 secretion	J:110826
	increased susceptibility to bacterial infection induced morbidity/mortality	J:83180
	increased susceptibility to experimental autoimmune encephalomyelitis	J:34161
	increased susceptibility to parasitic infection	J:110826
	increased susceptibility to parasitic infection induced morbidity/mortality	J:110826
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * BALB/c)	abnormal susceptibility to infection	J:39478
	decreased IgE level	J:114213
	decreased inflammatory response	J:114213
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)	decreased anti-double stranded DNA antibody level	J:39600
	decreased anti-nuclear antigen antibody level	J:39600
	decreased autoantibody level	J:39600
	decreased IgA level	J:39600
	decreased IgG2a level	J:39600
	decreased IgG2b level	J:39600
	decreased IgG3 level	J:39600
	decreased IgM level	J:39600
	decreased immunoglobulin level	J:39600
	decreased susceptibility to autoimmune disorder	J:39600
Ifng^tm1Ts/Ifng^tm1Ts (C.129S7(B6)-Ifng^tm1Ts/J)	abnormal adaptive immunity	J:115144
	abnormal circulating cytokine level	J:47459
	abnormal cytokine secretion	J:115144
	abnormal cytotoxic T cell physiology	J:115144
	abnormal inflammatory response	J:115144
	abnormal macrophage physiology	J:115144
	abnormal NK cell physiology	J:115144
	abnormal uterine NK cell physiology	J:56503
	decreased susceptibility to parasitic infection	J:50832
	increased circulating interleukin-6 level	J:47459
	increased susceptibility to bacterial infection	J:47459
	increased susceptibility to bacterial infection induced morbidity/mortality	J:47459
Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss)	decreased IgG2a level	J:119207
	decreased IgG level	J:119207
	decreased susceptibility to autoimmune disorder	J:119207
	increased IgG1 level	J:119207
Ifng^tm1Ts/Ifng^tm1Ts Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S7/SvEvBrd * C57BL/6)	brain inflammation	J:191055
Ifng^tm1Ts/Ifng^tm1Ts Socs1^tm1Jni/Socs1^tm1Jni (involves: 129S7/SvEvBrd)	increased interleukin-17 secretion	J:132905
Ifng^tm1Ts/Ifng^tm1Ts Tg(SFTPC-Il18)AThos/0 (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N * DBA/2)	lung inflammation	J:147547
Ifng^tm1Ts/Ifng^tm1Ts Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.129-Ifng^tm1Ts Tgfb1^tm1Doe)	liver inflammation	J:69346
Ifng^tm1Ts/Ifng^tm1Ts Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6J)	small intestinal inflammation	J:108572
Ifng^tm1Ts/Ifng^tm1Ts Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	increased susceptibility to fungal infection	J:119206
	lung inflammation	J:119206
Ifng^tm1Yiw/Ifng^tm1Yiw (involves: 129X1/SvJ * C57BL/6)	decreased inflammatory response	J:41632, J:88226
Ifng^tm1Yiw/Ifng^tm1Yiw (B6.129X1-Ifng^tm1Yiw)	abnormal circulating interferon level	J:91691
	increased susceptibility to Coronaviridae infection	J:91691, J:50405
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:91691, J:50405
	liver inflammation	J:50405
	peritoneal inflammation	J:50405
Ifng^tm1Yiw/Ifng^tm1Yiw (C.129X1-Ifng^tm1Yiw)	abnormal circulating interferon level	J:91691
	increased susceptibility to Coronaviridae infection	J:91691
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:91691
Ifngr1^m1Btlr/Ifngr1^m1Btlr (C57BL/6J-Ifngr1^m1Btlr)	decreased tumor necrosis factor secretion	J:236694
Ifngr1^tm1.1Rds/Ifngr1^tm1.1Rds Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6NTac.Cg-Ifngr1^tm1.1Rds Commd10^{Tg(Vav1-icre)A2Kio})	increased susceptibility to bacterial infection	J:206257
	increased susceptibility to bacterial infection induced morbidity/mortality	J:206257
Ifngr1^tm1.1Rds/Ifngr1^tm1.1Rds Tg(Itgax-cre,-EGFP)4097Ach/0 (B6NTac.Cg-Ifngr1^tm1.1Rds Tg(Itgax-cre,-EGFP)4097Ach)	decreased interferon-gamma secretion	J:206257
	decreased interleukin-12b secretion	J:206257
	increased susceptibility to bacterial infection	J:206257
	increased susceptibility to bacterial infection induced morbidity/mortality	J:206257
Ifngr1^tm1.1Rost/Ifngr1^tm1.1Rost (involves: BALB/cJ * C57BL/6)	abnormal chemokine level	J:152785
	decreased circulating interferon-gamma level	J:152785
	decreased circulating interleukin-12 level	J:152785
Ifngr1^tm1.2Rds/Ifngr1^tm1.2Rds (C57BL/6NTac-Ifngr1^tm1.2Rds)	decreased interleukin-12b secretion	J:206257
	increased susceptibility to bacterial infection	J:206257
	increased susceptibility to bacterial infection induced morbidity/mortality	J:206257
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd)	abnormal immunoglobulin level	J:38363, J:101427
	abnormal response to infection	J:115139
	abnormal uterine NK cell physiology	J:56503
	aortitis	J:115139
	arteritis	J:115139
	decreased circulating tumor necrosis factor level	J:17878
	decreased IgG2a level	J:38363
	decreased susceptibility to endotoxin shock	J:17878
	increased circulating interferon-gamma level	J:314959
	increased circulating interleukin-1 beta level	J:314959
	increased circulating interleukin-6 level	J:174397
	increased interferon-gamma secretion	J:38363
	increased susceptibility to bacterial infection	J:314959, J:174397
	increased susceptibility to bacterial infection induced morbidity/mortality	J:314959, J:174397
	increased susceptibility to experimental autoimmune encephalomyelitis	J:38363
	increased susceptibility to Herpesvirales infection	J:81243
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:115139
	increased susceptibility to parasitic infection	J:114203
	increased susceptibility to Poxviridae infection	J:101427
	increased tumor necrosis factor secretion	J:38363
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytotoxic T cell physiology	J:63815
	decreased IgG2a level	J:63815
	decreased IgG3 level	J:63815
	decreased susceptibility to experimental autoimmune myasthenia gravis	J:53577
	increased interferon-gamma secretion	J:99347
	increased interleukin-6 secretion	J:99347
	increased splenocyte proliferation	J:99347
	increased susceptibility to bacterial infection	J:63815
	increased susceptibility to experimental autoimmune uveoretinitis	J:99347
	increased susceptibility to Riboviria infection	J:63815
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:63815
Ifngr1^tm1Agt/Ifngr1^tm1Agt (B6.129S7-Ifngr1^tm1Agt/J)	abnormal circulating chemokine level	J:152785
	decreased circulating interleukin-12 level	J:152785
	decreased susceptibility to bacterial infection	J:147443
	increased interferon-gamma secretion	J:138728
	increased susceptibility to graft versus host disease	J:138728
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd * DBA/1OlaHsd)	decreased IgG2a level	J:40634
	increased susceptibility to induced arthritis	J:40634
Ifngr1^tm1Agt/Ifngr1^tm1Agt Tg(GZMB-Tax)#Lera/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal osteoclast physiology	J:147601
Ifngr1^tm1Dmer/Ifngr1^tm1Dmer (B6.Cg-Ifngr1^tm1Dmer)	abnormal response to infection	J:202844
Ifngr1^tm1Dmer/Ifngr1^tm1Dmer Tg(Thy1-cre)1Vln/0 (B6.Cg-Ifngr1^tm1Dmer Tg(Thy1-cre)1Vln)	abnormal response to infection	J:202844
Ifngr2^tm1Pbro/Ifngr2^tm1Pbro (involves: 129S1/Sv)	abnormal class switch recombination	J:48016
	decreased susceptibility to type IV hypersensitivity reaction	J:48016
	increased susceptibility to bacterial infection	J:48016
Ifngr2^tm1Pbro/Ifngr2^tm1Pbro (NOD.129S1-Ifngr2^tm1Pbro)	abnormal cytotoxic T cell physiology	J:72818
	abnormal diapedesis	J:72818
	abnormal T-helper 2 physiology	J:65986
	decreased susceptibility to autoimmune diabetes	J:72818
Ifnk^{tm1.1(KOMP)Vlcg}/Ifnk^{tm1.1(KOMP)Vlcg} (C57BL/6NTac-Ifnk^{tm1.1(KOMP)Vlcg})	decreased susceptibility to chemically induced skin inflammation	J:322130
Ifnl3^em1Mtba/Ifnl3^em1Mtba (involves: C57BL/6)	abnormal circulating interferon level	J:287260
	increased susceptibility to Orthomyxoviridae infection	J:287260
	increased susceptibility to Riboviria infection	J:287260
	increased susceptibility to viral infection	J:287260
Ifnlr1^{tm1b(EUCOMM)Wtsi}/Ifnlr1^{tm1b(EUCOMM)Wtsi} (B6(Cg)-Ifnlr1^{tm1b(EUCOMM)Wtsi})	increased susceptibility to Orthomyxoviridae infection	J:287260
	increased susceptibility to Riboviria infection	J:287260
	increased susceptibility to viral infection	J:287260
Ifnlr1^tm1Palu/Ifnlr1^tm1Palu (B6.Cg-Ifnlr1^tm1Palu)	abnormal susceptibility to infection	J:131989
Igdcc4^em1Bcgen/Igdcc4^em1Bcgen (involves: C57BL/6J)	decreased susceptibility to Orthomyxoviridae infection	J:320015
Igdcc4^em1Bcgen/Igdcc4^em1Bcgen (involves: C57BL/6J)	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:320015
Igf1r^tm1Jcbr/Igf1r^tm1Jcbr Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (B6.Cg-Ndor1^{Tg(UBC-cre/ERT2)1Ejb} Igf1r^tm1Jcbr)	decreased susceptibility to type I hypersensitivity reaction	J:241924
Igf1r^tm2Arge/Igf1r^tm2Arge Tg(BGLAP-cre)1Clem/0 (involves: 129 * FVB/N)	abnormal osteoclast physiology	J:80190
Igfbp1^tm1Taub/Igfbp1^tm1Taub (involves: 129X1/SvJ * C57BL/6)	liver inflammation	J:81123
Igh-7^tm1.1Lam/Igh-7^tm1.1Lam (involves: BALB/c)	decreased IgE level	J:146733
Igh-7^tm1Gach/Igh-7^tm1Gach (BALB/c-Igh-7^tm1Gach)	abnormal B cell physiology	J:143266
Igh-7^tm1Gach/Igh-7^tm1Gach (BALB/c-Igh-7^tm1Gach)	increased IgE level	J:143266
Igh-7^tm1Lam/Igh-7^tm1Lam (involves: BALB/c)	decreased IgE level	J:146733
Igh-7^tm1Lcwu/Igh-7^tm1Lcwu (involves: C57BL/6)	decreased IgE level	J:161452
Igh-7^tm1Led/Igh-7^tm1Led (C.129S4-Igh-7^tm1Led)	impaired eosinophil recruitment	J:133373
Igh-7^tm1Led/Igh-7^tm1Led Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal circulating complement protein level	J:161523
	increased anti-double stranded DNA antibody level	J:161523
	increased anti-nuclear antigen antibody level	J:161523
	increased IgA level	J:161523
	increased IgM level	J:161523
Igh-8^tm1.1Aak/Igh-8^tm1.1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:171251
Igh-8^tm1Aak/Igh-8^tm1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:107063
Igh-8^tm1Schr/Igh-8^tm1Schr (involves: 129P2/OlaHsd * Black Swiss)	increased IgM level	J:49847
Igh-8^tm1Schr/Igh-8^tm1Schr (C.129P2(BKSW)-Igh-8^tm1Schr)	increased IgG level	J:75577
	increased IgM level	J:75577
	increased susceptibility to bacterial infection	J:75577
Igh-8^{tm2(Ighg1)Aak}/Igh-8^{tm2(Ighg1)Aak} (involves: 129S2/SvPas)	abnormal class switch recombination	J:130574
	decreased IgG3 level	J:130574
Igh-J^{tm1(CB20)Riho}/Igh-J⁺ (involves: C57BL/10 * DBA/1)	increased susceptibility to induced arthritis	J:179456
Igh-J^{tm1(CB20)Riho}/Igh-J^{tm1(CB20)Riho} (involves: C57BL/10 * DBA/1)	increased susceptibility to induced arthritis	J:179456
Igh-J^{tm1(Ighel)Cys}/Igh-J^{tm1(Ighel)Cys} Myd88^tm1Aki/Myd88^tm1Aki Igkj1^{tm1(IgkHyHEL10)Mnz}/0 (involves: 129P2/OlaHsd)	increased IgM level	J:115059
Igh-J^{tm1(VDJ-KL25)Zbz}/Igh-J⁺ (involves: C57BL/6 * C57BL/6J * BALB/cJ)	increased IgG level	J:86411
	increased IgM level	J:86411
Igh-J^{tm1(VDJ-VI10)Zbz}/Igh-J⁺ (involves: C57BL/6 * C57BL/6J * BALB/cJ)	abnormal immune serum protein physiology	J:86411
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave (Not Specified)	abnormal immunoglobulin level	J:179317
	decreased IgM level	J:155798
	increased IgG level	J:155798
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave Igk-J^tm1.1Lave/Igk-J^tm1.1Lave (Not Specified)	abnormal B cell clonal deletion	J:179317
	abnormal B cell physiology	J:205708
	abnormal immunoglobulin level	J:179317
Igh-J^tm1Aigl/Igh-J⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:111543
Igh-J^tm1Aigl/Igh-J⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased susceptibility to experimental autoimmune encephalomyelitis	J:111543
Igh-J^tm1Aigl/Igh-J⁺ Mog^tm1Dpd/Mog^tm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	CNS inflammation	J:151335
	increased susceptibility to experimental autoimmune encephalomyelitis	J:151335
Igh-J^tm1Aigl/Igh-J⁺ Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	CNS inflammation	J:151335
	increased susceptibility to experimental autoimmune encephalomyelitis	J:151335
Igh-J^tm1Aigl/Igh-J^tm1Aigl Tg(H2-K^b-Tcra,-Tcrb)1640Kurs/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N * SJL/J)	increased autoantibody level	J:149511
	increased susceptibility to experimental autoimmune encephalomyelitis	J:149511
Igh-J^tm1Dhu/Igh-J⁺ Il2^tm1Hor/Il2^tm1Hor (involves: 129/Sv * C57BL/6)	colitis	J:29999
Igh-J^tm1Dhu/Igh-J^tm1Dhu Il2^tm1Hor/Il2^tm1Hor (involves: 129/Sv * C57BL/6)	colitis	J:29999
Igh-J^tm1Dhu/Igh-J^tm1Dhu Wdr1^rede/Wdr1^rede (involves: 129S7/SvEvBrd * BALB/c * C57BL/6)	abnormal immune system physiology	J:134092
Igh-J^tm1Dim/Igh-J⁺ Igk-J^tm1Dim/Igk-J⁺ (involves: 129S4/SvJae * C57BL/6)	increased IgG level	J:107241
	increased IgM level	J:107241
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv (involves: 129P2/OlaHsd * C57BL/6)	decreased IgM level	J:70038
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:23827
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd * C57BL/6J)	abnormal immunoglobulin level	J:70620
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2BM)7Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2CM)2Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yHG1/2)1Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yHG4)1Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:23827
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
Igh-J^tm1Mcdl/Igh-J^tm1Mcdl Igk-J^tm1Mcdl/Igk-J^tm1Mcdl Rag1^tm1Mom/Rag1^tm1Mom Tg(DO11.10)10Dlo/? (involves: 129S/Sv * BALB/c * C3H * C57BL/6)	increased IgE level	J:100072
	increased IgG level	J:100072
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (involves: 129P2/OlaHsd BALB/c * C57BL/6)	increased anti-double stranded DNA antibody level	J:126940
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (involves: 129P2/OlaHsd BALB/c)	increased anti-double stranded DNA antibody level	J:131138
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (B6.129P2-Igh-J^{tm2(3H9-VDJ)Mwg})	increased anti-double stranded DNA antibody level	J:142389
Igh-J^{tm2.1(4E10)Lave}/Igh-J^{tm2.1(4E10)Lave} (involves: C57BL/6)	decreased IgG1 level	J:205708
	decreased IgG2b level	J:205708
	decreased IgG3 level	J:205708
	decreased IgG level	J:205708
	decreased IgM level	J:205708
Igh-J^{tm2.1(4E10)Lave}/Igh-J^{tm2.1(4E10)Lave} Igk-J^{tm2.1(4E10)Lave}/Igk-J^{tm2.1(4E10)Lave} (involves: C57BL/6)	abnormal B cell physiology	J:205708
Igh-J^{tm3(3H9-VDJ)Mwg}/Igh-J^{tm3(3H9-VDJ)Mwg} (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	increased anti-double stranded DNA antibody level	J:126940
Igh-J^{tm3.1(48d)Lave}/Igh-J^{tm3.1(48d)Lave} (involves: C57BL/6)	decreased IgG1 level	J:205708
	decreased IgG2b level	J:205708
	decreased IgM level	J:205708
Igh-V^tm1Jjk/Igh-V^tm1Jjk (involves: 129S4/SvJae * C57BL/6)	abnormal adaptive immunity	J:62284
Igh-V^tm1Jjk/Igh-V^tm1Jjk (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to bacterial infection	J:62284
Igh^deltaD/Igh⁺ (involves: C57BL/6 * DBA/2)	decreased immunoglobulin level	J:95981
Igh^deltaD/Igh^deltaD (involves: C57BL/6 * DBA/2)	abnormal immunoglobulin level	J:95981
	decreased IgG1 level	J:95981
	increased IgA level	J:95981
Igh^{tm1(Ighppc1-5)Cche}/Igh⁺ (B6.Cg-Igh^{tm1(Ighppc1-5)Cche})	increased autoantibody level	J:138356
Igh^tm1(Myc)Janz/Igh⁺ (involves: 129X1/SvJ * C57BL/6)	increased B cell apoptosis	J:96785
Igh^tm1(Myc)Janz/Igh⁺ (involves: 129X1/SvJ * C57BL/6)	increased B cell proliferation	J:96785
Igh^tm1(Myc)Janz/Igh⁺ Mdm4^tm1.1Wahl/Mdm4^tm1.1Wahl (involves: 129S/Sv * C57BL/6)	increased splenocyte proliferation	J:150341
Igh^{tm1.1(b12)Nemz}/Igh^{tm1.1(b12)Nemz} (involves: C57BL/6N * FVB/N)	decreased IgM level	J:205766
Igh^{tm1.1(b12)Nemz}/Igh^{tm1.1(b12)Nemz} Igk^{tm1.1(b12)Nemz}/Igk^{tm1.1(b12)Nemz} (involves: C57BL/6N * C57BL/6NTac * FVB/N)	decreased IgM level	J:205766
Igh^{tm1.1(Igh564)Tik}/Igh^{tm1.1(Igh564)Tik} Igk^{tm1(Igk564)Tik}/Igk^{tm1(Igk564)Tik} (B6.129S4-Igk^{tm1(Igk564)Tik} Igh^{tm1(Igh564)Tik})	glomerulonephritis	J:113555
Igh^{tm1.1(Rr361-HBB)Aak}/Igh^{tm1.1(Rr361-HBB)Aak} (129.129S2(Cg)-Igh^{tm1.1(Rr361-HBB)Aak})	abnormal class switch recombination	J:333279
	decreased IgA level	J:333279
	decreased IgE level	J:333279
	decreased IgG1 level	J:333279
	decreased IgG2a level	J:333279
	decreased IgG2b level	J:333279
Igh^tm1.1Hws/Igh^tm1.1Hws (BALB/cJ-Igh^tm1.1Hws)	decreased IgM level	J:119391
Igh^tm1.1Hws/Igh^tm1.1Hws (BALB/cJ-Igh^tm1.1Hws)	decreased immunoglobulin level	J:119391
Igh^tm1.1Hws/Igh^tm1.1Hws (involves: BALB/c)	increased IgG3 level	J:142069
Igh^tm1.1Hws/Igh^tm1.1Hws (involves: BALB/c)	increased IgM level	J:142069
Igh^tm1.1Rsky/Igh^tm1.1Rsky (BALB/c-Igh^tm1.1Rsky)	abnormal class switch recombination	J:125719
Igh^tm1.1Rsky/Igh^tm1.1Rsky (BALB/c-Igh^tm1.1Rsky)	decreased IgM level	J:125719
Igh^tm1.1Twin/Igh^tm1.1Twin (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal marginal zone B cell physiology	J:174233
	decreased IgG3 level	J:174233
	decreased IgG level	J:174233
	decreased IgM level	J:174233
Igh^tm1.1Vmd/Igh⁺ (involves: C57BL/6)	abnormal class switch recombination	J:201147
Igh^tm1.1Vmd/Igh^tm1.1Vmd (involves: C57BL/6)	abnormal class switch recombination	J:201147
	decreased IgG1 level	J:201147
	decreased IgG3 level	J:201147
	increased IgE level	J:201147
Igh^tm1.2Rsky/Igh⁺ (BALB/c-Igh^tm1.2Rsky)	increased IgG1 level	J:125719
Igh^tm1.2Rsky/Igh^tm1.2Rsky (BALB/c-Igh^tm1.2Rsky)	abnormal B cell activation	J:125719
	abnormal B cell proliferation	J:125719
	decreased IgA level	J:125719
	decreased IgD level	J:125719
	decreased IgE level	J:125719
	decreased IgM level	J:125719
	decreased immunoglobulin level	J:125719
Igh^tm1.2Rsky/Igh^tm1.2Rsky Tg(CD19-cre/ERT2)1Cgn/? (involves: BALB/c)	abnormal B cell activation	J:125719
	abnormal class switch recombination	J:125719
Igh^tm1Cog/Igh^tm1Cog (involves: 129S2/SvPas * C57BL/6)	decreased IgA level	J:80654
	decreased IgE level	J:80654
	decreased IgG1 level	J:80654
	decreased IgG2a level	J:80654
	decreased IgG2b level	J:80654
	decreased IgG3 level	J:80654
	decreased IgM level	J:80654
	decreased immunoglobulin level	J:80654
Igh^tm1Cys/Igh⁺ Tg(Igk)5Cys/0 (B6.Cg-Igh^tm1Cys Tg(Igk)5Cys)	abnormal B cell physiology	J:118931
Igh^tm1Ktom/Igh^tm1Ktom (involves: ICR)	abnormal B cell physiology	J:59894
Igh^tm1Ktom/Igh^tm1Ktom (involves: ICR)	abnormal immunoglobulin level	J:178635
Igh^tm1Ktom/Igh^tm1Ktom Igk^tm1Ktom/Igk^tm1Ktom Tc(HSA14)SC20Ktom/0 Tc(HSA2)W23Ktom/0 (involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)	abnormal B cell physiology	J:59894
Igh^tm1Ktom/Igh^tm1Ktom Tc(HSA2)W23Ktom/0 (involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)	abnormal B cell physiology	J:59894
Igh^tm1Mnz/Igh^tm1Mnz (B6.129P2-Igh^tm1Mnz)	abnormal B cell physiology	J:75653
	increased B cell apoptosis	J:75653
	increased B cell proliferation	J:75653
	increased IgG level	J:75653
	increased IgM level	J:75653
Igh^tm1Mnz/Igh^tm1Mnz Dis3^tm1.1Uba/Dis3^tm1.1Uba Aicda^tm1(cre)Uba/Aicda⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:302856
Igh^tm1Mnz/Igh^tm1Mnz Lyn^tm1Sor/Lyn^tm1Sor (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal B cell physiology	J:75653
	increased B cell proliferation	J:75653
Igh^tm1Rbr/Igh⁺ Tg(IgkHyHEL10)1Rbr/0 (involves: C57BL/6)	increased IgA level	J:132538
	increased IgG1 level	J:132538
	increased IgG2a level	J:132538
	increased IgG2b level	J:132538
	increased IgG3 level	J:132538
	increased IgM level	J:132538
	increased immunoglobulin level	J:132538
Igh^tm1Rbr/Igh⁺ Tg(IgkHyHEL10)1Rbr/0 Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6 * C57BL/6JSfd)	abnormal B cell anergy	J:132538
Igh^{tm2.1(4E10)Nemz}/Igh^{tm2.1(4E10)Nemz} Igk^{tm2.1(4E10)Nemz}/Igk^{tm2.1(4E10)Nemz} (involves: C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)	decreased IgG level	J:101977
	decreased IgM level	J:101977
Igh^tm2.1Fwa/Igh^tm2.1Fwa (involves: 129S/SvEv * C57BL/6)	abnormal class switch recombination	J:161437
	abnormal somatic hypermutation frequency	J:161437
	decreased IgG1 level	J:161437
	increased IgE level	J:161437
Igh^tm2.1Hws/Igh^tm2.1Hws (involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)	abnormal humoral immune response	J:124421
	decreased IgG level	J:124421
	decreased IgM level	J:124421
Igh^tm2.1Hws/Igh^tm2.1Hws (involves: BALB/c)	decreased IgM level	J:142069
Igh^tm2.1Hws/Igh^tm2.1Hws (involves: BALB/c)	increased anti-nuclear antigen antibody level	J:142069
Igh^tm2Cgn/Igh⁺ Igk^tm2Rsky/Igk⁺ (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:150435
Igh^tm2Cgn/Igh⁺ Igk^tm2Rsky/Igk⁺ Prkdc^scid/Prkdc^scid (involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)	abnormal class switch recombination	J:150435
Igh^tm2Cgn/Igh⁺ Rr158^tm1Cgn/Rr158^tm1Cgn Arhgef1^tm1.1Rmt/Arhgef1^tm1.1Rmt (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:113295
Igh^tm2Cgn/Igh^tm2Cgn Igk^tm1Rsky/Igk^tm1Rsky Lig4^tm1Fwa/Lig4^tm1Fwa Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Igh^tm2Cgn/Igh^tm2Cgn Igk^tm1Rsky/Igk^tm1Rsky Trp53^tm1Tyj/Trp53^tm1Tyj Xrcc4^tm1Fwa/Xrcc4^tm1Fwa (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Igh^tm2Cog/Igh⁺ (involves: 129S2/SvPas * C57BL/6)	decreased IgG1 level	J:90548
	decreased IgG2b level	J:90548
	decreased IgG3 level	J:90548
	decreased IgG level	J:90548
Igh^tm2Cog/Igh^tm2Cog (involves: 129S2/SvPas * C57BL/6)	decreased IgG1 level	J:90548
	decreased IgG2a level	J:90548
	decreased IgG2b level	J:90548
	decreased IgG3 level	J:90548
	decreased IgG level	J:90548
Igh^tm2Mnz/Igh^tm2Mnz (B6.129P2-Igh^tm2Mnz)	increased B cell proliferation	J:75653
	increased IgG level	J:75653
	increased IgM level	J:75653
Igh^tm2Mnz/Igh^tm2Mnz Lyn^tm1Sor/Lyn^tm1Sor (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal B cell physiology	J:75653
	increased B cell proliferation	J:75653
Igh^tm3.1Cog/Igh^tm3.1Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal class switch recombination	J:71300
	decreased IgA level	J:71300
	decreased IgE level	J:71300
	decreased IgG2a level	J:71300
	decreased IgG2b level	J:71300
	decreased IgG3 level	J:71300
	decreased IgG level	J:71300
	decreased immunoglobulin level	J:71300
Igh^tm3Cgn/Igh^tm3Cgn (involves: C57BL/6)	abnormal immune system physiology	J:76117
Igh^tm3Hws/Igh^tm3Hws (involves: BALB/c)	abnormal immunoglobulin level	J:142069
	decreased IgG1 level	J:142069
	decreased IgG2a level	J:142069
	decreased IgG2b level	J:142069
	decreased IgM level	J:142069
	increased IgM level	J:142069
Igh^tm4.1Cog/Igh^tm4.1Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal class switch recombination	J:184094
	decreased IgA level	J:184094
	increased IgM level	J:184094
Igh^tm4Cog/Igh⁺ (involves: 129S2/SvPas * C57BL/6)	decreased IgM level	J:109988
Igh^tm4Cog/Igh⁺ (involves: 129S2/SvPas * C57BL/6)	increased IgA level	J:109988
Igh^tm5.1Cgn/Igh^tm5.1Cgn (BALB/c-Igh^tm5.1Cgn)	abnormal B cell activation	J:88472
Igh^tm5.1Cog/Igh^tm5.1Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:164513
	abnormal somatic hypermutation frequency	J:164513, J:333348
	decreased IgA level	J:164513
	decreased IgE level	J:164513
	decreased IgG2b level	J:164513
	decreased IgG3 level	J:164513
	decreased IgM level	J:164513
Igh^{tm7(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^{tm8(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^{tm9(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^tm12Cgn/Igh^tm12Cgn (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:66031
Igha^tm1(Myc)Janz/Igha⁺ (involves: 129S1/Sv * C57BL/6)	increased B cell apoptosis	J:90901
Igha^tm1(Myc)Janz/Igha⁺ (involves: 129S1/Sv * C57BL/6)	increased B cell proliferation	J:90901
Igha^tm1(Myc)Janz/Igha⁺ Tg(Igk-V21-Bax)1967Bvn/0 (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal B cell apoptosis	J:90901
	increased IgG level	J:90901
	increased IgM level	J:90901
Igha^tm1Grh/Igha^tm1Grh (involves: 129S7/SvEvBrd * C57BL/6)	abnormal dendritic cell physiology	J:125472
	abnormal immunoglobulin level	J:125472
	abnormal memory T cell physiology	J:125472
	abnormal T cell activation	J:53217
	decreased IgA level	J:53217, J:125472
	decreased IgE level	J:53217
	decreased IgG3 level	J:53217
	decreased interferon-gamma secretion	J:53217
	decreased T cell proliferation	J:125472
	increased IgG1 level	J:53217, J:125472
	increased IgG2a level	J:53217
	increased IgG2b level	J:53217
	increased IgG level	J:53217
	increased IgM level	J:53217, J:125472
	increased interferon-gamma secretion	J:125472
	increased interleukin-4 secretion	J:53217
	increased susceptibility to Orthomyxoviridae infection	J:125472
Igha^tm1Grh/Igha^tm1Grh (involves: 129 * C57BL/6)	increased susceptibility to parasitic infection	J:140515, J:74568
Igha^tm2Grh/Igha^tm2Grh (involves: 129S7/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:72521
Ighd^dmit/Ighd^dmit (C57BL/6JAnu-Ighd^dmit/AnuApb)	abnormal immunoglobulin level	J:104190
Ighd^M1Btlr/Ighd^M1Btlr (C57BL/6J-Ighd^M1Btlr)	decreased IgD level	J:255202
Ighd^m2Btlr/Ighd^m2Btlr (C57BL/6J-Ighd^m2Btlr)	decreased IgD level	J:255203
Ighd^tm1Cgn/Ighd^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:64281
Ighd^tm1Cgn/Ighd^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased IgE level	J:64281
Ighd^tm1Lam/Ighd^tm1Lam (involves: 129S2/SvPas * C57BL/6)	abnormal B cell physiology	J:111020
	decreased IgG2b level	J:111020
	increased IgA level	J:111020
Ighe^M1Btlr/Ighe^M1Btlr (C57BL/6J-Ighe^M1Btlr)	decreased IgE level	J:267480
Ighg1^em1Wliu/Ighg1^em1Wliu (C57BL/6-Ighg1^em1Wliu)	enhanced humoral immune response	J:266937
	increased anti-double stranded DNA antibody level	J:266937
	increased anti-nuclear antigen antibody level	J:266937
	increased autoantibody level	J:266937
	increased IgG1 level	J:266937
Ighg1^tm1(cre)Cgn/Ighg1⁺ Irf4^tm1Rdf/Irf4^tm1.1Rdf (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal class switch recombination	J:112643
	decreased IgG1 level	J:112643
Ighg1^tm1(cre)Cgn/Ighg1⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: 129P2/OlaHsd * C57BL/6NTac)	abnormal somatic hypermutation frequency	J:308792
	increased IgM level	J:308792
Ighg1^tm1.1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
Ighg1^tm1.1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG1 level	J:39568
Ighg1^tm1.1Ksho/Ighg1^tm1.1Ksho (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
	decreased IgG1 level	J:39568
Ighg1^tm1.1Pyu/Ighg1⁺ (B6.C(Cg)-Ighg1^tm1.1Pyu)	decreased IgG1 level	J:198154
	decreased IgG2c level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
	increased susceptibility to type I hypersensitivity reaction	J:198154
Ighg1^tm1.1Pyu/Ighg1^tm1.1Pyu (B6.C(Cg)-Ighg1^tm1.1Pyu)	decreased IgG1 level	J:198154
	decreased IgG2c level	J:198154
	increased IgE level	J:198154
	increased IgG2a level	J:198154
	increased IgG2b level	J:198154
	increased susceptibility to type I hypersensitivity reaction	J:198154
Ighg1^tm1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
Ighg1^tm1Ksho/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG1 level	J:39568
Ighg1^tm1Ksho/Ighg1^tm1Ksho (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:39568
	decreased IgG1 level	J:39568
Ighg1^tm2Cgn/Ighg1⁺ ((C57BL/6 x 129P2/OlaHsd)F1)	abnormal class switch recombination	J:146428
Ighg1^tm2Cgn/Ighg1⁺ ((C57BL/6 x 129P2/OlaHsd)F1)	decreased IgG1 level	J:146428
Ighg1^tm3Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal class switch recombination	J:166887
	decreased IgG1 level	J:166887
Ighm^tm1(Bcl6)Rdf/? (involves: 129/Sv * C57BL/6)	abnormal B cell proliferation	J:98937
Ighm^tm1(Bcl6)Rdf/? (involves: 129/Sv * C57BL/6)	decreased immunoglobulin level	J:98937
Ighm^{tm1.1(IGH-2)Cog}/Ighm^{tm1.1(IGH-2)Cog} (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased B cell proliferation	J:157575
	decreased IgA level	J:157575
	decreased IgG1 level	J:157575
	decreased IgG2a level	J:157575
	decreased IgG3 level	J:157575
	decreased IgG level	J:157575
	decreased IgM level	J:157575
	increased B cell proliferation	J:157575
Ighm^tm1.1Aak/Ighm^tm1.1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:171251
Ighm^tm1Bhe/Ighm^tm1Bhe (C.Cg-Ighm^tm1Bhe)	abnormal complement pathway	J:177421
	abnormal immune serum protein physiology	J:177421
	impaired complement classical pathway	J:177421
Ighm^tm1Cgn/Ighm⁺ (NOD.129S2-Ighm^tm1Cgn)	increased susceptibility to autoimmune diabetes	J:37287
Ighm^tm1Cgn/Ighm⁺ Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0 (NOD.Cg-Ighm^tm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)	increased susceptibility to autoimmune diabetes	J:91865
	insulitis	J:91865
Ighm^tm1Cgn/Ighm⁺ Tg(Igh-6/Igh-V281)3Jwt/0 (NOD.Cg-Ighm^tm1Cgn Tg(Igh-6/Igh-V281)3Jwt)	insulitis	J:91865
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	abnormal response to infection	J:119344
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	decreased IgM level	J:64298
Ighm^tm1Cgn/Ighm^tm1Cgn (NODCaj.129S2-Ighm^tm1Cgn)	insulitis	J:93190
Ighm^tm1Cgn/Ighm^tm1Cgn (NOD.129S2-Ighm^tm1Cgn)	decreased susceptibility to autoimmune diabetes	J:37287
Ighm^tm1Cgn/Ighm^tm1Cgn (B6.129S2-Ighm^tm1Cgn/J)	abnormal cytokine secretion	J:118565
	abnormal humoral immune response	J:119584
	decreased IgE level	J:125656
	decreased IgG1 level	J:125656
	decreased IgG level	J:119584, J:125656
	decreased immunoglobulin level	J:119584
	increased susceptibility to parasitic infection	J:74568
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas)	abnormal antigen presentation	J:112160
	abnormal CD4-positive, alpha-beta T cell physiology	J:112160
	decreased IgA level	J:157450
	decreased IgG level	J:157450
	decreased susceptibility to type IV hypersensitivity reaction	J:112160
	decreased T cell proliferation	J:112160
	increased susceptibility to induced arthritis	J:157619
	increased susceptibility to parasitic infection	J:163761
Ighm^tm1Cgn/Ighm^tm1Cgn (NOD.129S2-Ighm^tm1Cgn/DvsJ)	abnormal T cell proliferation	J:80859
Ighm^tm1Cgn/Ighm^tm1Cgn (NOD.129S2-Ighm^tm1Cgn/DvsJ)	decreased susceptibility to autoimmune diabetes	J:80859
Ighm^tm1Cgn/Ighm^tm1Cgn Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129)	decreased IgG level	J:130864
	decreased IgM level	J:130864
Ighm^tm1Cgn/Ighm^tm1Cgn Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0 (NOD.Cg-Ighm^tm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)	insulitis	J:91865
Ighm^tm1Cgn/Ighm^tm1Cgn Tg(Igh-6/Igh-V281)3Jwt/0 (NOD.Cg-Ighm^tm1Cgn Tg(Igh-6/Igh-V281)3Jwt)	insulitis	J:91865
Ighm^tm1Cgn/Ighm^tm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/? (NODCaj.Cg-Ighm^tm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ)	increased susceptibility to autoimmune diabetes	J:93190
Ighm^tm1Cgn/Ighm^tm1Cgn Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (NOD.Cg-Ighm^tm1Cgn Tg(IghelMD4)4Ccg/DvsJ)	abnormal B lymphocyte antigen presentation	J:80859
	abnormal T cell proliferation	J:80859
	decreased susceptibility to autoimmune diabetes	J:80859
	insulitis	J:80859
Ighm^tm1Cgn/Ighm^tm1Cgn Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * C57BL/6 * CF-1)	abnormal inflammatory response	J:99033
Ighm^tm1Cgn/Ighm^tm1Cgn Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)	small intestinal inflammation	J:108572
Ighm^tm1Cgn/Ighm^tm1Cgn Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased inflammatory response	J:181257
	kidney inflammation	J:181257
	myocarditis	J:181257
	tubular nephritis	J:181257
Ighm^tm1Cgn/Ighm^tm1Cgn X/Yaa (BXSB.129S2(B6)-Ighm^tm1Cgn/Dcr)	decreased susceptibility to systemic lupus erythematosus	J:206236
Ighm^tm1Che/Ighm^tm1Che (involves: 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:47425
	abnormal follicular dendritic cell antigen presentation	J:47425
	abnormal humoral immune response	J:47425
	abnormal immune system physiology	J:47425
	decreased IgG1 level	J:47425
	decreased IgG2b level	J:47425
	decreased IgM level	J:47425
	increased IgA level	J:47425
	increased IgG2a level	J:47425
	increased IgG3 level	J:47425
Ighm^tm1Che/Ighm^tm1Che (involves: 129 * C57BL/6)	increased susceptibility to parasitic infection	J:74568
Ighm^tm1Fbb/Ighm^tm1Fbb (involves: BALB/cJ)	increased susceptibility to Riboviria infection	J:57600
Ighm^tm1Msn/Ighm⁺ (involves: 129S/SvEv)	decreased IgM level	J:49405
Ighm^tm1Msn/Ighm^tm1Msn (involves: 129S/SvEv)	decreased IgG1 level	J:49405
	decreased IgM level	J:49405
	increased IgG3 level	J:49405
Ighm^tm1Msn/Ighm^tm1Msn (involves: 129S/SvEv * C57BL/6)	increased anti-double stranded DNA antibody level	J:111817
	increased autoantibody level	J:111817
	kidney inflammation	J:111817
Ighm^tm1Msn/Ighm^tm1Msn (B6.129S-Ighm^tm1Msn)	decreased IgM level	J:80656
Ighm^tm1Msn/Ighm^tm1Msn Tg(Igh-6)1Msn/? (B6.129S-Ighm^tm1Msn)	decreased IgM level	J:80656
Ighm^tm1Sls/Ighm^tm1Sls (Not Specified)	abnormal class switch recombination	J:99465
	decreased IgG1 level	J:99465
	decreased IgG2b level	J:99465
	decreased IgG3 level	J:99465
	decreased IgG level	J:99465
	increased IgM level	J:99465
Ighm^tm2.1Bgmn/Ighm^tm2.1Bgmn (involves: 129/Sv * C57BL/6 * CBA)	abnormal immune system physiology	J:118453
	decreased immunoglobulin level	J:118453
Ighm^tm3Bgmn/Ighm^tm3Bgmn (involves: 129)	abnormal B cell activation	J:131633
	decreased B cell proliferation	J:131633
	decreased IgM level	J:131633
Ighm^tm3Bgmn/Ighm^tm3Bgmn Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd * 129/Sv)	decreased IgG level	J:130864
	decreased IgM level	J:130864
Ighm^tm4Bgmn/Ighm^tm4Bgmn (involves: 129)	abnormal B cell activation	J:131633
	decreased B cell proliferation	J:131633
	decreased IgM level	J:131633
Igk-J^tm1Cog/Igk-J^tm1Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:110100
Igk^tm1Dhu/Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0 (C.Cg-Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)	arthritis	J:209872
Igk^tm1Dhu/Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0 (C.Cg-Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)	decreased susceptibility to autoimmune disorder	J:209872
Igkc^tm1(IGKC)Mnz/Rr166^tm4.1Wtg (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:193015
	abnormal immunoglobulin level	J:193015
Igkc^tm1Bgmn/Igkc^tm1Bgmn (involves: 129P2/OlaHsd)	abnormal humoral immune response	J:28868
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd)	decreased IgG level	J:130864
	decreased IgM level	J:130864
Igkc^tm1Jkbv/Igkc^tm1Jkbv (Not Specified)	abnormal immunoglobulin level	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:137738
Igkrs^tm1Nemz/Igkrs^tm1Nemz Tg(BCL2)22Wehi/? (involves: 129 * C57BL)	increased anti-double stranded DNA antibody level	J:132125
Igkrs^tm1Nemz/Igkrs^tm1Nemz Tg(UBC-scFv)2Nemz/? (involves: 129 * C57BL/6 * DBA/2)	abnormal B cell clonal deletion	J:132125
Igll1^tm1Cgn/Igll1^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	decreased IgG1 level	J:64284
	decreased IgG2b level	J:64284
	decreased IgG3 level	J:64284
	decreased IgG level	J:64284
Ignpq1^BALB/cAJcl/Ignpq1^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Ignpq1^HIGA/Nsc/Ignpq1^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Ignpq2^BALB/cAJcl/Ignpq2^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Ignpq2^HIGA/Nsc/Ignpq2^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	increased IgA level	J:116904
Ignpq3^BALB/cAJcl/Ignpq3^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	glomerulonephritis	J:116904
Ignpq3^HIGA/Nsc/Ignpq3^HIGA/Nsc (involves: BALB/cAJcl * HIGA/Nsc)	glomerulonephritis	J:116904
Igs2^{tm1(CAG-Ptgs2os)Scrp}/Igs2^{tm1(CAG-Ptgs2os)Scrp} (involves: C57BL/6)	abnormal circulating cytokine level	J:325487
	increased circulating interleukin-10 level	J:325487
Igtp^em1Myam/Igtp^em1Myam Irgm1^em1Myam/Irgm1^em1Myam (C57BL/6-Irgm1^em1Myam Igtp^em1Myam)	increased susceptibility to parasitic infection	J:308470
Igtp^em1Myam/Igtp^em1Myam Irgm1^em1Myam/Irgm1^em1Myam Irgm2^em2Myam/Irgm2^em2Myam (C57BL/6-Irgm1^em1Myam Igtp^em1Myam Irgm2^em2Myam)	increased susceptibility to parasitic infection	J:308470
Igtp^tm1Gvw/Igtp^tm1Gvw (involves: 129S1/Sv * C57BL/6)	increased circulating interferon-gamma level	J:59891
	increased circulating interleukin-12b level	J:59891
	increased susceptibility to parasitic infection	J:99144, J:59891
Iigp1^tm1.1Jcho/Iigp1^tm1.1Jcho (involves: C57BL/6)	increased susceptibility to parasitic infection	J:135070
Ikbip^em1Bcgen/Ikbip^em1Bcgen Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal cytokine level	J:282971
	decreased macrophage cytokine production	J:282971
	increased circulating interleukin-6 level	J:282971
	increased circulating tumor necrosis factor level	J:282971
	increased susceptibility to bacterial infection induced morbidity/mortality	J:282971
	increased susceptibility to induced colitis	J:282971
	lung inflammation	J:282971
Ikbkb^em1Macc/Ikbkb⁺ (involves: C57BL/6NCrl)	abnormal T cell activation	J:290616
Ikbkb^em1Macc/Ikbkb^em1Macc (involves: C57BL/6NCrl)	abnormal T cell activation	J:290616
Ikbkb^M1Btlr/Ikbkb⁺ (C57BL/6J-Ikbkb^M1Btlr)	abnormal B cell physiology	J:225271
	abnormal response to infection	J:225271
	increased response to antigen	J:225271
Ikbkb^M1Btlr/Ikbkb^M1Btlr (C57BL/6J-Ikbkb^M1Btlr)	abnormal B cell physiology	J:225271
Ikbkb^M1Btlr/Ikbkb^M1Btlr (C57BL/6J-Ikbkb^M1Btlr)	increased susceptibility to viral infection	J:225271
Ikbkb^tm1.1Cgn/Ikbkb^tm1.1Cgn (involves: C57BL/6)	decreased interleukin-6 secretion	J:79132, J:85810
Ikbkb^tm1Cgn/Ikbkb^tm1Cgn Il20ra^tm1Rsab/Il20ra^tm1Rsab Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * DBA/2)	skin inflammation	J:208995
Ikbkb^tm1Cgn/Ikbkb^tm1Cgn Il22^tm1Jcrd/Il22^tm1Jcrd Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * DBA/2)	skin inflammation	J:208995
Ikbkb^tm1Cgn/Ikbkb^tm1Cgn Il22ra1^tm1Rsab/Il22ra1^tm1Rsab Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * DBA/2)	skin inflammation	J:208995
Ikbkb^tm1Cgn/Ikbkb^tm1Cgn Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * DBA/2)	skin inflammation	J:208995
Ikbkb^tm1Cgn/Ikbkb^tm1Cgn Tnfrsf1a^tm2Gkl/Tnfrsf1a^tm2Gkl Tg(KRT14-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	skin inflammation	J:208995
Ikbkb^tm1Lex/Ikbkb^tm1Lex Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEvBrd)	impaired macrophage chemotaxis	J:159873
	impaired neutrophil chemotaxis	J:159873
	impaired neutrophil recruitment	J:159873
Ikbkb^tm2.1Cgn/Ikbkb^tm2.1Cgn (involves: C57BL/6)	decreased interleukin-6 secretion	J:79132
Ikbkb^tm2Cgn/Ikbkb^tm2.1Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal humoral immune response	J:85810
	decreased IgE level	J:85810
Ikbkb^tm2Mka/Ikbkb^tm2.1Mka Tg(Vil-cre)1Mka/0 (involves: 129/Sv * C57BL/6)	decreased acute inflammation	J:83313
	decreased circulating tumor necrosis factor level	J:83313
	impaired neutrophil recruitment	J:83313
Ikbkb^tm2Mka/Ikbkb^tm2Mka Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd)	increased macrophage apoptosis	J:80159
Ikbke^tm1Tman/Ikbke^tm1Tman (B6.Cg-Ikbke^tm1Tman)	increased susceptibility to Orthomyxoviridae infection	J:119791
Ikbke^tm1Tman/Ikbke^tm1Tman (B6.Cg-Ikbke^tm1Tman)	lung inflammation	J:119791
Ikbkg^m1Btlr/Y (C57BL/6J-Ikbkg^m1Btlr)	decreased tumor necrosis factor secretion	J:139558
Ikbkg^tm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal NK cell physiology	J:151485
	abnormal NK T cell physiology	J:151485
	increased interferon-gamma secretion	J:151485
	liver inflammation	J:151485
Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal NK cell physiology	J:151485
	abnormal NK T cell physiology	J:151485
	increased circulating tumor necrosis factor level	J:151485
	increased interferon-gamma secretion	J:151485
	liver inflammation	J:151485
Ikbkg^tm1.1Dwat/Y Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	liver inflammation	J:202106
Ikbkg^tm1.1Mpa/Y Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased T cell apoptosis	J:85810
Ikbkg^tm1.1Mpa/Y Tg(Vil1-cre)997Gum/0 (B6.Cg-Ikbkg^tm1.1Mpa Tg(Vil1-cre)997Gum)	colitis	J:175865
Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	abnormal cytokine secretion	J:118336
	abnormal inflammatory response	J:118336
	increased susceptibility to endotoxin shock	J:137861
	liver inflammation	J:118336
Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Tg(Vil1-cre)997Gum/0 (B6.Cg-Ikbkg^tm1.1Mpa Tg(Vil1-cre)997Gum)	colitis	J:175865
Ikbkg^tm1Dwb/Ikbkg^tm1Dwb (Not Specified)	abnormal chemokine secretion	J:136353
	abnormal humoral immune response	J:136353
	decreased interleukin-6 secretion	J:136353
	decreased interleukin-12b secretion	J:136353
	decreased susceptibility to endotoxin shock	J:136353
	decreased tumor necrosis factor secretion	J:136353
Ikbkg^tm1Mak/Y (involves: 129P2/OlaHsd * C57BL/6)	increased interleukin-6 secretion	J:61666
Ikbkg^tm1Mka/Ikbkg⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	erythroderma	J:63054
Ikbkg^tm1Mpa/Y (involves: C57BL/6)	decreased interleukin-6 secretion	J:63055
Ikbkg^tm1Mpa/Y (involves: C57BL/6)	decreased tumor necrosis factor secretion	J:63055
Ikbkg^tm1Mpa/Ikbkg⁺ (involves: C57BL/6)	skin inflammation	J:63055
Ikzf1^m1Btlr/Ikzf1^m1Btlr (C57BL/6J-Ikzf1^m1Btlr)	abnormal natural killer cell mediated cytotoxicity	J:265249
	enhanced humoral immune response	J:265249
	increased IgG level	J:265249
	increased response to antigen	J:265249
Ikzf1^tm1Kast/Ikzf1^tm1Kast (involves: 129S2/SvPas)	abnormal B cell activation	J:82813
	decreased B cell proliferation	J:82813
	decreased IgG3 level	J:82813
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal thymocyte activation	J:29355
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell proliferation	J:29355
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * BALB/c)	abnormal thymocyte activation	J:29355
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * BALB/c)	increased T cell proliferation	J:29355
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to bacterial infection	J:20671
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * C57BL/6)	lung inflammation	J:20671
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * BALB/c)	increased susceptibility to bacterial infection	J:20671
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * BALB/c)	lung inflammation	J:20671
Ikzf1^tm2Kge/Ikzf1^tm2Kge (involves: 129S4/SvJae)	increased T cell proliferation	J:37317
Ikzf1^tm3Kge/Ikzf1^tm3Kge Tg(CD2-icre)4Kio/? (involves: C57BL/10 * CBA/Ca)	abnormal B cell physiology	J:209927
Ikzf1^tm3Kge/Ikzf1^tm3Kge Tg(CD19-cre/ERT2)1Cgn/? (Not Specified)	abnormal B cell apoptosis	J:209927
Ikzf2^tm1.1Etms/Ikzf2^tm1.1Etms Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal regulatory T cell physiology	J:160098
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * C57BL/6)	abnormal type III hypersensitivity reaction	J:81805
	autoimmune response	J:81805
	decreased IgG2b level	J:50626
	decreased IgG3 level	J:50626
	decreased IgM level	J:50626
	glomerulonephritis	J:81805
	increased anti-double stranded DNA antibody level	J:81805
	increased anti-histone antibody level	J:81805
	increased anti-nuclear antigen antibody level	J:81805
	increased anti-single stranded DNA antibody level	J:81805
	increased autoantibody level	J:81805, J:50626
	increased B cell proliferation	J:50626
	increased IgE level	J:50626
	increased IgG1 level	J:50626
	increased IgG2a level	J:50626
	increased T cell proliferation	J:50626
Ikzf4^tm1.1Etms/Ikzf4^tm1.1Etms (Not Specified)	chronic inflammation	J:294549
	decreased T cell proliferation	J:295208
	increased susceptibility to experimental autoimmune encephalomyelitis	J:295208
Ikzf4^tm1Djr/Ikzf4^tm1Djr Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	chronic inflammation	J:294549
Il1a^tm1Yiw/Il1a^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating interleukin-1 alpha level	J:47429
	decreased interleukin-1 beta secretion	J:47429
Il1a^tm1Yiw/Il1a^tm1Yiw Il1b^tm1Yiw/Il1b^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating interleukin-1 alpha level	J:47429
	decreased circulating interleukin-1 beta level	J:47429
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:165513
	decreased susceptibility to type IV hypersensitivity reaction	J:165513
Il1a^tm1Yiw/Il1a^tm1Yiw Il1b^tm1Yiw/Il1b^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	impaired neutrophil recruitment	J:50775
Il1a^tm1Yiw/Il1a^tm1Yiw Il1b^tm1Yiw/Il1b^tm1Yiw Tg(KRT14-CASP1)1Miz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	dermatitis	J:78602
Il1a^tm1Yiw/Il1a^tm1Yiw Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:191055
Il1b^tm1Dch/Il1b^tm1Dch (involves: 129S2/SvPas)	decreased interleukin-1 beta secretion	J:33465
	decreased susceptibility to type IV hypersensitivity reaction	J:33465
	increased susceptibility to bacterial infection	J:112400
Il1b^tm1Lvp/Il1b^tm1Lvp (involves: 129S7/SvEvBrd * C57BL/6)	abnormal interleukin-6 secretion	J:27234
	abnormal lymphocyte physiology	J:67001
	decreased acute inflammation	J:27234
	decreased circulating interleukin-1 beta level	J:27234
	decreased inflammatory response	J:27234
	decreased interferon-gamma secretion	J:67001
	decreased interleukin-2 secretion	J:67001
	decreased interleukin-4 secretion	J:67001
	decreased susceptibility to experimental autoimmune myasthenia gravis	J:67001
Il1b^tm1Lvp/Il1b^tm1Lvp (involves: 129S7/SvEvBrd)	abnormal macrophage physiology	J:136368
	decreased interleukin-1 beta secretion	J:136368
	decreased susceptibility to Togaviridae infection	J:52841
	decreased susceptibility to Togaviridae infection induced morbidity/mortality	J:52841
	decreased susceptibility to viral infection	J:135243
	decreased tumor necrosis factor secretion	J:82394
	increased susceptibility to bacterial infection induced morbidity/mortality	J:136368
Il1b^tm1Yiw/Il1b^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased circulating interleukin-1 beta level	J:47429
Il1r1^em1Qizh/Il1r1^em1Qizh (C57BL/6-Il1r1^em1Qizh)	increased circulating interleukin-6 level	J:338375
	increased circulating tumor necrosis factor level	J:338375
	increased susceptibility to induced arthritis	J:338375
Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129 * C57BL/6)	decreased circulating interleukin-6 level	J:43088
	increased susceptibility to bacterial infection	J:58851
	osteomyelitis	J:58851
Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129S7/SvEvBrd)	abnormal neutrophil physiology	J:113110
Il1r1^tm1Imx/Il1r1^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	abnormal neutrophil physiology	J:112999
	decreased susceptibility to experimental autoimmune uveoretinitis	J:115094
Il1r1^tm1Imx/Il1r1^tm1Imx (B6.129S7-Il1r1^tm1Imx/J)	decreased circulating interleukin-6 level	J:125570
	decreased circulating interleukin-18 level	J:125570
	decreased interleukin-6 secretion	J:148779, J:125570
	decreased tumor necrosis factor secretion	J:125570
	increased circulating interleukin-1 beta level	J:125570
	increased circulating interleukin-18 level	J:125570
	increased susceptibility to bacterial infection	J:125570
	increased susceptibility to bacterial infection induced morbidity/mortality	J:125570
	increased susceptibility to induced arthritis	J:125570
	sepsis	J:125570
Il1r1^tm1Imx/Il1r1^tm1Imx Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	abnormal chemokine level	J:126652
	decreased interleukin-6 secretion	J:115094
	decreased susceptibility to experimental autoimmune uveoretinitis	J:115094
	impaired neutrophil recruitment	J:126652
	increased susceptibility to bacterial infection	J:58851
	interstitial pneumonia	J:126652
	lung inflammation	J:126652
	osteomyelitis	J:58851
Il1r1^tm1Imx/Il1r1^tm1Imx Vsig4^tm1Gne/Vsig4^tm1Gne (B6.Cg-Il1r1^tm1Imx Vsig4^tm1Gne)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:281762
	increased susceptibility to induced colitis	J:281762
Il1r1^tm1Quan/Il1r1^tm1Quan (involves: C57BL/6)	abnormal inflammatory response	J:219864
Il1r1^tm1Quan/Il1r1^tm1Quan (involves: C57BL/6)	abnormal microglial cell activation	J:219864
Il1r1^tm1Quan/Il1r1^tm1Quan Lyz2^tm1(cre)Ifo/Lyz2^tm1(cre)Ifo (involves: 129P2/OlaHsd * C57BL/6)	abnormal inflammatory response	J:219864
	abnormal microglial cell activation	J:219864
Il1r1^tm1Quan/Il1r1^tm1Quan Tg(Tek-cre)12Flv/0 (involves: C3H * C57BL/6)	abnormal inflammatory response	J:219864
	abnormal microglial cell activation	J:219864
Il1r1^tm1Roml/Il1r1^tm1Roml (involves: 129S1/Sv * C57BL/6)	decreased circulating interleukin-6 level	J:42373
	decreased circulating serum amyloid protein level	J:42373
	decreased interleukin-6 secretion	J:42373
	decreased susceptibility to type IV hypersensitivity reaction	J:42373
	increased susceptibility to bacterial infection	J:42373
Il1r1^tm1Roml/Il1r1^tm1Roml (NOD.Cg-Il1r1^tm1Roml)	decreased susceptibility to autoimmune diabetes	J:87251
Il1r1^tm1Roml/Il1r1^tm1Roml (C.Cg-Il1r1^tm1Roml)	decreased immunoglobulin level	J:82863
Il1r1^tm1Roml/Il1r1^tm1Roml (C.Cg-Il1r1^tm1Roml)	decreased T cell proliferation	J:82863
Il1r1^tm1Roml/Il1r1^tm1Roml (involves: 129S1/Sv * BALB/c)	impaired neutrophil chemotaxis	J:124226
Il1r1^tm1Roml/Il1r1^tm1Roml (involves: 129S1/Sv)	decreased susceptibility to induced arthritis	J:120707
Il1r1^tm1Roml/Il1r1^tm1Roml Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)	increased interleukin-1 beta secretion	J:172117
Il1r1^tm1Roml/Il1r1^tm1Roml Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S1/Sv * C57BL/6)	increased susceptibility to Riboviria infection	J:191055
Il1r1^tm1Roml/Il1r1^tm1Roml Nlrp3^tm1Hhf/Nlrp3⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	skin inflammation	J:150054
Il1rap^tm1Roml/Il1rap^tm1Roml (involves: 129S1/Sv)	decreased interleukin-6 secretion	J:68065
Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal eosinophil physiology	J:61108
	abnormal interleukin secretion	J:61108
	abnormal T-helper 2 physiology	J:61108
	decreased interleukin-4 secretion	J:61108
	decreased interleukin-5 secretion	J:61108
	granulomatous inflammation	J:61108
Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd)	decreased IgE level	J:159464
Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (C.129P2-Il1rl1^tm1Anjm)	increased susceptibility to induced pancreatitis	J:184801
Il1rl1^tm1Brl/Il1rl1^tm1Brl (involves: 129S/SvEv * C57BL/6)	abnormal response to infection	J:63507
Il1rl1^tm1Brl/Il1rl1^tm1Brl (involves: 129S/SvEv * C57BL/6)	decreased interleukin-5 secretion	J:63507
Il1rl2^tm1Hblu/Il1rl2^tm1Hblu (involves: 129 * C57BL/6)	abnormal dendritic cell physiology	J:296074
Il1rl2^tm1Hblu/Il1rl2^tm1Hblu (involves: 129 * C57BL/6)	abnormal macrophage activation involved in immune response	J:296074
Il1rl2^tm1Hblu/Il1rl2^tm1Hblu (involves: 129)	decreased interleukin-9 secretion	J:256437
	decreased interleukin-17 secretion	J:193548
	decreased susceptibility to induced colitis	J:256437
Il1rn^tm1.1Cga/Il1rn^tm1.1Cga Lyz2^tm1(cre)Ifo/Lyz2⁺ (D1.Cg-Il1rn^tm1.1Cga Lyz2^tm1(cre)Ifo)	abnormal chemokine secretion	J:162760
	increased interferon-gamma secretion	J:162760
	increased interleukin-1 beta secretion	J:162760
	increased interleukin-6 secretion	J:162760
	increased interleukin-17 secretion	J:162760
	increased susceptibility to induced arthritis	J:162760
	increased T cell proliferation	J:162760
Il1rn^tm1Dih/Il1rn⁺ (involves: 129S/SvEv * C57BL/6J)	decreased susceptibility to bacterial infection	J:36387
Il1rn^tm1Dih/Il1rn⁺ (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to endotoxin shock	J:36387
Il1rn^tm1Dih/Il1rn^tm1Dih (involves: 129S/SvEv * C57BL/6J)	decreased circulating interleukin-1 level	J:36387
	decreased susceptibility to bacterial infection	J:36387
	increased acute inflammation	J:61600, J:88605
	increased circulating interleukin-6 level	J:61600
	increased circulating serum amyloid protein level	J:61600
	increased susceptibility to endotoxin shock	J:36387
Il1rn^tm1Nick/Il1rn⁺ (involves: 129P2/OlaHsd * MF1)	aortitis	J:59410
Il1rn^tm1Nick/Il1rn^tm1Nick (involves: 129P2/OlaHsd * MF1)	aortitis	J:59410
Il1rn^tm1Nick/Il1rn^tm1Nick (involves: 129P2/OlaHsd * MF1)	chronic inflammation	J:59410
Il1rn^tm1Nick/Il1rn^tm1Nick (involves: 129P2/OlaHsd * MF1 * BALB/cAnNHsd)	aortitis	J:89034
	skin inflammation	J:89034
Il1rn^tm1Nick/Il1rn^tm1Nick (involves: BALB/cAnNHsd)	aortitis	J:89034
	rheumatoid arthritis	J:89034
	skin inflammation	J:89034
Il1rn^tm1Nick/Il1rn^tm1Nick (involves: BALB/cAnNHsd * C57BL/6)	aortitis	J:89034
	rheumatoid arthritis	J:89034
Il1rn^tm1Sush/Il1rn^tm1Sush (involves: 129P2/OlaHsd * C57BL/6)	granulomatous inflammation	J:97684
Il1rn^tm1Yiw/Il1rn^tm1Yiw (C.129-Il1rn^tm1Yiw)	increased interleukin-17 secretion	J:143719
Il1rn^tm1Yiw/Il1rn^tm1Yiw (C.129-Il1rn^tm1Yiw)	rheumatoid arthritis	J:143719
Il1rn^tm1Yiw/Il1rn^tm1Yiw Il17a^tm1Yiw/Il17a⁺ (involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)	decreased susceptibility to induced arthritis	J:83408
Il2^m1/Il2^m1 (MRL/MpJ)	abnormal T cell activation	J:75331
Il2^tm1.1Flv/Il2^tm1.1Flv (NOD/ShiLtJ-Il2^tm1.1Flv)	abnormal susceptibility to autoimmune disorder	J:150823
Il2^tm1.1Kasm/Il2^tm1.1Kasm Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/? (involves: 129S/SvEv * C57BL/6)	decreased circulating interleukin-17 level	J:190168
Il2^tm1Hor/Il2⁺ (NOD.129P2(B6)-Il2^tm1Hor/DvsJ)	increased susceptibility to autoimmune diabetes	J:120349
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:39981, J:39989, J:15573
	abnormal class switch recombination	J:15573
	abnormal cytotoxic T cell physiology	J:39981
	abnormal level of surface class II molecules	J:15223
	abnormal lymphocyte physiology	J:15223
	abnormal susceptibility to Riboviria infection	J:26861
	abnormal thymocyte activation	J:37220, J:39989
	colitis	J:37220, J:29999, J:15223
	decreased cytotoxic T cell cytolysis	J:15573, J:26198, J:26861
	decreased splenocyte proliferation	J:79241
	decreased T cell proliferation	J:39989, J:26198
	impaired natural killer cell mediated cytotoxicity	J:15573
	increased B cell proliferation	J:16662
	increased IgA level	J:15223
	increased IgE level	J:16662
	increased IgG1 level	J:39989, J:15223, J:16662
	increased IgG2a level	J:16662
	increased IgG2b level	J:16662
	increased length of allograft survival	J:26198
	increased T cell proliferation	J:15223, J:16662
Il2^tm1Hor/Il2^tm1Hor (C.129P2-Il2^tm1Hor)	abnormal regulatory T cell physiology	J:112603
	heart inflammation	J:29799
	increased B cell proliferation	J:29799
	increased IgG level	J:29799
	increased inflammatory response	J:29799
	increased susceptibility to autoimmune hemolytic anemia	J:29799
	increased T cell proliferation	J:29799
	liver inflammation	J:29799
	lung inflammation	J:29799
	pancreas inflammation	J:29799
Il2^tm1Hor/Il2^tm1Hor (B6.129P2-Il2^tm1Hor)	increased T cell proliferation	J:28924
Il2^tm1Hor/Il2^tm1Hor (B6.129P2-Il2^tm1Hor/J)	abnormal circulating cytokine level	J:190168
	abnormal response to transplant	J:113547
	abnormal T cell activation	J:190168
	abnormal T cell proliferation	J:190168
	decreased circulating interferon-gamma level	J:190168
	decreased circulating interleukin-4 level	J:190168
	decreased circulating interleukin-13 level	J:190168
	increased susceptibility to autoimmune disorder	J:113547
	lacrimal gland inflammation	J:125129
	large intestinal inflammation	J:125129
	salivary gland inflammation	J:125129
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating interleukin-17 level	J:120176
Il2^tm1Hor/Il2^tm1Hor Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal susceptibility to Riboviria infection	J:26861
	decreased cytotoxic T cell cytolysis	J:26861
	decreased IgG level	J:16662, J:26861
	increased B cell proliferation	J:16662
	increased T cell proliferation	J:16662
Il2^tm1Hor/Il2^tm1Hor Rag2^tm1Fwa/Rag2⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	colitis	J:29999
Il2^tm1Hor/Il2^tm1Hor Tg(DO11.10)10Dlo/? (C.Cg-Il2^tm1Hor Tg(DO11.10)10Dlo)	abnormal regulatory T cell physiology	J:88349
	increased T cell proliferation	J:88349
Il2^tm1Hor/Il2^tm1Hor Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Il2^tm1Hor Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	abnormal regulatory T cell physiology	J:112603
Il2ra^M1J/Il2ra^M1J (involves: 129S4/SvJae * C57BL/6)	abnormal regulatory T cell physiology	J:268677
Il2ra^tm1Dw/Il2ra^tm1Dw (involves: 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:64279
	abnormal T cell physiology	J:64279
	colitis	J:64279
	increased IgA level	J:64279
	increased IgG1 level	J:64279
	increased IgG2a level	J:64279
	increased IgG2b level	J:64279
	increased IgG level	J:64279
Il2ra^tm1Dw/Il2ra^tm1Dw (B6.129S4-Il2ra^tm1Dw)	abnormal regulatory T cell physiology	J:125748
Il2ra^tm1Dw/Il2ra^tm1Dw (B6.129S4-Il2ra^tm1Dw)	abnormal T cell activation	J:125748
Il2ra^tm1Dw/Il2ra^tm1Dw (B6.129S4-Il2ra^tm1Dw/J)	lacrimal gland inflammation	J:125129
	large intestinal inflammation	J:125129
	lung inflammation	J:125129
	salivary gland inflammation	J:125129
Il2ra^tm1Dw/Il2ra^tm1Dw Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Il2ra^tm1Dw Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	abnormal regulatory T cell physiology	J:112603
Il2rb^m2Btlr/Il2rb^m2Btlr (C57BL/6J-Il2rb^m2Btlr)	increased IgE level	J:272832
Il2rb^M3Btlr/Il2rb^M3Btlr (C57BL/6J-Il2rb^M3Btlr)	increased IgM level	J:272833
Il2rb^tm1Mak/Il2rb^tm1Mak (either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))	abnormal B cell activation	J:25940
	abnormal T cell activation	J:25940
	increased anti-nuclear antigen antibody level	J:25940
	increased IgE level	J:25940
	increased IgG1 level	J:25940
	increased susceptibility to autoimmune hemolytic anemia	J:25940
Il2rb^tm1Mak/Il2rb^tm1Mak (B6.129-Il2rb^tm1Mak)	abnormal response to transplant	J:113547
	abnormal T cell activation	J:113547
	decreased T cell proliferation	J:113547
	increased anti-double stranded DNA antibody level	J:113547
	increased susceptibility to autoimmune hemolytic anemia	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak (C.129-Il2rb^tm1Mak)	abnormal T cell activation	J:113547
	abnormal T cell clonal deletion	J:113547
	decreased T cell proliferation	J:113547
	increased anti-double stranded DNA antibody level	J:113547
	increased susceptibility to autoimmune hemolytic anemia	J:113547
	liver inflammation	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak (D2.129-Il2rb^tm1Mak)	abnormal T cell clonal deletion	J:113547
Il2rg^tm1.1Flv/Y Rag2^tm1.1Flv/Rag2^tm1.1Flv (involves: 129S4/SvJae * BALB/cAnNTac)	abnormal response to transplant	J:168303
	increased susceptibility to bacterial infection	J:168303
Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Csf2/Il3^{tm1.1(CSF2,IL3)Flv}/Csf2/Il3^{tm1.1(CSF2,IL3)Flv} Rag2^tm1.1Flv/Rag2^tm1.1Flv (involves: 129S4/SvJae * BALB/cAnNCr * BALB/cAnNTac)	abnormal response to transplant	J:168302
Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv (involves: 129S4/SvJae * BALB/cAnNTac)	abnormal response to transplant	J:168303
	increased susceptibility to bacterial infection	J:168303
Il2rg^tm1.1Flv/Il2rg^tm1.1Flv Rag2^tm1.1Flv/Rag2^tm1.1Flv Thpo^{tm1.1(TPO)Flv}/Thpo^{tm1.1(TPO)Flv} (involves: 129S4/SvJae * BALB/cAnNTac)	abnormal response to transplant	J:168301
Il2rg^tm1Cgn/Y (involves: 129 * CB20)	abnormal class switch recombination	J:22521
	abnormal thymocyte activation	J:22521
	decreased IgE level	J:22521
	decreased IgM level	J:22521
	decreased T cell proliferation	J:22521
	impaired natural killer cell mediated cytotoxicity	J:22521
Il2rg^tm1Cgn/Il2rg^tm1Cgn (involves: 129 * CB20)	abnormal class switch recombination	J:22521
	abnormal thymocyte activation	J:22521
	decreased IgE level	J:22521
	decreased IgM level	J:22521
	decreased T cell proliferation	J:22521
	impaired natural killer cell mediated cytotoxicity	J:22521
Il2rg^tm1Cgn/Il2rg^tm1Cgn Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal interleukin secretion	J:142654
	increased susceptibility to bacterial infection	J:142654
Il2rg^tm1Sug/Y (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))	abnormal immune serum protein physiology	J:31167
	abnormal immunoglobulin level	J:31167
	decreased IgG3 level	J:31167
	decreased IgG level	J:31167
Il2rg^tm1Wjl/Y (involves: 129S4/SvJae * C57BL/6)	abnormal basophil physiology	J:24117
	abnormal cell-mediated immunity	J:108209
	abnormal immune serum protein physiology	J:108209
	abnormal mast cell physiology	J:24117
	abnormal thymocyte activation	J:24117
	cecum inflammation	J:24117
	decreased immunoglobulin level	J:24117
	decreased interferon-gamma secretion	J:24117
	decreased interleukin-2 secretion	J:24117
	decreased interleukin-4 secretion	J:24117
	decreased T cell proliferation	J:24117
	impaired natural killer cell mediated cytotoxicity	J:24117
Il2rg^tm1Wjl/Y Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/Sz)	abnormal response to transplant	J:109833, J:140388
	decreased immunoglobulin level	J:109833
Il2rg^tm1Wjl/Y Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Il2rg^tm1Wjl/SzJ)	abnormal adaptive immunity	J:140388
	abnormal innate immunity	J:140388
	abnormal response to transplant	J:140388
Il2rg^tm1Wjl/Il2rg^tm1Wjl (B6.129S4-Il2rg^tm1Wjl/J)	abnormal dendritic cell physiology	J:123902
Il2rg^tm1Wjl/Il2rg^tm1Wjl Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/Sz)	abnormal response to transplant	J:109833
	decreased immunoglobulin level	J:109833
Il2rg^tm1Wjl/Il2rg^tm1Wjl Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S4/SvJae)	abnormal interferon secretion	J:140483
	increased susceptibility to bacterial infection	J:140483
	lung inflammation	J:140483
Il3^tm1Glli/Il3^tm1Glli (either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))	decreased susceptibility to type IV hypersensitivity reaction	J:80640
	increased susceptibility to parasitic infection	J:80500
Il3^tm1Glli/Il3^tm1Glli Kit^W/Kit^W-v (involves: 129S2/SvPas * C57BL/6 * WB)	increased susceptibility to parasitic infection	J:80500
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:89095
	abnormal splenocyte physiology	J:72587
	abnormal susceptibility to infection	J:113543
	abnormal T-helper 2 physiology	J:89095
	decreased IgE level	J:113543, J:72587
	decreased IgG1 level	J:72587
	decreased IgG level	J:89095
	decreased susceptibility to parasitic infection	J:72587
	granulomatous inflammation	J:113543
	increased susceptibility to parasitic infection	J:113543, J:89095
	increased susceptibility to parasitic infection induced morbidity/mortality	J:60609
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (C.129P2/OlaHsd-Il4/Il13^tm3Anjm)	abnormal interleukin-4 secretion	J:91403
	decreased IgE level	J:91403
	decreased interferon-gamma secretion	J:91403
	decreased interleukin-5 secretion	J:91403
	decreased interleukin-13 secretion	J:91403
	decreased susceptibility to autoimmune disorder	J:91403
	increased IgG2a level	J:91403
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * BALB/c)	abnormal splenocyte physiology	J:60609
	abnormal susceptibility to infection	J:60609, J:131994
	decreased IgG1 level	J:178986
	decreased inflammatory response	J:60609, J:165513
	ileum inflammation	J:60609
	increased susceptibility to parasitic infection	J:60609
	increased susceptibility to parasitic infection induced morbidity/mortality	J:60609
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:89095
	abnormal splenocyte physiology	J:72587
	abnormal susceptibility to infection	J:113543
	abnormal T-helper 2 physiology	J:89095
	decreased IgE level	J:113543, J:72587
	decreased IgG1 level	J:72587
	decreased IgG level	J:89095
	decreased susceptibility to parasitic infection	J:72587
	granulomatous inflammation	J:113543
	increased susceptibility to parasitic infection	J:113543, J:89095
	increased susceptibility to parasitic infection induced morbidity/mortality	J:60609
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (C.129P2/OlaHsd-Il4/Il13^tm3Anjm)	abnormal interleukin-4 secretion	J:91403
	decreased IgE level	J:91403
	decreased interferon-gamma secretion	J:91403
	decreased interleukin-5 secretion	J:91403
	decreased interleukin-13 secretion	J:91403
	decreased susceptibility to autoimmune disorder	J:91403
	increased IgG2a level	J:91403
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * BALB/c)	abnormal splenocyte physiology	J:60609
	abnormal susceptibility to infection	J:60609, J:131994
	decreased IgG1 level	J:178986
	decreased inflammatory response	J:60609, J:165513
	ileum inflammation	J:60609
	increased susceptibility to parasitic infection	J:60609
	increased susceptibility to parasitic infection induced morbidity/mortality	J:60609
Il4^tm1(CD2)Mmrs/Il4^tm1(CD2)Mmrs (involves: 129)	decreased IgE level	J:178986
	decreased IgG1 level	J:178986
	decreased interleukin-4 secretion	J:181313
Il4^tm1.1Wep/Il4⁺ (C.129P2-Il4^tm1.1Wep)	decreased IgE level	J:138827
Il4^tm1.1Wep/Il4⁺ Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Il4^tm1.1Wep)	decreased IgE level	J:138827
	impaired eosinophil recruitment	J:138827
Il4^tm1.1Wep/Il4^tm1.1Wep (involves: 129P2/OlaHsd * C57BL/6)	decreased interleukin-4 secretion	J:67964
Il4^tm1.1Wep/Il4^tm1.1Wep (C.129P2-Il4^tm1.1Wep)	decreased IgE level	J:138827
Il4^tm1.1Wep/Il4^tm1.1Wep (C.129P2-Il4^tm1.1Wep)	impaired eosinophil recruitment	J:138827
Il4^tm1.1Wep/Il4^tm1.1Wep Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Il4^tm1.1Wep)	decreased IgE level	J:138827
	impaired eosinophil recruitment	J:138827
Il4^tm1Cgn/Il4^tm1Cgn (B6.Cg-Il4^tm1Cgn)	abnormal humoral immune response	J:89095
Il4^tm1Cgn/Il4^tm1Cgn (B6.Cg-Il4^tm1Cgn)	abnormal T-helper 2 physiology	J:89095
Il4^tm1Cgn/Il4^tm1Cgn (NOD.129P2-Il4^tm1Cgn)	decreased susceptibility to autoimmune disorder	J:95105
Il4^tm1Cgn/Il4^tm1Cgn (NOD.129P2-Il4^tm1Cgn)	increased susceptibility to autoimmune disorder	J:95105
Il4^tm1Cgn/Il4^tm1Cgn (NOD.Cg-H2^b Il4^tm1Cgn)	lacrimal gland inflammation	J:105803
Il4^tm1Cgn/Il4^tm1Cgn (NOD.Cg-H2^b Il4^tm1Cgn)	salivary gland inflammation	J:105803
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * NOD)	abnormal cytokine secretion	J:85924
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * NOD)	decreased IgG1 level	J:85924
Il4^tm1Cgn/Il4^tm1Cgn (either: NOD.129-Il4^tm1Cgn or (involves: 129 * NOD))	autoimmune response	J:85924
	insulitis	J:85924
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:704
	decreased IgE level	J:704
	decreased IgG1 level	J:704
	granulomatous inflammation	J:113543
Il4^tm1Cgn/Il4^tm1Cgn (MRL.129P2-Il4^tm1Cgn)	lacrimal gland inflammation	J:132514
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)	decreased IgE level	J:39600
	decreased IgG1 level	J:39600
Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * A/WySn * C57BL/10SnSg * Swiss)	decreased IgG1 level	J:119207
	increased IgG2a level	J:119207
Il4^tm1Cgn/Il4^tm1Cgn Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd)	esophageal inflammation	J:205692
	increased inflammatory response	J:205692
	increased interleukin-2 secretion	J:205692
	lung inflammation	J:205692
Il4^tm1Cgn/Il4^tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (NOD.Cg-Il4^tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	decreased susceptibility to autoimmune diabetes	J:85924
	insulitis	J:85924
Il4^tm1Kopf/Il4^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	abnormal response to infection	J:14593
	decreased IgE level	J:14593
	decreased IgG1 level	J:14593
	decreased interleukin-3 secretion	J:14593
	decreased interleukin-4 secretion	J:14593
	decreased interleukin-5 secretion	J:14593
	decreased interleukin-10 secretion	J:14593
	increased IgG level	J:14593
Il4^tm1Kopf/Il4^tm1Kopf (involves: 129S2/SvPas)	decreased IgE level	J:113065
Il4^tm1Kopf/Il4^tm1Kopf (involves: 129S2/SvPas)	decreased interleukin-5 secretion	J:113065
Il4^tm1Kopf/Il4^tm1Kopf Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal circulating complement protein level	J:161523
	decreased IgE level	J:161523
	decreased IgG1 level	J:161523
	increased anti-double stranded DNA antibody level	J:161523
	increased anti-nuclear antigen antibody level	J:161523
	increased IgA level	J:161523
	increased IgG2a level	J:161523
	increased IgG2b level	J:161523
	increased IgM level	J:161523
Il4^tm1Lky/Il4⁺ Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:151840
Il4^tm1Lky/Il4^tm1Lky Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * BALB/c * C57BL/6J)	abnormal cytokine secretion	J:129883
	abnormal response to infection	J:129883
	abnormal T-helper 2 physiology	J:129883
Il4^tm1Nnt/Il4^tm1Nnt (C57BL/6-Il4^tm1Nnt/J)	abnormal T-helper 2 physiology	J:37196
	CNS inflammation	J:125605
	decreased IgE level	J:37196
	decreased IgG1 level	J:37196
	decreased IgM level	J:37196
	decreased interleukin-4 secretion	J:37196
	decreased interleukin-5 secretion	J:37196
	decreased interleukin-10 secretion	J:120556, J:37196
	granulomatous inflammation	J:37196
	increased IgA level	J:37196
	increased interferon-gamma secretion	J:120556, J:37196
	stomach inflammation	J:120556
Il4^tm1Nnt/Il4^tm1Nnt (involves: C57BL/6)	abnormal interleukin-4 secretion	J:91403
Il4^tm1Nnt/Il4^tm1Nnt (involves: C57BL/6)	decreased susceptibility to autoimmune disorder	J:91403
Il4^tm1Rao/Il4^tm1Rao (involves: 129S6/SvEvTac * C57BL/6)	abnormal mast cell physiology	J:78089
	abnormal T-helper 2 physiology	J:78089
	decreased interleukin-4 secretion	J:78089
	decreased interleukin-13 secretion	J:78089
Il4^tm2.1Kubo/Il4^tm2.1Kubo (B6.Cg-Il4^tm2.1Kubo)	decreased IgE level	J:167446
	decreased IgG1 level	J:167446
	decreased interleukin-4 secretion	J:167446
	impaired eosinophil recruitment	J:167446
	increased IgG2c level	J:167446
	increased interleukin-5 secretion	J:167446
	increased interleukin-13 secretion	J:167446
Il4^tm2Nnt/Il4^tm2Nnt (BALB/c-Il4^tm2Nnt/J)	abnormal dendritic cell antigen presentation	J:141937
	decreased IgE level	J:31486
	decreased IgG1 level	J:31486
	decreased interleukin-5 secretion	J:141937
	decreased interleukin-13 secretion	J:141937
	decreased susceptibility to autoimmune disorder	J:141937
	increased interferon-gamma secretion	J:141937
Il4^tm2Nnt/Il4^tm2Nnt (BALB/c-Il4^tm2Nnt)	abnormal splenocyte physiology	J:60609
	abnormal susceptibility to infection	J:60609
	ileum inflammation	J:60609
	increased susceptibility to parasitic infection	J:60609
	increased susceptibility to parasitic infection induced morbidity/mortality	J:60609
Il4^tm2Nnt/Il4^tm2Nnt Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.Cg-Tgfb1^tm1Doe Il4^tm2Nnt)	liver inflammation	J:69346
Il4^tm3.1Kubo/Il4^tm3.1Kubo (B6.Cg-Il4^tm3.1Kubo)	decreased interleukin-4 secretion	J:167446
Il4ppq^NZB/Slc/Il4ppq^NZW/Slc (involves: NZB/Slc * NZW/Slc)	abnormal cytokine secretion	J:117863
Il4ra^M1Btlr/Il4ra^M1Btlr (C57BL/6J-Il4ra^M1Btlr)	decreased IgE level	J:267558
Il4ra^M2Btlr/Il4ra^M2Btlr (C57BL/6J-Il4ra^M2Btlr)	decreased IgE level	J:272804
Il4ra^tm1Fbb/Il4ra^tm1Fbb (involves: BALB/c)	abnormal susceptibility to infection	J:55526
Il4ra^tm1Fbb/Il4ra^tm1Fbb (involves: BALB/cJ)	abnormal circulating cytokine level	J:133518
	abnormal circulating interferon-gamma level	J:133518
	abnormal cytokine secretion	J:114751
	abnormal immune system physiology	J:114751
	abnormal macrophage physiology	J:114751
	granulomatous inflammation	J:114751
	impaired macrophage chemotaxis	J:114751
	increased circulating interleukin-4 level	J:133518
	increased susceptibility to infection	J:114751
	increased susceptibility to parasitic infection	J:114751
	liver inflammation	J:114751
Il4ra^tm1Fbb/Il4ra^tm2Fbb Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * BALB/c)	abnormal immune system physiology	J:114751
	abnormal macrophage physiology	J:114751
	decreased susceptibility to parasitic infection	J:114751
	granulomatous inflammation	J:114751
	increased susceptibility to parasitic infection	J:114751
	liver inflammation	J:114751
Il4ra^tm1Sz/Il4ra^tm1Sz (BALB/c-Il4ra^tm1Sz/J)	abnormal susceptibility to infection	J:131994
	abnormal T-helper 2 physiology	J:43656
	decreased IgE level	J:43656
	decreased IgG1 level	J:43656
	decreased interleukin-4 secretion	J:43656
	decreased interleukin-5 secretion	J:43656
	decreased interleukin-10 secretion	J:43656
	increased IgG2a level	J:43656
Il4ra^tm1Sz/Il4ra^tm1Sz (BALB/c-Il4ra^tm1Sz)	increased IgG2a level	J:110429
Il4ra^tm1Sz/Il4ra^tm1Sz (BALB/c-Il4ra^tm1Sz)	increased susceptibility to parasitic infection	J:110429
Il4ra^tm1Tch/Il4ra^tm1Tch (involves: 129X1/SvJ * BALB/c)	abnormal immune serum protein physiology	J:86215
	decreased T cell proliferation	J:86215
	increased IgE level	J:86215
	increased IgG level	J:86215
	respiratory system inflammation	J:86215
Il4ra^tm2Tch/Il4ra^tm2Tch (C.129X1-Il4ra^tm2Tch)	abnormal T-helper 2 physiology	J:152376
	increased circulating interleukin-4 level	J:152376
	increased IgE level	J:152376
	increased susceptibility to type I hypersensitivity reaction	J:152376
	respiratory system inflammation	J:152376
Il4ra^tm2Tch/Il4ra^tm2Tch Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/? (B6.Cg-Il4ra^tm2Tch Tg(Scgb1a1-rtTA,tetO-IL13)1Eli)	respiratory system inflammation	J:152376
Il4ra^tm3.1Tch/Il4ra^tm3.1Tch (C.129X1-Il4ra^tm3.1Tch)	abnormal macrophage activation involved in immune response	J:160806
	increased IgE level	J:160806
	increased interleukin-4 secretion	J:160806
	increased susceptibility to type I hypersensitivity reaction	J:160806
Il5^{tm1.1(icre)Lky}/Il5⁺ (C57BL/6-Il5^{tm1.1(icre)Lky})	decreased circulating interleukin-5 level	J:206097
Il5^tm1Anjm/Il5^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell physiology	J:113543
	abnormal susceptibility to infection	J:113543
	decreased IgE level	J:113543
	granulomatous inflammation	J:113543
	increased susceptibility to parasitic infection	J:113543
Il5^tm1Anjm/Il5^tm1Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:113543
	abnormal interleukin level	J:113543
	abnormal mast cell physiology	J:113543
	abnormal susceptibility to infection	J:113543
	decreased IgE level	J:113543
	granulomatous inflammation	J:113543
	increased susceptibility to parasitic infection	J:113543
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf)	granulomatous inflammation	J:107418
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf)	increased interferon-gamma secretion	J:107418
Il5^tm1Ktk/Il5⁺ (B6.129S4-Il5^tm1Ktk)	decreased interleukin-5 secretion	J:180790
Il5^tm1Ktk/Il5^tm1Ktk (B6.129S4-Il5^tm1Ktk)	decreased interleukin-5 secretion	J:180790
Il5^tm2Anjm/Il5^tm2Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:113543
	abnormal interleukin level	J:113543
	abnormal susceptibility to infection	J:113543
	granulomatous inflammation	J:113543
	increased susceptibility to parasitic infection	J:113543
Il5^tm3Anjm/Il5^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	granulomatous inflammation	J:113543
Il5^tm3Anjm/Il5^tm3Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	granulomatous inflammation	J:113543
Il5ra^tm1Ktk/Il5ra^tm1Ktk (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:33140
	decreased IgA level	J:33140
	decreased IgG3 level	J:33140
	decreased IgM level	J:33140
	decreased immunoglobulin level	J:33140
	increased susceptibility to parasitic infection	J:33140
Il5ra^tm1Ktk/Il5ra^tm1Ktk (B6.129P2-Il5ra^tm1Ktk)	decreased B cell proliferation	J:89849
	decreased IgA level	J:89849
	decreased IgG1 level	J:89849
	decreased IgG3 level	J:89849
	decreased IgM level	J:89849
Il5ra^tm1Ktk/Il5ra^tm1Ktk Lyn^tm1Tya/Lyn^tm1Tya (involves: 129P2/OlaHsd * C57BL/6)	glomerulonephritis	J:91089
	increased anti-double stranded DNA antibody level	J:91089
	increased IgA level	J:91089
	increased IgM level	J:91089
	increased immunoglobulin level	J:91089
Il6^tm1Kopf/Il6⁺ Tg(ED-L2-IL1RN/IL1B)#Tcw/? (B6.Cg-Il6^tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw)	esophageal inflammation	J:180282
Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:17360
	decreased cytotoxic T cell cytolysis	J:17360
	increased susceptibility to bacterial infection	J:17360
	increased susceptibility to induced colitis	J:79073
	increased susceptibility to Poxviridae infection	J:17360
Il6^tm1Kopf/Il6^tm1Kopf (B6.129S2-Il6^tm1Kopf/J)	abnormal interleukin-6 secretion	J:109359
	decreased interferon-gamma secretion	J:123351
	decreased susceptibility to induced arthritis	J:208213
	increased interleukin-4 secretion	J:123351
Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas)	abnormal inflammatory response	J:160966
	abnormal T cell physiology	J:159479
	decreased interleukin-17 secretion	J:159479
	increased susceptibility to bacterial infection induced morbidity/mortality	J:161073
Il6^tm1Kopf/Il6^tm1Kopf Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv * 129S2/SvPas)	decreased susceptibility to endotoxin shock	J:168781
Il6^tm1Kopf/Il6^tm1Kopf Junb^tm3Wag/Junb^tm3Wag Tg(KRT5-cre)1Tak/0 (involves: 129/Sv * 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6)	skin inflammation	J:155575
Il6^tm1Kopf/Il6^tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw/? (B6.Cg-Il6^tm1Kopf Tg(ED-L2-IL1RN/IL1B)#Tcw)	esophageal inflammation	J:180282
Il6^tm1Mur/Il6^tm1Mur (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:25684
Il6^tm1Mur/Il6^tm1Mur (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:25684
Il6^tm1Mur/Il6^tm1Mur (involves: 129/Sv * C57BL/6)	abnormal interferon level	J:40579
	brain inflammation	J:40579
	increased susceptibility to parasitic infection	J:40579
Il6^tm1Mur/Il6^tm1Mur (B6.129P2(B6)-Il6^tm1Mur)	abnormal inflammatory response	J:85581
	abnormal microglial cell physiology	J:85581
	abnormal osteoclast physiology	J:65093
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * MF1)	abnormal macrophage physiology	J:79314
	abnormal neutrophil physiology	J:79314
	abnormal osteoclast physiology	J:17249
	abnormal T-helper 1 physiology	J:79314
	abnormal T-helper 2 physiology	J:79314
	decreased circulating interleukin-12 level	J:79314
	decreased IgA level	J:79314
	decreased IgE level	J:79314
	increased circulating interleukin-10 level	J:79314
	increased IgG2a level	J:79314
	increased susceptibility to fungal infection	J:79314
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * C57BL/6)	decreased inflammatory response	J:68063
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * C57BL/6)	impaired neutrophil recruitment	J:68063
Il6^tm1Poli/Il6^tm1Poli (CAnNCrl.129S(Cg)-Il6^tm1Poli)	abnormal B cell proliferation	J:42869
	abnormal immune system physiology	J:96706
	decreased inflammatory response	J:42869
Il6ra^{tm1.1(IL6R)Csk}/Il6ra^{tm1.1(IL6R)Csk} (involves: 129S6/SvEvTac * C57BL/6)	abnormal circulating serum amyloid protein level	J:207264
Il6ra^tm1.1Drew/Il6ra^tm1.1Drew Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * SJL)	decreased acute inflammation	J:160966
Il6ra^tm1.1Jcbr/Il6ra^tm1.1Jcbr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	decreased susceptibility to parasitic infection	J:188445
Il6ra^tm1.1Jcbr/Il6ra^tm1.1Jcbr Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N)	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	decreased susceptibility to parasitic infection	J:188445
	increased circulating interleukin-6 level	J:166367
	increased circulating tumor necrosis factor level	J:166367
Il6ra^tm1.2Drew/Il6ra^tm1.2Drew (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	abnormal inflammatory response	J:160966
Il6ra^tm1.2Jcbr/Il6ra^tm1.2Jcbr (involves: C57BL/6)	decreased circulating interleukin-1 beta level	J:188445
	decreased circulating tumor necrosis factor level	J:188445
	decreased susceptibility to parasitic infection	J:188445
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:188445
	liver inflammation	J:202764
Il6ra^tm1Saj/Il6ra^tm1Saj (involves: 129P2/OlaHsd * C57BL/6J)	abnormal CD4-positive, alpha-beta T cell physiology	J:159479
Il6st^tm1Ard/Il6st^tm1Ard (involves: 129S1/Sv * C57BL/6)	cecum inflammation	J:79555
	conjunctivitis	J:79555
	decreased IgA level	J:79555
	decreased IgG level	J:79555
	decreased immunoglobulin level	J:79555
	increased inflammatory response	J:79555
	increased susceptibility to induced colitis	J:79073
	increased susceptibility to parasitic infection	J:79555
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv * C57BL/6)	abnormal inflammatory response	J:139226
	decreased susceptibility to induced colitis	J:79073
	increased susceptibility to induced arthritis	J:142883
	stomach inflammation	J:87206
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv)	increased circulating interleukin-6 level	J:168781
	increased interleukin-6 secretion	J:168781
	increased susceptibility to endotoxin shock	J:168781
Il6st^tm1Ern/Il6st^tm1Ern Stat1^tm1Rds/Stat1^tm1Rds (involves: 129S1/Sv)	abnormal inflammatory response	J:139226
Il6st^tm1Ern/Il6st^tm1Ern Stat3^tm1Aki/Stat3⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	decreased circulating interleukin-6 level	J:168781
	decreased susceptibility to endotoxin shock	J:168781
Il6st^tm1Ern/Il6st^tm1Ern Tirap^tm1.1Pjh/Tirap^tm1.1Pjh (involves: 129S1/Sv)	decreased circulating interleukin-6 level	J:168781
	decreased susceptibility to endotoxin shock	J:168781
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * CD-1)	abnormal osteoclast physiology	J:88710
Il6st^tm1Thir/Il6st^tm1Thir (Not Specified)	abnormal B cell physiology	J:59922
	abnormal dendritic cell antigen presentation	J:113335
	decreased interleukin-4 secretion	J:59922
	increased IgG2a level	J:59922
	increased IgG2b level	J:59922
	increased interferon-gamma secretion	J:59922
Il6st^tm1Thir/Il6st^tm1Thir (involves: 129 * C57BL/6)	abnormal T cell activation	J:133059
	abnormal T cell clonal deletion	J:133059
	abnormal thymocyte activation	J:133059
	increased anti-double stranded DNA antibody level	J:133059
	increased anti-nuclear antigen antibody level	J:133059
	increased anti-single stranded DNA antibody level	J:133059
	increased autoantibody level	J:133059
	increased IgA level	J:133059
	increased IgG1 level	J:133059
	increased IgG2a level	J:133059
	increased IgG2b level	J:133059
	rheumatoid arthritis	J:133059
Il6st^tm1Wme/Il6st^tm1Wme (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:67677
	increased IgE level	J:67677
	increased IgG level	J:67677
Il6st^tm2Thir/Il6st^tm2Thir (Not Specified)	abnormal dendritic cell antigen presentation	J:113335
	decreased IgG1 level	J:59922
	decreased IgG2a level	J:59922
	decreased IgG2b level	J:59922
	decreased interferon-gamma secretion	J:59922
	increased IgM level	J:59922
Il6st^tm3Thir/Il6st^tm3Thir (Not Specified)	decreased IgA level	J:59922
	decreased IgG2a level	J:59922
	decreased IgG2b level	J:59922
Il7^tm2.1Iku/Il7^tm2.1Iku Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)	abnormal NK T cell physiology	J:190615
Il7r^tm1Abra/Il7r^tm1Abra (B6.129S4-Il7r^tm1Abra)	abnormal CD4-positive, alpha-beta T cell physiology	J:125360
Il7r^tm1Abra/Il7r^tm1Abra (B6.129S4-Il7r^tm1Abra)	abnormal T cell proliferation	J:125360
Il7r^tm1Imx/Il7r^tm1Imx Tg(Lck-Il7r)1676Trma/? (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	decreased T cell proliferation	J:66400
	increased thymocyte apoptosis	J:66400
Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal response to infection	J:82881
	granulomatous inflammation	J:82881, J:113543
	increased susceptibility to parasitic infection	J:82881
Il9^tm1Anjm/Il9^tm1Anjm (involves: C57BL/6)	abnormal cytokine secretion	J:115764
Il9^tm1Flv/Il9^tm1Flv (BALB/c-Il9^tm1Flv)	increased susceptibility to parasitic infection	J:208730
Il9r^tm1Jcrd/Il9r^tm1Jcrd (involves: C57BL/6)	abnormal regulatory T cell physiology	J:151907
Il9r^tm1Jcrd/Il9r^tm1Jcrd (involves: C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:151907
Il10^tm1.1Roer/Il10^tm1.1Roer (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:94537
	abnormal hypersensitivity reaction	J:94537
	abnormal innate immunity	J:94537
	increased susceptibility to bacterial infection	J:94537
	intestinal inflammation	J:94537
Il10^tm1.1Roer/Il10^tm1.1Roer (involves: 129P2/OlaHsd)	decreased circulating interleukin-10 level	J:151551
Il10^tm1.1Roer/Il10^tm1.1Roer (involves: 129P2/OlaHsd)	increased susceptibility to endotoxin shock	J:151551
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:35020
	abnormal immune system physiology	J:35020
	abnormal interferon level	J:35020, J:107077, J:125760
	abnormal interleukin level	J:35020, J:107077, J:51636
	abnormal Langerhans cell physiology	J:51636
	abnormal level of surface class II molecules	J:15222
	abnormal response to infection	J:15222
	abnormal tumor necrosis factor level	J:107077, J:51636
	abnormal type IV hypersensitivity reaction	J:35510
	cecum inflammation	J:35020
	chronic inflammation	J:15222
	colitis	J:68476
	decreased length of allograft survival	J:44346
	decreased T cell proliferation	J:125760
	increased IgE level	J:62283
	increased IgG1 level	J:62283
	increased IgG2a level	J:62283
	increased interferon-gamma secretion	J:15222
	increased susceptibility to parasitic infection	J:123927
	increased susceptibility to type IV hypersensitivity reaction	J:51636
	intestinal inflammation	J:35020, J:107077, J:15222
	large intestinal inflammation	J:35020
	small intestinal inflammation	J:35020
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd)	abnormal cytokine secretion	J:117122
	abnormal inflammatory response	J:117122
	increased circulating interleukin-12 level	J:118833
	increased circulating tumor necrosis factor level	J:118833
	increased susceptibility to endotoxin shock	J:117122, J:118833
	intestinal inflammation	J:113376
Il10^tm1Cgn/Il10^tm1Cgn (B6.129P2-Il10^tm1Cgn/J)	abnormal chemokine level	J:157787
	abnormal cytokine level	J:157787, J:139972
	abnormal regulatory T cell physiology	J:125748
	cecum inflammation	J:157787
	increased circulating interferon-gamma level	J:157787
	increased circulating interleukin-1 alpha level	J:157787
	increased circulating interleukin-1 beta level	J:157787, J:139972
	increased circulating interleukin-2 level	J:157787
	increased circulating interleukin-6 level	J:157787, J:139972
	increased circulating interleukin-12 level	J:157787
	increased circulating interleukin-17 level	J:157787
	increased circulating tumor necrosis factor level	J:157787
	increased susceptibility to induced colitis	J:157787
	increased susceptibility to parasitic infection	J:157787
	large intestinal inflammation	J:149347
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6 * DBA/1)	colitis	J:84100
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * 129S/SvEv)	colitis	J:59872
Il10^tm1Cgn/Il10^tm1Cgn (B10.129P2(B6)-Il10^tm1Cgn/J)	decreased length of allograft survival	J:44346
Il10^tm1Cgn/Il10^tm1Cgn (B6.129P2-Il10^tm1Cgn)	abnormal circulating interleukin-6 level	J:191723
Il10^tm1Cgn/Il10^tm1Cgn (B6.129P2-Il10^tm1Cgn)	abnormal circulating interleukin-12b level	J:191723
Il10^tm1Cgn/Il10^tm1Cgn Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	increased interferon-gamma secretion	J:111712
Il10^tm1Cgn/Il10^tm1Cgn Il12b^tm1Jm/Il12b^tm1Jm (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	increased interleukin-13 secretion	J:111712
Il10^tm1Cgn/Il10^tm1Cgn Il27ra^tm1Mak/Il27ra^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 physiology	J:136179
	abnormal T-helper 2 physiology	J:136179
	colitis	J:136179
	decreased interferon-gamma secretion	J:136179
	decreased susceptibility to induced colitis	J:136179
	increased interleukin-13 secretion	J:136179
Il10^tm1Cgn/Il10^tm1Cgn Nfil3^tm1Look/Nfil3^tm1Look (involves: 129P2/OlaHsd * 129X1/SvJ)	colitis	J:209365
	increased interleukin-12 secretion	J:209365
Il10^tm1Cgn/Il10^tm1Cgn Nfil3^tm1Pbro/Nfil3^tm1Pbro (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	colitis	J:209365
	increased interleukin-12 secretion	J:209365
Il10^tm1Cgn/Il10^tm1Cgn Rps6ka4^tm1Jsca/Rps6ka4^tm1Jsca Rps6ka5^tm1Jsca/Rps6ka5^tm1Jsca (B6.Cg-Il10^tm1Cgn Rps6ka5^tm1Jsca Rps6ka4^tm1Jsca)	decreased interleukin-10 secretion	J:139576
	increased interleukin-6 secretion	J:139576
	increased interleukin-12a secretion	J:139576
	increased interleukin-12b secretion	J:139576
	increased tumor necrosis factor secretion	J:139576
Il10^tm1Cgn/Il10^tm1Cgn Tg(MUC1)79.24Gend/0 (B6.Cg-Il10^tm1Cgn Tg(MUC1)79.24Gend)	large intestinal inflammation	J:149347
Il10^tm1Cgn/Il10^tm1Cgn Tg(Vil1-cre)997Gum/? Tlr5^tm1.1Gewr/Tlr5^tm1.1Gewr (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac * SJL)	colitis	J:229155
Il10^tm1Cgn/Il10^tm1Cgn Tlr5^tm1.1Gewr/Tlr5^tm1.1Gewr (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac)	colitis	J:229155
Il10^tm1Cgn/Il10^tm1Cgn Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:107077
	abnormal cytokine level	J:107077
	abnormal thymus involution	J:107077
	colitis	J:107077
	decreased T cell proliferation	J:107077
	increased T cell apoptosis	J:107077
	intestinal inflammation	J:107077
Il10^tm1Keny/Il10⁺ Nfil3^tm1.1Kubo/Nfil3^tm1.1Kubo (involves: 129 * C57BL/6)	decreased interleukin-10 secretion	J:172134
Il10^tm1Mhry/Il10^tm1Mhry (involves: 129P2/OlaHsd * C57BL/6)	intestinal inflammation	J:117628
Il10^tm1Roer/Il10^tm1Roer Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal regulatory T cell physiology	J:134513
	abnormal type IV hypersensitivity reaction	J:134513
	colitis	J:134513
	decreased interleukin-10 secretion	J:134513
	lung inflammation	J:134513
Il10^tm1Roer/Il10^tm1Roer Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal cytokine secretion	J:94537
	abnormal hypersensitivity reaction	J:94537
	increased susceptibility to parasitic infection	J:94537
	intestinal inflammation	J:94537
	liver inflammation	J:94537
	peritoneal inflammation	J:94537
Il10^tm2Roer/Il10^tm2Roer Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:117122
	abnormal inflammatory response	J:117122
	increased susceptibility to endotoxin shock	J:117122
Il10^tm2Roer/Il10^tm2Roer Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal inflammatory response	J:117122
	increased susceptibility to endotoxin shock	J:117122
Il10ra^m1Jskg/Il10ra^m1Jskg (B6.Cg-Il10ra^m1Jskg)	colitis	J:146644
Il10ra^NZW/Il10ra⁺ ((NZB x NZW)F1)	increased anti-chromatin antibody level	J:102087
Il10ra^NZW/Il10ra⁺ ((NZB x NZW)F1)	increased IgG level	J:102087
Il10ra^tm1.1Jack/Il10ra^tm1.1Jack Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal chemokine level	J:157787
	abnormal cytokine level	J:157787
	increased circulating interferon-gamma level	J:157787
	increased circulating interleukin-1 alpha level	J:157787
	increased circulating interleukin-1 beta level	J:157787
	increased circulating interleukin-2 level	J:157787
	increased circulating interleukin-12 level	J:157787
	increased circulating interleukin-17 level	J:157787
	increased circulating tumor necrosis factor level	J:157787
	increased susceptibility to parasitic infection	J:157787
Il10ra^tm1.1Tlg/Il10ra^tm1.1Tlg Tg(Cd4-cre)1Cwi/? (B6.Cg-Tg(Cd4-cre)1Cwi Il10ra^tm1.1Tlg)	autoimmune response	J:189797
	decreased splenocyte proliferation	J:189797
Il10ra^tm1.2Jack/Il10ra^tm1.2Jack (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)	abnormal chemokine level	J:157787
	abnormal cytokine level	J:157787
	cecum inflammation	J:157787
	increased circulating interferon-gamma level	J:157787
	increased circulating interleukin-1 alpha level	J:157787
	increased circulating interleukin-1 beta level	J:157787
	increased circulating interleukin-2 level	J:157787
	increased circulating interleukin-6 level	J:157787
	increased circulating interleukin-12 level	J:157787
	increased circulating interleukin-17 level	J:157787
	increased circulating tumor necrosis factor level	J:157787
	increased susceptibility to induced colitis	J:157787
	increased susceptibility to parasitic infection	J:157787
Il10rb^tm1Agt/Il10rb^tm1Agt (involves: 129S2/SvPas * C57BL/6)	colitis	J:134156
	increased interferon-gamma secretion	J:134156
	increased interleukin-17 secretion	J:134156
	large intestinal inflammation	J:45917
Il10rb^tm1Agt/Il10rb^tm1Agt Tg(Cd4-TGFBR2)16Flv/? (involves: 129S2/SvPas * C3H * C57BL/6)	abnormal cytokine level	J:134156
	abnormal cytokine secretion	J:134156
	colitis	J:134156
	increased circulating interferon-gamma level	J:134156
	increased circulating interleukin-6 level	J:134156
	increased circulating tumor necrosis factor level	J:134156
	increased interferon-gamma secretion	J:134156
	increased interleukin-17 secretion	J:134156
	increased tumor necrosis factor secretion	J:134156
	liver inflammation	J:134156
	lung inflammation	J:134156
	proctitis	J:134156
Il11ra1^tm1Wehi/Il11ra1^tm1Wehi Il6^tm1Kopf/Il6^tm1Kopf (involves: 129/Sv * C57BL/6)	increased susceptibility to induced colitis	J:79073
Il12a^m1Btlr/Il12a^m1Btlr (C57BL/6J-Il12a^m1Btlr)	increased susceptibility to Herpesvirales infection	J:267667
Il12a^tm1Cab/Il12a^tm1Cab (involves: 129S4/SvJae * C57BL/6)	decreased circulating interferon-gamma level	J:54482
Il12a^tm1Cab/Il12a^tm1Cab (involves: 129S4/SvJae * C57BL/6)	decreased circulating interleukin-12 level	J:54482
Il12a^tm1Cab/Il12a^tm1Cab (B6.129S4-Il12a^tm1Cab)	abnormal NK cell physiology	J:79552
Il12a^tm1Cab/Il12a^tm1Cab (B6.129S4-Il12a^tm1Cab)	decreased circulating interferon-gamma level	J:79552
Il12a^tm1Cab/Il12a^tm1Cab Il23a^tm1.1Thak/Il23a^tm1.1Thak (B6.Cg-Il12a^tm1Cab Il23a^tm1.1Thak)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:143970
Il12a^tm1Jm/Il12a^tm1Jm (129S1/Sv-Il12a^tm1Jm)	abnormal CD4-positive, alpha-beta T cell physiology	J:34164
	decreased susceptibility to type IV hypersensitivity reaction	J:34164
	increased susceptibility to parasitic infection	J:34164
Il12a^tm1Jm/Il12a^tm1Jm (C.129S1-Il12a^tm1Jm)	impaired natural killer cell mediated cytotoxicity	J:125611
Il12a^tm1Jm/Il12a^tm1Jm (involves: 129S1/Sv)	abnormal NK cell physiology	J:139001
Il12a^tm1Jm/Il12a^tm1Jm Il12b^tm1Jm/Il12b^tm1Jm (B6.129S1-Il12a^tm1Jm Il12b^tm1Jm)	impaired natural killer cell mediated cytotoxicity	J:125611
Il12a^tm1Jm/Il12a^tm1Jm Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S1/Sv * 129S6/SvEvTac)	abnormal interferon secretion	J:140483
	decreased susceptibility to bacterial infection	J:140483
	lung inflammation	J:140483
Il12b^tm1Jm/Il12b^tm1Jm (B6.129S1-Il12b^tm1Jm/J)	abnormal CD8-positive, alpha-beta T cell physiology	J:111568
	abnormal granulocyte physiology	J:111568
	abnormal lymphocyte physiology	J:120806
	abnormal macrophage physiology	J:111568
	abnormal NK cell physiology	J:120806
	decreased circulating interferon-gamma level	J:120806
	decreased interleukin-17 secretion	J:111568
	decreased susceptibility to type IV hypersensitivity reaction	J:120806
	increased susceptibility to bacterial infection	J:120806
Il12b^tm1Jm/Il12b^tm1Jm (129S1/Sv-Il12b^tm1Jm)	abnormal CD4-positive, alpha-beta T cell physiology	J:34164
	decreased susceptibility to type IV hypersensitivity reaction	J:34164
	increased susceptibility to parasitic infection	J:34164
Il12b^tm1Jm/Il12b^tm1Jm (involves: 129S1/SvImJ)	abnormal T-helper 1 physiology	J:46514
	decreased interferon-gamma secretion	J:46514
	impaired natural killer cell mediated cytotoxicity	J:46514
Il12b^tm1Jm/Il12b^tm1Jm (involves: 129S1/Sv)	increased susceptibility to bacterial infection induced morbidity/mortality	J:161073
Il12b^tm1Jm/Il12b^tm1Jm Il18^tm1Aki/Il18^tm1Aki (involves: 129P2/OlaHsd * 129S1/SvImJ)	abnormal T-helper 1 physiology	J:46514
	decreased interferon-gamma secretion	J:46514
	impaired natural killer cell mediated cytotoxicity	J:46514
Il12b^tm1Jm/Il12b^tm1Jm Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S1/Sv)	abnormal chemokine secretion	J:140483
	abnormal interferon secretion	J:140483
	increased susceptibility to bacterial infection	J:140483
	lung inflammation	J:140483
Il12b^tm1Jm/Il12b^tm1Jm Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S1/Sv * C57BL/6J)	small intestinal inflammation	J:108572
Il12rb1^tm1Jm/Il12rb1^tm1Jm (involves: 129S1/Sv * C57BL/6J)	abnormal lymphocyte physiology	J:42105
	decreased circulating interferon-gamma level	J:42105
	decreased interferon-gamma secretion	J:42105
Il12rb2^Ifnm-d/Il12rb2^Ifnm-d Tlr4^lps-del/Tlr4^lps-del (C57BL/10ScCr)	abnormal dendritic cell physiology	J:91014
	abnormal granulocyte physiology	J:91014
	abnormal immune cell physiology	J:91014
	abnormal macrophage physiology	J:91014
	abnormal NK cell physiology	J:91014
	decreased interferon-gamma secretion	J:91014, J:70821
	increased interleukin-4 secretion	J:91014
	increased susceptibility to bacterial infection	J:91014, J:70821
Il12rb2^tm1Jm/Il12rb2^tm1Jm (either: (involves: 129S1/Sv * BALB/cByJ) or (involves: 129S1/Sv * C57BL/6J))	abnormal lymphocyte physiology	J:65891
	abnormal NK cell physiology	J:65891
Il12rb2^tm1Jm/Il12rb2^tm1Jm (B6;129S1-Il12rb2^tm1Jm/J)	abnormal B cell activation	J:106805
	abnormal T cell activation	J:106805
	glomerulonephritis	J:106805
	increased anti-nuclear antigen antibody level	J:106805
	increased circulating interleukin-12 level	J:120061
	increased interleukin-6 secretion	J:106805
	liver inflammation	J:106805
	parotid gland inflammation	J:106805
	salivary gland inflammation	J:106805
	submandibular gland inflammation	J:106805
Il13^{tm1(YFP/cre)Lky}/Il13⁺ Il4^tm1(CD2)Mmrs/Il4⁺ Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	increased susceptibility to parasitic infection	J:178986
Il13^tm1.1Anjm/Il13^tm1.1Anjm (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-13 level	J:67965
	decreased IgE level	J:67965
	decreased interleukin-4 secretion	J:67965
	decreased interleukin-5 secretion	J:67965
	decreased interleukin-10 secretion	J:67965
	increased IgG2b level	J:67965
	increased IgM level	J:67965
	increased interferon-gamma secretion	J:67965
Il13^tm1.1Anjm/Il13^tm1.1Anjm (C.129P2-Il13^tm1.1Anjm)	abnormal dendritic cell antigen presentation	J:141937
	decreased IgE level	J:91403
	decreased interleukin-5 secretion	J:141937
	decreased interleukin-13 secretion	J:141937, J:91403
	decreased susceptibility to autoimmune disorder	J:141937, J:91403
	increased IgG2a level	J:91403
	increased interferon-gamma secretion	J:141937
Il13^tm1.1Anjm/Il13^tm1.1Anjm Tg(DO11.10)10Dlo/0 (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:91403
	decreased interleukin-13 secretion	J:91403
Il13^tm1Anjm/Il13⁺ Il4^tm1.1Wep/Il4⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	decreased interleukin-4 secretion	J:69099
Il13^tm1Anjm/Il13^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal interleukin secretion	J:82881
	decreased interleukin-4 secretion	J:82881
	decreased interleukin-5 secretion	J:82881
	decreased interleukin-9 secretion	J:82881
	granulomatous inflammation	J:82881, J:113543
	increased susceptibility to parasitic infection	J:113543
Il13^tm1Anjm/Il13^tm1Anjm (C.129P2-Il13^tm1Anjm)	decreased interleukin-4 secretion	J:69099
Il13^tm1Anjm/Il13^tm1Anjm (C.129P2-Il13^tm1Anjm)	decreased interleukin-13 secretion	J:69099
Il13^tm1Anjm/Il13^tm1Anjm Il5^tm3Anjm/Il5^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	granulomatous inflammation	J:113543
	increased susceptibility to parasitic infection	J:113543
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenocyte physiology	J:72587
	abnormal T-helper 2 physiology	J:89095
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:60609
	increased susceptibility to parasitic infection	J:89095
Il13^tm2Anjm/Il13^tm2Anjm (C.129P2(B6)-Il13^tm2Anjm)	abnormal response to transplant	J:110188
	abnormal type I hypersensitivity reaction	J:123772
	increased length of allograft survival	J:110188
	increased susceptibility to type I hypersensitivity reaction	J:123772
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129)	decreased circulating interleukin-13 level	J:67965
	decreased IgE level	J:67965
	decreased interleukin-4 secretion	J:67965
	decreased interleukin-5 secretion	J:67965
	decreased interleukin-10 secretion	J:67965
	increased IgG2b level	J:67965
	increased IgM level	J:67965
	increased interferon-gamma secretion	J:67965
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal chemokine level	J:131994
	abnormal macrophage physiology	J:176092
	abnormal susceptibility to infection	J:131994
	decreased susceptibility to bacterial infection	J:176092
	decreased susceptibility to parasitic infection	J:60609
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:60609
	impaired eosinophil recruitment	J:126675
	impaired neutrophil recruitment	J:105813
Il13^tm2Anjm/Il13^tm2Anjm (B6.129P2-Il13^tm2Anjm)	abnormal antigen presentation	J:131969
	abnormal leukocyte physiology	J:131969
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:131969
Il13ra1^tm1Twy/Y (C.Cg-Il13ra1^tm1Twy)	abnormal response to infection	J:130488
	abnormal T-helper 2 physiology	J:130488
	decreased IgE level	J:130488
	decreased susceptibility to parasitic infection	J:130488
	increased circulating interleukin-5 level	J:130488
	increased IgA level	J:130488
	increased IgG1 level	J:130488
	increased IgG3 level	J:130488
Il13ra2^tm1Gru/Il13ra2^tm1Gru (C.Cg-Il13ra2^tm1Gru)	abnormal macrophage physiology	J:82376
	decreased circulating interleukin-13 level	J:82376
	decreased interleukin-4 secretion	J:82376
	decreased susceptibility to endotoxin shock	J:82376
	increased IgA level	J:82376
	increased IgE level	J:82376
	increased IgG2a level	J:82376
	increased IgG2b level	J:82376
	increased interferon-gamma secretion	J:82376
	increased interleukin-10 secretion	J:82376
Il15^m1Hwata/Il15^m1Hwata (Not Specified)	abnormal interleukin secretion	J:184570
Il15^m1Hwata/Il15^m1Hwata (Not Specified)	decreased interferon-gamma secretion	J:184570
Il15^tm1Imx/Il15^tm1Imx (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:95221
	abnormal cytokine secretion	J:97620
	abnormal immune system physiology	J:60915
	abnormal susceptibility to infection	J:60915
	decreased IgG level	J:97620
	decreased IgM level	J:97620
	decreased immunoglobulin level	J:97620
	decreased interferon-gamma secretion	J:97620
	decreased interleukin-12 secretion	J:97620
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:84009
	decreased susceptibility to type IV hypersensitivity reaction	J:87137
	impaired natural killer cell mediated cytotoxicity	J:97620
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:97038
	increased susceptibility to parasitic infection	J:97620
	increased susceptibility to Poxviridae infection induced morbidity/mortality	J:60915
Il15^tm1Imx/Il15^tm1Imx (C57BL/6-Il15^tm1Imx)	abnormal dendritic cell physiology	J:123902
Il15^tm1Imx/Il15^tm1Imx X/Yaa (BXSB.B6-Il15^tm1Imx/Dcr)	increased susceptibility to systemic lupus erythematosus	J:179430
Il15ra^tm1.1Nsl/Il15ra^tm1.1Nsl (involves: 129X1/SvJ * C57BL/6)	abnormal T cell apoptosis	J:73738
	increased thymocyte apoptosis	J:73738
Il15ra^tm1.1Nsl/Il15ra^tm1.1Nsl (B6.129X1-Il15ra^tm1.1Nsl)	abnormal T cell activation	J:92705
	abnormal T cell proliferation	J:92705
	increased interleukin-2 secretion	J:92705
	increased T cell proliferation	J:92705
Il15ra^tm1.1Nsl/Il15ra^tm1.1Nsl Tg(TcrAND)53Hed/? (involves: 129X1/SvJ * C57BL/6 * SJL)	increased T cell proliferation	J:92705
Il15ra^tm1Ama/Il15ra^tm1Ama (involves: 129X1/SvJ)	abnormal NK cell physiology	J:119213
	decreased T cell proliferation	J:142570
	impaired natural killer cell mediated cytotoxicity	J:142570
Il15ra^tm1Ama/Il15ra^tm2.1Ama Lyz2^tm1(cre)Ifo/0 Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	abnormal immune system physiology	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	abnormal immune system physiology	J:155298
	abnormal NK cell physiology	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Tg(Itgax-cre)1-1Reiz/0 (involves: 129X1/SvJ * C57BL/6J * CBA)	abnormal NK cell physiology	J:155298
Il15ra^tm1Wjl/Il15ra^tm1Wjl (involves: 129 * C57BL/6)	abnormal T cell physiology	J:142570
Il15ra^tm1Wjl/Il15ra^tm1Wjl (involves: 129 * C57BL/6)	decreased T cell proliferation	J:142570
Il16^tm1Korn/Il16^tm1Korn (either: B6.129X1-Il16^tm1Korn or C.129X1-Il16^tm1Korn)	abnormal T cell physiology	J:97739
Il17a/Il17f^tm1.1Impr/Il17a/Il17f^tm1.1Impr (involves: C57BL/6)	decreased interleukin-17 secretion	J:187400
	increased T cell proliferation	J:187400
Il17a/Il17f^tm1.1Impr/Il17a/Il17f^tm1.1Impr (involves: C57BL/6)	decreased interleukin-17 secretion	J:187400
	increased T cell proliferation	J:187400
Il17a^tm1Cdon/Il17a^tm1Cdon (involves: C57BL/6)	chronic inflammation	J:136279
	decreased IgG1 level	J:136279
	decreased IgG2a level	J:136279
	decreased IgG2b level	J:136279
	decreased IgM level	J:136279
	decreased interleukin-17 secretion	J:136279
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:136279
	increased susceptibility to induced colitis	J:136279
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6J)	decreased IgG level	J:79127
	decreased immunoglobulin level	J:79127
	decreased interferon-gamma secretion	J:79127
	decreased susceptibility to type IV hypersensitivity reaction	J:79127
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)	abnormal interleukin level	J:79127
	abnormal Langerhans cell physiology	J:79127
	decreased IgE level	J:79127
	decreased IgG1 level	J:79127
	decreased immunoglobulin level	J:79127
	decreased susceptibility to type IV hypersensitivity reaction	J:79127
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:143719
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd)	abnormal immune system physiology	J:144710
Il17a^tm1Yiw/Il17a^tm1Yiw (B6.129P2-Il17a^tm1Yiw)	increased susceptibility to infection induced morbidity/mortality	J:160680
Il17a^tm1Yiw/Il17a^tm1Yiw Il1rn^tm1Yiw/Il1rn^tm1Yiw (involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)	decreased susceptibility to induced arthritis	J:83408
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm1Yiw/Il17f^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:143719
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm1Yiw/Il17f^tm1Yiw Il1rn^tm1Yiw/Il1rn^tm1Yiw (involves: 129 * BALB/c)	rheumatoid arthritis	J:143719
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm2Yiw/Il17f^tm2Yiw (involves: 129P2/OlaHsd * BALB/c)	decreased IgG3 level	J:143719
	increased IgG1 level	J:143719
	increased IgG2a level	J:143719
	increased IgG2b level	J:143719
	increased susceptibility to bacterial infection	J:143719
	nasal inflammation	J:143719
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm2Yiw/Il17f^tm2Yiw (B6.129P2-Il17a^tm1Yiw Il17f^tm2Yiw)	decreased IgG3 level	J:143719
	increased IgG1 level	J:143719
	increased IgG2a level	J:143719
	increased IgG2b level	J:143719
	increased susceptibility to infection induced morbidity/mortality	J:160680
Il17a^tm1Yiw/Il17a^tm1Yiw Tg(CD2-Rorc)#Staka/0 (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to autoimmune disorder	J:230700
Il17b^em1Cya/Il17b^em1Cya (C57BL/6-Il17b^em1Cya)	abnormal cytokine level	J:339366
	increased macrophage cytokine production	J:339366
	increased susceptibility to induced colitis	J:339366
Il17b^{Gt(371C12)Cmhd}/Il17b^{Gt(371C12)Cmhd} (B6.129-Il17b^{Gt(371C12)Cmhd})	abnormal chemokine secretion	J:229778
	abnormal interleukin secretion	J:229778
	decreased interleukin-4 secretion	J:229778
	increased interleukin-1 beta secretion	J:229778
	increased interleukin-5 secretion	J:229778
	increased interleukin-6 secretion	J:229778
	increased interleukin-13 secretion	J:229778
	increased susceptibility to bacterial infection	J:229778
	increased susceptibility to induced colitis	J:229778
	increased tumor necrosis factor secretion	J:229778
Il17c^tm1.1Cdon/Il17c^tm1.1Cdon (involves: 129S6/SvEvTac)	decreased interferon-gamma secretion	J:177650
	decreased interleukin-17 secretion	J:177650
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:177650
Il17f^tm1Awai/Il17f⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased interleukin-17 secretion	J:144710
Il17f^tm1Awai/Il17f^tm1Awai (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune system physiology	J:144710
	decreased interleukin-17 secretion	J:144710
Il17f^tm1Cdon/Il17f^tm1Cdon (involves: C57BL/6)	chronic inflammation	J:136279
	decreased acute inflammation	J:136279
	decreased interleukin-17 secretion	J:136279
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:136279
	decreased susceptibility to induced colitis	J:136279
	increased IgG2a level	J:136279
Il17f^tm1Yiw/Il17f^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:143719
Il17f^tm1Yiw/Il17f^tm1Yiw Il1rn^tm1Yiw/Il1rn^tm1Yiw (involves: 129 * BALB/c)	rheumatoid arthritis	J:143719
Il17ra^tm1.2Kurs/Il17ra^tm1.2Kurs (involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)	abnormal interleukin secretion	J:196483
	increased interleukin-6 secretion	J:196483
	increased interleukin-17 secretion	J:196483
	skin inflammation	J:196483
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129 * C57BL/6)	abnormal interleukin-5 secretion	J:139080
	abnormal interleukin-13 secretion	J:139080
	decreased inflammatory response	J:139080
	impaired neutrophil recruitment	J:71097
	increased susceptibility to infection	J:71097
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129)	decreased interleukin-9 secretion	J:158594
	decreased interleukin-17 secretion	J:177650
	impaired neutrophil recruitment	J:136279
Il17rb^tm1Anjm/Il17rb^tm1Anjm (BALB/c-Il17rb^tm1Anjm)	decreased IgE level	J:159464
Il17rb^tm1Anjm/Il17rb^tm1Anjm (BALB/c-Il17rb^tm1Anjm)	increased susceptibility to parasitic infection	J:159464
Il17rb^tm1Anjm/Il17rb^tm1Anjm Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * BALB/c)	decreased IgE level	J:159464
	increased susceptibility to parasitic infection	J:159464
Il17rb^tm1Bud/Il17rb^tm1Bud (B6.129-Il17rb^tm1Bud)	decreased inflammatory response	J:139080
	decreased interleukin-5 secretion	J:139080
	decreased interleukin-13 secretion	J:139080
Il17rb^tm1Lex/Il17rb^tm1Lex (C.129-Il17rb^tm1Lex)	abnormal chemokine secretion	J:159874
	decreased interleukin-5 secretion	J:159874
	decreased interleukin-6 secretion	J:159874
Il17rb^tm1Tgi/Il17rb⁺ (Not Specified)	decreased susceptibility to induced colitis	J:229778
Il17rb^tm1Tgi/Il17rb^tm1Tgi (B6.Cg-Il17rb^tm1Tgi)	abnormal interleukin secretion	J:184570
	decreased interleukin-9 secretion	J:184570
	decreased interleukin-10 secretion	J:184570
	decreased interleukin-13 secretion	J:184570
	decreased interleukin-17 secretion	J:184570
Il17rb^tm1Tgi/Il17rb^tm1Tgi (C.Cg-Il17rb^tm1Tgi)	abnormal interleukin secretion	J:184570
	decreased interleukin-5 secretion	J:184570
	decreased interleukin-9 secretion	J:184570
	decreased interleukin-10 secretion	J:184570
	decreased interleukin-13 secretion	J:184570
	decreased interleukin-17 secretion	J:184570
Il17rb^tm1Tgi/Il17rb^tm1Tgi (Not Specified)	decreased susceptibility to induced colitis	J:229778
Il17rc^tm1Lex/Il17rc^tm1Lex (involves: C57BL/6)	abnormal chemokine level	J:159874
	decreased inflammatory response	J:159874
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:159874
	increased interleukin-17 secretion	J:159874
Il17re^tm1Lex/Il17re^tm1Lex (B6.129S5-Il17re^tm1Lex)	increased susceptibility to induced colitis	J:178967
Il17re^tm1Sdl/Il17re^tm1Sdl (involves: C57BL/6)	increased susceptibility to bacterial infection	J:178966
Il17re^tm1Sdl/Il17re^tm1Sdl (involves: C57BL/6)	increased susceptibility to bacterial infection induced morbidity/mortality	J:178966
Il18^tm1Aki/Il18^tm1Aki (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:112400
	abnormal T-helper 1 physiology	J:46514
	decreased circulating interferon-gamma level	J:46514
	decreased circulating interleukin-18 level	J:122588, J:46514
	decreased interferon-gamma secretion	J:46514
	impaired natural killer cell mediated cytotoxicity	J:46514
	increased susceptibility to bacterial infection	J:112400
Il18^tm1Aki/Il18^tm1Aki (C.129P2-Il18^tm1Aki)	stomach inflammation	J:120594
Il18^tm1Aki/Il18^tm1Aki (B6.129P2-Il18^tm1Aki)	impaired neutrophil chemotaxis	J:125285
	increased susceptibility to bacterial infection	J:125285
	increased susceptibility to induced colitis	J:173245
Il18^tm1Aki/Il18^tm1Aki Il1b^tm1Dch/Il1b^tm1Dch (involves: 129P2/OlaHsd * 129S2/SvPas)	increased susceptibility to bacterial infection	J:112400
Il18^tm1Aki/Il18^tm1Aki Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129P2/OlaHsd * C57BL/6)	abnormal inflammatory response	J:191055
	myocarditis	J:191055
Il18^tm1Aki/Il18^tm1Aki Tg(KRT14-CASP1)1Miz/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased IgE level	J:78602
	decreased IgG1 level	J:78602
Il18^tm1Khe/Il18^tm1Khe (involves: 129P2/OlaHsd)	decreased circulating interferon-gamma level	J:62263
	decreased circulating interleukin-18 level	J:62263
	decreased susceptibility to endotoxin shock	J:62263
	increased circulating tumor necrosis factor level	J:62263
Il18^tm1Khe/Il18^tm1Khe (B6.129P2-Il18^tm1Khe)	abnormal cytokine level	J:138759
	decreased circulating interferon-gamma level	J:138759
	decreased circulating interleukin-6 level	J:138759
	decreased circulating interleukin-18 level	J:138759
	decreased interferon-gamma secretion	J:138759
	decreased susceptibility to bacterial infection	J:138759
	decreased tumor necrosis factor secretion	J:138759
Il18^tm1Liew/Il18^tm1Liew (involves: 129P2/OlaHsd * CD-1)	abnormal interferon level	J:86621
	abnormal interleukin level	J:86621
	abnormal tumor necrosis factor level	J:86621
	increased susceptibility to bacterial infection	J:86621
	increased susceptibility to parasitic infection	J:86621
	sepsis	J:86621
Il18bp^{tm1(KOMP)Vlcg}/Il18bp^{tm1(KOMP)Vlcg} (C57BL/6-Il18bp^{tm1(KOMP)Vlcg})	decreased interferon-gamma secretion	J:255309
	increased circulating interferon-gamma level	J:255309
Il18bp^{tm1.1(KOMP)Vlcg}/Il18bp^{tm1.1(KOMP)Vlcg} (involves: C57BL/6N)	abnormal circulating chemokine level	J:261967
	abnormal macrophage activation involved in immune response	J:261967
	increased circulating interferon-gamma level	J:261967
	increased circulating interleukin-18 level	J:261967
Il18r1^tm1Aki/Il18r1^tm1Aki (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal T-helper 1 physiology	J:70298
	decreased interferon-gamma secretion	J:70298
	impaired natural killer cell mediated cytotoxicity	J:70298
Il18rap^tm1Yeh/Il18rap^tm1Yeh (Not Specified)	abnormal cytokine secretion	J:98417
Il18rap^tm1Yeh/Il18rap^tm1Yeh (Not Specified)	abnormal leukocyte physiology	J:98417
Il19^tm2Vlcg/Il19^tm2Vlcg (B6.Cg-Il19^tm2Vlcg)	decreased interleukin-6 secretion	J:229575
	decreased interleukin-10 secretion	J:229575
	decreased interleukin-13 secretion	J:229575
	increased interferon-gamma secretion	J:229575
	increased interleukin-1 beta secretion	J:229575
	increased interleukin-6 secretion	J:229575
	increased interleukin-12 secretion	J:229575
	increased susceptibility to colitis induced morbidity/mortality	J:229575
	increased susceptibility to induced colitis	J:229575
	increased tumor necrosis factor secretion	J:229575
Il20^tm1Lex/Il20^tm1Lex (B6;129S5-Il20^tm1Lex/Mmucd)	abnormal type IV hypersensitivity reaction	J:171883
Il20rb^tm1Uwe/Il20rb^tm1Uwe (B6.129P2-Il20rb^tm1Uwe)	abnormal cytotoxic T cell physiology	J:143497
	abnormal T-helper 1 physiology	J:143497
	decreased interleukin-4 secretion	J:143497
	decreased interleukin-10 secretion	J:143497
	increased interferon-gamma secretion	J:143497
	increased interleukin-2 secretion	J:143497
	increased T cell proliferation	J:143497
Il20rb^tm1Uwe/Il20rb^tm1Uwe (C.129P2-Il20rb^tm1Uwe)	increased susceptibility to type IV hypersensitivity reaction	J:143497
Il21^tm1Lex/Il21^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal interleukin level	J:123351
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:123351
	increased susceptibility to experimental autoimmune encephalomyelitis	J:137377
Il21^tm1Lex/Il21^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:137867
	abnormal germinal center B cell physiology	J:137867
	decreased IgG1 level	J:137867
Il21^tm1Llit/Il21^tm1Llit (involves: 129 * C57BL/6J)	abnormal class switch recombination	J:114783
Il21^tm1Llit/Il21^tm1Llit (involves: 129 * C57BL/6J)	increased IgE level	J:114783
Il21r^tm1Day/Il21r^tm1Day (involves: BALB/c * C57BL/6)	abnormal dendritic cell physiology	J:144708
	abnormal Langerhans cell physiology	J:144708
	abnormal memory T cell physiology	J:76043
	abnormal NK cell physiology	J:76043
	abnormal plasmacytoid dendritic cell physiology	J:144708
	abnormal T cell activation	J:76043
	abnormal T cell physiology	J:76043
	abnormal thymocyte activation	J:76043
	decreased cytotoxic T cell cytolysis	J:76043
	decreased IgE level	J:144708
	decreased IgG1 level	J:76043, J:144708
	decreased IgG2a level	J:144708
	decreased IgG2b level	J:76043
	decreased interferon-gamma secretion	J:144708
	decreased interleukin-4 secretion	J:144708
	decreased interleukin-13 secretion	J:144708
	decreased interleukin-17 secretion	J:123352
	decreased susceptibility to type IV hypersensitivity reaction	J:144708
	impaired natural killer cell mediated cytotoxicity	J:76043
	increased IgE level	J:76043
	increased interferon-gamma secretion	J:76043, J:123352
Il21r^tm1Day/Il21r^tm1Day (C57BL/6-Il21r^tm1Day)	abnormal susceptibility to infection	J:111712
	abnormal T-helper 2 physiology	J:111712
	decreased IgG1 level	J:111712
	decreased IgG2b level	J:111712
	decreased interleukin-4 secretion	J:111712
	decreased interleukin-13 secretion	J:111712
	decreased interleukin-21 secretion	J:111712
Il21r^tm1Kopf/Il21r^tm1Kopf (involves: 129/Sv * BALB/c)	abnormal immunoglobulin level	J:137508
	abnormal lymphocyte physiology	J:137508
	decreased IgA level	J:137508
	decreased IgG1 level	J:137508
	impaired eosinophil recruitment	J:137508
	increased IgE level	J:137508
Il21r^tm1Kopf/Il21r^tm1Kopf (B6.129-Il21r^tm1Kopf)	abnormal immune system physiology	J:137508
	abnormal immunoglobulin level	J:137508
	abnormal leukocyte physiology	J:137508
	abnormal lymphocyte physiology	J:137508
	abnormal T-helper 1 physiology	J:137508
	abnormal T-helper 2 physiology	J:137508
	decreased IgA level	J:137508
	decreased IgG1 level	J:137508
	granulomatous inflammation	J:137508
	impaired eosinophil recruitment	J:137508
	increased IgE level	J:137508
	increased susceptibility to experimental autoimmune encephalomyelitis	J:137377
Il21r^tm1Wjl/Il21r^tm1Wjl (involves: 129 * C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:95221
	abnormal immunoglobulin level	J:80474
	decreased cytotoxic T cell cytolysis	J:95221
	decreased IgG1 level	J:80474
	decreased IgG2a level	J:80474
	decreased IgG2b level	J:80474
	decreased IgG3 level	J:80474
	decreased interleukin-17 secretion	J:124293
	increased IgE level	J:80474
Il21r^tm1Wjl/Il21r^tm1Wjl (NOD.Cg-Il21r^tm1Wjl)	decreased interleukin-17 secretion	J:139075
	decreased susceptibility to autoimmune diabetes	J:139075
	decreased T cell proliferation	J:139075
Il21r^tm1Wjl/Il21r^tm1Wjl Il4^tm1Cgn/Il4^tm1Cgn (involves: 129 * C57BL/6)	abnormal immunoglobulin level	J:80474
	decreased IgA level	J:80474
	decreased IgG1 level	J:80474
	decreased IgG2a level	J:80474
	decreased IgG2b level	J:80474
	decreased IgG3 level	J:80474
	decreased IgM level	J:80474
Il21r^tm1Wjl/Il21r^tm1Wjl X/Yaa (BXSB.129(Cg)-Il21r^tm1Wjl/Dcr)	decreased susceptibility to systemic lupus erythematosus	J:144484
Il22^{tm1.1(icre)Stck}/Il22^{tm1.1(icre)Stck} (involves: 129X1/SvJ * C57BL/6N)	increased susceptibility to bacterial infection	J:220074
Il22^tm1.1Lex/Il22^tm1.1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:118261
	ear inflammation	J:118261
Il22^tm1.1Lex/Il22^tm1.1Lex (involves: 129S5/SvEvBrd)	abnormal circulating cytokine level	J:179011
	colitis	J:161073
	decreased circulating interleukin-1 alpha level	J:179011
	decreased circulating interleukin-12 level	J:179011
	decreased circulating interleukin-12b level	J:179011
	decreased circulating tumor necrosis factor level	J:179011
	increased circulating interleukin-17 level	J:179011
	increased susceptibility to bacterial infection induced morbidity/mortality	J:161073
	increased susceptibility to fungal infection	J:179011
	lung inflammation	J:179011
Il22^tm1Flv/Il22⁺ (B6.Cg-Il22^tm1Flv)	increased susceptibility to endotoxin shock	J:126103
Il22^tm1Flv/Il22^tm1Flv (B6.Cg-Il22^tm1Flv)	increased susceptibility to endotoxin shock	J:126103
Il22^tm1Flv/Il22^tm1Flv (B6.Cg-Il22^tm1Flv)	liver inflammation	J:126103
Il22^tm1Flv/Il22^tm1Flv (involves: 129/Sv * C57BL/6)	increased susceptibility to induced colitis	J:189217
Il22^tm1Jcrd/Il22^tm1Jcrd (Not Specified)	increased interleukin-17 secretion	J:193548
Il22ra2^tm2Vlcg/Il22ra2^tm2Vlcg (B6.Cg-Il22ra2^tm2Vlcg)	colitis	J:189217
Il23a^tm1.1Thak/Il23a^tm1.1Thak (C57BL/6-Il23a^tm1.1Thak)	decreased interferon-gamma secretion	J:143970
	decreased interleukin-17 secretion	J:143970
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:143970
	decreased T cell proliferation	J:143970
Il23a^tm1Dnax/Il23a^tm1Dnax (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:95542
	decreased interleukin-17 secretion	J:95542
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:95542
Il23a^tm1Dnax/Il23a^tm1Dnax (B6.Cg-Il23a^tm1Dnax)	abnormal CD8-positive, alpha-beta T cell physiology	J:111568
	abnormal granulocyte physiology	J:111568
	abnormal interleukin level	J:111568
	abnormal macrophage physiology	J:111568
Il23a^tm1Dnax/Il23a^tm1Dnax (Not Specified)	decreased interleukin-17 secretion	J:193548
Il23a^tm1Gdy/Il23a⁺ (B6.Cg-Il23a^tm1Gdy)	increased susceptibility to induced colitis	J:139557
Il23a^tm1Gdy/Il23a^tm1Gdy (B6.Cg-Il23a^tm1Gdy)	increased susceptibility to induced colitis	J:139557
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:88235
	abnormal memory T cell physiology	J:88235
	decreased IgA level	J:88235
	decreased IgG2a level	J:88235
	decreased immunoglobulin level	J:88235
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129 * C57BL/6)	abnormal circulating interleukin level	J:216867
	abnormal memory T cell physiology	J:120806
	decreased susceptibility to induced colitis	J:216867
	granulomatous inflammation	J:120806
	increased circulating interleukin-17 level	J:216867
	increased susceptibility to bacterial infection	J:120806
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129)	increased susceptibility to bacterial infection induced morbidity/mortality	J:161073
Il23r^tm1.1Kuch/Il23r^tm1.1Kuch (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:151907
Il23r^tm1.1Kuch/Il23r^tm1.1Kuch (involves: C57BL/6)	decreased interleukin-9 secretion	J:151907
Il23r^tm1.1Ngh/Il23r^tm1.1Ngh (involves: C57BL/6)	abnormal circulating interleukin level	J:216867
	decreased susceptibility to induced colitis	J:216867
	increased circulating interleukin-17 level	J:216867
Il23r^tm1.1Ngh/Il23r^tm1.1Ngh Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	abnormal circulating interleukin level	J:216867
	decreased interleukin-17 secretion	J:216867
Il23r^tm1Kuch/Il23r^tm1Kuch (C57BL/6-Il23r^tm1Kuch)	abnormal CD4-positive, alpha-beta T cell physiology	J:148248
Il23r^tm1Kuch/Il23r^tm1Kuch (C57BL/6-Il23r^tm1Kuch)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:148248
Il25^tm1.1Cdon/Il25^tm1.1Cdon (involves: 129S6/SvEvTac)	abnormal chemokine secretion	J:229778
	abnormal interleukin secretion	J:229778
	decreased interleukin-1 beta secretion	J:229778
	decreased interleukin-4 secretion	J:229778, J:158594
	decreased interleukin-5 secretion	J:229778, J:158594
	decreased interleukin-9 secretion	J:158594
	decreased interleukin-13 secretion	J:229778, J:158594
	decreased susceptibility to bacterial infection	J:229778
	decreased susceptibility to induced colitis	J:229778
	decreased tumor necrosis factor secretion	J:229778
	increased susceptibility to type I hypersensitivity reaction	J:158594
	lung inflammation	J:158594
Il25^tm1Anjm/Il25^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal interleukin secretion	J:123748
	decreased interleukin-5 secretion	J:123748
	decreased interleukin-13 secretion	J:123748
	increased IgE level	J:123748
	increased susceptibility to parasitic infection	J:123748
Il25^tm1Cdon/Il25^tm1Cdon Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6N * SJL)	decreased susceptibility to induced colitis	J:229778
Il25^tm1Dart/Il25^tm1Dart (C57BL/6-Il25^tm1Dart)	abnormal interferon level	J:123808
	abnormal interleukin level	J:123808
	abnormal response to infection	J:123808
	decreased IgG2a level	J:123808
	increased susceptibility to parasitic infection	J:123808
	intestinal inflammation	J:123808
Il25^tm1Dart/Il25^tm1Dart (involves: C57BL/6)	abnormal interleukin level	J:125296
Il25^tm1Dart/Il25^tm1Dart (involves: C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:125296
Il27^tm1Cua/Il27^tm1Cua (C57BL/6-Il27^tm1Cua)	increased susceptibility to experimental autoimmune encephalomyelitis	J:147706
Il27^tm1Cua/Il27^tm1Cua (C57BL/6-Il27^tm1Cua)	increased susceptibility to type IV hypersensitivity reaction	J:147706
Il27^tm1Lex/Il27^tm1Lex (involves: 129S/SvEvBrd)	increased circulating interleukin-12b level	J:187660
	increased interferon-gamma secretion	J:187660
	increased susceptibility to parasitic infection induced morbidity/mortality	J:187660
Il27ra^tm1Fjs/Il27ra^tm1Fjs (B6.Cg-Il27ra^tm1Fjs)	abnormal T-helper 1 physiology	J:94856
Il27ra^tm1Fjs/Il27ra^tm1Fjs (B6.Cg-Il27ra^tm1Fjs)	decreased susceptibility to bacterial infection	J:94856
Il27ra^tm1Mak/Il27ra^tm1Mak (B6.129P2-Il27ra^tm1Mak)	abnormal T-helper 1 physiology	J:116610, J:89509
	decreased circulating interferon-gamma level	J:116610
	decreased interferon-gamma secretion	J:116610, J:89509
	decreased susceptibility to experimental autoimmune uveoretinitis	J:116610
	increased circulating interferon-gamma level	J:88618
	increased circulating interleukin-1 beta level	J:88618
	increased circulating interleukin-4 level	J:88618
	increased circulating interleukin-6 level	J:88618
	increased circulating interleukin-12 level	J:88618
	increased circulating tumor necrosis factor level	J:88618
	increased interferon-gamma secretion	J:88618
	increased interleukin-4 secretion	J:88618
	increased susceptibility to bacterial infection	J:89509
	increased susceptibility to parasitic infection	J:89509
	increased T cell proliferation	J:89509
Il27ra^tm1Mak/Il27ra^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to induced arthritis	J:151552
Il31ra^tm1Ngh/Il31ra^tm1Ngh (involves: C57BL/6)	abnormal interleukin level	J:123198
	abnormal macrophage physiology	J:123198
	granulomatous inflammation	J:123198
	increased IgE level	J:123198
	increased susceptibility to parasitic infection	J:123198
	increased T cell proliferation	J:123198
Il33^{tm1(KOMP)Vlcg}/Il33^{tm1(KOMP)Vlcg} (C57BL/6-Il33^{tm1(KOMP)Vlcg})	impaired macrophage chemotaxis	J:232676
Il33^tm1Aki/Il33^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal T-helper 2 physiology	J:182160
	decreased IgE level	J:182160
	increased susceptibility to parasitic infection	J:182160
Il33^tm1Amgn/Il33^tm1Amgn (B6.129-Il33^tm1Amgn)	abnormal immune cell physiology	J:192531
Il33^tm1Amgn/Il33^tm1Amgn (B6.129-Il33^tm1Amgn)	increased susceptibility to parasitic infection	J:192531
Il33^tm1Snak/Il33^tm1Snak (involves: C57BL/6 * CBA)	decreased inflammatory response	J:165513
	decreased interleukin-1 alpha secretion	J:165513
	decreased interleukin-1 beta secretion	J:165513
	decreased interleukin-6 secretion	J:165513
	decreased susceptibility to endotoxin shock	J:165513
	increased susceptibility to induced colitis	J:165513
	lung inflammation	J:165513
Il34^{tm1b(EUCOMM)Wtsi}/Il34^{tm1b(EUCOMM)Wtsi} (involves: BALB/cJ * C57BL/6N)	decreased interferon-gamma secretion	J:187643
	decreased susceptibility to fungal infection	J:187643
	decreased susceptibility to type IV hypersensitivity reaction	J:187643
	increased susceptibility to Flaviviridae infection	J:187643
	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:187643
Il36a^tm1Yiw/Il36a^tm1Yiw (B6.129P2-Il36a^tm1Yiw)	abnormal cytokine level	J:263315
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal interleukin level	J:264077
	abnormal tumor necrosis factor level	J:264077
	increased macrophage apoptosis	J:264077
	increased susceptibility to Orthomyxoviridae infection	J:264077
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:264077
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd)	decreased interleukin-9 secretion	J:256437
	decreased susceptibility to induced colitis	J:256437
	impaired neutrophil recruitment	J:280917
	increased susceptibility to Herpesvirales infection	J:280917
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:280917
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal cytokine level	J:296074
	abnormal macrophage activation involved in immune response	J:296074
	impaired macrophage phagocytosis	J:296074
	increased susceptibility to bacterial infection	J:296074
	increased susceptibility to bacterial infection induced morbidity/mortality	J:296074
Il36rn^tm1Hblu/Il36rn⁺ Tg(KRT14-Il1f6)1Hblu/? (involves: 129 * C57BL/6 * DBA/2)	skin inflammation	J:126327
Il36rn^tm1Hblu/Il36rn^tm1Hblu (C.129(B6)-Il36rn^tm1Hblu)	increased susceptibility to chemically induced skin inflammation	J:260118
Il36rn^tm1Hblu/Il36rn^tm1Hblu Tg(KRT14-Il1f6)1Hblu/? (involves: 129 * C57BL/6 * DBA/2)	skin inflammation	J:126327
Il36rn^tm1Kopf/Il36rn^tm1Kopf (B6.129S5-Il36rn^tm1Kopf)	dermatitis	J:193548
Ilf3^tm1.1Itl/Ilf3^tm1.1Itl (Not Specified)	increased susceptibility to Adenoviridae infection	J:167126
Ilk^tm1Star/Ilk^tm1Star Tg(KRT14-cre)1Amc/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	skin inflammation	J:172934
Ilk^tm1Star/Ilk^tm1Star Tg(NPHS2-cre)295Lbh/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	tubulointerstitial nephritis	J:129286, J:129244
Ilk^tm1Star/Ilk^tm2Star Tg(Acp5-cre)1Star/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast physiology	J:197593
Im1^Bioz:BP1/? (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:46394
Im2^Bioz:BP1/? (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:37251
Im2^Bioz:BP1/Im2^Bioz:BP1 (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:65671
Im3^Bioz:BP1/? (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:46394
Im4^Bioz:BP1/? (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:37251
Im5^Bioz:BP1/? (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:37251
Im6^Bioz:BP1/? (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:37251
Im7^Bioz:BP1/? (involves: Bioz:BP1 * Bioz:MP1)	abnormal humoral immune response	J:37251
Imh1^NZB/Imh1^NZB (involves: NZB * NZW)	increased IgM level	J:26266
Imh1^NZB/Imh1^NZB (involves: NZB * NZW)	increased susceptibility to systemic lupus erythematosus	J:26266
Imh1^NZB/Imh1^NZW (involves: NZB * NZW)	increased IgM level	J:26266
Imh1^NZB/Imh1^NZW (involves: NZB * NZW)	increased susceptibility to systemic lupus erythematosus	J:22353
Imm1^NZW/Imm1^NZB (involves: NZB * NZW)	abnormal immune system physiology	J:26266
Imm1^NZW/Imm1^NZW (involves: NZB * NZW)	abnormal immune system physiology	J:26266
Immp2l^{Tg(HLA-A/H2-D)2Enge}/? ((C57BL/6 x CBA)F1)	abnormal cytotoxic T cell physiology	J:31937
Impdh1^tm1Bmi/Impdh1^tm1Bmi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased T cell proliferation	J:85443
Impdh1^tm1Bmi/Impdh1^tm1Bmi Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal cytotoxic T cell physiology	J:85443
	decreased splenocyte proliferation	J:85443
	decreased T cell proliferation	J:85443
Imraq1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased IgG level	J:100370
Imraq2^DBA/2J/? Imraq3^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased IgG level	J:100370
Imrfq1^C57BL/6J/? Imrfq2^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased IgG level	J:100370
In(2a;Itch)18H/In(2a;Itch)18H (involves: 101/H * C3H/HeH)	chronic inflammation	J:24934
	increased inflammatory response	J:45910
	interstitial pneumonia	J:24934
	lung inflammation	J:24934
Inava^tm1.1Itl/Inava^tm1.1Itl (involves: 129S6/SvEvTac * C57BL/6NTac)	increased susceptibility to bacterial infection	J:257317
	increased susceptibility to induced colitis	J:257317
Inca1^tm1Cmt/Inca1^tm1Cmt (involves: 129 * C57BL/6N)	increased IgA level	J:175667
Ing1^{Gt(OST206270)Lex}/Ing1^{Gt(OST206270)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased thymocyte apoptosis	J:118602
Ing4^Gt(XG370)Byg/Ing4^Gt(XG370)Byg (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine level	J:161381
	increased circulating interleukin-6 level	J:161381
	increased interleukin-6 secretion	J:161381
Inha^tm1Bay/Inha^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	chronic liver inflammation	J:20450
Inhbb^tm1Jae/Inhbb^tm1Jae (either: (129S4/SvJae-Inhbb^tm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	increased incidence of corneal inflammation	J:16995
Inpp1^{tm1a(KOMP)Wtsi}/Inpp1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased susceptibility to bacterial infection	J:213427
Inpp5d^el20/Inpp5d^el20 (B6.129-Inpp5d^el20)	increased circulating interleukin-6 level	J:173266
	increased IgG2a level	J:173266
	increased IgM level	J:173266
	increased immunoglobulin level	J:173266
Inpp5d^m1Anu/Inpp5d^m1Anu (C57BL/6JAnu-Inpp5d^m1Anu)	lung inflammation	J:104190
Inpp5d^m1Btlr/Inpp5d^m1Btlr (C57BL/6J-Inpp5d^m1Btlr)	abnormal eosinophil physiology	J:140987
	abnormal neutrophil physiology	J:140987
	decreased cytotoxic T cell cytolysis	J:140987
	impaired natural killer cell mediated cytotoxicity	J:140987
Inpp5d^m4Btlr/Inpp5d^m4Btlr (C57BL/6J-Inpp5d^m4Btlr)	increased interferon-beta secretion	J:272854
Inpp5d^m4Btlr/Inpp5d^m4Btlr (C57BL/6J-Inpp5d^m4Btlr)	increased tumor necrosis factor secretion	J:272854
Inpp5d^tm1.1Wgk/Inpp5d^tm1.1Wgk (involves: 129S6/SvEvTac * C57BL/6J)	abnormal leukocyte physiology	J:94861
	decreased susceptibility to graft versus host disease	J:95215, J:94861
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (involves: 129P2/OlaHsd)	abnormal leukocyte physiology	J:77739
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (B6.129P2/OlaHsd-Inpp5d^tm1Dmt)	increased circulating interleukin-6 level	J:173266
Inpp5d^tm1Rav/Inpp5d^tm1Rav Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghAb36-65)1Wys/0 (involves: 129 * BALB/c * C57BL/6 * FVB/N)	abnormal B cell anergy	J:178833
	increased autoantibody level	J:178833
Inpp5d^tm1Rav/Inpp5d^tm1Rav Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:122796
	abnormal humoral immune response	J:122796
	abnormal interferon level	J:122796
	abnormal interleukin secretion	J:122796
	decreased susceptibility to parasitic infection	J:122796
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal macrophage chemotaxis	J:48193
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal interleukin level	J:173301
	ileum inflammation	J:173301
	increased circulating interleukin-6 level	J:117320
	intestinal inflammation	J:173301
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell physiology	J:110864
	abnormal CD4-positive, alpha-beta T cell physiology	J:110864
	abnormal CD8-positive, alpha-beta T cell physiology	J:110864
	abnormal cell-mediated immunity	J:110864
	abnormal macrophage chemotaxis	J:110864
	abnormal osteoclast physiology	J:78771
	abnormal T cell physiology	J:110864
	increased circulating interleukin-6 level	J:78771
	increased mast cell degranulation	J:120426
Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn/0 (B6.Cg-Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn)	abnormal leukocyte physiology	J:144110
Inpp5d^tm1Wgk/Inpp5d^tm1Wgk Tg(Mx1-cre)1Cgn/0 (B6.Cg-Inpp5d^tm1Wgk Tg(Mx1-cre)1Cgn)	decreased susceptibility to graft versus host disease	J:144110
Ins1^tm1Jja/Ins1^tm1Jja (NOD.129S2-Ins1^tm1Jja)	decreased susceptibility to autoimmune diabetes	J:85309
Ins1^tm1Jja/Ins1^tm1Jja Ins2^tm1Jja/Ins2^tm1Jja Tg(Ins2Y16A)1Ell/0 (NOD.Cg-Ins1^tm1Jja Ins2^tm1Jja Tg(Ins2Y16A)1Ell)	decreased susceptibility to autoimmune diabetes	J:98583
	salivary gland inflammation	J:98583
Ins1^tm1Jja/Ins1^tm1Jja Ins2^tm1Jja/Ins2^tm1Jja Tg(Ins2Y16A)3Ell/0 (NOD.Cg-Ins1^tm1Jja Ins2^tm1Jja Tg(Ins2Y16A)3Ell)	decreased anti-insulin autoantibody level	J:98583
	decreased susceptibility to autoimmune diabetes	J:98583
	salivary gland inflammation	J:98583
Ins1^tm1Jja/Ins1^tm1Jja Ins2^tm1Mnt/Ins2^tm1Mnt Tg(Aire-cre)1Mnt/0 (involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal immune system physiology	J:152798
	abnormal interferon-gamma secretion	J:152798
	abnormal T cell physiology	J:152798
	increased anti-insulin autoantibody level	J:152798
	pancreas inflammation	J:152798
Ins1^tm1Jja/Ins1^tm1Jja Tg(Ins2Y16A)1Ell/0 (NOD.Cg-Ins1^tm1Jja Tg(Ins2Y16A)1Ell)	increased susceptibility to autoimmune diabetes	J:98583
Ins1^tm1Jja/Ins1^tm1Jja Tg(Ins2Y16A)3Ell/0 (NOD.Cg-Ins1^tm1Jja Tg(Ins2Y16A)3Ell)	autoimmune response	J:98583
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita/J)	abnormal response to transplant	J:76224
Ins2^C95S/Ins2⁺ (C3HeB/FeJ-Ins2^C95S)	increased susceptibility to autoimmune diabetes	J:122098
Ins2^C95S/Ins2^C95S (C3HeB/FeJ-Ins2^C95S)	increased susceptibility to autoimmune diabetes	J:122098
Ins2^tm1Jja/Ins2^tm1Jja (NOD.129S2-Ins2^tm1Jja)	increased anti-insulin autoantibody level	J:85309
Ins2^tm1Jja/Ins2^tm1Jja (NOD.129S2-Ins2^tm1Jja)	insulitis	J:85309
Ins2^tm1Jja/Ins2^tm1Jja Tg(Ins2Y16A)3Ell/0 (NOD.Cg-Ins2^tm1Jja Tg(Ins2Y16A)3Ell)	autoimmune response	J:98583
	increased anti-insulin autoantibody level	J:98583
Insr^m1Btlr/Insr^m1Btlr (C57BL/6J-Insr^m1Btlr)	increased susceptibility to induced colitis	J:267534
Insr^tm1Khn/Insr^tm1Khn Lepr^tm1.1Chua/Lepr^tm1.1Chua Tg(Pomc1-cre)16Lowl/0 (involves: 129 * 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * FVB/N)	liver inflammation	J:192274
	ovary inflammation	J:192274
	white adipose tissue inflammation	J:192274
Ip6k2^tm1.1Snyd/Ip6k2^tm1.1Snyd (B6.129-Ip6k2^tm1.1Snyd)	abnormal B cell physiology	J:212482
Irak1^tm1.1Pcoh/? (involves: 129P2/OlaHsd)	decreased interferon-alpha secretion	J:205798
Irak1^tm1.1Pcoh/? Irak2^tm1.1Pcoh/? (involves: 129P2/OlaHsd * C57BL/6)	decreased interferon-alpha secretion	J:205798
Irak1^tm1Jth/Y (B6.Cg-Irak1^tm1Jth)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:82302
Irak1^tm1Jth/Y Irak2^tm1Aki/Irak2^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal dendritic cell physiology	J:136290
	abnormal macrophage physiology	J:136290
	decreased susceptibility to endotoxin shock	J:136290
Irak1^tm1Jth/Y Tg(Myh6-Tnf)1Brgi/? (involves: 129/Sv * C57BL/6J * SJL)	myocarditis	J:84829
Irak1^tm1Jth/Irak1^tm1Jth (B6.Cg-Irak1^tm1Jth)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:82302
Irak1^tm1Jth/Irak1^tm1Jth Tg(Myh6-Tnf)1Brgi/? (involves: 129/Sv * C57BL/6J * SJL)	myocarditis	J:84829
Irak2^tm1.1Pcoh/? (involves: C57BL/6)	decreased interferon-alpha secretion	J:205798
Irak2^tm1Aki/Irak2^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal macrophage physiology	J:136290
Irak2^tm1Aki/Irak2^tm1Aki (involves: 129/Sv * C57BL/6)	decreased susceptibility to endotoxin shock	J:136290
Irak2^tm1Jth/Irak2^tm1Jth (involves: 129 * C57BL/6)	abnormal chemokine level	J:149258
	decreased circulating interleukin-6 level	J:149258
	decreased circulating tumor necrosis factor level	J:149258
	decreased interleukin-6 secretion	J:149258
	decreased susceptibility to endotoxin shock	J:149258
	decreased tumor necrosis factor secretion	J:149258
Irak3^tm1Flv/Irak3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal inflammatory response	J:78189
	abnormal innate immunity	J:78189
	abnormal osteoclast physiology	J:98035
	increased interleukin-6 secretion	J:78189
	increased interleukin-12b secretion	J:78189
	increased susceptibility to endotoxin shock	J:78189
	increased tumor necrosis factor secretion	J:78189
Irak3^tm1Flv/Irak3^tm1Flv (NOD.129S1(B6)-Irak3^tm1Flv)	abnormal dendritic cell physiology	J:229884
	abnormal professional antigen presenting cell physiology	J:229884
	abnormal T cell activation	J:229884
	increased anti-insulin autoantibody level	J:229884
	increased susceptibility to autoimmune diabetes	J:229884
	insulitis	J:229884
Irak4^m1Btlr/Irak4^m1Btlr (C57BL/6J-Irak4^m1Btlr)	decreased tumor necrosis factor secretion	J:133271
Irak4^m1Btlr/Irak4^m1Btlr Ticam1^Lps2/Ticam1^Lps2 (involves: C57BL/6J)	decreased tumor necrosis factor secretion	J:187583
Irak4^tm1Aki/Irak4^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:125729
	decreased B cell proliferation	J:125729
	decreased interferon-alpha secretion	J:125729
	decreased interleukin-6 secretion	J:125729
	decreased interleukin-12b secretion	J:125729
	decreased susceptibility to endotoxin shock	J:125729
	decreased tumor necrosis factor secretion	J:125729
Irak4^tm1Gram/Irak4^tm1Gram (involves: BALB/c)	abnormal chemokine secretion	J:121912
Irak4^tm1Gram/Irak4^tm1Gram (involves: BALB/c)	abnormal cytokine secretion	J:121912
Irak4^tm1Lix/Irak4^tm1Lix (involves: C57BL/6)	abnormal chemokine secretion	J:125732
	decreased acute inflammation	J:125732
	decreased circulating interleukin-6 level	J:125732
	decreased circulating tumor necrosis factor level	J:125732
	decreased interferon-alpha secretion	J:125732
	decreased interferon-beta secretion	J:125732
	decreased interleukin-6 secretion	J:125732
	decreased susceptibility to endotoxin shock	J:125732
	decreased tumor necrosis factor secretion	J:125732
Irak4^tm1Yeh/Irak4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6J)	abnormal cytokine level	J:76098
	abnormal cytokine secretion	J:76098
	abnormal macrophage physiology	J:76098
	abnormal NK cell physiology	J:76098
	decreased B cell proliferation	J:76098
	decreased circulating interferon-gamma level	J:76098
	decreased circulating interleukin-1 level	J:76098
	decreased circulating interleukin-6 level	J:76098
	decreased circulating tumor necrosis factor level	J:76098
	decreased interleukin-6 secretion	J:76098
	decreased susceptibility to endotoxin shock	J:76098
	decreased tumor necrosis factor secretion	J:76098
	increased susceptibility to bacterial infection	J:76098
Irak4^tm2Aki/Irak4^tm2Aki (involves: 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:125729
	decreased B cell proliferation	J:125729
	decreased interferon-alpha secretion	J:125729
	decreased interleukin-6 secretion	J:125729
	decreased interleukin-12b secretion	J:125729
	decreased susceptibility to endotoxin shock	J:125729
	decreased tumor necrosis factor secretion	J:125729
Irav1^C57BL/J/Irav1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal cell-mediated immunity	J:122129
Irav1^C57BL/J/Irav1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal cytokine secretion	J:122129
Irav1^DBA/2J/Irav1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal cell-mediated immunity	J:122129
Irav1^DBA/2J/Irav1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal cytokine secretion	J:122129
Irf1^M1Btlr/Irf1⁺ (C57BL/6J-Irf1^M1Btlr)	impaired natural killer cell mediated cytotoxicity	J:162995
Irf1^M1Btlr/Irf1⁺ (C57BL/6J-Irf1^M1Btlr)	increased susceptibility to Herpesvirales infection	J:162995
Irf1^M1Btlr/Irf1^M1Btlr (C57BL/6J-Irf1^M1Btlr)	decreased interferon-alpha secretion	J:162995
	decreased interferon-beta secretion	J:162995
	impaired natural killer cell mediated cytotoxicity	J:162995
	increased susceptibility to Herpesvirales infection	J:162995
Irf1^tm1Cwe/Irf1^tm1Cwe (involves: 129/Sv * C57BL/6)	abnormal cytokine level	J:110672
	abnormal immune system physiology	J:43086
	abnormal immunoglobulin level	J:101427
	abnormal macrophage physiology	J:43086
	decreased circulating interleukin-2 level	J:110672
	decreased susceptibility to induced arthritis	J:43086
	increased circulating interferon-gamma level	J:110672
	increased circulating interleukin-3 level	J:110672
	increased circulating interleukin-4 level	J:110672
	increased circulating interleukin-5 level	J:110672
	increased circulating interleukin-6 level	J:110672
	increased susceptibility to Poxviridae infection	J:101427
Irf1^tm1Cwe/Irf1^tm1Cwe (involves: 129)	abnormal circulating interleukin-4 level	J:84367
	abnormal circulating interleukin-10 level	J:84367
	abnormal cytokine level	J:84367
	abnormal T cell proliferation	J:84367
	decreased circulating interferon-gamma level	J:84367
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:84367
	increased circulating interleukin-5 level	J:84367
	increased circulating interleukin-6 level	J:84367
	increased circulating interleukin-13 level	J:84367
Irf1^tm1Mak/Irf1^tm1Mak (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))	abnormal response to infection	J:64286
Irf1^tm1Mak/Irf1^tm1Mak (B6.129S2-Irf1^tm1Mak/J)	abnormal lymphocyte physiology	J:91927
Irf1^tm1Mak/Irf1^tm1Mak (B6.129S2-Irf1^tm1Mak/J)	decreased interferon-gamma secretion	J:91927
Irf2^tm1Mak/Irf2^tm1Mak (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))	abnormal immune system physiology	J:64286
	abnormal response to infection	J:64286
	decreased B cell proliferation	J:64286
	decreased IgG2a level	J:64286
Irf2^tm1Mak/Irf2^tm1Mak (involves: 129S2/SvPas * C57BL/6)	dermatitis	J:66034
Irf3^tm1Ttg/Irf3^tm1Ttg (involves: 129S/SvEv * C57BL/6J)	abnormal circulating interferon level	J:98127
Irf3^tm1Ttg/Irf3^tm1Ttg (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to Picornaviridae infection	J:98127
Irf3^tm1Ttg/Irf3^tm1Ttg Irf7^tm1Ttg/Irf7^tm1Ttg (involves: 129P2/OlaHsd * 129S/SvEv)	decreased interferon-beta secretion	J:158969
	decreased interleukin-1 beta secretion	J:158969
	increased susceptibility to bacterial infection	J:158969
	increased susceptibility to Herpesvirales infection	J:158969
	increased susceptibility to Paramyxoviridae infection	J:158969
Irf3^tm1Ttg/Irf3^tm1Ttg Irf9^tm1Ttg/Irf9^tm1Ttg (involves: 129S/SvEv * C57BL/6J)	abnormal cytokine secretion	J:98127
Irf3^tm1Ttg/Irf3^tm1Ttg Sting1^em1Jmin/Sting1^em1Jmin (involves: 129S/SvEv * C57BL/6N)	lung inflammation	J:251372
Irf4^m1Btlr/Irf4^m1Btlr (C57BL/6J-Irf4^m1Btlr)	abnormal B cell activation	J:160882
	decreased IgG level	J:160882
	decreased IgM level	J:160882
Irf4^m1Btlr/Irf4^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Irf4^M2Btlr/Irf4⁺ (C57BL/6J-Irf4^M2Btlr)	abnormal B cell activation	J:234245
	decreased IgG level	J:234245
	decreased IgM level	J:234245
Irf4^M2Btlr/Irf4^M2Btlr (C57BL/6J-Irf4^M2Btlr)	abnormal B cell activation	J:234245
	decreased IgG level	J:234245
	decreased IgM level	J:234245
Irf4^tm1.1Rdf/Irf4^tm1.1Rdf (involves: 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:112643
	decreased B cell proliferation	J:112643
	decreased IgG1 level	J:112643
Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd)	abnormal immune system physiology	J:42683
	decreased B cell proliferation	J:42683
	decreased immunoglobulin level	J:42683
	decreased T cell proliferation	J:42683
	increased susceptibility to Riboviria infection	J:42683
Irf4^tm1Mak/Irf4^tm1Mak (B6.129P2-Irf4^tm1Mak)	increased susceptibility to bacterial infection	J:78909
Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:81744
Irf4^tm1Rdf/Irf4^tm1.1Rdf (involves: 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal B cell physiology	J:112643
Irf5^tm1Ttg/Irf5^tm1Ttg (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 physiology	J:97567
	decreased circulating interleukin-6 level	J:97567
	decreased circulating interleukin-12b level	J:97567
	decreased circulating tumor necrosis factor level	J:97567
	decreased susceptibility to bacterial infection	J:97567
Irf5^tm1Ttg/Irf5^tm1Ttg (B6.129P2-Irf5^tm1Ttg)	abnormal response to infection	J:182658
	decreased interferon-alpha secretion	J:182658
	decreased interleukin-6 secretion	J:182658
	decreased tumor necrosis factor secretion	J:182658
Irf7^m1Btlr/Irf7⁺ (C57BL/6J-Irf7^m1Btlr)	decreased interferon-alpha secretion	J:159358
Irf7^m1Btlr/Irf7⁺ (C57BL/6J-Irf7^m1Btlr)	decreased interferon-beta secretion	J:159358
Irf7^m1Btlr/Irf7^m1Btlr (C57BL/6J-Irf7^m1Btlr)	decreased interferon-alpha secretion	J:159358
Irf7^m1Btlr/Irf7^m1Btlr (C57BL/6J-Irf7^m1Btlr)	decreased interferon-beta secretion	J:159358
Irf7^M2Btlr/Irf7⁺ (C57BL/6J-Irf7^M2Btlr)	decreased circulating interferon-beta level	J:217798
Irf7^M2Btlr/Irf7^M2Btlr (C57BL/6J-Irf7^M2Btlr)	decreased circulating interferon-beta level	J:217798
Irf7^tm1Ttg/Irf7^tm1Ttg (involves: 129P2/OlaHsd)	abnormal interferon level	J:97662
	abnormal T cell physiology	J:97662
	increased susceptibility to Herpesvirales infection	J:97662
	increased susceptibility to Picornaviridae infection	J:97662
Irf7^tm1Ttg/Irf7^tm1Ttg (B6.129P2-Irf7^tm1Ttg)	increased susceptibility to Orthomyxoviridae infection	J:233979
Irf7^tm1Ttg/Irf7^tm1Ttg (B6.129P2-Irf7^tm1Ttg)	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:233979
Irf8^M1Btlr/Irf8^M1Btlr (C57BL/6J-Irf8^M1Btlr)	abnormal interferon secretion	J:166600
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (BXH2/TyJ)	decreased interferon-gamma secretion	J:97931
	decreased interleukin-12 secretion	J:97931
	increased susceptibility to bacterial infection	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (involves: BXH2/TyJ * C57BL/6J)	increased susceptibility to bacterial infection	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (involves: BALB/cJ * BXH2/TyJ)	increased susceptibility to bacterial infection	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (involves: BXH2/TyJ * C3H/HeJ)	increased susceptibility to bacterial infection	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^s (involves: BXH2/TyJ * C57BL/6J)	increased susceptibility to bacterial infection	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^s (involves: BALB/cJ * BXH2/TyJ)	increased susceptibility to bacterial infection	J:97931
Irf8^myls/Irf8^myls Slc11a1^s/Slc11a1^s (involves: BALB/cJ * BXH2/TyJ)	increased susceptibility to bacterial infection	J:97931
Irf8^tm1Hor/Irf8^tm1Hor (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal cytotoxic T cell physiology	J:36038
	decreased interferon-gamma secretion	J:36038
	increased immunoglobulin level	J:36038
	increased susceptibility to Riboviria infection	J:36038
Irf8^tm1Hor/Irf8^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:181366
Irf8^tm1Hor/Irf8^tm1Hor Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	decreased IgM level	J:84577
Irf9^M1Btlr/Irf9⁺ (C57BL/6J-Irf9^M1Btlr)	increased circulating interferon-beta level	J:236674
Irf9^M1Btlr/Irf9^M1Btlr (C57BL/6J-Irf9^M1Btlr)	increased circulating interferon-beta level	J:236674
Irf9^tm1Ttg/Irf9^tm1Ttg (B6.Cg-Irf9^tm1Ttg)	decreased interferon-alpha secretion	J:97662
Irf9^tm1Ttg/Irf9^tm1Ttg (either: (involves: C57BL/6 * CBA * ICR) or (involves: A/J * C57BL/6 * CBA))	increased susceptibility to viral infection	J:77456
Irgm1^tm1Gat/Irgm1^tm1Gat (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased circulating interferon-gamma level	J:87535
	increased circulating interleukin-12 level	J:87535
	increased susceptibility to bacterial infection	J:87535
	increased susceptibility to parasitic infection	J:87535
Irgm2^em1Myam/Irgm2^em1Myam (C57BL/6-Irgm2^em1Myam)	increased susceptibility to parasitic infection	J:308470
Irgm2^em1Myam/Irgm2^em1Myam (C57BL/6-Irgm2^em1Myam)	increased susceptibility to parasitic infection induced morbidity/mortality	J:308470
Irs1^tm1Mfw/Irs1^tm1Mfw Irs2^tm2Mfw/Irs2^tm2Mfw Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	increased susceptibility to autoimmune diabetes	J:137845
Irs1^tm1Tka/Irs1^tm1Tka (involves: C57BL/6 * CBA)	abnormal osteoclast physiology	J:61479
Irs1^tm2Tka/Irs1^tm2Tka Irs2^tm2Tka/Irs2^tm2Tka Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)	increased susceptibility to autoimmune diabetes	J:137846
Isl1^Drsh/Isl1⁺ (C3HeB/FeJ-Isl1^Drsh)	increased susceptibility to otitis media	J:202214
Itch^tm1.1Alta/Itch^tm1.1Alta Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immunoglobulin level	J:204685
	abnormal interleukin secretion	J:204685
	abnormal regulatory T cell physiology	J:204685
	abnormal T-helper 2 physiology	J:204685
	dermatitis	J:204685
	increased IgA level	J:204685
	increased IgE level	J:204685
	increased IgG1 level	J:204685
	increased inflammatory response	J:204685
	increased interleukin-4 secretion	J:204685
	increased interleukin-5 secretion	J:204685
	increased interleukin-10 secretion	J:204685
	increased interleukin-13 secretion	J:204685
	increased interleukin-17 secretion	J:204685
	increased regulatory T cell apoptosis	J:204685
	lung inflammation	J:204685
Itch^tm1.1Alta/Itch^tm1.1Alta Gt(ROSA)26Sor^tm1Hjf/Gt(ROSA)26Sor⁺ Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased inflammatory response	J:204685
Itfg2^{Gt(OST215121)Lex}/Itfg2^{Gt(OST215121)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal B cell activation	J:205951
	abnormal humoral immune response	J:205951
	abnormal splenocyte physiology	J:205951
	decreased IgE level	J:205951
	decreased IgG1 level	J:205951
	decreased IgG2a level	J:205951
	decreased IgG2b level	J:205951
	decreased IgG3 level	J:205951
Itga3^tm1Son/Itga3^tm1Son Krt14^tm1(cre)Wbm/Krt14⁺ (involves: 129P2/OlaHsd * FVB/N)	skin inflammation	J:145988
Itga3^tm1Son/Itga3^tm1Son Tg(KRT5-cre)5132Jlj/? (involves: 129P2/OlaHsd * C57BL/6 * DBA)	skin inflammation	J:145988
Itga4^tm1Mgin/Itga4^tm1Mgin (B6.129-Itga4^tm1Mgin)	abnormal B cell physiology	J:106471
	abnormal lymphocyte physiology	J:106471
	abnormal T cell physiology	J:106471
	impaired macrophage chemotaxis	J:106471
Itga4^tm1Mshi/Itga4^tm1Mshi (C57BL/6-Itga4^tm1Mshi)	abnormal cellular extravasation	J:144092
	abnormal leukocyte adhesion	J:144092
	abnormal leukocyte migration	J:144092
Itga5^tm1Hyn/Itga5⁺ Nisch^edsn/Nisch⁺ (C3H.Cg-Nisch^edsn Itga5^tm1Hyn)	increased susceptibility to otitis media	J:244907
Itga5^tm1Hyn/Itga5⁺ Nisch^edsn/Nisch^edsn (C3H.Cg-Nisch^edsn Itga5^tm1Hyn)	increased susceptibility to otitis media	J:244907
Itga6^tm1Son/Itga6^tm1Son (involves: 129P2/OlaHsd * FVB)	abnormal T cell physiology	J:50235
Itga9^tm1Des/Itga9^tm1Des (involves: 129S4/SvJae * C57BL/6)	abnormal lymph circulation	J:63038
Itgad^tm1.1Zimm/Itgad^tm1.1Zimm (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune system physiology	J:130908
	abnormal macrophage physiology	J:130908
	abnormal susceptibility to infection	J:130908
	decreased susceptibility to parasitic infection	J:130908
	increased circulating interleukin-12 level	J:130908
	increased susceptibility to bacterial infection	J:130908
Itgad^tm1Bll/Itgad^tm1Bll (B6.129S7-Itgad^tm1Bll)	abnormal T cell activation	J:90954
Itgad^tm1Bll/Itgad^tm1Bll (B6.129S7-Itgad^tm1Bll)	decreased T cell proliferation	J:90954
Itgal^tm1.1Mshi/Itgal^tm1.1Mshi (involves: C57BL/6)	abnormal diapedesis	J:168533
	abnormal leukocyte adhesion	J:168533
	abnormal leukocyte migration	J:168533
	enhanced leukocyte tethering or rolling	J:168533
Itgal^tm1Bll/Itgal⁺ (involves: 129S7/SvEvBrd)	abnormal CD4-positive, alpha-beta T cell physiology	J:267548
Itgal^tm1Bll/Itgal^tm1Bll (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal cellular extravasation	J:83226
	abnormal leukocyte adhesion	J:83226
	abnormal leukocyte migration	J:83226
Itgal^tm1Bll/Itgal^tm1Bll (B6.129S7-Itgal^tm1Bll)	abnormal leukocyte adhesion	J:100242
	abnormal leukocyte tethering or rolling	J:100242
	decreased T cell proliferation	J:90954
	impaired natural killer cell mediated cytotoxicity	J:90954
Itgal^tm1Bll/Itgal^tm1Bll (B6.129S7-Itgal^tm1Bll/J)	abnormal inflammatory response	J:113463
Itgal^tm1Bll/Itgal^tm1Bll (involves: 129S7/SvEvBrd)	abnormal CD4-positive, alpha-beta T cell physiology	J:267548
	abnormal cellular extravasation	J:141063
	abnormal leukocyte adhesion	J:141063
	abnormal neutrophil physiology	J:141063
Itgal^tm1Hlz/Itgal^tm1Hlz (involves: 129P2/OlaHsd)	abnormal cellular extravasation	J:99286
	abnormal humoral immune response	J:99286
	abnormal leukocyte adhesion	J:99286
	abnormal T cell activation	J:99286
	decreased cytotoxic T cell cytolysis	J:99286
Itgal^tm1Hogg/Itgal^tm1Hogg (involves: 129P2/OlaHsd)	abnormal leukocyte adhesion	J:82587
Itgal^tm1Hogg/Itgal^tm1Hogg (involves: 129P2/OlaHsd)	abnormal leukocyte migration	J:82587
Itgal^tm1Mak/Itgal⁺ (B6.129P2-Itgal^tm1Mak)	decreased susceptibility to endotoxin shock	J:123460
Itgal^tm1Mak/Itgal^tm1Mak (B6.129P2-Itgal^tm1Mak)	decreased susceptibility to endotoxin shock	J:123460
	impaired natural killer cell mediated cytotoxicity	J:110889
	increased circulating interleukin-2 level	J:123460
	increased circulating interleukin-10 level	J:123460
	increased circulating tumor necrosis factor level	J:123460
Itgal^tm1Wpfl/Itgal^tm1Wpfl (involves: 129)	abnormal cytotoxic T cell physiology	J:37160
	abnormal leukocyte physiology	J:37160
	abnormal lymphocyte physiology	J:37160
Itgam^tm1Bll/Itgam^tm1Bll (B6.129S7-Itgam^tm1Bll)	abnormal leukocyte adhesion	J:100242
	abnormal T cell activation	J:90954
	decreased T cell proliferation	J:90954
	increased susceptibility to bacterial infection	J:94855
Itgam^tm1Bll/Itgam^tm1Bll (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal cellular extravasation	J:83226
	abnormal leukocyte adhesion	J:83226
	abnormal leukocyte migration	J:83226
	abnormal neutrophil physiology	J:39092
	impaired neutrophil phagocytosis	J:39092
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae * BALB/c * C57BL/6)	abnormal leukocyte adhesion	J:38052
	impaired neutrophil phagocytosis	J:38052
Itgam^tm1Myd/Itgam^tm1Myd (B6.129S4-Itgam^tm1Myd)	abnormal inflammatory response	J:113463
Itgam^tm1Myd/Itgam^tm1Myd (B6.129S4-Itgam^tm1Myd)	abnormal neutrophil physiology	J:113463
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae)	impaired leukocyte tethering or rolling	J:198197
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae)	impaired neutrophil phagocytosis	J:155479
Itgam^tm1Myd/Itgam^tm1Myd Syk^tm1Tyb/Syk^tm1.2Tara Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)	impaired granulocyte bactericidal activity	J:155479
Itgam^tm1Rws/Itgam^tm1Rws (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:65847
Itgav^tm1Blb/Itgav^tm1Blb Itgb1^tm1Ref/Itgb1^tm1Ref Itgb2^tm2Bay/Itgb2^tm2Bay Itgb7^tm1Cgn/Itgb7^tm1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * CBA)	abnormal cellular extravasation	J:134784
	abnormal dendritic cell physiology	J:134784
Itgav^tm2Hyn/Itgav^tm2.1Hyn Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB)	colitis	J:125508
	impaired macrophage phagocytosis	J:125508
	increased autoantibody level	J:125508
Itgav^tm2Hyn/Itgav^tm2.1Hyn Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL)	increased susceptibility to bacterial infection induced morbidity/mortality	J:94376
Itgav^tm2Hyn/Itgav^tm2.1Hyn Tg(Tek-cre)1Ywa/? (involves: 129S2/SvPas * C57BL/6 * FVB * SJL)	abnormal immune system physiology	J:125508
	abnormal interferon level	J:125508
	abnormal interleukin level	J:125508
	abnormal tumor necrosis factor level	J:125508
	colitis	J:125508
	impaired macrophage phagocytosis	J:125508
	increased autoantibody level	J:125508
	increased inflammatory response	J:125508
	large intestinal inflammation	J:125508
Itgax^{tm1.1(HBEGF)Ktak}/Itgax⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal response to infection	J:162397
Itgax^tm1Bll/Itgax^tm1Bll (B6.129S7-Itgax^tm1Bll)	decreased interferon-gamma secretion	J:122187
	decreased interleukin-17 secretion	J:122187
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:122187
	decreased tumor necrosis factor secretion	J:122187
	increased interleukin-2 secretion	J:122187
	increased interleukin-12 secretion	J:122187
	increased susceptibility to bacterial infection	J:94855
	increased T cell proliferation	J:122187
Itgb1^tm1Ref/Itgb1^tm1Ref Tg(KRT5-cre)5132Jlj/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)	skin inflammation	J:65038
Itgb2^M1Btlr/Itgb2^M1Btlr (C57BL/6J-Itgb2^M1Btlr)	decreased interferon-gamma secretion	J:139559
Itgb2^m2Btlr/Itgb2^m2Btlr (C57BL/6J-Itgb2^m2Btlr)	increased interferon-beta secretion	J:265125
Itgb2^m3Btlr/Itgb2^m3Btlr (C57BL/6J-Itgb2^m3Btlr)	abnormal cytotoxic T cell cytolysis	J:265126
	decreased IgG level	J:265126
	impaired humoral immune response	J:265126
	impaired natural killer cell mediated cytotoxicity	J:265126
	increased IgE level	J:265126
Itgb2^tm1.1Arte/Itgb2^tm1.1Arte (involves: C57BL/6NTac)	abnormal T cell physiology	J:202261
Itgb2^tm1.1Arte/Itgb2^tm1.1Arte (involves: C57BL/6NTac)	decreased T cell proliferation	J:202261
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd)	decreased inflammatory response	J:13599
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd * PL/J)	abnormal cytokine level	J:109598
	abnormal T cell activation	J:109598
	dermatitis	J:109598, J:32126
	increased interferon-gamma secretion	J:109598
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J * PL/J)	dermatitis	J:84126
Itgb2^tm1Bay/Itgb2^tm1Bay Psrs1^PL/J/Psrs1^PL/J (B6.Cg-(D10Mit126-D10Mit38) Itgb2^tm1Bay)	rheumatoid arthritis	J:134251
Itgb2^tm1Bay/Itgb2^tm1Bay Psrs1^PL/J/Psrs1^PL/J (B6.Cg-(D10Mit75-D10Mit271) Itgb2^tm1Bay)	rheumatoid arthritis	J:134251
Itgb2^tm1Bay/Itgb2^tm2Bay (PL.129S7-Itgb2^tm1Bay Itgb2^tm2Bay)	dermatitis	J:84126
Itgb2^tm1Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6J * PL/J)	dermatitis	J:84126
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte physiology	J:48542
	abnormal neutrophil physiology	J:48542
	abnormal T cell proliferation	J:48542
	conjunctivitis	J:48542
	dermatitis	J:48542
	increased circulating interleukin-3 level	J:48542
	increased circulating interleukin-6 level	J:48542
	increased IgA level	J:48542
	increased IgG level	J:48542
	increased IgM level	J:48542
	increased immunoglobulin level	J:48542
	increased inflammatory response	J:48542
	increased susceptibility to bacterial infection	J:48542
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd)	decreased T cell proliferation	J:90954
Itgb2^tm2Bay/Itgb2^tm2Bay (B6.129S7-Itgb2^tm2Bay)	abnormal leukocyte adhesion	J:83226
	abnormal leukocyte migration	J:83226
	decreased susceptibility to bacterial infection	J:94855
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6)	decreased acute inflammation	J:112286
	impaired neutrophil recruitment	J:112286
Itgb2^tm2Bay/Itgb2^tm2Bay (PL.129S7-Itgb2^tm2Bay)	decreased susceptibility to type IV hypersensitivity reaction	J:109598
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage physiology	J:119666
	dermatitis	J:52262
	impaired macrophage chemotaxis	J:119666
	myositis	J:119666
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas)	abnormal osteoclast physiology	J:60672
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * BALB/c)	increased IgG level	J:131241
Itgb4^tm2Son/Itgb4^tm2Son Tg(KRT14-cre)8Brn/0 (involves: 129P2/OlaHsd * FVB/N)	ear inflammation	J:96543
Itgb6^tm1Des/Itgb6^tm1Des (involves: 129S4/SvJae * C57BL/6J)	respiratory system inflammation	J:33139
Itgb6^tm1Des/Itgb6^tm1Des (involves: 129S4/SvJae)	abnormal immune system physiology	J:120085
Itgb6^tm1Des/Itgb6^tm1Des (involves: 129S4/SvJae * C57BL/6 * SJL)	respiratory system inflammation	J:51592
Itgb6^tm1Des/Itgb6^tm1Des Mmp12^tm1Sds/Mmp12^tm1Sds (involves: 129/Sv * 129T2/SvEms)	lung inflammation	J:89578
Itgb6^tm1Des/Itgb6^tm1Des Tg(SFTPC-ITGB6)1Des/? (involves: 129S4/SvJae * C57BL/6 * SJL)	respiratory system inflammation	J:51592
Itgb7^tm1Cgn/Itgb7^tm1Cgn (involves: C57BL/6)	abnormal immune system physiology	J:34306
	abnormal lymphocyte physiology	J:34306
	abnormal response to infection	J:62733
	impaired leukocyte tethering or rolling	J:34306
	increased susceptibility to parasitic infection	J:90262
Itgb7^tm1Cgn/Itgb7^tm1Cgn (C57BL/6-Itgb7^tm1Cgn/J)	abnormal leukocyte migration	J:127413
Itgb7^tm1Cgn/Itgb7^tm1Cgn (C57BL/6-Itgb7^tm1Cgn/J)	colitis	J:127413
Itgb7^tm1Cgn/Itgb7^tm1Cgn Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6)	abnormal inflammatory response	J:136667
	arthritis	J:136667
Itgb7^tm1Mshi/Itgb7^tm1Mshi (involves: C57BL/6)	abnormal leukocyte adhesion	J:127413
	abnormal leukocyte migration	J:127413
	colitis	J:127413
Itk^m1Btlr/Itk^m1Btlr (C57BL/6J-Itk^m1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236673
	abnormal CD8-positive, alpha-beta T cell physiology	J:236673
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236673
	increased IgE level	J:236673
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * C57BL/6J)	decreased T cell proliferation	J:31230
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae)	decreased T cell proliferation	J:54449
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae)	increased susceptibility to parasitic infection	J:54449
Itk^tm1Litt/Itk^tm1Litt (B6.129S4-Itk^tm1Litt)	decreased interleukin-2 secretion	J:141390
Itk^tm1Litt/Itk^tm1Litt (B6.129S4-Itk^tm1Litt)	decreased T cell proliferation	J:141390
Itk^tm1Litt/Itk^tm1Litt Tg(DO11.10)10Dlo/0 (involves: 129S4/SvJae * BALB/c * C3H * C57BL/6J)	abnormal T-helper 2 physiology	J:129883
Itk^tm1Litt/Itk^tm1Litt Txk^tm1Pls/Txk^tm1Pls (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased T cell proliferation	J:54449
	increased susceptibility to parasitic infection	J:54449
Itk^tm1Litt/Itk^tm1Litt Vav1^tm2Bbd/Vav1^tm2Bbd (B6.129-Itk^tm1Litt Vav1^tm2Bbd)	abnormal T cell physiology	J:141390
	increased T cell apoptosis	J:141390
Itk^tm1Ljb/Itk^tm1Ljb (involves: 129 * C57BL/6)	abnormal T cell activation	J:48231
Itk^tm1Ljb/Itk^tm1Ljb (involves: 129 * C57BL/6)	decreased interleukin-2 secretion	J:48231
Itk^tm1Ljb/Itk^tm1Ljb (B10.129-Itk^tm1Ljb)	abnormal CD8-positive, alpha-beta T cell physiology	J:113408
	decreased interferon-gamma secretion	J:148531
	increased IgE level	J:148531
	increased interferon-gamma secretion	J:113408
	increased interleukin-4 secretion	J:148531
	increased interleukin-10 secretion	J:148531
	increased interleukin-13 secretion	J:148531
Itk^tm1Ljb/Itk^tm1Ljb Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra5CC7,Tcrb5CC7)IWep/? (involves: 129 * C57BL/10)	decreased interferon-gamma secretion	J:93606
	decreased interleukin-4 secretion	J:93606
	decreased interleukin-5 secretion	J:93606
	decreased interleukin-10 secretion	J:93606
Itk^tm1Ljb/Itk^tm1Ljb Txk^tm1Pls/Txk^tm1Pls (B6.129-Txk^tm1Pls Itk^tm1Ljb)	abnormal CD8-positive, alpha-beta T cell physiology	J:113408
	increased interferon-gamma secretion	J:113408
Itln1^em1Cya/Itln1^em1Cya (involves: C57BL/6)	abnormal cytokine level	J:282124
	abnormal osteoclast physiology	J:282124
	increased circulating interleukin-1 alpha level	J:282124
	increased circulating interleukin-6 level	J:282124
	increased circulating interleukin-10 level	J:282124
	increased circulating tumor necrosis factor level	J:282124
Itpkb^T-less/Itpkb^T-less (C57BL/6-Itpkb^T-less)	abnormal T cell physiology	J:89286
Itpkb^tm1Ssch/Itpkb^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal thymocyte activation	J:86257
	abnormal thymus involution	J:86257
	decreased IgG1 level	J:86257
	decreased IgG2a level	J:86257
	decreased IgG2b level	J:86257
	decreased IgG level	J:86257
	increased susceptibility to parasitic infection	J:86257
Itpkb^tm1Ssch/Itpkb^tm1Ssch Itpkc^tm1Ssch/Itpkc^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal thymocyte activation	J:86257
Ity2^C57BL/6J/Ity2^MOLF/EiJ (involves: C57BL/6J * MOLF/Ei)	decreased susceptibility to bacterial infection	J:45962
Ity2^MOLF/EiJ/Ity2^MOLF/EiJ (involves: C57BL/6J * MOLF/Ei)	decreased susceptibility to bacterial infection	J:126552, J:45962
Ity2a^MOLF/EiJ/Ity2a^MOLF/EiJ (involves: C57BL/6J * MOLF/Ei)	decreased susceptibility to bacterial infection	J:126552
Ity2b^MOLF/EiJ/Ity2b^MOLF/EiJ (involves: C57BL/6J * MOLF/Ei)	decreased susceptibility to bacterial infection	J:126552
Ity3^C57BL/6J/Ity3^C57BL/6J (involves: C57BL/6J * MOLF/Ei)	decreased susceptibility to bacterial infection	J:45962
Ity3^C57BL/6J/Ity3^MOLF/EiJ (involves: C57BL/6J * MOLF/Ei)	decreased susceptibility to bacterial infection	J:45962
Ity3^MOLF/EiJ/Ity3^MOLF/EiJ (involves: C57BL/6J * MOLF/Ei)	increased susceptibility to bacterial infection	J:126552, J:45962
Ity3^MOLF/EiJ/Ity3^MOLF/EiJ (B6.MOLF-Slc11a1^r Ity3^MOLF/EiJ)	abnormal cytokine secretion	J:108692
Jagn1^{tm1c(EUCOMM)Hmgu}/Jagn1^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	abnormal neutrophil physiology	J:214828
	impaired neutrophil chemotaxis	J:214828
	impaired neutrophil recruitment	J:214828
	increased susceptibility to fungal infection	J:214828
Jak1^M1Mhda/Jak1⁺ (C3HeB/FeJ-Jak1^M1Mhda)	ear inflammation	J:199153
	increased anti-nuclear antigen antibody level	J:199153
	increased IgA level	J:199153
	increased IgG1 level	J:199153
	increased IgG2a level	J:199153
	increased IgM level	J:199153
	increased immunoglobulin level	J:199153
	skin inflammation	J:199153
Jak2^tm1.1Ble/Jak2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal cytokine level	J:257910
Jak3^m1Btlr/Jak3^m1Btlr (C57BL/6J-Jak3^m1Btlr)	decreased IgG level	J:217795
	decreased response to antigen	J:217795
	impaired humoral immune response	J:217795
	increased IgE level	J:217795
	increased susceptibility to Herpesvirales infection	J:217795
Jak3^M1Pgrs/Jak3⁺ (involves: C57BL/6J * C57BL/10J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:185217
Jak3^M1Pgrs/Jak3^M1Pgrs (involves: C57BL/6J * C57BL/10J)	decreased interferon-gamma secretion	J:185217
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:185217
	increased susceptibility to bacterial infection	J:185217
	increased susceptibility to bacterial infection induced morbidity/mortality	J:185217
Jak3^M1Pgrs/Jak3^tm1Ljb (involves: 129S4/SvJae * C57BL/6J * C57BL/10J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:185217
Jak3^m3Btlr/Jak3^m3Btlr (C57BL/6J-Jak3^m3Btlr)	decreased IgG level	J:225935
Jak3^m3Btlr/Jak3^m3Btlr (C57BL/6J-Jak3^m3Btlr)	impaired humoral immune response	J:225935
Jak3^m6Btlr/Jak3^m6Btlr (C57BL/6J-Jak3^m6Btlr)	decreased IgG level	J:272400
Jak3^m6Btlr/Jak3^m6Btlr (C57BL/6J-Jak3^m6Btlr)	impaired humoral immune response	J:272400
Jak3^m8Btlr/Jak3^m8Btlr (C57BL/6J-Jak3^m8Btlr)	decreased IgG level	J:274939
	decreased IgM level	J:274939
	decreased response to antigen	J:274939
	impaired humoral immune response	J:274939
Jak3^tm1Flv/Jak3^tm1Flv (involves: 129S1/Sv)	abnormal T cell proliferation	J:95794
Jak3^tm1Ljb/Jak3^tm1Ljb (involves: 129S4/SvJae * C57BL/6)	abnormal immune system physiology	J:29722
	abnormal leukocyte physiology	J:90510
	abnormal lymphocyte physiology	J:90510
	abnormal response to infection	J:29722
	abnormal T cell activation	J:29722
	decreased IgG level	J:29722
	decreased T cell proliferation	J:29722
Jak3^tm1Ljb/Jak3^tm1Ljb (involves: 129S4/SvJae)	abnormal T cell activation	J:128694, J:56629
	abnormal T cell physiology	J:128694
	chronic inflammation	J:56629
	decreased T cell proliferation	J:128694
Jak3^tm1Ljb/Jak3^tm1Ljb (B6;129S4-Jak3^tm1Ljb/J)	abnormal dendritic cell physiology	J:123902
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)1Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)	decreased T cell proliferation	J:128694
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)2Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6)	abnormal T cell activation	J:56629
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)2Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)	abnormal T cell activation	J:128694
	abnormal T cell physiology	J:128694
	decreased T cell proliferation	J:128694
Jak3^tm1Tks/Jak3⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte physiology	J:31231
Jak3^tm1Tks/Jak3^tm1Tks (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell physiology	J:31231
Jak3^wil/Jak3^wil (C57BL/6JSfdAnu-Jak3^wil/Anu)	large intestinal inflammation	J:104190
Jam3^tm1Rha/Jam3^tm1Rha (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:121841
Jam3^tm1Rha/Jam3^tm1Rha (involves: 129P2/OlaHsd * C57BL/6)	lung inflammation	J:121841
Jchain^Mat1/? Miju^C3HeB/FeJ/Miju^C57BL/6J (involves: C3HeB/FeJ * C57BL/6J)	increased IgA level	J:91062
Jchain^tm1Jse/Jchain^tm1Jse (involves: 129X1/SvJ)	abnormal B cell physiology	J:75843
Jchain^tm1Jse/Jchain^tm1Jse (involves: 129X1/SvJ)	increased IgA level	J:34042, J:75843
Jchain^tm1Jse/Jchain^tm1Jse (C.129X1-Jchain^tm1Jse)	decreased susceptibility to Herpesvirales infection	J:62298
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:62298
	increased susceptibility to parasitic infection	J:140515
Jchain^tm1Tl/Jchain^tm1Tl (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal humoral immune response	J:71355
	decreased IgG level	J:71355
	decreased IgM level	J:71355
	increased IgA level	J:71355
Jchain^tm2(Myc)Tl/Jchain^tm2(Myc)Tl (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal humoral immune response	J:71355
Jchain^tm3Tl/Jchain⁺ (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:56158
	abnormal immune cell physiology	J:49168
	decreased IgM level	J:49168, J:56158
	impaired complement classical pathway	J:49168
	increased IgA level	J:56158
	increased susceptibility to bacterial infection	J:56158
Jchain^tm3Tl/Jchain^tm3Tl (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:56158
	abnormal immune cell physiology	J:49168
	decreased IgG level	J:49168
	decreased IgM level	J:49168, J:56158
	impaired complement classical pathway	J:49168
	increased IgA level	J:49168, J:56158
	increased susceptibility to bacterial infection	J:56158
Jdp2^tm1Aki/Jdp2^tm1Aki (Not Specified)	abnormal neutrophil physiology	J:191061
	increased susceptibility to bacterial infection	J:191061
	increased susceptibility to fungal infection	J:191061
Jmjd6^tm1Gbf/Jmjd6^tm1Gbf (C57BL/6-Ptdsr^tm1Gbf)	abnormal macrophage activation involved in immune response	J:98905
Jmjd8^em1Kaso/Jmjd8^em1Kaso (C57BL/6-Jmjd8^em1Kaso)	decreased circulating interleukin-1 beta level	J:319518
Jmjd8^em1Kaso/Jmjd8^em1Kaso (C57BL/6-Jmjd8^em1Kaso)	decreased inflammatory response	J:319518
Jph4^tm1Hta/Jph4^tm1Hta (involves: 129S4/SvJae * C57BL/6J)	abnormal interleukin level	J:230995
Jph4^tm1Hta/Jph4^tm1Hta (involves: 129S4/SvJae * C57BL/6J)	abnormal T cell activation	J:230995
Jun^tm1Rsjo/Jun^tm1Rsjo Tg(KRT14-cre)8Brn/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	increased incidence of corneal inflammation	J:84743
Jun^tm4Wag/Jun^tm4Wag Junb^tm3Wag/Junb^tm3Wag Tg(Krt1-5-cre/ERT)1Ipc/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	arthritis	J:116380
	increased inflammatory response	J:116380
	skin inflammation	J:116380
Jun^tm4Wag/Jun^tm4Wag Tg(Sftpc-cre)1Blh/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal cytokine level	J:179883
	abnormal tumor necrosis factor level	J:179883
	lung inflammation	J:179883
Junb^tm3Wag/Junb^tm3Wag Tg(KRT5-cre)1Tak/0 (involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)	dermatitis	J:155575
	glomerulonephritis	J:155575
	increased anti-histone antibody level	J:155575
	increased circulating interleukin-6 level	J:155575
	increased IgE level	J:155575
	increased inflammatory response	J:155575
	increased interleukin-6 secretion	J:155575
	increased susceptibility to systemic lupus erythematosus	J:155575
	tubulointerstitial nephritis	J:155575
Jund^tm1Mya/Jund^tm1Mya (either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))	abnormal T-helper 2 physiology	J:89085
	increased susceptibility to endotoxin shock	J:65879
	increased T cell proliferation	J:89085
	liver inflammation	J:65879
Jup^tm1.1Glr/Jup^tm1.1Glr A1cf^{Tg(Myh6-cre/Esr1)1Jmk}/A1cf⁺ (involves: 129S6/SvEvTac C57BL/6 * FVB/N * SJL)	abnormal interleukin level	J:170618
	heart inflammation	J:170618
Kat5^tm1Jwl/Kat5⁺ Tg(IghMyc)22Bri/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL)	abnormal B cell physiology	J:125164
Kat14^{tm1a(KOMP)Wtsi}/Kat14^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased susceptibility to bacterial infection	J:213427
Kcna1^mceph/Kcna1^mceph (BALB/cByJ-Kcna1^mceph/J)	ear inflammation	J:119491
Kcna1^mceph/Kcna1^mceph (BALB/cByJ-Kcna1^mceph/J)	eye inflammation	J:119491
Kcna1^tm1Tem/Kcna1^tm1Tem (involves: 129S7/SvEvBrd * BALB/cByJ * C3HeB/FeJ)	ear inflammation	J:119491
	eye inflammation	J:119491
Kcne2^{tm1a(EUCOMM)Wtsi}/Kcne2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Kcne2^{tm1a(EUCOMM)Wtsi})	stomach inflammation	J:230226
Kcne3^tm1Gwab/Kcne3^tm1Gwab (involves: C57BL/6)	increased inflammatory response	J:210381
Kcnj8^gnite/Kcnj8^gnite (involves: C57BL/6J)	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:126658, J:105543
Kcnj8^mydy/Kcnj8^mydy (involves: C57BL/6J)	increased susceptibility to endotoxin shock	J:126658
Kcnj8^mydy/Kcnj8^mydy (involves: C57BL/6J)	increased susceptibility to Herpesvirales infection	J:126658
Kcnj8^slmbr/Kcnj8^slmbr (involves: C57BL/6J)	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:126658, J:105543
Kcnj8^sltr/Kcnj8^sltr (involves: C57BL/6J)	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:126658, J:105543
Kcnj8^sltr/Kcnj8^sltr (involves: C57BL/6J)	increased susceptibility to Riboviria infection	J:105543
Kcnj8^sos/Kcnj8^sos (C57BL/6J-Kcnj8^sos)	increased susceptibility to endotoxin shock	J:149353
Kcnk13^em1(IMPC)H/Kcnk13^em1(IMPC)H (involves: C57BL/6NTac)	abnormal microglial cell physiology	J:256020
Kcnn4^tm1Jemn/Kcnn4^tm1Jemn (involves: 129S1/Sv * C57BL/6J)	abnormal T cell physiology	J:94478
Kctd9^em1Beij/Kctd9^em1Beij (BALB/c-Kctd9^em1Beij)	abnormal NK cell physiology	J:281803
	decreased susceptibility to Coronaviridae infection	J:281803
	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	J:281803
	impaired natural killer cell mediated cytotoxicity	J:281803
Kdelr1^m1Btlr/Kdelr1^m1Btlr (C57BL/6J-Kdelr1^m1Btlr)	abnormal response to infection	J:224970
Kdelr1^m1Btlr/Kdelr1^m1Btlr (C57BL/6J-Kdelr1^m1Btlr)	increased susceptibility to Riboviria infection	J:224970
Kdm6b^tm1Aki/Kdm6b^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal response to infection	J:164690
Kdm6b^tm1Aki/Kdm6b^tm1Aki (involves: 129X1/SvJ * C57BL/6)	impaired eosinophil recruitment	J:164690
Kera^tm1Cyl/Kera^tm1Cyl (involves: 129S6/SvEvTac)	abnormal inflammatory response	J:128992
Khsrp^tm1.1Cyc/Khsrp^tm1.1Cyc (B6.Cg-Khsrp^tm1.1Cyc)	decreased susceptibility to Herpesvirales infection	J:175084
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:175084
	increased interferon-beta secretion	J:175084
Kif1c^{Ltxs1-DBA/2NCr}/Kif1c^{Ltxs1-DBA/2NCr} (involves: BALB/cAnPt * DBA/2NCr)	decreased susceptibility to infection	J:103336
Kif1c^{Ltxs1-DBA/2NCr}/Kif1c^{Ltxs1-DBA/2NCr} Ltxs2^DBA/2NCr/Ltxs2^DBA/2NCr Ltxs3^DBA/2NCr/Ltxs3^DBA/2NCr (involves: BALB/cAnPt * DBA/2NCr)	decreased susceptibility to infection	J:103336
Kif1c^Ltxs1/Kif1c⁺ (involves: C3H/HeJ * C57BL/6J)	increased susceptibility to bacterial infection	J:49726
Kif1c^Ltxs1/Kif1c^Ltxs1 (involves: C3H/HeJ * C57BL/6J)	increased susceptibility to bacterial infection	J:49726
Kif1c^{Orch3-BALB/cByJ}/Kif1c^{Orch3-BALB/cByJ} (involves: BALB/cByJ * DBA/2)	testis inflammation	J:35331
Kif1c^{Orch3-BALB/cByJ}/Kif1c^Orch3-DBA/2J (involves: BALB/cByJ * DBA/2)	decreased inflammatory response	J:35331
Kif1c^Orch3-DBA/2J/Kif1c^Orch3-DBA/2J (involves: BALB/cByJ * DBA/2)	decreased inflammatory response	J:35331
Kif27^{Gt(OST441915)Lex}/Kif27^{Gt(OST441915)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased susceptibility to otitis media	J:185566
	maxillary sinus inflammation	J:185566
Kifbp^{tm1a(KOMP)Wtsi}/Kifbp^{tm1a(KOMP)Wtsi} (C57BL/6N-Kifbp^{tm1a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Kit^tm1.1Bsm/Kit^tm1.1Bsm (involves: 129S1/Sv * BALB/c * C57BL/6J * FVB/N)	abnormal mast cell physiology	J:61141
Kit^tm2Bsm/Kit⁺ (involves: 129X1/SvJ * C57BL/6J)	increased mast cell degranulation	J:83616
Kit^tm3.1Bsm/Kit^tm3.1Bsm (involves: 129S1/Sv * C57BL/6)	abnormal mast cell physiology	J:90485
Kit^W-37J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	abnormal mast cell physiology	J:27513
Kit^W-42J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	abnormal mast cell physiology	J:27513
Kit^W-Jic/Kit^W (involves: C57BL/6 * WB)	abnormal mast cell physiology	J:27513
Kit^W-n/Kit^W (involves: WB)	abnormal mast cell physiology	J:27513
Kit^W-sh/Kit^W-sh (involves: 101/H * C3H/HeH)	decreased mast cell degranulation	J:157470
Kit^W-sh/Kit^W-sh (involves: 101/H * C3H/HeH)	increased susceptibility to parasitic infection	J:163761
Kit^W-sh/Kit^W-sh (involves: C57BL/6J)	decreased susceptibility to type I hypersensitivity reaction	J:197334
Kit^W-sh/Kit^W-sh (B6.Cg-Kit^W-sh/HNihrJaeBsmGlliJ)	decreased susceptibility to type I hypersensitivity reaction	J:275367
Kit^W-sh/Kit^W-sh Lyn^tm1Ard/Lyn^tm1Ard (involves: 101 * 129P2/OlaHsd * C3H/HeH)	abnormal circulating complement protein level	J:161523
	glomerulonephritis	J:161523
	increased anti-double stranded DNA antibody level	J:161523
	increased anti-nuclear antigen antibody level	J:161523
	increased IgA level	J:161523
	increased IgE level	J:161523
	increased IgG2b level	J:161523
	increased IgM level	J:161523
Kit^W/Kit^W-v (involves: C57BL/6 * WB)	abnormal response to transplant	J:6084
Kit^W/Kit^W-v ((WB/ReJ x C57BL/6J-Kit^W-v/J)F1-Kit^W/Kit^W-v/J)	abnormal interferon level	J:131785
	abnormal interleukin level	J:131785
	decreased inflammatory response	J:131785
	impaired neutrophil recruitment	J:123463
	kidney inflammation	J:113500
Kit^W/Kit^W-v ((WB Kit^W x B6.Cg-Kit^W-v)F1)	decreased susceptibility to induced arthritis	J:178942
Kit^W/Kit^W-v ((WB Kit^W x B6.Cg-Kit^W-v)F1)	decreased susceptibility to type I hypersensitivity reaction	J:197334
Kitl^Sl/Kitl^Sl-d (involves: C57BL/6 * WC)	dermatitis	J:5758
Kitl^Sl/Kitl^Sl-d (involves: C57BL/6 * WC)	stomach inflammation	J:2777
Kitl^Sl/Kitl^Sl-d (involves: C3H * C57BL/6 * DBA/2J * WC)	abnormal response to transplant	J:6084
Kl^ecalc1/Kl^ecalc1 (involves: C3H/HeH * C57BL/6J)	lung inflammation	J:229255
Klf2^tm2Ling/Klf2^tm2Ling Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased IgE level	J:151604
	increased IgG1 level	J:151604
	increased interleukin-4 secretion	J:151604
Klf4^tm1Khk/Klf4^tm1Khk Tg(Pax6-cre,GFP)1Pgr/0 (involves: 129S6/SvEvTac * FVB/N)	blepharitis	J:117671
Klf5^Gt(XB751)Byg/Klf5⁺ (B6.129P2-Klf5^Gt(XB751)Byg)	abnormal response to infection	J:136125
Klf5^M1Btlr/Klf5^M1Btlr (C57BL/6J-Klf5^M1Btlr)	increased susceptibility to induced colitis	J:265229
Klf5^tm1Jaw/Klf5^tm1Jaw Tg(Pax6-cre,GFP)1Pgr/0 (involves: FVB)	lacrimal gland inflammation	J:175263
Klf13^tm1Kren/Klf13^tm1Kren (B6.129-Klf13^tm1Kren)	decreased splenocyte apoptosis	J:145839
Klf13^tm1Kren/Klf13^tm1Kren (B6.129-Klf13^tm1Kren)	decreased thymocyte apoptosis	J:145839
Klf15^tm1Jain/Klf15^tm1Jain (involves: 129X1/SvJ)	blood vessel inflammation	J:203920
Klhdc10^tm1Hijo/Klhdc10^tm1Hijo (B6J.B6N-Klhdc10^tm1Hijo)	decreased circulating interleukin-6 level	J:251158
	decreased inflammatory response	J:251158
	decreased interleukin-6 secretion	J:251158
Klhl6^tm1Sato/Klhl6^tm1Sato (either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))	abnormal adaptive immunity	J:101363
Klhl22^em1Cya/Klhl22^em1Cya (C57BL/6N-Klhl22^em1Cya/Cya)	decreased interferon-gamma secretion	J:297538
Klhl22^em1Cya/Klhl22^em1Cya (C57BL/6N-Klhl22^em1Cya/Cya)	decreased tumor necrosis factor secretion	J:297538
Klk5^em1Mer/Klk5^em1Mer (BALB/c-Klk5^em1Mer)	abnormal acute inflammation	J:344772
Klk6^tm1Gsot/Klk6⁺ (involves: C57BL/6)	decreased inflammatory response	J:270051
Klk6^tm1Gsot/Klk6⁺ (involves: C57BL/6)	decreased susceptibility to chemically induced skin inflammation	J:270051
Klk6^tm1Gsot/Klk6^tm1Gsot (involves: C57BL/6)	abnormal cytokine level	J:270051
	decreased inflammatory response	J:270051
	decreased susceptibility to chemically induced skin inflammation	J:270051
Klk6^tm1Gsot/Klk6^tm1Gsot Spink5^tm1Drh/Spink5^tm1Drh (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:289877
	decreased inflammatory response	J:289877
Klra1^tm1.1Wyok/Klra1^tm1.1Wyok (involves: BALB/cJ * C57BL/6NTac)	abnormal natural killer cell mediated cytotoxicity	J:252851
Klra8^Cmv1-del/Klra8^Cmv1-r ((BXD8/TyJ x C57BL/6)F1)	decreased susceptibility to Herpesvirales infection	J:79093
Klra8^Cmv1-del/Klra8^Cmv1-s ((BXD8/TyJ x BALB/c)F1)	increased susceptibility to Herpesvirales infection	J:79093
Klra8^Cmv1-del/Klra8^Cmv1-s ((BXD8/TyJ x DBA/2)F1)	increased susceptibility to Herpesvirales infection	J:79093
Klra8^Cmv1-r/Klra8^Cmv1-r (C.B6-Klra8^Cmv1-r)	decreased IgG1 level	J:97203
	decreased IgG2a level	J:97203
	decreased IgG2b level	J:97203
	decreased IgG3 level	J:97203
	decreased IgG level	J:97203
	decreased interleukin-4 secretion	J:97203
	decreased susceptibility to Herpesvirales infection	J:22486, J:79093
	increased circulating interferon-gamma level	J:97203
	increased IgM level	J:97203
	increased susceptibility to infection induced morbidity/mortality	J:97203
	increased susceptibility to parasitic infection	J:97203
Klra15^tm1.1Apma/Klra15^tm1.1Apma (B6.129-Klra15^tm1.1Apma)	impaired natural killer cell mediated cytotoxicity	J:189106
Klra17^tm1.1Apma/Klra17^tm1.1Apma (involves: 129S1/Sv * 129X1/SvJ)	abnormal plasmacytoid dendritic cell physiology	J:152288
	abnormal response to infection	J:152288
	decreased circulating interferon-alpha level	J:152288
	decreased circulating interleukin-12 level	J:152288
	decreased interferon-alpha secretion	J:152288
	decreased interleukin-12 secretion	J:152288
	increased susceptibility to Herpesvirales infection	J:152288
Klrb1b^tm1.1Apma/Klrb1b^tm1.1Apma (B6.Cg-Klrb1b^tm1.1Apma)	abnormal NK cell physiology	J:222057
Klrc1^tm1Mmka/Klrc1^tm1Mmka (B6.129-Klrc1^tm1Mmka)	decreased tumor necrosis factor secretion	J:222503
	increased interferon-gamma secretion	J:222503
	increased interleukin-2 secretion	J:222503
	increased susceptibility to Adenoviridae infection	J:222503
	increased susceptibility to Orthomyxoviridae infection	J:222503
	increased tumor necrosis factor secretion	J:222503
	liver inflammation	J:222503
	lung inflammation	J:222503
Klre1^tm1Tgi/Klre1^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:92262
Klrk1^tm1.1Bpol/Klrk1^tm1.1Bpol (C57BL/6-Klrk1^tm1.1Bpol)	abnormal NK cell physiology	J:151878
	decreased susceptibility to Herpesvirales infection	J:151878
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:151878
	impaired natural killer cell mediated cytotoxicity	J:151878
	increased interferon-gamma secretion	J:151878
Klrk1^tm1Dhr/Klrk1^tm1Dhr (involves: C57BL/6 * CD-1)	impaired natural killer cell mediated cytotoxicity	J:134509
Klrk1^tm1Dhr/Klrk1^tm1Dhr (B6.Cg-Klrk1^tm1Dhr/J)	increased natural killer cell mediated cytotoxicity	J:221188
Klrk1^tm2.1Bpol/Klrk1^tm2.1Bpol (Not Specified)	decreased susceptibility to Herpesvirales infection	J:215590
Kmt2d^tm1.1Kaig/Kmt2d^tm1.1Kaig Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG1 level	J:228913
	decreased IgM level	J:228913
	increased B cell proliferation	J:228913
Kmt2e^tm1Apa/Kmt2e^tm1Apa (129S6/SvEvTac-Kmt2e^tm1Apa)	abnormal neutrophil physiology	J:145445
	blepharitis	J:145445
	increased susceptibility to bacterial infection	J:145445
Kmt5b^tm1Jnw/Kmt5b^tm1Jnw Kmt5c^tm1.1Jnw/Kmt5c^tm1.1Jnw Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)	abnormal class switch recombination	J:139510
Kpna4^tm1Bdr/Kpna4^tm1Bdr (B6.Cg-Kpna4^tm1Bdr)	increased susceptibility to Orthomyxoviridae infection	J:302003
Kprp^tm1Msug/Kprp⁺ (involves: C57BL/6)	increased IgE level	J:286659
Kprp^tm1Msug/Kprp⁺ (involves: C57BL/6)	increased susceptibility to chemically induced skin inflammation	J:286659
Kptn^{tm1a(EUCOMM)Wtsi}/Kptn^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	increased susceptibility to bacterial infection	J:200082
Kras^tm4Tyj/Kras⁺ Krt19^{tm1(cre/ERT)Ggu}/Krt19⁺ Pten^tm2Mak/Pten^tm2Mak (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac)	lung inflammation	J:254370
Kras^tm4Tyj/Kras⁺ Pten^tm1Hwu/Pten^tm1Hwu Scgb1a1^{tm1.1(cre)Fjd}/Scgb1a1⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	lung inflammation	J:131721
Kras^tm4Tyj/Kras⁺ Tg(MUC1)79.24Gend/0 (involves: 129S4/SvJae * C57BL/6)	decreased interferon-gamma secretion	J:154046
	increased IgG level	J:154046
	increased IgM level	J:154046
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	increased splenocyte proliferation	J:87429
Kras^tm4Tyj/Kras⁺ Tg(Scgb1a1-cre)1Kkw/? (involves: 129 * C57BL/6 * FVB/N)	increased inflammatory response	J:107260
Kras^tm4Tyj/Kras⁺ Trp53^tm2Tyj/Trp53⁺ (involves: 129S4/SvJae)	lung inflammation	J:191425
Kras^tm4Tyj/Kras^tm4Tyj Trim33^tm1Los/Trim33^tm1Los Tg(Pdx1-cre)89.1Dam/0 (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * DBA/2)	pancreas inflammation	J:151781
Krt1^tm1Tmm/Krt1^tm1Tmm (involves: 129 * C57BL/6)	abnormal circulating interleukin level	J:200244
	abnormal interleukin secretion	J:200244
	increased circulating interleukin-18 level	J:200244
Krt2^{tm1a(KOMP)Wtsi}/Krt2^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	skin inflammation	J:214772
Krt8^tm1Rgo/Krt8^tm1Rgo (involves: 129S2/SvPas * C57BL/6 * FVB/N)	chronic inflammation	J:86719, J:98058
Krt10^tm1Tmm/Krt10⁺ (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6))	increased susceptibility to infection	J:31853
Krt18^tm1Tmm/Krt18⁺ (involves: 129P2/OlaHsd)	liver inflammation	J:309021
Krt18^tm1Tmm/Krt18^tm1Tmm (involves: 129P2/OlaHsd)	liver inflammation	J:309021
Krt76^{tm1a(KOMP)Wtsi}/Krt76^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	skin inflammation	J:232539
Ksr1^tm1Shaw/Ksr1^tm1Shaw (Not Specified)	decreased susceptibility to induced arthritis	J:140520
Ksr1^tm1Shaw/Ksr1^tm1Shaw (Not Specified)	decreased T cell proliferation	J:75739
Ksr1^tm1Shaw/Ksr1^tm1Shaw Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6)	decreased interleukin-2 secretion	J:75739
	decreased T cell proliferation	J:75739
Lacc1^em1Arkr/Lacc1^em1Arkr (C57BL/6NTac-Lacc1^em1Arkr)	abnormal macrophage physiology	J:244365
	decreased circulating interleukin-1 beta level	J:244365
	decreased susceptibility to endotoxin shock	J:244365
Lacc1^em2Arkr/Lacc1^em2Arkr (C57BL/6NTac-Lacc1^em2Arkr)	abnormal macrophage physiology	J:244365
	decreased circulating interleukin-1 beta level	J:244365
	decreased susceptibility to endotoxin shock	J:244365
Lacc1^em3Arkr/Lacc1^em3Arkr (C57BL/6NTac-Lacc1^em3Arkr)	abnormal macrophage physiology	J:244365
	increased circulating interleukin-1 beta level	J:244365
	increased susceptibility to endotoxin shock	J:244365
Lacc1^em4Arkr/Lacc1^em4Arkr (C57BL/6NTac-Lacc1^em4Arkr)	abnormal macrophage physiology	J:244365
	increased circulating interleukin-1 beta level	J:244365
	increased susceptibility to endotoxin shock	J:244365
Lacc1^{tm1a(KOMP)Wtsi}/Lacc1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal macrophage physiology	J:244365
	decreased circulating tumor necrosis factor level	J:244365
	decreased interleukin-1 beta secretion	J:244365
	increased circulating interleukin-1 beta level	J:244365
	increased susceptibility to endotoxin shock	J:244365
Lag3^tm1Daav/Lag3⁺ Tg(Foxp3-EGFP/cre)1cJbs/0 (NOD.Cg-Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)	decreased susceptibility to autoimmune diabetes	J:260063
Lag3^tm1Daav/Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs/0 (NOD.Cg-Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)	abnormal CD8-positive, alpha-beta T cell physiology	J:260063
	abnormal interleukin level	J:260063
	abnormal tumor necrosis factor level	J:260063
	decreased susceptibility to autoimmune diabetes	J:260063
Lag3^tm1Doi/Lag3^tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal NK cell physiology	J:32509
Lag3^tm1Doi/Lag3^tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal T cell physiology	J:89653
Lair1^tm1.1Jco/Lair1^tm1.1Jco (involves: C57BL/6)	decreased IgG1 level	J:180203
Lair1^tm1Jco/Lair1^tm1Jco Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	decreased IgG2a level	J:180203
	decreased IgG2b level	J:180203
Lama2^dy/Lama2^dy (involves: 129P1/ReJ)	increased IgG level	J:102959
Lama2^dy/Lama2^dy (involves: 129P1/ReJ)	increased IgM level	J:102959
Lama2^tm1Eeng/Lama2^tm1Eeng (involves: 129S1/Sv)	myositis	J:170192
Lama2^tm1Stk/Lama2^tm1Stk (involves: 129P2/OlaHsd * BALB/c)	abnormal thymus physiology	J:61802
Lama3^tm1.1Grsb/Lama3^tm1.1Grsb (involves: C57BL/6)	abnormal chemokine level	J:235712
	abnormal tumor necrosis factor level	J:235712
	lung inflammation	J:235712
Lama3^tm1Arte/Lama3^tm1Arte Tg(KRT14-cre/ERT)20Efu/0 (involves: C57BL/6 * CD-1)	skin inflammation	J:240054
Lama5^tm1Lsor/Lama5^tm1Lsor Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	abnormal marginal zone B cell physiology	J:198783
	increased IgM level	J:198783
Lama5^tm2Jhm/Lama5^tm1Jhm Tg(NPHS2-cre)295Lbh/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	tubulointerstitial nephritis	J:185850
Lamb2^tm1Jrs/Lamb2^tm1Jrs (involves: 129S1/Sv * 129X1/SvJ)	glomerulonephritis	J:23783
Lamc2^jeb/Lamc2^jeb (129X1/SvJ-Lamc2^jeb)	ear inflammation	J:158873
Lancl1^tm1.1Pfw/Lancl1^tm1.1Pfw (involves: 129 * C57BL/6)	brain inflammation	J:214805
Lancl2^{tm2a(KOMP)Wtsi}/Lancl2^{tm2a(KOMP)Wtsi} (involves: C57BL/6N)	decreased susceptibility to bacterial infection	J:250673
Lancl2^{tm2c(KOMP)Wtsi}/Lancl2^{tm2c(KOMP)Wtsi} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: C57BL/6N)	decreased susceptibility to bacterial infection	J:250673
Lao1^tm1Oka/Lao1^tm1Oka (involves: 129S2/SvPas * C57BL/6J)	abnormal interleukin level	J:260668
	increased susceptibility to bacterial infection	J:260668
	increased susceptibility to bacterial infection induced morbidity/mortality	J:260668
	mastitis	J:260668
Laptm5^tm1Jow/Laptm5^tm1Jow (C57BL/6-Laptm5^tm1Jow)	abnormal T cell activation	J:137841
	abnormal type IV hypersensitivity reaction	J:137841
	increased interleukin-2 secretion	J:137841
	increased T cell proliferation	J:137841
Laq1^MRL/Laq1^MRL (involves: C57BL/6 * MRL)	increased susceptibility to autoimmune disorder	J:45708
Lar^SAMP1/? (involves: C57BL/10 * SAMP1)	abnormal humoral immune response	J:1953
Large1^myd/Large1^myd (MYD/Le-Os +/+ Large^myd/J)	myositis	J:5670
Large1^myd/Large1^myd (B6C3Fe a/a-Large1^myd/J)	myositis	J:27793
Lat2^tm1Mal/Lat2^tm1Mal (involves: 129S2/SvPas)	abnormal mast cell physiology	J:93950
Lat2^tm1Mal/Lat2^tm1Mal (B6.129S2-Lat2^tm1Mal)	increased anti-nuclear antigen antibody level	J:126321
Lat2^tm1Mal/Lat2^tm1Mal Lime1^tm1.1Mal/Lime1^tm1.1Mal (involves: 129 * C57BL/6)	increased anti-nuclear antigen antibody level	J:126321
Lat2^tm1Wz/Lat2^tm1Wz (involves: C57BL/6)	abnormal mast cell physiology	J:93951
Lat2^tm1Wz/Lat2^tm1Wz (B6.Cg-Lat2^tm1Wz)	abnormal CD8-positive, alpha-beta T cell physiology	J:116157
	abnormal cytokine secretion	J:116157
	abnormal T cell physiology	J:116157
	increased anti-double stranded DNA antibody level	J:116157
	increased autoantibody level	J:116157
	increased T cell proliferation	J:116157
Lat2^tm1Wz/Lat2^tm1Wz (Not Specified)	abnormal T cell physiology	J:181866
	decreased interleukin-12 secretion	J:181866
	increased circulating interleukin-6 level	J:181866
	increased circulating tumor necrosis factor level	J:181866
	increased interferon-gamma secretion	J:181866
	increased interleukin-10 secretion	J:181866
	increased mast cell degranulation	J:181866
	increased susceptibility to endotoxin shock	J:181866
Lat2^tm2Wz/Lat2^tm2Wz Tg(Lck-cre)548Jxm/0 (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:116157
	increased anti-double stranded DNA antibody level	J:116157
Lat2^tm3.1Wz/Lat2^tm3.1Wz (B6.Cg-Lat2^tm3.1Wz)	abnormal T cell physiology	J:181866
	increased interferon-gamma secretion	J:181866
	increased mast cell degranulation	J:181866
	increased susceptibility to endotoxin shock	J:181866
Lat^tm1.1Lov/Lat^tm1.1Lov (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:77099
	abnormal immunoglobulin level	J:77099
	abnormal T cell physiology	J:77099
	decreased T cell proliferation	J:77099
	increased anti-double stranded DNA antibody level	J:116157
	increased anti-nuclear antigen antibody level	J:77099
	increased autoantibody level	J:77099
	increased IgE level	J:77099
	increased IgG1 level	J:77099
	increased IgM level	J:77099
	increased T cell proliferation	J:77099
Lat^tm1.1Lov/Lat^tm1.1Lov Lat2^tm1Wz/Lat2^tm1Wz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased anti-double stranded DNA antibody level	J:116157
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas)	abnormal B cell activation	J:77098
	abnormal immune serum protein physiology	J:77098
	abnormal T-helper 2 physiology	J:125722
	chronic inflammation	J:77098
	glomerulonephritis	J:125722
	increased anti-chromatin antibody level	J:125722
	increased anti-erythrocyte antigen antibody level	J:125722
	increased anti-nuclear antigen antibody level	J:125722
	increased IgE level	J:125722, J:77098
	increased IgG1 level	J:262891, J:125722, J:77098
	increased IgM level	J:125722
	increased inflammatory response	J:262891
	increased interferon-gamma secretion	J:77098
	increased interleukin-4 secretion	J:77098
	increased susceptibility to autoimmune hemolytic anemia	J:125722
	increased T cell proliferation	J:77098
	kidney inflammation	J:262891
	liver inflammation	J:125722
	lung inflammation	J:125722
	pancreas inflammation	J:262891
	phlebitis	J:262891
	salivary gland inflammation	J:262891
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal T cell proliferation	J:131351
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:131351
Lat^tm1.1Mal/Lat^{tm6.1(HBEGF/EGFP)Mal} (involves: 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:151840
Lat^tm1Les/Lat^tm1.1Wz Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T cell physiology	J:147946
Lat^tm1Les/Lat^tm1Les Lat2^tm1Wz/Lat2^tm1Wz (involves: C57BL/6)	abnormal mast cell physiology	J:93951
Lat^tm1Les/Lat^tm1Les Tg(CD2-LAT2)1Wz/0 (Not Specified)	abnormal B cell physiology	J:116964
	abnormal interferon secretion	J:116964
	abnormal interleukin secretion	J:116964
	abnormal leukocyte physiology	J:116964
	increased IgG1 level	J:116964
	increased IgM level	J:116964
	increased interleukin-4 secretion	J:116964
	increased interleukin-10 secretion	J:116964
Lat^tm2.1Mal/Lat^tm2.1Mal (involves: 129S2/SvPas)	abnormal B cell activation	J:94074
	abnormal T cell activation	J:94074
	abnormal thymocyte activation	J:94074
	increased IgE level	J:94074
	increased IgG1 level	J:94074
	increased immunoglobulin level	J:94074
	increased interleukin-4 secretion	J:94074
Lat^tm2.1Mal/Lat^tm2.1Mal Lat2^tm1Mal/Lat2^tm1Mal (involves: 129S2/SvPas)	abnormal mast cell physiology	J:93950
Lat^tm3.1Mal/Lat^tm3.1Mal (involves: 129S2/SvPas)	abnormal thymocyte activation	J:94074
Lat^tm4.1Mal/Lat^tm4.1Mal (involves: 129P2/OlaHsd)	abnormal thymocyte activation	J:94074
Lat^tm4.1Mal/Lat^tm4.1Mal Tg(LckF505)3073Rmp/? (involves: 129P2/OlaHsd C57BL/6 * DBA/2)	abnormal T-helper 2 physiology	J:151840
	increased IgE level	J:151840
	increased IgG1 level	J:151840
	increased interleukin-4 secretion	J:151840
Lat^tm4.1Mal/Lat^{tm6.1(HBEGF/EGFP)Mal} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal T-helper 2 physiology	J:151840
Lat^{tm6.1(HBEGF/EGFP)Mal}/? Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal T cell physiology	J:138401
Lat^{tm6.1(HBEGF/EGFP)Mal}/Lat^{tm6.1(HBEGF/EGFP)Mal} (involves: 129S2/SvPas * C57BL/6)	abnormal T cell activation	J:151840
	abnormal T-helper 2 physiology	J:151840
	decreased interferon-gamma secretion	J:151840
Lat^tm9Mal/Lat^tm9Mal (involves: C57BL/6)	abnormal immune system physiology	J:205441
Lax1^tm1Wz/Lax1^tm1Wz (involves: C57BL/6)	abnormal B cell physiology	J:98403
	abnormal T cell activation	J:98403
	abnormal T cell physiology	J:98403
	increased IgE level	J:98403
	increased IgG1 level	J:98403
	increased IgG2a level	J:98403
Layn^em1Romd/Layn^em1Romd Tg(Cd8a-cre,-GFP)1Yzo/0 (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:302853
Lbca1^C57BL/6Igc/Lbca1^C57BL/6Igc (involves: BALB/cIgc * C57BL/6Igc)	abnormal B cell activation	J:139348
	increased B cell proliferation	J:139348
Lbca2^BALB/cIgc/Lbca2^C57BL/6Igc (involves: BALB/cIgc * C57BL/6Igc)	abnormal B cell activation	J:139348
	increased B cell proliferation	J:139348
Lbca2^C57BL/6Igc/Lbca2^C57BL/6Igc (involves: BALB/cIgc * C57BL/6Igc)	abnormal B cell activation	J:139348
	increased B cell proliferation	J:139348
Lbp^tm1Buru/Lbp^tm1Buru (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immune serum protein physiology	J:44878
	decreased tumor necrosis factor secretion	J:44878
Lbp^tm1Buru/Lbp^tm1Buru (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	decreased susceptibility to type I hypersensitivity reaction	J:67090
Lbp^tm1Buru/Lbp^tm1Buru (B6.129-Lbp^tm1Buru)	abnormal acute inflammation	J:129411
	abnormal chemokine level	J:129411
	abnormal innate immunity	J:129411
	abnormal neutrophil physiology	J:129411
	abnormal tumor necrosis factor secretion	J:129411
Lbp^tm1Jack/Lbp^tm1Jack (involves: 129P2/OlaHsd * BALB/c)	increased susceptibility to bacterial infection	J:43514
Lbr^ic-J/Lbr⁺ ((NZW/LacJ x C57BL/6J-Lbr^ic-J/J)F1)	increased anti-chromatin antibody level	J:234168
	increased anti-nuclear antigen antibody level	J:234168
	increased autoantibody level	J:234168
	increased susceptibility to systemic lupus erythematosus	J:234168
Lbr^lym3/Lbr^lym3 (C57BL/6-Lbr^lym3)	abnormal B cell physiology	J:180355
	abnormal T cell physiology	J:180355
	decreased T cell proliferation	J:180355
Lbw2^NZB/BlScr/Lbw2^NZB/BlScr (involves: NZB * NZW)	glomerulonephritis	J:45708
	increased anti-chromatin antibody level	J:98150
	increased autoantibody level	J:98150
Lbw2^NZB/BlScr/Lbw2^NZW/LacScr (involves: NZB * NZW)	glomerulonephritis	J:20991
	increased anti-chromatin antibody level	J:98150
	increased autoantibody level	J:98150
Lbw2^NZW/LacScr/Lbw2^NZW/LacScr (involves: NZB * NZW)	decreased autoantibody level	J:98150
	decreased IgG level	J:98150
	decreased IgM level	J:98150
Lbw4^NZW/LacScr/? (involves: C57BL/6J * NZM2410/Aeg)	decreased immunoglobulin level	J:52863
Lbw5^NZW/LacScr/Lbw5^NZB/BlScr (involves: NZB/BlScr * NZW/LacScr)	increased susceptibility to systemic lupus erythematosus	J:20991
Lbw5^NZW/LacScr/Lbw5^NZW/LacScr (involves: NZB/BlScr * NZW/LacScr)	increased susceptibility to systemic lupus erythematosus	J:20991
Lbw6^NZW/LacScr/Lbw6^NZW/LacScr (involves: NZB/BlScr * NZW/LacScr)	increased susceptibility to systemic lupus erythematosus	J:20991
Lbw7^NZB/BlScr/Lbw7^NZB/BlScr (involves: NZB/BlScr * NZW/LacScr)	increased susceptibility to systemic lupus erythematosus	J:20991
Lbw7^NZB/BlScr/Lbw7^NZW/LacScr (involves: NZB/BlScr * NZW/LacScr)	increased susceptibility to systemic lupus erythematosus	J:20991
Lbw8^NZB/BlScr/Lbw8^NZB/BlScr (involves: NZB/BlScr * NZW/LacScr)	increased susceptibility to autoimmune disorder	J:20991
Lbw8^NZB/BlScr/Lbw8^NZW/LacScr (involves: NZB/BlScr * NZW/LacScr)	increased susceptibility to autoimmune disorder	J:20991
Lck^m1Btlr/Lck^m1Btlr (C57BL/6J-Lck^m1Btlr)	decreased cytotoxic T cell cytolysis	J:144695
Lck^m2Btlr/Lck^m2Btlr (C57BL/6J-Lck^m2Btlr)	decreased IgG level	J:203759
Lck^tm1.1Litt/Lck^tm1.1Litt (Not Specified)	abnormal immunoglobulin level	J:152472
Lck^tm1Dbs/Lck^tm1Dbs (involves: C3H * C57BL/6)	decreased T cell proliferation	J:114660
Lck^tm1Dbs/Lck^tm1Dbs Tg(TcraTcrb)1100Mjb/0 (involves: C3H * C57BL/6)	decreased T cell proliferation	J:114660
Lck^tm1Litt/Lck^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ)	abnormal regulatory T cell physiology	J:152472
	decreased T cell proliferation	J:152472
Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas)	abnormal thymocyte activation	J:110847
	decreased IgG1 level	J:1119
	increased IgG2a level	J:1119
	increased IgG3 level	J:1119
	increased IgM level	J:1119
Lck^tm1Mak/Lck^tm1Mak (B6.129S2-Lck^tm1Mak)	decreased cytotoxic T cell cytolysis	J:111646
Lcn2^tm1Aade/Lcn2^tm1Aade (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:95107
	sepsis	J:95107
Lcn2^tm1Mak/Lcn2^tm1Mak (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to bacterial infection	J:106079
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (129(B6)-Lcn2^tm1Mrgr)	abnormal mast cell physiology	J:173490
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (129(B6)-Lcn2^tm1Mrgr)	decreased thymocyte apoptosis	J:173490
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (B6.129-Lcn2^tm1Mrgr)	abnormal mast cell physiology	J:173490
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (involves: 129 * C57BL/6)	abnormal mast cell physiology	J:173490
Lcp1^tm1Erjb/Lcp1^tm1Erjb (involves: 129X1/SvJ)	abnormal macrophage physiology	J:161042
	abnormal neutrophil physiology	J:161042
	decreased interleukin-1 secretion	J:161042
	increased susceptibility to bacterial infection	J:161042
Lcp2^m1Khoe/Lcp2^m1Khoe (C57BL/6J-Lcp2^m1Khoe)	abnormal NK cell physiology	J:196519
Lcp2^m1Khoe/Lcp2^m1Khoe (C57BL/6J-Lcp2^m1Khoe)	impaired natural killer cell mediated cytotoxicity	J:196519
Lcp2^tm1.1Wz/Lcp2^tm1.1Wz (B6.Cg-Lcp2^tm1.1Wz)	decreased interleukin-2 secretion	J:150304
Lcp2^tm1.1Wz/Lcp2^tm1.1Wz (B6.Cg-Lcp2^tm1.1Wz)	decreased T cell proliferation	J:150304
Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129S4/SvJae)	decreased interferon-gamma secretion	J:131621
Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129S4/SvJae)	impaired natural killer cell mediated cytotoxicity	J:131621
Lcp2^tm2Gak/Lcp2^tm2Gak Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased T cell apoptosis	J:107467
Lcp2^tm3Gak/Lcp2^tm3Gak (involves: 129S6/SvEvTac * C57BL/6)	abnormal T cell activation	J:132995
Lcp2^tm3Gak/Lcp2^tm3Gak Tg(TcrAND)53Hed/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal thymocyte activation	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal T cell activation	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak Tg(TcrAND)53Hed/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal thymocyte activation	J:132995
Lcp2^{tm5(Lat/Lcp2)Gak}/Lcp2^{tm5(Lat/Lcp2)Gak} (involves: 129S1/Sv * 129X1/SvJ)	abnormal thymocyte activation	J:147721
Lcp2^twm/Lcp2^twm (C57BL/6JSfdAnu-Lcp2^twm/Anu)	abnormal T cell physiology	J:104190
	autoimmune response	J:104190
	increased IgE level	J:104190
	increased IgG level	J:104190
Lctlp1^FVB/NJ/Lctlp1^FVB/NJ (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:122919
Lctlp2^FVB/NJ/Lctlp2^FVB/NJ (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:122919
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	liver inflammation	J:175559
Ldlr^tm1Her/Ldlr^tm1Her (B6.129S7-Ldlr^tm1Her)	decreased circulating interleukin-10 level	J:130794
	increased circulating interleukin-1 beta level	J:137264
	increased circulating interleukin-6 level	J:137264
	increased circulating tumor necrosis factor level	J:137264
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	impaired macrophage phagocytosis	J:137404
Ldlr^tm1Her/Ldlr^tm1Her Lrp1^tm2Her/Lrp1^tm2Her Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	abnormal microglial cell physiology	J:144185
Ldlr^tm1Her/Ldlr^tm1Her Olr1^tm1Meht/Olr1^tm1Meht (involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)	increased circulating interleukin-10 level	J:130794
Ldlr^tm1Her/Ldlr^tm1Her Pfn1^tm1Wit/Pfn1⁺ (B6.129S-Ldlr^tm1Her Pfn1^tm1Wit)	impaired macrophage chemotaxis	J:140294
Ldlr^tm1Her/Ldlr^tm1Her Soat1^tm1Far/Soat1^tm1Far (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)	skin inflammation	J:61147
Ldlr^tm1Her/Ldlr^tm1Her Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	abnormal interleukin secretion	J:96110
	decreased IgG level	J:96110
	decreased interferon-gamma secretion	J:96110
	increased IgM level	J:96110
Ldlr^tm1Her/Ldlr^tm1Her Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (B6.129-Ldlr^tm1Her Tcra-J^tm1Tgi)	decreased interferon-gamma secretion	J:140276
Ldlr^tm1Her/Ldlr^tm1Her Tg(H2-K-AKR1B1)1Tj/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	abnormal macrophage physiology	J:100916
Ldlr^tm1Her/Ldlr^tm1Her Tlr2^tm1Kir/Tlr2^tm1Kir (B6.129-Tlr2^tm1Kir Ldlr^tm1Her)	abnormal cellular extravasation	J:131783
	decreased tumor necrosis factor secretion	J:131783
Ldlr^tm1Her/Ldlr^tm1Her Vwf^tm1Wgr/Vwf^tm1Wgr (B6.129S-Vwf^tm1Wgr Ldlr^tm1Her)	impaired leukocyte tethering or rolling	J:106677
Ldlrad3^em1Diam/Ldlrad3^em1Diam (C57BL/6-Ldlrad3^em1Diam)	decreased susceptibility to Togaviridae infection	J:300132
Ldlrad3^em1Diam/Ldlrad3^em2Diam (C57BL/6-Ldlrad3^em1Diam Ldlrad3^em2Diam)	decreased susceptibility to Togaviridae infection	J:300132
Ldlrad3^em2Diam/Ldlrad3^em2Diam (C57BL/6-Ldlrad3^em2Diam)	decreased susceptibility to Togaviridae infection	J:300132
Lect2^tm1Ymg/Lect2^tm1Ymg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal cytokine secretion	J:90961
	abnormal leukocyte physiology	J:90961
	increased T cell apoptosis	J:90961
	liver inflammation	J:90961
Lef1^tm1Hhx/Lef1^tm1Hhx Tcf7^tm1Cle/Tcf7^tm1Cle Gt(ROSA)26Sor^tm2Sho/Gt(ROSA)26Sor⁺ Tg(GZMB-cre)1Jcb/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal memory T cell physiology	J:189838
	decreased tumor necrosis factor secretion	J:189838
Lep^ob/Lep^ob (B6.Cg-Lep^ob/J)	lung inflammation	J:115772
Lep^ob/Lep^ob (B6.Cg-Lep^ob/OlaHsd)	abnormal acute inflammation	J:124815
	abnormal chemokine secretion	J:124815
	increased interleukin-6 secretion	J:124815
	increased susceptibility to endotoxin shock	J:124815
	liver inflammation	J:124815
Lep^ob/Lep^ob (involves: STOCK Mlph^ln a Tgfa^wa1 Cdh23^v Ednrb^s)	abnormal microglial cell physiology	J:115569
	decreased circulating tumor necrosis factor level	J:115569
Lep^ob/Lep^ob (involves: C57BL/6)	decreased T cell proliferation	J:164339
Lep^ob/Lep^ob (B6.Cg-Lep^ob/JRj)	liver inflammation	J:277927
Lep^ob/Lep^ob Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal tumor necrosis factor level	J:70695
Lepr^db-5J/Lepr^db-5J (NOD/ShiLt-Lepr^db-5J)	pancreas inflammation	J:118305
Lepr^db-5J/Lepr^db-5J (NOD/ShiLt-Lepr^db-5J)	periinsulitis	J:118305
Lepr^db-lb/Lepr^db-lb (C57BL/6NCrl-Lepr^db-lb/Crl)	white adipose tissue inflammation	J:171755
Lepr^db/Lepr^db (involves: C57BLKS/J)	increased susceptibility to autoimmune diabetes	J:7005
Lepr^db/Lepr^db (B6.Cg-Dock7^m +/+ Lepr^db/J)	abnormal chemokine level	J:115772
	abnormal interleukin level	J:115772
	increased circulating interleukin-6 level	J:115772
	lung inflammation	J:115772
Lepr^db/Lepr^db (BKS.Cg-Dock7^m +/+ Lepr^db/OlaHsd)	abnormal acute inflammation	J:124815
	abnormal chemokine secretion	J:124815
	increased interleukin-6 secretion	J:124815
	increased susceptibility to endotoxin shock	J:124815
	liver inflammation	J:124815
Lepr^db/Lepr^db (B6.BKS(D)-Lepr^db/JOrlRj)	liver inflammation	J:277927
Lepr^db/Lepr^db (BKS.Cg-Dock7^m +/+ Lepr^db)	kidney inflammation	J:346348
Lepr^m7Btlr/Lepr^m7Btlr (C57BL/6J-Lepr^m7Btlr)	decreased response to antigen	J:236685
Lepr^m7Btlr/Lepr^m7Btlr (C57BL/6J-Lepr^m7Btlr)	increased IgE level	J:236685
Lepr^tm1.1Rll/Lepr⁺ (129P3/J-Lepr^tm1.1Rll)	increased susceptibility to parasitic infection	J:172012
Lepr^tm1.1Rll/Lepr^tm1.1Rll (129P3/J-Lepr^tm1.1Rll)	increased susceptibility to parasitic infection	J:172012
Lepr^tm4Mgmj/Lepr^tm4Mgmj (B6.Cg-Lepr^tm4Mgmj)	decreased T cell proliferation	J:164339
Lgals1^tm1Rob/Lgals1^tm1Rob (involves: 129S/SvEv)	increased interferon-gamma secretion	J:123416
	increased interleukin-2 secretion	J:123416
	increased susceptibility to experimental autoimmune encephalomyelitis	J:123416
Lgals1^tm1Rob/Lgals1^tm1Rob (involves: 129S/SvEv * 129S1/SvImJ * DBA/2J)	abnormal cytokine secretion	J:130208
Lgals2^tm1.1Cfg/Lgals2^tm1.1Cfg (involves: C57BL/6)	abnormal immune system physiology	J:217719
	enhanced humoral immune response	J:217719
	increased IgG2b level	J:217719
	increased IgG3 level	J:217719
	increased susceptibility to type IV hypersensitivity reaction	J:217719
Lgals3^tm1Ftl/Lgals3^tm1Ftl (B6.129S2-Lgals3^tm1Ftl)	abnormal dendritic cell physiology	J:109126
	abnormal interferon secretion	J:109126
	abnormal response to infection	J:109126
	brain inflammation	J:109126
	increased IgG level	J:109126
	increased interleukin-12b secretion	J:109126
	increased susceptibility to parasitic infection	J:109126
	lung inflammation	J:109126
	small intestinal inflammation	J:109126
Lgals3^tm1Ftl/Lgals3^tm1Ftl (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte physiology	J:60741
	abnormal macrophage physiology	J:60741
	increased macrophage apoptosis	J:60741
	peritoneal inflammation	J:60741
Lgals3^tm1Ftl/Lgals3^tm1Ftl (involves: 129S2/SvPas * CD-1)	liver inflammation	J:221030
Lgals3^tm1Poi/Lgals3^tm1Poi (involves: 129/Sv * C57BL/6 * SJL)	abnormal macrophage physiology	J:131971
	impaired macrophage chemotaxis	J:131971
	impaired macrophage phagocytosis	J:131407
	impaired neutrophil recruitment	J:131407
	increased interleukin-6 secretion	J:131407
	increased susceptibility to bacterial infection	J:131407
	increased tumor necrosis factor secretion	J:131407
	lung inflammation	J:131407
	sepsis	J:131407
Lgals3bp^tm1Megt/Lgals3bp^tm1Megt (involves: 129P2/OlaHsd * C57BL/Ka)	increased circulating interferon-gamma level	J:94936
	increased circulating interleukin-12 level	J:94936
	increased susceptibility to endotoxin shock	J:94936
	increased tumor necrosis factor secretion	J:94936
Lgals8^{tm1(KOMP)Vlcg}/Lgals8^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased susceptibility to Herpesvirales infection	J:235778
Lgals9^tm1.1Cfg/Lgals9^tm1.1Cfg (involves: C57BL/6)	enhanced humoral immune response	J:217719
Lgals9^tm1.1Cfg/Lgals9^tm1.1Cfg (involves: C57BL/6)	increased B cell proliferation	J:217719
Lgals9^tm1Glp/Lgals9^tm1Glp (B6.129S6-Lgals9^tm1Glp)	increased susceptibility to induced arthritis	J:132889
Lgmn^tm1Cptr/Lgmn^tm1Cptr (B6.129S6-Lgmn^tm1Cptr)	abnormal adaptive immunity	J:155339
	decreased interleukin-6 secretion	J:155339
	decreased interleukin-12b secretion	J:155339
	decreased tumor necrosis factor secretion	J:155339
Lgmn^tm1Ihn/Lgmn^tm1Ihn (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:143886
	abnormal NK cell physiology	J:143886
	increased circulating tumor necrosis factor level	J:143886
lgr/lgr (Not Specified)	eye inflammation	J:13879
Lgr4^{Gt(LST020)Byg}/Lgr4^{Gt(LST020)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased incidence of corneal inflammation	J:134299
Lhcgr^tm1Hht/Lhcgr^tm1Hht (involves: 129S7/SvEvBrd * C57BL/6J)	epididymis inflammation	J:105533
	prostate gland inflammation	J:105533
	reproductive system inflammation	J:105533
Lif^tm1Phb/Lif⁺ (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased T cell proliferation	J:77410
Lif^tm1Phb/Lif^tm1Phb (involves: 129S2/SvPas * C57BL/6 * DBA/2)	decreased T cell proliferation	J:77410
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * C57BL/6)	increased acute inflammation	J:119777
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * C57BL/6)	increased circulating interleukin-1 beta level	J:119777
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * BALB/c)	decreased interleukin-10 secretion	J:136940
	increased circulating interleukin-6 level	J:136940
	increased circulating serum amyloid protein level	J:136940
	increased circulating tumor necrosis factor level	J:136940
	increased susceptibility to bacterial infection induced morbidity/mortality	J:136940
	increased susceptibility to endotoxin shock	J:136940
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * MF1)	abnormal osteoclast physiology	J:137646
Lig1^tm3Dwm/Lig1^tm3Dwm (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen physiology	J:77902
Lig1^tm3Dwm/Lig1^tm3Dwm (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus physiology	J:77902
Lig4^m1Btlr/Lig4^m1Btlr (C57BL/6J-Lig4^m1Btlr)	decreased IgD level	J:267684
	decreased IgG level	J:267684
	impaired humoral immune response	J:267684
Lig4^tm1Fwa/Lig4^tm1Fwa Tg(Cr2-cre)3Cgn/0 Xrcc4^tm2Fwa/Xrcc4^tm2Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Lig4^tm2.1Fwa/Lig4^tm2.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell activation	J:157574
	abnormal immune system physiology	J:157574
	abnormal T cell activation	J:157574
	decreased IgA level	J:157574
	decreased IgG2b level	J:157574
	decreased IgG3 level	J:157574
	decreased IgG level	J:157574
	decreased IgM level	J:157574
	decreased immunoglobulin level	J:157574
	decreased interferon-gamma secretion	J:157574
	decreased interleukin-13 secretion	J:157574
	decreased T cell proliferation	J:157574
	increased anti-chromatin antibody level	J:157574
	increased anti-double stranded DNA antibody level	J:157574
	increased T cell apoptosis	J:157574
	intestinal inflammation	J:157574
	liver inflammation	J:157574
Lig4^tm3.1Fwa/Lig4^tm3.1Fwa Tg(Cr2-cre)3Cgn/0 (Not Specified)	abnormal class switch recombination	J:157537
Lilrb4a^tm1Eol/Lilrb4a^tm1Eol (B6.129P2-Lilrb4a^tm1Eol)	abnormal cellular extravasation	J:129969
	abnormal cytokine level	J:129969
	abnormal immune system physiology	J:129969
	abnormal interferon level	J:129969
	abnormal interleukin level	J:129969
	abnormal leukocyte physiology	J:129969
	decreased IgE level	J:129969
	increased inflammatory response	J:129969
	increased mast cell degranulation	J:129969
Lilrb4a^tm1Hrk/Lilrb4a^tm1Hrk (involves: 129/Sv * BALB/c)	abnormal mast cell physiology	J:70491
	increased mast cell degranulation	J:70491
	increased susceptibility to type I hypersensitivity reaction	J:70491
Lilrb4a^tm1Ttk/Lilrb4a^tm1Ttk (B6.129X1-Lilrb4a^tm1Ttk)	abnormal dendritic cell antigen presentation	J:141234
Lilrb4a^tm1Ttk/Lilrb4a^tm1Ttk (B6.129X1-Lilrb4a^tm1Ttk)	increased susceptibility to graft versus host disease	J:141234
Limd1^tm1Gdl/Limd1^tm1Gdl (involves: 129X1/SvJ)	abnormal macrophage physiology	J:118130
Limd1^tm1Gdl/Limd1^tm1Gdl (involves: 129X1/SvJ)	abnormal osteoclast physiology	J:118130
Limk2^{Gt(OST80053)Lex}/Limk2^{Gt(OST80053)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased incidence of corneal inflammation	J:192231
Limk2^whe/Limk2^whe (B6.Cg-Lep^ob Limk2^whe/GrsrJ)	increased incidence of corneal inflammation	J:127016
Lipa^{tm1c(EUCOMM)Hmgu}/Lipa^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1^{Tg(Alb-cre)21Mgn} (involves: C57BL/6J * C57BL/6N * C57BL/6NTac)	liver inflammation	J:270182
Lipa^tm1Ggb/Lipa^tm1Ggb (involves: 129P2/OlaHsd * CF-1)	chronic inflammation	J:101217
Lipa^tm1Ggb/Lipa^tm1Ggb (involves: 129P2/OlaHsd * CF-1)	lung inflammation	J:101217
Listr1^BALB/cByJ/? (involves: BALB/cByJ * C57BL/6ByJ)	decreased susceptibility to bacterial infection	J:68879
Listr1^BALB/cByJ/? Listr2^C57BL/6ByJ/? (involves: BALB/cByJ * C57BL/6ByJ)	decreased susceptibility to bacterial infection	J:68879
Listr2^C57BL/6ByJ/? (involves: BALB/cByJ * C57BL/6ByJ)	decreased susceptibility to bacterial infection	J:68879
Litaf^tm1.1Ics/Litaf^tm1.1Ics (Not Specified)	impaired macrophage chemotaxis	J:186411
Litaf^tm1Samr/Litaf^tm1Samr (involves: 129S4/SvJae)	abnormal cytokine secretion	J:113750
Litaf^tm1Samr/Litaf^tm1Samr (involves: 129S4/SvJae)	decreased susceptibility to endotoxin shock	J:113750
ll/ll X/Yaa (BXSB/MpJScr-ll)	decreased anti-nuclear antigen antibody level	J:10973
	decreased IgG level	J:10973
	decreased susceptibility to autoimmune disorder	J:10973
Lmb1^C57BL/6Scr/Lmb1^C57BL/6Scr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	increased anti-double stranded DNA antibody level	J:45708
Lmb1^C57BL/6Scr/Lmb1^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	increased anti-double stranded DNA antibody level	J:45708
Lmb2^C57BL/6Scr/Lmb2^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	increased anti-double stranded DNA antibody level	J:45708
Lmb2^MRL/MpScr/Lmb2^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	increased anti-double stranded DNA antibody level	J:45708
Lmbr1l^em1Btlr/Lmbr1l^em1Btlr (C57BL/6J-Lmbr1l^em1Btlr)	abnormal cytotoxic T cell physiology	J:274568
	decreased IgD level	J:274568
	decreased IgG level	J:274568
	decreased IgM level	J:274568
	impaired humoral immune response	J:274568
	impaired natural killer cell mediated cytotoxicity	J:274568
	increased IgM level	J:274568
Lmbr1l^m1Btlr/Lmbr1l^m1Btlr (C57BL/6J-Lmbr1l^m1Btlr)	abnormal cytotoxic T cell physiology	J:274568
	decreased IgE level	J:274568
	decreased IgG level	J:274568
	decreased IgM level	J:274568
	impaired humoral immune response	J:274568
	impaired natural killer cell mediated cytotoxicity	J:274568
Lmna^Dhe/Lmna⁺ (B6(D2)-Lmna^Dhe/TyGrsrJ)	increased susceptibility to otitis media	J:188496
Lmna^tm1.1Otin/Lmna^tm1.1Otin (involves: 129P2/OlaHsd * C57BL/6NTac)	keratoconjunctivitis sicca	J:261974
Lmo4^tm1Slp/Lmo4^tm1Slp Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal acute inflammation	J:282740
	abnormal lymphocyte physiology	J:282740
	increased susceptibility to bacterial infection	J:282740
Lmo4^tm1Slp/Lmo4^tm1Slp Yeats4^em1Zfa/Yeats4^em1Zfa Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal acute inflammation	J:282740
	abnormal lymphocyte physiology	J:282740
	increased susceptibility to bacterial infection	J:282740
Lmr1^BALB/c/Lmr1^BALB/c (involves: BALB/c * C57BL/6J)	increased susceptibility to parasitic infection	J:40874
Lmr1^BALB/c/Lmr1^BALB/c Lmr30^C57BL/6/Lmr30^BALB/c (involves: BALB/c * C57BL/6)	increased susceptibility to parasitic infection	J:57691
Lmr1^BALB/c/Lmr1^BALB/c Lmr30^C57BL/6/Lmr30^C57BL/6 (involves: BALB/c * C57BL/6)	increased susceptibility to parasitic infection	J:57691
Lmr1^BALB/c/Lmr1^C57BL/6J (involves: BALB/c * C57BL/6J)	decreased susceptibility to parasitic infection	J:40874
Lmr1^C57BL/6J/Lmr1^C57BL/6J (involves: BALB/c * C57BL/6J)	decreased susceptibility to parasitic infection	J:40874
Lmr2^BALB/c/Lmr2^BALB/c (involves: BALB/c * C57BL/6J)	increased susceptibility to parasitic infection	J:40874
Lmr2^BALB/c/Lmr2^C57BL/6J (involves: BALB/c * C57BL/6J)	decreased susceptibility to parasitic infection	J:40874
Lmr2^C57BL/6J/Lmr2^C57BL/6J (involves: BALB/c * C57BL/6J)	decreased susceptibility to parasitic infection	J:40874
Lmr3^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	abnormal tumor necrosis factor level	J:82715
Lmr3^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82715
Lmr4^BALB/cHeA/? Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	abnormal tumor necrosis factor level	J:82715
Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	abnormal interleukin level	J:82715
	abnormal tumor necrosis factor level	J:82715
	increased IgE level	J:82715
Lmr5^CcS5/Dem/Lmr5^CcS5/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-12 level	J:108764
Lmr7^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	decreased splenocyte proliferation	J:108764
Lmr8^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr9^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr9^BALB/cHeA/Lmr9^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr9^CcS20/Dem/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr9^CcS20/Dem/Lmr9^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr10^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr10^CcS20/Dem/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr11^BALB/cHeA/Lmr11^BALB/cHeA Lmr8^CcS20/Dem/Lmr8^CcS20/Dem (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr11^BALB/cHeA/Lmr11^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr11^CcS20/Dem/Lmr11^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-6 level	J:108764
Lmr12^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr12^BALB/cHeA/Lmr12^BALB/cHeA Lmr14^BALB/cHeA/Lmr14^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased circulating tumor necrosis factor level	J:108764
Lmr12^BALB/cHeA/Lmr12^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-4 level	J:108764
Lmr12^CcS16/Dem/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr12^CcS16/Dem/Lmr12^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-4 level	J:108764
Lmr13^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	decreased IgE level	J:82717
Lmr13^CcS16/Dem/Lmr13^CcS16/Dem Lmr14^CcS16/Dem/Lmr14^CcS16/Dem (involves: BALB/cHeA * STS/A)	decreased circulating tumor necrosis factor level	J:108764
Lmr14^BALB/cHeA/Lmr14^BALB/cHeA Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82715
Lmr14^BALB/cHeA/Lmr14^BALB/cHeA Lmr5^BALB/cHeA/Lmr5^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr14^BALB/cHeA/Lmr14^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interferon-gamma level	J:108764
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem (involves: BALB/cHeA * STS/A)	increased circulating interferon-gamma level	J:108764
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem Lmr5^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	increased IgE level	J:82715
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem Lmr5^BALB/cHeA/Lmr5^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased IgE level	J:82717
Lmr14^CcS16/Dem/Lmr14^CcS16/Dem Lmr5^CcS5/Dem/Lmr5^CcS5/Dem (involves: BALB/cHeA * STS/A)	increased circulating interleukin-12 level	J:108764
Lmr15^BALB/cHeA/Lmr15^CcS16/Dem (involves: BALB/cHeA * STS/A)	decreased circulating interferon-gamma level	J:108764
Lmr15^CcS16/Dem/Lmr15^CcS16/Dem (involves: BALB/cHeA * STS/A)	decreased circulating interferon-gamma level	J:108764
Lmr17^BALB/cHeA/Lmr17^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating tumor necrosis factor level	J:108764
Lmr17^CcS20/Dem/Lmr17^CcS20/Dem (involves: BALB/cHeA * STS/A)	increased circulating tumor necrosis factor level	J:108764
Lmr17^CcS20/Dem/Lmr17^CcS20/Dem Lmr3^BALB/cHeA/Lmr3^BALB/cHeA (involves: BALB/cHeA * STS/A)	increased circulating interferon-gamma level	J:108764
Lmr18^BALB/cHeA/Lmr18^BALB/cHeA (involves: BALB/cHeA * STS/A)	decreased splenocyte proliferation	J:108764
Lmr18^BALB/cHeA/Lmr18^CcS20/Dem (involves: BALB/cHeA * STS/A)	decreased splenocyte proliferation	J:108764
Lmrq1^BALB/cAnSim/Lmrq1^C57BL/10Sn (involves: BALB/cAnNSim * C57BL/10J)	decreased susceptibility to parasitic infection	J:40624
Lmrq2^BALB/cAnSim/Lmrq2^C57BL/10Sn (involves: BALB/cAnNSim * C57BL/10J)	decreased susceptibility to parasitic infection	J:40624
Lmrq3^BALB/cAnSim/Lmrq3^C57BL/10Sn (involves: BALB/cAnNSim * C57BL/10J)	decreased susceptibility to parasitic infection	J:40624
Lmrq4^BALB/cAnSim/Lmrq4^C57BL/10Sn (involves: BALB/cAnNSim * C57BL/10J)	decreased susceptibility to parasitic infection	J:40624
Lmrq4^C57BL/10Sn/Lmrq4^C57BL/10Sn (C.B10-(D11Mit2-D11Mit29))	decreased susceptibility to parasitic infection	J:40624
Lmrq5^BALB/cAnNSim/Lmrq5^C57BL/10Sn (involves: BALB/cAnNSim * C57BL/10J)	decreased susceptibility to parasitic infection	J:40624
Lmrq6^BALB/cAnSim/Lmrq6^C57BL/10Sn (involves: BALB/cAnNSim * C57BL/10J)	decreased susceptibility to parasitic infection	J:40624
Lncucc1^em1Bwu/Lncucc1^em1Bwu (C57BL/6-Lncucc1^em1Bwu)	abnormal susceptibility to colitis induced morbidity/mortality	J:340220
Lncucc1^em1Bwu/Lncucc1^em1Bwu (C57BL/6-Lncucc1^em1Bwu)	increased susceptibility to induced colitis	J:340220
Loricrin^tm1Der/Loricrin^tm1Der (FVB.129S7-Loricrin^tm1Der)	erythroderma	J:65187
Loxl2^tm1.2Acan/Loxl2^tm1.2Acan (Not Specified)	decreased inflammatory response	J:220689
Lpar2^tm1Dgen/Lpar2^tm1Dgen (B6.Cg-Lpar2^tm1Dgen)	abnormal dendritic cell physiology	J:184061
	decreased interleukin-10 secretion	J:184061
	increased IgE level	J:184061
	increased interleukin-13 secretion	J:184061
	increased susceptibility to type I hypersensitivity reaction	J:184061
	increased tumor necrosis factor secretion	J:184061
	lung inflammation	J:184061
Lpn1^NZB/Lpn1^NZB (involves: NZB * NZW)	kidney inflammation	J:6026
Lpn1^NZB/Lpn1^NZW (involves: NZB * NZW)	kidney inflammation	J:6026
Lpn2^NZB/Lpn2^NZW (involves: NZB * NZW)	kidney inflammation	J:6026
Lpn2^NZW/Lpn2^NZW (involves: NZB * NZW)	kidney inflammation	J:6026
Lpo^em1Zlu/Lpo^em1Zlu (involves: C57BL/6 * SJL)	aortitis	J:307289
	arteritis	J:307289
	blood vessel inflammation	J:307289
	cardiovalvulitis	J:307289
	gallbladder inflammation	J:307289
	glomerulonephritis	J:307289
	increased inflammatory response	J:307289
	intestinal inflammation	J:307289
	liver inflammation	J:307289
	lung inflammation	J:307289
	mastitis	J:307289
	myocarditis	J:307289
	myositis	J:307289
	pancreas inflammation	J:307289
	stomach inflammation	J:307289
Lppl1^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	abnormal leukocyte physiology	J:90647
Lprm3^MRL/MpJ/Lprm3^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	glomerulonephritis	J:44625
Lprm5^MRL/MpJ/Lprm5^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	abnormal humoral immune response	J:44625
Lptl1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal tumor necrosis factor level	J:90647
Lptl1^DBA/2J/Lptl1^DBA/2J Lptl2^DBA/2J/Lptl2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal tumor necrosis factor level	J:90647
Lptl2^DBA/2J/? (involves: C57BL/6J * DBA/2J)	abnormal tumor necrosis factor level	J:90647
Lpxn^{tm1b(EUCOMM)Hmgu}/Lpxn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lpxn^{tm1b(EUCOMM)Hmgu}/Wtsi)	decreased IgM level	J:305662
Lrba^em1Btlr/Lrba^em1Btlr (C57BL/6J-Lrba^em1Btlr)	increased susceptibility to induced colitis	J:274652
Lrba^em2Btlr/Lrba^em2Btlr (C57BL/6J-Lrba^em2Btlr)	increased susceptibility to induced colitis	J:274652
Lrba^em3Btlr/Lrba^em3Btlr (C57BL/6J-Lrba^em3Btlr)	increased susceptibility to induced colitis	J:274652
Lrba^{Gt(OST69142)Lex}/Lrba^{Gt(OST69142)Lex} (involves: 129 * 129S5/SvEvBrd)	abnormal NK cell physiology	J:237187
	decreased susceptibility to graft versus host disease	J:237187
	impaired natural killer cell mediated cytotoxicity	J:237187
	increased length of allograft survival	J:237187
Lrba^m1Btlr/Lrba^m1Btlr (C57BL/6J-Lrba^m1Btlr)	increased susceptibility to induced colitis	J:274652
Lrba^m2Btlr/Lrba^m2Btlr (C57BL/6J-Lrba^m2Btlr)	increased susceptibility to induced colitis	J:274652
Lrch1^em1Hwa/Lrch1^em1Hwa (Not Specified)	abnormal cellular extravasation	J:238772
Lrch1^em1Hwa/Lrch1^em1Hwa (Not Specified)	increased susceptibility to experimental autoimmune encephalomyelitis	J:238772
Lrdm1^MRL/MpJ/? (involves: CAST/Ei * MRL/MpJ-Fas^lpr/J)	kidney inflammation	J:3304
Lrdm2^MRL/MpJ/? (involves: CAST/Ei * MRL/MpJ-Fas^lpr/J)	kidney inflammation	J:3304
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2⁺ (involves: C57BL/10 * CBA)	decreased T cell proliferation	J:126456
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2⁺ Tg(H2-K-Myc)1Brn/? (involves: C57BL/10 * CBA * FVB/N)	lymph node hemorrhage	J:125805
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2^{Tg(CD2-Myb/en)5Kmw} (involves: C57BL/10 * CBA)	decreased T cell proliferation	J:126456
Lrig1^{tm1a(EUCOMM)Wtsi}/Lrig1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased susceptibility to bacterial infection	J:213427
Lrig2^tm1.1Hhed/Lrig2^tm1.1Hhed (involves: 129 * C57BL/6 * FVB/N)	increased inflammatory response	J:205929
Lrp1^tm2Her/Lrp1^tm2Her Tg(Camk2a-cre)T29-1Stl/0 (involves: 129S7/SvEvBrd * BALB/c * C57BL)	brain inflammation	J:167724
Lrp6^tm1Arma/Lrp6^tm1Arma (C57BL/6-Lrp6^tm1Arma)	liver inflammation	J:225450
Lrp12^em1Gpt/Lrp12^em1Gpt Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JGpt * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:338432
	enhanced leukocyte migration	J:338432
	increased susceptibility to induced colitis	J:338432
Lrrc4c^tm1Lex/Lrrc4c^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased circulating interleukin-6 level	J:171883
Lrrc8a^tm1.1Geha/Lrrc8a^tm1.1Geha (B6.129S1(Cg)-Lrrc8a^tm1.1Geha)	abnormal T cell physiology	J:211308
	abnormal thymus apoptosis	J:211308
	abnormal thymus physiology	J:211308
	decreased T cell proliferation	J:211308
	increased IgG2a level	J:211308
	increased thymocyte apoptosis	J:211308
Lrrc8e^em1Bcgen/Lrrc8e^em1Bcgen (C57BL/6N-Lrrc8e^em1Bcgen)	abnormal circulating cytokine level	J:288504
	decreased circulating interferon-beta level	J:288504
	decreased circulating tumor necrosis factor level	J:288504
	decreased interferon-beta secretion	J:288504
	increased susceptibility to viral infection	J:288504
	increased susceptibility to viral infection induced morbidity/mortality	J:288504
Lrrc19^tm1Ryag/Lrrc19^tm1Ryag (involves: C57BL/6J * C57BL/6NTac)	decreased circulating interleukin-6 level	J:271376
	decreased circulating tumor necrosis factor level	J:271376
	increased susceptibility to bacterial infection	J:271376
Lrrc25^em1Cya/Lrrc25^em1Cya (C57BL/6J-Lrrc25^em1Cya/Cya)	abnormal tumor necrosis factor level	J:270157
Lrrc25^em1Cya/Lrrc25^em1Cya (C57BL/6J-Lrrc25^em1Cya/Cya)	heart inflammation	J:270157
Lrrc32^tm1.1Hfuj/Lrrc32^tm1.1Hfuj Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2)	abnormal regulatory T cell physiology	J:204761
Lrrc55os^em1Caox/Lrrc55os^em1Caox (C57BL/6-Lrrc55os^em1Caox)	decreased circulating interferon-beta level	J:293325
	increased susceptibility to Riboviria infection	J:293325
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:293325
Lrrk1^tm1.1Smo/Lrrk1^tm1.1Smo (involves: 129S/Sv)	abnormal osteoclast physiology	J:208677
Lrrk2^tm2.1Shn/Lrrk2^tm2.1Shn (involves: 129 * C57BL/6)	kidney inflammation	J:160542
Lsm3^em1Caox/Lsm3^em1Caox (involves: C57BL/6J)	decreased susceptibility to Orthomyxoviridae infection	J:262834
	decreased susceptibility to Riboviria infection	J:262834
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:262834
	increased circulating interferon-alpha level	J:262834
	increased circulating interferon-beta level	J:262834
	increased circulating interleukin-6 level	J:262834
Lsp1^tm1Jejb/Lsp1^tm1Jejb (involves: 129S1/Sv * 129X1/SvJ)	abnormal cellular extravasation	J:96022
	abnormal leukocyte physiology	J:68128
	impaired neutrophil chemotaxis	J:68128
Lsr1^A/J/? (involves: A/J * C57BL/6J)	increased susceptibility to bacterial infection	J:7345
Lsr1^C57BL/6J/? (involves: A/J * C57BL/6J)	decreased susceptibility to bacterial infection	J:7345
Lst1^{tm1(KOMP)Vlcg}/Lst1^{tm1(KOMP)Vlcg} (C57BL/6N-Lst1^{tm1(KOMP)Vlcg})	increased susceptibility to Orthomyxoviridae infection	J:235700
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:235700
Lta4h^tm1Bhk/Lta4h^tm1Bhk (involves: 129P2/OlaHsd * 129S/SvEv)	decreased acute inflammation	J:58985
	decreased susceptibility to type I hypersensitivity reaction	J:58985
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129)	abnormal humoral immune response	J:31129
	decreased IgA level	J:31129
	increased susceptibility to parasitic infection	J:31129
	increased susceptibility to Poxviridae infection	J:31129
	increased susceptibility to Riboviria infection	J:31129
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129/Sv * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:115225
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129/Sv * C57BL/6)	decreased susceptibility to parasitic infection	J:37696
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (B6.129-Lta/Tnf^tm1Eug)	decreased circulating interferon-gamma level	J:115034
	decreased IgG1 level	J:115034
	decreased IgG2a level	J:115034
	decreased IgG3 level	J:115034
	decreased interferon-gamma secretion	J:115034
	decreased susceptibility to induced arthritis	J:115034
	impaired macrophage phagocytosis	J:115034
	increased IgM level	J:115034
	increased susceptibility to bacterial infection	J:115034
	increased susceptibility to bacterial infection induced morbidity/mortality	J:115034
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129)	abnormal humoral immune response	J:31129
	decreased IgA level	J:31129
	increased susceptibility to bacterial infection	J:31129
	increased susceptibility to Poxviridae infection	J:31129
	increased susceptibility to Riboviria infection	J:31129
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129/Sv * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:115225
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129/Sv * C57BL/6)	decreased susceptibility to parasitic infection	J:37696
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (B6.129-Lta/Tnf^tm1Eug)	decreased circulating interferon-gamma level	J:115034
	decreased IgG1 level	J:115034
	decreased IgG2a level	J:115034
	decreased IgG3 level	J:115034
	decreased interferon-gamma secretion	J:115034
	decreased susceptibility to induced arthritis	J:115034
	impaired macrophage phagocytosis	J:115034
	increased IgM level	J:115034
	increased susceptibility to bacterial infection	J:115034
	increased susceptibility to bacterial infection induced morbidity/mortality	J:115034
Lta/Tnf^tm1Fda/Lta/Tnf^tm1Fda (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to endotoxin shock	J:39519
	decreased tumor necrosis factor secretion	J:39519
	increased susceptibility to bacterial infection	J:39519
Lta/Tnf^tm1Fda/Lta⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to endotoxin shock	J:39519
	decreased tumor necrosis factor secretion	J:39519
	increased susceptibility to bacterial infection	J:39519
Lta/Tnf^tm1Fda/Lta/Tnf^tm1Fda (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to endotoxin shock	J:39519
	decreased tumor necrosis factor secretion	J:39519
	increased susceptibility to bacterial infection	J:39519
Lta/Tnf^tm1Fda/Tnf⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to endotoxin shock	J:39519
	decreased tumor necrosis factor secretion	J:39519
	increased susceptibility to bacterial infection	J:39519
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6J-Lta/Tnf^tm1Jods)	decreased immunoglobulin level	J:43602
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6-Lta/Tnf^tm1Jods)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:47428
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6J-Lta/Tnf^tm1Jods)	decreased immunoglobulin level	J:43602
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6-Lta/Tnf^tm1Jods)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:47428
Lta^hlb382/Lta^hlb382 (C57BL/6J-Lta^hlb382/J)	liver inflammation	J:134498
Lta^hlb382/Lta^hlb382 (C57BL/6J-Lta^hlb382/J)	lung inflammation	J:134498
Lta^tm1.1Sned/Lta^tm1.1Sned (B6.129-Lta^tm1.1Sned)	abnormal circulating tumor necrosis factor level	J:109621
	abnormal class switch recombination	J:109621
	abnormal humoral immune response	J:109621
	increased susceptibility to bacterial infection induced morbidity/mortality	J:109621
Lta^tm1Dch/Lta^tm1Dch (B6.129S2-Lta^tm1Dch)	abnormal class switch recombination	J:80616
	abnormal cytokine secretion	J:95222
	abnormal immune serum protein physiology	J:80616
	decreased IgG level	J:80616
	increased IgM level	J:80616
Lta^tm1Dch/Lta^tm1Dch (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:109621
	abnormal humoral immune response	J:39746
	decreased interferon-gamma secretion	J:109621
	decreased tumor necrosis factor secretion	J:109621
Lta^tm1Tab/Lta^tm1Tab (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * CF-1))	abnormal humoral immune response	J:28061
	decreased IgA level	J:28061
	increased IgM level	J:28061
Lta^tm1Tab/Lta^tm1Tab (involves: 129S2/SvPas * C57BL/6)	decreased tumor necrosis factor secretion	J:109621
Lta^tm1Tab/Lta^tm1Tab (B6.129S2-Lta^tm1Tab)	decreased susceptibility to parasitic infection	J:121070
Ltb4r1^tm1Adl/Ltb4r1^tm1Adl (involves: 129S4/SvJae * C57BL/6)	abnormal leukocyte adhesion	J:63873
	abnormal leukocyte migration	J:63873
	abnormal macrophage physiology	J:63873
	abnormal neutrophil physiology	J:63873
	impaired eosinophil recruitment	J:63873
	impaired neutrophil chemotaxis	J:63873
Ltb4r1^tm1Bodd/Ltb4r1^tm1Bodd (involves: 129S4/SvJaeSor * C57BL/6)	decreased susceptibility to autoimmune disorder	J:108446
Ltb4r1^tm1Bodd/Ltb4r1^tm1Bodd (involves: 129S4/SvJaeSor)	decreased susceptibility to induced arthritis	J:131779
Ltb4r1^tm1Bodd/Ltb4r1^tm1Bodd (either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6))	decreased susceptibility to induced arthritis	J:163271
	impaired neutrophil chemotaxis	J:163271
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (B6.Cg-Ltb4r1^tm1Tksh)	abnormal cytokine secretion	J:118995
	decreased IgE level	J:118995
	decreased susceptibility to type I hypersensitivity reaction	J:197334
	lung inflammation	J:118995
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (C.Cg-Ltb4r1^tm1Tksh)	abnormal mast cell physiology	J:133998
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal granulocyte physiology	J:118995
Ltb4r2^tm1Bodd/Ltb4r2^tm1Bodd (involves: 129S4/SvJaeSor * C57BL/6)	decreased susceptibility to induced arthritis	J:163271
Ltb4r2^tm1Tksh/Ltb4r2^tm1Tksh (C.Cg-Ltb4r2^tm1Tksh)	abnormal mast cell physiology	J:133998
Ltb4r2^tm1Tksh/Ltb4r2^tm1Tksh (B6.Cg-Ltb4r2^tm1Tksh)	decreased susceptibility to type I hypersensitivity reaction	J:197334
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	decreased IgG level	J:80616
	increased susceptibility to bacterial infection	J:80616
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	decreased IgG level	J:80616
	increased susceptibility to bacterial infection	J:80616
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	decreased IgG level	J:80616
	increased susceptibility to bacterial infection	J:80616
Ltb^tm1Flv/Ltb^tm1Flv (involves: 129S1/Sv * C57BL/6J)	abnormal humoral immune response	J:39746
Ltb^tm1Flv/Ltb^tm1Flv (involves: 129S1/Sv * C57BL/6J)	decreased IgA level	J:39746
Ltb^tm1Kpf/Ltb^tm1Kpf (B6.129P2-Ltb^tm1Kpf)	abnormal class switch recombination	J:80616
	colitis	J:158663
	decreased IgG level	J:80616
	increased IgM level	J:80616
	increased susceptibility to bacterial infection	J:80616, J:158663
	increased susceptibility to bacterial infection induced morbidity/mortality	J:158663
Ltb^tm1Krn/Ltb^tm1Krn (C57BL/6-Ltb^tm1Krn)	abnormal humoral immune response	J:78229
	decreased IgG1 level	J:78229
	decreased IgG2a level	J:78229
	increased IgM level	J:78229
	increased susceptibility to parasitic infection	J:78229
Ltbp3^tm1Bdvc/Ltbp3^tm1Bdvc (involves: 129S6/SvEvTac)	osteoarthritis	J:76213, J:79920
Ltbp4^{Gt(U3Cre)1Vmel}/Ltbp4^{Gt(U3Cre)1Vmel} (B6.129S2-Ltbp4^{Gt(U3Cre)1Vmel})	colitis	J:78819
	proctitis	J:78819
Ltbr^m1Btlr/Ltbr^m1Btlr (C57BL/6J-Ltbr^m1Btlr)	abnormal B cell physiology	J:212068
Ltbr^m1Btlr/Ltbr^m1Btlr (C57BL/6J-Ltbr^m1Btlr)	abnormal humoral immune response	J:212068
Ltbr^m2Btlr/Ltbr^m2Btlr (C57BL/6J-Ltbr^m2Btlr)	abnormal humoral immune response	J:254823
Ltbr^m2Btlr/Ltbr^m2Btlr (C57BL/6J-Ltbr^m2Btlr)	abnormal IgG level	J:254823
Ltbr^m3Btlr/Ltbr^m3Btlr (C57BL/6J-Ltbr^m3Btlr)	impaired natural killer cell mediated cytotoxicity	J:264642
Ltbr^tm1.1Thhe/Ltbr^tm1.1Thhe Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal macrophage physiology	J:183109
Ltbr^tm1Avt/Ltbr^tm1Avt Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	increased susceptibility to bacterial infection	J:158663
Ltbr^tm1Avt/Ltbr^tm1Avt Tg(Rorc-cre)1Litt/0 (Not Specified)	abnormal chemokine level	J:158663
	increased susceptibility to bacterial infection	J:158663
	increased susceptibility to bacterial infection induced morbidity/mortality	J:158663
Ltbr^tm1Avt/Ltbr^tm1Avt Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	increased susceptibility to bacterial infection	J:158663
Ltbr^tm1Kpf/Ltbr^tm1Kpf (involves: 129P2/OlaHsd)	abnormal immune system physiology	J:48837
	decreased IgE level	J:86810
	decreased interleukin-17 secretion	J:169863
Ltc4s^tm1Blam/Ltc4s^tm1Blam (involves: 129S7/SvEvBrd * C57BL/6)	respiratory system inflammation	J:88647
Ltc4s^tm1Blam/Ltc4s^tm1Blam (involves: 129S7/SvEvBrd * BALB/c)	abnormal hypersensitivity reaction	J:87909
	abnormal type I hypersensitivity reaction	J:87909
Ltc4s^tm1Blam/Ltc4s^tm1Blam (C.129S7-Ltc4s^tm1Blam)	autoimmune response	J:182213
Ltc4s^tm1Blam/Ltc4s^tm1Blam (B6.129S7-Ltc4s^tm1Blam)	decreased susceptibility to type I hypersensitivity reaction	J:197334
Ltxs2^BALB/cAnPt/Ltxs2^DBA/2NCr (involves: BALB/cAnPt * DBA/2NCr)	decreased susceptibility to infection	J:103336
Ltxs2^DBA/2NCr/Ltxs2^DBA/2NCr (involves: BALB/cAnPt * DBA/2NCr)	decreased susceptibility to infection	J:103336
Ltxs3^BALB/cAnPt/Ltxs3^DBA/2NCr (involves: BALB/cAnPt * DBA/2NCr)	decreased susceptibility to infection	J:103336
Ltxs3^DBA/2NCr/Ltxs3^DBA/2NCr (involves: BALB/cAnPt * DBA/2NCr)	decreased susceptibility to infection	J:103336
Lum^tm1Wwk/Lum^tm1Wwk (involves: 129P2/OlaHsd)	abnormal inflammatory response	J:128992
Lxw1^BXSB/Scr/? (involves: BXSB/Scr * NZW/LacScr)	increased anti-chromatin antibody level	J:86924
Lxw2^NZW/LacScr/Lxw2^NZW/LacScr (involves: BXSB/Scr * NZW/LacScr)	glomerulonephritis	J:86924
Lxw3^NZW/LacScr/? (involves: BXSB/Scr * NZW/LacScr)	increased anti-chromatin antibody level	J:86924
Ly6a^tm1Pmf/Ly6a^tm1Pmf (B6.129P2-Ly6a^tm1Pmf)	abnormal immunoglobulin level	J:42594
Ly6a^tm1Pmf/Ly6a^tm1Pmf (B6.129P2-Ly6a^tm1Pmf)	abnormal T cell proliferation	J:42594
Ly6e^{tm1c(EUCOMM)Hmgu}/Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio})	decreased inflammatory response	J:291868
	increased susceptibility to Coronaviridae infection	J:291868
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:291868
Ly9^tm1Mckn/Ly9^tm1Mckn (involves: 129/Sv * C57BL/6)	abnormal cytokine secretion	J:105482
Ly9^tm1Mckn/Ly9^tm1Mckn (involves: 129/Sv * C57BL/6)	decreased T cell proliferation	J:105482
Ly75^tm1Mnz/Ly75^tm1Mnz (Not Specified)	abnormal cytotoxic T cell physiology	J:97289
Ly86^tm1Kmiy/Ly86^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell proliferation	J:109720
	decreased IgG2b level	J:137066
	decreased IgG3 level	J:137066
	increased IgG level	J:109720
	increased IgM level	J:109720
Ly96^m1Btlr/Ly96^m1Btlr (C57BL/6J-Ly96^m1Btlr)	decreased interleukin-1 beta secretion	J:265259
	decreased macrophage apoptosis	J:265259
	decreased tumor necrosis factor secretion	J:265259
Ly96^tm1Kmiy/Ly96^tm1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune cell physiology	J:92494
	abnormal macrophage physiology	J:92494
	decreased B cell proliferation	J:92494
	decreased interleukin-6 secretion	J:92494
	decreased susceptibility to endotoxin shock	J:92494
	decreased tumor necrosis factor secretion	J:92494
	impaired neutrophil recruitment	J:92479
	increased susceptibility to bacterial infection	J:92494
Lyg1^{tm1(KOMP)Vlcg}/Lyg1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased interferon-gamma secretion	J:256594
Lyn^M2Btlr/Lyn⁺ (C57BL/6J-Lyn^M2Btlr)	decreased IgG level	J:217146
	decreased IgM level	J:217146
	impaired humoral immune response	J:217146
Lyn^M2Btlr/Lyn^M2Btlr (C57BL/6J-Lyn^M2Btlr)	decreased IgG level	J:217146
	decreased IgM level	J:217146
	impaired humoral immune response	J:217146
Lyn^m4Btlr/Lyn^m4Btlr (C57BL/6J-Lyn^m4Btlr)	decreased IgG level	J:272816
Lyn^m4Btlr/Lyn^m4Btlr (C57BL/6J-Lyn^m4Btlr)	impaired humoral immune response	J:272816
Lyn^mld4/Lyn^mld4 (involves: C57BL/6)	abnormal B cell activation	J:144799
	glomerulonephritis	J:144799
	increased anti-double stranded DNA antibody level	J:144799
	increased IgE level	J:144799
	increased IgM level	J:144799
	peritoneal inflammation	J:144799
Lyn^tm1.1Calo/Lyn^tm1.1Calo Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal circulating chemokine level	J:200745
	abnormal circulating cytokine level	J:200745
	abnormal dendritic cell physiology	J:200745
	abnormal leukocyte physiology	J:200745
	abnormal T cell activation	J:200745
	glomerulonephritis	J:200745
	increased autoantibody level	J:200745
	increased circulating interferon-gamma level	J:200745
	increased circulating interleukin-1 beta level	J:200745
	increased circulating interleukin-6 level	J:200745
	increased circulating interleukin-12 level	J:200745
	increased circulating interleukin-17 level	J:200745
	increased circulating tumor necrosis factor level	J:200745
	increased inflammatory response	J:200745
	liver inflammation	J:200745
	lung inflammation	J:200745
	skin inflammation	J:200745
Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd)	abnormal circulating complement protein level	J:161523
	abnormal level of surface class II molecules	J:161523
	glomerulonephritis	J:161523
	increased anti-double stranded DNA antibody level	J:161523
	increased anti-nuclear antigen antibody level	J:161523
	increased IgA level	J:161523
	increased IgE level	J:161523
	increased IgG2b level	J:161523
	increased IgM level	J:161523
Lyn^tm1Ard/Lyn^tm1Ard (B6.129P2-Lyn^tm1Ard)	abnormal B cell activation	J:144799
	glomerulonephritis	J:144799
	increased anti-double stranded DNA antibody level	J:144799
	increased anti-nuclear antigen antibody level	J:144799
	peritoneal inflammation	J:144799
Lyn^tm1Ard/Lyn^tm1Ard Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:110531
	increased IgM level	J:110531
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJae)	increased anti-double stranded DNA antibody level	J:42037
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJae)	increased B cell proliferation	J:42037
Lyn^tm1Sor/Lyn^tm1Sor (B6.129S4-Lyn^tm1Sor)	abnormal inflammatory response	J:113463
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor)	abnormal chemokine level	J:80658
	abnormal circulating chemokine level	J:200745
	abnormal circulating cytokine level	J:200745
	abnormal dendritic cell physiology	J:200745
	abnormal macrophage physiology	J:80658
	abnormal microglial cell physiology	J:80658
	glomerulonephritis	J:146161, J:200745
	increased anti-double stranded DNA antibody level	J:146161
	increased autoantibody level	J:200745
	increased B cell proliferation	J:146161
	increased circulating interferon-gamma level	J:200745
	increased circulating interleukin-6 level	J:200745
	increased circulating interleukin-12 level	J:200745
	increased circulating interleukin-17 level	J:200745
	increased IgA level	J:146161
	increased IgM level	J:146161
	liver inflammation	J:146161
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor * C57BL/6)	glomerulonephritis	J:71174
	increased anti-double stranded DNA antibody level	J:71174
	increased B cell proliferation	J:71174
	increased IgA level	J:71174
	increased IgG1 level	J:71174
	increased IgG2b level	J:71174
	increased IgG level	J:71174
	increased IgM level	J:71174
	increased susceptibility to systemic lupus erythematosus	J:71174
Lyn^tm1Tya/Lyn^tm1Tya (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:29751
	abnormal class switch recombination	J:29751
	decreased B cell proliferation	J:29751
	glomerulonephritis	J:29751
	increased anti-double stranded DNA antibody level	J:29751
	increased IgA level	J:29751
	increased IgM level	J:29751
	increased immunoglobulin level	J:29751
Lyn^weeb/Lyn^weeb (C57BL/6-Lyn^weeb)	glomerulonephritis	J:146161
	increased anti-double stranded DNA antibody level	J:146161
	increased B cell proliferation	J:146161
	increased IgM level	J:146161
	liver inflammation	J:146161
Lynf1^C57BL/10J/Lynf1^C57BL/10J Lynf3^C57BL/10J/Lynf3^C57BL/10J (involves: B10.O20 * O20/A)	abnormal acute inflammation	J:128728
Lynf2^C57BL/10J/Lynf2^C57BL/10J Lynf3^C57BL/10J/Lynf3^C57BL/10J (involves: B10.O20 * O20/A)	abnormal acute inflammation	J:128728
Lynf2^O20/A/Lynf2^O20/A (involves: B10.O20 * O20/A)	abnormal acute inflammation	J:128728
Lynf4^C57BL/10J/Lynf4^C57BL/10J (involves: B10.O20 * O20/A)	abnormal acute inflammation	J:128728
Lynf4^C57BL/10J/Lynf4^O20/A (involves: B10.O20 * O20/A)	abnormal acute inflammation	J:128728
Lypd8^tm2Ktak/Lypd8^tm2Ktak (B6.Cg-Lypd8^tm2Ktak)	increased susceptibility to colitis induced morbidity/mortality	J:232706
Lypd8^tm2Ktak/Lypd8^tm2Ktak (B6.Cg-Lypd8^tm2Ktak)	increased susceptibility to induced colitis	J:232706
Lyset^em1Janc/Lyset^em1Janc (C57BL/6J-Tmem251^em1Janc)	decreased susceptibility to viral infection	J:330704
Lyset^em1Janc/Lyset^em2Janc (C57BL/6J-Tmem251^em1Janc Tmem251^em2Janc)	decreased susceptibility to viral infection	J:330704
Lyset^em2Janc/Lyset^em2Janc (C57BL/6J-Tmem251^em2Janc)	decreased susceptibility to viral infection	J:330704
Lyst^bg-2Btlr/Lyst^bg-2Btlr (C57BL/6J-Lyst^bg-2Btlr)	abnormal NK cell physiology	J:133617
Lyst^bg-2Btlr/Lyst^bg-2Btlr (C57BL/6J-Lyst^bg-2Btlr)	increased susceptibility to Herpesvirales infection	J:133617
Lyst^bg-2J/Lyst^bg-2J (C3.Cg-Lyst^bg-2J/J)	abnormal susceptibility to infection	J:147940
Lyst^bg-2J/Lyst^bg-2J (C3.Cg-Lyst^bg-2J/J)	decreased susceptibility to fungal infection	J:147940
Lyst^bg-5Btlr/Lyst⁺ (C57BL/6J-Lyst^bg-5Btlr)	impaired macrophage phagocytosis	J:217864
Lyst^bg-5Btlr/Lyst^bg-5Btlr (C57BL/6J-Lyst^bg-5Btlr)	impaired macrophage phagocytosis	J:217864
Lyst^bg-6Btlr/Lyst^bg-6Btlr (C57BL/6J-Lyst^bg-6Btlr)	increased susceptibility to Herpesvirales infection	J:220065
Lyst^bg-Btlr/Lyst^bg-Btlr (C57BL/6J-Lyst^bg-Btlr)	abnormal NK cell physiology	J:133616
	increased susceptibility to bacterial infection	J:133616
	increased susceptibility to Herpesvirales infection	J:133616
Lyst^bg-J/Lyst^bg-J (C57BL/6J-Lyst^bg-J/J)	impaired natural killer cell mediated cytotoxicity	J:34814
Lyst^bg-J/Lyst^bg-J Prkdc^scid/Prkdc^scid (B6.Cg-Lyst^bg-J Prkdc^scid/Sz)	abnormal complement pathway	J:34814
	abnormal level of surface class II molecules	J:34814
	decreased immunoglobulin level	J:34814
	impaired natural killer cell mediated cytotoxicity	J:34814
Lyst^bg/Lyst^bg (B6.C3Rl-Lyst^bg)	alveolitis	J:110157
	decreased cytotoxic T cell cytolysis	J:6692
	impaired natural killer cell mediated cytotoxicity	J:6302, J:6213
Lyst^bg/Lyst^bg (B6.C3Rl-Lyst^bg/J)	abnormal NK cell physiology	J:6801
Lyst^bg/Lyst^bg (B6.C3Rl-Lyst^bg/J)	increased susceptibility to parasitic infection	J:6946
Lyst^bg/Lyst^bg Prkdc^scid/Prkdc^scid (Not Specified)	increased susceptibility to infection	J:4752
Lyve1^{tm1.1(EGFP/cre)Cys}/Lyve1⁺ Sphk1^tm2Cgh/Sphk1^tm2Cgh Sphk2^tm1.1Cgh/Sphk2^tm1.1Cgh (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal leukocyte migration	J:156826
Lyve1^tm1Lhua/Lyve1^tm1Lhua (B6.129S1-Lyve1^tm1Lhua)	abnormal lymph circulation	J:117713
Lyz2^tm1(cre)Ifo/Lyz2⁺ Pdcd10^tm1Wami/Pdcd10^tm1Wami (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:256076
Lyz2^tm1(cre)Ifo/Lyz2⁺ Pikfyve^{tm1b(EUCOMM)Hmgu}/Pikfyve^{tm1b(EUCOMM)Hmgu} (involves: 129P2/OlaHsd * C57BL/6N)	increased interleukin-4 secretion	J:244776
	increased interleukin-13 secretion	J:244776
	increased susceptibility to type I hypersensitivity reaction	J:244776
Lyz2^tm1(cre)Ifo/Lyz2⁺ St18^{tm1c(KOMP)Wtsi}/St18^{tm1c(KOMP)Wtsi} (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	increased circulating interleukin-1 beta level	J:298828
	increased inflammatory response	J:298828
Lyz2^tm1(cre)Ifo/Lyz2^tm1(cre)Ifo Nrros^tm1Wouy/Nrros^tm1Wouy (involves: 129P2/OlaHsd)	abnormal cellular extravasation	J:209569
	increased susceptibility to experimental autoimmune encephalomyelitis	J:209569
Lyz2^tm1.1Graf/Lyz2^tm1.1Graf (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased inflammatory response	J:82642
X/m1Nish (involves: C57BL/6N)	decreased IgG level	J:204833
	decreased IgM level	J:204833
	decreased T cell proliferation	J:204833
Macroh2a1^tm1Peh/Macroh2a1^tm1Peh Macroh2a2^tm1.1Peh/Macroh2a2^tm1.1Peh (129S6.Cg-Macroh2a2^tm1.1Peh Macroh2a1^tm1Peh)	blepharitis	J:220524
Madcam1^tm1.2Nwag/Madcam1^tm1.2Nwag (B6.129P2-Madcam1^tm1.2Nwag)	abnormal B cell physiology	J:169739
	decreased IgA level	J:169739
Maf^Ofl/Maf^Ofl (either: 102/ElH or C3H/HeH)	tubular nephritis	J:82475
Maf^tm1Glm/Maf^tm1Glm (involves: 129/Sv * BALB/c)	decreased interleukin-4 secretion	J:78382
Mag^tm1Rod/Mag^tm1Rod (involves: 129S1/Sv * 129X1/SvJ)	increased B cell proliferation	J:217719
Maged1^tm1.1Urfm/Maged1^tm1.1Urfm (involves: 129P2/OlaHsd)	abnormal tumor necrosis factor level	J:157549
Magi2^tm1Key/Magi2^tm1Key (involves: 129S4/SvJae)	tubulointerstitial nephritis	J:213553
Magt1^{Gt(IST13422E1)Tigm}/Y (involves: C57BL/6N)	increased B cell proliferation	J:260923
Malat1^tm1.2Dlsp/Malat1^tm1.2Dlsp (B6J.Cg-Malat1^tm1.2Dlsp)	brain inflammation	J:239375
Malt1^m1Btlr/Malt1⁺ (C57BL/6J-Malt1^m1Btlr)	impaired humoral immune response	J:221474
Malt1^m1Btlr/Malt1^m1Btlr (C57BL/6J-Malt1^m1Btlr)	impaired humoral immune response	J:221474
Malt1^m2Btlr/Malt1⁺ (C57BL/6J-Malt1^m2Btlr)	decreased IgM level	J:224671
Malt1^m2Btlr/Malt1⁺ (C57BL/6J-Malt1^m2Btlr)	impaired humoral immune response	J:224671
Malt1^m2Btlr/Malt1^m2Btlr (C57BL/6J-Malt1^m2Btlr)	decreased IgG level	J:224671
	decreased IgM level	J:224671
	impaired humoral immune response	J:224671
Malt1^m3Btlr/Malt1⁺ (C57BL/6J-Malt1^m3Btlr)	decreased IgM level	J:224672
Malt1^m3Btlr/Malt1⁺ (C57BL/6J-Malt1^m3Btlr)	impaired humoral immune response	J:224672
Malt1^m3Btlr/Malt1^m3Btlr (C57BL/6J-Malt1^m3Btlr)	decreased IgG level	J:224672
	decreased IgM level	J:224672
	impaired humoral immune response	J:224672
Malt1^tm1Mak/Malt1^tm1Mak (involves: 129P2/OlaHsd)	abnormal dendritic cell physiology	J:111706
	decreased IgG level	J:109545
	decreased IgM level	J:109545
	decreased T cell proliferation	J:109545
Malt1^tm1Vmd/Malt1^tm1Vmd (involves: C57BL/6N)	abnormal T cell proliferation	J:86770
	decreased immunoglobulin level	J:86770
	decreased interleukin-2 secretion	J:86770
Man2a1^tm1Jxm/Man2a1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immune serum protein physiology	J:74579
	abnormal immune system physiology	J:74579
	abnormal self tolerance	J:74579
	glomerulonephritis	J:74579
	increased IgA level	J:74579
	increased IgG level	J:74579
	increased IgM level	J:74579
	liver inflammation	J:74579
	lung inflammation	J:74579
Man2a1^tm1Jxm/Man2a1^tm1Jxm Rag1^tm1Mom/Rag1^tm1Mom (B6.129-Rag1^tm1Mom Man2a1^tm1Jxm)	kidney inflammation	J:124348
Man2c1^tm1.1Tbec/Man2c1^tm1.1Tbec (B6N.129P2-Man2c1^tm1.1Tbec)	abnormal microglial cell activation	J:205550
Map2k3^tm1Flv/Map2k3^tm1Flv (involves: 129S1/Sv)	abnormal CD4-positive, alpha-beta T cell physiology	J:85266
Map2k3^tm1Flv/Map2k3^tm1Flv (involves: 129S1/Sv)	decreased T cell apoptosis	J:85266
Map2k3^tm1Flv/Map2k3^tm1Flv (B6.129S1-Map2k3^tm1Flv)	increased susceptibility to bacterial infection	J:124327
Map2k6^tm1Flv/Map2k6^tm1Flv (involves: 129S1/Sv)	abnormal thymocyte apoptosis	J:85266
Map3k1^tm1Glj/Map3k1^tm1Glj (involves: 129S/SvEv)	heart inflammation	J:78068
Map3k2^tm1Bisu/Map3k2^tm1Bisu (Not Specified)	abnormal cytokine secretion	J:78072
	abnormal T cell activation	J:78072
	increased T cell proliferation	J:78072
Map3k3^tm1Bisu/Map3k3^tm2Bisu Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal T cell physiology	J:145923
	abnormal T cell proliferation	J:145923
Map3k3^tm1Kuro/Map3k3^tm1Kuro Tg(Lck-cre)1Jtak/0 (involves: C57BL/6)	decreased interferon-gamma secretion	J:147103
	decreased interleukin-2 secretion	J:147103
	decreased T cell proliferation	J:147103
Map3k4^tm1Flv/Map3k4^tm1Flv (involves: 129S6/SvEvTac * C57BL/6)	abnormal T-helper 1 physiology	J:90112
	decreased interferon-gamma secretion	J:90112
Map3k7^tm1.1Gkl/Map3k7^tm1.1Gkl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-10 level	J:211916
	decreased interleukin-10 secretion	J:211916
	increased circulating interleukin-1 beta level	J:211916
	increased circulating tumor necrosis factor level	J:211916
	increased inflammatory response	J:211916
	increased interleukin-1 beta secretion	J:211916
	increased interleukin-6 secretion	J:211916
	increased interleukin-10 secretion	J:211916
	increased susceptibility to endotoxin shock	J:211916
	increased tumor necrosis factor secretion	J:211916
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Alb1-cre)7Gsc/0 (involves: 129P2/OlaHsd * FVB/N)	liver inflammation	J:160521
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	abnormal T cell activation	J:112837
	colitis	J:112837
	decreased T cell proliferation	J:112837
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:238318
	abnormal cytokine level	J:238318
	abnormal regulatory T cell physiology	J:238318
	colitis	J:238318
	increased interferon-gamma secretion	J:238318
	increased interleukin-17 secretion	J:238318
Map3k7^tm1Zjc/Map3k7^tm1Zjc Tg(Lck-cre)548Jxm/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	increased thymocyte apoptosis	J:111794
Map3k8^M1Btlr/Map3k8⁺ (C57BL/6J-Map3k8^M1Btlr)	abnormal tumor necrosis factor secretion	J:140986
Map3k8^M1Btlr/Map3k8⁺ (C57BL/6J-Map3k8^M1Btlr)	decreased tumor necrosis factor secretion	J:140986
Map3k8^M1Btlr/Map3k8^M1Btlr (C57BL/6J-Map3k8^M1Btlr)	abnormal response to infection	J:140986
	decreased interferon-alpha secretion	J:140986
	decreased interferon-beta secretion	J:140986
	decreased interleukin-1 beta secretion	J:140986
	decreased interleukin-6 secretion	J:140986
	decreased tumor necrosis factor secretion	J:140986
	impaired natural killer cell mediated cytotoxicity	J:140986
	increased interleukin-12b secretion	J:140986
Map3k8^m2Btlr/Map3k8^m2Btlr (C57BL/6J-Map3k8^m2Btlr)	abnormal response to infection	J:212899
Map3k8^m3Btlr/Map3k8⁺ (C57BL/6J-Map3k8^m3Btlr)	decreased macrophage cytokine production	J:224668
Map3k8^m3Btlr/Map3k8⁺ (C57BL/6J-Map3k8^m3Btlr)	decreased tumor necrosis factor secretion	J:224668
Map3k8^m3Btlr/Map3k8^m3Btlr (C57BL/6J-Map3k8^m3Btlr)	decreased macrophage cytokine production	J:224668
Map3k8^m3Btlr/Map3k8^m3Btlr (C57BL/6J-Map3k8^m3Btlr)	decreased tumor necrosis factor secretion	J:224668
Map3k8^M4Btlr/Map3k8⁺ (C57BL/6J-Map3k8^M4Btlr)	decreased tumor necrosis factor secretion	J:254880
Map3k8^M4Btlr/Map3k8^M4Btlr (C57BL/6J-Map3k8^M4Btlr)	decreased tumor necrosis factor secretion	J:254880
Map3k8^tm1.2Gkl/Map3k8^tm1.2Gkl (involves: 129 * C57BL/6J * FVB/N)	decreased tumor necrosis factor secretion	J:193546
Map3k8^tm1Pnt/Map3k8^tm1Pnt (involves: 129S1/Sv * C57BL/6J)	decreased susceptibility to endotoxin shock	J:66503
Map3k8^tm1Pnt/Map3k8^tm1Pnt (involves: 129S1/Sv * C57BL/6J)	decreased tumor necrosis factor secretion	J:66503
Map3k8^tm1Pnt/Map3k8^tm1Pnt Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S1/Sv * 129S4/SvJae)	decreased circulating interleukin-12b level	J:196528
	decreased interleukin-12b secretion	J:196528
	decreased tumor necrosis factor secretion	J:196528
Map3k8^tm1Pnt/Map3k8^tm1Pnt Tnf^tm2Gkl/Tnf⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	small intestinal inflammation	J:108572
Map3k8^tm1Sley/Map3k8^tm1Sley Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae)	decreased tumor necrosis factor secretion	J:196528
Map3k8^tm1Tmat/Map3k8^tm1Tmat (involves: 129S/SvEv * C57BL/6)	abnormal cytokine secretion	J:92844
	abnormal dendritic cell antigen presentation	J:92844
	decreased IgE level	J:92844
	decreased IgG1 level	J:92844
	increased IgG2a level	J:92844
	increased T cell proliferation	J:92844
Map3k10^tm1Dsd/Map3k10^tm1Dsd Map3k11^tm1Rjd/Map3k11^tm1Rjd (involves: 129 * 129S6/SvEvTac * C57BL/6J)	abnormal circulating chemokine level	J:177426
	abnormal circulating cytokine level	J:177426
	abnormal response to infection	J:177426
Map3k10^tm1Dsd/Map3k10^tm1Dsd Map3k11^tm2.1Rjd/Map3k11^tm2.1Rjd (involves: 129 * C57BL/6J)	abnormal circulating chemokine level	J:177426
	abnormal circulating cytokine level	J:177426
	abnormal response to infection	J:177426
Map3k14^aly/Map3k14⁺ Relb^{Tg(H2-K1/GH1)106Bri}/Relb⁺ (involves: C57BL/6 * C57BL/6J)	decreased circulating interferon-gamma level	J:120659
Map3k14^aly/Map3k14^aly (involves: C57BL/6J)	abnormal dendritic cell antigen presentation	J:128211
	abnormal dendritic cell physiology	J:128211
	abnormal immune system physiology	J:147681
	abnormal T cell activation	J:38580
	bile duct inflammation	J:48224
	decreased circulating interferon-gamma level	J:120659
	decreased circulating interleukin-4 level	J:120659
	decreased IgE level	J:135748
	increased inflammatory response	J:38580, J:48224
	increased susceptibility to parasitic infection	J:135748
	kidney inflammation	J:38580
	lacrimal gland inflammation	J:38580
	liver inflammation	J:48224
	lung inflammation	J:48224
	pancreas inflammation	J:48224
Map3k14^aly/Map3k14^aly (involves: AEJ/GnRk * C57BL/6J)	decreased IgA level	J:16865, J:54529
	decreased IgG level	J:16865, J:54529
	decreased IgM level	J:16865, J:54529
	increased length of allograft survival	J:16865
Map3k14^aly/Map3k14^aly (C57BL/6J-Map3k14^aly)	increased susceptibility to infection	J:16865
Map3k14^m1Btlr/Map3k14^m1Btlr (C57BL/6J-Map3k14^m1Btlr)	abnormal B cell activation	J:152065
Map3k14^m1Btlr/Map3k14^m1Btlr (C57BL/6J-Map3k14^m1Btlr)	decreased IgG level	J:152065
Map3k14^m1Btlr/Map3k14^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Map3k14^m1Btlr/Map3k14^m1Btlr (involves: C57BL/6J)	decreased IgG level	J:185495
Map3k14^tm1.2Gne/Map3k14^tm1.2Gne (B6(Cg)-Map3k14^tm1.2Gne)	abnormal B cell physiology	J:240453
Map3k14^tm1.2Gne/Map3k14^tm1.2Gne (B6(Cg)-Map3k14^tm1.2Gne)	decreased IgA level	J:240453
Map3k14^tm1Rds/Map3k14^tm1Rds (involves: 129/Sv * C57BL/6)	decreased IgA level	J:68125
	decreased IgG2b level	J:68125
	decreased immunoglobulin level	J:68125
Map3k14^tm1Rds/Map3k14^tm1Rds (involves: 129)	abnormal class switch recombination	J:188560
Map4k1^tm1Ssaw/Map4k1^tm1Ssaw (B6.Cg-Map4k1^tm1Ssaw)	abnormal dendritic cell antigen presentation	J:150295
	abnormal dendritic cell physiology	J:150295
	increased interleukin-1 beta secretion	J:150295
	increased interleukin-6 secretion	J:150295
	increased interleukin-12 secretion	J:150295
	increased tumor necrosis factor secretion	J:150295
Map4k1^tm1Tht/Map4k1^tm1Tht (B6.129S7-Map4k1^tm1Tht)	increased susceptibility to experimental autoimmune encephalomyelitis	J:116613
Map4k1^tm1Tht/Map4k1^tm1Tht (involves: 129S7/SvEvBrd)	abnormal cytokine secretion	J:116613
	abnormal humoral immune response	J:116613
	increased T cell proliferation	J:116613
Map4k3^{Gt(RRO270)Byg}/Map4k3^{Gt(RRO270)Byg} (involves: 129P2/OlaHsd)	abnormal interleukin secretion	J:177642
	decreased IgG1 level	J:177642
	decreased IgG2a level	J:177642
	decreased IgG2b level	J:177642
	decreased IgG3 level	J:177642
	decreased IgM level	J:177642
	decreased immunoglobulin level	J:177642
	decreased interferon-gamma secretion	J:177642
	decreased interleukin-2 secretion	J:177642
	decreased interleukin-4 secretion	J:177642
	decreased interleukin-17 secretion	J:177642
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:177642
	decreased T cell proliferation	J:177642
Map4k5^{Gt(OST218153)Lex}/Map4k5^{Gt(OST218153)Lex} (B6;129S5-Map4k5^{Gt(OST218153)Lex}/Ieg)	increased IgG1 level	J:82809
Map7^mshi/Map7^mshi (involves: BALB/cBy)	decreased length of allograft survival	J:37165
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Lck-cre)1Cwi/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal T cell proliferation	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased T cell proliferation	J:113280
Mapk3^m1Btlr/Mapk3^m1Btlr (C57BL/6J-Mapk3^m1Btlr)	decreased interleukin-1 beta secretion	J:221481
Mapk3^tm1Gela/Mapk3^tm1Gela (either: 129(Cg)-Mapk3^tm1Gela or B6.129-Mapk3^tm1Gela)	abnormal cytokine secretion	J:107504
	increased susceptibility to experimental autoimmune encephalomyelitis	J:107504
Mapk3^tm1Gpg/Mapk3^tm1Gpg (involves: 129)	decreased T cell proliferation	J:58468
Mapk8^tm1Flv/Mapk8^tm1Flv (involves: 129S1/Sv)	abnormal cytokine secretion	J:51510
Mapk8^tm1Flv/Mapk8^tm1Flv (involves: 129S1/Sv)	increased T cell proliferation	J:51510
Mapk8^tm1Rjd/Mapk8^tm1Rjd Mapk9^tm2.1Rjd/Mapk9^tm2.1Rjd Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6J.Cg-Lyz2^tm1(cre)Ifo Mapk9^tm2.1Rjd Mapk8^tm1Rjd)	abnormal chemokine level	J:192551
	abnormal circulating chemokine level	J:192551
	abnormal circulating cytokine level	J:192551
	abnormal macrophage physiology	J:192551
	decreased inflammatory response	J:192551
	decreased macrophage cytokine production	J:192551
	impaired macrophage chemotaxis	J:192551
Mapk8^tm1Wag/Mapk8⁺ Mapk9^tm1Mka/Mapk9⁺ (involves: 129)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk8^tm1Wag/Mapk8⁺ Mapk9^tm1Mka/Mapk9^tm1Mka (involves: 129)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk8^tm1Wag/Mapk8^tm1Wag (involves: 129P2/OlaHsd)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk8^tm1Wag/Mapk8^tm1Wag Mapk9^tm1Mka/Mapk9⁺ (involves: 129)	abnormal T cell activation	J:78190
	decreased T cell apoptosis	J:78190
	decreased T cell proliferation	J:78190
Mapk9^tm1Flv/Mapk9^tm1Flv Tnf^tm2Gkl/Tnf⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	small intestinal inflammation	J:108572
Mapk9^tm1Mka/Mapk9^tm1Mka (either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ))	abnormal T cell activation	J:78129
	decreased T cell apoptosis	J:78129
	decreased T cell proliferation	J:78129
Mapk11^tm1Jda/Mapk11^tm1Jda Mapk14^tm1Jda/Mapk14^tm1Jda (involves: 129 * C57BL/6)	decreased interferon-gamma secretion	J:165966
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:165966
	decreased susceptibility to induced arthritis	J:165966
	decreased T cell proliferation	J:165966
	decreased tumor necrosis factor secretion	J:165966
	increased interleukin-10 secretion	J:165966
Mapk11^tm1Jsca/Mapk11^tm1Jsca Tnf^tm2Gkl/Tnf⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	arthritis	J:107771
	ileum inflammation	J:107771
Mapk14^tm1Jda/Mapk14^tm1Jda (B6.Cg-Mapk14^tm1Jda)	abnormal T-helper 1 physiology	J:146088
	decreased interferon-alpha secretion	J:146088
	decreased interferon-gamma secretion	J:146088
	decreased T cell proliferation	J:146088
Mapkapk2^tm1.2Gkl/Mapkapk2^tm1.2Gkl (involves: BALB/cJ * C57BL/6)	decreased circulating tumor necrosis factor level	J:262876
	decreased tumor necrosis factor secretion	J:262876
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal cytokine level	J:59678
	decreased circulating tumor necrosis factor level	J:59678
	decreased susceptibility to endotoxin shock	J:59678
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129S * C57BL/6)	decreased interferon-gamma secretion	J:76161
	decreased tumor necrosis factor secretion	J:76161
	impaired macrophage phagocytosis	J:76161
	increased interleukin-1 beta secretion	J:76161
	increased susceptibility to bacterial infection	J:76161
	increased susceptibility to bacterial infection induced morbidity/mortality	J:76161
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * 129S/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:117668
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl Mapkapk3^tm1.1Lex/Mapkapk3^tm1.1Lex (involves: 129P2/OlaHsd * 129S/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:117668
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl Tnf^tm2Gkl/Tnf⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	granulomatous inflammation	J:108572
	small intestinal inflammation	J:108572
Mar1^tm1Wtg/Mar1⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune system physiology	J:68024
Mar1^tm1Wtg/Mar1⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:68024
Mar1^tm1Wtg/Mar1^tm1Wtg (involves: 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:68024
Marchf1^tm1.1Sish/Marchf1^tm1.1Sish (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell physiology	J:119918
	abnormal dendritic cell antigen presentation	J:201198, J:157516
	abnormal level of surface class II molecules	J:119918
	decreased interleukin-12 secretion	J:157516
	decreased tumor necrosis factor secretion	J:157516
Marchf2^em1Cnu/Marchf2^em1Cnu (C57BL/6-Marchf2^em1Cnu)	decreased susceptibility to bacterial infection	J:297482
	decreased susceptibility to viral infection	J:297482
	increased circulating interferon-beta level	J:297482
	increased circulating interleukin-6 level	J:297482
	increased circulating interleukin-12 level	J:297482
	increased circulating tumor necrosis factor level	J:297482
	increased interleukin-6 secretion	J:297482
	increased interleukin-12 secretion	J:297482
	increased susceptibility to bacterial infection induced morbidity/mortality	J:297482
	increased susceptibility to endotoxin shock	J:297482
Marchf3^em1Hbsh/Marchf3^em1Hbsh (involves: C57BL/6J)	abnormal circulating cytokine level	J:267641
Marchf3^em1Hbsh/Marchf3^em1Hbsh (involves: C57BL/6J)	increased susceptibility to infection induced morbidity/mortality	J:267641
Marchf5^tm1.1Ygi/Marchf5^tm1.1Ygi Tg(Emx1-cre)#Ito/0 (involves: C57BL/6)	increased microglial cell activation	J:284572
Marchf5^{tm1a(EUCOMM)Wtsi}/Marchf5⁺ (C57BL/6-Marchf5^{tm1a(EUCOMM)Wtsi})	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:225000
	increased circulating interferon-beta level	J:225000
	increased circulating interleukin-6 level	J:225000
Marchf7^{Gt(ROSABetageo)1Summ}/Marchf7⁺ (involves: BALB/c)	abnormal cytokine secretion	J:96167
	abnormal interleukin level	J:96167
	increased interleukin-10 secretion	J:96167
	increased T cell proliferation	J:96167
Marchf7^{Gt(ROSABetageo)1Summ}/Marchf7^{Gt(ROSABetageo)1Summ} (involves: BALB/c)	abnormal cytokine secretion	J:96167
	abnormal interleukin level	J:96167
	increased interleukin-10 secretion	J:96167
	increased T cell proliferation	J:96167
Marcksl1^tm1Fsh/Marcksl1^tm1Fsh (involves: 129S4/SvJae)	abnormal macrophage physiology	J:115146
Marco^tm1Ktry/Marco^tm1Ktry (B6.129S6-Marco^tm1Ktry)	abnormal macrophage physiology	J:115081
	impaired macrophage phagocytosis	J:115081
	increased inflammatory response	J:115081
	increased susceptibility to bacterial infection	J:115081, J:122271
Marco^tm1Ktry/Marco^tm1Ktry Msr1^tm1Csk/Msr1^tm1Csk (B6.129-Marco^tm1Ktry Msr1^tm1Csk)	abnormal macrophage physiology	J:122271
	increased IgM level	J:122271
	increased susceptibility to bacterial infection	J:122271
Marco^tm1Spt/Marco^tm1Spt (C57BL/6-Marco^tm1Spt)	abnormal dendritic cell chemotaxis	J:204315
	abnormal dendritic cell physiology	J:204315
	increased interferon-gamma secretion	J:204315
Marif1^C57BL/10J/Marif1^C57BL/10J (involves: O20/A * NXT-10/Dem)	abnormal immune serum protein physiology	J:90251
	decreased interleukin-12 secretion	J:90251
	decreased tumor necrosis factor secretion	J:90251
Marif2^C57BL/10J/Marif2^C57BL/10J (involves: O20/A * NXT-10/Dem)	abnormal immune serum protein physiology	J:90251
	decreased interleukin-12 secretion	J:90251
	increased tumor necrosis factor secretion	J:90251
Marif3^C57BL/10J/Marif3^C57BL/10J (involves: O20/A * NXT-10/Dem)	increased interleukin-12 secretion	J:90251
Mark2^tm1Hpw/Mark2^tm1Hpw (involves: 129X1/SvJ * C57BL/6)	abnormal humoral immune response	J:68830
	abnormal immune system physiology	J:68830
	decreased B cell proliferation	J:68830
	decreased IgG3 level	J:68830
	decreased IgM level	J:68830
	glomerulonephritis	J:68830
	increased B cell proliferation	J:68830
	increased interferon-gamma secretion	J:68830
	increased interleukin-4 secretion	J:68830
	kidney inflammation	J:68830
	lung inflammation	J:68830
	salivary gland inflammation	J:68830
Masp1^tm1Tefu/Masp1^tm1Tefu (B6.129S4-Masp1^tm1Tefu)	impaired complement alternative pathway	J:177350
Masp1^tm1Tefu/Masp1^tm1Tefu (B6.129S4-Masp1^tm1Tefu)	impaired lectin complement pathway	J:134537
Masp2^tm1Tefu/Masp2^tm1Tefu (involves: 129 * C57BL/6)	abnormal complement pathway	J:140667
Masp2^tm1Wjsc/Masp2^tm1Wjsc (B6.129P2-Masp2^tm1Wjsc)	impaired lectin complement pathway	J:172218
Mat1a^tm1Jmm/Mat1a^tm1Jmm (involves: 129/Sv * C57BL/6)	liver inflammation	J:69408
Matn3^tm1Brd/Matn3^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	osteoarthritis	J:112002
Matr3^em1Tcp/Matr3^em1Tcp (C57BL/6J-Matr3^em1Tcp)	increased microglial cell activation	J:298091
Mavs^tm1Aki/Mavs^tm1Aki (Not Specified)	abnormal cytokine secretion	J:124405
	abnormal response to infection	J:124405
	decreased circulating interleukin-6 level	J:124405
	decreased interferon-alpha secretion	J:124405
	decreased interferon-beta secretion	J:124405
	decreased interleukin-6 secretion	J:124405
	increased susceptibility to Picornaviridae infection	J:124405
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-alpha level	J:130954
	decreased circulating interferon-beta level	J:130954
	decreased circulating interferon-gamma level	J:130954
	decreased circulating interleukin-6 level	J:130954
	decreased IgG1 level	J:130954
	decreased IgG2a level	J:130954
	decreased IgG level	J:130954
	decreased interferon-beta secretion	J:130954
	decreased interleukin-12b secretion	J:130954
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129S/SvEv * C57BL/6)	abnormal circulating interferon level	J:162888
	abnormal dendritic cell physiology	J:162888
	abnormal macrophage physiology	J:162888
	brain inflammation	J:162888
	CNS inflammation	J:162888
	decreased interferon-beta secretion	J:162888
	increased circulating interferon-gamma level	J:162888
	increased circulating interleukin-6 level	J:162888
	increased circulating tumor necrosis factor level	J:162888
	increased IgG2a level	J:162888
	increased IgG level	J:162888
	increased IgM level	J:162888
	increased susceptibility to Flaviviridae infection	J:162888
	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:162888
Mavs^tm1Aki/Mavs^tm1Aki Ifna6^tm1Aki/Ifna6⁺ (involves: 129P2/OlaHsd)	decreased interferon-alpha secretion	J:124340
Mavs^tm1Aki/Mavs^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interferon-alpha level	J:130954
	decreased circulating interferon-beta level	J:130954
	decreased circulating interferon-gamma level	J:130954
	decreased circulating interleukin-6 level	J:130954
	decreased circulating interleukin-12b level	J:130954
	decreased cytotoxic T cell cytolysis	J:130954
	decreased IgG1 level	J:130954
	decreased IgG2a level	J:130954
	decreased IgG level	J:130954
	decreased interferon-beta secretion	J:130954
	decreased interleukin-12b secretion	J:130954
Mavs^tm1Camb/Mavs^tm1Camb (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:180356
	decreased B cell proliferation	J:180356
	decreased interleukin-12 secretion	J:180356
	decreased tumor necrosis factor secretion	J:180356
Mavs^tm1Itl/Mavs^tm1Itl Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * C57BL/6)	increased inflammatory response	J:181257
	myocarditis	J:181257
	myositis	J:181257
	skin inflammation	J:181257
	stomach inflammation	J:181257
Mavs^tm1Tsc/Mavs^tm1Tsc (Not Specified)	decreased interferon-beta secretion	J:136289
Mavs^tm1Tsse/Mavs^tm1Tsse Tg(PVR)1Kkst/0 (involves: 129 * C57BL/6 * ICR)	abnormal interferon-alpha secretion	J:179625
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:179625
Mavs^tm1Zjc/Mavs⁺ (involves: 129/Sv * C57BL/6)	abnormal innate immunity	J:110905
Mavs^tm1Zjc/Mavs⁺ (involves: 129/Sv * C57BL/6)	increased susceptibility to Riboviria infection	J:110905
Mavs^tm1Zjc/Mavs^tm1Zjc (involves: 129/Sv * C57BL/6)	abnormal dendritic cell physiology	J:110905
	abnormal innate immunity	J:110905
	abnormal macrophage physiology	J:110905
	increased susceptibility to Riboviria infection	J:110905
Mavs^tm1Zjc/Mavs^tm1Zjc (B6.Cg-Mavs^tm1Zjc)	abnormal circulating interferon level	J:243916
Mavs^tm1Zjc/Mavs^tm1Zjc Rnaseh2a^tm1Crh/Rnaseh2a^tm1Crh (Not Specified)	abnormal innate immunity	J:232933
Mbd2^tm1Bh/Mbd2^tm1Bh (NOD.129P2(B6)-Mbd2^tm1Bh)	abnormal CD4-positive, alpha-beta T cell physiology	J:323838
	increased T cell proliferation	J:323838
	insulitis	J:323838
	salivary gland inflammation	J:323838
Mbd3^tm2Bh/Mbd3^tm2Bh Tg(Vil1-cre)20Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased susceptibility to induced colitis	J:167984
Mbis1^NOD/ShiLt/Mbis1^NOD/ShiLt (involves: BALB/c * NOD/Lt)	increased susceptibility to bacterial infection	J:75276
Mbis2^BALB/c/Mbis2^BALB/c (involves: BALB/c * NOD/Lt)	increased susceptibility to bacterial infection	J:75276
Mbis2^BALB/c/Mbis2^NOD/ShiLt (involves: BALB/c * NOD/Lt)	increased susceptibility to bacterial infection	J:75276
Mbis3^BALB/c/? (involves: BALB/c * NOD/Lt)	increased susceptibility to bacterial infection	J:75276
Mbis4^NOD/ShiLt/Mbis4^NOD/ShiLt (involves: BALB/c * NOD/Lt)	increased susceptibility to bacterial infection	J:75276
Mbl1^tm1Kata/Mbl1^tm1Kata (involves: 129S4/SvJae * C57BL/6J)	decreased circulating tumor necrosis factor level	J:90437
Mbl1^tm1Kata/Mbl1^tm1Kata Mbl2^tm1Kata/Mbl2^tm1Kata (involves: 129 * C57BL/6)	abnormal circulating interleukin-6 level	J:98124
	abnormal circulating tumor necrosis factor level	J:98124
	impaired macrophage phagocytosis	J:97686, J:98124
	increased susceptibility to bacterial infection	J:98124
Mbl1^tm1Kata/Mbl1^tm1Kata Mbl2^tm1Kata/Mbl2^tm1Kata (involves: 129 * C57BL/6J)	abnormal complement pathway	J:106351
	abnormal response to infection	J:106352
	increased susceptibility to bacterial infection	J:106353
Mbl1^tm1Rala/Mbl1^tm1Rala (involves: 129X1/SvJ * C57BL/6J)	abnormal immunoglobulin level	J:145279
	decreased IgG2b level	J:145279
	decreased IgM level	J:145279
	increased IgG1 level	J:145279
	increased IgG2a level	J:145279
	increased IgG3 level	J:145279
	increased susceptibility to parasitic infection	J:145279
Mbp^shi/Mbp^shi (C3Fe.SWV-Mbp^shi/J)	decreased susceptibility to Picornaviridae infection	J:41447
Mbp^shi/Mbp^shi (involves: BALB/c * C3HeB/Fe * SWV)	increased interferon-gamma secretion	J:48412
	increased interleukin-2 secretion	J:48412
	increased interleukin-4 secretion	J:48412
	increased susceptibility to experimental autoimmune encephalomyelitis	J:48412
	increased T cell proliferation	J:48412
Mbtps1^wrt/Mbtps1^wrt (C57BL/6J-Mbtps1^wrt)	decreased cytotoxic T cell cytolysis	J:94077
	decreased susceptibility to bacterial infection	J:123123
	increased interleukin-1 beta secretion	J:146454
	increased interleukin-6 secretion	J:146454
	increased susceptibility to Herpesvirales infection	J:94077, J:123123
	increased susceptibility to induced colitis	J:146454
Mc3r^tm1Butl/Mc3r^tm1Butl (B6.Cg-Mc3r^tm1Butl)	increased inflammatory response	J:178147
Mc4r^tm1Lowl/Mc4r^tm1Lowl (involves: 129S4/SvJae * C57BL/6J)	increased circulating interleukin-6 level	J:177386
	liver inflammation	J:177386
	white adipose tissue inflammation	J:177386
Mc4r^tm1Matsu/Mc4r^tm1Matsu (C57BL/6J-Mc4r^tm1Matsu)	liver inflammation	J:285412
Mcam^tm1Lex/Mcam^tm1Lex (involves: 129S/SvEvBrd)	abnormal cytokine level	J:193167
	abnormal response to infection	J:193167
	decreased macrophage cytokine production	J:193167
Mcemp1^em1Jngj/Mcemp1^em1Jngj (C57BL/6-Mcemp1^em1Jngj)	abnormal type I hypersensitivity reaction	J:335318
Mcl1^tm1Dmta/Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu/0 (B6.Cg-Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu)	decreased IgG1 level	J:166069
Mcl1^tm1Yen/Mcl1^tm1Yen (B6.129-Mcl1^tm1Yen)	abnormal CD8-positive, alpha-beta T cell physiology	J:146246
Mcl1^tm1Ywh/Mcl1^tm1Ywh Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal neutrophil physiology	J:137502
	impaired neutrophil recruitment	J:137502
Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased T cell apoptosis	J:137400
Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)	increased T cell apoptosis	J:137400
Mcl1^tm2Sjk/Mcl1^tm3Sjk Tg(Lck-cre)1Cwi/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	increased T cell apoptosis	J:86906
Mcl1^tm3Sjk/Mcl1^tm3Sjk Tg(Cpa3-cre)3Glli/0 (involves: 129X1/Sv * C57BL/6)	decreased inflammatory response	J:179080
	decreased susceptibility to type I hypersensitivity reaction	J:179080
Mcm3ap^tm1Imku/Mcm3ap^tm1Imku Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal germinal center B cell physiology	J:88276
	decreased B cell proliferation	J:88276
	decreased IgG level	J:88276
Mcoln1^tm1Sasl/Mcoln1^tm1Sasl (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage physiology	J:189070
Mcoln2^{tm1e.1(KOMP)Wtsi}/Mcoln2^{tm1e.1(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal chemokine level	J:239875
	abnormal chemokine secretion	J:239875
	abnormal innate immunity	J:239875
	impaired macrophage chemotaxis	J:239875
	impaired neutrophil chemotaxis	J:239875
Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1⁺ (involves: C57BL/6)	abnormal immune tolerance	J:52612
Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1⁺ (NOD.B6-Mcph1^{Tg(HLA-A2.1)1Enge})	increased susceptibility to autoimmune diabetes	J:109851
Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1^{Tg(HLA-A2.1)1Enge} (NOD.B6-Mcph1^{Tg(HLA-A2.1)1Enge})	increased susceptibility to autoimmune diabetes	J:109851
Mcph1^tm1.2Kali/Mcph1^tm1.2Kali (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal T cell physiology	J:156371
Mcpt1^tm1Hrpm/Mcpt1^tm1Hrpm (involves: 129P2/OlaHsd * MF1)	decreased circulating tumor necrosis factor level	J:93616
Mcpt1^tm1Hrpm/Mcpt1^tm1Hrpm (involves: 129P2/OlaHsd * MF1)	increased susceptibility to parasitic infection	J:93616, J:93795
Mcpt4^tm1Mabr/Mcpt4^tm1Mabr (involves: 129X1/SvJ * C57BL/6J)	abnormal mast cell physiology	J:84839
Mcpt8^{tm1.1(HBEGF)Hkar}/Mcpt8^{tm1.1(HBEGF)Hkar} (B6.Cg-Mcpt8^{tm1.1(HBEGF)Hkar})	increased susceptibility to parasitic infection	J:163761
Mdc1^{Gt(OST441263)Lex}/Mdc1^{Gt(OST441263)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:137341
Mdfic^em#Nlh/Mdfic^em#Nlh (C57BL/6J-Mdfic^em#Nlh)	abnormal lymph circulation	J:326462
Mdk^tm1Tmu/Mdk^tm1Tmu (129S2-Mdk^tm1Tmu)	tubular nephritis	J:93637
Mdk^tm1Tmu/Mdk^tm1Tmu (B6.129S2-Mdk^tm1Tmu)	abnormal macrophage chemotaxis	J:102069
Mdk^tm1Tmu/Mdk^tm1Tmu (B6.129S2-Mdk^tm1Tmu)	impaired neutrophil chemotaxis	J:102069
Mdm2^tm2.1Snj/Mdm2^tm2.1Snj (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte apoptosis	J:189297
Mdm4^tm1.1Wahl/Mdm4^tm1.1Wahl (involves: 129S/Sv * C57BL/6)	decreased thymocyte apoptosis	J:150341
Mecom^Jbo/Mecom⁺ (C3N.C-Mecom^Jbo)	increased susceptibility to otitis media	J:113445
Mecom^Jbo/Mecom⁺ (C3N.C-Mecom^Jbo)	respiratory system inflammation	J:113445
Mecom^Jbo/Mecom⁺ (involves: BALB/c)	increased susceptibility to otitis media	J:250208
Mecp2^tm1.1Bird/Y Sqle^Sum3-Jus/Sqle⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	dermatitis	J:198551
Mecp2^tm1.1Bird/Y Sum2^M1Jus/Sum2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	dermatitis	J:198551
	eye inflammation	J:198551
Mecp2^tm1.1Bird/Y Sum4^M1Jus/Sum4⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	dermatitis	J:198551
	eye inflammation	J:198551
Mecp2^tm1.1Bird/Y Sum5^M1Jus/Sum5⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	eye inflammation	J:198551
Med19^{tm1c(EUCOMM)Wtsi}/Med19^{tm1c(EUCOMM)Wtsi} Tg(Adipoq-icre/ERT2)1Soff/0 (involves: C57BL/6J * C57BL/6N)	white adipose tissue inflammation	J:298822
Mef2c^tm1Jjs/Mef2c^tm1Jjs Mir223^tm1Fcam/Mir223^tm1Fcam Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	abnormal neutrophil physiology	J:140009
Mefv^tm1Bhk/Mefv^tm1Bhk (129S6/SvEvTac-Mefv^tm1Bhk)	increased interleukin-1 beta secretion	J:192443
Mefv^tm1Bhk/Mefv^tm1Bhk (129S6/SvEvTac-Mefv^tm1Bhk)	increased interleukin-18 secretion	J:192443
Mefv^tm1Chae/Mefv^tm1Chae (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	decreased macrophage apoptosis	J:82763
	increased inflammatory response	J:82763
	increased susceptibility to endotoxin shock	J:82763
Mefv^{tm3.1(MEFV)Chae}/Mefv^{tm3.1(MEFV)Chae} (B6.129S6-Mefv^{tm3.1(MEFV)Chae})	arthritis	J:172117
	dermatitis	J:172117
	increased inflammatory response	J:172117
Mefv^{tm4.1(MEFV)Chae}/Mefv^{tm4.1(MEFV)Chae} (B6.129S6-Mefv^{tm4.1(MEFV)Chae})	arthritis	J:172117
	dermatitis	J:172117
	increased inflammatory response	J:172117
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} (B6.129S6-Mefv^{tm5.1(MEFV)Chae})	abnormal cytokine secretion	J:172117
	arthritis	J:172117
	decreased interleukin-3 secretion	J:172117
	dermatitis	J:172117
	increased circulating interleukin-1 beta level	J:172117
	increased circulating interleukin-6 level	J:172117
	increased circulating tumor necrosis factor level	J:172117
	increased inflammatory response	J:172117
	increased interferon-gamma secretion	J:172117
	increased interleukin-1 alpha secretion	J:172117
	increased interleukin-1 beta secretion	J:172117
	increased interleukin-2 secretion	J:172117
	increased interleukin-4 secretion	J:172117
	increased interleukin-5 secretion	J:172117
	increased interleukin-9 secretion	J:172117
	increased interleukin-10 secretion	J:172117
	increased interleukin-12 secretion	J:172117
	increased interleukin-12b secretion	J:172117
	increased interleukin-13 secretion	J:172117
	increased interleukin-17 secretion	J:172117
	joint inflammation	J:172117
	liver inflammation	J:172117
	skin inflammation	J:172117
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} Nlrp3^tm1Tsc/Nlrp3^tm1Tsc (involves: 129S6/SvEvTac * C57BL/6)	increased inflammatory response	J:172117
	increased interleukin-1 beta secretion	J:172117
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} Pycard^tm1Tno/Pycard^tm1Tno (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	decreased interleukin-1 beta secretion	J:172117
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:172117
	increased circulating interleukin-1 beta level	J:172117
	increased circulating interleukin-6 level	J:172117
	increased circulating tumor necrosis factor level	J:172117
	increased inflammatory response	J:172117
	increased interferon-gamma secretion	J:172117
	increased interleukin-1 beta secretion	J:172117
	increased interleukin-2 secretion	J:172117
	increased interleukin-4 secretion	J:172117
	increased interleukin-5 secretion	J:172117
	increased interleukin-9 secretion	J:172117
	increased interleukin-10 secretion	J:172117
	increased interleukin-12 secretion	J:172117
	increased interleukin-13 secretion	J:172117
	increased interleukin-17 secretion	J:172117
Men1^tm1Ctre/Men1⁺ (either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N))	pancreas inflammation	J:67128
Meox2^tm1(cre)Sor/Meox2⁺ Procr^tm2Cte/Procr^tm2Cte (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * Black Swiss * C57BL/6)	decreased circulating fibrinogen level	J:119529
	increased circulating C-reactive protein level	J:119529
Mep1a^tm1Bond/Mep1a^tm1Bond (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal chemokine level	J:145685
	abnormal circulating interleukin-1 beta level	J:145037
	abnormal cytokine level	J:145037, J:145685
	abnormal leukocyte physiology	J:145037
	abnormal tumor necrosis factor level	J:145037
	increased circulating interleukin-1 beta level	J:145685
	increased circulating interleukin-6 level	J:145685
	increased susceptibility to induced colitis	J:145685
	urinary bladder inflammation	J:145037
Mep1b^tm1Bond/Mep1b^tm1Bond (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased inflammatory response	J:132021
Mertk^nmf12/Mertk^nmf12 (involves: C57BL/6J)	abnormal tumor necrosis factor level	J:175587
Mertk^tm1Gkm/Mertk^tm1Gkm (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased circulating tumor necrosis factor level	J:53423
	increased susceptibility to endotoxin shock	J:53423
	increased tumor necrosis factor secretion	J:53423
Mertk^tm1Gkm/Mertk^tm1Gkm (NOD.129P2-Mertk^tm1Gkm)	decreased susceptibility to autoimmune diabetes	J:147153
	increased T cell apoptosis	J:147153
	insulitis	J:147153
Mertk^tm1Gkm/Mertk^tm1Gkm (B6.129P2-Mertk^tm1Gkm)	decreased autoantibody level	J:136377
Mertk^tm1Gkm/Mertk^tm1Gkm (B6.129P2-Mertk^tm1Gkm)	decreased susceptibility to graft versus host disease	J:136377
Mertk^tm1Gkm/Mertk^tm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (NOD.Cg-Mertk^tm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	increased T cell apoptosis	J:147153
Met^tm1Gvw/Met⁺ (involves: 129 * C57BL/6J)	glomerulonephritis	J:94722
Met^tm2Gvw/Met⁺ (involves: 129 * C57BL/6J)	glomerulonephritis	J:94722
Met^tm4Gvw/Met⁺ (involves: 129 * C57BL/6J)	glomerulonephritis	J:94722
Metrnl^{tm1d(KOMP)Wtsi}/Metrnl^{tm1d(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased IgG level	J:268270
	increased IgM level	J:268270
	increased susceptibility to endotoxin shock	J:268270
	kidney inflammation	J:268270
	liver inflammation	J:268270
	uterus inflammation	J:268270
Mex3b^tm1.1Mbld/Mex3b^tm1.1Mbld Plekha5^{Tg(AMH-cre)1Flor}/Plekha5⁺ (involves: C57BL/6 * SJL)	increased anti-sperm antibody level	J:213588
Mex3b^tm1.2Mbld/Mex3b^tm1.2Mbld (involves: C57BL/6 * CBA)	impaired macrophage phagocytosis	J:213588
Mex3c^tm1Aki/Mex3c^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal cytokine secretion	J:208870
	decreased interferon-beta secretion	J:208870
	decreased interleukin-6 secretion	J:208870
	decreased interleukin-12 secretion	J:208870
Mfge8^{Gt(KST227)Byg}/Mfge8^{Gt(KST227)Byg} (B6.129P2-Mfge8^{Gt(KST227)Byg})	impaired macrophage phagocytosis	J:98314
Mfge8^{Gt(KST227)Byg}/Mfge8^{Gt(KST227)Byg} (involves: 129P2/OlaHsd * C57BL/6)	impaired macrophage phagocytosis	J:107106
	mastitis	J:107106
Mfge8^tm1Osa/Mfge8^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired macrophage phagocytosis	J:90633
	increased anti-double stranded DNA antibody level	J:225063
Mfge8^tm1Osa/Mfge8^tm1Osa Timd4^tm1Osa/Timd4^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	impaired macrophage phagocytosis	J:187181
	increased anti-double stranded DNA antibody level	J:187181
	increased anti-nuclear antigen antibody level	J:187181
Mfge8^tm1Shur/Mfge8^tm1Shur (B6.129-Mfge8^tm1Shur)	spermatic granuloma	J:145962
Mfng^tm1.1Cfg/Mfng^tm1.1Cfg (involves: C57BL/6)	increased B cell proliferation	J:217719
Mfsd2a^tm1Dls/Mfsd2a^tm1Dls (B6.Cg-Mfsd2a^tm1Dls)	abnormal microglial cell activation	J:234197
Mfsd2b^{tm1a(KOMP)Wtsi}/Mfsd2b^{tm1a(KOMP)Wtsi} (C57BL/6-Mfsd2b^{tm1a(KOMP)Wtsi})	increased susceptibility to type I hypersensitivity reaction	J:250123
Mfsd8^{tm1a(EUCOMM)Hmgu}/Mfsd8^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	CNS inflammation	J:211608
Mgat2^tm1.1Jxm/Mgat2^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * ICR)	glomerulonephritis	J:80661
Mgat5^tm1Jwd/Mgat5^tm1Jwd (involves: 129S1/Sv * 129X1/SvJ)	abnormal inflammatory response	J:60960
	abnormal leukocyte physiology	J:94864
	abnormal T cell physiology	J:60960
	decreased interleukin-2 secretion	J:94864
	decreased interleukin-4 secretion	J:94864
	increased interleukin-10 secretion	J:94864
	increased tumor necrosis factor secretion	J:94864
Mgat5b^tm1.1Cfg/Mgat5b^tm1.1Cfg (involves: 129S6/SvEvTac)	enhanced humoral immune response	J:217719
Mgat5b^tm1.1Cfg/Mgat5b^tm1.1Cfg (involves: 129S6/SvEvTac)	increased IgG2b level	J:217719
Mgat5b^tm1Nta/Mgat5b^tm1Nta (Not Specified)	brain inflammation	J:199165
Mgl2^{tm1.1(HBEGF/EGFP)Aiwsk}/Mgl2⁺ (involves: C57BL/6 * FVB/N)	abnormal immune system physiology	J:201044
	decreased interleukin-4 secretion	J:201044
	increased susceptibility to parasitic infection	J:201044
Micu1^em#Fink/Micu1^em#Fink (C57BL/6N-Micu1^em#Fink)	increased B cell apoptosis	J:238984
Mif^tm1Dvd/Mif^tm1Dvd (involves: 129S4/SvJae * C57BL/6)	decreased circulating tumor necrosis factor level	J:52300
	decreased susceptibility to bacterial infection	J:52300
	decreased susceptibility to endotoxin shock	J:52300
	increased interleukin-4 secretion	J:52300
	increased susceptibility to parasitic infection	J:52300
Mif^tm1Mky/Mif^tm1Mky (C.129-Mif^tm1Mky)	abnormal cytokine secretion	J:106380
Mif^tm1Mky/Mif^tm1Mky (C.129-Mif^tm1Mky)	abnormal inflammatory response	J:106380
Miju^C3HeB/FeJ/Miju^C57BL/6J (involves: C3HeB/FeJ * C57BL/6J)	increased IgA level	J:91062
Milr1^tm1Shib/Milr1^tm1Shib (involves: C57BL/6N)	decreased mast cell degranulation	J:161854
Milr1^tm1Shib/Milr1^tm1Shib (involves: C57BL/6N)	increased susceptibility to type I hypersensitivity reaction	J:161854
Mir10b^em1Rosay/Mir10b^em1Rosay (C57BL/6J-Mir10b^em1Rosay)	large intestinal inflammation	J:342486
Mir21a^tm1.1Mer/Mir21a^tm1.1Mer (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal cytokine level	J:179235
	abnormal cytokine secretion	J:179235
	abnormal interferon level	J:179235
	abnormal interleukin level	J:179235
	decreased interleukin-4 secretion	J:179235
	increased interferon-gamma secretion	J:179235
	increased interleukin-12 secretion	J:179235
	increased susceptibility to type I hypersensitivity reaction	J:179235
Mir21a^tm1.1Mer/Mir21a^tm1.1Mer (B6.129S1-Mir21a^tm1.1Mer)	increased susceptibility to type IV hypersensitivity reaction	J:179235
Mir33^tm1.1Koho/Mir33^tm1.1Koho (involves: C57BL/6)	abnormal macrophage physiology	J:165420
Mir34a^tm1.1Pisc/Mir34a^tm1.1Pisc Mirc21^tm1.1Pisc/Mirc21^tm1.1Pisc Mirc34^tm1.1Pisc/Mirc34^tm1.1Pisc (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	increased susceptibility to bacterial infection induced morbidity/mortality	J:256929
	nasal inflammation	J:256929
Mir100^em1Nju/Mir100^em1Nju Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * DBA)	liver inflammation	J:281439
Mir122^tm1.1Apts/Mir122^tm1.1Apts (involves: 129 * C57BL/6)	increased circulating interleukin-6 level	J:190066
Mir122^tm1.1Apts/Mir122^tm1.1Apts (involves: 129 * C57BL/6)	liver inflammation	J:190066
Mir122^tm1.1Kgh/Mir122^tm1.1Kgh (involves: 129S1/Sv * 129X1/SvJ)	increased circulating interleukin-6 level	J:190067
	liver inflammation	J:190067
Mir122^tm1.2Kgh/Mir122^tm1.2Kgh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	increased circulating interleukin-6 level	J:190067
	increased interleukin-6 secretion	J:190067
	increased tumor necrosis factor secretion	J:190067
	liver inflammation	J:190067
Mir125a^tm1Smoc/Mir125a^tm1Smoc (involves: C57BL/6)	abnormal regulatory T cell physiology	J:224880
	increased interferon-gamma secretion	J:224880
	increased interleukin-17 secretion	J:224880
	increased susceptibility to experimental autoimmune encephalomyelitis	J:224880
Mir139^em1Jwli/Mir139^em1Jwli (C57BL/6J-Mir139^em1Jwli)	abnormal cytokine level	J:248779
	increased susceptibility to colitis induced morbidity/mortality	J:280467, J:248779
	increased susceptibility to induced colitis	J:248779
Mir140^tm1.1Asah/Mir140^tm1.1Asah (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased susceptibility to induced arthritis	J:160358
	osteoarthritis	J:160358
Mir142^tm1Teyo/Mir142^tm1Teyo (involves: C57BL/6)	decreased mast cell degranulation	J:211850
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6)	abnormal regulatory T cell physiology	J:167922
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6)	decreased interferon-gamma secretion	J:167922
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6 * FVB/N)	abnormal immune system physiology	J:173671
	abnormal immune tolerance	J:173671
	abnormal macrophage physiology	J:173671
	abnormal T cell activation	J:173671
	increased circulating interleukin-1 beta level	J:173671
	increased circulating interleukin-6 level	J:173671
	increased circulating interleukin-10 level	J:173671
	increased circulating tumor necrosis factor level	J:173671
	increased interleukin-1 beta secretion	J:173671
	increased interleukin-6 secretion	J:173671
	increased macrophage nitric oxide production	J:173671
	increased susceptibility to bacterial infection induced morbidity/mortality	J:173671
	increased susceptibility to endotoxin shock	J:173671
	increased tumor necrosis factor secretion	J:173671
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Mir146b^tm1.1Lfl/Mir146b^tm1.1Lfl Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased IgG level	J:266124
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Tg(Cr2-cre)3Cgn/0 (involves: C57BL/6)	increased anti-double stranded DNA antibody level	J:266124
	increased IgG1 level	J:266124
	increased IgG level	J:266124
Mir146^tm2.1Bal/Mir146^tm2.1Bal (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal immune system physiology	J:173671
	abnormal immune tolerance	J:173671
	abnormal macrophage physiology	J:173671
	abnormal T cell activation	J:173671
	increased acute inflammation	J:173671
	increased anti-double stranded DNA antibody level	J:173671
	increased circulating interleukin-1 beta level	J:173671
	increased circulating interleukin-6 level	J:173671
	increased circulating interleukin-10 level	J:173671
	increased circulating tumor necrosis factor level	J:173671
	increased interleukin-1 beta secretion	J:173671
	increased interleukin-6 secretion	J:173671
	increased macrophage nitric oxide production	J:173671
	increased susceptibility to bacterial infection induced morbidity/mortality	J:173671
	increased susceptibility to endotoxin shock	J:173671
	increased tumor necrosis factor secretion	J:173671
Mir148a^tm2942.1Arte/Mir148a^tm2942.1Arte Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased IgA level	J:307366
	decreased IgG level	J:307366
	decreased IgM level	J:307366
	impaired humoral immune response	J:307366
Mir148a^tm2942.1Arte/Mir148a^tm2942.1Arte Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal B cell physiology	J:307366
	impaired humoral immune response	J:307366
Mir148a^tm2942.2Arte/Mir148a^tm2942.2Arte (involves: C57BL/6 * FVB/N)	abnormal B cell physiology	J:307366
Mir149^em1Ydw/Mir149^em1Ydw (C57BL/6J-Mir149^em1Ydw)	increased susceptibility to endotoxin shock	J:294318
Mir150^tm1Rsky/Mir150^tm1Rsky (involves: C57BL/6)	increased IgA level	J:127234
	increased IgG1 level	J:127234
	increased IgG2b level	J:127234
	increased IgM level	J:127234
Mir155^tm1.1Brd/Mir155^tm1.1Brd (B6.Cg-Mir155^tm1.1Brd Tyr^c-Brd)	abnormal CD4-positive, alpha-beta T cell physiology	J:121095
	abnormal dendritic cell physiology	J:121095
	decreased IgG1 level	J:121095
	increased susceptibility to bacterial infection	J:121095
Mir155^tm1.1Rsky/Mir155^tm1.1Rsky (involves: 129 * C57BL/6)	abnormal B cell physiology	J:121084
	abnormal cytokine secretion	J:121084
	abnormal germinal center B cell physiology	J:121084
	abnormal humoral immune response	J:121084
	abnormal T cell physiology	J:121084
Mir155^tm1.1Rsky/Mir155^tm1.1Rsky (B6.Cg-Mir155^tm1Rsky/J)	abnormal T cell physiology	J:226678
	decreased interleukin-6 secretion	J:226678
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:226678
Mir155^tm1Brd/Mir155^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell physiology	J:121095
	abnormal class switch recombination	J:121095
	abnormal cytokine secretion	J:121095
	decreased IgM level	J:121095
	intestinal inflammation	J:121095
	lung inflammation	J:121095
Mir155^tm1Rsky/Mir155^tm1Rsky (involves: 129/Sv * C57BL/6)	abnormal cytokine secretion	J:121084
	abnormal humoral immune response	J:121084
	abnormal immune system physiology	J:121084
	decreased interferon-gamma secretion	J:121084
	decreased interleukin-4 secretion	J:121084
	decreased tumor necrosis factor secretion	J:121084
	increased interleukin-10 secretion	J:121084
Mir155^tm1Rsky/Mir155^tm1Rsky (involves: 129 * C57BL/6)	abnormal class switch recombination	J:136224
Mir210^tm1.1Wtsi/Mir210^tm1.1Wtsi (involves: C57BL/6J * C57BL/6N)	increased anti-chromatin antibody level	J:205868
	increased anti-double stranded DNA antibody level	J:205868
	increased anti-nuclear antigen antibody level	J:205868
Mir216a^em1Uf/Mir216a^em1Uf (C57BL/6-Mir216a^em1Uf)	increased susceptibility to induced pancreatitis	J:278847
Mir216a^em2Uf/Mir216a^em2Uf (C57BL/6-Mir216a^em2Uf)	increased susceptibility to induced pancreatitis	J:278847
Mir216b^em1Uf/Mir216b^em1Uf (C57BL/6-Mir216b^em1Uf)	increased susceptibility to induced pancreatitis	J:278847
Mir217^em1Uf/Mir217^em1Uf (C57BL/6-Mir217^em1Uf)	increased susceptibility to induced pancreatitis	J:278847
Mir217^em2Uf/Mir217^em2Uf (C57BL/6-Mir217^em2Uf)	increased susceptibility to induced pancreatitis	J:278847
Mir223^tm1Fcam/Mir223^tm1Fcam (involves: 129S4/SvJae * C57BL/6)	abnormal granulocyte physiology	J:140009
	abnormal neutrophil physiology	J:140009
	increased acute inflammation	J:140009
	lung inflammation	J:140009
Mir301^tm1Yoli/Mir301^tm1Yoli (involves: C57BL/6J)	abnormal response to transplant	J:237900
Mir378b^em#Yoo/Mir378b^em#Yoo (C57BL/6J-Mir378b^em#Yoo)	abnormal chemokine secretion	J:307588
	abnormal susceptibility to bacterial infection	J:307588
	decreased interferon-gamma secretion	J:307588
	decreased interleukin-12 secretion	J:307588
	decreased tumor necrosis factor secretion	J:307588
Mir425^em1Nju/Mir425⁺ (involves: C57BL/6)	increased tumor necrosis factor secretion	J:280159
Mir511^em1Clib/Mir511^em1Clib (C57BL/6J-Mir511^em1Clib)	abnormal macrophage physiology	J:345580
Mir511^em1Clib/Mir511^em1Clib (C57BL/6J-Mir511^em1Clib)	decreased susceptibility to induced colitis	J:345580
Mirc1^tm1.1Aven/Mirc1^tm1.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	increased B cell apoptosis	J:223213
Mirc1^tm1.2Tyj/Mirc1^tm1.2Tyj (involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)	increased B cell apoptosis	J:134861
Mirc1^tm1.3Tyj/Mirc1^tm1.3Tyj (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased B cell apoptosis	J:134861
Mirc1^tm1Tyj/Mirc1^tm1Tyj Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA * SJL)	increased B cell apoptosis	J:134861
Mirc1^tm2.1Aven/Mirc1^tm2.1Aven Tg(IghMyc)22Bri/? (involves: 129S4/SvJae * C57BL/6 * SJL/J)	increased B cell apoptosis	J:223213
Mirc1^tm3.1Aven/Mirc1^tm3.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	increased B cell apoptosis	J:223213
Mirc13^tm1.1Mtm/Mirc13^tm1.1Mtm (Not Specified)	abnormal macrophage activation involved in immune response	J:256444
Mirc14^tm1.1Ankr/Mirc14^tm1.1Ankr (involves: C57BL/6)	decreased interferon-gamma secretion	J:196134
	decreased interleukin-4 secretion	J:196134
	decreased interleukin-13 secretion	J:196134
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	abnormal T cell physiology	J:203157
	decreased T cell proliferation	J:203157
	decreased thymocyte apoptosis	J:203157
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv Tg(Cd4-TcraDN32D3)1Aben/0 (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	abnormal NK T cell physiology	J:203157
Mirc30^tm1.2Rdf/Mirc30^tm1.2Rdf (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal B cell proliferation	J:156946
Mirc32^tm1.1Jtm/Mirc32^tm1.1Jtm Tg(Myh11-cre,-EGFP)2Mik/? (B6.Cg-Mirc32^tm1.1Jtm Tg(Myh11-cre,-EGFP)2Mik)	increased susceptibility to induced colitis	J:214382
Mirc32^tm1.1Jtm/Mirc32^tm1.1Jtm Twist2^tm1(cre)Dor/Twist2⁺ (B6.129(Cg)-Twist2^{tm1.1(cre)Dor} Mirc32^tm1.1Jtm)	increased susceptibility to induced colitis	J:214382
Mirc32^tm1.2Jtm/Mirc32^tm1.2Jtm (B6.129(Cg)-Mirc32^tm1.2Jtm)	increased susceptibility to induced colitis	J:214382
Mirc33^tm1.1Cwh/Mirc33^tm1.1Cwh (involves: 129X1/SvJ)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:189763
	increased interferon-gamma secretion	J:189763
	increased interleukin-17 secretion	J:189763
Mirc33^tm1Bdes/Mirc33^tm1Bdes (Not Specified)	abnormal thymus involution	J:180783
Mirc40^tm1Jzb/Mirc40^tm1Jzb (Not Specified)	increased microglial cell activation	J:244554
Misp^em1Nsas/Misp^em1Nsas (FVB/NJcl-Misp^em1Nsas)	abnormal interleukin level	J:333842
Misp^em1Nsas/Misp^em1Nsas (FVB/NJcl-Misp^em1Nsas)	increased susceptibility to induced colitis	J:333842
Mitf^Mi-Or/Mitf^Mi-Or (involves: 101/Rl * C3H/Rl)	abnormal osteoclast physiology	J:30149
Mitf^mi-tg/Mitf^mi-tg (B6.Cg-Mitf^mi-tg)	abnormal mast cell physiology	J:53161
Mitf^mi-vit/Mitf^mi-vit (C57BL/6J-Mitf^mi-vit)	abnormal Langerhans cell physiology	J:102101
Mitf^Mi/Mitf^Mi (B6.Cg-Mitf^Mi)	abnormal mast cell physiology	J:53161
Mitf^{Tg(Tff3-Tmem207)2Tamo}/Mitf⁺ (involves: C57BL/6)	kidney inflammation	J:244533
Mlf1^tm1Swm/Mlf1^tm1Swm (involves: 129 * C57BL/6)	decreased splenocyte apoptosis	J:266833
Mlh1^m1Btlr/Mlh1^m1Btlr (C57BL/6J-Mlh1^m1Btlr)	abnormal humoral immune response	J:265206
Mlh1^m1Btlr/Mlh1^m1Btlr (C57BL/6J-Mlh1^m1Btlr)	increased IgM level	J:265206
Mlh1^m2Btlr/Mlh1^m2Btlr (C57BL/6J-Mlh1^m2Btlr)	abnormal humoral immune response	J:265207
	decreased IgE level	J:265207
	increased IgM level	J:265207
Mlh1^m3Btlr/Mlh1^m3Btlr (C57BL/6J-Mlh1^m3Btlr)	abnormal humoral immune response	J:265208
	decreased IgE level	J:265208
	increased IgM level	J:265208
Mlkl^em1Jhan/Mlkl^em1Jhan (involves: C57BL/6)	abnormal macrophage physiology	J:204622
Mlkl^m1Btlr/Mlkl⁺ (C57BL/6J-Mlkl^m1Btlr)	decreased inflammatory response	J:225934
Mlkl^m1Btlr/Mlkl^m1Btlr (C57BL/6J-Mlkl^m1Btlr)	decreased inflammatory response	J:225934
Mlkl^m2Btlr/Mlkl⁺ (C57BL/6J-Mlkl^m2Btlr)	decreased inflammatory response	J:234252
Mlkl^m2Btlr/Mlkl^m2Btlr (C57BL/6J-Mlkl^m2Btlr)	decreased inflammatory response	J:234252
Mlkl^m3Btlr/Mlkl⁺ (C57BL/6J-Mlkl^m3Btlr)	decreased inflammatory response	J:234251
Mlkl^m3Btlr/Mlkl^m3Btlr (C57BL/6J-Mlkl^m3Btlr)	decreased inflammatory response	J:234251
Mlkl^tm1.1Wsa/Mlkl^tm1.1Wsa Otulin^{tm1c(EUCOMM)Hmgu}/Otulin^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	dermatitis	J:312394
Mlrrq^DBA/2/Mlrrq^DBA/2 (C.D2-Mtv7^DBA/2)	decreased susceptibility to parasitic infection	J:41574
Mmd^tm1Beij/Mmd^tm1Beij (Not Specified)	decreased susceptibility to induced arthritis	J:304637
Mmd^tm1Beij/Mmd^tm1Beij (Not Specified)	increased macrophage apoptosis	J:304637
Mme^tm1Cge/Mme^tm1Cge (B6.129S4-Mme^tm1Cge)	dermatitis	J:66854
Mme^tm1Cge/Mme^tm1Cge (B6.129S4-Mme^tm1Cge)	increased susceptibility to type I hypersensitivity reaction	J:66854
Mmp1a^tm1Otin/Mmp1a^tm1Otin (involves: 129P2/OlaHsd * C57BL/6J)	abnormal interleukin secretion	J:198586
	decreased inflammatory response	J:198586
	increased interferon-gamma secretion	J:198586
	increased interleukin-1 alpha secretion	J:198586
	increased interleukin-2 secretion	J:198586
	increased interleukin-17 secretion	J:198586
Mmp2^tm1Ito/Mmp2^tm1Ito (involves: 129P2/OlaHsd * C57BL/6J)	abnormal inflammatory response	J:46091
	brain inflammation	J:94099
	decreased inflammatory response	J:46091
	increased susceptibility to experimental autoimmune encephalomyelitis	J:94099
Mmp2^tm1Ito/Mmp2^tm1Ito (involves: 129P2/OlaHsd)	arthritis	J:121780
Mmp2^tm1Ito/Mmp2^tm1Ito Timp1^tm1Pds/Timp1^tm1Pds (either: (involves: 129S4/SvJae) or (involves: C57BL/6))	decreased susceptibility to bacterial infection	J:94836
Mmp2^tm1Ito/Mmp2^tm1Ito Timp3^tm1Osya/Timp3^tm1Osya (involves: 129P2/OlaHsd * C57BL/6)	aortitis	J:193744
Mmp3^tm1Mrl/Mmp3^tm1Mrl (either: (129S7/SvEvBrd X B10.RIII)N2 or ((involves: 129S7/SvEvBrd * C57BL/6) X B10.RIII)N2)	arthritis	J:46038
	joint inflammation	J:46038
	osteoarthritis	J:46038
Mmp3^tm1Mrl/Mmp3^tm1Mrl (either: 129S7/SvEvBrd or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal CD4-positive, alpha-beta T cell physiology	J:93706
	increased susceptibility to bacterial infection	J:93706
Mmp3^tm1Mrl/Mmp3^tm1Mrl (involves: 129S7/SvEvBrd * C57BL/10ScSn * RIII)	abnormal lymphocyte physiology	J:55723
	decreased susceptibility to type IV hypersensitivity reaction	J:55723
Mmp3^tm1Mrl/Mmp3^tm1Mrl Timp1^tm1Pds/Timp1^tm1Pds (involves: C57BL/6)	decreased susceptibility to bacterial infection	J:94836
Mmp7^tm1Lmm/Mmp7^tm1Lmm (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to bacterial infection	J:153651
Mmp7^tm1Lmm/Mmp7^tm1Lmm (B6.129-Mmp7^tm1Lmm)	increased interleukin-1 beta secretion	J:149388
Mmp7^tm1Lmm/Mmp7^tm1Lmm (B6.129-Mmp7^tm1Lmm)	increased susceptibility to induced colitis	J:149388
Mmp7^tm1Lmm/Mmp7^tm1Lmm (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:124841
	decreased tumor necrosis factor secretion	J:124841
	impaired macrophage chemotaxis	J:124841
Mmp7^tm1Lmm/Mmp7^tm1Lmm Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae)	decreased susceptibility to bacterial infection	J:94836
Mmp8^tm1Otin/Mmp8^tm1Otin (involves: 129X1/SvJ * C57BL/6J)	abnormal inflammatory response	J:86393
	chronic inflammation	J:86393
	increased susceptibility to bacterial infection	J:97118
Mmp9^tm1Arnd/Mmp9^tm1Arnd (involves: 129P2/OlaHsd)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:58833
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac)	abnormal chemokine level	J:84293
	abnormal dendritic cell physiology	J:84293
	abnormal Langerhans cell physiology	J:76157
	decreased IgE level	J:84293
	decreased inflammatory response	J:84293
	increased circulating interferon-beta level	J:148442
	increased circulating interferon-gamma level	J:148442
	increased susceptibility to Picornaviridae infection	J:148442
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:148442
	myocarditis	J:148442
Mmp9^tm1Tvu/Mmp9^tm1Tvu (FVB.129S6-Mmp9^tm1Tvu)	abnormal neutrophil physiology	J:104644
Mmp9^tm1Tvu/Mmp9^tm1Tvu (FVB.129S6-Mmp9^tm1Tvu)	decreased susceptibility to induced colitis	J:104644
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129/Sv * 129S6/SvEvTac)	decreased circulating interleukin-10 level	J:55723
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129/Sv * 129S6/SvEvTac)	increased susceptibility to type IV hypersensitivity reaction	J:55723
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac * C57BL/6)	abnormal chemokine level	J:88065
	abnormal cytokine secretion	J:88065
	abnormal response to infection	J:126519
	decreased interferon-gamma secretion	J:88065
	increased IgE level	J:88065
	increased interferon-gamma secretion	J:88065
	increased interleukin-4 secretion	J:88065
	increased interleukin-5 secretion	J:88065
	increased interleukin-13 secretion	J:88065
	increased T cell proliferation	J:88065
	lung inflammation	J:88065
Mmp9^tm1Tvu/Mmp9^tm1Tvu (FVB.Cg-Mmp9^tm1Tvu/J)	decreased susceptibility to Flaviviridae infection	J:153406
Mmp9^tm1Tvu/Mmp9^tm1Tvu (FVB.Cg-Mmp9^tm1Tvu/J)	decreased susceptibility to Flaviviridae infection induced morbidity/mortality	J:153406
Mmp9^tm1Tvu/Mmp9^tm1Tvu (C3N.129S6-Mmp9^tm1Tvu)	decreased susceptibility to bacterial infection	J:150311
	decreased susceptibility to induced arthritis	J:150311
	joint inflammation	J:150311
Mmp9^tm1Tvu/Mmp9^tm1Tvu Tg(SOD1G93A)1Gur/0 (involves: 129S6/SvEvTac C57BL/6 * CD-1 * SJL)	decreased tumor necrosis factor secretion	J:141587
Mmp10^tm1Jkmg/Mmp10^tm1Jkmg (B6.129X1-Mmp10^tm1Jkmg)	increased susceptibility to bacterial infection	J:153651
Mmp10^tm1Jkmg/Mmp10^tm1Jkmg (B6.129X1-Mmp10^tm1Jkmg)	lung inflammation	J:153651
Mmp12^tm1Sds/Mmp12^tm1Sds (involves: 129X1/SvJ)	abnormal macrophage physiology	J:32902
Mmp12^tm1Sds/Mmp12^tm1Sds Timp1^tm1Pds/Timp1^tm1Pds (either: (involves: 129S4/SvJae) or (involves: C57BL/6))	decreased susceptibility to bacterial infection	J:94836
Mmp14^tm1Hbh/Mmp14^tm1Hbh (involves: 129P2/OlaHsd * Black Swiss)	abnormal osteoclast physiology	J:57969, J:86538
	arthritis	J:57969
Mmp14^tm1Ktry/Mmp14^tm1Ktry (involves: 129X1/SvJ)	abnormal dendritic cell physiology	J:138782
Mmp19^tm1Rase/Mmp19^tm1Rase (B6.129P2-Mmp19^tm1Rase)	abnormal cytokine level	J:137128
	abnormal T cell activation	J:137128
	decreased inflammatory response	J:137128
	decreased susceptibility to type IV hypersensitivity reaction	J:137128
	decreased T cell proliferation	J:137128
Mmp24^tm1Otin/Mmp24^tm1Otin (involves: 129P2/OlaHsd * C57BL/6J)	abnormal mast cell degranulation	J:153230
	increased mast cell degranulation	J:153230
Mmp28^tm1Mani/Mmp28^tm1Mani (B6.129X1-Mmp28^tm1Mani)	abnormal chemokine secretion	J:145912
	abnormal cytokine secretion	J:145912
	abnormal macrophage chemotaxis	J:145912
	decreased susceptibility to bacterial infection	J:145912
	impaired neutrophil recruitment	J:145912
	increased interleukin-6 secretion	J:145912
	increased tumor necrosis factor secretion	J:145912
Mmut^tm1Cpv/Mmut^tm1Cpv (involves: 129S/SvEv * C57BL/6 * FVB/N)	tubulointerstitial nephritis	J:147313
Mmut^tm1Cpv/Mmut^tm1Cpv Tg(Alb-Mut)#Cpv/0 (involves: C57BL/6)	tubulointerstitial nephritis	J:200689
Mnx1^tm4(cre)Tmj/Mnx1⁺ Tardbp^tm1.1Ckjs/Tardbp^tm1.2Cjks (involves: 129S1/Sv * C57BL/6J)	increased microglial cell activation	J:190254
Mocos^em2(IMPC)Ics/Mocos^em2(IMPC)Ics (involves: C57BL/6N)	kidney inflammation	J:336718
Mocos^em2(IMPC)Ics/Mocos^em2(IMPC)Ics (involves: C57BL/6N)	tubulointerstitial nephritis	J:336718
Mog^tm1(cre)Gkl/Mog^tm1(cre)Gkl Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (C57BL/6-Mog^tm1(cre)Gkl Tg(Tcra2D2,Tcrb2D2)1Kuch)	increased susceptibility to experimental autoimmune encephalomyelitis	J:151335
Mog^tm1Dpd/Mog^tm1Dpd (B6.129S2-Mog^tm1Dpd)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:85155
Mog^tm1Dpd/Mog^tm1Dpd Rag2^tm1Cgn/Rag2^tm1Cgn Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:151335
Mog^tm1Dpd/Mog^tm1Dpd Tg(H2-K^b-Tcra,-Tcrb)1640Kurs/0 (SJL.Cg-Mog^tm1Dpd Tg(H2-K^b-Tcra,-Tcrb)1640Kurs)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:149511
Mog^tm1Dpd/Mog^tm1Dpd Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129S2/SvPas * C57BL/6)	CNS inflammation	J:151335
	increased susceptibility to experimental autoimmune encephalomyelitis	J:151335
Mog^tm1Reid/Mog^tm1Reid (B6.129S1/Sv-Mog^tm1Reid)	increased susceptibility to experimental autoimmune encephalomyelitis	J:86663
Mog^tm1Reid/Mog^tm1Reid (129/Sv-Mog^tm1Reid)	abnormal cytokine secretion	J:86663
	abnormal T-helper 1 physiology	J:86663
	increased interleukin-2 secretion	J:86663
	increased interleukin-6 secretion	J:86663
	increased susceptibility to experimental autoimmune encephalomyelitis	J:86663
	increased T cell proliferation	J:86663
Mol1^BALB/cByJ/Mol1^BALB/cByJ (involves: BALB/cByJ * C57BL/6ByJ)	decreased B cell proliferation	J:58921
Mol2^DBA/2N/Mol2^DBA/2N (involves: BALB/cAnFcr * DBA/2N)	increased inflammatory response	J:58921
Morc2a^{em1(IMPC)Wtsi}/Morc2a^{em1(IMPC)Wtsi} (C57BL/6N-Morc2a^{em1(IMPC)Wtsi}/WtsiOulu)	blood in lymph vessels	J:239583
Morrbid^em1Flv/Morrbid^em1Flv (C57BL/6N-Morrbid^em1Flv)	abnormal eosinophil physiology	J:236609
	abnormal leukocyte physiology	J:236609
	abnormal neutrophil physiology	J:236609
	increased susceptibility to bacterial infection	J:236609
	increased susceptibility to bacterial infection induced morbidity/mortality	J:236609
mpc253H/mpc253H (involves: BALB/c * C3H/HeH * C57BL/6J)	colitis	J:234901
Mpdk2^C57BL/6J/Mpdk2^CAST/Ei (involves: C57BL/6J * CAST/Ei)	bile duct inflammation	J:99468
Mpdk2^CAST/Ei/Mpdk2^CAST/Ei (involves: C57BL/6J * CAST/Ei)	bile duct inflammation	J:99468
Mpdk7^C57BL/6J/Mpdk7^CAST/Ei (involves: C57BL/6J * CAST/Ei)	bile duct inflammation	J:99468
Mpdk7^CAST/Ei/Mpdk7^CAST/Ei (involves: C57BL/6J * CAST/Ei)	bile duct inflammation	J:99468
Mpdk8^C57BL/6J/Mpdk8^CAST/Ei (involves: C57BL/6J * CAST/Ei)	bile duct inflammation	J:99468
Mpdk8^CAST/Ei/Mpdk8^CAST/Ei (involves: C57BL/6J * CAST/Ei)	bile duct inflammation	J:99468
Mpeg1^tm1Pod/Mpeg1⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal susceptibility to infection induced morbidity/mortality	J:269474
Mpeg1^tm1Pod/Mpeg1⁺ (129X1/SvJ-Mpeg1^tm1Pod)	abnormal susceptibility to infection induced morbidity/mortality	J:269474
Mpeg1^tm1Pod/Mpeg1^tm1Pod (involves: 129X1/SvJ * C57BL/6)	abnormal susceptibility to infection induced morbidity/mortality	J:269474
Mpeg1^tm1Pod/Mpeg1^tm1Pod (129X1/SvJ-Mpeg1^tm1Pod)	abnormal susceptibility to infection induced morbidity/mortality	J:269474
Mpg^tm1Lds/Mpg^tm1Lds (involves: 129P2/OlaHsd * C57BL/6)	autoimmune response	J:118148
Mpg^tm1Lds/Mpg^tm1Lds (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to autoimmune diabetes	J:118148
Mpl^hlb219/Mpl^hlb219 (C57BL/6J-Mpl^hlb219/J)	abnormal circulating cytokine level	J:146577
Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv)	abnormal circulating chemokine level	J:162629
Mpo^tm1Lus/Mpo^tm1Lus (involves: 129X1/SvJ * C57BL/6J)	abnormal neutrophil physiology	J:67586
	decreased inflammatory response	J:102688
	increased susceptibility to experimental autoimmune encephalomyelitis	J:102965
	increased susceptibility to fungal infection	J:67586
	sepsis	J:126649
Mpo^tm1Lus/Mpo^tm1Lus (B6.129X1-Mpo^tm1Lus)	abnormal neutrophil physiology	J:112488
Mpo^tm1Mae/Mpo^tm1Mae (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:53993
Mpo^tm1Mae/Mpo^tm1Mae (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to fungal infection	J:53993
Mpp1^tm1Ahc/Mpp1^tm1Ahc (B6.129-Mpp1^tm1Ahc)	abnormal neutrophil physiology	J:154749
Mpp1^tm1Ahc/Mpp1^tm1Ahc (B6.129-Mpp1^tm1Ahc)	impaired neutrophil chemotaxis	J:154749
Mptx2^em1Yoxi/Mptx2^em1Yoxi (C57BL/6J-Mptx2^em1Yoxi)	increased susceptibility to bacterial infection	J:326562
Mpz^tm1Msch/Mpz⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:82432
	abnormal macrophage chemotaxis	J:67581
	abnormal T-helper 1 physiology	J:82432
Mpz^tm1Msch/Mpz⁺ (B6.129S7-Mpz^tm1Msch)	autoimmune response	J:59319
Mpzl3^rc/Mpzl3^rc (C57BL/6J-Mpzl3^rc/J)	dermatitis	J:93038
Mpzl3^rc/Mpzl3^rc (C57BL/6J-Mpzl3^rc/J)	liver inflammation	J:93038
Mpzl3^tm1(KOMP)Mbp/Mpzl3^tm1(KOMP)Mbp (C57BL/6-Tyr^c-Brd Mpzl3^tm1(KOMP)Mbp)	seborrheic dermatitis	J:210832
	skin inflammation	J:210832
Mr1^tm1Gfn/Mr1^tm1Gfn (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell physiology	J:113083
Mr1^tm1Gfn/Mr1^tm1Gfn (B6.129P2-Mr1^tm1Gfn)	increased susceptibility to experimental autoimmune encephalomyelitis	J:112657
Mr1^tm1Gfn/Mr1^tm1Gfn (involves: 129P2/OlaHsd)	abnormal susceptibility to bacterial infection	J:276912
Mrc1^tm1Mnz/Mrc1^tm1Mnz (involves: 129P2/OlaHsd)	abnormal macrophage physiology	J:124290
Mrc1^tm1Mnz/Mrc1^tm1Mnz (B6.129P2-Mrc1^tm1Mnz)	decreased susceptibility to parasitic infection	J:194065
Mrc1^tm1Mnz/Mrc1^tm1Mnz (B6.129P2-Mrc1^tm1Mnz)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:194065
Mrc1^tm1Mnz/Mrc1^tm1Mnz Mrc2^tm1Cmi/Mrc2^tm1Cmi (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:124290
Mre11a^tm1.1Rchd/Mre11a^tm1.1Rchd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:184053
Mrgprb2^em1Xzd/Mrgprb2^em1Xzd (C57BL/6-Mrgprb2^em1Xzd)	decreased inflammatory response	J:219209
Mrgprb2^em1Xzd/Mrgprb2^em1Xzd (C57BL/6-Mrgprb2^em1Xzd)	decreased mast cell degranulation	J:219209
Mrs2^em1Muma/Mrs2^em1Muma (B6.Cg-Mrs2^em1Muma)	decreased susceptibility to endotoxin shock	J:298361
Ms4a1^tm1Tft/Ms4a1^tm1Tft (involves: 129 * C57BL/6)	abnormal B cell physiology	J:88933
Ms4a2^tm1Chr/Ms4a2^tm1Chr (involves: 129S1/Sv * 129X1/SvJ)	abnormal mast cell physiology	J:53106
Ms4a2^tm1Chr/Ms4a2^tm1Chr (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to type I hypersensitivity reaction	J:53106
Ms4a2^tm1Knt/Ms4a2^tm1Knt (involves: 129 * BALB/c)	abnormal cytokine secretion	J:47138
	abnormal mast cell physiology	J:47138
	decreased susceptibility to type I hypersensitivity reaction	J:47138
Ms4a2^tm1Knt/Ms4a2^tm1Knt Tg(SV40/HTLV-FCER1A)1Bhk/0 (involves: 129 * BALB/c)	abnormal cytokine secretion	J:47138
	abnormal mast cell physiology	J:47138
	decreased susceptibility to type I hypersensitivity reaction	J:47138
Ms4a4a^em1Wwz/Ms4a4a^em1Wwz (C57BL/6NCrl-Ms4a4a^em1Wwz)	abnormal macrophage physiology	J:296429
	decreased interleukin-4 secretion	J:296429
	decreased interleukin-13 secretion	J:296429
	impaired eosinophil recruitment	J:296429
Ms4a6d^em1Cya/Ms4a6d^em1Cya (involves: C57BL/6)	decreased susceptibility to endotoxin shock	J:342776
Ms4a6d^em1Ywch/Ms4a6d^em1Ywch (C57BL/6-Ms4a6d^em1Ywch)	decreased susceptibility to endotoxin shock	J:342776
Ms4a6d^em2Ywch/Ms4a6d^em2Ywch (C57BL/6-Ms4a6d^em2Ywch)	decreased susceptibility to endotoxin shock	J:342776
Msh2^tm1Htr/Msh2^tm1Htr (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:80893
	abnormal inflammatory response	J:80893
	abnormal somatic hypermutation frequency	J:155454
	decreased IgG1 level	J:80893
	decreased IgG3 level	J:80893
Msh2^tm1Htr/Msh2^tm1Htr Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Msh2^tm1Mak)	abnormal class switch recombination	J:326431
Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Msh2^tm1Mak)	abnormal somatic hypermutation frequency	J:326431
Msh2^tm1Rak/Msh2^tm1Rak (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:56764
Msh2^tm1Wed/Msh2^tm1Wed (involves: C57BL/6)	abnormal class switch recombination	J:86278
Msh2^tm1Wed/Msh2^tm1Wed (involves: C57BL/6)	decreased IgG level	J:86278
Msh6^m1Btlr/Msh6^m1Btlr (C57BL/6J-Msh6^m1Btlr)	decreased IgE level	J:255208
Msmp^em1Jzx/Msmp^em1Jzx (C57BL/6-Msmp^em1Jzx)	decreased circulating interleukin-6 level	J:311042
	decreased circulating tumor necrosis factor level	J:311042
	liver inflammation	J:311042
Msn^tm1Sts/Y (involves: 129S4/SvJae * C57BL/6)	impaired leukocyte migration	J:189837
Msr1^tm1Csk/Msr1^tm1Csk (involves: 129X1/SvJ * ICR)	increased interleukin-12 secretion	J:110433
	increased susceptibility to bacterial infection induced morbidity/mortality	J:39079
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:39079
Msr1^tm1Csk/Msr1^tm1Csk (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal macrophage physiology	J:91911
Msr1^tm1Csk/Msr1^tm1Csk (B6.129X1-Msr1^tm1Csk)	decreased interferon-beta secretion	J:251008
Msr1^tm1Csk/Msr1^tm1Csk Scarf1^tm1Ishi/Scarf1^tm1Ishi (involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)	abnormal macrophage physiology	J:91911
Mst1^tm1Jab/Mst1^tm1Jab (involves: 129P2/OlaHsd * Black Swiss)	abnormal macrophage physiology	J:46185
	increased susceptibility to induced colitis	J:46185
Mst1r^Fv2-s/Mst1r^Fv2-s (B6.DDD-Mst1r^Fv2-s)	increased susceptibility to Retroviridae infection	J:5120
Mst1r^Fv2-s/Mst1r^Fv2-s (either: A/Crgl or C57BL/Crgl)	decreased susceptibility to Retroviridae infection	J:167666
Mst1r^Fv2-s/Mst1r^Fv2-s (either: BALB/cCrgl or DBA/2Crgl or Swiss)	increased susceptibility to Retroviridae infection	J:167666
Mst1r^Fv2-s/Mst1r^Fv2-s (C3H/Crgl)	increased susceptibility to Retroviridae infection	J:167666
Mst1r^tm1.1Sew/Mst1r^tm1.1Sew (involves: 129/Ola * CD-1 * NIH Black Swiss)	abnormal macrophage physiology	J:75503
	abnormal type IV hypersensitivity reaction	J:75503
	increased acute inflammation	J:75503
	increased susceptibility to endotoxin shock	J:75503
Mst1r^tm1Ber/Mst1r^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal macrophage physiology	J:76451
	abnormal type IV hypersensitivity reaction	J:76451
	increased inflammatory response	J:76451
	increased susceptibility to bacterial infection	J:76451
Mst1r^tm1Sjd/Mst1r⁺ (either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1) or (involves: 129 * NIH Black Swiss))	abnormal macrophage physiology	J:54903
	increased susceptibility to bacterial infection	J:54903
Mst1r^{tm2(Mst1r)Sew}/Mst1r^{tm2(Mst1r)Sew} (involves: 129P2/OlaHsd * Black Swiss * FVB/N)	increased susceptibility to Retroviridae infection	J:215969
Mst1r^{tm2(Mst1r)Sew}/Mst1r^{tm2(Mst1r)Sew} (FVB.129P2(Cg)-Mst1r^{tm2(Mst1r*)Sew})	increased circulating interferon-gamma level	J:215969
	increased interferon-gamma secretion	J:215969
Mstn^lean/Mstn^lean (C57BL/6J-Mstn^lean)	abnormal circulating tumor necrosis factor level	J:146513
Mstn^lean/Mstn^lean (C57BL/6J-Mstn^lean)	decreased circulating tumor necrosis factor level	J:146513
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (involves: 129S7/SvEvBrd)	abnormal microglial cell physiology	J:53929
	increased interleukin-1 beta secretion	J:103102
	increased interleukin-6 secretion	J:103102
	increased susceptibility to experimental autoimmune encephalomyelitis	J:103102
	increased tumor necrosis factor secretion	J:103102
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (129S7/SvEvBrd-Mt1^tm1Bri Mt2^tm1Bri/J)	abnormal humoral immune response	J:110643
	abnormal lymphocyte physiology	J:110643
	increased IgG level	J:110643
	increased IgM level	J:110643
	increased thymocyte apoptosis	J:57169
	kidney inflammation	J:126620
	lung inflammation	J:120196
mt-Co1^m1Jiha (involves: C57BL/6J * M. m. domesticus)	heart inflammation	J:132659
mt-Nd2^m1 (ALR/Lt)	decreased susceptibility to autoimmune diabetes	J:117602, J:97969
Mta2^tm1.1Yzha/Mta2^tm1.1Yzha (involves: 129S4/SvJae * C57BL/6 * FVB/N)	dermatitis	J:137101
	glomerulonephritis	J:137101
	increased anti-double stranded DNA antibody level	J:137101
	increased autoantibody level	J:137101
	increased circulating interferon-gamma level	J:137101
	increased circulating interleukin-2 level	J:137101
	increased circulating interleukin-4 level	J:137101
	increased susceptibility to systemic lupus erythematosus	J:137101
	increased T cell proliferation	J:137101
	liver inflammation	J:137101
	panniculitis	J:137101
	skin inflammation	J:137101
Mta2^tm1Yzha/Mta2^tm1Yzha Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	increased T cell proliferation	J:137101
Mtap^{Gt(RRK081)Byg}/Mtap⁺ (129P2/OlaHsd-Mtap^{Gt(RRK081)Byg})	arteritis	J:123675
Mtdh^tm1.2Dsar/Mtdh^tm1.2Dsar (either: B6.129(FVB)-Mtdh^tm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N))	decreased interleukin-1 beta secretion	J:216688
	decreased interleukin-6 secretion	J:216688
	decreased macrophage proliferation	J:216688
Mtmr4^{tm1a(EUCOMM)Wtsi}/Mtmr4⁺ (Not Specified)	decreased IgE level	J:165965
Mtor^tm1.2Koz/Mtor^tm1.2Koz Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased interferon-gamma secretion	J:150108
	decreased interleukin-2 secretion	J:150108
	decreased interleukin-17 secretion	J:150108
	decreased T cell proliferation	J:150108
	decreased tumor necrosis factor secretion	J:150108
Mtor^tm1Lgm/Mtor^tm1Lgm (involves: 129S1/Sv * C57BL/6)	abnormal B cell physiology	J:168600
	abnormal humoral immune response	J:168600
	abnormal T cell physiology	J:168600
	decreased B cell proliferation	J:168600
	decreased IgG level	J:168600
	decreased IgM level	J:168600
	decreased splenocyte apoptosis	J:168600
	decreased splenocyte proliferation	J:168600
Mtss1^{Gt(CSC156)Byg}/Mtss1^{Gt(CSC156)Byg} (B6.129P2-Mtss1^{Gt(CSC156)Byg})	abnormal B cell physiology	J:186118
	increased inflammatory response	J:186118
Mtus1^{Gt(RRA048)Byg}/Mtus1^{Gt(RRA048)Byg} (involves: 129P2/OlaHsd * C57BL/6)	glomerulonephritis	J:212144
	increased susceptibility to systemic lupus erythematosus	J:212144
	insulitis	J:212144
	salivary gland inflammation	J:212144
Mtv7^BALB/c/Mtv7^BALB/c (involves: B10.Q * BALB/c * DBA/2)	increased susceptibility to induced arthritis	J:27701
Mtv7^BALB/c/Mtv7^DBA/2 (involves: B10.Q * BALB/c * DBA/2)	decreased susceptibility to induced arthritis	J:27701
Mtv7^DBA/2/Mtv7^DBA/2 (C.D2-Mtv7^DBA/2)	decreased susceptibility to induced arthritis	J:27701
Muc2^eey/Muc2^eey (C57BL/6-Muc2^eey)	ileum inflammation	J:194148
	increased interferon-gamma secretion	J:194148
	increased interleukin-1 beta secretion	J:194148
	increased susceptibility to induced colitis	J:194148
	increased tumor necrosis factor secretion	J:194148
Muc2^M1Btlr/Muc2⁺ (C57BL/6J-Muc2^M1Btlr)	increased susceptibility to induced colitis	J:150326
Muc2^M1Btlr/Muc2^M1Btlr (C57BL/6J-Muc2^M1Btlr)	increased susceptibility to induced colitis	J:150326
Muc2^m2Btlr/? (C57BL/6J-Muc2^m2Btlr)	increased susceptibility to induced colitis	J:159359
Muc2^m3Btlr/Muc2^m3Btlr (C57BL/6J-Muc2^m3Btlr)	increased susceptibility to induced colitis	J:254906
Muc2^tm1Avel/Muc2^tm1Avel (involves: 129P2/OlaHsd * C57BL/6)	colitis	J:216831
	large intestinal inflammation	J:216831
Muc2^wnn/Muc2⁺ (C57BL/6-Muc2^wnn)	increased susceptibility to induced colitis	J:194148
Muc2^wnn/Muc2^wnn (C57BL/6-Muc2^wnn)	colitis	J:194148
	ileum inflammation	J:194148
	increased interferon-gamma secretion	J:194148
	increased interleukin-1 beta secretion	J:194148
	increased interleukin-13 secretion	J:194148
	increased susceptibility to induced colitis	J:194148
	increased tumor necrosis factor secretion	J:194148
Muc4^PWK/PhJ/Muc4^PWK/PhJ (PWK/PhJ)	abnormal susceptibility to viral infection	J:287566
Muc4^tm1Skb/Muc4^tm1Skb (involves: 129 * C57BL/6J)	decreased susceptibility to colitis induced morbidity/mortality	J:234205
Muc4^tm1Skb/Muc4^tm1Skb (involves: 129 * C57BL/6J)	decreased susceptibility to induced colitis	J:234205
Muc4^tm1Unc/Muc4^tm1Unc (B6NTac.129(FVB)-Muc4^tm1Unc/Rand)	increased susceptibility to Coronaviridae infection	J:287566
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:287566
	increased susceptibility to Togaviridae infection	J:287566
Muc5ac^tm1.1Evns/Muc5ac^tm1.1Evns (B6.129S1-Muc5ac^tm1.1Evns)	increased circulating interferon-gamma level	J:177306
	increased susceptibility to parasitic infection	J:177306
Muc5b^tm1.2Evns/Muc5b^tm1.2Evns (B6.129S1-Muc5b^tm1.2Evns)	abnormal professional antigen presenting cell physiology	J:207159
	decreased interleukin-23 secretion	J:207159
	impaired macrophage phagocytosis	J:207159
	increased macrophage apoptosis	J:207159
	increased susceptibility to bacterial infection	J:207159
	increased susceptibility to bacterial infection induced morbidity/mortality	J:207159
	increased susceptibility to otitis media	J:207159
	respiratory system inflammation	J:207159
	sepsis	J:207159
Muc13^tm1.1Mamg/Muc13^tm1.1Mamg (involves: 129 * C57BL/6)	increased susceptibility to colitis induced morbidity/mortality	J:313870
	increased susceptibility to induced colitis	J:313870
	large intestinal inflammation	J:313870
	small intestinal inflammation	J:313870
Muc19^sld/Muc19^sld (NFS/N-Muc19^sld)	increased susceptibility to autoimmune disorder	J:216958, J:20364
Mug1^tm1Vln/Mug1^tm1Vln (B.129P2-Mug1^tm1Vln)	abnormal cytokine level	J:57485
Mug1^tm1Vln/Mug1^tm1Vln (B.129P2-Mug1^tm1Vln)	liver inflammation	J:57485
Mug1^tm2Vln/Mug1^tm2Vln Pzp^tm1Vln/Pzp^tm1Vln (B.129P2-Pzp^tm1Vln Mug1^tm2Vln)	abnormal cytokine level	J:57485
	liver inflammation	J:57485
Mus81^tm1Esse/Mus81⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased inflammatory response	J:222498
Mus81^tm1Esse/Mus81^tm1Esse (involves: 129P2/OlaHsd * C57BL/6J)	increased interleukin-1 beta secretion	J:222498
	lung inflammation	J:222498
Mx1^r/Mx1^r (B6.A2G-Mx1^r)	abnormal susceptibility to infection	J:120938
Mx1^r/Mx1^r (B6.A2G-Mx1^r)	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:23752
Mx1^r/Mx1^r (C.A2G-Mx1^r)	decreased susceptibility to Orthomyxoviridae infection	J:23752
Mx1^r/Mx1^r (C.A2G-Mx1^r)	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:23752
Mx1^r/Mx1^r (A2G)	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:23752
Mx1^s1/Mx1^s1 (BALB/c)	increased susceptibility to Orthomyxoviridae infection	J:23752
Mx1^s1/Mx1^s1 (C57BL/6)	abnormal susceptibility to infection	J:120938
Mx1^s1/Mx1^s1 (C57BL/6)	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:23752
Mx1^s1/Mx1^s1 Tg(Hmgcr-MX1)LStae/? (involves: C57BL/6 * SJL)	decreased susceptibility to Orthomyxoviridae infection	J:128067
	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:128067
	decreased susceptibility to Riboviria infection	J:128067
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:128067
Mx1^s2/Mx1^s2 (CBA/J)	increased susceptibility to Orthomyxoviridae infection	J:23752
Mxd1^tm1Rne/Mxd1^tm1Rne (involves: 129S4/SvJaeSor * C57BL/6)	abnormal B cell physiology	J:45945
Mxi1^tm1Rdp/Mxi1^tm1Rdp (involves: 129/Sv * C57BL/6J * SJL)	increased T cell proliferation	J:48236
Mxra8^em1Diam/Mxra8⁺ (C57BL/6J-Mxra8^em1Diam)	decreased susceptibility to Togaviridae infection	J:280585
Mxra8^em1Diam/Mxra8^em1Diam (C57BL/6J-Mxra8^em1Diam)	abnormal cytokine level	J:280585
	decreased inflammatory response	J:280585
	decreased susceptibility to Togaviridae infection	J:280585
Mxra8^em2Diam/Mxra8^em2Diam (C57BL/6J-Mxra8^em2Diam)	decreased susceptibility to Togaviridae infection	J:280585
Mybl1^tm1Epr/Mybl1^tm1Epr (involves: 129 * C57BL/6)	abnormal humoral immune response	J:67604
	decreased IgG1 level	J:67604
	decreased IgG2a level	J:67604
	decreased IgG3 level	J:67604
Mybphl^{tm1a(KOMP)Wtsi}/Mybphl^{tm1a(KOMP)Wtsi} (C57BL/6N-Mybphl^{tm1a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Mybphl^{tm1b(KOMP)Wtsi}/Mybphl^{tm1b(KOMP)Wtsi} (C57BL/6N-Mybphl^{tm1b(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * FVB/N)	decreased T cell proliferation	J:73369
Myc^tm1Atp/Myc⁺ (B6.129P2-Myc^tm1Atp)	abnormal NK cell physiology	J:132730
Myc^tm1Atp/Myc⁺ (B6.129P2-Myc^tm1Atp)	decreased T cell proliferation	J:132730
Myc^tm1Atp/Myc^tm2.1Atp (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	decreased T cell proliferation	J:73369
Myc^tm1Lbox/Myc^tm1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	increased B cell apoptosis	J:97900
	increased B cell proliferation	J:97900
Myc^tm2.1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased T cell proliferation	J:73369
Myc^tm2Fwa/Myc^tm2Fwa Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased B cell proliferation	J:67222
Mycl^tm1.1Kmm/Mycl^tm1.1Kmm (B6.129S6(C)-Mycl^tm1.1Kmm)	abnormal dendritic cell physiology	J:206430
Mycl^tm1.1Kmm/Mycl^tm1.1Kmm (B6.129S6(C)-Mycl^tm1.1Kmm)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:206430
Myd88^lkd/Myd88^lkd (C57BL/6-Myd88^lkd)	abnormal adaptive immunity	J:110094
	abnormal cell-mediated immunity	J:110094
	abnormal innate immunity	J:110094
	abnormal macrophage physiology	J:110094
Myd88^M4Btlr/Myd88⁺ (C57BL/6J-Myd88^M4Btlr)	decreased tumor necrosis factor secretion	J:254917
Myd88^M4Btlr/Myd88^M4Btlr (C57BL/6J-Myd88^M4Btlr)	decreased tumor necrosis factor secretion	J:254917
Myd88^poc/Myd88^poc (C57BL/6-Myd88^poc)	abnormal immune system physiology	J:110094
	abnormal macrophage physiology	J:110094
	increased susceptibility to bacterial infection	J:110094
	increased susceptibility to Herpesvirales infection	J:110094
Myd88^tm1.1Defr/Myd88^tm1.1Defr (B6.129P2(SJL)-Myd88^tm1.1Defr)	abnormal CD4-positive, alpha-beta T cell physiology	J:224849
	abnormal macrophage physiology	J:224849
	abnormal microglial cell physiology	J:224849
	decreased interferon-gamma secretion	J:224849
	increased susceptibility to Coronaviridae infection	J:224849
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:224849
Myd88^tm1.1Medz/Myd88^tm1.1Medz Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:209373
	abnormal memory T cell physiology	J:209373
	abnormal T-helper 1 physiology	J:209373
	abnormal T-helper 17 cell physiology	J:209373
Myd88^tm1Aki/Myd88^tm1Aki (Not Specified)	abnormal cytokine secretion	J:89257, J:88906
	abnormal dendritic cell physiology	J:96773
	abnormal macrophage physiology	J:96773
	abnormal NK cell physiology	J:88906
	abnormal NK T cell physiology	J:88906
	abnormal T cell physiology	J:96773
	decreased B cell proliferation	J:96773
	increased susceptibility to Herpesvirales infection	J:88906
Myd88^tm1Aki/Myd88^tm1Aki (B6.129P2-Myd88^tm1Aki)	abnormal chemokine secretion	J:102879
	abnormal cytokine secretion	J:116670, J:162707
	abnormal dendritic cell physiology	J:116670, J:118954
	abnormal immune system physiology	J:121070
	abnormal innate immunity	J:162707
	abnormal macrophage physiology	J:116670
	abnormal NK cell physiology	J:139001
	abnormal response to infection	J:121070
	abnormal T cell physiology	J:97662
	bronchiolitis	J:162707
	decreased inflammatory response	J:123946
	decreased interferon-alpha secretion	J:97662
	decreased interferon-gamma secretion	J:116763, J:118954
	decreased interleukin-6 secretion	J:118954, J:121070
	decreased interleukin-12 secretion	J:116670
	decreased interleukin-12b secretion	J:116763, J:118954
	decreased susceptibility to parasitic infection	J:116763
	decreased tumor necrosis factor secretion	J:116670, J:116763, J:121070
	increased susceptibility to Coronaviridae infection	J:162707
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:162707
	increased susceptibility to Picornaviridae infection	J:97662
Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd)	abnormal cytokine level	J:174941
	abnormal cytokine secretion	J:167340
	abnormal dendritic cell physiology	J:174941, J:137522
	abnormal interferon level	J:137522
	abnormal macrophage physiology	J:174941
	abnormal neutrophil physiology	J:145345
	abnormal tumor necrosis factor level	J:103464, J:124334
	decreased circulating tumor necrosis factor level	J:139030
	decreased interferon-alpha secretion	J:144400
	decreased interferon-gamma secretion	J:210086
	decreased interleukin-6 secretion	J:167340
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:105435
	increased IgA level	J:210086
	increased IgE level	J:115059
	increased IgG1 level	J:115059
	increased susceptibility to bacterial infection	J:210086
	increased susceptibility to induced colitis	J:167340
	increased susceptibility to Picornaviridae infection	J:137522
Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine secretion	J:141143
	abnormal cytokine secretion	J:117688
	abnormal dendritic cell physiology	J:122394
	abnormal macrophage physiology	J:141143, J:117688
	decreased IgG2b level	J:137066
	decreased IgG3 level	J:137066
	decreased IgG level	J:137066
	decreased interleukin-1 beta secretion	J:124226
	decreased interleukin-6 secretion	J:147023
Myd88^tm1Aki/Myd88^tm1Aki (C.129P2-Myd88^tm1Aki)	decreased susceptibility to induced arthritis	J:178054
Myd88^tm1Aki/Myd88^tm1Aki (B6.129-Myd88^tm1Aki)	abnormal susceptibility to bacterial infection	J:189854
	decreased interleukin-6 secretion	J:189854
	decreased tumor necrosis factor secretion	J:189854
Myd88^tm1Aki/Myd88^tm1Aki Tank^tm1Aki/Tank^tm1Aki (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	increased anti-double stranded DNA antibody level	J:151757
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1⁺ (B6.129P2-Myd88^tm1Aki Ticam1^tm1Aki)	decreased macrophage cytokine production	J:140485
	decreased macrophage nitric oxide production	J:140485
	increased susceptibility to parasitic infection	J:140485
	increased susceptibility to parasitic infection induced morbidity/mortality	J:140485
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd)	abnormal dendritic cell physiology	J:174941
	abnormal macrophage physiology	J:174941
Myd88^tm1Aki/Myd88^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Myd88^tm1Aki Ticam1^tm1Aki)	decreased macrophage cytokine production	J:140485
	decreased macrophage nitric oxide production	J:140485
	increased susceptibility to parasitic infection	J:140485
	increased susceptibility to parasitic infection induced morbidity/mortality	J:140485
Myd88^tm1Aki/Myd88^tm1Aki Tnfaip3^tm1.1Gvl/Tnfaip3^tm1.1Gvl Tg(Vil1-cre)997Gum/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased susceptibility to induced colitis	J:163410
Myd88^tm1Aki/Myd88^tm1Aki Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	decreased circulating tumor necrosis factor level	J:139030
Myd88^tm1Defr/Myd88^tm1Defr Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal NK cell physiology	J:139001
Myd88^tm1Defr/Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz/0 (B6.Cg-Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz)	abnormal dendritic cell antigen presentation	J:139001
	abnormal dendritic cell physiology	J:139001
	abnormal NK cell physiology	J:139001
	decreased circulating interleukin-6 level	J:139001
	decreased circulating interleukin-12b level	J:139001
	decreased IgG1 level	J:139001
	decreased IgG2b level	J:139001
	decreased IgG2c level	J:139001
Myd88^tm1Hlz/Myd88^tm1Hlz (B6.129P2-Myd88^tm1Hlz)	abnormal chemokine level	J:188968
	decreased circulating interleukin-6 level	J:188968
	decreased circulating interleukin-10 level	J:188968
	decreased circulating interleukin-12b level	J:188968
	decreased interleukin-6 secretion	J:188968
	decreased interleukin-10 secretion	J:188968
	decreased tumor necrosis factor secretion	J:188968
Myd88^tm1Hlz/Myd88^tm1Hlz Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129P2-Myd88^tm1Hlz Lyz2^tm1(cre)Ifo)	abnormal circulating chemokine level	J:188968
	decreased CXCL10 level	J:188968
	increased circulating tumor necrosis factor level	J:188968
Mydgf^tm1Kcw/Mydgf^tm1Kcw (BALB/c-Mydgf^tm1Kcw)	decreased inflammatory response	J:216795
Myh4^arl/Myh4^arl (involves: C3H/HeH * C57BL/6J)	myositis	J:181892
Myh6^tm1Jse/Myh6⁺ Tg(Myh6-TNNI3G203S)1Chs/0 (involves: 129X1/SvJ C57BL/6)	liver inflammation	J:153302
	lung inflammation	J:153302
Myh9^{tm1.1(MYH9)Mjk}/Myh9⁺ (B6.Cg-Myh9^{tm1.1(MYH9)Mjk})	increased incidence of corneal inflammation	J:175367
Myh9^tm5Rsad/Myh9^tm5Rsad (involves: 129S6/SvEvTac * C57BL/6J)	abnormal leukocyte migration	J:164684
	abnormal T cell physiology	J:164684
Myh9^tm5Rsad/Myh9^tm5Rsad Tg(Lck-cre)#Nik/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:164684
	abnormal leukocyte adhesion	J:164684
	abnormal leukocyte migration	J:164684
	abnormal T cell physiology	J:164684
Myh10^tm7Rsad/Myh10^tm7Rsad Tg(Myh6-cre)2182Mds/0 (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	heart inflammation	J:170148
Myl3^{tm1a(EUCOMM)Hmgu}/Myl3^{tm1a(EUCOMM)Hmgu} Tg(Col2a1-cre)1Xya/0 (involves: C57BL/6J * C57BL/6N)	osteoarthritis	J:343166
Myl3^{tm1a(EUCOMM)Hmgu}/Myl3^{tm1a(EUCOMM)Hmgu} Tg(Col2a1-cre/ERT)KA3Smac/0 (involves: C57BL/6J * C57BL/6N * FVB/N)	increased susceptibility to induced arthritis	J:343166
Mylk^tm1Mzhu/Mylk^tm1Mzhu Tagln^{tm1(cre/ERT2)Feil}/? (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)	small intestinal inflammation	J:141907
Myo1d^em1Btlr/Myo1d^em1Btlr (C57BL/6J-Myo1d^em1Btlr)	increased susceptibility to colitis induced morbidity/mortality	J:267525
Myo1d^em1Btlr/Myo1d^em1Btlr (C57BL/6J-Myo1d^em1Btlr)	increased susceptibility to induced colitis	J:267525
Myo1d^m1Btlr/Myo1d^m1Btlr (C57BL/6J-Myo1d^m1Btlr)	increased susceptibility to induced colitis	J:267525
Myo1d^m1Btlr/Myo1d^m2Btlr (C57BL/6J-Myo1d^m1Btlr/Myo1d^m2Btlr)	increased susceptibility to induced colitis	J:267525
Myo1d^m2Btlr/Myo1d^m2Btlr (C57BL/6J-Myo1d^m2Btlr)	increased susceptibility to induced colitis	J:267525
Myo1d^m3Btlr/Myo1d^m3Btlr (C57BL/6J-Myo1d^m3Btlr)	increased susceptibility to induced colitis	J:267525
Myo1d^m4Btlr/Myo1d^m4Btlr (C57BL/6J-Myo1d^m4Btlr)	increased susceptibility to induced colitis	J:267525
Myo1f^tm1.1Flv/Myo1f^tm1.1Flv (involves: 129S6/SvEvTac)	impaired neutrophil chemotaxis	J:113020
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk (Not Specified)	abnormal B cell physiology	J:209304
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk (Not Specified)	decreased tumor necrosis factor secretion	J:209304
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk (involves: C57BL/6 * FVB/N * SJL)	abnormal T cell physiology	J:212451
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * FVB/N * SJL)	abnormal T cell physiology	J:212451
Myo9a^{tm1b(EUCOMM)Wtsi}/Myo9a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Myo9a^{tm1b(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Myo9b^tm1.2Bah/Myo9b^tm1.2Bah (B6.Cg-Myo9b^tm1.2Bah)	abnormal macrophage physiology	J:162326
Myo9b^tm1.2Bah/Myo9b^tm1.2Bah (B6.Cg-Myo9b^tm1.2Bah)	impaired macrophage chemotaxis	J:162326
mypy/mypy (C57BL/6J-mypy)	abnormal macrophage physiology	J:105543
	increased susceptibility to Herpesvirales infection	J:105543
	increased susceptibility to Riboviria infection	J:105543
Mysm1^{tm1a(KOMP)Wtsi}/Mysm1^{tm1a(KOMP)Wtsi} (Not Specified)	increased IgG2b level	J:165965
Mzb1^tm1.2Rug/Mzb1^tm1.2Rug (involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)	impaired humoral immune response	J:211639
N4bp1^em1Vmd/N4bp1^em1Vmd (C57BL/6N-N4bp1^em1Vmd)	decreased interleukin-6 secretion	J:297419
N4bp1^tm1.2Vmd/N4bp1^tm1.2Vmd (involves: C57BL/6)	abnormal macrophage physiology	J:297419
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:297419
	increased circulating interleukin-6 level	J:297419
	increased circulating tumor necrosis factor level	J:297419
	increased interleukin-6 secretion	J:297419
	increased tumor necrosis factor secretion	J:297419
	lung inflammation	J:297419
Nabp2^tm1.1Kkha/Nabp2^tm1.1Kkha Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	increased thymocyte apoptosis	J:195140
Naglu^tm1Efn/Naglu^tm1Efn (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to otitis media	J:129390
Naip5^Lgn1-s/Naip5^Lgn1-s (A/J)	increased susceptibility to bacterial infection	J:20633
Naip5^m1Btlr/Naip5^m1Btlr (C57BL/6J-Naip5^m1Btlr)	decreased interleukin-1 beta secretion	J:234250
Naip5^m2Btlr/Naip5⁺ (C57BL/6J-Naip5^m2Btlr)	decreased interleukin-1 beta secretion	J:234248
Naip5^m2Btlr/Naip5^m2Btlr (C57BL/6J-Naip5^m2Btlr)	decreased interleukin-1 beta secretion	J:234248
Naip5^tm1Vnce/Naip5^tm1Vnce (C57BL/6-Naip5^tm1Vnce)	decreased interleukin-1 beta secretion	J:141008
Naipc^tm1.1Kmma/Naipc^tm1.1Kmma (involves: BALB/cJ * C57BL/6)	decreased interleukin-1 beta secretion	J:222114
	decreased susceptibility to induced colitis	J:222114
Naipc^tm1Kmma/Naipc^tm1Kmma Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.Cg-Lyz2^tm1(cre)Ifo Naipc^tm1Kmma)	decreased susceptibility to induced colitis	J:222114
Naipc^tm1Kmma/Naipc^tm1Kmma Tg(Vil1-cre)997Gum/0 (B6.Cg-Naipc^tm1Kmma Tg(Vil1-cre)997Gum)	decreased susceptibility to induced colitis	J:222114
Nampt^{Gt(RRR084)Byg}/Nampt⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased interleukin-6 secretion	J:194883
Nba4^NZB/Nba4^NZB (involves: NZB * SWR)	glomerulonephritis	J:96060
	increased anti-double stranded DNA antibody level	J:96060
	increased anti-histone antibody level	J:96263
	increased anti-single stranded DNA antibody level	J:96060
	increased IgG3 level	J:96263
Nba4^NZB/Nba4^SWR (involves: NZB * SWR)	increased anti-histone antibody level	J:96263
Nba4^NZB/Nba4^SWR (involves: NZB * SWR)	increased IgG3 level	J:96263
Nba5^NZB/Nba5^NZB (C57BL/6-Nba5 Yaa)	glomerulonephritis	J:95829
Nba5^NZB/Nba5^NZB (C57BL/6-Nba5 Yaa)	increased susceptibility to type III hypersensitivity reaction	J:95829
Nba8^NZB/Nba8^NZB (involves: NZB * SWR)	glomerulonephritis	J:73097
Nba10^NZB/? (involves: C57BL/6 * NZB * SB/Le)	glomerulonephritis	J:95829
	increased anti-chromatin antibody level	J:95829
	increased anti-double stranded DNA antibody level	J:95829
	increased susceptibility to type III hypersensitivity reaction	J:95829
Nba10^NZB/Nba10^NZB Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J * NZB)	glomerulonephritis	J:134128
	increased anti-chromatin antibody level	J:134128
	increased anti-double stranded DNA antibody level	J:134128
	increased IgG level	J:134128
	increased IgM level	J:134128
	increased susceptibility to systemic lupus erythematosus	J:134128
Nba10^NZB/Nba10^NZB Tlr7^tm1Aki/Y X/Yaa (B6.Cg-Nba10^NZB Tlr7^tm1Aki Yaa)	abnormal immune serum protein physiology	J:137656
	glomerulonephritis	J:137656
	increased anti-chromatin antibody level	J:137656
Nba10^NZB/Nba10^NZB X/Yaa (C57BL/6-Nba2 Yaa)	abnormal immune serum protein physiology	J:137656
	glomerulonephritis	J:95829, J:137656
	increased anti-chromatin antibody level	J:137656
	increased anti-nuclear antigen antibody level	J:95829
	increased autoantibody level	J:137656
	increased susceptibility to autoimmune disorder	J:95829
	increased susceptibility to type III hypersensitivity reaction	J:95829
Nba11^NZB/Nba11^NZB (involves: NZB * SWR)	glomerulonephritis	J:96263
Nba11^NZB/Nba11^SWR (involves: NZB * SWR)	glomerulonephritis	J:96263
Nba12^NZB/Nba12^NZB (involves: NZB * SWR)	increased anti-double stranded DNA antibody level	J:96263
Nba12^NZB/Nba12^SWR (involves: NZB * SWR)	increased anti-double stranded DNA antibody level	J:96263
Nbeal2^{tm1a(EUCOMM)Wtsi}/Nbeal2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Nbeal2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased inflammatory response	J:220801
Nbn^tm1Nus/Nbn^tm2Nus Tg(CD19-cre/ERT2)1Cgn/0 (Not Specified)	abnormal B cell physiology	J:96102
	decreased B cell proliferation	J:96102
	decreased IgG1 level	J:96102
	decreased IgG2a level	J:96102
	decreased IgG2b level	J:96102
	decreased IgG3 level	J:96102
	decreased IgG level	J:96102
Nbn^tm1Xu/Nbn^tm1Xu (Not Specified)	abnormal cell-mediated immunity	J:75272
Nbr1^tm1.1Jmos/Nbr1^tm1.1Jmos Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ * C57BL/6J)	decreased inflammatory response	J:165438
	decreased interferon-gamma secretion	J:165438
	decreased interleukin-4 secretion	J:165438
	decreased interleukin-5 secretion	J:165438
	decreased interleukin-13 secretion	J:165438
Nbr1^tm1Whca/Nbr1^tm1Whca (B6.129P2-Nbr1^tm1Whca)	abnormal osteoclast physiology	J:162412
Nbwa1^NZB/? (involves: BALB/c * NZB * NZW)	increased anti-chromatin antibody level	J:88464
	increased anti-double stranded DNA antibody level	J:88464
	increased anti-single stranded DNA antibody level	J:88464
	increased susceptibility to systemic lupus erythematosus	J:88464
Nbwa2^NZB/? (involves: BALB/c * NZB * NZW)	glomerulonephritis	J:88464
	increased IgG level	J:88464
	increased IgM level	J:88464
	increased susceptibility to systemic lupus erythematosus	J:88464
Nbwa2^NZW/? (involves: BALB/c * NZB * NZW)	increased anti-double stranded DNA antibody level	J:88464
Nbwa2^NZW/? (involves: BALB/c * NZB * NZW)	increased susceptibility to systemic lupus erythematosus	J:88464
Ncapd2^em1Cya/Ncapd2⁺ (C57BL/6N-Ncapd2^em1Cya)	decreased susceptibility to induced colitis	J:310248
Nceh1^tm1Ishi/Nceh1^tm1Ishi (B6.129S7-Nceh1^tm1Ishi)	abnormal macrophage physiology	J:152385
Ncf1^m1J/Ncf1^m1J (B6.Cg-Dock7^m +/+ Lepr^db/J)	abnormal macrophage physiology	J:83428
	decreased susceptibility to Orthomyxoviridae infection	J:145306
	impaired granulocyte bactericidal activity	J:83428
Ncf1^tm1Hbd/Ncf1^tm1Hbd (involves: 129)	abnormal neutrophil physiology	J:77597, J:74593
Ncf1^tm1Hbd/Ncf1^tm1Hbd (involves: 129)	granulomatous inflammation	J:74593
Ncf1^tm1Shl/Ncf1^tm1Shl (involves: 129S2/SvPas * C57BL/6J)	abnormal response to infection	J:28267
	increased acute inflammation	J:28267
	increased susceptibility to infection	J:28267
Ncf1^tm1Shl/Ncf1^tm1Shl (B6.129S2-Ncf1^tm1Shl)	abnormal inflammatory response	J:142617
Ncf1^tm1Shl/Ncf1^tm1Shl (B6.129S2-Ncf1^tm1Shl)	granulomatous inflammation	J:111142
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2⁺ (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	increased anti-double stranded DNA antibody level	J:260777
	increased susceptibility to systemic lupus erythematosus	J:260777
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2^{tm1b(EUCOMM)Wtsi} (B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	increased susceptibility to fungal infection	J:260777
	lung inflammation	J:260777
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2^{tm1b(EUCOMM)Wtsi} (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	increased anti-double stranded DNA antibody level	J:260777
	increased susceptibility to systemic lupus erythematosus	J:260777
Ncf4^tm1Pth/Ncf4^tm2Pth (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:119217
Ncf4^tm1Pth/Ncf4^tm2Pth (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:119217
Ncf4^tm2Pth/Ncf4^tm2Pth (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:121820
Ncf4^tm2Pth/Ncf4^tm2Pth (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to bacterial infection	J:121820
Nckap1l^m1Iri/Nckap1l^m1Iri (involves: C57BL/6)	decreased T cell proliferation	J:141377
	heart inflammation	J:141377
	impaired macrophage phagocytosis	J:141377
	impaired neutrophil chemotaxis	J:141377
	impaired neutrophil phagocytosis	J:141377
	increased circulating interleukin-6 level	J:141377
	increased circulating interleukin-17 level	J:141377
	increased interleukin-6 secretion	J:141377
	increased interleukin-17 secretion	J:141377
	increased tumor necrosis factor secretion	J:141377
	liver inflammation	J:141377
	lung inflammation	J:141377
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6J)	decreased splenocyte apoptosis	J:109522
	increased B cell proliferation	J:109522
	increased T cell proliferation	J:109522
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6)	decreased interleukin-1 beta secretion	J:120086
	increased circulating interleukin-1 beta level	J:120086
	increased circulating interleukin-6 level	J:120086
	increased circulating tumor necrosis factor level	J:120086
	increased interleukin-6 secretion	J:120086
	increased susceptibility to bacterial infection induced morbidity/mortality	J:120086
	increased susceptibility to endotoxin shock	J:120086
	increased tumor necrosis factor secretion	J:120086
Ncoa5^tm1Hxia/Ncoa5⁺ (involves: 129 * C57BL/6)	chronic liver inflammation	J:207622
Ncr1^m1J/Ncr1^m1J Pepc^b/Pepc^b Ptprc^a/Ptprc^a (B6.SJL-Ptprc^a Pepc^b/BoyJ)	abnormal interferon level	J:257226
	abnormal NK cell physiology	J:257226
	abnormal susceptibility to infection induced morbidity/mortality	J:257226
	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:257226
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:257226
Ncr1^noe/Ncr1^noe (involves: C57BL/6J)	abnormal NK cell physiology	J:179728
	decreased susceptibility to Herpesvirales infection	J:179728
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:179728
	increased susceptibility to bacterial infection	J:179728
Ncr1^{tm1.1(icre)Viv}/Ncr1^{tm1.1(icre)Viv} (involves: C57BL/6)	abnormal NK cell physiology	J:179728
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:179728
	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:179728
Ncr1^tm1Oman/Ncr1^tm1Oman (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:112394
Ncr1^tm1Oman/Ncr1^tm1Oman (involves: 129S1/Sv * 129X1/SvJ)	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:112394
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0 (involves: 129)	abnormal splenocyte physiology	J:196407
Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell physiology	J:116617
	abnormal T-helper 2 physiology	J:116617
	dermatitis	J:116617
	increased inflammatory response	J:116617
	increased T cell proliferation	J:116617
	lung inflammation	J:116617
Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:205692
	increased interleukin-2 secretion	J:205692
	increased T cell proliferation	J:205692
Ndfip1^tm1.1Pmo/Ndfip1^tm1.1Pmo Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	esophageal inflammation	J:205692
	skin inflammation	J:205692
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rnpc3^{tm1c(EUCOMM)Wtsi}/Rnpc3^{tm1c(EUCOMM)Wtsi} (involves: 129S/SvEv * C57BL/6 * C57BL/6N)	esophageal inflammation	J:267519
	small intestinal inflammation	J:267519
Ndrg2^tm1.1Hori/Ndrg2^tm1.1Hori (B6.129-Ndrg2^tm1.1Hori)	abnormal microglial cell chemotaxis	J:214686
	decreased inflammatory response	J:214686
	decreased interleukin-6 secretion	J:214686
Ndst1^tm1Je/Ndst1^tm1Je Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal leukocyte adhesion	J:100456
	abnormal leukocyte migration	J:100456
	decreased inflammatory response	J:100456
	impaired leukocyte tethering or rolling	J:100456
Ndst2^tm1Lkj/Ndst2^tm1Lkj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased mast cell degranulation	J:57121
Ndst2^tm1Rls/Ndst2^tm1Rls (Not Specified)	abnormal response to infection	J:57120
Ndst2^tm1Rls/Ndst2^tm1Rls (Not Specified)	decreased mast cell degranulation	J:57120
Ndst2^tm1Rls/Ndst2^tm1Rls (B6.Cg-Ndst2^tm1Rls)	decreased susceptibility to induced arthritis	J:142880
Nedd4^Gt(XA209)Byg/Nedd4^Gt(XA209)Byg (involves: 129P2/OlaHsd)	abnormal T cell activation	J:143560
	decreased IgG1 level	J:143560
	decreased IgG2b level	J:143560
	decreased IgG3 level	J:143560
	decreased interleukin-2 secretion	J:143560
	decreased T cell proliferation	J:143560
	increased IgM level	J:143560
Nedd4^Gt(XB398)Byg/Nedd4^Gt(XB398)Byg (involves: 129P2/OlaHsd)	decreased IgG1 level	J:143560
	decreased IgG2b level	J:143560
	decreased IgG3 level	J:143560
	decreased interleukin-2 secretion	J:143560
	decreased T cell proliferation	J:143560
	increased IgM level	J:143560
Nedd4l^tm1.1Hkb/Nedd4l^tm1.1Hkb Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	lung inflammation	J:169296
Nedd4l^tm1Shkr/Nedd4l^tm1Shkr (involves: C57BL/6 * C57BL/6J)	lung inflammation	J:205657
Nedd4l^tm1Shkr/Nedd4l^tm1Shkr (involves: 129 * C57BL/6 * C57BL/6J)	lung inflammation	J:205657
Nedd9^m1Btlr/Nedd9^m1Btlr (C57BL/6J-Nedd9^m1Btlr)	increased susceptibility to Herpesvirales infection	J:267702
Nedd9^tm1Miku/Nedd9^tm1Miku (B6.CBA-Nedd9^tm1Miku)	abnormal follicular B cell physiology	J:116716
	abnormal leukocyte migration	J:116716
	abnormal T cell physiology	J:116716
Neil1^tm1Rsld/Neil1^tm1Rsld (involves: 129S1/Sv * C57BL/6)	joint inflammation	J:106077
Neil2^tm1.1Tkhz/Neil2^tm1.1Tkhz (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)	lung inflammation	J:225791
Neil3^tm1Bjor/Neil3^tm1Bjor (involves: 129 * C57BL/6)	decreased microglial cell activation	J:180177
Nek7^M1Btlr/Nek7⁺ (C57BL/6J-Nek7^M1Btlr)	abnormal macrophage physiology	J:226677
	decreased inflammatory response	J:226677
	decreased interleukin-1 beta secretion	J:226677
	decreased interleukin-18 secretion	J:226677
Nek7^M1Btlr/Nek7^M1Btlr (C57BL/6J-Nek7^M1Btlr)	abnormal macrophage physiology	J:226677
	decreased inflammatory response	J:226677
	decreased interleukin-1 beta secretion	J:226677
	decreased interleukin-18 secretion	J:226677
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:226677
Nek8^m1Btlr/Nek8^m1Btlr (C57BL/6J-Nek8^m1Btlr)	increased susceptibility to induced colitis	J:267544
Nf1^tm1.1Kest/Nf1^{tm1c(KOMP)Wtsi} Tg(Dhh-cre)1Mejr/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)	dermatitis	J:234172
Nf1^{tm1c(KOMP)Wtsi}/Nf1^{tm1c(KOMP)Wtsi} Tg(Dhh-cre)1Mejr/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * FVB/N)	dermatitis	J:234172
Nf1^tm1Tyj/Nf1⁺ (involves: 129S2/SvPas)	abnormal mast cell physiology	J:142439
Nf1^tm1Tyj/Nf1⁺ (involves: 129S2/SvPas)	increased mast cell degranulation	J:142439
Nf1^tm1Tyj/Nf1⁺ Pak1^tm1Cher/Pak1^tm1Cher (involves: 129S2/SvPas * C57BL/6)	abnormal mast cell physiology	J:142439
Nf2^tm1Gth/Nf2^tm2Gth Tg(Mpz-cre)2Brn/0 (involves: 129P2/OlaHsd * FVB/N)	increased susceptibility to otitis media	J:63264
Nf2^tm2Gth/Nf2^tm2Gth Tg(Mpz-cre)1Brn/0 (involves: 129P2/OlaHsd * FVB/N)	increased susceptibility to otitis media	J:63264
Nf2^tm2Gth/Nf2^tm2Gth Tg(Mpz-cre)2Brn/0 (involves: 129P2/OlaHsd * FVB/N)	increased susceptibility to otitis media	J:63264
Nfat5^tm1.1Joar/Nfat5^tm1.1Joar Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal T cell physiology	J:148271
Nfat5^tm1Rao/Nfat5^tm1Rao (B6.129-Nfat5^tm1Rao)	tubulointerstitial nephritis	J:88636
Nfat5^tm1Snh/Nfat5⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immunoglobulin level	J:91482
	decreased IgG level	J:91482
	decreased T cell proliferation	J:91482
Nfatc1^tm1Glm/Nfatc1^tm2Glm (chimera involves: 129S2/SvPas)	abnormal B cell physiology	J:78376
	abnormal immune system physiology	J:78376
	abnormal immunoglobulin level	J:78376
	abnormal interferon-gamma secretion	J:78376
	abnormal interleukin-2 secretion	J:78376
	abnormal lymphocyte physiology	J:78376
	abnormal T cell physiology	J:78376
	abnormal T-helper 2 physiology	J:78376
	decreased IgE level	J:78376
	decreased IgG1 level	J:78376
	decreased IgG2b level	J:78376
	decreased IgG3 level	J:78376
	decreased immunoglobulin level	J:78376
	decreased interleukin-4 secretion	J:78376
	increased IgA level	J:78376
	increased IgG2a level	J:78376
	increased IgM level	J:78376
	increased immunoglobulin level	J:78376
Nfatc1^tm1Rao/Nfatc1^tm1Rao Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	abnormal B cell physiology	J:177319
	abnormal class switch recombination	J:177319
	abnormal marginal zone B cell physiology	J:177319
	decreased B cell proliferation	J:177319
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:177319
	increased B cell apoptosis	J:177319
Nfatc1^tm1Rao/Nfatc1^tm1Rao Nfatc2^tm1Rao/Nfatc2^tm1Rao Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	abnormal B cell physiology	J:177319
	decreased interleukin-2 secretion	J:177319
Nfatc1^tm1Rao/Nfatc1^tm1Rao Tg(Fcer2a-cre)5Mbu/0 (involves: C57BL/6 * CBA)	abnormal B cell physiology	J:177319
	abnormal class switch recombination	J:177319
	decreased B cell proliferation	J:177319
	decreased IgG2a level	J:177319
	decreased IgG3 level	J:177319
	decreased IgM level	J:177319
	decreased interleukin-2 secretion	J:177319
	increased IgM level	J:177319
	increased interleukin-10 secretion	J:177319
Nfatc1^tm3Glm/Nfatc1^tm3Glm Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	liver inflammation	J:144598
	lung inflammation	J:144598
	lymph node inflammation	J:144598
	stomach inflammation	J:144598
Nfatc2^tm1Glm/Nfatc2^tm1Glm Nfatc3^{tm1c(EUCOMM)Hmgu}/Nfatc3^{tm1c(EUCOMM)Hmgu} Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6N * CBA)	decreased interleukin-2 secretion	J:346703
Nfatc2^tm1Glm/Nfatc2^tm1Glm Nfatc3^tm1Glm/Nfatc3^tm1Glm (involves: 129S2/SvPas)	blepharitis	J:51339
	increased inflammatory response	J:51339
	interstitial pneumonia	J:51339
Nfatc2^tm1Rao/Nfatc2^tm1Rao (B6.Cg-Nfatc2^tm1Rao)	abnormal mast cell physiology	J:78089
	decreased interleukin-4 secretion	J:78089
	decreased interleukin-13 secretion	J:78089
	decreased tumor necrosis factor secretion	J:78089
Nfatc2^tm1Rao/Nfatc2^tm1Rao Nfatc3^tm1Grc/Nfatc3^tm1Grc Tg(Lck-cre)I57Jxm/0 (involves: ICR)	increased T cell apoptosis	J:141917
Nfatc2^tm1Srf/Nfatc2^tm1Srf (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:110686
	abnormal lymphocyte physiology	J:110686
	abnormal T cell physiology	J:110686
	abnormal thymus involution	J:110686
Nfatc2^tm1Srf/Nfatc2^tm1Srf (involves: 129P2/OlaHsd)	abnormal immune system physiology	J:45252
	abnormal interleukin secretion	J:45252
	abnormal T cell physiology	J:45252
Nfatc2^tm1Srf/Nfatc2^tm1Srf (B6.Cg-Nfatc2^tm1Srf)	abnormal CD4-positive, alpha-beta T cell physiology	J:86279
	abnormal T-helper 1 physiology	J:86279
	abnormal T-helper 2 physiology	J:86279
	decreased interferon-gamma secretion	J:86279
	increased IgE level	J:86279
	increased IgG1 level	J:86279
	increased immunoglobulin level	J:86279
	increased interleukin-4 secretion	J:86279
	increased interleukin-5 secretion	J:86279
Nfatc2ip^tm1.1Glm/Nfatc2ip^tm1.1Glm (either: B6.129-Nfatc2ip^tm1.1Glm or C.129-Nfatc2ip^tm1.1Glm)	abnormal interleukin secretion	J:157559
	abnormal T-helper 2 physiology	J:157559
	decreased circulating interleukin-4 level	J:157559
	decreased interferon-gamma secretion	J:157559
	decreased interleukin-3 secretion	J:157559
	decreased interleukin-4 secretion	J:157559
	decreased interleukin-5 secretion	J:157559
	decreased interleukin-13 secretion	J:157559
	increased susceptibility to parasitic infection	J:157559
Nfatc3^tm1Grc/Nfatc3^tm1Grc Tg(Lck-cre)I57Jxm/0 (involves: ICR)	increased T cell apoptosis	J:141917
Nfe2^tm1Sho/Nfe2⁺ (C.129S4-Nfe2^tm1Sho)	increased susceptibility to Retroviridae infection	J:125982
Nfe2l1^tm1Jefc/Nfe2l1^tm1Ywk Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129X1/SvJ * C57BL/6J)	liver inflammation	J:97188
Nfe2l2^tm1.1Sred/Nfe2l2^tm1.1Sred Tg(Scgb1a1-cre)1Grau/0 (involves: C57BL/6 * C57BL/6J)	decreased interleukin-1 beta secretion	J:191916
	decreased tumor necrosis factor secretion	J:191916
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * ICR)	abnormal macrophage physiology	J:118068
	glomerulonephritis	J:104016
	increased anti-double stranded DNA antibody level	J:104016
	increased anti-nuclear antigen antibody level	J:104016
	increased IgG level	J:104016
	increased IgM level	J:104016
	lung inflammation	J:118068
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to induced colitis	J:116676
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * CD-1)	increased acute inflammation	J:122813
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:150597
	increased circulating interleukin-6 level	J:136120
	increased circulating tumor necrosis factor level	J:136120
	increased susceptibility to experimental autoimmune uveoretinitis	J:150597
	liver inflammation	J:136120
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (involves: 129X1/SvJ)	abnormal spleen physiology	J:91407
	abnormal splenocyte physiology	J:91407
	decreased circulating interleukin-1 beta level	J:100106
	increased circulating interleukin-1 beta level	J:100106
	increased splenocyte apoptosis	J:91407
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (B6.129X1-Nfe2l2^tm1Ywk/J)	abnormal neutrophil physiology	J:233699
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (B6.129X1-Nfe2l2^tm1Ywk)	increased anti-double stranded DNA antibody level	J:165602
Nfil3^tm1.1Brad/Nfil3^tm1.1Brad (B6.Cg-Nfil3^tm1.1Brad)	decreased interferon-gamma secretion	J:152774
Nfil3^tm1.1Brad/Nfil3^tm1.1Brad (B6.Cg-Nfil3^tm1.1Brad)	impaired natural killer cell mediated cytotoxicity	J:152774
Nfil3^tm1.1Kubo/Nfil3^tm1.1Kubo (B6.Cg-Nfil3^tm1.1Kubo)	abnormal interleukin secretion	J:184570
	decreased interleukin-9 secretion	J:184570
	decreased interleukin-10 secretion	J:172134, J:184570
	decreased interleukin-13 secretion	J:172134, J:184570
	decreased interleukin-17 secretion	J:184570
	increased susceptibility to experimental autoimmune encephalomyelitis	J:172134
	increased susceptibility to induced colitis	J:172134
Nfil3^tm1Look/Nfil3^tm1Look (B6.129X1-Nfil3^tm1Look)	decreased interferon-gamma secretion	J:155677
Nfil3^tm1Look/Nfil3^tm1Look (B6.129X1-Nfil3^tm1Look)	impaired natural killer cell mediated cytotoxicity	J:155677
Nfil3^tm1Pbro/Nfil3^tm1Pbro (involves: 129S6/SvEvTac * C57BL/6)	abnormal class switch recombination	J:156521
	decreased IgE level	J:156521
	decreased IgG1 level	J:156521
	decreased interleukin-4 secretion	J:156521
Nfil3^tm1Pbro/Nfil3^tm1Pbro (B6.129S6-Nfil3^tm1Pbro)	abnormal circulating cytokine level	J:209365
	abnormal cytokine secretion	J:209365
	colitis	J:209365
	increased circulating interferon-gamma level	J:209365
	increased circulating interleukin-10 level	J:209365
	increased circulating interleukin-12b level	J:209365
	increased circulating interleukin-17 level	J:209365
	increased circulating tumor necrosis factor level	J:209365
	increased interferon-gamma secretion	J:209365
	increased interleukin-10 secretion	J:209365
	increased interleukin-12b secretion	J:209365
	increased interleukin-17 secretion	J:209365
	increased macrophage cytokine production	J:209365
	increased tumor necrosis factor secretion	J:209365
Nfkb1^M1Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^M1Btlr)	decreased IgG level	J:216054
Nfkb1^M1Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^M1Btlr)	impaired humoral immune response	J:216054
Nfkb1^M1Btlr/Nfkb1^M1Btlr (C57BL/6J-Nfkb1^M1Btlr)	decreased IgG level	J:216054
Nfkb1^M1Btlr/Nfkb1^M1Btlr (C57BL/6J-Nfkb1^M1Btlr)	impaired humoral immune response	J:216054
Nfkb1^m2Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^m2Btlr)	abnormal humoral immune response	J:254822
Nfkb1^m2Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^m2Btlr)	decreased IgM level	J:254822
Nfkb1^m2Btlr/Nfkb1^m2Btlr (C57BL/6J-Nfkb1^m2Btlr)	abnormal humoral immune response	J:254822
	decreased IgE level	J:254822
	decreased IgG level	J:254822
	decreased IgM level	J:254822
Nfkb1^M3Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^M3Btlr)	abnormal humoral immune response	J:254821
	decreased IgE level	J:254821
	decreased IgG level	J:254821
Nfkb1^M3Btlr/Nfkb1^M3Btlr (C57BL/6J-Nfkb1^M3Btlr)	abnormal humoral immune response	J:254821
	decreased IgE level	J:254821
	decreased IgG level	J:254821
	increased susceptibility to induced colitis	J:254821
Nfkb1^M5Btlr/Nfkb1^M5Btlr (C57BL/6J-Nfkb1^M5Btlr)	decreased IgE level	J:272117
Nfkb1^M5Btlr/Nfkb1^M5Btlr (C57BL/6J-Nfkb1^M5Btlr)	decreased interleukin-1 beta secretion	J:272117
Nfkb1^M6Btlr/Nfkb1^M6Btlr (C57BL/6J-Nfkb1^M6Btlr)	decreased IgE level	J:272148
Nfkb1^{tm1a(KOMP)Wtsi}/Nfkb1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased IgA level	J:213427
	decreased IgG1 level	J:213427
	increased susceptibility to bacterial infection	J:213427
Nfkb1^tm1Bal/Nfkb1^tm1Bal (B6;129P-Nfkb1^tm1Bal/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:118907
	abnormal cytokine secretion	J:79107
	abnormal dendritic cell physiology	J:118907
	abnormal macrophage physiology	J:118907
	abnormal professional antigen presenting cell physiology	J:118907
	decreased susceptibility to autoimmune diabetes	J:118907
Nfkb1^tm1Bal/Nfkb1^tm1Bal (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:30268
	abnormal humoral immune response	J:37184
	cecum inflammation	J:67107
	decreased B cell proliferation	J:37184, J:30268
	decreased IgA level	J:37184
	decreased IgE level	J:37184
	decreased IgG1 level	J:37184
	decreased IgM level	J:30268
	decreased immunoglobulin level	J:37184
	decreased interleukin-6 secretion	J:37184
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:37184
	increased susceptibility to bacterial infection	J:37184, J:67107
	increased susceptibility to bacterial infection induced morbidity/mortality	J:37184
	large intestinal inflammation	J:67107
	peritoneal inflammation	J:67107
Nfkb1^tm1Bal/Nfkb1^tm1Bal (B6.Cg-Nfkb1^tm1Bal/J)	abnormal B cell physiology	J:113556
Nfkb1^tm1Bal/Nfkb1^tm1Bal Nfkb2^tm1Sbn/Nfkb2^tm1Sbn (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal macrophage physiology	J:45119
Nfkb1^tm1Bal/Nfkb1^tm1Bal Rel^tm1Grd/Rel^tm1Grd (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal immune system physiology	J:113514
	decreased interleukin-12 secretion	J:113514
Nfkb1^tm1Bal/Nfkb1^tm1Bal Rela^tm1Bal/Rela⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	cecum inflammation	J:67107
	increased susceptibility to bacterial infection	J:67107
	large intestinal inflammation	J:67107
	peritoneal inflammation	J:67107
Nfkb1^tm1Bal/Nfkb1^tm1Bal Tg(Tnfsf13b)1Fma/? (B6.Cg-Nfkb1^tm1Bal Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	abnormal class switch recombination	J:113556
Nfkb1^tm1Brv/Nfkb1^tm1Brv (involves: 129S1/Sv)	abnormal cytokine secretion	J:46912
	abnormal humoral immune response	J:46912
	abnormal inflammatory response	J:46912
	abnormal lymphocyte physiology	J:46912
	decreased IgG3 level	J:46912
	decreased interleukin-2 secretion	J:46912
	decreased interleukin-4 secretion	J:46912
	decreased T cell proliferation	J:46912
	decreased tumor necrosis factor secretion	J:46912
	increased B cell proliferation	J:46912
	increased IgE level	J:46912
	increased IgG1 level	J:46912
	increased immunoglobulin level	J:46912
	increased susceptibility to bacterial infection	J:46912
	liver inflammation	J:46912
	lung inflammation	J:46912
Nfkb1^tm1Brv/Nfkb1^tm1Brv Nfkb2^tm1Brv/Nfkb2^tm1Brv (involves: 129S1/Sv * C57BL/6)	abnormal cytokine secretion	J:44112
	decreased interleukin-6 secretion	J:44112
Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae * 129S8/SvEv)	decreased circulating interleukin-2 level	J:142340
	decreased T cell proliferation	J:142340
Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae)	decreased tumor necrosis factor secretion	J:196528
Nfkb2^Lym1/Nfkb2⁺ (BALB/c-Nfkb2^Lym1)	liver inflammation	J:154812
Nfkb2^Lym1/Nfkb2⁺ (BALB/c-Nfkb2^Lym1)	lung inflammation	J:154812
Nfkb2^Lym1/Nfkb2^Lym1 (involves: BALB/c)	abnormal class switch recombination	J:154812
	abnormal thymus physiology	J:154812
	autoimmune response	J:154812
	decreased B cell proliferation	J:154812
	decreased IgA level	J:154812
	decreased IgG1 level	J:154812
	decreased IgG2b level	J:154812
	decreased IgM level	J:154812
	decreased immunoglobulin level	J:154812
	liver inflammation	J:154812
	lung inflammation	J:154812
Nfkb2^tm1Brv/Nfkb2^tm1Brv (involves: 129S1/Sv * C57BL/6)	abnormal cytokine secretion	J:43469
	increased B cell proliferation	J:43469
	increased interleukin-2 secretion	J:43469
	increased interleukin-4 secretion	J:43469
	increased interleukin-10 secretion	J:43469
	increased T cell proliferation	J:43469
	increased tumor necrosis factor secretion	J:43469
Nfkb2^tm1Sbn/Nfkb2^tm1Sbn (involves: 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:45437
	abnormal immunoglobulin level	J:45437
	decreased IgA level	J:45437
	decreased IgG1 level	J:45437
	decreased IgG2a level	J:45437
	decreased IgG2b level	J:45437
	increased IgM level	J:45437
	increased susceptibility to parasitic infection	J:45437
Nfkb2^tm2Brv/Nfkb2^tm2Brv (involves: 129S1/Sv * C57BL/6)	decreased B cell proliferation	J:76380
	decreased IgA level	J:76380
	decreased IgG1 level	J:76380
	decreased IgG3 level	J:76380
	increased IgG2a level	J:76380
	increased IgM level	J:76380
	increased splenocyte apoptosis	J:76380
Nfkb2^tm2Brv/Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma/? (B6.Cg-Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
Nfkbia^tm1.1Pjc/Nfkbia^tm1.1Pjc (involves: C57BL/6)	abnormal circulating cytokine level	J:163686
	abnormal T cell activation	J:163686
	autoimmune response	J:163686
	chronic inflammation	J:163686
	increased anti-insulin autoantibody level	J:163686
	increased anti-nuclear antigen antibody level	J:163686
	increased circulating interleukin-1 alpha level	J:163686
	increased circulating interleukin-17 level	J:163686
	increased circulating tumor necrosis factor level	J:163686
	increased susceptibility to bacterial infection induced morbidity/mortality	J:163686
	increased T cell apoptosis	J:163686
	increased T cell proliferation	J:163686
Nfkbia^tm1.1Smiy/Nfkbia^tm1.1Smiy (B6.129-Nfkbia^tm1.1Smiy)	decreased B cell proliferation	J:168977
	decreased IgA level	J:168977
	decreased IgG1 level	J:168977
	decreased IgG2b level	J:168977
	increased activation-induced B cell apoptosis	J:168977
Nfkbia^tm1Bal/Nfkbia^tm1Bal Nfkbie^tm1Syme/Nfkbie^tm1Syme (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)	increased B cell apoptosis	J:88142
	increased T cell apoptosis	J:88142
Nfkbia^tm1Fey/Nfkbia^tm1Fey (involves: 129S6/SvEvTac * C57BL/6)	abnormal humoral immune response	J:110817
	decreased T cell proliferation	J:110817
	increased B cell proliferation	J:110817
	increased IgA level	J:110817
	increased IgE level	J:110817
	increased IgG level	J:110817
Nfkbia^tm1Stw/Nfkbia^tm1Stw (involves: 129S1/Sv)	abnormal macrophage physiology	J:32527
	abnormal tumor necrosis factor level	J:32527
	dermatitis	J:32527
Nfkbib^tm1.2Rsch/Nfkbib^tm1.2Rsch (B6.129P2-Nfkbib^tm1.2Rsch)	abnormal cytokine secretion	J:176877
	abnormal immune system physiology	J:176877
	abnormal interleukin-1 beta secretion	J:176877
	abnormal interleukin-6 secretion	J:176877
	abnormal tumor necrosis factor secretion	J:176877
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:176877
Nfkbib^tm1Bal/Nfkbib^tm1Bal (B6.129S1-Nfkbib^tm1Bal)	decreased circulating interleukin-1 beta level	J:163302
	decreased circulating interleukin-6 level	J:163302
	decreased circulating tumor necrosis factor level	J:163302
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:163302
	decreased susceptibility to endotoxin shock	J:163302
	decreased susceptibility to induced arthritis	J:163302
	decreased tumor necrosis factor secretion	J:163302
Nfkbid^m1Btlr/Nfkbid^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased B cell proliferation	J:185495
	decreased IgG1 level	J:185495
	decreased IgG3 level	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
	increased B cell apoptosis	J:185495
Nfkbid^{tm1a(EUCOMM)Wtsi}/Nfkbid^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal class switch recombination	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Nfkbid^tm1Clay/Nfkbid^tm1Clay (involves: 129S6/SvEvTac * C57BL/6)	abnormal NK cell physiology	J:132071
	abnormal thymocyte activation	J:132071
	decreased interferon-gamma secretion	J:132071
	decreased interleukin-2 secretion	J:132071
	decreased T cell proliferation	J:132071
Nfkbid^tm1Ktak/Nfkbid^tm1Ktak (involves: 129P2/OlaHsd * C57BL/6)	increased interferon-gamma secretion	J:113334
	increased interleukin-6 secretion	J:113334
	increased interleukin-12 secretion	J:113334
	increased interleukin-12b secretion	J:113334
	increased susceptibility to endotoxin shock	J:113334
	increased susceptibility to induced colitis	J:113334
Nfkbie^tm1Syme/Nfkbie^tm1Syme (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))	increased IgG1 level	J:88538
	increased IgM level	J:88538
Nfkbiz^tm1.1Muta/Nfkbiz^tm1.1Muta Tg(CAG-cre)13Miya/? (involves: C57BL/6)	dermatitis	J:194832
Nfkbiz^tm1.1Muta/Nfkbiz^tm1.1Muta Tg(KRT5-cre)1Tak/? (involves: C3H * C57BL/6)	dermatitis	J:194832
Nfkbiz^tm1Aki/Nfkbiz⁺ Stat6^tm1Aki/Stat6^tm1Aki (C.129P2-Stat6^tm1Aki Nfkbiz^tm1Aki)	skin inflammation	J:141704
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki (involves: 129P2/OlaHsd)	abnormal cytokine secretion	J:91297
	abnormal immune system physiology	J:194832
	abnormal leukocyte physiology	J:91297
	abnormal tumor necrosis factor secretion	J:91297
	blepharitis	J:96363
	conjunctivitis	J:96363
	corneal limbitis	J:96363
	decreased interleukin-6 secretion	J:91297
	decreased interleukin-12 secretion	J:91297
	dermatitis	J:194832, J:91297
	eye inflammation	J:96363
	increased immunoglobulin level	J:194832
	interstitial pneumonia	J:194832
	lacrimal gland inflammation	J:194832
	periocular dermatitis	J:194832
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki (C.129P2-Nfkbiz^tm1Aki)	blepharitis	J:141704
	conjunctivitis	J:141704
	dermatitis	J:141704
	eye inflammation	J:141704
	increased IgE level	J:141704
	perioral dermatitis	J:141704
	skin inflammation	J:141704
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki Stat6^tm1Aki/Stat6^tm1Aki (C.129P2-Stat6^tm1Aki Nfkbiz^tm1Aki)	blepharitis	J:141704
	dermatitis	J:141704
	eye inflammation	J:141704
	skin inflammation	J:141704
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki Tnf^tm1Sek/Tnf^tm1Sek (involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)	conjunctivitis	J:194832
	dermatitis	J:194832
Nfkbiz^tm1Mamo/Nfkbiz^tm1Mamo (involves: 129S7/SvEvBrd)	dermatitis	J:95040
Nfkbiz^tm1Mamo/Nfkbiz^tm1Mamo (involves: 129S7/SvEvBrd)	increased IgE level	J:95040
Ngfr^tm1Jae/Ngfr^tm1Jae (B6.129S4-Ngfr^tm1Jae)	increased susceptibility to experimental autoimmune encephalomyelitis	J:112769
Ngfr^tm1Jae/Ngfr^tm1Jae (involves: 129S4/SvJae)	abnormal tumor necrosis factor level	J:157549
Nhej1^tm1.1Ics/Nhej1^tm1.1Ics (involves: 129 * C57BL/6)	increased thymocyte apoptosis	J:194422
Nhej1^tm1.1Ics/Nhej1^tm1.1Ics Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	decreased thymocyte apoptosis	J:194422
Nhej1^tm1Fwa/Nhej1^tm1Fwa (involves: 129)	abnormal class switch recombination	J:138774
	decreased IgG1 level	J:138774
	decreased IgG3 level	J:138774
	increased IgM level	J:138774
Niban3^tm1Jyw/Niban3^tm1Jyw (B6.Cg-Niban3^tm1Jyw)	abnormal B cell physiology	J:282961
	abnormal class switch recombination	J:282961
	decreased IgA level	J:282961
	decreased IgG2c level	J:282961
	enhanced humoral immune response	J:282961
	increased B cell proliferation	J:282961
	increased IgG1 level	J:282961
	increased IgG3 level	J:282961
	increased IgG level	J:282961
	increased IgM level	J:282961
Nid2^{Gt(GST011)Byg}/Nid2^{Gt(GST011)Byg} (involves: 129P2/OlaHsd)	osteoarthritis	J:229684
Ninj1^tm1Gto/Ninj1⁺ (B6.129P2-Ninj1^tm1Gto)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:209516
Ninj1^tm1Gto/Ninj1^tm1Gto (B6.129P2-Ninj1^tm1Gto)	abnormal leukocyte adhesion	J:209516
	abnormal leukocyte physiology	J:209516
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:209516
	impaired macrophage chemotaxis	J:209516
Nipal3^tm1Pbfd/Nipal3^tm1Pbfd (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased IgM level	J:152829
	increased IgA level	J:152829
	increased IgE level	J:152829
	increased IgG2a level	J:152829
	increased IgM level	J:152829
Nipbl^{Gt(RRS564)Byg}/Nipbl⁺ (involves: 129P2/OlaHsd * CD-1)	abnormal inflammatory response	J:154117
	eye inflammation	J:154117
Nipbl^{Gt(RRS564)Byg}/Nipbl⁺ (involves: 129P2/OlaHsd * C57BL/6J * CD-1)	abnormal chemokine level	J:297059
Nisch^edsn/Nisch^edsn (C3H.B6-Nisch^edsn)	increased susceptibility to otitis media	J:244907
Nisch^edsn/Nisch^V33A (involves: BALB/c * C3H/HeH * C57BL/6J)	increased susceptibility to otitis media	J:244907
Nisch^V33A/Nisch^V33A (involves: BALB/c * C57BL/6J)	increased susceptibility to otitis media	J:244907
Nkg7^{tm1.1(KOMP)Vlcg}/Nkg7^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating interferon-gamma level	J:301637
	decreased circulating tumor necrosis factor level	J:301637
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:301637
	increased susceptibility to parasitic infection induced morbidity/mortality	J:301637
Nkx2-3^tm1Hha/Nkx2-3^tm1Hha (involves: 129S4/SvJae)	abnormal leukocyte migration	J:62129
Nkx2-3^tm1Rph/Nkx2-3^tm1Rph (involves: 129S1/Sv * C57BL/6)	abnormal leukocyte migration	J:64018
Nlrc3^tm1Bhk/Nlrc3^tm1Bhk (B6.129S6-Nlrc3^tm1Bhk)	increased circulating interleukin-6 level	J:187586
	increased circulating tumor necrosis factor level	J:187586
	increased susceptibility to endotoxin shock	J:187586
	increased tumor necrosis factor secretion	J:187586
Nlrc4^em1Vnce/Nlrc4^em1Vnce (C57BL/6-Nlrc4^em1Vnce)	decreased inflammatory response	J:294930
Nlrc4^em1Vnce/Nlrc4^em1Vnce (C57BL/6-Nlrc4^em1Vnce)	increased susceptibility to bacterial infection induced morbidity/mortality	J:294930
Nlrc4^em1Vnce/Nlrc4^em1Vnce Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (involves: C57BL/6J * C57BL/6N)	decreased inflammatory response	J:294930
Nlrc4^em2Vnce/Nlrc4^em2Vnce (C57BL/6-Nlrc4^em2Vnce)	decreased inflammatory response	J:294930
Nlrc4^em2Vnce/Nlrc4^em2Vnce Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (involves: C57BL/6J * C57BL/6N)	decreased inflammatory response	J:294930
Nlrc4^m1Btlr/Nlrc4⁺ (C57BL/6J-Nlrc4^m1Btlr)	decreased interleukin-1 beta secretion	J:225933
Nlrc4^m1Btlr/Nlrc4^m1Btlr (C57BL/6J-Nlrc4^m1Btlr)	decreased interleukin-1 beta secretion	J:225933
Nlrc4^tm1Gln/Nlrc4^tm1Gln Slc11a1^s/Slc11a1^s (B6.129S5-Nlrc4^tm1Gln)	increased susceptibility to bacterial infection	J:124378
Nlrc4^tm1Nnz/Nlrc4^tm1Nnz (involves: 129 * C57BL/6J)	abnormal macrophage physiology	J:112671, J:117251
Nlrc4^tm1Nnz/Nlrc4^tm1Nnz (involves: 129 * C57BL/6J)	increased susceptibility to bacterial infection	J:117251
Nlrc4^tm1Vmd/Nlrc4^tm1Vmd (C57BL/6N-Nlrc4^tm1Vmd)	decreased interleukin-1 beta secretion	J:91292
Nlrc4^tm1Vmd/Nlrc4^tm1Vmd (involves: C57BL/6N)	abnormal cytokine secretion	J:106976
Nlrc4^tm1Vmd/Nlrc4^tm1Vmd (involves: C57BL/6N)	abnormal response to infection	J:106976
Nlrc4^tm1Vmd/Nlrc4^tm1Vmd Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (C57BL/6-Nlrp3^tm1Vmd Nlrc4^tm1Vmd)	decreased interleukin-1 beta secretion	J:160545
Nlrc5^tm1.1Ggaur/Nlrc5^tm1.1Ggaur (involves: BALB/cJ)	abnormal T cell physiology	J:184076
Nlrc5^tm1Itl/Nlrc5^tm1Itl (C57BL/6-Nlrc5^tm1Itl)	decreased interferon-beta secretion	J:188857
Nlrc5^tm1Itl/Nlrc5^tm1Itl (C57BL/6-Nlrc5^tm1Itl)	decreased interleukin-6 secretion	J:188857
Nlrp1a^m1Btlr/Nlrp1a^m1Btlr (C57BL/6J-Nlrp1a^m1Btlr)	increased IgE level	J:265173
	increased macrophage apoptosis	J:265173
	increased tumor necrosis factor secretion	J:265173
Nlrp1a^m2Btlr/Nlrp1a^m2Btlr (C57BL/6J-Nlrp1a^m2Btlr)	decreased interleukin-1 beta secretion	J:265174
Nlrp1a^m2Btlr/Nlrp1a^m2Btlr (C57BL/6J-Nlrp1a^m2Btlr)	increased macrophage apoptosis	J:265174
Nlrp1a^Neut1/Nlrp1a⁺ (C.B6-Nlrp1a^Neut1)	increased inflammatory response	J:191055
	liver inflammation	J:191055
	lung inflammation	J:191055
	meningitis	J:191055
	myocarditis	J:191055
	pancreas inflammation	J:191055
Nlrp1a^Neut1/Nlrp1a^Neut1 (C.B6-Nlrp1a^Neut1)	increased inflammatory response	J:191055
	increased macrophage cytokine production	J:191055
	liver inflammation	J:191055
	lung inflammation	J:191055
	meningitis	J:191055
	myocarditis	J:191055
	pancreas inflammation	J:191055
Nlrp1a^Neut1/Nlrp1a^Neut1 Pycard^tm1Vmd/Pycard^tm1Vmd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:191055
Nlrp1b^tm1Bhk/Nlrp1b^tm1Bhk (129S6/SvEvTac-Nlrp1b^tm1Bhk)	abnormal macrophage physiology	J:189777
	decreased interleukin-1 alpha secretion	J:189777
	decreased interleukin-1 beta secretion	J:189777
Nlrp3^m1Btlr/Nlrp3^m1Btlr (C57BL/6J-Nlrp3^m1Btlr)	decreased interleukin-1 beta secretion	J:159357
Nlrp3^m2Btlr/? (C57BL/6J-Nlrp3^m2Btlr)	abnormal interleukin-1 beta secretion	J:164865
Nlrp3^m3Btlr/? (C57BL/6J-Nlrp3^m3Btlr)	abnormal interleukin-1 beta secretion	J:164866
Nlrp3^m4Btlr/Nlrp3^m4Btlr (involves: C57BL/6J)	decreased interleukin-1 beta secretion	J:171739
Nlrp3^m5Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^m5Btlr)	decreased interleukin-1 beta secretion	J:192651
Nlrp3^m5Btlr/Nlrp3^m5Btlr (C57BL/6J-Nlrp3^m5Btlr)	decreased interleukin-1 beta secretion	J:192651
Nlrp3^M6Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^M6Btlr)	decreased interleukin-1 beta secretion	J:216047
Nlrp3^M6Btlr/Nlrp3^M6Btlr (C57BL/6J-Nlrp3^M6Btlr)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:226677
Nlrp3^M7Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^M7Btlr)	abnormal macrophage cytokine production	J:216048
Nlrp3^M7Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^M7Btlr)	decreased interleukin-1 beta secretion	J:216048
Nlrp3^M7Btlr/Nlrp3^M7Btlr (C57BL/6J-Nlrp3^M7Btlr)	abnormal macrophage cytokine production	J:216048
Nlrp3^M7Btlr/Nlrp3^M7Btlr (C57BL/6J-Nlrp3^M7Btlr)	decreased interleukin-1 beta secretion	J:216048
Nlrp3^M8Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^M8Btlr)	decreased interleukin-1 beta secretion	J:217294
Nlrp3^M8Btlr/Nlrp3^M8Btlr (C57BL/6J-Nlrp3^M8Btlr)	decreased interleukin-1 beta secretion	J:217294
Nlrp3^M9Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^M9Btlr)	decreased interleukin-1 beta secretion	J:220071
Nlrp3^M9Btlr/Nlrp3^M9Btlr (C57BL/6J-Nlrp3^M9Btlr)	decreased interleukin-1 beta secretion	J:220071
Nlrp3^M10Btlr/Nlrp3⁺ (C57BL/6J-Nlrp3^M10Btlr)	decreased interleukin-1 beta secretion	J:234254
Nlrp3^M10Btlr/Nlrp3^M10Btlr (C57BL/6J-Nlrp3^M10Btlr)	decreased interleukin-1 beta secretion	J:234254
Nlrp3^M11Btlr/Nlrp3^M11Btlr (C57BL/6J-Nlrp3^M11Btlr)	decreased interleukin-1 beta secretion	J:255211
Nlrp3^m12Btlr/Nlrp3^m12Btlr (C57BL/6J-Nlrp3^m12Btlr)	decreased interleukin-1 beta secretion	J:272150
Nlrp3^tm1Bhk/Nlrp3^tm1Bhk (involves: 129S6/SvEvTac)	decreased interleukin-1 beta secretion	J:189777
Nlrp3^tm1Bhk/Nlrp3^tm1Bhk (B6.129S6-Nlrp3^tm1Bhk/J)	decreased interleukin-1 beta secretion	J:253629
Nlrp3^tm1Bhk/Nlrp3^tm1Bhk (B6.129S6-Nlrp3^tm1Bhk/J)	white adipose tissue inflammation	J:256504
Nlrp3^tm1Flv/Nlrp3^tm1Flv (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:113333
	decreased circulating interleukin-1 beta level	J:113333
	decreased circulating interleukin-18 level	J:113333
	decreased susceptibility to endotoxin shock	J:113333
	decreased susceptibility to type IV hypersensitivity reaction	J:113333
Nlrp3^tm1Flv/Nlrp3^tm1Flv (B6.129S5-Nlrp3^tm1Flv)	decreased interleukin-1 beta secretion	J:164725
Nlrp3^tm1Flv/Nlrp3^tm1Flv (involves: 129S5/SvEvBrd)	decreased susceptibility to induced colitis	J:173245
Nlrp3^tm1Flv/Nlrp3^tm1Flv Slc11a1^s/Slc11a1^s (B6.129S5-Nlrp3^tm1Flv)	increased susceptibility to bacterial infection	J:124378
Nlrp3^tm1Flv/Nlrp3^tm1Hhf Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	increased inflammatory response	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal circulating chemokine level	J:150054
	abnormal circulating cytokine level	J:150054
	increased circulating interleukin-1 beta level	J:150054
	increased circulating interleukin-6 level	J:150054
	increased circulating interleukin-18 level	J:150054
	increased circulating tumor necrosis factor level	J:150054
	increased inflammatory response	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Tg(CAG-cre/Esr1)5Amc/? (involves: 129/Sv C57BL/6 * CBA)	skin inflammation	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Tg(CAG-cre/Esr1)5Amc/? (involves: 129/Sv C57BL/6 * CBA)	abnormal dendritic cell antigen presentation	J:150054
	abnormal dendritic cell physiology	J:150054
	abnormal macrophage physiology	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Tg(Zp3-cre)3Mrt/? (involves: 129/Sv * FVB/N)	increased inflammatory response	J:150054
Nlrp3^tm1Tsc/Nlrp3^tm1Tsc (C57BL/6-Nlrp3^tm1Tsc)	decreased interleukin-1 beta secretion	J:124226
Nlrp3^tm1Tsc/Nlrp3^tm1Tsc (involves: C57BL/6)	decreased interleukin-1 beta secretion	J:172117
Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (involves: C57BL/6N)	abnormal cytokine secretion	J:106976
	abnormal response to infection	J:106976
	decreased susceptibility to endotoxin shock	J:106976
Nlrp3^tm1Vmd/Nlrp3^tm1Vmd (B6.B6N-Nlrp3^tm1Vmd)	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
	decreased interleukin-1 beta secretion	J:193522
	decreased susceptibility to endotoxin shock	J:193522
Nlrp3^tm1Wstr/Nlrp3⁺ (involves: C57BL/6)	abnormal dendritic cell physiology	J:150053
	abnormal macrophage physiology	J:150053
	chronic inflammation	J:150053
	dermatitis	J:150053
	increased anti-double stranded DNA antibody level	J:150053
	increased interleukin-1 beta secretion	J:150053
	increased interleukin-17 secretion	J:150053
	increased interleukin-18 secretion	J:150053
	increased susceptibility to type IV hypersensitivity reaction	J:150053
Nlrp3^tm2Hhf/Nlrp3⁺ Tg(CAG-cre/Esr1)5Amc/? (involves: 129/Sv C57BL/6 * CBA)	skin inflammation	J:150054
Nlrp3^tm2Hhf/Nlrp3⁺ Tg(CAG-cre/Esr1)5Amc/? (involves: 129/Sv C57BL/6 * CBA)	abnormal dendritic cell physiology	J:150054
	abnormal macrophage physiology	J:150054
Nlrp3^tm2Hhf/Nlrp3^tm2Hhf Vsig4^tm1Gne/Vsig4^tm1Gne (B6.Cg-Nlrp3^tm2Hhf Vsig4^tm1Gne)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:281762
Nlrp3^tm3.1Hhf/Nlrp3⁺ (involves: 129)	abnormal circulating chemokine level	J:202147
	decreased circulating interleukin-5 level	J:202147
	decreased circulating interleukin-12b level	J:202147
	increased circulating interleukin-1 beta level	J:202147
	increased circulating interleukin-3 level	J:202147
	increased circulating interleukin-4 level	J:202147
	increased circulating interleukin-6 level	J:202147
	increased circulating interleukin-9 level	J:202147
	increased circulating interleukin-13 level	J:202147
	increased circulating interleukin-18 level	J:202147
	increased circulating tumor necrosis factor level	J:202147
	increased inflammatory response	J:202147
	increased interferon-gamma secretion	J:202147
	increased interleukin-1 beta secretion	J:202147
	joint inflammation	J:202147
	meningitis	J:202147
	osteomyelitis	J:202147
Nlrp6^tm1Flv/Nlrp6^tm1Flv (B6.Cg-Nlrp6^tm1Flv)	decreased circulating interleukin-18 level	J:173245
	decreased interleukin-18 secretion	J:173245
	increased IgA level	J:173245
	increased IgG2c level	J:173245
	increased susceptibility to induced colitis	J:173245
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:243487
Nlrp6^tm1Macha/Nlrp6^tm1Macha (involves: 129S5/SvEvBrd * C57BL/6J)	increased susceptibility to induced colitis	J:173352
Nlrp9b^em1Flv/Nlrp9b^em1Flv (C57BL/6N-Nlrp9b^em1Flv)	increased susceptibility to Riboviria infection induced morbidity/mortality	J:243487
Nlrp10^tm1Seis/Nlrp10^tm1Seis (B6.Cg-Nlrp10^tm1Seis)	abnormal adaptive immunity	J:183989
	abnormal dendritic cell physiology	J:183989
	abnormal T-helper 2 physiology	J:183989
	decreased IgG1 level	J:183989
	decreased interferon-gamma secretion	J:183989
	decreased interleukin-17 secretion	J:183989
	decreased susceptibility to endotoxin shock	J:183989
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:183989
Nlrp12^tm1Jpyt/Nlrp12^tm1Jpyt (B6.Cg-Nlrp12^tm1Jpyt)	abnormal leukocyte migration	J:164725
	decreased susceptibility to type IV hypersensitivity reaction	J:164725
	impaired neutrophil chemotaxis	J:164725
Nlrp12^tm1Tdk/Nlrp12^tm1Tdk (B6.Cg-Nlrp12^tm1Tdk)	abnormal chemokine level	J:178951
	abnormal cytokine level	J:178951
	increased inflammatory response	J:178951
	increased susceptibility to induced colitis	J:178951
Nlrx1^tm1Jpyt/Nlrx1^tm1Jpyt (involves: C57BL/6 * C57BL/6J)	abnormal macrophage physiology	J:173995
	abnormal neutrophil physiology	J:173995
	increased circulating interleukin-6 level	J:173995
	increased interferon-beta secretion	J:173995
	increased interleukin-1 beta secretion	J:173995
	increased interleukin-6 secretion	J:173995
	increased susceptibility to endotoxin shock	J:173995
	increased susceptibility to Orthomyxoviridae infection	J:173995
Nme2^{Gt(69C10)Cmhd}/Nme2^{Gt(69C10)Cmhd} (B6.129-Nme2^{Gt(69C10)Cmhd})	abnormal CD4-positive, alpha-beta T cell physiology	J:167387
	abnormal T-helper 1 physiology	J:167387
	abnormal T-helper 2 physiology	J:167387
	decreased interferon-gamma secretion	J:167387
	decreased interleukin-2 secretion	J:167387
	decreased interleukin-13 secretion	J:167387
	decreased tumor necrosis factor secretion	J:167387
Nme5^tm1Lex/Nme5^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	maxillary sinus inflammation	J:185566
	nasal inflammation	J:185566
nmf370/nmf370 (C57BL/6J-nmf370/J)	ear inflammation	J:87349
nmf391/nmf391 (C57BL/6J-nmf391/J)	ear inflammation	J:87349
Nmi^em1Hhl/Nmi^em1Hhl (C57BL/6-Nmi^em1Hhl)	decreased circulating interleukin-6 level	J:298909
	decreased circulating tumor necrosis factor level	J:298909
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:298909
	decreased susceptibility to endotoxin shock	J:298909
Nmt1^tm1.1Poru/Nmt1^tm1.1Poru Nmt2^tm1.1Poru/Nmt2^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased circulating interferon-gamma level	J:226234
	decreased circulating interleukin-2 level	J:226234
	decreased circulating tumor necrosis factor level	J:226234
	decreased interferon-gamma secretion	J:226234
	decreased interleukin-2 secretion	J:226234
	decreased splenocyte proliferation	J:226234
	decreased susceptibility to endotoxin shock	J:226234
	decreased T cell proliferation	J:226234
	increased T cell apoptosis	J:226234
Nmu^tm1Sjab/Nmu^tm1Sjab (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-6 level	J:142907
Noa/Noa⁺ (NOA)	increased IgE level	J:43274
Noc2l^tm1.1Arte/Noc2l^tm1.1Arte Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal T cell proliferation	J:216490
	abnormal thymus involution	J:216490
	increased thymocyte apoptosis	J:216490
Nod1^tm1Inoh/Nod1^tm1Inoh (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine secretion	J:118808
	abnormal cytokine secretion	J:118808
	abnormal immune system physiology	J:118808
	abnormal macrophage physiology	J:132126, J:118808
	decreased interleukin-6 secretion	J:132126
	decreased tumor necrosis factor secretion	J:132126
Nod1^tm1Inoh/Nod1^tm1Inoh Nod2^tm1Flv/Nod2^tm1Flv (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:132126
	decreased interleukin-6 secretion	J:132126
	decreased tumor necrosis factor secretion	J:132126
	increased susceptibility to bacterial infection	J:132126
Nod2^tm1Daph/Nod2^tm1Daph (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:157879
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:132126, J:96035
	abnormal susceptibility to infection	J:96035
	decreased IgG level	J:96035
	decreased interleukin-6 secretion	J:132126
	decreased susceptibility to endotoxin shock	J:96035
	decreased tumor necrosis factor secretion	J:132126
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv)	abnormal response to infection	J:147177
	abnormal T-helper 1 physiology	J:147177
	impaired macrophage phagocytosis	J:147177
	impaired neutrophil phagocytosis	J:147177
	increased circulating interferon-gamma level	J:147177
	increased circulating interleukin-2 level	J:147177
	increased circulating tumor necrosis factor level	J:147177
	increased susceptibility to bacterial infection induced morbidity/mortality	J:147177
Nod2^tm1Flv/Nod2^tm1Flv (C.129S1-Nod2^tm1Flv)	decreased susceptibility to induced arthritis	J:178054
Nod2^tm1Jhgt/Nod2^tm1Jhgt (B6.Cg-Nod2^tm1Jhgt)	abnormal cytokine level	J:124575
	abnormal immune system physiology	J:124575
	abnormal interferon level	J:124575
	abnormal interleukin level	J:124575
	abnormal response to infection	J:124575
	abnormal tumor necrosis factor level	J:124575
	increased susceptibility to induced colitis	J:124575
Nod2^tm1Mka/Nod2^tm1Mka (involves: C57BL/6)	abnormal cytokine level	J:96128
	increased interleukin-1 beta secretion	J:96128
	increased susceptibility to induced colitis	J:96128
Nod2^tm1Pmu/Nod2^tm1Pmu (involves: BALB/c * C57BL/6)	abnormal macrophage physiology	J:86264
Nod2^tm1Pmu/Nod2^tm1Pmu (involves: BALB/c * C57BL/6)	decreased susceptibility to endotoxin shock	J:86264
Nod2^tm1Vmd/Nod2^tm1Vmd (B6.129-Nod2^tm1Vmd)	abnormal cytokine secretion	J:106976
Nos1^tm1Plh/Nos1^tm1Plh (involves: 129S4/SvJae)	abnormal leukocyte adhesion	J:55936
	abnormal neutrophil physiology	J:55936
	enhanced leukocyte tethering or rolling	J:55936
Nos1^tm1Plh/Nos1^tm1Plh (B6.129S4-Nos1^tm1Plh/J)	decreased inflammatory response	J:103018
Nos1^tm1Plh/Nos1^tm1Plh Nos2^tm1Mrl/Nos2^tm1Mrl Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal osteoclast physiology	J:150159
Nos2^tm1Lau/Nos2^tm1Lau (involves: 129P2/OlaHsd * C57BL/6)	abnormal adaptive immunity	J:90903
	increased susceptibility to bacterial infection	J:100513
	increased T cell proliferation	J:90903
	skin inflammation	J:64036
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau)	decreased susceptibility to induced colitis	J:87601
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau/J)	abnormal inflammatory response	J:103018
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau/J)	decreased inflammatory response	J:103018
Nos2^tm1Liew/Nos2^tm1Liew (involves: 129P2/Ola * MF1)	abnormal T-helper 1 physiology	J:25755
	decreased inflammatory response	J:25755
	decreased susceptibility to endotoxin shock	J:25755
	increased interferon-gamma secretion	J:25755
	increased susceptibility to parasitic infection	J:25755
	increased T cell proliferation	J:25755
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd)	abnormal immune system physiology	J:51635
	abnormal macrophage physiology	J:120499
	decreased susceptibility to endotoxin shock	J:25511
	increased IgG2a level	J:51635
	increased inflammatory response	J:51635
	increased interferon-gamma secretion	J:51635
	increased susceptibility to bacterial infection	J:25511
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd * C57BL/6)	increased length of allograft survival	J:54764
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd * C57BL/6)	pancreas inflammation	J:65562
Nos2^tm1Mrl/Nos2^tm1Mrl (B6.129S7-Nos2^tm1Mrl)	abnormal response to infection	J:98070
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd * PL/J)	increased susceptibility to experimental autoimmune encephalomyelitis	J:46192
Nos3^m1Btlr/Nos3^m1Btlr (C57BL/6J-Nos3^m1Btlr)	increased susceptibility to induced colitis	J:225268
Nos3^M2Btlr/Nos3^M2Btlr (C57BL/6J-Nos3^M2Btlr)	increased susceptibility to induced colitis	J:272392
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae)	abnormal leukocyte adhesion	J:55936
	abnormal neutrophil physiology	J:55936
	enhanced leukocyte tethering or rolling	J:55936
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to bacterial infection	J:105005
Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to bacterial infection induced morbidity/mortality	J:105005
Nos3^tm1Unc/Nos3^tm1Unc (B6.129P2-Nos3^tm1Unc/J)	abnormal osteoclast physiology	J:129477
	increased inflammatory response	J:103018
	kidney inflammation	J:148626
Notch1^tm1Agt/Notch1^tm1Agt Notch2^tm3Grid/Notch2^tm3Grid Tg(TcrAND)53Hed/? (involves: 129/Sv * 129S1/Sv * C57BL/6 * SJL)	abnormal humoral immune response	J:123631
	abnormal response to infection	J:123631
	decreased interleukin-4 secretion	J:123631
Notch1^tm1Con/Notch1⁺ (involves: 129S1/Sv * 129X1/SvJ * CD-1)	aortic valve inflammation	J:187551
Notch1^tm2Pst/Notch1^tm2Pst (B6.Cg-Notch1^tm2Pst)	increased T cell apoptosis	J:131563
Notch1^tm2Rko/Notch1^tm3(cre)Rko (involves: 129X1/SvJ * C57BL/6)	chronic liver inflammation	J:171829
Notch2^tm1.1Hhi/Notch2^tm1.1Hhi Tg(Cd8a-cre)1Itan/0 (involves: C57BL/6 * CBA)	abnormal CD8-positive, alpha-beta T cell physiology	J:141009
	abnormal cytotoxic T cell physiology	J:141009
	increased susceptibility to parasitic infection	J:141009
Notch2^tm1.1Hhtg/Notch2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal interleukin level	J:311038
	increased circulating interleukin-6 level	J:311038
	increased interleukin-6 secretion	J:311038
Notum^{Gt(OST172035)Lex}/Notum^{Gt(OST172035)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	chronic inflammation	J:274615
	periodontium inflammation	J:266040
Nox1^tm1.1Anrt/Nox1^tm1.1Anrt Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	colitis	J:194294
Nox1^tm1Cyn/Y (involves: 129S1/Sv * 129X1/SvJ)	abnormal cytokine secretion	J:218649
Nox4^tm1Syb/Nox4^tm1Syb (involves: 129S4/SvJae)	decreased interleukin-1 beta secretion	J:298830
	decreased susceptibility to endotoxin shock	J:298830
	decreased tumor necrosis factor secretion	J:298830
Npas3^tm1Mesu/Npas3^tm1Mesu (B6.129S6-Npas3^tm1Mesu)	bronchiectasis	J:150793
Npat^{tm1b(EUCOMM)Wtsi}/Npat^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Npat^{tm1b(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Npc1^m1N/Npc1^m1N (BALB/cNctr-Npc1^m1N/J)	nasal inflammation	J:209834
Npc1^m1N/Npc1^m1N (involves: BALB/c * C57BL/6 * CBA)	abnormal microglial cell physiology	J:144240
Npc1^m1N/Npc1^m1N (BALB/c-Npc1^m1N)	abnormal microglial cell activation	J:221855
Npc1^m1N/Npc1^m1N (BALB/c-Npc1^m1N)	increased microglial cell activation	J:221855
Npc1^m1N/Npc1^m1N Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * BALB/c)	abnormal cytokine secretion	J:118352
Npc1^nmf164/Npc1^nmf164 (C57BL/6J-Npc1^nmf164/J)	increased microglial cell activation	J:179744
Npc1^tm1.1Dso/Npc1^tm1.1Dso (B6.129-Npc1^tm1.1Dso)	abnormal microglial cell activation	J:221855
Npc1^tm1.1Dso/Npc1^tm1.1Dso (B6.129-Npc1^tm1.1Dso)	increased microglial cell activation	J:221855
Npc2^{Gt(LST105)Byg}/Npc2^{Gt(LST105)Byg} (B6.129P2-Npc2^{Gt(LST105)Byg})	abnormal immune system physiology	J:125609
Npc2^tm1Plob/Npc2^tm1Plob (C.129S1-Npc2^tm1Plob)	abnormal NK cell physiology	J:125609
Npc2^tm1Plob/Npc2^tm1Plob (C.129S1-Npc2^tm1Plob)	abnormal T cell physiology	J:125609
Npffr2^tm1.2Ics/Npffr2^tm1.2Ics (involves: C57BL/6N)	abnormal macrophage activation involved in immune response	J:245025
Npffr2^tm1.2Ics/Npffr2^tm1.2Ics (involves: C57BL/6N)	decreased macrophage proliferation	J:245025
Nphp3^pcy/Nphp3^pcy (KK-Nphp3^pcy)	kidney inflammation	J:8302
Nphp3^pcy/Nphp3^pcy (either: D2.KK-Nphp3^pcy or (involves: DBA/2Fg * DBA/2J * KK))	kidney inflammation	J:11399
Nphp3^pol/Nphp3^pol (C57BL/6JSfdAnu-Nphp3^pol/Anu)	kidney inflammation	J:104190
Npr1^tm1Gar/Npr1^tm1Gar (B6.129S7-Npr1^tm1Gar)	impaired neutrophil chemotaxis	J:70496
Npy1r^tm1.1Wpg/Npy1r^tm1.1Wpg (involves: 129X1/SvJ * C57BL/6)	abnormal immune cell physiology	J:118850
	abnormal immune system physiology	J:118850
	abnormal immunoglobulin level	J:118850
	abnormal inflammatory response	J:118850
	abnormal macrophage physiology	J:118850
	abnormal professional antigen presenting cell physiology	J:118850
	abnormal T cell activation	J:118850
	abnormal T-helper 1 physiology	J:118850
	decreased circulating interleukin-12 level	J:118850
	decreased circulating tumor necrosis factor level	J:118850
	decreased IgG2a level	J:118850
	decreased interferon-gamma secretion	J:118850
	decreased susceptibility to type IV hypersensitivity reaction	J:118850
	increased IgA level	J:118850
	increased IgG2b level	J:118850
	increased IgM level	J:118850
	increased immunoglobulin level	J:118850
Nr1h2^tm1.1Gstr/Nr1h2^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased microglial cell activation	J:278794
Nr1h2^tm1.1Gstr/Nr1h2^tm1.1Gstr Nr1h3^tm1.1Gstr/Nr1h3^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	lung inflammation	J:234268
Nr1h2^tm1Djm/Nr1h2^tm1Djm (involves: 129S6/SvEvTac * C57BL/6)	increased susceptibility to bacterial infection	J:81696
Nr1h2^tm1Djm/Nr1h2^tm1Djm Nr1h3^tm1Djm/Nr1h3^tm1Djm (involves: 129S6/SvEvTac * C57BL/6)	increased susceptibility to bacterial infection	J:81696
Nr1h3^tm1Djm/Nr1h3^tm1Djm (involves: 129S6/SvEvTac * C57BL/6)	increased inflammatory response	J:158168
	increased susceptibility to bacterial infection	J:81696
Nr1h3^tm1Wexi/Nr1h3^tm1Wexi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to endotoxin shock	J:155709
Nr1h4^tm1.1Mbj/Nr1h4^tm1.1Mbj (B6N.B6-Nr1h4^tm1.1Mbj)	liver inflammation	J:200842
Nr1h4^tm1Gonz/Nr1h4^tm1Gonz (involves: 129X1/SvJ * C57BL/6)	liver inflammation	J:118204
Nr2c2^tm1Amj/Nr2c2^tm1Amj (B6.129-Nr2c2^tm1Amj)	decreased inflammatory response	J:169333
Nr3c1^tm1.1Jaci/Nr3c1^tm1.1Jaci Tg(Myh6-cre)2182Mds/0 (involves: C57BL/6 * FVB/N)	heart inflammation	J:201995
Nr3c1^tm1.1Jda/Nr3c1⁺ Tg(Lck-cre)548Jxm/0 (B6.Cg-Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm)	decreased thymocyte apoptosis	J:189951
Nr3c1^tm1.1Jda/Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm/0 (B6.Cg-Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm)	abnormal humoral immune response	J:189951
	decreased thymocyte apoptosis	J:189951
Nr3c1^tm1Ljm/Nr3c1^tm1Ljm (involves: 129S6/SvEvTac * C57BL/6)	abnormal thymocyte apoptosis	J:82174
Nr3c1^tm2.1Gsc/Nr3c1⁺ (B6.129P2-Nr3c1^tm2.1Gsc)	decreased T cell apoptosis	J:126427
Nr3c1^tm2.1Gsc/Nr3c1⁺ (B6.129P2-Nr3c1^tm2.1Gsc)	increased susceptibility to experimental autoimmune encephalomyelitis	J:137157
Nr3c1^tm2.1Ljm/Nr3c1^tm2.1Ljm Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal interleukin-6 secretion	J:197150
	increased interleukin-1 beta secretion	J:197150
Nr3c1^tm2Gsc/Nr3c1^tm2Gsc Tg(Lck-cre)I57Jxm/0 (B6.Cg-Nr3c1^tm2Gsc Tg(Lck-cre)I57Jxm)	decreased T cell apoptosis	J:137157
	increased susceptibility to experimental autoimmune encephalomyelitis	J:137157
Nr3c1^tm2Ljm/Nr3c1^tm2Ljm Tg(Lck-cre)548Jxm/? (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal interferon level	J:97484
	abnormal interleukin level	J:97484
	abnormal tumor necrosis factor level	J:97484
	cecum inflammation	J:97484
	increased susceptibility to endotoxin shock	J:97484
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi (involves: 129S2/SvPas)	decreased B cell apoptosis	J:306652
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi (involves: 129S2/SvPas)	increased B cell proliferation	J:306652
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi (involves: 129S2/SvPas * C57BL/6)	increased susceptibility to endotoxin shock	J:239509
Nr4a1^tm1Pcn/Nr4a1^tm1Pcn Tg(Cr2-cre)3Cgn/0 (involves: 129)	increased B cell proliferation	J:306652
Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Tg(Lck-cre)1Jtak/0 (Not Specified)	increased susceptibility to induced colitis	J:205658
Nr5a2^tm1Auw/Nr5a2⁺ (involves: 129P2/OlaHsd)	increased susceptibility to induced colitis	J:123697
Nr5a2^tm1Sjns/Nr5a2^tm1Sjns Tg(Vil1-cre/ERT2)23Syr/? (involves: 129/Sv * C57BL/6 * DBA/2 * SJL)	increased susceptibility to induced colitis	J:123697
Nrp1^tm1Ddg/Nrp1^tm1Ddg (involves: 129P2/OlaHsd)	abnormal dendritic cell physiology	J:161856
Nrp1^tm1Ddg/Nrp1^tm1Ddg (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:161856
Nrp2^tm1.2Mom/Nrp2^tm1.2Mom (involves: 129P2/OlaHsd)	abnormal lymphatic system physiology	J:226501
Nrros^tm1Lex/Nrros^tm1Lex (B6.129S5-Nrros^tm1Lex)	decreased susceptibility to infection	J:209569
Nrros^tm1Lex/Nrros^tm1Lex (B6.129S5-Nrros^tm1Lex)	increased susceptibility to experimental autoimmune encephalomyelitis	J:209569
Nrtn^tm1Jmi/Nrtn^tm1Jmi (involves: 129X1/SvJ * C57BL/6)	increased incidence of corneal inflammation	J:85753
Nrtn^tm1Jmi/Nrtn^tm1Jmi (involves: 129X1/SvJ * C57BL/6)	keratoconjunctivitis sicca	J:85753
Nsmaf^tm1Mkr/Nsmaf^tm1Mkr (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:54972
Nsmaf^tm1Mkr/Nsmaf^tm1Mkr (B6.129P2-Nsmaf^tm1Mkr)	decreased susceptibility to endotoxin shock	J:89524
Nsmce2^tm2.1Ofc/Nsmce2^tm2.1Ofc Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * C57BL/6 * SJL)	abnormal thymus physiology	J:227197
Nsrp1^tm1.1Cdj/Nsrp1^tm1.1Cdj Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	increased T cell apoptosis	J:306261
	increased T cell proliferation	J:306261
Nss1^NOD/ShiLtJ/Nss1^NOD/ShiLtJ (involves: C57BL/10 * NOD)	salivary gland inflammation	J:73932
Nsv1^C57BL/6J/? (involves: BALB/cBy * C57BL/6J)	increased susceptibility to viral infection	J:71216
Ntan1^tm1Avar/Ntan1^tm1Avar (involves: 129)	abnormal T cell physiology	J:62140
	decreased splenocyte proliferation	J:62140
	increased acute inflammation	J:62140
Ntrk1^tm1Tes/Ntrk1^tm1Tes Tg(Tuba1-cre)1Tes/0 (involves: 129S1/Sv)	abnormal mast cell physiology	J:93578
	increased IgG1 level	J:93578
	increased IgG2a level	J:93578
	increased IgM level	J:93578
	increased immunoglobulin level	J:93578
Nucb2^tm1.2Vdix/Nucb2^tm1.2Vdix (involves: C57BL/6)	increased interleukin-1 beta secretion	J:270674
Nucb2^tm1.2Vdix/Nucb2^tm1.2Vdix (involves: C57BL/6)	increased tumor necrosis factor secretion	J:270674
Nudc^{tm1c(KOMP)Mbp}/Nudc^{tm1c(KOMP)Mbp} Tg(Rho-icre)1Ck/0 (involves: C57BL/6 * C57BL/6N * SJL)	increased microglial cell activation	J:346299
Nudt7^em1Ejj/Nudt7^em1Ejj (involves: C57BL/6N)	increased susceptibility to induced arthritis	J:266261
Nudt7^em1Ejj/Nudt7^em1Ejj (involves: C57BL/6N)	osteoarthritis	J:266261
Nudt21^tm1.1Ejwpj/Nudt21^tm1.1Ejwpj Tg(Col1a1-cre/ERT2)1Crm/0 (involves: C57BL/6J * CBA/J)	increased acute inflammation	J:283035
Nuggc^tm1Diaz/Nuggc^tm1Diaz Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: C57BL/6 * C57BL/6J * CBA)	abnormal somatic hypermutation frequency	J:190402
Nup98^tm1Bmaf/Nup98⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal level of surface class I molecules	J:110907
	abnormal level of surface class II molecules	J:110907
	abnormal MHC II cell surface expression on macrophages	J:110907
	decreased IgG1 level	J:110907
	decreased IgG level	J:110907
	decreased T cell proliferation	J:110907
	increased T cell proliferation	J:110907
Nup210^tm1.1Mdan/Nup210^tm1.1Mdan (B6.Cg-Nup210^tm1.1Mdan)	abnormal CD4-positive, alpha-beta T cell physiology	J:282451
Nup210^tm1.1Mdan/Nup210^tm1.1Mdan (B6.Cg-Nup210^tm1.1Mdan)	abnormal T cell activation	J:282451
Nup210^tm1Mdan/Nup210^tm1Mdan Tg(Cd4-cre/ERT2)11Gnri/0 (involves: 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:282451
Nwa2^NZW/LacJ/Nwa2^NZW/LacJ (involves: BALB/cJ * NZW/LacJ)	increased anti-histone antibody level	J:35434
Nwa2^NZW/LacJ/Nwa2^NZW/LacJ (involves: BALB/cJ * NZW/LacJ)	increased anti-single stranded DNA antibody level	J:35434
Oas1b^Flv-mr/Oas1b^Flv-mr (MOLD/RkJ)	decreased susceptibility to Flaviviridae infection	J:3674
Oas1b^Flv-r/Oas1b^Flv-r (multiple strains)	decreased susceptibility to Flaviviridae infection	J:15009
Oas1b^Flv-r/Oas1b^Flv-r (C3.PRI-Oas1b^Flv-r)	decreased susceptibility to Flaviviridae infection	J:175365
Oas1b^Flv-s/Oas1b^Flv-s (multiple strains)	increased susceptibility to Flaviviridae infection	J:15009
Oas1b^tm1.1Brin/Oas1b^tm1.1Brin (involves: 129X1/SvJ * C57BL/6J)	decreased susceptibility to Flaviviridae infection	J:175365
Oasl1^tm1Yjk/Oasl1^tm1Yjk (B6.129P2-Oasl1^tm1Yjk)	abnormal circulating interferon level	J:194467
	decreased susceptibility to Picornaviridae infection	J:194467
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:194467
Oca2^p-3Btlr/Oca2^p-3Btlr (C57BL/6J-Oca2^p-3Btlr)	abnormal NK cell physiology	J:133623
Oca2^p-3Btlr/Oca2^p-3Btlr (C57BL/6J-Oca2^p-3Btlr)	increased susceptibility to bacterial infection	J:133623
Oca2^p-4Btlr/Oca2^p-4Btlr (C57BL/6J-Oca2^p-4Btlr)	increased susceptibility to bacterial infection	J:133624
Oca2^p-8Btlr/Oca2^p-8Btlr (C57BL/6J-Oca2^p-8Btlr)	increased susceptibility to induced colitis	J:264643
Ocln^{Gt(ROSA)39Tshi}/Ocln^{Gt(ROSA)39Tshi} (involves: DBA/2)	stomach inflammation	J:110222
Ocln^tm1Sts/Ocln^tm1Sts (involves: 129S4/SvJae * C57BL/6)	stomach inflammation	J:99467
Ocln^tm1Tshi/Ocln^tm1Tshi (involves: C57BL/6 * DBA/2)	stomach inflammation	J:110222
Ocln^tm2Sts/Ocln^tm2Sts (involves: 129S4/SvJae * C57BL/6)	stomach inflammation	J:99467
Odf2^tm1.1Sats/Odf2^tm1.2Sats Tg(CAG-cre)13Miya/0 (involves: C57BL/6 * C57BL/6J)	increased susceptibility to otitis media	J:181294
	sinus inflammation	J:181294
Ogdh^{tm1e(KOMP)Wtsi}/Ogdh⁺ (C57BL/6N-Ogdh^{tm1e(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Ogt^tm1Gwh/Y Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased T cell apoptosis	J:93112
Olfm4^tm1Gpro/Olfm4^tm1Gpro (involves: 129X1/SvJ * Black Swiss)	abnormal cytokine level	J:161279
	increased circulating interleukin-3 level	J:161279
	increased circulating interleukin-12 level	J:161279
	increased susceptibility to bacterial infection	J:161279
	stomach inflammation	J:161279
Olr1^tm1Meht/Olr1^tm1Meht (B6.129X1-Olr1^tm1Meht/Meht)	increased circulating interleukin-10 level	J:130794
Oma1^tm1Otin/Oma1^tm1Otin (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)	granulomatous inflammation	J:184716
Onecut1^tm1.1Mga/Onecut1^tm1.1Mga Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)	pancreas inflammation	J:155058
Oprm1^tm1Lyu/Oprm1⁺ (involves: Black Swiss)	increased splenocyte proliferation	J:39864
Oprm1^tm1Lyu/Oprm1^tm1Lyu (involves: Black Swiss)	increased splenocyte proliferation	J:39864
Orai1^Gt(XL922)Byg/Orai1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal mast cell physiology	J:130479
	decreased interferon-gamma secretion	J:130479
Orai1^Gt(XL922)Byg/Orai1^Gt(XL922)Byg (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal mast cell physiology	J:130479
	decreased interferon-gamma secretion	J:130479
	decreased interleukin-2 secretion	J:130479
	decreased susceptibility to type I hypersensitivity reaction	J:130479
Orai1^tm1.1Hjm/Orai1^tm1.1Hjm Orai2^{tm1.1(KOMP)Vlcg}/Orai2^{tm1.1(KOMP)Vlcg} Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Orai1^tm1.1Hjm Orai2^{tm1.1(KOMP)Vlcg})	abnormal T cell physiology	J:241365
	decreased IgG level	J:241365
Orai1^tm1.1Hjm/Orai1^tm1.1Hjm Tg(Cd4-cre)1Cwi/0 (B6.Cg-Orai1^tm1.1Hjm Tg(Cd4-cre)1Cwi)	abnormal T cell physiology	J:241365
Orai1^tm1Rao/Orai1⁺ (C57BL/6-Orai1^tm1Rao)	abnormal B cell activation	J:139730
Orai1^tm1Rao/Orai1⁺ (C57BL/6-Orai1^tm1Rao)	abnormal T cell activation	J:139730
Orai1^tm1Rao/Orai1^tm1Rao (involves: C57BL/6NTac * ICR)	abnormal B cell activation	J:139730
	abnormal cell-mediated immunity	J:139730
	abnormal cytokine secretion	J:139730
	abnormal mast cell physiology	J:139730
	abnormal T cell activation	J:139730
	abnormal thymocyte activation	J:139730
	blepharitis	J:139730
	decreased interferon-gamma secretion	J:139730
	decreased interleukin-2 secretion	J:139730
	decreased interleukin-4 secretion	J:139730
	decreased interleukin-10 secretion	J:139730
Orai2^{tm1.1(KOMP)Vlcg}/Orai2^{tm1.1(KOMP)Vlcg} (B6.Cg-Orai2^{tm1.1(KOMP)Vlcg})	abnormal macrophage physiology	J:241365
	abnormal T cell physiology	J:241365
Orai2^tm1.1Itl/Orai2^tm1.1Itl Tg(Cma1-cre)#Roer/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N)	increased susceptibility to type I hypersensitivity reaction	J:278536
Orai2^tm1.2Itl/Orai2^tm1.2Itl (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6 * C57BL/6N)	abnormal mast cell physiology	J:278536
	increased mast cell degranulation	J:278536
Orch4^BALB/cByJ/Orch4^BALB/cByJ (involves: BALB/cByJ * DBA/2)	testis inflammation	J:35331
Orch4^BALB/cByJ/Orch4^DBA/2J (involves: BALB/cByJ * DBA/2)	decreased inflammatory response	J:35331
Orch4^DBA/2J/Orch4^DBA/2J (involves: BALB/cByJ * DBA/2)	decreased inflammatory response	J:35331
Orch5^BALB/cByJ/Orch5^BALB/cByJ (involves: BALB/cByJ * DBA/2)	testis inflammation	J:35331
Orch5^BALB/cByJ/Orch5^DBA/2J (involves: BALB/cByJ * DBA/2)	decreased inflammatory response	J:35331
Orch5^DBA/2J/Orch5^DBA/2J (involves: BALB/cByJ * DBA/2)	decreased inflammatory response	J:35331
Orm2^em1Bcgen/Orm2^em1Bcgen (involves: C57BL/6J)	liver inflammation	J:333118
Orm2^{tm1(KOMP)Vlcg}/Orm2^{tm1(KOMP)Vlcg} (C57BL/6N-Orm2^{tm1(KOMP)Vlcg}/Mmucd)	kidney inflammation	J:292194
Ormdl2^em1Pdra/Ormdl2^em1Pdra Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl2^em1Pdra Ormdl3^em1Pdra)	abnormal mast cell physiology	J:328837
	abnormal type I hypersensitivity reaction	J:328837
	increased interleukin-4 secretion	J:328837
	increased interleukin-6 secretion	J:328837
	increased mast cell degranulation	J:328837
	increased tumor necrosis factor secretion	J:328837
Ormdl3^em1Pdra/Ormdl3^em1Pdra (C57BL/6-Ormdl3^em1Pdra)	abnormal mast cell physiology	J:328837
	abnormal type I hypersensitivity reaction	J:328837
	increased mast cell degranulation	J:328837
Os/Os⁺ (ROP/GnLeJ)	glomerulonephritis	J:28323
Oscar^tm1Ywc/Oscar^tm1Ywc Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:178250
Osmr^tm1Mtan/Osmr^tm1Mtan (B6.129S-Osmr^tm1Mtan)	increased circulating interleukin-10 level	J:214124
	increased circulating tumor necrosis factor level	J:214124
	increased inflammatory response	J:214124
	white adipose tissue inflammation	J:214124
Ostm1^gl/Ostm1^gl (GL/Le Edar^dl-J +/+ Ostm1^gl/J)	eye inflammation	J:13053
Otc^spf-ash/Y (involves: C57BL/6)	increased susceptibility to parasitic infection	J:23205
Otc^spf-ash/Y (B6EiC3Sn a/A-Otc^spf-ash/J)	increased susceptibility to endotoxin shock	J:108979
Otub1^{tm1c(EUCOMM)Hmgu}/Otub1^{tm1c(EUCOMM)Hmgu} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal B cell activation	J:280549
	increased anti-double stranded DNA antibody level	J:280549
	increased anti-nuclear antigen antibody level	J:280549
	increased circulating interleukin-6 level	J:280549
	increased IgA level	J:280549
	increased IgG2a level	J:280549
	increased IgG2b level	J:280549
	increased IgM level	J:280549
	increased immunoglobulin level	J:280549
	increased susceptibility to autoimmune disorder	J:280549
	increased susceptibility to systemic lupus erythematosus	J:280549
Otud1^em2Gpt/Otud1^em2Gpt (C57BL/6-Otud1^em2Gpt)	abnormal innate immunity	J:287309
	decreased susceptibility to Herpesvirales infection	J:287309
	decreased susceptibility to Riboviria infection	J:287309
	increased circulating interferon-beta level	J:287309
	increased susceptibility to endotoxin shock	J:287309
Otud3^em1Nju/Otud3^em1Nju (involves: C57BL/6N)	abnormal chemokine secretion	J:294274
	decreased susceptibility to Riboviria infection	J:294274
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:294274
	increased interferon-beta secretion	J:294274
Otud5^tm1Vmd/Otud5^tm1Vmd Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased circulating interleukin-17 level	J:219495
	increased interleukin-9 secretion	J:219495
	increased interleukin-17 secretion	J:219495
	increased interleukin-21 secretion	J:219495
	intestinal inflammation	J:219495
Otud6a^em1Smoc/Otud6a^em1Smoc (C57BL/6J-Otud6a^em1Smoc)	abnormal innate immunity	J:345141
	decreased susceptibility to Herpesvirales infection	J:345141
	decreased susceptibility to Riboviria infection	J:345141
Otud7b^{tm1(NCOM)Cmhd}/Otud7b^{tm1(NCOM)Cmhd} (involves: C57BL/6N)	abnormal granulocyte physiology	J:209709
Otud7b^tm1Dgen/Otud7b^tm1Dgen (involves: 129 * C57BL/6)	decreased activation-induced B cell apoptosis	J:194553
	decreased susceptibility to bacterial infection	J:194553
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:194553
	increased B cell proliferation	J:194553
	increased IgA level	J:194553
Otulin^em1Gvl/Otulin^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * DBA/2)	dermatitis	J:312394
Otulin^{tm1c(EUCOMM)Hmgu}/Otulin^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	dermatitis	J:312394
Oxgr1^{tm1(KOMP)Vlcg}/Oxgr1^{tm1(KOMP)Vlcg} (involves: BALB/c * C57BL/6NTac)	abnormal immune system physiology	J:198383
Oxsr1^tm1.1Arte/Oxsr1⁺ (involves: 129S/SvEvBrd)	abnormal dendritic cell physiology	J:191351
P2rx2^tm1Ckn/P2rx2^tm1Ckn P2rx3^tm1Ckn/P2rx3^tm1Ckn (involves: 129P2/OlaHsd * C57BL/6)	lung inflammation	J:86890
P2rx4^tm1Dgen/P2rx4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:145232
P2rx7^tm1Gab/P2rx7^tm1Gab (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	abnormal interleukin-6 secretion	J:66835
	decreased interleukin-1 beta secretion	J:66835
P2rx7^tm1Gab/P2rx7^tm1Gab (B6.129P2-P2rx7^tm1Gab/J)	abnormal mast cell physiology	J:190651
P2rx7^tm1Ipch/P2rx7^tm1Ipch (B6.Cg-P2rx7^tm1Ipch)	abnormal inflammatory response	J:101945
P2rx7^tm1Ipch/P2rx7^tm1Ipch (involves: 129 * C57BL/6)	abnormal macrophage physiology	J:118561
P2rx7^tm1Lex/P2rx7^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:145020
P2ry6^tm1.1Brob/P2ry6^tm1.1Brob (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal macrophage physiology	J:169742
P2ry6^tm1Jabo/P2ry6^tm1Jabo Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6 * C57BL/6NTac)	decreased IgE level	J:179177
	decreased T cell apoptosis	J:179177
	increased interferon-gamma secretion	J:179177
	increased interleukin-4 secretion	J:179177
	increased interleukin-5 secretion	J:179177
	increased interleukin-13 secretion	J:179177
	increased T cell proliferation	J:179177
	lung inflammation	J:179177
P2ry6^tm1Jabo/P2ry6^tm1Jabo Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} P2ry6^tm1Jabo)	increased interferon-gamma secretion	J:179177
	increased interleukin-4 secretion	J:179177
	increased interleukin-5 secretion	J:179177
	increased interleukin-13 secretion	J:179177
	lung inflammation	J:179177
P4hb^tm1.1Geno/P4hb^tm1.2Geno Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	impaired neutrophil recruitment	J:197556
Paam1^MRL/MpJ/Paam1^MRL/MpJ (involves: C3H/HeJ * MRL/MpJ)	increased susceptibility to autoimmune disorder	J:76107
Paam2^MRL/MpJ/Paam2^MRL/MpJ (involves: C3H/HeJ * MRL/MpJ)	increased susceptibility to autoimmune disorder	J:76107
Pacsin1^{Gt(OST287788)Lex}/Pacsin1^{Gt(OST287788)Lex} (B6.129S5-Pacsin1^{Gt(OST287788)Lex})	abnormal plasmacytoid dendritic cell physiology	J:187784
	decreased circulating interferon-alpha level	J:187784
	decreased interferon-alpha secretion	J:187784
Padi2^tm1Lex/Padi2^tm1Lex (B6.129S5-Padi2^tm1Lex)	abnormal mast cell physiology	J:190651
Padi2^tm1Lex/Padi2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	autoimmune response	J:190651
Padi4^tm1.1Kmow/Padi4^tm1.1Kmow (involves: BALB/cJ * C57BL/6)	abnormal neutrophil physiology	J:174934
	decreased susceptibility to Orthomyxoviridae infection	J:174934
Padi4^tm1.1Ywan/Padi4^tm1.1Ywan (involves: 129S4/SvJae)	abnormal neutrophil physiology	J:165718
	impaired neutrophil phagocytosis	J:165718
	increased susceptibility to bacterial infection	J:165718
Pak1^tm1Cher/Pak1^tm1Cher (B6.129S2-Pak1^tm1Cher)	abnormal mast cell physiology	J:142439
Pak1^tm1Cher/Pak1^tm1Cher (B6.129S2-Pak1^tm1Cher)	decreased mast cell degranulation	J:145444
Panx1^tm1.2Vmd/Panx1^tm1.2Vmd (C57BL/6N-Panx1^tm1.2Vmd)	abnormal T cell physiology	J:173213
Panx3^{tm1c(KOMP)Wtsi}/Panx3^{tm1c(KOMP)Wtsi} Tg(Col2a1-cre)1Star/0 (involves: C3H * C57BL/6 * C57BL/6J * C57BL/6N)	decreased susceptibility to induced arthritis	J:233542
Panx3^{tm1d(KOMP)Wtsi}/Panx3^{tm1d(KOMP)Wtsi} (involves: BALB/cJ * C3H * C57BL/6 * C57BL/6N)	decreased susceptibility to induced arthritis	J:233542
Papss2^bm/Papss2^bm (involves: C57BL/6J * LDJ/Le)	arthritis	J:166514
Parg^tm1Zqw/Parg^tm1Zqw (involves: 129P2/OlaHsd * C57BL/6)	increased circulating tumor necrosis factor level	J:92244
Parg^tm1Zqw/Parg^tm1Zqw (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to endotoxin shock	J:92244
Parl^tm1.1Bdes/Parl^tm1.1Bdes (involves: 129P2/OlaHsd * C57BL/6J)	increased T cell apoptosis	J:116017
Parl^tm1.1Bdes/Parl^tm1.1Bdes (involves: 129P2/OlaHsd)	abnormal thymus apoptosis	J:269785
Parl^tm1Bdes/Parl^tm1Bdes Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal thymus apoptosis	J:269785
Parp1^tm1Jmdm/Parp1^tm1Jmdm (involves: 129S2/SvPas * C57BL/6)	abnormal inflammatory response	J:117701
	abnormal leukocyte migration	J:117701
Parp1^tm1Zqw/Parp1^tm1Zqw (involves: 129/Sv * C57BL/6)	decreased inflammatory response	J:94497
Parp1^tm1Zqw/Parp1^tm1Zqw (129S-Parp1^tm1Zqw/J)	abnormal microglial cell physiology	J:96548
Parp1^tm1Zqw/Parp1^tm1Zqw (129S-Parp1^tm1Zqw/J)	decreased inflammatory response	J:95418
Parp1^tm2Zqw/Parp1^tm2Zqw (either: (involves: 129P2/OlaHsd * 129/Sv) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal inflammatory response	J:93479
	abnormal macrophage physiology	J:93479
	decreased circulating interleukin-1 beta level	J:93479
	decreased circulating tumor necrosis factor level	J:93479
	decreased inflammatory response	J:93479
	decreased susceptibility to endotoxin shock	J:93479
Parp9^tm1.2Arte/Parp9^tm1.2Arte (involves: C57BL/6N * FVB/N)	abnormal circulating interferon level	J:306337
	abnormal interferon secretion	J:306337
	abnormal response to infection	J:306337
Parp14^{Gt(OST415485)Lex}/Parp14^{Gt(OST415485)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased B cell proliferation	J:146533
	decreased IgA level	J:146533
	increased B cell apoptosis	J:146533
	increased B cell proliferation	J:146533
Patz1^tm1.2Welm/Patz1^tm1.2Welm Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Patz1^tm1.2Welm Commd10^{Tg(Vav1-icre)A2Kio})	decreased interleukin-6 secretion	J:209168
Pawr^tm1Jmos/Pawr^tm1Jmos (involves: 129/Sv * CD-1)	abnormal T-helper 2 physiology	J:85495
	increased B cell proliferation	J:85495
	increased T cell proliferation	J:85495
Pax5^m1Btlr/Pax5^m1Btlr (C57BL/6J-Pax5^m1Btlr)	decreased IgA level	J:220072
	decreased IgG1 level	J:220072
	decreased IgG2a level	J:220072
	decreased IgG2b level	J:220072
	decreased IgG level	J:220072
	decreased IgM level	J:220072
	impaired humoral immune response	J:220072
Pax5^m3Btlr/Pax5^m3Btlr (C57BL/6J-Pax5^m3Btlr)	abnormal humoral immune response	J:254825
	decreased IgG level	J:254825
	decreased IgM level	J:254825
Pax5^m4Btlr/Pax5^m4Btlr (C57BL/6J-Pax5^m4Btlr)	decreased IgD level	J:265140
Pax5^M5Btlr/Pax5^M5Btlr (C57BL/6J-Pax5^M5Btlr)	decreased IgD level	J:265141
Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129S2/SvPas * C57BL/6)	decreased immunoglobulin level	J:113076
Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129S2/SvPas)	abnormal B cell physiology	J:123629
Pax6^Sey-4H/Pax6⁺ (involves: 101/H * C3H/HeCrj * C3H/HeH)	increased susceptibility to induced pancreatitis	J:124276
Pax7^{tm1.1(HBEGF,-EYFP)Mal}/Pax7⁺ (involves: C57BL/6)	myositis	J:180899
Paxx^em1Spj/Paxx^em1Spj Nhej1^tm1Fwa/Nhej1^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6NTac)	abnormal thymus involution	J:236776
Pbat1^BXSB/Slc/Pbat1^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Pbat1^BXSB/Slc/Pbat1^NZW/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Pbat2^BXSB/Slc/Pbat2^BXSB/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Pbat2^BXSB/Slc/Pbat2^NZW/Slc (involves: BXSB/Slc * NZW/Slc)	increased autoantibody level	J:49899
Pbk^tm1Zgdo/Pbk^tm1Zgdo (Not Specified)	decreased interleukin-6 secretion	J:176985
	increased interleukin-6 secretion	J:176985
	increased tumor necrosis factor secretion	J:176985
Pbrm1^tm1Zhwa/Pbrm1^tm1Zhwa Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased T cell proliferation	J:236906
	increased interleukin-4 secretion	J:236906
	increased interleukin-10 secretion	J:236906
Pbxip1^tm1Cya/Pbxip1^tm1Cya Tg(Col2a1-cre/ERT)KA3Smac/0 (involves: FVB/N)	osteoarthritis	J:270267
Pcare^tm1Kpal/Pcare^tm1Kpal (involves: C57BL/6J * C57BL/6NTac)	increased microglial cell activation	J:220866
Pcgf2^tm1Hko/Pcgf2^tm1Hko (involves: BALB/c * C57BL/6)	abnormal T-helper 2 physiology	J:71268
Pcna^tm1.1Mdsc/Pcna^tm1.1Mdsc Tg(Pcna*K164R)1Mdsc/0 (involves: FVB/N)	abnormal class switch recombination	J:141098
	abnormal somatic hypermutation frequency	J:141098
Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:125916
Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454, J:177630
Pcna^tm1Jcbs/Pcna^tm1Jcbs Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Pcsk1^tm1Dfs/Pcsk1^tm1Dfs (involves: 129 * C57BL/6J)	increased circulating interferon-gamma level	J:184882
	increased circulating interleukin-1 beta level	J:184882
	increased circulating interleukin-6 level	J:184882
	increased circulating interleukin-10 level	J:184882
	increased circulating interleukin-12 level	J:184882
	increased circulating tumor necrosis factor level	J:184882
	increased interleukin-1 beta secretion	J:184882
	increased susceptibility to endotoxin shock	J:184882
Pctp^tm1Bor/Pctp^tm1Bor (B6.129P2-Pctp^tm1Bor)	abnormal macrophage physiology	J:115284
Pctp^tm1Bor/Pctp^tm1Bor (B6.129P2-Pctp^tm1Bor)	increased macrophage apoptosis	J:115284
Pcyt1a^tm1Irt/Pcyt1a^tm1Irt Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6J)	abnormal immune cell physiology	J:65639
	abnormal macrophage physiology	J:65639
Pdap1^em1Rkuhn/Pdap1^em1Rkuhn Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal B cell physiology	J:298705
	abnormal class switch recombination	J:298705
	abnormal somatic hypermutation frequency	J:298705
	increased B cell apoptosis	J:298705
Pdcd1^tm1.1Liux/Pdcd1^tm1.1Liux Tg(MMTV-PyVT)634Mul/0 (involves: C57BL/6 * FVB/N)	decreased interleukin-17 secretion	J:190150
	increased interferon-gamma secretion	J:190150
	increased interleukin-2 secretion	J:190150
	increased tumor necrosis factor secretion	J:190150
Pdcd1^tm1.1Shr/Pdcd1^tm1.1Shr Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	abnormal immune tolerance	J:153040
	decreased T cell proliferation	J:153040
	increased susceptibility to autoimmune diabetes	J:153040
	increased T cell proliferation	J:153040
	insulitis	J:153040
	pancreas inflammation	J:153040
Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin level	J:50688
	increased B cell proliferation	J:50688
	increased IgA level	J:50688
	increased IgG2b level	J:50688
	increased IgG3 level	J:50688
Pdcd1^tm1Hon/Pdcd1^tm1Hon (B6.129S2-Pdcd1^tm1Hon)	abnormal response to transplant	J:119356
	arthritis	J:78802
	glomerulonephritis	J:78802
Pdcd1^tm1Hon/Pdcd1^tm1Hon (C.129S2(B6)-Pdcd1^tm1Hon)	increased autoantibody level	J:66979
Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129S2/SvPas)	abnormal T cell activation	J:222944
	increased IgA level	J:222944
	increased IgM level	J:222944
	increased inflammatory response	J:222944
	increased interferon-gamma secretion	J:222944
Pdcd1^tm1Hon/Pdcd1^tm1Hon Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129S2/SvPas)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:140751
Pdcd1^tm1Hon/Pdcd1^tm1Hon Vsir^tm1Lex/Vsir^tm1Lex (involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)	abnormal T cell activation	J:222944
	increased IgA level	J:222944
	increased IgM level	J:222944
	increased inflammatory response	J:222944
	increased interferon-gamma secretion	J:222944
	increased interleukin-17 secretion	J:222944
	increased tumor necrosis factor secretion	J:222944
Pdcd1^tm1Hon/Pdcd1^tm1Hon Vsir^tm1Lex/Vsir^tm1Lex Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:222944
Pdcd1^tm1Llc/Pdcd1^tm1Llc (involves: 129S5/SvEvBrd)	abnormal cytokine secretion	J:126829
Pdcd1^tm1Llc/Pdcd1^tm1Llc (involves: 129S5/SvEvBrd)	increased susceptibility to experimental autoimmune encephalomyelitis	J:126829
Pdcd1lg2^tm1Dmp/Pdcd1lg2^tm1Dmp (involves: 129X1/SvJ * 129S1/Sv * C57BL/6)	abnormal dendritic cell antigen presentation	J:84457
Pdcd1lg2^tm1Dmp/Pdcd1lg2^tm1Dmp (C.129-Pdcd1lg2^tm1Dmp)	abnormal cytokine secretion	J:99212
	abnormal cytotoxic T cell physiology	J:99212
	decreased IgG2a level	J:99212
	decreased T cell proliferation	J:99212
Pdcd1lg2^tm1Shr/Pdcd1lg2^tm1Shr (involves: 129/Sv * 129S4/SvJae)	increased IgG2a level	J:113851
	increased IgM level	J:113851
	increased susceptibility to parasitic infection	J:113851
Pdcd1lg2^tm2Shr/Pdcd1lg2^tm2Shr (C.B6-Pdcd1lg2^tm2Shr)	abnormal dendritic cell physiology	J:123785
	increased interferon-gamma secretion	J:123785
	increased interleukin-2 secretion	J:123785
Pdcd1lg2^tm3Shr/Pdcd1lg2^tm3Shr (involves: C57BL/6 * NOD/MrkTac)	abnormal CD8-positive, alpha-beta T cell physiology	J:123785
	increased susceptibility to autoimmune diabetes	J:123785
	insulitis	J:123785
Pdcd4^tm1Yhcn/Pdcd4^tm1Yhcn (B6.129S6-Pdcd4^tm1Yhcn)	abnormal cytokine secretion	J:120583
	decreased susceptibility to autoimmune diabetes	J:120583
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:120583
Pdcd10^tm1Kwhi/Pdcd10^tm1.1Kwhi Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/? (involves: C57BL/6 * CBA)	CNS inflammation	J:173947
Pde4b^tm1Mct/Pde4b⁺ Pde4d^tm1Mct/Pde4d^tm1Mct (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil recruitment	J:94853
Pde4b^tm1Mct/Pde4b^tm1Mct (involves: 129X1/SvJ * C57BL/6)	decreased tumor necrosis factor secretion	J:76862
Pde4b^tm1Mct/Pde4b^tm1Mct (involves: 129P2/OlaHsd * C57BL/6)	decreased tumor necrosis factor secretion	J:106828
	impaired neutrophil chemotaxis	J:94853
	impaired neutrophil recruitment	J:94853
Pde4b^tm1Mct/Pde4b^tm1Mct Pde4d^tm1Mct/Pde4d⁺ (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil recruitment	J:94853
Pde4d^tm1Mct/Pde4d^tm1Mct (involves: 129P2/OlaHsd * C57BL/6)	abnormal tumor necrosis factor level	J:94853
	impaired neutrophil chemotaxis	J:94853
	impaired neutrophil recruitment	J:94853
Pde7a^{Gt(Betageo-puro)1Yang}/Pde7a^{Gt(Betageo-puro)1Yang} (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:86923
Pdia6^em1Btlr/Pdia6^m1Btlr (involves: C57BL/6J)	abnormal circulating cytokine level	J:288824
Pdia6^em1Btlr/Pdia6^m1Btlr (involves: C57BL/6J)	abnormal T cell physiology	J:288824
Pdlim2^tm1Gru/Pdlim2^tm1Gru (Not Specified)	abnormal T-helper 1 physiology	J:99108
	increased interferon-gamma secretion	J:99108
	increased susceptibility to bacterial infection	J:99108
Pdpk1^tm1.1Mlw/Pdpk1^tm1.1Mlw Rag2^tm1Fwa/Rag2^tm1Fwa Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	dermatitis	J:226194
Pdpk1^tm1.1Mlw/Pdpk1^tm1.1Mlw Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal T cell physiology	J:226194
	dermatitis	J:226194
Pdpk1^tm1Mlw/Pdpk1^tm1Mlw Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased T cell proliferation	J:165626
Pdpn^tm1Mcws/Pdpn^tm1Mcws (involves: 129S6/SvEvTac)	abnormal lymph circulation	J:94978
Pdpn^tm2.1Mlkn/Pdpn^tm2.1Mlkn Tg(Pdgfrb-cre)9Rha/0 (involves: C57BL/6)	lymph node hemorrhage	J:205423
Pdss2^kd/Pdss2^kd (CBA/H-Pdss2^kd)	tubulointerstitial nephritis	J:197578
Pdss2^kd/Pdss2^kd (B6.CBACaH(CAST)-Pdss2^kd)	tubulointerstitial nephritis	J:101779
Pdss2^tm1Dalg/Pdss2^tm1Dalg Tg(NPHS2-cre)295Lbh/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	tubulointerstitial nephritis	J:136670
Pdx1^tm1Ted/Pdx1⁺ (involves: 129P2/OlaHsd)	pancreas inflammation	J:82969
Pdzk1^{tm2b(EUCOMM)Wtsi}/Pdzk1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Pdzk1^{tm2b(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Pecam1^tm1Mak/Pecam1⁺ (D1.129P2-Pecam1^tm1Mak)	increased susceptibility to induced arthritis	J:106275
Pecam1^tm1Mak/Pecam1^tm1Mak (D1.129P2-Pecam1^tm1Mak)	abnormal leukocyte physiology	J:106275
	increased interferon-gamma secretion	J:106275
	increased susceptibility to induced arthritis	J:106275
	joint inflammation	J:106275
Pecam1^tm1Mak/Pecam1^tm1Mak (B6.129P2-Pecam1^tm1Mak)	abnormal cytokine secretion	J:95226
Pecam1^tm1Mak/Pecam1^tm1Mak (B6.129P2-Pecam1^tm1Mak)	liver inflammation	J:95226
Pecam1^tm1Mak/Pecam1^tm1Mak Pitgp^C57BL/6/Pitgp^C57BL/6 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	peritoneal inflammation	J:144817
Peli1^tm1.1Arte/Peli1^tm1.1Arte (involves: C57BL/6N)	abnormal cytokine secretion	J:191578
	decreased interferon-alpha secretion	J:191578
	decreased interferon-beta secretion	J:191578
	decreased interleukin-6 secretion	J:191578
	decreased interleukin-10 secretion	J:191578
	decreased interleukin-12 secretion	J:191578
	decreased tumor necrosis factor secretion	J:191578
Peli1^tm1Tigm/Peli1^tm1Tigm (involves: 129/Sv * C57BL/6)	decreased B cell proliferation	J:152781
	decreased circulating interferon-beta level	J:152781
	decreased circulating interleukin-6 level	J:152781
	decreased circulating interleukin-12b level	J:152781
	decreased circulating tumor necrosis factor level	J:152781
	decreased interleukin-12 secretion	J:152781
	decreased susceptibility to endotoxin shock	J:152781
	increased B cell apoptosis	J:152781
Peli2^tm1.1Arte/Peli2^tm1.1Arte (involves: C57BL/6)	abnormal circulating cytokine level	J:265431
	abnormal cytokine secretion	J:265431
	decreased circulating interleukin-1 beta level	J:265431
	decreased interleukin-1 beta secretion	J:265431
	decreased interleukin-18 secretion	J:265431
	increased macrophage apoptosis	J:265431
Peli3^tm1.1Arte/Peli3^tm1.1Arte (involves: C57BL/6NTac)	abnormal dendritic cell physiology	J:188556
	abnormal macrophage cytokine production	J:188556
	decreased susceptibility to Picornaviridae infection	J:188556
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:188556
Penk-rs^tm1Pig/Penk-rs^tm1Pig (B6.129-Penk-rs^tm1Pig)	abnormal T-helper 2 physiology	J:62435
Penk-rs^tm1Pig/Penk-rs^tm1Pig (B6.129-Penk-rs^tm1Pig)	lung inflammation	J:62435
Perp^tm1Att/Perp^tm1Att (involves: 129S4/SvJae)	decreased thymocyte apoptosis	J:86549
Perp^tm2Att/Perp^tm2Att Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S4/SvJae)	skin inflammation	J:167545
Pex1^tm1.1Hrw/Pex1^tm1.1Hrw (involves: C57BL/6NTac)	liver inflammation	J:278655
Pex1^tm1.1Hrw/Pex1^tm1.1Hrw (involves: C57BL/6NTac)	phlebitis	J:278655
Pex5^tm1Pec/Pex5^tm1Pec Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal inflammatory response	J:123503
Pex7^tm1Nbra/Pex7^tm1Nbra (involves: 129S/SvEv * C57BL/6)	liver inflammation	J:158845
Pfdn1^{Gt(GTR1.3)1Rul}/Pfdn1^{Gt(GTR1.3)1Rul} (involves: 129)	abnormal B cell activation	J:137415
	abnormal T cell activation	J:137415
	sinus inflammation	J:137415
Pfkfb3^tm1.1Pec/Pfkfb3^tm1.1Pec Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)	abnormal macrophage physiology	J:296552
Pgam1^tm1.1Hiko/Pgam1^tm1.1Hiko Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased acute inflammation	J:293746
	decreased interleukin-2 secretion	J:293746
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:293746
Pgam5^{tm1d(EUCOMM)Wtsi}/Pgam5^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal interleukin-1 beta secretion	J:240016
	abnormal macrophage activation involved in immune response	J:240016
	decreased interleukin-1 beta secretion	J:240016
Pgap3^tm1.1Ymra/Pgap3^tm1.1Ymra (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:181221
	decreased T cell proliferation	J:181221
	increased susceptibility to experimental autoimmune encephalomyelitis	J:181221
	increased T cell proliferation	J:181221
Pgap3^tm1.1Ymra/Pgap3^tm1.1Ymra (B6.Cg-Pgap3^tm1.1Ymra)	decreased B cell proliferation	J:203443
	impaired macrophage phagocytosis	J:203443
	increased anti-double stranded DNA antibody level	J:203443
	increased anti-single stranded DNA antibody level	J:203443
Pgap4^em1Osbir/Pgap4^em1Osbir (involves: C57BL/6NSlc)	increased susceptibility to infection induced morbidity/mortality	J:333707
Pgap4^em1Osbir/Pgap4^em1Osbir (involves: C57BL/6NSlc)	increased susceptibility to prion infection	J:333707
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:306553
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 Tg(TcraTcrb)8Rest/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell physiology	J:306553
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * DBA/2)	abnormal cytotoxic T cell physiology	J:306553
Pgf^tm1Pec/Pgf^tm1Pec (involves: 129)	decreased susceptibility to type IV hypersensitivity reaction	J:81388
Pgia1^BALB/cCrl/Pgia1^DBA/2Crl (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
	increased susceptibility to autoimmune disorder	J:66460
Pgia2^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
Pgia3^DBA/2Crl/? (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
Pgia3^DBA/2Crl/? (involves: BALB/cCrl * DBA/2Crl)	increased inflammatory response	J:66460
Pgia4^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
Pgia5^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased inflammatory response	J:66460
Pgia6^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
Pgia7^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
Pgia8^DBA/2/Pgia8^DBA/2 (C.D2-(D15Mit12-D15Mit267))	decreased susceptibility to induced arthritis	J:137478
Pgia8^DBA/2/Pgia8^DBA/2 (involves: BALB/c * DBA/2)	decreased interleukin-6 secretion	J:137478
	decreased susceptibility to induced arthritis	J:137478
	increased tumor necrosis factor secretion	J:137478
Pgia8^DBA/2Crl/? (involves: BALB/cCrl * DBA/2Crl)	increased inflammatory response	J:66460
Pgia9^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased inflammatory response	J:66460
Pgia9^DBA/2/Pgia9^DBA/2 (C.D2-(D15Mit267-D15Mit41))	decreased susceptibility to induced arthritis	J:137478
Pgia9^DBA/2/Pgia9^DBA/2 (involves: BALB/c * DBA/2)	decreased susceptibility to induced arthritis	J:137478
	increased interleukin-6 secretion	J:137478
	increased tumor necrosis factor secretion	J:137478
Pgia10^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
Pgia10^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased inflammatory response	J:66460
Pgia11^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased autoantibody level	J:66460
Pgia12^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased inflammatory response	J:66460
Pgia13^C3H/HeJCr/Pgia13^C3H/HeJCr (involves: C3H/HeJCr * C57BL/6)	increased susceptibility to induced arthritis	J:65424
Pgia14^C3H/HeJCr/Pgia14^C3H/HeJCr (involves: C3H/HeJCr * C57BL/6)	increased susceptibility to induced arthritis	J:65424
Pgia15^C3H/HeJCr/Pgia15^C3H/HeJCr (involves: C3H/HeJCr * C57BL/6)	increased susceptibility to induced arthritis	J:65424
Pgia16^C3H/HeJCr/Pgia16^C3H/HeJCr (involves: C3H/HeJCr * C57BL/6)	increased susceptibility to autoimmune disorder	J:65424
Pgia26^BALB/cCrl/? (involves: BALB/cCrl * DBA/2Crl)	increased inflammatory response	J:84150
Pgia26^DBA/2Crl/? (involves: BALB/cCrl * DBA/2Crl)	abnormal inflammatory response	J:84150
Pgia39^DBA/2Crl/? Pgia6^BALB/cCrl/Pgia6^DBA/2Crl (involves: BALB/cCrl * DBA/2Crl)	decreased inflammatory response	J:84150
Pgia39^DBA/2Crl/Pgia39^DBA/2Crl Pgia6^DBA/2Crl/Pgia6^DBA/2Crl (involves: BALB/cCrl * DBA/2Crl)	increased susceptibility to induced arthritis	J:84150
Pgia39^DBA/2Crl/Pgia39^DBA/2Crl Pgia26^BALB/cCrl/Pgia26^BALB/cCrl (involves: BALB/cCrl * DBA/2Crl)	increased susceptibility to induced arthritis	J:84150
Pgis1^DBA/2/Pgis1^DBA/2 (involves: BALB/c * DBA/2)	increased susceptibility to induced arthritis	J:107496
Pgis1^DBA/2/Pgis1^DBA/2 Pgis2^BALB/c/Pgis2^BALB/c (involves: BALB/c * DBA/2)	increased susceptibility to induced arthritis	J:107496
Pgis1^DBA/2/Pgis1^DBA/2 Pgis2^BALB/c/Pgis2^DBA/2 (involves: BALB/c * DBA/2)	increased susceptibility to induced arthritis	J:107496
Pgis2^BALB/c/Pgis2^BALB/c (involves: BALB/c * DBA/2)	increased susceptibility to induced arthritis	J:107496
Pgis2^BALB/c/Pgis2^DBA/2 (involves: BALB/c * DBA/2)	increased susceptibility to induced arthritis	J:107496
Pglyrp1^tm1.1Lky/Pglyrp1^tm1.1Lky (B6.129S4-Pglyrp1^tm1.1Lky)	abnormal neutrophil physiology	J:171412
	increased susceptibility to bacterial infection	J:171412
Pglyrp1^tm1Rdz/Pglyrp1^tm1Rdz (involves: 129S5/SvEvBrd)	abnormal neutrophil physiology	J:84680
	impaired granulocyte bactericidal activity	J:84680
	increased susceptibility to bacterial infection	J:84680
	increased susceptibility to bacterial infection induced morbidity/mortality	J:84680
Pglyrp1^tm1Rdz/Pglyrp1^tm1Rdz (C.129S-Pglyrp1^tm1Rdz)	increased susceptibility to induced arthritis	J:178054
Pglyrp1^tm1Rdz/Pglyrp1^tm1Rdz (involves: 129S5/SvEvBrd * BALB/c)	abnormal chemokine secretion	J:178053
	increased interleukin-6 secretion	J:178053
	increased susceptibility to induced colitis	J:178053
Pglyrp1^tm1Rdz/Pglyrp1^tm1Rdz Pglyrp2^tm1Rdz/Pglyrp2^tm1Rdz (C.129S-Pglyrp1^tm1Rdz Pglyrp2^tm1Rdz)	decreased susceptibility to induced arthritis	J:178054
Pglyrp2^tm1Lky/Pglyrp2^tm1Lky (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage physiology	J:159600
	abnormal tumor necrosis factor level	J:159600
	decreased circulating interleukin-6 level	J:159600
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:159600
Pglyrp2^tm1Rdz/Pglyrp2^tm1Rdz (C.129S-Pglyrp2^tm1Rdz)	abnormal circulating chemokine level	J:178054
Pglyrp2^tm1Rdz/Pglyrp2^tm1Rdz (C.129S-Pglyrp2^tm1Rdz)	decreased susceptibility to induced arthritis	J:178054
Pglyrp2^tm1Rdz/Pglyrp2^tm1Rdz (involves: 129S/SvEv * BALB/c)	abnormal chemokine secretion	J:178053
	increased interleukin-6 secretion	J:178053
	increased susceptibility to induced colitis	J:178053
Pglyrp3^tm1Rdz/Pglyrp3^tm1Rdz (involves: 129S6/SvEvTac * BALB/c)	abnormal chemokine secretion	J:178053
	increased interleukin-6 secretion	J:178053
	increased susceptibility to induced colitis	J:178053
Pglyrp4^tm1Rdz/Pglyrp4^tm1Rdz (involves: 129S6/SvEvTac * BALB/c)	abnormal chemokine secretion	J:178053
	increased interleukin-6 secretion	J:178053
	increased susceptibility to induced colitis	J:178053
Pgm3^{Gt(W037B08)Wrst}/Pgm3^mld1 (involves: 129S1/Sv * C57BL/6)	glomerulonephritis	J:125094
Pgr^tm1Bwo/Pgr^tm1Bwo (either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))	uterus inflammation	J:28980
Pgr^tm1Lyd/Pgr^tm1Lyd (involves: 129S7/SvEvBrd)	abnormal cytokine secretion	J:130208
Pgr^tm2(cre)Lyd/Pgr⁺ Cripto^tm2.2Mms/Cripto^tm2.2Mms (involves: 129/Sv * C57BL/6N * CD-1)	endometrium inflammation	J:324146
Pgrmc1^em1Ejho/Pgrmc1^em1Ejho (involves: C57BL/6N)	liver inflammation	J:268130
Phex^Hyp-Duk/Y (involves: BALB/cAnBomUrd)	ear inflammation	J:132678
Phex^Hyp-Duk/Y (involves: BALB/cAnBomUrd)	increased susceptibility to otitis media	J:132678
Phex^Hyp/? (involves: C57BL/6J)	enthesitis	J:192371
Phex^Mhdabap024/Y (C3HeB/FeJ-Phex^Mhdabap024)	decreased circulating C-reactive protein level	J:264682
Phex^Ska1/Phex^Ska1 (C57BL/6-Phex^Ska1)	abnormal osteoclast physiology	J:79953
Phf6^tm1.1Avo/Y Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	increased circulating interferon-alpha level	J:276228
Phf11d^m1H/Phf11d^m1H (C3H.CAnNCrl(C3)-Phf11d^m1H)	abnormal inflammatory response	J:217094
Phlpp1^tm1.1Saco/Phlpp1^tm1.1Saco Phlpp2^{tm1d(EUCOMM)Hmgu}/Phlpp2^{tm1d(EUCOMM)Hmgu} (involves: 129 * C57BL/6N)	decreased susceptibility to induced colitis	J:231241
Phyh^tm1Safe/Phyh^tm1Safe (involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N)	liver inflammation	J:142512
Pi4ka^m1Btlr/Pi4ka^m1Btlr (C57BL/6J-Pi4ka^m1Btlr)	decreased macrophage apoptosis	J:265261
	decreased tumor necrosis factor secretion	J:265261
	increased interleukin-1 beta secretion	J:265261
Pi16^tm1.2Engl/Pi16^tm1.2Engl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N * SJL)	abnormal immune system physiology	J:244259
Pias1^tm1Kes/Pias1^tm1Kes (involves: 129S/Sv * C57BL/6)	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:92167
	increased susceptibility to bacterial infection induced morbidity/mortality	J:92167
	increased susceptibility to endotoxin shock	J:92167
Pierce1^{tm2b(EUCOMM)Wtsi}/Pierce1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Pierce1^{tm2b(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Piga^tm1Tak/Piga^tm1Tak Tg(FES-cre)31Bsl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca)	abnormal T cell activation	J:162065
	abnormal T cell physiology	J:162065
Pigr^tm1Fejo/Pigr^tm1Fejo (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:57987
	abnormal immunoglobulin transcytosis	J:57987
	decreased IgA level	J:57987
	increased IgA level	J:57987
	increased IgG level	J:57987
Pigr^tm1Fejo/Pigr^tm1Fejo (involves: 129 * C57BL/6)	increased IgA level	J:140515
Pigr^tm1Fejo/Pigr^tm1Fejo (involves: 129 * C57BL/6)	increased susceptibility to parasitic infection	J:140515
Pigr^tm1Ohw/Pigr^tm1Ohw (involves: 129X1/SvJ * C57BL/6J)	decreased IgA level	J:58454
	increased IgA level	J:58454
	increased IgE level	J:58454
	increased IgG level	J:58454
Pigr^tm1Ohw/Pigr^tm1Ohw (B6.129X1-Pigr^tm1Ohw)	abnormal lymphocyte physiology	J:97824
	decreased IgA level	J:108538
	decreased interferon-gamma secretion	J:108538
	decreased tumor necrosis factor secretion	J:108538
	increased IgA level	J:108538, J:97824
	increased susceptibility to bacterial infection	J:108538
Pigr^tm1Ohw/Pigr^tm1Ohw Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	increased IgA level	J:97824
Pigr^tm1Rast/Pigr^tm1Rast (C57BL/6-Pigr^tm1Rast)	abnormal immunoglobulin level	J:81984
	abnormal immunoglobulin transcytosis	J:81984
	decreased IgA level	J:81984
	increased IgA level	J:81984
	increased IgG level	J:81984
Pik3ap1^m1Btlr/Pik3ap1^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Pik3ap1^m2Btlr/Pik3ap1^m2Btlr (C57BL/6J-Pik3ap1^m2Btlr)	impaired humoral immune response	J:255271
Pik3ap1^m2Btlr/Pik3ap1^m2Btlr (C57BL/6J-Pik3ap1^m2Btlr)	increased IgM level	J:255271
Pik3ap1^tm1Kuro/Pik3ap1^tm1Kuro (involves: 129P2/OlaHsd)	decreased B cell proliferation	J:84669
	decreased IgG2b level	J:75075
	decreased IgG3 level	J:75075
	decreased IgM level	J:75075
	decreased immunoglobulin level	J:75075
Pik3c2a^{Gt(OST288105)Lex}/Pik3c2a^{Gt(OST288105)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	glomerulonephritis	J:169710
	increased anti-double stranded DNA antibody level	J:169710
	increased IgA level	J:169710
	increased IgG level	J:169710
	increased IgM level	J:169710
Pik3c3^tm1.1Flv/Pik3c3^tm1.1Flv Tg(Cd8a-cre)1Itan/0 (involves: C57BL/6 * C57BL/6N)	increased T cell apoptosis	J:184753
Pik3cd^{Gt(OST451938)Lex}/Pik3cd^{Gt(OST451938)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased IgG1 level	J:103485
Pik3cd^m1Btlr/Pik3cd^m1Btlr (C57BL/6J-Pik3cd^m1Btlr)	abnormal humoral immune response	J:213049
Pik3cd^m2Btlr/Pik3cd⁺ (C57BL/6J-Pik3cd^m2Btlr)	decreased IgG level	J:236693
	decreased IgM level	J:236693
	decreased response to antigen	J:236693
Pik3cd^m2Btlr/Pik3cd^m2Btlr (C57BL/6J-Pik3cd^m2Btlr)	decreased IgG level	J:236693
	decreased IgM level	J:236693
	decreased response to antigen	J:236693
	increased circulating interferon-alpha level	J:236693
	increased IgE level	J:236693
	increased response to antigen	J:236693
	increased susceptibility to Herpesvirales infection	J:236693
Pik3cd^tm1.1Bvan/Pik3cd^tm1.1Bvan (involves: 129P2/OlaHsd * BALB/c)	decreased IgA level	J:78412
	decreased IgM level	J:78412
	decreased immunoglobulin level	J:78412
	intestinal inflammation	J:78412
Pik3cd^tm1Jni/Pik3cd^tm1Jni (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:80614
	abnormal humoral immune response	J:80614
	decreased B cell proliferation	J:80614
	decreased immunoglobulin level	J:80614
Pik3cd^tm1Jni/Pik3cd^tm1Jni Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	decreased cytotoxic T cell cytolysis	J:124330
	decreased interferon-gamma secretion	J:124330
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr (involves: 129S4/SvJae)	abnormal B cell physiology	J:113491
	abnormal humoral immune response	J:79133
	decreased B cell proliferation	J:113491, J:79133
	decreased IgG1 level	J:79133
	decreased IgG2a level	J:79133
	decreased IgG2b level	J:79133
	decreased IgG3 level	J:79133
	decreased IgM level	J:79133
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr (B6.129S4-Pik3cd^tm1Tnr)	decreased inflammatory response	J:134324
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr (B6.129S4-Pik3cd^tm1Tnr)	decreased susceptibility to induced arthritis	J:134324
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal T cell physiology	J:125791
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (B6.129-Pik3cd^tm1Tnr Pik3cg^tm1Pngr)	decreased inflammatory response	J:134324
	decreased susceptibility to induced arthritis	J:134324
	impaired neutrophil chemotaxis	J:134324
	impaired neutrophil recruitment	J:134324
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pten^tm2.1Ppp/Pten^tm2.1Ppp Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:130950
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased IgE level	J:164283
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal adaptive immunity	J:164283
	abnormal humoral immune response	J:164283
	decreased IgG1 level	J:164283
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal humoral immune response	J:164283
	decreased IgG1 level	J:164283
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (Not Specified)	decreased immunoglobulin level	J:60348
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (Not Specified)	impaired neutrophil chemotaxis	J:60348
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (B6.Cg-Pik3cg^tm1Dwu)	abnormal CD8-positive, alpha-beta T cell physiology	J:131923
	abnormal response to infection	J:131923
	increased susceptibility to Poxviridae infection	J:131923
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:131923
	abnormal response to infection	J:131923
Pik3cg^tm1Ehi/Pik3cg^tm1Ehi (Not Specified)	impaired macrophage chemotaxis	J:91945
Pik3cg^tm1Ehi/Pik3cg^tm1Ehi (Not Specified)	impaired neutrophil recruitment	J:91945
Pik3cg^tm1Lste/Pik3cg^tm1Lste (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:147259
	impaired neutrophil chemotaxis	J:147259
	impaired neutrophil recruitment	J:147259
Pik3cg^tm1Lste/Pik3cg^tm1Lste (involves: 129P2/OlaHsd)	impaired neutrophil chemotaxis	J:238900
Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune cell physiology	J:60347
	abnormal neutrophil physiology	J:60347
	abnormal T cell activation	J:60347
	abnormal T cell physiology	J:60347
	abnormal T-helper 2 physiology	J:60347
	decreased cytotoxic T cell cytolysis	J:124330
	decreased interferon-gamma secretion	J:60347, J:124330
	decreased interleukin-2 secretion	J:60347
	decreased T cell proliferation	J:60347
	impaired neutrophil chemotaxis	J:60347
	impaired neutrophil recruitment	J:60347
Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (B6.129P2-Pik3cg^tm1Pngr)	decreased inflammatory response	J:134324
	decreased susceptibility to induced arthritis	J:134324
	impaired neutrophil chemotaxis	J:134324
Pik3cg^tm1Wym/Pik3cg^tm1Wym (either: 129/Sv-Pik3cg^tm1Wym or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal leukocyte physiology	J:60349
	abnormal neutrophil physiology	J:60349
	impaired macrophage chemotaxis	J:60349
	impaired neutrophil chemotaxis	J:60349
	impaired neutrophil recruitment	J:60349
	increased susceptibility to bacterial infection	J:60349
Pik3cg^tm1Wym/Pik3cg^tm1Wym (involves: 129S1/Sv * 129X1/SvJ)	abnormal neutrophil physiology	J:147259
	impaired neutrophil chemotaxis	J:238900
	impaired neutrophil recruitment	J:147259
Pik3cg^tm2Ehi/Pik3cg^tm2Ehi (Not Specified)	abnormal inflammatory response	J:124856
	abnormal macrophage physiology	J:124856
	impaired macrophage chemotaxis	J:124856
	impaired neutrophil chemotaxis	J:124856
	increased interleukin-1 beta secretion	J:124856
	increased interleukin-6 secretion	J:124856
	increased tumor necrosis factor secretion	J:124856
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr (involves: 129S6/SvEvTac * C57BL/6)	decreased B cell proliferation	J:52229
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd * 129S6/SvEvTac)	increased B cell apoptosis	J:104166
Pik3r1^tm1Tka/Pik3r1^tm1Tka (involves: C57BL/6 * CBA)	abnormal B cell physiology	J:113491
	abnormal humoral immune response	J:52228
	decreased B cell proliferation	J:113491, J:52228
	increased susceptibility to bacterial infection	J:52228
Pik3r4^tm1.1Mpnd/Pik3r4^tm1.1Mpnd Tg(ACTA1-cre)79Jme/0 (involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL)	myositis	J:198770
Pik3r5^tm1Lste/Pik3r5^tm1Lste (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil chemotaxis	J:147259
	impaired neutrophil recruitment	J:147259
Pik3r5^tm1Lste/Pik3r5^tm1Lste (involves: 129P2/OlaHsd)	impaired neutrophil chemotaxis	J:238900
Pik3r6^tm1.1Lste/Pik3r6^tm1.1Lste (Not Specified)	abnormal neutrophil physiology	J:238900
Pikfyve^tm2.1Tssk/Pikfyve^tm2.1Tssk Tg(Vil1-cre)20Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	intestinal inflammation	J:193689
Pilra^tm1Osb/Pilra^tm1Osb (B6.129-Pilra^tm1Osb)	abnormal leukocyte adhesion	J:191085
	abnormal neutrophil physiology	J:191085
	increased susceptibility to bacterial infection induced morbidity/mortality	J:191085
	increased susceptibility to endotoxin shock	J:191085
Pilrb1^tm1Pgh/Pilrb1^tm1Pgh (involves: C57BL/6)	abnormal chemokine level	J:157763
	abnormal cytokine level	J:157763
	abnormal cytokine secretion	J:157763
	decreased circulating interleukin-1 beta level	J:157763
	decreased circulating interleukin-6 level	J:157763
	decreased circulating tumor necrosis factor level	J:157763
	decreased interleukin-1 beta secretion	J:157763
	decreased susceptibility to bacterial infection	J:157763
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:157763
	decreased tumor necrosis factor secretion	J:157763
	increased circulating interferon-gamma level	J:157763
	increased circulating interleukin-12 level	J:157763
	increased interferon-gamma secretion	J:157763
	increased interleukin-10 secretion	J:157763
	increased interleukin-12 secretion	J:157763
Pim1^tm1Pwl/Pim1^tm1Pwl (involves: 129P2/OlaHsd * BALB/c)	abnormal mast cell physiology	J:15259, J:14715
Pim1^tm1Pwl/Pim1^tm1Pwl Pim2^tm1Brn/Pim2^tm1Brn Pim3^tm1Brn/Pim3^tm1Brn (involves: 129P/Ola * FVB/N)	decreased B cell proliferation	J:91592
	decreased T cell proliferation	J:91592
Pim2^tm1.1Lex/Pim2^tm1.1Lex (involves: 129S/SvEvBrd * C57BL/6)	decreased interleukin-6 secretion	J:166403
Pim2^tm1Brn/Pim2^tm1Brn (involves: 129P/Ola * FVB/N)	decreased T cell proliferation	J:91592
Pink1^tm1Hbu/Pink1^tm1Hbu (involves: 129S7/SvEvBrd * C57BL/6)	increased interleukin-1 beta secretion	J:169471
	increased interleukin-10 secretion	J:169471
	increased interleukin-12 secretion	J:169471
Pip4k2c^{tm1b(KOMP)Wtsi}/Pip4k2c^{tm1b(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal circulating chemokine level	J:234283
	abnormal T cell activation	J:234283
	chronic inflammation	J:234283
	chronic liver inflammation	J:234283
	increased circulating interferon-gamma level	J:234283
	increased circulating interleukin-2 level	J:234283
	increased circulating interleukin-4 level	J:234283
	increased circulating interleukin-10 level	J:234283
	increased circulating interleukin-12 level	J:234283
	increased circulating interleukin-12b level	J:234283
	increased IgG3 level	J:234283
	increased inflammatory response	J:234283
	increased interferon-gamma secretion	J:234283
	increased interleukin-17 secretion	J:234283
	increased T cell proliferation	J:234283
	intestinal inflammation	J:234283
	kidney inflammation	J:234283
	lung inflammation	J:234283
	salivary gland inflammation	J:234283
Pip5k1b^tm1Tssk/Pip5k1b^tm1Tssk (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell physiology	J:97991
	increased susceptibility to type I hypersensitivity reaction	J:97991
Pip5k1c^tm1.2Ref/Pip5k1c^tm1.2Ref Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	abnormal T cell physiology	J:164732
	increased interferon-gamma secretion	J:164732
	increased interleukin-2 secretion	J:164732
	increased T cell proliferation	J:164732
Pip^tm1Myal/Pip^tm1Myal (involves: 129S/SvEv * C57BL/6)	arteritis	J:202016
Pip^tm1Myal/Pip^tm1Myal (involves: 129S/SvEv * C57BL/6)	colitis	J:202016
Pirb^em1Fgla/Pirb^em1Fgla (C57BL/6-Pirb^em1Fgla)	decreased length of allograft survival	J:290663
Pirb^tm1Ttk/Pirb^tm1Ttk (involves: 129X1/SvJ)	abnormal B cell physiology	J:76770
	abnormal leukocyte physiology	J:76770
	abnormal T cell physiology	J:76770
	abnormal T-helper 2 physiology	J:76770
	increased B cell proliferation	J:76770
Pitm1^C57BL/FaDk/Pitm1^C57BL/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitm1^C57BL/FaDk/Pitm1^RIII/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitm2^C57BL/FaDk/Pitm2^C57BL/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitm2^C57BL/FaDk/Pitm2^RIII/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitm3^C57BL/FaDk/Pitm3^C57BL/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitm3^C57BL/FaDk/Pitm3^RIII/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitm4^C57BL/FaDk/Pitm4^C57BL/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitm4^C57BL/FaDk/Pitm4^RIII/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:70033
Pitx3^eyl/Pitx3^eyl (involves: C3H/He * C57BL/6)	abnormal immunoglobulin level	J:156878
	decreased IgG3 level	J:156878
	decreased IgM level	J:156878
Pja2^tm1.2Afel/Pja2^tm1.2Afel (involves: 129S6/SvEvTac * C57BL/6J)	kidney inflammation	J:345592
Pkd1^tm1Djmp/Pkd1^tm1Djmp (involves: 129P2/OlaHsd * C57BL/6)	kidney inflammation	J:94582
Pkd1^tm1Jzh/Pkd1⁺ (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c))	bile duct inflammation	J:52573
	kidney inflammation	J:52573
Pkhd1^tm1.1Ggg/Pkhd1^tm1.1Ggg (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	bile duct inflammation	J:125113
Pklr^char4/Pklr^char4 (involves: A/J * C57BL/6)	decreased susceptibility to parasitic infection	J:141722, J:86735
Pklr^char4/Pklr^char4 (involves: A/J * C57BL/6)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:141722
Pklr^slc/Pklr^slc (CBA/NSlc-Pklr^slc)	decreased susceptibility to parasitic infection	J:141722
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:141722
	increased susceptibility to bacterial infection induced morbidity/mortality	J:128518
Pkn1^tm1Kik/Pkn1^tm1Kik (B6.129P2-Pkn1^tm1Kik)	abnormal germinal center B cell physiology	J:193187
	abnormal somatic hypermutation frequency	J:193187
	decreased activation-induced B cell apoptosis	J:193187
	glomerulonephritis	J:193187
	increased anti-double stranded DNA antibody level	J:193187
	increased B cell proliferation	J:193187
	increased IgG1 level	J:193187
	increased IgG2a level	J:193187
	increased IgG2b level	J:193187
	increased IgM level	J:193187
Pknox1^{Gt(OST71835)Lex}/Pknox1^{Gt(OST71835)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased T cell apoptosis	J:103769
Pknox1^tm1Ngc/Pknox1⁺ Tg(IghMyc)22Bri/0 (involves: C57BL * SJL)	decreased B cell apoptosis	J:192251
	increased B cell proliferation	J:192251
Pkp3^tm1.1Fvr/Pkp3^tm1.1Fvr (involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)	dermatitis	J:136451
Pla1a^em1Appsc/Pla1a^em1Appsc (C57BL/6J-Pla1a^em1Appsc)	abnormal interleukin level	J:333902
	decreased susceptibility to chemically induced skin inflammation	J:333902
	decreased susceptibility to induced arthritis	J:333902
Pla2g2d^tm1.1Mhg/Pla2g2d^tm1.1Mhg (B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg)	abnormal cytotoxic T cell physiology	J:229035
	abnormal dendritic cell migration	J:229035
	abnormal dendritic cell physiology	J:201008
	decreased interleukin-6 secretion	J:201008
	decreased susceptibility to Coronaviridae infection	J:229035
	decreased susceptibility to Coronaviridae infection induced morbidity/mortality	J:229035
	decreased tumor necrosis factor secretion	J:201008
	increased interferon-gamma secretion	J:229035
	increased susceptibility to type IV hypersensitivity reaction	J:201008
Pla2g3^tm1Murm/Pla2g3^tm1Murm (involves: 129S/SvEv * C57BL/6)	decreased mast cell degranulation	J:197334
	decreased susceptibility to type I hypersensitivity reaction	J:197334
	ear inflammation	J:197334
Pla2g4a^tm1Jvb/Pla2g4a^tm1Jvb (involves: 129S4/SvJae)	increased mast cell degranulation	J:54619
Pla2g4a^tm1Tksh/Pla2g4a^tm1Tksh (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to type I hypersensitivity reaction	J:39254
Pla2g4a^tm1Tksh/Pla2g4a^tm1Tksh (NOD.129P2(B6)-Pla2g4a^tm1Tksh)	abnormal macrophage physiology	J:99775
	insulitis	J:99775
Pla2g4a^tm1Tksh/Pla2g4a^tm1Tksh (B6.129P2-Pla2g4a^tm1Tksh)	abnormal cytokine level	J:107430
	decreased interferon-gamma secretion	J:107430
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:107430
	decreased tumor necrosis factor secretion	J:107430
Pla2g4e^em1Murm/Pla2g4e^em1Murm (C57BL/6NSlc-Pla2g4e^em1Murm)	increased susceptibility to chemically induced skin inflammation	J:333700
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (involves: 129 * C57BL/6J)	abnormal macrophage physiology	J:89490
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (involves: 129 * C57BL/6J)	decreased acute inflammation	J:89490
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (involves: 129 * BALB/c)	impaired macrophage phagocytosis	J:110309
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (C.129-Pla2g5^tm1Jarm)	impaired macrophage phagocytosis	J:110309
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (involves: 129 * C57BL/6)	impaired macrophage phagocytosis	J:110309
Pla2g5^tm1Jarm/Pla2g5^tm1Jarm (B6.129-Pla2g5^tm1Jarm)	impaired macrophage phagocytosis	J:110309
Pla2g7^tm1.1Mcap/Pla2g7^tm1.1Mcap (B6.Cg-Pla2g7^tm1.1Mcap)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:228564
Pla2g7^tm1.1Mcap/Pla2g7^tm1.1Mcap (B6.Cg-Pla2g7^tm1.1Mcap)	increased susceptibility to bacterial infection	J:228564
Pla2g10^Gt712Lex/Pla2g10^Gt712Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal interleukin level	J:125607
	decreased IgE level	J:125607
	decreased inflammatory response	J:125607
Pla2g10^tm1Kiku/Pla2g10^tm1Kiku (B6.129P2-Pla2g10^tm1Kiku)	abnormal neutrophil physiology	J:155082
Pla2g10^tm1Kiku/Pla2g10^tm1Kiku (B6.129P2-Pla2g10^tm1Kiku)	impaired neutrophil chemotaxis	J:155082
Pla2g15^tm1.1Jash/Pla2g15^tm1.1Jash (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:111561
Pla2r1^tm1Itoh/Pla2r1^tm1Itoh (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to endotoxin shock	J:44868
Plac8^tm1Bhk/Plac8^tm1Bhk (involves: 129S6/SvEvTac * C57BL/6)	abnormal neutrophil physiology	J:145277
Plac8^tm1Bhk/Plac8^tm1Bhk (129S/SvEv-Plac8^tm1Bhk)	abnormal neutrophil physiology	J:145277
Plac8^tm1Bhk/Plac8^tm1Bhk (129S/SvEv-Plac8^tm1Bhk)	increased susceptibility to bacterial infection	J:145277
Plat^tm1Mlg/Plat^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:63134, J:82604
Plat^tm1Mlg/Plat^tm1Mlg (B6.Cg-Plat^tm1Mlg)	abnormal acute phase protein level	J:75303
	abnormal cytokine level	J:75303
	arthritis	J:75303
	chronic joint inflammation	J:75303
Plat^tm1Mlg/Plat^tm1Mlg (involves: 129S2/SvPas)	abnormal microglial cell physiology	J:144185
Plat^tm1Mlg/Plat^tm1Mlg (B6.129S2-Plat^tm1Mlg/J)	abnormal susceptibility to Coronaviridae infection	J:288556
Plat^tm1Mlg/Plat^tm1Mlg (B6.129S2-Plat^tm1Mlg/J)	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:288556
Plau^tm1.1Bug/Plau^tm1.1Bug (involves: C57BL/6)	chronic inflammation	J:164542
	liver inflammation	J:164542
	trachea inflammation	J:164542
Plau^tm1Mlg/Plau^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:63134, J:82604
	abnormal cell-mediated immunity	J:87817, J:95638
	abnormal macrophage physiology	J:17427
	abnormal neutrophil physiology	J:75573, J:91980
	impaired granulocyte bactericidal activity	J:91980
	impaired macrophage chemotaxis	J:63134
	impaired neutrophil phagocytosis	J:91980
	increased susceptibility to fungal infection	J:95637
	increased susceptibility to parasitic infection	J:87817
Plau^tm1Mlg/Plau^tm1Mlg (B6.Cg-Plau^tm1Mlg)	abnormal acute phase protein level	J:68083
	abnormal cytokine level	J:75303
	decreased inflammatory response	J:68083
	decreased susceptibility to induced arthritis	J:75303
	decreased T cell proliferation	J:75303
	impaired macrophage chemotaxis	J:68083
Plau^tm1Mlg/Plau^tm1Mlg (B6.129S2-Plau^tm1Mlg)	chronic inflammation	J:164542
	increased inflammatory response	J:164542
	liver inflammation	J:164542
	trachea inflammation	J:164542
Plaur^tm1Jld/Plaur^tm1Jld (involves: 129P2/OlaHsd * Black Swiss)	abnormal macrophage physiology	J:26874
Plaur^tm1Jld/Plaur^tm1Jld (B6.129P2-Plaur^tm1Jld)	chronic inflammation	J:164542
	increased inflammatory response	J:164542
	liver inflammation	J:164542
	trachea inflammation	J:164542
Plaur^tm1Jld/Plaur^tm1Jld Tg(MSR1-Plau)1Ddi/0 (B6.Cg-Plaur^tm1Jld Tg(MSR1-Plau)1Ddi)	heart inflammation	J:113474
Plaur^tm1Mlg/Plaur^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal cytokine level	J:75573
	abnormal macrophage physiology	J:31253
	abnormal neutrophil physiology	J:75573, J:91980
	impaired neutrophil phagocytosis	J:91980
	increased susceptibility to bacterial infection	J:75573
Plcb2^tm1Dwu/Plcb2^tm1Dwu (involves: 129)	abnormal leukocyte physiology	J:41948
	decreased susceptibility to bacterial infection	J:41948
	decreased susceptibility to infection	J:41948
	decreased susceptibility to viral infection	J:41948
Plcb2^tm1Dwu/Plcb2^tm1Dwu Plcb3^tm1Dwu/Plcb3^tm1Dwu (involves: 129S1/Sv)	abnormal neutrophil physiology	J:60348
	increased immunoglobulin level	J:60348
Plcd1^tm1.1Kfu/Plcd1^tm1.1Kfu Tg(KRT14-cre)1Amc/0 (involves: C57BL/6 * C57BL/6JJcl * CBA)	increased circulating interleukin-17 level	J:205633
	increased interleukin-17 secretion	J:205633
	increased susceptibility to type IV hypersensitivity reaction	J:205633
Plcd1^tm1Tta/Plcd1^tm1Tta (involves: 129P2/OlaHsd)	increased circulating interleukin-17 level	J:205633
Plcd1^tm1Tta/Plcd1^tm1Tta (involves: 129P2/OlaHsd)	increased interleukin-17 secretion	J:205633
Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 (either: B6.Cg-Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))	abnormal T cell activation	J:157757
	dermatitis	J:157757
	ear inflammation	J:157757
	increased anti-double stranded DNA antibody level	J:157757
	increased T cell proliferation	J:157757
	skin inflammation	J:157757
Plcg2^Ali5/Plcg2⁺ (C3HeB/FeJ-Plcg2^Ali5)	abnormal B cell physiology	J:97930
	chronic inflammation	J:97930
	dermatitis	J:97930
	osteoarthritis	J:97930
Plcg2^Ali5/Plcg2⁺ (involves: C57BL/6J * C3HeB/FeJ-Plcg2^Ali5)	abnormal B cell physiology	J:97930
	glomerulonephritis	J:97930
Plcg2^Ali5/Plcg2⁺ Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C3HeB/FeJ * C3HeB/FeJ-Plcg2^Ali5)	chronic inflammation	J:97930
	dermatitis	J:97930
	osteoarthritis	J:97930
Plcg2^Ali5/Plcg2^Ali5 (involves: C57BL/6J * C3HeB/FeJ-Plcg2^Ali5)	abnormal B cell physiology	J:97930
	chronic inflammation	J:97930
	glomerulonephritis	J:97930
Plcg2^Ali14/Plcg2⁺ (C3HeB/FeJ-Plcg2^Ali14)	abnormal inflammatory response	J:166106
Plcg2^em1Msasn/Plcg2^em1Msasn (B6.Cg-Plcg2^em1Msasn/J)	impaired macrophage phagocytosis	J:308279
Plcg2^m1Btlr/Plcg2^m1Btlr (C57BL/6J-Plcg2^m1Btlr)	decreased IgM level	J:165702
Plcg2^m1Btlr/Plcg2^m1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Plcg2^M2Btlr/Plcg2⁺ (C57BL/6J-Plcg2^M2Btlr)	decreased tumor necrosis factor secretion	J:218966
Plcg2^M2Btlr/Plcg2^M2Btlr (C57BL/6J-Plcg2^M2Btlr)	decreased tumor necrosis factor secretion	J:218966
Plcg2^M3Btlr/Plcg2^M3Btlr (C57BL/6J-Plcg2^M3Btlr)	abnormal humoral immune response	J:265101
Plcg2^M3Btlr/Plcg2^M3Btlr (C57BL/6J-Plcg2^M3Btlr)	decreased IgM level	J:265101
Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (B6.Cg-Plcg2^tm1.1Kuro)	decreased interferon-gamma secretion	J:131621
Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (B6.Cg-Plcg2^tm1.1Kuro)	impaired natural killer cell mediated cytotoxicity	J:131621
Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (Not Specified)	abnormal NK cell physiology	J:187430
Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:80614
	abnormal dendritic cell chemotaxis	J:157619
	abnormal dendritic cell physiology	J:157619
	decreased B cell proliferation	J:80614
	decreased susceptibility to induced arthritis	J:157619
	increased B cell apoptosis	J:86373
Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:117023
	decreased interferon-gamma secretion	J:100716
	impaired natural killer cell mediated cytotoxicity	J:100716
	increased B cell proliferation	J:117023
	increased susceptibility to Herpesvirales infection	J:100716
Plcg2^tm1Kuro/Plcg2^tm1Kuro Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal humoral immune response	J:63744
	decreased B cell proliferation	J:63744
Plcl2^tm1Tta/Plcl2^tm1Tta (involves: 129P2/OlaHsd)	abnormal adaptive immunity	J:85960
	abnormal B cell physiology	J:85960
	increased anti-nuclear antigen antibody level	J:85960
	increased B cell proliferation	J:85960
	increased IgM level	J:85960
Pld2^tm1.1Mjow/Pld2^tm1.1Mjow (Not Specified)	abnormal neutrophil physiology	J:183062
Pld3^em1Nemz/Pld3^em1Nemz (C57BL/6J-Pld3^em1Nemz)	increased interleukin-6 secretion	J:281205
Pld3^em1Nemz/Pld3^em1Nemz Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.Cg-Pld3^em1Nemz Pld4^tm1.1Nemz)	abnormal circulating chemokine level	J:281205
	hemophagocytosis	J:281205
	increased circulating CXCL10 level	J:281205
	increased circulating interferon-gamma level	J:281205
	increased circulating tumor necrosis factor level	J:281205
	liver inflammation	J:281205
Pld4^thss/Pld4^thss (BALB/cJ-Pld4^thss/GrsrJ)	abnormal immunoglobulin level	J:278304
	increased anti-nuclear antigen antibody level	J:278304
	increased IgA level	J:278304
	increased IgE level	J:278304
	increased IgG2b level	J:278304
	increased IgG3 level	J:278304
	increased IgG level	J:278304
	increased IgM level	J:278304
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.129(Cg)-Pld4^tm1.1Nemz)	increased circulating CXCL10 level	J:281205
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.129(Cg)-Pld4^tm1.1Nemz)	increased circulating interferon-gamma level	J:281205
Plec^tm3Gwi/Plec^tm3Gwi (involves: 129P2/OlaHsd)	abnormal T cell physiology	J:104701
Plec^tm3Gwi/Plec^tm3Gwi (involves: 129P2/OlaHsd)	impaired macrophage chemotaxis	J:104701
Plekha7^tm1.1Janc/Plekha7^tm1.1Janc (involves: C57BL/6)	decreased susceptibility to bacterial infection	J:227858
Plekha7^tm1.1Janc/Plekha7^tm1.1Janc (involves: C57BL/6)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:227858
Plekhf1^tm1.1Caox/Plekhf1^tm1.1Caox Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.Cg-Plekhf1^tm1.1Caox Lyz2^tm1(cre)Ifo)	abnormal cytokine secretion	J:277440
	abnormal macrophage physiology	J:277440
	decreased circulating interferon-beta level	J:277440
	decreased circulating interleukin-6 level	J:277440
	decreased circulating tumor necrosis factor level	J:277440
	increased susceptibility to bacterial infection	J:277440
	increased susceptibility to bacterial infection induced morbidity/mortality	J:277440
Plekhm1^tm1.2Hzhao/Plekhm1^tm1.2Hzhao (involves: 129S1/Sv * C57BL/6J)	abnormal osteoclast physiology	J:236517
Plekhm2^{tm1a(EUCOMM)Wtsi}/Plekhm2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased susceptibility to bacterial infection	J:233985
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:233985
Plekho2^em1Lzhn/Plekho2^em1Lzhn (C57BL/6-Plekho2^em1Lzhn)	increased macrophage apoptosis	J:270531
Plet1^tm1Cupe/Plet1^tm1Cupe (Not Specified)	abnormal dendritic cell migration	J:271548
Plg^tm1.1Fjc/Plg^tm1.1Fjc (involves: C57BL/6 * C57BL/6JJcl)	increased circulating fibrinogen level	J:210802
Plg^tm1Dco/Plg⁺ (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:80114
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas * C57BL/6)	abnormal acute phase protein level	J:82604
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:80114
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas)	increased circulating fibrinogen level	J:210802
Plg^tm1Jld/Plg^tm1Jld (involves: 129P2/OlaHsd * NIH Black Swiss)	proctitis	J:39419
Plg^tm1Jld/Plg^tm1Jld (B6.129P2-Plg^tm1Jld)	conjunctivitis	J:46096
Plg^tm1Jld/Plg^tm1Jld (B6.129P2-Plg^tm1Jld)	eye inflammation	J:46096
Plg^tm1Jld/Plg^tm1Jld (involves: 129P2/OlaHsd * Black Swiss)	colitis	J:36591
Plg^tm1Jld/Plg^tm1Jld (B6.129P2-Plg^tm1Jld/J)	abnormal microglial cell physiology	J:141739
Plgr1^BALB/cJ/Plgr1^BALB/cJ (involves: BALB/cJ * C57BL/6J)	decreased susceptibility to bacterial infection	J:138895
Plgr1^BALB/cJ/Plgr1^BALB/cJ (B6.C-Plgr1^BALB/cJ)	decreased susceptibility to bacterial infection	J:138895
Plgr1^BALB/cJ/Plgr1^C57BL/6J (involves: BALB/cJ * C57BL/6J)	decreased susceptibility to bacterial infection	J:138895
Plgr1^BALB/cJ/Plgr1^C57BL/6J (B6.C-Plgr1^BALB/cJ)	decreased susceptibility to bacterial infection	J:138895
Plgrkt^tm1Rjpr/Plgrkt⁺ (B6.Cg-Plgrkt^tm1Rjpr)	dermatitis	J:282437
Plgrkt^tm1Rjpr/Plgrkt^tm1Rjpr (B6.Cg-Plgrkt^tm1Rjpr)	abnormal macrophage physiology	J:282437
	dermatitis	J:282437
	impaired leukocyte migration	J:282437
	impaired macrophage chemotaxis	J:282437
Plin2^tm1.1Asg/Plin2^tm1.1Asg (B6.129S2(Cg)-Plin2^tm1.1Asg)	decreased inflammatory response	J:196302
Plp1^jp-rsh/Plp1^jp-rsh (involves: 101/H * C3H)	decreased susceptibility to Picornaviridae infection	J:41447
Plp1^tm1Kan/Y Tspan2^tm1Hbw/Tspan2^tm1Hbw (B6.Cg-Tspan2^tm1Hbw Plp1^tm1Kan)	brain inflammation	J:201143
Pls1^tm1Fri/Pls1^tm1Fri (B6.129-Pls1^tm1Fri)	increased susceptibility to colitis induced morbidity/mortality	J:216723
Pls1^tm1Fri/Pls1^tm1Fri (B6.129-Pls1^tm1Fri)	increased susceptibility to induced colitis	J:216723
plt/plt (involves: DDD/1)	abnormal immune system physiology	J:47819
plt/plt (involves: DDD/1)	abnormal leukocyte migration	J:47819, J:47460
plt/plt (C.DDD-plt)	abnormal T cell activation	J:119345
plt/plt (C.DDD-plt)	increased length of allograft survival	J:119345
plt/plt (B6.DDD-plt)	abnormal leukocyte migration	J:93960
plt/plt (either: B6.DDD-plt or C.DDD-plt)	abnormal leukocyte migration	J:110910
	increased inflammatory response	J:110910
	increased susceptibility to autoimmune disorder	J:110910
	lacrimal gland inflammation	J:110910
	parotid gland inflammation	J:110910
	salivary gland inflammation	J:110910
	submandibular gland inflammation	J:110910
Plxna1^tm1Kik/Plxna1^tm1Kik (either: B6.Cg-Plxna1^tm1Kik or C.Cg-Plxna1^tm1Kik)	abnormal CD4-positive, alpha-beta T cell physiology	J:110786
	abnormal dendritic cell physiology	J:110786
Plxna1^tm1Kik/Plxna1^tm1Kik (Not Specified)	abnormal dendritic cell physiology	J:161856
Plxna1^tm1Kik/Plxna1^tm1Kik Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6)	decreased T cell proliferation	J:161856
Plyid^HIGA/Nsc/Plyid^HIGA/Nsc (involves: BALB/cA * HIGA/Nsc)	abnormal humoral immune response	J:91769
	increased IgA level	J:91769
Pmepa1^em1Akt/Pmepa1^em1Akt (C57BL/6N-Pmepa1^em1Akt)	abnormal osteoclast physiology	J:329578
Pml^tm1Ppp/Pml^tm1Ppp (involves: 129S7/SvEvBrd)	increased susceptibility to bacterial infection	J:46381
Pms2^tm1.1Wed/Pms2^tm1.1Wed (involves: 129S6/SvEvTac * C57BL/6NCr)	abnormal class switch recombination	J:162378
Pms2^tm1Lisk/Pms2^tm1Lisk (involves: 129S2/SvPas)	abnormal class switch recombination	J:162378
Pnliprp2^tm1Gru/Pnliprp2^tm1Gru (involves: 129S2/SvPas * BALB/c)	decreased cytotoxic T cell cytolysis	J:51627
Pnp^bata/Pnp^bata (C57BL/6JSfdAnu-Pnp^bata)	decreased B cell proliferation	J:104190
Pnp^e/Pnp^e (C57BL/6J-Pnp^e)	abnormal leukocyte physiology	J:39328
Pnp^f/Pnp^f (C57BL/6J-Pnp^f)	abnormal leukocyte physiology	J:39328
Pnp^g/Pnp^g (involves: C57BL/6 * DBA/2J)	abnormal leukocyte physiology	J:39328
Pnp^M1Btlr/Pnp^M1Btlr (C57BL/6J-Pnp^M1Btlr)	impaired humoral immune response	J:265147
Pnp^M1Btlr/Pnp^M1Btlr (C57BL/6J-Pnp^M1Btlr)	increased IgM level	J:265147
Pnp^tm1Cmr/Pnp^tm1Cmr (involves: 129)	decreased cytotoxic T cell cytolysis	J:62870
Pnp^tm1Cmr/Pnp^tm1Cmr (involves: 129)	increased thymocyte apoptosis	J:62870
Pofut1^tm2Pst/Pofut1^tm1Pst Shh^{tm2(cre/ERT2)Cjt}/Shh⁺ (involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL)	lung inflammation	J:150051
Polb^tm1.1Jbsw/Polb⁺ (involves: 129/Sv * C57BL/6)	dermatitis	J:206872
	glomerulonephritis	J:206872
	increased anti-nuclear antigen antibody level	J:206872
	increased IgG level	J:206872
	lymph node inflammation	J:206872
	salivary gland inflammation	J:206872
Polb^tm1.1Jbsw/Polb^tm1.1Jbsw (involves: 129/Sv * C57BL/6)	abnormal somatic hypermutation frequency	J:206872
	dermatitis	J:206872
	glomerulonephritis	J:206872
	increased anti-nuclear antigen antibody level	J:206872
	increased IgG level	J:206872
	increased splenocyte apoptosis	J:183837, J:206872
	increased susceptibility to systemic lupus erythematosus	J:206872
	lymph node inflammation	J:206872
	salivary gland inflammation	J:206872
Pole3^em3Tbo/Pole3^em3Tbo (FVB-Pole3^em3Tbo)	abnormal thymus apoptosis	J:298827
Pole3^em3Tbo/Pole3^em3Tbo (FVB-Pole3^em3Tbo)	increased thymocyte apoptosis	J:298827
Pole3^em4Tbo/Pole3^em4Tbo (FVB-Pole3^em4Tbo)	abnormal thymus apoptosis	J:298827
Pole3^em4Tbo/Pole3^em4Tbo (FVB-Pole3^em4Tbo)	increased thymocyte apoptosis	J:298827
Polg^tm1Prol/Polg^tm1Prol (involves: 129S7/SvEvBrd * C57BL/6J * ICR)	abnormal thymus involution	J:99764
Polh^tm1Crey/Polh^tm1Crey (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:98037
Polh^tm1Crey/Polh^tm1Crey Poli^d/Poli^d (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:98037
Polh^tm1Fmh/Polh^tm1Fmh (involves: C57BL/6)	abnormal B cell physiology	J:99721
Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell proliferation	J:85190
Polq^tm1Jcs/Polq^tm1Jcs (involves: 129S4/SvJae * C57BL/6J)	abnormal somatic hypermutation frequency	J:103365
Polq^tm1Jow/Polq^tm1Jow (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	abnormal B cell physiology	J:101409
	abnormal somatic hypermutation frequency	J:101409
	decreased IgG1 level	J:101409
	decreased IgG level	J:101409
	decreased IgM level	J:101409
	decreased immunoglobulin level	J:101409
Polq^tm2Jow/Polq^tm2Jow (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal somatic hypermutation frequency	J:115989
Pomc^tm1Low/Pomc^tm1Low (involves: 129S2/SvPas * C57BL/6)	increased circulating interleukin-6 level	J:102955
	increased interleukin-6 secretion	J:102955
	increased splenocyte proliferation	J:102955
	increased tumor necrosis factor secretion	J:102955
Pomt1^{Gt(OST194127)Lex}/Pomt1⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	decreased IgG level	J:103485
Pon2^Gt(XE661)Byg/Pon2^Gt(XE661)Byg (B6.129P2-Pon2^Gt(XE661)Byg)	abnormal macrophage chemotaxis	J:116935
	abnormal macrophage physiology	J:116935
	increased susceptibility to bacterial infection	J:116935
Pon3^tm1Dmsh/Pon3^tm1Dmsh (B6J.129X1-Pon3^tm1Dmsh)	liver inflammation	J:234615
Postn^tm1Sjc/Postn^tm1Sjc (involves: C57BL/6)	periodontium inflammation	J:103753
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln (C57BL/6-Pou2af1^tm1Pjln)	decreased IgA level	J:37085
	decreased IgG1 level	J:37085
	decreased IgG2a level	J:37085
	decreased IgG2b level	J:37085
	decreased IgG3 level	J:37085
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln (involves: C57BL/6)	abnormal T-helper 1 physiology	J:123039
	abnormal T-helper 2 physiology	J:123039
	decreased interferon-gamma secretion	J:123039
	decreased interleukin-2 secretion	J:123039
	increased B cell apoptosis	J:67362
	increased interleukin-4 secretion	J:123039
	increased interleukin-13 secretion	J:123039
	increased susceptibility to parasitic infection	J:123039
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln Tg(tetO-Pou2af1)1Pjln/0 Tg(tTA)1Pjln/0 (involves: C57BL/6)	decreased immunoglobulin level	J:67362
Pou2af1^tm1Pmt/Pou2af1^tm1Pmt (involves: 129P2/OlaHsd * C57BL/6)	decreased immunoglobulin level	J:125114
Pou2af1^tm1Pmt/Pou2af1^tm1Pmt Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased IgA level	J:81805
	decreased IgD level	J:81805
	decreased IgE level	J:81805
	decreased IgG level	J:81805
	decreased IgM level	J:81805
	decreased immunoglobulin level	J:81805
Pou2af1^tm1Rgr/Pou2af1^tm1Rgr (either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))	decreased B cell proliferation	J:35785
	decreased IgA level	J:35785
	decreased IgE level	J:35785
	decreased IgG1 level	J:35785
	decreased IgG2a level	J:35785
	decreased IgG2b level	J:35785
	decreased IgG3 level	J:35785
	decreased IgG level	J:35785
	decreased immunoglobulin level	J:35785
	increased B cell proliferation	J:114816
	increased IgM level	J:35785
Pou2f2^tm1Bal/Pou2f2⁺ (involves: 129S2/SvPas)	decreased IgG1 level	J:4555
Pou2f2^tm1Bal/Pou2f2⁺ (involves: 129S2/SvPas)	decreased IgM level	J:4555
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas * C57BL/6)	decreased immunoglobulin level	J:88240
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas)	decreased IgG1 level	J:4555
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas)	decreased IgM level	J:4555
Pou2f2^tm1Lmc/Pou2f2^tm1Lmc (involves: C57BL/6)	decreased immunoglobulin level	J:88240
Ppara^tm1Gonz/Ppara^tm1Gonz (involves: 129S4/SvJae)	heart inflammation	J:63801
Ppard^tm1Jps/Ppard^tm1Jps (involves: 129/Sv * C57BL/6N)	skin inflammation	J:63040
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal macrophage activation involved in immune response	J:168799
	glomerulonephritis	J:168799
	impaired macrophage phagocytosis	J:168799
	increased anti-double stranded DNA antibody level	J:168799
	increased anti-nuclear antigen antibody level	J:168799
	increased anti-single stranded DNA antibody level	J:168799
	increased autoantibody level	J:168799
	increased IgG level	J:168799
	increased IgM level	J:168799
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Tg(Mx1-cre)1Cgn/? (involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)	abnormal macrophage physiology	J:75777
Pparg^tm1Tka/Pparg⁺ (involves: C57BL/6 * CBA)	leukostasis	J:116269
Pparg^tm1Tka/Pparg⁺ (involves: C57BL/6 * CBA * ICR)	abnormal B cell physiology	J:58222
	abnormal humoral immune response	J:58222
	increased B cell proliferation	J:58222
	increased IgG level	J:58222
	increased IgM level	J:58222
	increased interferon-gamma secretion	J:58222
	increased interleukin-2 secretion	J:58222
	increased susceptibility to induced arthritis	J:58222
Pparg^tm2Rev/Pparg^tm2Rev Tg(Cd4-cre)1Cwi/? (involves: 129S4/SvJae * C57BL/6 * DBA/2)	increased susceptibility to experimental autoimmune encephalomyelitis	J:153358
Pparg^tm2Rev/Pparg^tm2Rev Tg(Krt1-15-cre/PGR)22Cot/? (involves: 129S4/SvJae C57BL/6 * SJL)	skin inflammation	J:150977
Pparg^tm2Rev/Pparg^tm2Rev Tg(Tek-cre)1Ywa/? (involves: 129S4/SvJae * C57BL/6 * SJL)	skin inflammation	J:123403
Ppargc1a^tm1Brsp/Ppargc1a⁺ (involves: 129S4/SvJae * C57BL/6)	increased inflammatory response	J:264271
Ppargc1a^tm1Brsp/Ppargc1a^tm1Brsp (involves: 129 * FVB/N)	increased interleukin-6 secretion	J:127403
Ppargc1a^tm1Brsp/Ppargc1a^tm2Brsp Tg(Myog-cre)1Eno/0 (involves: 129 * C57BL/6 * FVB/N)	increased circulating interleukin-6 level	J:127403
Ppargc1a^tm2Brsp/Ppargc1a⁺ Tg(Myog-cre)1Eno/0 (involves: 129 * C57BL/6)	increased circulating interleukin-6 level	J:127403
Ppbp^{tm1(KOMP)Vlcg}/Ppbp^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal leukocyte migration	J:198197
	abnormal leukocyte physiology	J:198197
Ppia^tm1Lubn/Ppia^tm1Lubn (129S6.129P2-Ppia^tm1Lubn)	abnormal CD4-positive, alpha-beta T cell physiology	J:93591
	blepharitis	J:93591
	heart inflammation	J:93591
	increased circulating interleukin-4 level	J:93591
	increased IgE level	J:93591
	increased IgG1 level	J:93591
	increased immunoglobulin level	J:93591
	increased inflammatory response	J:93591
	increased interleukin-2 secretion	J:93591
	increased interleukin-4 secretion	J:93591
	increased susceptibility to type I hypersensitivity reaction	J:93591
	liver inflammation	J:93591
	pancreas inflammation	J:93591
Ppm1a^tm1.2Lavi/Ppm1a^tm1.2Lavi (B.129(Cg)-Ppm1a^tm1.2Lavi)	increased acute inflammation	J:216372
Ppm1d^tm1Lad/Ppm1d^tm1Lad (involves: 129S7/SvEvBrd * C57BL/6)	chronic inflammation	J:74284
	decreased B cell proliferation	J:74284
	decreased T cell proliferation	J:74284
	increased susceptibility to Orthomyxoviridae infection	J:74284
Ppp1r8^tm1.1Itl/Ppp1r8^tm1Ave Tg(Alb1-cre)7Gsc/0 (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NTac * FVB/N)	liver inflammation	J:238108
Ppp1r12a^tm1Mzhu/Ppp1r12a^tm1Mzhu Tg(Acta2-cre)#Xya/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	small intestinal inflammation	J:207752
Ppp1r13b^tm1Suda/Ppp1r13b^tm1Suda (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymph circulation	J:135686
Ppp1r13l^wa3-J/Ppp1r13l^wa3-J (BALB/cJ-Ppp1r13l^wa3-J/J)	heart inflammation	J:264272
Ppp1r14c^tm1Uhl/Ppp1r14c^tm1Uhl (B6;129S6-Ppp1r14c^tm1Uhl/J)	increased susceptibility to Coronaviridae infection	J:288523
Ppp1r18^em1Mgin/Ppp1r18^em1Mgin (B6J.B6N-Ppp1r18^em1Mgin)	abnormal T cell physiology	J:331428
Ppp1r18^em1Mgin/Ppp1r18^em1Mgin (B6J.B6N-Ppp1r18^em1Mgin)	impaired leukocyte migration	J:331428
Ppp1r18^em3Mgin/Ppp1r18^em3Mgin (B6J.B6N-Ppp1r18^em3Mgin)	abnormal T cell physiology	J:331428
Ppp1r18^em3Mgin/Ppp1r18^em3Mgin (B6J.B6N-Ppp1r18^em3Mgin)	impaired leukocyte migration	J:331428
Ppp2r2d^em1Gct/Ppp2r2d^em1Gct Tg(Lck-icre)3779Nik/0 (involves: C57BL/6 * DBA/2)	abnormal regulatory T cell physiology	J:308373
	increased interleukin-2 secretion	J:308373
Ppp2r3c^tm1Imku/Ppp2r3c^tm1Imku Tg(CD19-cre/ERT2)1Cgn/? (involves: C57BL/6)	abnormal B cell activation	J:100706
	abnormal humoral immune response	J:100706
	decreased B cell proliferation	J:100706
Ppp3ca^tm1Jse/Ppp3ca^tm1Jse (either: (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6))	decreased interferon-gamma secretion	J:71750
	decreased interleukin-2 secretion	J:71750
	decreased interleukin-4 secretion	J:71750
	decreased T cell proliferation	J:71750
Ppp3cb^M1Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236670
	abnormal CD8-positive, alpha-beta T cell physiology	J:236670
	abnormal NK cell physiology	J:236670
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236670
Ppp3cb^M1Btlr/Ppp3cb^M1Btlr (C57BL/6J-Ppp3cb^M1Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236670
	abnormal CD8-positive, alpha-beta T cell physiology	J:236670
	abnormal NK cell physiology	J:236670
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236670
Ppp3cb^m2Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^m2Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236671
	abnormal CD8-positive, alpha-beta T cell physiology	J:236671
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236671
Ppp3cb^m2Btlr/Ppp3cb^m2Btlr (C57BL/6J-Ppp3cb^m2Btlr)	abnormal CD4-positive, alpha-beta T cell physiology	J:236671
	abnormal CD8-positive, alpha-beta T cell physiology	J:236671
	abnormal NK cell physiology	J:236671
	decreased response to antigen	J:236671
	increased CD8-positive, alpha-beta memory T cell proliferation	J:236671
Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac * C57BL/6)	decreased T cell proliferation	J:77729
Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac)	abnormal cytokine secretion	J:109586
Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac)	decreased T cell proliferation	J:109586
Ppp4c^tm1Tht/Ppp4c^tm1Tht Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal T cell activation	J:117684
Ppp6c^tm1Shma/Ppp6c^tm1Shma Tg(KRT14-cre/ERT)20Efu/0 (involves: C57BL/6 * CBA * CD-1)	increased susceptibility to chemically induced skin inflammation	J:231809
Ppt1^tm1.1Dprc/Ppt1^tm1.1Dprc (involves: 129S6/SvEvTac * BALB/cJ * C57BL/6)	abnormal microglial cell activation	J:213552
Ppt1^tm1Aj/Ppt1^tm1Aj (involves: 129S4/SvJae * C57BL/6)	brain inflammation	J:95522
Ppt1^tm1Hof/Ppt1^tm1Hof (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:177265
	brain inflammation	J:177265
Pram1^tm1Gak/Pram1^tm1Gak (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal neutrophil physiology	J:95253
Prap1^tm1Lex/Prap1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal humoral immune response	J:171883
	increased immunoglobulin level	J:171883
Prap1^tm1Lex/Prap1^tm1Lex (B6.129S5-Prap1^tm1Lex)	increased circulating interleukin-2 level	J:304152
	increased circulating interleukin-4 level	J:304152
	increased circulating interleukin-12 level	J:304152
	increased inflammatory response	J:304152
	increased interleukin-12b secretion	J:304152
Prcd^tm1Vya/Prcd^tm1Vya (B6.Cg-Prcd^tm1Vya)	increased microglial cell activation	J:276708
Prdm1^tm1.1Liz/Prdm1^tm1.1Liz (involves: 129S/SvEv)	abnormal splenocyte physiology	J:163979
Prdm1^tm1Clme/Prdm1^tm1Clme Tg(Itgax-cre)1-1Reiz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal CD4-positive, alpha-beta T cell physiology	J:178876
	abnormal germinal center B cell physiology	J:178876
	abnormal immune system physiology	J:178876
	increased anti-double stranded DNA antibody level	J:178876
	increased anti-nuclear antigen antibody level	J:178876
	increased autoantibody level	J:178876
	increased IgG level	J:178876
	increased immunoglobulin level	J:178876
	increased interleukin-6 secretion	J:178876
	kidney inflammation	J:178876
Prdm1^tm2.1Nutt/Prdm1^tm2.1Nutt Tg(Lck-cre)1Cwi/? (involves: C57BL/6)	increased susceptibility to Orthomyxoviridae infection	J:151858
Prdm11^tm1.1Ahl/Prdm11^tm1.1Ahl (B6.129(C)-Prdm11^tm1.1Ahl)	abnormal humoral immune response	J:233986
	increased interferon-gamma secretion	J:233986
	increased interleukin-2 secretion	J:233986
Prdt1^CAST/EiJH/Prdt1^CAST/EiJH (involves: CAST/Ei * NZW/OlaHsd)	decreased susceptibility to prion infection	J:80787
Prdt1^NZW/OlaHsd/Prdt1^NZW/OlaHsd (involves: CAST/Ei * NZW/OlaHsd)	increased susceptibility to prion infection	J:80787
Prdt3^CAST/EiJH/Prdt3^CAST/EiJH (involves: CAST/Ei * NZW/OlaHsd)	decreased susceptibility to prion infection	J:80787
Prdt3^NZW/OlaHsd/Prdt3^NZW/OlaHsd (involves: CAST/Ei * NZW/OlaHsd)	increased susceptibility to prion infection	J:80787
Prdx1^tm1Rave/Prdx1^tm1Rave (involves: 129S6/SvEvTac * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:84677
Prdx3^{Gt(Betageo-puro)711Lex}/Prdx3^{Gt(Betageo-puro)711Lex} (involves: 129S5/SvEvBrd * C57BL/6)	lung inflammation	J:118595
Prdx5^{tm1.1(KOMP)Vlcg}/Prdx5^{tm1.1(KOMP)Vlcg} (involves: C57BL/6J * C57BL/6NTac)	increased circulating interleukin-12b level	J:271141
	increased circulating tumor necrosis factor level	J:271141
	increased interleukin-6 secretion	J:271141
	increased interleukin-12b secretion	J:271141
	increased tumor necrosis factor secretion	J:271141
Prex1^tm1Dwu/Prex1^tm1Dwu (Not Specified)	impaired neutrophil chemotaxis	J:102213
Prex1^tm1Hcew/Prex1^tm1Hcew (involves: 129P2/OlaHsd * C57BL/6)	impaired neutrophil chemotaxis	J:102214
	impaired neutrophil recruitment	J:102214
Prf1^m1Btlr/Prf1^m1Btlr (C57BL/6J-Prf1^m1Btlr)	increased susceptibility to Herpesvirales infection	J:216044
Prf1^m1Btlr/Prf1^m1Btlr (C57BL/6J-Prf1^m1Btlr)	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:216044
Prf1^tm1Clrk/Prf1^tm1Clrk (involves: 129S7/SvEvBrd * C57BL/6)	decreased cytotoxic T cell cytolysis	J:21531
	increased susceptibility to Riboviria infection	J:21531
Prf1^tm1Clrk/Prf1^tm1Clrk (C.129S7(B6)-Prf1^tm1Clrk)	abnormal cytokine secretion	J:71576
	increased interferon-gamma secretion	J:71576
	increased susceptibility to Riboviria infection	J:71576
	increased tumor necrosis factor secretion	J:71576
Prf1^tm1Clrk/Prf1^tm1Clrk (involves: 129S7/SvEvBrd * BALB/c * NOD)	decreased susceptibility to autoimmune diabetes	J:64051
Prf1^tm1Clrk/Prf1^tm1Clrk Tg(INS-Il10)#Sar/0 (involves: 129S7/SvEvBrd * BALB/c * NOD)	decreased susceptibility to autoimmune diabetes	J:64051
Prf1^tm1Sdz/Prf1⁺ (NOD.B6-Prf1^tm1Sdz)	decreased susceptibility to autoimmune diabetes	J:43468
	insulitis	J:43468
	periinsulitis	J:43468
Prf1^tm1Sdz/Prf1⁺ (A.B6-Prf1^tm1Sdz)	impaired natural killer cell mediated cytotoxicity	J:211842
Prf1^tm1Sdz/Prf1^tm1Sdz (C57BL/6-Prf1^tm1Sdz)	abnormal inflammatory response	J:17986
	abnormal leukocyte physiology	J:17986
	abnormal NK cell physiology	J:113213
	decreased cytotoxic T cell cytolysis	J:17986
	impaired natural killer cell mediated cytotoxicity	J:17986
	increased interleukin-10 secretion	J:123934
	increased susceptibility to bacterial infection	J:123934
	increased susceptibility to infection	J:17986
	increased susceptibility to parasitic infection	J:81397
	increased susceptibility to Riboviria infection	J:17986
Prf1^tm1Sdz/Prf1^tm1Sdz (NOD.B6-Prf1^tm1Sdz)	decreased susceptibility to autoimmune diabetes	J:43468
	insulitis	J:43468
	periinsulitis	J:43468
Prf1^tm1Sdz/Prf1^tm1Sdz (C57BL/6-Prf1^tm1Sdz/J)	abnormal circulating cytokine level	J:92260
	abnormal cytotoxic T cell physiology	J:193137
	abnormal lymphocyte physiology	J:120427
	abnormal macrophage activation involved in immune response	J:92260
	abnormal T cell activation	J:92260
	brain inflammation	J:92260, J:120427
	CNS inflammation	J:120427
	decreased circulating fibrinogen level	J:92260
	decreased cytotoxic T cell cytolysis	J:193137
	decreased interferon-gamma secretion	J:92260
	decreased NK cell degranulation	J:193137
	increased circulating interferon-alpha level	J:92260
	increased circulating interferon-gamma level	J:92260, J:193137
	increased circulating interleukin-1 beta level	J:193137
	increased circulating interleukin-6 level	J:92260, J:193137
	increased circulating interleukin-10 level	J:92260
	increased circulating interleukin-18 level	J:92260
	increased circulating tumor necrosis factor level	J:92260, J:193137
	increased susceptibility to Picornaviridae infection	J:120427
	increased susceptibility to Riboviria infection	J:92260, J:193137
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:92260
	increased susceptibility to viral infection induced morbidity/mortality	J:193137
	liver inflammation	J:92260
	lymph node inflammation	J:92260
Prf1^tm1Sdz/Prf1^tm1Sdz (involves: BALB/c * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:73948
Prf1^tm1Sdz/Prf1^tm1Sdz (A.B6-Prf1^tm1Sdz)	impaired natural killer cell mediated cytotoxicity	J:211842
Prf1^tm1Sdz/Prf1^tm1Sdz Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Prf1^tm1Sdz/SzJ)	abnormal response to transplant	J:91764
Prf1^tm1Sdz/Prf1^tm1Sdz X/Yaa (BXSB.B6-Prf1^tm1Sdz/Dcr)	autoimmune response	J:179430
Prf1^tm1Tsc/Prf1⁺ (involves: 129S2/SvPas)	decreased cytotoxic T cell cytolysis	J:21731
Prf1^tm1Tsc/Prf1⁺ (involves: 129S2/SvPas)	impaired natural killer cell mediated cytotoxicity	J:21731
Prf1^tm1Tsc/Prf1^tm1Tsc (involves: 129S2/SvPas)	decreased cytotoxic T cell cytolysis	J:21731
	decreased susceptibility to bacterial infection	J:50903
	impaired natural killer cell mediated cytotoxicity	J:21731
Prf1^tm1Tsc/Prf1^tm1Tsc (129X1.129S2-Prf1^tm1Tsc)	abnormal NK cell physiology	J:126114
Prf1^tm1Tsc/Prf1^tm1Tsc (129X1.129S2-Prf1^tm1Tsc)	decreased T cell apoptosis	J:126114
Prg2^tm1Nal/Prg2^tm1Nal (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal inflammatory response	J:65655
	respiratory system inflammation	J:65655
Primpol^em1Nki/Primpol^em1Nki (C57BL/6-Primpol^em1Nki)	abnormal somatic hypermutation frequency	J:242620
Prkab1^tm1Eihl/Prkab1^tm1Eihl (involves: C57BL/6)	decreased circulating interleukin-6 level	J:158295
Prkag2^tm1.1Geno/Prkag2^tm1.1Geno (B6J.129S(Cg)-Prkag2^tm1.1Geno)	abnormal inflammatory response	J:235379
	white adipose tissue inflammation	J:235379
Prkar1a^tm2Gsm/Prkar1a^tm2Gsm Tg(Cr2-cre)3Cgn/0 (involves: 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:147785
Prkar1b^tm1Gsm/Prkar1b^tm1Gsm (Not Specified)	decreased inflammatory response	J:43080
Prkcb^M1Btlr/Prkcb⁺ (C57BL/6J-Prkcb^M1Btlr)	decreased IgM level	J:164864
Prkcb^M1Btlr/Prkcb^M1Btlr (C57BL/6J-Prkcb^M1Btlr)	decreased IgM level	J:164864
Prkcb^M1Btlr/Prkcb^M1Btlr (involves: C57BL/6J)	decreased IgM level	J:185495
Prkcb^M2Btlr/Prkcb⁺ (C57BL/6J-Prkcb^M2Btlr)	decreased IgM level	J:217791
	decreased response to antigen	J:217791
	impaired humoral immune response	J:217791
Prkcb^M2Btlr/Prkcb^M2Btlr (C57BL/6J-Prkcb^M2Btlr)	decreased IgM level	J:217791
	decreased response to antigen	J:217791
	impaired humoral immune response	J:217791
Prkcb^M3Btlr/Prkcb⁺ (C57BL/6J-Prkcb^M3Btlr)	decreased IgM level	J:217793
	decreased response to antigen	J:217793
	impaired humoral immune response	J:217793
Prkcb^M3Btlr/Prkcb^M3Btlr (C57BL/6J-Prkcb^M3Btlr)	decreased IgM level	J:217793
	decreased response to antigen	J:217793
	impaired humoral immune response	J:217793
Prkcb^M5Btlr/Prkcb^M5Btlr (C57BL/6J-Prkcb^M5Btlr)	decreased IgM level	J:274861
Prkcb^M5Btlr/Prkcb^M5Btlr (C57BL/6J-Prkcb^M5Btlr)	impaired humoral immune response	J:274861
Prkcb^tilc/Prkcb⁺ (involves: C57BL/6JSfdAnu)	abnormal humoral immune response	J:221236
	decreased IgG3 level	J:221236
	decreased IgM level	J:221236
Prkcb^tilc/Prkcb^tilc (C57BL/6JSfdAnu-Prkcb^tilc/AnuApb)	decreased IgM level	J:104190
Prkcb^tilc/Prkcb^tilc (involves: C57BL/6JSfdAnu)	abnormal humoral immune response	J:221236
	decreased B cell proliferation	J:221236
	decreased IgG3 level	J:221236
	decreased IgM level	J:221236
Prkcb^tm1Tara/Prkcb⁺ (involves: 129)	abnormal humoral immune response	J:34818
	decreased IgG3 level	J:34818
	decreased IgM level	J:34818
Prkcb^tm1Tara/Prkcb^tm1Tara (involves: 129)	abnormal humoral immune response	J:34818
	decreased B cell proliferation	J:34818
	decreased IgG3 level	J:34818
	decreased IgM level	J:34818
Prkcd^M1Btlr/Prkcd^M1Btlr (C57BL/6J-Prkcd^M1Btlr)	increased susceptibility to induced colitis	J:265145
Prkcd^m2Btlr/Prkcd^m2Btlr (C57BL/6J-Prkcd^m2Btlr)	enhanced humoral immune response	J:265146
	increased IgM level	J:265146
	increased susceptibility to induced colitis	J:265146
Prkcd^tm1.1Chou/Prkcd^tm1.1Chou (involves: C57BL/6 * C57BL/6NTac)	abnormal neutrophil physiology	J:217880
Prkcd^tm1Kin/Prkcd^tm1Kin (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:143854
	glomerulonephritis	J:76135
	increased acute inflammation	J:76135
	increased anti-chromatin antibody level	J:76135
	increased B cell proliferation	J:76135, J:143854
	increased IgA level	J:76135, J:143854
	increased IgG1 level	J:76135, J:143854
	increased IgM level	J:143854
	increased interleukin-6 secretion	J:76135
Prkcd^tm1Msg/Prkcd^tm1Msg (involves: 129X1/SvJ * C57BL/6J)	abnormal neutrophil physiology	J:91377
Prkcd^tm1Qxu/Prkcd^tm1Qxu (involves: 129P2/OlaHsd)	abnormal response to transplant	J:78680
Prkcd^tm1Qxu/Prkcd^tm1Qxu (involves: 129P2/OlaHsd * C57BL/6)	increased anti-nuclear antigen antibody level	J:76134
	increased B cell apoptosis	J:76134
	increased IgA level	J:76134
	increased IgG1 level	J:76134
	increased IgM level	J:76134
Prkcd^tm1Qxu/Prkcd^tm1Qxu Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:76134
	abnormal B cell proliferation	J:76134
	abnormal self tolerance	J:76134
	autoimmune response	J:76134
Prkce^tm1Bsca/Prkce^tm1Bsca (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-1 beta level	J:103337
	decreased circulating tumor necrosis factor level	J:103337
	decreased macrophage apoptosis	J:103337
	decreased macrophage nitric oxide production	J:103337
	decreased T cell proliferation	J:103337
	increased susceptibility to bacterial infection	J:103337
Prkce^tm1Ltg/Prkce^tm1Ltg (involves: 129P2/OlaHsd * FVB/N)	decreased tumor necrosis factor secretion	J:86056
Prkcg^tm1Stl/Prkcg^tm1Stl (Not Specified)	decreased inflammatory response	J:25061
Prkch^tm1.2Gasc/Prkch^tm1.2Gasc (involves: C57BL/6 * FVB/N * SJL)	decreased T cell proliferation	J:186080
Prkch^tm1.2Gasc/Prkch^tm1.2Gasc Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	decreased T cell proliferation	J:186080
Prkci^tm1Rfar/Prkci⁺ Tg(Ckmm-cre)5Khn/? (involves: 129P2/OlaHsd * C57BL/6 * FVB)	increased susceptibility to autoimmune diabetes	J:123964
Prkcq^m1Btlr/Prkcq^m1Btlr (C57BL/6J-Prkcq^m1Btlr)	decreased IgG level	J:255214
Prkcq^m1Btlr/Prkcq^m1Btlr (C57BL/6J-Prkcq^m1Btlr)	impaired humoral immune response	J:255214
Prkcq^m2Btlr/Prkcq^m2Btlr (C57BL/6J-Prkcq^m2Btlr)	decreased IgG level	J:255216
Prkcq^m2Btlr/Prkcq^m2Btlr (C57BL/6J-Prkcq^m2Btlr)	impaired humoral immune response	J:255216
Prkcq^tm1.1Bai/Prkcq^tm1.1Bai (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell physiology	J:83733
	decreased interleukin-2 secretion	J:83733
	decreased T cell proliferation	J:83733
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd)	abnormal T cell activation	J:83922
	decreased interleukin-2 secretion	J:83922
	decreased T cell proliferation	J:83922, J:123989
Prkcq^tm1Litt/Prkcq^tm1Litt (B6.129P2-Prkcq^tm1Litt)	abnormal CD4-positive, alpha-beta T cell physiology	J:94285
	abnormal T-helper 2 physiology	J:94285
	decreased interferon-gamma secretion	J:129421, J:94285
	decreased interleukin-2 secretion	J:129421, J:94285
	decreased interleukin-4 secretion	J:129421, J:94285
	decreased interleukin-5 secretion	J:94285
	decreased interleukin-13 secretion	J:94285
	decreased interleukin-17 secretion	J:129421
	decreased splenocyte proliferation	J:129421
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:129421
	decreased T cell proliferation	J:94285
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell proliferation	J:186080
	increased T cell apoptosis	J:141128
Prkcq^tm1Litt/Prkcq^tm1Litt (either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal response to infection	J:141930
	decreased T cell apoptosis	J:141930
	decreased T cell proliferation	J:141930
Prkcq^tm1Litt/Prkcq^tm1Litt Tcra^tm1Mom/Tcra^tm1Mom (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased interleukin-4 secretion	J:135589
	decreased T cell proliferation	J:135589
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(DO11.10)10Dlo/0 (involves: 129 * BALB/c * C3H * C57BL/6)	decreased T cell apoptosis	J:141930
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(TcrLCMV)327Sdz/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal T cell anergy	J:123989
	decreased cytotoxic T cell cytolysis	J:123989
	decreased splenocyte proliferation	J:123989
	decreased T cell proliferation	J:123989
Prkd2^tm1.1Daca/Prkd2^tm1.1Daca (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:166867
	abnormal CD8-positive, alpha-beta T cell physiology	J:166867
	decreased IgG1 level	J:166867
	decreased IgM level	J:166867
	decreased interferon-gamma secretion	J:166867
	decreased interleukin-2 secretion	J:166867
Prkdc^hanky/Prkdc^hanky (either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))	cecum inflammation	J:104190
	colitis	J:104190
	interstitial pneumonia	J:104190
	liver inflammation	J:104190
Prkdc^m1Btlr/Prkdc^m1Btlr (C57BL/6J-Prkdc^m1Btlr)	abnormal immune system physiology	J:178522
Prkdc^m1Btlr/Prkdc^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Prkdc^m2Btlr/Prkdc^m2Btlr (C57BL/6J-Prkdc^m2Btlr)	abnormal B cell physiology	J:204502
	decreased IgG level	J:204502
	decreased IgM level	J:204502
Prkdc^m3Btlr/Prkdc^m3Btlr (C57BL/6J-Prkdc^m3Btlr)	decreased IgG level	J:224665
Prkdc^m3Btlr/Prkdc^m3Btlr (C57BL/6J-Prkdc^m3Btlr)	impaired humoral immune response	J:224665
Prkdc^m7Btlr/Prkdc^m7Btlr (C57BL/6J-Prkdc^m7Btlr)	abnormal humoral immune response	J:255223
Prkdc^m7Btlr/Prkdc^m7Btlr (C57BL/6J-Prkdc^m7Btlr)	decreased IgG level	J:255223
Prkdc^M11Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M11Btlr)	enhanced humoral immune response	J:255270
Prkdc^M11Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M11Btlr)	increased IgM level	J:255270
Prkdc^M11Btlr/Prkdc^M11Btlr (C57BL/6J-Prkdc^M11Btlr)	enhanced humoral immune response	J:255270
Prkdc^M11Btlr/Prkdc^M11Btlr (C57BL/6J-Prkdc^M11Btlr)	increased IgM level	J:255270
Prkdc^scid/Prkdc^scid (C.BKa-Prkdc^scid)	abnormal humoral immune response	J:6958
	abnormal response to transplant	J:22026
	decreased B cell proliferation	J:6958
	decreased IgG level	J:6958
	decreased immunoglobulin level	J:6958, J:22026
	decreased T cell proliferation	J:6958
	increased length of allograft survival	J:6958, J:22026
	salivary gland inflammation	J:21965
Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid)	abnormal response to transplant	J:109833, J:22026
	decreased immunoglobulin level	J:22026
	decreased level of surface class I molecules	J:22026
	impaired complement classical pathway	J:22026
	impaired natural killer cell mediated cytotoxicity	J:22026
	increased length of allograft survival	J:22026
Prkdc^scid/Prkdc^scid (B6.Cg-Prkdc^scid/Sz)	abnormal complement pathway	J:34814, J:22026
	abnormal level of surface class II molecules	J:34814
	abnormal NK cell physiology	J:34814
	decreased immunoglobulin level	J:34814
	stomach inflammation	J:120556
Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid/J)	abnormal response to transplant	J:91764
Prkdc^scid/Prkdc^scid (involves: BALB/c * C57BL/6 * C57BL/Ka)	abnormal NK cell physiology	J:115033
Prkdc^scid/Prkdc^scid Sst1^C57BL/6J/Sst1^C57BL/6J (involves: C3HeB/FeJ * C57BL/6J)	decreased susceptibility to bacterial infection	J:93705
Prkdc^scid/Prkdc^scid Tg(B2M)55Hpl/0 Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1⁺ (NOD.Cg-Mcph1^{Tg(HLA-A2.1)1Enge} Prkdc^scid Tg(B2M)55Hpl/Sz)	abnormal response to transplant	J:91764
Prkdc^scid/Prkdc^scid Tg(CSF2)2Ygy/0 Tg(IL3)1Ygy/0 (CB17.Cg-Prkdc^scid Tg(CSF2)2Ygy Tg(IL3)1Ygy)	abnormal response to transplant	J:94302
Prkdc^scid/Prkdc^scid Tg(CSF2)2Ygy/0 Tg(IL3)1Ygy/0 Tg(KITLG)3Ygy/0 (CB17.Cg-Prkdc^scid Tg(CSF2)2Ygy Tg(IL3)1Ygy Tg(KITLG)3Ygy)	abnormal response to transplant	J:106416, J:94302
Prkdc^scid/Prkdc^scid Tg(CSF2)2Ygy/0 Tg(IL3)1Ygy/0 Tg(KITLG)3Ygy/0 (NOD.Cg-Prkdc^scid Tg(CSF2)2Ygy Tg(IL3)1Ygy Tg(KITLG)3Ygy)	abnormal response to transplant	J:107052
	decreased susceptibility to graft versus host disease	J:107052
Prkdc^scid/Prkdc^scid Tg(Ins2-Fasl)24Ach/0 (NOD.Cg-Prkdc^scid Tg(Ins2-Fasl)24Ach)	decreased susceptibility to autoimmune diabetes	J:81416
	increased susceptibility to autoimmune diabetes	J:81416
Prkdc^scid/Prkdc^scid Tg(INS-Il10)#Sar/0 (NOD.Cg-Prkdc^scid Tg(INS-Il10)#Sar)	increased susceptibility to autoimmune diabetes	J:66103
Prkdc^scid/Prkdc^scid Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-Prkdc^scid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	increased susceptibility to autoimmune diabetes	J:93553
Prkdc^tm1Gcl/Prkdc^tm1Gcl (involves: 129S1/Sv)	decreased thymocyte apoptosis	J:126920
Prkdc^tm1Get/Prkdc^tm1Get (involves: 129S4/SvJae * Black Swiss)	decreased IgM level	J:50222
Prmt3^{tm1a(EUCOMM)Wtsi}/Prmt3^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased incidence of corneal inflammation	J:213427
Prmt7^{tm1a(EUCOMM)Wtsi}/Prmt7^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Prmt7^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Prmt9^em1Cya/Prmt9^em1Cya Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	decreased susceptibility to viral infection	J:328263
	increased circulating interferon-beta level	J:328263
	increased interferon-beta secretion	J:328263
Prnp^a/Prnp^a (NZW)	increased susceptibility to prion infection	J:8918
Prnp^b/Prnp^b (I/LnJ)	decreased susceptibility to prion infection	J:8918
Prnp^c/Prnp^c (MAI/Pas)	decreased susceptibility to prion infection	J:90099
Prnp^{tm1(PRNP)Tkit}/Prnp^{tm1(PRNP)Tkit} (Not Specified)	decreased susceptibility to prion infection	J:86603
Prnp^{tm1(PRNP)Tkit}/Prnp^{tm1(PRNP)Tkit} (Not Specified)	increased susceptibility to prion infection	J:86603
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Nefh-cre)22Jcol/? Tg(Prnp)37Jcol/? (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)	decreased susceptibility to prion infection	J:126424
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Nefh-cre)22Jcol/? Tg(Prnp)46Jcol/? (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)	decreased susceptibility to prion infection	J:74652
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(PRNP)35Jcol/Tg(PRNP)35Jcol (involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N)	increased susceptibility to prion infection	J:131494
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)37Jcol/? (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)	increased susceptibility to prion infection	J:74652, J:126424
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(PRNP)45Jcol/Tg(PRNP)45Jcol (involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N)	increased susceptibility to prion infection	J:131494
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)4053Sbp/0 (involves: 129S7/SvEvBrd * FVB/N)	increased susceptibility to prion infection	J:136434
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(PRNP)23454Sbp/0 (involves: 129S7/SvEvBrd * FVB/N)	increased susceptibility to prion infection	J:236012
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)a19Cwe/0 (Not Specified)	increased susceptibility to prion infection	J:32214
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)a20Cwe/0 (Not Specified)	increased susceptibility to prion infection	J:32214
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)c35Cwe/0 (Not Specified)	increased susceptibility to prion infection	J:32214
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(PrnpS170NN174T)1020Aag/0 (involves: 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to prion infection	J:143528
Prnp^tm1Edin/Prnp^tm1Edin (129P2/OlaHsd-Prnp^tm1Edin/EdinH)	abnormal susceptibility to prion infection	J:58820
Prnp^tm1Lnq/Prnp^tm1Lnq (involves: 129P2/OlaHsd * C57BL/6N)	decreased susceptibility to prion infection	J:154937
Prnp^tm1Miy/Prnp^tm1Miy (involves: 129S4/SvJae * C57BL/6)	decreased susceptibility to prion infection	J:69186
Prnp^tm1Rcm/Prnp^tm1Rcm (129P2/OlaHsd-Prnp^tm1Rcm)	abnormal susceptibility to prion infection	J:45908
Prnp^tm1Tuzi/Prnp⁺ (involves: 129P2/OlaHsd)	decreased susceptibility to prion infection	J:92302
Prnp^tm1Tuzi/Prnp^tm2Edin (involves: 129P2/OlaHsd)	decreased susceptibility to prion infection	J:92302
Prnp^tm1Tuzi/Prnp^tm2Edin Tg(CMV-cre)1Cgn/? (involves: 129P2/OlaHsd * BALB/cJ)	decreased susceptibility to prion infection	J:92302
Prnp^{tm2(PRNP129M)Tkit}/Prnp^{tm2(PRNP129M)Tkit} (Not Specified)	decreased susceptibility to prion infection	J:126777, J:105882
	increased susceptibility to prion infection	J:126777, J:105882
Prnp^{tm2(PRNP129M)Tkit}/Prnp^{tm2(PRNP129M)Tkit} Tg(Prnp-PRNP*129M)1Tkit/? (Not Specified)	decreased susceptibility to prion infection	J:126777
	increased susceptibility to prion infection	J:126777
Prnp^{tm2(PRNP129M)Tkit}/Prnp^{tm3(PRNP129V)Tkit} (Not Specified)	decreased susceptibility to prion infection	J:105882
Prnp^tm2Tuzi/Prnp⁺ Tg(CMV-cre)1Cgn/? (involves: 129P2/OlaHsd * BALB/cJ)	decreased susceptibility to prion infection	J:92302
Prnp^tm2Tuzi/Prnp^tm2Edin (involves: 129P2/OlaHsd)	decreased susceptibility to prion infection	J:92302
Prnp^tm2Tuzi/Prnp^tm2Edin Tg(CMV-cre)1Cgn/? (involves: 129P2/OlaHsd * BALB/cJ)	decreased susceptibility to prion infection	J:92302
Prnp^{tm3(PRNP129V)Tkit}/Prnp^{tm3(PRNP129V)Tkit} (Not Specified)	decreased susceptibility to prion infection	J:126777, J:105882
	increased susceptibility to prion infection	J:126777
Prnp^{tm3(PRNP129V)Tkit}/Prnp^{tm3(PRNP129V)Tkit} Tg(Prnp-PRNP*129V)139Tkit/? (Not Specified)	abnormal susceptibility to infection	J:126777
	decreased susceptibility to prion infection	J:105882
Prnp^{tm3(PRNP129V)Tkit}/Prnp^{tm3(PRNP129V)Tkit} Tg(Prnp-PRNP*129V)144Tkit/? (Not Specified)	decreased susceptibility to prion infection	J:105882
Prnp^{tm4(PRNP)Tkit}/Prnp^{tm4(PRNP)Tkit} (Not Specified)	increased susceptibility to prion infection	J:105882
Prnp^{tm4(PRNP)Tkit}/Prnp^{tm4(PRNP)Tkit} Tg(Prnp-PRNP)32Tkit/? (Not Specified)	increased susceptibility to prion infection	J:105882
Prnp^{tm5(PRNP)TKit}/Prnp^{tm5(PRNP)TKit} Tg(Prnp-PRNP*)1Tkit/? (Not Specified)	decreased susceptibility to prion infection	J:126777
	increased susceptibility to prion infection	J:126777
Prnr1^RIII/FaDk/Prnr1^RIII/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:89558
Prnr2^C57BL/FaDk/Prnr2^C57BL/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:89558
Prnr2^C57BL/FaDk/Prnr2^RIII/FaDk (involves: C57BL/FaDk * RIII/FaDk)	decreased susceptibility to prion infection	J:89558
Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * Swiss)	abnormal innate immunity	J:50527
	liver inflammation	J:50527
Procr^tm1.1Pcl/Procr^tm1.1Pcl (involves: 129S2/SvPas * C57BL/6)	increased circulating interleukin-6 level	J:225914
	increased susceptibility to endotoxin shock	J:225914
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal lymph circulation	J:102652, J:57646
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ * NMRI)	increased inflammatory response	J:102652
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymph circulation	J:57646
Prox1^tm2Gco/Prox1⁺ Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * C57BL/6 * NMRI * SJL)	abnormal lymph circulation	J:102652
Prph2^em1Sal/Prph2⁺ (C57BL/6J-Prph2^em1Sal)	eye inflammation	J:342243
Prph2^em1Sal/Prph2^em1Sal (C57BL/6J-Prph2^em1Sal)	eye inflammation	J:342243
Prph2^em1Sal/Prph2^em1Sal (C57BL/6J-Prph2^em1Sal)	increased microglial cell activation	J:342243
Prps2^{tm1a(KOMP)Wtsi}/Y (involves: C57BL/6N)	abnormal B cell physiology	J:214383
Prps2^{tm1a(KOMP)Wtsi}/Y Tg(IghMyc)22Bri/0 (involves: C57BL/6N * SJL)	abnormal B cell physiology	J:214383
	increased B cell apoptosis	J:214383
Prss3b^tm1.1Satom/Prss3b⁺ (B6(FVB)-Prss3b^tm1.1Satom)	acute pancreas inflammation	J:267764
Prss3b^tm1.1Satom/Prss3b⁺ (B6(FVB)-Prss3b^tm1.1Satom)	chronic pancreas inflammation	J:267764
Prss34^tm1.1Hkar/Prss34^tm1.1Hkar (involves: C57BL/6)	decreased inflammatory response	J:238924
Prss57^tm1.1Gne/Prss57^tm1.1Gne (C57BL/6N-Prss57^tm1.1Gne)	abnormal mast cell physiology	J:301479
Prss57^tm1Lex/Prss57^tm1Lex (involves: 129S5/SvEvBrd)	abnormal mast cell physiology	J:301479
Prtn3^tm1.1Hrlu/Prtn3^tm1.1Hrlu (involves: C57BL/6)	abnormal neutrophil physiology	J:217636
Prxl2a^{tm1(KOMP)Vlcg}/Prxl2a^{tm1(KOMP)Vlcg} (C57BL/6N-Prxl2a^{tm1(KOMP)Vlcg})	white adipose tissue inflammation	J:234040
Psap^tm1Ggb/Psap^tm1Ggb (involves: 129S/SvEv * C57BL/6J)	abnormal microglial cell physiology	J:121761
Psap^tm1Juma/Psap^tm1Juma (FVB.129S-Psap^tm1Juma)	abnormal microglial cell physiology	J:121761
Psap^tm2Ggb/Psap^tm2Ggb (involves: 129S/SvEv * C57BL/6J)	CNS inflammation	J:137650
Psap^tm2Ggb/Psap^tm2Ggb (involves: 129S/SvEv * C57BL/6J)	kidney inflammation	J:137650
Psap^tm2Suz/Psap^tm2Suz (involves: 129S/SvEv * C57BL/6J)	CNS inflammation	J:78223
Pscr1^DBA/2/Pscr1^DBA/2 (involves: BALB/c * DBA/2)	decreased susceptibility to bacterial infection	J:8914
Pscr1^DBA/2/Pscr1^DBA/2 Pscr2^DBA/2/Pscr2^DBA/2 Pscr3^DBA/2/Pscr3^DBA/2 (involves: C57BL/6 * DBA/2)	decreased susceptibility to bacterial infection	J:8914
Pscr2^DBA/2/Pscr2^DBA/2 (involves: BALB/c * DBA/2)	decreased susceptibility to bacterial infection	J:8914
Pscr3^DBA/2/Pscr3^DBA/2 (involves: BALB/c * DBA/2)	decreased susceptibility to bacterial infection	J:8914
Psen1^tm1Bdes/Psen1⁺ Psen2^tm1Bdes/Psen2^tm1Bdes (involves: 129P2/OlaHsd)	arteritis	J:91235
	autoimmune response	J:91235
	chronic inflammation	J:91235
	dermatitis	J:91235
	glomerulonephritis	J:91235
	increased anti-single stranded DNA antibody level	J:91235
	increased immunoglobulin level	J:91235
	increased incidence of corneal inflammation	J:91235
	increased inflammatory response	J:91235
	increased susceptibility to autoimmune disorder	J:91235
	kidney inflammation	J:91235
	skin inflammation	J:91235
Psip1^{Gt(betageo)1Hgs}/Psip1^{Gt(betageo)1Hgs} (B6.129P2-Psip1^{Gt(betageo)1Hgs})	blepharitis	J:112975
Psip1^{Gt(betageo)1Hgs}/Psip1^{Gt(betageo)1Hgs} (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1))	blepharitis	J:112975
Psmb8^tm1Hjf/Psmb8^tm1Hjf (either: 129P2/OlaHsd or (involves: 129P2/OlaHsd * C57BL/6))	decreased level of surface class I molecules	J:20012
	defective intracellular transport of class I molecules	J:20012
Psmb8^tm1Hjf/Psmb8^tm1Hjf (involves: 129P2/OlaHsd)	abnormal dendritic cell antigen presentation	J:180765
Psmb8^tm1Hjf/Psmb8^tm1Hjf (involves: 129P2/OlaHsd)	decreased level of surface class I molecules	J:180765
Psmb9^tm1Stl/Psmb9^tm1Stl (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:21549
	increased susceptibility to Orthomyxoviridae infection	J:21549
Psmb10^tm1Mgro/Psmb10^tm1Mgro (involves: 129S2/SvPas * C57BL/6)	abnormal cytotoxic T cell physiology	J:125058
	decreased T cell proliferation	J:125058
Psmb10^tm1Mgro/Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr/Psmb9/Psmb8^tm1Klr (B6.129-Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr)	abnormal antigen presentation via MHC class I	J:180765
	abnormal B lymphocyte antigen presentation	J:180765
	abnormal dendritic cell antigen presentation	J:180765
	decreased level of surface class I molecules	J:180765
Psmb10^tm1Mgro/Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr/Psmb9/Psmb8^tm1Klr (B6.129-Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr)	abnormal antigen presentation via MHC class I	J:180765
	abnormal B lymphocyte antigen presentation	J:180765
	abnormal dendritic cell antigen presentation	J:180765
	decreased level of surface class I molecules	J:180765
Psmb10^Tub6/Psmb10⁺ (C3HeB/FeJ-Psmb10^Tub6)	abnormal T cell activation	J:261081
	decreased interferon-gamma secretion	J:261081
	increased susceptibility to bacterial infection induced morbidity/mortality	J:261081
Psmb10^Tub6/Psmb10^Tub6 (C3HeB/FeJ-Psmb10^Tub6)	decreased immunoglobulin level	J:261081
	increased circulating interleukin-1 level	J:261081
	increased circulating interleukin-6 level	J:261081
	increased circulating tumor necrosis factor level	J:261081
	increased inflammatory response	J:261081
	skin inflammation	J:261081
Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} (involves: C57BL/6)	abnormal self tolerance	J:196156
	increased T cell proliferation	J:196156
Psme2^tm1Yya/Psme2^tm1Yya (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell physiology	J:58875
	decreased cytotoxic T cell cytolysis	J:58875
	defective assembly of class I molecules	J:58875
Psme3^tm1Jjm/Psme3^tm1Jjm (B6.129X1-Psme3^tm1Jjm)	increased susceptibility to fungal infection	J:88626
Psph^{tm1a(EUCOMM)Hmgu}/Psph^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Psph^{tm1a(EUCOMM)Hmgu}/Wtsi)	blood in lymph vessels	J:239583
Pstpip1^tm1Spg/Pstpip1^tm1Spg (involves: 129S/SvEv * C57BL/6)	abnormal T cell physiology	J:101977
Pstpip2^cmo/Pstpip2^cmo (C.D2-Qa2)	chronic inflammation	J:1534
Pstpip2^cmo/Pstpip2^cmo (C.Cg-Pstpip2^cmo/J)	ear inflammation	J:104476
Pstpip2^cmo/Pstpip2^cmo (C.Cg-Pstpip2^cmo/J)	osteomyelitis	J:104476, J:105410
Pstpip2^Lupo/Pstpip2^Lupo (either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J))	abnormal cytokine secretion	J:125785
	increased autoantibody level	J:125785
	increased IgE level	J:125785
	increased IgG1 level	J:125785
	increased IgG2a level	J:125785
	increased IgG level	J:125785
	skin inflammation	J:125785
Pstpip2^Lupo/Pstpip2^Lupo Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C3HeB/FeJ * C57BL/6J)	skin inflammation	J:125785
Pstpip2^m1Bcs/Pstpip2^m1Bcs (involves: C57BL/6)	abnormal inflammatory response	J:196534
	autoimmune response	J:196534
	ear inflammation	J:196534
	skin inflammation	J:196534
Ptafr^tm1Tksh/Ptafr^tm1Tksh (involves: 129P2/OlaHsd * C57BL/6)	decreased inflammatory response	J:87866
	increased susceptibility to parasitic infection	J:87866
	increased susceptibility to type I hypersensitivity reaction	J:88505
Ptafr^tm1Tksh/Ptafr^tm1Tksh (C57BL/6-Ptafr^tm1Tksh)	decreased susceptibility to bacterial infection	J:88589
Pten^tm1Engc/Pten^tm1Engc (involves: CD-1)	abnormal microglial cell physiology	J:210487
Pten^tm1Hwu/Pten^tm1Hwu Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal cytokine level	J:148947
	abnormal macrophage chemotaxis	J:148947
	abnormal neutrophil physiology	J:148947, J:114699, J:145331
	decreased susceptibility to bacterial infection	J:148947
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:148947
	impaired neutrophil recruitment	J:148947
	increased susceptibility to bacterial infection	J:148947
	increased susceptibility to bacterial infection induced morbidity/mortality	J:148947
	lung inflammation	J:148947
Pten^tm1Hwu/Pten^tm1Hwu Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0 Tg(TPO-cre)1Shk/0 (involves: 129S4/SvJae * FVB/NCr * FVB/NJ)	abnormal thymus physiology	J:177181
Pten^tm1Hwu/Pten^tm1Hwu Tg(Fabp4-cre)1Abel/0 (involves: 129S4/SvJae)	abnormal cytokine level	J:97588
Pten^tm1Hwu/Pten^tm1Hwu Tg(GZMB-cre)1Jcb/0 (involves: 129S4/SvJae * FVB/N)	abnormal CD8-positive, alpha-beta T cell physiology	J:164425
	decreased interleukin-2 secretion	J:164425
Pten^tm1Hwu/Pten^tm1Hwu Tg(Pbsn-cre)4Prb/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)	prostate gland inflammation	J:93902
	pyelonephritis	J:124208
Pten^tm2.1Ppp/Pten^tm2.1Ppp Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased IgG1 level	J:164283
Pten^tm2Mak/Pten^tm2Mak Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * C57BL/6 * DBA)	liver inflammation	J:138099
Ptgdr2^tm1Byl/Ptgdr2^tm1Byl (involves: C57BL/6J)	abnormal cytokine secretion	J:107519
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (involves: 129/Sv * BALB/c)	impaired eosinophil recruitment	J:130892
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (C.129-Ptgdr2^tm1Tasa)	abnormal chemokine level	J:131146
	abnormal inflammatory response	J:131146
	decreased IgE level	J:131146
	decreased inflammatory response	J:131146
	decreased susceptibility to type IV hypersensitivity reaction	J:131146
Ptgdr2^tm1Tasa/Ptgdr2^tm1Tasa (B6.129-Ptgdr2^tm1Tasa)	increased susceptibility to type I hypersensitivity reaction	J:197334
Ptgdr^tm1Sna/Ptgdr^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage activation involved in immune response	J:243958
	brain inflammation	J:243958
	decreased microglial cell activation	J:243958
	increased interleukin-1 beta secretion	J:243958
	increased susceptibility to Coronaviridae infection	J:243958
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:243958
	respiratory system inflammation	J:61023
Ptgdr^tm1Sna/Ptgdr^tm1Sna (B6.129P2-Ptgdr^tm1Sna/Sna)	abnormal mast cell physiology	J:197334
	decreased mast cell degranulation	J:197334
	decreased susceptibility to type I hypersensitivity reaction	J:197334
Ptgds^tm1Ohy/Ptgds^tm1Ohy (B6.129P2-Ptgds^tm1Ohy)	decreased mast cell degranulation	J:197334
Ptgds^tm1Ohy/Ptgds^tm1Ohy (B6.129P2-Ptgds^tm1Ohy)	decreased susceptibility to type I hypersensitivity reaction	J:197334
Ptger1^tm1Sna/Ptger1^tm1Sna (B6CrSlc.129P2-Ptger1^tm1Sna/Sna)	abnormal interferon-gamma secretion	J:128435
	abnormal response to infection	J:82750
	decreased susceptibility to type IV hypersensitivity reaction	J:128435
Ptger2^tm1.1Kand/Ptger2^tm1.1Kand Tg(ITGAM-cre)2781Gkl/0 (involves: C57BL/6 * CBA)	abnormal microglial cell physiology	J:202677
	decreased susceptibility to endotoxin shock	J:202677
Ptger2^tm1Brey/Ptger2^tm1Brey (involves: 129S6/SvEvTac * C57BL/6)	abnormal response to infection	J:120725
Ptger2^tm1Brey/Ptger2^tm1Brey (C.129S6-Ptger2^tm1Brey)	abnormal microglial cell physiology	J:97062
Ptger2^tm1Brey/Ptger2^tm1Brey (involves: 129S6/SvEvTac * BALB/c)	abnormal response to infection	J:164638
Ptger3^tm1Sna/Ptger3^tm1Sna (B6.129P2-Ptger3^tm1Sna/Sna)	abnormal response to infection	J:82750
Ptger3^tm1Sna/Ptger3^tm1Sna (B6.129P2-Ptger3^tm1Sna/Sna)	increased susceptibility to type I hypersensitivity reaction	J:197334
Ptger4^tm1.1Matb/Ptger4^tm1.1Matb Tg(Myh6-cre)2182Mds/0 (involves: 129S6/SvEvTac * FVB/N)	heart inflammation	J:158439
Ptger4^tm1Bhk/Ptger4^tm1Bhk (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal circulating interleukin-6 level	J:78964
	abnormal circulating serum amyloid protein level	J:78964
	abnormal cytokine level	J:78964
	abnormal macrophage physiology	J:78964
	decreased susceptibility to induced arthritis	J:78964
	rheumatoid arthritis	J:78964
Ptger4^tm1Sna/Ptger4^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	abnormal Langerhans cell physiology	J:83725
	abnormal osteoclast physiology	J:63070
	abnormal T cell activation	J:83725
	decreased interferon-gamma secretion	J:83725
	decreased susceptibility to type IV hypersensitivity reaction	J:83725
	decreased T cell proliferation	J:83725
Ptges2^tm1Kymm/Ptges2^tm1Kymm (B6.Cg-Ptges2^tm1Kymm)	increased susceptibility to type I hypersensitivity reaction	J:197334
Ptges^tm1.1Gaf/Ptges^tm1.1Gaf Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	abnormal leukocyte physiology	J:210141
Ptges^tm1Aki/Ptges^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal inflammatory response	J:91821
	chronic inflammation	J:91821
	impaired macrophage chemotaxis	J:91821
Ptges^tm1Aki/Ptges^tm1Aki (B6.129P2-Ptges^tm1Aki)	increased susceptibility to type I hypersensitivity reaction	J:197334
Ptges^tm1Lpa/Ptges^tm1Lpa (DBA/1LacJ-Ptges^tm1Lpa)	decreased inflammatory response	J:89960, J:90980
Ptgir^tm1Sna/Ptgir^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	decreased acute inflammation	J:42275
Ptgs1^tm1Fun/Ptgs1^tm1Fun (involves: 129S6/SvEvTac * C57BL/6)	decreased inflammatory response	J:97351
Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased inflammatory response	J:29511
	increased susceptibility to endotoxin shock	J:75611
	increased susceptibility to induced colitis	J:158426, J:60668
Ptgs1^tm1Unc/Ptgs1^tm1Unc (B6.129P2-Ptgs1^tm1Unc)	decreased susceptibility to induced arthritis	J:110716
Ptgs2^tm1.1Fun/Ptgs2^tm1.1Fun (involves: 129S6/SvEvTac)	kidney inflammation	J:148699
Ptgs2^tm1.1Wls/Ptgs2^tm1.1Wls (B6.129-Ptgs2^tm1.1Wls)	increased susceptibility to endotoxin shock	J:156331
Ptgs2^tm1Jed/Ptgs2^tm1Jed (involves: 129S7/SvEvBrd)	pyelonephritis	J:29974
Ptgs2^tm1Jed/Ptgs2^tm1Jed (involves: 129S7/SvEvBrd * C57BL/6)	peritoneal inflammation	J:118171
Ptgs2^tm1Jed/Ptgs2^tm1Jed (involves: 129S7/SvEvBrd * CD-1)	abnormal response to infection	J:120725
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:29510
	peritoneal inflammation	J:29510
	tubulointerstitial nephritis	J:29510
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to endotoxin shock	J:75611
	increased susceptibility to induced colitis	J:158426, J:60668
	increased tumor necrosis factor secretion	J:108054
	peritoneal inflammation	J:60668
Ptgs2^tm1Unc/Ptgs2^tm1Unc (B6.129P2-Ptgs2^tm1Unc)	abnormal class switch recombination	J:140698
	abnormal response to infection	J:140698
	decreased IgG1 level	J:140698
	decreased IgG2a level	J:140698
	decreased IgG3 level	J:140698
	decreased susceptibility to induced arthritis	J:110716
	increased IgM level	J:140698
Ptgs2^tm1Unc/Ptgs2^tm2.1Hahe (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased susceptibility to induced colitis	J:158426
Ptgs2^{tm2(Ptgs1)Fun}/Ptgs2^{tm2(Ptgs1)Fun} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:118171
Ptgs2^{tm2.1(Ptgs1)Fun}/Ptgs2^{tm2.1(Ptgs1)Fun} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)	abnormal macrophage physiology	J:118171
	kidney inflammation	J:118171
	peritoneal inflammation	J:118171
Ptgs2os^tm1Scrp/Ptgs2os^tm1Scrp (Not Specified)	abnormal chemokine level	J:325487
	decreased CCL3 level	J:325487
	decreased circulating CCL3 level	J:325487
	decreased circulating interleukin-6 level	J:325487
	increased interferon-beta secretion	J:325487
Pth1r^{tm1a(EUCOMM)Hmgu}/Pth1r^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Pth1r^{tm1a(EUCOMM)Hmgu}/Wtsi)	blood in lymph vessels	J:239583
Ptk2b^tm1Schl/Ptk2b^tm1Schl (involves: 129S1/Sv * 129X1/SvJ)	abnormal macrophage physiology	J:99741
	decreased acute inflammation	J:99741
	impaired macrophage chemotaxis	J:99741
Ptn^tm1Tmu/Ptn^tm1Tmu (B6.Cg-Ptn^tm1Tmu)	impaired macrophage chemotaxis	J:102069
Ptn^tm1Tmu/Ptn^tm1Tmu (B6.Cg-Ptn^tm1Tmu)	impaired neutrophil recruitment	J:102069
Ptpn2^tm1.1Kry/Ptpn2^tm1.1Kry Tg(Col1a1-cre)1Kry/0 (involves: 129 * C57BL/6J * FVB)	abnormal osteoclast physiology	J:183709
Ptpn2^tm1Mtr/Ptpn2^tm1Mtr (involves: 129S4/SvJae * BALB/c)	abnormal inflammatory response	J:90541
	abnormal thymus involution	J:42595
	increased inflammatory response	J:90541
	increased interferon-gamma secretion	J:90541
	increased interleukin-12 secretion	J:90541
	increased tumor necrosis factor secretion	J:90541
Ptpn6^m1Amgn/Ptpn6^m1Amgn (involves: C3H/HeSnJ * C57BL/6J * Swiss)	increased circulating interleukin-17 level	J:168664
Ptpn6^m1Anu/Ptpn6^m1Anu (C57BL/6JAnu-Ptpn6^m1Anu)	decreased IgM level	J:225105
Ptpn6^m1Btlr/Ptpn6^m1Btlr (C57BL/6J-Ptpn6^m1Btlr/Mmucd)	decreased susceptibility to bacterial infection	J:142845
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:142845
	increased anti-chromatin antibody level	J:142845
	increased IgM level	J:142845
	increased inflammatory response	J:94077
	lung inflammation	J:142845
	salivary gland inflammation	J:142845
Ptpn6^M5Btlr/Ptpn6^M5Btlr (C57BL/6J-Ptpn6^M5Btlr)	decreased IgD level	J:265075
Ptpn6^M5Btlr/Ptpn6^M5Btlr (C57BL/6J-Ptpn6^M5Btlr)	decreased IgM level	J:265075
Ptpn6^me-B2/Ptpn6^me-B2 (involves: BALB/c)	abnormal circulating chemokine level	J:169850
	increased circulating interferon-gamma level	J:169850
	increased circulating interleukin-1 beta level	J:169850
	increased circulating interleukin-6 level	J:169850
	increased circulating interleukin-10 level	J:169850
	increased circulating serum amyloid protein level	J:169850
	increased IgG level	J:169850
	increased IgM level	J:169850
	interstitial pneumonia	J:169850
	skin inflammation	J:169850
Ptpn6^me-v/Ptpn6^me-v (C57BL/6J-Ptpn6^me-v)	abnormal immunoglobulin level	J:7665
	abnormal inflammatory response	J:20845
	abnormal T cell physiology	J:1661
	chronic inflammation	J:20845
	interstitial pneumonia	J:7531
	rheumatoid arthritis	J:20845
Ptpn6^me/Ptpn6^me (C57BL/6J-Ptpn6^me/J)	abnormal humoral immune response	J:5579
	autoimmune response	J:5579
	increased IgA level	J:5579
	increased IgG level	J:5579
	increased IgM level	J:5579
	increased immunoglobulin level	J:5579
Ptpn6^me/Ptpn6^me (involves: C3H/HeN * C57BL/6J * NFS)	increased autoantibody level	J:30994
	increased IgM level	J:30994
	increased splenocyte proliferation	J:30994
Ptpn6^me/Ptpn6^me (C3FeLe.B6 a/a-Ptpn6^me/J)	increased microglial cell activation	J:88807
Ptpn6^me/Ptpn6^me (either: (involves: C3H * C57BL/6J) or (involves: C57BL/6J * C57BL/6N))	lung inflammation	J:5999
Ptpn9^tm1Dny/Ptpn9^tm1Dny (B6.129-Ptpn9^tm1Dny)	decreased T cell proliferation	J:118880
Ptpn11^tm1Gsf/Ptpn11^tm1Gsf Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	increased acute inflammation	J:172422
	increased circulating interleukin-6 level	J:172422
	liver inflammation	J:172422
Ptpn11^tm1Gsf/Ptpn11^tm1Gsf Stat3^tm1Vpo/Stat3^tm1Vpo Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	liver inflammation	J:172422
Ptpn12^tm1Vei/Ptpn12^tm1Vei Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Ptpn12^tm1Vei)	abnormal cytokine secretion	J:163910
	abnormal T cell physiology	J:163910
	decreased T cell proliferation	J:163910
Ptpn12^tm1Vei/Ptpn12^tm1Vei Tg(Lck-cre)1Cwi/0 (B6.Cg-Ptpn12^tm1Vei Tg(Lck-cre)1Cwi)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:163910
Ptpn13^tm1Gru/Ptpn13^tm1Gru (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:118426
	abnormal cytokine secretion	J:118426
	decreased susceptibility to bacterial infection	J:118426
Ptpn22^tm1.1Draw/Ptpn22⁺ (involves: 129 * C57BL/6)	abnormal B cell physiology	J:201448
	abnormal T cell physiology	J:201448
	autoimmune response	J:201448
	decreased B cell apoptosis	J:201448
	increased anti-double stranded DNA antibody level	J:201448
	increased B cell proliferation	J:201448
	increased IgG1 level	J:201448
	increased interleukin-2 secretion	J:201448
	increased T cell proliferation	J:201448
Ptpn22^tm1.1Draw/Ptpn22^tm1.1Draw (involves: 129 * C57BL/6)	abnormal B cell activation	J:201448
	abnormal B cell physiology	J:201448
	abnormal T cell physiology	J:201448
	autoimmune response	J:201448
	decreased B cell apoptosis	J:201448
	glomerulonephritis	J:201448
	increased anti-double stranded DNA antibody level	J:201448
	increased anti-insulin autoantibody level	J:201448
	increased B cell proliferation	J:201448
	increased IgE level	J:201448
	increased IgG1 level	J:201448
	increased IgG3 level	J:201448
	increased IgM level	J:201448
	increased inflammatory response	J:201448
	increased interleukin-2 secretion	J:201448
	increased T cell proliferation	J:201448
Ptpn22^tm1.1Kas/Ptpn22^tm1.1Kas (involves: C57BL/6)	abnormal dendritic cell physiology	J:176519
	increased B cell proliferation	J:176519
	increased IgG2a level	J:176519
	increased IgG3 level	J:176519
	increased IgM level	J:176519
	increased interleukin-12 secretion	J:176519
	increased T cell proliferation	J:176519
Ptpn22^tm1.1Kas/Ptpn22^tm1.1Kas Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	increased T cell proliferation	J:176519
Ptpn22^tm1Achn/Ptpn22^tm1Achn (involves: C57BL/6)	abnormal T cell physiology	J:90029
	increased IgE level	J:90029
	increased IgG1 level	J:90029
	increased IgG2a level	J:90029
Ptpn22^tm2Achn/Ptpn22^tm2Achn (involves: C57BL/6)	abnormal T cell physiology	J:90029
	increased IgE level	J:90029
	increased IgG1 level	J:90029
	increased IgG2a level	J:90029
Ptpn22^tm2Achn/Ptpn22^tm2Achn (B6.Cg-Ptpn22^tm2Achn)	abnormal T cell activation	J:147129
Ptpn22^tm2Achn/Ptpn22^tm2Achn (B6.Cg-Ptpn22^tm2Achn)	abnormal thymocyte activation	J:147129
Ptpn22^tm2Achn/Ptpn22^tm2Achn Ptprc^tm1Weis/Ptprc^tm1Weis (B6.Cg-Ptprc^tm1Weis Ptpn22^tm2Achn)	abnormal B cell activation	J:147129
	abnormal follicular B cell physiology	J:147129
	abnormal T cell activation	J:147129
	abnormal thymocyte activation	J:147129
	glomerulonephritis	J:147129
	increased autoantibody level	J:147129
	liver inflammation	J:147129
	lung inflammation	J:147129
Ptprc^loc/Ptprc^loc (C57BL/6JSfdAnu-Ptprc^loc/AnuApb)	abnormal thymocyte activation	J:104190
Ptprc^m1Smv/Ptprc^m1Smv (involves: C57BL/6J * C57BL/10J)	abnormal immune system physiology	J:214487
	CNS inflammation	J:214487
	increased susceptibility to Herpesvirales infection	J:214487
Ptprc^m2Btlr/Ptprc^m2Btlr (C57BL/6J-Ptprc^m2Btlr)	abnormal humoral immune response	J:216796
Ptprc^M10Btlr/Ptprc^M10Btlr (C57BL/6J-Ptprc^M10Btlr)	decreased IgE level	J:272777
Ptprc^tm1Mak/Ptprc^tm1Mak (involves: 129/Sv * C57BL/6)	abnormal response to infection	J:13163
	decreased B cell proliferation	J:13163
	decreased cytotoxic T cell cytolysis	J:13163
	decreased T cell proliferation	J:13163
Ptprc^tm1Mak/Ptprc^tm1Mak (involves: 129)	abnormal osteoclast physiology	J:141275
	decreased mast cell degranulation	J:110782
	decreased susceptibility to type I hypersensitivity reaction	J:110782
Ptprc^tm1Mak/Ptprc^tm1Mak (B6.Cg-Ptprc^tm1Mak)	abnormal NK cell physiology	J:109462
	decreased cytotoxic T cell cytolysis	J:111646
	increased T cell apoptosis	J:111646
Ptprc^tm1Mak/Ptprc^tm1Mak Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal B cell physiology	J:131736
	abnormal cytokine secretion	J:131736
	impaired macrophage phagocytosis	J:131736
Ptprc^tm1Mak/Ptprc^tm1Mak Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (B6.Cg-Ptprc^tm1Mak Ptprj^tm1.2Weis)	liver inflammation	J:131736
	lung inflammation	J:131736
Ptprc^tm1Tyb/Ptprc^tm1Tyb (C.129S2-Ptprc^tm1Tyb)	abnormal T cell physiology	J:57681
Ptprc^tm1Tyb/Ptprc^tm1Tyb (B6.129S2-Ptprc^tm1Tyb)	abnormal chemokine secretion	J:98190
	abnormal cytokine secretion	J:98190
	abnormal NK cell physiology	J:98190
Ptprc^tm1Weis/Ptprc⁺ (involves: 129X1/SvJ * C57BL/6)	increased anti-double stranded DNA antibody level	J:66501
	increased IgG2a level	J:66501
	increased susceptibility to autoimmune disorder	J:66501
Ptprc^tm1Weis/Ptprc^tm1Weis (involves: 129X1/SvJ * C57BL/6)	abnormal B cell activation	J:66501
	abnormal T cell activation	J:66501
	glomerulonephritis	J:66501
	increased anti-double stranded DNA antibody level	J:66501
	increased IgA level	J:66501
	increased IgG2a level	J:66501
	increased susceptibility to autoimmune disorder	J:66501
Ptprc^tm1Weis/Ptprc^tm1Weis (B6.129X1-Ptprc^tm1Weis)	abnormal B cell activation	J:147129
	abnormal follicular B cell physiology	J:147129
	abnormal T cell activation	J:147129
	abnormal thymocyte activation	J:147129
	liver inflammation	J:147129
	lung inflammation	J:147129
Ptprcap^tm1Tkda/Ptprcap^tm1Tkda (involves: 129X1/SvJ)	abnormal cytotoxic T cell physiology	J:48387
	decreased B cell proliferation	J:48387
	decreased T cell proliferation	J:48387
Ptpre^tm1Ael/Ptpre^tm1Ael (involves: 129S6/SvEvTac * C57BL/6)	abnormal osteoclast physiology	J:90031
Ptprn^tm1Aln/Ptprn^tm1Aln (NOD.129S4-Ptprn^tm1Aln)	increased susceptibility to autoimmune diabetes	J:107161
Ptprn^tm1Aln/Ptprn^tm1Aln (NOD.129S4-Ptprn^tm1Aln)	insulitis	J:107161
Ptprz1^tm1Mno/Ptprz1^tm1Mno (B6.129-Ptprz1^tm1Mno)	decreased susceptibility to bacterial infection	J:85826
Ptprz1^tm1Schl/Ptprz1^tm1Schl (involves: 129 * Swiss Webster)	increased susceptibility to experimental autoimmune encephalomyelitis	J:79860
Pttg1^tm1Sme/Pttg1^tm1Sme (involves: 129S4/SvJae * C57BL/6)	decreased IgG level	J:72267
	decreased IgM level	J:72267
	decreased immunoglobulin level	J:72267
Ptx3^tm1Mant/Ptx3^tm1Mant (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal dendritic cell physiology	J:85080
	abnormal macrophage physiology	J:85080
	abnormal professional antigen presenting cell physiology	J:85080
	abnormal T-helper 1 physiology	J:85080
	impaired macrophage phagocytosis	J:85080
	increased susceptibility to bacterial infection	J:85080
	increased susceptibility to fungal infection	J:85080
	lung inflammation	J:85080
Ptx3^tm1Zuk/Ptx3^tm1Zuk (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to Coronaviridae infection	J:188421
Pvr^tm1Gbn/Pvr^tm1Gbn (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * BALB/c))	abnormal response to infection	J:123540
	decreased IgA level	J:123540
	decreased IgG1 level	J:123540
	decreased IgG2a level	J:123540
	decreased IgG2b level	J:123540
	decreased IgG level	J:123540
Pvrig^tm1.2Sgng/Pvrig^tm1.2Sgng (B6(Cg)-Pvrig^tm1.1Sgng)	abnormal CD8-positive, alpha-beta T cell physiology	J:324171
Pvrig^tm1.2Sgng/Pvrig^tm1.2Sgng (B6(Cg)-Pvrig^tm1.1Sgng)	abnormal T cell physiology	J:324171
Pxdn^mhdakta048/Pxdn^mhdakta048 (involves: C3HeB/FeJ * C57BL/6J)	eye inflammation	J:213336
Pycard^tm1Ayaz/Pycard^tm1Ayaz Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased interleukin-1 alpha secretion	J:191239
	decreased interleukin-1 beta secretion	J:191239
	decreased interleukin-6 secretion	J:191239
	decreased tumor necrosis factor secretion	J:191239
Pycard^tm1Flv/Pycard^tm1Flv (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:113333
	decreased circulating interleukin-1 beta level	J:113333
	decreased circulating interleukin-18 level	J:113333, J:158969
	decreased interleukin-1 alpha secretion	J:113333
	decreased interleukin-1 beta secretion	J:113333
	decreased susceptibility to endotoxin shock	J:113333
	decreased susceptibility to type IV hypersensitivity reaction	J:113333
	increased susceptibility to Herpesvirales infection	J:158969
Pycard^tm1Flv/Pycard^tm1Flv (B6.129S5-Pycard^tm1Flv)	increased IgA level	J:173245
	increased IgG2c level	J:173245
	increased susceptibility to induced colitis	J:173245
Pycard^tm1Flv/Pycard^tm1Flv Slc11a1^s/Slc11a1^s (B6.129S5-Pycard^tm1Flv)	increased susceptibility to bacterial infection	J:124378
Pycard^tm1Nnz/Pycard^tm1Nnz (involves: 129 * C57BL/6)	decreased interleukin-1 beta secretion	J:129871
Pycard^tm1Nnz/Pycard^tm1Nnz (involves: 129 * C57BL/6)	decreased interleukin-18 secretion	J:129871
Pycard^tm1Tno/Pycard^tm1Tno (involves: 129S4/SvJae * C57BL/6)	decreased interferon-gamma secretion	J:100807
	decreased interleukin-1 beta secretion	J:100807
	decreased interleukin-18 secretion	J:100807
	decreased susceptibility to endotoxin shock	J:100807
Pycard^tm1Vmd/Pycard^tm1Vmd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	decreased inflammatory response	J:91292
	decreased interleukin-1 alpha secretion	J:91292
	decreased interleukin-1 beta secretion	J:91292
	decreased interleukin-18 secretion	J:91292
Pycard^tm1Vmd/Pycard^tm1Vmd (involves: 129S1/Sv * 129X1/SvJ)	abnormal response to infection	J:106976
	decreased interleukin-1 beta secretion	J:124226, J:106976
	decreased interleukin-18 secretion	J:106976
Pycard^tm1Vmd/Pycard^tm1Vmd (B6.129-Pycard^tm1Vmd)	abnormal macrophage physiology	J:160545
	decreased circulating interleukin-1 beta level	J:193522
	decreased circulating interleukin-18 level	J:193522
	decreased interleukin-1 beta secretion	J:193522, J:160545
	decreased susceptibility to endotoxin shock	J:193522
	increased interferon-beta secretion	J:160545
	increased tumor necrosis factor secretion	J:160545
Pygl^{tm1a(KOMP)Wtsi}/Pygl^{tm1a(KOMP)Wtsi} (C57BL/6N-Pygl^{tm1a(KOMP)Wtsi})	liver inflammation	J:284765
Pymr^129X1/SvJMs/Pymr^NC/JicJcl (involves: 129X1/SvJMs * NC/JicJcl)	decreased susceptibility to parasitic infection	J:92924
Pymr^NC/JicJcl/Pymr^NC/JicJcl (involves: 129X1/SvJMs * NC/JicJcl)	increased susceptibility to parasitic infection	J:92924
Pzp^tm1Vln/Pzp^tm1Vln (involves: 129P2/OlaHsd * C57BL)	increased susceptibility to induced pancreatitis	J:28328
Pzp^tm1Vln/Pzp^tm1Vln (involves: 129P2/OlaHsd * C57BL)	pancreas inflammation	J:28328
Pzp^tm1Vln/Pzp^tm1Vln (B.129P2-Pzp^tm1Vln)	abnormal cytokine level	J:57485
Pzp^tm1Vln/Pzp^tm1Vln (B.129P2-Pzp^tm1Vln)	liver inflammation	J:57485
Pzp^tm1Vln/Pzp^tm1Vln (B6.129P2-Pzp^tm1Vln)	abnormal cytokine secretion	J:113532
Qprt^{Gt(OST337946)Lex}/Qprt^{Gt(OST337946)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal cytokine level	J:282516
	abnormal macrophage physiology	J:282516
Rab7^tm1.1Ale/Rab7^tm1.1Ale Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell physiology	J:211733
	decreased T cell proliferation	J:211733
Rab7b^tm1Ciphe/Rab7b^tm1Ciphe Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6N * CBA)	abnormal dendritic cell migration	J:321707
Rab11a^tm1.1Ngao/Rab11a^tm1.1Ngao Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6J * SJL)	abnormal cytokine secretion	J:215917
	increased interleukin-1 beta secretion	J:215917
	increased interleukin-6 secretion	J:215917
	intestinal inflammation	J:215917
Rab11a^tm1.1Ngao/Rab11a^tm1.1Ngao Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased interleukin-6 secretion	J:215917
Rab13^tm1.1Ktg/Rab13^tm1.1Ktg (involves: C57BL/6)	abnormal leukocyte adhesion	J:259093
	abnormal T cell physiology	J:259093
	decreased lymphocyte chemotaxis	J:259093
	impaired leukocyte migration	J:259093
Rab20^{tm1a(EUCOMM)Hmgu}/Rab20^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal macrophage physiology	J:243883
Rab26^em1Guwa/Rab26^em1Guwa (Not Specified)	increased susceptibility to endotoxin shock	J:306921
Rab27a^ash/Rab27a^ash (involves: C3H/HeDiSn)	abnormal NK cell degranulation	J:111253
	decreased cytotoxic T cell cytolysis	J:111253, J:67600
	impaired natural killer cell mediated cytotoxicity	J:111253
Rab27a^ash/Rab27a^ash (B6.C3Sn-Rab27a^ash)	abnormal cytotoxic T cell physiology	J:193137
	decreased cytotoxic T cell cytolysis	J:193137
	decreased NK cell degranulation	J:193137
	increased circulating interferon-gamma level	J:193137
	increased circulating interleukin-1 beta level	J:193137
	increased circulating interleukin-6 level	J:193137
	increased circulating tumor necrosis factor level	J:193137
	increased susceptibility to Riboviria infection	J:193137
Rab27a^cct/Rab27a^cct (C57BL/6-Rab27a^cct)	abnormal neutrophil physiology	J:114299
Rab32^{tm1c(KOMP)Wtsi}/Rab32^{tm1c(KOMP)Wtsi} Tg(Itgax-cre)1-1Reiz/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)	abnormal cytokine secretion	J:267497
	increased susceptibility to bacterial infection	J:231298, J:267497
	increased susceptibility to colitis induced morbidity/mortality	J:267497
	increased susceptibility to induced colitis	J:267497
Rab43^tm1.2Kmm/Rab43^tm1.2Kmm (B6.129S(C)-Rab43^tm1.2Kmm)	abnormal dendritic cell antigen presentation	J:101977
Rab44^em1Rbrc/Rab44^em1Rbrc (Not Specified)	abnormal mast cell physiology	J:304506
Rab44^em1Rbrc/Rab44^em1Rbrc (Not Specified)	increased susceptibility to type I hypersensitivity reaction	J:304506
Rabgef1^tm1Glli/Rabgef1^tm1Glli (either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal inflammatory response	J:91790
	chronic inflammation	J:91790
	increased IgE level	J:91790
	increased interleukin-6 secretion	J:91790
	increased tumor necrosis factor secretion	J:91790
Rabgef1^tm2Glli/Rabgef1^tm2Glli (WBB6F1)	increased interleukin-6 secretion	J:91790
Rabgef1^tm2Glli/Rabgef1^tm2Glli (WBB6F1)	increased tumor necrosis factor secretion	J:91790
Rabggta^gm/Rabggta⁺ (C57BL/6J-Rabggta^gm)	decreased cytotoxic T cell cytolysis	J:67600
Rabggta^gm/Rabggta^gm (C57BL/6J-Rabggta^gm)	decreased cytotoxic T cell cytolysis	J:67600
Rac1^tm1Djk/Rac1^tm1.1Djk Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased acute inflammation	J:83457
	impaired neutrophil chemotaxis	J:83457
	impaired neutrophil recruitment	J:83457
Rac2^m1Btlr/Rac2⁺ (C57BL/6J-Rac2^m1Btlr)	decreased IgM level	J:221478
Rac2^m1Btlr/Rac2⁺ (C57BL/6J-Rac2^m1Btlr)	impaired humoral immune response	J:221478
Rac2^m1Btlr/Rac2^m1Btlr (C57BL/6J-Rac2^m1Btlr)	decreased IgM level	J:221478
Rac2^m1Btlr/Rac2^m1Btlr (C57BL/6J-Rac2^m1Btlr)	impaired humoral immune response	J:221478
Rac2^m3Btlr/Rac2^m3Btlr (C57BL/6J-Rac2^m3Btlr)	decreased IgM level	J:236680
Rac2^m3Btlr/Rac2^m3Btlr (C57BL/6J-Rac2^m3Btlr)	decreased response to antigen	J:236680
Rac2^M4Btlr/Rac2⁺ (C57BL/6J-Rac2^M4Btlr)	abnormal cytotoxic T cell physiology	J:255273
	decreased IgG level	J:255273
	decreased IgM level	J:255273
	impaired humoral immune response	J:255273
	impaired natural killer cell mediated cytotoxicity	J:255273
	increased IgM level	J:255273
Rac2^M4Btlr/Rac2^M4Btlr (C57BL/6J-Rac2^M4Btlr)	abnormal cytotoxic T cell physiology	J:255273
	decreased IgE level	J:255273
	decreased IgG level	J:255273
	decreased IgM level	J:255273
	impaired humoral immune response	J:255273
	impaired natural killer cell mediated cytotoxicity	J:255273
Rac2^tm1Mddw/Rac2^tm1Mddw (involves: 129S/SvEv * C57BL/6)	abnormal neutrophil physiology	J:53362
	decreased T cell proliferation	J:119437
	impaired neutrophil chemotaxis	J:53362
	increased susceptibility to bacterial infection	J:53362
Rac2^tm1Mddw/Rac2^tm1Mddw (involves: 129S/SvEv)	abnormal neutrophil physiology	J:131305
Rac2^tm1Mddw/Rac2^tm1Mddw (B6.129S-Rac2^tm1Mddw)	abnormal neutrophil physiology	J:83457
Rac2^tm1Mddw/Rac2^tm1Mddw Tg(TcrAND)53Hed/0 (involves: 129S/SvEv * C57BL/6 * SJL)	abnormal T cell activation	J:119437
	decreased circulating interleukin-2 level	J:119437
	decreased T cell proliferation	J:119437
Rad21^tm1.1Mmk/Rad21^tm1.1Mmk Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:175827
Rad23b^tm1Gvh/Rad23b^tm1Gvh (involves: 129P2/OlaHsd * C57BL/6)	blepharitis	J:74288
	conjunctivitis	J:74288
Rad50^tm1Flv/Rad50^tm1Flv (involves: 129S6/SvEvTac * C57BL/6)	abnormal T-helper 2 physiology	J:94870
	decreased interleukin-4 secretion	J:94870
	decreased interleukin-5 secretion	J:94870
	decreased interleukin-13 secretion	J:94870
Rad50^tm2.1Flv/Rad50^tm2.1Flv (B6.129S6-Rad50^tm2.1Flv)	decreased interleukin-4 secretion	J:196154
	decreased interleukin-5 secretion	J:196154
	decreased interleukin-13 secretion	J:196154
Rad50^tm2.1Flv/Rad50^tm2.2Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T-helper 1 physiology	J:165055
	abnormal T-helper 2 physiology	J:165055
	decreased IgE level	J:165055
	decreased inflammatory response	J:165055
	decreased interferon-gamma secretion	J:165055
	decreased interleukin-4 secretion	J:165055
	decreased interleukin-5 secretion	J:165055
	decreased interleukin-13 secretion	J:165055
Rad50^tm3.1Flv/Rad50^tm3.1Flv (B6.129S6-Rad50^tm3.1Flv)	decreased interleukin-4 secretion	J:196154
	decreased interleukin-5 secretion	J:196154
	decreased interleukin-13 secretion	J:196154
Rad50^tm4.1Flv/Rad50^tm4.1Flv (B6.129S6-Rad50^tm4.1Flv)	decreased interleukin-5 secretion	J:196154
	decreased interleukin-13 secretion	J:196154
	increased interleukin-4 secretion	J:196154
	increased interleukin-5 secretion	J:196154
	increased interleukin-13 secretion	J:196154
Raet1d^em1Dhr/Raet1d^em1Dhr Raet1e^em1Dhr/Raet1e^em1Dhr (involves: C57BL/6)	increased natural killer cell mediated cytotoxicity	J:221188
Rag1^m2Btlr/Rag1^m2Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Rag1^tm1Bal/Rag1^tm1Bal Tnfrsf1a^tm1.1Gkl/Tnfrsf1a^tm1.1Gkl (involves: 129/Sv * C57BL/6)	liver inflammation	J:92470
Rag1^tm1Jsek/Rag1^tm1Jsek (involves: 129S6/SvEvTac)	abnormal immunoglobulin level	J:146912
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * CD-1)	decreased IgM level	J:1934
Rag1^tm1Mom/Rag1^tm1Mom (B6.129S7-Rag1^tm1Mom)	decreased IgM level	J:78613
	decreased immunoglobulin level	J:111828
	dermatitis	J:111828
	ear inflammation	J:111828
Rag1^tm1Mom/Rag1^tm1Mom (NOD.129S7(B6)-Rag1^tm1Mom)	abnormal level of surface class II molecules	J:109843
	decreased immunoglobulin level	J:109843
	impaired natural killer cell mediated cytotoxicity	J:109843
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6)	abnormal response to infection	J:119344
	autoimmune response	J:138466
	decreased susceptibility to induced colitis	J:194587
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd)	decreased inflammatory response	J:94420
Rag1^tm1Mom/Rag1^tm1Mom Prf1^tm1Sdz/Prf1^tm1Sdz (NOD.Cg-Rag1^tm1Mom Prf1^tm1Sdz/Sz)	abnormal level of surface class II molecules	J:109843
	abnormal response to transplant	J:109843
	decreased immunoglobulin level	J:109843
	impaired natural killer cell mediated cytotoxicity	J:109843
Rag1^tm1Mom/Rag1^tm1Mom Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J)	increased circulating tumor necrosis factor level	J:117880
	increased inflammatory response	J:117880
Rag1^tm1Mom/Rag1^tm1Mom Slc46a2^tm1Moki/Slc46a2⁺ Tg(TcraB12,TcrbB12)1Rest/0 (involves: 129 * C57BL/6)	increased T cell apoptosis	J:140121
Rag1^tm1Mom/Rag1^tm1Mom Tg(CAG-Lyn)#Paau/0 (involves: 129S7/SvEvBrd C57BL/6)	decreased inflammatory response	J:151886
Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-Rag1^tm1Mom Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs/Dvs)	increased susceptibility to autoimmune diabetes	J:94192
Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	increased susceptibility to autoimmune diabetes	J:111874
Rag1^tm1Mom/Rag1^tm1Mom Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6)	rheumatoid arthritis	J:54056
	small intestinal inflammation	J:54056
Rag1^tm1Mom/Rag1^tm1Mom Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/10)	abnormal osteoclast physiology	J:129304
Rag1^tm1Mom/Rag1^tm1Mom Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (involves: 129S/SvEvBrd * 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to bacterial infection	J:145712
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:145712
Rag2^m1Btlr/Rag2^m1Btlr (C57BL/6J-Rag2^m1Btlr)	abnormal humoral immune response	J:203045
	decreased IgG level	J:203045
	decreased IgM level	J:203045
Rag2^tm1.1Cgn/Rag2^tm1.1Cgn Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0 (involves: C57BL/6 * DBA/2)	autoimmune response	J:134764
	CNS inflammation	J:134764
Rag2^tm1Avla/Rag2^tm1Avla (involves: 129/Sv * C57BL/6)	abnormal B cell physiology	J:122108
	abnormal lymphocyte physiology	J:122108
	colitis	J:122108
	decreased IgA level	J:122108
	decreased IgG level	J:122108
	decreased T cell proliferation	J:122108
	erythroderma	J:122108
Rag2^tm1Cgn/Rag2^tm1.1Cgn Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal B cell activation	J:72214
Rag2^tm1Cgn/Rag2^tm1Cgn Xrcc4^tm1Fwa/Xrcc4^tm2Fwa Tg(Cr2-cre)3Cgn/? (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal class switch recombination	J:150339
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * MF1)	decreased IgM level	J:1935
	increased natural killer cell mediated cytotoxicity	J:1935
	increased susceptibility to infection	J:1935
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv)	abnormal chemokine secretion	J:140483
	abnormal interferon secretion	J:140483
	abnormal macrophage physiology	J:140483
	abnormal response to transplant	J:116136
	abnormal T-helper 1 physiology	J:116136
	colitis	J:116136
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:140483
	increased susceptibility to bacterial infection	J:140483
	lung inflammation	J:140483
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	decreased susceptibility to parasitic infection	J:64283
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	decreased susceptibility to type IV hypersensitivity reaction	J:165513
Rag2^tm1Fwa/Rag2^tm1Fwa Cd47^tm1Fpl/Cd47^tm1Fpl Il2rg^tm1Cgn/Y (involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to graft versus host disease	J:203904
	increased susceptibility to Retroviridae infection	J:203904
Rag2^tm1Fwa/Rag2^tm1Fwa Sos1^tm1.1Les/Sos1^tm1.1Les Tg(Lck-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6)	decreased T cell proliferation	J:174536
Rag2^tm1Fwa/Rag2^tm1Fwa Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S/SvEv * 129S6/SvEvTac)	colitis	J:141481
	increased tumor necrosis factor secretion	J:141481
	large intestinal inflammation	J:141481
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraCN.B1,TcrbCN.B1)SM1Jen/0 (involves: 129S/SvEv * C57BL/6)	increased susceptibility to bacterial infection induced morbidity/mortality	J:162539
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S/SvEv * C57BL/6J * DBA/2J)	abnormal CD8-positive, alpha-beta T cell physiology	J:125259
	abnormal cytotoxic T cell physiology	J:66565
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcrHEL3A9)1Mmd/0 (involves: 129S/SvEv * C57BL/6)	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	thyroid gland inflammation	J:78309
Rag2^tm1Fwa/Rag2^tm1Fwa Wdr1^rede/Wdr1^rede (involves: 129S/SvEv * C57BL/6)	abnormal immune system physiology	J:134092
Rag2^tm1Libo/Rag2^tm1Libo (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal B cell physiology	J:84563
Rala^{tm1a(EUCOMM)Wtsi}/Rala^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rala^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Ramp1^tm1.1Tsuj/Ramp1^tm1.1Tsuj (C.129S2-Ramp1^tm1.1Tsuj)	abnormal chemokine secretion	J:125974
	abnormal cytokine secretion	J:125974
	increased circulating interferon-gamma level	J:125974
	increased circulating interleukin-6 level	J:125974
	increased circulating tumor necrosis factor level	J:125974
Rap1a^tm1Laaq/Rap1a^tm1Laaq (either: B6.Cg-Rap1a^tm1Laaq or (involves: C57BL/6))	abnormal leukocyte migration	J:140471
	abnormal macrophage physiology	J:140471
	abnormal neutrophil physiology	J:140471
Rap1a^tm1Tze/Rap1a^tm1Tze (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:144145
	decreased interleukin-2 secretion	J:144145
	decreased T cell proliferation	J:144145
Rap1gds1^tm1Ytk/Rap1gds1^tm1Ytk (involves: 129X1/SvJ * C57BL/6 * DBA)	increased thymocyte apoptosis	J:62244
Rapgef3^tm1Skc/Rapgef3^tm1Skc (Not Specified)	insulitis	J:201171
Raph1^tm1.2Fbg/Raph1^tm1.2Fbg (involves: 129S4/SvJae * C57BL/6)	abnormal cytokine level	J:238262
	increased inflammatory response	J:238262
	increased susceptibility to bacterial infection	J:238262
	large intestinal inflammation	J:238262
Rarres1^tm1.2Mhl/Rarres1^tm1.2Mhl (involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)	abnormal B cell activation	J:324270
	abnormal B cell physiology	J:324270
	decreased B cell apoptosis	J:324270
	increased B cell proliferation	J:324270
Rasa1^tm1Wid/Rasa1^tm1Wid (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6N)	increased susceptibility to induced colitis	J:189241
Rasa4^tm1Ywh/Rasa4^tm1Ywh (B6.129S6-Rasa4^tm1Ywh)	impaired macrophage phagocytosis	J:100455
Rasa4^tm1Ywh/Rasa4^tm1Ywh (B6.129S6-Rasa4^tm1Ywh)	increased susceptibility to bacterial infection	J:100455
Rasal3^tm1.1Fuj/Rasal3^tm1.1Fuj (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	decreased circulating interferon-gamma level	J:229641
	decreased circulating interleukin-4 level	J:229641
	decreased interferon-gamma secretion	J:229641
	decreased interleukin-4 secretion	J:229641
Rasgrf2^tm1Esn/Rasgrf2^tm1Esn (involves: 129S1/Sv * C57BL/10 * C57BR/cd)	decreased interleukin-2 secretion	J:128985
	decreased tumor necrosis factor secretion	J:128985
Rasgrf2^tm1Esn/Rasgrf2^tm1Esn Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S1/Sv * 129S2/SvPas * C57BL/10 * C57BR/cd)	abnormal T cell physiology	J:128985
	decreased interleukin-2 secretion	J:128985
	decreased T cell proliferation	J:128985
	decreased tumor necrosis factor secretion	J:128985
Rasgrp1^lag/Rasgrp1^lag (involves: 129 * C57BL/6)	abnormal T cell physiology	J:85189
	decreased T cell proliferation	J:85189
	glomerulonephritis	J:85189
	increased IgG level	J:85189
	increased susceptibility to systemic lupus erythematosus	J:85189
Rasgrp1^m1Anu/Rasgrp1⁺ (involves: C57BL/6JSfdAnu * CBA/J)	increased anti-nuclear antigen antibody level	J:207898
Rasgrp1^m1Anu/Rasgrp1^m1Anu (C57BL/6JSfdAnu-Rasgrp1^m1Anu)	autoimmune response	J:104190
Rasgrp1^m1Anu/Rasgrp1^m1Anu (involves: C57BL/6JSfdAnu * CBA/J)	increased anti-nuclear antigen antibody level	J:207898
Rasgrp1^m1Btlr/Rasgrp1^m1Btlr (C57BL/6J-Rasgrp1^m1Btlr)	abnormal humoral immune response	J:265163
	decreased IgM level	J:265163
	increased IgA level	J:265163
	increased IgE level	J:265163
	increased IgM level	J:265163
Rasgrp1^m3Btlr/Rasgrp1^m3Btlr (C57BL/6J-Rasgrp1^m3Btlr)	increased IgM level	J:265255
Rasgrp1^tm1.1Wz/Rasgrp1^tm1.1Wz (B6.Cg-Rasgrp1^tm1.1Wz)	abnormal immune system physiology	J:225109
	abnormal immunoglobulin level	J:225109
	decreased T cell proliferation	J:225109
	increased autoantibody level	J:225109
	increased IgE level	J:225109
	increased IgG1 level	J:225109
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn (involves: 129P3/J * C57BL/6J)	abnormal humoral immune response	J:108677
	increased immunoglobulin level	J:108677
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn Rasgrp3^tm1Jstn/Rasgrp3^tm1Jstn (involves: 129P3/J * C57BL/6J)	abnormal humoral immune response	J:108677
Rasgrp2^tm1Amg/Rasgrp2^tm1Amg (Not Specified)	abnormal neutrophil physiology	J:122618
Rasgrp2^tm1Amg/Rasgrp2^tm1Amg (Not Specified)	impaired neutrophil recruitment	J:122618
Rasgrp3^tm1Jstn/Rasgrp3^tm1Jstn (involves: 129P3/J * C57BL/6J)	abnormal humoral immune response	J:108677
	decreased IgG1 level	J:108677
	decreased IgG2a level	J:108677
	decreased IgG level	J:108677
Rasgrp4^tm1(cre)Rls/Rasgrp4^tm1(cre)Rls (C57BL/6-Rasgrp4^tm1(cre)Rls)	decreased susceptibility to induced arthritis	J:186519
	decreased susceptibility to induced colitis	J:186519
Rasgrp4^{tm1a(KOMP)Lste}/Rasgrp4^{tm1a(KOMP)Lste} (involves: C57BL/6)	abnormal neutrophil physiology	J:186412
	impaired neutrophil chemotaxis	J:186412
Rasgrp4^{tm1d(KOMP)Lste}/Rasgrp4^{tm1d(KOMP)Lste} (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	abnormal neutrophil physiology	J:186412
	impaired neutrophil chemotaxis	J:186412
Rassf5^tm1Kina/Rassf5^tm1Kina (involves: C57BL/6 * CBA * ICR)	abnormal dendritic cell physiology	J:92670
	abnormal leukocyte migration	J:92670
Rassf5^tm1Kina/Rassf5^tm1Kina (B6.Cg-Rassf5^tm1Kina)	abnormal lymphocyte physiology	J:168749
	glomerulonephritis	J:168749
	increased anti-double stranded DNA antibody level	J:168749
	increased B cell proliferation	J:168749
	increased IgG level	J:168749
	increased T cell proliferation	J:168749
Rbl1^tm1Mru/Rbl1^tm1Mru (involves: 129S4/SvJae * BALB/cJ)	abnormal inflammatory response	J:51060
Rbm4^{tm1a(EUCOMM)Hmgu}/Rbm4⁺ (C57BL/6N-Rbm4^{tm1a(EUCOMM)Hmgu}/Cnrm)	decreased IgG2b level	J:165965
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal cytokine secretion	J:125869
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Lck-cre)19Hhan/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal immune system physiology	J:168475
	abnormal regulatory T cell physiology	J:168475
	increased T cell proliferation	J:168475
Rbpj^tm1Kyo/Rbpj⁺ (involves: 129S2/SvPas * CD-1)	aortic valve inflammation	J:187551
Rbpj^tm1Kyo/Rbpj^tm1Kyo (involves: 129S2/SvPas)	abnormal humoral immune response	J:123631
	abnormal response to infection	J:123631
	decreased interleukin-4 secretion	J:123631
Rc3h1^{Gt(CC0753)Wtsi}/Rc3h1^{Gt(CC0753)Wtsi} (B6.129P2-Rc3h1^{Gt(CC0753)Wtsi})	chronic liver inflammation	J:199407
	ileum inflammation	J:199407
	intestinal inflammation	J:199407
Rc3h1^san/Rc3h1⁺ (involves: C57BL/6JSfdAnu)	abnormal T follicular helper cell physiology	J:189087
Rc3h1^san/Rc3h1⁺ (involves: C57BL/6JSfdAnu)	increased IgG level	J:189087
Rc3h1^san/Rc3h1^san (either: C57BL/6JSfdAnu-Rc3h1^san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))	glomerulonephritis	J:98938
	increased anti-double stranded DNA antibody level	J:98938
	increased anti-nuclear antigen antibody level	J:98938
	liver inflammation	J:98938
Rc3h1^san/Rc3h1^san (involves: C57BL/6JSfdAnu)	cecum inflammation	J:199407
	chronic liver inflammation	J:199407
	colitis	J:199407
	granulomatous inflammation	J:199407
	ileum inflammation	J:199407
	increased circulating tumor necrosis factor level	J:196137
	increased T cell proliferation	J:199407
	small intestinal inflammation	J:199407
Rc3h1^san/Rc3h1^san Rc3h2^tm1.2Cgv/Rc3h2^tm1.2Cgv (involves: C57BL/6 * C57BL/6JSfdAnu)	increased circulating tumor necrosis factor level	J:196137
	increased inflammatory response	J:196137
	increased susceptibility to bacterial infection	J:196137
	kidney inflammation	J:196137
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)	abnormal germinal center B cell physiology	J:177784
	decreased IgA level	J:177784
	decreased IgG1 level	J:177784
	decreased IgG3 level	J:177784
	increased IgG2b level	J:177784
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Rc3h2^{tm1c(KOMP)Wtsi}/Rc3h2^{tm1c(KOMP)Wtsi} Tg(Cd4-cre)1Cwi/? (involves: C57BL/6N * DBA/2)	abnormal immune system physiology	J:196136
	increased T cell proliferation	J:196136
Rc3h2^tm1.2Cgv/Rc3h2^tm1.2Cgv (involves: C57BL/6)	increased macrophage cytokine production	J:196137
Rc3h2^tm1.2Cgv/Rc3h2^tm1.2Cgv (involves: C57BL/6)	increased tumor necrosis factor secretion	J:196137
Rcan1^tm1Fmc/Rcan1^tm1Fmc (involves: 129S4/SvJae)	abnormal T cell apoptosis	J:85148
	abnormal T-helper 1 physiology	J:85148
	decreased IgG2a level	J:85148
	decreased interferon-gamma secretion	J:85148
	decreased T cell proliferation	J:85148
	increased susceptibility to endotoxin shock	J:152536
Rcan1^tm1Jmol/Rcan1^tm1Jmol Rcan2^tm1Jmol/Rcan2^tm1Jmol (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:109586
	abnormal cytokine secretion	J:109586
	decreased T cell proliferation	J:109586
Rcan1^tm1Jmol/Rcan1^tm1Jmol Rcan2^tm1Jmol/Rcan2^tm1Jmol Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:109586
	abnormal cytokine secretion	J:109586
	decreased T cell proliferation	J:109586
Rcbtb2^tm1.1Xyw/Rcbtb2^tm1.1Xyw (involves: C57BL/6 * CBA)	abnormal splenocyte physiology	J:282928
Rcc1l^{tm1a(EUCOMM)Hmgu}/Rcc1l⁺ (Not Specified)	decreased IgG1 level	J:165965
Rdh7^{tm1c(KOMP)Wtsi}/Rdh7^{tm1c(KOMP)Wtsi} Tg(RARE-Hspa1b/lacZ)12Jrt/0 Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * C57BL/6N * CD-1 * SJL)	decreased susceptibility to bacterial infection	J:279231
Rdns/Rdns⁺ (C57BL/6J-Rdns/GrsrJ)	increased susceptibility to otitis media	J:223062
Rdur^em1Jiche/Rdur^em1Jiche (Not Specified)	increased circulating interleukin-1 level	J:340209
	increased circulating interleukin-6 level	J:340209
	increased susceptibility to viral infection	J:340209
	increased susceptibility to viral infection induced morbidity/mortality	J:340209
Reg3g^tm1.1Lvh/Reg3g^tm1.1Lvh (B6.129-Reg3g^tm1.1Lvh)	increased IgA level	J:177506
Reg3g^{tm1a(KOMP)Wtsi}/Reg3g^{tm1a(KOMP)Wtsi} (C57BL/6-Reg3g^{tm1a(KOMP)Wtsi})	increased susceptibility to Orthomyxoviridae infection	J:233979
Rel^M1Btlr/Rel⁺ (C57BL/6J-Rel^M1Btlr)	decreased IgE level	J:236682
	decreased IgG level	J:236682
	decreased IgM level	J:236682
	decreased response to antigen	J:236682
Rel^M1Btlr/Rel^M1Btlr (C57BL/6J-Rel^M1Btlr)	decreased IgE level	J:236682
	decreased IgG level	J:236682
	decreased IgM level	J:236682
	decreased response to antigen	J:236682
Rel^m3Btlr/Rel^m3Btlr (C57BL/6J-Rel^m3Btlr)	decreased IgM level	J:272801
Rel^m3Btlr/Rel^m3Btlr (C57BL/6J-Rel^m3Btlr)	impaired humoral immune response	J:272801
Rel^tm1Brv/Rel^tm1Brv (involves: 129S1/Sv)	abnormal leukocyte physiology	J:46911
	abnormal macrophage physiology	J:46911
	abnormal T cell physiology	J:46911
	decreased IgG1 level	J:46911
	decreased IgG2b level	J:46911
	decreased IgG3 level	J:46911
	decreased IgG level	J:46911
	dermatitis	J:46911
	impaired macrophage chemotaxis	J:46911
	increased IgA level	J:46911
	increased IgG2a level	J:46911
	increased IgM level	J:46911
	increased susceptibility to bacterial infection	J:46911
Rel^tm1Grd/Rel⁺ (involves: 129S1/Sv * C57BL/6)	abnormal humoral immune response	J:28435
Rel^tm1Grd/Rel⁺ (involves: 129S1/Sv * C57BL/6)	decreased B cell proliferation	J:28435
Rel^tm1Grd/Rel^tm1Grd (involves: 129S1/Sv * C57BL/6)	abnormal cytokine secretion	J:37541, J:28435
	abnormal humoral immune response	J:28435
	abnormal macrophage physiology	J:37541
	decreased B cell proliferation	J:28435
	decreased IgG1 level	J:28435
	decreased IgG2a level	J:28435
	decreased IgG2b level	J:28435
	decreased IgG3 level	J:28435
	decreased IgM level	J:28435
	decreased susceptibility to parasitic infection	J:37541
	decreased T cell proliferation	J:28435
Rel^tm1Hcl/Rel⁺ (involves: 129S4/SvJae * C57BL/6)	decreased T cell proliferation	J:53513
Rel^tm1Hcl/Rel^tm1Hcl (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:79107, J:118907
	abnormal cytokine secretion	J:53513, J:79107
	abnormal dendritic cell physiology	J:118907
	abnormal macrophage physiology	J:118907
	abnormal professional antigen presenting cell physiology	J:118907
	decreased B cell proliferation	J:75621
	decreased cytotoxic T cell cytolysis	J:53513
	decreased IgE level	J:58987
	decreased susceptibility to autoimmune diabetes	J:118907
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:79107
	decreased T cell proliferation	J:53513, J:79107
Rela^tm1Asba/Rela^tm1Asba Tg(Vil1-cre)997Gum/0 (involves: 129 * C57BL/6J * SJL)	increased susceptibility to induced colitis	J:131977
Rela^tm1Bal/Rela^tm1Bal Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S4/SvJae * C57BL/6)	heart inflammation	J:60742
	liver inflammation	J:60742
	lung inflammation	J:60742
Rela^tm1Mpa/Rela^tm1Mpa Tg(Alb1-cre)7Gsc/0 (involves: FVB/N)	increased susceptibility to endotoxin shock	J:137861
Rela^tm1Rsch/Rela^tm1Rsch Ptf1a^tm1(cre)Hnak/? (involves: C57BL/6)	abnormal interleukin level	J:122194
	abnormal tumor necrosis factor level	J:122194
	lung inflammation	J:122194
	pancreas inflammation	J:122194
Rela^tm1Rsch/Rela^tm1Rsch Tg(Lck-cre)I57Jxm/0 (involves: ICR)	decreased interleukin-17 secretion	J:169863
	increased susceptibility to bacterial infection	J:169863
Rela^tm1Yuo/Rela^tm1Yuo (involves: 129S/SvEv)	abnormal lymphocyte physiology	J:63099
	decreased B cell proliferation	J:63099
	decreased IgA level	J:63099
	decreased IgG1 level	J:63099
	decreased T cell proliferation	J:63099
Rela^tm2.1Gho/Rela^tm2.1Gho (involves: 129S6/SvEvTac * C57BL/6)	increased inflammatory response	J:163663
	interstitial pneumonia	J:163663
	liver inflammation	J:163663
	lung inflammation	J:163663
	myositis	J:163663
Rela^tm2.1Gho/Rela^tm2.1Gho Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * 129S6/SvEvTac)	increased incidence of corneal inflammation	J:163663
	liver inflammation	J:163663
Relb^shep/Relb^shep (A;C-Relb^shep/GrsrJ)	liver inflammation	J:171971
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (C57BL/6-Relb^{Tg(H2-K1/GH1)106Bri})	abnormal antigen presentation	J:23081
	decreased T cell proliferation	J:76450
	glomerulonephritis	J:76450
	increased inflammatory response	J:23081, J:76450
	liver inflammation	J:76450
	lung inflammation	J:76450
	skin inflammation	J:76450
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (involves: C57BL/6)	decreased circulating interleukin-4 level	J:120659
	increased inflammatory response	J:120659
Relb^tm1.1Fwei/Relb^tm1.1Fwei Tg(Lck-cre)I57Jxm/0 (involves: ICR)	decreased interleukin-17 secretion	J:169863
	increased susceptibility to bacterial infection	J:169863
Relb^tm1Brv/Relb^tm1Brv (involves: 129S2/SvPas * C57BL/6)	abnormal cell-mediated immunity	J:22675
	abnormal cytokine level	J:40630
	abnormal cytotoxic T cell physiology	J:40630
	abnormal humoral immune response	J:40630
	abnormal immune system physiology	J:22675, J:40630
	abnormal immunoglobulin level	J:40630
	abnormal interferon level	J:40630
	abnormal interleukin level	J:40630
	abnormal macrophage physiology	J:40630
	abnormal tumor necrosis factor level	J:40630
	decreased B cell proliferation	J:40630
	decreased susceptibility to type IV hypersensitivity reaction	J:22675
	epididymis inflammation	J:22675
	impaired neutrophil phagocytosis	J:40630
	increased IgE level	J:40630
	increased IgM level	J:40630
	increased susceptibility to bacterial infection	J:40630
	increased susceptibility to Riboviria infection	J:40630
	intestinal inflammation	J:22675
	liver inflammation	J:22675
	lung inflammation	J:22675
	myositis	J:22675
	ovary inflammation	J:22675
	salivary gland inflammation	J:22675
	stomach inflammation	J:22675
Relb^tm1Brv/Relb^tm1Brv (either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6))	dermatitis	J:63950
	lung inflammation	J:63950
Relt^tm1Hlee/Relt^tm1Hlee (Not Specified)	increased T cell proliferation	J:266480
Ren1^tm1Tkh/Ren1^tm1Tkh (C57BL/6-Ren1^tm1Tkh)	kidney inflammation	J:110082
Retn^tm1Laz/Retn^tm1Laz Tg(CD68-RETN)#Laz/? (involves: 129S6/SvEvTac * C57BL/6)	white adipose tissue inflammation	J:171262
Retnla^tm1Mer/Retnla^tm1Mer (C57BL/6-Retnla^tm1Mer)	abnormal chemokine secretion	J:144784
	decreased interleukin-5 secretion	J:144784
	decreased interleukin-6 secretion	J:144927
	decreased susceptibility to induced colitis	J:144784, J:144927
	impaired eosinophil recruitment	J:144784
	increased interleukin-10 secretion	J:144927
Retnla^tm1Mer/Retnla^tm1Mer (C.B6-Retnla^tm1Mer)	decreased susceptibility to induced colitis	J:144784, J:144927
Retnla^tm1Mer/Retnla^tm1Mer (involves: C57BL/6)	abnormal macrophage physiology	J:147863
	abnormal T-helper 2 physiology	J:147863
	increased IgE level	J:147863
	increased IgG1 level	J:147863
	increased interleukin-4 secretion	J:147863
	increased interleukin-5 secretion	J:147863
	increased interleukin-13 secretion	J:147863
Retnlb^tm1Gdw/Retnlb^tm1Gdw (involves: 129S/SvEv * C57BL/6)	decreased inflammatory response	J:114507
Retnlb^tm1Gdw/Retnlb^tm1Gdw (involves: 129S/SvEv * C57BL/6)	decreased susceptibility to induced colitis	J:114507
Retnlb^tm1Lex/Retnlb^tm1Lex (FVB.129S5-Retnlb^tm1Lex)	abnormal CD4-positive, alpha-beta T cell physiology	J:235058
	decreased circulating interleukin-6 level	J:235058
	increased circulating interleukin-13 level	J:235058
	liver inflammation	J:235058
	white adipose tissue inflammation	J:235058
Retnlb^tm1Mer/Retnlb^tm1Mer (involves: 129S1/Sv * C57BL/6)	decreased susceptibility to induced colitis	J:141524
Retnlb^tm1Mer/Retnlb^tm1Mer (involves: 129S1/Sv * C57BL/6)	increased susceptibility to induced colitis	J:141524
Retnlb^tm1Mer/Retnlb^tm1Mer (involves: 129S1/Sv)	decreased IgG2a level	J:141446
	decreased interferon-gamma secretion	J:141446
	decreased susceptibility to parasitic infection	J:141446
	decreased tumor necrosis factor secretion	J:141446
	increased IgG1 level	J:141446
Rev1^tm1.1Jow/Rev1^tm1.1Jow (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:151700
Rev1^tm1Ndew/Rev1^tm1Ndew (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:119176
Rev3l^tm1.1Kunk/Rev3l^tm1.1Kunk (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:188723
Rev3l^tm1Rsky/Rev3l^tm1.1Rsky Tg(Cr2-cre)3Cgn/? (involves: C57BL/6)	abnormal class switch recombination	J:146453
	abnormal somatic hypermutation frequency	J:146453
	decreased B cell proliferation	J:146453
	decreased IgG1 level	J:146453
Rfk^tm1.1Jcbr/Rfk^tm1.1Jcbr Tg(Mx1-cre)1Cgn/? (involves: C57BL/6 * CBA)	decreased macrophage nitric oxide production	J:151999
Rftn1^tm1Ayos/Rftn1^tm1Ayos (B6.Cg-Rftn1^tm1Ayos)	decreased IgG2a level	J:150299
	decreased interferon-gamma secretion	J:150299
	decreased interleukin-4 secretion	J:150299
	decreased interleukin-17 secretion	J:150299
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:150299
Rfx5^tm1.1Ifo/Rfx5^tm1.1Ifo (involves: 129 * C57BL/6)	abnormal B lymphocyte antigen presentation	J:67941
	abnormal level of surface class II molecules	J:67941
	abnormal MHC II cell surface expression on macrophages	J:67941
	decreased IgG1 level	J:67941
	decreased IgM level	J:67941
Rfx5^tm1Ifo/Rfx5^tm1.1Ifo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6 * C.B-20)	abnormal MHC II cell surface expression on macrophages	J:67924
Rfx7^tm1.1Ggaur/Rfx7^tm1.1Ggaur Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: C57BL/6)	abnormal NK cell physiology	J:282535
	increased susceptibility to viral infection	J:282535
Rgcc^tm1Hrus/Rgcc^tm1Hrus (involves: 129S6/SvEvTac * C57BL/6)	increased interleukin-2 secretion	J:279555
	increased T cell proliferation	J:279555
Rgs1^tm1Jhk/Rgs1^tm1Jhk (B6.129P2-Rgs1^tm1Jhk)	abnormal B cell physiology	J:90780
	abnormal dendritic cell physiology	J:89680
	increased immunoglobulin level	J:90780
Rgs2^tm1Pngr/Rgs2^tm1Pngr (involves: C57BL/6J)	abnormal T cell proliferation	J:77273
Rgs3^tm1Ndul/Rgs3^tm1Ndul (B6.129-Rgs3^tm1Ndul)	increased susceptibility to type I hypersensitivity reaction	J:210195
Rgs3^tm1Ndul/Rgs3^tm1Ndul (B6.129-Rgs3^tm1Ndul)	lung inflammation	J:210195
Rgs4^tm1Sdlk/Rgs4^tm1Sdlk Tg(Myh11-icre/ERT2)1Soff/? (involves: FVB/N)	abnormal macrophage chemotaxis	J:215588
Rgs13^tm1.1Jhk/Rgs13^tm1.1Jhk (involves: C57BL/6)	abnormal humoral immune response	J:199530
	increased IgA level	J:199530
	increased IgG1 level	J:199530
	increased IgG2b level	J:199530
	increased IgG2c level	J:199530
	increased IgG3 level	J:199530
	increased IgM level	J:199530
Rgs13^tm1Drue/Rgs13^tm1Drue (B6.129S-Rgs13^tm1Drue)	abnormal mast cell physiology	J:130209
Rgs13^tm1Drue/Rgs13^tm1Drue (B6.129S-Rgs13^tm1Drue)	increased susceptibility to type I hypersensitivity reaction	J:130209
Rgs16^tm1.1Drue/Rgs16^tm1.1Drue (involves: C57BL/6)	abnormal T-helper 1 physiology	J:188966
	abnormal T-helper 2 physiology	J:188966
	granulomatous inflammation	J:188966
	increased interleukin-5 secretion	J:188966
	increased interleukin-10 secretion	J:188966
	increased interleukin-13 secretion	J:188966
	increased susceptibility to parasitic infection	J:188966
Rgsc844/Rgsc844⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal neutrophil physiology	J:133634
Rgsc1045/Rgsc1045⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal neutrophil physiology	J:133634
Rgsc1354/Rgsc1354⁺ (involves: C3H * C57BL/6JJcl)	abnormal neutrophil physiology	J:133634
Rgsc1547/Rgsc1547⁺ (involves: C3H * C57BL/6JJcl)	increased susceptibility to otitis media	J:133634
Rhbdd1^tm1.1Mfm/Rhbdd1^tm1.1Mfm (involves: 129S/SvEv * C57BL/6J)	increased interleukin-6 secretion	J:346394
	increased susceptibility to endotoxin shock	J:346394
	increased tumor necrosis factor secretion	J:346394
Rhbdd3^tm1Caox/Rhbdd3^tm1Caox (B6.129S6-Rhbdd3^tm1Caox)	abnormal dendritic cell physiology	J:197348
	increased circulating interferon-gamma level	J:197348
	increased circulating interleukin-6 level	J:197348
	increased interferon-gamma secretion	J:197348
	increased interleukin-6 secretion	J:197348
	increased natural killer cell mediated cytotoxicity	J:197348
	liver inflammation	J:197348
Rhbdf2^cub/Rhbdf2^cub (B6.Cg-Rhbdf2^cub)	white adipose tissue inflammation	J:82006
Rhbdf2^m1Btlr/Rhbdf2^m1Btlr (C57BL/6J-Rhbdf2^m1Btlr)	decreased tumor necrosis factor secretion	J:187583
Rhbdf2^m1Btlr/Rhbdf2^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased tumor necrosis factor secretion	J:187583
Rhbdf2^M2Btlr/Rhbdf2⁺ (C57BL/6J-Rhbdf2^M2Btlr)	abnormal immune system physiology	J:213194
Rhbdf2^M3Btlr/Rhbdf2⁺ (C57BL/6J-Rhbdf2^M3Btlr)	abnormal immune system physiology	J:220064
Rhbdf2^M3Btlr/Rhbdf2^M3Btlr (C57BL/6J-Rhbdf2^M3Btlr)	abnormal immune system physiology	J:220064
Rhbdf2^tm1.1Mfm/Rhbdf2^tm1.1Mfm (B6.129S-Rhbdf2^tm1.1Mfm)	decreased circulating tumor necrosis factor level	J:179654
Rhbdf2^tm1.1Mfm/Rhbdf2^tm1.1Mfm (B6.129S-Rhbdf2^tm1.1Mfm)	decreased tumor necrosis factor secretion	J:179654
Rhbdf2^{tm1a(KOMP)Wtsi}/Rhbdf2^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	decreased tumor necrosis factor secretion	J:187583
Rhbdf2^tm1Mak/Rhbdf2^tm1Mak (B6.129P2-Rhbdf2^tm1Mak)	abnormal B cell physiology	J:179653
	abnormal immune serum protein physiology	J:179653
	decreased circulating tumor necrosis factor level	J:179653
	decreased susceptibility to infection induced morbidity/mortality	J:179653
	decreased tumor necrosis factor secretion	J:179653
	increased susceptibility to bacterial infection	J:179653
	increased susceptibility to bacterial infection induced morbidity/mortality	J:179653
Rhbdf2^tm1Mak/Rhbdf2^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte physiology	J:221411
	abnormal microglial cell physiology	J:221411
	decreased tumor necrosis factor secretion	J:221411
Rhoa^tm1.1Tpal/Rhoa⁺ Tg(Cd4-cre/ERT2)11Gnri/0 (involves: C57BL/6)	increased T cell proliferation	J:257764
Rhog^tm1Tnr/Rhog^tm1Tnr (involves: 129)	abnormal CD4-positive, alpha-beta T cell physiology	J:87580
	abnormal leukocyte physiology	J:87580
	abnormal T-helper 2 physiology	J:87580
	increased B cell proliferation	J:87580
	increased immunoglobulin level	J:87580
Rhoh^tm1Brak/Rhoh^tm1Brak (involves: 129/Sv * C57BL/6)	abnormal T cell proliferation	J:143161
	decreased T cell apoptosis	J:143161
	decreased T cell proliferation	J:143161
	increased T cell proliferation	J:143161
Rhoh^tm1Hasu/Rhoh^tm1Hasu (B6.Cg-Rhoh^tm1Hasu)	abnormal mast cell physiology	J:143491
	decreased mast cell degranulation	J:143491
	decreased susceptibility to type I hypersensitivity reaction	J:143491
Rhs1^C57BL/6/Rhs1^C57BL/6 (involves: BALB/c * C57BL/6)	decreased susceptibility to Herpesvirales infection	J:69352
Rictor^tm1.1Klg/Rictor^tm1.1Klg Tg(Mx1-cre)1Cgn/0 (B6.Cg-Rictor^tm1.1Klg Tg(Mx1-cre)1Cgn)	decreased T cell proliferation	J:189736
Rif1^{Gt(XT0278)Wtsi}/Rif1^{Gt(XT0278)Wtsi} (involves: 129P2/OlaHsd * CD-1 * MF1)	abnormal class switch recombination	J:195061
	decreased IgA level	J:195061
	decreased IgG1 level	J:195061
	decreased IgG2b level	J:195061
	decreased IgG3 level	J:195061
	decreased IgG level	J:195061
	increased susceptibility to bacterial infection	J:195061
Rigi^tm1Aki/Rigi^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal dendritic cell physiology	J:137522
Rigi^tm1Aki/Rigi^tm1Aki (involves: 129/Sv * C57BL/6 * ICR)	abnormal interferon level	J:137522
Rigi^tm1Aki/Rigi^tm1Aki (involves: 129/Sv * C57BL/6 * ICR)	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:137522
Rigi^tm1Zgwg/Rigi^tm1Zgwg (involves: 129S1/Sv)	abnormal granulocyte physiology	J:139016
	colitis	J:139868
	increased susceptibility to induced colitis	J:139868
Rinl^tm1.1Boun/Rinl^tm1.1Boun (B6.Cg-Rinl^tm1.1Boun)	abnormal susceptibility to Riboviria infection	J:346452
Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	abnormal CD4-positive, alpha-beta T cell physiology	J:305794
	abnormal circulating interleukin level	J:305794
	abnormal interleukin secretion	J:305794
Riox2^tm1Mtsun/Riox2^tm1Mtsun (B6CrSlc.Cg-Riox2^tm1Mtsun)	abnormal circulating interferon-gamma level	J:201871
	abnormal circulating interleukin-4 level	J:201871
	abnormal immunoglobulin level	J:201871
	decreased inflammatory response	J:201871
Ripk1^tm1.1Vmd/Ripk1^tm1.1Vmd (involves: C57BL/6N)	increased thymocyte apoptosis	J:209137
Ripk1^tm1Led/Ripk1^tm1Led (involves: 129S6/SvEvTac)	lymph node inflammation	J:46522
Ripk2^tm1Cfl/Ripk2^tm1Cfl (involves: 129S5/SvEvBrd)	abnormal macrophage physiology	J:107130
Ripk2^tm1Flv/Ripk2^tm1Flv (involves: 129S1/Sv)	abnormal cytokine secretion	J:75400
	abnormal T-helper 1 physiology	J:75400
	decreased interleukin-6 secretion	J:75400
	decreased T cell proliferation	J:75400
	decreased tumor necrosis factor secretion	J:75400
Ripk2^tm1Flv/Ripk2^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal macrophage physiology	J:132126
	decreased interleukin-6 secretion	J:132126
	decreased tumor necrosis factor secretion	J:132126
Ripk2^tm1Ghc/Ripk2^tm1Ghc (involves: 129S4/SvJae * C57BL/6)	decreased IgG2a level	J:75401
	decreased interferon-gamma secretion	J:75401
	decreased T cell proliferation	J:75401
	increased susceptibility to infection	J:75401
Ripk3^tm1Vmd/Ripk3^tm1Vmd (B6.129-Ripk3^tm1Vmd)	decreased inflammatory response	J:179279
Rmcf^r/Rmcf^r (DBA/1J)	decreased susceptibility to Retroviridae infection	J:7108
Rmcf^r/Rmcf^r (DBA/2J)	decreased susceptibility to Retroviridae infection	J:7108
Rmcf^r/Rmcf^r (CBA/N)	decreased susceptibility to Retroviridae infection	J:7108
Rmcf^s/Rmcf^s (CBA/J)	increased susceptibility to Retroviridae infection	J:7108
Rmcf^s/Rmcf^s (C57L/J)	increased susceptibility to Retroviridae infection	J:7108
Rmcf^s/Rmcf^s (C57BR/cdJ)	increased susceptibility to Retroviridae infection	J:7108
Rmp1^DBA/2J/Rmp1^DBA/2J (involves: C57BL/6J * DBA/2J)	increased susceptibility to Poxviridae infection	J:28150
Rmp2^DBA/2J/Rmp2^DBA/2J (involves: C57BL/6J * DBA/2J)	increased susceptibility to Poxviridae infection	J:11032
Rmp3^DBA/2J/Rmp3^DBA/2J (involves: C57BL/6J * DBA/2J)	increased susceptibility to Poxviridae infection	J:11032
Rmp4^C57BL/6NCr/Rmp4^C57BL/6NCr (involves: C57BL/6NCr * DBA/2NCr)	decreased susceptibility to Poxviridae infection	J:29241
Rmp5^C57BL/6NCr/Rmp5^C57BL/6NCr (involves: C57BL/6NCr * DBA/2NCr)	decreased susceptibility to Poxviridae infection	J:3240
Rmp6^C57BL/6NCr/Rmp6^C57BL/6NCr (involves: C57BL/6NCr * DBA/2NCr)	decreased susceptibility to Poxviridae infection	J:3240
Rnaseh2a^tm1Crh/Rnaseh2a^tm1Crh (Not Specified)	abnormal innate immunity	J:232933
Rnaseh2a^tm1Crh/Rnaseh2a^tm1Crh (Not Specified)	decreased susceptibility to Riboviria infection	J:232933
Rnaseh2b^em1Anu/Rnaseh2b⁺ Tlr7^em2Anu/Tlr7⁺ (C57BL/6NCrl-Rnaseh2b^em1Anu Tlr7^em2Anu)	increased autoantibody level	J:324448
Rnaseh2b^{tm1c(EUCOMM)Wtsi}/Rnaseh2b^{tm1c(EUCOMM)Wtsi} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * SJL)	decreased B cell proliferation	J:186986
Rnasel^tm1Slvm/Rnasel^tm1Slvm (involves: 129P2/OlaHsd)	decreased T cell apoptosis	J:44292
Rnasel^tm1Slvm/Rnasel^tm1Slvm (involves: 129P2/OlaHsd)	increased susceptibility to Picornaviridae infection	J:44292
Rnf8^{Gt(AS0574)Wtsi}/Rnf8⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
Rnf8^{Gt(AS0574)Wtsi}/Rnf8^{Gt(AS0574)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
	decreased IgG1 level	J:161240
	decreased IgG2b level	J:161240
	decreased IgG3 level	J:161240
	increased thymocyte apoptosis	J:161240
Rnf8^{Gt(RRR260)Byg}/Rnf8^{Gt(RRR260)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
	decreased IgG1 level	J:161240
	decreased IgG2b level	J:161240
	decreased IgG3 level	J:161240
	increased thymocyte apoptosis	J:161240
Rnf19b^tm1Jkorn/Rnf19b^tm1Jkorn (B6.129S-Rnf19b^tm1Jkorn)	decreased interferon-gamma secretion	J:157393
Rnf19b^tm1Jkorn/Rnf19b^tm1Jkorn (B6.129S-Rnf19b^tm1Jkorn)	impaired natural killer cell mediated cytotoxicity	J:157393
Rnf20^{Gt(RRJ249)Byg}/Rnf20⁺ (involves: 129P2/OlaHsd)	abnormal leukocyte physiology	J:268221
	abnormal T cell physiology	J:268221
	increased interferon-gamma secretion	J:268221
	increased susceptibility to induced colitis	J:268221
	increased tumor necrosis factor secretion	J:268221
Rnf31^tm1.1Kiwa/Rnf31^tm1.1Kiwa Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6NCrlj * CBA/JNCrlj)	abnormal humoral immune response	J:201885
	decreased IgA level	J:201885
	decreased IgG1 level	J:201885
	decreased IgG2a level	J:201885
	decreased IgG2b level	J:201885
	decreased IgG3 level	J:201885
	decreased IgM level	J:201885
Rnf40^tm1.1Sajo/Rnf40^tm1.1Sajo Tg(Car1-cre)5Flt/0 (involves: 129S2/SvPas * C57BL/6J)	decreased susceptibility to induced colitis	J:311838
Rnf43^em2Mage/Rnf43^em2Mage (Not Specified)	increased interferon-gamma secretion	J:285428
Rnf43^em2Mage/Rnf43^em2Mage (Not Specified)	stomach inflammation	J:285428
Rnf115^em1Gpt/Rnf115^em1Gpt (C57BL/6JGpt-Rnf115^em1Gpt/Gpt)	decreased susceptibility to viral infection	J:297834
	decreased susceptibility to viral infection induced morbidity/mortality	J:297834
	increased circulating interferon-beta level	J:297834
	increased interferon-beta secretion	J:297834
	increased susceptibility to viral infection induced morbidity/mortality	J:297834
Rnf123^em1Nmea/Rnf123^em1Nmea (NC/Jic-Rnf123^em1Nmea)	decreased susceptibility to parasitic infection	J:327312
Rnf123^em1Nmea/Rnf123^em1Nmea (NC/Jic-Rnf123^em1Nmea)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:327312
Rnf123^em2Nmea/Rnf123^em2Nmea (NC/Jic-Rnf123^em2Nmea)	decreased susceptibility to parasitic infection	J:327312
Rnf123^em2Nmea/Rnf123^em2Nmea (NC/Jic-Rnf123^em2Nmea)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:327312
Rnf128^tm1.1Flv/Y (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:153216
	abnormal peripheral T cell anergy	J:153216
	increased circulating interleukin-2 level	J:153216
	increased interferon-gamma secretion	J:153216
	increased T cell proliferation	J:153216
Rnf128^tm1.1Flv/Y Tg(TcraTcrb)425Cbn/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal peripheral T cell anergy	J:153216
	decreased T cell proliferation	J:153216
	increased circulating interleukin-2 level	J:153216
Rnf128^tm1.1Flv/Rnf128^tm1.1Flv (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:153216
	abnormal peripheral T cell anergy	J:153216
	increased circulating interleukin-2 level	J:153216
	increased interferon-gamma secretion	J:153216
	increased T cell proliferation	J:153216
Rnf128^tm1.1Flv/Rnf128^tm1.1Flv Tg(TcraTcrb)425Cbn/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal peripheral T cell anergy	J:153216
	decreased T cell proliferation	J:153216
	increased circulating interleukin-2 level	J:153216
Rnf128^tm1.2Cmse/Rnf128^tm1.2Cmse (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:245025
Rnf128^tm1Cdon/Rnf128⁺ (involves: 129 * C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:160681
Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: C57BL/6)	increased anti-double stranded DNA antibody level	J:160681
	increased interferon-gamma secretion	J:160681
	increased interleukin-2 secretion	J:160681
	increased interleukin-17 secretion	J:160681
	increased T cell proliferation	J:160681
Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: 129 * C57BL/6)	abnormal immune tolerance	J:160681
	abnormal interleukin secretion	J:160681
	abnormal regulatory T cell physiology	J:160681
	CNS inflammation	J:160681
	decreased interleukin-4 secretion	J:160681
	decreased interleukin-5 secretion	J:160681
	decreased interleukin-13 secretion	J:160681
	increased anti-double stranded DNA antibody level	J:160681
	increased IgG1 level	J:160681
	increased IgM level	J:160681
	increased interferon-gamma secretion	J:160681
	increased interleukin-2 secretion	J:160681
	increased interleukin-4 secretion	J:160681
	increased interleukin-17 secretion	J:160681
	increased interleukin-21 secretion	J:160681
	increased splenocyte proliferation	J:160681
	increased susceptibility to experimental autoimmune encephalomyelitis	J:160681
	lung inflammation	J:160681
Rnf128^tm1Cdon/Rnf128^tm1Cdon Tg(TcraTcrb)425Cbn/0 (involves: 129 * BALB/c * C57BL/6)	abnormal immune tolerance	J:160681
	increased interferon-gamma secretion	J:160681
	increased interleukin-2 secretion	J:160681
	increased splenocyte proliferation	J:160681
Rnf139^{tm1(KOMP)Wtsi}/Rnf139^{tm1(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	liver inflammation	J:231404
Rnf144a^em1Smoc/Rnf144a^em1Smoc (C57BL/6J-Rnf144a^em1Smoc/Smoc)	abnormal innate immunity	J:347002
	increased susceptibility to Herpesvirales infection	J:347002
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:347002
Rnf146^tm1.1Rtpl/Rnf146^tm1.1Rtpl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating tumor necrosis factor level	J:243612
Rnf168^{Gt(156B6)Cmhd}/Rnf168^{Gt(156B6)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:198260
	decreased IgG1 level	J:198260
	decreased IgG2a level	J:198260
	decreased IgG3 level	J:198260
	decreased IgG level	J:198260
Rnf168^{Gt(405F11)Cmhd}/Rnf168^{Gt(405F11)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:198260
	decreased IgG1 level	J:198260
	decreased IgG2a level	J:198260
	decreased IgG3 level	J:198260
	decreased IgG level	J:198260
Rnf186^em1Ktak/Rnf186^em1Ktak (involves: C57BL/6 * DBA/2)	increased susceptibility to colitis induced morbidity/mortality	J:258197
Rnf186^em1Ktak/Rnf186^em1Ktak (involves: C57BL/6 * DBA/2)	increased susceptibility to induced colitis	J:258197
Rnf186^tm1Ktak/Rnf186^tm1Ktak (involves: 129S4/SvJae * C57BL/6)	increased susceptibility to colitis induced morbidity/mortality	J:258197
	increased susceptibility to induced colitis	J:258197
Ro60^tm1Woln/Ro60⁺ (involves: 129S1/Sv * C57BL/6)	increased anti-nuclear antigen antibody level	J:84627
Ro60^tm1Woln/Ro60⁺ (involves: 129S1/Sv * C57BL/6)	increased IgG2a level	J:84627
Ro60^tm1Woln/Ro60^tm1Woln (involves: 129S1/Sv * C57BL/6)	glomerulonephritis	J:84627
	increased anti-chromatin antibody level	J:84627
	increased anti-double stranded DNA antibody level	J:84627
	increased anti-histone antibody level	J:84627
	increased anti-nuclear antigen antibody level	J:84627
	increased anti-single stranded DNA antibody level	J:84627
	increased IgG2a level	J:84627
	increased IgM level	J:84627
Rock1^tm1Liao/Rock1⁺ (C57BL/6-Rock1^tm1Liao)	abnormal leukocyte adhesion	J:135152
	abnormal leukocyte migration	J:135152
	impaired macrophage chemotaxis	J:135152
	impaired neutrophil recruitment	J:135152
Rock1^tm1Sna/Rock1^tm1Sna (B6N.129X1-Rock1^tm1Sna)	blepharitis	J:98250
Rock2^tm1.1Itl/Rock2⁺ Tg(Tagln-cre)1Her/0 (B6.Cg-Rock2^tm1.1Itl Tg(Tagln-cre)1Her)	abnormal cytokine secretion	J:222206
Rora^sg/Rora^sg (involves: C57BL/6)	abnormal immune system physiology	J:2228
	abnormal macrophage physiology	J:28095
	increased IgE level	J:135863
	increased interleukin-1 secretion	J:28095
	lung inflammation	J:135863
Rorc^m2Btlr/Rorc^m2Btlr (C57BL/6J-Rorc^m2Btlr)	decreased IgM level	J:217792
	decreased response to antigen	J:217792
	impaired humoral immune response	J:217792
Rorc^m3Btlr/Rorc^m3Btlr (C57BL/6J-Rorc^m3Btlr)	decreased IgG level	J:234257
	decreased IgM level	J:234257
	decreased response to antigen	J:234257
	impaired humoral immune response	J:234257
Rorc^tm1.1Zsun/Rorc^tm1.1Zsun (B6(129S4)-Rorc^tm1.1Zsun)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:248565
Rorc^tm1Amj/Rorc^tm1Amj (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))	abnormal interleukin level	J:123351
	abnormal T cell physiology	J:64381
	increased T cell apoptosis	J:64381
Rorc^tm1Litt/Rorc^tm1Litt (involves: 129P2/OlaHsd)	colitis	J:158663
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:248565
	increased susceptibility to bacterial infection	J:158663
	increased susceptibility to bacterial infection induced morbidity/mortality	J:158663
	increased thymocyte apoptosis	J:248565
Rorc^tm2Litt/Rorc^tm2Litt (involves: 129P2/OlaHsd)	increased thymocyte apoptosis	J:87395
Rosq1^DBA/1J/Rosq1^DBA/1J (involves: DBA/1J * FVB/NJ)	abnormal neutrophil physiology	J:122919
Rosq1^DBA/1J/Rosq1^FVB/NJ (involves: DBA/1J * FVB/NJ)	abnormal neutrophil physiology	J:122919
Rpap3^{tm1c(KOMP)Wtsi}/Rpap3^{tm1c(KOMP)Wtsi} Tg(Vil1-cre/ERT2)23Syr/0 (involves: C57BL/6N * DBA/2)	small intestinal inflammation	J:314346
Rpl13a^tm1.1Jesc/Rpl13a^tm1.1Jesc (NOD.129S5(Cg)-Rpl13a^tm1.1Jesc)	decreased susceptibility to autoimmune diabetes	J:237822
Rpl13a^tm1.1Mazu/Rpl13a^tm1.1Mazu Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: C57BL/6)	abnormal cytokine level	J:194920
	abnormal macrophage chemotaxis	J:194920
	increased circulating tumor necrosis factor level	J:194920
Rpl22^{Gt(GST000137)Lex}/Rpl22^{Gt(GST000137)Lex} (involves: 129S5/SvEvBrd)	glomerulonephritis	J:123569
	increased T cell apoptosis	J:123569
Rpl38^Ts/Rpl38⁺ (TSJ/Le)	increased susceptibility to otitis media	J:168509
Rprd1b^tm1Tshu/Rprd1b^tm1Tshu Tg(Vil1-cre)20Syr/0 (involves: C57BL/6 * DBA/2)	increased susceptibility to colitis induced morbidity/mortality	J:300857
Rps6ka4^tm1Jsca/Rps6ka4^tm1Jsca Rps6ka5^tm1Jsca/Rps6ka5^tm1Jsca (Not Specified)	decreased T cell proliferation	J:124301
Rps6ka4^tm1Jsca/Rps6ka4^tm1Jsca Rps6ka5^tm1Jsca/Rps6ka5^tm1Jsca (B6.Cg-Rps6ka5^tm1Jsca Rps6ka4^tm1Jsca)	abnormal cytokine level	J:139576
	abnormal cytokine secretion	J:139576
	decreased circulating interleukin-10 level	J:139576
	decreased interleukin-10 secretion	J:139576
	increased circulating interleukin-6 level	J:139576
	increased circulating interleukin-12a level	J:139576
	increased circulating interleukin-12b level	J:139576
	increased circulating tumor necrosis factor level	J:139576
	increased interleukin-6 secretion	J:139576
	increased interleukin-12a secretion	J:139576
	increased interleukin-12b secretion	J:139576
	increased susceptibility to endotoxin shock	J:139576
	increased tumor necrosis factor secretion	J:139576
	skin inflammation	J:139576
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} (C57BL/6-Rps27l^{Gt(IST11658B7)Tigm})	increased thymocyte apoptosis	J:223276
Rptor^tm1Ahir/Rptor^tm1Ahir Tg(Itgax-cre)1-1Reiz/0 (B6.Cg-Rptor^tm1Ahir Tg(Itgax-cre)1-1Reiz)	increased susceptibility to induced colitis	J:188676
Rr9^tm1.1Kubo/Rr9^tm1.1Kubo (C57BL/6-Rr9^tm1.1Kubo)	decreased interleukin-13 secretion	J:167446
Rr17^tm1.1Cdon/Rr17^tm1.1Cdon (involves: 129S6/SvEvTac * C57BL/6)	decreased interleukin-17 secretion	J:181186
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:181186
	increased interleukin-17 secretion	J:181186
Rr32^tm1.1Weav/Rr32^tm1.1Weav (involves: C57BL/6)	decreased interferon-gamma secretion	J:208819
Rr38^tm1.2Aafo/Rr38^tm1.2Aafo (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	abnormal thymus physiology	J:227747
Rr79^em2Rtew/Rr79^em2Rtew (C57BL/6J-Rr79^em2Rtew/J)	abnormal T cell activation	J:332957
Rr79^em2Rtew/Rr79^em2Rtew (C57BL/6J-Rr79^em2Rtew/J)	abnormal T cell physiology	J:332957
Rr79^em2Rtew/Rr79^em2Rtew Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6J)	abnormal T cell activation	J:332957
Rr155^tm1.1Erpi/Rr155^tm1.1Erpi (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal immunoglobulin level	J:160101
	decreased IgG1 level	J:160101
	decreased IgG2a level	J:160101
Rr156^tm6.1Cog/Rr156^tm6.1Cog (involves: 129P2/OlaHsd * C57BL/6)	decreased IgM level	J:165617
Rr156^tm6Cog/Rr156^tm6Cog (involves: 129P2/OlaHsd * C57BL/6)	decreased IgM level	J:165617
Rr160^tm1Wtg/Rr160^tm1Wtg (involves: 129S6/SvEvTac * C57BL/6)	abnormal immunoglobulin level	J:134885
	abnormal somatic hypermutation frequency	J:134885
Rr163^tm1Lfdn/Rr163⁺ (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CB20))	abnormal immune system physiology	J:31727
Rr163^tm1Lfdn/Rr163^tm1Lfdn (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CB20))	abnormal immune system physiology	J:31727
Rr166^tm4.1Wtg/Rr166^tm4.1Wtg (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:193015
	abnormal immunoglobulin level	J:193015
Rr169^tm2Rao/Rr169^tm2Rao (involves: 129S6/SvEvTac * C57BL/6J)	increased susceptibility to parasitic infection	J:94039
Rr170^tm1.1Iku/Rr170^tm1.1Iku (B6.Cg-Rr170^tm1.1Iku)	decreased T cell proliferation	J:333539
Rr170^tm1.1Iku/Rr170^tm1.1Iku (B6.Cg-Rr170^tm1.1Iku)	increased T cell apoptosis	J:333539
Rr185^tm3Cog/Rr185^tm3Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:71300
	decreased IgA level	J:71300
	decreased IgE level	J:71300
	decreased IgG1 level	J:71300
	decreased IgG2a level	J:71300
	decreased IgG2b level	J:71300
	decreased IgG3 level	J:71300
	decreased IgG level	J:71300
	decreased IgM level	J:71300
	decreased immunoglobulin level	J:71300
Rr253^em1Kmm/Rr253^em1Kmm (C57BL/6-Rr253^em1Kmm)	abnormal class switch recombination	J:316113
Rr253^em1Kmm/Rr253^em1Kmm (C57BL/6-Rr253^em1Kmm)	increased susceptibility to viral infection induced morbidity/mortality	J:316113
Rr253^em6Kmm/Rr253^em6Kmm (C57BL/6J-Rr253^em6Kmm)	abnormal T-helper 2 physiology	J:334296
Rr253^em6Kmm/Rr253^em6Kmm (C57BL/6J-Rr253^em6Kmm)	increased susceptibility to parasitic infection induced morbidity/mortality	J:334296
Rr364^tm1.1Aak/Rr364^tm1.1Aak (129.129S2(Cg)-Rr364^tm1.1Aak)	abnormal class switch recombination	J:242276
	decreased IgG3 level	J:242276
	increased IgG2a level	J:242276
	increased IgG2b level	J:242276
Rr395^em1Bhao/Rr395^em1Bhao (Not Specified)	increased thymocyte apoptosis	J:333961
Rr250409^tm1Lky/Rr250409⁺ (involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB)	decreased interleukin-4 secretion	J:125684
Rr250409^tm1Lky/Rr250409^tm1Lky (involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB)	abnormal response to infection	J:125684
	decreased IgE level	J:125684
	decreased interleukin-4 secretion	J:125684
	decreased interleukin-5 secretion	J:125684
	decreased interleukin-13 secretion	J:125684
	decreased susceptibility to parasitic infection	J:125684
Rr250409^tm1Lky/Rr250409^tm1Lky (involves: 129X1/SvJ * BALB/c)	decreased interleukin-4 secretion	J:167446
Rragc^em1Efe/Rragc⁺ (Not Specified)	abnormal B cell activation	J:320567
	abnormal B cell physiology	J:320567
	abnormal class switch recombination	J:320567
	decreased B cell proliferation	J:320567
	decreased IgG1 level	J:320567
	decreased IgM level	J:320567
	impaired humoral immune response	J:320567
Rragc^em1Efe/Rragc⁺ Tg(Vav-BCL2)69Jad/0 (Not Specified)	decreased susceptibility to autoimmune disorder	J:320567
Rras2^{Gt(OST361011)Lex}/Rras2^{Gt(OST361011)Lex} (involves: 129S5/SvEvBrd)	abnormal B cell activation	J:151653
	abnormal B cell physiology	J:151653
	abnormal CD4-positive, alpha-beta T cell physiology	J:151653
	abnormal CD8-positive, alpha-beta T cell physiology	J:151653
	decreased B cell proliferation	J:151653
Rras^tm1Itl/Rras^tm1Itl (involves: 129S6/SvEvTac * C57BL/6)	abnormal dendritic cell physiology	J:181730
Rsad2^tm1Aki/Rsad2^tm1Aki (involves: 129/Sv * C57BL/6)	decreased circulating interferon-alpha level	J:169840
	decreased interferon-alpha secretion	J:169840
	decreased interferon-beta secretion	J:169840
Rsad2^tm1Kchc/Rsad2^tm1Kchc (B6.129-Rsad2^tm1Kchc)	decreased IgG1 level	J:148305
	decreased interleukin-4 secretion	J:148305
	decreased interleukin-5 secretion	J:148305
	decreased interleukin-13 secretion	J:148305
	increased interferon-gamma secretion	J:148305
rsm1/rsm1 (either: P/J or P/N)	abnormal cell-mediated immunity	J:8396
Rsph9^em1Jwji/Rsph9^em1Jwji (B6.Cg-Rsph9^em1Jwji)	increased microglial cell activation	J:294184
Rsph9^em1Jwji/Rsph9^em1Jwji (B6.Cg-Rsph9^em1Jwji)	sinus inflammation	J:294184
Rtcb^{tm1c(KOMP)Wtsi}/Rtcb^{tm1c(KOMP)Wtsi} Tg(Fcer2a-cre)5Mbu/0 (involves: C57BL/6 * CBA * SJL)	abnormal B cell physiology	J:216740
	decreased IgM level	J:216740
Rthyd1^NOD/MrkTac/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd2^B10.Br/SgSnJ/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd3^B10.Br/SgSnJ/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd5^NOD/MrkTac/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rtl5^em1Tmki/Rtl5^em1Tmki Rtl6^tm2.1Tmki/Rtl6^tm2.1Tmki (involves: C57BL/6NCrlj * C57BL/6NSlc * CBA/JNCrlj)	abnormal inflammatory response	J:329352
	decreased susceptibility to endotoxin shock	J:329352
Rtl5^tm1.1Tmki/Rtl5^tm1.1Tmki Rtl6^tm1.1Tmki/Rtl6^tm1.1Tmki (involves: C57BL/6NCrlj * C57BL/6NSlc * CBA/JNCrlj)	abnormal inflammatory response	J:329352
Rtl9^em2Tmki/Rtl9^em2Tmki (C57BL/6N-Rtl9^em2Tmki)	abnormal innate immunity	J:343808
Rtp4^em#Xzs/Rtp4^em#Xzs (involves: C57BL/6)	decreased susceptibility to parasitic infection	J:293929
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:293929
	decreased susceptibility to viral infection	J:293929
Rubcn^em1Dgre/Rubcn^em1Dgre (C57BL/6-Rubcn^em1Dgre)	abnormal macrophage physiology	J:261225
Rubcn^em1Dgre/Rubcn^em1Dgre (involves: C57BL/6 * C57BL/6N)	abnormal circulating chemokine level	J:235399
	abnormal macrophage physiology	J:235399
	decreased circulating interleukin-10 level	J:235399
	glomerulonephritis	J:235399
	increased anti-double stranded DNA antibody level	J:235399
	increased anti-nuclear antigen antibody level	J:235399
	increased autoantibody level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased IgG level	J:235399
	increased susceptibility to systemic lupus erythematosus	J:235399
Rubcn^em1Dgre/Rubcn^em1Dgre Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * C57BL/6NCrlj * DBA/2)	abnormal macrophage physiology	J:261225
Rubcn^em1Dgre/Rubcn^em1Dgre Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal circulating chemokine level	J:235399
	abnormal macrophage physiology	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
Runx1^tm1Yg/Runx1^tm1Yg (either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	increased thymocyte apoptosis	J:125830
Runx1^tm8Spe/Runx1^tm8Spe (involves: 129/Sv * C57BL/6)	lung inflammation	J:120100
Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased IgA level	J:125953
	lung inflammation	J:125953
Runx3^tm1Yg/Runx3^tm1Yg (either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	abnormal cytokine level	J:93240
	abnormal dendritic cell physiology	J:88424, J:100348
	abnormal inflammatory response	J:93240
	abnormal interferon level	J:93240
	abnormal interleukin level	J:93240
	abnormal tumor necrosis factor level	J:93240
	colitis	J:93240
	increased IgE level	J:100348
	intestinal inflammation	J:93240
	lung inflammation	J:88424
	small intestinal inflammation	J:93240
	stomach inflammation	J:93240
Runx3^tm3.1Yg/Runx3^tm3.1Yg (Not Specified)	abnormal immune system physiology	J:224898
Runx3^tm3.1Yg/Runx3^tm3.1Yg (Not Specified)	intestinal inflammation	J:224898
Ruvbl2^M1Btlr/Ruvbl2⁺ (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased IgG1 level	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Rxfp2^{tm1a(EUCOMM)Wtsi}/Rxfp2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rxfp2^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased IgE level	J:165965
Rxra^pke/Rxra^pke (C57BL/6J-Rxra^pke)	abnormal dendritic cell physiology	J:103186
Rxra^pke/Rxra^pke (C57BL/6J-Rxra^pke)	abnormal regulatory T cell physiology	J:103186
Rxra^tm1Ipc/Rxra^tm4Ipc Rxrb^tm1Mma/Rxrb^tm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S2/SvPas)	increased immunoglobulin level	J:102470
Rxra^tm1Krc/Rxra^tm1Krc Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal macrophage activation involved in immune response	J:168799
	glomerulonephritis	J:168799
	impaired macrophage phagocytosis	J:168799
	increased anti-double stranded DNA antibody level	J:168799
	increased anti-nuclear antigen antibody level	J:168799
	increased anti-single stranded DNA antibody level	J:168799
	increased autoantibody level	J:168799
	increased IgG level	J:168799
	increased IgM level	J:168799
Rxra^tm2Ipc/Rxra^tm4Ipc Tg(KRT14-cre)1Ipc/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	skin inflammation	J:67149
Rxra^tm4Ipc/Rxra^tm4Ipc Rxrb^tm1Pcn/Rxrb^tm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S2/SvPas)	dermatitis	J:102470
	ear inflammation	J:102470
Ryr2^{tm1(CAG-KRASG12V,-lacZ)Nobs}/Ryr2^{tm1(CAG-KRASG12V,-lacZ)Nobs} Trp53^tm1Sia/Trp53^tm1Sia (involves: 129X1/SvJ * C57BL/6 * CBA)	myositis	J:117828
S1pr1^tm1.1Cys/S1pr1^tm1.1Cys (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal B cell physiology	J:176118
S1pr1^tm1.1Thla/S1pr1^tm1.1Thla (B6.Cg-S1pr1^tm1.1Thla)	abnormal leukocyte migration	J:163389
S1pr1^tm1.1Thla/S1pr1^tm1.1Thla (B6.Cg-S1pr1^tm1.1Thla)	abnormal lymphocyte physiology	J:163389
S1pr1^tm1Cys/S1pr1^tm1Cys (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:176118
S1pr1^tm1Jch/S1pr1^tm1Jch Tg(GFAP-cre)25Mes/? (involves: C57BL/6J * FVB/N)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:168824
S1pr1^tm1Jch/S1pr1^tm1Jch Tg(Nes-cre)1Kln/0 (involves: C57BL/6J * SJL)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:168824
S1pr2^tm1Rlp/S1pr2^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	decreased B cell apoptosis	J:174313
	increased B cell proliferation	J:174313
S1pr3^tm1Jch/S1pr3^tm1Jch (involves: 129S1/Sv * 129X1/SvJ)	abnormal cytokine level	J:133917
S1pr3^tm1Jch/S1pr3^tm1Jch (involves: 129S1/Sv * 129X1/SvJ)	decreased susceptibility to endotoxin shock	J:133917
S1pr3^tm1Rlp/S1pr3^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:91161
S1pr5^tm1Club/S1pr5^tm1Club (B6.129P2-S1pr5^tm1Club)	abnormal NK cell physiology	J:178789
S100a4^tm1.1Abres/S100a4^tm1.1Abres (B6.Cg-S100a4^tm1.1Abres)	abnormal eosinophil physiology	J:182865
	impaired macrophage chemotaxis	J:182865
S100a9^tm1Hogg/S100a9^tm1Hogg (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil physiology	J:82513
S100a9^tm1Nck/S100a9^tm1Nck (B6.129P2-S100a9^tm1Nck)	decreased circulating tumor necrosis factor level	J:125179
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:125179
	decreased susceptibility to endotoxin shock	J:125179
	decreased susceptibility to fungal infection	J:209808
S100a9^tm1Nck/S100a9^tm1Nck (involves: 129P2/OlaHsd * C57BL/6)	abnormal cellular extravasation	J:81642
Saa3^{tm1(KOMP)Vlcg}/Saa3^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating serum amyloid protein level	J:220630
Sac3d1^tm1Hnaka/Sac3d1⁺ (involves: 129P2/OlaHsd)	abnormal mast cell physiology	J:144601
Sac3d1^tm1Hnaka/Sac3d1^tm1Hnaka (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:144601
	abnormal mast cell physiology	J:144601
	increased T cell proliferation	J:144601
Sall4^tm1Brd/Sall4⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	ear inflammation	J:117866
Sall4^tm1Brd/Sall4⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	increased susceptibility to otitis media	J:117866
Samd9l^tm1Homy/Samd9l⁺ (involves: 129P2/OlaHsd)	increased susceptibility to Retroviridae infection	J:202604
Samd9l^tm1Homy/Samd9l^tm1Homy (involves: 129P2/OlaHsd)	increased susceptibility to Retroviridae infection	J:202604
Samhd1^tm1.2Crs/Samhd1^tm1.2Crs (involves: C57BL/6N * C57BL/6NTac)	increased susceptibility to Retroviridae infection	J:201909
Samhd1^{tm1d(EUCOMM)Wtsi}/Samhd1^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal response to infection	J:202757
Samhd1^tm2.2Crs/Samhd1^tm2.2Crs (involves: 129S6/SvEvTac * C57BL/6J)	increased susceptibility to Retroviridae infection	J:201909
Samsn1^tm1Xyw/Samsn1^tm1Xyw (B6.129P2-Samsn1^tm1Xyw)	abnormal dendritic cell physiology	J:158032
	abnormal T-helper 1 physiology	J:158032
	abnormal T-helper 2 physiology	J:158032
	increased B cell proliferation	J:158032
	increased circulating interferon-gamma level	J:158032
	increased IgG3 level	J:158032
	increased IgM level	J:158032
	increased interleukin-4 secretion	J:158032
	increased interleukin-12 secretion	J:158032
	increased T cell proliferation	J:158032
Sarm1^tm1.1Diam/Sarm1^tm1.1Diam (involves: 129X1/SvJ * C57BL/6)	abnormal circulating tumor necrosis factor level	J:200140
	decreased microglial cell activation	J:200140
	increased susceptibility to Flaviviridae infection	J:200140
	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:200140
Sash3^tm1Hlz/Sash3^tm1Hlz (B6.129P2-Sash3^tm1Hlz)	abnormal B cell physiology	J:102171
	abnormal humoral immune response	J:102171
	abnormal inflammatory response	J:102171
	abnormal marginal zone B cell physiology	J:102171
	decreased IgG1 level	J:102171
	decreased IgG2a level	J:102171
	decreased IgG level	J:102171
	decreased IgM level	J:102171
	decreased interferon-gamma secretion	J:102171
	decreased interleukin-2 secretion	J:102171
	decreased interleukin-4 secretion	J:102171
	decreased interleukin-10 secretion	J:102171
	decreased T cell proliferation	J:102171
	decreased tumor necrosis factor secretion	J:102171
	increased length of allograft survival	J:102171
Satb1^tm1Kos/Satb1^tm1Kos (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell proliferation	J:61085
Satb1^tm2Kos/Satb1^tm2Kos Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	increased anti-nuclear antigen antibody level	J:252606
	increased autoantibody level	J:252606
	increased susceptibility to autoimmune disorder	J:252606
	kidney inflammation	J:252606
	pancreas inflammation	J:252606
	salivary gland inflammation	J:252606
Sbno2^tm1.1Aki/Sbno2^tm1.1Aki (involves: 129 * C57BL/6)	abnormal osteoclast physiology	J:202853
Sbsn^em1Ham/Sbsn^em1Ham (C57BL/6N-Sbsn^em1Ham)	decreased interleukin-4 secretion	J:296400
	decreased susceptibility to type IV hypersensitivity reaction	J:296400
	increased susceptibility to type IV hypersensitivity reaction	J:296400
Scara5^tm1Ktry/Scara5^tm1Ktry (B6N.129X1-Scara5^tm1Ktry)	adipose tissue inflammation	J:195536
	increased anti-nuclear antigen antibody level	J:195536
	interstitial pneumonia	J:195536
	liver inflammation	J:195536
	lung inflammation	J:195536
	skin inflammation	J:195536
	urinary bladder inflammation	J:195536
Scarb1^tm1.1Thh/Scarb1^tm1.1Thh (B6.129X1-Scarb1^tm1.1Thh)	increased circulating interleukin-6 level	J:114663
Scarb1^tm1Thh/Scarb1^tm1Thh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Scarb1^tm1Thh Speer6-ps1^{Tg(Alb-cre)21Mgn})	increased circulating interleukin-6 level	J:114663
Scarf1^tm1Tkms/Scarf1^tm1Tkms (involves: C57BL/6)	abnormal B cell physiology	J:208237
	abnormal dendritic cell physiology	J:208237
	glomerulonephritis	J:208237
	impaired macrophage phagocytosis	J:208237
	increased anti-histone antibody level	J:208237
	increased anti-nuclear antigen antibody level	J:208237
	increased anti-single stranded DNA antibody level	J:208237
	increased IgG level	J:208237
	increased susceptibility to systemic lupus erythematosus	J:208237
	skin inflammation	J:208237
Scd1^ab-2J/Scd1^ab-2J (DBA/1LacJ-Scd1^ab-2J/J)	granulomatous inflammation	J:62699
Scd1^flk/Scd1^flk (C57BL/6J-Scd1^flk)	increased susceptibility to bacterial infection	J:100424
Scd2^swty/Scd2^swty (C57BL/6JSfdAnu-Scd2^swty/Anu)	blepharitis	J:104190
Scgb1a1^tm1Abm/Scgb1a1⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal complement protein level	J:57504
Scgb1a1^tm1Abm/Scgb1a1⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased IgA level	J:57504
Scgb1a1^tm1Abm/Scgb1a1^tm1Abm (involves: 129S1/Sv * 129X1/SvJ)	abnormal complement protein level	J:57504
	increased IgA level	J:57504
Scgn^em1Ezb/Scgn^em1Ezb (C57BL/6-Scgn^em1Ezb)	increased susceptibility to colitis induced morbidity/mortality	J:285572
Scgn^em2Ezb/Scgn^em2Ezb (C57BL/6-Scgn^em2Ezb)	increased susceptibility to colitis induced morbidity/mortality	J:285572
Scin^tm1Glog/Scin^tm1Glog Tg(Acp5-cre)4Rda/0 (either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * CBA))	abnormal osteoclast physiology	J:223220
Scl2^C57BL/6J/Scl2^C57BL/6J (involves: C57BL/6J * DBA/2J)	increased susceptibility to parasitic infection	J:12046
Scn3b^{tm1a(KOMP)Wtsi}/Scn3b^{tm1a(KOMP)Wtsi} (C57BL/6N-Scn3b^{tm1a(KOMP)Wtsi}/Wtsi)	myositis	J:232539
Scn9a^tm1Dgen/Scn9a^tm1Dgen (either: (involves: 129P2/OlaHsd * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))	dermatitis	J:223425
Scp2^tm1Kier/Scp2^tm1Kier (involves: 129P2/OlaHsd * C57BL/6NCr)	liver inflammation	J:124895
Sctr^tm1Bkcc/Sctr^tm1Bkcc (B6.129S7-Sctr^tm1Bkcc)	abnormal cytokine secretion	J:121376
Sctr^tm1Bkcc/Sctr^tm1Bkcc (B6.129S7-Sctr^tm1Bkcc)	kidney inflammation	J:121376
Sdc1^tm1Cma/Sdc1^tm1Cma (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	decreased susceptibility to bacterial infection	J:69845
Sdc1^tm1Cma/Sdc1^tm1Cma (either: C.Cg-Sdc1^tm1Cma or B6.Cg-Sdc1^tm1Cma)	increased inflammatory response	J:80682
Sdc1^tm1Cma/Sdc1^tm1Cma (B6.Cg-Sdc1^tm1Cma)	decreased susceptibility to bacterial infection	J:104294
Sdc1^tm1Cma/Sdc1^tm1Cma (B6.Cg-Sdc1^tm1Cma)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:104294
Sdc1^tm1Cma/Sdc1^tm1Cma (involves: 129S4/SvJae)	decreased IgG1 level	J:107378
	decreased interleukin-10 secretion	J:107378
	decreased interleukin-13 secretion	J:107378
	increased susceptibility to parasitic infection	J:107378
seb/seb (Him:OF1)	dermatitis	J:64455
	lymph node inflammation	J:20987
	skin inflammation	J:8983
Sec1^em1Cya/Sec1^em1Cya (C57BL/6-Sec1^em1Cya)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:325740
Sec23b^{Gt(AD0407)Wtsi}/Sec23b^{Gt(AD0407)Wtsi} (B6J.129P2-Sec23b^{Gt(AD0407)Wtsi})	pancreas inflammation	J:186391
Secia1^DBA/1J/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Secia2^DBA/1J/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Secia3^FVB/NJ/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Secia4^DBA/1J/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Secia5^DBA/1J/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Secia6^DBA/1J/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Secia7^FVB/NJ/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Secia8^FVB/NJ/? (involves: DBA/1J * FVB/NJ)	increased susceptibility to induced arthritis	J:123131
Sectm1a^em1Gcfa/Sectm1a^em1Gcfa (C57BL/6-Sectm1a^em1Gcfa)	abnormal interleukin level	J:317204
	abnormal macrophage physiology	J:317204
	abnormal tumor necrosis factor level	J:317204
	heart inflammation	J:317204
	increased circulating interleukin-1 beta level	J:317204
	increased circulating interleukin-6 level	J:317204
	increased circulating tumor necrosis factor level	J:317204
	increased susceptibility to endotoxin shock	J:317204
Sele^tm1Alb/Sele^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6J)	eye inflammation	J:101979
	increased susceptibility to bacterial infection	J:101979
Sele^tm1Dmil/Sele^tm1Dmil (involves: 129S4/SvJae * C57BL/6J)	abnormal leukocyte adhesion	J:113169
Sele^tm1Hyn/Sele^tm1Hyn Sell^tm1Hyn/Sell^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
Sele^tm1Hyn/Sele^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	abnormal cytokine level	J:31626
	impaired leukocyte tethering or rolling	J:31626
	impaired neutrophil recruitment	J:31626
	increased circulating interleukin-3 level	J:31626
	increased susceptibility to bacterial infection	J:31626
Sele^tm1Hyn/Sele^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
Sele^tm1Roml/Sele^tm1Roml (involves: 129S1/Sv * C57BL/6)	abnormal T cell physiology	J:113536
Sele^tm1Roml/Sele^tm1Roml (involves: 129S1/Sv)	abnormal T cell physiology	J:113536
Sele^tm2Alb/Sele^tm2Alb Sell^tm2Alb/Sell^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cellular extravasation	J:70682
	impaired leukocyte tethering or rolling	J:70682
	lung inflammation	J:70682
Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	eye inflammation	J:101979
	increased susceptibility to bacterial infection	J:101979
Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cytokine secretion	J:70682
	abnormal neutrophil physiology	J:112286
	decreased acute inflammation	J:112286
	impaired leukocyte tethering or rolling	J:70682
Sele^tm2Hyn/Sele^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	enhanced leukocyte tethering or rolling	J:57973
Sele^tm2Hyn/Sele^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	impaired neutrophil recruitment	J:57973
Sele^tm2Hyn/Sele^tm2Hyn (B6.129S2-Sele^tm2Hyn)	abnormal type IV hypersensitivity reaction	J:121083
Selenok^tm1.2Itl/Selenok^tm1.2Itl (involves: BALB/cJ * C57BL/6)	abnormal circulating chemokine level	J:169169
	abnormal macrophage physiology	J:169169
	abnormal neutrophil physiology	J:169169
	abnormal T cell physiology	J:169169
	decreased interleukin-6 secretion	J:169169
	decreased T cell proliferation	J:169169
	decreased tumor necrosis factor secretion	J:169169
	impaired neutrophil chemotaxis	J:169169
	increased susceptibility to Flaviviridae infection	J:169169
	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:169169
Selenop^tm1Rfb/Selenop^tm1Rfb (B6.129-Selenop^tm1Rfb)	increased susceptibility to parasitic infection	J:134536
Sell^m2Btlr/Sell^m2Btlr (C57BL/6J-Sell^m2Btlr)	decreased response to antigen	J:231806
Sell^tm1.1Rpmc/Sell^tm1.1Rpmc (involves: 129S1/Sv * C57BL/6J * FVB/N)	abnormal granulocyte physiology	J:249558
	abnormal neutrophil physiology	J:249558
	increased inflammatory response	J:249558
Sell^tm1Flv/Sell⁺ (involves: C57BL/6 * NOD)	decreased susceptibility to autoimmune diabetes	J:88947
Sell^tm1Flv/Sell⁺ (involves: C57BL/6 * NOD)	pancreas inflammation	J:88947
Sell^tm1Flv/Sell^tm1Flv (involves: 129S2/SvPas * C57BL/6)	abnormal type IV hypersensitivity reaction	J:89253
Sell^tm1Flv/Sell^tm1Flv (involves: C57BL/6 * NOD)	decreased susceptibility to autoimmune disorder	J:88947
Sell^tm1Flv/Sell^tm1Flv (involves: C57BL/6 * NOD)	pancreas inflammation	J:88947
Sell^tm1Pest/Sell⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal hypersensitivity reaction	J:112550
Sell^tm1Pest/Sell⁺ (involves: 129S4/SvJae * C57BL/6)	impaired leukocyte tethering or rolling	J:112550
Sell^tm1Pest/Sell^tm1Pest (involves: 129S4/SvJae)	abnormal hypersensitivity reaction	J:111233
	abnormal leukocyte adhesion	J:111233
	impaired leukocyte tethering or rolling	J:111233
	increased T cell proliferation	J:111233
Sell^tm1Pest/Sell^tm1Pest (involves: 129S4/SvJae * C57BL/6)	abnormal cell-mediated immunity	J:112550
	abnormal dendritic cell physiology	J:112550
	abnormal hypersensitivity reaction	J:112550
	abnormal leukocyte migration	J:112550
	decreased T cell proliferation	J:112550
	impaired leukocyte tethering or rolling	J:112550
Sell^tm1Tft/Sell^tm1Tft (involves: 129P2/OlaHsd * C57BL/6)	abnormal cellular extravasation	J:25005
	abnormal leukocyte migration	J:25005
	impaired leukocyte tethering or rolling	J:25005
Sell^tm1Tft/Sell^tm1Tft (B6.129-Sell^tm1Tft)	abnormal cellular extravasation	J:66107
Sell^tm1Tft/Sell^tm1Tft (B6.129-Sell^tm1Tft)	abnormal leukocyte migration	J:66107
Sell^tm1Tft/Sell^tm1Tft (B6.129P2-Sell^tm1Tft)	abnormal cellular extravasation	J:48271
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:48271
Sell^tm2.1Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal neutrophil physiology	J:142184
Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	impaired leukocyte tethering or rolling	J:57973
Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	impaired neutrophil recruitment	J:57973
Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * BALB/c)	impaired leukocyte tethering or rolling	J:114317
Sell^tm2Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:142184
	abnormal neutrophil physiology	J:142184
	abnormal regulatory T cell physiology	J:141931
	impaired leukocyte tethering or rolling	J:142184
Sell^tm3Hyn/Sell^tm3Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
Sell^tm4Hyn/Sell^tm4Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
Selp^tm1.1Rpmc/Selp^tm1.1Rpmc (B6.129S1-Selp^tm1.1Rpmc)	impaired leukocyte tethering or rolling	J:230041
Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte migration	J:24239
	eye inflammation	J:101979
	increased susceptibility to bacterial infection	J:101979
Selp^tm1Bay/Selp^tm1Bay (D1.129S7(B6J)-Selp^tm1Bay)	abnormal cytokine secretion	J:57086
	increased IgG level	J:57086
	increased susceptibility to induced arthritis	J:57086
Selp^tm1Bay/Selp^tm1Bay (B6.129S7-Selp^tm1Bay/J)	abnormal T cell physiology	J:113536
Selp^tm1Bay/Selp^tm1Bay (either: B6.129S7-Selp^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal leukocyte tethering or rolling	J:31374
Selp^tm1Bay/Selp^tm1Bay (B6.129S7-Selp^tm1Bay)	decreased susceptibility to type IV hypersensitivity reaction	J:121083
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6J)	impaired leukocyte tethering or rolling	J:77329
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6J)	impaired neutrophil recruitment	J:77329
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	impaired leukocyte tethering or rolling	J:29814
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	impaired macrophage chemotaxis	J:29814
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	impaired eosinophil recruitment	J:57973
	impaired leukocyte tethering or rolling	J:57973
	impaired neutrophil recruitment	J:57973
Selp^tm2Hyn/Selp^tm2Hyn (involves: 129S2/SvPas * C57BL/6J)	impaired leukocyte tethering or rolling	J:51068
Selp^tm2Hyn/Selp^tm2Hyn (involves: 129S2/SvPas * C57BL/6J)	impaired neutrophil recruitment	J:51068
Selplg^tm1Fur/Selplg^tm1Fur (involves: 129/Sv * C57BL/6J * SJL)	impaired leukocyte tethering or rolling	J:75412
	impaired neutrophil chemotaxis	J:75412
Selplg^tm1Rpmc/Selplg^tm1Rpmc (involves: 129S1/Sv * C57BL/6J)	abnormal leukocyte adhesion	J:75829
	impaired leukocyte tethering or rolling	J:75829, J:138731
Selplg^tm1Rpmc/Selplg^tm1Rpmc (involves: 129S1/Sv)	abnormal chemokine secretion	J:115682
Selplg^tm2Rpmc/Selplg^tm2Rpmc (B6.Cg-Selplg^tm2Rpmc)	impaired leukocyte tethering or rolling	J:138731
Sema3a^tm1.1Tyag/Sema3a^tm1.1Tyag (involves: C57BL/6 * CBA)	abnormal dendritic cell physiology	J:161856
Sema3a^tm1.1Tyag/Sema3a^tm1.1Tyag (involves: C57BL/6 * CBA)	abnormal T cell physiology	J:161856
Sema3f^tm1.2Ddg/Sema3f^tm1.2Ddg (Not Specified)	abnormal lymphatic system physiology	J:226501
Sema4a^tm1Kik/Sema4a^tm1Kik (either: B6.Cg-Sema4a^tm1Kik or C.Cg-Sema4a^tm1Kik)	abnormal CD4-positive, alpha-beta T cell physiology	J:97027
	abnormal cytokine secretion	J:97027
	abnormal dendritic cell antigen presentation	J:97027
	decreased susceptibility to type IV hypersensitivity reaction	J:97027
Sema4b^tm1Akum/Sema4b^tm1Akum (either: B6.Cg-Sema4b^tm1Akum or C.Cg-Sema4b^tm1Akum)	abnormal immune system physiology	J:169386
	increased IgE level	J:169386
	increased IgG1 level	J:169386
Sema4d^tm1Kik/Sema4d^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:66033
	decreased B cell proliferation	J:66033
Senp1^tm1Wami/Senp1^tm1Wami Tg(Fabp4-cre)#Abel/0 (B6.Cg-Senp1^tm1Wami Tg(Fabp4-cre)#Abel)	abnormal chemokine level	J:228009
	abnormal circulating cytokine level	J:228009
	abnormal cytokine level	J:228009
	increased anti-insulin autoantibody level	J:228009
	increased circulating C-reactive protein level	J:228009
	increased circulating interleukin-1 beta level	J:228009
	increased circulating interleukin-6 level	J:228009
	increased circulating tumor necrosis factor level	J:228009
	increased susceptibility to autoimmune diabetes	J:228009
	myocarditis	J:228009
	pancreas inflammation	J:228009
Septin9^tm2.1Emfu/Septin9^tm2.1Emfu Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	decreased T cell proliferation	J:205027
Serpina1^em#Chmu/Serpina1^em#Chmu (involves: C57BL/6J)	increased susceptibility to endotoxin shock	J:259615
Serpina1^em#Chmu/Serpina1^em#Chmu (involves: C57BL/6J)	respiratory system inflammation	J:259615
Serpina3c^em1Smoc/Serpina3c^em1Smoc (C57BL/6-Serpina3c^em1Smoc)	white adipose tissue inflammation	J:343846
Serpina3g^tm1.1Arp/Serpina3g^tm1.1Arp (involves: C57BL/6)	abnormal response to infection	J:189782
Serpina3g^tm1.1Arp/Serpina3g^tm1.1Arp (involves: C57BL/6)	decreased T cell proliferation	J:189782
Serpina3g^tm1.1Arp/Serpina3g^tm1.1Arp Tg(TcrLCMV)#Sdz/0 (involves: C57BL/6 * DBA/2)	decreased T cell proliferation	J:189782
Serpina6^tm1Tew/Serpina6^tm1Tew (involves: 129/SvEmcTer * C57BL/6N)	abnormal circulating cytokine level	J:112974
	abnormal cytokine level	J:112974
	increased susceptibility to endotoxin shock	J:112974
Serpinb1a^tm1.1Cben/Serpinb1a^tm1.1Cben (129S6/SvEvTac-Serpinb1a^tm1.1Cben)	abnormal chemokine secretion	J:125918
	abnormal circulating cytokine level	J:125918
	abnormal neutrophil physiology	J:125918
	impaired neutrophil chemotaxis	J:125918
	increased interleukin-1 beta secretion	J:125918
	increased susceptibility to bacterial infection	J:125918
	increased susceptibility to bacterial infection induced morbidity/mortality	J:125918
	increased tumor necrosis factor secretion	J:125918
	lung inflammation	J:125918
	sepsis	J:125918
Serpinb3a^tm1Gsil/Serpinb3a^tm1Gsil (C.129-Serpinb3a^tm1Gsil)	decreased susceptibility to type I hypersensitivity reaction	J:189949
Serpinb9^tm1.1Pib/Serpinb9^tm1.1Pib (involves: BALB/cJ * C57BL/6J)	abnormal dendritic cell antigen presentation	J:252016
	abnormal immune system physiology	J:252016
	decreased cytotoxic T cell apoptosis	J:252016
Serpinb9^tm1Arp/Serpinb9^tm1Arp (involves: C57BL/6)	abnormal cytotoxic T cell physiology	J:113349
	decreased cytotoxic T cell cytolysis	J:113349
	increased susceptibility to Riboviria infection	J:113349
Serpinb9^tm1Arp/Serpinb9^tm1Arp Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6)	abnormal response to transplant	J:113349
Serpinc1^tm1Dwr/Serpinc1^tm1Dwr (involves: 129S1/Sv * 129X1/SvJ)	liver inflammation	J:115658
Serpine1^tm1.1Vlp/Serpine1^tm1.1Vlp (involves: 129 * C57BL/6)	decreased susceptibility to endotoxin shock	J:229191
Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	abnormal acute inflammation	J:133227
	abnormal interleukin level	J:133227
	decreased circulating interleukin-6 level	J:133227
	glomerulonephritis	J:85989
	increased acute inflammation	J:133227
	respiratory system inflammation	J:66093
Serpine1^tm1Mlg/Serpine1^tm1Mlg (B6.129S2-Serpine1^tm1Mlg/J)	heart inflammation	J:101486
	increased susceptibility to bacterial infection	J:124327
	increased susceptibility to Coronaviridae infection	J:288556
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:288556
Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas)	decreased susceptibility to endotoxin shock	J:229191
Serpine2^tm1Dmn/Serpine2^tm1Dmn (B6.129P2-Serpine2^tm1Dmn)	abnormal acute phase protein level	J:121263
Sertad2^{Gt(OST98734)Lex}/Sertad2^{Gt(OST98734)Lex} (B6.129S5-Sertad2^{Gt(OST98734)Lex})	abnormal macrophage physiology	J:194928
Sertad3^em1Bcgen/Sertad3^em1Bcgen (involves: C57BL/6N)	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:300469
Ses1a^C57BL/6J/Ses1a^C57BL/6J (involves: 129 * C57BL/6J)	decreased susceptibility to bacterial infection	J:81412
Ses1a^C57BL/6J/Ses1a^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses1a^C57BL/6J/Ses1a^C57BL/6J (129.B6-Ses1a^C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses1a^C57BL/6J/Ses1a^C57BL/6J Ses4^C57BL/6J/Ses4^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses1a^C57BL/6J/Ses1a^C57BL/6J Ses5^C57BL/6J/Ses5^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses1a^C57BL/6J/Ses1a^C57BL/6J Ses6^C57BL/6J/Ses6^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses1b^C57BL/6J/Ses1b^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses1b^C57BL/6J/Ses1b^C57BL/6J (129.B6-Ses1b^C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses2^C57BL/6J/Ses2^C57BL/6J (involves: 129 * C57BL/6J)	decreased susceptibility to bacterial infection	J:81412
Ses3^C57BL/6J/Ses3^C57BL/6J (involves: 129 * C57BL/6J)	decreased susceptibility to bacterial infection	J:81412
Ses7^{129S6/SvEvTac}/Ses7^C57BL/6J Ses8^C57BL/6J/Ses8^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses7^C57BL/6J/Ses7^C57BL/6J Ses8^C57BL/6J/Ses8^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Ses9^C57BL/6J/Ses9^C57BL/6J Ses10^C57BL/6J/Ses10^C57BL/6J (involves: 129S6/SvEvTac * C57BL/6J)	decreased susceptibility to bacterial infection	J:100367
Sesn1^{tm1a(EUCOMM)Wtsi}/Sesn1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal class switch recombination	J:240602
	increased immunoglobulin level	J:240602
	increased interferon-gamma secretion	J:240602
	increased interleukin-2 secretion	J:240602
	increased T cell proliferation	J:240602
Setd3^{tm1.1(NCOM)Mfgc}/Setd3^{tm1.1(NCOM)Mfgc} (involves: C57BL/6NCrl)	decreased susceptibility to Riboviria infection	J:293475
Setd5^{tm1a(EUCOMM)Wtsi}/Setd5⁺ (C57BL/6N-Setd5^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Setd7^tm1Frga/Setd7⁺ (involves: 129 * C57BL/6)	abnormal spleen physiology	J:136558
Setd7^tm1Frga/Setd7^tm1Frga (involves: 129 * C57BL/6)	abnormal spleen physiology	J:136558
Setdb2^tm1Desr/Setdb2^tm1Desr (B6.Cg-Setdb2^tm1Desr)	abnormal response to infection	J:222611
Setdb2^tm1Desr/Setdb2^tm1Desr (B6.Cg-Setdb2^tm1Desr)	increased susceptibility to bacterial infection	J:222611
Sfn^tm1Mak/Sfn^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	decreased IgG level	J:168328
	decreased IgM level	J:168328
	increased B cell apoptosis	J:168328
	increased B cell proliferation	J:168328
	increased susceptibility to Riboviria infection	J:168328
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:168328
Sftpa1^tm1Haw/Sftpa1^tm1Haw (involves: 129/Sv * C57BL/6 * CD-1)	abnormal cytokine level	J:86024
	abnormal inflammatory response	J:85432
	abnormal interferon level	J:86024
	abnormal interleukin level	J:86024
	increased susceptibility to Orthomyxoviridae infection	J:86024
Sftpa1^tm1Kor/Sftpa1^tm1Kor (involves: 129P2/OlaHsd * NIH Black Swiss)	increased susceptibility to bacterial infection	J:120552, J:110382
	lung inflammation	J:110382
Sftpa1^tm1Kor/Sftpa1^tm1Kor (involves: 129P2/OlaHsd)	lung inflammation	J:107841
Sftpa1^tm1Kor/Sftpa1^tm1Kor (involves: 129P2/OlaHsd * Black Swiss * C3H/HeN)	increased susceptibility to bacterial infection	J:130297
Sftpc^tm1Swg/Sftpc^tm1Swg (either: 129 or (involves: 129 * Black Swiss))	conjunctivitis	J:82925
Sftpd^tm1Haw/Sftpd^tm1Haw (involves: C57BL/6J * CD-1)	abnormal macrophage physiology	J:98220
Sftpd^tm1Jhf/Sftpd^tm1Jhf (involves: 129P2/OlaHsd * Black Swiss)	abnormal chemokine level	J:72681
	abnormal cytokine level	J:72681, J:62282
	abnormal macrophage physiology	J:62282
	abnormal neutrophil physiology	J:72681
	increased susceptibility to Orthomyxoviridae infection	J:72681
	lung inflammation	J:62282, J:50436
Sgca^tm1Kcam/Sgca^tm1Kcam (involves: 129S1/Sv * 129X1/SvJ)	heart inflammation	J:177563
Sgca^tm1Kcam/Sgca^tm1Kcam Sgce^tm1Vinni/Sgce^tm1Vinni (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	heart inflammation	J:177563
Sgcb^tm1Oza/Sgcb^tm1Oza (involves: 129S4/SvJae * C57BL/6J)	myositis	J:57590
Sgk3^fz-ica/Sgk3^fz-ica (Swiss albino)	abnormal inflammatory response	J:107373
sgl/sgl (involves: C3H * C57BL/6J)	conjunctivitis	J:56826
Sgms1^tm1Jia/Sgms1^tm1Jia (involves: C57BL/6)	abnormal cytokine level	J:201497
	abnormal cytokine secretion	J:201497
	decreased circulating interleukin-6 level	J:201497
	decreased circulating tumor necrosis factor level	J:201497
	decreased interleukin-6 secretion	J:201497
	decreased tumor necrosis factor secretion	J:201497
Sgms2^tm1Jia/Sgms2^tm1Jia (involves: 129 * C57BL/6)	abnormal macrophage physiology	J:162192, J:162226
Sgp5^NZB/? (involves: C57BL/6 * NZB * SB/Le)	abnormal immune serum protein physiology	J:95829
	glomerulonephritis	J:95829
	increased susceptibility to type III hypersensitivity reaction	J:95829
Sgp5^NZB/Sgp5^NZB (C57BL/6-Nba2 Yaa)	abnormal immune serum protein physiology	J:95829
Sgpl1^{Gt(ROSA)78Sor}/Sgpl1^{Gt(ROSA)78Sor} (involves: 129S4/SvJaeSor)	kidney inflammation	J:117491
Sgpl1^{Gt(ROSA)78Sor}/Sgpl1^{Gt(ROSA)78Sor} (involves: 129S4/SvJaeSor * C57BL/6)	abnormal immune system physiology	J:187619
	abnormal leukocyte migration	J:187619
	abnormal T cell physiology	J:187619
Sh2b2^tm1Yeb/Sh2b2^tm1Yeb (involves: C57BL/6)	increased IgG3 level	J:88527
Sh2d1a^tm1.1Knic/Y Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	abnormal NK T cell physiology	J:196692
	decreased circulating interleukin-4 level	J:196692
	decreased interferon-gamma secretion	J:196692
Sh2d1a^tm1.1Knic/Sh2d1a^tm1.1Knic Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	abnormal NK T cell physiology	J:196692
	decreased circulating interleukin-4 level	J:196692
	decreased interferon-gamma secretion	J:196692
Sh2d1a^tm1Cpt/Y (involves: 129S4/SvJae * C57BL/6)	abnormal cytokine secretion	J:97756
	abnormal germinal center B cell physiology	J:189126
	abnormal humoral immune response	J:189126
	abnormal immunoglobulin level	J:189126
	abnormal NK T cell physiology	J:189126
	increased susceptibility to Riboviria infection	J:97756
	increased T cell proliferation	J:97756
Sh2d1a^tm1Cpt/Y (involves: 129S4/SvJae * BALB/c)	abnormal cytokine secretion	J:97756
	decreased IgE level	J:97756
	decreased IgG level	J:189126
	decreased susceptibility to parasitic infection	J:97756
Sh2d1a^tm1Cpt/Y Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)	decreased IgG level	J:189126
Sh2d1a^tm1Cpt/Sh2d1a⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal cytokine secretion	J:97756
Sh2d1a^tm1Cpt/Sh2d1a⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell proliferation	J:97756
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (B6.129S4-Sh2d1a^tm1Cpt)	abnormal humoral immune response	J:97388
	decreased IgG1 level	J:97388
	decreased IgM level	J:97388
	increased IgG2a level	J:97388
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (C.129S4-Sh2d1a^tm1Cpt)	decreased IgG level	J:97388
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (C.129S4-Sh2d1a^tm1Cpt)	decreased IgM level	J:97388
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae * C57BL/6)	abnormal cytokine secretion	J:97756
	abnormal germinal center B cell physiology	J:189126
	abnormal humoral immune response	J:189126
	abnormal immunoglobulin level	J:189126
	abnormal NK T cell physiology	J:189126
	increased susceptibility to Riboviria infection	J:97756
	increased T cell proliferation	J:97756
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae * BALB/c)	abnormal cytokine secretion	J:97756
	decreased IgE level	J:97756
	decreased IgG level	J:189126
	decreased susceptibility to parasitic infection	J:97756
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: 129S4/SvJae * BALB/cJ)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: 129S4/SvJae * BALB/cJ)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)	decreased IgG level	J:189126
Sh2d1a^tm1Lyin/Y (involves: 129S2/SvPas * C57BL/6)	abnormal immune system physiology	J:97346
	chronic inflammation	J:97346
	decreased IgE level	J:97346
	decreased IgG level	J:97346
	decreased immunoglobulin level	J:97346
Sh2d1a^tm1Lyin/Sh2d1a^tm1Lyin (involves: 129S2/SvPas * C57BL/6)	abnormal immune system physiology	J:97346
	chronic inflammation	J:97346
	decreased IgE level	J:97346
	decreased IgG level	J:97346
	decreased immunoglobulin level	J:97346
Sh2d1a^tm1Lyin/Sh2d1a^tm1Lyin (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:110195
Sh2d1a^tm1Pls/Y (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
	abnormal cytotoxic T cell physiology	J:187431
	decreased IgG level	J:157915
	decreased interleukin-21 secretion	J:157915
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))	decreased IgE level	J:70032
	increased susceptibility to infection	J:70032
	increased susceptibility to parasitic infection	J:70032
	increased susceptibility to Riboviria infection	J:70032
	increased T cell proliferation	J:70032
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (involves: BALB/c)	decreased susceptibility to parasitic infection	J:90484
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (B6.129S6-Sh2d1a^tm1Pls)	abnormal CD4-positive, alpha-beta T cell physiology	J:93886
	abnormal NK cell physiology	J:187430
	decreased IgE level	J:93886
	decreased interferon-gamma secretion	J:187430
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (involves: 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
	abnormal cytotoxic T cell physiology	J:187431
	decreased IgG level	J:157915
	decreased interleukin-21 secretion	J:157915
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls Sh2d1b1^tm3Vei/Sh2d1b1^tm3Vei (involves: 129S6/SvEvTac * C57BL/6)	abnormal NK cell physiology	J:187430
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls Tg(DO11.10)10Dlo/Tg(DO11.10)10Dlo (involves: BALB/c * C3H * C57BL/6)	abnormal cytokine secretion	J:90484
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:157915
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls Tg(TcraTcrb)1100Mjb/0 (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytotoxic T cell physiology	J:187431
	decreased cytotoxic T cell cytolysis	J:187431
	decreased interferon-gamma secretion	J:187431
Sh2d1a^tm1Vei/Sh2d1a^tm1Vei (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:93886
	abnormal memory T cell physiology	J:93886
	decreased IgE level	J:93886
Sh2d1a^tm1Vei/Sh2d1a^tm1Vei (B6.129-Sh2d1a^tm1Vei)	abnormal NK cell physiology	J:187430
Sh2d1a^tm1Vei/Sh2d1a^tm1Vei (B6.129-Sh2d1a^tm1Vei)	decreased interferon-gamma secretion	J:187430
Sh2d1a^tm1Vei/Sh2d1a^tm1Vei Sh2d1b1^tm3Vei/Sh2d1b1^tm3Vei (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal NK cell physiology	J:187430
Sh2d1a^tm2.1Cpt/Y Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal germinal center B cell physiology	J:189126
	abnormal humoral immune response	J:189126
	decreased IgG level	J:189126
	decreased IgM level	J:189126
Sh2d1a^tm2.1Cpt/Sh2d1a^tm2.1Cpt Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal germinal center B cell physiology	J:189126
	abnormal humoral immune response	J:189126
	decreased IgG level	J:189126
	decreased IgM level	J:189126
Sh2d1a^tm2.1Vei/Sh2d1a^tm2.1Vei (involves: C57BL/6)	decreased IgE level	J:131618
	decreased IgG1 level	J:131618
	decreased IgG2a level	J:131618
	decreased IgG2b level	J:131618
	decreased IgG3 level	J:131618
	decreased IgM level	J:131618
Sh2d1a^tm2Vei/Sh2d1a^tm2Vei Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased IgE level	J:131618
	decreased IgG1 level	J:131618
	decreased IgG2a level	J:131618
	decreased IgG2b level	J:131618
	decreased IgG3 level	J:131618
	decreased IgM level	J:131618
Sh2d1a^tm2Vei/Sh2d1a^tm2Vei Tg(Lck-cre)1Cwi/0 (involves: C57BL/6)	decreased IgE level	J:131618
	decreased IgG1 level	J:131618
	decreased IgG2a level	J:131618
	decreased IgG2b level	J:131618
	decreased IgG3 level	J:131618
	decreased IgM level	J:131618
Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: BALB/cJ)	decreased interferon-gamma secretion	J:166054
	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b1/Sh2d1b2^tm1.1Cpt/Sh2d1b1/Sh2d1b2^tm1.1Cpt (involves: BALB/cJ)	decreased interferon-gamma secretion	J:166054
	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b1^tm1.1Cpt/Sh2d1b1^tm1.1Cpt (involves: BALB/cJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b1^tm1Vei/Sh2d1b1^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	increased interferon-gamma secretion	J:110195
	increased natural killer cell mediated cytotoxicity	J:110195
Sh2d1b1^tm2Vei/Sh2d1b1^tm2Vei Sh2d1b2^tm1Vei/Sh2d1b2^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:145969
Sh2d1b1^tm3Vei/Sh2d1b1^tm3Vei (involves: C57BL/6)	abnormal NK cell physiology	J:187430
Sh2d1b2^tm1.1Cpt/Sh2d1b2^tm1.1Cpt (involves: BALB/cJ * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:166054
Sh2d1b2^tm1Vei/Sh2d1b2^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:145969
	increased natural killer cell mediated cytotoxicity	J:110195
Sh2d2a^tm1Jbs/Sh2d2a^tm1Jbs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased interferon-gamma secretion	J:64938
	decreased interleukin-2 secretion	J:64938
	decreased T cell proliferation	J:64938
	increased interleukin-4 secretion	J:64938
Sh2d3c^tm1Lex/Sh2d3c^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal B cell physiology	J:161448
	abnormal humoral immune response	J:161448
	abnormal leukocyte migration	J:161448
	abnormal marginal zone B cell physiology	J:161448
	decreased IgG1 level	J:161448
	decreased IgG2b level	J:161448
	decreased IgG3 level	J:161448
	decreased IgM level	J:161448
	decreased interleukin-6 secretion	J:161448
Sh3bp2^tm1.1Ics/Sh3bp2⁺ (involves: 129S2/SvPas * C57BL/6)	abnormal circulating cytokine level	J:221901
	abnormal macrophage physiology	J:221901
	increased susceptibility to bacterial infection	J:221901
	increased tumor necrosis factor secretion	J:221901
Sh3bp2^tm1.1Ics/Sh3bp2^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	abnormal circulating cytokine level	J:221901
	increased circulating interleukin-6 level	J:221901
	increased circulating interleukin-12 level	J:221901
	increased circulating tumor necrosis factor level	J:221901
	increased inflammatory response	J:221901
	increased tumor necrosis factor secretion	J:221901
Sh3bp2^tm1Bjro/Sh3bp2⁺ (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal osteoclast physiology	J:117880
Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal macrophage physiology	J:117880
	abnormal osteoclast physiology	J:117880
	blepharitis	J:117880
	dermatitis	J:117880
	increased circulating tumor necrosis factor level	J:117880
	increased inflammatory response	J:117880
	joint inflammation	J:117880
	liver inflammation	J:117880
	lung inflammation	J:117880
	myositis	J:117880
	osteomyelitis	J:117880
	spinal cord inflammation	J:117880
	stomach inflammation	J:117880
Sh3bp2^tm1Geha/Sh3bp2^tm1Geha (Not Specified)	abnormal B cell physiology	J:110319
Sh3bp2^tm1Geha/Sh3bp2^tm1Geha (Not Specified)	decreased B cell proliferation	J:110319
Sh3bp2^tm1Rtpl/Sh3bp2^tm1Rtpl (B6.129P2-Sh3bp2^tm1Rtpl)	abnormal marginal zone B cell physiology	J:121380
	decreased B cell proliferation	J:121380
	decreased IgA level	J:121380
	decreased IgG1 level	J:121380
	decreased IgG3 level	J:121380
	decreased IgM level	J:121380
	decreased immunoglobulin level	J:121380
	increased B cell apoptosis	J:121380
Sh3bp2^tm1Rtpl/Sh3bp2^tm1Rtpl (involves: 129P2/OlaHsd * C57BL/6)	abnormal circulating cytokine level	J:221901
	abnormal interleukin-6 secretion	J:221901
	abnormal macrophage physiology	J:221901
	decreased tumor necrosis factor secretion	J:221901
	impaired macrophage phagocytosis	J:221901
Sh3glb2^{Gt(OST224737)Lex}/Sh3glb2^{Gt(OST224737)Lex} (B6.129S5-Sh3glb2^{Gt(OST224737)Lex})	abnormal response to infection	J:246421
Sh3kbp1^tm1Kuro/Sh3kbp1^tm1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * NZB)	abnormal B cell physiology	J:176805
	abnormal humoral immune response	J:176805
Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Sh3pxd2a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Sh3pxd2b^nee/Sh3pxd2b^nee (B10.Cg-H2^h4 Sh3pxd2b^nee/GrsrJ)	eye inflammation	J:262132
	hypopyon	J:262132
	increased susceptibility to otitis media	J:153369
Sh3yl1^tm1Syb/Sh3yl1^tm1Syb (involves: C57BL/6N)	decreased interleukin-1 beta secretion	J:298830
	decreased susceptibility to endotoxin shock	J:298830
	decreased tumor necrosis factor secretion	J:298830
Sharpin^cpdm-Dem/Sharpin^cpdm-Dem (CBy.OcB3-Sharpin^cpdm-Dem)	dermatitis	J:121810
	skin inflammation	J:121810
Sharpin^cpdm/Sharpin^cpdm (C57BL/KaLawRij-Sharpin^cpdm)	abnormal humoral immune response	J:53575
	decreased IgA level	J:53575
	decreased IgE level	J:31745, J:53575
	decreased IgG level	J:53575
	decreased immunoglobulin level	J:53575
	dermatitis	J:14539
	esophageal inflammation	J:31745
	folliculitis	J:31745
	increased IgM level	J:53575
	joint inflammation	J:14539
	lung inflammation	J:31745
	lymph node inflammation	J:31745
	stomach inflammation	J:31745
Sharpin^cpdm/Sharpin^cpdm (involves: C57BL/KaLawRij * FVB/NJ)	skin inflammation	J:121810
Shcbp1^{tm1c(EUCOMM)Wtsi}/Shcbp1^{tm1c(EUCOMM)Wtsi} Tg(Lck-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:212898
Shcbp1^{tm1d(EUCOMM)Wtsi}/Shcbp1^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N * FVB/N)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:212898
Shld1^em1Nus/Shld1^em1Nus (involves: C57BL/6NCrl)	abnormal class switch recombination	J:307190
Sials^MRL/MpJ/Sials^MRL/MpJ (involves: C3H/HeJ * MRL/MpJ)	salivary gland inflammation	J:66636
Sidt2^tm1.1Hzha/Sidt2^tm1.1Hzha (involves: 129S6/SvEvTac * C57BL/6J)	liver inflammation	J:236042
Sigirr^tm1Lix/Sigirr^tm1Lix (involves: 129S6/SvEvTac * BALB/c)	abnormal chemokine secretion	J:85151
	abnormal splenocyte proliferation	J:85151
	increased inflammatory response	J:85151
	increased susceptibility to endotoxin shock	J:85151
Sigirr^tm1Mant/Sigirr^tm1Mant (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal chemokine secretion	J:88907
	abnormal dendritic cell physiology	J:88907
	abnormal interleukin secretion	J:88907
	increased interleukin-6 secretion	J:88907
	increased susceptibility to induced colitis	J:88907
Siglec1^{tm1(HBEGF)Mtka}/Siglec1^{tm1(HBEGF)Mtka} 1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/? (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal dendritic cell physiology	J:123958
	abnormal immune system physiology	J:123958
	abnormal immune tolerance	J:123958
	abnormal macrophage physiology	J:123958
Siglec1^tm1Croc/Siglec1^tm1Croc (B6.129-Siglec1^tm1Croc)	decreased circulating interleukin-6 level	J:189854
	decreased circulating tumor necrosis factor level	J:189854
	decreased IgM level	J:105546
	decreased interleukin-6 secretion	J:189854
	decreased interleukin-10 secretion	J:189854
	decreased interleukin-12 secretion	J:189854
	decreased tumor necrosis factor secretion	J:189854
	impaired macrophage phagocytosis	J:189854
	increased susceptibility to bacterial infection	J:189854
Siglec1^tm2.1Croc/Siglec1^tm2.1Croc (B6.129P2(C)-Siglec1^tm2.1Croc)	decreased circulating interleukin-6 level	J:189854
	decreased circulating tumor necrosis factor level	J:189854
	decreased susceptibility to bacterial infection	J:189854
	impaired macrophage phagocytosis	J:189854
Siglece^{tm1.1(SIGLEC16)Avrk}/Siglece^{tm1.1(SIGLEC16)Avrk} (involves: C57BL/6)	abnormal cytokine level	J:264224
	decreased susceptibility to bacterial infection	J:264224
	increased circulating interleukin-6 level	J:264224
	increased circulating interleukin-12 level	J:264224
Siglece^tm1Arte/Siglece^tm1Arte (involves: C57BL/6)	abnormal macrophage physiology	J:195429
Siglece^tm1Arte/Siglece^tm1Arte (involves: C57BL/6)	abnormal neutrophil physiology	J:195429
Siglece^tm1Croc/Siglece^tm1Croc (B6.129P2-Siglece^tm1Croc)	abnormal macrophage physiology	J:195429
Siglece^tm1Croc/Siglece^tm1Croc (B6.129P2-Siglece^tm1Croc)	abnormal neutrophil physiology	J:195429
Siglecf^tm1.2Avrk/Siglecf^tm1.2Avrk (B6.129(FVB)-Siglecf^tm1.2Avrk)	abnormal eosinophil physiology	J:204811
	lung inflammation	J:204811
Siglecg^M3Btlr/Siglecg^M3Btlr (C57BL/6J-Siglecg^M3Btlr)	decreased IgM level	J:265185
Siglecg^tm1Lnit/Siglecg^tm1Lnit (involves: BALB/c)	autoimmune response	J:123353
	decreased IgG2a level	J:123353
	increased IgM level	J:123353
Siglecg^tm1Yliu/Siglecg^tm1Yliu (C57BL/6-Siglecg^tm1Yliu)	increased IgM level	J:130017
Siglech^tm1.1Cfg/Siglech^tm1.1Cfg (involves: C57BL/6)	increased T cell proliferation	J:217719
Siglech^tm1.1Ksat/Siglech^tm1.1Ksat (B6.Cg-Siglech^tm1.1Ksat)	abnormal circulating cytokine level	J:179283
	abnormal dendritic cell antigen presentation	J:179283
	abnormal plasmacytoid dendritic cell physiology	J:179283
	decreased circulating interferon-alpha level	J:179283
	decreased circulating interleukin-12b level	J:179283
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:179283
	decreased susceptibility to infection induced morbidity/mortality	J:179283
	increased circulating interferon-alpha level	J:179283
	increased circulating interleukin-12b level	J:179283
Sik2^tm1Lex/Sik2^tm1Lex (involves: 129S/SvEvBrd)	increased inflammatory response	J:229999
Sirpa^tm1Nog/Sirpa^tm1Nog (involves: 129P2/OlaHsd * C57BL/6)	abnormal Langerhans cell physiology	J:88694
	abnormal macrophage physiology	J:79592
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129)	interstitial pneumonia	J:81010
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129)	lung inflammation	J:81010
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129S1/Sv * 129X1/SvJ * CD-1)	glomerulonephritis	J:160869
	increased anti-nuclear antigen antibody level	J:160869
	increased immunoglobulin level	J:160869
	interstitial pneumonia	J:81010
	lung inflammation	J:81010
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129S1/Sv * 129X1/SvJ)	increased autoantibody level	J:241633
Sirt3^tm1.1Fwa/Sirt3^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal cytokine level	J:178653
	increased circulating interferon-gamma level	J:178653
	increased circulating interleukin-6 level	J:178653
	increased circulating interleukin-10 level	J:178653
	increased circulating interleukin-12 level	J:178653
	increased circulating tumor necrosis factor level	J:178653
	liver inflammation	J:178653
Sirt6^tm1Fwa/Sirt6^tm1Fwa (involves: 129S6/SvEvTac * 129X1/SvJ)	colitis	J:112817
Sirt6^tm2.1Cxd/Sirt6^tm2.1Cxd (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal spleen physiology	J:167023
Sirt6^tm2.2Cxd/Sirt6^tm2.2Cxd (involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)	abnormal spleen physiology	J:167023
Sirt7^tm1Evbo/Sirt7^tm1Evbo (involves: 129/Sv * C57BL/6)	abnormal cytokine level	J:147652
	increased interleukin-4 secretion	J:147652
	increased interleukin-12 secretion	J:147652
	increased interleukin-13 secretion	J:147652
Sirt7^tm1Fwa/Sirt7^tm1Fwa (involves: 129S1/Sv)	liver inflammation	J:205529
Sit1^tm1Lsmn/Sit1^tm1Lsmn (B6.Cg-Sit1^tm1Lsmn)	abnormal cytokine secretion	J:100408
	increased interferon-gamma secretion	J:100408
	increased interleukin-2 secretion	J:100408
	increased susceptibility to experimental autoimmune encephalomyelitis	J:100408
	increased T cell proliferation	J:100408
	increased tumor necrosis factor secretion	J:100408
Skap1^Gt713Lex/Skap1^Gt713Lex (B6.129S5-Skap1^Gt713Lex)	abnormal CD4-positive, alpha-beta T cell physiology	J:126545
	abnormal immune system physiology	J:126545
	abnormal T cell physiology	J:126545
	decreased interferon-gamma secretion	J:126545
	decreased interleukin-2 secretion	J:126545
	decreased T cell proliferation	J:126545
Skap2^{Gt(VICTR20)21Lex}/Skap2^{Gt(VICTR20)21Lex} (B6.129S5-Skap2^{Gt(VICTR20)21Lex})	abnormal B cell activation	J:101373
	abnormal dendritic cell antigen presentation	J:151350
	abnormal dendritic cell physiology	J:151350
	decreased B cell proliferation	J:101373
	decreased IgG2a level	J:101373
	decreased IgM level	J:101373
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:101373
Skil^tm1Spw/Skil^tm1Spw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	decreased T cell proliferation	J:84554
Skil^tm2Spw/Skil^tm2Spw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	decreased T cell proliferation	J:84554
Sla^tm1Weis/Sla^tm1Weis Sla2^tm1Amch/Sla2^tm1Amch (involves: 129)	abnormal dendritic cell physiology	J:169170
	decreased interleukin-12 secretion	J:169170
	decreased tumor necrosis factor secretion	J:169170
Slamf1^tm1Cpt/Slamf1^tm1Cpt (B6.129S4-Slamf1^tm1Cpt)	abnormal cytokine secretion	J:90484
	abnormal macrophage physiology	J:90484
	increased susceptibility to parasitic infection	J:90484
Slamf1^tm1Cpt/Slamf1^tm1Cpt (C.129S4-Slamf1^tm1Cpt)	abnormal cytokine secretion	J:90484
Slamf1^tm1Cpt/Slamf1^tm1Cpt (C.129S4-Slamf1^tm1Cpt)	abnormal macrophage physiology	J:90484
Slamf1^tm1Cpt/Slamf1^tm1Cpt Tg(DO11.10)10Dlo/Tg(DO11.10)10Dlo (involves: BALB/c * C3H * C57BL/6)	abnormal cytokine secretion	J:90484
Slamf1^tm1Oono/Slamf1^tm1Oono (B6.129-Slamf1^tm1Oono)	increased susceptibility to Paramyxoviridae infection	J:117810
Slamf1^tm1Vei/Slamf1^tm1Vei (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:133047, J:93886
Slamf6^tm1Dhow/Slamf6^tm1Dhow (involves: 129/Sv * C57BL/6)	abnormal neutrophil physiology	J:98995
	abnormal T-helper 2 physiology	J:98995
	decreased interleukin-4 secretion	J:98995
	decreased susceptibility to parasitic infection	J:98995
	impaired granulocyte bactericidal activity	J:98995
	increased circulating interleukin-12b level	J:98995
	increased circulating interleukin-16 level	J:98995
	increased circulating tumor necrosis factor level	J:98995
	increased susceptibility to bacterial infection	J:98995
	increased susceptibility to bacterial infection induced morbidity/mortality	J:98995
Slamf7^tm1Vei/Slamf7^tm1Vei (involves: 129S1/Sv * 129X1/SvJ)	impaired natural killer cell mediated cytotoxicity	J:145969
Slamf8^tm1Mill/Slamf8^tm1Mill (involves: BALB/c)	abnormal macrophage physiology	J:188963
Slamf8^tm1Mill/Slamf8^tm1Mill (involves: BALB/c)	increased susceptibility to bacterial infection	J:188963
Slamf9^em1Isha/Slamf9^em1Isha (involves: C57BL/6)	abnormal plasmacytoid dendritic cell physiology	J:279164
Slamf9^em1Isha/Slamf9^em1Isha (involves: C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:279164
Slc1a5^tm1Tac/Slc1a5^tm1Tac (involves: 129S/SvEv * C57BL/6)	abnormal T cell physiology	J:254980
Slc1a5^tm1Tac/Slc1a5^tm1Tac (involves: 129S/SvEv * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:254980
Slc2a4^tm1Mch/Slc2a4⁺ (involves: 129/Sv * C57BL/6J * CD-1 * SJL)	heart inflammation	J:43650
Slc2a6^em1Kusu/Slc2a6^em1Kusu (involves: C57BL/6JCrlj)	abnormal macrophage physiology	J:270487
	increased circulating tumor necrosis factor level	J:270487
	increased susceptibility to endotoxin shock	J:270487
Slc2a9^tm1.2Thor/Slc2a9^tm1.2Thor (involves: C57BL/6 * C57BL/6N)	kidney inflammation	J:153089
	tubulointerstitial nephritis	J:153089
Slc3a1^pbl/Slc3a1^pbl (C3HeB/FeJ-Slc3a1^pbl)	tubulointerstitial nephritis	J:85461
Slc3a1^pbl/Slc3a1^pbl (involves: C3HeB/FeJ * MRL/MpJ)	kidney inflammation	J:85461
Slc3a2^tm1.1Merl/Slc3a2⁺ Tg(Vil1-cre)997Gum/0 (B6.Cg-Slc3a2^tm1.1Merl Tg(Vil1-cre)997Gum)	decreased susceptibility to induced colitis	J:173946
Slc3a2^tm1.1Yait/Slc3a2^tm1.1Yait Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6NCrSlc)	abnormal macrophage antigen presentation	J:188365
	abnormal macrophage physiology	J:188365
	impaired macrophage phagocytosis	J:188365
Slc4a2^tm1Ges/Slc4a2^tm1Ges (involves: 129S6/SvEvTac)	abnormal osteoclast physiology	J:193823
Slc4a2^tm2Ges/Slc4a2^tm2Ges Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast physiology	J:193823
Slc4a2^tm2Ges/Slc4a2^tm2Ges Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast physiology	J:193823
Slc5a2^m2Btlr/Slc5a2^m2Btlr (C57BL/6J-Slc5a2^m2Btlr)	increased susceptibility to induced colitis	J:265117
Slc5a2^m2Btlr/Slc5a2^m2Btlr (C57BL/6J-Slc5a2^m2Btlr)	increased tumor necrosis factor secretion	J:265117
Slc5a2^tm1Lex/Slc5a2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased susceptibility to autoimmune diabetes	J:195941
Slc5a6^tm1.1Said/Slc5a6^tm1.1Said Tg(Vil1-cre/ERT2)23Syr/0 (involves: C57BL/6 * DBA/2)	cecum inflammation	J:307482
	small intestinal inflammation	J:307482
Slc5a7^{tm1a(KOMP)Wtsi}/Slc5a7^{tm1a(KOMP)Wtsi} (C57BL/6N-Slc5a7^{tm1a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Slc6a14^tm1Gana/Slc6a14^tm1Gana (Not Specified)	abnormal circulating chemokine level	J:226105
	abnormal circulating cytokine level	J:226105
	decreased circulating interleukin-1 alpha level	J:226105
	decreased circulating interleukin-4 level	J:226105
Slc6a14^tm1Gana/Slc6a14^tm1Gana Tg(MMTV-PyVT)634Mul/0 (Not Specified)	abnormal immunoglobulin level	J:226105
Slc7a2^tm1Clm/Slc7a2^tm1Clm (involves: 129S7/SvEvBrd * C57BL/6)	abnormal immune system physiology	J:69414
Slc7a9^tm1Nune/Slc7a9^tm1Nune (involves: 129P2/OlaHsd * C57BL/6J)	tubulointerstitial nephritis	J:85462
Slc7a11^m1Mtka/Slc7a11^m1Mtka (C57BL/6-Slc7a11^m1Mtka)	abnormal dendritic cell physiology	J:159323
Slc7a11^m1Mtka/Slc7a11^m1Mtka (C57BL/6-Slc7a11^m1Mtka)	abnormal macrophage physiology	J:159323
Slc9a2^tm1Ges/Slc9a2^tm1Ges (involves: 129X1/SvJ * Black Swiss)	stomach inflammation	J:65754
Slc9a4^tm1Ges/Slc9a4^tm1Ges (involves: 129S6/SvEvTac * Black Swiss)	stomach inflammation	J:98566
Slc9a8^m1Btlr/Slc9a8^m1Btlr (C57BL/6J-Slc9a8^m1Btlr)	increased susceptibility to induced colitis	J:267481
Slc11a1^r/Slc11a1^r (C3H/HeJ-Slc11a1^r)	decreased susceptibility to bacterial infection	J:35004
Slc11a1^r/Slc11a1^r (129/Sv)	decreased susceptibility to bacterial infection	J:81412
Slc11a1^r/Slc11a1^s ((129/Sv x BALB/c)F1)	decreased susceptibility to bacterial infection	J:28278
Slc11a1^s/Slc11a1^r ((129/Sv x C57BL/6J)F1)	abnormal susceptibility to bacterial infection	J:81412
Slc11a1^s/Slc11a1^s (C57BL/6J)	increased susceptibility to bacterial infection	J:81412
Slc11a1^s/Slc11a1^s (BALB/c)	increased susceptibility to bacterial infection	J:28278
Slc11a1^tm1Mcg/Slc11a1^s (involves: 129S4/SvJae * BALB/c)	increased susceptibility to bacterial infection	J:28278
Slc11a1^tm1Mcg/Slc11a1^tm1Mcg (involves: 129S4/SvJae * BALB/c)	increased susceptibility to bacterial infection	J:28278
Slc12a1^urehr3/Slc12a1^urehr3 (involves: C3HeB/FeJ)	pyelitis	J:159994
Slc12a1^urehr3/Slc12a1^urehr3 (involves: C3HeB/FeJ)	pyelonephritis	J:159994
Slc12a2^em1Dlp/Slc12a2⁺ (involves: C57BL/6J * DBA/2J)	increased susceptibility to bacterial infection	J:285398
Slc12a2^em1Dlp/Slc12a2^em1Dlp (involves: C57BL/6J * DBA/2J)	increased susceptibility to bacterial infection	J:285398
Slc12a2^em1Dlp/Slc12a2^em1Dlp (involves: C57BL/6J * DBA/2J)	large intestinal inflammation	J:285398
Slc15a4^m1Btlr/Slc15a4^m1Btlr (C57BL/6J-Slc15a4^m1Btlr)	abnormal interferon secretion	J:166600
	decreased interleukin-6 secretion	J:166600
	decreased interleukin-12 secretion	J:166600
	decreased tumor necrosis factor secretion	J:166600
Slc15a4^tm1Tkyo/Slc15a4^tm1Tkyo (involves: C57BL/6)	abnormal circulating cytokine level	J:270965
	abnormal cytokine secretion	J:270965
	decreased circulating interleukin-1 beta level	J:270965
	decreased circulating interleukin-6 level	J:270965
	decreased interferon-beta secretion	J:270965
	decreased interleukin-1 beta secretion	J:270965
	decreased interleukin-6 secretion	J:270965
	decreased interleukin-12 secretion	J:270965
	decreased interleukin-12b secretion	J:270965
	decreased interleukin-15 secretion	J:270965
	decreased interleukin-18 secretion	J:270965
	decreased susceptibility to induced colitis	J:270965
	decreased tumor necrosis factor secretion	J:270965
Slc19a3^tm1Said/Slc19a3^tm1Said (involves: C57BL/6)	chronic liver inflammation	J:170952
Slc19a3^tm1Said/Slc19a3^tm1Said (involves: C57BL/6)	kidney inflammation	J:170952
Slc22a4^tm1Atsu/Slc22a4^tm1Atsu (involves: C57BL/6J)	intestinal inflammation	J:207006
Slc24a3^em#Ebje/Slc24a3^em#Ebje (C57BL/6J-Slc24a3^em#Ebje)	increased susceptibility to induced colitis	J:308448
Slc25a17^Gt(XB686)Byg/Slc25a17^Gt(XB686)Byg (involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster)	liver inflammation	J:291257
Slc26a1^tm1Mark/Slc26a1^tm1Mark (involves: 129X1/SvJ * CD-1)	kidney inflammation	J:158567
Slc26a4^m2Btlr/Slc26a4^m2Btlr (C57BL/6J-Slc26a4^m2Btlr)	increased susceptibility to induced colitis	J:236690
Slc29a1^tm2Msg/Slc29a1^tm2Msg Epor^{tm1.1(EGFP/icre)Uk}/Epor⁺ (involves: 129X1/SvJ * BALB/cJ)	decreased interleukin-6 secretion	J:244602
Slc29a2^{Gt(OST207791)Lex}/Slc29a2^{Gt(OST207791)Lex} (involves: 129S5/SvEvBrd)	decreased interleukin-6 secretion	J:203572
Slc29a3^tm1Lex/Slc29a3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage physiology	J:179286
	increased macrophage apoptosis	J:179286
	increased susceptibility to bacterial infection	J:179286
	increased susceptibility to bacterial infection induced morbidity/mortality	J:179286
Slc30a2^tm1Kgna/Slc30a2^tm1Kgna (involves: 129 * C57BL/6)	abnormal macrophage physiology	J:264481
Slc30a4^lm/Slc30a4^lm (C57BL/6J-Slc30a4^lm)	dermatitis	J:5911, J:7690
Slc33a1^tm1.1Lpu/Slc33a1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal circulating cytokine level	J:211266
	abnormal cytokine secretion	J:211266
	abnormal T cell activation	J:211266
	brain inflammation	J:211266
	conjunctivitis	J:211266
	dermatitis	J:211266
	increased circulating interleukin-17 level	J:211266
	increased circulating interleukin-18 level	J:211266
	increased inflammatory response	J:211266
	increased interferon-gamma secretion	J:211266
	increased interleukin-4 secretion	J:211266
	increased interleukin-17 secretion	J:211266
	increased susceptibility to infection	J:211266
	preputial gland inflammation	J:211266
	prostate gland inflammation	J:211266
	salivary gland inflammation	J:211266
	stomach inflammation	J:211266
	urinary bladder inflammation	J:211266
Slc35c1^tm1Cknr/Slc35c1^tm1Cknr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal leukocyte adhesion	J:121151
	impaired leukocyte tethering or rolling	J:121151
Slc37a2^tm1Dgen/Slc37a2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage physiology	J:311521
	increased interleukin-1 beta secretion	J:311521
	increased interleukin-6 secretion	J:311521
	increased susceptibility to endotoxin shock	J:311521
	increased tumor necrosis factor secretion	J:311521
Slc37a4^tm1Jyc/Slc37a4^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	abnormal chemokine secretion	J:86005
	abnormal inflammatory response	J:86005
	abnormal neutrophil physiology	J:86005
	decreased inflammatory response	J:86005
	impaired neutrophil chemotaxis	J:86005
Slc38a8^em1Cya/Slc38a8^em1Cya (C57BL/6J-Slc38a8^em1Cya)	decreased susceptibility to viral infection	J:336781
Slc38a8^em1Cya/Slc38a8^em1Cya (C57BL/6J-Slc38a8^em1Cya)	decreased susceptibility to viral infection induced morbidity/mortality	J:336781
Slc39a5^tm1.1Gka/Slc39a5^tm1.1Gka (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	increased susceptibility to induced pancreatitis	J:209760
Slc39a5^tm1Gka/Slc39a5^tm1Gka Tg(Cela1-cre/ERT)1Lgdn/0 (involves: 129P2/OlaHsd * C57BL/6)	increased susceptibility to induced pancreatitis	J:209760
Slc39a10^tm1.1Tfk/Slc39a10^tm1.1Tfk Tg(Foxn1-cre)8Ghr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	increased thymocyte apoptosis	J:254216
Slc40a1^ffe/Slc40a1⁺ (either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J))	abnormal macrophage physiology	J:118592
Slc40a1^Pcm/Slc40a1⁺ (A.Cg-Slc40a1^Pcm)	abnormal spleen physiology	J:98335
Slc40a1^Pcm/Slc40a1⁺ (A.Cg-Slc40a1^Pcm)	increased splenocyte apoptosis	J:98335
Slc40a1^Pcm/Slc40a1^Pcm (A.Cg-Slc40a1^Pcm)	increased splenocyte apoptosis	J:98335
Slc43a2^{Gt(258C1)Cmhd}/Slc43a2^{Gt(258C1)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	liver inflammation	J:237439
Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * C57BL/6J)	abnormal macrophage physiology	J:282829
Sle1^NZM2410/Aeg/Sle1^NZM2410/Aeg Sle3^NZM2410/Aeg/Sle3^NZM2410/Aeg (B6;NZM-Sle1^NZM2410/Aeg Sle2^NZM2410/Aeg Sle3^NZM2410/Aeg/LmoJ)	abnormal marginal zone B cell physiology	J:138314
Sle1^NZW/Sle1^NZW Sles1^NZW/Sles1^NZW (involves: C57BL/6 * NZW)	abnormal T cell physiology	J:100678
	decreased susceptibility to systemic lupus erythematosus	J:100678
Sle1^NZW/Sle1^NZW Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J * NZW)	glomerulonephritis	J:134128
	increased IgG level	J:134128
	increased IgM level	J:134128
	increased susceptibility to systemic lupus erythematosus	J:134128
Sle1a^C57BL/6J/Sle1a^NZM2410/J (involves: C57BL/6J * NZM2410/J)	increased anti-chromatin antibody level	J:67544
Sle1a^NZM2410/J/Sle1a^NZM2410/J (involves: C57BL/6J * NZM2410/J)	increased anti-chromatin antibody level	J:67544
Sle1b^C57BL/6J/Sle1b^NZM2410/J (involves: C57BL/6J * NZM2410/J)	increased anti-chromatin antibody level	J:67544
Sle1b^NZM2410/J/Sle1b^NZM2410/J (involves: C57BL/6J * NZM2410/J)	increased anti-chromatin antibody level	J:67544
Sle1c^C57BL/6J/Sle1c^NZM2410/J (involves: C57BL/6J * NZM2410/J)	increased anti-chromatin antibody level	J:67544
Sle1c^NZB/Sle1c^NZM2410/J (involves: C57BL/6J * NZB * NZM2410/J)	glomerulonephritis	J:145133
	increased autoantibody level	J:145133
Sle1c^NZM2410/J/Sle1c^NZM2410/J (involves: C57BL/6J * NZM2410/J)	increased anti-chromatin antibody level	J:67544
Sle2^NZM2410/Aeg/Sle2^NZM2410/Aeg (involves: C57BL/6J * NZM2410/Aeg)	glomerulonephritis	J:25006
Sle3^NZM2410/Aeg/? (involves: C57BL/6J * NZM2410/Aeg)	glomerulonephritis	J:52863
	increased IgG level	J:52863
	increased IgM level	J:52863
Sle6^NZW/Sle6^NZW (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sle7^BXSB/J/Sle7^BXSB/J (involves: BXSB/J * C57BL/10Ola)	glomerulonephritis	J:60445
Sle8^BXSB/J/Sle8^BXSB/J (involves: BXSB/J * C57BL/10Ola)	glomerulonephritis	J:60445
Sle9^BXSB/J/Sle9^BXSB/J (involves: BXSB/J * C57BL/10Ola)	increased anti-nuclear antigen antibody level	J:60445
Sle11^BXSB/J/Sle11^BXSB/J (involves: BXSB/J * C57BL/10Ola)	increased IgG3 level	J:60445
Sle12^C57BL/6J/Sle12^C57BL/6J (involves: C57BL/6J * NZM2410/Aeg)	glomerulonephritis	J:52863
Sle12^C57BL/6J/Sle12^NZM2410/Aeg (involves: C57BL/6J * NZM2410/Aeg)	glomerulonephritis	J:52863
Sle12^NZM2410/Aeg/Sle12^NZM2410/Aeg (involves: C57BL/6J * NZM2410/Aeg)	glomerulonephritis	J:52863
Sle16^{129S6/SvEvTac}/? (involves: 129X1/Sv * C57BL/6)	abnormal immune serum protein physiology	J:93297
Sle16^{129S6/SvEvTac}/Sle16^{129S6/SvEvTac} (B6.129-Sle16^{129S6/SvEvTac})	increased autoantibody level	J:122132
	increased susceptibility to systemic lupus erythematosus	J:122132
Sle17^{129S6/SvEvTac}/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune serum protein physiology	J:93297
Sle18^C57BL/6/? (involves: 129X1/Sv * C57BL/6)	abnormal immune serum protein physiology	J:93297
Sles1^C57BL/6/Sles1^C57BL/6 (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sles1^C57BL/6/Sles1^NZW (involves: C57BL/6 * NZW)	abnormal immune system physiology	J:57246
Sles1^NZW/Sles1^NZW (involves: C57BL/6 * NZW)	decreased susceptibility to systemic lupus erythematosus	J:57246
Sles2^C57BL/6/Sles2^C57BL/6 (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sles2^C57BL/6/Sles2^NZW (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sles2^NZW/Sles2^NZW (involves: C57BL/6 * NZW)	decreased susceptibility to systemic lupus erythematosus	J:57246
Sles3^C57BL/6/Sles3^C57BL/6 (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sles3^C57BL/6/Sles3^NZW (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sles3^NZW/Sles3^NZW (involves: C57BL/6 * NZW)	decreased susceptibility to systemic lupus erythematosus	J:57246
Sles4^C57BL/6/Sles4^C57BL/6 (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sles4^C57BL/6/Sles4^NZW (involves: C57BL/6 * NZW)	increased susceptibility to systemic lupus erythematosus	J:57246
Sles4^NZW/Sles4^NZW (involves: C57BL/6 * NZW)	decreased susceptibility to systemic lupus erythematosus	J:57246
Slfn2^m1Btlr/Slfn2^m1Btlr (C57BL/6J-Slfn2^m1Btlr)	abnormal leukocyte physiology	J:158985
	abnormal T cell activation	J:158985
	abnormal T cell proliferation	J:158985
	decreased T cell proliferation	J:158985
	increased susceptibility to bacterial infection	J:158985
	increased susceptibility to bacterial infection induced morbidity/mortality	J:158985
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:158985
	increased susceptibility to Riboviria infection	J:158985
	increased T cell apoptosis	J:158985
Slfn2^m2Btlr/Slfn2^m2Btlr (C57BL/6J-Slfn2^m2Btlr)	decreased IgG level	J:234262
	decreased response to antigen	J:234262
	impaired humoral immune response	J:234262
Slfn4^{tm1c(EUCOMM)Wtsi}/Slfn4^{tm1c(EUCOMM)Wtsi} Gli1^{tm3(cre/ERT2)Alj}/Gli1⁺ (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * Swiss Webster)	abnormal interleukin level	J:337060
	abnormal tumor necrosis factor level	J:337060
	decreased susceptibility to bacterial infection	J:337060
Slfn8^tm1Aki/Slfn8^tm1Aki (involves: 129X1/SvJ * C57BL/6)	decreased interferon-gamma secretion	J:258797
	decreased interleukin-1 beta secretion	J:258797
	decreased interleukin-6 secretion	J:258797
	decreased interleukin-17 secretion	J:258797
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:258797
Slpd1^NZB/BlNJ/Slpd1^NZB/BlNJ (involves: DBA/2J * NZB/BlNJ)	increased B cell proliferation	J:124364
Slpi^tm1Ktak/Slpi^tm1Ktak (B6.129P2-Slpi^tm1Ktak)	increased susceptibility to bacterial infection	J:132933
Slpi^tm1Nkw/Slpi^tm1Nkw (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:82214
	increased B cell proliferation	J:82214
	increased interleukin-6 secretion	J:82214
	increased susceptibility to endotoxin shock	J:82214
Smad2^tm3Rob/Smad2^tm3Rob Smad3^tm1Xfw/Smad3^tm1Xfw (involves: 129/Sv * 129S/SvEv * C57BL/6 * ICR)	osteoarthritis	J:95374
Smad3^tm1Cxd/Smad3^tm1Cxd (either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))	abnormal T cell activation	J:53510
	abnormal T cell physiology	J:53510
	abnormal thymus involution	J:53510
	colitis	J:53510
	impaired neutrophil chemotaxis	J:53510
	increased inflammatory response	J:53510
	pancreas inflammation	J:53510
	small intestinal inflammation	J:53510
	stomach inflammation	J:53510
Smad3^tm1Cxd/Smad3^tm1Cxd (B6.129S6-Smad3^tm1Cxd)	tubulointerstitial nephritis	J:102084
Smad3^tm1Cxd/Smad3^tm1Cxd (involves: 129S6/SvEvTac)	abnormal leukocyte physiology	J:59673
	decreased B cell apoptosis	J:140567
	osteoarthritis	J:68792
Smad3^tm1Par/Smad3^tm1Par (129-Smad3^tm1Par/J)	abnormal circulating interleukin-6 level	J:175290
	abnormal cytokine secretion	J:175290
	decreased interleukin-6 secretion	J:175290
	increased inflammatory response	J:106572
Smad3^tm1Xfw/Smad3^tm1Xfw (involves: 129/Sv * C57BL/6)	abnormal B cell proliferation	J:53948
	abnormal cytokine secretion	J:53948
	abnormal T cell proliferation	J:53948
Smad4^tm1.1Gsu/Smad4^tm1.1Gsu Ptf1a^{tm1.1(cre)Cvw}/Ptf1a⁺ Tg(MtTGFA)Lmb/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1)	chronic pancreas inflammation	J:229184
Smad4^tm2.1Cxd/Smad4^tm2.1Cxd Tg(Foxn1-cre)8Ghr/0 (B6.Cg-Smad4^tm2.1Cxd Tg(Foxn1-cre)8Ghr)	abnormal thymus physiology	J:138837
Smad7^tm1.1Ink/Smad7^tm1.1Ink Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased interferon-gamma secretion	J:184670
	decreased interleukin-9 secretion	J:184670
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:184670
	decreased T cell proliferation	J:184670
Smad7^tm1Rheu/Smad7^tm1Rheu (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal class switch recombination	J:120714
	decreased B cell proliferation	J:120714
	increased B cell apoptosis	J:120714
Smad9^tm3Jfm/Smad9^tm3Jfm (involves: 129S4/SvJaeSor)	lung inflammation	J:150213
Smarcc1^tm2.1Rhs/Smarcc1^tm2.1Rhs Tg(Mx1-cre)1Cgn/0 (involves: BALB/c * C57BL/6 * CBA)	decreased B cell proliferation	J:184060
	increased B cell apoptosis	J:184060
Smc6^tm1.1Arln/Smc6^tm1.1Arln (involves: 129P2/OlaHsd * C57BL/6 * FVB)	decreased IgG2b level	J:220422
Smcr8^em1Btlr/Smcr8^em1Btlr (C57BL/6J-Smcr8^em1Btlr)	increased circulating interleukin-12b level	J:268243
	increased interleukin-6 secretion	J:268243
	increased susceptibility to induced colitis	J:268243
	increased tumor necrosis factor secretion	J:268243
Smcr8^em2Btlr/Smcr8^em2Btlr (C57BL/6J-Smcr8^em2Btlr)	increased circulating interleukin-12b level	J:268243
	increased interleukin-6 secretion	J:268243
	increased susceptibility to induced colitis	J:268243
	increased tumor necrosis factor secretion	J:268243
Smcr8^m1Btlr/Smcr8⁺ (C57BL/6J-Smcr8^m1Btlr)	increased susceptibility to induced colitis	J:268243
Smcr8^m1Btlr/Smcr8^m1Btlr (C57BL/6J-Smcr8^m1Btlr)	increased susceptibility to induced colitis	J:268243
Smcr8^m1Btlr/Smcr8^m1Btlr (C57BL/6J-Smcr8^m1Btlr)	increased tumor necrosis factor secretion	J:268243
Smcr8^m2Btlr/Smcr8^m2Btlr (C57BL/6J-Smcr8^m2Btlr)	increased susceptibility to induced colitis	J:268243
Smcr8^m2Btlr/Smcr8^m2Btlr (C57BL/6J-Smcr8^m2Btlr)	increased tumor necrosis factor secretion	J:268243
Smcr8^m3Btlr/Smcr8^m3Btlr (C57BL/6J-Smcr8^m3Btlr)	increased susceptibility to induced colitis	J:268243
Smcr8^m3Btlr/Smcr8^m3Btlr (C57BL/6J-Smcr8^m3Btlr)	increased tumor necrosis factor secretion	J:268243
Smg1^{Gt(AG0297)Wtsi}/Smg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	chronic inflammation	J:193626
	decreased circulating interleukin-1 beta level	J:193626
	increased circulating interleukin-6 level	J:193626
Smg9^{tm1b(EUCOMM)Wtsi}/Smg9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Smg9^{tm1b(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv * C57BL/6J)	abnormal granulocyte physiology	J:81982
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv * C57BL/6J)	increased susceptibility to bacterial infection	J:81982
Smpdl3b^{tm1a(EUCOMM)Wtsi}/Smpdl3b^{tm1a(EUCOMM)Wtsi} (C57BL/6-Smpdl3b^{tm1a(EUCOMM)Wtsi})	abnormal chemokine secretion	J:224870
	abnormal circulating chemokine level	J:224870
	increased circulating interleukin-6 level	J:224870
	increased circulating interleukin-12b level	J:224870
	increased circulating tumor necrosis factor level	J:224870
	increased susceptibility to endotoxin shock	J:224870
Smtn^tm1Gve/Smtn^tm1Gve (involves: 129/Sv * C57BL/6)	intestinal inflammation	J:104648
Smtn^tm1Gve/Smtn^tm1Gve (involves: 129/Sv * C57BL/6)	sepsis	J:104648
Snai2^tm1Look/Snai2^tm1Look (involves: 129X1/SvJ * C57BL/6)	blepharitis	J:80652
Snai2^tm2Grid/Snai2^tm2Grid (involves: 129S1/Sv)	blepharitis	J:48521
Snai2^tm2Grid/Snai2^tm2Grid (involves: 129S1/Sv)	conjunctivitis	J:48521
Snai2^tm2Grid/Snai2^tm2Grid Snai3^tm1.2Jhws/Snai3^tm1.2Jhws (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal thymus involution	J:204710
Snca^tm1Rosl/Snca^tm1Rosl (involves: 129X1/SvJ)	decreased susceptibility to bacterial infection	J:138194
Snca^tm1Rosl/Snca^tm1Rosl Tg(Prnp-SNCA)7Vle/Tg(Prnp-SNCA)7Vle (involves: 129X1/SvJ * C3H * C57BL/6)	abnormal response to infection	J:138194
Snca^tm1Rosl/Snca^tm1Rosl Tg(Prnp-SNCAA53T)83Vle/Tg(Prnp-SNCAA53T)83Vle (involves: 129X1/SvJ * C3H * C57BL/6)	increased susceptibility to bacterial infection	J:138194
Snrk^tm1.1Hxu/Snrk^tm1.1Hxu Tg(Adipoq-cre)1Evdr/0 (B6.Cg-Snrk^tm1.1Hxu Tg(Adipoq-cre)1Evdr)	abnormal circulating chemokine level	J:257980
	brown adipose tissue inflammation	J:257980
	increased circulating interleukin-6 level	J:257980
	increased circulating tumor necrosis factor level	J:257980
	white adipose tissue inflammation	J:257980
Snrnp40^em1Btlr/Snrnp40^swp (C57BL/6J-Snrnp40^em1Btlr/Snrnp40^swp)	abnormal CD4-positive, alpha-beta T cell physiology	J:282417
	abnormal CD8-positive, alpha-beta T cell physiology	J:282417
	decreased T cell proliferation	J:282417
	impaired natural killer cell mediated cytotoxicity	J:282417
	increased circulating interferon-beta level	J:282417
	increased circulating interferon-gamma level	J:282417
	increased circulating interleukin-6 level	J:282417
	increased circulating interleukin-12 level	J:282417
	increased circulating interleukin-17 level	J:282417
	increased circulating tumor necrosis factor level	J:282417
	increased susceptibility to viral infection	J:282417
	increased susceptibility to viral infection induced morbidity/mortality	J:282417
Snx8^tm1Hbsh/Snx8^tm1Hbsh (Not Specified)	abnormal chemokine secretion	J:254306
	abnormal circulating chemokine level	J:254306
	abnormal dendritic cell physiology	J:254306
	abnormal macrophage physiology	J:254306
	decreased circulating CXCL10 level	J:254306
	decreased circulating tumor necrosis factor level	J:254306
	decreased CXCL10 secretion	J:254306
	decreased macrophage cytokine production	J:254306
	increased susceptibility to bacterial infection	J:254306
	increased susceptibility to bacterial infection induced morbidity/mortality	J:254306
Snx10^em1Ael/Snx10^em1Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal osteoclast physiology	J:289051
	osteomyelitis	J:289051
Snx10^em2Ael/Snx10^em2Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal osteoclast physiology	J:289051
	osteomyelitis	J:289051
Snx10^{tm1a(EUCOMM)Raba}/Snx10^{tm1a(EUCOMM)Raba} (involves: 129S4/SvJae * C57BL/6 * C57BL/6J)	abnormal osteoclast physiology	J:224711
Socs1^tm1.1Ayr/Socs1^tm1.1Ayr (involves: C57BL/6)	abnormal T cell physiology	J:226678
Socs1^tm1.1Ayr/Socs1^tm1.1Ayr (involves: C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:226678
Socs1^tm1Ayos/Socs1^tm1Ayos Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	blepharitis	J:167922
	conjunctivitis	J:167922
	dermatitis	J:167922
Socs1^tm1Ayos/Socs1^tm1Ayos Tg(Lck-cre)1Jtak/0 (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:132905
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:132905
Socs1^tm1Jni/Socs1⁺ (Not Specified)	abnormal cytokine level	J:91651
Socs1^tm1Jni/Socs1⁺ (Not Specified)	abnormal interleukin level	J:91651
Socs1^tm1Jni/Socs1^tm1Jni (Not Specified)	abnormal cytokine secretion	J:57475
Socs1^tm1Kish/Socs1^tm1Kish (B6.129P2-Socs1^tm1Kish)	abnormal lymphocyte physiology	J:69472
Socs1^tm1Kish/Socs1^tm1Kish (B6.129P2-Socs1^tm1Kish)	liver inflammation	J:69472
Socs1^tm1Kish/Socs1^tm1Kish Stat1^tm1Rds/Stat1^tm1Rds (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	liver inflammation	J:69472
Socs1^tm1Kish/Socs1^tm1Kish Stat6^tm1Aki/Stat6^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	liver inflammation	J:69472
Socs1^tm1Wehi/Socs1^tm1Wehi (involves: 129S1/Sv * C57BL/6)	abnormal inflammatory response	J:57474
	abnormal macrophage physiology	J:57474
	decreased susceptibility to Togaviridae infection induced morbidity/mortality	J:57474
	heart inflammation	J:51281
	increased inflammatory response	J:72528
	liver inflammation	J:51281
	pancreas inflammation	J:51281
Socs1^tm1Wehi/Socs1^tm3Wehi Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * ICR)	abnormal T cell activation	J:83009
Socs1^tm2Wehi/Socs1^tm2Wehi (C57BL/6-Socs1^tm2Wehi)	glomerulonephritis	J:72528
	increased incidence of corneal inflammation	J:72528
	increased inflammatory response	J:72528
	intestinal inflammation	J:72528
	liver inflammation	J:72528
	myocarditis	J:72528
	myositis	J:72528
	pancreas inflammation	J:72528
	salivary gland inflammation	J:72528
	skin inflammation	J:72528
Socs1^tm3.1Wehi/Socs1^tm3.1Wehi (C57BL/6-Socs1^tm3.1Wehi)	abnormal inflammatory response	J:83009
Socs1^tm3.1Wehi/Socs1^tm3.1Wehi (C57BL/6-Socs1^tm3.1Wehi)	increased circulating interferon-gamma level	J:83009
Socs2^tm1Wehi/Socs2^tm1Wehi (involves: C57BL/6 * C57BL/6J)	abnormal circulating cytokine level	J:186227
	abnormal macrophage physiology	J:186227
	increased circulating interferon-gamma level	J:186227
	increased circulating interleukin-1 beta level	J:186227
	increased interferon-gamma secretion	J:186227
	increased interleukin-1 beta secretion	J:186227
	increased tumor necrosis factor secretion	J:186227
	liver inflammation	J:186227
Socs3^tm1Ayos/Socs3^tm1Ayos Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	decreased susceptibility to endotoxin shock	J:92040
Socs3^tm1Jni/Socs3⁺ (involves: 129P2/OlaHsd)	increased interleukin-2 secretion	J:128797
Socs3^tm1Robb/Socs3^tm1Robb (involves: C57BL/6)	increased susceptibility to induced arthritis	J:145513
Socs3^tm1Wsa/Socs3^tm2Wsa Lyz2^tm1(cre)Ifo/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:83645
Socs3^tm1Wsa/Socs3^tm2Wsa Tg(Vav1-cre)1Awr/0 (involves: C57BL/6)	increased inflammatory response	J:89785
	liver inflammation	J:89785
	lung inflammation	J:89785
	peritoneal inflammation	J:89785
Socs4^m1Nch/Socs4^m1Nch (C.C3Fe-Socs4^m1Nch)	abnormal chemokine secretion	J:241977
	abnormal T cell activation	J:241977
	increased interferon-gamma secretion	J:241977
	increased interleukin-1 secretion	J:241977
	increased interleukin-4 secretion	J:241977
	increased interleukin-5 secretion	J:241977
	increased interleukin-6 secretion	J:241977
	increased interleukin-12b secretion	J:241977
	increased interleukin-13 secretion	J:241977
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:241977
Socs4^m1Nch/Socs4^m1Nch (C3H/He-Socs4^m1Nch)	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:241977
Socs4^m1Nch/Socs4^m1Nch (C6.C3Fe-Socs4^m1Nch)	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:241977
Sod1^m1H/Sod1^m1H (involves: C3H/HeH * C57BL/6J)	liver inflammation	J:219360
Sod1^tm1Leb/Sod1^tm1Leb (involves: 129S7/SvEvBrd * C57BL/6)	blepharitis	J:219024
	increased circulating interleukin-6 level	J:219024
	increased circulating tumor necrosis factor level	J:219024
	increased interleukin-6 secretion	J:219024
	increased tumor necrosis factor secretion	J:219024
	Meibomian gland inflammation	J:219024
Sod3^tm1Mrkl/Sod3^tm1Mrkl (D1.129P2-Sod3^tm1Mrkl)	arthritis	J:106273
	increased susceptibility to induced arthritis	J:106273
	increased tumor necrosis factor secretion	J:106273
Sod3^tm1Svp/Sod3^tm1Svp (involves: 129S6/SvEvTac * C57BL/6NTac)	decreased susceptibility to endotoxin shock	J:285340
Sort1^tm1Camo/Sort1^tm1Camo (B6.129X1-Sort1^tm1Camo)	abnormal tumor necrosis factor level	J:157549
Sos1^tm1.1Les/Sos1^tm1.1Les Tg(Lck-cre)1Cwi/0 (involves: 129 * C57BL/6)	decreased T cell proliferation	J:174536
Sox2^tm3(TK)Hoch/Sox2⁺ (involves: 129S4/SvJae * C57BL/6)	stomach inflammation	J:177655
Sox2^tm3(TK)Hoch/Sox2⁺ (involves: 129S4/SvJae * C57BL/6)	tongue inflammation	J:177655
Sox9^{em1(cre/ERT2)Smoc}/Sox9⁺ Tnfsf18^em1Pwan/Tnfsf18^em1Pwan (involves: C57BL/6J)	abnormal T cell activation	J:346395
	decreased inflammatory response	J:346395
Sox13^tm1Jskg/Sox13^tm1Jskg (involves: C57BL/6)	increased T cell proliferation	J:117301
Sox17^tm1Ysk/Sox17⁺ (involves: 129S1/Sv * C57BL/6)	liver inflammation	J:194071
Sox17^tm1Ysk/Sox17⁺ (B6.129S1-Sox17^tm1Ysk)	gallbladder inflammation	J:241569
Sox17^tm1Ysk/Sox17⁺ (B6.129S1-Sox17^tm1Ysk)	liver inflammation	J:194071
Sox17^tm2Sjm/Sox17⁺ Tg(Pdx1-cre)6Tuv/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	liver inflammation	J:241569
Sp140^em1Vnce/Sp140^em1Vnce (C57BL/6J-Sp140^em1Vnce)	increased susceptibility to bacterial infection	J:313901
Sp140^em1Vnce/Sp140^em1Vnce (C57BL/6J-Sp140^em1Vnce)	increased susceptibility to bacterial infection induced morbidity/mortality	J:313901
Sparc^tm1Hwe/Sparc^tm1Hwe (involves: 129S/SvEv * C57BL/6J)	eye inflammation	J:52120
Sparc^tm1Hwe/Sparc^tm1Hwe (involves: 129S/SvEv * C57BL/6J)	vitreous body inflammation	J:52120
Spata2^{tm1(KOMP)Vlcg}/Spata2^{tm1(KOMP)Vlcg} (C57BL/6-Spata2^{tm1(KOMP)Vlcg})	increased inflammatory response	J:244164
spcy/spcy (C57BL/6J-spcy)	abnormal innate immunity	J:94077
Spdef^tm1Shiv/Spdef^tm1Shiv (involves: 129S4/SvJae)	small intestinal inflammation	J:166876
Spdef^tm1Shiv/Spdef^tm1Shiv (involves: 129S4/SvJae)	stomach inflammation	J:166876
Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ Trmu^tm1Tomik/Trmu^tm1Tomik (involves: C57BL/6 * DBA)	abnormal inflammatory response	J:235644
Spef2^bgh/Spef2^bgh (involves: 129S6/SvEvTac * C57BL/6J * C57BL/10J)	sinus inflammation	J:176695
Sphk1^tm1.1Cgh/Sphk1^tm2Cgh Sphk2^tm1.1Cgh/Sphk2^tm1.1Cgh Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal immune serum protein physiology	J:120783
Sphk1^tm1Rlp/Sphk1^tm1Rlp (involves: 129S6/SvEvTac)	abnormal cytokine level	J:133917
Sphk1^tm1Rlp/Sphk1^tm1Rlp (involves: 129S6/SvEvTac)	decreased susceptibility to endotoxin shock	J:133917
Sphk2^tm1.1Stlp/Sphk2^tm1.1Stlp (involves: BALB/c)	abnormal CD4-positive, alpha-beta T cell physiology	J:153014
Sphk2^tm1Npa/Sphk2^tm1Npa (BALB/c-Sphk2^tm1Npa)	abnormal B cell physiology	J:129314
Spi1^tm1.3Dgt/Spi1^tm1.3Dgt (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	increased IgM level	J:106040
Spi1^tm1Ram/Spi1^tm1Ram (involves: 129S2/SvPas * C57BL/6)	sepsis	J:36473
Spi1^tm1Sing/Spi1⁺ Spib^tm1Mcs/Spib⁺ (involves: 129S/SvEv * 129X1/SvJ)	decreased B cell proliferation	J:88257
Spi1^tm1Sing/Spi1⁺ Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S/SvEv * 129X1/SvJ)	decreased B cell proliferation	J:88257
	increased B cell apoptosis	J:88257
Spib^tm1Ksho/Spib^tm1Ksho (involves: C57BL/6J)	increased susceptibility to bacterial infection	J:187649
Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased B cell proliferation	J:88257
Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S1/Sv * 129X1/SvJ)	abnormal humoral immune response	J:45245
	decreased B cell proliferation	J:45245
	decreased IgG1 level	J:45245
	decreased IgG2a level	J:45245
	decreased IgG2b level	J:45245
	increased B cell apoptosis	J:45245
	increased IgM level	J:45245
Spic^tm1.1Kmm/Spic^tm1.1Kmm (involves: 129S6/SvEvTac * C57BL/6)	impaired macrophage phagocytosis	J:143900
Spic^tm1Kmm/Spic^tm1Kmm (involves: 129S6/SvEvTac * C57BL/6)	impaired macrophage phagocytosis	J:143900
Spink7^em1Cya/Spink7^em1Cya (C57BL/6N-Spink7^em1Cya/Cya)	increased interleukin-1 beta secretion	J:310883
	increased interleukin-6 secretion	J:310883
	increased susceptibility to induced colitis	J:310883
Spink14^{tm1e(KOMP)Wtsi}/Spink14^{tm1e(KOMP)Wtsi} (C57BL/6N-Spink14^{tm1e(KOMP)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Spint1^tm2.1Hk/Spint1^tm2.1Hk Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6J * SJL)	increased susceptibility to induced colitis	J:179937
Spir1^BALB/cOlaHsd/Spir1^BALB/cOlaHsd (involves: BALB/cOlaHsd * CBA/CaOlaHsd)	decreased susceptibility to bacterial infection	J:84089
Spir1^BALB/cOlaHsd/Spir1^CBA/CaOlaHsd (involves: BALB/cOlaHsd * CBA/CaOlaHsd)	decreased susceptibility to bacterial infection	J:84089
Spir1^CBA/CaOlaHsd/Spir1^CBA/CaOlaHsd (involves: BALB/cOlaHsd * CBA/CaOlaHsd)	increased susceptibility to bacterial infection	J:84089
Spn^tm1Bam/Spn^tm1Bam (involves: 129S4/SvJae * C57BL/6)	abnormal T cell physiology	J:29272
Spn^tm1Bam/Spn^tm1Bam (involves: 129S4/SvJae * C57BL/6)	increased T cell proliferation	J:29272, J:88252
Spn^tm1Bam/Spn^tm1Bam (B6;129S4-Spn^tm1Bam/J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:86932
Spns2^tm1.1Nmoc/Spns2^tm1.1Nmoc Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)	abnormal B cell physiology	J:184558
	abnormal T cell physiology	J:184558
Spns2^tm1.2Nmoc/Spns2^tm1.2Nmoc (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal B cell physiology	J:184558
	abnormal T cell physiology	J:184558
Spns2^{tm1a(KOMP)Wtsi}/Spns2^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	abnormal humoral immune response	J:188933
	decreased IgG1 level	J:188933
	decreased IgG level	J:188933
	increased incidence of corneal inflammation	J:213427
	increased susceptibility to bacterial infection	J:213427
Spon2^tm1Mjb/Spon2^tm1Mjb (involves: 129S6/SvEvTac * C57BL/6)	abnormal interleukin level	J:87393
	abnormal susceptibility to infection	J:87393
	abnormal tumor necrosis factor level	J:87393
Spp1^Ric-r/Spp1⁺ (AKR/J)	decreased susceptibility to bacterial infection	J:5949
Spp1^Ric-r/Spp1⁺ (A/J)	decreased susceptibility to bacterial infection	J:5949
Spp1^Ric-r/Spp1⁺ (BALB/cJ)	decreased susceptibility to bacterial infection	J:5949
Spp1^Ric-r/Spp1⁺ (C57BL/6J)	decreased susceptibility to bacterial infection	J:5949
Spp1^Ric-r/Spp1⁺ (C57L/J)	decreased susceptibility to bacterial infection	J:5949
Spp1^Ric-r/Spp1⁺ (SWR/J)	decreased susceptibility to bacterial infection	J:5949
Spp1^Ric-r/Spp1⁺ (C3H/Rv)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:7240
Spp1^Ric-s/Spp1⁺ (A/HeJ)	increased susceptibility to bacterial infection	J:5949
Spp1^Ric-s/Spp1⁺ (C3H/HeJ)	increased susceptibility to bacterial infection	J:5949
Spp1^Ric-s/Spp1⁺ (C3H/HeN)	increased susceptibility to bacterial infection	J:5949
Spp1^Ric-s/Spp1⁺ (C3H/St)	increased susceptibility to bacterial infection	J:5949
Spp1^Ric-s/Spp1⁺ (CBA/J)	increased susceptibility to bacterial infection	J:5949
Spp1^Ric-s/Spp1⁺ (DBA/1J)	increased susceptibility to bacterial infection	J:5949
Spp1^Ric-s/Spp1⁺ (DBA/2J)	increased susceptibility to bacterial infection	J:5949
Spp1^Ric-s/Spp1⁺ (SJL/J)	increased susceptibility to bacterial infection	J:5949
Spp1^tm1.1Dhd/Spp1^tm1.1Dhd (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:237104
Spp1^tm1Blh/Spp1⁺ (BKSW.129S6-Spp1^tm1Blh)	abnormal immune system physiology	J:113585
Spp1^tm1Blh/Spp1⁺ (involves: 129S6/SvEvTac * Black Swiss)	abnormal leukocyte migration	J:86531
Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * Black Swiss)	abnormal chemokine level	J:127389
	abnormal leukocyte migration	J:86531
	abnormal leukocyte physiology	J:86531
	abnormal macrophage chemotaxis	J:140014
	abnormal macrophage physiology	J:127389
	abnormal response to infection	J:103013
	abnormal susceptibility to infection	J:140014
	decreased circulating interleukin-6 level	J:127389
	granulomatous inflammation	J:140014
Spp1^tm1Blh/Spp1^tm1Blh (B6.129S6-Spp1^tm1Blh)	decreased susceptibility to experimental autoimmune uveoretinitis	J:116272
Spp1^tm1Blh/Spp1^tm1Blh (B6.129S6-Spp1^tm1Blh)	granulomatous inflammation	J:116272
Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune system physiology	J:119298
Spp1^tm1Blh/Spp1^tm1Blh (BKSW.129S6-Spp1^tm1Blh)	abnormal immune system physiology	J:113585
Spp1^tm1Blh/Spp1^tm1Blh (BKSW.129S6-Spp1^tm1Blh)	impaired macrophage chemotaxis	J:113585
Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6)	abnormal inflammatory response	J:60284
	abnormal osteoclast physiology	J:68872, J:56353
	abnormal response to infection	J:60284
	decreased interferon-gamma secretion	J:60284
	decreased interleukin-12 secretion	J:60284
	decreased susceptibility to Herpesvirales infection	J:60284
	decreased susceptibility to type IV hypersensitivity reaction	J:60284
	increased interleukin-4 secretion	J:60284
	increased interleukin-10 secretion	J:60284
Spp1^tm1Rit/Spp1^tm1Rit (B6.129S7-Spp1^tm1Rit)	decreased acute inflammation	J:93915
	decreased interferon-gamma secretion	J:93915
	decreased tumor necrosis factor secretion	J:93915
Sppl2a^chompB/Sppl2a^chompB (involves: C57BL/6)	abnormal class switch recombination	J:194595
	abnormal humoral immune response	J:194595
	decreased activation-induced B cell apoptosis	J:194595
	decreased B cell proliferation	J:194595
	decreased IgG1 level	J:194595
	decreased IgG2b level	J:194595
	decreased IgG3 level	J:194595
	decreased IgM level	J:194595
Sppl2a^m1Anu/Sppl2a^m1Anu (involves: C57BL/6JAnu)	abnormal immunoglobulin level	J:194663
	decreased IgG1 level	J:194663
	decreased IgM level	J:194663
Sppl2a^m1Btlr/Sppl2a^m1Btlr (C57BL/6J-Sppl2a^m1Btlr)	decreased IgG level	J:236687
Sppl2a^m1Btlr/Sppl2a^m1Btlr (C57BL/6J-Sppl2a^m1Btlr)	decreased response to antigen	J:236687
Sppl2a^m2Btlr/Sppl2a^m2Btlr (C57BL/6J-Sppl2a^m2Btlr)	decreased IgG level	J:236688
	decreased IgM level	J:236688
	decreased response to antigen	J:236688
Sppl2a^tm1Basc/Sppl2a^tm1Basc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)	abnormal B cell physiology	J:194664
	decreased IgA level	J:194664
	decreased IgG1 level	J:194664
	decreased IgG2a level	J:194664
	decreased IgG2b level	J:194664
	decreased IgG3 level	J:194664
	decreased IgM level	J:194664
Sppl2a^tm1Basc/Sppl2a^tm1Basc Sppl2b^{Gt(Ayu21-T160)Imeg}/Sppl2b^{Gt(Ayu21-T160)Imeg} (B6N.Cg-Sppl2a^tm1Basc Sppl2b^{Gt(Ayu21-T160)Imeg})	decreased immunoglobulin level	J:213519
Sppl2a^tm1Dgen/Sppl2a^tm1Dgen (B6.129P2-Sppl2a^tm1Dgen)	decreased IgA level	J:194595
	decreased IgG1 level	J:194595
	decreased IgG2b level	J:194595
	decreased IgG3 level	J:194595
	decreased IgM level	J:194595
Sppl3^tm1Itl/Sppl3^tm1Itl Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)	impaired natural killer cell mediated cytotoxicity	J:280182
Sppl3^tm1Itl/Sppl3^tm1Itl Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: 129S/SvEv * C57BL/6)	abnormal NK cell physiology	J:280182
	impaired natural killer cell mediated cytotoxicity	J:280182
Spred1^tm1.1Ayos/Spred1^tm1.1Ayos (involves: 129 * C57BL/6 * SJL)	increased mast cell degranulation	J:186742
Spred1^tm1Hiin/Spred1^tm1Hiin (involves: C57BL/6)	abnormal cytokine secretion	J:95263
Spred1^tm1Hiin/Spred1^tm1Hiin (involves: C57BL/6)	abnormal eosinophil physiology	J:95263
Spta1^sph-ha/Spta1^sph-ha (either: (B6.D1-Spta1^sph-ha x WB.D1-Spta1^sph-ha)F1 or (WB.D1-Spta1^sph-ha x B6.D1-Spta1^sph-ha)F1)	alveolitis	J:12830
	increased B cell proliferation	J:1967
	increased IgA level	J:12830
	increased IgG level	J:12830
	increased susceptibility to bacterial infection	J:12830
	increased T cell proliferation	J:1967
	interstitial pneumonia	J:12830
Spta1^sph/Spta1^sph (either: (B6.C3-Spta1^sph x WB.C3-Spta1^sph)F1 or (WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	decreased susceptibility to parasitic infection	J:111131
Spta1^sph/Spta1^sph ((WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	glomerulonephritis	J:44313
Spta1^sph/Spta1^sph ((WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	tubular nephritis	J:44313
Sptb^ja/Sptb^ja ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	glomerulonephritis	J:44313
Sptb^ja/Sptb^ja ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	tubular nephritis	J:44313
Sptbn4^qv/Sptbn4^qv (either: (involves: BALB/c) or (involves: C57BL/10))	eye inflammation	J:167
Sptlc2^tm1Yhir/Sptlc2^tm1Yhir Tg(KRT5-cre)1Tak/0 (involves: C3H * C57BL/6)	abnormal Langerhans cell physiology	J:202388
	skin inflammation	J:202388
Sqstm1^tm1Jjw/Sqstm1^tm1Jjw (involves: 129 * C57BL/6)	abnormal osteoclast physiology	J:141179
Sqstm1^tm1Jmos/Sqstm1^tm1Jmos (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased interleukin-6 secretion	J:90010
Sqstm1^tm1Keta/Sqstm1^tm1Keta (involves: 129 * C57BL/6N)	abnormal osteoclast physiology	J:264183
Sra1^{tm1a(EUCOMM)Hmgu}/Sra1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6J * C57BL/6N)	decreased circulating tumor necrosis factor level	J:214131
Src^tm1Sor/Src^tm1Sor (either: 129S7/SvEvBrd-Src^tm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	increased inflammatory response	J:67040
	periodontium inflammation	J:67040
Srcr/Srcr⁺ (BALB/c-Srcr/Cui)	abnormal innate immunity	J:83618
Sros1^em1Caox/Sros1^em1Caox (involves: C57BL/6J)	abnormal circulating chemokine level	J:306407
	decreased susceptibility to bacterial infection	J:306407
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:306407
	increased circulating CXCL10 level	J:306407
Srr^Rgsc34/Srr⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	abnormal neutrophil physiology	J:133634
Srrt^tm1.1Thsn/Srrt^tm1.2Thsn Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal thymus physiology	J:152729
	increased splenocyte apoptosis	J:152729
Srxn1^tm1Mtol/Srxn1^tm1Mtol (either: B6.129S2-Srxn1^tm1Mtol or (involves: 129S2/SvPasCrl * C57BL/6))	increased susceptibility to endotoxin shock	J:199277
Ss18l1^em1Zqi/Ss18l1⁺ (involves: C57BL/6)	increased microglial cell activation	J:278840
Ss18l1^em1Zqi/Ss18l1^em1Zqi (involves: C57BL/6)	increased microglial cell activation	J:278840
Ss18l1^em2Zqi/Ss18l1^em2Zqi (involves: C57BL/6)	increased microglial cell activation	J:278840
Ssb^tm1Rjma/Ssb^tm2.1Rjma Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S/SvEv * BALB/c)	decreased IgG level	J:207687
	decreased IgM level	J:207687
Ssbp2^tm1Lana/Ssbp2^tm1Lana (involves: 129S/SvEv * C57BL/6)	arteritis	J:162035
Ssial1^NOD/Ssial1^NOD (involves: C57BL/6J * NOD)	periinsulitis	J:11442
Ssial1^NOD/Ssial1^NOD (involves: C57BL/6J * NOD)	salivary gland inflammation	J:75908
Ssial2^NOD/? (involves: C57BL/6J * NOD)	salivary gland inflammation	J:75908
Ssial3^NOD/Ssial3^NOD (involves: C57BL/6J * NOD)	salivary gland inflammation	J:75908
Ssial4^C57BL/6/Ssial4^NOD (involves: C57BL/6J * NOD)	salivary gland inflammation	J:75908
Ssial4^NOD/Ssial4^NOD (involves: C57BL/6J * NOD)	salivary gland inflammation	J:75908
Sst1^C3HeB/FeJ/Sst1^C3HeB/FeJ (involves: C3HeB/FeJ * C57BL/6J)	increased susceptibility to bacterial infection	J:63410
Sst1^C3HeB/FeJ/Sst1^C3HeB/FeJ (B6.C3-Sst1^C3HeB/FejKrmn/Mmnc)	increased susceptibility to bacterial infection	J:313901
	increased susceptibility to bacterial infection induced morbidity/mortality	J:313901
Sst1^C3HeB/FeJ/Sst1^C57BL/6J (involves: C3HeB/FeJ * C57BL/6J)	decreased susceptibility to bacterial infection	J:63410
Sst1^C57BL/6J/Sst1^C57BL/6J (involves: C3HeB/FeJ * C57BL/6J)	decreased susceptibility to bacterial infection	J:63410, J:93705
Sstr4^tm1Szo/Sstr4^tm1Szo (B6.129P2-Sstr4^tm1Szo)	abnormal neutrophil physiology	J:152015
	increased interferon-gamma secretion	J:152015
	increased interleukin-1 beta secretion	J:152015
	increased susceptibility to type IV hypersensitivity reaction	J:152015
	increased tumor necrosis factor secretion	J:152015
Ssu72^tm1Cwl/Ssu72^tm1Cwl Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (B6.Cg-Ssu72^tm1Cwl Speer6-ps1^{Tg(Alb-cre)21Mgn})	liver inflammation	J:309624
St3gal2^tm1Jxm/St3gal2^tm1Jxm (Not Specified)	decreased T cell proliferation	J:217719
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm)	abnormal leukocyte tethering or rolling	J:117085
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (B6.129-St3gal4^tm1.1Jxm)	abnormal response to infection	J:136946
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ)	abnormal leukocyte migration	J:189086
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm St3gal6^tm1.1Jxm/St3gal6^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte migration	J:189086
	impaired leukocyte tethering or rolling	J:189086
	impaired neutrophil recruitment	J:189086
St3gal6^tm1.1Jxm/St3gal6^tm1.1Jxm (B6.Cg-St3gal6^tm1.1Jxm)	impaired leukocyte tethering or rolling	J:189086
St3gal6^tm1.1Jxm/St3gal6^tm1.1Jxm (B6.Cg-St3gal6^tm1.1Jxm)	impaired neutrophil recruitment	J:189086
St6gal1^tm1Jlau/St6gal1^tm1Jlau (129S4/SvJae-St6gal1^tm1Jlau)	abnormal neutrophil physiology	J:140702
	increased susceptibility to bacterial infection	J:140702
St6gal1^tm1Jlau/St6gal1^tm1Jlau (B6.129S4-St6gal1^tm1Jlau)	abnormal neutrophil physiology	J:140547
St6gal1^tm1Jlau/St6gal1^tm1Jlau (B6.129S4-St6gal1^tm1Jlau)	peritoneal inflammation	J:140547
St6gal1^tm1Jxm/St6gal1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ)	abnormal dendritic cell physiology	J:132991
	peritoneal inflammation	J:140547
St6galnac1^em1Len/St6galnac1^em1Len (Not Specified)	increased susceptibility to colitis induced morbidity/mortality	J:324883
St6galnac2^tm1.1Cfg/St6galnac2^tm1.1Cfg (involves: 129S1/Sv * 129X1/SvJ)	decreased IgA level	J:217719
	increased B cell proliferation	J:217719
St6galnac3^em1Staka/St6galnac3^em1Staka St6galnac4^em1Staka/St6galnac4^em1Staka (C57BL/6J-St6galnac3^em1Staka St6galnac4^em1Staka)	lymph node hemorrhage	J:340690
St8sia1^tm1Kfk/St8sia1^tm1Kfk (Not Specified)	increased T cell proliferation	J:73818
St14^tm1Bug/St14^tm1Bug (involves: 129P2/OlaHsd * Black Swiss)	increased thymocyte apoptosis	J:87125
St14^tm2Bug/St14^tm3Bug Tg(MMTV-cre)4Mam/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)	abnormal chemokine secretion	J:213072
	abnormal cytokine secretion	J:213072
	increased anti-nuclear antigen antibody level	J:213072
	increased autoantibody level	J:213072
	lacrimal gland inflammation	J:213072
	submandibular gland inflammation	J:213072
St14^tm2Bug/St14^tm3Bug Tg(Vil1-cre)997Gum/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * SJL)	colitis	J:153070
Stam^tm2Sug/Stam^tm2Sug Stam2^tm1Sug/Stam2^tm1Sug Tg(Lck-cre)I57Jxm/0 (involves: 129S4/SvJae * C57BL/6 * ICR)	decreased T cell proliferation	J:80617
Stard7^{tm1a(EUCOMM)Wtsi}/Stard7⁺ (involves: C57BL/6N)	dermatitis	J:242746
	increased susceptibility to type I hypersensitivity reaction	J:242746
	lung inflammation	J:242746
Stard13^{tm1a(KOMP)Wtsi}/Stard13^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased susceptibility to bacterial infection	J:213427
Stat1^fae/Stat1^fae (C57BL/6JSfdAnu-Stat1^fae/Anu)	abnormal T cell activation	J:105311
	abnormal T-helper 2 physiology	J:105311
	increased IgG level	J:105311
Stat1^m1Anu/Stat1^m1Anu (C57BL/6JSfdAnu-Stat1^m1Anu)	abnormal response to infection	J:104190
Stat1^m1Btlr/Stat1^m1Btlr (C57BL/6J-Stat1^m1Btlr)	abnormal macrophage physiology	J:105543
	increased susceptibility to Herpesvirales infection	J:105543
	increased susceptibility to Riboviria infection	J:105543
Stat1^m2Btlr/Stat1^m2Btlr (C57BL/6J-Stat1^m2Btlr)	decreased interferon-gamma secretion	J:134096
	decreased NK cell degranulation	J:134096
	impaired natural killer cell mediated cytotoxicity	J:134096
	increased susceptibility to Herpesvirales infection	J:134096
Stat1^m3Btlr/Stat1^m3Btlr (C57BL/6J-Stat1^m3Btlr)	impaired natural killer cell mediated cytotoxicity	J:254835
Stat1^m5Btlr/Stat1^m5Btlr (C57BL/6J-Stat1^m5Btlr)	decreased cytotoxic T cell cytolysis	J:274938
Stat1^tm1Dlv/Stat1^tm1Dlv (either: (involves: 129S/SvEv * C57BL/6) or (involves: 129S/SvEv * C57BL/6 * CD-1))	abnormal leukocyte physiology	J:31325
	increased susceptibility to Coronaviridae infection	J:31325
	increased susceptibility to Riboviria infection	J:31325
Stat1^tm1Dlv/Stat1^tm1Dlv (B6.129-Stat1^tm1Dlv)	increased susceptibility to Herpesvirales infection	J:81243
Stat1^tm1Dlv/Stat1^tm1Dlv (B6.129-Stat1^tm1Dlv)	increased susceptibility to Togaviridae infection	J:81243
Stat1^tm1Dlv/Stat1^tm1Dlv (involves: 129S/SvEv)	abnormal MHC II cell surface expression on macrophages	J:130622
	decreased level of surface class I molecules	J:130622
	decreased susceptibility to endotoxin shock	J:130622
	increased circulating interferon-gamma level	J:130622
	increased susceptibility to bacterial infection	J:130622
	increased susceptibility to Riboviria infection	J:130622
Stat1^tm1Dlv/Stat1^tm1Dlv (B6.129S-Stat1^tm1Dlv)	abnormal NK cell physiology	J:79552
	impaired natural killer cell mediated cytotoxicity	J:79552
	increased circulating interferon-gamma level	J:79552
	increased circulating interleukin-12b level	J:79552
Stat1^tm1Dlv/Stat1^tm1Dlv Tg(ANPEP)270Mmul/Tg(ANPEP)270Mmul (involves: 129S/SvEv * ICR)	increased susceptibility to Coronaviridae infection	J:99728
Stat1^tm1Dlv/Stat1^tm1Dlv Tg(ANPEP)861Mmul/Tg(ANPEP)861Mmul (involves: 129S/SvEv * ICR)	increased susceptibility to Coronaviridae infection	J:99728
Stat1^tm1Rds/Stat1^tm1Rds (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	increased susceptibility to bacterial infection	J:31326
	increased susceptibility to Riboviria infection	J:31326
Stat1^tm1Rds/Stat1^tm1Rds (involves: 129)	increased susceptibility to Herpesvirales infection	J:81243
	increased susceptibility to Riboviria infection	J:66564
	increased susceptibility to Togaviridae infection	J:81243
Stat1^tm1Rds/Stat1^tm1Rds (129S6/SvEv-Stat1^tm1Rds/Tac)	abnormal macrophage physiology	J:136368
	bronchiolitis	J:286237
	decreased circulating interferon-gamma level	J:122801
	decreased interleukin-1 beta secretion	J:136368
	increased susceptibility to Coronaviridae infection	J:286237
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:286237
	lung inflammation	J:286237
	peritoneal inflammation	J:286237
	pleuritis	J:286237
Stat1^tm1Rds/Stat1^tm1Rds Stat2^tm1Shnd/Stat2^tm1Shnd (involves: 129/Sv * 129S1/Sv * 129X1/SvJ)	increased susceptibility to Riboviria infection	J:66564
Stat1^tm1Rds/Stat1^tm1Rds Stat3^tm2Aki/Stat3^tm2Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	colitis	J:83280
	increased interferon-gamma secretion	J:83280
	increased interleukin-6 secretion	J:83280
	increased tumor necrosis factor secretion	J:83280
Stat1^tm1Tdec/Stat1^tm1Tdec (involves: 129P2/OlaHsd * BALB/c)	abnormal macrophage physiology	J:130622
	abnormal MHC II cell surface expression on macrophages	J:130622
	decreased susceptibility to endotoxin shock	J:130622
	increased susceptibility to bacterial infection	J:130622
	increased susceptibility to Riboviria infection	J:130622
Stat1^tm1Uvin/Stat1^tm1Uvin (involves: 129 * C57BL/6)	increased macrophage nitric oxide production	J:174863
Stat1^tm2.1Uvin/Stat1^tm2.1Uvin (B6.129P2-Stat1^tm2.1Uvin)	decreased susceptibility to endotoxin shock	J:209388
	increased susceptibility to bacterial infection	J:209388
	increased susceptibility to bacterial infection induced morbidity/mortality	J:209388
Stat2^p117/Stat2^p117 (C57BL/6J-Stat2^P117)	abnormal level of surface class II molecules	J:164049
	decreased level of surface class I molecules	J:164049
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:164049
Stat2^{tm1.1(STAT2)Diam}/Stat2^{tm1.1(STAT2)Diam} (C57BL/6-Stat2^{tm1.1(STAT2)Diam})	increased susceptibility to Flaviviridae infection	J:261503
	increased susceptibility to Flaviviridae infection induced morbidity/mortality	J:261503
Stat2^tm1Shnd/Stat2^tm1Shnd (involves: 129S1/Sv * 129X1/SvJ)	increased susceptibility to Riboviria infection	J:66564
Stat3^tm1Aki/Stat3^tm1Aki Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal interleukin level	J:123351
Stat3^tm1Desi/Stat3^tm1Desi (involves: 129X1/SvJ * C57BL/6)	increased susceptibility to endotoxin shock	J:77307
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	decreased interleukin-17 secretion	J:124293
	increased interferon-gamma secretion	J:124293
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(Csf1r-icre)1Jwp/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal acute inflammation	J:156593
	abnormal inflammatory response	J:156593
	colitis	J:156593
Stat3^tm1Dnl/Stat3^tm1Dlv (involves: C57BL/6)	increased thymocyte apoptosis	J:87599
Stat3^tm1Flv/Stat3^tm1Flv Tg(Tek-cre)1Xyfu/0 (involves: C57BL/6)	abnormal cytokine secretion	J:86655
	increased susceptibility to endotoxin shock	J:86655
Stat3^tm1Flv/Stat3^tm1Flv Tg(Tek-cre)12Flv/0 (involves: 129 * C3H * C57BL/6)	abnormal inflammatory response	J:81973
	abnormal innate immunity	J:81973
	abnormal T-helper 1 physiology	J:81973
	cecum inflammation	J:81973
	colitis	J:81973
	granulomatous inflammation	J:81973
	ileum inflammation	J:81973
	increased circulating interferon-gamma level	J:81973
	increased circulating tumor necrosis factor level	J:81973
	intestinal inflammation	J:81973
	liver inflammation	J:81973
Stat3^tm1Vpo/Stat3^tm1Vpo Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CBA)	abnormal macrophage physiology	J:89194
	increased interleukin-6 secretion	J:89194
	increased tumor necrosis factor secretion	J:89194
Stat3^tm1Vpo/Stat3^tm2Vpo Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * BALB/cAn)	abnormal macrophage physiology	J:89194
	increased interleukin-6 secretion	J:89194
	increased tumor necrosis factor secretion	J:89194
Stat3^tm1Xyfu/Stat3⁺ Tg(Myh6-cre)2182Mds/0 (involves: 129S1/Sv * FVB/N)	increased susceptibility to endotoxin shock	J:86400
	increased tumor necrosis factor secretion	J:86400
Stat3^tm1Xyfu/Stat3^tm1.1Xyfu Tg(Myh6-cre)2182Mds/0 (involves: 129S1/Sv * FVB/N)	increased susceptibility to endotoxin shock	J:86400
	increased tumor necrosis factor secretion	J:86400
Stat3^tm2Aki/Stat3^tm2Aki (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal response to infection	J:122213
Stat3^tm2Aki/Stat3^tm2Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	colitis	J:83280
	increased interferon-gamma secretion	J:83280
	increased interleukin-12 secretion	J:83280
Stat3^tm2Aki/Stat3^tm2Aki Tg(KRT5-cre)1Tak/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	conjunctivitis	J:194832
	dermatitis	J:194832
	lacrimal gland inflammation	J:194832
Stat3^tm2Aki/Stat3^tm2Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	decreased T cell proliferation	J:50443
	increased T cell apoptosis	J:50443
Stat3^tm2Aki/Stat3^tm2Aki Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:87622
	lung inflammation	J:87622
Stat3^tm2Aki/Stat3^tm2Aki Tlr4^tm1Aki/Tlr4^tm1Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	colitis	J:83280
	decreased interferon-gamma secretion	J:83280
	decreased susceptibility to endotoxin shock	J:83280
Stat3^tm2Aki/Stat3^tm2Aki Tnf^tm1Sek/Tnf^tm1Sek Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	colitis	J:83280
	increased interferon-gamma secretion	J:83280
	increased interleukin-6 secretion	J:83280
	increased interleukin-12b secretion	J:83280
Stat3^tm3Vpo/Stat3^tm3Vpo (involves: C57BL/6 * CBA * BALB/cAn)	abnormal macrophage physiology	J:89194
Stat4^ity14/Stat4^ity14 (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating interferon-gamma level	J:207092
	decreased interferon-gamma secretion	J:207092
	increased circulating interleukin-12 level	J:207092
	increased susceptibility to bacterial infection	J:207092
	increased susceptibility to bacterial infection induced morbidity/mortality	J:207092
Stat4^ity14/Stat4^tm1Gru (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)	increased susceptibility to bacterial infection induced morbidity/mortality	J:207092
Stat4^tm1Gru/Stat4^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal lymphocyte physiology	J:34059
	abnormal NK cell physiology	J:34059
	abnormal T cell proliferation	J:34059
	abnormal T-helper 1 physiology	J:34059
	abnormal T-helper 2 physiology	J:34059
	decreased circulating interferon-gamma level	J:163843
	decreased interferon-gamma secretion	J:34059
	increased susceptibility to bacterial infection	J:163843
	increased susceptibility to bacterial infection induced morbidity/mortality	J:163843
Stat4^tm1Gru/Stat4^tm1Gru (NOD.129S2-Stat4^tm1Gru)	abnormal inflammatory response	J:90600
	decreased circulating interferon-gamma level	J:90600
	decreased circulating interleukin-2 level	J:90600
	decreased susceptibility to autoimmune diabetes	J:90600
Stat4^tm1Gru/Stat4^tm1Gru (C.129S2-Stat4^tm1Gru)	decreased circulating interferon-gamma level	J:90600
Stat4^tm1Gru/Stat4^tm1Gru (C.129S2-Stat4^tm1Gru)	decreased circulating interleukin-2 level	J:90600
Stat4^tm1Gru/Stat4^tm1Gru (involves: 129S2/SvPas)	abnormal cytokine secretion	J:112600
Stat4^tm1Gru/Stat4^tm1Gru Tg(Ins2-GP)34-20Olds/0 (involves: 129S2/SvPas * BALB/c * C57BL/6)	abnormal susceptibility to autoimmune disorder	J:107047
Stat4^tm1Gru/Stat4^tm1Gru Tg(Ins2-NP)25-3Olds/0 (involves: 129S2/SvPas * BALB/c * C57BL/6)	abnormal cytotoxic T cell physiology	J:107047
	decreased interferon-gamma secretion	J:107047
	decreased susceptibility to autoimmune diabetes	J:107047
	insulitis	J:107047
Stat4^tm1Jni/Stat4^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal NK cell physiology	J:79552
	decreased circulating interferon-gamma level	J:79552
	decreased susceptibility to autoimmune diabetes	J:96338
	increased interleukin-4 secretion	J:96338
Stat4^tm1Jni/Stat4^tm1Jni Stat6^tm1Jni/Stat6^tm1Jni (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased interleukin-4 secretion	J:96338
	increased interferon-gamma secretion	J:96338
	increased susceptibility to autoimmune diabetes	J:96338
Stat5a^tm1.1Wjl/Stat5a^tm1.1Wjl Stat5b^tm2.1Wjl/Stat5b^tm2.1Wjl (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	abnormal regulatory T cell physiology	J:187325
	decreased T cell proliferation	J:187325
	increased T cell apoptosis	J:187325
Stat5a^tm1Jni/Stat5a^tm1Jni Stat5b^tm2Jni/Stat5b^tm2Jni (involves: 129 * C57BL/6)	abnormal mast cell physiology	J:84889
Stat5a^tm1Mam/Stat5a^tm1Mam (involves: 129S6/SvEvTac * C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:112035
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)	increased circulating interleukin-17 level	J:120176
	increased interleukin-17 secretion	J:120176
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Lck-cre)I57Jxm/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)	abnormal acute inflammation	J:122463
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal neutrophil physiology	J:155489
Stat5b^tm1Hwd/Stat5b^tm1Hwd (involves: C57BL/6)	decreased T cell proliferation	J:112035
Stat5b^tm1Hwd/Stat5b^tm1Hwd (involves: C57BL/6)	impaired natural killer cell mediated cytotoxicity	J:112035
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)	increased circulating interleukin-17 level	J:120176
	increased interleukin-17 secretion	J:120176
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Lck-cre)I57Jxm/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)	abnormal acute inflammation	J:122463
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal neutrophil physiology	J:155489
Stat6^tm1Aki/Stat6^tm1Aki (involves: 129P2/OlaHsd)	abnormal T-helper 2 physiology	J:32561
	decreased B cell proliferation	J:32561
	decreased IgE level	J:32561
	decreased IgG1 level	J:32561
	decreased T cell proliferation	J:32561
	increased IgA level	J:32561
	increased IgG level	J:32561
Stat6^tm1Aki/Stat6^tm1Aki (C.129P2-Stat6^tm1Aki Nfkbiz^tm1Aki)	skin inflammation	J:141704
Stat6^tm1Aki/Stat6^tm1Aki Tg(KRT14-CASP1)1Miz/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased IgE level	J:78602
	decreased IgG1 level	J:78602
	dermatitis	J:78602
	increased circulating interleukin-18 level	J:78602
Stat6^tm1Gru/Stat6⁺ Tg(Scgb1a1-Il13)2Eli/? (involves: 129S2/SvPas * C57BL/6 * CBA)	respiratory system inflammation	J:132385
Stat6^tm1Gru/Stat6^tm1Gru (C.129S2-Stat6^tm1Gru/J)	abnormal humoral immune response	J:107370
	decreased IgA level	J:107370
	decreased IgG3 level	J:107370
	decreased IgM level	J:107370
	decreased interleukin-4 secretion	J:107370
	decreased susceptibility to Herpesvirales infection	J:107370
	increased interferon-gamma secretion	J:107370
	increased interleukin-2 secretion	J:107370
Stat6^tm1Gru/Stat6^tm1Gru (129S2/SvPas-Stat6^tm1Gru)	abnormal interleukin secretion	J:31932
	decreased IgE level	J:31932
	decreased interleukin-4 secretion	J:31932
	decreased interleukin-5 secretion	J:31932
	decreased T cell proliferation	J:31932
Stat6^tm1Gru/Stat6^tm1Gru (involves: 129S2/SvPas)	abnormal cytokine secretion	J:112600
Stat6^tm1Gru/Stat6^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal acute inflammation	J:85386
	abnormal granulocyte physiology	J:85386
	abnormal macrophage physiology	J:85386
	impaired eosinophil chemotaxis	J:85386
	impaired neutrophil chemotaxis	J:85386
	increased circulating tumor necrosis factor level	J:85386
Stat6^tm1Gru/Stat6^tm1Gru (C.129S2-Stat6^tm1Gru)	abnormal circulating interleukin level	J:66222
	abnormal circulating interleukin-4 level	J:66222
	abnormal circulating interleukin-5 level	J:66222
	abnormal cytotoxic T cell physiology	J:65894
	abnormal immune serum protein physiology	J:66222
	abnormal immunoglobulin level	J:66222
	abnormal leukocyte migration	J:74497
	abnormal leukocyte physiology	J:74497
	decreased IgE level	J:74497, J:66222
	decreased IgG1 level	J:66222
	impaired eosinophil recruitment	J:66222
	increased IgG2a level	J:66222
Stat6^tm1Jni/Stat6^tm1Jni (involves: 129S/SvEv)	abnormal B cell physiology	J:32607
	abnormal B cell proliferation	J:32607
	abnormal class switch recombination	J:32607
	abnormal level of surface class II molecules	J:32607
	increased B cell apoptosis	J:146533
Stat6^tm1Jni/Stat6^tm1Jni (involves: 129S/SvEv * C57BL/6)	decreased IgE level	J:51096
	decreased IgG1 level	J:51096
	decreased interleukin-4 secretion	J:96338
	decreased susceptibility to autoimmune diabetes	J:96338
	increased IgE level	J:110429
	increased IgG1 level	J:110429
	increased IgG2a level	J:51096
	increased interferon-gamma secretion	J:51096, J:96338
	increased interleukin-12 secretion	J:51096
	increased susceptibility to parasitic infection	J:110429
Steap3^tm1.1Atel/Steap3^tm1.1Atel (involves: C57BL/6)	decreased splenocyte apoptosis	J:154356
Stia1^NOD/ShiLtDoi/? (involves: C57BL/6J * NOD/LtDoi)	increased inflammatory response	J:70882
Stia2^C57BL/6J/Stia2^C57BL/6J (involves: C57BL/6J * NOD/LtDoi)	increased inflammatory response	J:70882
Stia2^C57BL/6J/Stia2^NOD/ShiLtDoi (involves: C57BL/6J * NOD/LtDoi)	increased inflammatory response	J:70882
Stim1^tm1.1Kuro/Stim1⁺ (C57BL/6-Stim1^tm1.1Kuro)	decreased susceptibility to type I hypersensitivity reaction	J:130477
Stim1^tm1.1Kuro/Stim1^tm1.1Kuro (C57BL/6-Stim1^tm1.1Kuro)	abnormal cytokine secretion	J:130477
	abnormal interleukin secretion	J:130477
	decreased interleukin-6 secretion	J:130477
	decreased interleukin-13 secretion	J:130477
	decreased mast cell degranulation	J:130477
	decreased tumor necrosis factor secretion	J:130477
Stim1^tm1Kuro/Stim1^tm1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:172608
	decreased B cell proliferation	J:172608
	decreased interleukin-10 secretion	J:172608
Stim1^tm1Kuro/Stim1^tm1Kuro Stim2^tm1.1Kuro/Stim2^tm1.1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:172608
	decreased B cell proliferation	J:172608
	decreased interleukin-10 secretion	J:172608
	increased interferon-gamma secretion	J:172608
	increased interleukin-10 secretion	J:172608
	increased interleukin-17 secretion	J:172608
	increased susceptibility to experimental autoimmune encephalomyelitis	J:172608
Stim1^tm1Rao/Stim1^tm1Rao Stim2^tm1Rao/Stim2^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha-beta T cell physiology	J:133262
	abnormal immune system physiology	J:133262
	blepharitis	J:133262
	decreased interferon-gamma secretion	J:133262
	decreased interleukin-2 secretion	J:133262
	decreased T cell proliferation	J:133262
	dermatitis	J:133262
	increased IgG1 level	J:133262
Stim1^tm1Rao/Stim1^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha-beta T cell physiology	J:133262
	decreased interleukin-2 secretion	J:133262
Stim1^tm3Ics/Stim1⁺ (involves: C57BL/6N)	myositis	J:277842
Stim2^tm1.1Kuro/Stim2^tm1.1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell physiology	J:172608
Stim2^tm1Rao/Stim2^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha-beta T cell physiology	J:133262
	abnormal T-helper 1 physiology	J:133262
	abnormal T-helper 2 physiology	J:133262
	decreased interferon-gamma secretion	J:133262
	decreased interleukin-2 secretion	J:133262
	decreased interleukin-4 secretion	J:133262
Sting1^em1Jmin/Sting1⁺ (involves: C57BL/6N)	abnormal cytokine level	J:251372
	increased circulating interleukin-10 level	J:251372
	increased circulating interleukin-13 level	J:251372
	increased circulating tumor necrosis factor level	J:251372
	increased IgM level	J:251372
	lung inflammation	J:251372
Sting1^gt/Sting1^gt (C57BL/6-Sting1^gt)	abnormal dendritic cell physiology	J:201167
	abnormal humoral immune response	J:201167
	abnormal immune cell physiology	J:201167
	abnormal macrophage physiology	J:201167
	abnormal plasmacytoid dendritic cell physiology	J:201167
	abnormal response to infection	J:168746
	decreased circulating interferon-alpha level	J:201167
	decreased circulating interferon-beta level	J:201167, J:168746
	increased susceptibility to Herpesvirales infection	J:201167
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:201167
Sting1^gt/Sting1^gt (involves: C57BL/6)	increased susceptibility to Retroviridae infection	J:265023
Sting1^tm1Camb/Sting1^tm1Camb (involves: C57BL/6N)	decreased circulating interferon-beta level	J:179270
Sting1^tm1Camb/Sting1^tm1Camb (involves: C57BL/6N)	decreased circulating interleukin-6 level	J:179270
Sting1^tm1Gnb/Sting1^tm1Gnb (involves: 129P2/OlaHsd * C57BL/6)	abnormal innate immunity	J:141011
	abnormal susceptibility to Herpesvirales infection	J:141011
	increased susceptibility to Riboviria infection	J:141011
Sting1^tm1Gnb/Sting1^tm1Gnb (involves: 129P2/OlaHsd)	abnormal response to infection	J:168746
Stip1^tm1.2Mamp/Stip1^tm1.2Mamp (involves: C57BL/6)	increased acute inflammation	J:201097
Stk3^tm1.1Jav/Stk3^tm1.1Jav Stk4^tm1Kina/Stk4^tm1Kina Tg(Nkx2-1-cre)2Sand/? (involves: 129 * C57BL/6)	lung inflammation	J:197340
Stk4^{Gt(AJ0315)Wtsi}/Stk4^{Gt(AJ0315)Wtsi} (B6.129P2-Stk4^{Gt(AJ0315)Wtsi})	increased interferon-gamma secretion	J:142674
	increased interleukin-2 secretion	J:142674
	increased interleukin-4 secretion	J:142674
	increased T cell apoptosis	J:142674
	increased T cell proliferation	J:142674
Stk4^m1Btlr/Stk4^m1Btlr (C57BL/6J-Stk4^m1Btlr)	abnormal humoral immune response	J:265233
	decreased IgD level	J:265233
	increased IgE level	J:265233
	increased IgM level	J:265233
Stk4^m2Btlr/Stk4^m2Btlr (C57BL/6J-Stk4^m2Btlr)	decreased IgD level	J:265237
Stk4^m2Btlr/Stk4^m2Btlr (C57BL/6J-Stk4^m2Btlr)	increased IgE level	J:265237
Stk4^m4Btlr/Stk4^m4Btlr (C57BL/6J-Stk4^m4Btlr)	decreased IgD level	J:272536
	decreased IgG level	J:272536
	impaired humoral immune response	J:272536
Stk4^tm1.1Kina/Stk4^tm1.1Kina (involves: C57BL/6)	abnormal B cell physiology	J:148791
	abnormal dendritic cell physiology	J:148791
	abnormal leukocyte adhesion	J:148791
	abnormal leukocyte migration	J:148791
	abnormal T cell physiology	J:148791
	increased T cell proliferation	J:148791
Stk4^tm1.2Wtao/Stk4^tm1.2Wtao (involves: 129S4/SvJaeSor * 129S6/SvEvTac)	abnormal CD4-positive, alpha-beta T cell physiology	J:152323
	abnormal CD8-positive, alpha-beta T cell physiology	J:152323
	abnormal T cell physiology	J:152323
Stk4^tm1Dlim/Stk4^tm1Dlim (Not Specified)	abnormal T cell physiology	J:155001
Stk10^tm1Hkar/Stk10^tm1Hkar (involves: 129S1/Sv)	abnormal T cell physiology	J:60738
Stk11^tm1.1Rdp/Stk11^tm1.1Rdp Tg(Pdx1-cre)89.1Dam/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR)	pancreas inflammation	J:134078
Stk11^tm1.1Rdp/Stk11^tm1.1Rdp Tg(Sprr2f-cre)1Dcas/0 (involves: 129S6/SvEvTac * FVB/N)	peritoneal inflammation	J:158190
	sepsis	J:158190
Stk11^tm1Keis/Stk11^tm1Keis Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	increased circulating interleukin-10 level	J:191723
Stk17b^tm1Hed/Stk17b^tm1Hed (involves: 129X1/SvJ * C57BL/6)	increased T cell proliferation	J:94685
Stk17b^tm1Hed/Stk17b^tm1Hed (B6.129X1-Stk17b^tm1Hed)	abnormal cytokine secretion	J:94685
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:94685
	increased interferon-gamma secretion	J:94685
	increased interleukin-2 secretion	J:94685
	increased T cell proliferation	J:94685
	increased tumor necrosis factor secretion	J:94685
Stk24^{Gt(AM0826)Wtsi}/Stk24^{Gt(AM0826)Wtsi} (B6.129P2-Stk24^{Gt(AM0826)Wtsi})	abnormal neutrophil physiology	J:256076
Stk36^tm1Fjs/Stk36^tm1Fjs (involves: 129S1/Sv * C57BL/6)	rhinitis	J:116391
Stk36^tm1Lex/Stk36^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased susceptibility to otitis media	J:185566
Stk38^tm1Hem/Stk38^tm1Hem (involves: 129P2/Ola * C57BL/6)	abnormal T cell physiology	J:185408
Stk38^tm1Hem/Stk38^tm1Hem (involves: 129P2/Ola * C57BL/6)	decreased thymocyte apoptosis	J:185408
Stk38^tm1Xen/Stk38^tm1Xen (involves: 129S5/SvEvBrd * C57BL/6)	increased circulating interleukin-6 level	J:224932
	increased circulating tumor necrosis factor level	J:224932
	increased interleukin-6 secretion	J:224932
	increased susceptibility to bacterial infection	J:224932
	increased susceptibility to bacterial infection induced morbidity/mortality	J:224932
	increased tumor necrosis factor secretion	J:224932
Stub1^tm1Cpat/Stub1^tm1Cpat (involves: 129S/SvEv * C57BL/6)	increased thymocyte apoptosis	J:86213
Stx2^tm1Dcru/Stx2^tm1Dcru (involves: 129X1/SvJ * C57BL/6J)	decreased susceptibility to induced colitis	J:110376
Stx3^{Gt(EUCE320f12)1.1Hmgu}/Stx3^{Gt(EUCE320f12)1.1Hmgu} Tg(Cma1-cre)ARoer/0 (B6.Cg-Stx3^{Gt(EUCE320f12)1.1Hmgu} Tg(Cma1-cre)ARoer)	abnormal mast cell degranulation	J:275367
	decreased mast cell degranulation	J:275367
Stx3^{Gt(EUCE320f12)1.2Hmgu}/Stx3⁺ (B6.129P2(Cg)-Stx3^{Gt(EUCE320f12)1.2Hmgu})	abnormal mast cell degranulation	J:275367
Stx11^tm1.2Ics/Stx11^tm1.2Ics (involves: C57BL/6NTac)	abnormal cytotoxic T cell physiology	J:193137
	decreased cytotoxic T cell cytolysis	J:193137
	decreased NK cell degranulation	J:193137
	increased circulating interferon-gamma level	J:193137
	increased circulating interleukin-1 beta level	J:193137
	increased circulating interleukin-6 level	J:193137
	increased circulating tumor necrosis factor level	J:193137
	increased susceptibility to Riboviria infection	J:193137
Stx11^tm1Bupa/Stx11^tm1Bupa (B6.129-Stx11^tm1Bupa)	abnormal cell-mediated immunity	J:191103
	abnormal cytokine secretion	J:191103
	abnormal lymphocyte physiology	J:191103
	abnormal neutrophil physiology	J:191103
	impaired natural killer cell mediated cytotoxicity	J:191103
	increased interferon-gamma secretion	J:191103
	increased tumor necrosis factor secretion	J:191103
Stxbp2^tm1Bdic/Stxbp2⁺ (involves: 129S * C57BL/6)	decreased mast cell degranulation	J:188931
Stxbp2^tm1Bdic/Stxbp2⁺ (involves: 129S * C57BL/6)	decreased susceptibility to type I hypersensitivity reaction	J:188931
Sucnr1^tm1Dgen/Sucnr1^tm1Dgen (B6.129P2-Sucnr1^tm1Dgen)	abnormal dendritic cell physiology	J:143337
	abnormal interleukin-2 secretion	J:143337
	abnormal Langerhans cell physiology	J:143337
	abnormal T cell activation	J:143337
	decreased T cell proliferation	J:143337
	increased length of allograft survival	J:143337
Suco^{Gt(KST050)Byg}/Suco^{Gt(KST050)Byg} (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	abnormal osteoclast physiology	J:159823
Sugct^tm1.2Kald/Sugct^tm1.2Kald (B6.Cg-Sugct^tm1.2Kald)	kidney inflammation	J:293423
Sugct^tm1.2Kald/Sugct^tm1.2Kald (B6.Cg-Sugct^tm1.2Kald)	white adipose tissue inflammation	J:293423
Sulf1^{Gt(OST352220)Lex}/Sulf1^{Gt(OST352220)Lex} (involves: 129S5/SvEvBrd * C57BL/6N)	decreased susceptibility to bacterial infection	J:171883
Sumf1^{Gt(RST760)Byg}/Sumf1^{Gt(RST760)Byg} (involves: 129P2/OlaHsd * C57BL/6)	CNS inflammation	J:120146
Supv3l1^tm2.1Jkl/Supv3l1^tm2.2Jkl Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd 129S4/SvJaeSor * C57BL/6 * FVB/N)	lung inflammation	J:144991
Supv3l1^tm2Jkl/Supv3l1^tm2Jkl Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd C57BL/6)	lung inflammation	J:144991
Supv3l1^tm2Jkl/Supv3l1^tm2Jkl Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	interstitial pneumonia	J:144991
Susd4^tm1Lex/Susd4^tm1Lex (B6.129S5-Susd4^tm1Lex)	abnormal complement protein level	J:306852
Susd4^tm1Lex/Susd4^tm1Lex (B6.129S5-Susd4^tm1Lex)	increased microglial cell activation	J:306852
Suv39h1^tm1Jnw/Suv39h1^tm1Jnw (involves: 129)	abnormal T-helper 2 physiology	J:186702
Suv39h1^tm1Jnw/Suv39h1^tm1Jnw (involves: 129)	decreased susceptibility to type I hypersensitivity reaction	J:186702
Swap70^tm1Jess/Swap70^tm1Jess (involves: 129T2/SvEms * 129X1/SvJ)	abnormal class switch recombination	J:71160
	decreased IgE level	J:71160
	increased autoantibody level	J:71160
Swrl1^NZB/Swrl1^NZB (involves: NZB * SWR)	abnormal type II hypersensitivity reaction	J:73097
Swrl1^NZB/Swrl1^SWR (involves: NZB * SWR)	abnormal type II hypersensitivity reaction	J:73097
Swrl1^SWR/Swrl1^SWR (involves: NZB * SWR)	increased IgG3 level	J:96263
Swrl2^NZB/Swrl2^SWR (involves: NZB * SWR)	glomerulonephritis	J:73097
Swrl2^SWR/Swrl2^SWR (involves: NZB * SWR)	glomerulonephritis	J:73097
Swrl2^SWR/Swrl2^SWR (involves: NZB * SWR)	increased anti-single stranded DNA antibody level	J:96060
Swrl3^NZB/Swrl3^SWR (involves: NZB * SWR)	increased anti-double stranded DNA antibody level	J:96060
	increased anti-histone antibody level	J:96060
	increased anti-nuclear antigen antibody level	J:73097
Swrl3^SWR/Swrl3^SWR (involves: NZB * SWR)	increased anti-double stranded DNA antibody level	J:96060
	increased anti-histone antibody level	J:96060
	increased anti-nuclear antigen antibody level	J:73097
Sycn^tm1Rja/Sycn^tm1Rja (involves: 129P2/OlaHsd)	increased susceptibility to induced pancreatitis	J:74654
Syk^m1Btlr/Syk^m1Btlr (involves: C57BL/6J)	increased tumor necrosis factor secretion	J:199281
Syk^M2Btlr/Syk⁺ (C57BL/6J-Syk^M2Btlr)	decreased inflammatory response	J:231803
Syk^M2Btlr/Syk^M2Btlr (C57BL/6J-Syk^M2Btlr)	decreased inflammatory response	J:231803
Syk^tm1.1Tara/Syk^tm1.1Tara (involves: 129P2/OlaHsd * C57BL/6)	increased B cell proliferation	J:114816
Syk^tm1Tyb/Syk^tm1.2Tara Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal neutrophil physiology	J:155479
	impaired granulocyte bactericidal activity	J:155479
Syk^tm1Tyb/Syk^tm1.2Tara Tg(S100A8-cre,-EGFP)1Ilw/0 (involves: 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6)	impaired granulocyte bactericidal activity	J:155479
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas)	abnormal dendritic cell antigen presentation	J:147472
	abnormal neutrophil physiology	J:155479
	decreased tumor necrosis factor secretion	J:155479
	impaired granulocyte bactericidal activity	J:155479
	impaired neutrophil phagocytosis	J:155479
Syk^{tm2.1(ZAP70)Fkfr}/Syk^{tm2.1(ZAP70)Fkfr} (B6.129-Syk^{tm2.1(ZAP70)Fkfr})	abnormal B cell physiology	J:188422
	abnormal neutrophil physiology	J:188422
	decreased IgG1 level	J:188422
	decreased IgG2a level	J:188422
	decreased IgG2b level	J:188422
	glomerulonephritis	J:188422
	increased anti-insulin autoantibody level	J:188422
	increased B cell apoptosis	J:188422
	increased IgM level	J:188422
Syne1^tm1.1Mcn/Syne1^tm1.1Mcn (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL)	conjunctivitis	J:144757
Syt7^tm1Nan/Syt7^tm1Nan (involves: 129S1/Sv * C57BL/6)	increased anti-nuclear antigen antibody level	J:85201
	increased inflammatory response	J:85201
	increased susceptibility to autoimmune disorder	J:85201
	myositis	J:85201
Sytl1^{tm1a(KOMP)Wtsi}/Sytl1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased IgG2b level	J:213427
	epididymis inflammation	J:213427
	meningitis	J:213427
Syvn1^tm1Tn/Syvn1⁺ (D1.Cg-Syvn1^tm1Tn)	decreased susceptibility to induced arthritis	J:86009
t^AE5/t^AE5 (Not Specified)	increased susceptibility to infection	J:83862
Tab2^tm2.1Aki/Tab2^tm2.1Aki Tab3^tm1Aki/Tab3^tm1Aki Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:195289
	abnormal immune serum protein physiology	J:195289
	decreased B cell proliferation	J:195289
	decreased circulating interleukin-6 level	J:195289
	decreased IgD level	J:195289
	decreased IgE level	J:195289
	decreased IgG level	J:195289
	decreased immunoglobulin level	J:195289
	increased B cell apoptosis	J:195289
Tacr1^tm1Nge/Tacr1^tm1Nge (involves: 129S4/SvJae)	abnormal humoral immune response	J:35529
Tacr1^tm1Nge/Tacr1^tm1Nge (involves: 129S4/SvJae * C57BL)	abnormal mast cell physiology	J:84660
Tacr1^tm1Sph/Tacr1^tm1Sph (involves: 129P2/OlaHsd * C57BL/6)	decreased inflammatory response	J:46629
	joint inflammation	J:103700
Taf4^tm1Idvd/Taf4^tm1Idvd Tg(KRT14-cre/ERT2)1Ipc/0 (involves: C57BL/6 * SJL)	chronic inflammation	J:124111
Taf7^tm1.1Dss/Taf7^tm1.2Dss Tg(Cd8a*-cre)B8Asin/0 (involves: C57BL/6)	decreased T cell proliferation	J:185745
Taf7^tm1.1Dss/Taf7^tm1.2Dss Tg(Lck-cre)1Cwi/0 (involves: C57BL/6)	abnormal thymus physiology	J:185745
Tagln2^tm1Cdj/Tagln2^tm1Cdj (involves: 129S4/SvJae * C57BL/6)	abnormal cytotoxic T cell physiology	J:256656
	abnormal T cell physiology	J:256656
Tagln2^tm1Cdj/Tagln2^tm1Cdj Tg(TcraTcrb)425Cbn/0 (involves: 129S4/SvJae * C57BL/6)	abnormal T cell activation	J:256656
Tagln2^tm1Cdj/Tagln2^tm1Cdj Tg(TcraTcrb)1100Mjb/0 (involves: 129S4/SvJae * C57BL/6)	abnormal T cell activation	J:256656
Tank^tm1Aki/Tank^tm1Aki (involves: 129/Sv * C57BL/6)	abnormal dendritic cell physiology	J:151757
	abnormal macrophage physiology	J:151757
	abnormal plasmacytoid dendritic cell physiology	J:151757
	glomerulonephritis	J:151757
	increased anti-double stranded DNA antibody level	J:151757
	increased anti-nuclear antigen antibody level	J:151757
	increased B cell proliferation	J:151757
	increased IgA level	J:151757
	increased IgG1 level	J:151757
	increased IgG2a level	J:151757
	increased IgG2b level	J:151757
	increased IgM level	J:151757
	increased interferon-alpha secretion	J:151757
	increased interleukin-6 secretion	J:151757
	increased tumor necrosis factor secretion	J:151757
	liver inflammation	J:151757
	lung inflammation	J:151757
Tap1^m2Btlr/Tap1^m2Btlr (C57BL/6J-Tap1^m2Btlr)	increased susceptibility to Herpesvirales infection	J:236697
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * C57BL/6)	abnormal antigen presentation	J:122479
	abnormal dendritic cell antigen presentation	J:112436
	abnormal lymphocyte physiology	J:122479
	decreased level of surface class I molecules	J:3524
	defective intracellular transport of class I molecules	J:3524
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas)	abnormal antigen presentation via MHC class I	J:64349
	abnormal dendritic cell antigen presentation	J:64349
	decreased cytotoxic T cell cytolysis	J:64349
	decreased level of surface class I molecules	J:64177, J:64349
	defective assembly of class I molecules	J:64177
	defective intracellular transport of class I molecules	J:64177
Tap1^tm1Arp/Tap1^tm1Arp (B6.129S2-Tap1^tm1Arp/J)	decreased susceptibility to bacterial infection	J:123934
Tap1^tm1Arp/Tap1^tm1Arp (B6.129S2-Tap1^tm1Arp/J)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:123934
Tap1^tm1Arp/Tap1^tm1Arp X/Yaa (BXSB.129S2(B6)-Tap1^tm1Arp/Dcr)	increased susceptibility to systemic lupus erythematosus	J:179430
Tap2^m1Btlr/Tap2^m1Btlr (C57BL/6J-Tap2^m1Btlr)	abnormal cytotoxic T cell physiology	J:159355
	abnormal NK cell physiology	J:159355
	decreased level of surface class I molecules	J:159355
	defective assembly of class I molecules	J:159355
Tapbp^tm1Gjh/Tapbp^tm1Gjh (involves: 129S2/SvPas)	abnormal antigen presentation via MHC class I	J:64349
	abnormal dendritic cell antigen presentation	J:64349
	abnormal NK cell physiology	J:64349
	decreased cytotoxic T cell cytolysis	J:64349
	decreased level of surface class I molecules	J:64349
Tapbp^tm1Luc/Tapbp^tm1Luc (involves: 129S6/SvEvTac * C57BL/6)	abnormal lymphocyte physiology	J:122479
Tapbp^tm1Luc/Tapbp^tm1Luc (involves: 129S6/SvEvTac)	abnormal antigen presentation via MHC class I	J:64177
	abnormal cytotoxic T cell physiology	J:64177
	decreased level of surface class I molecules	J:64177
	defective assembly of class I molecules	J:64177
Tapr^BALB/c/? (involves: BALB/c * DBA/2)	abnormal inflammatory response	J:72894
Tarm1^tm1Yiw/Tarm1^tm1Yiw (involves: C57BL/6 * C57BL/6NSlc)	abnormal dendritic cell antigen presentation	J:301164
	abnormal interleukin-6 secretion	J:301164
	abnormal lymphocyte physiology	J:301164
	abnormal tumor necrosis factor secretion	J:301164
	decreased IgG2a level	J:301164
	decreased IgG2b level	J:301164
	decreased IgG3 level	J:301164
	decreased interferon-gamma secretion	J:301164
	decreased interleukin-17 secretion	J:301164
	decreased susceptibility to induced arthritis	J:301164
	decreased T cell proliferation	J:301164
	decreased tumor necrosis factor secretion	J:301164
Tax1bp1^tm1Ktj/Tax1bp1^tm1Ktj (B6.129P2-Tax1bp1^tm1Ktj)	abnormal hypersensitivity reaction	J:131849
	abnormal leukocyte physiology	J:131849
	abnormal macrophage chemotaxis	J:131849
	abnormal neutrophil physiology	J:131849
	abnormal T cell physiology	J:131849
	cardiovalvulitis	J:131849
	increased interleukin-1 beta secretion	J:131849
	increased interleukin-2 secretion	J:131849
	increased tumor necrosis factor secretion	J:131849
	skin inflammation	J:131849
tb/tb (Not Specified)	abnormal thymus involution	J:12166
Tbc1d10c^tm1.1Psou/Tbc1d10c^tm1.2Psou Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S2/SvPas * BALB/c * C57BL/6J)	abnormal B cell physiology	J:211913
	increased anti-double stranded DNA antibody level	J:211913
	increased IgG level	J:211913
	increased IgM level	J:211913
	increased susceptibility to systemic lupus erythematosus	J:211913
Tbc1d10c^tm1.2Psou/Tbc1d10c^tm1.2Psou (involves: 129S2/SvPas * C57BL/6J)	abnormal B cell physiology	J:211913
	abnormal response to infection	J:211913
	abnormal T cell activation	J:211913
	increased anti-double stranded DNA antibody level	J:211913
	increased IgG level	J:211913
	increased susceptibility to systemic lupus erythematosus	J:211913
	increased T cell proliferation	J:211913
Tbc1d23^{Gt(BA0556)Wtsi}/Tbc1d23^{Gt(BA0556)Wtsi} (B6.129P2-Tbc1d23^{Gt(BA0556)Wtsi})	abnormal tumor necrosis factor level	J:181861
	increased circulating interleukin-6 level	J:181861
	increased circulating tumor necrosis factor level	J:181861
	increased inflammatory response	J:181861
Tbk1^M1Btlr/Tbk1⁺ (involves: C57BL/6J)	abnormal interferon secretion	J:188770
Tbk1^M1Btlr/Tbk1⁺ (involves: C57BL/6J)	abnormal macrophage physiology	J:188770
Tbk1^tm1.1Lex/Tbk1⁺ (involves: 129S4/SvJae * 129S5/SvEvBrd)	abnormal inflammatory response	J:166476
Tbk1^tm1.1Lex/Tbk1^tm1.1Lex (involves: 129S4/SvJae * 129S5/SvEvBrd)	abnormal cytokine level	J:166476
	abnormal cytokine secretion	J:166476
	abnormal inflammatory response	J:166476
	decreased interferon-beta secretion	J:166476
	increased circulating interleukin-1 beta level	J:166476
	increased circulating interleukin-6 level	J:166476
	increased circulating interleukin-10 level	J:166476
	increased circulating tumor necrosis factor level	J:166476
	increased IgA level	J:166476
	increased interleukin-6 secretion	J:166476
	increased susceptibility to bacterial infection induced morbidity/mortality	J:166476
	increased susceptibility to endotoxin shock	J:166476
	increased tumor necrosis factor secretion	J:166476
	skin inflammation	J:166476
Tbk1^tm1Aki/Tbk1^tm1Aki Tnf^tm1Sek/Tnf^tm1Sek (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal cytotoxic T cell physiology	J:132662
	decreased cytotoxic T cell cytolysis	J:132662
	decreased IgG1 level	J:132662
	decreased IgG2a level	J:132662
	decreased IgG level	J:132662
	decreased interferon-gamma secretion	J:132662
Tbk1^tm1Arte/Tbk1^tm1Arte Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:188560
	abnormal class switch recombination	J:188560
	increased anti-double stranded DNA antibody level	J:188560
	increased anti-nuclear antigen antibody level	J:188560
	increased IgA level	J:188560
	increased IgM level	J:188560
Tbk1^tm1Arte/Tbk1^tm1Arte Map3k14^tm1Rds/Map3k14^tm1Rds Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin level	J:188560
Tbp^tm1.1Ees/Tbp^tm1.1Ees (B6.129X1(Cg)-Tbp^tm1.1Ees)	hemophagocytosis	J:77714
Tbrs1^C57BL/6J/Tbrs1^C57BL/6J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:67658
Tbrs2^C57BL/6J/Tbrs2^C57BL/6J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:67658
Tbrs2^C57BL/6J/Tbrs2^DBA/2J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:67658
Tbrs3^C57BL/6J/Tbrs3^C57BL/6J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:67658
Tbrs3^C57BL/6J/Tbrs3^C57BL/6J Tbrs4^C57BL/6J/Tbrs4^C57BL/6J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:83619
Tbrs3^C57BL/6J/Tbrs3^DBA/2J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:67658
Tbrs4^C57BL/6J/Tbrs4^C57BL/6J (involves: C57BL/6J * DBA/2J)	decreased susceptibility to bacterial infection	J:83619
Tbs1^I/StSnEgYCit/Tbs1^A/SnYCit (involves: A/SnYCit * I/StSnEgYCit)	decreased susceptibility to bacterial infection	J:80972
Tbs2^I/StSnEgYCit/Tbs2^A/SnYCit (involves: A/SnYCit * I/StSnEgYCit)	decreased susceptibility to bacterial infection	J:80972
Tbx1^tm1Bem/Tbx1⁺ (FVB.Cg-Tbx1^tm1Bem)	increased susceptibility to otitis media	J:91664
Tbx21^m1Btlr/Tbx21^m1Btlr (C57BL/6J-Tbx21^m1Btlr)	increased IgM level	J:267478
Tbx21^{tm1.1(flpe/ERT2)Gmld}/Tbx21^{tm1.1(flpe/ERT2)Gmld} (involves: 129S2/SvPas * C57BL/6)	decreased interferon-gamma secretion	J:207104
Tbx21^tm1Glm/Tbx21⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:73833
	abnormal interleukin level	J:73832
	abnormal NK cell physiology	J:73833
	abnormal tumor necrosis factor level	J:73832
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytokine level	J:73832
	abnormal immunoglobulin level	J:73833
	abnormal interleukin level	J:73832
	abnormal NK cell physiology	J:73833
	abnormal tumor necrosis factor level	J:73832
	decreased interferon-gamma secretion	J:73833
	impaired natural killer cell mediated cytotoxicity	J:73833
	increased natural killer cell mediated cytotoxicity	J:73833
	increased susceptibility to parasitic infection	J:73833
	respiratory system inflammation	J:73832
Tbx21^tm1Glm/Tbx21^tm1Glm (C.129S6-Tbx21^tm1Glm/J)	abnormal CD4-positive, alpha-beta T cell physiology	J:111932
	abnormal cytokine secretion	J:111932
	CNS inflammation	J:111932
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:111932
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac)	abnormal cytokine level	J:112600
	abnormal leukocyte migration	J:163822
	increased interleukin-17 secretion	J:163822
	increased susceptibility to induced colitis	J:141481
Tbx21^tm2Srnr/Tbx21⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	increased susceptibility to Riboviria infection	J:174315
Tbx21^tm2Srnr/Tbx21^tm2Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	increased interleukin-2 secretion	J:174315
	increased interleukin-17 secretion	J:174315
	increased susceptibility to Riboviria infection	J:174315
	increased tumor necrosis factor secretion	J:174315
Tbxa2r^tm1Sna/Tbxa2r^tm1Sna (either: (involves: 129/Ola * BALB/c) or (involves: 129/Ola * C57BL/6))	abnormal immune serum protein physiology	J:84085
	abnormal immune system physiology	J:84085
	abnormal type I hypersensitivity reaction	J:84085
Tbxa2r^tm1Sna/Tbxa2r^tm1Sna (B6.Cg-Tbxa2r^tm1Sna)	increased susceptibility to type I hypersensitivity reaction	J:197334
Tbxas1^tm1Swl/Tbxas1^tm1Swl (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)	decreased inflammatory response	J:90922
Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:226241
Tcf3^tm1Xhsu/Tcf3^tm1Xhsu Tg(Lck-Stat5b)1Mafa/0 (involves: 129X1/SvJ C57BL/6 * FVB/N)	increased B cell proliferation	J:132669
Tcf4^tm1.1Hmb/Tcf4^tm1.1Hmb (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell physiology	J:136143
Tcf7^tm1Cle/Tcf7^tm1Cle (involves: 129P2/OlaHsd)	abnormal memory T cell physiology	J:189838
Tcf7l2^m1Btlr/Tcf7l2^m1Btlr (C57BL/6J-Tcf7l2^m1Btlr)	increased susceptibility to induced colitis	J:267536
Tcf12^tm2Zhu/Tcf12^tm2Zhu (Not Specified)	abnormal response to transplant	J:120411
Tcf12^tm3Zhu/Tcf12^tm3Zhu Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJae * C57BL/6 * SJL/J)	increased T cell proliferation	J:129570
Tcirg1^M1Jeau/Tcirg1⁺ (either: (involves: C3H/HeJ * C57BL/6) or (involves: C3H/HeJ * C57BL/6 * FVB/N))	abnormal osteoclast physiology	J:196503
Tcirg1^tm1.2Ywd/Tcirg1^tm1.2Ywd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)	abnormal macrophage physiology	J:150327
Tcirg1^tm1Utku/Tcirg1^tm1Utku (involves: 129X1/SvJ * C57BL/6)	abnormal immune serum protein physiology	J:92730
	abnormal immune system physiology	J:92730
	increased IgG1 level	J:92730
	increased IgG2a level	J:92730
	increased IgM level	J:92730
	increased immunoglobulin level	J:92730
Tcirg1^tm1Ypl/Tcirg1^tm1Ypl (involves: 129S4/SvJae * C57BL/6J)	abnormal osteoclast physiology	J:58795
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (B6.129-Tcra-J^tm1Tgi)	decreased circulating interleukin-5 level	J:121037
	decreased IgE level	J:121037
	decreased IgG level	J:99107
	decreased susceptibility to induced arthritis	J:99107
	increased incidence of corneal inflammation	J:132503
	liver inflammation	J:135830
	lung inflammation	J:121037
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ)	decreased circulating interferon-gamma level	J:155199
	decreased interferon-gamma secretion	J:155199
	decreased susceptibility to bacterial infection	J:155199
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal immune serum protein physiology	J:84720
	abnormal interleukin secretion	J:84720
	decreased IgE level	J:84720
	decreased interleukin-4 secretion	J:84720
	decreased interleukin-13 secretion	J:84720
	liver inflammation	J:105977
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	lung inflammation	J:89695
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (C.129-Tcra-J^tm1Tgi)	abnormal interleukin secretion	J:184570
	decreased interleukin-5 secretion	J:184570
	decreased interleukin-9 secretion	J:184570
	decreased interleukin-10 secretion	J:184570
	decreased interleukin-13 secretion	J:184570
	decreased interleukin-17 secretion	J:184570
Tcra^Ln1Ogu/Tcra⁺ (involves: 129/Sv * C57BL/6)	abnormal cytokine secretion	J:152041
	decreased IgG2a level	J:152041
	increased IgG1 level	J:152041
	increased interferon-gamma secretion	J:152041
	increased interleukin-2 secretion	J:152041
	increased interleukin-4 secretion	J:152041
	increased interleukin-10 secretion	J:152041
Tcra^tm1Cgn/Tcra^tm1Mass Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell physiology	J:201417
Tcra^tm1Mjo/Tcra⁺ (NOD.129P2-Tcra^tm1Mjo)	abnormal T cell physiology	J:108590
Tcra^tm1Mjo/Tcra⁺ (NOD.129P2-Tcra^tm1Mjo)	decreased susceptibility to autoimmune diabetes	J:108590
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * BALB/c)	increased anti-double stranded DNA antibody level	J:111129
	increased anti-nuclear antigen antibody level	J:111129
	increased autoantibody level	J:111129
	increased IgE level	J:111129
	increased IgG1 level	J:111129
	increased immunoglobulin level	J:111129
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd)	colitis	J:37699
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd)	decreased T cell proliferation	J:110898
Tcra^tm1Mom/Tcra^tm1Mom (B6.129S2-Tcra^tm1Mom)	abnormal response to transplant	J:91742
	colitis	J:135597
	increased susceptibility to bacterial infection	J:106241
Tcra^tm1Mom/Tcra^tm1Mom (involves: 129S2/SvPas * C57BL/6)	abnormal response to infection	J:119344
	colitis	J:15221
	decreased IgG level	J:119344
Tcra^tm1Mom/Tcra^tm1Mom Tcrg^tm1.1Hish/Tcrg^tm1.1Hish (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	colitis	J:135597
	impaired macrophage chemotaxis	J:135597
	impaired neutrophil recruitment	J:135597
Tcra^tm1Mom/Tcra^tm1Mom Tg(TcraAV19AJ33)1Shima/? (involves: 129S2/SvPas * C57BL/6)	abnormal NK T cell physiology	J:140924
Tcra^tm1Mom/Tcra^tm1Mom Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	colitis	J:181257
	increased inflammatory response	J:181257
	myositis	J:181257
	skin inflammation	J:181257
Tcrb^tm1Mom/Tcrb⁺ Tg(SOD1G93A)1Gur/0 (B6.Cg-Tcrb^tm1Mom Tg(SOD1G93A)1Gur/J)	abnormal microglial cell physiology	J:143173
Tcrb^tm1Mom/Tcrb^tm1Mom (involves: 129P2/OlaHsd * BALB/c)	colitis	J:15221
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd * C57BL/6)	abnormal response to infection	J:119344
	decreased IgG level	J:119344
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (B6.129P2-Tcrb^tm1Mom Tcrd^tm1Mom/J)	decreased autoantibody level	J:187766
	decreased IgE level	J:125656
	decreased IgG1 level	J:125656
	decreased IgG level	J:125656, J:187766
	increased IgM level	J:187766
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129 * BALB/c * C57BL/6)	colitis	J:15221
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd)	decreased IgA level	J:97824
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (B6.129P2-Tcrb^tm1Mom Igh-J^{tm2(3H9-VDJ)Mwg} Tcrd^tm1Mom)	increased anti-double stranded DNA antibody level	J:142389
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (B6.129-Tcrb^tm1Mom Traf3ip2^tm1.1Lix Tcrd^tm1Mom)	decreased IgG level	J:187766
	increased anti-chromatin antibody level	J:187766
	increased anti-double stranded DNA antibody level	J:187766
	increased anti-histone antibody level	J:187766
	increased autoantibody level	J:187766
	increased IgM level	J:187766
Tcrb^tm1Mom/Tcrb^tm1Mom Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)	decreased IgE level	J:100506
	skin inflammation	J:100506
Tcrd^tm1Mom/Tcrd^tm1Mom (FVB.129P2-Tcrd^tm1Mom)	dermatitis	J:75915
Tcrd^tm1Mom/Tcrd^tm1Mom (FVB.129P2-Tcrd^tm1Mom)	increased susceptibility to type IV hypersensitivity reaction	J:75915
Tcrd^tm1Mom/Tcrd^tm1Mom (NOD.129P2-Tcrd^tm1Mom)	dermatitis	J:75915
Tcrd^tm1Mom/Tcrd^tm1Mom Tnf^tm2Gkl/Tnf⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	small intestinal inflammation	J:108572
Tcrg^tm1Scar/Tcrg^tm1Scar (B6.Cg-Tcrg^tm1Scar)	impaired granulocyte bactericidal activity	J:105477
Tdrd3^{Gt(RRK474)Byg}/Tdrd3^{Gt(RRK474)Byg} (involves: 129P2/OlaHsd)	abnormal B cell physiology	J:210647
Tdrd7^nmf166/Tdrd7^nmf166 (involves: C3H * C57BL/6J)	uveitis	J:169836
Tecpr1^tm1Chsa/Tecpr1^tm1Chsa (involves: 129S4/SvJae)	abnormal susceptibility to infection	J:198333
Tent5c^em1Adki/Tent5c^em1Adki (involves: C57BL/6J * CBA)	decreased B cell proliferation	J:252302
Tent5c^{tm1b(KOMP)Wtsi}/Tent5c^{tm1b(KOMP)Wtsi} (C57BL/6N-Tent5c^{tm1b(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * C57BL/6J * SJL)	decreased B cell proliferation	J:60223
	decreased T cell proliferation	J:60223
	increased B cell apoptosis	J:60223
Terf1^tm1.1Blas/Terf1^tm1.1Blas Tg(KRT5-cre)1Tak/0 (involves: 129 * C3H * C57BL/6 * SJL)	skin inflammation	J:152077
Terf2ip^Gt(XD108)Byg/Terf2ip⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:163158
	decreased susceptibility to endotoxin shock	J:163158
Tespa1^tm1Smoc/Tespa1^tm1Smoc (B6.129-Tespa1^tmSmoc)	decreased interferon-gamma secretion	J:186446
	decreased interleukin-2 secretion	J:186446
	decreased T cell proliferation	J:186446
	increased T cell proliferation	J:186446
Tet1^tm1.2Jae/Tet1^tm1.2Jae Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tet3^tm1.1Yzhg/Tet3^tm1.1Yzhg Tg(Rorc-cre)1Litt/0 (involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)	increased susceptibility to autoimmune disorder	J:333574
Tet2^{Gt(AN0709)Wtsi}/Tet2⁺ (B6.129P2-Tet2^{Gt(AN0709)Wtsi})	liver inflammation	J:174052
Tet2^{Gt(AN0709)Wtsi}/Tet2^{Gt(AN0709)Wtsi} (B6.129P2-Tet2^{Gt(AN0709)Wtsi})	liver inflammation	J:174052
Tfeb^em1Xinli/Tfeb^em1Xinli (involves: C57BL/6J)	increased susceptibility to bacterial infection induced morbidity/mortality	J:342735
Tff2^tm1Blin/Tff2^tm1Blin (involves: 129S7/SvEvBrd * C57BL/6)	abnormal adaptive immunity	J:105277
	abnormal innate immunity	J:105277
Tff3^tm1Dkpy/Tff3^tm1Dkpy (involves: 129S4/SvJae)	increased susceptibility to induced colitis	J:35882
Tfpi2^tm1Dgen/Tfpi2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6J)	increased circulating interleukin-6 level	J:301794
	increased circulating interleukin-10 level	J:301794
	increased interleukin-10 secretion	J:301794
	increased susceptibility to bacterial infection	J:301794
	increased susceptibility to bacterial infection induced morbidity/mortality	J:301794
Tfpi^tm1Gjb/Tfpi^tm1Gjb (involves: 129)	abnormal acute phase protein level	J:51137
Tg(Ace2-ACE2)1Cqin/0 (involves: ICR)	alveolitis	J:141460
	increased susceptibility to Coronaviridae infection	J:141460, J:287631, J:288244
	interstitial pneumonia	J:141460, J:287631
	lymph node hemorrhage	J:141460
	pyelitis	J:141460
	submandibular gland inflammation	J:141460
Tg(ACTA1-Il15)10941Lsq/0 (involves: C3H * C57BL/6)	abnormal interleukin level	J:145611
Tg(ACTA1-Il15)11650Lsq/0 (involves: C3H C57BL/6)	abnormal interleukin level	J:145611
Tg(ACTA1-Il15)11650Lsq/0 (involves: C3H C57BL/6)	increased circulating interleukin-15 level	J:145611
Tg(Acta2-cre/ERT2)#Pcn/0 Tgfbr2^tm1Karl/Tgfbr2^tm1Karl Tg(H2-K-Fosl2,-EGFP)13Wag/0 (B6.Cg-Tgfbr2^tm1Karl Tg(Acta2-cre/ERT2)#Pcn Tg(H2-K-Fosl2,-EGFP)13Wag)	lung inflammation	J:238723
Tg(Acta2-RAC1G12V)33Pjgc/Tg(Acta2-RAC1G12V)33Pjgc (involves: C57BL/6 * FVB/N)	abnormal chemokine secretion	J:150015
	increased interleukin-6 secretion	J:150015
	increased tumor necrosis factor secretion	J:150015
Tg(ACTB-eGFP,-RAMP1)#Afru/0 Tg(Nes-cre)1Kln/0 (involves: C57BL/6J * SJL/J)	increased inflammatory response	J:120077
Tg(ACTB-Eif4e)#Ppp/0 Tg(IghMyc)22Bri/0 (involves: C57BL * SJL)	decreased B cell apoptosis	J:89878
Tg(ACTB-Fpr2)#Jimw/0 (involves: FVB)	abnormal dendritic cell physiology	J:160074
Tg(ACTB-Fpr2)#Jimw/0 (involves: FVB)	respiratory system inflammation	J:160074
Tg(ACTB-TNFRSF6B)754Jwu/? (B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)	abnormal type IV hypersensitivity reaction	J:148162
	increased anti-double stranded DNA antibody level	J:148162
	increased autoantibody level	J:148162
	increased IgE level	J:148162
	increased IgG1 level	J:148162
	increased IgG2b level	J:148162
	increased interleukin-4 secretion	J:148162
Tg(Actb-Tnfsf4)1Nish/0 (B6.D2-Tg(Actb-Tnfsf4)1Nish)	abnormal cytokine secretion	J:80214
	increased susceptibility to type IV hypersensitivity reaction	J:80214
	increased T cell proliferation	J:80214
Tg(Adipoq-Apol6)#Hsul/0 (C57BL/6J-Tg(Adipoq-Apol6)#Hsul)	white adipose tissue inflammation	J:344362
Tg(Adipoq-cre)1Evdr/0 Tg(CAG-Jmjd8)#Kaso/0 (involves: C57BL/6 * FVB/NJ)	white adipose tissue inflammation	J:319518
Tg(AGER)#Eca/0 (C57BL/6J-Tg(AGER)#Eca)	lung inflammation	J:205092
Tg(AGT)2-5Afu/0 (involves: C57BL/6)	heart inflammation	J:194606
Tg(Alb1-GP33/H2-K^b)1Hpi/0 (B6.Cg-Tg(Alb1-GP33/H2-K^b)1Hpi)	abnormal cytotoxic T cell physiology	J:162605
Tg(Alb1-GP33/H2-K^b)1Hpi/0 (B6.Cg-Tg(Alb1-GP33/H2-K^b)1Hpi)	decreased cytotoxic T cell cytolysis	J:162605
Tg(Alb1-GP33/H2-K^b)1Hpi/0 Tg(Alb1-HBV)66Bri/0 (involves: C57BL/6 * C57BL/10 * DBA/2)	liver inflammation	J:162605
Tg(Alb1-GP33/H2-K^b)1Hpi/0 Tg(Alb1-HBV)66Bri/0 Tg(TcrLCMV)318Sdz/0 (involves: C57BL/6 * C57BL/10 * DBA/2)	liver inflammation	J:162605
Tg(Alb1-Ren)1Unc/0 (involves: 129S6/SvEvTac * C57BL/6)	kidney inflammation	J:89252
Tg(Alb1-Ren)2Unc/0 (involves: 129S6/SvEvTac * C57BL/6)	kidney inflammation	J:89252
Tg(Alb1HBV)44Bri/0 (C57BL/6J-Tg(Alb1HBV)44Bri/J)	liver inflammation	J:223921
Tg(Alb-PDGFC)#Jcam/0 (involves: C57BL/6)	chronic liver inflammation	J:211984
Tg(Alb-PDGFC)#Jcam/0 (involves: C57BL/6)	increased circulating interleukin-6 level	J:211984
Tg(Alb-PLG)1Dgi/0 (involves: C57BL/6 * C57BL/6J * SJL)	increased susceptibility to bacterial infection	J:120780
Tg(Alb-SND1)3aDsar/0 (involves: C57BL/6 * CBA)	chronic liver inflammation	J:242582
Tg(Alb-TAg)#Arnd/0 ((C3Fe.Cg-Tg(Alb-TAg)#Arnd x C57BL/6N)F1)	abnormal immune system physiology	J:171880
Tg(Amy1TAg)501Knw/0 (involves: C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:84288
Tg(ANX6)2Agh/0 (FVB/N-Tg(ANX6)2Agh)	myocarditis	J:92579
Tg(aP2-SREBF1c)9884Reh/0 (involves: C57BL/6J * SJL)	decreased interleukin-6 secretion	J:249664
	decreased tumor necrosis factor secretion	J:249664
	liver inflammation	J:249664
Tg(APCS-Ifng)5Imeg/0 (involves: C57BL/6 * DBA/2)	abnormal cytokine level	J:135124
	chronic liver inflammation	J:135124
	increased circulating interleukin-12 level	J:135124
	liver inflammation	J:16979
	myocarditis	J:135124
	pancreas inflammation	J:135124
Tg(APOA1)1Rub/Tg(APOA1)1Rub (C57BL/6-Tg(APOA1)1Rub/J)	abnormal circulating interleukin-17 level	J:190966
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (C57BL/6-Tg(APOC1)1Lmh)	dermatitis	J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (C57BL/6-Tg(APOC1)1Lmh)	folliculitis	J:65036
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (involves: C57BL/6)	dermatitis	J:135501
	increased IgE level	J:135501
	increased mast cell degranulation	J:135501
	skin inflammation	J:135501
Tg(APOE-DGAT1)1Far/0 (involves: C57BL/6NHsd)	liver inflammation	J:124005
Tg(APOE-DGAT2)1Far/0 (involves: C57BL/6NHsd)	liver inflammation	J:124005
Tg(APOE-FGF23R176Q)#Ack/0 (involves: C57BL/6J CBA)	enthesitis	J:192371
Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas/0 (involves: C57BL/6 * SJL)	brain inflammation	J:112949
Tg(APPSwFlLon,PSEN1M146LL286V)6799Vas/? (involves: C57BL/6 * SJL)	increased microglial cell activation	J:208030
Tg(ARR2/Pbsn-FGF8)3Prb/0 (involves: C57BL/6 * DBA/2)	increased inflammatory response	J:78918
Tg(ARR2/Pbsn-FGF8)3Prb/0 (involves: C57BL/6 * DBA/2)	prostate gland inflammation	J:78918
Tg(B2M)55Hpl/? Tg(CD8aCD8b)57Scr/? Tg(HLA-B)22Hpl/? (involves: C57BL/6 * C57BL/LiA * CBA)	abnormal cytotoxic T cell physiology	J:127813
Tg(B19-RNAi:Il3)241Ckn/? (involves: BALB/cJ * C57BL/6J * FVB/N)	decreased interleukin-3 secretion	J:107618
Tg(BCL2)22Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell physiology	J:93111
Tg(BCL2)22Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	increased susceptibility to autoimmune disorder	J:93111
Tg(BCL2)25Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal T cell physiology	J:93111
Tg(BCL2)36Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell physiology	J:93111
	abnormal T cell physiology	J:93111
	increased immunoglobulin level	J:93111
	increased susceptibility to autoimmune disorder	J:93111
Tg(BCL2)36Wehi/? (B6.Cg-Tg(BCL2)36Wehi/J)	abnormal B cell proliferation	J:90963
Tg(BCL2)36Wehi/? (B6.Cg-Tg(BCL2)36Wehi/J)	decreased B cell apoptosis	J:90963
Tg(BCL2/IGH)1Tjd/? (involves: C3H/He * C57BL/6)	abnormal B cell physiology	J:81147
Tg(BCL2/IGH)#Jcre/0 Tg(H2-K/Igh-Traf2)#Ywc/0 (involves: BALB/c C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)	decreased B cell apoptosis	J:94116
Tg(BCL2/IGH)M23Tjd/? (involves: C3H/He * C57BL/6)	abnormal B cell physiology	J:81147
Tg(BLG-STAT5A)15Itb/0 (involves: FVB/N)	increased inflammatory response	J:80588
Tg(CAG-ACE2)AC63Ctkt/0 (either: (involves: BALB/c * C3H/HeJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6 * C57BL/6J))	increased susceptibility to Coronaviridae infection	J:117824
Tg(CAG-ACE2)AC70Ctkt/0 (either: (involves: BALB/c * C3H/HeJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6 * C57BL/6J))	abnormal cytokine level	J:117824
	increased susceptibility to Coronaviridae infection	J:117824
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:117824
	interstitial pneumonia	J:117824
Tg(CAG-APP)0304Shoj/0 (involves: C3H * C57BL/6N)	abnormal circulating serum amyloid protein level	J:100977
Tg(CAG-C1qtnf6)#Yiw/0 (involves: C57BL/6JJcl)	abnormal complement protein level	J:227217
	decreased IgG level	J:227217
	decreased susceptibility to induced arthritis	J:227217
	impaired complement alternative pathway	J:227217
Tg(CAG-cat,-Il18)#Thos/0 Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * C57BL/6)	increased interferon-gamma secretion	J:147547
	interstitial pneumonia	J:147547
Tg(CAG-DPP4)4Yuzh/0 (C57BL/6-Tg(CAG-DPP4)4Yuzh)	abnormal circulating cytokine level	J:286175
	brain inflammation	J:286175
	increased circulating interferon-gamma level	J:286175
	increased circulating interleukin-17 level	J:286175
	increased susceptibility to Coronaviridae infection	J:286175
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:286175
	kidney inflammation	J:286175
	liver inflammation	J:286175
	lung inflammation	J:286175
Tg(CAG-DPP4)52Ctkt/0 (involves: C3H/HeJ * C57BL/6J)	brain inflammation	J:227925
	increased inflammatory response	J:227925
	increased microglial cell activation	J:227925
	increased susceptibility to Coronaviridae infection	J:227925, J:258199
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:227925, J:258199
	interstitial pneumonia	J:258199
	lung inflammation	J:227925
Tg(CAG-Has2)99Nita/0 Tg(MMTV-cre)4Mam/0 Tg(MMTVneu)202Mul/0 (FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul)	impaired macrophage chemotaxis	J:164205
Tg(CAG-LacZ,-ACVR1,-EGFP)35-1Mis/0 (involves: C57BL/6 DBA/2)	myositis	J:142253
Tg(CAG-Lyn)#Paau/0 (B6.Cg-Tg(CAG-Lyn)#Paau)	skin inflammation	J:151886
Tg(CAG-Ncoa6)71Hwl/0 (involves: FVB)	lung inflammation	J:80609
Tg(CAG-Ncoa6)87Hwl/0 (involves: FVB)	lung inflammation	J:80609
Tg(CAG-NRIP1)51Row/0 (involves: FVB/N)	lung inflammation	J:175885
Tg(CAG-OVAL)916Jen/? (C57BL/6-Tg(CAG-OVAL)916Jen)	abnormal dendritic cell antigen presentation	J:91742
Tg(CAG-OVAL)916Jen/? (C57BL/6-Tg(CAG-OVAL)916Jen)	decreased length of allograft survival	J:91742
Tg(CAG-p35)1Miur/0 (involves: C57BL/6)	autoimmune response	J:126593
Tg(CAG-p35)1Miur/0 Tg(Mbp-cre)29Miur/0 (involves: C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:126593
Tg(CAG-Pgam2)#Hiko/0 (involves: C57BL/6)	increased susceptibility to chemically induced skin inflammation	J:306793
Tg(CAG-PGDS)1Groy/0 (involves: FVB/N)	abnormal cytokine secretion	J:107651
Tg(CAG-PGDS)1Groy/0 (involves: FVB/N)	decreased inflammatory response	J:107651
Tg(CAG-PLA2G3)#aMurm/0 (Not Specified)	increased mast cell degranulation	J:197334
Tg(CAG-PLA2G3)#aMurm/0 (Not Specified)	increased susceptibility to type I hypersensitivity reaction	J:197334
Tg(CAG-Ptafr)1Tksh/0 (B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc)	increased susceptibility to endotoxin shock	J:38639
Tg(CAG-SYVN1)1Tn/? (D1.Cg-Tg(CAG-SYVN1)1Tn)	rheumatoid arthritis	J:86009
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-APPSwInd)107Dbo/0 (involves: C3H/HeJ * C57BL/6 * CBA)	CNS inflammation	J:109829
Tg(CD2-Ccdc86)1Hfuj/? (B6.FVB-Tg(CD2-Ccdc86)1Hfuj)	increased T cell apoptosis	J:151722
Tg(CD2-Ceacam1*4L)1Rsb/0 (involves: C57BL/6)	abnormal T cell physiology	J:116136
	decreased interleukin-2 secretion	J:116136
	decreased T cell proliferation	J:116136
Tg(CD2-Ceacam14L)1Rsb/0 Tg(TcraTcrb)425Cbn/0 (involves: BALB/c C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:116136
Tg(CD2-Foxj1)#Stlp/0 (C57BL/6-Tg(CD2-Foxj1)#Stlp)	abnormal T cell physiology	J:122222
Tg(CD2-Ifngr2)1Pbro/? (B6.Cg-Tg(CD2-Ifngr2)1Pbro)	abnormal T-helper 1 physiology	J:134448
	decreased susceptibility to type IV hypersensitivity reaction	J:134448
	increased susceptibility to parasitic infection	J:134448
Tg(CD2-Ifngr2)2Pbro/? (B6.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal T-helper 1 physiology	J:134448
Tg(CD2-Ifngr2)2Pbro/? (B6.Cg-Tg(CD2-Ifngr2)2Pbro)	increased susceptibility to parasitic infection	J:134448
Tg(CD2-Ifngr2)2Pbro/? (NOD.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal T-helper 1 physiology	J:81981
	decreased interferon-gamma secretion	J:81981
	decreased interleukin-4 secretion	J:81981
	decreased tumor necrosis factor secretion	J:81981
	insulitis	J:81981
	myositis	J:81981
	ovary inflammation	J:81981
Tg(CD2-LAT2)1Wz/0 (Not Specified)	abnormal CD8-positive, alpha-beta T cell physiology	J:116157
Tg(CD2-Lrch1)#Liux/0 (involves: C57BL/6)	abnormal cellular extravasation	J:238772
Tg(CD2-Lrch1)#Liux/0 (involves: C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:238772
Tg(CD2-Myb/en)2Kmw/? (involves: C57BL/10 * CBA)	decreased T cell proliferation	J:126456
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw (involves: C57BL/10 * CBA)	decreased T cell proliferation	J:126456
Tg(CD2-Nfat5)1Snh/0 (involves: BALB/c * C57BL/6)	abnormal cytotoxic T cell physiology	J:80066
	abnormal T cell physiology	J:80066
	decreased splenocyte proliferation	J:80066
	decreased T cell proliferation	J:80066
Tg(CD2-Ppp2ca)#Gct/0 (involves: C57BL/6J)	glomerulonephritis	J:184067
Tg(CD2-Ppp2ca)#Gct/0 (involves: C57BL/6J)	increased interleukin-17 secretion	J:184067
Tg(CD2-Rorc)#Staka/0 (involves: C57BL/6)	abnormal susceptibility to Picornaviridae infection	J:236222
	abnormal T-helper 17 cell physiology	J:236222
	decreased IgG2c level	J:236222
	decreased IgG3 level	J:236222
	decreased IgG level	J:236222
	decreased interferon-gamma secretion	J:236222
	decreased interleukin-10 secretion	J:236222
	increased anti-nuclear antigen antibody level	J:230700
	increased autoantibody level	J:230700
	increased interferon-gamma secretion	J:236222
	increased interleukin-17 secretion	J:236222
	increased susceptibility to autoimmune disorder	J:230700
	lacrimal gland inflammation	J:230700
	lung inflammation	J:230700
	salivary gland inflammation	J:230700
Tg(CD2-S1PR1)1Ejg/? (involves: C57BL/6 * DBA/2)	abnormal humoral immune response	J:96558
	abnormal lymphocyte chemotaxis	J:96558
	decreased susceptibility to type IV hypersensitivity reaction	J:96558
	decreased T cell proliferation	J:96558
	impaired leukocyte migration	J:96558
	increased IgE level	J:96558
Tg(CD2-Sh2d1a)#Vei/0 (involves: 129S1/Sv * 129X1/SvJ)	increased natural killer cell mediated cytotoxicity	J:110195
Tg(CD2-Sh2d1b1)#Vei/0 (B6.Cg-Tg(CD2-Sh2d1b1)#Vei)	decreased interferon-gamma secretion	J:110195
Tg(CD2-Sh2d1b1)#Vei/0 (B6.Cg-Tg(CD2-Sh2d1b1)#Vei)	impaired natural killer cell mediated cytotoxicity	J:110195
Tg(CD2-Sh2d1b2)#Vei/0 (B6.Cg-Tg(CD2-Sh2d1b2)#Vei)	impaired natural killer cell mediated cytotoxicity	J:110195
Tg(Cd2-Smad7)#Chbe/0 (involves: C57BL/6)	decreased interleukin-9 secretion	J:184670
	decreased interleukin-10 secretion	J:184670
	decreased interleukin-17 secretion	J:184670
	increased interferon-gamma secretion	J:184670
	increased susceptibility to experimental autoimmune encephalomyelitis	J:184670
Tg(CD2-Stat6V625AT626A)78Mhk/0 (involves: C3H * C57BL/6)	dermatitis	J:160119
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 (involves: C57BL/6 C57BL/10)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * C57BL/10)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(CD2-Tgfbr2)1Grs/0 (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	increased T cell proliferation	J:97523
Tg(CD2-Tgfbr2)1Grs/? (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	increased T cell proliferation	J:93665
Tg(Cd3d-Il5)NJ.1638Nal/? (involves: C57BL/6J * CBA/J)	peritoneal inflammation	J:123440
Tg(Cd4-BCL2G101AD102A*D103A)AWnt/0 (involves: C57BL/6)	abnormal T cell clonal deletion	J:217939
	abnormal T cell proliferation	J:217939
	decreased thymocyte apoptosis	J:217939
	glomerulonephritis	J:217939
	increased anti-nuclear antigen antibody level	J:217939
	increased autoantibody level	J:217939
	increased interferon-gamma secretion	J:217939
	increased susceptibility to autoimmune disorder	J:217939
	kidney inflammation	J:217939
	liver inflammation	J:217939
	lung inflammation	J:217939
	skin inflammation	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 (involves: C57BL/6 CBA/J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 Tg(Nr4a1-EGFP/cre)820Khog/0 (involves: C57BL/6 C57BL/6J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 C57BL/6J * DBA/2J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(Cd4-CD4)2362Litt/0 Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0 (involves: C57BL/6 * DBA/2 * SJL)	CNS inflammation	J:134764
	increased susceptibility to experimental autoimmune encephalomyelitis	J:134764
Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)425Cbn/? Traf6^tm2Ywc/Traf6^tm2Ywc (involves: C57BL/6 * DBA/2)	abnormal lymphocyte anergy	J:130882
	increased interleukin-2 secretion	J:130882
Tg(Cd4-cre)1Cwi/0 Trmt6^em1Hbgl/Trmt6^em1Hbgl (involves: C57BL/6 * DBA/2J)	decreased T cell proliferation	J:336736
Tg(Cd4-cre)1Cwi/0 Trmt61a^em1Hbgl/Trmt61a^em1Hbgl (involves: C57BL/6 * DBA/2J)	abnormal T cell activation	J:336736
	colitis	J:336736
	decreased T cell proliferation	J:336736
Tg(Cd4-DsRed)4Lt/0 (NOD/ShiLt-Tg(Cd4-DsRed)4Lt)	decreased susceptibility to autoimmune diabetes	J:127785
Tg(Cd4-Dtx1)1Mzl/? (involves: C57BL/6)	abnormal T cell activation	J:151605
	abnormal thymocyte activation	J:151605
	decreased interleukin-2 secretion	J:151605
	decreased T cell proliferation	J:151605
Tg(CD4-HIV)F21380Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F21380Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(CD4-HIV)F21388Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F21388Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(CD4-HIV)F21407Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F21407Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(CD4-HIV)F26605Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F26605Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(CD4-HIV)F26622Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F26622Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(CD4-HIV)F26990Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F26990Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(CD4-HIV)F27011Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F27011Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(CD4-HIV)F27367Pjo/0 (involves: C3H * C57BL/6)	interstitial pneumonia	J:78756
Tg(CD4-HIV)F27367Pjo/0 (involves: C3H * C57BL/6)	tubular nephritis	J:78756
Tg(Cd4-Il17rb)#Cdon/? (involves: C57BL/6)	decreased interferon-gamma secretion	J:158594
	increased interleukin-5 secretion	J:158594
	increased interleukin-9 secretion	J:158594
	increased interleukin-13 secretion	J:158594
	increased susceptibility to type I hypersensitivity reaction	J:158594
	lung inflammation	J:158594
Tg(CD4-Il17re)#Cdon/0 (involves: C57BL/6)	abnormal interleukin secretion	J:177650
	decreased interleukin-17 secretion	J:177650
	increased susceptibility to experimental autoimmune encephalomyelitis	J:177650
Tg(Cd4-NPM/ALK)N1Ingh/0 (either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster))	increased immunoglobulin level	J:82127
Tg(Cd4-TGFBR2)16Flv/? (involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)	abnormal T cell activation	J:97554
	abnormal T cell proliferation	J:97554
	abnormal thymus involution	J:97554
	colitis	J:97554
	glomerulonephritis	J:97554
	increased anti-nuclear antigen antibody level	J:97554
	increased IgA level	J:97554
	increased IgG1 level	J:97554
	increased IgG2a level	J:97554
	increased immunoglobulin level	J:97554
	increased inflammatory response	J:97554
	liver inflammation	J:97554
	lung inflammation	J:97554
	pancreas inflammation	J:97554
Tg(Cd4-TGFBR2)16Flv/? (involves: C3H * C57BL/6)	abnormal T cell proliferation	J:134473
	colitis	J:134156
	increased interferon-gamma secretion	J:134156
	increased tumor necrosis factor secretion	J:134156
Tg(CD8aCD8b)57Scr/? (B6;SJL-Tg(CD8aCD8b)57Scr/J)	abnormal cytotoxic T cell physiology	J:92994
Tg(CD19)1Tft/0 (involves: C57BL/6 * C57BL/6J * SJL)	increased B cell proliferation	J:27236
Tg(CD19)1Tft/Tg(CD19)1Tft (involves: C57BL/6 * C57BL/6J * SJL)	decreased IgG1 level	J:27236
	decreased IgG3 level	J:27236
	increased B cell proliferation	J:27236
	increased IgG2a level	J:27236
	increased IgG2b level	J:27236
	increased IgM level	J:27236
Tg(CD46)2Gsv/0 (involves: C57BL/6 * FVB/N)	abnormal cell-mediated immunity	J:109895
	abnormal chemokine level	J:109895
	abnormal cytokine secretion	J:109895
	abnormal humoral immune response	J:109895
	abnormal response to transplant	J:113644
	decreased cytotoxic T cell cytolysis	J:109895
	increased susceptibility to Paramyxoviridae infection	J:109895
Tg(Cd68-BCL2)526Medz/0 (involves: 129 * C57BL/6)	abnormal immune cell physiology	J:82809
Tg(Cd68-BCL2)526Medz/0 (involves: 129 * C57BL/6)	increased inflammatory response	J:82809
Tg(Cd68-BCL2)535Medz/0 (involves: 129 * C57BL/6)	abnormal dendritic cell physiology	J:211458
	decreased dendritic cell apoptosis	J:211458
	increased inflammatory response	J:82809
Tg(Cd68-Fem1a)1Seno/0 (C57BL/6-Tg(Cd68-Fem1a)1Seno)	abnormal susceptibility to induced colitis	J:228893
Tg(Cd74-Nlrc4*)1Kyas/0 (involves: C57BL/6N)	arthritis	J:219652
	dermatitis	J:219652
	increased circulating interleukin-1 beta level	J:219652
	increased circulating interleukin-17 level	J:219652
	increased inflammatory response	J:219652
	increased interleukin-1 beta secretion	J:219652
	joint inflammation	J:219652
	skin inflammation	J:219652
Tg(Cd79b-TCL1A)BKTeit/0 (involves: C3H * C57BL/6)	decreased B cell apoptosis	J:79703
	decreased T cell apoptosis	J:79703
	increased B cell proliferation	J:79703
	increased T cell proliferation	J:79703
Tg(Cd152Ig)1Jbs/0 (involves: C3H * NOD)	increased susceptibility to autoimmune diabetes	J:35353
Tg(CD207-Dta)312Dhka/? (FVB-Tg(CD207-Dta)312Dhka)	increased susceptibility to type IV hypersensitivity reaction	J:113309
Tg(Cebpb-tTA)5Bjd/0 Tg(tetO-MYC,-OVAL)#Gtgm/0 (B6J.Cg-Tg(Cebpb-tTA)5Bjd Tg(tetO-MYC,-OVAL)#Gtgm)	abnormal immune tolerance	J:186226
Tg(Cga-LHB/CGB)94Jhn/? (involves: C57BL/6 * SJL)	pyelonephritis	J:55157
Tg(Cga-LHB/CGB)94Jhn/? (involves: C57BL/6 * SJL)	tubulointerstitial nephritis	J:55157
Tg(Ckm-APPSw)A2Lfa/0 (involves: C57BL/6 * SJL)	myositis	J:76338
Tg(Ckm-APPSw)A6Lfa/0 (involves: C57BL/6 * SJL)	myositis	J:76338
Tg(CKMM-tTA)A3Rhvh/0 Tg(tetO-H2-K1)#Papl/0 (B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl)	abnormal cytokine level	J:205907
	increased anti-nuclear antigen antibody level	J:205907
	increased autoantibody level	J:205907
	myositis	J:205907
Tg(CLEC4C-HBEGF)956Cln/0 (C57BL/6-Tg(CLEC4C-HBEGF)956Cln)	abnormal chemokine secretion	J:166504
	abnormal cytotoxic T cell physiology	J:166504
	abnormal NK cell physiology	J:166504
	abnormal NK T cell physiology	J:166504
	decreased interferon-alpha secretion	J:166504
	impaired natural killer cell mediated cytotoxicity	J:166504
	increased interferon-gamma secretion	J:166504
	increased interleukin-12 secretion	J:166504
	increased susceptibility to Herpesvirales infection	J:166504
Tg(Cma1-cre)ARoer/0 Tg(Kit*D814V)1Roer/0 (involves: C57BL/6)	colitis	J:169611
Tg(CMV-cre)1Cgn/0 Tg(KitD814V)1Roer/0 (involves: BALB/cJ C57BL/6)	large intestinal inflammation	J:169611
Tg(CMV-IghvaD11)CCat/0 Tg(CMV-IgkvaD11)BCat/0 (involves: C57BL/6 * SJL)	increased splenocyte apoptosis	J:79946
Tg(CMV-IghvaD11)DCat/0 Tg(CMV-IgkvaD11)ACat/0 (involves: C57BL/6 * SJL)	increased splenocyte apoptosis	J:79946
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1ax2as)1Stra/0 (involves: C57BL/6 NMRI * SJL)	pancreas inflammation	J:94953
Tg(Col1a1-Dkk1)1Hmk/? (B6.FVB-Tg(Col1a1-Dkk1)1Hmk)	abnormal osteoclast physiology	J:158620
Tg(Col1a1-Dkk1)1Hmk/? (B6.FVB-Tg(Col1a1-Dkk1)1Hmk)	abnormal response to transplant	J:238121
Tg(Col1a1-FGF2,-Sapphire)203Mmh/Tg(Col1a1-FGF2,-Sapphire)203Mmh (involves: FVB/N)	osteoarthritis	J:240777
Tg(Col2a1-cre/ERT2)1Dic/0 Tgfbr1^tm1.1Karl/Tgfbr1^tm1.1Karl (involves: 129 * C57BL/6)	osteoarthritis	J:271724
Tg(Col2a1-Mir140)#Asah/0 (C57BL/6-Tg(Col2a1-Mir140)#Asah)	decreased susceptibility to induced arthritis	J:160358
Tg(Col2a1-rtTA,tetO-COMP)2Jath/0 (C57BL/6-Tg(Col2a1-rtTA,tetO-COMP)2Jath)	increased inflammatory response	J:233238
Tg(Comp-tTA)#Yeli/0 Tg(tetO-DDR2)#Yeli/0 (Not Specified)	osteoarthritis	J:176308
Tg(Cr2-cre)3Cgn/? Xrcc4^tm1Fwa/Xrcc4^tm2Fwa (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal class switch recombination	J:150339
Tg(Csf1r-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	increased interferon-gamma secretion	J:169462
Tg(Csf1r-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	small intestinal inflammation	J:169462
Tg(CSF2)2Ygy/0 Tg(IL3)1Ygy/0 Tg(KITLG)3Ygy/0 (C.Cg-Tg(CSF2)2Ygy Tg(IL3)1Ygy Tg(KITLG)3Ygy)	abnormal response to transplant	J:107052
	decreased susceptibility to graft versus host disease	J:107052
Tg(CYP1A1-PPARD)#Jfoe/0 (involves: C57BL/6J * CBA)	increased T cell proliferation	J:158907
Tg(CYP1A1-PPARD)#Jfoe/0 (involves: C57BL/6J * CBA)	skin inflammation	J:158907
Tg(DO11.10)10Dlo/? (involves: BALB/c * C3H * C57BL/6)	abnormal thymus physiology	J:70572
Tg(DO11.10)10Dlo/0 Crlf2^tm1Wjl/Crlf2^tm1Wjl (involves: 129 * BALB/c * C3H * C57BL/6)	decreased inflammatory response	J:107431
Tg(DPP4)2Nnag/0 (B6.Cg-Tg(DPP4)2Nnag)	abnormal cytokine level	J:286321
	increased susceptibility to Coronaviridae infection	J:286321
	lung inflammation	J:286321
Tg(DPP4)2Nnag/0 Tmprss2^{tm1(KOMP)Vlcg}/Tmprss2^{tm1(KOMP)Vlcg} (involves: C57BL/6NCr * C57BL/6NTac * DBA)	abnormal cytokine secretion	J:283077
	decreased susceptibility to Coronaviridae infection	J:283077
Tg(DUX4)1Maar/? (involves: C57BL/6J CBA/J)	increased incidence of corneal inflammation	J:195481
Tg(ED-L2-IL1RN/IL1B)#Tcw/? (B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)	abnormal interleukin level	J:180282
	esophageal inflammation	J:180282
	increased circulating interleukin-6 level	J:180282
	increased inflammatory response	J:180282
Tg(EIF1AX-Il31ra)1Jagr/0 (involves: C3H * C57BL/6)	abnormal immune system physiology	J:91124
	conjunctivitis	J:91124
	dermatitis	J:91124
Tg(Ela1-TAg)18Bri/0 (involves: C57BL/6 * SJL)	pancreas inflammation	J:107545
Tg(Ela2a-Prss1,-GFP)1Dbs/0 (C57BL/6-Tg(Ela2a-Prss1,-GFP)1Dbs)	chronic pancreas inflammation	J:144663
	increased susceptibility to induced pancreatitis	J:144663
Tg(Ela-KRASG12D)9Eps/0 (involves: C57BL/6 FVB)	pancreas inflammation	J:231759
Tg(Ela-KRASG12D)9Eps/0 Tg(Mt1-TGFBR2)AM3Epb/0 (involves: C57BL/6 * FVB)	pancreas inflammation	J:231759
Tg(Emu-TXLNA)1Amjr/0 (B6.Cg-Tg(Emu-TXLNA)1Amjr)	abnormal B cell physiology	J:117018
	enhanced humoral immune response	J:145185
	increased autoantibody level	J:117018
	increased circulating interferon-alpha level	J:117018
	increased IgA level	J:117018
	increased IgG2a level	J:117018
	increased IgM level	J:117018
	increased immunoglobulin level	J:117018
	increased susceptibility to autoimmune disorder	J:117018, J:145185
	interstitial pneumonia	J:145185
	kidney inflammation	J:117018
	lacrimal gland inflammation	J:145185
	parotid gland inflammation	J:145185
	salivary gland inflammation	J:117018, J:145185
	submandibular gland inflammation	J:145185
Tg(EmuSR-HDAC9)1468Kpet/0 (involves: C57BL/6 * CBA)	abnormal lymphocyte physiology	J:237420
Tg(EmuSR-HDAC9)1468Kpet/0 (involves: C57BL/6 * CBA)	increased B cell proliferation	J:237420
Tg(F2RL1)1Mslb/0 (involves: FVB/NCrl)	increased inflammatory response	J:79757
Tg(F2RL1)1Mslb/0 (involves: FVB/NCrl)	respiratory system inflammation	J:79757
Tg(Fabp1-cre)1Jig/0 Vhl^tm1Jae/Vhl^tm1Jae (involves: 129S4/SvJae * BALB/c * FVB/N)	decreased susceptibility to induced colitis	J:93476
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla (involves: FVB)	decreased IgM level	J:80204
Tg(Fabp4-Angptl2)5Yo/0 (involves: C57BL/6)	abnormal macrophage chemotaxis	J:152387
	chronic inflammation	J:152387
	white adipose tissue inflammation	J:152387
Tg(Fabp4-Apol6)#Hsul/0 (C57BL/6J-Tg(Fabp4-Apol6)#Hsul)	white adipose tissue inflammation	J:344362
Tg(Fabp4-Phb*Y114F)#Smis/0 (Not Specified)	abnormal circulating chemokine level	J:227976
Tg(Fabp4-Phb*Y114F)#Smis/0 (Not Specified)	abnormal circulating cytokine level	J:227976
Tg(FCGR2A)11Mkz/0 Tg(PF4)#Zcy/0 (involves: C57BL/6 * SJL)	increased acute inflammation	J:72220
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz (involves: C57BL/6 * SJL)	abnormal macrophage physiology	J:136516
	arthritis	J:136516
	glomerulonephritis	J:136516
	increased anti-histone antibody level	J:136516
	increased IgG2a level	J:136516
	increased susceptibility to induced arthritis	J:136516
	increased tumor necrosis factor secretion	J:136516
	interstitial pneumonia	J:136516
Tg(Fga,Fgb,Fgg)1Unc/? (C57BL/6-Tg(Fga,Fgb,Fgg)1Unc)	increased circulating fibrinogen level	J:118353
Tg(FOXJ1-ACE2)1Rba/0 (involves: C3H * C57BL/6)	increased susceptibility to Coronaviridae infection	J:287092, J:288386
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:287092, J:288386
	interstitial pneumonia	J:288386
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0 (involves: C57BL/6NCrl)	increased inflammatory response	J:125295
	increased susceptibility to type IV hypersensitivity reaction	J:125295
	insulitis	J:125295
	lung inflammation	J:125295
	skin inflammation	J:125295
Tg(Gfap-Ifna1)12Ilc/0 (involves: BALB/c * C57BL/6J)	CNS inflammation	J:68811
	decreased susceptibility to Riboviria infection	J:68811
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:68811
	meningoencephalitis	J:68811
Tg(Gfap-Ifna1)39Ilc/0 (involves: BALB/c * C57BL/6J)	CNS inflammation	J:68811
Tg(Gfap-Ifna1)39Ilc/0 (involves: BALB/c * C57BL/6J)	meningoencephalitis	J:68811
Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/0 (involves: C57BL/6)	abnormal microglial cell activation	J:132679
Tg(Gfap-TK)7.1Mvs/0 (involves: C57BL/10 * CBA * CFLP)	abnormal inflammatory response	J:104241
	brain inflammation	J:113202
	small intestinal inflammation	J:104241
Tg(Gfap-TNF)K21Gkl/0 (involves: C57BL/6 CBA)	CNS inflammation	J:106592
Tg(GFAP-tTA)78Pop/0 Tg(tetO-Ifng)184Pop/0 (B6.Cg-Tg(GFAP-tTA)78Pop Tg(tetO-Ifng)184Pop)	abnormal interferon-gamma secretion	J:109838
	CNS inflammation	J:109838
Tg(H2-Aa)26Dim/? Tg(H2-Ab1)62Dim/? (B6.Cg-Tg(H2-Aa)26Dim Tg(H2-Ab1)62Dim)	abnormal antigen presentation via MHC class II	J:110897
	abnormal level of surface class II molecules	J:110897
	increased immunoglobulin level	J:110897
Tg(H2-Aa)26Dim/? Tg(H2-Ab1)62Dim/? (SJL.Cg-Tg(H2-Aa)26Dim Tg(H2-Ab1)62Dim)	abnormal level of surface class II molecules	J:110897
Tg(H2-D-Il15)3304Clgr/? (FVB/N-Tg(H2-D-Il15)3304Clgr)	abnormal inflammatory response	J:67478
	abnormal lymphocyte physiology	J:67478
	dermatitis	J:67478
Tg(H2-D^b)2Bujf/0 (FVB/NPas-Tg(H2-D^b)2Bujf)	decreased susceptibility to Picornaviridae infection	J:18556
Tg(H2-Ea)16Dim/? (involves: C57BL/6 * SJL)	increased immunoglobulin level	J:111128
Tg(H2-Ea-G6pc2)69Tkay/? (NOD-Tg(H2-Ea-G6pc2)69Tkay)	abnormal CD4-positive, alpha-beta T cell physiology	J:117352
	abnormal immune tolerance	J:117352
	decreased T cell proliferation	J:117352
	increased anti-insulin autoantibody level	J:117352
	increased susceptibility to autoimmune diabetes	J:117352
	insulitis	J:117352
Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)	abnormal circulating cytokine level	J:209872
	arthritis	J:209872
	heart inflammation	J:209872
	increased circulating interleukin-6 level	J:209872
	increased IgG level	J:209872
	joint inflammation	J:209872
	kidney inflammation	J:209872
Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)	abnormal CD4-positive, alpha-beta T cell physiology	J:209872
	abnormal circulating cytokine level	J:209872
	arthritis	J:209872
	decreased circulating interleukin-6 level	J:209872
	increased circulating interleukin-17 level	J:209872
	increased IgG level	J:209872
	joint inflammation	J:209872
Tg(H2-Ea-Ins2)1Wehi/0 (NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)	abnormal T cell proliferation	J:100232
Tg(H2-Ea-Ins2)1Wehi/0 (NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)	salivary gland inflammation	J:100232
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi (NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)	decreased anti-insulin autoantibody level	J:117352
	decreased T cell proliferation	J:117352
Tg(H2-Ea-LACK)1Ngkh/0 (C.Cg-Tg(H2-Ea-LACK)1Ngkh)	abnormal immune system physiology	J:181384
	abnormal T-helper 1 physiology	J:181384
	abnormal T-helper 2 physiology	J:181384
	decreased susceptibility to parasitic infection	J:181384
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:181384
Tg(H2-Ea-Tnfsf9)16Lpc/0 (involves: C57BL/6)	abnormal B cell physiology	J:132372
Tg(H2-Ea-Tnfsf9)16Lpc/0 (involves: C57BL/6)	decreased IgG level	J:132372
Tg(H2-Ea^d)5Lt/0 (NOD/ShiLt-Tg(H2-Ea^d)5Lt)	autoimmune response	J:36435
	decreased interferon-gamma secretion	J:36435
	decreased susceptibility to autoimmune diabetes	J:36435
	increased interleukin-4 secretion	J:36435
	periinsulitis	J:36435
Tg(H2-Ea^d)12Lt/0 (NOD/ShiLt-Tg(H2-Ea^d)12Lt)	autoimmune response	J:36435
	decreased interferon-gamma secretion	J:36435
	decreased susceptibility to autoimmune diabetes	J:36435
	increased interleukin-4 secretion	J:36435
	insulitis	J:36435
Tg(H2-K1-HLA-A)28Mpla/0 (B10.Cg-Tg(H2-K1-HLA-A)28Mpla)	choroid inflammation	J:67871
Tg(H2-K1-HLA-A)28Mpla/0 (B10.Cg-Tg(H2-K1-HLA-A)28Mpla)	eye inflammation	J:67871
Tg(H2-K-Cd86)7All/0 (B6.Cg-Tg(H2-K-Cd86)7All)	abnormal inflammatory response	J:112266
Tg(H2-K-DUSP5)21Wjl/0 (involves: C57BL/6J * CBA)	decreased T cell proliferation	J:138077
	dermatitis	J:138077
	skin inflammation	J:138077
Tg(H2-K-Fosl2,-EGFP)13Wag/0 (B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag)	lung inflammation	J:238723
Tg(H2-K-HLA-G,B2M)1Alm/0 (CBA/Ca-Tg(H2-K-HLA-G,B2M)1Alm/CmwJ)	abnormal cytotoxic T cell physiology	J:140016
	increased T cell proliferation	J:140016
Tg(H2-K-IL6)2Srj/0 (B6.Cg-Tg(H2-K-IL6)2Srj)	increased IgG level	J:185153
Tg(H2-K-MC159/EGFP)13Fkmc/0 (involves: C57BL/6)	decreased B cell apoptosis	J:138050
	decreased T cell apoptosis	J:138050
	increased B cell proliferation	J:138050
Tg(H2-K-MC159/EGFP)13Fkmc/Tg(H2-K-MC159/EGFP)13Fkmc (involves: C57BL/6)	increased anti-double stranded DNA antibody level	J:138050
	increased IgG2b level	J:138050
Tg(H2-K-TcrbP14)128Mak/? (involves: C57BL/6 * C57L * DBA/2)	abnormal T cell clonal deletion	J:111265
Tg(H2-K^b-IL21)5Wjl/0 (involves: 129)	abnormal class switch recombination	J:93740
	increased B cell apoptosis	J:93740
	increased IgG1 level	J:93740
	increased IgM level	J:93740
Tg(H2-K^b-Tcra,-Tcrb)1640Kurs/0 (SJL.FVB-Tg(H2-K^b-Tcra,-Tcrb)1640Kurs)	abnormal cytokine level	J:149511
	brain inflammation	J:149511
	CNS inflammation	J:149511
	increased autoantibody level	J:149511
	increased susceptibility to experimental autoimmune encephalomyelitis	J:149511
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish (C57BL/6-Tg(H2-L-IL6)1Kish)	glomerulonephritis	J:128016, J:138762
	increased IgG1 level	J:128016
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (C57BL/6-Tg(H2-L-IL6)46Kish)	glomerulonephritis	J:40405
	increased immunoglobulin level	J:40405
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (involves: BALB/c * C57BL/6)	increased IgA level	J:40405
	increased immunoglobulin level	J:40405
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (C.B6-Tg(H2-L-IL6)46Kish)	increased IgG1 level	J:74377
	increased IgG2b level	J:74377
	increased IgG level	J:74377
Tg(H2-L^d)LoxNibl/0 (C57BL/6-Tg(H2-L^d)LoxNibl)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:284394
Tg(H2-L^d)LoxNibl/0 (C57BL/6-Tg(H2-L^d)LoxNibl)	increased response to antigen	J:284394
Tg(H2KePCC)2403Stoe/? (involves: C57BL/6 * SJL)	abnormal immune tolerance	J:92997
Tg(H2KePCC)2403Stoe/? Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	abnormal immune tolerance	J:92997
	abnormal T cell anergy	J:92997
Tg(H2KmPCC)2939Stoe/? (involves: C57BL/6 * SJL)	abnormal immune tolerance	J:92997
Tg(H2KmPCC)2939Stoe/0 Tg(Tcra2B4)1Mmd/0 Tg(Tcrb2B4)1Mmd/0 (involves: C3H/HeJ * C57BL/6 * SJL)	decreased T cell proliferation	J:50143
Tg(H2KmPCC)2939Stoe/? Tg(TcrAND)53Hed/? (involves: C57BL/6 * SJL)	abnormal immune tolerance	J:92997
	abnormal T cell anergy	J:92997
Tg(H2KmPCC)2939Stoe/? Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	abnormal immune tolerance	J:92997
	abnormal T cell anergy	J:92997
Tg(HBB-Myc)#Cos/0 (involves: C57BL/6J * CBA/J)	kidney inflammation	J:276641
Tg(HBV)10Imeg/0 (involves: C57BL/6)	abnormal cytokine secretion	J:95283
Tg(HBV)10Imeg/0 (involves: C57BL/6)	abnormal dendritic cell physiology	J:95283
Tg(HCRT-tTA)1Ahky/0 Tg(tetO-DTA)1Gfi/0 (B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)	increased microglial cell activation	J:211045
Tg(HIV)26Aln/0 (involves: FVB/N)	kidney inflammation	J:90297
	myositis	J:90297
	uveitis	J:136652
Tg(HLA-A2/H2-K)1Scr/? (involves: C57BL/6)	abnormal cytotoxic T cell physiology	J:127813
Tg(HLA-A/H2-D/B2M)1Dvs/0 (NOD/ShiLtDvs-Tg(HLA-A/H2-D/B2M)1Dvs)	increased susceptibility to autoimmune diabetes	J:121685
Tg(HLA-B27)30-4Trg/? (involves: C57BL/6J * NOD)	decreased susceptibility to autoimmune diabetes	J:109851
Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0 (B6.Cg-Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv)	decreased susceptibility to autoimmune diabetes	J:59245
Tg(HLA-DR2)#Lfug/0 Tg(TCROb.1A12)#Lfug/0 (involves: C57BL/6 * DBA/2)	CNS inflammation	J:134764
	increased susceptibility to experimental autoimmune encephalomyelitis	J:134764
Tg(HLA-DRA0101,HLA-DRB10101)1Dmz/Tg(HLA-DRA0101,HLA-DRB10101)1Dmz (involves: C57BL/6 * C57BL/10Sn * SJL/J)	abnormal T cell physiology	J:108635
	increased autoantibody level	J:108635
	increased susceptibility to induced arthritis	J:108635
Tg(Hmgcr-MX1)LStae/Tg(Hmgcr-MX1)LStae (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	decreased susceptibility to Orthomyxoviridae infection	J:119783
	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:119783
Tg(HTT*)NXwy/0 (involves: FVB/NJ)	CNS inflammation	J:219890
Tg(ICAM1)4Grom/? (involves: BALB/cAnNTac)	increased susceptibility to Picornaviridae infection	J:92607
Tg(Igh3H9)41Mwg/? (involves: C57BL/6 * SJL)	decreased IgD level	J:119625
Tg(Igh3H9)41Mwg/? (involves: C57BL/6 * SJL)	increased anti-single stranded DNA antibody level	J:119625
Tg(Igh*-Mir125b-1)116Toki/0 (Not Specified)	decreased B cell apoptosis	J:178816
Tg(Igh-6-Cd80)1Gjf/0 (involves: FVB)	abnormal CD4-positive, alpha-beta T cell physiology	J:44271
	abnormal humoral immune response	J:112474
	abnormal T cell activation	J:44271
	decreased immunoglobulin level	J:112474
Tg(Igh-6-Cd80)1Gjf/0 (NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)	abnormal B cell activation	J:131077
	abnormal CD8-positive, alpha-beta T cell physiology	J:131077
	abnormal level of surface class II molecules	J:131077
	decreased IgG1 level	J:131077
	decreased IgG2b level	J:131077
	decreased IgG3 level	J:131077
	decreased IgM level	J:131077
	decreased immunoglobulin level	J:131077
	decreased susceptibility to autoimmune diabetes	J:131077
	insulitis	J:131077
Tg(Igh-6-Cd86)1Akab/0 (involves: FVB)	abnormal CD4-positive, alpha-beta T cell physiology	J:44271
Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0 (NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)	increased susceptibility to autoimmune diabetes	J:91865
	insulitis	J:91865
Tg(Igh-6/Igh-V281)3Jwt/0 (NOD.B6-Tg(Igh-6/Igh-V281)3Jwt)	decreased susceptibility to autoimmune diabetes	J:91865
Tg(Igh-6/Igh-V281)3Jwt/0 (NOD.B6-Tg(Igh-6/Igh-V281)3Jwt)	insulitis	J:91865
Tg(Igh-HMGA2)#Cro/0 (FVB/N-Tg(Igh-HMGA2)#Cro)	decreased IgG1 level	J:233225
	decreased IgG2a level	J:233225
	decreased IgG2b level	J:233225
	decreased IgG3 level	J:233225
	decreased response to antigen	J:233225
	increased circulating interleukin-6 level	J:233225
	increased circulating tumor necrosis factor level	J:233225
Tg(Igh-Lmp2a)ERlon/0 (involves: C57BL/6 * SJL)	abnormal B cell proliferation	J:129571
Tg(Igh-Maf)68Staka/0 (C57BL/6-Tg(Igh-Maf)68Staka)	increased IgG level	J:168074
	increased IgM level	J:168074
	increased immunoglobulin level	J:168074
Tg(Igh-Maf)524Staka/0 (involves: C57BL/6 * C57BL/6J * DBA/2)	increased IgG level	J:168074
	increased IgM level	J:168074
	increased immunoglobulin level	J:168074
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0 (FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)	abnormal B cell physiology	J:162077
	decreased IgG1 level	J:162077
	decreased IgG2a level	J:162077
	decreased IgG2b level	J:162077
	increased B cell proliferation	J:162077
Tg(Igh-Mir155)8Cro/0 (involves: FVB/N)	increased B cell proliferation	J:109591
Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs (B6.Cg-Tg(Igh-Mir210)#aKgcs)	abnormal class switch recombination	J:205868
	decreased IgA level	J:205868
	decreased IgG1 level	J:205868
	decreased IgG2a level	J:205868
	decreased IgG2b level	J:205868
	decreased IgG3 level	J:205868
Tg(Igh-Nfil3)#Kubo/0 (B6.Cg-Tg(Igh-Nfil3)#Kubo)	increased interleukin-3 secretion	J:172134
	increased interleukin-10 secretion	J:172134
	increased interleukin-13 secretion	J:172134
Tg(Igh-TCL1A)1Ypek/0 (FVB/N-Tg(Igh-TCL1A)1Ypek)	abnormal circulating chemokine level	J:160184
	abnormal humoral immune response	J:160184
	abnormal lymphocyte physiology	J:160184
	decreased IgG1 level	J:160184
	decreased IgG2a level	J:160184
	decreased IgG2b level	J:160184
	decreased IgG3 level	J:160184
	decreased IgM level	J:160184
	increased circulating tumor necrosis factor level	J:160184
Tg(Igh-V186.2-TCL1A)3Cro/0 (involves: C3H * C57BL/6)	peritoneal inflammation	J:76574
Tg(Igh-V-CD40lg)#Tsub/0 (C57BL/6-Tg(Igh-V-CD40lg)#Tsub)	glomerulonephritis	J:128824
	increased anti-double stranded DNA antibody level	J:128824
	increased anti-histone antibody level	J:128824
	increased anti-single stranded DNA antibody level	J:128824
Tg(Igh-V-CD40lg)#Tsub/0 (involves: C57BL/6)	colitis	J:89855
	glomerulonephritis	J:89855
	increased autoantibody level	J:89855
	increased IgG level	J:89855
	increased IgM level	J:89855
	increased interferon-gamma secretion	J:89855
	increased splenocyte proliferation	J:89855
Tg(IGH@yH1)2BJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:23827
Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:23827
Tg(IghelMD4)4Ccg/0 (involves: C57BL/6)	abnormal B cell activation	J:73608
Tg(IghelMD4)4Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg)	increased IgG2b level	J:132538
Tg(IghelMD4)4Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg)	increased IgM level	J:78308, J:132538
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)	abnormal B cell anergy	J:89156
	abnormal B cell clonal deletion	J:89156
	decreased IgM level	J:89156
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)	abnormal B cell anergy	J:89156, J:78308
	abnormal central B cell anergy	J:109923
	decreased IgM level	J:89156, J:78308
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6)	abnormal B cell anergy	J:73608, J:132538
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6)	abnormal B cell physiology	J:76134
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)	abnormal T cell proliferation	J:80859
	increased susceptibility to autoimmune diabetes	J:80859
Tg(IghH280)48Dvs/? (NOD/ShiLtDvs-Tg(IghH280)48Dvs/J)	increased susceptibility to autoimmune diabetes	J:274578
Tg(IghH280)48Dvs/? (NOD/ShiLtDvs-Tg(IghH280)48Dvs/J)	insulitis	J:274578
Tg(IghH280)48Dvs/? Tg(IgkH280)934Dvs/? (NOD/ShiLtDvs-Tg(IghH280)48Dvs Tg(IgkH280)934Dvs/Dvs)	increased susceptibility to autoimmune diabetes	J:274578
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0 (involves: FVB/N)	abnormal B cell physiology	J:113109
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0 (NOD.FVB-Tg(Ighm-Ctla4Ig/Cd80)1Jbs)	decreased susceptibility to autoimmune diabetes	J:113109
Tg(IghMyc)22Bri/0 (involves: C57BL/6N * SJL)	increased B cell apoptosis	J:214383
Tg(IghMyc)22Bri/0 Xiap^tm1Hs/Xiap^tm1Hs (B6.Cg-Xiap^tm1Hs Tg(IghMyc)22Bri)	decreased B cell proliferation	J:138979
	increased B cell apoptosis	J:138979
Tg(Igk-V21-Bax)1967Bvn/0 (involves: FVB/N)	increased IgA level	J:89049
	increased IgE level	J:89049
	increased IgG1 level	J:89049
	increased IgG2a level	J:89049
	increased IgG level	J:89049, J:90901
	increased IgM level	J:89049
	increased immunoglobulin level	J:89049
Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin level	J:23827
Tg(IgkH280)934Dvs/? (NOD/ShiLtDvs-Tg(IgkH280)934Dvs/J)	increased susceptibility to autoimmune diabetes	J:274578
Tg(IgkH280)934Dvs/? (NOD/ShiLtDvs-Tg(IgkH280)934Dvs/J)	insulitis	J:274578
Tg(Igkv3-5-MYC)24Plbe/0 (C57BL/6J-Tg(Igkv3-5-MYC)DLoxP4Plbe/PlbeMmmh)	abnormal humoral immune response	J:131912
	abnormal immunoglobulin level	J:131912
	increased IgG1 level	J:131912
	increased IgG3 level	J:131912
Tg(Igl-2MOPC315)1275Ust/? (C57BL/6-Tg(Igl-2MOPC315)1275Ust)	decreased IgM level	J:134666
Tg(Il1rn)1Dih/0 (involves: C57BL/6 * CBA)	decreased circulating interleukin-6 level	J:88605
	decreased circulating serum amyloid protein level	J:61600
	decreased inflammatory response	J:88605
	decreased susceptibility to endotoxin shock	J:36387
	decreased susceptibility to Herpesvirales infection	J:88605
	increased susceptibility to bacterial infection	J:36387
Tg(Il1rn)1Dih/Tg(Il1rn)1Dih (involves: C57BL/6 * CBA)	decreased susceptibility to endotoxin shock	J:36387
	increased circulating interleukin-1 level	J:36387
	increased susceptibility to bacterial infection	J:36387
Tg(IL2-Il10)1Kro/0 (involves: C3H * C57BL/6)	abnormal cytokine secretion	J:41588
	decreased susceptibility to parasitic infection	J:41588
	increased susceptibility to bacterial infection	J:80569
Tg(ILK3mHEL)3Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	insulitis	J:78309
Tg(Ins1-Cat,Tyr)25Pne/0 (NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne)	increased susceptibility to autoimmune diabetes	J:108415
Tg(Ins1-Cd80)378Psoh/0 Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2 * FVB/N)	insulitis	J:209714
	periinsulitis	J:209714
Tg(Ins1-EGFP/GH1)14Hara/0 (NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)	increased susceptibility to autoimmune diabetes	J:127015
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara (NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara)	decreased susceptibility to autoimmune disorder	J:127015
	insulitis	J:127015
Tg(Ins2Y16A)1Ell/0 (NOD-Tg(Ins2Y16A)1Ell)	increased susceptibility to autoimmune diabetes	J:98583
Tg(Ins2Y16A)3Ell/0 (NOD-Tg(Ins2Y16A)3Ell)	increased susceptibility to autoimmune diabetes	J:98583
Tg(Ins2-CD80)3B7Flv/? (involves: C57BL/6 * CBA/Ca * NOD/Caj)	increased susceptibility to autoimmune diabetes	J:26618
	insulitis	J:26618
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-H2-Ea^d,Ins2-H2-Eb1^b)187-7Bri/0 (involves: C57BL/6 * CBA/Ca * SJL)	increased susceptibility to autoimmune diabetes	J:93555
	insulitis	J:93555
Tg(Ins2-CD80)3B7Flv/0 Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6 * CBA/Ca)	abnormal cytokine secretion	J:93555
	increased susceptibility to autoimmune diabetes	J:93555
Tg(Ins2-CD86)12B70Flv/0 (involves: C57BL/6 * CBA/Ca)	abnormal cytokine secretion	J:93555
	decreased susceptibility to autoimmune diabetes	J:93555
	periinsulitis	J:93555
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-H2-Ea^d,Ins2-H2-Eb1^b)187-7Bri/0 (involves: C57BL/6 * CBA/Ca * SJL)	abnormal cytokine secretion	J:93555
	increased susceptibility to autoimmune diabetes	J:93555
	insulitis	J:93555
Tg(Ins2-CD86)12B70Flv/0 Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6 * CBA/Ca)	abnormal cytokine secretion	J:93555
	increased susceptibility to autoimmune diabetes	J:93555
Tg(Ins2-Cd274)2Mdos/? (NOD/ShiLt-Tg(Ins2-Cd274)2Mdos)	increased susceptibility to autoimmune diabetes	J:118934
Tg(Ins2-cre)5Lt/0 (NOD/ShiLt-Tg(Ins2-cre)5Lt)	increased susceptibility to autoimmune diabetes	J:127015
Tg(Ins2-cre)5Lt/Tg(Ins2-cre)5Lt (NOD/ShiLt-Tg(Ins2-cre)5Lt)	decreased susceptibility to autoimmune disorder	J:127015
Tg(Ins2-cre)5Lt/Tg(Ins2-cre)5Lt (NOD/ShiLt-Tg(Ins2-cre)5Lt)	insulitis	J:127015
Tg(Ins2-crmA)27Ngkh/? (NOD-Tg(Ins2-CrmA)27Ngkh)	increased susceptibility to autoimmune diabetes	J:132052
Tg(Ins2-E3)1Dvs/? (NOD.Cg-Tg(Ins2-E3)1Dvs)	decreased susceptibility to autoimmune diabetes	J:68996
Tg(Ins2-E3309)5Dvs/? (NOD/ShiLtDvs-Tg(Ins2-E3309)5Dvs/Dvs)	decreased susceptibility to autoimmune diabetes	J:83195
Tg(Ins2-E3704)2Dvs/? (NOD/ShiLtDvs-Tg(Ins2-E3704)2Dvs)	decreased susceptibility to autoimmune diabetes	J:83195
Tg(Ins2-E3734)3Dvs/0 (NOD/ShiLtDvs-Tg(Ins2-E3734)3Dvs/DvsJ)	decreased susceptibility to autoimmune diabetes	J:106340
Tg(Ins2-E3734)4Dvs/? (NOD/ShiLtDvs-Tg(Ins2-E3734)4Dvs/DvsJ)	decreased susceptibility to autoimmune diabetes	J:106340
Tg(Ins2-FasI246N)1Ach/0 (NOD-Tg(Ins2-FasI246N)1Ach)	decreased susceptibility to autoimmune diabetes	J:81416
Tg(Ins2-FasI246N)1Ach/0 Tg(Ins2-Fasl)24Ach/0 (NOD-Tg(Ins2-FasI246N)1Ach Tg(Ins2-Fasl)24Ach)	decreased susceptibility to autoimmune diabetes	J:81416
Tg(Ins2-Fasl)24Ach/0 (NOD-Tg(Ins2-Fasl)24Ach/J)	increased susceptibility to autoimmune diabetes	J:78679, J:81416
Tg(Ins2-GAD2)1Lt/0 (NOD/ShiLt-Tg(Ins2-GAD2)1Lt)	insulitis	J:100251
Tg(Ins2-GAD2)2Lt/0 (NOD/ShiLt-Tg(Ins2-GAD2)2Lt)	abnormal cytokine secretion	J:100251
	decreased susceptibility to autoimmune diabetes	J:100251
	insulitis	J:100251
Tg(Ins2-GP)34-20Olds/0 (involves: BALB/c * C57BL/6)	abnormal lymphocyte physiology	J:81287
	abnormal T cell physiology	J:81287
	increased susceptibility to autoimmune diabetes	J:81287
Tg(Ins2-GP)#Psoh/0 (involves: C57BL/6)	insulitis	J:81285
Tg(Ins2-H2-Ea^d,Ins2-H2-Eb1^b)187-7Bri/0 (involves: C57BL/6 * SJL)	decreased susceptibility to autoimmune diabetes	J:93555
Tg(Ins2-HA)165Bri/0 (B10.Cg- H2^d Tg(Ins2-HA)165Bri/ShrmJ)	abnormal CD4-positive, alpha-beta T cell physiology	J:86430
Tg(Ins2-HA)165Bri/0 (B10.Cg- H2^d Tg(Ins2-HA)165Bri/ShrmJ)	decreased T cell proliferation	J:86430
Tg(Ins2-HA)165Bri/0 Tg(TcraCl4,TcrbCl4)1Shrm/0 (involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2)	insulitis	J:99756
Tg(Ins2-HA)165Bri/? Tg(TcraCl4,TcrbCl4)1Shrm/? (involves: BALB/c * C57BL/6 * C57BL/10)	insulitis	J:99756
Tg(Ins2-Iapp)6Soel/Tg(Ins2-Iapp)6Soel (involves: FVB/N)	decreased susceptibility to autoimmune diabetes	J:130022
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel (involves: FVB/N)	increased susceptibility to autoimmune diabetes	J:130022
Tg(Ins2-Lta)#Flv/0 (involves: NOD)	insulitis	J:91820
	kidney inflammation	J:91820
	periinsulitis	J:91820
Tg(Ins2-Lta)#Flv/0 (involves: C57BL/6)	insulitis	J:91820
	kidney inflammation	J:91820
	periinsulitis	J:91820
Tg(Ins2-Lta)#Flv/0 (involves: C57BL/6 * CBA)	insulitis	J:127705
Tg(Ins2-Lta)#Flv/0 (involves: C57BL/6 * CBA)	periinsulitis	J:127705
Tg(Ins2-NP)25-3Olds/0 (involves: BALB/c * C57BL/6)	decreased susceptibility to autoimmune diabetes	J:81287
Tg(Ins2-NP)25-3Olds/0 (involves: BALB/c * C57BL/6)	increased susceptibility to autoimmune diabetes	J:81287
Tg(Ins2-OVA)59Wehi/? (involves: BALB/c * C57BL/6)	abnormal T cell activation	J:99560
Tg(Ins2-OVA)59Wehi/? (involves: BALB/c * C57BL/6)	increased susceptibility to autoimmune diabetes	J:99560
Tg(Ins2-OVA)307Wehi/? (involves: BALB/c * C57BL/6)	increased susceptibility to autoimmune diabetes	J:99560
Tg(Ins2-OVA)307Wehi/0 Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * C57BL/6JWehi)	autoimmune response	J:99451
Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: C57BL/6)	abnormal leukocyte migration	J:98589
	decreased interferon-gamma secretion	J:122114
	increased susceptibility to autoimmune diabetes	J:122114
Tg(Ins2-TFRC/OVA)296Wehi/0 1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: C57BL/6 * FVB)	decreased T cell proliferation	J:122114
Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6 * CBA * NOD)	insulitis	J:91820
Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6 * CBA)	insulitis	J:91820
Tg(INS-Il10)#Sar/0 (involves: BALB/c)	pancreas inflammation	J:107927
Tg(INS-Il10)#Sar/0 (involves: BALB/c)	periinsulitis	J:107927
Tg(INS-Il10)#Sar/0 Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6J * NOD)	increased susceptibility to autoimmune diabetes	J:64051
Tg(INS-Il10)#Sar/0 Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129S2/SvPas * C57BL/6J * NOD)	increased susceptibility to autoimmune diabetes	J:64051
Tg(INS-MT2A,Tyr)1Pne/0 (FVB-Tg(INS-MT2A,Tyr)1Pne)	abnormal response to transplant	J:95089
Tg(ITGA2)1067Fmw/0 Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1067Fmw/0 Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1067Fmw/0 Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1070Fmw/0 Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1070Fmw/0 Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1070Fmw/0 Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1075Fmw/0 Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1075Fmw/0 Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA2)1075Fmw/0 Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0794Fmw/0 Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0794Fmw/0 Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0794Fmw/0 Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0844Fmw/0 Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0844Fmw/0 Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0844Fmw/0 Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0858Fmw/0 Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0858Fmw/0 Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(ITGA5)0858Fmw/0 Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
	eye inflammation	J:30249
Tg(Itgam-FCAR)83Rcmo/0 (involves: C57BL/6 * NOD)	glomerulonephritis	J:120534
Tg(Itgam-FCAR)83Rcmo/0 (involves: C57BL/6 * NOD)	increased IgA level	J:120534
Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0 (C57BL/6-Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh)	abnormal susceptibility to infection	J:194800
Tg(Itgax-HBEGF/OVA/EGFP)1Garbi/0 (C57BL/6-Tg(Itgax-HBEGF/OVA/EGFP)1Garbi)	abnormal susceptibility to infection	J:194800
Tg(Itgax-TGFBR2)1Flv/0 (C.Cg-Tg(Itgax-TGFBR2)1Flv)	abnormal immune system physiology	J:98953
	abnormal interferon level	J:98953
	decreased susceptibility to parasitic infection	J:98953
Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
Tg(ITGB1)0840Fmw/0 (involves: C57BL/10 * CBA)	eye inflammation	J:30249
Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
Tg(ITGB1)0869Fmw/0 (involves: C57BL/10 * CBA)	eye inflammation	J:30249
Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	dermatitis	J:30249
Tg(ITGB1)0870Fmw/0 (involves: C57BL/10 * CBA)	eye inflammation	J:30249
Tg(IVL-KLK5)#Hov/0 (involves: C57BL/6 * CBA)	abnormal circulating cytokine level	J:210758
	erythroderma	J:210758
	increased IgE level	J:210758
	lymph node inflammation	J:210758
	skin inflammation	J:210758
Tg(K18-ACE2)2Prlmn/0 (involves: C57BL/6J * SJL/J)	increased susceptibility to Coronaviridae infection	J:283648
Tg(K18-ACE2)2Prlmn/0 (involves: C57BL/6J * SJL/J)	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:283648
Tg(K18-ACE2)2Prlmn/0 (B6.Cg-Tg(K18-ACE2)2Prlmn/J)	abnormal chemokine level	J:302313
	abnormal circulating chemokine level	J:294084
	abnormal circulating cytokine level	J:302313
	abnormal cytokine level	J:294084, J:302313
	abnormal interferon level	J:300960, J:302313
	abnormal interleukin level	J:300960, J:302313
	abnormal tumor necrosis factor level	J:300960, J:302313
	blood vessel inflammation	J:300960
	brain inflammation	J:294084
	bronchiolitis	J:302313
	conjunctivitis	J:294084
	cytokine storm	J:300960
	enhanced humoral immune response	J:302313
	increased circulating CXCL10 level	J:302313
	increased circulating interferon-gamma level	J:302313
	increased circulating interleukin-6 level	J:294084
	increased circulating interleukin-10 level	J:294084, J:302313
	increased circulating tumor necrosis factor level	J:294084
	increased CXCL10 level	J:300960
	increased IgG level	J:302313
	increased IgM level	J:302313
	increased susceptibility to Coronaviridae infection	J:294084, J:300960, J:302313, J:296067
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:294084, J:300960
	increased susceptibility to Orthomyxoviridae infection	J:296067
	increased susceptibility to viral infection	J:296067
	increased susceptibility to viral infection induced morbidity/mortality	J:296067
	interstitial pneumonia	J:300960, J:302313
	liver inflammation	J:300960
	lung inflammation	J:294084, J:302313
	meningitis	J:294084, J:302313
	meningoencephalitis	J:300960, J:296067
	rhinitis	J:300960
Tg(KitD814V)1Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	colitis	J:169611
	large intestinal inflammation	J:169611
	small intestinal inflammation	J:169611
Tg(KitD814V)2Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	colitis	J:169611
	large intestinal inflammation	J:169611
	small intestinal inflammation	J:169611
Tg(KitD814V)3Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	colitis	J:169611
	large intestinal inflammation	J:169611
Tg(KRT5-IKBKB)1Armz/0 (involves: C57BL/6 * DBA/2)	increased interleukin-1 alpha secretion	J:160072
	increased interleukin-6 secretion	J:160072
	increased tumor necrosis factor secretion	J:160072
Tg(KRT5-IKBKB)2Armz/0 (involves: C57BL/6 * DBA/2)	abnormal cytokine level	J:160072
	abnormal immune serum protein physiology	J:160072
	dermatitis	J:160072
	increased circulating interferon-gamma level	J:160072
	increased circulating interleukin-1 alpha level	J:160072
	increased circulating interleukin-2 level	J:160072
	increased circulating interleukin-4 level	J:160072
	increased circulating interleukin-5 level	J:160072
	increased circulating interleukin-6 level	J:160072
	increased circulating interleukin-10 level	J:160072
	increased circulating tumor necrosis factor level	J:160072
	increased interleukin-1 alpha secretion	J:160072
	increased interleukin-6 secretion	J:160072
	increased tumor necrosis factor secretion	J:160072
Tg(KRT5-Nfkbia)3Rto/0 Tg(Krt5-Tnfr1)#Rsab/0 Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas C57BL/6 * CBA)	skin inflammation	J:208995
Tg(KRT5-rtTA)1Glk/0 Tg(tetO-Tfrc/EGFP/Ova)#Sfz/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: C3H * C57BL/6 * FVB/N)	increased T cell proliferation	J:199558
	respiratory system inflammation	J:199558
	skin inflammation	J:199558
Tg(KRT5-rtTA)1Glk/0 Tg(tetO-TGFB1C223SC225S)1Glk/0 (involves: FVB/N)	dermatitis	J:70670
	skin inflammation	J:70670
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: C3H * C57BL/6 * FVB/N)	abnormal cytokine level	J:100506
	conjunctivitis	J:100506
	decreased IgG2a level	J:100506
	dermatitis	J:100506
	increased IgE level	J:100506
	increased IgG1 level	J:100506
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)	abnormal B cell activation	J:182756
	increased autoantibody level	J:182756
	increased B cell proliferation	J:182756
	increased circulating interleukin-4 level	J:182756
	increased susceptibility to autoimmune hemolytic anemia	J:182756
Tg(KRT5-rtTA)#Glk/0 Tg(tetO-S100a7a)#Yus/0 (involves: FVB/N)	abnormal chemokine secretion	J:168000
	increased interleukin-1 alpha secretion	J:168000
	increased tumor necrosis factor secretion	J:168000
Tg(KRT5-TGFB1)F2020Xjw/0 (involves: C57BL/6 * DBA/2 * ICR)	abnormal Langerhans cell physiology	J:90118
Tg(KRT5-TGFB1)F2020Xjw/0 (involves: C57BL/6 * DBA/2 * ICR)	skin inflammation	J:90118
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Il13)1Tazh/0 (B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh)	dermatitis	J:150232
	increased IgE level	J:150232
	increased IgG1 level	J:150232
	increased interleukin-4 secretion	J:150232
	increased interleukin-13 secretion	J:150232
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-LMNA*G608G,-EGFP)VF1-07Maer/0 (involves: FVB/N)	periodontium inflammation	J:145312
	skin inflammation	J:145312
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Tek)1Dmt/0 (involves: CD-1 * FVB/N)	abnormal interleukin secretion	J:147438
	increased interferon-gamma secretion	J:147438
	increased interleukin-12 secretion	J:147438
	increased interleukin-17 secretion	J:147438
	increased interleukin-23 secretion	J:147438
	skin inflammation	J:147438
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-TGFB1C223SC225S)1Glk/0 (involves: FVB/N)	dermatitis	J:70670
	skin inflammation	J:70670
Tg(Krt14-Angptl2)1Yo/0 (C.Cg-Tg(Krt14-Angptl2)1Yo)	skin inflammation	J:152387, J:181261
Tg(KRT14-CASP1)1Miz/0 (involves: C57BL/6)	abnormal T cell physiology	J:78602
	dermatitis	J:78602, J:79706
	increased circulating interleukin-18 level	J:78602, J:79706
	increased IgE level	J:78602
	increased IgG1 level	J:78602
	increased susceptibility to bacterial infection	J:79706
	increased susceptibility to bacterial infection induced morbidity/mortality	J:79706
Tg(KRT14-cre)1Amc/0 Trpv3^tm1.1Clph/Trpv3^tm1.1Clph (involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA * Swiss Webster)	erythroderma	J:164741
Tg(Krt14-Ifnk)#Cya/0 (C57BL/6N-Tg(Krt14-Ifnk)#Cya)	increased susceptibility to chemically induced skin inflammation	J:322130
Tg(KRT14-Il1f6)1Hblu/? (involves: C57BL/6 * DBA/2)	abnormal chemokine level	J:126327
Tg(KRT14-Il1f6)1Hblu/? (involves: C57BL/6 * DBA/2)	skin inflammation	J:126327
Tg(KRT14-Il4)#Lsch/0 (involves: BALB/cBy * C57BL/6)	blepharitis	J:126285
	conjunctivitis	J:126285
	decreased IgG2a level	J:126285
	dermatitis	J:126285
	increased IgE level	J:126285
	increased IgG1 level	J:126285
	increased mast cell degranulation	J:126285
	increased susceptibility to bacterial infection	J:126285
	skin inflammation	J:126285
Tg(KRT14-Il7)1Tsk/0 (FVB/N-Tg(KRT14-Il7)1Tsk)	blepharitis	J:42565
Tg(KRT14-Il7)1Tsk/0 (FVB/N-Tg(KRT14-Il7)1Tsk)	skin inflammation	J:42565
Tg(KRT14-Il7)1Tsk/Tg(KRT14-Il7)1Tsk (FVB/N-Tg(KRT14-Il7)1Tsk)	skin inflammation	J:42565
Tg(KRT14-Il18)#Knak/0 (C57BL/6-Tg(KRT14-Il18)#Knak)	abnormal T cell physiology	J:78602
	dermatitis	J:78602
	increased circulating interleukin-18 level	J:78602
	increased IgE level	J:78602
	increased IgG1 level	J:78602
Tg(Krt14-Rac1*G12V)#Mrnk/0 (involves: CBA/CaJ)	abnormal circulating interleukin level	J:237134
	joint inflammation	J:237134
	skin inflammation	J:237134
Tg(KRT14-Tslp)1Pcn/0 (involves: C57BL/6 * SJL)	abnormal lymphocyte physiology	J:102470
Tg(KRT14-Tslp)1Pcn/0 (involves: C57BL/6 * SJL)	increased immunoglobulin level	J:102470
Tg(KRT14-Vegfa)3Dtm/0 (FVB/N-Tg(KRT14-Vegfa)3Dtm)	abnormal leukocyte adhesion	J:104245
Tg(KRT14-Vegfa)3Dtm/0 (FVB/N-Tg(KRT14-Vegfa)3Dtm)	enhanced leukocyte tethering or rolling	J:104245
Tg(KRT14-VP16/NR1I2)13Sdub/? (involves: C57BL/6)	abnormal dendritic cell migration	J:258435
	abnormal innate immunity	J:258435
	decreased interleukin-1 beta secretion	J:258435
	dermatitis	J:258435
	enhanced humoral immune response	J:258435
	increased IgE level	J:258435
	increased IgG1 level	J:258435
	skin inflammation	J:258435
Tg(KRT18*R89C)22Rgo/0 (involves: FVB/N)	chronic liver inflammation	J:241700
Tg(KRT18*R89C)30Rgo/0 (involves: FVB/N)	chronic liver inflammation	J:241700
Tg(KRT18*R89C)50Rgo/0 (involves: FVB/N)	chronic liver inflammation	J:241700
Tg(KRT18-DPP4)3Pbmj/0 (involves: C57BL/6J * SJL/J)	abnormal cytokine secretion	J:285467
	brain inflammation	J:285467
	increased susceptibility to Coronaviridae infection	J:286231, J:285467
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:286231, J:285467
	interstitial pneumonia	J:286231
	lung inflammation	J:286231, J:285467
Tg(LANA,vFLIP,vCYC)801Dtmr/? (involves: C57BL/6)	abnormal B cell activation	J:196403
	abnormal germinal center B cell physiology	J:196403
	abnormal marginal zone B cell physiology	J:196403
	increased B cell proliferation	J:196403
	increased IgG1 level	J:196403
	increased IgG3 level	J:196403
Tg(Lck-Bcl2l1)1Cant/? (B6.Cg-Tg(Lck-Bcl2l1)1Cant)	increased interleukin-2 secretion	J:77507
Tg(Lck-Bcl2l1)1Cant/? (B6.Cg-Tg(Lck-Bcl2l1)1Cant)	increased T cell proliferation	J:77507
Tg(Lck-cre)548Jxm/? Tgfb1^tm2.1Doe/Tgfb1^tm2.1Doe (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)	abnormal T cell activation	J:150024
	increased inflammatory response	J:150024
	increased interferon-gamma secretion	J:150024
	increased interleukin-2 secretion	J:150024
	lung inflammation	J:150024
	salivary gland inflammation	J:150024
Tg(Lck-cre)I57Jxm/? Traf3^tm1Rbr/Traf3^tm1Rbr (involves: C57BL/6 * ICR * SJL)	abnormal T cell physiology	J:132877
Tg(Lck-CrmA)1Hed/0 (involves: BALB/c * C57BL/6J)	decreased T cell apoptosis	J:100451
Tg(Lck-CrmA)1Hed/? (involves: BALB/c * C57BL/6J)	decreased thymocyte apoptosis	J:100451
Tg(Lck-Cxadr)1Jdgr/0 (FVB-Tg(Lck-Cxadr)1Jdgr)	abnormal T cell physiology	J:109884
	decreased T cell apoptosis	J:109884
	decreased T cell proliferation	J:109884
Tg(Lck-FADD)1Hed/0 (involves: BALB/c * C57BL/6)	abnormal T cell proliferation	J:100451
Tg(Lck-FADD)1Hed/? (involves: BALB/c * C57BL/6)	abnormal T cell physiology	J:100451
Tg(Lck-FADD)1Hed/? (involves: BALB/c * C57BL/6)	decreased thymocyte apoptosis	J:100451
Tg(Lck-Il31)1Jagr/0 (involves: C3H * C57BL/6)	abnormal immune system physiology	J:91124
	conjunctivitis	J:91124
	dermatitis	J:91124
Tg(Lck-LMO1)11Sjk/0 Tg(STIL-TAL1)A5(3)Alpa/0 (involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros)	abnormal inflammatory response	J:40868
Tg(LCK-NFKBIA)5Dwb/0 (involves: C57BL/6 * DBA/2)	decreased interleukin-2 secretion	J:93003
	decreased T cell proliferation	J:93003
	increased T cell apoptosis	J:93003
Tg(LCK-NFKBIA)5Dwb/? (involves: BALB/c * C57BL/6 * DBA/2)	abnormal T-helper 1 physiology	J:145531
	decreased interferon-gamma secretion	J:145531
	decreased susceptibility to type I hypersensitivity reaction	J:145531
	decreased susceptibility to type IV hypersensitivity reaction	J:145531
Tg(LCK-NFKBIA)5Dwb/? Tg(Tcra,Tcrb)1Mcd/? (involves: BALB/c * C57BL/6 * DBA/2)	decreased interferon-gamma secretion	J:145531
Tg(Lck-Socs3)1Kubo/0 (Not Specified)	decreased interleukin-2 secretion	J:128797
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:132905
	decreased T cell proliferation	J:128797
Tg(Lck-Sox13)#Jskg/0 (involves: C57BL/6)	decreased T cell proliferation	J:117301
Tg(Lck-Sox13)#Jskg/0 (involves: C57BL/6)	increased thymocyte apoptosis	J:117301
Tg(Lck-Stat5b*)1Mafa/0 (Not Specified)	increased B cell proliferation	J:132669
Tg(Lck-Stk17b)26.1Wals/? (B6.Cg-Tg(Lck-Stk17b)26.1Wals)	increased anti-nuclear antigen antibody level	J:149973
	increased interleukin-2 secretion	J:149973
	increased susceptibility to experimental autoimmune encephalomyelitis	J:149973
	increased T cell proliferation	J:149973
Tg(Lck-Tax)53Hall/0 (involves: C57BL/6)	increased susceptibility to fungal infection	J:129531
Tg(Lck-Tnfsf4)1Nish/0 (B6.Cg-Tg(Lck-Tnfsf4)1Nish)	abnormal CD4-positive, alpha-beta T cell physiology	J:194882
	abnormal cytokine secretion	J:80214
	increased interleukin-13 secretion	J:194882
	increased susceptibility to type IV hypersensitivity reaction	J:80214
	increased T cell proliferation	J:80214
	lung inflammation	J:194882
Tg(Lck-Tnfsf4)1Nish/0 (C.Cg-Tg(Lck-Tnfsf4)1Nish)	abnormal CD4-positive, alpha-beta T cell physiology	J:194882
Tg(Lck-Tnfsf4)1Nish/0 (C.Cg-Tg(Lck-Tnfsf4)1Nish)	increased interleukin-13 secretion	J:194882
Tg(Lck-TNFSF13)3919Mhah/0 (B6.Cg-Tg(Lck-TNFSF13)3919Mhah)	decreased B cell apoptosis	J:94628
Tg(Lck-TNFSF13)3919Mhah/0 (B6.Cg-Tg(Lck-TNFSF13)3919Mhah)	increased IgA level	J:94628
Tg(Lck-Tnfsf14)24Yxf/? (C57BL/6-Tg(Lck-Tnfsf14)24Yxf)	abnormal complement protein level	J:128976
	abnormal inflammatory response	J:128976
	abnormal T cell physiology	J:120962, J:129951
	colitis	J:129951
	glomerulonephritis	J:129951
	increased anti-double stranded DNA antibody level	J:129951
	increased anti-nuclear antigen antibody level	J:128976
	increased autoantibody level	J:129951
	increased IgA level	J:128976
	increased IgG level	J:128976
	increased T cell proliferation	J:129951
	intestinal inflammation	J:128976
	liver inflammation	J:129951
	lung inflammation	J:129951
	myositis	J:129951
	small intestinal inflammation	J:120962
Tg(Lck-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	increased interferon-gamma secretion	J:169462
	increased interleukin-17 secretion	J:169462
	small intestinal inflammation	J:169462
Tg(Lck-Tslp)1Chea/0 (B6.Cg-Tg(Lck-Tslp)1Chea)	glomerulonephritis	J:72982
	increased anti-nuclear antigen antibody level	J:72982
	increased immunoglobulin level	J:72982
	liver inflammation	J:72982
	lung inflammation	J:72982
Tg(Lck-VIPR2)1Ejg/0 (C57BL/6-Tg(Lck-VIPR2)1Ejg)	decreased interferon-gamma secretion	J:127974
	decreased susceptibility to type IV hypersensitivity reaction	J:127974
	increased IgE level	J:127974
	increased IgG1 level	J:127974
	increased interleukin-4 secretion	J:127974
	increased interleukin-5 secretion	J:127974
	increased susceptibility to type I hypersensitivity reaction	J:127974
Tg(Lck/Emu-Rftn1)1Ayos/? (involves: C57BL/6)	increased IgG1 level	J:150299
	increased IgG2a level	J:150299
	increased IgG3 level	J:150299
	increased IgM level	J:150299
	increased interferon-gamma secretion	J:150299
	increased interleukin-4 secretion	J:150299
	increased interleukin-17 secretion	J:150299
	increased susceptibility to experimental autoimmune encephalomyelitis	J:150299
	increased T cell proliferation	J:150299
Tg(LckIl4)1315Dbl/0 (involves: C57BL/6J * DBA/2J)	abnormal osteoclast physiology	J:107359
	abnormal T cell activation	J:92453
	abnormal thymocyte activation	J:92453
	increased IgG2a level	J:92453
	increased interleukin-4 secretion	J:92453
	increased susceptibility to parasitic infection	J:92453
Tg(LCKprBCL2)36Sjk/? (involves: C3H * C57BL/6)	decreased T cell apoptosis	J:11548
Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * CBA/J)	abnormal T cell clonal deletion	J:217939
Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * CBA/J)	decreased thymocyte apoptosis	J:217939
Tg(LCKprBCL2)36Sjk/0 Tg(Nr4a1-EGFP/cre)820Khog/0 (involves: C57BL/6 * C57BL/6J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(LCKprBCL2)36Sjk/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal T cell clonal deletion	J:217939
	decreased thymocyte apoptosis	J:217939
Tg(Ly6a-GCSAM)102AIsg/0 (involves: C57BL/6J * CBA)	increased B cell proliferation	J:221238
	increased IgG level	J:221238
	increased inflammatory response	J:221238
Tg(Ly6a-SET/NUP214)2969Gcg/0 (involves: FVB/NJ)	increased B cell apoptosis	J:142938
Tg(LYZ-rtTA2SM2,tetO-ELAVL1)632Dkon/0 (B6.Cg-Tg(LYZ-rtTA2SM2,tetO-ELAVL1)632Dkon)	decreased susceptibility to induced colitis	J:184388
Tg(Mbp-Pad2)28Fgm/0 (involves: CD-1)	abnormal tumor necrosis factor level	J:142650
Tg(Mbp-SNCA)1Ema/0 (involves: C57BL/6 * DBA/2)	brain inflammation	J:207162
Tg(MCL1)8Caig/0 (involves: C57BL/6 * SJL)	abnormal leukocyte physiology	J:50604
	abnormal macrophage apoptosis	J:95913
	decreased B cell apoptosis	J:50604
	decreased splenocyte apoptosis	J:50604
	decreased T cell apoptosis	J:50604
	increased susceptibility to bacterial infection	J:95913
Tg(Mcpt8-cre)1Voeh/0 (involves: C57BL/6)	decreased inflammatory response	J:164432
Tg(Mir125a)#Smoc/0 (involves: C57BL/6)	decreased interferon-gamma secretion	J:224880
Tg(Mir125a)#Smoc/0 (involves: C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:224880
Tg(ML5sHEL)5Ccg/0 (C57BL/6-Tg(ML5sHEL)5Ccg)	abnormal B cell anergy	J:78308
Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6JSfd * CBA)	abnormal B cell anergy	J:78308
Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6JSfd * CBA)	abnormal T cell anergy	J:78308
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	thyroid gland inflammation	J:78309
Tg(MMTV-ENPP2)#Gbm/0 (FVB/N-Tg(MMTV-ENPP2)#Gbm)	mastitis	J:149661
Tg(MMTV-LPAR1)2Gbm/Tg(MMTV-LPAR1)2Gbm (FVB/N-Tg(MMTV-LPAR1)2Gbm)	mastitis	J:149661
Tg(MMTV-LPAR1)7Gbm/Tg(MMTV-LPAR1)7Gbm (FVB/N-Tg(MMTV-LPAR1)7Gbm)	mastitis	J:149661
Tg(MMTV-LPAR1)#Gbm/Tg(MMTV-LPAR1)#Gbm (FVB/N-Tg(MMTV-LPAR1)#Gbm)	mastitis	J:149661
Tg(MMTV-LPAR2)3Gbm/Tg(MMTV-LPAR2)3Gbm (FVB/N-Tg(MMTV-LPAR2)3Gbm)	mastitis	J:149661
Tg(MMTV-LPAR2)6Gbm/Tg(MMTV-LPAR2)6Gbm (FVB/N-Tg(MMTV-LPAR2)6Gbm)	mastitis	J:149661
Tg(MMTV-LPAR2)#Gbm/Tg(MMTV-LPAR2)#Gbm (FVB/N-Tg(MMTV-LPAR2)#Gbm)	mastitis	J:149661
Tg(MMTV-LPAR3)3Gbm/Tg(MMTV-LPAR3)3Gbm (FVB/N-Tg(MMTV-LPAR3)3Gbm)	mastitis	J:149661
Tg(MMTV-LPAR3)#Gbm/Tg(MMTV-LPAR3)#Gbm (FVB/N-Tg(MMTV-LPAR3)#Gbm)	mastitis	J:149661
Tg(MMTV-PyVT)#Mul/0 (B6.FVB-Tg(MMTV-PyVT)#Mul)	abnormal circulating cytokine level	J:147923
	abnormal T cell physiology	J:147923
	decreased B cell proliferation	J:147923
	decreased splenocyte proliferation	J:147923
	decreased T cell proliferation	J:147923
	increased circulating tumor necrosis factor level	J:147923
Tg(MMTV-Scgb1a1)#Abm/0 (involves: C57BL/6 * SJL)	increased IgA level	J:57504
Tg(Mpz-RAF1/ESR1)A668Ayld/0 (involves: C57BL/6J * CBA/J)	increased inflammatory response	J:182703
Tg(Msr1-MMP9)#Apar/0 (B6.Cg-Tg(Msr1-MMP9)#Apar)	abnormal macrophage physiology	J:136830
Tg(Msr1-MMP9)#Apar/0 (B6.Cg-Tg(Msr1-MMP9)#Apar)	decreased inflammatory response	J:129959
Tg(MSR1-Plau)1Ddi/0 (involves: C57BL/6 * SJL)	heart inflammation	J:101486
Tg(Mt1-Crry)26Quig/? (involves: CD-1)	abnormal inflammatory response	J:117777
Tg(Mt1-IL6)28Gci/0 (involves: C57BL/6 * DBA/2)	increased circulating interleukin-6 level	J:177825
	increased circulating serum amyloid protein level	J:177825
	increased IgG1 level	J:18424
	increased IgG level	J:177825, J:18424
Tg(Mt1-TGFBR2*)AM3Epb/0 (involves: FVB/N)	pancreas inflammation	J:76993
Tg(MT2A-TGFBR2)4Rser/0 (involves: C57BL/6 * DBA)	osteoarthritis	J:44579
Tg(MUC1)79.24Gend/0 (involves: C57BL/6)	abnormal humoral immune response	J:128899
	increased IgG level	J:154046
	increased IgM level	J:154046
Tg(Mup3-Plau)350-2Eps/? (C57BL/6-Tg(Mup3-Plau)350-2Eps)	increased interleukin-1 beta secretion	J:233146
	increased tumor necrosis factor secretion	J:233146
	liver inflammation	J:233146
Tg(Mx1-cre)1Cgn/0 Znrf1^tm1Lchs/Znrf1^tm1Lchs (involves: C57BL/6)	decreased susceptibility to endotoxin shock	J:250572
Tg(Myh6*/tetO-Capn1)L3Gwd/0 (involves: FVB/N)	heart inflammation	J:133797
Tg(Myh6-BAG3P209L)#Mswi/0 (involves: C57BL/6 DBA/2)	heart inflammation	J:234278
Tg(Myh6-Grem2)1Akh/0 (involves: C57BL/6)	decreased inflammatory response	J:250034
Tg(Myh6-Grem2)1Akh/0 (involves: C57BL/6)	decreased interleukin-10 secretion	J:250034
Tg(Myh6-JUP)1Dpju/0 (FVB/N-Tg(Myh6-JUP)1Dpju)	heart inflammation	J:235770
Tg(Myh6-Tnf)1Brgi/? (involves: C57BL/6J * SJL)	myocarditis	J:84829, J:100006
Tg(Myh6-Tnf)2Brgi/? (involves: C57BL/6J * SJL)	myocarditis	J:84829, J:100006
Tg(Myh6-Tnnt2*R92Q)2Lnwd/0 (involves: C57BL/6)	heart inflammation	J:56911
Tg(Myh6-Tnnt2*R92Q)3Lnwd/0 (involves: C57BL/6)	heart inflammation	J:56911
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-EDN1,-lacZ)9Mhus/0 (involves: C57BL/6 * CBA)	heart inflammation	J:131245
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-HDAC5)1Eno/0 (involves: C3H C57BL/6 * CBA)	myocarditis	J:81967
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-NOS2,-lacZ)240iMhus/0 (involves: C57BL/6 * CBA)	heart inflammation	J:132082
Tg(Myh6-tTA)6Smbf/0 Tg(tetO-Spp1)5Gad/0 (involves: C57BL/6 * CBA)	heart inflammation	J:194810
	myocarditis	J:194810
Tg(Myl1-SOD1G93A)#Amu/0 (FVB/NJ-Tg(Myl1-SOD1G93A)#Amu)	increased microglial cell activation	J:143747
Tg(Nlrp1b)1Die/0 (involves: 129S1/SvImJ * C57BL/6 * SJL)	abnormal macrophage physiology	J:99748
Tg(OMP-SV40T)13Bse/0 (involves: C57BL/6 * SJL)	abnormal immune tolerance	J:54269
Tg(Pcp2-TBP*)69Hmhl/0 (involves: FVB/N)	brain inflammation	J:174239
Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	abnormal regulatory T cell physiology	J:112603
Tg(Pim1-Il9)5Jcrd/0 (involves: BALB/c * FVB/N)	increased susceptibility to type I hypersensitivity reaction	J:100568
Tg(Pim1-Il9)5Jcrd/0 (involves: FVB/N)	increased interleukin-5 secretion	J:115764
Tg(Pim1-Il9)5Jcrd/0 (involves: FVB/N)	increased susceptibility to type I hypersensitivity reaction	J:100568
Tg(PLP1*)4Rsj/0 (involves: CD-1)	CNS inflammation	J:161344
Tg(Plp1-Eif2ak3)18Pop/0 (C57BL/6J-Tg(Plp1-Eif2ak3)18Pop)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:238042
Tg(Prdx6)153Pgn/0 (C57BL/6-Tg(Prdx6)153Pgn/Pgn)	abnormal macrophage physiology	J:86528
Tg(PRG1)18Wlad/0 (involves: C57BL/6J * CBA/J)	decreased susceptibility to Picornaviridae infection	J:127826
	increased susceptibility to Picornaviridae infection	J:92990
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:92990
Tg(PRG3)9Wlad/0 (involves: C57BL/6J * CBA/J)	increased susceptibility to Picornaviridae infection	J:92990, J:127826
Tg(Prnp)4053Sbp/0 (involves: FVB/N)	increased susceptibility to prion infection	J:136434
Tg(Prnp)a20Cwe/0 (Not Specified)	increased susceptibility to prion infection	J:130657, J:143528
Tg(Prnp-ATXN792Q)6529Als/Y (involves: C3H/HeJ C57BL/6J)	colitis	J:135615
Tg(Prnp-Immt/SOD1G93A)7Gmnf/Tg(Prnp-Immt/SOD1G93A)7Gmnf (involves: C57BL/6 * CBA * SJL)	dermatitis	J:177846
Tg(Prnp-ITM2B)1Ruvi/Tg(Prnp-ITM2B)1Ruvi Tg(Prnp-MAPTP301L)#Ruvi/Tg(Prnp-MAPTP301L)#Ruvi (involves: C3HeB/FeJ * C57BL/6)	increased inflammatory response	J:197198
Tg(Prnp-MAPTP301L)JNPL3Hlmc/? (involves: C57BL/6 DBA/2)	eye inflammation	J:63887
Tg(Psp-Rbbp4)1Yoha/0 (involves: C57BL/6)	abnormal antigen presentation	J:141378
	abnormal T cell activation	J:141378
	increased autoantibody level	J:141378
	increased interferon-gamma secretion	J:141378
	increased interleukin-2 secretion	J:141378
	increased interleukin-18 secretion	J:141378
	increased susceptibility to autoimmune disorder	J:141378
	lacrimal gland inflammation	J:141378
	salivary gland inflammation	J:141378
Tg(PVR)1Kkst/0 (involves: ICR)	increased susceptibility to Picornaviridae infection	J:153943
Tg(RIP1-Tag)5Dh/? (C3HeB/FeJ-Tg(RIP1-Tag)5Dh)	pancreas inflammation	J:80168
Tg(Scgb1a1-IL6)9Flv/0 (involves: C57BL/6 * CBA)	lung inflammation	J:128762, J:156430
Tg(Scgb1a1-Il13)2Eli/? (involves: C57BL/6 * CBA)	abnormal leukocyte physiology	J:53612
Tg(Scgb1a1-Il13)2Eli/? (involves: C57BL/6 * CBA)	respiratory system inflammation	J:53612
Tg(Scgb1a1-Il17a)3Cdon/0 (C57BL/6-Tg(Scgb1a1-Il17a)3Cdon)	abnormal chemokine level	J:112600
Tg(Scgb1a1-Il17a)3Cdon/0 (C57BL/6-Tg(Scgb1a1-Il17a)3Cdon)	lung inflammation	J:112600
Tg(Scgb1a1-Il17f,GFP)1Cdon/? (C57BL/6-Tg(Scgb1a1-Il17f,GFP)1Cdon)	lung inflammation	J:136279
Tg(Scgb1a1-Muc5b,-AcGFP)#Evns/0 (involves: C57BL/6J * C57BL/6N)	decreased susceptibility to bacterial infection	J:207159
Tg(Scgb1a1-PLUNC)#Chuh/0 (involves: FVB/N)	decreased susceptibility to bacterial infection	J:171589
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-EGFRT790ML858R)19Kkw/0 (involves: 129 * C57BL/6 * FVB/N)	interstitial pneumonia	J:122849
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-IL1B)KBry/0 (involves: 129 * C57BL/6)	abnormal chemokine level	J:107601, J:130523
	lung inflammation	J:107601, J:130523
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0 (Not Specified)	decreased T cell apoptosis	J:148490
Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1*)1Eli/0 (involves: C57BL/6)	lung inflammation	J:92469
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * CBA)	abnormal T-helper 2 physiology	J:148490
Tg(Scgb1a1-Scnn1b)6608Bouc/0 (involves: C3H * C57BL/6)	bronchitis	J:91139
Tg(Scgb1a1-Scnn1b)6608Bouc/0 (B6.Cg-Tg(Scgb1a1-Scnn1b)6608Bouc)	respiratory system inflammation	J:191673
Tg(Scgb1a1-Scnn1b)6608Bouc/0 (C.Cg-Tg(Scgb1a1-Scnn1b)6608Bouc)	respiratory system inflammation	J:191673
Tg(SERPINA1E342K)#Slcw/0 (involves: C57BL/6 ICR)	liver inflammation	J:149132
Tg(SERPINA1-HBVX)1655Jtsb/0 (involves: C3H * C57BL/6 * ICR)	liver inflammation	J:90305
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz/? (involves: C3H * C57BL/6)	abnormal eosinophil physiology	J:63507
	abnormal response to infection	J:63507
	decreased interleukin-5 secretion	J:63507
Tg(SFTPC-DPP4)3Pbmj/0 (involves: C57BL/6J * SJL/J)	abnormal susceptibility to Coronaviridae infection	J:285467
Tg(SFTPC-Il18)AThos/0 (B6N.Cg-Tg(SFTPC-Il18)AThos)	increased interferon-gamma secretion	J:147547
	increased interleukin-13 secretion	J:147547
	lung inflammation	J:147547
Tg(SFTPC-rtTA)2Jaw/0 Tg(tetO-CTGF)#Swu/0 (involves: 129 * C57BL/6 * C57BL/6J)	lung inflammation	J:171151
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0 (involves: C57BL/6 * SJL)	lung inflammation	J:97297
Tg(SFTPC-Tnf)2Pva/0 (involves: C57BL/6 * DBA/2)	alveolitis	J:28120
Tg(SFTPC-Tnf)2Pva/0 (involves: C57BL/6 * DBA/2)	interstitial pneumonia	J:28120
Tg(Sirt1)ASrn/? (involves: C57BL/6 * CBA)	increased susceptibility to endotoxin shock	J:137868
Tg(SOD1G93A)1Gur/0 (B6.Cg-Tg(SOD1G93A)1Gur/J)	abnormal T cell physiology	J:138237
Tg(SOD1G93A)1Gur/0 (B6SJL-Tg(SOD1G93A)1Gur/J)	CNS inflammation	J:110437
Tg(Stat3*)9199Alau/0 (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:210877
	decreased IgG1 level	J:210877
	decreased IgG3 level	J:210877
	increased IgE level	J:210877
	increased inflammatory response	J:210877
	increased susceptibility to bacterial infection	J:210877
	increased susceptibility to bacterial infection induced morbidity/mortality	J:210877
	increased susceptibility to endotoxin shock	J:210877
	intestinal inflammation	J:210877
Tg(SV40-Igh-64C8)H3Hon/0 Tg(SV40-Igk4C8)L1Hon/0 (involves: C57BL/6)	abnormal B cell clonal deletion	J:139864
	increased anti-erythrocyte antigen antibody level	J:139864
Tg(SV40-KLK7)1010Teg/0 (involves: C57BL/6J * CBA)	dermatitis	J:75714
Tg(TARDBPG348C)#Jpj/0 (involves: C3H C57BL/6)	abnormal cytokine level	J:195184
Tg(TCF3/HLF)1Mlc/0 (involves: FVB/N)	abnormal thymus involution	J:55022
Tg(Tcra2C,Tcrb2C)1Dlo/? (involves: C57L * DBA/2 * SJL)	abnormal memory T cell physiology	J:95380
Tg(Tcra2C,Tcrb2C)1Dlo/? (involves: C57L * DBA/2 * SJL)	seborrheic dermatitis	J:95380
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6)	abnormal cytokine secretion	J:83278
	blepharitis	J:83278
	CNS inflammation	J:83278
	increased susceptibility to autoimmune disorder	J:83278
	increased susceptibility to experimental autoimmune encephalomyelitis	J:83278
Tg(Tcra2D2,Tcrb2D2)1Kuch/? (involves: C57BL/6 * CD-1)	decreased interleukin-17 secretion	J:125296
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased interferon-gamma secretion	J:189919
	decreased interleukin-2 secretion	J:189919
	decreased interleukin-10 secretion	J:189919
	decreased T cell proliferation	J:189919
	increased interferon-gamma secretion	J:189919
	increased interleukin-6 secretion	J:189919
	increased interleukin-17 secretion	J:189919
	increased T cell apoptosis	J:189919
	increased T cell proliferation	J:189919
Tg(Tcra5CC7,Tcrb5CC7)IWep/0 (involves: C57BL/6)	abnormal T cell activation	J:73608
Tg(Tcra,Tcrb)3Ayr/0 (involves: C57BL/6 * DBA/2)	abnormal lymphocyte anergy	J:80775
Tg(Tcra,Tcrb)3Ayr/0 (involves: C57BL/6 * DBA/2)	decreased T cell proliferation	J:80775
Tg(Tcra,Tcrb)24Efro/0 (D1.Cg-Tg(Tcra,Tcrb)24Efro)	abnormal cytokine secretion	J:104243
	autoimmune response	J:104243
	decreased T cell proliferation	J:104243
	increased autoantibody level	J:104243
	increased susceptibility to autoimmune disorder	J:104243
	increased T cell proliferation	J:104243
Tg(Tcra,Tcrb)HRCAll/0 (B6.Cg-Tg(Tcra,Tcrb)HRCAll)	decreased cytotoxic T cell cytolysis	J:131347
Tg(Tcra,Tcrb)HRCAll/0 (B6.Cg-Tg(Tcra,Tcrb)HRCAll)	decreased interferon-gamma secretion	J:131347
Tg(TcraAI4)1Dvs/0 (NOD-Tg(TcraAI4)1Dvs)	increased susceptibility to autoimmune diabetes	J:93553
Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	abnormal cytotoxic T cell physiology	J:94192
	increased susceptibility to autoimmune diabetes	J:94192
Tg(TcraAV19AJ33)1Shima/? (involves: 129S4/SvJae * C57BL/6)	abnormal NK T cell physiology	J:112657
Tg(TcraAV19AJ33)1Shima/? (involves: 129S4/SvJae * C57BL/6)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:112657
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	decreased susceptibility to autoimmune diabetes	J:87251
	insulitis	J:52940
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: C57BL/6 * NOD * SJL)	insulitis	J:137009
Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * DBA/2J)	abnormal cytotoxic T cell physiology	J:66565
Tg(TcrAND)53Hed/? (involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)	abnormal T cell proliferation	J:85777
	abnormal thymocyte activation	J:85777
Tg(TcraR28,TcrbR28)KRNDim/0 (involves: C57BL/6 * NOD * SJL)	abnormal macrophage chemotaxis	J:36815
	abnormal T cell activation	J:36815
	abnormal T cell anergy	J:36815
	abnormal T cell clonal deletion	J:36815
	abnormal T cell proliferation	J:36815
	chronic joint inflammation	J:36815
	glomerulonephritis	J:36815
	impaired neutrophil recruitment	J:36815
	increased IgG1 level	J:36815
	kidney inflammation	J:36815
	rheumatoid arthritis	J:36815
Tg(TcraTcrb)8Rest/? (C57BL/6-Tg(TcraTcrb)8Rest)	abnormal cytotoxic T cell physiology	J:85058
Tg(TcraTcrb)8Rest/? (C57BL/6-Tg(TcraTcrb)8Rest)	increased interferon-gamma secretion	J:85058
Tg(TcraTcrb)425Cbn/0 (involves: C57BL/6)	abnormal cytokine level	J:112600
Tg(TcraTcrb)425Cbn/0 Trim30a^tm1Yjk/Trim30a^tm1Yjk (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	increased T cell proliferation	J:215171
Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal cytotoxic T cell physiology	J:92867, J:133645
	abnormal T cell clonal deletion	J:92867
	increased T cell proliferation	J:92867
Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6 * MRL/Mp)	liver inflammation	J:72817
Tg(TcraTcrbNY4.1)1Pesa/0 (NOD.Cg-Tg(TcraTcrbNY4.1)1Pesa)	increased susceptibility to autoimmune diabetes	J:108768
Tg(TcraTcrbNY4.1)1Pesa/0 (NOD.Cg-Tg(TcraTcrbNY4.1)1Pesa)	insulitis	J:108768
Tg(TcraTcrbNY8.3)1Pesa/? (involves: C57BL/6 * NOD * SJL)	pancreas inflammation	J:44202
Tg(TcraY1,TcrbY1)416Tev/0 (involves: C57BL/6J * DBA/2J)	abnormal immune tolerance	J:84288
Tg(Tcrb)93Vbo/0 (involves: C57BL/6 * C57BL/LiA * CBA/BrA)	abnormal cytotoxic T cell physiology	J:66565
Tg(Tcrb)93Vbo/0 (involves: C57BL/6 * C57BL/LiA * CBA/BrA)	abnormal T cell clonal deletion	J:66565
Tg(TcrbBL17)1Lmor/0 (involves: DBA/1J * SWR/J)	increased susceptibility to induced arthritis	J:134111
Tg(TcrbBL17)1Lmor/Tg(TcrbBL17)1Lmor (involves: DBA/1J * SWR/J)	increased susceptibility to induced arthritis	J:134111
Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6)	abnormal interleukin secretion	J:73608
	abnormal T cell activation	J:73608
	increased T cell proliferation	J:73608
Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha-beta T cell physiology	J:78309
	abnormal T cell activation	J:78309
	abnormal T cell proliferation	J:78309
	thyroid gland inflammation	J:78309
Tg(TcrLCMV)1Aox/? (C57BL/6-Tg(TcrLCMV)1Aox)	abnormal cytotoxic T cell physiology	J:92228
Tg(TcrLCMV)1Aox/? (C57BL/6-Tg(TcrLCMV)1Aox)	increased IgG level	J:92228
Tg(TcrLCMV)2Aox/? (C57BL/6-Tg(TcrLCMV)2Aox)	abnormal cytotoxic T cell physiology	J:92228
Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2)	decreased cytotoxic T cell cytolysis	J:77696
Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2)	decreased T cell proliferation	J:77696
Tg(TcrLCMV)327Sdz/Tg(TcrLCMV)327Sdz (NOD.Cg-Tg(TcrLCMV)327Sdz/Dvs)	autoimmune response	J:71050
Tg(Tek-cre)1Ywa/0 Thbd^tm2Rdr/Thbd^tm2Wlr (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal acute phase protein level	J:71269
	increased circulating interleukin-6 level	J:71269
Tg(Tek-Jam3)1Maal/? (B6.Cg-Tg(Tek-Jam3)1Maal)	abnormal cellular extravasation	J:99020
	abnormal leukocyte adhesion	J:99020
	abnormal leukocyte physiology	J:99020
	impaired neutrophil chemotaxis	J:99020
	lung inflammation	J:99020
	peritoneal inflammation	J:99020
Tg(Tek-Procr)1Cte/0 (B6.FVB-Tg(Tek-Procr)1Cte)	abnormal acute phase protein level	J:119637
	abnormal immune system physiology	J:119637
	abnormal inflammatory response	J:119637
Tg(Tek-Tnf)5382Mcla/0 (B6.Cg-Tg(Tek-Tnf)5382Mcla)	chronic inflammation	J:71622
	chronic liver inflammation	J:71622
	decreased inflammatory response	J:71622
	kidney inflammation	J:71622
	lung inflammation	J:71622
Tg(Tek-tTA)1Dmt/0 Tg(tetO-Tek)1Dmt/0 (involves: CD-1)	skin inflammation	J:96718, J:137745
Tg(tetO-MAP2K1)#Ahsa/? Tg(CD2-rtTA)CRza/? (involves: C57BL/6 * C57BL/10 * CBA * SJL)	increased anti-double stranded DNA antibody level	J:174339
Tg(tetO/CMV-CD200)1Rmgo/Tg(tetO/CMV-CD200)1Rmgo (involves: C57BL/6)	abnormal dendritic cell physiology	J:134313
Tg(TetOp-Polb/tTA)2Sbl/0 (B6.Cg-Tg(TetOp-Polb/tTA)2Sbl)	glomerulonephritis	J:152481
Tg(Tgfa)1Efu/0 (Not Specified)	ear inflammation	J:65045
Tg(Th-SNCA)5Eric/Tg(Th-SNCA)5Eric (involves: C57BL/6)	abnormal microglial cell physiology	J:140907
Tg(THY1-APP)2Somm/0 (involves: C57BL/6J * DBA/2)	brain inflammation	J:44603
Tg(Thy1-APP)3Somm/0 (involves: C57BL/6J * DBA/2)	brain inflammation	J:44603
Tg(Thy1-APPSwDutIowa)BWevn/0 (involves: C57BL/6)	abnormal microglial cell physiology	J:124911
Tg(Thy1-Fcer2a)2431Putt/? (involves: BALB/c * C57BL/6)	abnormal immune system physiology	J:129296
	decreased IgE level	J:20421
	decreased IgG1 level	J:20421
Tg(Thy1-MAPTP301S)2541Godt/Tg(Thy1-MAPTP301S)2541Godt (involves: C57BL/6J * CBA/Ca)	eye inflammation	J:108870
Tg(Thy1-SNCA)61Ema/0 (involves: C57BL/6 * DBA/2)	abnormal microglial cell activation	J:238066
Tg(Thy1-UBQLN2P497S)3Mont/? (involves: C3H C57BL/6 * C57BL/6J)	increased microglial cell activation	J:239510
Tg(Thy1-UBQLN2P506T)6Mont/? (involves: C3H C57BL/6 * C57BL/6J)	decreased microglial cell activation	J:239510
Tg(Thy1/THY1)T12Gsv/0 (involves: C57BL/10 * CBA)	increased IgG level	J:133943
Tg(Thy1/THY1)T12Gsv/0 (involves: C57BL/10 * CBA)	increased IgM level	J:133943
Tg(Tk1-DPP4)27Ysj/0 (involves: C57BL/6 * FVB/N)	abnormal chemokine level	J:290259
	abnormal innate immunity	J:290259
	abnormal interleukin level	J:290259
	abnormal macrophage activation involved in immune response	J:290259
	abnormal tumor necrosis factor level	J:290259
	increased susceptibility to Coronaviridae infection	J:290259
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:290259
	lung inflammation	J:290259
Tg(Tlr7)1Boll/0 (involves: C57BL/6)	abnormal circulating chemokine level	J:127600
	autoimmune response	J:127600
	glomerulonephritis	J:127600
	increased anti-nuclear antigen antibody level	J:127600
	increased circulating interleukin-6 level	J:127600
	increased circulating tumor necrosis factor level	J:127600
	liver inflammation	J:127600
X/Tg(Tlr7)6Boll (involves: C57BL/6)	abnormal B cell activation	J:127600
	abnormal T cell activation	J:127600
	autoimmune response	J:127600
	glomerulonephritis	J:127600
	increased anti-nuclear antigen antibody level	J:127600
	increased splenocyte proliferation	J:127600
	liver inflammation	J:127600
	lung inflammation	J:127600
Tg(TNF)197Gkl/0 (involves: C57BL/6 * CBA)	arthritis	J:97992, J:92576
Tg(TNF)197Gkl/0 Tnfrsf1a^tm1.1Gkl/Tnfrsf1a^tm1.1Gkl (involves: 129 * C57BL/6 * CBA)	arthritis	J:92470
Tg(TNF)3647Gkl/0 (involves: C57BL/6 * CBA)	arthritis	J:190204
Tg(Tnf)6074Gkl/0 (involves: C57BL/6 * CBA)	brain inflammation	J:106592
Tg(Tnf)6074Gkl/0 Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129S2/SvPas * C57BL/6 * CBA)	CNS inflammation	J:106592
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J)	abnormal B cell physiology	J:58798
	abnormal T cell physiology	J:58798
	increased anti-double stranded DNA antibody level	J:58798
	increased anti-single stranded DNA antibody level	J:58798
	increased autoantibody level	J:58798
	increased IgG level	J:58798
	increased IgM level	J:58798
	increased immunoglobulin level	J:58798
Tg(Tnfsf13b)1Fma/0 (B6.Cg-Tg(Tnfsf13b)1Fma)	increased autoantibody level	J:114782
	increased IgA level	J:114782
	kidney inflammation	J:73711
	salivary gland inflammation	J:73711
Tg(Tnfsf13b)1Fma/? (B6.Cg-Tg(Tnfsf13b)1Fma)	abnormal B cell activation	J:113556
	abnormal marginal zone B cell physiology	J:113556
	glomerulonephritis	J:113556
	increased anti-double stranded DNA antibody level	J:113556
Tg(Tnfsf13b)1Fma/? Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (B6.Cg-Tnfrsf13b^tm1Rjb Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
Tg(Tnfsf13b)1Fma/? Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (B6.Cg-Tnfrsf13c^tm1Mass Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
Tg(Tnfsf13b)1Fma/0 Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)	increased IgA level	J:114782
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma (involves: C57BL/6 * DBA/2)	abnormal immunoglobulin level	J:178227
	increased IgA level	J:178227
	increased IgM level	J:178227
	increased immunoglobulin level	J:178227
	kidney inflammation	J:178227
Tg(Trp53)1Srn/0 (involves: C57BL/6 * CBA)	increased thymocyte apoptosis	J:80311
Tg(Trp53)1Srn/0 Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte apoptosis	J:80311
Tg(Trp53)bSrn/0 (involves: C57BL/6 * CBA)	increased thymocyte apoptosis	J:80311
Tg(Tyr-NRASQ61K)1Bee/? (involves: BALB/c C57BL/6J * DBA/2)	skin inflammation	J:98545
Tg(Tyr-NRASQ61K)1Bee/? (involves: C57BL/6J DBA/2)	skin inflammation	J:98545
Tg(UBC-scFv)2Nemz/0 (involves: C57BL/6 * DBA/2)	abnormal immune tolerance	J:96759
Tg(UBC-scFv)2Nemz/0 (involves: C57BL/6 * DBA/2)	abnormal immunoglobulin level	J:96759
Tg(Umod*C147W)958Lura/0 (involves: FVB)	kidney inflammation	J:161532
Tg(Vav1-Lin28b)C3Apla/0 (involves: C57BL/6)	abnormal cytokine level	J:189197
	abnormal inflammatory response	J:189197
	increased IgG level	J:189197
	increased T cell proliferation	J:189197
Tg(Vav1-STAT5BN642H)726Biat/0 (C57BL/6NCrl-Tg(Vav1-STAT5BN642H)726Biat)	increased T cell proliferation	J:257519
Tg(Vav-BCL2)69Jad/0 (involves: C57BL/6J)	abnormal class switch recombination	J:88565
	abnormal somatic hypermutation frequency	J:88565
	glomerulonephritis	J:88565
Tg(Vil1-cre)997Gum/? Tlr4^lps-del/Tlr4^lps-del Tlr5^tm1.1Gewr/Tlr5^tm1.1Gewr (involves: C57BL/6J * C57BL/6NTac * C57BL/10ScN * SJL)	large intestinal inflammation	J:229155
Tg(Vil1-cre)997Gum/? Tlr5^tm1.1Gewr/Tlr5^tm1.1Gewr (involves: C57BL/6J * C57BL/6NTac * SJL/J)	increased interleukin-1 beta secretion	J:229155
	increased susceptibility to colitis induced morbidity/mortality	J:229155
	large intestinal inflammation	J:229155
Tg(Vil1-cre)997Gum/0 Tnfrsf11a^tm1.1Irw/Tnfrsf11a^tm1.1Irw (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * SJL)	decreased IgA level	J:226603
Tg(Vil-SLC3A2)HEMerl/0 (involves: FVB/N)	colitis	J:173946
	increased circulating tumor necrosis factor level	J:173946
	increased susceptibility to induced colitis	J:173946
Tg(VIM-Tag)3Pau/0 (either: (involves: C57BL/6 * CBA * SJL/J) or (involves: C57BL/6 * SJL/J))	glomerulonephritis	J:92226
Tg^m3Btlr/Tg^m3Btlr (C57BL/6J-Tg^m3Btlr)	decreased IgE level	J:265197
Tg^m3Btlr/Tg^m3Btlr (C57BL/6J-Tg^m3Btlr)	increased susceptibility to induced colitis	J:265197
Tg^m4Btlr/Tg^m4Btlr (C57BL/6J-Tg^m4Btlr)	increased IgE level	J:272522
Tgfa^tm1Ard/Tgfa^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	increased incidence of corneal inflammation	J:4606
Tgfa^wa1/Tgfa^wa1 (Not Specified)	conjunctivitis	J:13115
Tgfa^wa1/Tgfa^wa1 (Not Specified)	keratoconjunctivitis	J:13115
Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * CF-1)	abnormal inflammatory response	J:2892
	brain inflammation	J:2892
	conjunctivitis	J:2892
	diaphragmitis	J:2892
	eye inflammation	J:2892
	heart inflammation	J:2892
	lacrimal gland inflammation	J:2892
	liver inflammation	J:2892
	lung inflammation	J:2892
	myositis	J:2892
	pancreas inflammation	J:2892
	salivary gland inflammation	J:2892
	skin inflammation	J:2892
	stomach inflammation	J:2892
Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * BALB/c * CF-1)	heart inflammation	J:69346
	increased interferon-gamma secretion	J:69346
	liver inflammation	J:69346
	lung inflammation	J:69346
Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.129S2-Tgfb1^tm1Doe)	heart inflammation	J:69346
	increased interferon-gamma secretion	J:69346
	liver inflammation	J:69346
Tgfb1^tm1Doe/Tgfb1^tm2.1Doe Tg(Lck-cre)548Jxm/? (involves: 129S2/SvPas * 129S6/SvEvTac * Black Swiss * BALB/c * C57BL/6 * CBA)	lung inflammation	J:150024
	salivary gland inflammation	J:150024
Tgfb1^tm1Jmu/Tgfb1^tm1Jmu (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune system physiology	J:120085
	heart inflammation	J:120085
	liver inflammation	J:120085
	lung inflammation	J:120085
	pancreas inflammation	J:120085
	stomach inflammation	J:120085
Tgfb1^tm1Jmu/Tgfb1^tm1Jmu (involves: 129S6/SvEvTac * C57BL/6 * Swiss Webster)	abnormal immune system physiology	J:120085
Tgfb1^tm1N/Tgfb1^tm1N (involves: 129S/SvEv)	abnormal immune system physiology	J:120085
	atrial endocarditis	J:50848
	increased inflammatory response	J:50848
	interstitial pneumonia	J:50848
	lymph node inflammation	J:50848
	myocarditis	J:50848
	pancreas inflammation	J:50848
	pericarditis	J:50848
	phlebitis	J:50848
	salivary gland inflammation	J:50848
Tgfb1^tm1Rif/Tgfb1^tm1Rif (Not Specified)	abnormal immune system physiology	J:141786
Tgfb1^tm1Rif/Tgfb1^tm1Rif (either: (involves: 129) or (involves: 129S/SvEv * C57BL/6))	cecum inflammation	J:142353
	heart inflammation	J:142353
	increased inflammatory response	J:142353
	large intestinal inflammation	J:142353
	lung inflammation	J:142353
	proctitis	J:142353
	small intestinal inflammation	J:142353
	stomach inflammation	J:142353
Tgfb1^tm3.1Flv/Tgfb1^tm3.1Flv Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)	increased susceptibility to autoimmune diabetes	J:196160
Tgfb2^tm1Doe/Tgfb2^tm1Doe (involves: 129P2/OlaHsd * Black Swiss)	abnormal macrophage physiology	J:73681
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell activation	J:148747
	autoimmune response	J:148747
	liver inflammation	J:148747
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD)	increased inflammatory response	J:196160
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)	abnormal immune serum protein physiology	J:196160
	abnormal immune system physiology	J:196160
	abnormal interleukin secretion	J:196160
	decreased interleukin-9 secretion	J:196160
	decreased interleukin-17 secretion	J:196160
	increased interferon-gamma secretion	J:196160
	increased interleukin-2 secretion	J:196160
	increased interleukin-21 secretion	J:196160
	increased susceptibility to autoimmune diabetes	J:196160
	pancreas inflammation	J:196160
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129 * C57BL/6 * NOD * SJL)	increased susceptibility to autoimmune diabetes	J:196160
Tgfbr2^tm1Karl/Tgfbr2^tm1Karl Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	eye inflammation	J:77844
	increased inflammatory response	J:77844
	liver inflammation	J:77844
	pancreas inflammation	J:77844
	stomach inflammation	J:77844
Tgif1^tm1.1Caw/Tgif1^tm1.1Caw (B6.129S-Tgif1^tm1.1Caw)	abnormal cytokine level	J:198238
Tgif1^tm1.1Caw/Tgif1^tm1.1Caw (B6.129S-Tgif1^tm1.1Caw)	increased susceptibility to otitis media	J:198238
Tgm2^tm1.1Rmgr/Tgm2^tm1.1Rmgr (involves: 129S1/SvImJ * C57BL/6)	abnormal T cell physiology	J:95130
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6)	decreased susceptibility to endotoxin shock	J:131975
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	impaired macrophage phagocytosis	J:132254
Tgm6^em1Bge/Tgm6^em1Bge (C57BL/6N-Tgm6^em1Bge)	increased susceptibility to bacterial infection	J:268324
TgTn(pb-CAG-Gm614)#Cya/0 (involves: C57BL/6)	decreased B cell apoptosis	J:307345
TgTn(pb-CAG-Gm614)#Cya/0 (involves: C57BL/6)	increased susceptibility to systemic lupus erythematosus	J:307345
TgTn(pb-CAG-Gm40600)#Rew/0 (C57BL/6-TgTn(pb-CAG-Gm40600)#Rew)	decreased IgA level	J:311878
	decreased IgE level	J:311878
	decreased IgG1 level	J:311878
	decreased IgG2b level	J:311878
	decreased IgG2c level	J:311878
	decreased IgG3 level	J:311878
	decreased IgG level	J:311878
	decreased IgM level	J:311878
	increased IgA level	J:311878
	increased IgE level	J:311878
	increased IgG1 level	J:311878
	increased IgG2b level	J:311878
	increased IgG2c level	J:311878
	increased IgG3 level	J:311878
	increased IgG level	J:311878
	increased IgM level	J:311878
Thbd^tm1.1Hlwu/Thbd^tm1.1Hlwu Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129-Thbd^tm1.1Hlwu Lyz2^tm1(cre)Ifo)	decreased circulating interleukin-6 level	J:188879
	decreased circulating tumor necrosis factor level	J:188879
	decreased susceptibility to bacterial infection	J:188879
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:188879
	decreased tumor necrosis factor secretion	J:188879
Thbd^tm1Wlr/Thbd^tm1Wlr (B6.129S2-Thbd^tm1Wlr)	decreased circulating tumor necrosis factor level	J:111502
	increased circulating interleukin-1 beta level	J:111502
	increased circulating interleukin-6 level	J:111502
	increased susceptibility to endotoxin shock	J:111502
Thbd^tm2.1Emc/Thbd^tm2.1Emc (involves: 129/Sv * BALB/c * C57BL/6)	abnormal leukocyte adhesion	J:118000
	abnormal leukocyte physiology	J:118000
	increased circulating interleukin-1 beta level	J:118000
	increased circulating tumor necrosis factor level	J:118000
	increased susceptibility to endotoxin shock	J:118000
Thbd^tm2Emc/Thbd^tm2Emc (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal leukocyte physiology	J:118000
Thbs1^tm1Hyn/Thbs1^tm1Hyn (either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))	lung inflammation	J:46182, J:48446
	pancreas inflammation	J:48446
Thbs1^tm1Hyn/Thbs1^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	decreased interferon-gamma secretion	J:153126
	increased anti-single stranded DNA antibody level	J:153126
	increased interleukin-17 secretion	J:153126
	lacrimal gland inflammation	J:153126
Thbs1^tm1Hyn/Thbs1^tm1Hyn Thbs2^tm1Bst/Thbs2^tm1Bst (involves: 129T2/SvEms * 129X1/SvJ)	impaired macrophage chemotaxis	J:78876
	lung inflammation	J:78876
Thcr^BALB/cJ/? (involves: BALB/cJ * C57BL/10J * DBA/2J)	decreased interferon-gamma secretion	J:86188
Thcr^BALB/cJ/? (involves: BALB/cJ * C57BL/10J * DBA/2J)	increased interleukin-4 secretion	J:86188
Thcr^C57BL/10Sn/? (involves: BALB/cJ * C57BL/10J * DBA/2J)	decreased interleukin-4 secretion	J:86188
Thcr^C57BL/10Sn/? (involves: BALB/cJ * C57BL/10J * DBA/2J)	increased interferon-gamma secretion	J:86188
Themis^m1Btlr/Themis^m1Btlr (C57BL/6J-Themis^m1Btlr)	impaired humoral immune response	J:211400
Themis^tm1Gasc/Themis^tm1Gasc (B6.129S-Themis^tm1Gasc)	decreased T cell proliferation	J:151074
Themis^tm1Hasu/Themis^tm1Hasu (involves: C57BL/6 * CBA)	increased T cell proliferation	J:153235
thnh/thnh (NOD.Cg-H2^b thnh/J)	folliculitis	J:142872
Thop1^{Gt(CSG163)Byg}/Thop1^{Gt(CSG163)Byg} (B6.129P2-Thop1^{Gt(CSG163)Byg})	decreased susceptibility to infection	J:290567
	decreased susceptibility to infection induced morbidity/mortality	J:290567
	increased susceptibility to experimental autoimmune encephalomyelitis	J:290567
Thra^tm1Syc/Thra⁺ (involves: 129S6/SvEvTac * C57BL/6J * NIH Black Swiss)	abnormal osteoclast physiology	J:217018
Thra^tm2Jas/Thra^tm2Jas (involves: 129)	abnormal osteoclast physiology	J:120899
Thra^tm2Ven/Thra^tm2Ven (involves: 129P2/OlaHsd * BALB/c)	abnormal osteoclast physiology	J:72959
Thrb^tm1Olc/Thrb^tm1Olc (involves: 129)	abnormal osteoclast physiology	J:120899
Thypr1^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased T cell proliferation	J:76931
Thypr2^DBA/2J/? (involves: C57BL/6J * DBA/2J)	increased T cell proliferation	J:76931
Tia1^tm1Andp/Tia1^tm1Andp (C.129S2-Tia1^tm1Andp)	abnormal macrophage physiology	J:88770
Tia1^tm1Andp/Tia1^tm1Andp (C.129S2-Tia1^tm1Andp)	increased susceptibility to endotoxin shock	J:88770
Tia1^tm1Andp/Tia1^tm1Andp (B6.Cg-Tia1^tm1Andp)	arthritis	J:88443
Tia1^tm1Andp/Tia1^tm1Andp Zfp36^tm1Pjb/Zfp36^tm1Pjb (B6.Cg-Tia1^tm1Andp Zfp36^tm1Pjb)	abnormal macrophage physiology	J:88443
	arthritis	J:88443
Ticam1^Lps2/Ticam1^Lps2 (involves: C57BL/6)	abnormal cytokine secretion	J:110201
	abnormal macrophage physiology	J:84896
	decreased circulating tumor necrosis factor level	J:86521
	decreased macrophage apoptosis	J:84896, J:92674
	decreased macrophage cytokine production	J:84896
	decreased macrophage nitric oxide production	J:84896
	decreased susceptibility to bacterial infection	J:86521, J:92674
	decreased susceptibility to endotoxin shock	J:84896
	decreased tumor necrosis factor secretion	J:84896
	increased susceptibility to Herpesvirales infection	J:84896
Ticam1^Lps2/Ticam1^Lps2 (C57BL/6J-Ticam1^Lps2)	abnormal circulating tumor necrosis factor level	J:138963
	abnormal cytokine secretion	J:167340
	decreased interleukin-6 secretion	J:167340
	decreased susceptibility to induced colitis	J:167340
Ticam1^Lps2/Ticam1^Lps2 (C57BL/6J-Ticam1^Lps2/J)	abnormal chemokine level	J:288471
	increased interferon-beta secretion	J:288471
	increased susceptibility to Coronaviridae infection	J:288471
	increased susceptibility to Coronaviridae infection induced morbidity/mortality	J:288471
Ticam1^Lps2/Ticam1^Lps2 Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:84896
	decreased tumor necrosis factor secretion	J:84896
Ticam1^M2Btlr/Ticam1⁺ (C57BL/6J-Ticam1^M2Btlr)	abnormal cytokine secretion	J:234240
	abnormal macrophage physiology	J:234240
	decreased macrophage cytokine production	J:234240
	decreased tumor necrosis factor secretion	J:234240
Ticam1^M2Btlr/Ticam1^M2Btlr (C57BL/6J-Ticam1^M2Btlr)	abnormal cytokine secretion	J:234240
	abnormal macrophage physiology	J:234240
	decreased macrophage cytokine production	J:234240
	decreased tumor necrosis factor secretion	J:234240
Ticam1^M3Btlr/Ticam1⁺ (C57BL/6J-Ticam1^M3Btlr)	decreased tumor necrosis factor secretion	J:255300
Ticam1^M3Btlr/Ticam1^M3Btlr (C57BL/6J-Ticam1^M3Btlr)	decreased tumor necrosis factor secretion	J:255300
Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd)	abnormal B cell activation	J:174941
	abnormal B cell physiology	J:84679
	abnormal cytokine level	J:174941
	abnormal cytokine secretion	J:84679
	abnormal dendritic cell physiology	J:174941
	abnormal interleukin level	J:137522
	abnormal macrophage physiology	J:174941, J:84679
	abnormal microglial cell physiology	J:185198
	abnormal NK cell physiology	J:174941
	abnormal NK T cell physiology	J:174941
	decreased circulating interleukin-6 level	J:145306
	decreased splenocyte proliferation	J:84679
	decreased susceptibility to endotoxin shock	J:84679
	decreased susceptibility to Orthomyxoviridae infection	J:145306
	impaired macrophage phagocytosis	J:185198
Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine level	J:169158
	abnormal susceptibility to Poxviridae infection	J:162716
	decreased circulating interferon-gamma level	J:130954
	decreased circulating interleukin-6 level	J:130954
	decreased circulating interleukin-12b level	J:130954
	decreased IgG2a level	J:130954
	decreased IgG level	J:130954
	decreased interferon-beta secretion	J:130954
	decreased interleukin-12b secretion	J:130954
	decreased susceptibility to type I hypersensitivity reaction	J:161445
	increased susceptibility to Picornaviridae infection	J:169158
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:169158
	myocarditis	J:169158
Ticam1^tm1Aki/Ticam1^tm1Aki (B6.129P2-Ticam1^tm1Aki)	abnormal cytokine level	J:144301
	abnormal response to infection	J:144301
	decreased circulating tumor necrosis factor level	J:144301
	decreased macrophage cytokine production	J:144301
	impaired neutrophil recruitment	J:144301
	increased susceptibility to bacterial infection	J:144301
Ticam1^tm1Tsse/Ticam1^tm1Tsse (B6.129-Ticam1^tm1Tsse)	impaired natural killer cell mediated cytotoxicity	J:118750
Ticam1^tm1Tsse/Ticam1^tm1Tsse Tg(PVR)1Kkst/0 (involves: 129 * C57BL/6 * ICR)	abnormal interferon-alpha secretion	J:179625
	increased susceptibility to Picornaviridae infection	J:179625
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:179625
Ticam2^M1Btlr/Ticam2⁺ (C57BL/6J-Ticam2^M1Btlr)	decreased tumor necrosis factor secretion	J:215010
Ticam2^M1Btlr/Ticam2^M1Btlr (C57BL/6J-Ticam2^M1Btlr)	decreased tumor necrosis factor secretion	J:215010
Ticam2^M2Btlr/Ticam2⁺ (C57BL/6J-Ticam2^M2Btlr)	decreased interleukin-1 beta secretion	J:254908
Ticam2^M2Btlr/Ticam2^M2Btlr (C57BL/6J-Ticam2^M2Btlr)	decreased interleukin-1 beta secretion	J:254908
Ticam2^M3Btlr/Ticam2⁺ (C57BL/6J-Ticam2^M3Btlr)	decreased tumor necrosis factor secretion	J:254912
Ticam2^M3Btlr/Ticam2^M3Btlr (C57BL/6J-Ticam2^M3Btlr)	decreased tumor necrosis factor secretion	J:254912
Ticam2^tm1Aki/Ticam2^tm1Aki (involves: C57BL/6)	abnormal immune system physiology	J:86256
	decreased interleukin-6 secretion	J:86256
	increased susceptibility to Coronaviridae infection	J:270045
Ticam2^tm1Btlr/Ticam2^tm1Btlr (C57BL/6J-Ticam2^tm1Btlr)	abnormal interferon secretion	J:133619
Ticam2^tm1Btlr/Ticam2^tm1Btlr (C57BL/6J-Ticam2^tm1Btlr)	decreased tumor necrosis factor secretion	J:133619
Tie1^tm1Scba/Tie1^tm1Scba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymph circulation	J:158668
Tigar^{Gt(EUCE0047g05)Hmgu}/Tigar^{Gt(EUCE0047g05)Hmgu} (involves: 129P2/OlaHsd)	increased susceptibility to induced colitis	J:198650
Tigar^tm1.1Khv/Tigar^tm1.1Khv Tg(CMV-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL)	increased susceptibility to induced colitis	J:198650
Tigit^tm1Sdl/Tigit^tm1Sdl (involves: C57BL/6)	abnormal professional antigen presenting cell physiology	J:168902
	decreased interleukin-10 secretion	J:168902
	increased susceptibility to experimental autoimmune encephalomyelitis	J:168902
	increased T cell proliferation	J:168902
Tigit^tm1Sdl/Tigit^tm1Sdl Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6)	decreased interleukin-10 secretion	J:168902
	increased susceptibility to experimental autoimmune encephalomyelitis	J:168902
Timd2^{tm1(GAL4)Pdre}/Timd2^{tm1(GAL4)Pdre} (C.129S4-Timd2^{tm1(GAL4)Pdre})	abnormal inflammatory response	J:125054
	abnormal interleukin secretion	J:125054
	increased interferon-gamma secretion	J:125054
	increased tumor necrosis factor secretion	J:125054
Timd4^tm1Kuch/Timd4^tm1Kuch (C57BL/6-Timd4^tm1Kuch)	abnormal B cell physiology	J:160747
	abnormal macrophage physiology	J:160747
	increased anti-double stranded DNA antibody level	J:160747
	increased IgA level	J:160747
	increased IgG2a level	J:160747
	increased IgG2b level	J:160747
	increased interferon-gamma secretion	J:160747
	increased interleukin-17 secretion	J:160747
	increased splenocyte proliferation	J:160747
Timd4^tm1Kuch/Timd4^tm1Kuch (involves: C57BL/6)	abnormal circulating chemokine level	J:235399
	decreased circulating interleukin-10 level	J:235399
	increased anti-double stranded DNA antibody level	J:235399
	increased circulating interleukin-1 beta level	J:235399
	increased circulating interleukin-6 level	J:235399
	increased circulating interleukin-12b level	J:235399
	increased susceptibility to systemic lupus erythematosus	J:235399
Timd4^tm1Osa/Timd4^tm1Osa (involves: C57BL/6)	impaired macrophage phagocytosis	J:187181
Timd4^tm1Wouy/Timd4^tm1Wouy (involves: 129)	abnormal macrophage physiology	J:160304
	decreased tumor necrosis factor secretion	J:160304
	impaired macrophage phagocytosis	J:160304
	increased IgG2a level	J:160304
	increased tumor necrosis factor secretion	J:160304
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae)	decreased susceptibility to bacterial infection	J:94836
Timp1^tm1Pds/Timp1^tm1Pds (involves: C57BL/6)	decreased susceptibility to bacterial infection	J:94836
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae * C57BL/6)	lung inflammation	J:112941
Timp3^tm1Osya/Timp3^tm1Osya (B6.129P2-Timp3^tm1Osya)	aortitis	J:193744
Timp3^tm1Rkho/Timp3^tm1Rkho (B6.129-Timp3^tm1Rkho)	increased tumor necrosis factor secretion	J:92948
Timp3^tm1Rkho/Timp3^tm1Rkho (B6.129-Timp3^tm1Rkho)	liver inflammation	J:92948
Tinf2^tm2.2Tdl/Tinf2⁺ (involves: BALB/cJ * C57BL/6)	dermatitis	J:207367
Tiparp^{Gt(ROSA)79Sor}/Tiparp^{Gt(ROSA)79Sor} (involves: 129S4/SvJaeSor)	kidney inflammation	J:117491
Tiparp^{Gt(ROSA)79Sor}/Tiparp^{Gt(ROSA)79Sor} (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J)	abnormal thymus involution	J:250417
Tir2^BALB/cOlaHsd/Tir2^{C57BL/6JOlaHsd} (involves: BALB/cOlaHsd * C57BL/6JOlaHsd)	abnormal immune serum protein physiology	J:40771
Tir2^{C57BL/6JOlaHsd}/Tir2^{C57BL/6JOlaHsd} (involves: A/JOlaHsd * C57BL/6JOlaHsd)	decreased susceptibility to parasitic infection	J:40771
Tir2^{C57BL/6JOlaHsd}/Tir2^{C57BL/6JOlaHsd} (involves: BALB/cOlaHsd * C57BL/6JOlaHsd)	decreased susceptibility to parasitic infection	J:40771
Tir2^{C57BL/6JOlaHsd}/Tir2^{C57BL/6JOlaHsd} (A.B6-Tir2)	decreased susceptibility to parasitic infection	J:97672
Tir2^{C57BL/6JOlaHsd}/Tir2^{C57BL/6JOlaHsd} (A.B6-(D5Mit200-D5Mit10))	decreased susceptibility to parasitic infection	J:135428
Tir3^BALB/cOlaHsd/Tir3^{C57BL/6JOlaHsd} (involves: BALB/cOlaHsd * C57BL/6JOlaHsd)	decreased susceptibility to parasitic infection	J:40771
Tir3^{C57BL/6JOlaHsd}/Tir3^{C57BL/6JOlaHsd} (involves: BALB/cOlaHsd * C57BL/6JOlaHsd)	decreased susceptibility to parasitic infection	J:40771
Tir3^{C57BL/6JOlaHsd}/Tir3^{C57BL/6JOlaHsd} (A.B6-Tir3)	decreased susceptibility to parasitic infection	J:97672
Tir3^{C57BL/6JOlaHsd}/Tir3^{C57BL/6JOlaHsd} (A.B6-(D1Mit60-D1Mit217))	decreased susceptibility to parasitic infection	J:135428
Tir4^{C57BL/6JOlaHsd}/? (involves: BALB/cOlaHsd * C57BL/6JOlaHsd)	decreased susceptibility to parasitic infection	J:40771
Tir4^{C57BL/6JOlaHsd}/Tir4^{C57BL/6JOlaHsd} (involves: A/JOlaHsd * C57BL/6JOlaHsd)	decreased susceptibility to parasitic infection	J:40771
Tir4^{C57BL/6JOlaHsd}/Tir4^{C57BL/6JOlaHsd} (involves: BALB/cOlaHsd * C57BL/6JOlaHsd)	decreased susceptibility to parasitic infection	J:40771
Tir4^{C57BL/6JOlaHsd}/Tir4^{C57BL/6JOlaHsd} (A.B6-Tir1)	decreased susceptibility to parasitic infection	J:97672
Tir4^{C57BL/6JOlaHsd}/Tir4^{C57BL/6JOlaHsd} (A.B6-(D17Mit29-D17Mit11))	decreased susceptibility to parasitic infection	J:135428
Tir9^C57BL/6/Tir9^C57BL/6 (involves: C57BL/6 * DBA/2)	increased susceptibility to parasitic infection	J:84716
Tir10^C57BL/6/Tir10^C57BL/6 (involves: C57BL/6 * DBA/2)	increased susceptibility to parasitic infection	J:84716
Tirap^m1Btlr/Tirap^m1Btlr (C57BL/6J-Tirap^m1Btlr)	abnormal interferon secretion	J:133618
Tirap^m1Btlr/Tirap^m1Btlr (C57BL/6J-Tirap^m1Btlr)	decreased tumor necrosis factor secretion	J:133618
Tirap^tm1Aki/Tirap^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:111205
	abnormal level of surface class II molecules	J:111205
	decreased IgG3 level	J:137066
Tirap^tm1Aki/Tirap^tm1Aki (B6.129P2-Tirap^tm1Aki)	abnormal dendritic cell physiology	J:118954
	decreased interleukin-6 secretion	J:118954
	decreased interleukin-12b secretion	J:118954
Tirap^tm1Medz/Tirap^tm1Medz (involves: 129S1/Sv * C57BL/6)	abnormal dendritic cell physiology	J:96773
	abnormal macrophage physiology	J:96773
	decreased B cell proliferation	J:96773
Tirap^tm1Medz/Tirap^tm1Medz (involves: 129S1/Sv)	abnormal macrophage physiology	J:96018
Tirap^tm1Medz/Tirap^tm1Medz (involves: 129S1/Sv)	increased susceptibility to bacterial infection	J:96018
Tk1^tm1Vnd/Tk1^tm1Vnd (involves: 129P2/OlaHsd * C57BL/6)	arteritis	J:101669
	liver inflammation	J:101669
	lung inflammation	J:101669
	thyroid gland inflammation	J:101669
Tktl1^tm1Arte/Tktl1^tm1Arte (C57BL/6-Tktl1^tm1Arte)	increased susceptibility to induced colitis	J:171154
Tle4^tm1.2Dasw/Tle4^tm1.2Dasw (B6.129S6(Cg)-Tle4^tm1.2Dasw)	increased thymocyte apoptosis	J:219243
Tlr1^tm1Aki/Tlr1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:103395
	decreased interleukin-6 secretion	J:103395
	decreased tumor necrosis factor secretion	J:103395
Tlr1^tm1Flv/Tlr1^tm1Flv (involves: 129S1/Sv)	abnormal macrophage physiology	J:95726
	decreased immunoglobulin level	J:95726
	increased susceptibility to bacterial infection	J:95726
Tlr2^lngd/Tlr2^lngd (C57BL/6J-Tlr2^lngd)	abnormal macrophage physiology	J:94077
Tlr2^lngd/Tlr2^lngd (C57BL/6J-Tlr2^lngd)	increased susceptibility to bacterial infection	J:94077
Tlr2^tm1Aki/Tlr2^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal chemokine level	J:88174
	abnormal macrophage physiology	J:76115, J:95726
	abnormal tumor necrosis factor level	J:124334
	decreased immunoglobulin level	J:95726
	decreased interleukin-6 secretion	J:76115, J:88174
	decreased microglial cell activation	J:122551
	decreased susceptibility to Herpesvirales infection	J:88174
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:88174
	decreased tumor necrosis factor secretion	J:76115
	increased susceptibility to bacterial infection	J:95726
Tlr2^tm1Aki/Tlr2^tm1Aki (B6.129P2-Tlr2^tm1Aki)	abnormal dendritic cell physiology	J:118954
	abnormal interleukin level	J:118954
	decreased interleukin-6 secretion	J:118954
	decreased interleukin-12b secretion	J:118954
	decreased susceptibility to parasitic infection	J:116763
Tlr2^tm1Aki/Tlr2^tm1Aki (involves: 129P2/OlaHsd)	abnormal cytokine secretion	J:70578
	abnormal leukocyte migration	J:171379
	abnormal macrophage physiology	J:103464, J:130138, J:70578
	abnormal osteoclast physiology	J:130138
	decreased circulating interleukin-1 beta level	J:119941
	decreased circulating tumor necrosis factor level	J:119941
	decreased inflammatory response	J:146111
	decreased interleukin-6 secretion	J:70578
	decreased interleukin-12 secretion	J:70578
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:146111
	decreased tumor necrosis factor secretion	J:103395, J:70578
	increased B cell apoptosis	J:135830
Tlr2^tm1Aki/Tlr2^tm1Aki (NOD.129P2-Tlr2^tm1Aki)	insulitis	J:124334
Tlr2^tm1Aki/Tlr2^tm1Aki Tlr4^tm1Aki/Tlr4^tm1Aki (B6.129P2-Tlr2^tm1Aki Tlr4^tm1Aki)	abnormal chemokine secretion	J:102879
Tlr2^tm1Aki/Tlr2^tm1Aki Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:117688
	abnormal macrophage physiology	J:117688
	decreased IgG3 level	J:117688
Tlr2^tm1Aki/Tlr2^tm1Aki Tlr6^tm1Aki/Tlr6^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased interleukin-6 secretion	J:70578
Tlr2^tm1Kir/Tlr2^tm1Kir (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * C57BL/6J))	abnormal innate immunity	J:85323
	abnormal macrophage physiology	J:85323
	decreased interleukin-6 secretion	J:85323
	decreased interleukin-10 secretion	J:85323
	decreased macrophage cytokine production	J:85323
	decreased macrophage nitric oxide production	J:85323
	increased susceptibility to bacterial infection	J:85323
Tlr2^tm1Kir/Tlr2^tm1Kir (Not Specified)	abnormal macrophage physiology	J:96018
Tlr2^tm1Kir/Tlr2^tm1Kir (Not Specified)	increased susceptibility to bacterial infection	J:96018
Tlr2^tm1Kir/Tlr2^tm1Kir (B6.129-Tlr2^tm1Kir)	abnormal cellular extravasation	J:171028
	abnormal cytokine secretion	J:121930
	decreased circulating tumor necrosis factor level	J:162168
	decreased interleukin-1 beta secretion	J:129871
	decreased interleukin-6 secretion	J:129871
	decreased splenocyte proliferation	J:121930
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:121930
	decreased tumor necrosis factor secretion	J:129871
	increased susceptibility to induced colitis	J:165105
Tlr2^tm1Kir/Tlr2^tm1Kir (involves: 129)	abnormal interleukin secretion	J:94463
	decreased interleukin-1 secretion	J:94463
	decreased interleukin-6 secretion	J:94463
	decreased tumor necrosis factor secretion	J:94463
	increased susceptibility to bacterial infection induced morbidity/mortality	J:147177
Tlr2^tm1Kir/Tlr2^tm1Kir Tlr4^Lps-d/Tlr4^Lps-d (C3.Cg-Tlr2^tm1Kir Tlr4^Lps-d)	abnormal macrophage physiology	J:121930
Tlr3^M1Btlr/Tlr3⁺ (C57BL/6J-Tlr3^M1Btlr)	decreased macrophage cytokine production	J:224670
Tlr3^M1Btlr/Tlr3⁺ (C57BL/6J-Tlr3^M1Btlr)	decreased tumor necrosis factor secretion	J:224670
Tlr3^M1Btlr/Tlr3^M1Btlr (C57BL/6J-Tlr3^M1Btlr)	decreased macrophage cytokine production	J:224670
Tlr3^M1Btlr/Tlr3^M1Btlr (C57BL/6J-Tlr3^M1Btlr)	decreased tumor necrosis factor secretion	J:224670
Tlr3^M2Btlr/Tlr3⁺ (C57BL/6J-Tlr3^M2Btlr)	decreased tumor necrosis factor secretion	J:254925
Tlr3^M2Btlr/Tlr3^M2Btlr (C57BL/6J-Tlr3^M2Btlr)	decreased tumor necrosis factor secretion	J:254925
Tlr3^tm1Aki/Tlr3^tm1Aki (involves: 129P2/OlaHsd)	abnormal dendritic cell physiology	J:114555
Tlr3^tm1Aki/Tlr3^tm1Aki Tlr7^tm1Aki/Tlr7^tm1Aki (involves: 129P2/OlaHsd)	decreased interferon-alpha secretion	J:144400
Tlr3^tm1Flv/Tlr3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal B cell physiology	J:72167
	abnormal macrophage physiology	J:72167
	decreased inflammatory response	J:72167
Tlr3^tm1Flv/Tlr3^tm1Flv (involves: C57BL/6)	abnormal macrophage physiology	J:86617
Tlr3^tm1Flv/Tlr3^tm1Flv (Not Specified)	abnormal cytokine secretion	J:88906
	abnormal NK cell physiology	J:88906
	abnormal NK T cell physiology	J:88906
	increased susceptibility to Herpesvirales infection	J:88906
Tlr3^tm1Flv/Tlr3^tm1Flv (involves: 129S1/Sv)	abnormal cytokine level	J:119967
	abnormal interferon level	J:119967
	abnormal interleukin level	J:119967
	abnormal tumor necrosis factor level	J:119967
	decreased susceptibility to Riboviria infection	J:136330
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:136330
	heart inflammation	J:119967
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:119967
Tlr3^tm1Flv/Tlr3^tm1Flv (B6.129S1-Tlr3^tm1Flv/Apb)	abnormal cytokine level	J:129533
	abnormal interleukin level	J:126415
	decreased interferon-beta secretion	J:251008
Tlr3^tm1Flv/Tlr3^tm1Flv (B6N.129S1-Tlr3^tm1Flv/J)	increased susceptibility to Coronaviridae infection	J:288471
Tlr4^Lps-2Btlr/? (C57BL/6J-Tlr4^Lps-2Btlr)	decreased tumor necrosis factor secretion	J:147339
Tlr4^Lps-2Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-2Btlr)	decreased interleukin-1 beta secretion	J:147339
Tlr4^lps-2J/Tlr4^lps-2J (BXD29-Tlr4^lps-2J/J)	abnormal inflammatory response	J:107391
Tlr4^Lps-3Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-3Btlr)	decreased interferon-beta secretion	J:217295
Tlr4^Lps-3Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-3Btlr)	decreased tumor necrosis factor secretion	J:217295
Tlr4^Lps-3Btlr/Tlr4^Lps-3Btlr (C57BL/6J-Tlr4^Lps-3Btlr)	decreased interferon-beta secretion	J:217295
Tlr4^Lps-3Btlr/Tlr4^Lps-3Btlr (C57BL/6J-Tlr4^Lps-3Btlr)	decreased tumor necrosis factor secretion	J:217295
Tlr4^lps-4Btlr/Tlr4⁺ (C57BL/6J-Tlr4^lps-4Btlr)	decreased macrophage cytokine production	J:224664
Tlr4^lps-4Btlr/Tlr4⁺ (C57BL/6J-Tlr4^lps-4Btlr)	decreased tumor necrosis factor secretion	J:224664
Tlr4^lps-4Btlr/Tlr4^lps-4Btlr (C57BL/6J-Tlr4^lps-4Btlr)	decreased macrophage apoptosis	J:224664
	decreased macrophage cytokine production	J:224664
	decreased tumor necrosis factor secretion	J:224664
Tlr4^lps-5Btlr/Tlr4^lps-5Btlr (C57BL/6J-Tlr4^lps-5Btlr)	decreased macrophage cytokine production	J:224666
Tlr4^lps-5Btlr/Tlr4^lps-5Btlr (C57BL/6J-Tlr4^lps-5Btlr)	decreased tumor necrosis factor secretion	J:224666
Tlr4^Lps-6Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-6Btlr)	decreased macrophage cytokine production	J:224667
Tlr4^Lps-6Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-6Btlr)	decreased tumor necrosis factor secretion	J:224667
Tlr4^Lps-6Btlr/Tlr4^Lps-6Btlr (C57BL/6J-Tlr4^Lps-6Btlr)	decreased macrophage cytokine production	J:224667
Tlr4^Lps-6Btlr/Tlr4^Lps-6Btlr (C57BL/6J-Tlr4^Lps-6Btlr)	decreased tumor necrosis factor secretion	J:224667
Tlr4^lps-7Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-7Btlr)	decreased interleukin-1 beta secretion	J:234239
	decreased macrophage cytokine production	J:234239
	decreased tumor necrosis factor secretion	J:234239
Tlr4^lps-7Btlr/Tlr4^lps-7Btlr (C57BL/6J-Tlr4^Lps-7Btlr)	decreased interleukin-1 beta secretion	J:234239
	decreased macrophage cytokine production	J:234239
	decreased tumor necrosis factor secretion	J:234239
Tlr4^Lps-8Btlr/Tlr4⁺ (C57BL/6J-Tlr4^Lps-8Btlr)	decreased interleukin-1 beta secretion	J:234241
	decreased macrophage cytokine production	J:234241
	decreased tumor necrosis factor secretion	J:234241
Tlr4^Lps-8Btlr/Tlr4^Lps-8Btlr (C57BL/6J-Tlr4^Lps-8Btlr)	decreased interleukin-1 beta secretion	J:234241
	decreased macrophage cytokine production	J:234241
	decreased tumor necrosis factor secretion	J:234241
Tlr4^lps-Btlr/Tlr4^lps-Btlr (C57BL/6J-Tlr4^lps-Btlr)	abnormal macrophage physiology	J:128416
Tlr4^Lps-d/Tlr4^Lps-d (involves: C3H/HeJ)	abnormal T-helper 2 physiology	J:96356
	abnormal tumor necrosis factor level	J:124334, J:114368
	increased susceptibility to bacterial infection	J:5721, J:51522, J:87807
	increased susceptibility to induced arthritis	J:96356
Tlr4^Lps-d/Tlr4^Lps-d (C3H/HeJ-Tlr4^Lps-d)	abnormal cytokine level	J:96680
	abnormal interleukin level	J:96680
	abnormal macrophage chemotaxis	J:122597
	abnormal microglial cell physiology	J:99051
	abnormal susceptibility to infection	J:162716
	abnormal tumor necrosis factor level	J:96680
	increased circulating interleukin-6 level	J:37271
	increased susceptibility to Poxviridae infection induced morbidity/mortality	J:162716
	liver inflammation	J:135830
	lung inflammation	J:96680
Tlr4^lps-del/Tlr4^lps-del (C57BL/10ScCr)	abnormal cytokine secretion	J:88996
	abnormal macrophage physiology	J:88996
	increased susceptibility to bacterial infection	J:51522, J:88996
Tlr4^lps-del/Tlr4^lps-del (involves: C57BL/10ScN)	abnormal tumor necrosis factor level	J:114368
	decreased interleukin-6 secretion	J:147023
	decreased interleukin-10 secretion	J:147023
Tlr4^lps-hypo/Tlr4^lps-hypo (B6.Cg-Tlr4^lps-hypo Cln8^mnd)	decreased susceptibility to bacterial infection	J:103167
Tlr4^lps-n/Tlr4^lps-n (C3H/HeN)	decreased acute inflammation	J:37271
Tlr4^tm1.1Djh/Tlr4^tm1.1Djh (involves: FVB/N)	decreased susceptibility to endotoxin shock	J:192520
Tlr4^tm1Aki/Tlr4^lps-2J (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)	abnormal inflammatory response	J:107391
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd)	decreased circulating interleukin-6 level	J:145306
	decreased susceptibility to Orthomyxoviridae infection	J:145306
	increased susceptibility to bacterial infection	J:53519
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6J)	abnormal acute inflammation	J:98224
	impaired neutrophil chemotaxis	J:98224
	increased susceptibility to bacterial infection	J:98224
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal level of surface class II molecules	J:76115
	abnormal macrophage physiology	J:76115
	decreased B cell proliferation	J:76115
	decreased interleukin-6 secretion	J:76115
	decreased susceptibility to endotoxin shock	J:76115
	decreased tumor necrosis factor secretion	J:76115
	increased susceptibility to bacterial infection	J:111778
Tlr4^tm1Aki/Tlr4^tm1Aki (C.129P2-Tlr4^tm1Aki)	decreased susceptibility to induced arthritis	J:178054
Tlr4^tm1Aki/Tlr4^tm1Aki Tlr5^tm1Flv/Tlr5^tm1Flv (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	increased susceptibility to bacterial infection	J:111778
Tlr5^tm1Aki/Tlr5^tm1Aki (B6.129P2-Tlr5^tm1Aki)	decreased interleukin-6 secretion	J:112391
	decreased interleukin-12b secretion	J:112391
	decreased susceptibility to bacterial infection	J:112391
Tlr5^tm1Aki/Tlr5^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:112671
Tlr5^tm1Aki/Tlr5^tm1Aki (involves: 129P2/OlaHsd)	increased interleukin-1 beta secretion	J:229155
Tlr5^tm1Aki/Tlr5^tm1Aki (involves: 129P2/OlaHsd)	increased susceptibility to colitis induced morbidity/mortality	J:229155
Tlr5^tm1Flv/Tlr5^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal cytokine secretion	J:111778
	abnormal dendritic cell physiology	J:111778
	abnormal response to transplant	J:111778
	increased susceptibility to autoimmune diabetes	J:158055
	increased susceptibility to bacterial infection	J:111778
	increased susceptibility to induced colitis	J:158055
	increased susceptibility to induced pancreatitis	J:158055
	lung inflammation	J:111778
Tlr5^tm1Flv/Tlr5^tm1Flv (involves: 129S1/Sv)	abnormal leukocyte migration	J:171379
Tlr6^int/Tlr6^int (C57BL/6-Tlr6^int)	abnormal adaptive immunity	J:110094
	abnormal cell-mediated immunity	J:110094
	abnormal innate immunity	J:110094
	abnormal macrophage physiology	J:110094
Tlr6^m2Btlr/Tlr6^m2Btlr (C57BL/6J-Tlr6^m2Btlr)	abnormal macrophage physiology	J:144166
Tlr6^m2Btlr/Tlr6^m2Btlr (C57BL/6J-Tlr6^m2Btlr)	decreased tumor necrosis factor secretion	J:144166
Tlr6^m3Btlr/Tlr6^m3Btlr (C57BL/6J-Tlr6^m3Btlr)	abnormal macrophage physiology	J:144167
Tlr6^m3Btlr/Tlr6^m3Btlr (C57BL/6J-Tlr6^m3Btlr)	decreased tumor necrosis factor secretion	J:144167
Tlr6^m4Btlr/Tlr6^m4Btlr (C57BL/6J-Tlr6^m4Btlr)	abnormal macrophage physiology	J:144168
Tlr6^m4Btlr/Tlr6^m4Btlr (C57BL/6J-Tlr6^m4Btlr)	decreased tumor necrosis factor secretion	J:144168
Tlr6^tm1Aki/Tlr6^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:70578
	abnormal macrophage physiology	J:70578
	decreased interleukin-6 secretion	J:70578
	decreased interleukin-12 secretion	J:70578
	decreased tumor necrosis factor secretion	J:70578
Tlr7^em2Anu/Y (C57BL/6NCrl-Tlr7^em2Anu)	abnormal B cell physiology	J:324448
	abnormal macrophage physiology	J:324448
	decreased B cell apoptosis	J:324448
	decreased B cell proliferation	J:324448
	increased anti-double stranded DNA antibody level	J:324448
	increased anti-nuclear antigen antibody level	J:324448
	increased anti-single stranded DNA antibody level	J:324448
	increased autoantibody level	J:324448
	increased circulating interferon-gamma level	J:324448
	increased circulating interleukin-6 level	J:324448
	increased circulating interleukin-10 level	J:324448
	increased circulating tumor necrosis factor level	J:324448
	increased susceptibility to systemic lupus erythematosus	J:324448
	liver inflammation	J:324448
	lung inflammation	J:324448
	lymph node inflammation	J:324448
Tlr7^em2Anu/Tlr7⁺ (C57BL/6NCrl-Tlr7^em2Anu)	abnormal plasmacytoid dendritic cell physiology	J:324448
	increased anti-double stranded DNA antibody level	J:324448
	increased anti-nuclear antigen antibody level	J:324448
	increased anti-single stranded DNA antibody level	J:324448
	increased autoantibody level	J:324448
	increased circulating interferon-gamma level	J:324448
	increased circulating interleukin-6 level	J:324448
	increased circulating interleukin-10 level	J:324448
	increased circulating tumor necrosis factor level	J:324448
Tlr7^em2Anu/Tlr7^em2Anu (C57BL/6NCrl-Tlr7^em2Anu)	abnormal plasmacytoid dendritic cell physiology	J:324448
	glomerulonephritis	J:324448
	increased anti-nuclear antigen antibody level	J:324448
	increased anti-single stranded DNA antibody level	J:324448
	increased inflammatory response	J:324448
	increased susceptibility to systemic lupus erythematosus	J:324448
	liver inflammation	J:324448
	lung inflammation	J:324448
	lymph node inflammation	J:324448
	pancreas inflammation	J:324448
	salivary gland inflammation	J:324448
Tlr7^rsq1/Y (C57BL/6J-Tlr7^rsq1)	abnormal macrophage physiology	J:128404
Tlr7^rsq1/Y (C57BL/6J-Tlr7^rsq1)	decreased tumor necrosis factor secretion	J:128404
Tlr7^rsq1/Tlr7^rsq1 (C57BL/6J-Tlr7^rsq1)	abnormal macrophage physiology	J:128404
Tlr7^rsq1/Tlr7^rsq1 (C57BL/6J-Tlr7^rsq1)	decreased tumor necrosis factor secretion	J:128404
Tlr7^rsq2/Y (C57BL/6J-Tlr7^rsq2)	abnormal macrophage physiology	J:140020
Tlr7^rsq2/Y (C57BL/6J-Tlr7^rsq2)	decreased tumor necrosis factor secretion	J:140020
Tlr7^tm1Aki/Tlr7^tm1Aki (B6.129P2-Tlr7^tm1Aki)	abnormal dendritic cell physiology	J:118954
Tlr7^tm1Aki/Tlr7^tm1Aki (B6.129P2-Tlr7^tm1Aki)	decreased interleukin-12b secretion	J:118954
Tlr7^tm1Aki/Tlr7^tm1Aki (involves: 129P2/OlaHsd)	decreased interferon-alpha secretion	J:144400
Tlr7^tm1Flv/Y (B6.129S1-Tlr7^tm1Flv)	decreased splenocyte proliferation	J:127600
Tlr7^tm1Flv/Tlr7^tm1Flv (involves: 129S1/Sv)	decreased circulating interferon-alpha level	J:89257
Tlr7^tm1Flv/Tlr7^tm1Flv (B6.129S1-Tlr7^tm1Flv)	decreased anti-insulin autoantibody level	J:165267
	decreased IgG1 level	J:165267
	decreased IgG2a level	J:165267
	decreased IgG level	J:165267
	decreased IgM level	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr8/Tlr7^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg)	decreased anti-insulin autoantibody level	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr7⁺ Tlr8/Tlr7^tm1Vlcg/Tlr8^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg Tlr8^tm1Vlcg)	decreased anti-insulin autoantibody level	J:165267
	decreased IgG level	J:165267
	decreased IgM level	J:165267
	increased IgG level	J:165267
	increased IgM level	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr8/Tlr7^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg Tlr8^tm1Vlcg)	decreased anti-insulin autoantibody level	J:165267
Tlr8^tm1Vlcg/Tlr8^tm1Vlcg (B6.129S1-Tlr8^tm1Vlcg)	decreased IgG1 level	J:165267
	glomerulonephritis	J:165267
	increased anti-double stranded DNA antibody level	J:165267
	increased anti-nuclear antigen antibody level	J:165267
	increased circulating interleukin-12 level	J:165267
	increased IgG2a level	J:165267
	increased IgG level	J:165267
	increased IgM level	J:165267
	increased interleukin-6 secretion	J:165267
Tlr9^M1Btlr/Tlr9^M1Btlr (involves: C57BL/6)	abnormal cytokine secretion	J:88906
	abnormal macrophage physiology	J:88906
	abnormal NK cell physiology	J:88906
	abnormal NK T cell physiology	J:88906
	increased susceptibility to Herpesvirales infection	J:88906
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:88906
Tlr9^M2Btlr/Tlr9⁺ (C57BL/6J-Tlr9^M2Btlr)	abnormal macrophage physiology	J:128405
Tlr9^M2Btlr/Tlr9^M2Btlr (C57BL/6J-Tlr9^M2Btlr)	abnormal macrophage physiology	J:128405
Tlr9^M2Btlr/Tlr9^M2Btlr (C57BL/6J-Tlr9^M2Btlr)	increased susceptibility to Herpesvirales infection	J:128405
Tlr9^m3Btlr/Tlr9^m3Btlr (C57BL/6J-Tlr9^m3Btlr)	abnormal macrophage physiology	J:128406
Tlr9^m3Btlr/Tlr9^m3Btlr (C57BL/6J-Tlr9^m3Btlr)	decreased B cell proliferation	J:128406
Tlr9^m4Btlr/Tlr9⁺ (C57BL/6J-Tlr9^m4Btlr)	abnormal macrophage physiology	J:132489
	abnormal plasmacytoid dendritic cell physiology	J:132489
	decreased B cell proliferation	J:132489
Tlr9^M5Btlr/? (C57BL/6J-Tlr9^M5Btlr)	abnormal macrophage physiology	J:147856
Tlr9^M5Btlr/? (C57BL/6J-Tlr9^M5Btlr)	decreased tumor necrosis factor secretion	J:147856
Tlr9^M5Btlr/Tlr9⁺ (C57BL/6J-Tlr9^M5Btlr)	decreased interferon-alpha secretion	J:147856
Tlr9^M5Btlr/Tlr9⁺ (C57BL/6J-Tlr9^M5Btlr)	decreased interferon-beta secretion	J:147856
Tlr9^m6Btlr/Tlr9^m6Btlr (C57BL/6J-Tlr9^m6Btlr)	increased susceptibility to induced colitis	J:155728
Tlr9^M7Btlr/Tlr9⁺ (C57BL/6J-Tlr9^M7Btlr)	decreased tumor necrosis factor secretion	J:165701
Tlr9^M7Btlr/Tlr9^M7Btlr (C57BL/6J-Tlr9^M7Btlr)	decreased tumor necrosis factor secretion	J:165701
Tlr9^M8Btlr/Tlr9^M8Btlr (involves: C57BL/6J)	decreased interferon-gamma secretion	J:168138
Tlr9^M9Btlr/Tlr9⁺ (C57BL/6J-Tlr9^M9Btlr)	decreased tumor necrosis factor secretion	J:220063
Tlr9^M9Btlr/Tlr9^M9Btlr (C57BL/6J-Tlr9^M9Btlr)	decreased tumor necrosis factor secretion	J:220063
Tlr9^tm1Aki/Tlr9^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell physiology	J:66049
	abnormal dendritic cell physiology	J:66049
	abnormal macrophage physiology	J:117688, J:66049
	abnormal T-helper 1 physiology	J:66049
	decreased inflammatory response	J:66049
Tlr9^tm1Aki/Tlr9^tm1Aki (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal dendritic cell physiology	J:88244
Tlr9^tm1Aki/Tlr9^tm1Aki (B6.129P2-Tlr9^tm1Aki)	abnormal immune system physiology	J:121070
	abnormal response to infection	J:121070
	decreased interferon-alpha secretion	J:125611
	decreased interferon-beta secretion	J:125611
	decreased interleukin-12b secretion	J:125611, J:118954
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:105435
	decreased susceptibility to parasitic infection	J:116763
	decreased tumor necrosis factor secretion	J:121070
	impaired natural killer cell mediated cytotoxicity	J:125611
Tlr9^tm1Aki/Tlr9^tm1Aki (involves: 129P2/OlaHsd)	abnormal leukocyte migration	J:171379
Tlr12^tm1Gho/Tlr12^tm1Gho (Not Specified)	abnormal macrophage physiology	J:89754
Tlr12^tm1Gho/Tlr12^tm1Gho (Not Specified)	increased susceptibility to bacterial infection	J:89754
Tlx1^tm1Thr/Tlx1^tm1Thr (involves: 129P2/OlaHsd * MF1)	increased splenocyte apoptosis	J:28700
Tmem30a^tm1.1Xjz/Tmem30a^tm1.1Xjz Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6J * DBA)	liver inflammation	J:249038
Tmem41b^em1Cya/Tmem41b⁺ (involves: C57BL/6)	decreased susceptibility to Coronaviridae infection	J:316472
Tmem79^ma/Tmem79^ma (involves: C57BL/6JJcl * CBA/CaGr)	dermatitis	J:202316
Tmem79^ma/Tmem79^ma (B6.CBACaGr-Tmem79^ma/J)	blepharitis	J:202453
	dermatitis	J:202453
	increased IgE level	J:202453
	skin inflammation	J:202453
Tmem102^tm1.1Jyen/Tmem102^tm1.1Jyen (B6.Cg-Tmem102^tm1.1Jyen)	abnormal leukocyte adhesion	J:200103
	impaired leukocyte migration	J:200103
Tmem109^tm1Yamt/Tmem109^tm1Yamt (B6.Cg-Tmem109^tm1Yamt)	decreased thymocyte apoptosis	J:157864
Tmem160^em1.1Bros/Tmem160^em1.1Bros (involves: C57BL/6JRj * FVB/N)	abnormal cytokine level	J:328221
Tmem178^tm1Lex/Tmem178^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal osteoclast physiology	J:228311
	increased susceptibility to induced arthritis	J:228311
Tmem219^{tm1(KOMP)Vlcg}/Tmem219^{tm1(KOMP)Vlcg} (B6J.B6N-Tmem219^{tm1(KOMP)Vlcg})	increased IgE level	J:236976
	increased interleukin-4 secretion	J:236976
	increased interleukin-13 secretion	J:236976
Tmem219^{tm1(KOMP)Vlcg}/Tmem219^{tm1(KOMP)Vlcg} Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)	lung inflammation	J:236976
Tmem234^tm1Lex/Tmem234^tm1Lex (B6;129S5-Tmem234^tm1Lex/Mmucd)	increased IgG2a level	J:171883
Tmem258^{tm1.1(KOMP)Vlcg}/Tmem258⁺ (involves: C57BL/6NTac)	increased susceptibility to colitis induced morbidity/mortality	J:240635
Tmem258^{tm1.1(KOMP)Vlcg}/Tmem258⁺ (involves: C57BL/6NTac)	increased susceptibility to induced colitis	J:240635
Tmevp2^C57BL/10SnSg/Tmevp2^C57BL/10SnSg (involves: A/WySn * C57BL/10SnSg * SJL/J * Swiss)	decreased susceptibility to Picornaviridae infection	J:54593
Tmevp3^C57BL/10SnSg/Tmevp3^C57BL/10SnSg (involves: A/WySn * C57BL/10SnSg * SJL/J * Swiss)	decreased susceptibility to Picornaviridae infection	J:54593
Tmevp3^C57BL/10SnSg/Tmevp3^SJL/J (involves: A/WySn * C57BL/10SnSg * SJL/J * Swiss)	decreased susceptibility to Picornaviridae infection	J:54593
Tmprss2^{tm1(KOMP)Vlcg}/Tmprss2^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal cytokine secretion	J:283077
	decreased susceptibility to Coronaviridae infection	J:283077
	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:214427
	lung inflammation	J:214427
Tmprss2^tm1Psn/Tmprss2^tm1Psn (B6JRj.129S1-Tmprss2^tm1Psn)	decreased susceptibility to Orthomyxoviridae infection	J:287633
Tmprss2^tm1Psn/Tmprss2^tm1Psn (B6JRj.129S1-Tmprss2^tm1Psn)	decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:287633
Tmprss2^tm1Psn/Tmprss2^tm1Psn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased susceptibility to Orthomyxoviridae infection	J:244166
Tmprss2^{tm2.1(ETV1)Sho}/Tmprss2^{tm2.1(ETV1)Sho} (involves: C57BL/6 * DBA/2)	prostate gland inflammation	J:212219
Tnbs1^SJL/J/? (involves: C57BL/6J * SJL/J)	increased susceptibility to induced colitis	J:82095
Tnbs2^SJL/J/? (involves: C57BL/6J * SJL/J)	increased interleukin-12b secretion	J:82095
Tnbs2^SJL/J/? (involves: C57BL/6J * SJL/J)	increased susceptibility to induced colitis	J:82095
Tnf^Bpsm1/Tnf⁺ (involves: C57BL/6)	aortic valve inflammation	J:226052
	increased circulating tumor necrosis factor level	J:226052
	mitral valve inflammation	J:226052
	rheumatoid arthritis	J:226052
Tnf^Bpsm1/Tnf⁺ (C.Cg-Tnf^Bpsm1)	aortic valve inflammation	J:226052
	cardiovalvulitis	J:226052
	mitral valve inflammation	J:226052
Tnf^Bpsm1/Tnf⁺ Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6)	increased circulating tumor necrosis factor level	J:226052
Tnf^Bpsm1/Tnf^Bpsm1 (involves: C57BL/6)	accelerated temporomandibular joint osteoarthritis	J:226052
	aortic valve inflammation	J:226052
	increased circulating tumor necrosis factor level	J:226052
	mitral valve inflammation	J:226052
	rheumatoid arthritis	J:226052
Tnf^Bpsm1/Tnf^Bpsm1 Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6)	increased circulating tumor necrosis factor level	J:226052
Tnf^em4Boui/Tnf⁺ (C57BL/6-Tnf^em4Boui)	arthritis	J:306876
	cardiovalvulitis	J:306876
	colitis	J:306876
	esophageal inflammation	J:306876
	ileum inflammation	J:306876
Tnf^em5Boui/Tnf⁺ Tnfrsf1a^tm1Mak/Tnfrsf1a⁺ (involves: 129S2/SvPas * C57BL/6)	arthritis	J:306876
	cardiovalvulitis	J:306876
	colitis	J:306876
Tnf^M1Btlr/Tnf^M1Btlr (C57BL/6J-Tnf^M1Btlr)	increased susceptibility to bacterial infection	J:124642
Tnf^M2Btlr/Tnf⁺ (C57BL/6J-Tnf^M2Btlr)	decreased macrophage cytokine production	J:213047
Tnf^M2Btlr/Tnf⁺ (C57BL/6J-Tnf^M2Btlr)	decreased tumor necrosis factor secretion	J:213047
Tnf^R8H/Tnf^R8H (involves: I/St)	increased susceptibility to bacterial infection	J:114302
Tnf^tm1.1Sned/Tnf^tm1.1Sned Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal chemokine secretion	J:95684
	decreased circulating tumor necrosis factor level	J:95684
	decreased susceptibility to autoimmune disorder	J:95684
	decreased susceptibility to endotoxin shock	J:95684
	increased susceptibility to bacterial infection	J:95684
Tnf^tm1.1Sned/Tnf^tm1.1Sned Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased circulating tumor necrosis factor level	J:95684
	decreased susceptibility to autoimmune disorder	J:95684
	decreased susceptibility to endotoxin shock	J:95684
	increased susceptibility to bacterial infection	J:95684
Tnf^tm1.2Sned/Tnf^tm1.2Sned (involves: 129/Sv * C57BL/6)	decreased susceptibility to bacterial infection	J:97783
Tnf^tm1.2Sned/Tnf^tm1.2Sned (involves: 129/Sv * C57BL/6)	increased susceptibility to parasitic infection	J:97783
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * C57BL/6)	abnormal inflammatory response	J:114740
	abnormal lymphocyte physiology	J:114740
	abnormal macrophage physiology	J:114740
	decreased inflammatory response	J:56068
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:114740
	decreased susceptibility to type IV hypersensitivity reaction	J:47673
	increased susceptibility to bacterial infection	J:47673, J:114740
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv)	abnormal chemokine secretion	J:95684
	decreased circulating tumor necrosis factor level	J:95684
	decreased susceptibility to autoimmune disorder	J:95684
	decreased susceptibility to endotoxin shock	J:95684
	increased susceptibility to bacterial infection	J:95684
Tnf^tm1Gkl/Tnf^tm1Gkl (either: B6.129-Tnf^tm1Gkl or (involves: 129 * C57BL/6))	decreased susceptibility to bacterial infection	J:97783
	increased susceptibility to parasitic infection	J:97783
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * C57BL/6J)	increased susceptibility to bacterial infection	J:124642
Tnf^tm1Gkl/Tnf^tm1Gkl Tnfaip3^tm1Ama/Tnfaip3^tm1Ama (involves: 129S/SvEv * C57BL/6J)	abnormal cytokine secretion	J:92694
	abnormal inflammatory response	J:92694
Tnf^tm1Gkl/Tnf^tm2Gkl (involves: 129S/SvEv * C57BL/6)	increased circulating tumor necrosis factor level	J:54056
	increased susceptibility to endotoxin shock	J:54056
	increased tumor necrosis factor secretion	J:54056
	rheumatoid arthritis	J:54056
Tnf^tm1Jods/Tnf^tm1Jods (involves: C57BL/6)	abnormal immune system physiology	J:98591
	decreased susceptibility to endotoxin shock	J:98591
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:44545, J:98591
	increased susceptibility to bacterial infection	J:115034, J:98170
Tnf^tm1Jods/Tnf^tm1Jods (C57BL/6-Tnf^tm1Jods)	abnormal cytokine level	J:118417
Tnf^tm1Jods/Tnf^tm1Jods (C57BL/6-Tnf^tm1Jods)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:118417
Tnf^tm1Jods/Tnf^tm1Jods (C57BL/6-Lta^tm1Jods)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:47428
Tnf^tm1Ljo/Tnf⁺ (involves: 129S1/Sv)	increased susceptibility to bacterial infection	J:41992
Tnf^tm1Ljo/Tnf⁺ (involves: 129S1/Sv)	increased susceptibility to fungal infection	J:41992
Tnf^tm1Ljo/Tnf^tm1Ljo (involves: 129S1/Sv)	abnormal chemokine secretion	J:95684
	abnormal cytokine secretion	J:41992
	abnormal follicular dendritic cell physiology	J:41992
	abnormal susceptibility to infection	J:41992
	decreased circulating tumor necrosis factor level	J:95684
	decreased IgG level	J:41992
	decreased susceptibility to autoimmune disorder	J:95684
	decreased susceptibility to endotoxin shock	J:95684, J:41992
	increased susceptibility to bacterial infection	J:80616, J:95684, J:41992
	increased susceptibility to fungal infection	J:41992
Tnf^tm1Ljo/Tnf^tm1Ljo (either: B6.129-Tnf^tm1Ljo or (involves: 129 * C57BL/6))	decreased susceptibility to bacterial infection	J:97783
	increased susceptibility to parasitic infection	J:97783
Tnf^tm1Ljo/Tnf^tm1Ljo (B6.129S1-Tnf^tm1Ljo)	lung inflammation	J:127028
Tnf^tm1Ljo/Tnf^tm1Ljo (involves: 129S1/Sv * C57BL/6)	abnormal neutrophil physiology	J:127028
	decreased immunoglobulin level	J:127028
	increased interferon-gamma secretion	J:127028
	increased susceptibility to parasitic infection	J:127028
	skin inflammation	J:127028
Tnf^tm1Sek/Tnf^tm1Sek (B6.Cg-Tnf^tm1Sek)	abnormal cytokine secretion	J:44841
	abnormal macrophage physiology	J:44841
	decreased circulating interferon-gamma level	J:44841
	decreased circulating interleukin-1 alpha level	J:44841
	decreased circulating interleukin-1 beta level	J:44841
	decreased circulating interleukin-6 level	J:44841
	decreased susceptibility to endotoxin shock	J:44841
Tnf^tm2.1Gkl/Tnf^tm2.1Gkl Tg(Fabp1-cre)1Jig/0 (involves: 129S/SvEv * FVB/N)	ileum inflammation	J:204557
	increased circulating tumor necrosis factor level	J:204557
	large intestinal inflammation	J:204557
	small intestinal inflammation	J:204557
Tnf^tm2.1Gkl/Tnf^tm2.1Gkl Tg(Lck-cre)I57Jxm/0 (involves: 129S/SvEv * ICR)	small intestinal inflammation	J:108572
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:136667
	abnormal circulating chemokine level	J:204922
	abnormal T cell physiology	J:136667
	abnormal T-helper 17 cell physiology	J:204922
	arthritis	J:92307, J:136667
	decreased inflammatory response	J:204922
	ileum inflammation	J:204922
	increased circulating tumor necrosis factor level	J:54056, J:204922
	intestinal inflammation	J:136667
	rheumatoid arthritis	J:54056
	small intestinal inflammation	J:92307, J:54056, J:204922
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6 * SPRET/Ei)	arthritis	J:92307
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6 * SPRET/Ei)	small intestinal inflammation	J:92307
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6J)	abnormal cytotoxic T cell physiology	J:108572
	abnormal response to transplant	J:108572
	increased circulating tumor necrosis factor level	J:264147
	increased tumor necrosis factor secretion	J:264147
	small intestinal inflammation	J:108572
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6 * CBA)	arthritis	J:131930
Tnf^tm2Gkl/Tnf⁺ (B6.129S-Tnf^tm2Gkl/Jarn)	abnormal CD4-positive, alpha-beta T cell physiology	J:145626
	ileum inflammation	J:131978, J:145626
	increased interferon-gamma secretion	J:131978
	increased interleukin-2 secretion	J:145626
	increased tumor necrosis factor secretion	J:145626
Tnf^tm2Gkl/Tnf⁺ Tnfrsf1a^tm2Gkl/Tnfrsf1a^tm2Gkl Tg(Col6a1-cre)1Gkl/? (involves: 129S/SvEv * C57BL/6 * CBA)	arthritis	J:131930
	small intestinal inflammation	J:131930
Tnf^tm2Gkl/Tnf⁺ Tnfrsf1b^tm1.1Gkl/Tnfrsf1b^tm1.1Gkl Tg(Col6a1-cre)1Gkl/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA)	increased circulating tumor necrosis factor level	J:264147
	increased tumor necrosis factor secretion	J:264147
	joint inflammation	J:264147
Tnf^tm2Gkl/Tnf⁺ Tnfrsf1b^tm1.2Gkl/Tnfrsf1b^tm1.2Gkl (involves: 129S/SvEv * C57BL/6 * C57BL/6J)	aortic valve inflammation	J:264147
	arthritis	J:264147
	increased circulating tumor necrosis factor level	J:264147
	increased tumor necrosis factor secretion	J:264147
Tnf^tm2Gkl/Tnf⁺ Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	rheumatoid arthritis	J:54056
	small intestinal inflammation	J:54056
Tnf^tm2Gkl/Tnf^tm2Gkl (involves: 129S/SvEv * C57BL/6)	cardiovalvulitis	J:226052
	increased circulating tumor necrosis factor level	J:54056
	rheumatoid arthritis	J:54056
	small intestinal inflammation	J:54056
Tnf^tm2Gkl/Tnf^tm2Gkl Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	increased circulating tumor necrosis factor level	J:54056
	increased tumor necrosis factor secretion	J:54056
Tnf^tm2Jods/Tnf^tm2Jods (involves: C57BL/6)	decreased immunoglobulin level	J:127028
Tnf^tm2Jods/Tnf^tm2Jods (involves: C57BL/6)	increased susceptibility to bacterial infection	J:98170
Tnf^tm2Jods/Tnf^tm2Jods (C57BL/6-Tnf^tm2Jods)	abnormal immune system physiology	J:98591
	decreased susceptibility to endotoxin shock	J:98591
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:98591
Tnf^tm3Gkl/Tnf^tm3Gkl (involves: 129S/SvEv * C57BL/6)	abnormal lymphocyte physiology	J:114740
	autoimmune response	J:114740
	decreased circulating tumor necrosis factor level	J:114740
	decreased IgG1 level	J:114740
	decreased susceptibility to bacterial infection	J:114740
	decreased susceptibility to endotoxin shock	J:114740
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:114740
	decreased tumor necrosis factor secretion	J:114740
Tnfaip3^m1Apb/Tnfaip3^m1Apb (C57BL/6-Tnfaip3^m1Apb)	CNS inflammation	J:324062
	increased microglial cell activation	J:324062
	uterus inflammation	J:324062
Tnfaip3^tm1.1Gvl/Tnfaip3^tm1.1Gvl Tg(Vil1-cre)997Gum/0 (B6.Cg-Tnfaip3^tm1.1Gvl Tg(Vil1-cre)997Gum)	increased circulating interleukin-6 level	J:163410
	increased susceptibility to induced colitis	J:163410
Tnfaip3^tm1.1Gvl/Tnfaip3^tm1.1Gvl Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak Tg(Vil1-cre)997Gum/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased susceptibility to induced colitis	J:163410
	increased susceptibility to induced colitis	J:163410
Tnfaip3^tm1Ama/Tnfaip3^tm1Ama (involves: C57BL/6J)	abnormal cytokine secretion	J:92694
Tnfaip3^tm1Ama/Tnfaip3^tm1Ama (involves: C57BL/6J)	abnormal inflammatory response	J:92694
Tnfaip3^tm1Ama/Tnfaip3^tm1Ama (Not Specified)	increased inflammatory response	J:92931
	intestinal inflammation	J:92931
	joint inflammation	J:92931
	kidney inflammation	J:92931
	liver inflammation	J:92931
Tnfaip3^tm1Ama/Tnfaip3^tm1Ama Tnfrsf1a^tm1Imx/Tnfrsf1a⁺ (involves: C57BL/6J)	abnormal inflammatory response	J:92694
Tnfaip3^tm1Ama/Tnfaip3^tm1Ama Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: C57BL/6J)	abnormal inflammatory response	J:92694
Tnfaip3^tm1Homy/Tnfaip3^tm1Homy Tg(Mx1-cre)1Cgn/? (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal circulating cytokine level	J:212681
	abnormal circulating interleukin level	J:212681
	increased circulating interferon-gamma level	J:212681
	increased circulating interleukin-1 beta level	J:212681
	increased circulating interleukin-6 level	J:212681
	increased circulating tumor necrosis factor level	J:212681
	liver inflammation	J:212681
	lung inflammation	J:212681
Tnfaip3^tm2Ama/Tnfaip3^tm2Ama Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell activation	J:163917
	decreased B cell apoptosis	J:163917
	increased autoantibody level	J:163917
	increased B cell proliferation	J:163917
	increased IgG level	J:163917
	increased IgM level	J:163917
	increased immunoglobulin level	J:163917
	increased interleukin-6 secretion	J:163917
	increased susceptibility to autoimmune disorder	J:163917
Tnfaip3^tm3.1Ama/Tnfaip3^tm3.1Ama (C57BL/6J-Tnfaip3^tm3.1Ama)	abnormal chemokine secretion	J:203160
	decreased interleukin-6 secretion	J:203160
	increased susceptibility to induced colitis	J:203160
Tnfaip3^tm4.1Ama/Tnfaip3^tm4.1Ama (C57BL/6J-Tnfaip3^tm4.1Ama)	abnormal chemokine secretion	J:203160
	decreased interleukin-6 secretion	J:203160
	increased susceptibility to induced colitis	J:203160
Tnfaip6^tm1Cful/Tnfaip6^tm1Cful (involves: 129S6/SvEvTac * BALB/c)	decreased inflammatory response	J:193758
Tnfaip8^{Gt(IST13629C1)Tigm}/Tnfaip8^{Gt(IST13629C1)Tigm} (involves: C57BL/6N)	increased circulating interleukin-6 level	J:223320
	increased circulating interleukin-17 level	J:223320
	increased interleukin-1 beta secretion	J:223320
	increased interleukin-6 secretion	J:223320
	increased interleukin-17 secretion	J:223320
	increased susceptibility to induced colitis	J:223320
Tnfaip8^{Gt(IST13629C1)Tigm}/Tnfaip8^{Gt(IST13629C1)Tigm} Tnfaip8l1^em1Huwa/Tnfaip8l1^em1Huwa (involves: C57BL/6 * C57BL/6N)	colitis	J:342074
Tnfaip8l1^em1Huwa/Tnfaip8l1^em1Huwa (C57BL/6-Tnfaip8l1^em1Huwa)	increased susceptibility to colitis induced morbidity/mortality	J:342074
	increased susceptibility to induced colitis	J:342074
Tnfaip8l2^tm1Yhcn/Tnfaip8l2^tm1Yhcn (129S6/SvEvTac-Tnfaip8l2^tm1Yhcn)	abnormal B cell activation	J:139785
	abnormal B cell physiology	J:139785
	abnormal CD4-positive, alpha-beta T cell physiology	J:139785
	abnormal cytotoxic T cell physiology	J:139785
	abnormal inflammatory response	J:139785
	abnormal macrophage activation involved in immune response	J:139785
	abnormal T cell apoptosis	J:139785
	chronic inflammation	J:139785
	decreased IgG2a level	J:139785
	decreased IgG2b level	J:139785
	increased circulating interleukin-1 beta level	J:139785
	increased circulating interleukin-6 level	J:139785
	increased circulating interleukin-10 level	J:139785
	increased circulating interleukin-12 level	J:139785
	increased circulating tumor necrosis factor level	J:139785
	increased interferon-gamma secretion	J:139785
	increased interleukin-1 beta secretion	J:139785
	increased interleukin-2 secretion	J:139785
	increased interleukin-4 secretion	J:139785
	increased interleukin-6 secretion	J:139785
	increased interleukin-12 secretion	J:139785
	increased interleukin-17 secretion	J:139785
	increased susceptibility to endotoxin shock	J:139785
	increased tumor necrosis factor secretion	J:139785
	intestinal inflammation	J:139785
	liver inflammation	J:139785
	lung inflammation	J:139785
	lymph node inflammation	J:139785
Tnfrsf1a^tm1.1Gkl/Tnfrsf1a⁺ (involves: 129/Sv * C57BL/6)	liver inflammation	J:92470
Tnfrsf1a^tm1.1Gkl/Tnfrsf1a^tm1.1Gkl (involves: 129/Sv * C57BL/6)	abnormal cytokine secretion	J:92470
	decreased susceptibility to bacterial infection	J:92470
	increased susceptibility to experimental autoimmune encephalomyelitis	J:92470
	liver inflammation	J:92470
Tnfrsf1a^tm1.1Gkl/Tnfrsf1a^tm1.1Gkl Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129/Sv * C57BL/6)	liver inflammation	J:92470
Tnfrsf1a^tm1Blt/Tnfrsf1a⁺ (involves: 129P2/OlaHsd)	decreased circulating interleukin-6 level	J:210950
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:14424
	decreased IgG1 level	J:115225
	decreased interleukin-6 secretion	J:14424
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:115225
	increased susceptibility to bacterial infection	J:14424
	increased susceptibility to parasitic infection	J:114203
	increased susceptibility to type I hypersensitivity reaction	J:92307
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	decreased susceptibility to bacterial infection	J:50903
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129P2/OlaHsd)	impaired humoral immune response	J:210950
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129P2/OlaHsd)	increased susceptibility to bacterial infection induced morbidity/mortality	J:210950
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased IgG1 level	J:115225
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:115225
	increased susceptibility to parasitic infection	J:114203
Tnfrsf1a^tm1Imx/Tnfrsf1a⁺ (involves: C57BL/6)	decreased circulating interleukin-6 level	J:210950
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	abnormal immune system physiology	J:45147
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx)	decreased inflammatory response	J:45147
	decreased susceptibility to endotoxin shock	J:45147
	increased circulating tumor necrosis factor level	J:45147
	increased susceptibility to bacterial infection	J:45147
	lung inflammation	J:120174
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx/J)	abnormal chemokine secretion	J:160543
	abnormal macrophage physiology	J:160543
	decreased circulating interleukin-6 level	J:160543
	decreased interleukin-6 secretion	J:160543
	decreased susceptibility to endotoxin shock	J:160543
	increased circulating tumor necrosis factor level	J:160543
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: C57BL/6)	impaired humoral immune response	J:210950
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: C57BL/6)	increased susceptibility to bacterial infection induced morbidity/mortality	J:210950
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	decreased inflammatory response	J:45147
	decreased microglial cell activation	J:33864
	decreased susceptibility to endotoxin shock	J:45147
	decreased susceptibility to experimental autoimmune uveoretinitis	J:115094
	decreased susceptibility to induced arthritis	J:120707
	increased circulating tumor necrosis factor level	J:45147
	increased susceptibility to bacterial infection	J:58851
	osteomyelitis	J:58851
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (B6.129S-Tnfrsf1b^tm1Imx Tnfrsf1a^tm1Imx/J)	decreased susceptibility to Coronaviridae infection	J:288523
Tnfrsf1a^tm1Mak/Tnfrsf1a⁺ (involves: 129S2/SvPas)	decreased circulating interleukin-6 level	J:210950
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	granulomatous inflammation	J:55889
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas * C57BL/6J * NOD)	decreased susceptibility to autoimmune diabetes	J:64051
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas)	decreased circulating interleukin-6 level	J:138824
	decreased IgG level	J:139030
	decreased susceptibility to bacterial infection	J:4753, J:121930
	impaired humoral immune response	J:210950
	increased circulating tumor necrosis factor level	J:139030
	increased susceptibility to bacterial infection induced morbidity/mortality	J:4753, J:139030, J:210950
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak Tnip1^{Gt(E059E05)Wrst}/Tnip1^{Gt(E059E05)Wrst} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	glomerulonephritis	J:180054
	increased susceptibility to systemic lupus erythematosus	J:180054
Tnfrsf1a^tm1Rsie/Tnfrsf1a⁺ (B6.Cg-Tnfrsf1a^tm1Rsie)	increased circulating tumor necrosis factor level	J:160543
	increased interleukin-6 secretion	J:160543
	increased susceptibility to endotoxin shock	J:160543
Tnfrsf1a^tm1Rsie/Tnfrsf1a^tm1Rsie (B6.Cg-Tnfrsf1a^tm1Rsie)	abnormal chemokine secretion	J:160543
	abnormal macrophage physiology	J:160543
	decreased circulating interleukin-1 beta level	J:160543
	decreased circulating interleukin-6 level	J:160543
	decreased interleukin-6 secretion	J:160543
	decreased susceptibility to endotoxin shock	J:160543
	increased circulating tumor necrosis factor level	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a⁺ (B6.Cg-Tnfrsf1a^tm2.1Rsie)	abnormal macrophage physiology	J:160543
	decreased circulating interleukin-1 beta level	J:160543
	decreased circulating interleukin-6 level	J:160543
	decreased interleukin-6 secretion	J:160543
	increased interleukin-6 secretion	J:160543
	increased susceptibility to endotoxin shock	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a⁺ (involves: 129S6/SvEvTac)	increased susceptibility to endotoxin shock	J:160543
Tnfrsf1a^tm2.1Rsie/Tnfrsf1a^tm2.1Rsie (B6.Cg-Tnfrsf1a^tm2.1Rsie)	abnormal chemokine secretion	J:160543
	abnormal macrophage physiology	J:160543
	decreased circulating interleukin-6 level	J:160543
	decreased interleukin-6 secretion	J:160543
	decreased susceptibility to endotoxin shock	J:160543
	increased circulating tumor necrosis factor level	J:160543
Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	increased circulating tumor necrosis factor level	J:45147
	increased inflammatory response	J:45147
	lung inflammation	J:120174
Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (B6.129S2-Tnfrsf1b^tm1Mwm/J)	decreased interferon-gamma secretion	J:107039
	decreased interleukin-2 secretion	J:107039
	decreased T cell proliferation	J:107039
Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129S2/SvPas * C57BL/6J)	abnormal immune system physiology	J:21815
	increased susceptibility to bacterial infection	J:21815
Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129S2/SvPas * C57BL/6J * NOD)	decreased susceptibility to autoimmune diabetes	J:64051
	periinsulitis	J:64051
Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129S2/SvPas * C57BL/6)	decreased susceptibility to bacterial infection	J:50903
	increased susceptibility to experimental autoimmune encephalomyelitis	J:115225
	increased susceptibility to parasitic infection	J:114203
Tnfrsf4^tm1Mfb/Tnfrsf4^tm1Mfb (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:59204
Tnfrsf4^tm1Nik/Tnfrsf4^tm1Nik (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:64552
	abnormal T-helper 2 physiology	J:68588
	decreased susceptibility to type I hypersensitivity reaction	J:68588
	decreased T cell proliferation	J:58979, J:64552
Tnfrsf8^tm1Mak/Tnfrsf8^tm1Mak (involves: C57BL/6)	decreased susceptibility to graft versus host disease	J:92723
Tnfrsf9^em1Ygch/Tnfrsf9^em1Ygch (NOD/ShiLtDvs-Tnfrsf9^em1Ygch)	abnormal T cell physiology	J:208927
	insulitis	J:208927
Tnfrsf9^em2Ygch/Tnfrsf9^em2Ygch (NOD/ShiLtDvs-Tnfrsf9^em2Ygch)	abnormal T cell physiology	J:208927
	insulitis	J:208927
Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (B6.Cg-Tnfrsf9^tm1Byk)	abnormal cytotoxic T cell physiology	J:83996
	decreased IgG2a level	J:83996
	decreased IgG3 level	J:83996
	decreased interferon-gamma secretion	J:83996
	decreased interleukin-2 secretion	J:83996
	decreased interleukin-4 secretion	J:83996
	increased T cell proliferation	J:83996
Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (C.Cg-Tnfrsf9^tm1Byk)	abnormal cytotoxic T cell physiology	J:83722
	abnormal immunoglobulin level	J:83996
	decreased IgG2a level	J:83996
	decreased IgG3 level	J:83996
	decreased interferon-gamma secretion	J:83996
	decreased interleukin-2 secretion	J:83996
	decreased interleukin-4 secretion	J:83996
	decreased interleukin-12 secretion	J:83722
	increased IgA level	J:83722
	increased IgG2a level	J:83722
	increased IgG2b level	J:83722
	increased splenocyte proliferation	J:83722
	increased T cell proliferation	J:83996
Tnfrsf9^tm1Lpc/Tnfrsf9^tm1Lpc (B6.129-Tnfrsf9^tm1Lpc)	abnormal memory T cell physiology	J:145439
Tnfrsf10b^tm1Wnt/Tnfrsf10b^tm1Wnt (involves: 129S6/SvEvTac * C57BL/6)	abnormal innate immunity	J:94681
	abnormal interferon level	J:94681
	decreased susceptibility to Herpesvirales infection	J:94681
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:94681
	increased circulating interferon-gamma level	J:94681
	increased circulating interleukin-12b level	J:94681
	increased interleukin-12 secretion	J:94681
	increased tumor necrosis factor secretion	J:94681
Tnfrsf11a^tm1.1Pngr/Tnfrsf11a^tm1.2Pngr Tg(Gfap-cre)2Brn/0 (involves: 129 * C57BL/6 * C57BL/6NTac * FVB/N)	decreased susceptibility to endotoxin shock	J:155398
Tnfrsf11a^tm1.1Pngr/Tnfrsf11a^tm1.2Pngr Tg(Nes-cre)1Kln/0 (involves: 129 * C57BL/6 * C57BL/6NTac * SJL)	decreased susceptibility to endotoxin shock	J:155398
Tnfrsf11a^tm1.1Sral/Tnfrsf11a⁺ (B6.129P2(Cg)-Tnfrsf11a^tm1.1Sral)	abnormal osteoclast physiology	J:312215
Tnfrsf11b^tm1Eac/Tnfrsf11b^tm1Eac (involves: 129S4/SvJaeSor)	abnormal dendritic cell antigen presentation	J:67105
	abnormal immune system physiology	J:67105
	abnormal immunoglobulin level	J:67105
Tnfrsf11b^tm1Khs/Tnfrsf11b^tm1Khs (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast physiology	J:111153
Tnfrsf12a^tm1Biib/Tnfrsf12a^tm1Biib (B6.129S4-Tnfrsf12a^tm1Biib)	abnormal chemokine secretion	J:126416
Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (involves: 129X1/SvJ * C57BL/6)	abnormal B cell activation	J:69474
	decreased IgA level	J:69474
	decreased IgM level	J:69474
	increased B cell proliferation	J:69474
Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (involves: 129X1/SvJ)	abnormal class switch recombination	J:95288
	decreased IgA level	J:95288
	decreased IgE level	J:95288
	decreased IgG1 level	J:95288
Tnfrsf13b^tm1Vmd/Tnfrsf13b^tm1Vmd (involves: C57BL/6)	abnormal immunoglobulin level	J:70172
	glomerulonephritis	J:82331
	increased anti-double stranded DNA antibody level	J:82331
	increased anti-nuclear antigen antibody level	J:82331
	increased B cell proliferation	J:70172
	increased IgG1 level	J:70172
	kidney inflammation	J:82331
	liver inflammation	J:82331
Tnfrsf13c^Bcmd1/Tnfrsf13c^Bcmd1 (A/WySnJ)	abnormal lymphocyte physiology	J:92334
	decreased B cell proliferation	J:122315
	decreased IgG level	J:122315
	decreased interferon-gamma secretion	J:92334
	decreased T cell proliferation	J:92334
	increased length of allograft survival	J:92334
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (C57BL/6-Tnfrsf13c^tm1Mass)	abnormal B cell physiology	J:113556
	decreased IgG1 level	J:92732
	decreased IgG2a level	J:92732
	decreased IgG2b level	J:92732
	decreased IgG3 level	J:92732
	decreased IgG level	J:92732
	decreased IgM level	J:92732
Tnfrsf13c^tm1Msc/Tnfrsf13c^tm1Msc (involves: 129P2/OlaHsd * C57BL/6)	abnormal humoral immune response	J:92676
	decreased IgD level	J:92676
	decreased IgG1 level	J:92676
	decreased IgG level	J:92676
	decreased IgM level	J:92676
Tnfrsf14^tm1Csj/Tnfrsf14^tm1Csj (B6.Cg-Tnfrsf14^tm1Csj)	decreased interferon-gamma secretion	J:169369
	decreased interleukin-6 secretion	J:169369
	decreased interleukin-10 secretion	J:169369
	decreased susceptibility to induced colitis	J:169369
	decreased tumor necrosis factor secretion	J:169369
Tnfrsf14^tm1Kpf/Tnfrsf14^tm1Kpf (B6.129P2-Tnfrsf14^tm1Kpf)	abnormal T cell physiology	J:99456
Tnfrsf14^tm1Kpf/Tnfrsf14^tm1Kpf (B6.129P2-Tnfrsf14^tm1Kpf)	increased T cell proliferation	J:99456
Tnfrsf14^tm1Kro/Tnfrsf14^tm1Kro (C57BL/6-Tnfrsf14^tm1Kro)	decreased susceptibility to Herpesvirales infection	J:243038
Tnfrsf14^tm1Wwhk/Tnfrsf14^tm1Wwhk (B6.Cg-Tnfrsf14^tm1Wwhk)	decreased length of allograft survival	J:119356
Tnfrsf18^tm1Ppp/Tnfrsf18^tm1Ppp (involves: 129/Sv * C57BL/6)	abnormal T cell activation	J:77393
	increased interleukin-2 secretion	J:77393
	increased T cell apoptosis	J:77393
	increased T cell proliferation	J:77393
Tnfrsf21^tm1Ddy/Tnfrsf21^tm1Ddy (involves: 129S1/Sv * 129X1/SvJ)	abnormal T-helper 1 physiology	J:70594
	abnormal T-helper 2 physiology	J:70594
	increased B cell proliferation	J:109341
	increased IgG1 level	J:109341
	increased IgG2a level	J:109341
	increased IgG2b level	J:109341
	increased IgG3 level	J:109341
	increased IgM level	J:109341
	increased interleukin-4 secretion	J:70594
	increased interleukin-5 secretion	J:70594
	increased interleukin-10 secretion	J:70594
	increased interleukin-13 secretion	J:70594
	increased T cell proliferation	J:70594
Tnfrsf21^tm1Vmd/Tnfrsf21^tm1Vmd (involves: C57BL/6)	abnormal cell-mediated immunity	J:72761
	abnormal T-helper 2 physiology	J:72761
	increased IgE level	J:72761
	increased IgG1 level	J:72761
	increased IgG2a level	J:72761
	increased IgM level	J:72761
	increased interferon-gamma secretion	J:72761
	increased interleukin-2 secretion	J:72761
	increased interleukin-4 secretion	J:72761
	increased T cell proliferation	J:72761
Tnfrsf25^tm1Mjo/Tnfrsf25^tm1Mjo (involves: 129P2/OlaHsd)	decreased T cell apoptosis	J:84536
Tnfsf4^tm1Shr/Tnfsf4^tm1Shr (involves: 129S4/SvJae)	abnormal cell-mediated immunity	J:59203
	abnormal dendritic cell antigen presentation	J:59203
	decreased interferon-gamma secretion	J:59203
	decreased interleukin-2 secretion	J:59203
	decreased interleukin-4 secretion	J:59203
	decreased susceptibility to type IV hypersensitivity reaction	J:59203
	decreased T cell proliferation	J:59203
Tnfsf4^tm1Shr/Tnfsf4^tm1Shr (NOD.129S4-Tnfsf4^tm1Shr)	decreased susceptibility to autoimmune diabetes	J:86926
Tnfsf4^tm1Shr/Tnfsf4^tm1Shr (C.129S4-Tnfsf4^tm1Shr)	abnormal cytokine secretion	J:59203
Tnfsf4^tm1Shr/Tnfsf4^tm1Shr (C.129S4-Tnfsf4^tm1Shr)	abnormal dendritic cell antigen presentation	J:59203
Tnfsf4^tm1Sug/Tnfsf4^tm1Sug (B6.129S4-Tnfsf4^tm1Sug)	abnormal cytokine secretion	J:80214
	decreased susceptibility to type IV hypersensitivity reaction	J:80214
	decreased T cell proliferation	J:80214
Tnfsf8^tm1Pod/Tnfsf8^tm1Pod (B6.129X1-Tnfsf8^tm1Pod)	decreased susceptibility to graft versus host disease	J:92723
Tnfsf9^tm1Thw/Tnfsf9^tm1Thw (involves: 129 * C57BL/6)	abnormal cytotoxic T cell physiology	J:76373
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (C.129-Tnfsf10^tm1Mjs)	decreased susceptibility to bacterial infection	J:87620
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:87620
	impaired natural killer cell mediated cytotoxicity	J:73948
	liver inflammation	J:87620
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (B6.129-Tnfsf10^tm1Mjs)	increased IgG1 level	J:82145
	increased IgG2a level	J:82145
	increased interferon-gamma secretion	J:82145
	increased interleukin-2 secretion	J:82145
	increased susceptibility to autoimmune diabetes	J:82145
	increased susceptibility to experimental autoimmune encephalomyelitis	J:101672
	increased susceptibility to induced arthritis	J:82145
Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system physiology	J:52369
	decreased interferon-gamma secretion	J:52369
	decreased interleukin-2 secretion	J:52369
	decreased interleukin-4 secretion	J:52369
	decreased interleukin-5 secretion	J:52369
	decreased interleukin-6 secretion	J:52369
Tnfsf12^tm1Ash/Tnfsf12^tm1Ash (B6.129-Tnfsf12^tm1Ash)	abnormal cytokine secretion	J:104801
	decreased interleukin-10 secretion	J:104801
	increased interferon-gamma secretion	J:104801
	increased interleukin-12 secretion	J:104801
	increased susceptibility to bacterial infection	J:104801
Tnfsf13^tm1Geha/Tnfsf13^tm1Geha (involves: 129S4/SvJae)	abnormal class switch recombination	J:88910
	decreased IgA level	J:88910
	decreased IgM level	J:88910
	increased IgG level	J:88910
Tnfsf13^tm1Pod/Tnfsf13⁺ (B6.Cg-Tnfsf13^tm1Pod)	decreased IgA level	J:141374
Tnfsf13^tm1Pod/Tnfsf13^tm1Pod (B6.Cg-Tnfsf13^tm1Pod)	abnormal interleukin secretion	J:141374
	decreased IgA level	J:141374
	decreased IgG2a level	J:141374
	decreased interleukin-10 secretion	J:141374
	decreased interleukin-17 secretion	J:141374
	decreased susceptibility to induced arthritis	J:141374
	increased IgG1 level	J:141374
	increased interferon-gamma secretion	J:141374
	increased interleukin-4 secretion	J:141374
	increased interleukin-5 secretion	J:141374
	increased interleukin-13 secretion	J:141374
	increased interleukin-17 secretion	J:141374
	increased T cell proliferation	J:141374
Tnfsf13b^M1Btlr/Tnfsf13b⁺ (C57BL/6J-Tnfsf13b^M1Btlr)	decreased IgG level	J:220069
	decreased IgM level	J:220069
	impaired humoral immune response	J:220069
Tnfsf13b^M1Btlr/Tnfsf13b^M1Btlr (C57BL/6J-Tnfsf13b^M1Btlr)	decreased IgG level	J:220069
	decreased IgM level	J:220069
	impaired humoral immune response	J:220069
Tnfsf13b^m2Btlr/Tnfsf13b^m2Btlr (C57BL/6J-Tnfsf13b^m2Btlr)	decreased IgG level	J:220070
Tnfsf13b^m2Btlr/Tnfsf13b^m2Btlr (C57BL/6J-Tnfsf13b^m2Btlr)	impaired humoral immune response	J:220070
Tnfsf13b^tm1Cleg/Tnfsf13b^tm1Cleg (involves: 129S5/SvEvBrd)	abnormal B cell physiology	J:71301
	decreased IgG level	J:71301
	decreased IgM level	J:71301
Tnfsf13b^tm1Msc/Tnfsf13b⁺ (involves: 129S2/SvPas * C57BL/6)	decreased immunoglobulin level	J:71681
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129S2/SvPas * C57BL/6)	abnormal humoral immune response	J:71681
	decreased immunoglobulin level	J:71681
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129S2/SvPas)	decreased T cell proliferation	J:92334
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129S2/SvPas)	increased length of allograft survival	J:92334
Tnfsf14^tm1Ddy/Tnfsf14^tm1Ddy (involves: 129S1/Sv * 129X1/SvJ)	abnormal cytotoxic T cell physiology	J:84366
	abnormal T cell activation	J:84366
	decreased T cell proliferation	J:84366
Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	decreased cytotoxic T cell cytolysis	J:77250
	decreased interferon-gamma secretion	J:77250
	decreased interleukin-2 secretion	J:77250
	decreased interleukin-4 secretion	J:77250
	decreased interleukin-10 secretion	J:77250
	decreased splenocyte proliferation	J:77250
	decreased T cell proliferation	J:77250
Tnfsf14^tm1Lpc/Tnfsf14^tm1Lpc (involves: 129X1/SvJ * C57BL/6)	abnormal cytotoxic T cell physiology	J:76414
	decreased cytotoxic T cell cytolysis	J:76414
	decreased inflammatory response	J:107803
	decreased interferon-gamma secretion	J:76414
	decreased tumor necrosis factor secretion	J:76414
Tnfsf14^tm1Wwh/Tnfsf14^tm1Wwh (involves: 129 * C57BL/6)	increased length of allograft survival	J:75705
Tnfsf15^tm1Cdon/Tnfsf15^tm1Cdon (B6.129-Tnfsf15^tm1Cdon)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:136280
Tnfsf15^tm1Hluo/Tnfsf15^tm1Hluo (D1LacJ.129(B6)-Tnfsf15^tm1Hluo)	decreased IgG2a level	J:207029
	decreased IgG2b level	J:207029
	decreased IgG level	J:207029
	decreased susceptibility to induced arthritis	J:207029
Tnip1^{Gt(E059E05)Wrst}/Tnip1^{Gt(E059E05)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	decreased interleukin-12 secretion	J:180054
	decreased interleukin-12b secretion	J:180054
	glomerulonephritis	J:180054
	increased anti-double stranded DNA antibody level	J:180054
	increased anti-nuclear antigen antibody level	J:180054
	increased IgA level	J:180054
	increased IgG1 level	J:180054
	increased IgG2b level	J:180054
	increased IgM level	J:180054
	increased susceptibility to systemic lupus erythematosus	J:180054
Tnip1^m1Btlr/Tnip1^m1Btlr (C57BL/6J-Tnip1^m1Btlr)	increased anti-double stranded DNA antibody level	J:265175
	increased IgA level	J:265175
	increased IgE level	J:265175
	increased susceptibility to induced colitis	J:265175
Tnip1^tm1.1Pcoh/Tnip1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased anti-double stranded DNA antibody level	J:176826
Tnip1^tm1.1Pcoh/Tnip1^tm1.1Pcoh (involves: 129P2/OlaHsd * C57BL/6)	abnormal complement pathway	J:176826
	glomerulonephritis	J:176826
	increased anti-double stranded DNA antibody level	J:176826
	increased anti-nuclear antigen antibody level	J:176826
	increased B cell proliferation	J:176826
	increased IgA level	J:176826
	increased IgE level	J:176826
	increased IgG1 level	J:176826
	increased IgG2a level	J:176826
	increased IgG2b level	J:176826
	increased IgG3 level	J:176826
	increased IgG level	J:176826
	increased IgM level	J:176826
	increased immunoglobulin level	J:176826
	increased interleukin-6 secretion	J:176826
	increased interleukin-12b secretion	J:176826
	increased tumor necrosis factor secretion	J:176826
Tnip1^tm1.2Ama/Tnip1^tm1.2Ama Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6J * CBA)	increased interleukin-6 secretion	J:205446
	increased interleukin-12 secretion	J:205446
	increased interleukin-23 secretion	J:205446
	increased tumor necrosis factor secretion	J:205446
Tnip2^tm1.1Sley/Tnip2^tm1.1Sley (involves: 129S4/SvJae * 129S8/SvEv * C57BL/6)	abnormal macrophage physiology	J:112395
Tns1^tm1Efu/Tns1^tm1Efu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	tubulointerstitial nephritis	J:39202
Tns2^nph/Tns2^nph (involves: ICR)	glomerulonephritis	J:108691
Tob2^tm1Tya/Tob2^tm1Tya (involves: 129S4/SvJae * C57BL/6)	abnormal osteoclast physiology	J:134287
Tollip^tm1Kbns/Tollip^tm1Kbns (involves: C57BL/6)	decreased circulating interleukin-6 level	J:105514
	decreased interleukin-6 secretion	J:105514
	decreased tumor necrosis factor secretion	J:105514
Tom1l2^Gt(XG909)Byg/Tom1l2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased susceptibility to infection	J:133892
Tom1l2^Gt(XG909)Byg/Tom1l2^Gt(XG909)Byg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal humoral immune response	J:133892
	abnormal immune system physiology	J:133892
	abnormal inflammatory response	J:133892
	conjunctivitis	J:133892
	dermatitis	J:133892
	increased inflammatory response	J:133892
	increased susceptibility to bacterial infection	J:133892
	increased susceptibility to infection	J:133892
Tomm5^{Gt(OST44663)Lex}/Tomm5^{Gt(OST44663)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	lung inflammation	J:186382
Top3b^tm1Jcw/Top3b^tm1Jcw (involves: 129S6/SvEvTac * C57BL/6)	dermatitis	J:69405
	glomerulonephritis	J:69405
	increased inflammatory response	J:69405
	pancreas inflammation	J:69405
	stomach inflammation	J:69405
Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac)	decreased cytotoxic T cell cytolysis	J:131287
Tpcn1^tm1.1Dren/Tpcn1^tm1.1Dren Tpcn2^tm1.1Dren/Tpcn2^tm1.1Dren (Not Specified)	abnormal macrophage physiology	J:189070
Tpp2^{Gt(OST432061)Lex}/Tpp2^{Gt(OST432061)Lex} (B6.129S5-Tpp2^{Gt(OST432061)Lex})	abnormal level of surface class I molecules	J:157195
Tpp2^{Gt(OST432061)Lex}/Tpp2^{Gt(OST432061)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal antigen presentation	J:157195
Tpp2^tm1.1Gnie/Tpp2^tm1.1Gnie (involves: 129S6/SvEvTac * C57BL/6)	abnormal cytotoxic T cell physiology	J:133572
	increased T cell apoptosis	J:133572
Tpp2^tm1.1Gnie/Tpp2^tm1.1Gnie (involves: 129S6/SvEvTac)	abnormal lymphocyte physiology	J:221205
	increased anti-nuclear antigen antibody level	J:221205
	increased autoantibody level	J:221205
Tpsab1^m1/Tpsab1^m1 Tpsb2^tm1(cre)Adch/Tpsb2^tm1(cre)Adch (B6.Cg-Tpsb2^tm1(cre)Adch Tpsab1^m1)	decreased susceptibility to induced arthritis	J:142880
Tpsb2^tm1(cre)Adch/Tpsb2^tm1(cre)Adch (B6.Cg-Tpsb2^tm1(cre)Adch)	increased susceptibility to bacterial infection	J:124554
Tpsb2^tm1.1Mfg/Tpsb2^tm1.1Mfg (B6.129-Tpsb2^tm1.1Mfg)	decreased susceptibility to induced arthritis	J:142880
	impaired eosinophil recruitment	J:133373
	impaired neutrophil chemotaxis	J:142880
	increased susceptibility to parasitic infection	J:133373
Tpsg1^tm1.2Rls/Tpsg1^tm1.2Rls (involves: C57BL/6 * C57BL/6NTac)	decreased susceptibility to colitis induced morbidity/mortality	J:243813
Tpx2^{Gt(D028B03)Wrst}/Tpx2⁺ (involves: 129S2/SvPas * C57BL/6J)	granulomatous inflammation	J:184948
Tradd^tm1.1Mak/Tradd⁺ (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))	decreased acute inflammation	J:138824
Tradd^tm1.1Mak/Tradd^tm1.1Mak (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))	decreased acute inflammation	J:138824
	decreased circulating interleukin-6 level	J:138824
	decreased inflammatory response	J:138824
	decreased interleukin-6 secretion	J:138824
Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: C57BL/6)	decreased interferon-beta secretion	J:136289
Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	abnormal interleukin level	J:139030
	decreased circulating tumor necrosis factor level	J:139030
	decreased IgG level	J:139030
	increased susceptibility to bacterial infection	J:139030
Traf1^tm1Tsi/Traf1^tm1Tsi (involves: 129S4/SvJae * C57BL/6)	increased T cell proliferation	J:72327
Traf2^tm1Mak/Traf2^tm1Mak (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))	increased circulating tumor necrosis factor level	J:44360
	increased thymocyte apoptosis	J:44360
Traf3^m1Btlr/Traf3^m1Btlr (C57BL/6J-Traf3^m1Btlr)	impaired humoral immune response	J:212064
Traf3^m2Btlr/Traf3^m2Btlr (C57BL/6J-Traf3^m2Btlr)	decreased IgG level	J:217797
Traf3^m2Btlr/Traf3^m2Btlr (C57BL/6J-Traf3^m2Btlr)	decreased response to antigen	J:217797
Traf3^tm1Bal/Traf3^tm1Bal (involves: 129S4/SvJae * C57BL/6J)	abnormal T cell physiology	J:37065
Traf3^tm1Bshp/Traf3^tm1Bshp Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal adaptive immunity	J:124329
	abnormal immune system physiology	J:124329
	autoimmune response	J:124329
	decreased B cell apoptosis	J:124329
	increased anti-double stranded DNA antibody level	J:124329
	increased IgA level	J:124329
	increased IgG2a level	J:124329
	increased IgG2b level	J:124329
	increased IgG3 level	J:124329
	increased IgG level	J:124329
	increased IgM level	J:124329
Traf3ip2^adjm/Traf3ip2^adjm (KOR-Traf3ip2^adjm)	dermatitis	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (A.KOR-Traf3ip2^adjm)	dermatitis	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (A.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (B6.KOR-Traf3ip2^adjm)	dermatitis	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (B6.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (C.KOR-Traf3ip2^adjm)	dermatitis	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (C.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (AK.KOR-Traf3ip2^adjm)	dermatitis	J:162859
Traf3ip2^adjm/Traf3ip2^adjm (AK.KOR-Traf3ip2^adjm)	increased IgE level	J:162859
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (involves: 129/Sv * BALB/c)	abnormal immune system physiology	J:93923
	increased anti-double stranded DNA antibody level	J:93923
	increased anti-histone antibody level	J:93923
	increased anti-single stranded DNA antibody level	J:93923
	increased autoantibody level	J:93923
	increased IgE level	J:93923
	increased IgG level	J:93923
	increased immunoglobulin level	J:93923
	increased inflammatory response	J:93923
	respiratory system inflammation	J:93923
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (C.129-Traf3ip2^tm1.1Lix)	blepharitis	J:138560
	glomerulonephritis	J:138560
	increased autoantibody level	J:138560
	increased inflammatory response	J:138560
	kidney inflammation	J:138560
	lacrimal gland inflammation	J:138560
	parotid gland inflammation	J:138560
	stomatitis	J:138560
	submandibular gland inflammation	J:138560
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (B6.129-Traf3ip2^tm1.1Lix)	increased anti-chromatin antibody level	J:187766
	increased anti-double stranded DNA antibody level	J:187766
	increased anti-histone antibody level	J:187766
	increased anti-nuclear antigen antibody level	J:187766
	increased autoantibody level	J:187766
	increased IgG1 level	J:187766
	increased IgG2c level	J:187766
	increased IgG level	J:187766
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129 * 129S2/SvPas * BALB/c)	increased autoantibody level	J:138560
Traf3ip2^tm1Lix/Traf3ip2^tm1.1Lix Tg(CD19-cre/ERT2)1Cgn/0 (involves: 129/Sv * BALB/c)	increased immunoglobulin level	J:93923
Traf3ip2^tm1Sbn/Traf3ip2^tm1Sbn (either: B6.129-Traf3ip2^tm1Sbn or (involves: 129) or (involves: 129 * BALB/c))	abnormal cytokine secretion	J:144320
	decreased interleukin-6 secretion	J:144320
	decreased susceptibility to autoimmune disorder	J:144320
	impaired eosinophil recruitment	J:144320
	impaired macrophage chemotaxis	J:144320
	impaired neutrophil recruitment	J:144320
Traf3ip2^tm1Sbn/Traf3ip2^tm1Sbn (involves: 129 * C57BL/6)	decreased inflammatory response	J:191090
Traf4^tm1Lind/Traf4^tm1Lind (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	lung inflammation	J:74252
Traf4^tm1Mrio/Traf4^tm1Mrio (involves: 129X1/SvJ)	abnormal dendritic cell physiology	J:142780
Traf4^tm2Lind/Traf4^tm2Lind (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	lung inflammation	J:74252
Traf5^tm1Hna/Traf5^tm1Hna (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal B cell proliferation	J:57114
	abnormal humoral immune response	J:57114
	abnormal T cell proliferation	J:57114
	decreased IgG1 level	J:57114
	decreased IgM level	J:57114
Traf6^tm1.1Mpa/Traf6^tm1.1Mpa Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased circulating interleukin-6 level	J:145306
Traf6^tm1Mak/Traf6^tm1Mak (involves: 129P3/J)	abnormal macrophage physiology	J:54467
	abnormal osteoclast physiology	J:54467
	decreased B cell proliferation	J:54467
	decreased tumor necrosis factor secretion	J:54467
Traf6^tm1Ywc/Traf6^tm1Ywc (Not Specified)	abnormal dendritic cell physiology	J:85808
	decreased interleukin-6 secretion	J:85808
	decreased interleukin-12 secretion	J:85808
Traf6^{tm2a(EUCOMM)Wtsi}/Traf6^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Traf6^{tm2a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Traf6^tm2Ywc/Traf6^tm2Ywc Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	abnormal lymphocyte anergy	J:130882
Trafd1^tm1Ayos/Trafd1^tm1Ayos (involves: 129 * C57BL/6J)	decreased susceptibility to Riboviria infection	J:144594
	increased circulating interleukin-6 level	J:144594
	increased interleukin-6 secretion	J:144594
	increased interleukin-12 secretion	J:144594
	increased susceptibility to endotoxin shock	J:144594
	increased tumor necrosis factor secretion	J:144594
Traj18^em1Hwata/Traj18^em1Hwata (C57BL/6-Traj18^em1Hwata)	abnormal cytokine secretion	J:256533
Traj18^em1Hwata/Traj18^em1Hwata (C.B6-Traj18^em1Hwata)	abnormal cytokine secretion	J:256533
Traj18^tm1.1Kro/Traj18^tm1.1Kro (involves: C57BL/6NTac)	abnormal circulating interleukin-4 level	J:232957
	abnormal interferon-gamma secretion	J:232957
	decreased inflammatory response	J:232957
Trap1^{Gt(E150H04)Wrst}/Trap1^{Gt(E150H04)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	decreased inflammatory response	J:226880
Trappc9^{tm1a(EUCOMM)Wtsi}/Trappc9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trappc9^{tm1a(EUCOMM)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Trem1^{tm1(KOMP)Vlcg}/Trem1^{tm1(KOMP)Vlcg} (C57BL/6N-Trem1^{tm1(KOMP)Vlcg}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Trem2^em2Bwef/Trem2^em2Bwef (involves: C57BL/6J * DBA/2J * FVB/N)	decreased macrophage proliferation	J:242126
	decreased microglial cell activation	J:242126
	impaired macrophage phagocytosis	J:242126
	increased circulating interleukin-6 level	J:242126
	increased circulating tumor necrosis factor level	J:242126
	increased macrophage apoptosis	J:242126
	increased susceptibility to endotoxin shock	J:242126
Trem2^{tm1(KOMP)Vlcg}/Trem2^{tm1(KOMP)Vlcg} (C57BL/6N-Trem2^{tm1(KOMP)Vlcg})	abnormal microglial cell physiology	J:239381
	decreased microglial cell activation	J:239381
Trem2^tm1Cln/Trem2^tm1Cln (B6.129P2-Trem2^tm1Cln)	abnormal interferon level	J:138057
	abnormal interleukin level	J:138057
	abnormal tumor necrosis factor level	J:138057
Treml1^tm1Mcvic/Treml1^tm1Mcvic (C57BL/6-Treml1^tm1Mcvic)	increased susceptibility to endotoxin shock	J:150578
Treml1^tm1Mcvic/Treml1^tm1Mcvic (C57BL/6-Treml1^tm1Mcvic)	increased tumor necrosis factor secretion	J:150578
Trex1^em3Gpt/Trex1^em3Gpt (C57BL/6JGpt-Trex1^em3Gpt)	increased circulating tumor necrosis factor level	J:330879
Trex1^em3Gpt/Trex1^em3Gpt (C57BL/6JGpt-Trex1^em3Gpt)	increased susceptibility to autoimmune disorder	J:330879
Trex1^tm1.1Fwpe/Trex1^tm1.1Fwpe (involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)	abnormal T cell activation	J:220965
	bronchiolitis	J:220965
	glomerulonephritis	J:220965
	heart inflammation	J:220965
	increased anti-double stranded DNA antibody level	J:220965
	increased IgG level	J:220965
	increased inflammatory response	J:220965
	increased susceptibility to systemic lupus erythematosus	J:220965
	lacrimal gland inflammation	J:220965
	pancreas inflammation	J:220965
	salivary gland inflammation	J:220965
	tubulointerstitial nephritis	J:220965
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd)	abnormal interferon secretion	J:234263
	heart inflammation	J:202757
	increased autoantibody level	J:202757
	myocarditis	J:92264
	skin inflammation	J:202757
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * C57BL/6)	dermatitis	J:181257
	folliculitis	J:181257
	glomerulonephritis	J:181257
	increased anti-nuclear antigen antibody level	J:181257
	increased IgG level	J:181257
	increased inflammatory response	J:181257
	increased susceptibility to systemic lupus erythematosus	J:181257
	kidney inflammation	J:181257
	myocarditis	J:181257
	myositis	J:181257
	skin inflammation	J:181257
	stomach inflammation	J:181257
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)	heart inflammation	J:234263
	increased autoantibody level	J:234263
	increased inflammatory response	J:234263
	kidney inflammation	J:234263
	myositis	J:234263
	stomach inflammation	J:234263
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd * C57BL/6J)	dermatitis	J:243357
	increased susceptibility to autoimmune disorder	J:243357
Tria4^STS/A/? (involves: BALB/c * STS/A)	abnormal leukocyte physiology	J:56029
Tria5^STS/A/? (involves: BALB/cHeA * STS/A)	abnormal leukocyte physiology	J:56029
Trib1^tm1Aki/Trib1^tm1Aki (involves: 129P2/OlaHsd)	decreased interleukin-12 secretion	J:126085
Trib3^tm1Tord/Trib3^tm1Tord (involves: C57BL/6)	abnormal mast cell physiology	J:192615
Trib3^tm1Tord/Trib3^tm1Tord (involves: C57BL/6)	decreased mast cell degranulation	J:192615
Tril^tm1.1Kaf/Tril^tm1.1Kaf (involves: C57BL/6)	abnormal chemokine secretion	J:301765
	abnormal cytokine secretion	J:301765
	decreased interferon-beta secretion	J:301765
	decreased interleukin-6 secretion	J:301765
	decreased tumor necrosis factor secretion	J:301765
Trim6^em1Raj/Trim6^em1Raj (C57BL/6J-Trim6^em1Raj)	abnormal response to infection	J:326927
Trim7^em1Jiew/Trim7^em1Jiew (C57BL/6-Trim7^em1Jiew)	decreased susceptibility to Herpesvirales infection	J:292408
Trim7^em1Jiew/Trim7^em1Jiew (C57BL/6-Trim7^em1Jiew)	decreased susceptibility to viral infection	J:292408
Trim8^tm1Hbsh/Trim8^tm1Hbsh (involves: 129S6/SvEvTac)	abnormal chemokine secretion	J:251270
	abnormal circulating chemokine level	J:251270
	decreased interleukin-6 secretion	J:251270
	decreased tumor necrosis factor secretion	J:251270
	increased circulating interleukin-6 level	J:251270
	increased circulating tumor necrosis factor level	J:251270
	increased interferon-beta secretion	J:251270
	increased interleukin-6 secretion	J:251270
	increased macrophage cytokine production	J:251270
	increased susceptibility to bacterial infection	J:251270
	increased susceptibility to bacterial infection induced morbidity/mortality	J:251270
	increased susceptibility to endotoxin shock	J:251270
	increased tumor necrosis factor secretion	J:251270
Trim13^tm1.1Jskg/Trim13^tm1.1Jskg (B6.129S7(Cg)-Trim13^tm1.1Jskg)	abnormal circulating interferon level	J:243916
	decreased circulating interferon-beta level	J:243916
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:243916
	increased interferon-beta secretion	J:243916
Trim14^em1Rfw/Trim14^em1Rfw (involves: C57BL/6J)	decreased interferon-beta secretion	J:249057
	increased susceptibility to Herpesvirales infection	J:249057
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:249057
Trim21^tm1Mwah/Trim21⁺ (C57BL/6-Trim21^tm1Mwah)	dermatitis	J:151775
Trim21^tm1Mwah/Trim21^tm1Mwah (C57BL/6-Trim21^tm1Mwah)	abnormal interleukin level	J:151775
	abnormal T cell activation	J:151775
	abnormal tumor necrosis factor level	J:151775
	autoimmune response	J:151775
	dermatitis	J:151775
	increased autoantibody level	J:151775
	increased inflammatory response	J:151775
Trim25^tm1Mura/Trim25⁺ Usp15^L749R/Usp15⁺ (involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:259382
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:259382
Trim25^tm1Mura/Trim25^tm1Mura (involves: 129S4/SvJae)	decreased susceptibility to parasitic infection	J:259382
Trim25^tm1Mura/Trim25^tm1Mura (involves: 129S4/SvJae)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:259382
Trim27^{Gt(345D11)Cmhd}/Trim27^{Gt(345D11)Cmhd} (B6.129-Trim27^{Gt(345D11)Cmhd})	abnormal T-helper 1 physiology	J:180433
	abnormal T-helper 2 physiology	J:180433
	increased interferon-gamma secretion	J:180433
	increased tumor necrosis factor secretion	J:180433
Trim30a^tm1Yjk/Trim30a^tm1Yjk (B6.129P2-Trim30a^tm1Yjk)	abnormal CD4-positive, alpha-beta T cell physiology	J:215171
Trim30a^tm1Yjk/Trim30a^tm1Yjk (B6.129P2-Trim30a^tm1Yjk)	increased T cell proliferation	J:215171
Trim31^em1Cya/Trim31^em1Cya (involves: C57BL/6)	abnormal circulating cytokine level	J:243237
	decreased susceptibility to induced colitis	J:243237
	increased circulating interleukin-1 beta level	J:243237
Trim35^em1Smoc/Trim35^em1Smoc (C57BL/6J-Trim35^em1Smoc)	decreased circulating interferon-beta level	J:303214
	decreased macrophage cytokine production	J:303214
	increased susceptibility to Orthomyxoviridae infection	J:303214
	increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality	J:303214
Trim38^{tm1(KOMP)Vlcg}/Trim38^{tm1(KOMP)Vlcg} (involves: C57BL/6N)	increased circulating interferon-alpha level	J:239773
	increased circulating interferon-beta level	J:239773
	increased circulating interleukin-6 level	J:239773
	increased circulating tumor necrosis factor level	J:239773
	increased susceptibility to bacterial infection	J:239773
	increased susceptibility to bacterial infection induced morbidity/mortality	J:239773
	increased susceptibility to infection induced morbidity/mortality	J:239773
Trim40^em1Caox/Trim40^em1Caox (involves: C57BL/6J)	abnormal immune system physiology	J:255265
	abnormal macrophage physiology	J:255265
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:255265
Trim45^{tm1a(KOMP)Wtsi}/Trim45^{tm1a(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Trim45^{tm1a(KOMP)Wtsi} Tyr^c-Brd/Wtsi)	blood in lymph vessels	J:239583
Trim55^tm1Slbt/Trim55^tm1Slbt (involves: 129 * C57BL/6)	decreased susceptibility to Coronaviridae infection	J:268979
Trim58^tm2313.1Arte/Trim58^tm2313.1Arte Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased susceptibility to induced colitis	J:279270
Trim58^tm2313.2Arte/Trim58^tm2313.2Arte (involves: BALB/cJ * C57BL/6N)	increased susceptibility to induced colitis	J:279270
Trim65^em1Cya/Trim65^em1Cya (involves: C57BL/6)	decreased circulating interferon-alpha level	J:240099
	decreased circulating interferon-beta level	J:240099
	decreased interferon-alpha secretion	J:240099
	decreased interferon-beta secretion	J:240099
	increased susceptibility to Picornaviridae infection	J:240099
	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:240099
Trim65^em2Cya/Trim65^em2Cya (involves: C57BL/6)	decreased interferon-beta secretion	J:240099
Trim65^em3Cya/Trim65^em3Cya (involves: C57BL/6)	decreased interferon-beta secretion	J:240099
Trip10^tm1.1Geha/Trip10^tm1.1Geha (B6.129S1-Trip10^tm1.1Geha)	abnormal T cell physiology	J:164363
	decreased IgE level	J:164363
	decreased IgG level	J:164363
	decreased susceptibility to type IV hypersensitivity reaction	J:164363
Trmq3^FVB/N/? (involves: DBA/1J * FVB/N)	abnormal T cell proliferation	J:94347
Trp53^tm1.1Awbr/Trp53^tm1.1Awbr (involves: C57BL/6)	decreased thymocyte apoptosis	J:173271
Trp53^tm1.1Thst/Trp53^tm1.1Thst (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	decreased thymocyte apoptosis	J:198482
Trp53^tm1.1Tldo/Trp53^tm1.1Tldo (involves: 129S2/SvPas * BALB/c * C57BL/6)	increased thymocyte apoptosis	J:199308
Trp53^tm1.1Wgu/Trp53^tm1.1Wgu (involves: 129S6/SvEvTac * C57BL/6)	decreased thymocyte apoptosis	J:186159
Trp53^tm1.2Awbr/Trp53⁺ (involves: C57BL/6)	increased inflammatory response	J:173271
Trp53^tm1.2Awbr/Trp53⁺ (involves: C57BL/6)	liver inflammation	J:173271
Trp53^tm1.2Awbr/Trp53^tm1.2Awbr (involves: C57BL/6)	adipose tissue inflammation	J:173271
	decreased thymocyte apoptosis	J:173271
	increased circulating interferon-gamma level	J:173271
	increased circulating interleukin-3 level	J:173271
	increased circulating interleukin-5 level	J:173271
	increased circulating interleukin-6 level	J:173271
	increased circulating tumor necrosis factor level	J:173271
	increased inflammatory response	J:173271
	increased splenocyte proliferation	J:173271
	liver inflammation	J:173271
	lung inflammation	J:173271
Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S7/SvEvBrd)	abnormal thymus physiology	J:175018
Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S7/SvEvBrd)	decreased thymocyte apoptosis	J:186159
Trp53^tm1Brd/Trp53^tm1Brd Trp73^tm2Mak/Trp73^tm2Mak (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte apoptosis	J:157905
Trp53^tm1Glo/Trp53^tm1Glo (involves: 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte apoptosis	J:172038
Trp53^tm1Holl/Trp53^tm7.1Xu (involves: 129P2/OlaHsd)	decreased thymocyte apoptosis	J:160414
Trp53^tm1Thst/Trp53^tm1Thst (involves: 129S1/Sv * 129X1/SvJ)	decreased thymocyte apoptosis	J:198482
Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas)	decreased thymocyte apoptosis	J:158953
Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte apoptosis	J:80311
Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas)	decreased splenocyte apoptosis	J:195018
	decreased T cell apoptosis	J:109354
	decreased thymocyte apoptosis	J:158953, J:195018, J:126920
Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte apoptosis	J:80311
Trp53^tm1Tyj/Trp53^tm1Tyj Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S2/SvPas * C57BL/6N * C57BL/10 * CBA/Ca)	abnormal interleukin secretion	J:305794
Trp53^tm1Xu/Trp53^tm1Xu (involves: 129S4/SvJae)	abnormal thymocyte apoptosis	J:86185
Trp53^tm1Yjc/Trp53^tm1Yjc (B6.129S1-Trp53^tm1Yjc)	decreased splenocyte apoptosis	J:195018
Trp53^tm2.1Snj/Trp53^tm2.1Snj (involves: 129S4/SvJae * C57BL/6)	abnormal thymus physiology	J:175018
Trp53^tm2.1Wgu/Trp53^tm2.1Wgu (involves: 129S6/SvEvTac * C57BL/6)	decreased thymocyte apoptosis	J:186159
Trp53^tm2Xu/Trp53^tm2Xu (involves: 129S6/SvEvTac)	decreased T cell apoptosis	J:109354
Trp53^tm2Xu/Trp53^tm2Xu (involves: 129S6/SvEvTac)	decreased T cell proliferation	J:109354
Trp53^tm3.1Holl/Trp53^tm3.1Holl (Not Specified)	increased thymocyte apoptosis	J:191183
Trp53^tm7.1Xu/Trp53⁺ (Not Specified)	abnormal thymus physiology	J:160414
Trp53^tm7.1Xu/Trp53^tm7.1Xu (Not Specified)	abnormal thymus physiology	J:160414
Trp53^tm7.1Xu/Trp53^tm7.1Xu (Not Specified)	decreased thymocyte apoptosis	J:160414
Trp53bp1^m2Btlr/Trp53bp1^m2Btlr (C57BL/6J-Trp53bp1^m2Btlr)	decreased IgD level	J:254841
	decreased IgG level	J:254841
	impaired humoral immune response	J:254841
Trp53bp1^m3Btlr/Trp53bp1^m3Btlr (C57BL/6J-Trp53bp1^m3Btlr)	decreased IgD level	J:254848
Trp53bp1^m4Btlr/Trp53bp1^m4Btlr (C57BL/6J-Trp53bp1^m4Btlr)	decreased IgD level	J:254852
Trp53bp1^m5Btlr/Trp53bp1^m5Btlr (C57BL/6J-Trp53bp1^m5Btlr)	decreased IgD level	J:272848
Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129)	abnormal class switch recombination	J:194603, J:231089, J:307190
Trp53bp2^tm1Cdlo/Trp53bp2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell physiology	J:146764
Trp53inp1^tm1Acar/Trp53inp1^tm1Acar (involves: 129/Sv * C57BL/6)	increased susceptibility to induced colitis	J:118867
	large intestinal inflammation	J:118867
Trp63^tm2Brd/Trp63⁺ (involves: 129S7/SvEvBrd)	increased susceptibility to infection	J:100483
	kidney inflammation	J:100483
	uterine cervix inflammation	J:100483
Trp73^tm1Fmc/Trp73^tm1Fmc (involves: 129S4/SvJae)	chronic inflammation	J:60896
	conjunctivitis	J:60896
	increased susceptibility to bacterial infection	J:60896
	increased susceptibility to otitis media	J:60896
	rhinitis	J:60896
	sinus inflammation	J:60896
Trp73^tm2Mak/Trp73^tm2Mak (either: B6.129P2-Trp73^tm2Mak or (involves: 129P2/OlaHsd * C57BL/6J))	increased thymocyte apoptosis	J:157905
Trpa1^tm1Jul/Trpa1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal acute inflammation	J:115886
Trpm2^tm1.1Alp/Trpm2^tm1.1Alp (B6.129P2-Trpm2^tm1.1Alp)	decreased circulating interferon-gamma level	J:174397
	decreased circulating interleukin-12 level	J:174397
	decreased circulating interleukin-12b level	J:174397
	decreased interferon-gamma secretion	J:174397
	decreased interleukin-12 secretion	J:174397
	increased susceptibility to bacterial infection	J:174397
	increased susceptibility to bacterial infection induced morbidity/mortality	J:174397
Trpm2^tm1Lhj/Trpm2^tm1Lhj (Not Specified)	abnormal macrophage physiology	J:202791
Trpm2^tm1Yamo/Trpm2^tm1Yamo (involves: 129S4/SvJae * C57BL/6J)	abnormal interferon level	J:137676
	abnormal interleukin level	J:137676
	abnormal leukocyte physiology	J:137676
	abnormal macrophage physiology	J:137676
	decreased inflammatory response	J:137676
	impaired neutrophil recruitment	J:137676
Trpm4^tm1.1Knt/Trpm4^tm1.1Knt (Not Specified)	abnormal dendritic cell physiology	J:140991
Trpm4^tm1.1Knt/Trpm4^tm1.1Knt Trpm5^tm1Csz/Trpm5^tm1Csz (involves: 129S1/Sv * 129X1/SvJ)	abnormal dendritic cell physiology	J:140991
Trpm4^tm1.1Mfre/Trpm4^tm1.1Mfre (involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)	increased susceptibility to type I hypersensitivity reaction	J:118679
Trpm7^tm1Agry/Trpm7⁺ (involves: 129)	increased susceptibility to type IV hypersensitivity reaction	J:205665
Trpm7^tm1Clph/Trpm7^tm1.1Clph Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal T cell physiology	J:140630
Trpv1^tm1Jul/Trpv1^tm1Jul (involves: 129X1/SvJ * C57BL/6)	decreased susceptibility to endotoxin shock	J:104828
Trpv1^tm1Jul/Trpv1^tm1Jul (B6.129X1-Trpv1^tm1Jul)	abnormal chemokine secretion	J:154624
	increased interleukin-6 secretion	J:154624
	increased tumor necrosis factor secretion	J:154624
	kidney inflammation	J:154624
Trpv2^tm1Mijc/Trpv2^tm1Mijc (involves: 129S6/SvEvTac * C57BL/6)	impaired macrophage chemotaxis	J:158505
	impaired macrophage phagocytosis	J:158505
	increased susceptibility to bacterial infection	J:158505
	increased susceptibility to bacterial infection induced morbidity/mortality	J:158505
Trpv3^Nh/Trpv3⁺ (involves: DS)	dermatitis	J:42153
Trpv3^Nh/Trpv3⁺ (involves: DS)	increased susceptibility to bacterial infection	J:42153
Trpv3^tm1.2Clph/Trpv3^tm1.2Clph (involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * CBA)	erythroderma	J:164741
Trpv5^Hcalc1/Trpv5⁺ (involves: C3H/HeH * C57BL/6J)	kidney inflammation	J:196612
Trpv5^Hcalc1/Trpv5^Hcalc1 (involves: C3H/HeH * C57BL/6J)	kidney inflammation	J:196612
Trpv5^m1Btlr/Trpv5^m1Btlr (C57BL/6J-Trpv5^m1Btlr)	increased susceptibility to induced colitis	J:192586
Trpv5^m1Btlr/Trpv5^m1Btlr (C57BL/6J-Trpv5^m1Btlr)	intestinal inflammation	J:192586
Tsc22d3^tm1.2Efmd/Y (Not Specified)	abnormal susceptibility to autoimmune disorder	J:201728
	increased interferon-gamma secretion	J:201728
	increased interleukin-17 secretion	J:201728
	increased susceptibility to type IV hypersensitivity reaction	J:201728
Tsiq1^BALB/cOla/Tsiq1^BALB/cOla (involves: BALB/cOla * C57BL/6Ola)	increased interleukin-4 secretion	J:99489
Tsiq1^BALB/cOla/Tsiq1^BALB/cOla Tsiq2^BALB/cOla/Tsiq2^BALB/cOla Tsiq3^BALB/cOla/Tsiq3^C57BL/6Ola (involves: BALB/cOla * C57BL/6Ola)	increased interleukin-4 secretion	J:99489
Tsiq2^BALB/cOla/Tsiq2^BALB/cOla (involves: BALB/cOla * C57BL/6Ola)	increased interleukin-4 secretion	J:99489
Tsiq3^BALB/cOla/Tsiq3^C57BL/6Ola (involves: BALB/cOla * C57BL/6Ola)	increased interleukin-4 secretion	J:99489
Tslp^{tm1(KOMP)Vlcg}/Tslp^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal immune system physiology	J:187770
	abnormal immunoglobulin level	J:187770
	decreased acute inflammation	J:187770
	decreased circulating interleukin-4 level	J:187770
	increased interferon-gamma secretion	J:187770
	respiratory system inflammation	J:187770
Tslp^tm1.1Pcn/Tslp^tm1.1Pcn Tg(KRT14-cre)1Ipc/0 (involves: 129 * C57BL/6 * SJL)	decreased IgE level	J:146511
Tslp^tm1Mak/Tslp^tm1Mak (B6.Cg-Tslp^tm1Mak)	colitis	J:175844
Tslp^tm1Sfz/Tslp^tm1Sfz (involves: 129)	abnormal interleukin secretion	J:197193
	abnormal T-helper 2 physiology	J:197193
	increased interleukin-5 secretion	J:197193
	increased interleukin-13 secretion	J:197193
Tspan32^{Gt(pMS-1)1Jmt}/Tspan32^{Gt(pMS-1)1Jmt} (involves: 129S1/Sv)	increased T cell proliferation	J:78033
Ttc7^fsn-Jic/Ttc7^fsn-Jic (C3.INT-Ttc7^fsn-Jic)	liver inflammation	J:115742
Ttc7^fsn/Ttc7^fsn (involves: A/J)	stomach inflammation	J:2777
Ttc39aos1^tm1Kaf/Ttc39aos1^tm1Kaf (C57BL/6-Ttc39aos1^tm1Kaf)	increased susceptibility to endotoxin shock	J:234649
Ttll1^{Gt(OST372941)Lex}/Ttll1^{Gt(OST372941)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased susceptibility to otitis media	J:186050
	rhinitis	J:186050
Ttll1^tm1Seto/Ttll1^tm1Seto (involves: 129S/SvEv * C57BL/6)	rhinosinusitis	J:161297
Ttn^mdm/Ttn^mdm (Not Specified)	myositis	J:14016
Ttn^tm1.1Isrd/Ttn^tm1.1Isrd (involves: 129S2/SvPas * C57BL/6)	myositis	J:165576
Tub^tub/Tub^tub (C57BL/6J-Tub^tub)	abnormal Langerhans cell physiology	J:13772
Tusc2^tm1Avi/Tusc2⁺ (involves: 129S1/Sv * C57BL/6J)	arteritis	J:119985
	glomerulonephritis	J:119985
	increased anti-nuclear antigen antibody level	J:119985
	increased susceptibility to autoimmune disorder	J:119985
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv * C57BL/6J)	arteritis	J:119985
	decreased interleukin-15 secretion	J:119985
	glomerulonephritis	J:119985
	increased anti-nuclear antigen antibody level	J:119985
	increased susceptibility to autoimmune disorder	J:119985
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv)	arteritis	J:309768
	chronic inflammation	J:309768
	decreased T cell proliferation	J:309768
	increased susceptibility to autoimmune disorder	J:309768
Tvp23b^em3Eetr/Tvp23b^em3Eetr (C57BL/6J-Tvp23b^em3Eetr)	increased susceptibility to induced colitis	J:340685
Tvp23b^m1Btlr/Tvp23b^m1Btlr (C57BL/6J-Tvp23b^m1Btlr)	increased susceptibility to induced colitis	J:340685
Twist2^tm1(cre)Dor/Twist2^tm1(cre)Dor (involves: 129/Sv * 129X1/SvJ)	abnormal interleukin level	J:81485
	abnormal tumor necrosis factor level	J:81485
Twsg1^tm1Nosa/Twsg1^tm1Nosa (involves: 129P2/OlaHsd * C57BL/6)	increased thymocyte apoptosis	J:82738
Txk^tm1Pls/Txk^tm1Pls (involves: 129S6/SvEvTac)	abnormal cytokine secretion	J:54449
Txk^tm1Pls/Txk^tm1Pls (involves: 129S6/SvEvTac)	increased susceptibility to parasitic infection	J:54449
Txndc2^tm1Lex/Txndc2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased circulating interleukin-6 level	J:103485
Txnip^tm1Yu/Txnip^tm1Yu (involves: 129)	abnormal NK cell physiology	J:96677
Txnip^tm1Yu/Txnip^tm1Yu (involves: 129)	increased T cell proliferation	J:96677
Tyk2^E775K/Tyk2^E775K (B10.D1-H2^q/SgJ)	abnormal T-helper 1 physiology	J:69051
	decreased IgG1 level	J:69051
	decreased IgG2a level	J:69051
	decreased IgG level	J:69051
	decreased interferon-gamma secretion	J:69051, J:120304
	decreased susceptibility to induced arthritis	J:69051
	increased circulating interleukin-12 level	J:120304
	increased susceptibility to parasitic infection	J:120304
Tyk2^tm1Biat/Tyk2^tm1Biat (involves: 129P2/OlaHsd * C57BL/6)	abnormal response to infection	J:116703
	decreased interferon-gamma secretion	J:65408
	decreased macrophage nitric oxide production	J:65408
	increased susceptibility to Herpesvirales infection	J:116703
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:116703
	increased susceptibility to Riboviria infection	J:65408
	increased susceptibility to viral infection induced morbidity/mortality	J:65408
Tyk2^tm1Biat/Tyk2^tm1Biat (B6NCrl.129P2-Tyk2^tm1Biat)	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:187818
Tyk2^tm1Biat/Tyk2^tm1Biat (B6NCrl.129P2-Tyk2^tm1Biat)	increased susceptibility to Riboviria infection induced morbidity/mortality	J:187818
Tyk2^tm1Shmd/Tyk2^tm1Shmd (involves: 129P2/OlaHsd)	abnormal splenocyte physiology	J:65409
	abnormal T cell physiology	J:65409
	decreased interferon-gamma secretion	J:65409
Tyk2^tm3.1Biat/Tyk2^tm3.1Biat (B6NCrl.129P2(C)-Tyk2^tm3.1Biat)	increased susceptibility to Picornaviridae infection induced morbidity/mortality	J:187818
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:187818
Tymp^tm1Akiy/Tymp^tm1Akiy Upp1^tm1Akiy/Upp1^tm1Akiy (involves: 129X1/SvJ)	brain inflammation	J:78036
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	decreased susceptibility to type IV hypersensitivity reaction	J:64764
	impaired natural killer cell mediated cytotoxicity	J:64764
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (B6.129P2-Tyrobp^tm1.1Viv)	abnormal osteoclast physiology	J:129304, J:95232
Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd * C57BL/6)	decreased interferon-gamma secretion	J:64763
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:64763
	decreased T cell proliferation	J:64763
	impaired natural killer cell mediated cytotoxicity	J:64763
	increased natural killer cell mediated cytotoxicity	J:64763
Tyrobp^tm1Lll/Tyrobp^tm1Lll (B6.129P2-Tyrobp^tm1Lll)	abnormal NK T cell physiology	J:147867
Tyrobp^tm1Lll/Tyrobp^tm1Lll (B6.129P2-Tyrobp^tm1Lll)	decreased interferon-gamma secretion	J:147867
Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd)	decreased susceptibility to induced arthritis	J:158811
Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (involves: 129P2/OlaHsd * C57BL/6)	abnormal dendritic cell physiology	J:110786
	abnormal osteoclast physiology	J:81823
Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (B6.129P2-Tyrobp^tm1Ttk)	increased anti-double stranded DNA antibody level	J:177613
	increased autoantibody level	J:177613
	increased B cell proliferation	J:177613
	increased IgG2a level	J:177613
	increased IgG3 level	J:177613
	increased interleukin-6 secretion	J:177613
Tyrobp^tm1Viv/Tyrobp^tm1Viv (B6.129P2-Tyrobp^tm1Viv)	increased susceptibility to Herpesvirales infection	J:124749
U90926^em1Dnkv/U90926^em1Dnkv (C57BL6/J-U90926^em1Dnkv)	increased circulating interleukin-6 level	J:340649
	increased susceptibility to bacterial infection induced morbidity/mortality	J:340649
	increased susceptibility to endotoxin shock	J:340649
Uaca^tm1Kiy/Uaca^tm1Kiy (B6.129P2-Uaca^tm1Kiy)	increased tumor necrosis factor secretion	J:157049
	liver inflammation	J:157049
	lung inflammation	J:157049
Ubash3b^tm1Jni/Ubash3b^tm1Jni Ubash3a^tm1Jni/Ubash3a^tm1Jni (Not Specified)	abnormal cytokine secretion	J:89761
	increased susceptibility to experimental autoimmune encephalomyelitis	J:89761
	increased T cell proliferation	J:89761
Ubd^tm1Smwe/Ubd^tm1Smwe (B6.129S6-Ubd^tm1Smwe)	abnormal lymphocyte physiology	J:110321
Ubd^tm1Smwe/Ubd^tm1Smwe (B6.129S6-Ubd^tm1Smwe)	increased susceptibility to bacterial infection	J:110321
Ube2n^{Gt(OST374154)Lex}/Ube2n⁺ (involves: 129S5/SvEvBrd * C57BL/6)	abnormal leukocyte physiology	J:120846
	abnormal macrophage physiology	J:120846
	decreased B cell proliferation	J:120846
	decreased susceptibility to endotoxin shock	J:120846
	decreased T cell proliferation	J:120846
Ube2n^tm1Aki/Ube2n^tm1Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage physiology	J:112287
Ube2s^tm1.1Smoc/Ube2s^tm1.1Smoc (involves: C57BL/6)	abnormal macrophage physiology	J:306461
	decreased susceptibility to Herpesvirales infection	J:306461
	decreased susceptibility to Picornaviridae infection	J:306461
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:306461
	decreased susceptibility to Riboviria infection	J:306461
	increased circulating interferon-alpha level	J:306461
	increased circulating interferon-beta level	J:306461
	increased circulating interleukin-6 level	J:306461
	increased circulating tumor necrosis factor level	J:306461
	increased interferon level	J:306461
	increased interferon-beta secretion	J:306461
Ube3b^{Gt(RRJ142)Byg}/Ube3b^{Gt(RRJ142)Byg} (involves: 129P2/OlaHsd * CBA/Ca)	eye inflammation	J:203652
Ucp2^tm1Rcq/Ucp2^tm1Rcq (involves: 129X1/SvJ * C57BL/6J)	abnormal macrophage physiology	J:66262
	decreased susceptibility to bacterial infection	J:66262
	decreased susceptibility to infection induced morbidity/mortality	J:66262
	decreased susceptibility to parasitic infection	J:66262
Uggt1^{tm1a(KOMP)Wtsi}/Uggt1⁺ (involves: C57BL/6N)	abnormal susceptibility to Picornaviridae infection	J:244058
	decreased susceptibility to Picornaviridae infection	J:244058
	decreased susceptibility to Picornaviridae infection induced morbidity/mortality	J:244058
Ulk4^tm1Lex/Ulk4^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased susceptibility to otitis media	J:185566
	maxillary sinus inflammation	J:185566
	nasal inflammation	J:185566
Umod^em1Duf/Umod⁺ (C57BL/6J-Umod^em1Duf)	kidney inflammation	J:252597
Umod^tm1.1Rvt/Umod⁺ (either: B6J.129-Umod^tm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))	kidney inflammation	J:242593
Umod^tm1.1Rvt/Umod^tm1.1Rvt (either: B6J.129-Umod^tm1.1Rvt or (involves: 129S1/Sv * 129X1/SvJ))	kidney inflammation	J:242593
Umod^tm1Xrw/Umod^tm1Xrw (involves: 129S6/SvEvTac)	increased susceptibility to bacterial infection	J:95431
Unc13d^Jinx/Unc13d^Jinx (C57BL/6J-Unc13d^Jinx/Mmucd)	abnormal cytokine secretion	J:119974
	abnormal macrophage physiology	J:105543
	abnormal NK cell physiology	J:119974
	decreased cytotoxic T cell cytolysis	J:119974
	hemophagocytosis	J:119974
	increased susceptibility to Herpesvirales infection	J:105543, J:119974
	increased susceptibility to Riboviria infection	J:105543, J:119974
Unc93b1^3d/Unc93b1^3d (C57BL/6J-Unc93b1^3d)	abnormal antigen presentation via MHC class I	J:105484
	abnormal antigen presentation via MHC class II	J:105484
	abnormal circulating interferon level	J:105484
	abnormal dendritic cell antigen presentation	J:105484
	abnormal macrophage physiology	J:105484
	abnormal tumor necrosis factor secretion	J:105484
	decreased interleukin-12b secretion	J:105484
	increased circulating tumor necrosis factor level	J:105484
	increased susceptibility to bacterial infection	J:105484
	increased susceptibility to Herpesvirales infection	J:105484
Unc93b1^3d/Unc93b1^3d (C57BL/6-Unc93b1^3d)	abnormal dendritic cell antigen presentation	J:159599
	decreased interleukin-6 secretion	J:159599
	decreased interleukin-12b secretion	J:159599
Unc93b1^{tm1(KOMP)Vlcg}/Unc93b1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal dendritic cell antigen presentation	J:211069
	abnormal dendritic cell physiology	J:211069
	abnormal tumor necrosis factor level	J:211069
	decreased circulating interleukin-6 level	J:211069
	decreased circulating interleukin-12b level	J:211069
Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	abnormal cytokine secretion	J:174308
	decreased B cell proliferation	J:174308
	decreased interferon-alpha secretion	J:174308
	decreased interleukin-12b secretion	J:174308
	decreased tumor necrosis factor secretion	J:174308
	glomerulonephritis	J:174308
	increased anti-nuclear antigen antibody level	J:174308
	increased autoantibody level	J:174308
	increased B cell proliferation	J:174308
	increased IgG2a level	J:174308
	increased IgG2b level	J:174308
	increased interferon-alpha secretion	J:174308
	increased interleukin-12b secretion	J:174308
	increased tumor necrosis factor secretion	J:174308
	liver inflammation	J:174308
Ung^tm1Tld/Ung^tm1Tld (Not Specified)	abnormal class switch recombination	J:79590
	decreased IgG3 level	J:79590
	increased IgM level	J:79590
Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:306598
Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Uox^em1Cli/Uox^em1Cli (C57BL/6J-Uox^em1Cli)	abnormal cytokine level	J:271949
Uox^em1Cli/Uox^em1Cli (C57BL/6J-Uox^em1Cli)	kidney inflammation	J:271949
Uoxⁱⁿ/Uoxⁱⁿ (involves: C57BL/6J * DBA/2J)	chronic inflammation	J:70677
Uox^tm1Bay/Uox^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	tubulointerstitial nephritis	J:16490
Upf2^tm1Btp/Upf2^tm1Btp Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased T cell proliferation	J:134765
Urah^plt2/Urah^plt2 (C57BL/6-Urah^plt2)	increased T cell proliferation	J:267227
Uri1^tm1.1Ndj/Uri1^tm1.1Ndj Alb^{tm1(cre/ERT2)Mtz}/Alb⁺ (B6.Cg-Alb^{tm1(cre/ERT2)Mtz} Uri1^tm1.1Ndj)	liver inflammation	J:217463
Usp4^tm1Xilu/Usp4^tm1Xilu (B6.129-Usp4^tm1Xilu)	increased splenocyte apoptosis	J:173192
Usp4^tm1Xilu/Usp4^tm1Xilu (B6.129-Usp4^tm1Xilu)	increased thymocyte apoptosis	J:173192
Usp12^{tm1a(EUCOMM)Hmgu}/Usp12^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased IgA level	J:165965
Usp13^em1Nmw/Usp13^em1Nmw (B6.Cg-Usp13^em1Nmw)	increased interleukin-1 beta secretion	J:285981
	increased interleukin-6 secretion	J:285981
	increased susceptibility to bacterial infection	J:285981
	increased tumor necrosis factor secretion	J:285981
	lung inflammation	J:285981
Usp15^em1Peih/Usp15^em1Peih (involves: C57BL/6)	abnormal macrophage physiology	J:306461
Usp15^L749R/Usp15⁺ (involves: 129S1/SvImJ * C57BL/6J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:259382
Usp15^L749R/Usp15⁺ (involves: 129S1/SvImJ * C57BL/6J)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:259382
Usp15^L749R/Usp15^L749R (involves: 129S1/SvImJ * C57BL/6J)	abnormal T-helper 1 physiology	J:259382
	decreased susceptibility to bacterial infection	J:259382
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:259382
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:259382
	decreased susceptibility to parasitic infection	J:259382
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:259382
Usp15^L749R/Usp15^tm1Pgrs (involves: 129S1/SvImJ * C57BL/6J)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:259382
	decreased susceptibility to parasitic infection induced morbidity/mortality	J:259382
Usp15^tm1Pgrs/Usp15^tm1Pgrs (Not Specified)	decreased susceptibility to experimental autoimmune encephalomyelitis	J:259382
Usp15^tm1Pgrs/Usp15^tm1Pgrs (Not Specified)	decreased susceptibility to parasitic infection induced morbidity/mortality	J:259382
Usp18^ity9/Usp18^ity9 (involves: 129S1/SvImJ * C57BL/6)	decreased circulating interferon-gamma level	J:163843
	decreased interferon-gamma secretion	J:163843
	increased circulating interleukin-6 level	J:163843
	increased interleukin-6 secretion	J:163843
	increased susceptibility to bacterial infection	J:163843
	increased susceptibility to bacterial infection induced morbidity/mortality	J:163843
	increased susceptibility to endotoxin shock	J:163843
Usp18^ity9/Usp18^tm1Dez (involves: 129 * C57BL/6 * FVB/N)	increased susceptibility to bacterial infection	J:163843
Usp18^ity9/Usp18^tm1Dez (involves: 129 * C57BL/6 * FVB/N)	increased susceptibility to bacterial infection induced morbidity/mortality	J:163843
Usp18^tm1Dez/Usp18^tm1Dez (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal cytokine level	J:214425
	decreased circulating interferon-alpha level	J:214425
	decreased circulating interferon-beta level	J:214425
	decreased circulating interferon-gamma level	J:214425
	decreased susceptibility to Coronaviridae infection	J:214425
Usp20^em1Dalin/Usp20^em1Dalin (involves: C57BL/6)	abnormal circulating chemokine level	J:274572
	decreased circulating interferon-beta level	J:274572
	decreased circulating interleukin-6 level	J:274572
	decreased interferon-beta secretion	J:274572
	decreased tumor necrosis factor secretion	J:274572
	increased susceptibility to Herpesvirales infection	J:274572
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:274572
Usp21^tm1.1Jhy/Usp21^tm1.1Jhy (B6.129S7(Cg)-Usp21^tm1.1Jhy)	abnormal interferon level	J:208320
	decreased susceptibility to Riboviria infection	J:208320
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:208320
	increased circulating interferon-alpha level	J:208320
	increased circulating interferon-beta level	J:208320
Usp25^{Gt(RRS805)Byg}/Usp25^{Gt(RRS805)Byg} (involves: 129P2/OlaHsd)	decreased interferon-gamma secretion	J:188557
	increased interleukin-6 secretion	J:188557
	increased susceptibility to experimental autoimmune encephalomyelitis	J:188557
	lung inflammation	J:188557
Usp38^em1Cya/Usp38^em1Cya (C57BL/6-Usp38^em1Cya)	lung inflammation	J:321973
Usp49^em1Gpt/Usp49^em1Gpt (involves: C57BL/6NGpt)	decreased susceptibility to Herpesvirales infection	J:285681
	decreased susceptibility to Herpesvirales infection induced morbidity/mortality	J:285681
	increased circulating interferon-beta level	J:285681
	increased circulating interleukin-6 level	J:285681
	increased interferon-beta secretion	J:285681
	increased interleukin-6 secretion	J:285681
Uvrag^{Tn(pb-Act-RFP)1.100107015-HRAZhu}/Uvrag^{Tn(pb-Act-RFP)1.100107015-HRAZhu} (involves: FVB/NJ)	abnormal interleukin level	J:219546
	abnormal tumor necrosis factor level	J:219546
	heart inflammation	J:219546
Uxs1^tm1Lex/Uxs1⁺ (B6;129S5-Uxs1^tm1Lex/Mmucd)	abnormal humoral immune response	J:171883
Uxs1^tm1Lex/Uxs1⁺ (B6;129S5-Uxs1^tm1Lex/Mmucd)	increased IgG1 level	J:171883
Vamp8^{Gt(OST20346)Lex}/Vamp8^{Gt(OST20346)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal mast cell physiology	J:131926
Vamp8^tm1Hong/Vamp8^tm1Hong (involves: 129P2/OlaHsd * C57BL/6)	abnormal dendritic cell physiology	J:131528
	abnormal type I hypersensitivity reaction	J:133439
	decreased mast cell degranulation	J:133439
Varc/Varc⁺ (C3H/HeJ-Varc/J)	increased susceptibility to otitis media	J:241135
Varc/Varc⁺ (C3OuJ.C3-Varc/Kjn)	increased susceptibility to otitis media	J:241135
Vav1^m1Btlr/Vav1^m1Btlr (C57BL/6J-Vav1^m1Btlr)	abnormal humoral immune response	J:265128
	decreased IgD level	J:265128
	decreased IgG level	J:265128
	increased IgM level	J:265128
Vav1^M3Btlr/Vav1^M3Btlr (C57BL/6J-Vav1^M3Btlr)	decreased IgG level	J:272527
Vav1^M3Btlr/Vav1^M3Btlr (C57BL/6J-Vav1^M3Btlr)	impaired humoral immune response	J:272527
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas * 129S8/SvEv)	abnormal T cell physiology	J:113270
	decreased T cell proliferation	J:113270
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas)	abnormal T cell physiology	J:86654, J:79323
	decreased interferon-gamma secretion	J:86654
	decreased interleukin-2 secretion	J:86654
	decreased T cell proliferation	J:86654
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas * C57BL/10 * C57BR/cd)	abnormal T cell physiology	J:128985
	decreased interleukin-2 secretion	J:128985
	decreased T cell proliferation	J:128985
	decreased tumor necrosis factor secretion	J:128985
Vav1^tm1Tyb/Vav1^tm1Tyb (either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))	abnormal CD8-positive, alpha-beta T cell physiology	J:190087
	abnormal immune system physiology	J:190087
	abnormal interleukin-2 secretion	J:190087
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * 129S2/SvPas)	decreased B cell proliferation	J:86654
	decreased interferon-gamma secretion	J:86654
	decreased interleukin-2 secretion	J:86654
	decreased T cell proliferation	J:86654
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:86654
	abnormal humoral immune response	J:86654
	abnormal T cell physiology	J:86654
	decreased B cell proliferation	J:86654
	decreased IgG1 level	J:86654
	decreased IgG2b level	J:86654
	decreased IgG3 level	J:86654
	decreased IgM level	J:86654
	decreased immunoglobulin level	J:86654
	decreased interferon-gamma secretion	J:86654
	decreased interleukin-2 secretion	J:86654
	decreased T cell proliferation	J:86654
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac)	abnormal macrophage physiology	J:145345
	abnormal neutrophil physiology	J:145345
	abnormal NK cell physiology	J:187430
	decreased interleukin-10 secretion	J:145345
	decreased tumor necrosis factor secretion	J:145345
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Tnr/Vav2^tm1Tnr (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal B cell physiology	J:69807
	decreased B cell proliferation	J:69807
Vav1^tm1Tyb/Vav1^tm1Tyb Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	decreased B cell proliferation	J:86654
	decreased interferon-gamma secretion	J:86654
	decreased interleukin-2 secretion	J:86654
	decreased T cell proliferation	J:86654
Vav1^tm2Bbd/Vav1^tm2Bbd (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal T cell activation	J:47596
	decreased interleukin-2 secretion	J:47596
	decreased T cell proliferation	J:47596
Vav1^tm2Bbd/Vav1^tm2Bbd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal response to infection	J:55647
	decreased B cell proliferation	J:55647, J:69806
	decreased IgG1 level	J:55647
	decreased IgG2a level	J:55647
	decreased IgG3 level	J:69806
	decreased IgG level	J:55647
Vav1^tm2Bbd/Vav1^tm2Bbd (B6.129-Vav1^tm2Bbd)	abnormal T cell physiology	J:141390
	decreased interleukin-4 secretion	J:71161
	impaired natural killer cell mediated cytotoxicity	J:71161
Vav1^tm2Bbd/Vav1^tm2Bbd Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell activation	J:69806
	decreased B cell proliferation	J:69806
	decreased IgG1 level	J:69806
	decreased IgG2b level	J:69806
	decreased IgG3 level	J:69806
	decreased IgM level	J:69806
	decreased immunoglobulin level	J:69806
Vav1^tm2Tyb/Vav1^tm2Tyb (involves: 129S4/SvJae * 129S8/SvEv)	abnormal T cell physiology	J:113270
	decreased T cell proliferation	J:113270
Vav1^tm4Tyb/Vav1^tm4Tyb (either: 129S8.129S4-Vav1^tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))	abnormal CD4-positive, alpha-beta T cell physiology	J:190087
	abnormal CD8-positive, alpha-beta T cell physiology	J:190087
	abnormal immune serum protein physiology	J:190087
	abnormal immune system physiology	J:190087
	abnormal interleukin-2 secretion	J:190087
	abnormal T cell physiology	J:190087
	increased circulating interferon-gamma level	J:190087
Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * C57BL/6)	decreased B cell proliferation	J:69806
Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * C57BL/6)	decreased IgG3 level	J:69806
Vav2^tm1Tnr/Vav2^tm1Tnr (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:69807
	decreased B cell proliferation	J:69807
	decreased IgG1 level	J:69807
	decreased IgG2b level	J:69807
	decreased IgG3 level	J:69807
	decreased IgM level	J:69807
Vcam1^tm2Flv/Vcam1^tm3Flv Tg(Tek-cre)12Flv/0 (involves: 129S1/Sv * C3H * C57BL/6)	abnormal B cell physiology	J:68147
	abnormal CD4-positive, alpha-beta T cell physiology	J:68147
	abnormal CD8-positive, alpha-beta T cell physiology	J:68147
	abnormal lymphocyte physiology	J:68147
Vcam1^tm2Roml/Vcam1^tm2Roml Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal humoral immune response	J:68148
Vdac2^tm1.1Ehyc/Vdac2^tm1.1Ehyc Tg(Lck-cre)1Cwi/? (involves: 129X1/SvJ * C57BL/6 * DBA/2)	abnormal thymocyte apoptosis	J:220951
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6)	abnormal interleukin level	J:107077
	abnormal tumor necrosis factor level	J:107077
	increased susceptibility to induced colitis	J:130511
	intestinal inflammation	J:107077
Vdr^tm1Rge/Vdr^tm1Rge (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal macrophage physiology	J:134827
	decreased susceptibility to parasitic infection	J:134827
Vdr^tm1Ska/Vdr^tm1Ska (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal macrophage chemotaxis	J:112519
	decreased splenocyte proliferation	J:112519
	decreased susceptibility to autoimmune diabetes	J:112519
	dermatitis	J:111828
Vdr^tm1Ska/Vdr^tm1Ska (NOD.Cg-Vdr^tm1Ska/CmatJ)	abnormal chemokine secretion	J:127787
	abnormal interleukin-1 secretion	J:127787
	decreased interleukin-6 secretion	J:127787
	increased susceptibility to autoimmune diabetes	J:127787
Vdr^tm2Ska/Vdr^tm2Ska (involves: C57BL/6NCrlj * CBA/JNCrlj)	ear inflammation	J:111828
Vegfa^tm2Gne/Vegfa^tm2Gne Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd)	decreased inflammatory response	J:107682
Vegfa^tm2Gne/Vegfa^tm2Gne Tg(SFTPC-cre)#Mliu/0 (involves: 129/Sv * ICR)	lung inflammation	J:158566
Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymph circulation	J:87394
Vhl^tm1Jae/Vhl^tm1Jae Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	increased inflammatory response	J:107682
Vim^tm1Cba/Vim^tm1Cba (involves: 129S2/SvPas * C57BL/6)	abnormal cellular extravasation	J:129405
	abnormal leukocyte adhesion	J:129405
	abnormal leukocyte migration	J:129405
	abnormal leukocyte tethering or rolling	J:129405
Vip^tm1Clw/Vip^tm1Clw (involves: 129S/Sv * C57BL/6)	lung inflammation	J:132313
Vipr2^tm1Ajh/Vipr2^tm1Ajh (B6.129P2-Vipr2^tm1Ajh)	abnormal cytokine secretion	J:72933
	decreased IgE level	J:72933
	decreased interleukin-4 secretion	J:72933
	decreased susceptibility to type I hypersensitivity reaction	J:72933
	increased interferon-gamma secretion	J:72933
	increased interleukin-2 secretion	J:72933
	increased susceptibility to type IV hypersensitivity reaction	J:72933
Vms1^A/J/Vms1^A/J (involves: A/J * C57BL/10SnSg)	myocarditis	J:121574
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm/Vpreb1b^tm1Ilm (B6.129P2-Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm)	decreased IgG level	J:67609
Vps13b^tm1.2Ics/Vps13b^tm1.2Ics (involves: C57BL/6N)	eye inflammation	J:296007
Vps54^wr/Vps54^wr (involves: C57BL/6J * C57BL/Fa)	increased microglial cell activation	J:181019
Vsig4^tm1Gne/Vsig4^tm1Gne (involves: C57BL/6N)	increased susceptibility to bacterial infection	J:138691
Vsig4^tm1Gne/Vsig4^tm1Gne (C57BL/6-Vsig4^tm1Gne)	abnormal macrophage physiology	J:281762
	decreased susceptibility to induced colitis	J:281762
	increased circulating interleukin-1 beta level	J:281762
	increased interleukin-1 beta secretion	J:281762
	increased susceptibility to experimental autoimmune encephalomyelitis	J:281762
Vsir^tm1Lex/Vsir^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal T cell activation	J:222944
	increased IgA level	J:222944
	increased IgM level	J:222944
	increased inflammatory response	J:222944
	increased interferon-gamma secretion	J:222944
	increased interleukin-17 secretion	J:222944
Vsir^tm1Lex/Vsir^tm1Lex Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129S5/SvEvBrd * C57BL/6)	increased susceptibility to experimental autoimmune encephalomyelitis	J:222944
Vstm5^em1Cdj/Vstm5^em1Cdj (Not Specified)	decreased interleukin-2 secretion	J:267548
Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (B6.129S-Vtcn1^tm1Lpc)	decreased susceptibility to bacterial infection	J:145712
Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (B6.129S-Vtcn1^tm1Lpc)	decreased susceptibility to bacterial infection induced morbidity/mortality	J:145712
Vtcn1^tm1Mak/Vtcn1^tm1Mak (C.Cg-Vtcn1^tm1Mak)	decreased interleukin-4 secretion	J:112130
	decreased susceptibility to parasitic infection	J:112130
	increased interferon-gamma secretion	J:112130
Vtcn1^tm1Xxz/Vtcn1^tm1Xxz (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased interleukin-17 secretion	J:177612
	increased susceptibility to autoimmune diabetes	J:177612
	increased susceptibility to experimental autoimmune encephalomyelitis	J:177612
Vwf^tm1.1Geno/Vwf⁺ (involves: C57BL/6)	increased acute inflammation	J:250145
Vwf^tm1.1Geno/Vwf^tm1.1Geno (involves: C57BL/6)	increased acute inflammation	J:250145
Vwf^tm1Wgr/Vwf^tm1Wgr (B6.129S2-Vwf^tm1Wgr)	increased susceptibility to bacterial infection	J:140334
Vwf^tm1Wgr/Vwf^tm1Wgr (B6.129S2-Vwf^tm1Wgr)	increased susceptibility to experimental autoimmune encephalomyelitis	J:140334
Was^tm1Itl/Y (Not Specified)	abnormal dendritic cell physiology	J:153247
	decreased T cell proliferation	J:153247
	increased anti-double stranded DNA antibody level	J:153247
Was^tm1Itl/Was^tm1Itl (Not Specified)	abnormal dendritic cell physiology	J:153247
	decreased T cell proliferation	J:153247
	increased anti-double stranded DNA antibody level	J:153247
Was^tm1Sbs/Y (involves: 129S6/SvEvTac)	abnormal dendritic cell physiology	J:153247
	decreased T cell proliferation	J:153247
	increased anti-double stranded DNA antibody level	J:153247
Was^tm1Sbs/Y (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:182528
	increased anti-chromatin antibody level	J:182528
	increased anti-double stranded DNA antibody level	J:182528
	increased anti-single stranded DNA antibody level	J:182528
	increased autoantibody level	J:182528
	increased IgA level	J:182528
	increased IgE level	J:182528
	increased IgM level	J:182528
Was^tm1Sbs/Was^tm1Sbs (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	colitis	J:48836
	decreased T cell proliferation	J:48836
Was^tm1Sbs/Was^tm1Sbs (involves: C57BL/6 * CBA)	abnormal B cell physiology	J:95909
Was^tm1Sbs/Was^tm1Sbs (involves: 129S/SvEv)	abnormal cytokine secretion	J:86835
	abnormal mast cell physiology	J:86835
	abnormal osteoclast physiology	J:90542
Was^tm1Sbs/Was^tm1Sbs (involves: BALB/c)	abnormal dendritic cell antigen presentation	J:84131
Was^tm1Sbs/Was^tm1Sbs (involves: BALB/c)	decreased T cell proliferation	J:84131
Was^tm1Sbs/Was^tm1Sbs (involves: 129S6/SvEvTac)	abnormal dendritic cell physiology	J:153247
	abnormal thymocyte activation	J:125309
	decreased T cell proliferation	J:153247
	increased anti-double stranded DNA antibody level	J:153247
Was^tm1Sbs/Was^tm1Sbs (129S6/SvEvTac-Was^tm1Sbs/J)	glomerulonephritis	J:180407
	increased IgA level	J:180407
	increased IgM level	J:180407
Was^tm1Sbs/Was^tm1Sbs (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell physiology	J:182528
	increased anti-chromatin antibody level	J:182528
	increased anti-double stranded DNA antibody level	J:182528
	increased anti-single stranded DNA antibody level	J:182528
	increased autoantibody level	J:182528
	increased IgA level	J:182528
	increased IgE level	J:182528
	increased IgM level	J:182528
Was^tm1Sbs/Was^tm1Sbs Wasl^tm2Sbs/Wasl^tm2Sbs Tg(Lck-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal thymocyte activation	J:125309
	colitis	J:125309
Was^tm2Itl/Y (Not Specified)	abnormal dendritic cell physiology	J:153247
	decreased T cell proliferation	J:153247
	increased anti-double stranded DNA antibody level	J:153247
Was^tm2Itl/Was^tm2Itl (Not Specified)	abnormal dendritic cell physiology	J:153247
	decreased T cell proliferation	J:153247
	increased anti-double stranded DNA antibody level	J:153247
Wasl^tm1.1Ttha/Wasl^tm1.1Ttha Tg(KRT14-cre)1Amc/0 (involves: C57BL/6 * C57BL/6N * CBA)	abnormal circulating chemokine level	J:271857
	dermatitis	J:271857
	increased circulating interleukin-1 alpha level	J:271857
	increased circulating interleukin-6 level	J:271857
	increased circulating interleukin-17 level	J:271857
	increased circulating tumor necrosis factor level	J:271857
	increased susceptibility to bacterial infection	J:271857
	skin inflammation	J:271857
Wdr1^Gt(XN462)Byg/Wdr1^rede (involves: 129P2/OlaHsd * C57BL/6)	ear inflammation	J:134092
	skin inflammation	J:134092
Wdr1^rede/Wdr1^rede (Not Specified)	increased inflammatory response	J:85113
Wdr1^rede/Wdr1^rede (C57BL/6-Wdr1^rede)	abnormal osteoclast physiology	J:134092
	ear inflammation	J:134092
	impaired neutrophil chemotaxis	J:134092
	skin inflammation	J:134092
Wdr41^m1Btlr/Wdr41^m1Btlr (C57BL/6J-Wdr41^m1Btlr)	increased circulating interleukin-12b level	J:268243
	increased susceptibility to induced colitis	J:268243
	increased tumor necrosis factor secretion	J:268243
Wdr41^m2Btlr/Wdr41^m2Btlr (C57BL/6J-Wdr41^m2Btlr)	increased tumor necrosis factor secretion	J:268243
Wdr83^tm1Guwo/Wdr83⁺ (involves: C57BL/6)	kidney inflammation	J:153983
Wfdc1^tm1Bcm/Wfdc1^tm1Bcm (involves: 129S7/SvEvBrd * C57BL/6)	decreased susceptibility to Orthomyxoviridae infection	J:216357
Wfdc2^tm1.1Ohbo/Wfdc2^tm1.1Ohbo (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal cytokine level	J:282576
	lung inflammation	J:282576
Why1^MOLF/EiJ/? (involves: C57BL/6J * MOLF/Ei)	increased interleukin-6 secretion	J:131437
Why2^MOLF/EiJ/? (involves: C57BL/6J * MOLF/Ei)	decreased interleukin-6 secretion	J:131437
Wipf1^tm1Geha/Wipf1^tm1Geha (involves: 129S6/SvEvTac)	abnormal T cell physiology	J:74719
	decreased T cell proliferation	J:74719
	increased B cell proliferation	J:74719
	increased IgE level	J:74719
	increased IgM level	J:74719
Wipf1^tm1Geha/Wipf1^tm1Geha (involves: 129S6/SvEvTac * C57BL/6)	colitis	J:116168
	glomerulonephritis	J:116168
	increased autoantibody level	J:116168
	increased IgA level	J:116168
	interstitial pneumonia	J:116168
	joint inflammation	J:116168
	lung inflammation	J:116168
Wls^tm1.1Arte/Wls^tm1.1Arte Krt14^tm1(cre)Wbm/Krt14⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell physiology	J:202499
	increased T cell proliferation	J:202499
	skin inflammation	J:202499
Wrn^tm1Led/Wrn^tm1Led (involves: 129S6/SvEvTac * Black Swiss)	heart inflammation	J:106446
	increased susceptibility to infection	J:106446
Wt1^tm1Jae/Wt1^tm1Jae (involves: 129S4/SvJae * C57BL/6 * MF1)	increased splenocyte apoptosis	J:56651
Wt1^tm1Mlh/Wt1⁺ (involves: 129P2/OlaHsd * C57BL/6)	glomerulonephritis	J:135449
Wt1^tm1Mlh/Wt1⁺ (129P2/OlaHsd-Wt1^tm1Mlh)	glomerulonephritis	J:135449
Wt1^tm1Mlh/Wt1⁺ (involves: 129P2/OlaHsd * C57BL/6 * MF1)	glomerulonephritis	J:135449
Wwc1^tm1Arsc/Wwc1^tm1Arsc Wwc2^tm1.1Arte/Wwc2^tm1.1Arte Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129 * C57BL/6 * C57BL/6J * DBA)	liver inflammation	J:305034
Wwox^tm1Ria/Wwox^tm1Ria (involves: 129X1/SvJ * C57BL/6J)	abnormal osteoclast physiology	J:138140
Wwp2^tm1.1Yyiw/Wwp2^tm1.1Yyiw (involves: 129S/SvEv * C57BL/6 * FVB/N)	increased circulating interferon-beta level	J:228707
	increased circulating interleukin-6 level	J:228707
	increased circulating tumor necrosis factor level	J:228707
Wwtr1^tm1Benj/Wwtr1^tm1Benj (129S6/SvEvTac-Wwtr1^tm1Benj)	intestinal inflammation	J:125326
Wwtr1^tm1Benj/Wwtr1^tm1Benj (129S6/SvEvTac-Wwtr1^tm1Benj)	lung inflammation	J:125326
Wwtr1^tm1Benj/Wwtr1^tm1Benj (129S-Wwtr1^tm1Benj/J)	intestinal inflammation	J:156586
Wwtr1^tm1Benj/Wwtr1^tm1Benj (129S-Wwtr1^tm1Benj/J)	lung inflammation	J:156586
Wwtr1^tm1Hku/Wwtr1^tm1Hku (involves: 129 * C57BL/6 * ICR)	alveolitis	J:164957
Wwtr1^tm1Hku/Wwtr1^tm1Hku (involves: 129 * C57BL/6 * ICR)	lung inflammation	J:164957
Wwtr1^tm1Whun/Wwtr1^tm1Whun (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	tubular nephritis	J:119488
Xbp1^{tm1a(EUCOMM)Wtsi}/Xbp1⁺ (C57BL/6N-Xbp1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased IgG1 level	J:165965
Xbp1^tm2Glm/Xbp1⁺ Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL)	small intestinal inflammation	J:188627
Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Defa6-icre)1Rsb/0 (involves: 129S6/SvEvTac * C57BL/6)	small intestinal inflammation	J:206084
Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	decreased susceptibility to prion infection	J:131028
Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL)	increased susceptibility to bacterial infection	J:188627
	increased susceptibility to induced colitis	J:188627
	small intestinal inflammation	J:188627
Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	small intestinal inflammation	J:206084
Xbp1^tm2Glm/Xbp1^tm2Glm Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	small intestinal inflammation	J:206084
Xbp1^tm2Glm/Xbp1^tm2Glm Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tg(Vil1-cre)997Gum/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	small intestinal inflammation	J:206084
Xbp1^tm3Glm/Xbp1^tm3Glm Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	small intestinal inflammation	J:188627
Xcl1^tm1.1Dnax/Xcl1^tm1.1Dnax (either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6))	autoimmune response	J:176844
	heart inflammation	J:176844
	increased inflammatory response	J:176844
	lacrimal gland inflammation	J:176844
	liver inflammation	J:176844
	salivary gland inflammation	J:176844
	stomach inflammation	J:176844
Xcl1^tm1Rakr/Xcl1^tm1Rakr (B6.129-Xcl1^tm1Rakr)	decreased cytotoxic T cell cytolysis	J:155297
Xcl1^tm1Rakr/Xcl1^tm1Rakr Tg(TcraTcrb)1100Mjb/0 (involves: 129/Sv * C57BL/6)	abnormal CD8-positive, alpha-beta T cell physiology	J:155297
	decreased cytotoxic T cell cytolysis	J:155297
	decreased interferon-gamma secretion	J:155297
Xcr1^tm1Dgen/Xcr1^tm1Dgen (B6.129P2-Xcr1^tm1Dgen/J)	abnormal dendritic cell physiology	J:155297
Xcr1^{tm2(HBEGF/Venus)Ksho}/Xcr1⁺ (involves: C57BL/6 * C57BL/6J)	abnormal antigen presentation	J:204851
	abnormal CD8-positive, alpha-beta T cell physiology	J:204851
	decreased interferon-gamma secretion	J:204851
	decreased susceptibility to bacterial infection	J:204851
Xdh^tm1Fink/Xdh^tm1Fink (involves: 129X1/SvJ * C57BL/6J)	tubulointerstitial nephritis	J:166326
Xkrx^{tm1b(EUCOMM)Wtsi}/Xkrx^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Xkrx^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased anti-nuclear antigen antibody level	J:211773
Xpa^tm1Tnka/Xpa^tm1Tnka (involves: C57BL/6 * CBA)	abnormal immune system physiology	J:35054
	abnormal Langerhans cell physiology	J:35054
	abnormal lymphocyte physiology	J:55739
	abnormal NK cell physiology	J:55739
Xpnpep1^{tm1a(KOMP)Wtsi}/Xpnpep1^{tm1a(KOMP)Wtsi} (C57BL/6N-Xpnpep1^{tm1a(KOMP)Wtsi}/Wtsi)	blood in lymph vessels	J:239583
Xpr1^Sxv/Xpr1^Sxv (M. spretus)	increased susceptibility to Retroviridae infection	J:7951
Xrcc5^tm1Nus/Xrcc5^tm1Nus (involves: 129S1/Sv * 129X1/SvJ)	abnormal class switch recombination	J:120658
Xrcc5^tm1Nus/Xrcc5^tm1Nus (involves: 129S1/Sv * 129X1/SvJ)	abnormal humoral immune response	J:120658
Xrcc6^tm1Fwa/Xrcc6^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6J)	decreased IgM level	J:44361
X/Yaa ((NZB x BXSB)F1)	abnormal immune cell physiology	J:6235
	increased anti-erythrocyte antigen antibody level	J:6235
	increased anti-nuclear antigen antibody level	J:6235
	increased autoantibody level	J:6235
	increased susceptibility to autoimmune disorder	J:6235
X/Yaa ((SJL/J x BXSB)F1)	increased susceptibility to autoimmune disorder	J:6235
X/Yaa ((C57BL/6J x BXSB)F1)	increased susceptibility to autoimmune disorder	J:6235
X/Yaa (involves: BXSB * NZB)	increased susceptibility to autoimmune disorder	J:6235
X/Yaa (BXSB/MpJ)	glomerulonephritis	J:6235
	increased anti-erythrocyte antigen antibody level	J:6235
	increased anti-nuclear antigen antibody level	J:179430
	increased circulating interleukin-21 level	J:93740
	increased IgG1 level	J:179430, J:93740
	increased IgG2a level	J:179430
	increased IgG2b level	J:179430
	increased IgG3 level	J:93740
	increased susceptibility to autoimmune disorder	J:108760, J:6235
X/Yaa ((NZW x SB)F1)	abnormal immune serum protein physiology	J:7276
	glomerulonephritis	J:7276
	increased susceptibility to autoimmune disorder	J:7276
X/Yaa ((NZW x BXSB)F1)	abnormal immune serum protein physiology	J:7276
X/Yaa ((NZW x BXSB)F1)	increased susceptibility to autoimmune disorder	J:7276
X/Yaa (BXSB/MpJScr)	glomerulonephritis	J:10973
	increased anti-nuclear antigen antibody level	J:10973
	increased IgG level	J:10973
	increased susceptibility to autoimmune disorder	J:10973
X/Yaa (B6.SB-Yaa/J)	increased splenocyte proliferation	J:127600
Yaa2^BXSB/J/? (involves: BXSB/J * C57BL/10Ola)	kidney inflammation	J:49868
Yaa3^BXSB/J/? (involves: BXSB/J * C57BL/10Ola)	kidney inflammation	J:49868
Yaa4^BXSB/J/? (involves: BXSB/J * C57BL/10Ola)	kidney inflammation	J:49868
Yaail^NZW/Ola/? (involves: C57BL/6Ola * NZW/Ola)	glomerulonephritis	J:52110
Yaail^NZW/Ola/? (involves: C57BL/6Ola * NZW/Ola)	increased anti-double stranded DNA antibody level	J:52110
Yap1^M1Btlr/Yap1^M1Btlr (C57BL/6J-Yap1^M1Btlr)	increased susceptibility to induced colitis	J:267549
Yap1^tm1.1Dupa/Yap1^tm1.1Dupa Tg(Vil1-cre)997Gum/0 (involves: 129P2/OlaHsd * C57BL/6J * SJL)	increased susceptibility to induced colitis	J:165471
Yeats4^em1Zfa/Yeats4^em1Zfa Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal acute inflammation	J:282740
	abnormal interleukin secretion	J:282740
	abnormal lymphocyte physiology	J:282740
	decreased interferon-gamma secretion	J:282740
	decreased interleukin-5 secretion	J:282740
	decreased interleukin-12 secretion	J:282740
	increased susceptibility to bacterial infection	J:282740
Yipf6^M1Btlr/Y (C57BL/6J-Yipf6^M1Btlr/Mmucd)	colitis	J:187584
Yipf6^M1Btlr/Y (C57BL/6J-Yipf6^M1Btlr/Mmucd)	increased susceptibility to induced colitis	J:187584
Yipf6^M1Btlr/Yipf6^M1Btlr (C57BL/6J-Yipf6^M1Btlr/Mmucd)	colitis	J:187584
Yipf6^M1Btlr/Yipf6^M1Btlr (C57BL/6J-Yipf6^M1Btlr/Mmucd)	increased susceptibility to induced colitis	J:187584
Ythdf3^em1Caox/Ythdf3^em1Caox (involves: C57BL/6J)	abnormal macrophage physiology	J:276397
	decreased susceptibility to Riboviria infection	J:276397
	decreased susceptibility to Riboviria infection induced morbidity/mortality	J:276397
Zap70^m1Btlr/Zap70^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	abnormal humoral immune response	J:167119
	decreased IgG level	J:185495
Zap70^m1Saka/Zap70^m1Saka (involves: BALB/c)	abnormal T cell clonal deletion	J:154166
	abnormal thymocyte activation	J:154166
	chronic joint inflammation	J:86607
	decreased interleukin-2 secretion	J:154166
	decreased T cell proliferation	J:154166, J:86607
	increased autoantibody level	J:86607
	increased immunoglobulin level	J:86607
	increased interleukin-17 secretion	J:154166
	increased susceptibility to induced arthritis	J:154166
	lung inflammation	J:86607
	rheumatoid arthritis	J:86607
Zap70^m1Saka/Zap70^m1Saka Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6)	decreased T cell proliferation	J:86607
Zap70^m1Saka/Zap70^m1Saka Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: BALB/c * C57BL/6J * DBA/2J)	arthritis	J:86607
Zap70^m1Saka/Zap70^tm1Dlo (involves: 129P2/OlaHsd * BALB/c)	arthritis	J:86607
Zap70^m1Saka/Zap70^tm2.1Weis (involves: 129S4/SvJae * BALB/c)	abnormal T cell clonal deletion	J:154166
	decreased susceptibility to induced arthritis	J:154166
Zap70^m3Btlr/Zap70^m3Btlr (C57BL/6J-Zap70^m3Btlr)	decreased IgG level	J:225043
Zap70^m3Btlr/Zap70^m3Btlr (C57BL/6J-Zap70^m3Btlr)	impaired humoral immune response	J:225043
Zap70^m5Btlr/Zap70^m5Btlr (C57BL/6J-Zap70^m5Btlr)	abnormal humoral immune response	J:254830
Zap70^m5Btlr/Zap70^m5Btlr (C57BL/6J-Zap70^m5Btlr)	decreased IgG level	J:254830
Zap70^m6Btlr/Zap70^m6Btlr (C57BL/6J-Zap70^m6Btlr)	abnormal humoral immune response	J:254831
Zap70^m6Btlr/Zap70^m6Btlr (C57BL/6J-Zap70^m6Btlr)	decreased IgG level	J:254831
Zap70^m6Hefl/Zap70^m6Hefl (C3HeB/FeJ-Zap70^m6Hefl)	abnormal humoral immune response	J:137446
	increased IgE level	J:137446
	increased IgG1 level	J:137446
Zap70^m6Hefl/Zap70^tm1Weis (involves: 129X1/SvJ * C3HeB/FeJ * C57BL/10 * DBA/2)	increased IgE level	J:137446
Zap70^m7Btlr/Zap70^m7Btlr (C57BL/6J-Zap70^m7Btlr)	abnormal humoral immune response	J:254832
Zap70^m7Btlr/Zap70^m7Btlr (C57BL/6J-Zap70^m7Btlr)	decreased IgG level	J:254832
Zap70^mur/Zap70^mur (C57BL/6Apb-Zap70^mur/ApbH)	abnormal T cell activation	J:104190
	abnormal T cell physiology	J:104190
	increased IgG2b level	J:104190
Zap70^st/Zap70^st (involves: C57BL/6)	abnormal T cell physiology	J:41170
Zap70^tm1.1Mmal/Zap70^tm1.1Mmal Tg(TcrLCMV)327Sdz/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)	abnormal cytokine secretion	J:71099
	abnormal T cell proliferation	J:71099
Zap70^tm2.1Weis/Zap70^tm2.1Weis (C.129S4-Zap70^tm2.1Weis)	abnormal regulatory T cell physiology	J:154166
	abnormal T cell clonal deletion	J:154166
	abnormal thymocyte activation	J:154166
	decreased interleukin-2 secretion	J:154166
	decreased T cell proliferation	J:154166
	increased interleukin-17 secretion	J:154166
Zap70^tm2.1Weis/Zap70^tm2.1Weis Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S4/SvJae * C57BL/6J * DBA/2J)	abnormal T cell clonal deletion	J:154166
Zbp1^tm1.1Jreh/Zbp1^tm1.1Jreh (involves: C57BL/6 * C57BL/6N)	increased susceptibility to Herpesvirales infection	J:252669
Zbtb1^m1Btlr/Zbtb1^m1Btlr (involves: C3H/HeN * C57BL/6J)	abnormal immune system physiology	J:178820
Zbtb7a^tm1Ppp/Zbtb7a^tm1Ppp (B6.129S1-Zbtb7a^tm1Ppp)	abnormal response to transplant	J:121576
Zbtb7a^tm1Ppp/Zbtb7a^tm2Ppp Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal response to transplant	J:121576
Zbtb7b^hpls/Zbtb7b^hpls (involves: C57BL/6JAnu)	abnormal humoral immune response	J:104190
Zbtb7b^tm1Itan/Zbtb7b^tm1Tani (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha-beta T cell physiology	J:141142
Zbtb7b^tm1Litt/Zbtb7b^tm1.2Litt (involves: C57BL/6)	increased interferon-gamma secretion	J:141144
Zbtb17^tm1Cksn/Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio})	increased T cell apoptosis	J:170508
Zbtb32^tm1Iho/Zbtb32^tm1Iho (involves: BALB/c)	abnormal cytokine secretion	J:94944
Zbtb32^tm1Iho/Zbtb32^tm1Iho (involves: BALB/c)	increased T cell proliferation	J:94944
Zbtb32^tm1Iho/Zbtb32^tm1Iho (involves: C57BL/6)	increased T cell proliferation	J:94944
Zbtb32^tm2Ppp/Zbtb32^tm2Ppp (involves: 129S1/Sv)	abnormal cytokine secretion	J:95119
Zbtb32^tm2Ppp/Zbtb32^tm2Ppp (involves: 129S1/Sv)	increased T cell proliferation	J:95119
Zbtb46^{tm1(HBEGF)Mnz}/Zbtb46⁺ (C57BL/6-Zbtb46^{tm1(HBEGF)Mnz})	abnormal memory T cell physiology	J:189122
	abnormal response to infection	J:189122
	abnormal T-helper 1 physiology	J:189122
	increased susceptibility to parasitic infection	J:189122
Zbtb46^tm1Kmm/Zbtb46^tm1Kmm (129S/SvEv-Zbtb46^tm1Kmm)	abnormal dendritic cell physiology	J:184205
Zc3h7ait^em1Caox/Zc3h7ait^em1Caox (C57BL/6J-Zc3h7ait^em1Caox)	abnormal interferon secretion	J:282488
	abnormal macrophage activation involved in immune response	J:282488
	decreased circulating interferon-alpha level	J:282488
	decreased circulating interferon-beta level	J:282488
	decreased circulating interleukin-6 level	J:282488
	decreased interferon-alpha secretion	J:282488
	decreased interferon-beta secretion	J:282488
	decreased interleukin-6 secretion	J:282488
	increased susceptibility to Riboviria infection	J:282488
	increased susceptibility to Riboviria infection induced morbidity/mortality	J:282488
Zc3h12a^tm1Aki/Zc3h12a^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal acute inflammation	J:147868
	abnormal class switch recombination	J:147868
	granulomatous inflammation	J:147868
	increased anti-double stranded DNA antibody level	J:147868
	increased anti-nuclear antigen antibody level	J:147868
	increased IgA level	J:147868
	increased IgG1 level	J:147868
	increased IgG2a level	J:147868
	increased IgG2b level	J:147868
	increased IgG3 level	J:147868
	increased IgM level	J:147868
	increased immunoglobulin level	J:147868
	increased interferon-gamma secretion	J:147868
	increased interleukin-6 secretion	J:147868
	increased interleukin-12b secretion	J:147868
Zc3h12a^{tm1c(EUCOMM)Hmgu}/Zc3h12a^{tm1c(EUCOMM)Hmgu} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	increased inflammatory response	J:304105
Zc3h12a^{tm1c(EUCOMM)Hmgu}/Zc3h12a^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	bile duct inflammation	J:304105
	granulomatous inflammation	J:304105
	increased anti-nuclear antigen antibody level	J:304105
	increased autoantibody level	J:304105
	increased IgG level	J:304105
	increased IgM level	J:304105
	liver inflammation	J:304105
Zc3h12a^tm1Fum/Zc3h12a^tm1Fum (C57BL/6-Zc3h12a^tm1Fum)	abnormal chemokine secretion	J:176866
	abnormal circulating chemokine level	J:176866
	increased circulating tumor necrosis factor level	J:176866
	increased interleukin-1 beta secretion	J:176866
	increased interleukin-6 secretion	J:176866
	increased tumor necrosis factor secretion	J:176866
Zc3h12c^{tm2d(EUCOMM)Hmgu}/Zc3h12c^{tm2d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * C57BL/6N)	increased circulating interferon-gamma level	J:277714
	increased IgA level	J:277714
	increased IgG level	J:277714
	increased IgM level	J:277714
Zc3h12d^tm1Tom/Zc3h12d^tm1Tom (B6.Cg-Zc3h12d^tm1Tom)	increased interleukin-6 secretion	J:209383
	increased interleukin-10 secretion	J:209383
	increased susceptibility to experimental autoimmune encephalomyelitis	J:209383
	increased T cell proliferation	J:209383
Zcchc3^em1Hbsh/Zcchc3^em1Hbsh (involves: C57BL/6)	abnormal innate immunity	J:271802
	decreased circulating CXCL10 level	J:271802
	decreased circulating interferon-beta level	J:271802
	decreased circulating interleukin-6 level	J:271802
	increased susceptibility to Herpesvirales infection	J:271802
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:271802
	increased susceptibility to Poxviridae infection induced morbidity/mortality	J:271802
Zdhhc1^tm1Yyiw/Zdhhc1^tm1Yyiw (involves: 129S6/SvEvTac)	abnormal circulating cytokine level	J:284987
	decreased circulating interferon-alpha level	J:284987
	decreased circulating interferon-beta level	J:284987
	decreased circulating interleukin-6 level	J:284987
	decreased circulating tumor necrosis factor level	J:284987
	increased susceptibility to Herpesvirales infection	J:284987
	increased susceptibility to Herpesvirales infection induced morbidity/mortality	J:284987
Zdhhc2^em1Eko/Zdhhc2^em1Eko (C57BL/6-Zdhhc2^em1Eko)	abnormal cytokine level	J:303593
	abnormal interferon level	J:303593
	abnormal interleukin level	J:303593
	abnormal plasmacytoid dendritic cell physiology	J:303593
	abnormal T cell activation	J:303593
	abnormal tumor necrosis factor level	J:303593
	decreased susceptibility to chemically induced skin inflammation	J:303593
Zdhhc9^tm1Lex/Y (involves: 129S5/SvEvBrd * C57BL/6)	abnormal leukocyte physiology	J:231488
Zdhhc11^{tm1.1(KOMP)Vlcg}/Zdhhc11^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased circulating interleukin-6 level	J:310891
	decreased susceptibility to endotoxin shock	J:310891
	decreased susceptibility to viral infection	J:310891
Zeb1^m1Btlr/Zeb1^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	abnormal memory B cell physiology	J:185495
	decreased B cell proliferation	J:185495
	decreased IgG1 level	J:185495
	decreased IgG level	J:185495
	decreased IgM level	J:185495
Zeb1^m2Btlr/Zeb1^m2Btlr (C57BL/6J-Zeb1^m2Btlr)	impaired humoral immune response	J:221490
Zfat^tm2.1Sawa/Zfat^tm2.1Sawa Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)	abnormal CD4-positive, alpha-beta T cell physiology	J:187164
	decreased interleukin-2 secretion	J:187164
	decreased T cell proliferation	J:187164
	increased T cell apoptosis	J:187164
Zfp14^tm1Xch/Zfp14⁺ (involves: C57BL/6)	chronic pancreas inflammation	J:331393
Zfp14^tm1Xch/Zfp14⁺ (involves: C57BL/6)	increased inflammatory response	J:331393
Zfp14^tm1Xch/Zfp14^tm1Xch (involves: C57BL/6)	chronic pancreas inflammation	J:331393
Zfp14^tm1Xch/Zfp14^tm1Xch (involves: C57BL/6)	increased inflammatory response	J:331393
Zfp35^tm1Naka/Zfp35^tm1Naka (either: B6.Cg-Zfp35^tm1Naka or C.Cg-Zfp35^tm1Naka)	increased circulating interleukin-4 level	J:153828
	increased circulating interleukin-5 level	J:153828
	increased circulating interleukin-13 level	J:153828
Zfp36^tm1Pjb/Zfp36^tm1Pjb (Not Specified)	arthritis	J:33986
	conjunctivitis	J:33986
	dermatitis	J:33986
	heart inflammation	J:33986
	liver inflammation	J:33986
Zfp36^tm1Pjb/Zfp36^tm1Pjb (B6.Cg-Zfp36^tm1Pjb)	abnormal macrophage physiology	J:88443
	arthritis	J:88443
	blood vessel inflammation	J:214114
Zfp36^tm2.1Pjb/Zfp36^tm2.1Pjb (involves: C57BL/6)	decreased inflammatory response	J:229078
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:229078
	decreased susceptibility to induced arthritis	J:229078
Zfp36^tm4.1Pjb/Zfp36^tm4.1Pjb Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	alveolitis	J:188677
	arthritis	J:188677
	increased circulating tumor necrosis factor level	J:188677
	increased inflammatory response	J:188677
	increased susceptibility to endotoxin shock	J:188677
Zfp131^tm1.1Mytk/Zfp131^tm1.1Mytk Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal thymocyte activation	J:271921
	decreased T cell proliferation	J:271921
Zfp131^tm1.1Mytk/Zfp131^tm1.2Mytk Tg(Lck-cre)1Jtak/0 (involves: C57BL/6N * FVB/N)	decreased T cell proliferation	J:271921
Zfp148^tm1.1Jmer/Zfp148^tm1.1Jmer Tg(Vil1-cre)997Gum/0 (involves: C57BL/6 * C57BL/6J * SJL)	increased inflammatory response	J:198847
	increased susceptibility to bacterial infection	J:198847
	increased susceptibility to bacterial infection induced morbidity/mortality	J:198847
Zfp148^tm1Djl/Zfp148^tm1Djl (involves: 129)	increased susceptibility to induced colitis	J:107441
Zfp292^em1Zfa/Zfp292^em1Zfa (involves: C57BL/6)	increased susceptibility to bacterial infection	J:259392
Zfp292^em1Zfa/Zfp292^em1Zfa (involves: C57BL/6)	increased susceptibility to bacterial infection induced morbidity/mortality	J:259392
Zfp318^m1Anu/Zfp318⁺ (C57BL/6JAnu-Zfp318^m1Anu)	decreased IgD level	J:207375
Zfp318^m1Anu/Zfp318⁺ (C57BL/6JAnu-Zfp318^m1Anu)	increased IgM level	J:207375
Zfp318^m1Anu/Zfp318^m1Anu (C57BL/6JAnu-Zfp318^m1Anu)	abnormal follicular B cell physiology	J:207375
	abnormal marginal zone B cell physiology	J:207375
	decreased IgD level	J:207375, J:104190
	increased IgM level	J:207375, J:104190
Zfp318^M1Btlr/Zfp318⁺ (C57BL/6J-Zfp318^M1Btlr)	decreased IgD level	J:218965
Zfp318^M1Btlr/Zfp318^M1Btlr (C57BL/6J-Zfp318^M1Btlr)	decreased IgD level	J:218965
Zfp318^tm1.1Jhws/Zfp318^tm1.1Jhws Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zfp318^tm1.1Jhws Tg^Vav1-creA2Kio)	decreased IgD level	J:215815
	increased IgM level	J:215815
Zfp318^tm1Hhag/Zfp318^tm1Hhag (involves: 129 * C57BL/6)	decreased IgD level	J:207375
Zfp318^tm1Hhag/Zfp318^tm1Hhag (involves: 129 * C57BL/6)	increased IgM level	J:207375
Zfp467^{tm1.1(KOMP)Vlcg}/Zfp467^{tm1.1(KOMP)Vlcg} (B6(Cg)-Zfp467^{tm1.1(KOMP)Vlcg})	abnormal osteoclast physiology	J:302865
Zfp639^tm1.2Jaty/Zfp639^tm1.2Jaty (involves: 129 * BALB/cJ * C57BL/6 * SJL)	decreased susceptibility to Retroviridae infection	J:305874
Zfp683^{Gt(OST314703)Lex}/Zfp683^{Gt(OST314703)Lex} (B6.129S5-Zfp683^{Gt(OST314703)Lex})	abnormal susceptibility to infection	J:187727
	increased interferon-gamma secretion	J:187727
Zfp760^{tm1a(EUCOMM)Hmgu}/Zfp760⁺ (C57BL/6N-Zfp760^{tm1a(EUCOMM)Hmgu}/Ieg)	decreased IgE level	J:165965
Zfp871^{tm1a(EUCOMM)Wtsi}/Zfp871⁺ (C57BL/6N-Zfp871^{tm1a(EUCOMM)Wtsi}/BayMmucd)	liver inflammation	J:317166
Zfp950^{Gt(ROSA)76Sor}/Zfp950^{Gt(ROSA)76Sor} (involves: 129S4/SvJaeSor)	kidney inflammation	J:117491
Zfpm1^tm1.1Geab/Zfpm1^tm1.1Geab (Not Specified)	abnormal circulating chemokine level	J:162629
Zfyve1^em1Hbsh/Zfyve1^em1Hbsh (C57BL/6J-Zfyve1^em1Hbsh)	decreased susceptibility to viral infection	J:292942
Zfyve1^em1Hbsh/Zfyve1^em1Hbsh (C57BL/6J-Zfyve1^em1Hbsh)	decreased susceptibility to viral infection induced morbidity/mortality	J:292942
Zfyve16^{tm2a(KOMP)Wtsi}/Zfyve16^{tm2a(KOMP)Wtsi} (C57BL/6N-Zfyve16^{tm2a(KOMP)Wtsi})	decreased B cell proliferation	J:302014
Zg16^tm1Lex/Zg16^tm1Lex (B6.129S-Zg16^tm1Lex)	increased circulating interferon-gamma level	J:239095
	increased circulating interleukin-6 level	J:239095
	increased susceptibility to bacterial infection	J:239095
Zkscan3^tm1.2Itl/Zkscan3^tm1.2Itl (B6.Cg-Zkscan3^tm1.2Itl)	abnormal response to infection	J:318724
Zmynd10^{tm1(KOMP)Wtsi}/Zmynd10^{tm1(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	lung inflammation	J:261915
Zmynd11^{em1(IMPC)Wtsi}/Zmynd11^{em1(IMPC)Wtsi} (C57BL/6N-Zmynd11^{em1(IMPC)Wtsi}/WtsiIeg)	blood in lymph vessels	J:239583
Zranb1^em1Shios/Zranb1^em1Shios (involves: C57BL/6)	increased susceptibility to colitis induced morbidity/mortality	J:333468
Zranb1^{tm1c(EUCOMM)Hmgu}/Zranb1^{tm1c(EUCOMM)Hmgu} Tg(Itgax-cre)1-1Reiz/0 (involves: 129S4/SvJaeSor * C57BL/6N * CBA)	abnormal dendritic cell physiology	J:235701
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:235701
Zranb1^{tm1d(EUCOMM)Hmgu}/Zranb1^{tm1d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)	decreased circulating interferon-gamma level	J:235701
	decreased circulating interleukin-17 level	J:235701
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:235701
Zscan10^{Gt(285B6)1.1Cmhd}/Zscan10^{Gt(285B6)1.1Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal IgG level	J:221010
	increased IgG1 level	J:221010
	increased IgG2b level	J:221010

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/30/2024 MGI 6.23